PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Moreno, JD				Moreno, Jonathan D.			Long shadow of the stem-cell ruling	NATURE			English	Editorial Material									Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Moreno, JD (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.								0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1031	1032		10.1038/4671031a	http://dx.doi.org/10.1038/4671031a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	671XW	20981069				2022-12-28	WOS:000283548600013
J	Ripatti, S; Tikkanen, E; Orho-Melander, M; Havulinna, AS; Silander, K; Sharma, A; Guiducci, C; Perola, M; Jula, A; Sinisalo, J; Lokki, ML; Nieminen, MS; Melander, O; Salomaa, V; Peltonen, L; Kathiresan, S				Ripatti, Samuli; Tikkanen, Emmi; Orho-Melander, Marju; Havulinna, Aki S.; Silander, Kaisa; Sharma, Amitabh; Guiducci, Candace; Perola, Markus; Jula, Antti; Sinisalo, Juha; Lokki, Marja-Liisa; Nieminen, Markku S.; Melander, Olle; Salomaa, Veikko; Peltonen, Leena; Kathiresan, Sekar			A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses	LANCET			English	Article							HOSPITAL DISCHARGE REGISTER; CARDIOVASCULAR EVENTS; PREDICTIVE ABILITY; ROC CURVE; RECLASSIFICATION; STATISTICS; MARKER; AREA	Background Comparison of patients with coronary heart disease and controls in genome-wide association studies has revealed several single nucleotide polymorphisms (SNPs) associated with coronary heart disease. We aimed to establish the external validity of these findings and to obtain more precise risk estimates using a prospective cohort design. Methods We tested 13 recently discovered SNPs for association with coronary heart disease in a case-control design including participants differing from those in the discovery samples (3829 participants with prevalent coronary heart disease and 48 897 controls free of the disease) and a prospective cohort design including 30 725 participants free of cardiovascular disease from Finland and Sweden. We modelled the 13 SNPs as a multilocus genetic risk score and used Cox proportional hazards models to estimate the association of genetic risk score with incident coronary heart disease. For case-control analyses we analysed associations between individual SNPs and quintiles of genetic risk score using logistic regression. Findings In prospective cohort analyses, 1264 participants had a first coronary heart disease event during a median 10.7 years' follow-up (IQR 6.7-13.6). Genetic risk score was associated with a first coronary heart disease event. When compared with the bottom quintile of genetic risk score, participants in the top quintile were at 1.66-times increased risk of coronary heart disease in a model adjusting for traditional risk factors (95% CI 1.35-2.04, p value for linear trend=7.3x10(-10)). Adjustment for family history did not change these estimates. Genetic risk score did not improve C index over traditional risk factors and family history (p=0.19), nor did it have a significant effect on net reclassification improvement (2.2%, p=0.18); however, it did have a small effect on integrated discrimination index (0.004, p=0.0006). Results of the case-control analyses were similar to those of the prospective cohort analyses. Interpretation Using a genetic risk score based on 13 SNPs associated with coronary heart disease, we can identify the 20% of individuals of European ancestry who are at roughly 70% increased risk of a first coronary heart disease event. The potential clinical use of this panel of SNPs remains to be defined.	[Ripatti, Samuli; Tikkanen, Emmi; Silander, Kaisa; Peltonen, Leena] Univ Helsinki, FIMM, FIM-00014 Helsinki, Finland; [Ripatti, Samuli; Tikkanen, Emmi; Havulinna, Aki S.; Silander, Kaisa; Perola, Markus; Jula, Antti; Salomaa, Veikko; Peltonen, Leena] Natl Inst Hlth & Welf, Helsinki, Finland; [Orho-Melander, Marju; Sharma, Amitabh; Melander, Olle] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden; [Guiducci, Candace; Peltonen, Leena; Kathiresan, Sekar] Broad Inst, Cambridge, MA USA; [Sinisalo, Juha; Nieminen, Markku S.] Helsinki Univ Cent Hosp, Dept Med, Div Cardiol, Helsinki, Finland; [Lokki, Marja-Liisa] Univ Helsinki, Haartman Inst, Transplantat Lab, FIM-00014 Helsinki, Finland; [Peltonen, Leena] Wellcome Trust Sanger Inst, Hinxton, England; [Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	University of Helsinki; Finland National Institute for Health & Welfare; Lund University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Wellcome Trust Sanger Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Ripatti, S (corresponding author), Univ Helsinki, FIMM, POB 20, FIM-00014 Helsinki, Finland.	samuli.ripatti@fimm.fi	Ripatti, Samuli/H-9446-2014; Havulinna, Aki/AAM-4769-2021	Ripatti, Samuli/0000-0002-0504-1202; Sinisalo, Juha/0000-0002-0169-5137; Melander, Olle/0000-0002-2581-484X; Perola, Markus/0000-0003-4842-1667	Merck; Daiichi Sankyo; Alnylam; Pfizer; Wellcome Trust [WT089062/Z/097Z, WT089061/Z/09/Z]; US National Institutes of Health [R01 HL087676]; Donovan Family Foundation; Center of Excellence for Complex Disease Genetics of the Academy of Finland [213506, 129680]; Biocentrum Helsinki Foundation; Nordic Center of Excellence in Disease Genetics; Academy of Finland [129494]; Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation; Finnish Academy [129322]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087676] Funding Source: NIH RePORTER	Merck(Merck & Company); Daiichi Sankyo(Daiichi Sankyo Company Limited); Alnylam; Pfizer(Pfizer); Wellcome Trust(Wellcome TrustEuropean Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donovan Family Foundation; Center of Excellence for Complex Disease Genetics of the Academy of Finland(Academy of Finland); Biocentrum Helsinki Foundation; Nordic Center of Excellence in Disease Genetics; Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Academy(Academy of Finland); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SK has received consultancy fees from Merck and Daiichi Sankyo and grants from Alnylam and Pfizer. All other authors declare that they have no conflicts of interest.; We wish to dedicate this paper to the memory of Leena Peltonen, who passed away on March 11, 2010. This work was supported by the Wellcome Trust (WT089062/Z/097Z, WT089061/Z/09/Z), US National Institutes of Health (R01 HL087676), and the Donovan Family Foundation. We thank David Altshuler for guidance and helpful suggestions regarding study design and analyses. LP was supported by the Center of Excellence for Complex Disease Genetics of the Academy of Finland (grants 213506, 129680), the Biocentrum Helsinki Foundation, and The Nordic Center of Excellence in Disease Genetics. VS is supported by the Academy of Finland (grant number 129494), the Finnish Foundation for Cardiovascular Research, and the Sigrid Juselius Foundation. JS was funded by Finnish Foundation for Cardiovascular Research, Special governmental subsidy for health sciences research (EVO). MP was supported by Finnish Foundation for Cardiovascular Research and Finnish Academy Salve Program, grant number 129322	Antolini L, 2004, COMMUN STAT-THEOR M, V33, P2117, DOI 10.1081/STA-200026579; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Cook NR, 2008, STAT MED, V27, P191, DOI 10.1002/sim.2987; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Healy DG, 2006, LANCET NEUROL, V5, P701, DOI 10.1016/S1474-4422(06)70524-5; Hedges LV, 2014, STAT METHODS META AN; Heistaro S., 2008, METHODOLOGY REPORT H; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kattainen A, 2006, EUR HEART J, V27, P296, DOI 10.1093/eurheartj/ehi630; Langholz B, 1996, STAT SCI, V11, P35; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Musunuru K, 2010, ANNU REV GENOM HUM G, V11, P91, DOI 10.1146/annurev-genom-082509-141637; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; Paynter NP, 2010, JAMA-J AM MED ASSOC, V303, P631, DOI 10.1001/jama.2010.119; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Persson M, 2007, ARTERIOSCL THROM VAS, V27, P1411, DOI 10.1161/ATVBAHA.107.142679; SAMANI NJ, 2007, NEW ENGL J MED, V357, P1; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Steyerberg EW, 2010, ANN INTERN MED, V152, P195, DOI 10.7326/0003-4819-152-3-201002020-00019; Tolonen H, 2007, EUR J CARDIOV PREV R, V14, P380, DOI 10.1097/01.hjr.0000239466.26132.f2; VARTIAINEN E, 2009, INT J EPIDEMIOL, V12, P1; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249	29	398	418	0	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 23	2010	376	9750					1393	1400		10.1016/S0140-6736(10)61267-6	http://dx.doi.org/10.1016/S0140-6736(10)61267-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672ZO	20971364	Green Published			2022-12-28	WOS:000283627500034
J	Makrides, M; Gibson, RA; McPhee, AJ; Yelland, L; Quinlivan, J; Ryan, P				Makrides, Maria; Gibson, Robert A.; McPhee, Andrew J.; Yelland, Lisa; Quinlivan, Julie; Ryan, Philip		DOMInO Investigative Team	Effect of DHA Supplementation During Pregnancy on Maternal Depression and Neurodevelopment of Young Children A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOCOSAHEXAENOIC ACID; POSTNATAL DEPRESSION; PRETERM INFANTS; AGE; VALIDATION; OUTCOMES; SCALE; FOOD; TERM; FAT	Context Uncertainty about the benefits of dietary docosahexaenoic acid (DHA) for pregnant women and their children exists, despite international recommendations that pregnant women increase their DHA intakes. Objective To determine whether increasing DHA during the last half of pregnancy will result in fewer women with high levels of depressive symptoms and enhance the neurodevelopmental outcome of their children. Design, Setting, and Participants A double-blind, multicenter, randomized controlled trial (DHA to Optimize Mother Infant Outcome [DOMInO] trial) in 5 Australian maternity hospitals of 2399 women who were less than 21 weeks' gestation with singleton pregnancies and who were recruited between October 31, 2005, and January 11, 2008. Follow-up of children (n=726) was completed December 16, 2009. Intervention Docosahexaenoic acid-rich fish oil capsules (providing 800 mg/d of DHA) or matched vegetable oil capsules without DHA from study entry to birth. Main Outcome Measures High levels of depressive symptoms in mothers as indicated by a score of more than 12 on the Edinburgh Postnatal Depression Scale at 6 weeks or 6 months postpartum. Cognitive and language development in children as assessed by the Bayley Scales of Infant and Toddler Development, Third Edition, at 18 months. Results Of 2399 women enrolled, 96.7% completed the trial. The percentage of women with high levels of depressive symptoms during the first 6 months postpartum did not differ between the DHA and control groups (9.67% vs 11.19%; adjusted relative risk, 0.85; 95% confidence interval [CI], 0.70-1.02; P=.09). Mean cognitive composite scores (adjusted mean difference, 0.01; 95% CI, -1.36 to 1.37; P=.99) and mean language composite scores (adjusted mean difference, -1.42; 95% CI, -3.07 to 0.22; P=.09) of children in the DHA group did not differ from children in the control group. Conclusion The use of DHA-rich fish oil capsules compared with vegetable oil capsules during pregnancy did not result in lower levels of postpartum depression in mothers or improved cognitive and language development in their offspring during early childhood.	[Makrides, Maria; Gibson, Robert A.] Womens & Childrens Hosp, Child Nutr Res Ctr, Flinders Med Ctr, Adelaide, SA, Australia; [Makrides, Maria; Gibson, Robert A.] Childrens Hlth Res Inst, Adelaide, SA, Australia; [Makrides, Maria] Univ Adelaide, Sch Pediat & Reprod Hlth, Adelaide, SA, Australia; [Gibson, Robert A.] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia; [Yelland, Lisa; Ryan, Philip] Univ Adelaide, Sch Populat Hlth & Clin Practice, Adelaide, SA, Australia; [McPhee, Andrew J.] Womens & Childrens Hosp, Dept Neonatal Med, Adelaide, SA, Australia; [Quinlivan, Julie] Univ Notre Dame Australia, Sch Med, Melbourne, Vic, Australia; [Quinlivan, Julie] Sunshine Hosp, Melbourne, Vic, Australia	Flinders Medical Centre; Womens & Childrens Hospital Australia; University of Adelaide; University of Adelaide; University of Adelaide; Womens & Childrens Hospital Australia; University of Notre Dame Australia	Makrides, M (corresponding author), Womens & Childrens Hosp, Womens & Childrens Hlth Res Inst, Child Nutr Res Ctr, 72 King William Rd, Adelaide, SA 5006, Australia.	maria.makrides@health.sa.gov.au	Else, Paul/AAX-1636-2020; Yelland, Lisa N/GPP-4533-2022; Colditz, Paul B/F-6772-2010; Best, Karen P/E-3293-2016; Anderson, Peter J/B-6839-2015; Makrides, Maria/B-6392-2014; Gibson, Robert Alan/E-7546-2012; Meyer, Barbara/AAC-6078-2019; Anderson, Peter John/O-5302-2019; Pritchard, Margo A/G-5188-2010	Yelland, Lisa N/0000-0003-3803-8728; Colditz, Paul B/0000-0002-6408-8238; Best, Karen P/0000-0002-7653-5074; Anderson, Peter J/0000-0001-7430-868X; Makrides, Maria/0000-0003-3832-541X; Gibson, Robert Alan/0000-0002-8750-525X; Meyer, Barbara/0000-0001-7962-7890; Anderson, Peter John/0000-0001-7430-868X; Pritchard, Margo A/0000-0002-1058-9117; Quinlivan, Julie/0000-0003-4706-2412; Doyle, Lex/0000-0002-7667-7312; Else, Paul/0000-0001-9368-3231	Australian National Health and Medical Research Council [349301]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grant 349301 from the Australian National Health and Medical Research Council. Treatment and placebo capsules were donated by Efamol, England. Infrastructure support was also provided by the Women's and Children's Health Research Institute, The University of Adelaide, Women's and Children's Hospital Adelaide, Flinders Medical Centre Adelaide, Sunshine Hospital Melbourne, University of Notre Dame Australia, University of Wollongong, Campbelltown Hospital Sydney, Royal Brisbane and Women's Hospital, and University of Queensland.	AL MDM, 1995, BRIT J NUTR, V74, P55, DOI 10.1079/BJN19950106; Anderson PJ, 2008, SEMIN PERINATOL, V32, P51, DOI 10.1053/j.semperi.2007.12.009; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; BOYCE P, 1993, AUST NZ J PSYCHIAT, V27, P472, DOI 10.3109/00048679309075805; Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X; Brenna JT, 2009, ANN NUTR METAB, V55, P97, DOI 10.1159/000228998; Brown S, 1998, BRIT J OBSTET GYNAEC, V105, P156, DOI 10.1111/j.1471-0528.1998.tb10045.x; Carpenter D O, 2001, Int J Occup Med Environ Health, V14, P209; CHAN A, 2008, PREGNANCY OUTCOME S; Chan A, 2007, PREGNANCY OUTCOME S; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dunstan JA, 2008, ARCH DIS CHILD-FETAL, V93, pF45, DOI 10.1136/adc.2006.099085; Golding J, 2009, EPIDEMIOLOGY, V20, P598, DOI 10.1097/EDE.0b013e31819d6a57; Helland IB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e39; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; Hibbeln JR, 2009, PROSTAG LEUKOTR ESS, V81, P179, DOI 10.1016/j.plefa.2009.06.005; Innis SM, 2003, J PEDIATR-US, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2; Judge MP, 2007, LIPIDS, V42, P117, DOI 10.1007/s11745-006-3007-3; Koletzko B, 2007, BRIT J NUTR, V98, P873, DOI 10.1017/S0007114507764747; Makrides M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003402.pub2; Makrides M, 2009, JAMA-J AM MED ASSOC, V301, P175, DOI 10.1001/jama.2008.945; Malcolm CA, 2003, ARCH DIS CHILD-FETAL, V88, pF383, DOI 10.1136/fn.88.5.F383; Meyer BJ, 2003, LIPIDS, V38, P391, DOI 10.1007/s11745-003-1074-0; MURRAY L, 1990, BRIT J PSYCHIAT, V157, P288, DOI 10.1192/bjp.157.2.288; Oken E, 2008, AM J EPIDEMIOL, V167, P1171, DOI 10.1093/aje/kwn034; Olsen SF, 2000, BRIT J OBSTET GYNAEC, V107, P382, DOI 10.1111/j.1471-0528.2000.tb13235.x; Pascoe J M, 1988, Fam Med, V20, P271; Ramakrishnan U, 2009, AM J CLIN NUTR, V89, p958S, DOI 10.3945/ajcn.2008.26692F; Smithers LG, 2008, PROSTAG LEUKOTR ESS, V79, P141, DOI 10.1016/j.plefa.2008.09.015; WALTER T, 1989, PEDIATRICS, V84, P7	30	381	393	6	90	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2010	304	15					1675	1683		10.1001/jama.2010.1507	http://dx.doi.org/10.1001/jama.2010.1507			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666PZ	20959577	Bronze			2022-12-28	WOS:000283129700021
J	Kirby, T				Kirby, Tony			Robert Edwards: Nobel Prize for father of in-vitro fertilisation Profile	LANCET			English	Biographical-Item																			0	14	14	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 16	2010	376	9749					1293	1293		10.1016/S0140-6736(10)61903-4	http://dx.doi.org/10.1016/S0140-6736(10)61903-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671RX	20951879				2022-12-28	WOS:000283528600014
J	Grayson, M				Grayson, Michelle			Curiosity aroused INTRODUCTION	NATURE			English	Editorial Material																			0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					S2	S3		10.1038/467S2a	http://dx.doi.org/10.1038/467S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944617	Bronze			2022-12-28	WOS:000282898700002
J	Greenberg, DS				Greenberg, Daniel S.			A two-year plan for US science	NATURE			English	Editorial Material												danielg523@aol.com							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					781	782		10.1038/467781a	http://dx.doi.org/10.1038/467781a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944714				2022-12-28	WOS:000282898700034
J	Lachmann, P				Lachmann, Peter			Personal View An open letter to the health secretary: how to really save money on the NHS	BRITISH MEDICAL JOURNAL			English	Editorial Material							DEATH; RISK		Univ Cambridge, Cambridge CB2 1TN, England	University of Cambridge	Lachmann, P (corresponding author), Univ Cambridge, Cambridge CB2 1TN, England.	pjl1000@cam.ac.uk	Lachmann, P J/I-7968-2019	Lachmann, P J/0000-0003-2849-3524				*ASTRAZENECA, ASTRAZENECA ANN AGR; Black D, 2002, CLIN MED, V2, P263, DOI 10.7861/clinmedicine.2-3-263; Cooksey D., 2006, REV UK HLTH RES FUND; Graham DJ, 2010, JAMA-J AM MED ASSOC, V304, P411, DOI 10.1001/jama.2010.920; Lynn J, 2003, LIVING WELL END LIFE; Pasupathy D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3498	6	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 14	2010	341								c5618	10.1136/bmj.c5618	http://dx.doi.org/10.1136/bmj.c5618			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	668FF	20947579				2022-12-28	WOS:000283253300001
J	Smoot, GF				Smoot, George F.			Thinking in aeons	NATURE			English	Editorial Material									Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Smoot, GF (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.								0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					S12	S12		10.1038/467S12a	http://dx.doi.org/10.1038/467S12a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944612	Bronze			2022-12-28	WOS:000282898700011
J	Wiegand, KC; Shah, SP; Al-Agha, OM; Zhao, YJ; Tse, K; Zeng, T; Senz, J; McConechy, MK; Anglesio, MS; Kalloger, SE; Yang, W; Heravi-Moussavi, A; Giuliany, R; Chow, C; Fee, J; Zayed, A; Prentice, L; Melnyk, N; Turashvili, G; Delaney, AD; Madore, J; Yip, S; McPherson, AW; Ha, G; Bell, L; Fereday, S; Tam, A; Galletta, L; Tonin, PN; Provencher, D; Miller, D; Jones, SJM; Moore, RA; Morin, GB; Oloumi, A; Boyd, N; Aparicio, SA; Shih, IM; Mes-Masson, AM; Bowtell, DD; Hirst, M; Gilks, B; Marra, MA; Huntsman, DG				Wiegand, Kimberly C.; Shah, Sohrab P.; Al-Agha, Osama M.; Zhao, Yongjun; Tse, Kane; Zeng, Thomas; Senz, Janine; McConechy, Melissa K.; Anglesio, Michael S.; Kalloger, Steve E.; Yang, Winnie; Heravi-Moussavi, Alireza; Giuliany, Ryan; Chow, Christine; Fee, John; Zayed, Abdalnasser; Prentice, Leah; Melnyk, Nataliya; Turashvili, Gulisa; Delaney, Allen D.; Madore, Jason; Yip, Stephen; McPherson, Andrew W.; Ha, Gavin; Bell, Lynda; Fereday, Sian; Tam, Angela; Galletta, Laura; Tonin, Patricia N.; Provencher, Diane; Miller, Dianne; Jones, Steven J. M.; Moore, Richard A.; Morin, Gregg B.; Oloumi, Arusha; Boyd, Niki; Aparicio, Samuel A.; Shih, Ie-Ming; Mes-Masson, Anne-Marie; Bowtell, David D.; Hirst, Martin; Gilks, Blake; Marra, Marco A.; Huntsman, David G.			ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLEAR-CELL CARCINOMA; DISTINCT-HISTOLOGIC-TYPE; GRADE SEROUS CARCINOMA; POOR-PROGNOSIS; MECHANISMS; EXPRESSION; RESISTANCE; CANCER; COMPONENT; STAGE	BACKGROUND Ovarian clear-cell and endometrioid carcinomas may arise from endometriosis, but the molecular events involved in this transformation have not been described. METHODS We sequenced the whole transcriptomes of 18 ovarian clear-cell carcinomas and 1 ovarian clear-cell carcinoma cell line and found somatic mutations in ARID1A (the AT-rich interactive domain 1A [SWI-like] gene) in 6 of the samples. ARID1A encodes BAF250a, a key component of the SWI-SNF chromatin remodeling complex. We sequenced ARID1A in an additional 210 ovarian carcinomas and a second ovarian clear-cell carcinoma cell line and measured BAF250a expression by means of immunohistochemical analysis in an additional 455 ovarian carcinomas. RESULTS ARID1A mutations were seen in 55 of 119 ovarian clear-cell carcinomas (46%), 10 of 33 endometrioid carcinomas (30%), and none of the 76 high-grade serous ovarian carcinomas. Seventeen carcinomas had two somatic mutations each. Loss of the BAF250a protein correlated strongly with the ovarian clear-cell carcinoma and endometrioid carcinoma subtypes and the presence of ARID1A mutations. In two patients, ARID1A mutations and loss of BAF250a expression were evident in the tumor and contiguous atypical endometriosis but not in distant endometriotic lesions. CONCLUSIONS These data implicate ARID1A as a tumor-suppressor gene frequently disrupted in ovarian clear-cell and endometrioid carcinomas. Since ARID1A mutation and loss of BAF250a can be seen in the preneoplastic lesions, we speculate that this is an early event in the transformation of endometriosis into cancer.	[Huntsman, David G.] BC Canc Agcy, Ctr Translat & Appl Genom, Vancouver, BC, Canada; [Zhao, Yongjun; Tse, Kane; Zeng, Thomas; Delaney, Allen D.; Tam, Angela; Jones, Steven J. M.; Moore, Richard A.; Morin, Gregg B.; Hirst, Martin; Marra, Marco A.] Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Fee, John; Turashvili, Gulisa; Oloumi, Arusha; Aparicio, Samuel A.] BC Canc Res Ctr, Vancouver, BC, Canada; [Chow, Christine; Gilks, Blake; Huntsman, David G.] Genet Pathol Evaluat Ctr, Vancouver, BC, Canada; [Wiegand, Kimberly C.; Miller, Dianne; Morin, Gregg B.; Aparicio, Samuel A.; Gilks, Blake; Marra, Marco A.; Huntsman, David G.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Morin, Gregg B.; Marra, Marco A.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Madore, Jason; Provencher, Diane; Mes-Masson, Anne-Marie] CHU Montreal, Hop Notre Dame, Inst Canc Montreal, Ctr Rech, Montreal, PQ, Canada; [Tonin, Patricia N.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Provencher, Diane; Mes-Masson, Anne-Marie] Univ Montreal, Montreal, PQ, Canada; [Fereday, Sian; Galletta, Laura; Bowtell, David D.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Bowtell, David D.] Univ Melbourne, Melbourne, Vic, Australia; [Shih, Ie-Ming] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia; Simon Fraser University; Universite de Montreal; McGill University; Universite de Montreal; Peter Maccallum Cancer Center; University of Melbourne; Johns Hopkins University	Huntsman, DG (corresponding author), BC Canc Agcy, Ctr Translat & Appl Genom, Rm 3427,600 W 10th Ave, Vancouver, BC, Canada.	dhuntsma@bccancer.bc.ca	Hirst, Martin/B-7684-2016; Marra, Marco A/B-5987-2008; sdsd, shihieih/ABE-6190-2020; Morin, Gregg B/E-9123-2012; Huntsman, David/ABE-6082-2020; Jones, Steven J/C-3621-2009; Ha, Gavin/N-1984-2019; Bowtell, David/H-1007-2016; Yip, Stephen/E-9994-2012	Marra, Marco A/0000-0001-7146-7175; Morin, Gregg B/0000-0001-8949-4374; Jones, Steven J/0000-0003-3394-2208; Ha, Gavin/0000-0001-7578-7272; Bowtell, David/0000-0001-9089-7525; Yip, Stephen/0000-0002-8514-9861; Mes-Masson, Anne-Marie/0000-0002-6498-266X; Aparicio, Samuel/0000-0002-0487-9599; Fereday, Sian/0000-0002-8559-8579; Anglesio, Michael/0000-0003-1639-5003; Madore, Jason/0000-0002-3499-474X; Turashvili, Gulisa/0000-0001-6125-5865	British Columbia (BC) Cancer Foundation; Vancouver General Hospital (VGH)-University of British Columbia Hospital Foundation; Canadian Institutes of Health Research (CIHR); Genome Canada; OvCaRe; Michael Smith Foundation for Health Research (MSFHR); CIHR [STP-53912]; Canadian Breast Cancer Foundation; Canada Research Chair in Molecular Oncology; Sanofi-Aventis, Canada; Ovarian Cancer Canada; U.S. Army Medical Research and Materiel Command [DAMD17-O1-1-0729]; Cancer Council Tasmania; Cancer Foundation of Western Australia; National Health and Medical Research Council of Australia; National Cancer Institute, National Institutes of Health [RO1CA103937, RO1CA129080]; NATIONAL CANCER INSTITUTE [R01CA129080, R01CA103937] Funding Source: NIH RePORTER	British Columbia (BC) Cancer Foundation; Vancouver General Hospital (VGH)-University of British Columbia Hospital Foundation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); OvCaRe; Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canada Research Chair in Molecular Oncology(Canada Research Chairs); Sanofi-Aventis, Canada(Sanofi-Aventis); Ovarian Cancer Canada; U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cancer Council Tasmania(Cancer Council Tasmania); Cancer Foundation of Western Australia(Cancer Council Western Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the British Columbia (BC) Cancer Foundation and the Vancouver General Hospital (VGH)-University of British Columbia Hospital Foundation (to the OvCaRe ovarian cancer research team in Vancouver) and the Canadian Institutes of Health Research (CIHR). The Michael Smith Genome Sciences Centre (MSGSC), with which many of the authors are affiliated, is funded by Genome Canada, and OvCaRe and the MSGSC are also funded by the Michael Smith Foundation for Health Research (MSFHR). Salary support is provided by MSFHR to Drs. Shah, Marra, Jones, and Huntsman; by the CIHR Training Program for Clinician Scientists in Molecular Oncologic Pathology to Drs. Al-Agha and Turashvili (STP-53912); by the CIHR Bioinformatics Training Program for Health Research to Mr. McPherson and Mr. Ha; by the Canadian Breast Cancer Foundation to Dr. Shah; and a Canada Research Chair in Molecular Oncology to Dr. Aparicio. The Genetic Pathology Evaluation Centre, which constructed the tissue microarrays, has received nondirected research grants from Sanofi-Aventis, Canada. The contributing tumor banks were supported by OvCaRe and Ovarian Cancer Canada (VGH, Banque de Tissus et de Donnees of the Reseau de Recherche sur le Cancer of the Fonds de la Recherche en Sante du Quebec, affiliated with the Canadian Tumor Repository Network), and by a grant (DAMD17-O1-1-0729) from the U.S. Army Medical Research and Materiel Command; grants from the Cancer Council Tasmania, the Cancer Foundation of Western Australia, and the National Health and Medical Research Council of Australia to AOCS; and grants from the National Cancer Institute, National Institutes of Health (RO1CA103937 and RO1CA129080).	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Crotzer DR, 2007, GYNECOL ONCOL, V105, P404, DOI 10.1016/j.ygyno.2006.12.024; Dagan T, 2002, MOL BIOL EVOL, V19, P1022, DOI 10.1093/oxfordjournals.molbev.a004161; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; Dent J, 2003, BRIT J CANCER, V88, P1578, DOI 10.1038/sj.bjc.6600896; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; GILKS CB, 2009, J ONCOL         1230; Goff BA, 1996, GYNECOL ONCOL, V60, P412, DOI 10.1006/gyno.1996.0065; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Huang JM, 2007, GENE CHROMOSOME CANC, V46, P745, DOI 10.1002/gcc.20459; Itamochi H, 2008, CANCER SCI, V99, P653, DOI 10.1111/j.1349-7006.2008.00747.x; JEMAL A, 2010, CA CANC J CLIN  0707; Kobel M, 2010, INT J GYNECOL PATHOL, V29, P203, DOI 10.1097/PGP.0b013e3181c042b6; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kobel M, 2009, AM J SURG PATHOL, V33, P14, DOI 10.1097/PAS.0b013e3181788546; Kozmik Z, 2001, GENOMICS, V73, P140, DOI 10.1006/geno.2001.6477; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; LAU DHM, 1991, CANCER RES, V51, P5181; Mitelman F, 1997, CANCER GENET CYTOGEN, V95, P1, DOI 10.1016/S0165-4608(96)00252-X; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Ness RB, 2003, AM J OBSTET GYNECOL, V189, P280, DOI 10.1067/mob.2003.408; Press JZ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-17; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Sato N, 2000, CANCER RES, V60, P7052; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Suehiro Y, 2000, ONCOLOGY-BASEL, V59, P50, DOI 10.1159/000012137; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Tavassoli F.A., 2003, PATHOLOGY GENETICS T, V4; Vigano P, 2006, HUM REPROD UPDATE, V12, P77, DOI 10.1093/humupd/dmi037; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wang XM, 2004, INT J CANCER, V112, P636, DOI 10.1002/ijc.20450	35	1114	1168	5	137	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2010	363	16					1532	1543		10.1056/NEJMoa1008433	http://dx.doi.org/10.1056/NEJMoa1008433			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663KP	20942669	Bronze, Green Accepted			2022-12-28	WOS:000282887100007
J	Field, GD; Gauthier, JL; Sher, A; Greschner, M; Machado, TA; Jepson, LH; Shlens, J; Gunning, DE; Mathieson, K; Dabrowski, W; Paninski, L; Litke, AM; Chichilnisky, EJ				Field, Greg D.; Gauthier, Jeffrey L.; Sher, Alexander; Greschner, Martin; Machado, Timothy A.; Jepson, Lauren H.; Shlens, Jonathon; Gunning, Deborah E.; Mathieson, Keith; Dabrowski, Wladyslaw; Paninski, Liam; Litke, Alan M.; Chichilnisky, E. J.			Functional connectivity in the retina at the resolution of photoreceptors	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; CELL RECEPTIVE-FIELDS; MACAQUE MONKEY RETINA; MIDGET GANGLION-CELLS; PRIMATE RETINA; COLOR-VISION; CONE INPUTS; BIPOLAR CELLS; S-CONE; PHYSIOLOGICAL-BASIS	To understand a neural circuit requires knowledge of its connectivity. Here we report measurements of functional connectivity between the input and ouput layers of the macaque retina at single-cell resolution and the implications of these for colour vision. Multi-electrode technology was used to record simultaneously from complete populations of the retinal ganglion cell types (midget, parasol and small bistratified) that transmit high-resolution visual signals to the brain. Fine-grained visual stimulation was used to identify the location, type and strength of the functional input of each cone photoreceptor to each ganglion cell. The populations of ON and OFF midget and parasol cells each sampled the complete population of long- and middle-wavelength-sensitive cones. However, only OFF midget cells frequently received strong input from short-wavelength-sensitive cones. ON and OFF midget cells showed a small non-randomtendency to selectively sample from either long- or middle-wavelength-sensitive cones to a degree not explained by clumping in the cone mosaic. These measurements reveal computations in a neural circuit at the elementary resolution of individual neurons.	[Field, Greg D.; Gauthier, Jeffrey L.; Greschner, Martin; Machado, Timothy A.; Jepson, Lauren H.; Shlens, Jonathon; Chichilnisky, E. J.] Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA; [Sher, Alexander; Litke, Alan M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Gunning, Deborah E.; Mathieson, Keith] Univ Glasgow, Dept Phys & Astron, Glasgow G12 8QQ, Lanark, Scotland; [Dabrowski, Wladyslaw] AGH Univ Sci & Technol, Fac Phys & Appl Comp Sci, PL-2330059 Krakow, Poland; [Paninski, Liam] Columbia Univ, Dept Stat, New York, NY 10027 USA; [Paninski, Liam] Columbia Univ, Ctr Theoret Neurosci, New York, NY 10027 USA	Salk Institute; University of California System; University of California Santa Cruz; University of Glasgow; AGH University of Science & Technology; Columbia University; Columbia University	Chichilnisky, EJ (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ej@salk.edu	Gunning, Deborah/P-5825-2015; Dabrowski, Wladyslaw/AAS-6369-2020; Mathieson, Keith/G-6308-2011; Field, Greg/AAI-1428-2021	Dabrowski, Wladyslaw/0000-0001-9061-9568; Mathieson, Keith/0000-0002-9517-8076; Field, Greg/0000-0001-5942-2679; Chichilnisky, E.J./0000-0002-5613-0248; Gauthier, Jeffrey/0000-0002-0509-8532; Machado, Tim/0000-0003-3762-1460; Sher, Alexander/0000-0001-6655-6456	Helen Hay Whitney Foundation; German Research Foundation; National Institutes of Health (NIH) National Research Service [NS054519-01]; Chapman Foundation; Miller Institute for Basic Research in Science; Polish Ministry of Science and Higher Education; Burroughs Wellcome Fund Career Award at Scientific Interface; Engineering and Physical Sciences Research Council; Royal Society of Edinburgh; McKnight Foundation; NSF [PHY-0750525]; Sloan Research Fellowship; NIH [EY13150]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054519] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/G042446/1, EP/E039731/1] Funding Source: researchfish; EPSRC [EP/G042446/1, EP/E039731/1] Funding Source: UKRI	Helen Hay Whitney Foundation; German Research Foundation(German Research Foundation (DFG)); National Institutes of Health (NIH) National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chapman Foundation; Miller Institute for Basic Research in Science; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Burroughs Wellcome Fund Career Award at Scientific Interface(Burroughs Wellcome Fund); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society of Edinburgh; McKnight Foundation; NSF(National Science Foundation (NSF)); Sloan Research Fellowship(Alfred P. Sloan Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Helen Hay Whitney Foundation (G.D.F.), German Research Foundation (M.G.), National Institutes of Health (NIH) National Research Service Award (NS054519-01) and Chapman Foundation (J.L.G.), Miller Institute for Basic Research in Science (J.S.), Polish Ministry of Science and Higher Education (W.D.), Burroughs Wellcome Fund Career Award at Scientific Interface (A.S.), Engineering and Physical Sciences Research Council (D.E.G.), Royal Society of Edinburgh (K.M.), McKnight Foundation (A.M.L. and E.J.C.), NSF Grant PHY-0750525 (A.M.L.), a Sloan Research Fellowship and NIH Grant EY13150 (E.J.C). We thank C. K. Hulse for technical assistance; M. I. Grivich, D. Petrusca, A. Grillo, P. Grybos, P. Hottowy and S. Kachiguine for technical development; H. Fox, M. Taffe, E. Callaway and K. Osborn for providing access to retinas; S. Barry for machining; F. Rieke and T. Sejnowski for providing comments on the manuscript. We thank the San Diego Supercomputer Center and the National Science Foundation (Cooperative Agreements 05253071 and 0438741) for large-scale data storage.	[Anonymous], 1991, COMPUTATIONAL MODELS, DOI [10.7551/mitpress/2002.003.0010, DOI 10.7551/MITPRESS/2002.003.0010]; BAYLOR DA, 1987, J PHYSIOL-LONDON, V390, P145, DOI 10.1113/jphysiol.1987.sp016691; Buzas P, 2006, J NEUROSCI, V26, P11148, DOI 10.1523/JNEUROSCI.3237-06.2006; Calkins DJ, 1999, NEURON, V24, P313, DOI 10.1016/S0896-6273(00)80846-6; CALKINS DJ, 1994, NATURE, V371, P70, DOI 10.1038/371070a0; Chatterjee S, 2002, NEURON, V35, P1135, DOI 10.1016/S0896-6273(02)00874-7; Chichilnisky EJ, 1999, NAT NEUROSCI, V2, P889, DOI 10.1038/13189; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; Dacey D, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P281; Dacey DM, 2000, ANNU REV NEUROSCI, V23, P743, DOI 10.1146/annurev.neuro.23.1.743; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P197, DOI 10.1113/jphysiol.1975.sp011087; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; DEVALOIS RL, 1966, J OPT SOC AM, V56, P966, DOI 10.1364/JOSA.56.000966; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; Diggle PJ, 1983, STAT ANAL SPATIAL PO; Diller L, 2004, J NEUROSCI, V24, P1079, DOI 10.1523/JNEUROSCI.3828-03.2004; Field GD, 2007, J NEUROSCI, V27, P13261, DOI 10.1523/JNEUROSCI.3437-07.2007; Frechette ES, 2005, J NEUROPHYSIOL, V94, P119, DOI 10.1152/jn.01175.2004; Gegenfurtner KR, 2003, NAT REV NEUROSCI, V4, P563, DOI 10.1038/nrn1138; Ghosh KK, 1996, J COMP NEUROL, V366, P76, DOI 10.1002/(SICI)1096-9861(19960226)366:1<76::AID-CNE6>3.0.CO;2-H; Hofer H, 2005, J NEUROSCI, V25, P9669, DOI 10.1523/JNEUROSCI.2414-05.2005; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; JACOBS GH, 1965, NATURE, V206, P487, DOI 10.1038/206487a0; Jusuf PR, 2006, J NEUROSCI, V26, P3908, DOI 10.1523/JNEUROSCI.4891-05.2006; KAISER PK, 1990, J PHYSIOL-LONDON, V422, P153, DOI 10.1113/jphysiol.1990.sp017978; Klug K, 2003, J NEUROSCI, V23, P9881; KOUYAMA N, 1992, J NEUROSCI, V12, P1233; LEE BB, 1994, VISION RES, V34, P3081, DOI 10.1016/0042-6989(94)90074-4; Lee BB, 1996, VISION RES, V36, P631, DOI 10.1016/0042-6989(95)00167-0; LEE BB, 1988, J PHYSIOL-LONDON, V404, P323, DOI 10.1113/jphysiol.1988.sp017292; Lee SCS, 2007, J COMP NEUROL, V502, P126, DOI 10.1002/cne.21284; Litke AM, 2004, IEEE T NUCL SCI, V51, P1434, DOI 10.1109/TNS.2004.832706; Martin PR, 2001, NATURE, V410, P933, DOI 10.1038/35073587; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; Neitz J, 2002, NEURON, V35, P783, DOI 10.1016/S0896-6273(02)00818-8; Packer OS, 1996, J NEUROSCI, V16, P2251; REID RC, 1992, NATURE, V356, P716, DOI 10.1038/356716a0; Reid RC, 2002, J NEUROSCI, V22, P6158; Rodieck R.W., 1998, 1 STEPS SEEING; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; Sincich LC, 2009, NAT NEUROSCI, V12, P967, DOI 10.1038/nn.2352; Solomon SG, 2007, NAT REV NEUROSCI, V8, P276, DOI 10.1038/nrn2094; Solomon SG, 2005, J NEUROSCI, V25, P4527, DOI 10.1523/JNEUROSCI.3921-04.2005; Sun H, 2006, J NEUROPHYSIOL, V95, P837, DOI 10.1152/jn.00714.2005; Tailby C, 2008, J PHYSIOL-LONDON, V586, P5947, DOI 10.1113/jphysiol.2008.161893; Wachtler T, 2007, J VISION, V7, DOI 10.1167/7.8.6; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; WASSLE H, 1994, VISION RES, V34, P561, DOI 10.1016/0042-6989(94)90013-2; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115	51	200	206	6	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					673	U54		10.1038/nature09424	http://dx.doi.org/10.1038/nature09424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20930838	Green Accepted			2022-12-28	WOS:000282572500030
J	Bragg, F; Cromwell, DA; Edozien, LC; Gurol-Urganci, I; Mahmood, TA; Templeton, A; van der Meulen, JH				Bragg, Fiona; Cromwell, David A.; Edozien, Leroy C.; Gurol-Urganci, Ipek; Mahmood, Tahir A.; Templeton, Allan; van der Meulen, Jan H.			Variation in rates of caesarean section among English NHS trusts after accounting for maternal and clinical risk: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DELIVERY RATES; LABOR; OUTCOMES; BIRTH; WOMEN; CHILDBIRTH; MORTALITY; QUALITY; HEALTH	Objective To determine whether the variation in unadjusted rates of caesarean section derived from routine data in NHS trusts in England can be explained by maternal characteristics and clinical risk factors. Design A cross sectional analysis using routinely collected hospital episode statistics was performed. A multiple logistic regression model was used to estimate the likelihood of women having a caesarean section given their maternal characteristics (age, ethnicity, parity, and socioeconomic deprivation) and clinical risk factors (previous caesarean section, breech presentation, and fetal distress). Adjusted rates of caesarean section for each NHS trust were produced from this model. Setting 146 English NHS trusts. Population Women aged between 15 and 44 years with a singleton birth between 1 January and 31 December 2008. Main outcome measure Rate of caesarean sections per 100 births (live or stillborn). Results Among 620 604 singleton births, 147 726 (23.8%) were delivered by caesarean section. Women were more likely to have a caesarean section if they had had one previously (70.8%) or had a baby with breech presentation (89.8%). Unadjusted rates of caesarean section among the NHS trusts ranged from 13.6% to 31.9%. Trusts differed in their patient populations, but adjusted rates still ranged from 14.9% to 32.1%. Rates of emergency caesarean section varied between trusts more than rates of elective caesarean section. Conclusion Characteristics of women delivering at NHS trusts differ, and comparing unadjusted rates of caesarean section should be avoided. Adjusted rates of caesarean section still vary considerably and attempts to reduce this variation should examine issues linked to emergency caesarean section.	[Cromwell, David A.] Univ London London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Cromwell, DA (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, Keppel St, London WC1E 7HT, England.	david.cromwell@lshtm.ac.uk	Cromwell, David/AAD-6519-2019	Gurol-Urganci, Ipek/0000-0002-6517-3485; Bragg, Fiona/0000-0002-9181-6886; van der Meulen, Jan/0000-0002-9451-2335; Edozien, Leroy/0000-0002-1815-7300	Department of Health; NHS	Department of Health; NHS	JHvdM received a national public health career scientist award from the Department of Health and NHS research and development programme.	Alfirevic Z, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066; Althabe F, 2006, BIRTH-ISS PERINAT C, V33, P270, DOI 10.1111/j.1523-536X.2006.00118.x; [Anonymous], 1985, LANCET, V2, P436; Aron DC, 1998, JAMA-J AM MED ASSOC, V279, P1968, DOI 10.1001/jama.279.24.1968; Belizan JM, 1999, BMJ-BRIT MED J, V319, P1397, DOI 10.1136/bmj.319.7222.1397; BOSELEY S, 2009, GUARDIAN        1027; Brown HC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004907.pub2; Chen JS, 2010, J CLIN EPIDEMIOL, V63, P672, DOI 10.1016/j.jclinepi.2009.08.019; CHURCHILL H, 2006, CAESAREAN BIRTH BRIT; Deneux-Tharaux C, 2006, OBSTET GYNECOL, V108, P541, DOI 10.1097/01.AOG.0000233154.62729.24; DiMatteo MR, 1996, HEALTH PSYCHOL, V15, P303, DOI 10.1037/0278-6133.15.4.303; Dixon J, 1998, J PUBLIC HEALTH MED, V20, P63, DOI 10.1093/oxfordjournals.pubmed.a024721; Fantini MP, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-100; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; Healthcare Commission, 2008, BETT BIRTHS REV MAT; Henderson T, 2006, MED CARE, V44, P1011, DOI 10.1097/01.mlr.0000228018.48783.34; HENRY OA, 1995, AM J PUBLIC HEALTH, V85, P1143, DOI 10.2105/AJPH.85.8_Pt_1.1143; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; *INF CTR, 2009, NHS MAT STAT ENGL 20; Landon MB, 2004, NEW ENGL J MED, V351, P2581, DOI 10.1056/NEJMoa040405; Librero J, 2000, J EPIDEMIOL COMMUN H, V54, P631, DOI 10.1136/jech.54.8.631; Lydon-Rochelle M, 2001, NEW ENGL J MED, V345, P3, DOI 10.1056/NEJM200107053450101; Middle C, 1995, BRIT J OBSTET GYNAEC, V102, P970, DOI 10.1111/j.1471-0528.1995.tb10904.x; *NAT COLL CTR WOM, 2004, CAES SECT; National Collaborating Centre for Women's and Children's Health, 2007, CAR HLTH WOM THEIR B; *OFF NAT STAT, 2008, BIRTH STAT BIRTHS PA; Office of the Deputy Prime Minister, 2004, ENGL IND DEPR 2004 S; Paranjothy S, 2005, BJOG-INT J OBSTET GY, V112, P658, DOI 10.1111/j.1471-0528.2005.00501.x; Porreco RP, 1996, AM J OBSTET GYNECOL, V175, P369, DOI 10.1016/S0002-9378(96)70148-5; Rabilloud M, 1998, EUR J OBSTET GYN R B, V78, P11, DOI 10.1016/S0301-2115(97)00277-7; Roberts CL, 2009, PAEDIATR PERINAT EP, V23, P144, DOI 10.1111/j.1365-3016.2008.00980.x; Robson MS, 1996, AM J OBSTET GYNECOL, V174, P199, DOI 10.1016/S0002-9378(96)70394-0; Shorten A, 2007, BRIT MED J, V335, P1003, DOI 10.1136/bmj.39372.587650.80; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; Thomas J., 2001, NATL SENTINEL CAESAR; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Yang Q, 2007, BJOG-INT J OBSTET GY, V114, P609, DOI 10.1111/j.1471-0528.2007.01295.x; Yasmeen S, 2006, AM J OBSTET GYNECOL, V194, P992, DOI 10.1016/j.ajog.2005.08.058; 2009, BBC NEWS        1027	39	164	172	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2010	341								c5065	10.1136/bmj.c5065	http://dx.doi.org/10.1136/bmj.c5065			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663JE	20926490	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000282879400017
J	Koplan, JP; Brownell, KD				Koplan, Jeffrey P.; Brownell, Kelly D.			Response of the Food and Beverage Industry to the Obesity Threat	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Koplan, Jeffrey P.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA; [Brownell, Kelly D.] Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT USA	Emory University; Yale University	Koplan, JP (corresponding author), Emory Univ, Emory Global Hlth Inst, 1599 Clifton Rd NE,Ste 6-101, Atlanta, GA 30322 USA.	jkoplan@emory.edu						[Anonymous], PREV CHILDH OB HLTH; Brandt AM., 2007, CIGARETTE CENTURY RI; Brownell KD, 2009, MILBANK Q, V87, P259, DOI 10.1111/j.1468-0009.2009.00555.x; Cashore Benjamin, 2004, GOVERNING MARKETS FO; *COC COL CO, COC COL CO 2009 4 QU; *I MED, 2009, LOC GOV ACT PREV CHI; Institute of Medicine, 2006, FOOD MARK CHILDR YOU; Sharma LL, 2010, AM J PUBLIC HEALTH, V100, P240, DOI 10.2105/AJPH.2009.160960; World Health Organization, 2006, MARK FOOD NON BEV CH	9	54	54	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2010	304	13					1487	1488		10.1001/jama.2010.1436	http://dx.doi.org/10.1001/jama.2010.1436			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	658SO	20924016				2022-12-28	WOS:000282509900026
J	Sambur, JB; Novet, T; Parkinson, BA				Sambur, Justin B.; Novet, Thomas; Parkinson, B. A.			Multiple Exciton Collection in a Sensitized Photovoltaic System	SCIENCE			English	Article							QUANTUM-DOT SENSITIZATION; JUNCTION SOLAR-CELLS; CARRIER MULTIPLICATION; SEMICONDUCTOR NANOCRYSTALS; MULTIEXCITON GENERATION; ELECTRON-TRANSFER; COLLOIDAL PBSE; SINGLE-PHOTON; EFFICIENCY; FILMS	Multiple exciton generation, the creation of two electron-hole pairs from one high-energy photon, is well established in bulk semiconductors, but assessments of the efficiency of this effect remain controversial in quantum-confined systems like semiconductor nanocrystals. We used a photoelectrochemical system composed of PbS nanocrystals chemically bound to TiO(2) single crystals to demonstrate the collection of photocurrents with quantum yields greater than one electron per photon. The strong electronic coupling and favorable energy level alignment between PbS nanocrystals and bulk TiO(2) facilitate extraction of multiple excitons more quickly than they recombine, as well as collection of hot electrons from higher quantum dot excited states. Our results have implications for increasing the efficiency of photovoltaic devices by avoiding losses resulting from the thermalization of photogenerated carriers.	[Sambur, Justin B.; Parkinson, B. A.] Univ Wyoming, Dept Chem, Laramie, WY 82071 USA; [Sambur, Justin B.; Parkinson, B. A.] Univ Wyoming, Sch Energy Resources, Laramie, WY 82071 USA; [Sambur, Justin B.] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA; [Novet, Thomas] Voxtel Inc, Beaverton, OR 97006 USA	University of Wyoming; University of Wyoming; Colorado State University	Parkinson, BA (corresponding author), Univ Wyoming, Dept Chem, Laramie, WY 82071 USA.	bparkin1@uwyo.edu	Sambur, Justin/Q-2982-2016	Sambur, Justin/0000-0002-8457-4946	U.S. Department of Energy-Basic Energy Sciences [DE-FG03-96ER14625]; Department of Energy [DE-FG36-08GO18025]	U.S. Department of Energy-Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE))	We thank M. G. Bawendi, A. J. Nozik, and D. P. Shepherd for helpful discussions. J. B. S. and B. A. P. acknowledge U.S. Department of Energy-Basic Energy Sciences grant no. DE-FG03-96ER14625 for funding. T.N. acknowledges Department of Energy grant no. DE-FG36-08GO18025 for financial support.	Beard MC, 2009, NANO LETT, V9, P836, DOI 10.1021/nl803600v; Ben-Lulu M, 2008, NANO LETT, V8, P1207, DOI 10.1021/nl080199u; BENISTY H, 1995, PHYS REV B, V51, P13281, DOI 10.1103/PhysRevB.51.13281; Delerue C, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.125306; DISSANAYAKE D, 2008, APPL PHYS LETT, V93, P3; Ellingson RJ, 2005, NANO LETT, V5, P865, DOI 10.1021/nl0502672; Franceschetti A, 2006, NANO LETT, V6, P2191, DOI 10.1021/nl0612401; Gabor NM, 2009, SCIENCE, V325, P1367, DOI 10.1126/science.1176112; Gachet D, 2010, NANO LETT, V10, P164, DOI 10.1021/nl903172f; Green M. A., 2001, 3 GENERATION PHOTOVO; Hanna MC, 2006, J APPL PHYS, V100, DOI 10.1063/1.2356795; Hodes G, 2008, J PHYS CHEM C, V112, P17778, DOI 10.1021/jp803310s; Huang J, 2010, J AM CHEM SOC, V132, P4858, DOI 10.1021/ja100106z; Hyun BR, 2008, ACS NANO, V2, P2206, DOI 10.1021/nn800336b; Istrate E, 2008, J PHYS CHEM B, V112, P2757, DOI 10.1021/jp076809g; Ji MB, 2009, NANO LETT, V9, P1217, DOI 10.1021/nl900103f; Kamat PV, 2008, J PHYS CHEM C, V112, P18737, DOI 10.1021/jp806791s; Kobayashi Y, 2009, CHEM LETT, V38, P830, DOI 10.1246/cl.2009.830; Lee H, 2009, ADV FUNCT MATER, V19, P2735, DOI 10.1002/adfm.200900081; Leventis HC, 2010, J AM CHEM SOC, V132, P2743, DOI 10.1021/ja909172p; Luther JM, 2008, NANO LETT, V8, P3488, DOI 10.1021/nl802476m; Mcguire JA, 2008, ACCOUNTS CHEM RES, V41, P1810, DOI 10.1021/ar800112v; Murphy JE, 2006, J AM CHEM SOC, V128, P3241, DOI 10.1021/ja0574973; Nair G, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.125325; Nozik AJ, 2008, CHEM PHYS LETT, V457, P3, DOI 10.1016/j.cplett.2008.03.094; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Pattantyus-Abraham AG, 2010, ACS NANO, V4, P3374, DOI 10.1021/nn100335g; Pijpers JJH, 2008, J PHYS CHEM C, V112, P4783, DOI 10.1021/jp800834h; Plass R, 2002, J PHYS CHEM B, V106, P7578, DOI [10.1021/jp020453l, 10.1021/jp0204531]; Rupasov VI, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.125321; Sambur JB, 2010, LANGMUIR, V26, P4839, DOI 10.1021/la903618x; Sambur JB, 2010, J AM CHEM SOC, V132, P2130, DOI 10.1021/ja9098577; Schaller RD, 2007, NANO LETT, V7, P3469, DOI 10.1021/nl072046x; Shabaev A, 2006, NANO LETT, V6, P2856, DOI 10.1021/nl062059v; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Strehlow W. H., 1973, Journal of Physical and Chemical Reference Data, V2, P163, DOI 10.1063/1.3253115; Stubbs SK, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.081303; Sukhovatkin V, 2009, SCIENCE, V324, P1542, DOI 10.1126/science.1173812; Tang J, 2010, ACS NANO, V4, P869, DOI 10.1021/nn901564q; Tisdale WA, 2010, SCIENCE, V328, P1543, DOI 10.1126/science.1185509; Trinh MT, 2008, NANO LETT, V8, P1713, DOI 10.1021/nl0807225; Wang SJ, 2010, NANO LETT, V10, P2381, DOI 10.1021/nl100343j	42	716	731	7	493	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					63	66		10.1126/science.1191462	http://dx.doi.org/10.1126/science.1191462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929804				2022-12-28	WOS:000282334500033
J	Hillman, M				Hillman, Mayer			Personal View More daylight, better health: why we shouldn't be putting the clocks back this weekend	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Westminster, Policy Studies Inst, London W1R 8AL, England	University of Westminster	Hillman, M (corresponding author), Univ Westminster, Policy Studies Inst, London W1R 8AL, England.	mayer.hillman@blueyonder.co.uk						Hillman M, 2010, MAKING MOST DAYLIGHT; HILLMAN M, 1988, MAKING MOST DAYLIGHT	2	3	3	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2010	341								c5964	10.1136/bmj.c5964	http://dx.doi.org/10.1136/bmj.c5964			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674YY	20980369				2022-12-28	WOS:000283790400010
J	Ng, SF; Lin, RCY; Laybutt, DR; Barres, R; Owens, JA; Morris, MJ				Ng, Sheau-Fang; Lin, Ruby C. Y.; Laybutt, D. Ross; Barres, Romain; Owens, Julie A.; Morris, Margaret J.			Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring	NATURE			English	Article							LOW-BIRTH-WEIGHT; BODY-MASS INDEX; CHILDHOOD; OBESITY; UNDERNUTRITION; TRANSMISSION; ASSOCIATION; PROTEIN; PLASMA; ISLETS	The global prevalence of obesity is increasing across most ages in both sexes. This is contributing to the early emergence of type 2 diabetes and its related epidemic(1,2). Having either parent obese is an independent risk factor for childhood obesity(3). Although the detrimental impacts of diet-induced maternal obesity on adiposity and metabolism in offspring are well established(4), the extent of any contribution of obese fathers is unclear, particularly the role of non-genetic factors in the causal pathway. Here we show that paternal high-fat-diet (HFD) exposure programs beta-cell 'dysfunction' in rat F-1 female offspring. Chronic HFD consumption in Sprague-Dawley fathers induced increased body weight, adiposity, impaired glucose tolerance and insulin sensitivity. Relative to controls, their female offspring had an early onset of impaired insulin secretion and glucose tolerance that worsened with time, and normal adiposity. Paternal HFD altered the expression of 642 pancreatic islet genes in adult female offspring (P < 0.01); genes belonged to 13 functional clusters, including cation and ATP binding, cytoskeleton and intracellular transport. Broader pathway analysis of 2,492 genes differentially expressed (P < 0.05) demonstrated involvement of calcium-, MAPK- and Wnt-signalling pathways, apoptosis and the cell cycle. Hypomethylation of the Il13ra2 gene, which showed the highest fold difference in expression (1.76-fold increase), was demonstrated. This is the first report in mammals of non-genetic, intergenerational transmission of metabolic sequelae of a HFD from father to offspring.	[Ng, Sheau-Fang; Morris, Margaret J.] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW 2052, Australia; [Lin, Ruby C. Y.] Univ New S Wales, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia; [Lin, Ruby C. Y.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Laybutt, D. Ross] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Barres, Romain] Univ New S Wales, Sch Med Sci, Dept Anat, Sydney, NSW 2052, Australia; [Owens, Julie A.] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Adelaide	Morris, MJ (corresponding author), Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW 2052, Australia.	m.morris@unsw.edu.au	Lin, Ruby CY/A-1636-2009; Owens, Julie A/C-9744-2009; BARRES, Romain/N-2501-2016; Morris, Margaret J/J-4285-2013	Lin, Ruby CY/0000-0003-4163-511X; Owens, Julie A/0000-0002-7498-1353; BARRES, Romain/0000-0002-0158-519X; Morris, Margaret/0000-0003-2285-5117	National Health and Medical Research Council (NHMRC) of Australia; Ministry of Higher Education; National University of Malaysia; NHMRC	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR)); National University of Malaysia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by the National Health and Medical Research Council (NHMRC) of Australia (M.J.M.). S.F.N. is supported by Ministry of Higher Education and National University of Malaysia, R.C.Y.L. is supported by the NHMRC Peter Doherty Fellowship.	Aitken RJ, 2004, NATURE, V432, P48, DOI 10.1038/432048a; Bouchard C, 2009, AM J CLIN NUTR, V89, pS1494, DOI 10.3945/ajcn.2009.27113C; Chamson-Reig A, 2006, J ENDOCRINOL, V191, P83, DOI 10.1677/joe.1.06754; David M, 2002, ANN NY ACAD SCI, V973, P207, DOI 10.1111/j.1749-6632.2002.tb04633.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Du Plessis SS, 2010, NAT REV UROL, V7, P153, DOI 10.1038/nrurol.2010.6; Dunn GA, 2009, ENDOCRINOLOGY, V150, P4999, DOI 10.1210/en.2009-0500; Figueroa-Colon R, 2000, AM J CLIN NUTR, V71, P829, DOI 10.1093/ajcn/71.3.829; Fujisawa T, 2009, CANCER RES, V69, P8678, DOI 10.1158/0008-5472.CAN-09-2100; Ghanayem BI, 2010, BIOL REPROD, V82, P96, DOI 10.1095/biolreprod.109.078915; Gluckman PD, 2009, LANCET, V373, P1654, DOI 10.1016/S0140-6736(09)60234-8; Grunau C, 2000, NUCLEIC ACIDS RES, V28, P1053, DOI 10.1093/nar/28.5.1053; Guo YF, 2006, J CLIN ENDOCR METAB, V91, P4001, DOI 10.1210/jc.2006-0549; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Henquin JC, 2009, DIABETES OBES METAB, V11, P168, DOI 10.1111/j.1463-1326.2009.01109.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hypponen E, 2003, BMJ-BRIT MED J, V326, P19, DOI 10.1136/bmj.326.7379.19; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kasturi SS, 2008, J ANDROL, V29, P251, DOI 10.2164/jandrol.107.003731; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Laybutt DR, 2002, DIABETES, V51, P413, DOI 10.2337/diabetes.51.2.413; Le Stunff C, 2001, NAT GENET, V29, P96, DOI 10.1038/ng707; Leibel NI, 2006, J CLIN ENDOCR METAB, V91, P1275, DOI 10.1210/jc.2005-1707; Li L, 2009, AM J CLIN NUTR, V89, P551, DOI 10.3945/ajcn.2008.26759; Lindsay RS, 2000, DIABETES, V49, P445, DOI 10.2337/diabetes.49.3.445; Morris Margaret J, 2009, Expert Rev Endocrinol Metab, V4, P625, DOI 10.1586/eem.09.45; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042; Power C, 2003, J EPIDEMIOL COMMUN H, V57, P969, DOI 10.1136/jech.57.12.969; Prior LJ, 2008, INT J OBESITY, V32, P1585, DOI 10.1038/ijo.2008.141; Robertson SA, 2005, CELL TISSUE RES, V322, P43, DOI 10.1007/s00441-005-1127-3; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sharpe RM, 2010, PHILOS T R SOC B, V365, P1697, DOI 10.1098/rstb.2009.0206; Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2; Tarquini B, 1999, PEDIATRICS, V103, P998, DOI 10.1542/peds.103.5.998; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; ZHANG XY, 1993, MOL CELL BIOL, V13, P6810, DOI 10.1128/MCB.13.11.6810	42	931	980	3	191	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 21	2010	467	7318					963	U103		10.1038/nature09491	http://dx.doi.org/10.1038/nature09491			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962845				2022-12-28	WOS:000283254700038
J	Thorne, RM; Ni, BB; Tao, X; Horne, RB; Meredith, NP				Thorne, Richard M.; Ni, Binbin; Tao, Xin; Horne, Richard B.; Meredith, Nigel P.			Scattering by chorus waves as the dominant cause of diffuse auroral precipitation	NATURE			English	Article							PITCH-ANGLE; ELECTROSTATIC-WAVES; RADIATION; DISTRIBUTIONS; CYCLOTRON; DRIVEN	Earth's diffuse aurora occurs over a broad latitude range(1) and is primarily caused by the precipitation of low-energy (0.1-30-keV) electrons originating in the central plasma sheet(2), which is the source region for hot electrons in the nightside outer magnetosphere. Although generally not visible, the diffuse auroral precipitation provides the main source of energy for the high-latitude nightside upper atmosphere(3), leading to enhanced ionization and chemical changes. Previous theoretical studies have indicated that two distinct classes of magnetospheric plasma wave, electrostatic electron cyclotron harmonic waves(4,5) and whistler-mode chorus waves(6,7), could be responsible for the electron scattering that leads to diffuse auroral precipitation, but it has hitherto not been possible to determine which is the more important. Here we report an analysis of satellite wave data and Fokker-Planck diffusion calculations which reveals that scattering by chorus is the dominant cause of the most intense diffuse auroral precipitation. This resolves a long-standing controversy. Furthermore, scattering by chorus can remove most electrons as they drift around Earth's magnetosphere, leading to the development of observed pancake distributions(8), and can account for the global morphology of the diffuse aurora(1,3).	[Thorne, Richard M.; Ni, Binbin; Tao, Xin] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Horne, Richard B.; Meredith, Nigel P.] British Antarctic Survey, Cambridge CB3 0ET, England; [Horne, Richard B.] Univ Sheffield, Dept Automat Control & Syst Engn, Sheffield S1 3JD, S Yorkshire, England	University of California System; University of California Los Angeles; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Sheffield	Thorne, RM (corresponding author), Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, 405 Hilgard Ave, Los Angeles, CA 90095 USA.	rmt@atmos.ucla.edu	Ni, Binbin/I-5244-2013; Meredith, Nigel P/C-5806-2018; Horne, Richard B/U-3764-2019	Horne, Richard B/0000-0002-0412-6407; Meredith, Nigel/0000-0001-5032-3463	NSF [ATM 0802843]; UK Natural Environment Research Council; NERC [bas0100023, bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100023, bas0100025] Funding Source: researchfish	NSF(National Science Foundation (NSF)); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded in part by NSF grant ATM 0802843 and by the UK Natural Environment Research Council. We thank R. R. Anderson for provision of the CRRES plasma wave data used in this study and S. Petrinec for reproduction of the PIXIE observations.	EATHER RH, 1971, J GEOPHYS RES, V76, P1746, DOI 10.1029/JA076i007p01746; HORNE RB, 1989, J GEOPHYS RES-SPACE, V94, P8895, DOI 10.1029/JA094iA07p08895; Horne RB, 2000, J GEOPHYS RES-SPACE, V105, P5391, DOI 10.1029/1999JA900447; Lanzerotti L. J., 1974, PARTICLE DIFFUSION R, DOI DOI 10.1007/978-3-642-65675-0; Li W, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014845; Li W, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037595; Li W, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013554; LYONS LR, 1974, J GEOPHYS RES, V79, P575, DOI 10.1029/JA079i004p00575; LYONS LR, 1974, J PLASMA PHYS, V12, P417, DOI 10.1017/S002237780002537X; Meredith NP, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014230; Meredith NP, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017698; Meredith NP, 1999, J GEOPHYS RES-SPACE, V104, P12431, DOI 10.1029/1998JA900083; Newell PT, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014326; Ni B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034032; Petrinec SM, 1999, GEOPHYS RES LETT, V26, P1565, DOI 10.1029/1999GL900295; VILLALON E, 1995, J GEOPHYS RES-SPACE, V100, P19361, DOI 10.1029/95JA01161	16	366	372	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					943	946		10.1038/nature09467	http://dx.doi.org/10.1038/nature09467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962841				2022-12-28	WOS:000283254700033
J	Richardson, DJ				Richardson, David J.			Filling the Light Pipe	SCIENCE			English	Editorial Material									Univ Southampton, Optoelect Res Ctr, Southampton SO17 1BJ, Hants, England	University of Southampton	Richardson, DJ (corresponding author), Univ Southampton, Optoelect Res Ctr, Southampton SO17 1BJ, Hants, England.	djr@orc.soton.ac.uk	Richardson, David J/N-5129-2014; Richardson, David/N-5129-2014	Richardson, David J/0000-0002-4092-6970; Richardson, David/0000-0002-7751-1058				[Anonymous], 2009, CISCO VISUAL NETWORK; CAI JX, 2010, P 2010 OPT FIB COMM; Essiambre RJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.163901; KAO KC, 1966, P I ELECTR ENG, V113, P1151, DOI 10.1049/piee.1966.0189; MAIMAN TH, 1960, NATURE, V187, P493, DOI 10.1038/187493a0; Mitra PP, 2001, NATURE, V411, P1027, DOI 10.1038/35082518; SANO A, 2010, P 2010 OPT FIB COMM; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; ZHOU X, 2010, P 2010 OPT FIB COMM	9	258	266	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					327	328		10.1126/science.1191708	http://dx.doi.org/10.1126/science.1191708			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947751				2022-12-28	WOS:000282986700025
J	Sima, CS; Panageas, KS; Schrag, D				Sima, Camelia S.; Panageas, Katherine S.; Schrag, Deborah			Cancer Screening Among Patients With Advanced Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; BREAST-CANCER; INCIDENCE TRENDS; PROSTATE-CANCER; MAMMOGRAPHY; OVERDIAGNOSIS; CARE; PHYSICIANS; WOMEN	Context Cancer screening has been integrated into routine primary care but does not benefit patients with limited life expectancy. Objective To evaluate the extent to which patients with advanced cancer continue to be screened for new cancers. Design, Setting, and Participants Utilization of cancer screening procedures (mammography, Papanicolaou test, prostate-specific antigen [PSA], and lower gastrointestinal [GI] endoscopy) was assessed in 87 736 fee-for-service Medicare enrollees aged 65 years or older diagnosed with advanced lung, colorectal, pancreatic, gastroesophageal, or breast cancer between 1998 and 2005, and reported to one of the Surveillance, Epidemiology, and End Results (SEER) tumor registries. Participants were followed up until death or December 31, 2007, whichever came first. A group of 87 307 Medicare enrollees without cancer were individually matched by age, sex, race, and SEER registry to patients with cancer and observed over the same period to evaluate screening rates in context. Demographic and clinical characteristics associated with screening were also investigated. Main Outcome Measure For each cancer screening test, utilization rates were defined as the percentage of patients who were screened following the diagnosis of an incurable cancer. Results Among women following advanced cancer diagnosis compared with controls, at least 1 screening mammogram was received by 8.9% (95% confidence interval [CI], 8.6%-9.1%) vs 22.0% (95% CI, 21.7%-22.5%); Papanicolaou test screening was received by 5.8% (95% CI, 5.6%-6.1%) vs 12.5% (95% CI, 12.2%-12.8%). Among men following advanced cancer diagnosis compared with controls, PSA test was received by 15.0% (95% CI, 14.7%-15.3%) vs 27.2% (95% CI, 26.8%-27.6%). For all patients following advanced diagnosis compared with controls, lower GI endoscopy was received by 1.7% (95% CI, 1.6%-1.8%) vs 4.7% (95% CI, 4.6%-4.9%). Screening was more frequent among patients with a recent history of screening (16.2% [95% CI, 15.4%-16.9%] of these patients had mammography, 14.7% [95% CI, 13.7%-15.6%] had a Papanicolaou test, 23.3% [95% CI, 22.6%-24.0%] had a PSA test, and 6.1% [95% CI, 5.2%-7.0%] had lower GI endoscopy). Conclusion A sizeable proportion of patients with advanced cancer continue to undergo cancer screening tests that do not have a meaningful likelihood of providing benefit. JAMA. 2010;304(14):1584-1591 www.jama.com	[Sima, Camelia S.; Panageas, Katherine S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Schrag, Deborah] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute	Sima, CS (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 307 E 63rd St,2nd Floor, New York, NY 10065 USA.	simac@mskcc.org	Hug, Balthasar L./G-1568-2010		National Cancer Institute [R01 1147503]; Schrag; NATIONAL CANCER INSTITUTE [R01CA131847] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Schrag; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Obtained funding: Schrag.; This research was supported by grant R01 1147503 from the National Cancer Institute (Dr Schrag).	Amer College Physicians, 2004, ANN INTERN MED, V141, P226, DOI 10.7326/0003-4819-141-3-200408030-00015; American Cancer Society, AM CANC SOC GUID EAR; [Anonymous], 2002, AJCC CANC STAGING MA; [Anonymous], INT CLASSIFICATION D, V3rd; [Anonymous], US PREV SERV TASK FO; Armstrong K, 2007, ANN INTERN MED, V146, P516, DOI 10.7326/0003-4819-146-7-200704030-00008; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Back AL, 2005, JAMA-J AM MED ASSOC, V293, P1374, DOI 10.1001/jama.293.11.1374; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; CREWDSON J, 2009, ATLANTIC        1119; Cronin KA, 2005, CANCER CAUSE CONTROL, V16, P701, DOI 10.1007/s10552-005-0693-8; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Elmore JG, 2005, JAMA-J AM MED ASSOC, V293, P1245, DOI 10.1001/jama.293.10.1245; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Etzioni R, 2002, J NATL CANCER I, V94, P981; GRADY D, NY TIMES        1103; Iglehart JK, 2009, NEW ENGL J MED, V361, P229, DOI 10.1056/NEJMp0904854; Jerant AF, 2008, ARCH INTERN MED, V168, P1317, DOI 10.1001/archinte.168.12.1317; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Keating NL, 2010, CANCER-AM CANCER SOC, V116, P998, DOI 10.1002/cncr.24761; Partridge AH, 2009, NEW ENGL J MED, V361, P2499, DOI 10.1056/NEJMp0911288; Rousseau P, 2000, J CLIN ONCOL, V18, P2000, DOI 10.1200/JCO.2000.18.9.2000; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; *SEER PROGR, LOC REG DIST STAG AD; Sirovich BE, 2004, JAMA-J AM MED ASSOC, V291, P2990, DOI 10.1001/jama.291.24.2990; Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208; The National Cancer Institute, SEER MED MED ENR CLA; Truog RD, 2009, NEW ENGL J MED, V361, P2501, DOI 10.1056/NEJMp0911447; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Warren JL, 2002, MED CARE, V40, P3; WELCH GH, 2004, SHOULD I BE TESTED C; Welch HG, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b1425; Woloshin S, 2010, JAMA-J AM MED ASSOC, V303, P164, DOI 10.1001/jama.2009.2007; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244; 2007, CPT STANDARD EDITION	35	56	57	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1584	1591		10.1001/jama.2010.1449	http://dx.doi.org/10.1001/jama.2010.1449			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940384	Green Accepted, Bronze			2022-12-28	WOS:000282816500023
J	Adli, M; Kleinert, S; Smith, SK; Ganten, D				Adli, Mazda; Kleinert, Sabine; Smith, Stephen K.; Ganten, Detlev			Academic medicine must take its global role: the M8 Alliance of Academic Health Centers and Medical Universities	LANCET			English	Editorial Material									[Adli, Mazda; Ganten, Detlev] Charite, D-10117 Berlin, Germany; [Kleinert, Sabine] The Lancet, London, England; [Smith, Stephen K.] Univ London Imperial Coll Sci Technol & Med, London, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Imperial College London	Adli, M (corresponding author), Charite, D-10117 Berlin, Germany.	Mazda.Adli@charite.de	Adli, Mazda/GYV-2083-2022	Adli, Mazda/0000-0002-0993-5617				Adli M, 2009, LANCET, V373, P519, DOI 10.1016/S0140-6736(09)60177-X; DeNavas-Walt C., 2009, INCOME POVERTY HLTH; *GERM AC SCI LEOP, REC NAT AC G8 COUNTR; SIEGMUNDSCHULTZ.N, 2009, DTSCH ARZTEBL, V106, pA2123; World Health Organization, 2004, WORLD HLTH REP 2004	5	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 9	2010	376	9748					1197	1198		10.1016/S0140-6736(10)61549-8	http://dx.doi.org/10.1016/S0140-6736(10)61549-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	664ZT	20934578				2022-12-28	WOS:000283003500004
J	Ben-David, O; Cohen, G; Fineberg, J				Ben-David, Oded; Cohen, Gil; Fineberg, Jay			The Dynamics of the Onset of Frictional Slip	SCIENCE			English	Article							STICK-SLIP; RUPTURE PROPAGATION; SUPERSHEAR RUPTURE; SHEAR CRACKS; EARTHQUAKE; FRONTS; FAULT	The way in which a frictional interface fails is critical to our fundamental understanding of failure processes in fields ranging from engineering to the study of earthquakes. Frictional motion is initiated by rupture fronts that propagate within the thin interface that separates two sheared bodies. By measuring the shear and normal stresses along the interface, together with the subsequent rapid real-contact-area dynamics, we find that the ratio of shear stress to normal stress can locally far exceed the static-friction coefficient without precipitating slip. Moreover, different modes of rupture selected by the system correspond to distinct regimes of the local stress ratio. These results indicate the key role of nonuniformity to frictional stability and dynamics with implications for the prediction, selection, and arrest of different modes of earthquakes.	[Ben-David, Oded; Cohen, Gil; Fineberg, Jay] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Fineberg, J (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.	jay@vms.huji.ac.il		Fineberg, Jay/0000-0002-8381-6675	U.S.-Israel Binational Science Foundation [2006288]; James S. McDonnell Foundation; European Science Foundation via the Israel Science Foundation [57/07]; Max Born Chair for Natural Philosophy	U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); James S. McDonnell Foundation; European Science Foundation via the Israel Science Foundation; Max Born Chair for Natural Philosophy	We thank E. Bouchbinder and A. Sagy for insightful comments and S. Kimhi for help with the system design. We acknowledge the support of grant 2006288 awarded by the U.S.-Israel Binational Science Foundation and the James S. McDonnell Foundation. We also acknowledge the European Science Foundation EUROCORES program FANAS for support via the Israel Science Foundation (grant 57/07). J.F. thanks the Max Born Chair for Natural Philosophy for support.	ANDREWS DJ, 1976, J GEOPHYS RES, V81, P5679, DOI 10.1029/JB081i032p05679; ARCHULETA RJ, 1984, J GEOPHYS RES, V89, P4559, DOI 10.1029/JB089iB06p04559; Baumberger T, 2006, ADV PHYS, V55, P279, DOI 10.1080/00018730600732186; Ben-David O, 2010, NATURE, V463, P76, DOI 10.1038/nature08676; Ben-Zion Y, 2008, REV GEOPHYS, V46, DOI 10.1029/2008RG000260; Bouchon M, 2003, SCIENCE, V301, P824, DOI 10.1126/science.1086832; Bowden F, 2001, AM J PHYS, DOI DOI 10.1119/1.1933017; Braun OM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.194301; BURRIDGE R, 1973, GEOPHYS J ROY ASTR S, V35, P439, DOI 10.1111/j.1365-246X.1973.tb00608.x; Das S, 2003, PURE APPL GEOPHYS, V160, P579, DOI 10.1007/PL00012551; DAS S, 1977, GEOPHYS J ROY ASTR S, V50, P643, DOI 10.1111/j.1365-246X.1977.tb01339.x; Dunham EM, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004717; Freund LB, 1990, DYNAMIC FRACTURE MEC, DOI [10.1017/oretCBO9780511546761-en, DOI 10.1017/ORETCBO9780511546761-EN]; Ito Y, 2007, SCIENCE, V315, P503, DOI 10.1126/science.1134454; JOHNSON TL, 1976, J GEOPHYS RES, V81, P881, DOI 10.1029/JB081i005p00881; Linde AT, 1996, NATURE, V383, P65, DOI 10.1038/383065a0; Liu YJ, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003424; Madariaga R, 2000, PURE APPL GEOPHYS, V157, P1981, DOI 10.1007/PL00001071; Nielsen S, 2010, GEOPHYS J INT, V180, P697, DOI 10.1111/j.1365-246X.2009.04444.x; Ohnaka M, 1999, J GEOPHYS RES-SOL EA, V104, P817, DOI 10.1029/1998JB900007; OKUBO PG, 1984, J GEOPHYS RES, V89, P5817, DOI 10.1029/JB089iB07p05817; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Rubinstein SM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.256103; Rubinstein SM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.226103; Rubinstein SM, 2004, NATURE, V430, P1005, DOI 10.1038/nature02830; Scholz C.H., 2002, MECH EARTHQUAKES FAU, DOI 10.1017/CBO9780511818516; Shi ZQ, 2008, J MECH PHYS SOLIDS, V56, P5, DOI 10.1016/j.jmps.2007.04.006; Xia KW, 2004, SCIENCE, V303, P1859, DOI 10.1126/science.1094022	28	193	201	10	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					211	214		10.1126/science.1194777	http://dx.doi.org/10.1126/science.1194777			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929771				2022-12-28	WOS:000282644600039
J	Barnes, PJ				Barnes, Peter J.			Neutrophils Find Smoke Attractive	SCIENCE			English	Editorial Material							PROLINE-GLYCINE-PROLINE; N-ALPHA-PGP; INFLAMMATION; DISEASES; TARGETS; CXCR2; COPD		Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England	Imperial College London	Barnes, PJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England.	p.j.barnes@imperial.ac.uk		Barnes, Peter/0000-0002-5122-4018				Barnes PJ, 2007, J ALLERGY CLIN IMMUN, V119, P1055, DOI 10.1016/j.jaci.2007.01.015; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Beeh KM, 2003, CHEST, V123, P1240, DOI 10.1378/chest.123.4.1240; Culpitt SV, 2005, RESP MED, V99, P703, DOI 10.1016/j.rmed.2004.10.022; de Kruijf P, 2010, EUR J PHARMACOL, V643, P29, DOI 10.1016/j.ejphar.2010.06.017; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Gaggar Amit, 2010, Open Respir Med J, V4, P32, DOI 10.2174/1874306401004020032; Holz O, 2010, EUR RESPIR J, V35, P564, DOI 10.1183/09031936.00048509; O'Reilly P, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-38; PFISTER RR, 1995, INVEST OPHTH VIS SCI, V36, P1306; Snelgrove RJ, 2010, SCIENCE, V330, P90, DOI 10.1126/science.1190594; van Houwelingen AH, 2008, FASEB J, V22, P3403, DOI 10.1096/fj.07-096230; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361	14	21	23	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					40	41		10.1126/science.1196017	http://dx.doi.org/10.1126/science.1196017			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929796				2022-12-28	WOS:000282334500022
J	Pereira, HM; Leadley, PW; Proenca, V; Alkemade, R; Scharlemann, JPW; Fernandez-Manjarres, JF; Araujo, MB; Balvanera, P; Biggs, R; Cheung, WWL; Chini, L; Cooper, HD; Gilman, EL; Guenette, S; Hurtt, GC; Huntington, HP; Mace, GM; Oberdorff, T; Revenga, C; Rodrigues, P; Scholes, RJ; Sumaila, UR; Walpole, M				Pereira, Henrique M.; Leadley, Paul W.; Proenca, Vania; Alkemade, Rob; Scharlemann, Joern P. W.; Fernandez-Manjarres, Juan F.; Araujo, Miguel B.; Balvanera, Patricia; Biggs, Reinette; Cheung, William W. L.; Chini, Louise; Cooper, H. David; Gilman, Eric L.; Guenette, Sylvie; Hurtt, George C.; Huntington, Henry P.; Mace, Georgina M.; Oberdorff, Thierry; Revenga, Carmen; Rodrigues, Patricia; Scholes, Robert J.; Sumaila, Ussif Rashid; Walpole, Matt			Scenarios for Global Biodiversity in the 21st Century	SCIENCE			English	Review							CLIMATE-CHANGE; LAND-USE; RANGE SHIFTS; FUTURE; MODELS; DISTRIBUTIONS; VULNERABILITY; UNCERTAINTY; EXTINCTIONS; DIVERSITY	Quantitative scenarios are coming of age as a tool for evaluating the impact of future socioeconomic development pathways on biodiversity and ecosystem services. We analyze global terrestrial, freshwater, and marine biodiversity scenarios using a range of measures including extinctions, changes in species abundance, habitat loss, and distribution shifts, as well as comparing model projections to observations. Scenarios consistently indicate that biodiversity will continue to decline over the 21st century. However, the range of projected changes is much broader than most studies suggest, partly because there are major opportunities to intervene through better policies, but also because of large uncertainties in projections.	[Pereira, Henrique M.; Proenca, Vania; Rodrigues, Patricia] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, P-1749016 Lisbon, Portugal; [Leadley, Paul W.; Fernandez-Manjarres, Juan F.] Univ Paris 11, CNRS, Lab Ecol Systemat & Evolut, UMR 8079, F-91405 Orsay, France; [Alkemade, Rob] Netherlands Environm Assessment Agcy PBL, NL-3720 AH Bilthoven, Netherlands; [Scharlemann, Joern P. W.; Walpole, Matt] United Nations Environm Programme World Conservat, Cambridge CB3 0EL, England; [Araujo, Miguel B.] CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolut, E-28006 Madrid, Spain; [Araujo, Miguel B.] Univ Evora, Ctr Invest Biodiversidade & Recursos Genet, Catedra Rui Nabeiro Biodiversidade, P-7000 Evora, Portugal; [Balvanera, Patricia] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia 58090, Michoacan, Mexico; [Biggs, Reinette] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Cheung, William W. L.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Chini, Louise; Hurtt, George C.] Univ Maryland, Dept Geog, College Pk, MD 20742 USA; [Cooper, H. David] World Trade Ctr, Secretariat Convent Biol Divers, Montreal, PQ H2Y 1N9, Canada; [Gilman, Eric L.] Hawaii Pacific Univ, Coll Nat & Computat Sci, Honolulu, HI 96822 USA; [Guenette, Sylvie; Sumaila, Ussif Rashid] Univ British Columbia, AERL, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada; [Hurtt, George C.] Pacific NW Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA; [Huntington, Henry P.] Pew Environm Grp, Eagle River, AK 99577 USA; [Mace, Georgina M.] Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; [Oberdorff, Thierry] Museum Natl Hist Nat, UMR IRD 207, Lab Biol Organismes & Ecosyst Aquat, F-75005 Paris, France; [Revenga, Carmen] Nature Conservancy, Arlington, VA 22203 USA; [Scholes, Robert J.] CSIR Nat Resources & Environm, ZA-0001 Pretoria, South Africa	Universidade de Lisboa; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Evora; Universidad Nacional Autonoma de Mexico; Stockholm University; University of East Anglia; University System of Maryland; University of Maryland College Park; University of British Columbia; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Imperial College London; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Nature Conservancy; Council for Scientific & Industrial Research (CSIR) - South Africa	Pereira, HM (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, P-1749016 Lisbon, Portugal.	hpereira@fc.ul.pt	Gilman, Eric/AAF-2147-2019; Pereira, Henrique/B-3975-2009; Oberdorff, Thierry/AGD-5797-2022; oberdorff, thierry/I-3109-2016; Cheung, William/F-5104-2013; Hurtt, George/A-8450-2012; Proença, Vânia/H-9372-2013; Scharlemann, Jorn/A-4737-2008; Sumaila, U. Rashid/ABE-6475-2020; Biggs, Reinette/A-5155-2010; Rodrigues, Patrícia/L-7883-2013; Mace, Georgina M/I-3072-2016; Leadley, Paul/E-4773-2012; Araújo, Miguel B/B-6117-2008; Alkemade, Rob/U-3663-2017	Gilman, Eric/0000-0002-4216-2513; Pereira, Henrique/0000-0003-1043-1675; Oberdorff, Thierry/0000-0001-7323-2599; oberdorff, thierry/0000-0001-7323-2599; Cheung, William/0000-0003-3626-1045; Hurtt, George/0000-0001-7278-202X; Proença, Vânia/0000-0001-8245-357X; Scharlemann, Jorn/0000-0002-2834-6367; Biggs, Reinette/0000-0003-0300-4149; Mace, Georgina M/0000-0001-8965-5211; Araújo, Miguel B/0000-0002-5107-7265; Cooper, David/0000-0003-4538-205X; Alkemade, Rob/0000-0001-8761-1768; Scholes, Robert/0000-0001-5537-6935	Department of the Environment, Food and Rural Affairs of the UK; European Commission; UNEP; Fundacao para a Ciencia e Tecnologia [PTDC/AMB/73901/2006]; Natural Environment Research Council [cpb010001] Funding Source: researchfish; NERC [cpb010001] Funding Source: UKRI	Department of the Environment, Food and Rural Affairs of the UK; European Commission(European CommissionEuropean Commission Joint Research Centre); UNEP; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was developed in the context of a scenarios synthesis coordinated by DIVERSITAS and UNEP World Conservation Monitoring Centre for the Secretariat of the Convention on Biological Diversity, with financial support from the Department of the Environment, Food and Rural Affairs of the UK, the European Commission, and UNEP. We thank L. Simpson for organizing a workshop. H. M. P. was supported in part by grant PTDC/AMB/73901/2006 from Fundacao para a Ciencia e Tecnologia.	Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; ALCAMO J, 2005, ECOSYSTEMS HUMAN WEL, P147; ALDER J, 2007, FISHERIES CTR RES RE, V15; Alkemade R, 2009, ECOSYSTEMS, V12, P374, DOI 10.1007/s10021-009-9229-5; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Balmford A, 2003, TRENDS ECOL EVOL, V18, P326, DOI 10.1016/S0169-5347(03)00067-3; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Bouwman AF, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002314; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Duraiappah A.K., 2005, ECOSYSTEMS HUMAN WEL; Fischlin A., 2007, CONTRIBUTION WORKING, P211; Green RE, 2008, BIOL LETTERS, V4, P599, DOI 10.1098/rsbl.2008.0052; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hurtt G. C., 2009, ILEAPS NEWSLETTER, V7; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; KAREIVA P, 2005, ECOSYSTEMS HUMAN WEL, P73; Leadley P, 2010, SECR CONV BIOL DIV M; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Mace G.M., 2005, ECOSYSTEMS HUMAN WEL, P77; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Maynard JA, 2008, CORAL REEFS, V27, P745, DOI 10.1007/s00338-008-0432-1; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Pereira HM, 2006, ECOLOGY, V87, P1877, DOI 10.1890/0012-9658(2006)87[1877:MBDICL]2.0.CO;2; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Sala O.E., 2005, ECOSYSTEMS HUMAN WEL, P375; Scholes RJ, 2008, SCIENCE, V321, P1044, DOI 10.1126/science.1162055; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Stork NE, 2009, CONSERV BIOL, V23, P1438, DOI 10.1111/j.1523-1739.2009.01335.x; TENBRINK B, 2006, 550500012006 MNP; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; THOMSON AM, 2010, P NATL ACAD SCI US; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; UNEP, 2007, GLOB ENV OUTL; van Vuuren DP, 2006, ECOL SOC, V11; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Willis KJ, 2009, SCIENCE, V326, P806, DOI 10.1126/science.1178838; Wise M, 2009, SCIENCE, V324, P1183, DOI 10.1126/science.1168475; Xenopoulos MA, 2005, GLOBAL CHANGE BIOL, V11, P1557, DOI 10.1111/j.1365-2486.2005.001008.x; 2009, UNEPCBDSPPREP2	60	1142	1198	35	1427	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2010	330	6010					1496	1501		10.1126/science.1196624	http://dx.doi.org/10.1126/science.1196624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	20978282				2022-12-28	WOS:000285153500053
J	Rea, N; Esposito, P; Turolla, R; Israel, GL; Zane, S; Stella, L; Mereghetti, S; Tiengo, A; Gotz, D; Gogus, E; Kouveliotou, C				Rea, N.; Esposito, P.; Turolla, R.; Israel, G. L.; Zane, S.; Stella, L.; Mereghetti, S.; Tiengo, A.; Goetz, D.; Gogus, E.; Kouveliotou, C.			A Low-Magnetic-Field Soft Gamma Repeater	SCIENCE			English	Article							X-RAY PULSARS; NEUTRON-STARS; RADIATIVE MECHANISM; RADIO-EMISSION; VARIABILITY; KES-75; PERIOD	Soft gamma repeaters (SGRs) and anomalous x-ray pulsars form a rapidly increasing group of x-ray sources exhibiting sporadic emission of short bursts. They are believed to be magnetars, that is, neutron stars powered by extreme magnetic fields, B similar to 10(14) to 10(15) gauss. We report on a soft gamma repeater with low magnetic field, SGR 0418+5729, recently detected after it emitted bursts similar to those of magnetars. X-ray observations show that its dipolar magnetic field cannot be greater than 7.5 x 10(12) gauss, well in the range of ordinary radio pulsars, implying that a high surface dipolar magnetic field is not necessarily required for magnetar-like activity. The magnetar population may thus include objects with a wider range of B-field strengths, ages, and evolutionary stages than observed so far.	[Rea, N.] Fac Ciencies, CSIC, Inst Estudis Espacias Catalunya, Inst Ciencies Espai, Bellaterra 08193, Barcelona, Spain; [Esposito, P.] Osserv Astron Capodimonte, Ist Nazl Astrofis INAF, I-09012 Capoterra, Italy; [Turolla, R.] Univ Padua, Dipartimento Fis, I-35131 Padua, Italy; [Turolla, R.; Zane, S.] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Israel, G. L.; Stella, L.] Osserv Astron Roma, INAF, I-00040 Monte Porzio Catone, Italy; [Mereghetti, S.; Tiengo, A.] Ist Astrofis Spaziale & Fis Cosm Milano, INAF, I-20133 Milan, Italy; [Goetz, D.] Univ Paris Diderot, Inst Rech Lois Fondament Univers, Serv Astrophys,CNRS,Direct Sci Matiere, Commissariat Energie Atom & Energies Alternat, F-91191 Gif Sur Yvette, France; [Gogus, E.] Sabanci Univ, TR-34956 Istanbul, Turkey; [Kouveliotou, C.] NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); Istituto Nazionale Astrofisica (INAF); University of Padua; University of London; University College London; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Sabanci University; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center	Rea, N (corresponding author), Fac Ciencies, CSIC, Inst Estudis Espacias Catalunya, Inst Ciencies Espai, Campus UAB,Torre C5 Parell,2A Planta, Bellaterra 08193, Barcelona, Spain.	rea@ieec.uab.es	Esposito, Paolo/Q-2639-2019; Esposito, Paolo/ABE-6389-2020; Rea, Nanda/I-2853-2015; Gogus, Ersin/F-6208-2013	Esposito, Paolo/0000-0003-4849-5092; Esposito, Paolo/0000-0003-4849-5092; Rea, Nanda/0000-0003-2177-6388; Tiengo, Andrea/0000-0002-6038-1090; Zane, Silvia/0000-0001-5326-880X; Gogus, Ersin/0000-0002-5274-6790; Stella, Luigi/0000-0002-0018-1687; TUROLLA, ROBERTO/0000-0002-5825-8149; Israel, GianLuca/0000-0001-5480-6438; MEREGHETTI, SANDRO/0000-0003-3259-7801	Consejo Superior de Investigaciones Cientficas [AYA2009-07391, SGR2009-811]; Autonomous Region of Sardinia; Centre National d'Etudes Spatiales; INAF Agenzia Spaziale Italiana [AAE I/088/06/0]; Science and Technology Facilities Council [ST/H00260X/1] Funding Source: researchfish; STFC [ST/H00260X/1] Funding Source: UKRI	Consejo Superior de Investigaciones Cientficas; Autonomous Region of Sardinia(Regione Sardegna); Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales); INAF Agenzia Spaziale Italiana; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	N.R. is supported by a Ramon y Cajal fellowship through Consejo Superior de Investigaciones Cientficas and by grants AYA2009-07391 and SGR2009-811. N.R. thanks D. F. Torres for useful discussions. P. E. acknowledges financial support from the Autonomous Region of Sardinia through a research grant under the program PO Sardegna FSE 2007-2013, L.R. 7/2007 "Promoting scientific research and innovation technology in Sardinia." D.G. acknowledges the Centre National d'Etudes Spatiales for financial support. The work of R.T., G.L.I., L.S., S.M., and A.T. is partially supported by INAF Agenzia Spaziale Italiana through grant AAE I/088/06/0. We are grateful to H. Tananbaum, N. Gehrels, and N. Schartel for granting us Chandra, Swift, and XMM-Newton time, respectively, for this research.	Beloborodov AM, 2009, ASTROPHYS J, V703, P1044, DOI 10.1088/0004-637X/703/1/1044; Camilo F, 2007, ASTROPHYS J, V666, pL93, DOI 10.1086/521826; Camilo F, 2006, NATURE, V442, P892, DOI 10.1038/nature04986; CHENG AF, 1980, ASTROPHYS J, V235, P576, DOI 10.1086/157661; Colpi M, 2000, ASTROPHYS J, V529, pL29, DOI 10.1086/312448; Dib R, 2007, ASTROPHYS J, V666, P1152, DOI 10.1086/519726; Esposito P, 2010, MON NOT R ASTRON SOC, V405, P1787, DOI 10.1111/j.1365-2966.2010.16551.x; Gavriil FP, 2008, SCIENCE, V319, P1802, DOI 10.1126/science.1153465; Gavriil FP, 2002, ASTROPHYS J, V567, P1067, DOI 10.1086/338698; GOGUS E, 2009, ASTRON TELEGRAM, P2076; Kaspi VM, 2010, P NATL ACAD SCI USA, V107, P7147, DOI 10.1073/pnas.1000812107; Kumar HS, 2008, ASTROPHYS J LETT, V678, pL43, DOI 10.1086/588284; Levin L, 2010, ASTROPHYS J LETT, V721, pL33, DOI 10.1088/2041-8205/721/1/L33; Manchester RN, 2005, ASTRON J, V129, P1993, DOI 10.1086/428488; Mereghetti S, 1998, MON NOT R ASTRON SOC, V296, P689, DOI 10.1046/j.1365-8711.1998.01396.x; Mereghetti S, 2008, ASTRON ASTROPHYS REV, V15, P225, DOI [10.1007/s00159-008-0011-z, 10.1007/s00159-008-0011-Z]; Pons JA, 2009, ASTRON ASTROPHYS, V496, P207, DOI 10.1051/0004-6361:200811229; Thompson C, 2001, ASTROPHYS J, V561, P980, DOI 10.1086/323256; Thompson C, 2002, ASTROPHYS J, V574, P332, DOI 10.1086/340586; Thompson C, 1996, ASTROPHYS J, V473, P322, DOI 10.1086/178147; THOMPSON C, 1995, MON NOT R ASTRON SOC, V275, P255, DOI 10.1093/mnras/275.2.255; Turolla R, 2009, ASTROPHYS SPACE SC L, V357, P141; van der Horst AJ, 2010, ASTROPHYS J LETT, V711, pL1, DOI 10.1088/2041-8205/711/1/L1; Vietri M, 2007, ASTROPHYS J, V661, P1089, DOI 10.1086/517506; Zhang B, 2000, ASTROPHYS J, V531, pL135, DOI 10.1086/312542	25	232	233	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					944	946		10.1126/science.1196088	http://dx.doi.org/10.1126/science.1196088			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	20947727	Green Submitted			2022-12-28	WOS:000284118000036
J	Jost, TS				Jost, Timothy Stoltzfus			Writing New Rules for Insurers -- Progress on the Medical Loss Ratio.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA	Washington & Lee University	Jost, TS (corresponding author), Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA.							ABELSON R, 2010, NY TIMES        0922; BAUCUS M, 2010, COMMUNICATION   0810; Hungerford Thomas L., 2009, MARKET STRUCTURE HLT; Johnson A, 2010, WALL STREET J, pB1	4	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 11	2010	363	20					1883	1885		10.1056/NEJMp1011717	http://dx.doi.org/10.1056/NEJMp1011717			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	678CR	20979464				2022-12-28	WOS:000284047600002
J	Nakagawa, K; Hirota, Y; Sawada, N; Yuge, N; Watanabe, M; Uchino, Y; Okuda, N; Shimomura, Y; Suhara, Y; Okano, T				Nakagawa, Kimie; Hirota, Yoshihisa; Sawada, Natsumi; Yuge, Naohito; Watanabe, Masato; Uchino, Yuri; Okuda, Naoko; Shimomura, Yuka; Suhara, Yoshitomo; Okano, Toshio			Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme	NATURE			English	Article							DIETARY PHYLLOQUINONE; GENE; VITAMIN-K-2; CONVERSION; ACCUMULATION; METABOLISM; MUTATIONS; TISSUES; RATS	Vitamin K occurs in the natural world in several forms, including a plant form, phylloquinone (PK), and a bacterial form, menaquinones (MKs). In many species, including humans, PK is a minor constituent of hepatic vitamin K content, with most hepatic vitamin K content comprising long-chain MKs. Menaquinone-4 (MK-4) is ubiquitously present in extrahepatic tissues, with particularly high concentrations in the brain, kidney and pancreas of humans and rats(1-3). It has consistently been shown that PK is endogenously converted to MK-4 (refs 4-8). This occurs either directly within certain tissues or by interconversion to menadione (K-3), followed by prenylation to MK-4 (refs 9-12). No previous study has sought to identify the human enzyme responsible for MK-4 biosynthesis. Previously we provided evidence for the conversion of PK and K3 into MK-4 in mouse cerebra(13). However, the molecular mechanisms for these conversion reactions are unclear. Here we identify a human MK-4 biosynthetic enzyme. We screened the human genome database for prenylation enzymes and found UbiA prenyltransferase containing 1 (UBIAD1), a human homologue of Escherichia coli prenyltransferase menA. We found that short interfering RNA against the UBIAD1 gene inhibited the conversion of deuterium-labelled vitamin K derivatives into deuterium-labelled-MK-4 (MK-4-d(7)) in human cells. We confirmed that the UBIAD1 gene encodes an MK-4 biosynthetic enzyme through its expression and conversion of deuterium-labelled vitamin K derivatives into MK-4-d(7) in insect cells infected with UBIAD1 baculovirus. Converted MK-4-d(7) was chemically identified by H-2-NMR analysis. MK-4 biosynthesis by UBIAD1 was not affected by the vitamin K antagonist warfarin. UBIAD1 was localized in endoplasmic reticulum and ubiquitously expressed in several tissues of mice. Our results show that UBIAD1 is a human MK-4 biosynthetic enzyme; this identification will permit more effective decisions to be made about vitamin K intake and bone health.	[Nakagawa, Kimie; Hirota, Yoshihisa; Sawada, Natsumi; Yuge, Naohito; Watanabe, Masato; Uchino, Yuri; Okuda, Naoko; Shimomura, Yuka; Suhara, Yoshitomo; Okano, Toshio] Kobe Pharmaceut Univ, Dept Hyg Sci, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Kobe Pharmaceutical University	Okano, T (corresponding author), Kobe Pharmaceut Univ, Dept Hyg Sci, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	t-okano@kobepharma-u.ac.jp	Hirota, Yoshihisa/R-6741-2019	Hirota, Yoshihisa/0000-0002-6462-9479; Suhara, Yoshitomo/0000-0002-4770-2910	Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank M. Sugiura and A. Takeuchi for technical support with <SUP>2</SUP>H-NMR analysis and LC-APCI-MS/MS analysis. This work was supported in part by priority areas from the Ministry of Education, Culture, Sports, Science and Technology (to K.N. and T.O.).	BILLETER M, 1960, BIOCHEM Z, V333, P430; Booth SL, 1998, J NUTR, V128, P785, DOI 10.1093/jn/128.5.785; Davidson RT, 1998, J NUTR, V128, P220, DOI 10.1093/jn/128.2.220; DIALAMEH G H, 1970, Biochimica et Biophysica Acta, V223, P332; GUILLAUMONT M, 1992, INT J VITAM NUTR RES, V62, P15; Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200; Igarashi M, 2007, MOL CELL BIOL, V27, P7947, DOI 10.1128/MCB.00813-07; Lin E. C. C., 1987, ESCHERICHIA COLI SAL, P202; Lopez-Martin JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058; MARTIUS C, 1961, AM J CLIN NUTR, V9, P97, DOI 10.1093/ajcn/9.4.97; MARTIUS C, 1959, BIOCHEM Z, V331, P1; MEGANATHAN R, 1996, ESCHERICHIA COLI SAL, P642; Okano T, 2008, J BIOL CHEM, V283, P11270, DOI 10.1074/jbc.M702971200; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; Ronden JE, 1998, BBA-GEN SUBJECTS, V1379, P69, DOI 10.1016/S0304-4165(97)00089-5; Shearer M.J., 1988, CURRENT ADV VITAMIN, P437; Shearer MJ, 2008, THROMB HAEMOSTASIS, V100, P530, DOI 10.1160/TH08-03-0147; Spronk HMH, 2003, J VASC RES, V40, P531, DOI 10.1159/000075344; Suhara Y, 2009, BIOORG MED CHEM LETT, V19, P1054, DOI 10.1016/j.bmcl.2009.01.021; Suvarna K, 1998, J BACTERIOL, V180, P2782, DOI 10.1128/JB.180.10.2782-2787.1998; Tabb MM, 2003, J BIOL CHEM, V278, P43919, DOI 10.1074/jbc.M303136200; TAGGART WV, 1969, BIOCHEMISTRY-US, V8, P1141, DOI 10.1021/bi00831a047; Thijssen HHW, 2006, BRIT J NUTR, V95, P260, DOI 10.1079/BJN20051630; Thijssen HHW, 1996, BRIT J NUTR, V75, P121, DOI 10.1079/BJN19960115; THIJSSEN HHW, 1994, BRIT J NUTR, V72, P415, DOI 10.1079/BJN19940043; Thijssen HHW, 1996, J NUTR, V126, P537, DOI 10.1093/jn/126.2.537; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8; Weiss JS, 2008, AM J MED GENET A, V146A, P271, DOI 10.1002/ajmg.a.32201; Weiss JS, 2007, INVEST OPHTH VIS SCI, V48, P5007, DOI 10.1167/iovs.07-0845; [No title captured]	30	214	234	2	58	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					117	+		10.1038/nature09464	http://dx.doi.org/10.1038/nature09464			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20953171				2022-12-28	WOS:000283786900047
J	Giomataris, I				Giomataris, Ioannis			Georges Charpak (1924-2010) OBITUARY	NATURE			English	Biographical-Item									CEA Saclay, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay	Giomataris, I (corresponding author), CEA Saclay, F-91191 Gif Sur Yvette, France.	ioanis.giomataris@cern.ch						CHARPAK G, PUBLICATION LIST	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1048	1048		10.1038/4671048a	http://dx.doi.org/10.1038/4671048a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20981084	Bronze			2022-12-28	WOS:000283548600031
J	Wright, SI; Barrett, SCH				Wright, Stephen I.; Barrett, Spencer C. H.			The Long-Term Benefits of Self-Rejection	SCIENCE			English	Editorial Material							SELECTION; SPECIATION		[Wright, Stephen I.; Barrett, Spencer C. H.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of Toronto	Wright, SI (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	stephen.wright@utoronto.ca	Wright, Stephen I/C-3113-2008; Barrett, Spencer C.H./S-5782-2019; Barrett, Spencer CH/M-3751-2013	Wright, Stephen I/0000-0001-9973-9697; Barrett, Spencer C.H./0000-0002-7762-3455; 				Coyne J.A., 2004, SPECIATION; ESCOBAR J, 2010, EVOLUTION AOP, DOI DOI 10.1111/J.1558-5646.2010.01045.X; FitzJohn RG, 2009, SYST BIOL, V58, P595, DOI 10.1093/sysbio/syp067; Franklin-Tong V. E., 2008, P237, DOI 10.1007/978-3-540-68486-2_11; Glemin S, 2007, GENETICS, V177, P905, DOI 10.1534/genetics.107.073601; Goldberg EE, 2010, SCIENCE, V330, P493, DOI 10.1126/science.1194513; Keightley PD, 2007, GENETICS, V177, P2251, DOI 10.1534/genetics.107.080663; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; Schoen DJ, 1997, EVOLUTION, V51, P1090, DOI [10.2307/2411038, 10.1111/j.1558-5646.1997.tb03956.x]; Slotte T, 2010, MOL BIOL EVOL, V27, P1813, DOI 10.1093/molbev/msq062; Takebayashi N, 2001, AM J BOT, V88, P1143, DOI 10.2307/3558325; Wright SI, 2008, INT J PLANT SCI, V169, P105, DOI 10.1086/523366	12	16	17	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					459	460		10.1126/science.1198063	http://dx.doi.org/10.1126/science.1198063			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966240				2022-12-28	WOS:000283329100025
J	Skaug, B; Chen, ZJJ				Skaug, Brian; Chen, Zhijian J.			Emerging Role of ISG15 in Antiviral Immunity	CELL			English	Review							VIRUS NS1 PROTEIN; STIMULATED GENE-15; SINDBIS VIRUS; INFLUENZA; CONJUGATION; TARGETS; CELLS; EXPRESSION; ISGYLATION; MOLECULE	Cells express a plethora of interferon-stimulated genes (ISGs) in response to viral infection. Among these is ISG15, a ubiquitin-like protein (UBL) that can be covalently attached to both host and viral proteins. Here we review recent advances toward understanding the role and mechanism of ISG15 modification in antiviral defense.	[Skaug, Brian; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Chen, Zhijian/C-6039-2012; Skaug, Brian/AAD-6152-2022	Chen, Zhijian/0000-0002-8475-8251; Skaug, Brian/0000-0002-6689-4655	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063692] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM063692-08, R01 GM063692] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chang YG, 2008, J BIOL CHEM, V283, P13370, DOI 10.1074/jbc.M800162200; Desai SD, 2006, CANCER RES, V66, P921, DOI 10.1158/0008-5472.CAN-05-1123; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; Giannakopoulos NV, 2009, J VIROL, V83, P1602, DOI 10.1128/JVI.01590-08; Hsiang TY, 2009, J VIROL, V83, P5971, DOI 10.1128/JVI.01667-08; Jeon YJ, 2010, BBA-MOL BASIS DIS, V1802, P485, DOI 10.1016/j.bbadis.2010.02.006; Jeon YJ, 2009, EMBO REP, V10, P374, DOI 10.1038/embor.2009.23; Kim KI, 2006, MOL CELL BIOL, V26, P472, DOI 10.1128/MCB.26.2.472-479.2006; Lai C, 2009, J VIROL, V83, P1147, DOI 10.1128/JVI.00105-08; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Shi HX, 2010, MOL CELL BIOL, V30, P2424, DOI 10.1128/MCB.01466-09; Sridharan H, 2010, J BIOL CHEM, V285, P7852, DOI 10.1074/jbc.C109.095703; Tang YJ, 2010, J IMMUNOL, V184, P5777, DOI 10.4049/jimmunol.0903588; Versteeg GA, 2010, J VIROL, V84, P5423, DOI 10.1128/JVI.02395-09; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zhao C, 2010, P NATL ACAD SCI USA, V107, P2253, DOI 10.1073/pnas.0909144107	20	162	171	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					187	190		10.1016/j.cell.2010.09.033	http://dx.doi.org/10.1016/j.cell.2010.09.033			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946978	Green Accepted, Bronze			2022-12-28	WOS:000283052200008
J	de Duve, C				de Duve, Christian			The joy of discovery	NATURE			English	Editorial Material									[de Duve, Christian] Catholic Univ Louvain, B-3000 Louvain, Belgium; [de Duve, Christian] Rockefeller Univ, New York, NY 10021 USA	Universite Catholique Louvain; Rockefeller University	de Duve, C (corresponding author), Catholic Univ Louvain, B-3000 Louvain, Belgium.								0	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					S5	S5		10.1038/467S5a	http://dx.doi.org/10.1038/467S5a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944620	Bronze			2022-12-28	WOS:000282898700004
J	Pang, SS; Berry, R; Chen, ZJ; Kjer-Nielsen, L; Perugini, MA; King, GF; Wang, C; Chew, SH; La Gruta, NL; Williams, NK; Beddoe, T; Tiganis, T; Cowieson, NP; Godfrey, DI; Purcell, AW; Wilce, MCJ; McCluskey, J; Rossjohn, J				Pang, Siew Siew; Berry, Richard; Chen, Zhenjun; Kjer-Nielsen, Lars; Perugini, Matthew A.; King, Glenn F.; Wang, Christina; Chew, Sock Hui; La Gruta, Nicole L.; Williams, Neal K.; Beddoe, Travis; Tiganis, Tony; Cowieson, Nathan P.; Godfrey, Dale I.; Purcell, Anthony W.; Wilce, Matthew C. J.; McCluskey, James; Rossjohn, Jamie			The structural basis for autonomous dimerization of the pre-T-cell antigen receptor	NATURE			English	Article							ANALYTICAL ULTRACENTRIFUGATION; SEDIMENTATION-VELOCITY; ALPHA; TCR; BETA; SELECTION; ANGSTROM; OPINION; CHAINS; PHENIX	The pre-T-cell antigen receptor (pre-TCR), expressed by immature thymocytes, has a pivotal role in early T-cell development, including TCR beta-selection, survival and proliferation of CD4(-)CD8(-) double-negative thymocytes, and subsequent ab T-cell lineage differentiation(1-3). Whereas alpha beta TCR ligation by the peptide-loaded major histocompatibility complex initiates T-cell signalling(4), preTCR-induced signalling occurs by means of a ligand-independent dimerization event(5). The pre-TCR comprises an invariant a-chain (pre-T alpha) that pairs with any TCR beta-chain (TCR beta) following successful TCR beta-gene rearrangement(6). Here we provide the basis of pre-T alpha-TCR beta assembly and pre-TCR dimerization. The pre-T alpha chain comprised a single immunoglobulin-like domain that is structurally distinct from the constant (C) domain of the TCR alpha-chain(7); nevertheless, the mode of association between pre-T alpha and TCRb mirrored that mediated by the C alpha-C beta domains of the abTCR. The pre-TCR had a propensity to dimerize in solution, and the molecular envelope of the pre-TCR dimer correlated well with the observed head-to-tail pre-TCR dimer. This mode of pre-TCR dimerization enabled the pre-T alpha domain to interact with the variable (V) beta domain through residues that are highly conserved across the V beta and joining (J) beta gene families, thus mimicking the interactions at the core of the alpha beta TCR's V alpha-V beta interface. Disruption of this pre-T alpha-V beta dimer interface abrogated pre-TCR dimerization in solution and impaired pre-TCR expression on the cell surface. Accordingly, we provide a mechanism of pre-TCR self-association that allows the pre-T alpha chain to simultaneously 'sample' the correct folding of both the V and C domains of any TCR beta-chain, regardless of its ultimate specificity, which represents a critical checkpoint in T-cell development. This unusual dual-chaperone-like sensing function of pre-T alpha represents a unique mechanism in nature whereby developmental quality control regulates the expression and signalling of an integral membrane receptor complex.	[Chen, Zhenjun; Kjer-Nielsen, Lars; La Gruta, Nicole L.; Godfrey, Dale I.; McCluskey, James] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Pang, Siew Siew; Berry, Richard; Wang, Christina; Chew, Sock Hui; Williams, Neal K.; Beddoe, Travis; Tiganis, Tony; Cowieson, Nathan P.; Wilce, Matthew C. J.; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Prot Crystallog Unit, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Perugini, Matthew A.; Purcell, Anthony W.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Perugini, Matthew A.; Purcell, Anthony W.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [King, Glenn F.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld 4072, Australia	University of Melbourne; Monash University; University of Melbourne; University of Melbourne; University of Queensland	McCluskey, J (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	jamesm1@unimelb.edu.au; jamie.rossjohn@monash.edu	Beddoe, Travis/F-3415-2014; King, Glenn F/J-5059-2012; Purcell, Anthony/AAH-1942-2019; Rossjohn, Jamie/F-9032-2013; McCluskey, James/A-1291-2007; Tiganis, Tony/AAV-3495-2020	Beddoe, Travis/0000-0003-4550-2277; King, Glenn F/0000-0002-2308-2200; Purcell, Anthony/0000-0003-0532-8331; Rossjohn, Jamie/0000-0002-2020-7522; McCluskey, James/0000-0002-8597-815X; Tiganis, Tony/0000-0002-8065-9942; La Gruta, Nicole/0000-0001-5358-9363; Godfrey, Dale/0000-0002-3009-5472; berry, richard/0000-0001-7043-0469	Australian Research Council; National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank S. Turner for discussions; S. Ramarathinam for technical assistance; the staff at the Australian synchrotron (MX and SAXS/WAXS beamlines) and Berkeley Advanced Light Source (SIBYLS beamline) for assistance with data collection; and T. Caradoc-Davies for advice on processing of merohedral twinned X-ray data. This research was supported by grants from the Australian Research Council and the National Health and Medical Research Council of Australia. A.W.P., T.T. and M.C.J.W. are supported by NHMRC Senior Research Fellowships, and D.I.G. is supported by an NHMRC Principal Research Fellowship. M.A.P. is supported by an ARC Future Fellowship and J.R. is supported by an ARC Federation Fellowship.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Borowski C, 2004, J EXP MED, V199, P607, DOI 10.1084/jem.20031973; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P423, DOI 10.1007/s00249-009-0418-0; Burger R, 1999, LEUKEMIA RES, V23, P19, DOI 10.1016/S0145-2126(98)00133-7; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Dave VP, 2009, IMMUNOL REV, V232, P22, DOI 10.1111/j.1600-065X.2009.00835.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; HIRANO T, 1979, J IMMUNOL, V123, P1133; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; Kuhns MS, 2007, IMMUNITY, V26, P357, DOI 10.1016/j.immuni.2007.01.015; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Saint-Ruf C, 2000, NATURE, V406, P524, DOI 10.1038/35020093; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; von Boehmer H, 2005, NAT REV IMMUNOL, V5, P571, DOI 10.1038/nri1636; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290; Yamasaki S, 2007, TRENDS IMMUNOL, V28, P39, DOI 10.1016/j.it.2006.11.006; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	30	59	66	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					844	U110		10.1038/nature09448	http://dx.doi.org/10.1038/nature09448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944746				2022-12-28	WOS:000282898700067
J	Leke, RGF				Leke, Rose Gana Fomban			Global health governance-the response to infectious diseases	LANCET			English	Editorial Material									Univ Yaounde 1, Fac Med & Biomed Sci, Yaounde, Cameroon	University of Yaounde I	Leke, RGF (corresponding author), Univ Yaounde 1, Fac Med & Biomed Sci, Yaounde, Cameroon.	roseleke@yahoo.com						Dodgson R, 2002, GLOBAL HLTH GOVERNAN; *GLOB FUND, 2010, INN IMP; Kay A, 2009, INT POLIT ECON SER, P1; Liese B, 2010, LANCET, V375, P67, DOI 10.1016/S0140-6736(09)61749-9; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; PIOT P, 2010, EVERYBODYS BUSINESS, P347; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Sambo L. G., 2010, AFR HLTH MONITOR, V11, P2; SIDDIQI M, 2008, HLTH POLICY, V90, P13; Third High Level Forum on Aid Effectiveness, 2008, ACCR AG ACT; Waage J, 2010, LANCET, V376, P991, DOI 10.1016/S0140-6736(10)61196-8	12	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 9	2010	376	9748					1200	1201		10.1016/S0140-6736(10)61511-5	http://dx.doi.org/10.1016/S0140-6736(10)61511-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	664ZT	20934580				2022-12-28	WOS:000283003500006
J	Canfield, DE; Glazer, AN; Falkowski, PG				Canfield, Donald E.; Glazer, Alexander N.; Falkowski, Paul G.			The Evolution and Future of Earth's Nitrogen Cycle	SCIENCE			English	Review							ABIOTIC FIXATION; OXYGEN; TERRESTRIAL; CARBON; REDUCTION; STABILITY; IMPACTS; AMMONIA; NITRITE; METALS	Atmospheric reactions and slow geological processes controlled Earth's earliest nitrogen cycle, and by similar to 2.7 billion years ago, a linked suite of microbial processes evolved to form the modern nitrogen cycle with robust natural feedbacks and controls. Over the past century, however, the development of new agricultural practices to satisfy a growing global demand for food has drastically disrupted the nitrogen cycle. This has led to extensive eutrophication of fresh waters and coastal zones as well as increased inventories of the potent greenhouse gas nitrous oxide (N2O). Microbial processes will ultimately restore balance to the nitrogen cycle, but the damage done by humans to the nitrogen economy of the planet will persist for decades, possibly centuries, if active intervention and careful management strategies are not initiated.	[Canfield, Donald E.] Univ So Denmark, Inst Biol, Odense M, Denmark; [Canfield, Donald E.] Univ So Denmark, Nord Ctr Earth Evolut, Odense M, Denmark; [Glazer, Alexander N.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Falkowski, Paul G.] Rutgers State Univ, Inst Marine & Coastal Studies, New Brunswick, NJ 08901 USA; [Falkowski, Paul G.] Rutgers State Univ, Dept Earth & Planetary Sci, New Brunswick, NJ 08901 USA	University of Southern Denmark; University of Southern Denmark; University of California System; University of California Berkeley; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Canfield, DE (corresponding author), Univ So Denmark, Inst Biol, Campusvej 55, Odense M, Denmark.	dec@biology.sdu.dk	Canfield, Don/C-1735-2012	Canfield, Don/0000-0001-7602-8366	Agouron Institute; Danish National Research Foundation; NASA; NSF	Agouron Institute(Pfizer); Danish National Research Foundation(Danmarks Grundforskningsfond); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	This review stems from a meeting on the nitrogen cycle sponsored by the Agouron Institute. We acknowledge M. Simon, J. Abelson, J. Kobori, and the rest of the Agouron Institute for funding, encouragement, and support. We thank the meeting attendees for valuable discussions. Supported by the Danish National Research Foundation (D. E. C.) and the NASA Exobiology program and NSF (P.G.F.).	Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Berner R.A., 2004, PHANEROZOIC CARBON C; Berner RA, 2006, GEOLOGY, V34, P413, DOI 10.1130/G22470.1; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; BOUWMAN AF, 1990, SOILS AND THE GREENHOUSE EFFECT, P61; Brandes JA, 2008, ASTROBIOLOGY, V8, P1113, DOI 10.1089/ast.2007.0187; Brocks JJ, 2005, NATURE, V437, P866, DOI 10.1038/nature04068; Canfield DE, 2005, ADV MAR BIOL, V48, P313; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 2006, PHILOS T R SOC B, V361, P1819, DOI 10.1098/rstb.2006.1906; Canfield DE, 2008, SCIENCE, V321, P949, DOI 10.1126/science.1154499; Capone DG, 2001, CURR OPIN MICROBIOL, V4, P341, DOI 10.1016/S1369-5274(00)00215-0; CHAMBERS HE, 1981, QUINQUEREME, V4, P291; Codispoti LA, 2010, SCIENCE, V327, P1339, DOI 10.1126/science.1184945; Demaneche S, 2009, APPL ENVIRON MICROB, V75, P534, DOI 10.1128/AEM.01706-08; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dore JE, 1998, NATURE, V396, P63, DOI 10.1038/23921; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Eady RR, 1996, CHEM REV, V96, P3013, DOI 10.1021/cr950057h; Falkowski PG, 2008, PHILOS T R SOC B, V363, P2705, DOI 10.1098/rstb.2008.0054; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Fennel K, 2005, AM J SCI, V305, P526, DOI 10.2475/ajs.305.6-8.526; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; FIRESTONE MK, 1989, LIFE SCI R, V47, P7; Fixen PE, 2002, AMBIO, V31, P169, DOI 10.1639/0044-7447(2002)031[0169:NFMCC]2.0.CO;2; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Frei R, 2009, NATURE, V461, P250, DOI 10.1038/nature08266; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Godfrey LV, 2009, NAT GEOSCI, V2, P725, DOI 10.1038/NGEO633; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Holland HD., 1984, CHEM EVOLUTION ATMOS; Howard JB, 2006, P NATL ACAD SCI USA, V103, P17088, DOI 10.1073/pnas.0603978103; Iniguez AL, 2004, MOL PLANT MICROBE IN, V17, P1078, DOI 10.1094/MPMI.2004.17.10.1078; Johnston DT, 2009, P NATL ACAD SCI USA, V106, P16925, DOI 10.1073/pnas.0909248106; KASTING JF, 1990, ORIGINS LIFE EVOL B, V20, P199, DOI 10.1007/BF01808105; KASTING JF, 1981, J GEOPHYS RES-OCEANS, V86, P1147, DOI 10.1029/JC086iC02p01147; KASTING JF, 1982, J GEOPHYS RES-OCEANS, V87, P3091, DOI 10.1029/JC087iC04p03091; Likens GE, 1981, SOME PERSPECTIVES MA, P93; MANCINELLI RL, 1988, ORIGINS LIFE EVOL B, V18, P311, DOI 10.1007/BF01808213; Mosier AR, 1998, CLIMATIC CHANGE, V40, P7, DOI 10.1023/A:1005386614431; Peoples MB, 2009, SYMBIOSIS, V48, P1, DOI 10.1007/BF03179980; PETERSEN BT, 2007, AM GEOPH UN FALL M A; Pina-Ochoa E, 2010, P NATL ACAD SCI USA, V107, P1148, DOI 10.1073/pnas.0908440107; Quan TM, 2009, GEOBIOLOGY, V7, P124, DOI 10.1111/j.1472-4669.2008.00182.x; Raun WR, 2002, AGRON J, V94, P815; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Rudnick R.L., 2004, TREATISE GEOCHEMISTR, P1, DOI DOI 10.1016/B0-08-043751-6/03016-4; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Seitzinger SP, 2002, ESTUARIES, V25, P640, DOI 10.1007/BF02804897; Smirnov A, 2008, GEOCHEM T, V9, DOI 10.1186/1467-4866-9-5; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; Subbarao GV, 2009, BREEDING SCI, V59, P529, DOI 10.1270/jsbbs.59.529; Summers DP, 2007, ASTROBIOLOGY, V7, P333, DOI 10.1089/ast.2006.0032; SUMMERS DP, 1993, NATURE, V365, P630, DOI 10.1038/365630a0; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Thamdrup B, 2008, MICROBIAL ECOLOGY OC, P527, DOI [10.1002/9780470281840.ch14, DOI 10.1002/9780470281840.CH14]; TRENBERTH KE, 1994, J GEOPHYS RES-ATMOS, V99, P23079, DOI 10.1029/94JD02043; U.S. Geological Survey, 2010, MIN COMM SUMM 2010; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Yokochi R, 2009, GEOCHIM COSMOCHIM AC, V73, P4843, DOI 10.1016/j.gca.2009.05.054	68	1360	1462	131	2135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2010	330	6001					192	196		10.1126/science.1186120	http://dx.doi.org/10.1126/science.1186120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929768				2022-12-28	WOS:000282644600032
J	Collins, F				Collins, Francis			Scientists need a shorter path to research freedom	NATURE			English	Editorial Material												francis.collins@nih.gov							0	11	11	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					635	635		10.1038/467635a	http://dx.doi.org/10.1038/467635a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20930798	Bronze			2022-12-28	WOS:000282572500046
J	Lipsker, D				Lipsker, Dan			A White Hand and a Red Hand -- Erythromelalgia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Strasbourg, Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Lipsker, D (corresponding author), Univ Strasbourg, Strasbourg, France.	dan.lipsker@chru-strasbourg.fr		Lipsker, Dan/0000-0003-4675-0336					0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2010	363	15					1463	1463		10.1056/NEJMicm0901376	http://dx.doi.org/10.1056/NEJMicm0901376			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	659NV	20925548				2022-12-28	WOS:000282575100011
J	Sellmeyer, DE				Sellmeyer, Deborah E.			Atypical Fractures as a Potential Complication of Long-term Bisphosphonate Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUPPRESSED BONE TURNOVER; TOTAL KNEE ARTHROPLASTY; POSTMENOPAUSAL OSTEOPOROSIS; ALENDRONATE THERAPY; VERTEBRAL FRACTURES; INTERVENTION TRIAL; FEMORAL FRACTURES; RANDOMIZED-TRIAL; DIAPHYSEAL FEMUR; ZOLEDRONIC ACID	The development of bisphosphonate therapy represented an important advance in the treatment of low bone mass and osteoporosis, conditions that affect more than half of individuals older than 50 years. Currently available bisphosphonates have been shown to reduce spine, nonspine, and hip fractures in individuals at increased risk of fracture. Case reports and limited clinical series over the past 5 years have raised concern that prolonged bisphosphonate therapy may suppress bone remodeling to the extent that normal bone repair is impaired, resulting in increased fracture risk. Fractures potentially resulting from suppressed bone turnover have been described as "atypical," affecting sites such as the subtrochanteric femur that are infrequently affected by osteoporotic fractures. A prodrome of thigh pain, lack of trauma prior to the fracture, and specific radiological characteristics have also been reported. Data are limited on the prevalence of, risk factors for, and treatment of this potential problem. Current strategies include fracture risk assessment, targeting bisphosphonate therapy appropriately to individuals at increased risk of fracture, considering a 12-month interruption in therapy after 5 years in patients who are clinically stable, and considering teriparatide treatment in individuals who experience an atypical fracture while receiving bisphosphonate therapy. JAMA. 2010; 304(13): 1480-1484	Johns Hopkins Sch Med, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine	Sellmeyer, DE (corresponding author), Johns Hopkins Sch Med, 5200 Eastern Ave,Mason F Lord Ctr Tower,Ste 4300, Baltimore, MD 21224 USA.	dsellme1@jhmi.edu			Novartis; Amgen	Novartis(Novartis); Amgen(Amgen)	Dr Sellmeyer reports having received research funding from Novartis and Amgen.	Abrahamsen B, 2009, J BONE MINER RES, V24, P1095, DOI [10.1359/JBMR.081247, 10.1359/jbmr.081247]; [Anonymous], 2010, CLIN GUID PREV TREAT; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Black DM, 2005, NEW ENGL J MED, V353, P555, DOI 10.1056/NEJMoa050336; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Capeci CM, 2009, J BONE JOINT SURG AM, V91A, P2556, DOI 10.2106/JBJS.H.01774; Chapurlat RD, 2007, J BONE MINER RES, V22, P1502, DOI 10.1359/JBMR.070609; Chavassieux PM, 1997, J CLIN INVEST, V100, P1475, DOI 10.1172/JCI119668; Chesnut CH, 2004, J BONE MINER RES, V19, P1241, DOI 10.1359/JBMR.040325; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Dawson-Hughes B, 2008, OSTEOPOROSIS INT, V19, P449, DOI 10.1007/s00198-008-0559-5; Ettinger B, 2004, J BONE MINER RES, V19, P745, DOI 10.1359/JBMR.040117; Farley JF, 2009, AM J HEALTH-SYST PH, V66, P1191, DOI 10.2146/ajhp080248; Giusti A, 2010, BONE, V47, P169, DOI 10.1016/j.bone.2010.05.019; Goh SK, 2007, J BONE JOINT SURG BR, V89B, P349, DOI 10.1302/0301-620X.89B3.18146; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Ing-Lorenzini K, 2009, DRUG SAFETY, V32, P775, DOI 10.2165/00002018-200932090-00002; Kumm DA, 1997, J ARTHROPLASTY, V12, P580, DOI 10.1016/S0883-5403(97)90184-4; Lenart BA, 2009, OSTEOPOROSIS INT, V20, P1353, DOI 10.1007/s00198-008-0805-x; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Neviaser AS, 2008, J ORTHOP TRAUMA, V22, P346, DOI 10.1097/BOT.0b013e318172841c; Nieves JW, 2010, OSTEOPOROSIS INT, V21, P399, DOI 10.1007/s00198-009-0962-6; Niimi R, 2008, J ORTHOP SCI, V13, P572, DOI 10.1007/s00776-008-1262-2; Odvina CV, 2010, CLIN ENDOCRINOL, V72, P161, DOI 10.1111/j.1365-2265.2009.03581.x; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Recker R, 2004, J BONE MINER RES, V19, P1628, DOI 10.1359/JBMR.040710; Recker R, 2004, J BONE MINER RES, V19, pS45; Recker RR, 2008, J BONE MINER RES, V23, P6, DOI 10.1359/JBMR.070906; Schwartz AV, 2010, J BONE MINER RES, V25, P976, DOI 10.1002/jbmr.11; Seeman E, 2009, OSTEOPOROSIS INT, V20, P187, DOI 10.1007/s00198-008-0813-x; Siris ES, 2003, J CLIN ENDOCR METAB, V88, P3482, DOI 10.1210/jc.2003-030568; Ste-Marie LG, 2004, CALCIFIED TISSUE INT, V75, P469, DOI 10.1007/s00223-004-0039-7; Subbiah V, 2010, OSTEOPOROSIS INT, V21, P1041, DOI 10.1007/s00198-009-1004-0; Tosteson ANA, 2008, OSTEOPOROSIS INT, V19, P437, DOI 10.1007/s00198-007-0550-6; Visekruna M, 2008, J CLIN ENDOCR METAB, V93, P2948, DOI 10.1210/jc.2007-2803; Watts NB, 2008, OSTEOPOROSIS INT, V19, P365, DOI 10.1007/s00198-007-0460-7; Watts NB, 2010, J CLIN ENDOCR METAB, V95, P1555, DOI 10.1210/jc.2009-1947	39	73	76	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2010	304	13					1480	1484		10.1001/jama.2010.1360	http://dx.doi.org/10.1001/jama.2010.1360			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658SO	20924014				2022-12-28	WOS:000282509900024
J	Rosenbaum, S				Rosenbaum, Sara			A "Broader Regulatory Scheme" - The Constitutionality of Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									George Washington Univ, Med Ctr, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC 20037 USA	George Washington University	Rosenbaum, S (corresponding author), George Washington Univ, Med Ctr, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC 20037 USA.							PRIEST AJG, 1970, LAW CONTEMP PROBL, V35, P839, DOI 10.2307/1190952	1	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 11	2010	363	20					1881	1883		10.1056/NEJMp1010850	http://dx.doi.org/10.1056/NEJMp1010850			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	678CR	20979465				2022-12-28	WOS:000284047600001
J	Keller, SA				Keller, Sallie Ann			Vital statistics	NATURE			English	Editorial Material									[Keller, Sallie Ann] Sci & Technol Policy Inst, Washington, DC 20006 USA			skeller@ida.org		Keller, Sallie/0000-0001-7303-7267					0	5	5	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					914	914		10.1038/467914a	http://dx.doi.org/10.1038/467914a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962824	Bronze			2022-12-28	WOS:000283254700016
J	Moreno, RP; Rhodes, A				Moreno, Rui Paulo; Rhodes, Andrew			Intensive care medicine: a specialty coming to LIFE	LANCET			English	Editorial Material									[Moreno, Rui Paulo] EPE, Ctr Hosp Lisboa Cent, Hosp Santo Antonio dos Capuchos, Unidade Cuidados Intens Polivalente, P-1169050 Lisbon, Portugal; [Rhodes, Andrew] St Georges Healthcare NHS Trust, London, England	Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; St Georges University London	Moreno, RP (corresponding author), EPE, Ctr Hosp Lisboa Cent, Hosp Santo Antonio dos Capuchos, Unidade Cuidados Intens Polivalente, P-1169050 Lisbon, Portugal.	r.moreno@mail.telepac.pt	Rhodes, Andrew/G-4265-2011	Rhodes, Andrew/0000-0002-8737-574X				Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; CHICHE JD, 2009, PATIENT SAFETY QUALI, P127; Curtis JR, 2010, LANCET, V376, P1347, DOI 10.1016/S0140-6736(10)60143-2; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; IBSEN B, 1954, P ROY SOC MED, V47, P72, DOI 10.1177/003591575404700120; Kraemer HC, 2010, JAMA-J AM MED ASSOC, V304, P683, DOI 10.1001/jama.2010.1133; LASSEN HCA, 1953, LANCET, V264, P37; Moreno RP, 2009, INTENS CARE MED, V35, P1667, DOI 10.1007/s00134-009-1621-2; NEGOVSKY VA, 1961, CIRCULATION, V23, P452, DOI 10.1161/01.CIR.23.3.452; NEGOVSKY VA, 1986, ESSAYS REANIMATOLOGY; Vincent JL, 2010, LANCET, V376, P1354, DOI 10.1016/S0140-6736(10)60575-2; 2005, OFFICIAL J EURO 0930	12	12	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2010	376	9749					1275	1276		10.1016/S0140-6736(10)61502-4	http://dx.doi.org/10.1016/S0140-6736(10)61502-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	671RX	20934210	Green Submitted			2022-12-28	WOS:000283528600004
J	Srikanth, CV; Wall, DM; Maldonado-Contreras, A; Shi, HN; Zhou, DG; Demma, Z; Mumy, KL; McCormick, BA				Srikanth, C. V.; Wall, Daniel M.; Maldonado-Contreras, Ana; Shi, Hai Ning; Zhou, Daoguo; Demma, Zachary; Mumy, Karen L.; McCormick, Beth A.			Salmonella Pathogenesis and Processing of Secreted Effectors by Caspase-3	SCIENCE			English	Article							EPITHELIAL-CELLS; TYPHIMURIUM; PROTEIN; INVASION; ACTIN; IDENTIFICATION; FILAMENTS; ABILITY; GROWTH; DOMAIN	The enteric pathogen Salmonella enterica serovar Typhimurium causes food poisoning resulting in gastroenteritis. The S. Typhimurium effector Salmonella invasion protein A (SipA) promotes gastroenteritis by functional motifs that trigger either mechanisms of inflammation or bacterial entry. During infection of intestinal epithelial cells, SipA was found to be responsible for the early activation of caspase-3, an enzyme that is required for SipA cleavage at a specific recognition motif that divided the protein into its two functional domains and activated SipA in a manner necessary for pathogenicity. Other caspase-3 cleavage sites identified in S. Typhimurium appeared to be restricted to secreted effector proteins, which indicates that this may be a general strategy used by this pathogen for processing of its secreted effectors.	[Srikanth, C. V.; Wall, Daniel M.; Shi, Hai Ning; Mumy, Karen L.; McCormick, Beth A.] Harvard Univ, Sch Med, Dept Pediat Gastroenterol & Nutr, Boston, MA 02129 USA; [Srikanth, C. V.; Wall, Daniel M.; Shi, Hai Ning; Mumy, Karen L.; McCormick, Beth A.] Massachusetts Gen Hosp, Boston, MA 02129 USA; [Srikanth, C. V.; Maldonado-Contreras, Ana; Demma, Zachary; Mumy, Karen L.; McCormick, Beth A.] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA; [Wall, Daniel M.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8QQ, Lanark, Scotland; [Zhou, Daoguo] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of Glasgow; Purdue University System; Purdue University; Purdue University West Lafayette Campus	McCormick, BA (corresponding author), Harvard Univ, Sch Med, Dept Pediat Gastroenterol & Nutr, Boston, MA 02129 USA.	Beth.McCormick@umassmed.edu	Maldonado-Contreras, Ana/ABA-2738-2020	Maldonado-Contreras, Ana/0000-0002-5967-9623	NIH [DK56754, DK33506]; Crohn's and Colitis Foundation of America; Tenovus Scotland; Society for General Microbiology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK033506, P30DK040561, R01DK056754] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Tenovus Scotland; Society for General Microbiology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research was supported by grants from the NIH (DK56754 and DK33506) and the Crohn's and Colitis Foundation of America to B. A. M. Additional grant support was provided by Tenovus Scotland and a Society for General Microbiology travel award to D. M. W. The use of human volunteers in this study was in accordance with appropriate guidelines and was approved by the University of Massachusetts Medical School Review Board for the Protection of Human Subjects (approval no. 13006).	Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Cherayil BJ, 2000, INFECT IMMUN, V68, P5567, DOI 10.1128/IAI.68.10.5567-5574.2000; Chiu HJ, 2005, MICROBIOL-SGM, V151, P3277, DOI 10.1099/mic.0.28115-0; Deane JE, 2008, J MOL BIOL, V377, P985, DOI 10.1016/j.jmb.2008.01.072; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; Lee CA, 2000, P NATL ACAD SCI USA, V97, P12283, DOI 10.1073/pnas.97.22.12283; LEE CA, 1992, P NATL ACAD SCI USA, V89, P1847, DOI 10.1073/pnas.89.5.1847; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433; MCCORMICK BA, 1988, INFECT IMMUN, V56, P2209, DOI 10.1128/IAI.56.9.2209-2217.1988; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; Nhan TQ, 2006, AM J PATHOL, V169, P729, DOI 10.2353/ajpath.2006.060105; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Ramarao N, 2007, FEBS LETT, V581, P853, DOI 10.1016/j.febslet.2007.01.057; Van Nhieu GT, 1999, EMBO J, V18, P3249, DOI 10.1093/emboj/18.12.3249; Wall DM, 2007, CELL MICROBIOL, V9, P2299, DOI 10.1111/j.1462-5822.2007.00960.x; Wood MW, 2000, CELL MICROBIOL, V2, P293, DOI 10.1046/j.1462-5822.2000.00054.x; Zakeri Z, 2008, ADV EXP MED BIOL, V615, P1, DOI 10.1007/978-1-4020-6554-5_1; Zhang Y, 2006, MOL MICROBIOL, V62, P786, DOI 10.1111/j.1365-2958.2006.05407.x; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176	22	76	82	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					390	393		10.1126/science.1194598	http://dx.doi.org/10.1126/science.1194598			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947770	Green Accepted			2022-12-28	WOS:000282986700046
J	Crutzen, PJ				Crutzen, Paul J.			Anthropocene man	NATURE			English	Editorial Material									[Crutzen, Paul J.] Stockholm Hgsk, Dept Meteorol, Stockholm, Sweden; [Crutzen, Paul J.] NCAR, Boulder, CO USA	National Center Atmospheric Research (NCAR) - USA			Crutzen, Paul J/F-6044-2012						0	14	15	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					S10	S10		10.1038/467S10a	http://dx.doi.org/10.1038/467S10a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944610	Bronze			2022-12-28	WOS:000282898700009
J	Avorn, J				Avorn, Jerry			Medication Use in Older Patients Better Policy Could Encourage Better Practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Avorn, Jerry] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; [Avorn, Jerry] Harvard Univ, Sch Med, Boston, MA USA; [Avorn, Jerry] Brigham & Womens Hosp, Dept Med, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Ste 3030,1620 Tremont St, Boston, MA 02120 USA.	javorn@medsoc.harvard.edu						Avorn J, 2005, POWERFUL MED BENEFIT; Avorn J, 2003, GERIATRIC MED EVIDEN, P65; Boult C, 2010, HEALTH AFFAIR, V29, P811, DOI 10.1377/hlthaff.2010.0095; Boult C, 2009, J AM GERIATR SOC, V57, P2328, DOI 10.1111/j.1532-5415.2009.02571.x; *FUT HLTH CAR WORK, 2008, RET AG AM BUILD HLTH; *IND DRUG INF SERV, BAL DAT MED; Peterson JF, 2005, ARCH INTERN MED, V165, P802, DOI 10.1001/archinte.165.7.802; Platt R, 2009, NEW ENGL J MED, V361, P645, DOI 10.1056/NEJMp0905338; SCHONDELMEYER SW, 2010, RX PRICE WATCH REPOR; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233	10	30	31	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1606	1607		10.1001/jama.2010.1495	http://dx.doi.org/10.1001/jama.2010.1495			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940388				2022-12-28	WOS:000282816500027
J	Glocker, EO; Frede, N; Perro, M; Sebire, N; Elawad, M; Shah, N; Grimbacher, B				Glocker, Erik-Oliver; Frede, Natalie; Perro, Mario; Sebire, Neil; Elawad, Mamoun; Shah, Neil; Grimbacher, Bodo			Infant colitis-it's in the genes	LANCET			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE; INTERLEUKIN-10		[Glocker, Erik-Oliver; Perro, Mario; Grimbacher, Bodo] UCL, Royal Free Hosp, Dept Immunol, Div Infect & Immun, London NW3 2PF, England; [Frede, Natalie] Univ Hosp Freiburg, Dept Haematol, Freiburg, Germany; [Sebire, Neil] UCL, Great Ormond St Hosp, Dept Paediat Lab Med, London NW3 2PF, England; [Elawad, Mamoun; Shah, Neil] UCL, Great Ormond St Hosp, Dept Paediat Gastroenterol, London NW3 2PF, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Freiburg; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Grimbacher, B (corresponding author), UCL, Royal Free Hosp, Dept Immunol, Div Infect & Immun, London NW3 2PF, England.	b.grimbacher@ucl.ac.uk	Perro, Mario/AAB-5554-2021	Perro, Mario/0000-0003-1375-8155; Sebire, Neil/0000-0001-5348-9063				Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Braat H, 2006, CLIN GASTROENTEROL H, V4, P754, DOI 10.1016/j.cgh.2006.03.028; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250	5	191	198	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 9	2010	376	9748					1272	1272		10.1016/S0140-6736(10)61008-2	http://dx.doi.org/10.1016/S0140-6736(10)61008-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	664ZT	20934598				2022-12-28	WOS:000283003500037
J	Ajikumar, PK; Xiao, WH; Tyo, KEJ; Wang, Y; Simeon, F; Leonard, E; Mucha, O; Phon, TH; Pfeifer, B; Stephanopoulos, G				Ajikumar, Parayil Kumaran; Xiao, Wen-Hai; Tyo, Keith E. J.; Wang, Yong; Simeon, Fritz; Leonard, Effendi; Mucha, Oliver; Phon, Too Heng; Pfeifer, Blaine; Stephanopoulos, Gregory			Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli	SCIENCE			English	Article							LYCOPENE PRODUCTION; BIOSYNTHETIC GENES; CYTOCHROME-P450; TERPENOIDS; TAXADIENE; CONSTRUCTION; OXYGENASES; CELLS; YEAST; STEP	Taxol (paclitaxel) is a potent anticancer drug first isolated from the Taxus brevifolia Pacific yew tree. Currently, cost-efficient production of Taxol and its analogs remains limited. Here, we report a multivariate-modular approach to metabolic-pathway engineering that succeeded in increasing titers of taxadiene-the first committed Taxol intermediate-approximately 1 gram per liter (similar to 15,000-fold) in an engineered Escherichia coli strain. Our approach partitioned the taxadiene metabolic pathway into two modules: a native upstream methylerythritol-phosphate (MEP) pathway forming isopentenyl pyrophosphate and a heterologous downstream terpenoid-forming pathway. Systematic multivariate search identified conditions that optimally balance the two pathway modules so as to maximize the taxadiene production with minimal accumulation of indole, which is an inhibitory compound found here. We also engineered the next step in Taxol biosynthesis, a P450-mediated 5 alpha-oxidation of taxadiene to taxadien-5 alpha-ol. More broadly, the modular pathway engineering approach helped to unlock the potential of the MEP pathway for the engineered production of terpenoid natural products.	[Wang, Yong; Pfeifer, Blaine] Tufts Univ, Dept Biol & Chem Engn, Medford, MA 02155 USA; [Ajikumar, Parayil Kumaran; Xiao, Wen-Hai; Tyo, Keith E. J.; Simeon, Fritz; Leonard, Effendi; Mucha, Oliver; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Ajikumar, Parayil Kumaran; Phon, Too Heng; Stephanopoulos, Gregory] Singapore MIT Alliance, Chem & Pharmaceut Engn Program, Singapore 117546, Singapore	Tufts University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART)	Pfeifer, B (corresponding author), Tufts Univ, Dept Biol & Chem Engn, 4 Colby St, Medford, MA 02155 USA.	blaine.pfeifer@tufts.edu; gregstep@mit.edu	Tyo, Keith/H-6227-2012; Tyo, Keith/D-1817-2009; Tyo, Keith/AAM-4543-2020	Tyo, Keith/0000-0002-2342-0687	Singapore-MIT Alliance [SMA-2]; NIH [1-R01-GM085323-01A1]; Milheim Foundation [2006-17]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085323] Funding Source: NIH RePORTER	Singapore-MIT Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Milheim Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Renu for extraction, purification, and characterization of metabolite Indole; C. Santos for providing the pACYCmelA plasmid, constructive suggestions during the experiments, and preparation of the manuscript; D. Dugar, H. Zhou, and X. Huang for helping with experiments and suggestions; and K. Hiller for data analysis and comments on the manuscript. We gratefully acknowledge support by the Singapore-MIT Alliance (SMA-2) and NIH, grant 1-R01-GM085323-01A1. B.P. acknowledges the Milheim Foundation Grant for Cancer Research 2006-17. A patent application that is based on the results presented here has been filed by MIT. P. K. A. designed the experiments and performed the engineering and screening of the strains; W-H. X. performed screening of the strains, bioreactor experiments, and GC-MS analysis; F. S. carried out the quantitative PCR measurements; O.M. performed the extraction and characterization of taxadiene standard; E. L., Y.W., and B. P. supported with cloning experiments; P. K. A., K.E.J.T., T. H. P., B. P. and G. S. analyzed the data; P. K. A., K.E.J.T., and G. S. wrote the manuscript; G. S. supervised the research; and all of the authors contributed to discussion of the research and edited and commented on the manuscript.	Ajikumar PK, 2008, MOL PHARMACEUT, V5, P167, DOI 10.1021/mp700151b; Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Chang MCY, 2006, NAT CHEM BIOL, V2, P674, DOI 10.1038/nchembio836; DeJong JM, 2006, BIOTECHNOL BIOENG, V93, P212, DOI 10.1002/bit.20694; Engels B, 2008, METAB ENG, V10, P201, DOI 10.1016/j.ymben.2008.03.001; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; Farmer WR, 2001, BIOTECHNOL PROGR, V17, P57, DOI 10.1021/bp000137t; Frense D, 2007, APPL MICROBIOL BIOT, V73, P1233, DOI 10.1007/s00253-006-0711-0; Goodman J., 2001, STORY TAXOL NATURE P; HOLTON RA, 1994, J AM CHEM SOC, V116, P1597, DOI 10.1021/ja00083a066; Holton RA., 1995, TAXOL SCI APPL, P97, DOI DOI 10.1002/CHIN.199552275; Huang QL, 2001, BIOORGAN MED CHEM, V9, P2237, DOI 10.1016/S0968-0896(01)00072-4; Jennewein S, 2005, BIOTECHNOL BIOENG, V89, P588, DOI 10.1002/bit.20390; Jennewein S, 2004, P NATL ACAD SCI USA, V101, P9149, DOI 10.1073/pnas.0403009101; Jennewein S, 2004, CHEM BIOL, V11, P379, DOI 10.1016/j.chembiol.2004.02.022; Jin YS, 2007, METAB ENG, V9, P337, DOI 10.1016/j.ymben.2007.03.003; Jones KL, 2000, METAB ENG, V2, P328, DOI 10.1006/mben.2000.0161; Kaspera Rudiger, 2006, Phytochemistry Reviews, V5, P433, DOI 10.1007/s11101-006-9006-4; Kingston DGI, 2007, PHYTOCHEMISTRY, V68, P1844, DOI 10.1016/j.phytochem.2006.11.009; Klein-Marcuschamer D, 2007, TRENDS BIOTECHNOL, V25, P417, DOI 10.1016/j.tibtech.2007.07.006; Leonard E, 2007, APPL ENVIRON MICROB, V73, P7246, DOI 10.1128/AEM.01411-07; Leonard E, 2010, P NATL ACAD SCI USA, V107, P13654, DOI 10.1073/pnas.1006138107; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Morrone D, 2010, APPL MICROBIOL BIOT, V85, P1893, DOI 10.1007/s00253-009-2219-x; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; NICOLAOU KC, 1994, NATURE, V367, P630, DOI 10.1038/367630a0; Roberts SC, 2007, NAT CHEM BIOL, V3, P387, DOI 10.1038/nchembio.2007.8; Rontein D, 2008, J BIOL CHEM, V283, P6067, DOI 10.1074/jbc.M708950200; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; Suffness M, 1995, TAXOL SCI APPL, P3; Tyo KE, 2007, TRENDS BIOTECHNOL, V25, P132, DOI 10.1016/j.tibtech.2007.01.003; Walji AM, 2007, SYNLETT, P1477, DOI 10.1055/s-2007-980382; Walker K, 2001, PHYTOCHEMISTRY, V58, P1, DOI 10.1016/S0031-9422(01)00160-1; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Yuan LZ, 2006, METAB ENG, V8, P79, DOI 10.1016/j.ymben.2005.08.005	36	1106	1271	47	1001	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					70	74		10.1126/science.1191652	http://dx.doi.org/10.1126/science.1191652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929806	Green Accepted, Green Submitted			2022-12-28	WOS:000282334500035
J	Dhingra, N; Jha, P; Sharma, VP; Cohen, AA; Jotkar, RM; Rodriguez, PS; Bassani, DG; Suraweera, W; Laxminarayan, R; Peto, R				Dhingra, Neeraj; Jha, Prabhat; Sharma, Vinod P.; Cohen, Alan A.; Jotkar, Raju M.; Rodriguez, Peter S.; Bassani, Diego G.; Suraweera, Wilson; Laxminarayan, Ramanan; Peto, Richard		Million Death Study Collaborators	Adult and child malaria mortality in India: a nationally representative mortality survey	LANCET			English	Article							VERBAL AUTOPSIES; DEATHS; BURDEN; VALIDATION; FRACTIONS; DISEASES; SMOKING; AFRICA; HEALTH; RATES	Background National malaria death rates are difficult to assess because reliably diagnosed malaria is likely to be cured, and deaths in the community from undiagnosed malaria could be misattributed in retrospective enquiries to other febrile causes of death, or vice-versa. We aimed to estimate plausible ranges of malaria mortality in India, the most populous country where the disease remains common. Methods Full-time non-medical field workers interviewed families or other respondents about each of 122 000 deaths during 2001-03 in 6671 randomly selected areas of India, obtaining a half-page narrative plus answers to specific questions about the severity and course of any fevers. Each field report was sent to two of 130 trained physicians, who independently coded underlying causes, with discrepancies resolved either via anonymous reconciliation or adjudication. Findings Of all coded deaths at ages 1 month to 70 years, 2681 (3.6%) of 75 342 were attributed to malaria. Of these, 2419 (90%) were in rural areas and 2311 (86%) were not in any health-care facility. Death rates attributed to malaria correlated geographically with local malaria transmission rates derived independently from the Indian malaria control programme. The adjudicated results show 205 000 malaria deaths per year in India before age 70 years (55 000 in early childhood, 30 000 at ages 5-14 years, 120 000 at ages 15-69 years); 1.8% cumulative probability of death from malaria before age 70 years. Plausible lower and upper bounds (on the basis of only the initial coding) were 125 000-277 000. Malaria accounted for a substantial minority of about 1.3 million unattended rural fever deaths attributed to infectious diseases in people younger than 70 years. Interpretation Despite uncertainty as to which unattended febrile deaths are from malaria, even the lower bound greatly exceeds the WHO estimate of only 15 000 malaria deaths per year in India (5000 early childhood, 10 000 thereafter). This low estimate should be reconsidered, as should the low WHO estimate of adult malaria deaths worldwide.	[Dhingra, Neeraj; Jha, Prabhat; Cohen, Alan A.; Jotkar, Raju M.; Rodriguez, Peter S.; Bassani, Diego G.; Suraweera, Wilson] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 2C5, Canada; [Dhingra, Neeraj; Jha, Prabhat; Cohen, Alan A.; Jotkar, Raju M.; Rodriguez, Peter S.; Bassani, Diego G.; Suraweera, Wilson] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5B 2C5, Canada; [Dhingra, Neeraj] Natl AIDS Control Org, New Delhi, India; [Sharma, Vinod P.] Indian Inst Technol, Ctr Rural Dev & Technol, New Delhi, India; [Jotkar, Raju M.] St Johns Res Inst, Bangalore, Karnataka, India; [Laxminarayan, Ramanan] Resources Future Inc, Washington, DC 20036 USA; [Peto, Richard] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Peto, Richard] Univ Oxford, Epidemiol Studies Unit, Oxford, England	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; St. John's National Academy of Health Sciences; St. John's Research Institute; Resources for the Future; University of Oxford; University of Oxford	Jha, P (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 2C5, Canada.	prabhatjha@utoronto.ca	Suraweera, Wilson MG/O-8962-2014; Laxminarayan, Ramanan/ABD-5050-2021; Bassani, Diego/G-2827-2015	Bassani, Diego/0000-0001-6704-3820; Cohen, Alan/0000-0003-4113-3988; Rodriguez, Peter/0000-0003-2272-9962; Suraweera, Wilson/0000-0001-9673-5746; Jha, Prabhat/0000-0001-7067-8341	Fogarty International Center of the US National Institutes of Health [R01 TW05991-01]; Canadian Institute of Health Research (CIHR) [IEG-53506]; Li Ka Shing Knowledge Institute; UK Medical Research Council; Keenan Research Centre at St Michael's Hospital, University of Toronto; FOGARTY INTERNATIONAL CENTER [R01TW005991] Funding Source: NIH RePORTER; Medical Research Council [MC_U137686857] Funding Source: researchfish; MRC [MC_U137686857] Funding Source: UKRI	Fogarty International Center of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Li Ka Shing Knowledge Institute(University of Toronto); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Keenan Research Centre at St Michael's Hospital, University of Toronto; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Registrar General of India established the SRS in 1971, has continued it ever since, and is collaborating with several of the authors on the ongoing Million Death Study. External funding is from the Fogarty International Center of the US National Institutes of Health (grant R01 TW05991-01), Canadian Institute of Health Research (CIHR; IEG-53506), Li Ka Shing Knowledge Institute and Keenan Research Centre at St Michael's Hospital, University of Toronto (CGHR support), and UK Medical Research Council (CTSU support). Additional support was provided by the Disease Control Priorities Network, University of Washington. PI le supported by the Canada Research Chair programme. The opinions expressed in this paper are those of the authors and do not necessarily represent those of the Government of India. We thank David Fisman, Hellen Gelband, Adrianna Murphy, and Torn Peto for comments, and Brendon Pezzack for graphics.	Adjuik M, 2006, B WORLD HEALTH ORGAN, V84, P181, DOI 10.2471/BLT.05.026492; Anker M, 1997, INT J EPIDEMIOL, V26, P1090, DOI 10.1093/ije/26.5.1090; [Anonymous], 2008, WORLD MAL REP 2008; Bawah AA, 2007, AM J TROP MED HYG, V77, P145, DOI 10.4269/ajtmh.2007.77.145; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bhat PNM, 2002, POP STUD-J DEMOG, V56, P119, DOI 10.1080/00324720215930; *CENTR BUR HLTH IN, 2007, NAT HLTH PROF 2007; Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x; Chaturvedi HK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-301; Cohen AA, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-1; Diamond-Smith Nadia, 2009, Malar J, V8, P24, DOI 10.1186/1475-2875-8-24; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; Gajalakshmi V, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-7; Gogoi S. C., 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P526; Gupta E, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-92; Hamer DH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-210; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; *INT I POP SCI, 2002, NAT FAM HLTH SURV 2; *INT I POP SCI, 2006, DLHS2 INT I POP SCI; Jain V, 2008, AM J TROP MED HYG, V79, P636; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P, 2001, NATL MED J INDIA, V14, P129; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c621; Joshi R, 2006, INT J EPIDEMIOL, V35, P1522, DOI 10.1093/ije/dyl168; Kleinschmidt I, 2000, INT J EPIDEMIOL, V29, P355, DOI 10.1093/ije/29.2.355; Kumar A, 2007, AM J TROP MED HYG, V77, P69, DOI 10.4269/ajtmh.2007.77.69; Kumar R, 2006, Indian J Public Health, V50, P90; Maude GH, 1997, INT J EPIDEMIOL, V26, P1097, DOI 10.1093/ije/26.5.1097; *NIMR NVBDCP, 2007, IN DEPTH REV MAL NAT; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; *REG GEN IND, 2005, MED CERT CAUS DEATH; *REG GEN IND, 2005, SAMPL REG SYST STAT; Registrar General of India and Center for Global Health Research, 2009, CAUS DEATH IND 2001; Reuben Rachel, 1997, Indian Journal of Pediatrics, V64, P243, DOI 10.1007/BF02752458; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Runsewe-Abiodun Iyabo T, 2006, BMC Pediatr, V6, P19, DOI 10.1186/1471-2431-6-19; Sarkar J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-133; Sharma SK, 2004, ANN TROP MED PARASIT, V98, P459, DOI 10.1179/000349804225003569; SIVANANDAN V, 2004, ASSESSMENT COMPLETEN; Smith D. L., 2009, SHRINKING MALARIA MA, P108; SNOW RW, 1992, LANCET, V340, P351, DOI 10.1016/0140-6736(92)91414-4; Talisuna A, 2009, LANCET, V374, P1224, DOI 10.1016/S0140-6736(09)61767-0; Tripathy R, 2007, PEDIATRICS, V120, pE454, DOI 10.1542/peds.2006-3171; United Nations Department of Economic and Social Affairs Population Division, 2008, WORLD POP PROSP; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 1994, INT STAT CLASS DIS R; [No title captured]	48	191	195	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 20	2010	376	9754					1768	1774		10.1016/S0140-6736(10)60831-8	http://dx.doi.org/10.1016/S0140-6736(10)60831-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	690EI	20970179	Green Accepted			2022-12-28	WOS:000284984900032
J	Vikstrom, I; Carotta, S; Luthje, K; Peperzak, V; Jost, PJ; Glaser, S; Busslinger, M; Bouillet, P; Strasser, A; Nutt, SL; Tarlinton, DM				Vikstrom, Ingela; Carotta, Sebastian; Luethje, Katja; Peperzak, Victor; Jost, Philipp J.; Glaser, Stefan; Busslinger, Meinrad; Bouillet, Philippe; Strasser, Andreas; Nutt, Stephen L.; Tarlinton, David M.			Mcl-1 Is Essential for Germinal Center Formation and B Cell Memory	SCIENCE			English	Article							PROSURVIVAL BCL-2 PROTEINS; ANTIBODY-FORMING-CELLS; AFFINITY MATURATION; SOMATIC HYPERMUTATION; CLONAL SELECTION; IMMUNE-RESPONSE; EXPRESSION; RECRUITMENT; MICE; FAS	Lymphocyte survival during immune responses is controlled by the relative expression of pro- and anti-apoptotic molecules, regulating the magnitude, quality, and duration of the response. We investigated the consequences of deleting genes encoding the anti-apoptotic molecules Mcl1 and Bcl2l1 (Bcl-xL) from B cells using an inducible system synchronized with expression of activation-induced cytidine deaminase (Aicda) after immunization. This revealed Mcl1 and not Bcl2l1 to be indispensable for the formation and persistence of germinal centers (GCs). Limiting Mcl1 expression reduced the magnitude of the GC response with an equivalent, but not greater, effect on memory B cell formation and no effect on persistence. Our results identify Mcl1 as the main anti-apoptotic regulator of activated B cell survival and suggest distinct mechanisms controlling survival of GC and memory B cells.	[Vikstrom, Ingela; Carotta, Sebastian; Luethje, Katja; Peperzak, Victor; Jost, Philipp J.; Glaser, Stefan; Bouillet, Philippe; Strasser, Andreas; Nutt, Stephen L.; Tarlinton, David M.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; [Bouillet, Philippe; Strasser, Andreas; Nutt, Stephen L.; Tarlinton, David M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia	Walter & Eliza Hall Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Melbourne	Tarlinton, DM (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	tarlinto@wehi.edu.au	Nutt, Stephen L/C-9256-2013; Strasser, Andreas/C-7581-2013; Busslinger, Meinrad J./J-1249-2016; Bouillet, Philippe/E-1241-2013; Jost, Philipp J./S-4962-2016	Nutt, Stephen L/0000-0002-0020-6637; Strasser, Andreas/0000-0002-5020-4891; Busslinger, Meinrad J./0000-0002-9111-9351; Bouillet, Philippe/0000-0002-9012-6058; Jost, Philipp J./0000-0003-2454-0362; Tarlinton, David/0000-0001-9928-686X	National Health and Medical Research Council (NHMRC) Australia [356202, 461221]; Leukemia and Lymphoma Society [7413]; NIH [CA43540, CA80188]; NHMRC; Pfizer Australia; Olle Engkvist Byggmastare Foundation; Wenner-Gren Foundation; German Academic Exchange Service; Charles and Sylvia Viertel Charitable Foundation; Boehringer Ingelheim; NATIONAL CANCER INSTITUTE [R01CA080188, R01CA043540] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Pfizer Australia(PfizerPfizer Australia); Olle Engkvist Byggmastare Foundation; Wenner-Gren Foundation; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Charles and Sylvia Viertel Charitable Foundation; Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Health and Medical Research Council (NHMRC) Australia (356202 to D. M. T. and S.L.N. and 461221 to P. B. and A. S.), the Leukemia and Lymphoma Society (SCOR grant 7413), and the NIH (CA43540 and CA80188). D. M. T. and A. S. are supported by fellowships from the NHMRC; S.L.N. by a Pfizer Australia Research Fellowship; I. V. by the Olle Engkvist Byggmastare and Wenner-Gren Foundations; K. L. by a fellowship from the German Academic Exchange Service; P. B. by the Charles and Sylvia Viertel Charitable Foundation; and M. B. by Boehringer Ingelheim. DNA sequence data are available in GenBank (accession number HM804028-HM804084). We are indebted to the facilities of our respective institutes, particularly those responsible for animal husbandry and flow cytometry. We also acknowledge the assistance of L. O'Reilly for Western blot antibodies and the many helpful discussions with members of the Walter and Eliza Hall Institute B Cell Program. Author contributions are as follows: I. V. and D. M. T. designed the research; I. V., K. L., S. G., V. P., S. C., and P.J. performed experiments and contributed to interpretation and discussion; M. B., P. B., A. S., and S.L.N. contributed to the design of experiments, interpretation of results, and drafting the manuscript; I. V., K. L., and V. P. analyzed data and prepared figures; and I. V. and D. M. T. wrote the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; ALLEN D, 1987, IMMUNOL REV, V96, P5, DOI 10.1111/j.1600-065X.1987.tb00506.x; Carrington EM, 2010, P NATL ACAD SCI USA, V107, P10967, DOI 10.1073/pnas.1005256107; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cho-Vega JH, 2004, HUM PATHOL, V35, P1095, DOI 10.1016/j.humpath.2004.04.018; CUMANO A, 1986, EMBO J, V5, P2459, DOI 10.1002/j.1460-2075.1986.tb04522.x; Fischer SF, 2007, BLOOD, V110, P3978, DOI 10.1182/blood-2007-05-091306; Haberman AM, 2003, NAT REV IMMUNOL, V3, P757, DOI 10.1038/nri1178; Hao ZY, 2008, IMMUNITY, V29, P615, DOI 10.1016/j.immuni.2008.07.016; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Ridderstad A, 1998, J IMMUNOL, V160, P4688; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; SMITH KGC, 1994, IMMUNITY, V1, P803, DOI 10.1016/S1074-7613(94)80022-7; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Takahashi Y, 1999, J EXP MED, V190, P399, DOI 10.1084/jem.190.3.399; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Wagner KU, 2000, DEVELOPMENT, V127, P4949; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yokoyama T, 2002, IMMUNOL LETT, V81, P107, DOI 10.1016/S0165-2478(02)00003-2	34	157	158	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1095	1099		10.1126/science.1191793	http://dx.doi.org/10.1126/science.1191793			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	20929728	Green Accepted			2022-12-28	WOS:000284374700041
J	Landers, SH				Landers, Steven H.			Why Health Care Is Going Home	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Cleveland Clin, Independence, OH USA	Cleveland Clinic Foundation	Landers, SH (corresponding author), Cleveland Clin, Independence, OH USA.							Corwin P, 2005, BRIT MED J, V330, P129, DOI 10.1136/bmj.38309.447975.EB; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Howard L, 2006, GASTROENTEROLOGY, V130, pS52, DOI 10.1053/j.gastro.2005.09.065; *J HOPK U RW JOHNS, 2004, PARTN SOL BETT LIV P; Leff B, 2005, ANN INTERN MED, V143, P798, DOI 10.7326/0003-4819-143-11-200512060-00008	5	45	45	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 28	2010	363	18					1690	1691		10.1056/NEJMp1000401	http://dx.doi.org/10.1056/NEJMp1000401			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	671XF	20961239				2022-12-28	WOS:000283546400003
J	Payne, D				Payne, David			Nutrition Sticky labels	BRITISH MEDICAL JOURNAL			English	Editorial Material							OSTEOARTHRITIS; GLUCOSAMINE		[Payne, David] BMJ, London WC1H 9JR, England		Payne, D (corresponding author), BMJ, London WC1H 9JR, England.	dpayne@bmj.com						*ALL NAT HLTH, 2009, NEUT OUR FREED SPEEC; BOWLER N, 2010, BBC NEWS        0707; Wandel S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4675; Wilkens P, 2010, JAMA-J AM MED ASSOC, V304, P45, DOI 10.1001/jama.2010.893; 1999, MIRROR          1004; 2010, C BRUSS 26 27 MAY; 2010, R LEHMANS J BLO 0712; NUTR HLTH CLAIMS EUR	8	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 26	2010	341								c5861	10.1136/bmj.c5861	http://dx.doi.org/10.1136/bmj.c5861			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674YE	20978067				2022-12-28	WOS:000283786800026
J	Smith, SK; Trevena, L; Simpson, JM; Barratt, A; Nutbeam, D; McCaffery, KJ				Smith, Sian K.; Trevena, Lyndal; Simpson, Judy M.; Barratt, Alexandra; Nutbeam, Don; McCaffery, Kirsten J.			A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PATIENT DECISION; INFORMATION NEEDS; QUALITY; INTERVENTIONS; PREFERENCES; LITERACY; OUTCOMES; CONSENT; ANXIETY; CARE	Objective To determine whether a decision aid designed for adults with low education and literacy can support informed choice and involvement in decisions about screening for bowel cancer. Design Randomised controlled trial. Setting Areas in New South Wales, Australia identified as socioeconomically disadvantaged (low education attainment, high unemployment, and unskilled occupations). Participants 572 adults aged between 55 and 64 with low educational attainment, eligible for bowel cancer screening. Intervention Patient decision aid comprising a paper based interactive booklet (with and without a question prompt list) and a DVD, presenting quantitative risk information on the possible outcomes of screening using faecal occult blood testing compared with no testing. The control group received standard information developed for the Australian national bowel screening programme. All materials and a faecal occult blood test kit were posted directly to people's homes. Main outcome measures Informed choice (adequate knowledge and consistency between attitudes and screening behaviour) and preferences for involvement in screening decisions. Results Participants who received the decision aid showed higher levels of knowledge than the controls; the mean score (maximum score 12) for the decision aid group was 6.50 (95% confidence interval 6.15 to 6.84) and for the control group was 4.10 (3.85 to 4.36; P<0.001). Attitudes towards screening were less positive in the decision aid group, with 51% of the participants expressing favourable attitudes compared with 65% of participants in the control group (14% difference, 95% confidence interval 5% to 23%; P=0.002). The participation rate for screening was reduced in the decision aid group: completion of faecal occult blood testing was 59% v 75% in the control group (16% difference, 8% to 24%; P=0.001). The decision aid increased the proportion of participants who made an informed choice, from 12% in the control group to 34% in the decision aid group (22% difference, 15% to 29%; P<0.001). More participants in the decision aid group had no decisional conflict about the screening decision compared with the controls (51% v 38%; P=0.02). The groups did not differ for general anxiety or worry about bowel cancer. Conclusions Tailored decision support information can be effective in supporting informed choices and greater involvement in decisions about faecal occult blood testing among adults with low levels of education, without increasing anxiety or worry about developing bowel cancer. Using a decision aid to make an informed choice may, however, lead to lower uptake of screening.	[Smith, Sian K.; Trevena, Lyndal; Barratt, Alexandra; McCaffery, Kirsten J.] Univ Sydney, Sydney Sch Publ Hlth, Ctr Med Psychol & Evidence Based Decis Making, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia; [Nutbeam, Don] Univ Southampton, Off Vice Chancellor, Southampton SO9 5NH, Hants, England	University of Sydney; University of Southampton	Smith, SK (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Ctr Med Psychol & Evidence Based Decis Making, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia.	sian.smith@sydney.edu.au	McCaffery, Kirsten/K-7945-2019; Nutbeam, Don/AAU-1571-2021; Barratt, Alexandra/A-7349-2011; Smith, Sian K/F-6470-2012; Smith-Lickess, Sian/V-5845-2019	McCaffery, Kirsten/0000-0003-2696-5006; Barratt, Alexandra/0000-0002-2561-3319; Smith, Sian K/0000-0002-9541-2221; Smith-Lickess, Sian/0000-0002-9541-2221; Simpson, Judy M/0000-0001-5172-3004; Nutbeam, Don/0000-0001-6497-2827; Trevena, Lyndal/0000-0003-1419-1832	National Health and Medical Research Council of Australia [457381]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the National Health and Medical Research Council of Australia (No 457381). The funder had no role in the design or conduct of the study, in the collection, analysis and interpretation of data, or in the preparation or approval of the manuscript.	*AG HEALTHC RES QU, 2009, MISS STAT BUDG; *AUSTR COMM SAF QU, 2009, WE WORK CONS ENG; *AUSTR I HLTH WELF, 2007, NAT BOW CANC SCREEN; Australian Bureau of Statistics, 2003, INF PAP CENS POP HOU; Australian Bureau of Statistics (ABS), 2008, AD LIT LIF SKILLS SU; Barnato AE, 2007, MED DECIS MAKING, V27, P626, DOI 10.1177/0272989x07306788; Bekker HL, 2010, PATIENT EDUC COUNS, V78, P357, DOI 10.1016/j.pec.2010.01.002; Bekker HL, 2003, PATIENT EDUC COUNS, V50, P255, DOI 10.1016/S0738-3991(03)00045-4; Campbell NC, 2007, BMJ-BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE; Clement S, 2009, PATIENT EDUC COUNS, V75, P340, DOI 10.1016/j.pec.2009.01.008; Crockett R, 2008, HEALTH CARE ANAL, V16, P17, DOI 10.1007/s10728-007-0056-6; Degner L F, 1997, Can J Nurs Res, V29, P21; *DEP HLTH UK, 2009, NHS CONST NHS BEL US; *DEP HLTH UK, 2009, NAT HLTH SERV CONST; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Doak CC, 1996, TEACHING PATIENTS LO; Dolan JG, 2002, MED DECIS MAKING, V22, P125, DOI 10.1177/02729890222063017; Elwyn G, 2006, BMJ-BRIT MED J, V333, P417, DOI 10.1136/bmj.38926.629329.AE; Elwyn G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004705; Entwistle VA, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1591; General Medical Council UK, 2008, CONS GUID PAT DOCT M; Gigerenzer G, 2003, BMJ-BRIT MED J, V327, P741, DOI 10.1136/bmj.327.7417.741; Gotzsche PC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b86; Griffith JM, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-10; Harrison JD, 2009, PATIENT EDUC COUNS, V76, P120, DOI 10.1016/j.pec.2008.12.013; Haynes R Brian, 2002, ACP J Club, V136, pA11; Healthier Hospitals Tools, 2015, HLTH HOSP PRACT GREE; Hibbard JH, 2003, ANNU REV PUBL HEALTH, V24, P413, DOI 10.1146/annurev.publhealth.24.100901.141005; Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI 10.1016/j.pec.2005.05.004; Howard K, 2005, J MED SCREEN, V12, P96, DOI 10.1258/0969141053908276; Huang N, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-18; Irwig L, 2006, BMJ-BRIT MED J, V332, P1148, DOI 10.1136/bmj.332.7550.1148; Kinnersley P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a485; MALENKA DJ, 1993, J GEN INTERN MED, V8, P543, DOI 10.1007/BF02599636; Marteau T M, 2001, Health Expect, V4, P99, DOI 10.1046/j.1369-6513.2001.00140.x; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Mathieu E, 2007, ARCH INTERN MED, V167, P2039, DOI 10.1001/archinte.167.19.2039; McCaffery K, 2007, MED DECIS MAKING, V27, P619, DOI 10.1177/0272989x07306787; Michie S, 2002, PATIENT EDUC COUNS, V48, P87, DOI 10.1016/S0738-3991(02)00089-7; Montori VM, 2008, JAMA-J AM MED ASSOC, V300, P1814, DOI 10.1001/jama.300.15.1814; *NAT HLTH MRC AUST, 2000, GUID PREV EARL DET M; Nelson WL, 2007, MED DECIS MAKING, V27, P609, DOI 10.1177/0272989x07306780; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; O'Connor AM, 1999, BRIT MED J, V319, P731, DOI 10.1136/bmj.319.7212.731; O'Connor AM., 1995, DECISION SELF EFFICA; OCONNOR AM, 2008, DECISIONAL CONFLICT; OCONNOR AM, 1996, ACCEPTABILITY TOOL U; Pignone M, 2000, ANN INTERN MED, V133, P761, DOI 10.7326/0003-4819-133-10-200011210-00008; Raffle A E, 2001, Health Expect, V4, P92, DOI 10.1046/j.1369-6513.2001.00138.x; Sainfort F, 2000, MED DECIS MAKING, V20, P51, DOI 10.1177/0272989X0002000107; *SENS SCI, 2009, MAK SENS SCREEN; Smith SK, 2008, HEALTH EXPECT, V11, P123, DOI 10.1111/j.1369-7625.2008.00489.x; Smith SK, 2009, PATIENT EDUC COUNS, V75, P358, DOI 10.1016/j.pec.2009.01.012; SUTTON S, 1994, J EPIDEMIOL COMMUN H, V48, P65, DOI 10.1136/jech.48.1.65; TORGERSON DJ, 1994, BMJ-BRIT MED J, V308, P117, DOI 10.1136/bmj.308.6921.117; Trevena LJ, 2008, J MED SCREEN, V15, P76, DOI 10.1258/jms.2008.007110; Wolf AMD, 2000, J GEN INTERN MED, V15, P24, DOI 10.1046/j.1525-1497.2000.01079.x; Young AF, 2001, AUST NZ J PUBL HEAL, V25, P417, DOI 10.1111/j.1467-842X.2001.tb00284.x	58	161	161	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	2010	341								c5370	10.1136/bmj.c5370	http://dx.doi.org/10.1136/bmj.c5370			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674YE	20978060	hybrid, Green Published			2022-12-28	WOS:000283786800003
J	Whitehead, M; Hanratty, B; Popay, J				Whitehead, Margaret; Hanratty, Barbara; Popay, Jennie			NHS reform: untried remedies for misdiagnosed problems?	LANCET			English	Editorial Material									[Whitehead, Margaret; Hanratty, Barbara] Univ Liverpool, Dept Hlth Inequal & Social Determinants Hlth, Liverpool L69 3GB, Merseyside, England; [Popay, Jennie] Univ Lancaster, Div Hlth Res, Lancaster, England	University of Liverpool; Lancaster University	Whitehead, M (corresponding author), Univ Liverpool, Dept Hlth Inequal & Social Determinants Hlth, Liverpool L69 3GB, Merseyside, England.	mmw@liverpool.ac.uk	Hanratty, Barbara/AAH-1801-2019	Hanratty, Barbara/0000-0002-3122-7190	National Institute for Health Research [CDF-2009-02-37] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Beral V, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4112; Britten N., 2008, MED SOC PATIENTS PRO; COOTE A, 2008, ENGAGING PATIENTS PU; Davis K, 2010, MIRROR MIRROR WALL U; Department of Health, 2010, EQ EXC LIB NHS; Dixon A, PATIENT CHOICE PATIE; Dixon Anna, 2006, J Health Serv Res Policy, V11, P162, DOI 10.1258/135581906777641668; Leatherman S, 2008, QUEST QUALITY REFINI; Popay J., 2007, COMMUNITY ENGAGEMENT; Thorlby R, 2010, HIGH PERFORMING NHS; Walshe K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3843; WHITEHEAD M, 1994, BRIT MED J, V308, P1284, DOI 10.1136/bmj.308.6939.1284; Wilkinson E, 2009, LANCET, V374, P964, DOI 10.1016/S0140-6736(09)61648-2	13	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 23	2010	376	9750					1373	1375		10.1016/S0140-6736(10)61231-7	http://dx.doi.org/10.1016/S0140-6736(10)61231-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	672ZO	20932566				2022-12-28	WOS:000283627500010
J	Schultz, PH; Hermalyn, B; Colaprete, A; Ennico, K; Shirley, M; Marshall, WS				Schultz, Peter H.; Hermalyn, Brendan; Colaprete, Anthony; Ennico, Kimberly; Shirley, Mark; Marshall, William S.			The LCROSS Cratering Experiment	SCIENCE			English	Article							WATER; IMPACTS; SURFACE	As its detached upper-stage launch vehicle collided with the surface, instruments on the trailing Lunar Crater Observation and Sensing Satellite (LCROSS) Shepherding Spacecraft monitored the impact and ejecta. The faint impact flash in visible wavelengths and thermal signature imaged in the mid-infrared together indicate a low-density surface layer. The evolving spectra reveal not only OH within sunlit ejecta but also other volatile species. As the Shepherding Spacecraft approached the surface, it imaged a 25- to-30-meter-diameter crater and evidence of a high-angle ballistic ejecta plume still in the process of returning to the surface-an evolution attributed to the nature of the impactor.	[Schultz, Peter H.; Hermalyn, Brendan] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Colaprete, Anthony; Ennico, Kimberly; Shirley, Mark; Marshall, William S.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Marshall, William S.] Univ Space Res Assoc, Mountain View, CA 94043 USA	Brown University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Universities Space Research Association (USRA)	Schultz, PH (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	peter_schultz@brown.edu	Ennico, Kimberly/L-9606-2014		LCROSS Project; NASA's Exploration Systems Mission Directorate (ESMD); NASA Science Mission Directorate (SMD); NASA	LCROSS Project; NASA's Exploration Systems Mission Directorate (ESMD); NASA Science Mission Directorate (SMD)(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA))	We thank the LCROSS Project and NASA's Exploration Systems Mission Directorate (ESMD) and NASA Science Mission Directorate (SMD; Planetary Geology and Geophysics) for support. We are also very grateful to the NASA Ames Vertical Gun Range technical team and the Thermophysics Facilities Branch at NASA Ames for their continued support in experiments. B. H. was supported through a NASA Rhode Island Space Grant fellowship for part of this study.	Anderson JLB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002075; Clark RN, 2009, SCIENCE, V326, P562, DOI 10.1126/science.1178105; Colaprete A, 2010, SCIENCE, V330, P463, DOI 10.1126/science.1186986; Ernst CA, 2007, ICARUS, V190, P334, DOI 10.1016/j.icarus.2007.03.030; ERNST CM, 2005, LUN PLAN SCI C, V36, P1475; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Gladstone GR, 2010, SCIENCE, V330, P472, DOI 10.1126/science.1186474; HARRIS RS, 2007, 1360 LPI; Hermalyn B., 2010, LUNAR PLANET SCI, P41; Hermalyn B, 2010, ICARUS, V209, P866, DOI 10.1016/j.icarus.2010.05.025; HODGES RR, 1973, J GEOPHYS RES, V78, P8055, DOI 10.1029/JA078i034p08055; HOUSEN KR, 1983, J GEOPHYS RES, V88, P2485, DOI 10.1029/JB088iB03p02485; Korycansky DG, 2009, METEORIT PLANET SCI, V44, P603, DOI 10.1111/j.1945-5100.2009.tb00755.x; Ong L, 2010, ICARUS, V207, P578, DOI 10.1016/j.icarus.2009.12.012; Paige DA, 2010, SCIENCE, V330, P479, DOI 10.1126/science.1187726; Pieters CM, 2009, SCIENCE, V326, P568, DOI 10.1126/science.1178658; POTTER AE, 1988, SCIENCE, V241, P675, DOI 10.1126/science.241.4866.675; Schultz PH, 2007, ICARUS, V190, P295, DOI 10.1016/j.icarus.2007.06.006; Schultz PH, 2006, NATURE, V444, P184, DOI 10.1038/nature05303; SCHULTZ PH, 2006, WORKSH LUN CRAT OBS; SCHULTZ PH, 2009, EOS T AGU, V90; Sunshine JM, 2009, SCIENCE, V326, P565, DOI 10.1126/science.1179788	22	112	114	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					468	472		10.1126/science.1187454	http://dx.doi.org/10.1126/science.1187454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966243				2022-12-28	WOS:000283329100029
J	Sharma, M; Yi, MG; Dong, H; Qin, HJ; Peterson, E; Busath, DD; Zhou, HX; Cross, TA				Sharma, Mukesh; Yi, Myunggi; Dong, Hao; Qin, Huajun; Peterson, Emily; Busath, David D.; Zhou, Huan-Xiang; Cross, Timothy A.			Insight into the Mechanism of the Influenza A Proton Channel from a Structure in a Lipid Bilayer	SCIENCE			English	Article							M2 ION-CHANNEL; VIRUS; TRANSMEMBRANE; SELECTIVITY; AMANTADINE; STATE; HISTIDINE; PROTEIN; MODEL; CONDUCTANCE	The M2 protein from the influenza A virus, an acid-activated proton-selective channel, has been the subject of numerous conductance, structural, and computational studies. However, little is known at the atomic level about the heart of the functional mechanism for this tetrameric protein, a His(37)-Trp(41) cluster. We report the structure of the M2 conductance domain (residues 22 to 62) in a lipid bilayer, which displays the defining features of the native protein that have not been attainable from structures solubilized by detergents. We propose that the tetrameric His(37)-Trp(41) cluster guides protons through the channel by forming and breaking hydrogen bonds between adjacent pairs of histidines and through specific interactions of the histidines with the tryptophan gate. This mechanism explains the main observations on M2 proton conductance.	[Yi, Myunggi; Dong, Hao; Zhou, Huan-Xiang] Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA; [Sharma, Mukesh; Qin, Huajun; Cross, Timothy A.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Sharma, Mukesh; Cross, Timothy A.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Yi, Myunggi; Dong, Hao; Zhou, Huan-Xiang; Cross, Timothy A.] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Peterson, Emily; Busath, David D.] Brigham Young Univ, Dept Physiol & Dev Biol, Provo, UT 84602 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Brigham Young University	Zhou, HX (corresponding author), Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA.	hzhou4@fsu.edu; cross@magnet.fsu.edu	Zhou, Huan-Xiang/M-5170-2016; Sharma, Mukesh/F-8328-2010; Dong, Hao/H-2054-2011; zhou, huan/GYJ-4398-2022; Zhou, Huan-Xiang/AAH-9836-2020	Zhou, Huan-Xiang/0000-0001-9020-0302; Sharma, Mukesh/0000-0003-3036-1846; Zhou, Huan-Xiang/0000-0001-9020-0302; Cross, Timothy/0000-0002-9413-0505	National Institute of Allergy and Infectious Diseases [AI023007]; NSF Division of Materials Research [0654118]; State of Florida [0654118]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023007] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NSF Division of Materials Research(National Science Foundation (NSF)); State of Florida; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institute of Allergy and Infectious Diseases grant AI023007. The spectroscopy was conducted at the National High Magnetic Field Laboratory supported by Cooperative Agreement 0654118 between the NSF Division of Materials Research and the State of Florida. T.A.C., H.-X.Z., D.D.B., M.S., and M.Y. have applied for a patent on the mechanism reported here. The structure (an ensemble of eight models) has been deposited in the Protein Data Bank with accession code 2L0J.	Acharya R, 2010, P NATL ACAD SCI USA, V107, P15075, DOI 10.1073/pnas.1007071107; Cady SD, 2008, P NATL ACAD SCI USA, V105, P1483, DOI 10.1073/pnas.0711500105; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Chizhmakov IV, 2003, J PHYSIOL-LONDON, V546, P427, DOI 10.1113/jphysiol.2002.028910; Chizhmakov IV, 1996, J PHYSIOL-LONDON, V494, P329, DOI 10.1113/jphysiol.1996.sp021495; Cross TA, 2011, TRENDS BIOCHEM SCI, V36, P117, DOI 10.1016/j.tibs.2010.07.005; GUBAREVA L, 2009, MMWR-MORBID MORTAL W, V58, P1; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Hu J, 2007, BIOPHYS J, V92, P4335, DOI 10.1529/biophysj.106.090183; KRAUSE JA, 1991, ACTA CRYSTALLOGR B, V47, P506, DOI 10.1107/S0108768191000915; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Li C, 2007, BBA-BIOMEMBRANES, V1768, P3162, DOI 10.1016/j.bbamem.2007.08.025; Lin TI, 2001, J VIROL, V75, P3647, DOI 10.1128/JVI.75.8.3647-3656.2001; Ma CL, 2009, P NATL ACAD SCI USA, V106, P12283, DOI 10.1073/pnas.0905726106; Mould JA, 2000, J BIOL CHEM, V275, P8592, DOI 10.1074/jbc.275.12.8592; Nishimura K, 2002, BIOCHEMISTRY-US, V41, P13170, DOI 10.1021/bi0262799; Okada A, 2001, BIOCHEMISTRY-US, V40, P6053, DOI 10.1021/bi0028441; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; QUICK A, 1976, CAN J CHEM, V54, P2465, DOI 10.1139/v76-350; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Song XJ, 2001, MAGN RESON CHEM, V39, pS37, DOI 10.1002/mrc.957; Song XJ, 2001, MAGN RESON CHEM, V39, pS30, DOI 10.1002/mrc.956; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Takeda M, 2002, J VIROL, V76, P1391, DOI 10.1128/JVI.76.3.1391-1399.2002; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; Tatara W, 2003, J PHYS CHEM A, V107, P7827, DOI 10.1021/jp030065z; Tian CL, 2003, PROTEIN SCI, V12, P2597, DOI 10.1110/ps.03168503; Venkataraman P, 2005, J BIOL CHEM, V280, P21463, DOI 10.1074/jbc.M412406200; Yi M, 2008, J PHYS CHEM B, V112, P7977, DOI 10.1021/jp800171m; Yi MG, 2009, P NATL ACAD SCI USA, V106, P13311, DOI 10.1073/pnas.0906553106	31	365	366	6	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					509	512		10.1126/science.1191750	http://dx.doi.org/10.1126/science.1191750			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966252	Green Accepted			2022-12-28	WOS:000283329100041
J	Duker, AP; Espay, AJ				Duker, Andrew P.; Espay, Alberto J.			Hemichorea-Hemiballism after Diabetic Ketoacidosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Duker, Andrew P.; Espay, Alberto J.] Univ Cincinnati, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Duker, AP (corresponding author), Univ Cincinnati, Cincinnati, OH 45221 USA.	andrew.duker@uc.edu	Espay, Alberto J./AAC-4255-2020	Espay, Alberto J./0000-0002-3389-136X; Duker, Andrew/0000-0002-7142-9563					0	18	19	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2010	363	17					E27	E27		10.1056/NEJMicm0909769	http://dx.doi.org/10.1056/NEJMicm0909769			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668BD	20961240				2022-12-28	WOS:000283242700011
J	Lahtela, J; Nousiainen, HO; Stefanovic, V; Tallila, J; Viskari, H; Karikoski, R; Gentile, M; Saloranta, C; Varilo, T; Salonen, R; Kestila, M				Lahtela, Jenni; Nousiainen, Heidi O.; Stefanovic, Vedran; Tallila, Jonna; Viskari, Heli; Karikoski, Riitta; Gentile, Massimiliano; Saloranta, Carola; Varilo, Teppo; Salonen, Riitta; Kestila, Marjo			Brief Report: Mutant CHUK and Severe Fetal Encasement Malformation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BARTSOCAS-PAPAS-SYNDROME; KAPPA-B-KINASE; IKK-ALPHA; EPIDERMAL DIFFERENTIATION; MICE LACKING; SKIN; MORPHOGENESIS; CANCER	We report an autosomal recessive lethal syndrome characterized by multiple fetal malformations, the most obvious anomalies being the defective face and seemingly absent limbs, which are bound to the trunk and encased under the skin. We identified the molecular defect that causes this syndrome, using a combined strategy of gene-expression arrays, candidate-gene analysis, clinical studies, and genealogic investigations. A point mutation in two affected fetuses led to the loss of the conserved helix-loop-helix ubiquitous kinase (CHUK), also known as I(kappa)B kinase (alpha). CHUK has an essential role in the development of skin epidermis and its derivatives, along with various other morphogenetic events. (Funded by the Academy of Finland and others.).	[Kestila, Marjo] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Biomedicum Helsinki, Helsinki 00251, Finland; [Stefanovic, Vedran] Helsinki Univ Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Karikoski, Riitta] Helsinki Univ Hosp, Dept Pathol, Helsinki, Finland; [Saloranta, Carola] Helsinki Univ Hosp, Dept Clin Genet, Helsinki, Finland; [Gentile, Massimiliano] Univ Helsinki, Biomedicum Genom, Helsinki, Finland; [Varilo, Teppo] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Salonen, Riitta] Vaestoliitto, Dept Med Genet, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki	Kestila, M (corresponding author), Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Biomedicum Helsinki, POB 104, Helsinki 00251, Finland.	marjo.kestila@thl.fi	Gentile, Massimo/R-3270-2016; Stefanovic, Vedran/L-8905-2013	Gentile, Massimo/0000-0002-5256-0726; Stefanovic, Vedran/0000-0001-5230-1698; Varilo, Teppo/0000-0002-5839-8854; Lahtela, Jenni Salla Pauliina/0000-0001-5664-0021	Academy of Finland [211124, 118468]; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	Supported by grants (211124 and 118468) from the Academy of Finland and by grants from the Sigrid Juselius Foundation (all to Dr. Kestil).	BARTSOCAS CS, 1972, J MED GENET, V9, P222, DOI 10.1136/jmg.9.2.222; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Davis George E., 2007, Birth Defects Research, V81, P270, DOI 10.1002/bdrc.20107; Descargues P, 2008, EMBO J, V27, P2639, DOI 10.1038/emboj.2008.196; Gareus R, 2007, NAT CELL BIOL, V9, P461, DOI 10.1038/ncb1560; HENNEKAM RCM, 1994, AM J MED GENET, V53, P102, DOI 10.1002/ajmg.1320530203; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Lanford, 1987, P GREENWOOD GENET CT, V6, P10; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; VARILO T, 1999, THESIS U HELINSKI HE; Veenstra-Knol HE, 2003, AM J MED GENET A, V123A, P243, DOI 10.1002/ajmg.a.20308; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	18	44	46	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2010	363	17					1631	1637		10.1056/NEJMoa0911698	http://dx.doi.org/10.1056/NEJMoa0911698			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668BD	20961246				2022-12-28	WOS:000283242700007
J	Roignant, JY; Treisman, JE				Roignant, Jean-Yves; Treisman, Jessica E.			Exon Junction Complex Subunits Are Required to Splice Drosophila MAP Kinase, a Large Heterochromatic Gene	CELL			English	Article							OSKAR MESSENGER-RNA; RECEPTOR TYROSINE KINASE; MAGO-NASHI; SIGNALING PATHWAY; BINDING PROTEIN; CORE COMPLEX; CELL-DEATH; NONSENSE; EXPRESSION; TRANSLATION	The exon junction complex (EJC) is assembled on spliced mRNAs upstream of exon-exon junctions and can regulate their subsequent translation, localization, or degradation. We isolated mutations in Drosophila mago nashi (mago), which encodes a core EJC subunit, based on their unexpectedly specific effects on photoreceptor differentiation. Loss of Mago prevents epidermal growth factor receptor signaling, due to a large reduction in MAPK mRNA levels. MAPK expression also requires the EJC subunits Y14 and eIF4AIII and EJC-associated splicing factors. Mago depletion does not affect the transcription or stability of MAPK mRNA but alters its splicing pattern. MAPK expression from an exogenous promoter requires Mago only when the template includes introns. MAPK is the primary functional target of mago in eye development; in cultured cells, Mago knockdown disproportionately affects other large genes located in heterochromatin. These data support a nuclear role for EJC components in splicing a specific subset of introns.	[Roignant, Jean-Yves; Treisman, Jessica E.] NYU Sch Med, Kimmel Ctr Biol & Med, Dept Cell Biol, Skirball Inst, New York, NY 10016 USA	New York University	Treisman, JE (corresponding author), NYU Sch Med, Kimmel Ctr Biol & Med, Dept Cell Biol, Skirball Inst, 540 1st Ave, New York, NY 10016 USA.	jessica.treisman@med.nyu.edu		Roignant, Jean-Yves/0000-0003-1395-2150; Treisman, Jessica/0000-0002-7453-107X	National Institutes of Health [EY13777]; NATIONAL EYE INSTITUTE [R01EY013777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Robert Boswell, Barry Dickson, Anne Ephrussi, Ruth Lehmann, James Skeath, Daniel St Johnston, Marc Therrien, the Developmental Studies Hybridoma Bank, the Drosophila Genomics Resource Center, and the Bloomington Drosophila stock center for reagents. We also thank Antonio-Javier Lopez for searching for recursive splice sites in MAPK pre-mRNA and Madeline Crosby for providing a list of heterochromatic genes. We are grateful to the NYU Cancer Institute Genomics Facility and Laura Hogan for assistance with qRT-PCR and deep sequencing and to Stuart Brown and Zuojian Tang for bio-informatics analysis. The manuscript was improved by the critical comments of Sergio Astigarraga, Ines Carrrera, Kerstin Hofmeyer, Kevin Legent, Sylvie Ozon Rickman, Hyung Don Ryoo, Josie Steinhauer, Andrea Zamparini, and Jiri Zavadil. This work was supported by the National Institutes of Health (grant EY13777 to J.E.T.).	Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; BOSWELL RE, 1991, DEVELOPMENT, V113, P373; Burnette JM, 2005, GENETICS, V170, P661, DOI 10.1534/genetics.104.039701; Carrera I, 2008, MOL CELL BIOL, V28, P5238, DOI 10.1128/MCB.00747-08; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; CHENG J, 1994, MOL CELL BIOL, V14, P6317, DOI 10.1128/MCB.14.9.6317; Ciapponi L, 2001, GENE DEV, V15, P1540, DOI 10.1101/gad.886301; Degot S, 2004, J BIOL CHEM, V279, P33702, DOI 10.1074/jbc.M402754200; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Dimitri P, 2003, MOL BIOL EVOL, V20, P503, DOI 10.1093/molbev/msg048; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; EBERL DF, 1993, GENETICS, V134, P277; Fox-Walsh KL, 2005, P NATL ACAD SCI USA, V102, P16176, DOI 10.1073/pnas.0508489102; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; Gehring NH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000120; Gehring NH, 2009, CELL, V137, P536, DOI 10.1016/j.cell.2009.02.042; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Golembo M, 1996, DEVELOPMENT, V122, P223; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; Halfar K, 2001, DEVELOPMENT, V128, P1687; HAY BA, 1994, DEVELOPMENT, V120, P2121; Herold N, 2009, MOL CELL BIOL, V29, P281, DOI 10.1128/MCB.01415-08; HOU XS, 1995, CELL, V81, P63, DOI 10.1016/0092-8674(95)90371-2; Ideue T, 2007, GENE DEV, V21, P1993, DOI 10.1101/gad.1557907; Janody F, 2004, GENETICS, V166, P187, DOI 10.1534/genetics.166.1.187; Karim FD, 1998, DEVELOPMENT, V125, P1; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lee MH, 2007, PLOS GENET, V3, P2540, DOI 10.1371/journal.pgen.0030233; Li C, 2003, MOL CELL BIOL, V23, P7363, DOI 10.1128/MCB.23.20.7363-7376.2003; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Martin-Blanco E, 1999, DEVELOPMENT, V126, P5739; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Miura GI, 2006, DEV CELL, V10, P167, DOI 10.1016/j.devcel.2005.11.017; Mohr SE, 2001, GENE DEV, V15, P2886; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NEWMARK PA, 1994, DEVELOPMENT, V120, P1303; Newmark PA, 1997, DEVELOPMENT, V124, P3197; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Nykamp K, 2008, RNA, V14, P1378, DOI 10.1261/rna.1066008; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Parma DH, 2007, DEV BIOL, V308, P507, DOI 10.1016/j.ydbio.2007.06.007; Ponicsan SL, 2010, CURR OPIN GENET DEV, V20, P149, DOI 10.1016/j.gde.2010.01.004; Queenan AM, 1997, DEVELOPMENT, V124, P3871; Reichert VL, 2002, GENE DEV, V16, P2778, DOI 10.1101/gad.1030602; Roignant JY, 2009, INT J DEV BIOL, V53, P795, DOI 10.1387/ijdb.072483jr; Roignant JY, 2006, GENE DEV, V20, P795, DOI 10.1101/gad.1390506; Schwartz S, 2010, EMBO J, V29, P1629, DOI 10.1038/emboj.2010.71; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Shepard S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007853; Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; Srivastava M, 2007, CELL DEATH DIFFER, V14, P92, DOI 10.1038/sj.cdd.4401931; Stalder L, 2008, TRENDS CELL BIOL, V18, P315, DOI 10.1016/j.tcb.2008.04.005; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Trembley JH, 2005, MOL CELL BIOL, V25, P1446, DOI 10.1128/MCB.25.4.1446-1457.2005; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; Yang LH, 2003, DEV CELL, V4, P359, DOI 10.1016/S1534-5807(03)00059-5; Yu J, 2002, GENOME RES, V12, P1185, DOI 10.1101/gr.224602; Zhai RG, 2003, P NATL ACAD SCI USA, V100, P10860, DOI 10.1073/pnas.1832753100; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P11574, DOI 10.1073/pnas.0704946104	70	90	94	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					238	250		10.1016/j.cell.2010.09.036	http://dx.doi.org/10.1016/j.cell.2010.09.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946982	Green Accepted, Bronze			2022-12-28	WOS:000283052200013
J	Mather, JC				Mather, John C.			Politics and prophecy	NATURE			English	Editorial Material									NASA, Goddard Space Flight Ctr, Greenbelt, MD USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Mather, JC (corresponding author), NASA, Goddard Space Flight Ctr, Greenbelt, MD USA.								0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					S9	S9		10.1038/467S9a	http://dx.doi.org/10.1038/467S9a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944624	Bronze			2022-12-28	WOS:000282898700008
J	Wieseler, B; McGauran, N; Kaiser, T				Wieseler, Beate; McGauran, Natalie; Kaiser, Thomas			Finding studies on reboxetine: a tale of hide and seek	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIALS; REGISTRATION; PUBLICATION; DEPRESSION; GABAPENTIN; DOCUMENTS		[Wieseler, Beate; McGauran, Natalie; Kaiser, Thomas] Inst Qual & Efficiency Hlth Care, D-51105 Cologne, Germany		Wieseler, B (corresponding author), Inst Qual & Efficiency Hlth Care, Dillenburger Strasse 27, D-51105 Cologne, Germany.	beate.wieseler@iqwig.de		Wieseler, Beate/0000-0002-3519-754X; Kaiser, Thomas/0000-0003-0795-538X				Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; *FDA, 2010, IMPR SAF IMP FOOD ME; Hill KP, 2008, ANN INTERN MED, V149, P251, DOI 10.7326/0003-4819-149-4-200808190-00006; *I QUAL EFF HLTH C, 2009, A0520C I QUAL EFF HL; *I QUAL EFF HLTH C, 2008, GEN METH VERS 3 0; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; Page ME, 2003, CNS DRUG REV, V9, P327; Preskorn Sheldon H, 2004, J Psychiatr Pract, V10, P57, DOI 10.1097/00131746-200401000-00006; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Stafford N, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2521; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008; Turner EH, 2008, SCIENCE, V322, P44, DOI 10.1126/science.322.5898.44c; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Wood AJJ, 2009, NEW ENGL J MED, V360, P824, DOI 10.1056/NEJMsr0806582	17	21	21	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 12	2010	341								c4942	10.1136/bmj.c4942	http://dx.doi.org/10.1136/bmj.c4942			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663KN	20940211				2022-12-28	WOS:000282886900011
J	Hutchison, WD; Burkness, EC; Mitchell, PD; Moon, RD; Leslie, TW; Fleischer, SJ; Abrahamson, M; Hamilton, KL; Steffey, KL; Gray, ME; Hellmich, RL; Kaster, LV; Hunt, TE; Wright, RJ; Pecinovsky, K; Rabaey, TL; Flood, BR; Raun, ES				Hutchison, W. D.; Burkness, E. C.; Mitchell, P. D.; Moon, R. D.; Leslie, T. W.; Fleischer, S. J.; Abrahamson, M.; Hamilton, K. L.; Steffey, K. L.; Gray, M. E.; Hellmich, R. L.; Kaster, L. V.; Hunt, T. E.; Wright, R. J.; Pecinovsky, K.; Rabaey, T. L.; Flood, B. R.; Raun, E. S.			Areawide Suppression of European Corn Borer with Bt Maize Reaps Savings to Non-Bt Maize Growers	SCIENCE			English	Article							PEST-MANAGEMENT; INSECT RESISTANCE; TRANSGENIC CROPS; LEPIDOPTERA; PYRALIDAE; TOXIN; POPULATIONS; CRAMBIDAE; EVOLUTION; BOLLWORM	Transgenic maize engineered to express insecticidal proteins from the bacterium Bacillus thuringiensis (Bt) has become widely adopted in U. S. agriculture. In 2009, Bt maize was planted on more than 22.2 million hectares, constituting 63% of the U. S. crop. Using statistical analysis of per capita growth rate estimates, we found that areawide suppression of the primary pest Ostrinia nubilalis (European corn borer) is associated with Bt maize use. Cumulative benefits over 14 years are an estimated $3.2 billion for maize growers in Illinois, Minnesota, and Wisconsin, with more than $2.4 billion of this total accruing to non-Bt maize growers. Comparable estimates for Iowa and Nebraska are $3.6 billion in total, with $1.9 billion for non-Bt maize growers. These results affirm theoretical predictions of pest population suppression and highlight economic incentives for growers to maintain non-Bt maize refugia for sustainable insect resistance management.	[Hutchison, W. D.; Burkness, E. C.; Moon, R. D.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; [Mitchell, P. D.] Univ Wisconsin, Dept Agr & Appl Econ, Madison, WI 53706 USA; [Leslie, T. W.] Long Isl Univ, Dept Biol, Brooklyn, NY 11201 USA; [Fleischer, S. J.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Abrahamson, M.] Minnesota Dept Agr, St Paul, MN 55107 USA; [Hamilton, K. L.] Wisconsin Dept Agr Trade & Consumer Protect, Madison, WI 53718 USA; [Steffey, K. L.; Gray, M. E.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Hellmich, R. L.] ARS, USDA, Corn Insects & Crop Genet Res Unit, Genet Lab, Ames, IA 50011 USA; [Kaster, L. V.] Syngenta Seeds Inc, Slater, IA 50244 USA; [Hunt, T. E.] Univ Nebraska, Dept Entomol, NEREC, Haskell Agr Lab, Concord, NE 68728 USA; [Wright, R. J.] Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA; [Pecinovsky, K.] Iowa State Univ, Nashua, IA 50658 USA; [Rabaey, T. L.] Gen Mills Inc, Le Sueur, MN 56058 USA; [Flood, B. R.] Del Monte Foods, Rochelle, IL 61068 USA; [Raun, E. S.] Pest Management Co, Lincoln, NE 68506 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; Long Island University-Brooklyn Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA); Syngenta; University of Nebraska System; University of Nebraska System; University of Nebraska Lincoln; Iowa State University	Hutchison, WD (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.	hutch002@umn.edu	Moon, Roger/ABA-7225-2020; Fleischer, Shelby/AAD-6663-2020; Fleischer, Shelby/AAN-1392-2020	Hutchison, William D./0000-0001-9605-2996	University of Minnesota	University of Minnesota(University of Minnesota System)	This study is part of a large-scale monitoring program for O. nubilalis via cooperating members of USDA Multistate Project NC-205, "Ecology and Management of European Corn Borer and Other Lepidopteran Pests of Corn." Support was also provided by personnel with state departments of agriculture, agricultural experiment stations, and cooperative extension, and a grant from the Rapid Agricultural Response Fund, University of Minnesota. We acknowledge numerous growers who permitted data collection from commercial maize fields over the past 50 years. We thank J. Dyer, L. Lewis, B. Gunnarson, and R. Ritland for technical support, and Y. Carriere, J. Chapman, J.-Z. Zhou, and J. P. Chavas for reviews of earlier versions of the manuscript. P. D. M. also provides limited private economic consulting services to agencies, universities, and private companies, which in the past 3 years has included small projects for Monsanto, Pioneer Hi-Bred International, and Syngenta on topics unrelated to this paper. Mention of a proprietary product does not constitute an endorsement or a recommendation for its use by the universities associated with this research or the USDA.	ALSTAD DN, 1995, SCIENCE, V268, P1894, DOI 10.1126/science.268.5219.1894; Bartels DW, 1997, J ECON ENTOMOL, V90, P449, DOI 10.1093/jee/90.2.449; Brookes G., 2008, AgBioForum, V11, P21; Burkness EC, 2002, CROP PROT, V21, P157, DOI 10.1016/S0261-2194(01)00080-1; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Goldberger J., 2005, AgBioForum, V8, P151; Hellmich RL, 1999, J ECON ENTOMOL, V92, P1014, DOI 10.1093/jee/92.5.1014; HILL RE, 1979, ENVIRON ENTOMOL, V8, P91, DOI 10.1093/ee/8.1.91; Hurley TM, 2004, AM J AGR ECON, V86, P345, DOI 10.1111/j.0092-5853.2004.00583.x; HUTCHISON W, 2008, MINNESOTA FRUIT 0606; Lewis LC, 2009, BIOL CONTROL, V48, P223, DOI 10.1016/j.biocontrol.2008.10.009; LEWIS P, 2001, 200007A SAP US EPA, P5; MASON CE, 1996, NCR327 IOW STAT U; Mitchell PD, 2002, J AGR RESOUR ECON, V27, P390; O'Rourke ME, 2010, ECOL APPL, V20, P1228, DOI 10.1890/09-0067.1; Onstad DW, 1999, J ECON ENTOMOL, V92, P1256, DOI 10.1093/jee/92.6.1256; OSTLIE KR, 1997, NCR602 U MINN; Pereira EJG, 2008, B ENTOMOL RES, V98, P621, DOI 10.1017/S0007485308005920; Pilcher CD, 2002, J ECON ENTOMOL, V95, P878, DOI 10.1603/0022-0493-95.5.878; Reardon BJ, 2006, J ECON ENTOMOL, V99, P1641, DOI 10.1603/0022-0493-99.5.1641; Royama T., 1992, ANAL POPULATION ECOL; Shelton AM, 2006, ANNU REV ENTOMOL, V51, P285, DOI 10.1146/annurev.ento.51.110104.150959; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; Sisterson MS, 2004, J ECON ENTOMOL, V97, P1413, DOI 10.1603/0022-0493-97.4.1413; Storer Nicholas P., 2008, V5, P273, DOI 10.1007/978-1-4020-8373-0_10; Tabashnik BE, 2008, P NATL ACAD SCI USA, V105, P19029, DOI 10.1073/pnas.0810763106; USDA-ARS, AD GEN ENG CROPS US; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550	29	460	490	3	225	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					222	225		10.1126/science.1190242	http://dx.doi.org/10.1126/science.1190242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929774	Green Published			2022-12-28	WOS:000282644600042
J	Zapperi, S				Zapperi, Stefano			Looking at How Things Slip	SCIENCE			English	Editorial Material							FRICTION; ONSET		[Zapperi, Stefano] CNR IENI, I-20125 Milan, Italy; [Zapperi, Stefano] ISI Fdn, I-10133 Turin, Italy	Consiglio Nazionale delle Ricerche (CNR)	Zapperi, S (corresponding author), CNR IENI, Via R Cozzi 53, I-20125 Milan, Italy.	stefano.zapperi@cnr.it	Zapperi, Stefano/C-9473-2009	Zapperi, Stefano/0000-0001-5692-5465				Ben-David O, 2010, SCIENCE, V330, P211, DOI 10.1126/science.1194777; Bertotti G., 1998, HYSTERESIS MAGNETISM; Braun OM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.194301; Chauve P, 1998, EUROPHYS LETT, V44, P110, DOI 10.1209/epl/i1998-00443-7; He G, 1999, SCIENCE, V284, P1650, DOI 10.1126/science.284.5420.1650; Reguzzoni M, 2010, P NATL ACAD SCI USA, V107, P1311, DOI 10.1073/pnas.0909993107; Rubinstein SM, 2004, NATURE, V430, P1005, DOI 10.1038/nature02830	7	4	4	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					184	185		10.1126/science.1196859	http://dx.doi.org/10.1126/science.1196859			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929763				2022-12-28	WOS:000282644600027
J	Haigh, JD; Winning, AR; Toumi, R; Harder, JW				Haigh, Joanna D.; Winning, Ann R.; Toumi, Ralf; Harder, Jerald W.			An influence of solar spectral variations on radiative forcing of climate	NATURE			English	Article							IRRADIANCE VARIATIONS; UV IRRADIANCE; RECONSTRUCTION; MODEL	The thermal structure and composition of the atmosphere is determined fundamentally by the incoming solar irradiance. Radiation at ultraviolet wavelengths dissociates atmospheric molecules, initiating chains of chemical reactions-specifically those producing stratospheric ozone-and providing the major source of heating for the middle atmosphere, while radiation at visible and near-infrared wavelengths mainly reaches and warms the lower atmosphere and the Earth's surface(1). Thus the spectral composition of solar radiation is crucial in determining atmospheric structure, as well as surface temperature, and it follows that the response of the atmosphere to variations in solar irradiance depends on the spectrum(2). Daily measurements of the solar spectrum between 0.2 mu m and 2.4 mu m, made by the Spectral Irradiance Monitor (SIM) instrument on the Solar Radiation and Climate Experiment (SORCE) satellite(3) since April 2004, have revealed(4) that over this declining phase of the solar cycle there was a four to six times larger decline in ultraviolet than would have been predicted on the basis of our previous understanding. This reduction was partially compensated in the total solar output by an increase in radiation at visible wavelengths. Here we show that these spectral changes appear to have led to a significant decline from 2004 to 2007 in stratospheric ozone below an altitude of 45 km, with an increase above this altitude. Our results, simulated with a radiative-photochemical model, are consistent with contemporaneous measurements of ozone from the Aura-MLS satellite, although the short time period makes precise attribution to solar effects difficult. We also show, using the SIM data, that solar radiative forcing of surface climate is out of phase with solar activity. Currently there is insufficient observational evidence to validate the spectral variations observed by SIM, or to fully characterize other solar cycles, but our findings raise the possibility that the effects of solar variability on temperature throughout the atmosphere may be contrary to current expectations.	[Haigh, Joanna D.; Winning, Ann R.; Toumi, Ralf] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2AZ, England; [Harder, Jerald W.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA	Imperial College London; University of Colorado System; University of Colorado Boulder	Haigh, JD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Prince Consort Rd, London SW7 2AZ, England.	j.haigh@imperial.ac.uk	Haigh, Joanna D/F-6847-2014	Haigh, Joanna D/0000-0001-5504-4754	UK Natural Environment Research Council SOLCLI consortium; NERC [NE/D002753/1] Funding Source: UKRI; Natural Environment Research Council [NE/D002753/1] Funding Source: researchfish	UK Natural Environment Research Council SOLCLI consortium; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was partially funded by the UK Natural Environment Research Council SOLCLI consortium project. We are grateful to J. L. Lean for providing solar spectra, to W. J. Randel for advice on data analysis and to L. Froidevaux for advice on the EOS Aura-MLS data. The MLS data were obtained from the instrument website (http://mls.jpl.nasa.gov/index-eos-mls.php).	Bekki S, 1996, GEOPHYS RES LETT, V23, P2669, DOI 10.1029/96GL02088; Brasseur G., 1984, AERONOMY MIDDLE ATMO; Cahalan RF, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041898; Frohlich C, 2009, ASTRON ASTROPHYS, V501, pL27, DOI 10.1051/0004-6361/200912318; Gray LJ, 2010, REV GEOPHYS, V48, DOI 10.1029/2009RG000282; HAIGH JD, 1994, NATURE, V370, P544, DOI 10.1038/370544a0; HAIGH JD, 1979, NATURE, V279, P222, DOI 10.1038/279222a0; Harder J, 2005, SOL PHYS, V230, P141, DOI 10.1007/s11207-005-5007-5; Harder JW, 2010, SOL PHYS, V263, P3, DOI 10.1007/s11207-010-9555-y; Harder JW, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036797; HARWOOD RS, 1975, Q J ROY METEOR SOC, V101, P723, DOI 10.1002/qj.49710143003; Krivova NA, 2006, ASTRON ASTROPHYS, V452, P631, DOI 10.1051/0004-6361:20064809; Krivova NA, 2003, ASTRON ASTROPHYS, V399, pL1, DOI 10.1051/0004-6361:20030029; Larkin A, 2000, SPACE SCI REV, V94, P199, DOI 10.1023/A:1026771307057; Lean J, 2000, GEOPHYS RES LETT, V27, P2425, DOI 10.1029/2000GL000043; Randel WJ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007339; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Soukharev BE, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007107; Warwick NJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019224	19	183	194	2	74	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 7	2010	467	7316					696	699		10.1038/nature09426	http://dx.doi.org/10.1038/nature09426			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20930841	Green Submitted			2022-12-28	WOS:000282572500035
J	Malekpour, M; Esfandbod, M				Malekpour, Mahdi; Esfandbod, Mohsen			Huntington's Chorea.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Malekpour, Mahdi; Esfandbod, Mohsen] Univ Tehran Med Sci, Tehran, Iran	Tehran University of Medical Sciences	Malekpour, M (corresponding author), Univ Tehran Med Sci, Tehran, Iran.		Malekpour, Mahdi/B-6174-2009; Nagele, Peter/A-2922-2008	Malekpour, Mahdi/0000-0002-7337-3479; Nagele, Peter/0000-0001-8369-3858; Esfandbod, Mohsen/0000-0002-6497-2306					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2010	363	15					E24	E24		10.1056/NEJMicm0908798	http://dx.doi.org/10.1056/NEJMicm0908798			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	659NV	20925538				2022-12-28	WOS:000282575100012
J	Nankivell, BJ; Alexander, SI				Nankivell, Brian J.; Alexander, Stephen I.			Mechanisms of Disease: Rejection of the Kidney Allograft.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ANTIBODY-MEDIATED REJECTION; RENAL-TRANSPLANT REJECTION; TUMOR-NECROSIS-FACTOR; CD4(+) T-CELLS; ORGAN-TRANSPLANTATION; CARDIAC ALLOGRAFTS; GRAFT-REJECTION; MESSENGER-RNA; EXPRESSION; COMPLEMENT		[Nankivell, Brian J.] Westmead Hosp, Dept Renal Med, Sydney, NSW, Australia; [Alexander, Stephen I.] Childrens Hosp Westmead, Ctr Kidney Res, Sydney, NSW, Australia; [Nankivell, Brian J.; Alexander, Stephen I.] Univ Sydney, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Nankivell, BJ (corresponding author), Westmead Hosp, Dept Renal Med, Westmead, NSW 2145, Australia.	brian_nankivell@wsahs.nsw.gov.au						Akalin E, 2001, TRANSPLANTATION, V72, P948, DOI 10.1097/00007890-200109150-00034; Al-Lamki RS, 2001, LAB INVEST, V81, P1503, DOI 10.1038/labinvest.3780364; Alegre ML, 2008, TRANSPLANTATION, V86, P1, DOI 10.1097/TP.0b013e31817c11e6; Anglicheau D, 2008, TRANSPLANTATION, V86, P192, DOI 10.1097/TP.0b013e31817eef7b; Baddoura FK, 2005, AM J TRANSPLANT, V5, P510, DOI 10.1111/j.1600-6143.2004.00714.x; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Bestard O, 2008, J AM SOC NEPHROL, V19, P1419, DOI 10.1681/ASN.2007050539; Bonsib SM, 2000, KIDNEY INT, V58, P2206, DOI 10.1046/j.1523-1755.2000.00395.x; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; Briscoe DM, 1998, CURR OPIN IMMUNOL, V10, P525, DOI 10.1016/S0952-7915(98)80218-5; Brown KM, 2006, NEW ENGL J MED, V354, P2014, DOI 10.1056/NEJMoa052825; Bunnag S, 2008, AM J TRANSPLANT, V8, P1423, DOI 10.1111/j.1600-6143.2008.02268.x; Chen Y, 2007, TRANSPLANTATION, V84, P1071, DOI 10.1097/01.tp.0000287126.12083.48; Colvin RB, 2007, J AM SOC NEPHROL, V18, P1046, DOI 10.1681/ASN.2007010073; Cornell LD, 2008, ANNU REV PATHOL-MECH, V3, P189, DOI 10.1146/annurev.pathmechdis.3.121806.151508; Csencsits KL, 2003, AM J TRANSPLANT, V3, P107, DOI 10.1034/j.1600-6143.2003.00036.x; Danovitch GM, 2003, AM J KIDNEY DIS, V42, P882, DOI 10.1016/j.ajkd.2003.07.017; Dooms H, 2006, IMMUNOL REV, V211, P23, DOI 10.1111/j.0105-2896.2006.00387.x; Dragun D, 2005, NEW ENGL J MED, V352, P558, DOI 10.1056/NEJMoa035717; Ely LK, 2008, CURR OPIN IMMUNOL, V20, P575, DOI 10.1016/j.coi.2008.07.006; Gudmundsdottir H, 2001, J IMMUNOL, V167, P3699, DOI 10.4049/jimmunol.167.7.3699; HAGERTY DT, 1992, J IMMUNOL, V148, P2324; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Hoffmann SC, 2005, AM J TRANSPLANT, V5, P573, DOI 10.1111/j.1600-6143.2005.00719.x; Hu HZ, 2009, TRANSPLANTATION, V87, P1814, DOI 10.1097/TP.0b013e3181a66b3e; IMAGAWA DK, 1991, TRANSPLANTATION, V51, P57, DOI 10.1097/00007890-199101000-00008; Jiang SQ, 2004, CURR OPIN IMMUNOL, V16, P550, DOI 10.1016/j.coi.2004.07.011; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kim IK, 2008, TRANSPLANTATION, V86, P889, DOI 10.1097/TP.0b013e318186ac4a; Kowalski RJ, 2006, TRANSPLANTATION, V82, P663, DOI 10.1097/01.tp.0000234837.02126.70; Kreisel D, 2002, J IMMUNOL, V169, P6154, DOI 10.4049/jimmunol.169.11.6154; LARSEN CP, 1990, J EXP MED, V171, P307, DOI 10.1084/jem.171.1.307; Li BG, 2001, NEW ENGL J MED, V344, P947, DOI 10.1056/NEJM200103293441301; Li XC, 2009, IMMUNOL REV, V229, P271, DOI 10.1111/j.1600-065X.2009.00781.x; Locke JE, 2009, AM J TRANSPLANT, V9, P231, DOI 10.1111/j.1600-6143.2008.02451.x; Lynch RJ, 2008, CURR OPIN ORGAN TRAN, V13, P165, DOI 10.1097/MOT.0b013e3282f6391e; Mariat C, 2009, TRANSPLANTATION, V87, pS84, DOI 10.1097/TP.0b013e3181a2ba83; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Middleton J, 2002, BLOOD, V100, P3853, DOI 10.1182/blood.V100.12.3853; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Morris PJ, 2004, NEW ENGL J MED, V351, P2678, DOI 10.1056/NEJMp048256; Muthukumar T, 2005, NEW ENGL J MED, V353, P2342, DOI 10.1056/NEJMoa051907; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Pescovitz MD, 2006, AM J TRANSPLANT, V6, P859, DOI 10.1111/j.1600-6143.2006.01288.x; Pratt JR, 2002, NAT MED, V8, P582, DOI 10.1038/nm0602-582; Reeve J, 2009, AM J TRANSPLANT, V9, P1802, DOI 10.1111/j.1600-6143.2009.02694.x; Robertson H, 2000, TRANSPLANTATION, V69, P684, DOI 10.1097/00007890-200002270-00039; Robertson H, 2003, AM J TRANSPLANT, V3, P3, DOI 10.1034/j.1600-6143.2003.30102.x; Sarwal M, 2003, NEW ENGL J MED, V349, P125, DOI 10.1056/NEJMoa035588; Sayegh MH, 2004, NEW ENGL J MED, V351, P2761, DOI 10.1056/NEJMon043418; Scornik JC, 2007, AM J TRANSPLANT, V7, P1808, DOI 10.1111/j.1600-6143.2007.01855.x; Segerer S, 2001, AM J KIDNEY DIS, V37, P518; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Stegall MD, 2010, CURR OPIN ORGAN TRAN, V15, P8, DOI 10.1097/MOT.0b013e3283342712; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Stratta RJ, 2006, SURGERY, V139, P324, DOI 10.1016/j.surg.2005.09.032; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; Sumitran-Holgersson S, 2008, CURR OPIN IMMUNOL, V20, P607, DOI 10.1016/j.coi.2008.07.005; Sun Q, 2006, KIDNEY INT, V70, P377, DOI 10.1038/sj.ki.5001552; Terasaki PI, 2003, AM J TRANSPLANT, V3, P665, DOI 10.1034/j.1600-6143.2003.00135.x; TERASAKI PI, 1995, NEW ENGL J MED, V333, P333, DOI 10.1056/NEJM199508103330601; Trowsdale J, 2004, EUR J IMMUNOL, V34, P7, DOI 10.1002/eji.200324693; Vella JP, 1997, TRANSPLANTATION, V64, P1823, DOI 10.1097/00007890-199712270-00033; Vincenti F, 2007, AM J TRANSPLANT, V7, P1770, DOI 10.1111/j.1600-6143.2007.01845.x; Vincenti F, 2005, NEW ENGL J MED, V353, P770, DOI 10.1056/NEJMoa050085; Vo AA, 2008, NEW ENGL J MED, V359, P242, DOI 10.1056/NEJMoa0707894; Womer KL, 2001, PHILOS T ROY SOC B, V356, P639, DOI 10.1098/rstb.2001.0843; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Wyburn KR, 2005, TRANSPLANTATION, V80, P1641, DOI 10.1097/01.tp.0000173903.26886.20; Zhai Y, 1999, CRIT REV IMMUNOL, V19, P155; Zhou WD, 2007, CURR OPIN IMMUNOL, V19, P569, DOI 10.1016/j.coi.2007.07.007; Zorn E, 2004, J EXP MED, V199, P1133, DOI 10.1084/jem.20031560; Zou YZ, 2007, NEW ENGL J MED, V357, P1293, DOI 10.1056/NEJMoa067160	74	398	426	1	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2010	363	15					1451	1462		10.1056/NEJMra0902927	http://dx.doi.org/10.1056/NEJMra0902927			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	659NV	20925547				2022-12-28	WOS:000282575100010
J	Maroulis, S; Guimera, R; Petry, H; Stringer, MJ; Gomez, LM; Amaral, LAN; Wilensky, U				Maroulis, S.; Guimera, R.; Petry, H.; Stringer, M. J.; Gomez, L. M.; Amaral, L. A. N.; Wilensky, U.			Complex Systems View of Educational Policy Research	SCIENCE			English	Editorial Material									[Maroulis, S.; Guimera, R.; Stringer, M. J.; Amaral, L. A. N.; Wilensky, U.] Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL 60208 USA; [Maroulis, S.; Petry, H.; Wilensky, U.] Northwestern Univ, Ctr Connected Learning & Comp Based Modeling, Evanston, IL 60208 USA; [Maroulis, S.] Ford Motor Co, Ctr Global Citizenship, Kellogg Sch Management, Evanston, IL 60208 USA; [Guimera, R.] Univ Rovira & Virgili, Inst Catalana Recerca & Estudis Advancats & Chem, Tarragona 43007, Catalonia, Spain; [Gomez, L. M.] Univ Pittsburgh, Sch Educ, Pittsburgh, PA 15260 USA; [Amaral, L. A. N.] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Ford Motor Company; Northwestern University; ICREA; Universitat Rovira i Virgili; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; Northwestern University	Wilensky, U (corresponding author), Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL 60208 USA.	uri@northwestern.edu	Amaral, LAN/A-4980-2008; Amaral, Luis N./C-5485-2009; Wilensky, Uriel/B-7279-2009; Guimera, Roger/C-1727-2008; Guimera, Roger/M-9808-2019	Amaral, LAN/0000-0002-3762-789X; Guimera, Roger/0000-0002-3597-4310; Guimera, Roger/0000-0002-3597-4310	Howard Hughes Medical Institute Funding Source: Medline; ICREA Funding Source: Custom	Howard Hughes Medical Institute(Howard Hughes Medical Institute); ICREA(ICREA)		ANDERSON R M, 1991; Borman GD, 2008, EDUC EVAL POLICY AN, V30, P389, DOI 10.3102/0162373708326283; Burt RS, 2000, RES ORGAN BEHAV, V22, P345, DOI 10.1016/S0191-3085(00)22009-1; CHEN C, 2009, AGENT BASED MODELING; Coburn CE, 2006, AM EDUC RES J, V43, P343, DOI 10.3102/00028312043003343; Cohen D. K., 1990, EDUC EVAL POLICY AN, V12, P311, DOI [10.3102/01623737012003311, DOI 10.3102/01623737012003311]; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Epple D, 2008, INT ECON REV, V49, P1395, DOI 10.1111/j.1468-2354.2008.00516.x; Epstein JM, 2009, NATURE, V460, P687, DOI 10.1038/460687a; Frank KA, 2008, AM J SOCIOL, V113, P1645, DOI 10.1086/587153; Goldhaber DD, 2003, EDUC EVAL POLICY AN, V25, P217, DOI 10.3102/01623737025002217; Goldstone RL, 2008, J LEARN SCI, V17, P465, DOI [10.1080/10508400802394898, 10.1080/10508400802394878]; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Heckman JJ, 2001, J POLIT ECON, V109, P673, DOI 10.1086/322086; Heckman JJ, 1998, AM ECON REV, V88, P293; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Holland J. H., 1995, HIDDEN ORDER ADAPTAT; Hong GL, 2005, EDUC EVAL POLICY AN, V27, P205, DOI 10.3102/01623737027003205; Johnson R. B., 2004, ED RES, V33, P14, DOI [10.3102/0013189X033007014, DOI 10.3102/0013189X033007014]; Lazear EP, 2001, Q J ECON, V116, P777, DOI 10.1162/00335530152466232; Maroulis S, 2008, TEACH COLL REC, V110, P1901; Miller JH, 2007, PRINC STUD COMPLEX, P1, DOI 10.1007/1-4020-5602-8_1; Mishel L., 2002, CLASS SIZE DEBATE; Moody J, 2005, AM J SOCIOL, V110, P1206, DOI 10.1086/421509; Nechyba TJ, 2003, NATL TAX J, V56, P387, DOI 10.17310/ntj.2003.2.06; Resnick M, 1996, J LEARN SCI, V5, P1, DOI 10.1207/s15327809jls0501_1; Wilensky U, 1999, NETLOGO; Wilensky U., 1999, J SCI EDUC TECHNOL, V8, P3, DOI DOI 10.1023/A:1009421303064; Wilensky U, 2006, COGNITION INSTRUCT, V24, P171, DOI 10.1207/s1532690xci2402_1; Woodhouse D E, 1995, NIDA Res Monogr, V151, P131	30	55	55	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2010	330	6000					38	39		10.1126/science.1195153	http://dx.doi.org/10.1126/science.1195153			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	656KW	20929795				2022-12-28	WOS:000282334500021
J	Acar, M; Pando, BF; Arnold, FH; Elowitz, MB; van Oudenaarden, A				Acar, Murat; Pando, Bernardo F.; Arnold, Frances H.; Elowitz, Michael B.; van Oudenaarden, Alexander			A General Mechanism for Network-Dosage Compensation in Gene Circuits	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; BINDING; YEAST; ROBUSTNESS; PROTEIN; REPRESSION; SYSTEMS; GAL80P; MEMORY; SIGNAL	Coping with variations in network dosage is crucial for maintaining optimal function in gene networks. We explored how network structure facilitates network-level dosage compensation. By using the yeast galactose network as a model, we combinatorially deleted one of the two copies of its four regulatory genes and found that network activity was robust to the change in network dosage. A mathematical analysis revealed that a two-component genetic circuit with elements of opposite regulatory activity (activator and inhibitor) constitutes a minimal requirement for network-dosage invariance. Specific interaction topologies and a one-to-one interaction stoichiometry between the activating and inhibiting agents were additional essential elements facilitating dosage invariance. This mechanism of network-dosage invariance could represent a general design for gene network structure in cells.	[Acar, Murat; Elowitz, Michael B.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Pando, Bernardo F.; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Arnold, Frances H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Arnold, Frances H.] CALTECH, Div Biochem & Mol Biophys, Pasadena, CA 91125 USA; [Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Elowitz, Michael B.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA	California Institute of Technology; Massachusetts Institute of Technology (MIT); California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Massachusetts Institute of Technology (MIT)	Acar, M (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	acar@caltech.edu	van Oudenaarden, Alexander/AAA-1705-2019; Acar, Murat/AIB-8244-2022	Arnold, Frances H./0000-0002-4027-364X	Center for Biological Circuit Design at Caltech; NIH; NSF; Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079771, R01GM068664, R01GM068957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028299] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003936] Funding Source: NIH RePORTER	Center for Biological Circuit Design at Caltech; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank J. J. Collins, M. Thattai, and H. Youk for helpful discussions and/or comments on the manuscript. M. A. was supported by a fellowship grant from the Center for Biological Circuit Design at Caltech. B. F. P. and A.v.O were supported by grants from NIH and NSF. Work in the Elowitz laboratory was supported by the Packard Foundation, NSF, and NIH. Work in the Arnold laboratory was supported by NIH.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alon U, 2007, INTRO SYSTEMS BIOL D; Bardwell L, 1998, GENE DEV, V12, P2887, DOI 10.1101/gad.12.18.2887; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Di Talia S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000221; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Fell D., 1997, UNDERSTANDING CONTRO; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; LIU YJ, 1995, MOL GEN GENET, V248, P182, DOI 10.1007/BF02190799; Melcher K, 2001, EMBO J, V20, P841, DOI 10.1093/emboj/20.4.841; Mizutani A, 2003, EMBO J, V22, P2178, DOI 10.1093/emboj/cdg220; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Peng G, 2000, MOL CELL BIOL, V20, P5140, DOI 10.1128/MCB.20.14.5140-5148.2000; Peng G, 2002, P NATL ACAD SCI USA, V99, P8548, DOI 10.1073/pnas.142100099; Ramsey SA, 2006, NAT GENET, V38, P1082, DOI 10.1038/ng1869; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; Shinar G, 2007, P NATL ACAD SCI USA, V104, P19931, DOI 10.1073/pnas.0706792104; SuzukiFujimoto T, 1996, MOL CELL BIOL, V16, P2504; Timson DJ, 2002, BIOCHEM J, V363, P515, DOI 10.1042/0264-6021:3630515; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	28	74	75	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1656	1660		10.1126/science.1190544	http://dx.doi.org/10.1126/science.1190544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929850	Green Accepted			2022-12-28	WOS:000282098100045
J	Wang, BX; Yang, W; Wen, W; Sun, J; Su, B; Liu, B; Ma, DL; Lv, D; Wen, YR; Qu, T; Chen, M; Sun, MA; Shen, Y; Zhang, X				Wang, Baoxi; Yang, Wei; Wen, Wen; Sun, Jing; Su, Bin; Liu, Bo; Ma, Donglai; Lv, Dan; Wen, Yaran; Qu, Tao; Chen, Min; Sun, Miao; Shen, Yan; Zhang, Xue			gamma-Secretase Gene Mutations in Familial Acne Inversa	SCIENCE			English	Article							HIDRADENITIS-SUPPURATIVA; DISEASE		[Yang, Wei; Sun, Jing; Lv, Dan; Wen, Yaran; Sun, Miao; Shen, Yan; Zhang, Xue] Peking Union Med Coll, Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100021, Peoples R China; [Wang, Baoxi; Su, Bin; Ma, Donglai; Qu, Tao] Peking Union Med Coll, Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100021, Peoples R China; [Wen, Wen; Zhang, Xue] China Med Univ, Shenyang, Peoples R China; [Liu, Bo; Shen, Yan] Chinese Natl Human Genome Ctr Beijing, Beijing, Peoples R China; [Chen, Min] Peking Union Med Coll, Chinese Acad Med Sci, Inst Dermatol, Nanjing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; China Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Peking Union Medical College	Shen, Y (corresponding author), Peking Union Med Coll, Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100021, Peoples R China.	shen.yan@imicams.ac.cn; xuezhang@pumc.edu.cn	miao, sun/E-2834-2018; Wen, Yaran/D-4453-2012	Wen, Yaran/0000-0001-6346-8653; Wang, Baoxi/0000-0002-9514-5098				Bergmans BA, 2010, LANCET NEUROL, V9, P215, DOI 10.1016/S1474-4422(09)70332-1; Gao M, 2006, J INVEST DERMATOL, V126, P1302, DOI 10.1038/sj.jid.5700272; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Prokop S, 2005, J NEUROCHEM, V94, P57, DOI 10.1111/j.1471-4159.2005.03165.x; Revuz J, 2009, J EUR ACAD DERMATOL, V23, P985, DOI 10.1111/j.1468-3083.2009.03356.x; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shuster S, 2008, BRIT J DERMATOL, V158, P1, DOI 10.1111/j.1365-2133.2007.08282.x	7	276	310	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1065	1065		10.1126/science.1196284	http://dx.doi.org/10.1126/science.1196284			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	20929727				2022-12-28	WOS:000284374700032
J	Sabo, JL; Finlay, JC; Kennedy, T; Post, DM				Sabo, John L.; Finlay, Jacques C.; Kennedy, Theodore; Post, David M.			The Role of Discharge Variation in Scaling of Drainage Area and Food Chain Length in Rivers	SCIENCE			English	Article							ECOSYSTEM SIZE; ENERGY AVAILABILITY; WEB STRUCTURE; FRESH-WATERS; DISTURBANCE; FISH; STREAMS; HETEROGENEITY; LAKES	Food chain length (FCL) is a fundamental component of food web structure. Studies in a variety of ecosystems suggest that FCL is determined by energy supply, environmental stability, and/or ecosystem size, but the nature of the relationship between environmental stability and FCL, and the mechanism linking ecosystem size to FCL, remain unclear. Here we show that FCL increases with drainage area and decreases with hydrologic variability and intermittency across 36 North American rivers. Our analysis further suggests that hydrologic variability is the mechanism underlying the correlation between ecosystem size and FCL in rivers. Ecosystem size lengthens river food chains by integrating and attenuating discharge variation through stream networks, thereby enhancing environmental stability in larger river systems.	[Sabo, John L.] Arizona State Univ, Sch Life Sci, Fac Ecol Evolut & Environm Sci, Tempe, AZ 85287 USA; [Finlay, Jacques C.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Kennedy, Theodore] US Geol Survey, SW Biol Sci Ctr, Flagstaff, AZ 86001 USA; [Post, David M.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	Arizona State University; Arizona State University-Tempe; University of Minnesota System; University of Minnesota Twin Cities; United States Department of the Interior; United States Geological Survey; Yale University	Sabo, JL (corresponding author), Arizona State Univ, Sch Life Sci, Fac Ecol Evolut & Environm Sci, POB 874501, Tempe, AZ 85287 USA.	John.L.Sabo@asu.edu	Post, David M/A-6987-2009; Finlay, Jacques/B-6081-2011; Sabo, John L/B-1872-2013	Post, David M/0000-0003-1434-7729; Finlay, Jacques/0000-0002-7968-7030; Kennedy, Theodore/0000-0003-3477-3629	NSF [DEB-0315990, DEB-0316679, DEB-0317137, DEB-0635088, EF-0553768]; University of California, Santa Barbara; State of California	NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California	The authors thank S. Beck, M. Bernot, M. Booth, M. Caron, O. Champoux, C. Crenshaw, D. Cunjak, D. Caissie, R. Doucett, S. J. Fisher, N. B. Grimm, R. O. Hall, T. K. Harms, B. Hungate, K. Luttermoser, W. McDowell, G. Morin, P. Mulholland, R. J. Naiman, J. Regetz, E. Rosi-Marshall, R. Sponseller, C. U. Soykan, and L. Thompson; the Minnesota Department of Natural Resources for fish samples; the STROUD New York Watersheds Project for access to study sites and metabolism data; the Los Angeles Department of Water and Power, the Coweeta Long-Term Ecological Research (LTER) project, the H. J. Andrews LTER project, Oak Ridge National Laboratory, Environment Canada, and the U.S. Forest Service for flow data. This work was supported by grants from NSF, including DEB-0315990 to J.C.F., DEB-0316679 to D.M.P., and DEB-0317137 and DEB-0635088 to J.L.S.. The work was also supported by a Sabbatical Fellowship to J.L.S. at the National Center for Ecological Analysis and Synthesis, a center funded by NSF (grant EF-0553768); the University of California, Santa Barbara; and the State of California. Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the U.S. government.	Barnett TP, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006704; CLOSS GP, 1994, ECOL MONOGR, V64, P1, DOI 10.2307/2937053; Elton C., 1927, ANIMAL ECOLOGY; FISHER SG, 1982, ECOL MONOGR, V52, P93, DOI 10.2307/2937346; GROSSMAN GD, 1982, AM NAT, V120, P423, DOI 10.1086/284004; Guegan JF, 1998, NATURE, V391, P382, DOI 10.1038/34899; HAIRSTON NG, 1993, AM NAT, V142, P379, DOI 10.1086/285546; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; Jackson RB, 2001, ECOL APPL, V11, P1027, DOI 10.1890/1051-0761(2001)011[1027:WIACW]2.0.CO;2; KIDD KA, 1995, SCIENCE, V269, P240, DOI 10.1126/science.269.5221.240; Knighton D., 1998, FLUVIAL FORMS PROCES; Leopold L.B., 1953, HYDRAULIC GEOMETRY S, V252, P22; Liang S, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR007971; McHugh PA, 2010, ECOL LETT, V13, P881, DOI 10.1111/j.1461-0248.2010.01484.x; McIntyre PB, 2007, P NATL ACAD SCI USA, V104, P4461, DOI 10.1073/pnas.0608148104; PIMM SL, 1982, FOOD WEBS; Post DM, 2007, GEOMORPHOLOGY, V89, P111, DOI 10.1016/j.geomorph.2006.07.014; Post DM, 2007, OIKOS, V116, P775, DOI 10.1111/j.2007.0030-1299.15552.x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; Power ME, 2008, ECOL MONOGR, V78, P263, DOI 10.1890/06-0902.1; Sabo JL, 2008, ECOL MONOGR, V78, P19, DOI 10.1890/06-1340.1; Sabo JL, 2009, ANN NY ACAD SCI, V1162, P187, DOI 10.1111/j.1749-6632.2009.04445.x; Schindler DE, 1997, SCIENCE, V277, P248, DOI 10.1126/science.277.5323.248; SCHOENER TW, 1989, ECOLOGY, V70, P1559, DOI 10.2307/1938088; Takimoto G, 2008, ECOLOGY, V89, P3001, DOI 10.1890/07-1990.1; Thompson RM, 2005, OIKOS, V108, P137, DOI 10.1111/j.0030-1299.2005.11600.x; Townsend CR, 1998, ECOL LETT, V1, P200; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Walters AW, 2008, ECOLOGY, V89, P3261, DOI 10.1890/08-0273.1; Wootton JT, 1996, SCIENCE, V273, P1558, DOI 10.1126/science.273.5281.1558	33	163	169	5	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					965	967		10.1126/science.1196005	http://dx.doi.org/10.1126/science.1196005			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	20947729				2022-12-28	WOS:000284118000043
J	Das-Munshi, J; Becares, L; Dewey, ME; Stansfeld, SA; Prince, MJ				Das-Munshi, Jayati; Becares, Laia; Dewey, Michael E.; Stansfeld, Stephen A.; Prince, Martin J.			Understanding the effect of ethnic density on mental health: multi-level investigation of survey data from England	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RACIAL-DISCRIMINATION; SMALL-AREA; DISORDER; LONDON; DEPRIVATION; MINORITIES; LINK	Objectives To determine if living in areas where higher proportions of people of the same ethnicity reside is protective for common mental disorders, and associated with a reduced exposure to discrimination and improved social support. Finally, to determine if any protective ethnic density effects are mediated by reduced exposure to racism and improved social support. Design Multi-level logistic regression analysis of national survey data, with area-level, own-group ethnic density modelled as the main exposure. Participants and setting 4281 participants of Irish, black Caribbean, Indian, Pakistani, Bangladeshi, and white British ethnicity, aged 16-74 years, randomly sampled from 892 "middle layer super output areas" in England. Main outcome measures Common mental disorders (assessed via structured interviews); discrimination (assessed via structured questionnaire); and social support and social networks (assessed via structured questionnaire). Results Although the most ethnically dense areas were also the poorest, for each 10 percentage point increase in own-group ethnic density, there was evidence of a decreased risk of common mental disorders, for the full ethnic minority sample (odds ratio 0.94 (95% confidence interval 0.89 to 0.99); P=0.02, trend), for the Irish group (odds ratio 0.21 (0.06 to 0.74); P=0.01, trend), and for the Bangladeshi group (odds ratio 0.75 (0.62 to 0.91); P=0.005, trend), after adjusting for a priori confounders. For some groups, living in areas of higher own-group density was associated with a reduction in the reporting of discrimination and with improved social support and improved social networks. However, none of these factors mediated ethnic density effects. Conclusions A protective effect of living in areas of higher own-group ethnic density was present for common mental disorders for some minority groups. People living in areas of higher own-group density may report improved social support and less discrimination, but these associations did not fully account for density effects.	[Das-Munshi, Jayati] Kings Coll London, Inst Psychiat, MRC, London SE5 8AF, England; [Becares, Laia] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Stansfeld, Stephen A.] Univ London, Barts & London Sch Med, Ctr Psychiat, London WC1E 7HU, England	University of London; King's College London; University of London; University College London; University of London; Queen Mary University London	Das-Munshi, J (corresponding author), Kings Coll London, Inst Psychiat, MRC, London SE5 8AF, England.	jayati.das-munshi@kcl.ac.uk	Das-Munshi, Jayati/F-1910-2010; Dewey, Michael E/E-2049-2010; Bécares, Laia/J-6027-2015; Prince, Martin J/A-9170-2010	Das-Munshi, Jayati/0000-0002-3913-6859; Dewey, Michael E/0000-0002-7522-3677; Bécares, Laia/0000-0002-4207-074X; Prince, Martin J/0000-0003-1379-7146	Institute of Social Psychiatry; MRC; Economic and Social Research Council (ESRC); MRC [G0701595] Funding Source: UKRI; Medical Research Council [G0701595] Funding Source: researchfish	Institute of Social Psychiatry; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Institute of Social Psychiatry provided a small funds grant to enable retrieval of area-level data, which was then matched to individual records by the National Centre for Social Research. JD is supported by an MRC fellowship. LB was partially supported by the Economic and Social Research Council (ESRC). None of the funding bodies played a part in the research protocol, data analyses, data interpretation, or writing of the report.	Becares L, 2009, HEALTH PLACE, V15, P700, DOI 10.1016/j.healthplace.2008.10.008; Bhui K, 2008, J EPIDEMIOL COMMUN H, V62, P435, DOI 10.1136/jech.2007.063149; Bhui K, 2009, J PUBLIC HEALTH-UK, V31, P322, DOI 10.1093/pubmed/fdp071; Boydell J, 2001, BMJ-BRIT MED J, V323, P1336, DOI 10.1136/bmj.323.7325.1336; Cole SR, 2002, INT J EPIDEMIOL, V31, P163, DOI 10.1093/ije/31.1.163; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; Essed P., 1991, UNDERSTANDING EVERYD; Faris Robert E.L, 1939, MENTAL DISORDERS URB; HALPERN D, 1993, SOC SCI MED, V36, P597, DOI 10.1016/0277-9536(93)90056-A; Harris R, 2006, LANCET, V367, P2005, DOI 10.1016/S0140-6736(06)68890-9; Karlsen S, 2005, PSYCHOL MED, V35, P1795, DOI 10.1017/S0033291705005830; Karlsen S, 2002, AM J PUBLIC HEALTH, V92, P624, DOI 10.2105/AJPH.92.4.624; Kim IC, 2008, GENES GENOM, V30, P101; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Mair C, 2008, J EPIDEMIOL COMMUN H, V62, P940, DOI 10.1136/jech.2007.066605; McKenzie K, 2002, BRIT J PSYCHIAT, V181, P280, DOI 10.1192/bjp.181.4.280; Neeleman J, 2001, J EPIDEMIOL COMMUN H, V55, P85, DOI 10.1136/jech.55.2.85; Neeleman J, 1999, PSYCHOL MED, V29, P429, DOI 10.1017/S003329179800806X; Noble M, 2006, ENVIRON PLANN A, V38, P169, DOI 10.1068/a37168; *OFF NAT STAT, 2010, MIGR STAT Q REP 4; Office for National Statistics, BEG GUID UK GEOGR SU; Office for National Statistics, 2003, ETHN GROUP STAT GUID; Office of Population Censuses and Surveys, 1992, CENS DEF GREAT BRIT; Paradies Y, 2006, INT J EPIDEMIOL, V35, P888, DOI 10.1093/ije/dyl056; Petersen ML, 2006, EPIDEMIOLOGY, V17, P276, DOI 10.1097/01.ede.0000208475.99429.2d; Pickett KE, 2008, ETHNIC HEALTH, V13, P321, DOI 10.1080/13557850701882928; Platt Lucinda, 2005, Popul Trends, P35; Ryan L, 2006, BRIT J PSYCHIAT, V188, P560, DOI 10.1192/bjp.188.6.560; Sproston J, 2002, ETHNIC MINORITY PSYC; Stafford M, 2008, HEALTH PLACE, V14, P394, DOI 10.1016/j.healthplace.2007.08.006; Stafford M, 2010, UNDERST POPUL TRENDS, V3, P225, DOI 10.1007/978-90-481-9103-1_11; STANSFELD S, 1992, SOC SCI MED, V35, P1027, DOI 10.1016/0277-9536(92)90242-I; StataCorp L, 2007, STAT DAT AN STAT SOF; *UCLA AC TECHN SER, PERF SOB GOODM MED T; *UKDA, ETHN MIN PSYCH ILLN; Veling W, 2008, AM J PSYCHIAT, V165, P66, DOI 10.1176/appi.ajp.2007.07030423; Wadsworth E, 2007, OCCUP MED-OXFORD, V57, P18, DOI 10.1093/occmed/kql088; Walters P, 2008, BRIT J PSYCHIAT, V193, P235, DOI 10.1192/bjp.bp.107.038299; Weich S, 2004, PSYCHOL MED, V34, P1543, DOI 10.1017/S0033291704002715; Whitley R, 2005, HEALTH PLACE, V11, P237, DOI 10.1016/j.healthplace.2004.05.002; Whitley R, 2006, INT J SOC PSYCHIATR, V52, P376, DOI 10.1177/0020764006067239; Wilkinson R, 2006, SOCIAL DETERMINANTS, V2nd	42	84	86	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2010	341								c5367	10.1136/bmj.c5367	http://dx.doi.org/10.1136/bmj.c5367			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	671ZQ	20966012	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000283553200001
J	De Luca, GC; Wijdicks, EFM				De Luca, Gabriele Carmine; Wijdicks, Eelco F. M.			Agitation Associated with Acute Bladder Obstruction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[De Luca, Gabriele Carmine; Wijdicks, Eelco F. M.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	De Luca, GC (corresponding author), Mayo Clin, Rochester, MN 55905 USA.			De Luca, Gabriele/0000-0003-0342-5197					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2010	363	17					1656	1656		10.1056/NEJMicm0808606	http://dx.doi.org/10.1056/NEJMicm0808606			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668BD	20961249				2022-12-28	WOS:000283242700010
J	Secord, R; Gingerich, PD; Lohmann, KC; MacLeod, KG				Secord, Ross; Gingerich, Philip D.; Lohmann, Kyger C.; MacLeod, Kenneth G.			Continental warming preceding the Palaeocene-Eocene thermal maximum	NATURE			English	Article							BIGHORN BASIN; STABLE-ISOTOPES; METHANE HYDRATE; CLIMATE-CHANGE; TEMPERATURE; MAMMALS; MODEL; WATER; RECONSTRUCTION; FRACTIONATION	Marine and continental records(1) show an abrupt negative shift in carbon isotope values at similar to 55.8 Myr ago. This carbon isotope excursion (CIE) is consistent with the release of a massive amount of isotopically light carbon into the atmosphere and was associated with a dramatic rise in global temperatures termed the Palaeocene-Eocene thermal maximum (PETM). Greenhouse gases released during the CIE, probably including methane, have often been considered the main cause of PETM warming. However, some evidence from the marine record suggests that warming directly preceded the CIE(2-4), raising the possibility that the CIE and PETM may have been linked to earlier warming with different origins. Yet pre-CIE warming is still uncertain. Disentangling the sequence of events before and during the CIE and PETM is important for understanding the causes of, and Earth system responses to, abrupt climate change. Here we show that continental warming of about 5 degrees C preceded the CIE in the Bighorn Basin, Wyoming. Our evidence, based on oxygen isotopes in mammal teeth (which reflect temperature-sensitive fractionation processes) and other proxies, reveals a marked temperature increase directly below the CIE, and again in the CIE. Pre-CIE warming is also supported by a negative amplification of delta(13)C values in soil carbonates below the CIE. Our results suggest that at least two sources of warming-the earlier of which is unlikely to have been methane-contributed to the PETM.	[Secord, Ross] Univ Nebraska, Dept Earth & Atmospher Sci, Lincoln, NE 68588 USA; [Secord, Ross; Gingerich, Philip D.; Lohmann, Kyger C.] Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; [Secord, Ross] Florida Museum Nat Hist, Gainesville, FL 32611 USA; [MacLeod, Kenneth G.] Univ Missouri, Dept Geol Sci, Columbia, MO 65211 USA	University of Nebraska System; University of Nebraska Lincoln; University of Michigan System; University of Michigan; University of Missouri System; University of Missouri Columbia	Secord, R (corresponding author), Univ Nebraska, Dept Earth & Atmospher Sci, Lincoln, NE 68588 USA.	rsecord2@unl.edu	MacLeod, Kenneth G./C-4042-2017; Gingerich, Philip D/A-6903-2008; MacLeod, Kenneth/GWU-8940-2022	MacLeod, Kenneth G./0000-0002-6016-0837; Gingerich, Philip D/0000-0002-1550-2674; Lohmann, Kyger/0000-0002-0709-9192	American Chemical Society; National Science Foundation; Geological Society of America; University of Michigan Department of Geological Sciences	American Chemical Society(American Chemical Society); National Science Foundation(National Science Foundation (NSF)); Geological Society of America; University of Michigan Department of Geological Sciences	We thank D. C. Fisher, G. F. Gunnell, G. R. Smith, L. Wingate, D. L. Dettman, W. J. Sanders, D. L. Fox, P. L. Koch, R. E. Blake, H. C. Fricke, G. J. Bowen, J. I. Bloch, F. A. Smith-McInerney, B. H. Wilkinson, T. Huston, R. Lange and Y. Zhang for their help and advice; S. L. Wing, A. Rountrey, and A. R. Wood for manuscript comments; I. S. Zalmout, D. M. Boyer, and P. Rose for field support. This work was supported by grants from the American Chemical Society (to P.D.G.), the National Science Foundation (to P.D.G.), the Geological Society of America (to R.S.), and the University of Michigan Department of Geological Sciences (to R.S.).	Balasse M, 2003, J ARCHAEOL SCI, V30, P205, DOI 10.1006/jasc.2002.0833; Bowen GJ, 2004, NATURE, V432, P495, DOI 10.1038/nature03115; Bowen GJ., 2001, PALEOCENE EOCENE STR, P73; BRYANT JD, 1995, GEOCHIM COSMOCHIM AC, V59, P4523; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; DANSGAARD W, 1964, TELLUS, V16, P436; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Fricke HC, 1998, EARTH PLANET SC LETT, V160, P193, DOI 10.1016/S0012-821X(98)00088-0; Fricke HC, 1999, EARTH PLANET SC LETT, V170, P181, DOI 10.1016/S0012-821X(99)00105-3; Gingerich PD, 2006, TRENDS ECOL EVOL, V21, P246, DOI 10.1016/j.tree.2006.03.006; Koch PL, 1998, ANNU REV EARTH PL SC, V26, P573, DOI 10.1146/annurev.earth.26.1.573; KOCH PL, 1995, PALAEOGEOGR PALAEOCL, V115, P61, DOI 10.1016/0031-0182(94)00107-J; Koch PL., 2003, GEOLOGICAL SOC AM SP, V369, P49, DOI DOI 10.1130/0-8137-2369-8.49; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P4811, DOI 10.1016/S0016-7037(96)00240-2; Kraus MJ, 2007, PALAEOGEOGR PALAEOCL, V245, P444, DOI 10.1016/j.palaeo.2006.09.011; Kurtz AC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000908; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; LONGINELLI A, 1973, EARTH PLANET SC LETT, V19, P373, DOI 10.1016/0012-821X(73)90088-5; Pagani M, 2006, SCIENCE, V314, P1556, DOI 10.1126/science.1136110; Panchuk K, 2008, GEOLOGY, V36, P315, DOI 10.1130/G24474A.1; Secord R, 2008, PALEOBIOLOGY, V34, P282, DOI 10.1666/0094-8373(2008)034[0282:SIIEEM]2.0.CO;2; Secord R, 2006, AM J SCI, V306, P211, DOI 10.2475/ajs.306.4.211; Sluijs A, 2007, NATURE, V450, P1218, DOI 10.1038/nature06400; Storey M, 2007, SCIENCE, V316, P587, DOI 10.1126/science.1135274; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Thomas DJ, 2002, GEOLOGY, V30, P1067, DOI 10.1130/0091-7613(2002)030<1067:WTFFTF>2.0.CO;2; Tripati A, 2005, SCIENCE, V308, P1894, DOI 10.1126/science.1109202; WANG Y, 1994, PALAEOGEOGR PALAEOCL, V107, P281, DOI 10.1016/0031-0182(94)90100-7; Wilf P, 2000, GEOL SOC AM BULL, V112, P292, DOI 10.1130/0016-7606(2000)112<0292:LPEECC>2.3.CO;2; Wing S.L., 2000, WARM CLIMATES EARTH, P197; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913	31	58	60	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					955	958		10.1038/nature09441	http://dx.doi.org/10.1038/nature09441			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962843				2022-12-28	WOS:000283254700036
J	Paul, GS				Paul, Gregory S.			Comment on "Narrow Primary Feather Rachises in Confuciusornis and Archaeopteryx Suggest Poor Flight Ability"	SCIENCE			English	Editorial Material								Nudds and Dyke (Reports, 14 May 2010, p. 887) reported that the primary features of the early birds Archaeopteryx and Confuciusornis were too weak to power flight. This conclusion is not supported because the authors overestimated the mass of the subjects and understated the strength of the primary shafts in at least one example. The total biology of the birds indicates that they could achieve flapping flight.			Paul, GS (corresponding author), 3109 N Calvert St, Baltimore, MD 21218 USA.	GSP1954@aol.com						Chang M., 2003, JEHOL BIOTA; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Elzanowski Andrzej, 2002, P129; Nudds RL, 2010, SCIENCE, V328, P887, DOI 10.1126/science.1188895; OLSON SL, 1979, NATURE, V278, P247, DOI 10.1038/278247a0; Paul G., 1988, PREDATORY DINOSAURS; Paul Gregory S., 1997, P129; PAUL GS, 2010, DINOSAURS AIR; YALDEN DW, 1984, ZOOL J LINN SOC-LOND, V82, P177, DOI 10.1111/j.1096-3642.1984.tb00541.x	9	10	10	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2010	330	6002								10.1126/science.1192963	http://dx.doi.org/10.1126/science.1192963			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947747				2022-12-28	WOS:000282986700018
J	Schubeler, D				Schuebeler, Dirk			Chromatin in Multicolor	CELL			English	Editorial Material							DNA-REPLICATION	Chromatin consists of DNA and a large number of associated proteins. Filion et al. (2010) provide a genome-wide analysis of the location of 53 chromatin proteins in Drosophila, revealing important principles underlying chromatin regulation and providing colorful insights into their organization.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Schubeler, D (corresponding author), Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.	dirk@fmi.ch						Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Heitz E., 1928, JAHRB WISS BOT, V69, P762; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871	9	3	3	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 15	2010	143	2					183	184		10.1016/j.cell.2010.09.045	http://dx.doi.org/10.1016/j.cell.2010.09.045			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946976	Bronze			2022-12-28	WOS:000283052200006
J	Palumbo, P; Lindsey, JC; Hughes, MD; Cotton, MF; Bobat, R; Meyers, T; Bwakura-Dangarembizi, M; Chi, BH; Musoke, P; Kamthunzi, P; Schimana, W; Purdue, L; Eshleman, SH; Abrams, EJ; Millar, L; Petzold, E; Mofenson, LM; Jean-Philippe, P; Violari, A				Palumbo, Paul; Lindsey, Jane C.; Hughes, Michael D.; Cotton, Mark F.; Bobat, Raziya; Meyers, Tammy; Bwakura-Dangarembizi, Mutsawashe; Chi, Benjamin H.; Musoke, Philippa; Kamthunzi, Portia; Schimana, Werner; Purdue, Lynette; Eshleman, Susan H.; Abrams, Elaine J.; Millar, Linda; Petzold, Elizabeth; Mofenson, Lynne M.; Jean-Philippe, Patrick; Violari, Avy			Antiretroviral Treatment for Children with Peripartum Nevirapine Exposure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SINGLE-DOSE NEVIRAPINE; HIV-1 VERTICAL TRANSMISSION; K103N RESISTANCE MUTATION; INFECTED CHILDREN; RECEIVING NEVIRAPINE; UGANDAN WOMEN; THERAPY; PREVENTION; ZIDOVUDINE; GROWTH	BACKGROUND Single-dose nevirapine is the cornerstone of the regimen for prevention of mother-to-child transmission of human immunodeficiency virus (HIV) in resource-limited settings, but nevirapine frequently selects for resistant virus in mothers and children who become infected despite prophylaxis. The optimal antiretroviral treatment strategy for children who have had prior exposure to single-dose nevirapine is unknown. METHODS We conducted a randomized trial of initial therapy with zidovudine and lamivudine plus either nevirapine or ritonavir-boosted lopinavir in HIV-infected children 6 to 36 months of age, in six African countries, who qualified for treatment according to World Health Organization (WHO) criteria. RESULTS are reported for the cohort that included children exposed to single-dose nevirapine prophylaxis. The primary end point was virologic failure or discontinuation of treatment by study week 24. Enrollment in this cohort was terminated early on the recommendation of the data and safety monitoring board. Results A total of 164 children were enrolled. The median percentage of CD4+ lymphocytes was 19%; a total of 56% of the children had WHO stage 3 or 4 disease. More children in the nevirapine group than in the ritonavir-boosted lopinavir group reached a primary end point (39.6% vs. 21.7%; weighted difference, 18.6 percentage-points; 95% confidence interval, 3.7 to 33.6; nominal P = 0.02). Baseline resistance to nevirapine was detected in 18 of 148 children (12%) and was predictive of treatment failure. No significant between-group differences were seen in the rate of adverse events. CONCLUSIONS Among children with prior exposure to single-dose nevirapine for perinatal prevention of HIV transmission, antiretroviral treatment consisting of zidovudine and lamivudine plus ritonavir-boosted lopinavir resulted in better outcomes than did treatment with zidovudine and lamivudine plus nevirapine. Since nevirapine is used for both treatment and perinatal prevention of HIV infection in resource-limited settings, alternative strategies for the prevention of HIV transmission from mother to child, as well as for the treatment of HIV infection, are urgently required.	[Palumbo, Paul] Dartmouth Med Sch, Dept Med, Lebanon, NH 03765 USA; [Lindsey, Jane C.; Hughes, Michael D.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Cotton, Mark F.] Univ Stellenbosch, Tygerberg Childrens Hosp, ZA-7505 Tygerberg, South Africa; [Bobat, Raziya] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Durban, South Africa; [Meyers, Tammy] Univ Witwatersrand, Chris Hani Baragwanath Hosp, Harriet Shezi Childrens Clin, Johannesburg, South Africa; [Violari, Avy] Perinatal HIV Res Unit, Johannesburg, South Africa; [Bwakura-Dangarembizi, Mutsawashe] Univ Zimbabwe, Coll Hlth Sci, Dept Paediat & Child Hlth, Harare, Zimbabwe; [Chi, Benjamin H.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Musoke, Philippa] Johns Hopkins Univ, Res Collaborat, Makerere Univ, Kampala, Uganda; [Kamthunzi, Portia] Univ N Carolina Project, Lilongwe, Malawi; [Schimana, Werner] Duke Univ, KCMC Collaborat, Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Schimana, Werner] NIAID, Pharmaceut Affairs Branch, Div Aids, NIH, Bethesda, MD 20892 USA; [Jean-Philippe, Patrick] NIAID, Henry Jackson Fdn, Div Aids, NIH, Bethesda, MD 20892 USA; [Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Abrams, Elaine J.] Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care & Treatment Programs, New York, NY USA; [Petzold, Elizabeth] Social & Sci Syst, Silver Spring, MD USA; [Mofenson, Lynne M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pediat Adolescent & Maternal AIDS Branch, NIH, Rockville, MD USA; [Millar, Linda] Frontier Sci & Technol Res Fdn Inc, Amherst, NY USA	Dartmouth College; Harvard University; Harvard T.H. Chan School of Public Health; Stellenbosch University; University of Kwazulu Natal; University of Witwatersrand; University of Zimbabwe; Makerere University; Duke University; Kilimanjaro Christian Medical Centre; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Columbia University; Social & Scientific Systems; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Frontier Science Foundation	Palumbo, P (corresponding author), Dartmouth Med Sch, Dept Med, Borwell C330W,1 Med Ctr Dr, Lebanon, NH 03765 USA.	paul.e.palumbo@dartmouth.edu	Mofenson, Lynne/P-9631-2019; Cotton, Mark/AAQ-9936-2020; Bwakura-Dangarembizi, Mutsa/D-5686-2018	Mofenson, Lynne/0000-0002-2818-9808; Cotton, Mark/0000-0003-2559-6034; Bwakura-Dangarembizi, Mutsa/0000-0001-7751-6177	National Institutes of Health; National Institute of Allergy and Infectious Diseases (NIAID) [U01 AI068632, 5 U01 AI41110, 1 U01 AI068616, HHSN272200800014C]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Mental Health; PACTG [5 U01 AI41110]; IMPAACT Group [1 U01 AI068616]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068632, UM1AI069521, U01AI041110, U01AI068616] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PACTG; IMPAACT Group; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institutes of Health; Supported by grants to the Pediatric AIDS Clinical Trials Group (PACTG) and the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group from the National Institute of Allergy and Infectious Diseases (NIAID) (U01 AI068632), the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health. The Statistical and Data Analysis Center at the Harvard School of Public Health was supported by NIAID cooperative agreements with the PACTG (5 U01 AI41110) and the IMPAACT Group (1 U01 AI068616). Support of the sites was provided by the NIAID. Additional support was provided by the NIAID (contract no. HHSN272200800014C).	Aldrovandi GM, 2009, AIDS, V23, P661, DOI 10.1097/QAD.0b013e3283269dfb; Buchacz K, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e72; Chaix ML, 2006, J INFECT DIS, V193, P482, DOI 10.1086/499966; Chi BH, 2008, LANCET, V371, P650; Chi BH, 2007, LANCET, V370, P1698, DOI 10.1016/S0140-6736(07)61605-5; Chi BH, 2007, AIDS, V21, P957, DOI 10.1097/QAD.0b013e32810996b2; Cressey TR, 2005, JAIDS-J ACQ IMM DEF, V38, P283; Dabis F, 2005, AIDS, V19, P309; Dreimane D, 2001, PEDIATR INFECT DIS J, V20, P315, DOI 10.1097/00006454-200103000-00020; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; Flys TS, 2006, JAIDS-J ACQ IMM DEF, V42, P610, DOI 10.1097/01.qai.0000221686.67810.20; Jackson JB, 2000, AIDS, V14, pF111, DOI 10.1097/00002030-200007280-00001; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Lallemant M, 2000, NEW ENGL J MED, V343, P982, DOI 10.1056/NEJM200010053431401; Lockman S, 2010, NEW ENGL J MED, V363, P1499, DOI 10.1056/NEJMoa0906626; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; McIntyre JA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000172; Mirochnick M, 2001, PEDIATR INFECT DIS J, V20, P803, DOI 10.1097/00006454-200108000-00017; Musoke P, 1999, AIDS, V13, P479, DOI 10.1097/00002030-199903110-00006; Nachman SA, 2002, ARCH PEDIAT ADOL MED, V156, P497, DOI 10.1001/archpedi.156.5.497; World Health Organization, 2008, WHO ANT THER INF CHI	22	179	182	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2010	363	16					1510	1520		10.1056/NEJMoa1000931	http://dx.doi.org/10.1056/NEJMoa1000931			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663KP	20942667	Green Accepted			2022-12-28	WOS:000282887100005
J	Steinman, MA; Hanlon, JT				Steinman, Michael A.; Hanlon, Joseph T.			Managing Medications in Clinically Complex Elders "There's Got to Be a Happy Medium"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE DRUG EVENTS; EMERGENCY-DEPARTMENT VISITS; OLDER-ADULTS; RISK-FACTORS; DISCONTINUING MEDICATIONS; PHARMACIST INTERVENTION; GENERAL-PRACTITIONERS; QUALITY INDICATORS; ADVANCED DEMENTIA; CONTROLLED-TRIAL	Multiple medication use is common in older adults and may ameliorate symptoms, improve and extend quality of life, and occasionally cure disease. Unfortunately, multiple medication use is also a major risk factor for prescribing and adherence problems, adverse drug events, and other adverse health outcomes. Using the case of an older patient taking multiple medications, this article summarizes the evidence-based literature about improving medication use and withdrawing specific drugs and drug classes. It also describes a systematic approach for how health professionals can assess and improve medication regimens to benefit patients and their caregivers and families. JAMA. 2010;304(14):1592-1601 www.jama.com	[Steinman, Michael A.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Steinman, Michael A.] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA; [Hanlon, Joseph T.] Univ Pittsburgh, Dept Epidemiol, Dept Med, Div Geriatr Med, Pittsburgh, PA 15261 USA; [Hanlon, Joseph T.] Univ Pittsburgh, Dept Pharm & Therapeut, Pittsburgh, PA USA; [Hanlon, Joseph T.] Vet Affairs Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA; [Hanlon, Joseph T.] Vet Affairs Pittsburgh Healthcare Syst, Ctr Hlth Equity Res & Promot, Pittsburgh, PA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Steinman, MA (corresponding author), San Francisco VA Med Ctr, 4150 Clement St,Box 181G, San Francisco, CA 94121 USA.	mike.steinman@ucsf.edu			National Institute on Aging and the American Federation for Aging Research [K23 AG030999]; Department of Veterans Affairs [IIR 06-080]; National Institute of Aging [R01AG027017, P30AG024827, T32 AG021885, K07AG033174, R01AG034056]; National Institute of Mental Health [R34 MH082682]; National Institute of Nursing Research [R01 NR010135]; Agency for Healthcare Research and Quality [HS017695, HS018721]; Veterans Administration Health Services [IIR06-062]; SCAN Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018721, R01HS017695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH082682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034056, T32AG021885, K07AG033174, P30AG024827, R01AG027017, K23AG030999] Funding Source: NIH RePORTER	National Institute on Aging and the American Federation for Aging Research; Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Veterans Administration Health Services; SCAN Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Steinman was supported by the National Institute on Aging and the American Federation for Aging Research (K23 AG030999) and by the Department of Veterans Affairs (IIR 06-080). Dr Hanlon was supported by grants from the National Institute of Aging (R01AG027017, P30AG024827, T32 AG021885, K07AG033174, and R01AG034056), the National Institute of Mental Health (R34 MH082682), the National Institute of Nursing Research (R01 NR010135), the Agency for Healthcare Research and Quality (HS017695 and HS018721), and a Veterans Administration Health Services research grant (IIR06-062). The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	Agostini JV, 2004, J AM GERIATR SOC, V52, P1719, DOI 10.1111/j.1532-5415.2004.52467.x; Bain KT, 2008, J AM GERIATR SOC, V56, P1946, DOI 10.1111/j.1532-5415.2008.01916.x; Bayoumi I, 2009, ANN PHARMACOTHER, V43, P1667, DOI 10.1345/aph.1M059; Bedell SE, 2000, ARCH INTERN MED, V160, P2129, DOI 10.1001/archinte.160.14.2129; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Bischoff-Ferrari HA, 2009, ARCH INTERN MED, V169, P551, DOI 10.1001/archinternmed.2008.600; Boockvar KS, 2009, QUAL SAF HEALTH CARE, V18, P32, DOI 10.1136/qshc.2007.025957; *BOST U SLON EP CT, 2006, PATT MED US US; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Budnitz DS, 2007, ANN INTERN MED, V147, P755, DOI 10.7326/0003-4819-147-11-200712040-00006; Charpentier G, 2000, DIABETES METAB, V26, P73; CHRISCHILLES EA, 1992, ANN INTERN MED, V117, P634, DOI 10.7326/0003-4819-117-8-634; Chrischilles E, 2007, J AM GERIATR SOC, V55, P29, DOI 10.1111/j.1532-5415.2006.01034.x; Claxton AJ, 2001, CLIN THER, V23, P1296, DOI 10.1016/S0149-2918(01)80109-0; Conn VS, 2009, GERONTOLOGIST, V49, P447, DOI 10.1093/geront/gnp037; Cowper PA, 1998, PHARMACOTHERAPY, V18, P327; Cutler DM, 2010, NEW ENGL J MED, V362, P1553, DOI 10.1056/NEJMp1002305; Doucette WR, 2005, CLIN THER, V27, P1104, DOI 10.1016/S0149-2918(05)00146-3; Drenth-van Maanen AC, 2009, DRUG AGING, V26, P687, DOI 10.2165/11316400-000000000-00000; Farlow M, 2003, ARCH NEUROL-CHICAGO, V60, P843, DOI 10.1001/archneur.60.6.843; Feldstein AC, 2006, ARCH INTERN MED, V166, P1848, DOI 10.1001/archinte.166.17.1848; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Field TS, 2004, J AM GERIATR SOC, V52, P1349, DOI 10.1111/j.1532-5415.2004.52367.x; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gangji AS, 2007, DIABETES CARE, V30, P389, DOI 10.2337/dc06-1789; Garfinkel D, 2007, ISR MED ASSOC J, V9, P430; GERETY MB, 1993, J AM GERIATR SOC, V41, P1326; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Goulding MR, 2004, ARCH INTERN MED, V164, P305, DOI 10.1001/archinte.164.3.305; Grant K, 2006, PHARM WORLD SCI, V28, P189, DOI 10.1007/s11096-006-9028-4; Graves T, 1997, ARCH INTERN MED, V157, P2205, DOI 10.1001/archinte.157.19.2205; Gray SL, 2001, ANN PHARMACOTHER, V35, P539, DOI 10.1345/aph.10295; Green Jacqueline L, 2007, Am J Geriatr Pharmacother, V5, P31, DOI 10.1016/j.amjopharm.2007.03.004; Greenfield S, 2009, ANN INTERN MED, V151, P854, DOI 10.7326/0003-4819-151-12-200912150-00005; Gurwitz JH, 2004, ARCH INTERN MED, V164, P1957, DOI 10.1001/archinte.164.18.1957; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Hajjar Emily R, 2003, Am J Geriatr Pharmacother, V1, P82; Hajjar ER, 2005, J AM GERIATR SOC, V53, P1518, DOI 10.1111/j.1532-5415.2005.53523.x; Hanlon JT, 2006, J GERONTOL A-BIOL, V61, P511, DOI 10.1093/gerona/61.5.511; Hanlon JT, 2001, J AM GERIATR SOC, V49, P200, DOI 10.1046/j.1532-5415.2001.49042.x; Hanlon JT, 1996, AM J MED, V100, P428, DOI 10.1016/S0002-9343(97)89519-8; Hanlon JT, 1997, J AM GERIATR SOC, V45, P945, DOI 10.1111/j.1532-5415.1997.tb02964.x; Hebel, 1989, J AGING HEALTH, V1, P470, DOI [10.1177/089826438900100404, DOI 10.1177/089826438900100404]; Higashi T, 2004, ANN INTERN MED, V140, P714, DOI 10.7326/0003-4819-140-9-200405040-00011; Holmes C, 2004, NEUROLOGY, V63, P214, DOI 10.1212/01.WNL.0000129990.32253.7B; Holmes HM, 2006, ARCH INTERN MED, V166, P605, DOI 10.1001/archinte.166.6.605; Holmes HM, 2008, J AM GERIATR SOC, V56, P1306, DOI 10.1111/j.1532-5415.2008.01741.x; Hsu J, 2008, JAMA-J AM MED ASSOC, V299, P1929, DOI 10.1001/jama.299.16.1929; Hurley JS, 2005, J GEN INTERN MED, V20, P331, DOI 10.1111/j.1525-1497.2005.40182.x; Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265; Iyer S, 2008, DRUG AGING, V25, P1021, DOI 10.2165/0002512-200825120-00004; Kaboli PJ, 2004, AM J MANAG CARE, V10, P872; Kongkaew C, 2008, ANN PHARMACOTHER, V42, P1017, DOI 10.1345/aph.1L037; Kripalani S, 2007, ARCH INTERN MED, V167, P540, DOI 10.1001/archinte.167.6.540; Krska J, 2001, AGE AGEING, V30, P205, DOI 10.1093/ageing/30.3.205; Krska J, 2006, MED EDUC, V40, P1217, DOI 10.1111/j.1365-2929.2006.02633.x; LARSON EB, 1987, ANN INTERN MED, V107, P169, DOI 10.7326/0003-4819-107-2-169; Lenaghan E, 2007, AGE AGEING, V36, P292, DOI 10.1093/ageing/afm036; LIPTON HL, 1992, MED CARE, V30, P646, DOI 10.1097/00005650-199207000-00006; Madden JM, 2008, JAMA-J AM MED ASSOC, V299, P1922, DOI 10.1001/jama.299.16.1922; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Minett TSC, 2003, INT J GERIATR PSYCH, V18, P988, DOI 10.1002/gps.995; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; *NAT COMM QUAL ASS, HEDIS 2010; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Parsons C, 2010, DRUG AGING, V27, P435, DOI 10.2165/11536760-000000000-00000; Pit SW, 2007, J AM GERIATR SOC, V55, P927, DOI 10.1111/j.1532-5415.2007.01181.x; Pugh MJV, 2006, J MANAGE CARE PHARM, V12, P537, DOI 10.18553/jmcp.2006.12.7.537; Raebel MA, 2007, PHARMACOEPIDEM DR S, V16, P55, DOI 10.1002/pds.1217; Raebel MA, 2010, J GEN INTERN MED, V25, P326, DOI 10.1007/s11606-009-1228-x; Reuben DB, 2009, JAMA-J AM MED ASSOC, V302, P2686, DOI 10.1001/jama.2009.1871; Richard C, 2006, PATIENT EDUC COUNS, V64, P207, DOI 10.1016/j.pec.2006.02.003; Rochon PA, 1997, BMJ-BRIT MED J, V315, P1096, DOI 10.1136/bmj.315.7115.1096; Russell CL, 2006, AM J HEALTH BEHAV, V30, P636, DOI 10.5993/AJHB.30.6.10; Ryan C, 2009, BRIT J CLIN PHARMACO, V68, P936, DOI 10.1111/j.1365-2125.2009.03531.x; Schmader KE, 2004, AM J MED, V116, P394, DOI 10.1016/j.amjmed.2003.10.031; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Scott IA, 2010, ARCH INTERN MED, V170, P387; Scuffham PA, 2010, J GEN INTERN MED, V25, P906, DOI 10.1007/s11606-010-1352-7; Shorr RI, 1997, ARCH INTERN MED, V157, P1681, DOI 10.1001/archinte.157.15.1681; Shrank WH, 2007, J AM GERIATR SOC, V55, pS373, DOI 10.1111/j.1532-5415.2007.01345.x; Simon SR, 2005, J AM GERIATR SOC, V53, P227, DOI 10.1111/j.1532-5415.2005.53107.x; Steinman MA, 2006, J AM GERIATR SOC, V54, P1516, DOI 10.1111/j.1532-5415.2006.00889.x; Steinman MA, 2009, ARCH INTERN MED, V169, P1326, DOI 10.1001/archinternmed.2009.206; Steinman Michael A, 2007, Am J Geriatr Pharmacother, V5, P314, DOI 10.1016/j.amjopharm.2007.12.009; Thomas L, 2010, J MANAGE CARE PHARM, V16, P122, DOI 10.18553/jmcp.2010.16.2.122; THOMPSON CA, 2010, AM J HLTH SYST PHARM, V67, P690; Vik SA, 2004, ANN PHARMACOTHER, V38, P303, DOI 10.1345/aph.1D252; WALLSTEN SM, 1995, ANN PHARMACOTHER, V29, P359, DOI 10.1177/106002809502900403; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Weber V, 2008, J GEN INTERN MED, V23, P399, DOI 10.1007/s11606-007-0482-z; Weingart SN, 2005, ARCH INTERN MED, V165, P234, DOI 10.1001/archinte.165.2.234; Wenger NS, 2007, J AM GERIATR SOC, V55, pS457, DOI 10.1111/j.1532-5415.2007.01375.x; Williams ME, 2004, J AM GERIATR SOC, V52, P93, DOI 10.1111/j.1532-5415.2004.52016.x; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357; Zhan Chunliu, 2001, JAMA (Journal of the American Medical Association), V286, P2823	97	217	223	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1592	1601		10.1001/jama.2010.1482	http://dx.doi.org/10.1001/jama.2010.1482			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940385	Green Accepted			2022-12-28	WOS:000282816500024
J	Salisbury, C; Wallace, M; Montgomery, AA				Salisbury, Chris; Wallace, Marc; Montgomery, Alan A.			Patients' experience and satisfaction in primary care: secondary analysis using multilevel modelling	BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-HEALTH-CARE; GENERAL-PRACTICE; QUESTIONNAIRE; ASSESSMENTS; PREDICTORS; QUALITY	Objective To explore whether responses to questions in surveys of patients that purport to assess the performance of general practices or doctors reflect differences between practices, doctors, or the patients themselves. Design Secondary analysis of data from a study of access to general practice, combining data from a survey of patients with information about practice organisation and doctors consulted, and using multilevel modelling at practice, doctor, and patient level. Setting Nine primary care trusts in England. Participants 4573 patients who consulted 150 different doctors in 27 practices. Main outcome measures Overall satisfaction; experience of wait for an appointment; reported access to care; satisfaction with communication skills. Results The experience based measure of wait for an appointment was more discriminating between practices (practice level accounted for 20.2% (95% confidence interval 9.1% to 31.3%) of variance) than was the overall satisfaction measure (practice level accounted for 4.6% (1.6% to 7.6%) of variance). Only 6.3% (3.8% to 8.9%) of the variance in the doctors' communication skills measure was due to differences between doctors; 92.4% (88.5% to 96.4%) of the variance occurred at the level of the patient (including differences between patients' perceptions and random variation). At least 79% of the variance on all measures occurred at the level of the patient, and patients' age, sex, ethnicity, and housing and employment status explained some of this variation. However, adjustment for patients' characteristics made very little difference to practices' scores or the ranking of individual practices. Conclusions Analyses of surveys of patients should take account of the hierarchical nature of the data by using multilevel models. Measures related to patients' experience discriminate more effectively between practices than do measures of general satisfaction. Surveys of patients' satisfaction fail to distinguish effectively between individual doctors because most of the variation in doctors' reported performance is due to differences between patients and random error rather than differences between doctors. Although patients' reports of satisfaction and experience are systematically related to patients' characteristics such as age and sex, the effect of adjusting practices' scores for the characteristics of their patients is small.	[Salisbury, Chris; Montgomery, Alan A.] Univ Bristol, Bristol BS8 2AA, Avon, England; [Wallace, Marc] Royal Berkshire Hosp, Reading RG1 5AN, Berks, England	University of Bristol; Royal Berkshire Hospital	Salisbury, C (corresponding author), Univ Bristol, Bristol BS8 2AA, Avon, England.	c.salisbury@bristol.ac.uk	Salisbury, Chris/C-6724-2008	Salisbury, Chris/0000-0002-4378-3960; Montgomery, Alan/0000-0003-0450-1606	NHS [SDO/70/2004]	NHS	The evaluation of advanced access was funded by the NHS Research and Development Programme on Service and Delivery Organisation (ref SDO/70/2004). The views expressed in this publication are those of the authors and not necessarily those of the funders. This secondary analysis had no specific funding. The funders had no input into study design; the collection, analysis, or interpretation of data; the writing of the report; or the decision to submit the article for publication. The authors are independent from the research funders.	Bleich SN, 2009, B WORLD HEALTH ORGAN, V87, P271, DOI 10.2471/BLT.07.050401; BMA & NHS Employers, 2009, QUALITY OUTCOMES FRA; Campbell JL, 2001, QUAL HEALTH CARE, V10, P90, DOI 10.1136/qhc.10.2.90; Campbell SM, 2001, BMJ-BRIT MED J, V323, P784, DOI 10.1136/bmj.323.7316.784; Damman OC, 2009, MED CARE, V47, P496, DOI 10.1097/MLR.0b013e31818afa05; *DEP HLTH, 2007, APPR GPS; Goldstein H., 2009, MULTILEVEL STAT MODE; Haggerty JL, 2008, ANN FAM MED, V6, P116, DOI 10.1370/afm.802; HALL JA, 1990, SOC SCI MED, V30, P811, DOI 10.1016/0277-9536(90)90205-7; Hargraves JL, 2001, MED CARE, V39, P635; Hekkert KD, 2009, SOC SCI MED, V69, P68, DOI 10.1016/j.socscimed.2009.04.016; Jenkinson C, 2002, QUAL SAF HEALTH CARE, V11, P335, DOI 10.1136/qhc.11.4.335; Leckie G, 2009, J R STAT SOC A STAT, V172, P835, DOI 10.1111/j.1467-985X.2009.00597.x; Mead N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3450; National Primary Care Research and Development Centre, 2009, GPAQ PAT QUEST GEN P; Perneger TV, 2004, INT J QUAL HEALTH C, V16, P433, DOI 10.1093/intqhc/mzh090; Rodriguez HP, 2009, MED CARE, V47, P835, DOI 10.1097/MLR.0b013e318197b1e1; ROLAND M, 2009, SURVEY, V339, P3851; Salisbury C, 2007, EVALUATION ADV ACCES; Salisbury C, 2007, BRIT J GEN PRACT, V57, P615; Salisbury C, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4224; Sans-Corrales M, 2006, FAM PRACT, V23, P308, DOI 10.1093/fampra/cmi112; Sheikh A, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3797; Sixma HJ, 1998, MED CARE, V36, P212, DOI 10.1097/00005650-199802000-00010; Solomon LS, 2002, HEALTH CARE FINANC R, V23, P85; Thorndike EL, 1920, J APPL PSYCHOL, V4, P25, DOI 10.1037/h0071663; WILLIAMS SJ, 1991, FAM PRACT, V8, P237, DOI 10.1093/fampra/8.3.237; Zaslavsky AM, 2007, STAT MED, V26, P1885, DOI 10.1002/sim.2808	28	101	102	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 12	2010	341								c5004	10.1136/bmj.c5004	http://dx.doi.org/10.1136/bmj.c5004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663KN	20940212	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000282886900005
J	Tabashnik, BE				Tabashnik, Bruce E.			Communal Benefits of Transgenic Corn	SCIENCE			English	Editorial Material							BT CROPS; INSECT RESISTANCE; LEPIDOPTERA; SUPPRESSION; BOLLWORM; ECOLOGY; COTTON		Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	University of Arizona	Tabashnik, BE (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	brucet@cals.arizona.edu						Alstad DN, 1996, AGBIOTECH NEWS INFOR, V8, P177; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; National Research Council, 2010, IMP GEN ENG CROPS FA; Onstad D. W., 2008, INSECT RESISTANCE MA; Siegfried Blair D., 2007, American Entomologist, V53, P208; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Stodola TJ, 2006, J ECON ENTOMOL, V99, P502, DOI 10.1603/0022-0493-99.2.502; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; US Environmental Protection Agency, CURR PREV REG SECT 3; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550	16	40	48	1	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					189	190		10.1126/science.1196864	http://dx.doi.org/10.1126/science.1196864			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929767				2022-12-28	WOS:000282644600031
J	McDaniel, LD; Young, E; Delaney, J; Ruhnau, F; Ritchie, KB; Paul, JH				McDaniel, Lauren D.; Young, Elizabeth; Delaney, Jennifer; Ruhnau, Fabian; Ritchie, Kim B.; Paul, John H.			High Frequency of Horizontal Gene Transfer in the Oceans	SCIENCE			English	Article							TRANSFER AGENT GENES; MARINE		[McDaniel, Lauren D.; Young, Elizabeth; Delaney, Jennifer; Paul, John H.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Ruhnau, Fabian] Univ Duisburg Essen, Biofilm Ctr, D-47057 Duisburg, Germany; [Ritchie, Kim B.] Ctr Coral Reef Res, Mote Marine Lab, Sarasota, FL 34236 USA	State University System of Florida; University of South Florida; University of Duisburg Essen; Mote Marine Laboratory & Aquarium	McDaniel, LD (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	mcdaniel@marine.usf.edu						Biers EJ, 2008, APPL ENVIRON MICROB, V74, P2933, DOI 10.1128/AEM.02129-07; Jiang SC, 1998, APPL ENVIRON MICROB, V64, P2780; Lang AS, 2007, TRENDS MICROBIOL, V15, P54, DOI 10.1016/j.tim.2006.12.001; Sanchez Federico, 2008, Plant Biology (Rockville), V2008, P65; Williams HG, 1997, MOL MAR BIOL BIOTECH, V6, P238; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Zhao YL, 2010, APPL ENVIRON MICROB, V76, P589, DOI 10.1128/AEM.01450-09	7	212	218	6	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					50	50		10.1126/science.1192243	http://dx.doi.org/10.1126/science.1192243			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	656KW	20929803				2022-12-28	WOS:000282334500029
J	Pavelka, N; Rancati, G; Zhu, J; Bradford, WD; Saraf, A; Florens, L; Sanderson, BW; Hattem, GL; Li, R				Pavelka, Norman; Rancati, Giulia; Zhu, Jin; Bradford, William D.; Saraf, Anita; Florens, Laurence; Sanderson, Brian W.; Hattem, Gaye L.; Li, Rong			Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast	NATURE			English	Article							IDENTIFICATION TECHNOLOGY; SACCHAROMYCES-CEREVISIAE; CELLS; EVOLUTION; PEPTIDES	Aneuploidy, referring here to genome contents characterized by abnormal numbers of chromosomes, has been associated with developmental defects, cancer and adaptive evolution in experimental organisms(1-9). However, it remains unresolved how aneuploidy impacts gene expression and whether aneuploidy could directly bring about phenotypic variation and improved fitness over that of euploid counterparts. Here we show, using quantitative mass spectrometry-based proteomics and phenotypic profiling, that levels of protein expression in aneuploid yeast strains largely scale with chromosome copy numbers, following the same trend as that observed for the transcriptome, and that aneuploidy confers diverse phenotypes. We designed a novel scheme to generate, through random meiotic segregation, 38 stable and fully isogenic aneuploid yeast strains with distinct karyotypes and genome contents between 1N and 3N without involving any genetic selection. Through quantitative growth assays under various conditions or in the presence of a panel of chemotherapeutic or antifungal drugs, we found that some aneuploid strains grew significantly better than euploid control strains under conditions suboptimal for the latter. These results provide strong evidence that aneuploidy directly affects gene expression at both the transcriptome and proteome levels and can generate significant phenotypic variation that could bring about fitness gains under diverse conditions. Our findings suggest that the fitness ranking between euploid and aneuploid cells is dependent on context and karyotype, providing the basis for the notion that aneuploidy can directly underlie phenotypic evolution and cellular adaptation.	[Pavelka, Norman; Rancati, Giulia; Zhu, Jin; Bradford, William D.; Saraf, Anita; Florens, Laurence; Sanderson, Brian W.; Hattem, Gaye L.; Li, Rong] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Li, Rong] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Li, R (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rli@stowers.org	Pavelka, Norman/G-4577-2018	Pavelka, Norman/0000-0003-4542-9970; Florens, Laurence/0000-0002-9310-6650; Hattem, Gaye/0000-0002-2411-3056; Rancati, Giulia/0000-0003-0835-0139	NIH [RO1GM059964]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059964] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. W. Seidel for assistance with microarray data analysis, B. Fleharty and A. Peak for technical assistance with microarray hybridization, A. Perera and K. Walton for assistance in genome resequencing, W. McDowell for technical assistance with qPCR, J. Haug for technical support with flow cytometry experiments, G. Chen for technical suggestions, and A. Paulson for assistance with the submission of microarray and sequencing data to public repositories. This work was performed to fulfil, in part, requirements for J. Zhu's PhD thesis research as a student registered with the Open University. This work was supported by NIH grant RO1GM059964 to R.L.	de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens Laurence, 2006, V328, P159; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; MACK M, 1988, MOL GEN GENET, V211, P260, DOI 10.1007/BF00330602; PARRY EM, 1970, GENET RES, V16, P333, DOI 10.1017/S0016672300002597; Pavelka N, 2010, CURR OPIN CELL BIOL, V22, P809, DOI 10.1016/j.ceb.2010.06.003; Polakova S, 2009, P NATL ACAD SCI USA, V106, P2688, DOI 10.1073/pnas.0809793106; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; Selmecki A, 2008, MOL MICROBIOL, V68, P624, DOI 10.1111/j.1365-2958.2008.06176.x; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Selmecki AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000705; Springer M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.19; STCHARLES J, 2010, GENETICS        0810, DOI DOI 10.1534/GENETICS.110.121533; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	25	386	389	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					321	325		10.1038/nature09529	http://dx.doi.org/10.1038/nature09529			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	20962780	Green Accepted			2022-12-28	WOS:000284051000054
J	Timmins, N				Timmins, Nick			Health Economics Where do the cuts leave the NHS?	BRITISH MEDICAL JOURNAL			English	Editorial Material												Nick.Timmins@FT.com							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 26	2010	341								c6024	10.1136/bmj.c6024	http://dx.doi.org/10.1136/bmj.c6024			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674YE	20978056				2022-12-28	WOS:000283786800032
J	Rappaport, SM; Smith, MT				Rappaport, Stephen M.; Smith, Martyn T.			Environment and Disease Risks	SCIENCE			English	Editorial Material							GENOME; DAMAGE		[Rappaport, Stephen M.; Smith, Martyn T.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Rappaport, SM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	srappaport@berkeley.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705, U54ES016115] Funding Source: NIH RePORTER; NIEHS NIH HHS [P42ES04705, P42 ES004705, U54 ES016115, U54ES016115] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Dunn WB, 2008, INT J EPIDEMIOL, V37, P23, DOI 10.1093/ije/dym281; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Haltdorsson TL, 2009, ENVIRON RES, V109, P22, DOI 10.1016/j.envres.2008.08.011; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Liebler DC, 2008, CHEM RES TOXICOL, V21, P117, DOI 10.1021/tx700235t; McHale CM, 2010, MUTAT RES-REV MUTAT, V705, P172, DOI 10.1016/j.mrrev.2010.04.001; Mounicou S, 2009, CHEM SOC REV, V38, P1119, DOI 10.1039/b713633c; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; Rubino FM, 2009, MASS SPECTROM REV, V28, P725, DOI 10.1002/mas.20207; Vineis P, 2004, INT J EPIDEMIOL, V33, P945, DOI 10.1093/ije/dyh277; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055	15	481	510	10	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					460	461		10.1126/science.1192603	http://dx.doi.org/10.1126/science.1192603			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966241	Green Accepted			2022-12-28	WOS:000283329100026
J	Lehnert, MD; Nesvadba, NPH; Cuby, JG; Swinbank, AM; Morris, S; Clement, B; Evans, CJ; Bremer, MN; Basa, S				Lehnert, M. D.; Nesvadba, N. P. H.; Cuby, J. -G.; Swinbank, A. M.; Morris, S.; Clement, B.; Evans, C. J.; Bremer, M. N.; Basa, S.			Spectroscopic confirmation of a galaxy at redshift z=8.6	NATURE			English	Article							LYMAN-BREAK GALAXIES; LY-ALPHA EMITTERS; ULTRA-DEEP-FIELD; IONIZED BUBBLES; REIONIZATION; EVOLUTION; CONTINUUM; Z-SIMILAR-TO-3; UNIVERSE; QUASARS	Galaxies had their most significant impact on the Universe when they assembled their first generations of stars. Energetic photons emitted by young, massive stars in primeval galaxies ionized the intergalactic medium surrounding their host galaxies, cleared sight-lines along which the light of the young galaxies could escape, and fundamentally altered the physical state of the intergalactic gas in the Universe continuously until the present day(1,2). Observations of the cosmic microwave background(3), and of galaxies and quasars at the highest redshifts(4), suggest that the Universe was reionized through a complex process that was completed about a billion years after the Big Bang, by redshift z approximate to 6. Detecting ionizing Lyman-alpha photons from increasingly distant galaxies places important constraints on the timing, location and nature of the sources responsible for reionization. Here we report the detection of Ly alpha photons emitted less than 600 million years after the Big Bang. UDFy-38135539 (ref. 5) is at a redshift of z = 8.5549 +/- 0.0002, which is greater than those of the previously known most distant objects, at z = 8.2 (refs 6 and 7) and z = 6.96 (ref. 8). We find that this single source is unlikely to provide enough photons to ionize the volume necessary for the emission line to escape, requiring a significant contribution from other, probably fainter galaxies nearby(9).	[Lehnert, M. D.] Univ Paris Diderot, CNRS, Observ Paris, GEPI, F-92190 Meudon, France; [Nesvadba, N. P. H.] Univ Paris 11, CNRS, Inst Astrophys Spatiale, UMR 8617, F-91405 Orsay, France; [Cuby, J. -G.; Clement, B.; Basa, S.] Univ Aix Marseille, Lab Astrophys Marseille, OAMP, F-13388 Marseille 13, France; [Cuby, J. -G.; Clement, B.; Basa, S.] CNRS, F-13388 Marseille 13, France; [Swinbank, A. M.] Univ Durham, Dept Phys, Inst Computat Cosmol, Durham DH1 3LE, England; [Morris, S.] Univ Durham, Dept Phys, Durham DH1 3AJ, England; [Evans, C. J.] Royal Observ, UK Astron Technol Ctr, Edinburgh EH9 3HJ, Midlothian, Scotland; [Bremer, M. N.] Univ Bristol, HH Wills Phys Lab, Dept Phys, Bristol BS8 1TL, Avon, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Durham University; Durham University; University of Edinburgh; University of Bristol	Lehnert, MD (corresponding author), Univ Paris Diderot, CNRS, Observ Paris, GEPI, 5 Pl Jules Janssen, F-92190 Meudon, France.	matthew.lehnert@obspm.fr; nicole.nesvadba@ias.u-psud.fr	Morris, Simon L/G-7981-2011	Morris, Simon L/0000-0003-4866-110X; swinbank, mark/0000-0003-1192-5837; Lehnert, Matthew/0000-0003-1939-5885	STFC [ST/F002963/1, ST/H005234/1, ST/F002742/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/E001181/1, ST/F002742/1, ST/H005234/1, ST/F002963/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Bergvall N, 2006, ASTRON ASTROPHYS, V448, P513, DOI 10.1051/0004-6361:20053788; Bouwens RJ, 2010, ASTROPHYS J LETT, V708, pL69, DOI 10.1088/2041-8205/708/2/L69; Castellano M, 2010, ASTRON ASTROPHYS, V511, DOI 10.1051/0004-6361/200913300; Choudhury TR, 2009, MON NOT R ASTRON SOC, V394, P960, DOI 10.1111/j.1365-2966.2008.14383.x; Deharveng JM, 2001, ASTRON ASTROPHYS, V375, P805, DOI 10.1051/0004-6361:20010920; Dijkstra M, 2010, MON NOT R ASTRON SOC, V408, P352, DOI 10.1111/j.1365-2966.2010.17112.x; Fan XH, 2006, ASTRON J, V132, P117, DOI 10.1086/504836; Furlanetto SR, 2008, ASTROPHYS J, V686, P25, DOI 10.1086/591047; Inoue AK, 2005, ASTRON ASTROPHYS, V435, P471, DOI 10.1051/0004-6361:20041769; Iye M, 2006, NATURE, V443, P186, DOI 10.1038/nature05104; KOMATSU E, 2010, ASTROPHYS J SU UNPUB; Labbe I, 2010, ASTROPHYS J LETT, V716, pL103, DOI 10.1088/2041-8205/716/2/L103; Loeb A, 2005, ASTROPHYS J, V620, P553, DOI 10.1086/427229; Mesinger A, 2007, ASTROPHYS J, V669, P663, DOI 10.1086/521806; Miralda-Escude J, 1998, ASTROPHYS J, V501, P15, DOI 10.1086/305799; Miralda-Escude J, 2000, ASTROPHYS J, V530, P1, DOI 10.1086/308330; Ota K, 2008, ASTROPHYS J, V677, P12, DOI 10.1086/529006; Ouchi M, 2008, ASTROPHYS J SUPPL S, V176, P301, DOI 10.1086/527673; Ouchi M, 2009, ASTROPHYS J, V706, P1136, DOI 10.1088/0004-637X/706/2/1136; Salvaterra R, 2009, NATURE, V461, P1258, DOI 10.1038/nature08445; SCALO J, 1998, ASP C SER, V142, P210; Stark DP, 2009, ASTROPHYS J, V697, P1493, DOI 10.1088/0004-637X/697/2/1493; Tanvir NR, 2009, NATURE, V461, P1254, DOI 10.1038/nature08459; Verma A, 2007, MON NOT R ASTRON SOC, V377, P1024, DOI 10.1111/j.1365-2966.2007.11455.x; Wyithe JSB, 2004, NATURE, V432, P194, DOI 10.1038/nature03033; Wyithe JSB, 2005, ASTROPHYS J, V625, P1, DOI 10.1086/429529	29	95	95	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					940	942		10.1038/nature09462	http://dx.doi.org/10.1038/nature09462			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962840	Green Submitted			2022-12-28	WOS:000283254700032
J	Menikoff, J				Menikoff, Jerry			The Paradoxical Problem with Multiple-IRB Review.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Off Human Res Protect, Rockville, MD USA		Menikoff, J (corresponding author), Off Human Res Protect, Rockville, MD USA.							[Anonymous], 2006, NAT C ALT IRB MOD OP; Burman W, 2009, CLIN INFECT DIS, V49, P328, DOI 10.1086/605454; Department of Health and Human Services, 2009, FED REGISTER, V74, P9578; 2005, NCI POSITION PAPER P	4	79	80	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2010	363	17					1591	1593		10.1056/NEJMp1005101	http://dx.doi.org/10.1056/NEJMp1005101			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668BD	20942660				2022-12-28	WOS:000283242700002
J	Lacis, AA; Schmidt, GA; Rind, D; Ruedy, RA				Lacis, Andrew A.; Schmidt, Gavin A.; Rind, David; Ruedy, Reto A.			Atmospheric CO2: Principal Control Knob Governing Earth's Temperature	SCIENCE			English	Article							SUN	Ample physical evidence shows that carbon dioxide (CO2) is the single most important climate-relevant greenhouse gas in Earth's atmosphere. This is because CO2, like ozone, N2O, CH4, and chlorofluorocarbons, does not condense and precipitate from the atmosphere at current climate temperatures, whereas water vapor can and does. Noncondensing greenhouse gases, which account for 25% of the total terrestrial greenhouse effect, thus serve to provide the stable temperature structure that sustains the current levels of atmospheric water vapor and clouds via feedback processes that account for the remaining 75% of the greenhouse effect. Without the radiative forcing supplied by CO2 and the other noncondensing greenhouse gases, the terrestrial greenhouse would collapse, plunging the global climate into an icebound Earth state.	[Lacis, Andrew A.; Schmidt, Gavin A.; Rind, David; Ruedy, Reto A.] NASA, Goddard Inst Space Studies, New York, NY 10025 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Lacis, AA (corresponding author), NASA, Goddard Inst Space Studies, 2880 Broadway, New York, NY 10025 USA.	andrew.a.lacis@nasa.gov	Lacis, Andrew A/D-4658-2012; Schmidt, Gavin/D-4427-2012; Lacis, Andrew/GVT-2947-2022	Schmidt, Gavin/0000-0002-2258-0486; Ruedy, Reto/0000-0002-1270-1088	NASA Earth Science Research Division	NASA Earth Science Research Division	We thank B. Carlson, A. Del Genio, J. Hansen, G. Russell, R. Stothers, and L. Travis for comments and the NASA Earth Science Research Division managed by J. Kaye and D. Considine for support.	Archer D, 2009, ANNU REV EARTH PL SC, V37, P117, DOI 10.1146/annurev.earth.031208.100206; Arrhenius S., 1896, LOND EDINB DUBLIN PH, V41, P237, DOI [10.1080/14786449608620846, DOI 10.1080/14786449608620846]; Berner R.A., 2004, PHANEROZOIC CARBON C; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Fourier Joseph., 1824, ANN CHIM PHYS 2, V27, P136; Hansen J, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005776; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Hansen J., 1984, GEOPHYS MONOGR SER, P130, DOI [10.1029/gm029p0130, 10.1029/GM029p0130, DOI 10.1029/GM029P0130]; Harvey LDD, 2007, CLIMATIC CHANGE, V82, P1, DOI 10.1007/s10584-006-9183-6; Jansen E, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P433; Joos F, 2008, P NATL ACAD SCI USA, V105, P1425, DOI 10.1073/pnas.0707386105; Kirschvink J. L., 1992, PROTEROZOIC BIOSPHER, P51; LINDZEN RS, 1995, PHYS TODAY, V48, P78, DOI 10.1063/1.2807926; LINDZEN RS, 1991, Q J ROY METEOR SOC, V117, P651; Sackmann IJ, 2003, ASTROPHYS J, V583, P1024, DOI 10.1086/345408; Schmidt GA, 2006, J CLIMATE, V19, P153, DOI 10.1175/JCLI3612.1; Schmidt GA, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000757; TOMKIN J, 1992, PHYS TODAY, V45, P13, DOI 10.1063/1.2809904; Tyndall J., 1863, LONDON EDINBURGH DUB, V25, P200, DOI [10.1080/14786446308643443, DOI 10.1080/14786446308643443]; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	23	271	283	18	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					356	359		10.1126/science.1190653	http://dx.doi.org/10.1126/science.1190653			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947761				2022-12-28	WOS:000282986700037
J	Cresci, G; Mannucci, F; Maiolino, R; Marconi, A; Gnerucci, A; Magrini, L				Cresci, G.; Mannucci, F.; Maiolino, R.; Marconi, A.; Gnerucci, A.; Magrini, L.			Gas accretion as the origin of chemical abundance gradients in distant galaxies	NATURE			English	Article							INTEGRAL FIELD SPECTROSCOPY; STAR-FORMING GALAXIES; LYMAN-BREAK GALAXIES; SIMILAR-TO 2; EVOLUTION; METALLICITY; STELLAR; MASS; Z-SIMILAR-TO-2; DIAGNOSTICS	It has recently been suggested(1,2) that galaxies in the early Universe could have grown through the accretion of cold gas, and that this may have been the main driver of star formation and stellar mass growth(3-5). Because the cold gas is essentially primordial, it has a very low abundance of elements heavier than helium (referred to as metallicity). If funnelled to the centre of a galaxy, it will result in the central gas having an overall lower metallicity than gas further from the centre, because the gas further out has been enriched by supernovae and stellar winds, and not diluted by the primordial gas. Here we report chemical abundances across three rotationally supported star-forming galaxies at redshift z approximate to 3, only 2 Gyr after the Big Bang. We find 'inverse' gradients, with the central, star-forming regions having lower metallicities than less active ones, which is opposite to what is seen in local galaxies(6,7). We conclude that the central gas has been diluted by the accretion of primordial gas, as predicted by 'cold flow' models.	[Cresci, G.; Mannucci, F.; Magrini, L.] INAF Osservatorio Astrofis Arcetri, I-50125 Florence, Italy; [Cresci, G.] Max Planck Inst Extraterr Phys MPE, D-85748 Garching, Germany; [Maiolino, R.] INAF Osservatorio Astron Roma, I-00040 Monte Porzio Catone, Italy; [Marconi, A.; Gnerucci, A.] Univ Florence, Dipartimento Fis & Astron, I-50125 Florence, Italy	Istituto Nazionale Astrofisica (INAF); Max Planck Society; Istituto Nazionale Astrofisica (INAF); University of Florence	Cresci, G (corresponding author), INAF Osservatorio Astrofis Arcetri, Largo E Fermi 5, I-50125 Florence, Italy.	gcresci@arcetri.astro.it	Magrini, Laura/ABB-6430-2020; Magrini, Laura/ABH-7262-2020; Marconi, Alessandro/AAF-7375-2021; Cresci, Giovanni/ABD-7239-2020; Marconi, Alessandro/C-5880-2009; Magrini, Laura/J-2485-2012	Magrini, Laura/0000-0003-4486-6802; Marconi, Alessandro/0000-0002-9889-4238; Cresci, Giovanni/0000-0002-5281-1417; Marconi, Alessandro/0000-0002-9889-4238; Magrini, Laura/0000-0003-4486-6802; Maiolino, Roberto/0000-0002-4985-3819; mannucci, filippo/0000-0002-4803-2381	ESO; INAF; ASI	ESO; INAF(Istituto Nazionale Astrofisica (INAF)); ASI(Agenzia Spaziale Italiana (ASI))	SINFONI data were obtained from observations made with the ESO Telescopes at the Paranal Observatories. We thank the ESO staff for their work and support. This work was supported by INAF and ASI.	Bouche N, 2007, ASTROPHYS J, V671, P303, DOI 10.1086/522221; Bournaud F, 2009, ASTROPHYS J LETT, V694, pL158, DOI 10.1088/0004-637X/694/2/L158; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Cresci G, 2009, ASTROPHYS J, V697, P115, DOI 10.1088/0004-637X/697/1/115; Daddi E, 2007, ASTROPHYS J, V670, P156, DOI 10.1086/521818; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Dopita MA, 2006, ASTROPHYS J SUPPL S, V167, P177, DOI 10.1086/508261; Eisenhauer F, 2003, P SOC PHOTO-OPT INS, V4841, P1548, DOI 10.1117/12.459468; Erb DK, 2008, ASTROPHYS J, V674, P151, DOI 10.1086/524727; Garnett DR, 1997, ASTROPHYS J, V489, P63, DOI 10.1086/304775; Genzel R, 2008, ASTROPHYS J, V687, P59, DOI 10.1086/591840; Hopkins AM, 2006, ASTROPHYS J, V651, P142, DOI 10.1086/506610; Hou JL, 2000, ASTRON ASTROPHYS, V362, P921; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Kennicutt RC, 1998, ASTROPHYS J, V498, P541, DOI 10.1086/305588; Keres D, 2005, MON NOT R ASTRON SOC, V363, P2, DOI 10.1111/j.1365-2966.2005.09451.x; Levesque EM, 2010, ASTRON J, V139, P712, DOI 10.1088/0004-6256/139/2/712; Magrini L, 2009, ASTRON ASTROPHYS, V494, P95, DOI 10.1051/0004-6361:200810634; Maiolino R, 2008, ASTRON ASTROPHYS, V488, P463, DOI 10.1051/0004-6361:200809678; Mannucci F, 2009, MON NOT R ASTRON SOC, V398, P1915, DOI 10.1111/j.1365-2966.2009.15185.x; MANNUCCI F, 2010, MON NOT R A IN PRESS; Martin-Manjon ML, 2010, MON NOT R ASTRON SOC, V403, P2012, DOI 10.1111/j.1365-2966.2009.16239.x; Molla M, 1997, ASTROPHYS J, V475, P519, DOI 10.1086/303550; Nagao T, 2006, ASTRON ASTROPHYS, V459, P85, DOI 10.1051/0004-6361:20065216; Pozzetti L, 2007, ASTRON ASTROPHYS, V474, P443, DOI 10.1051/0004-6361:20077609; Schreiber NMF, 2009, ASTROPHYS J, V706, P1364, DOI 10.1088/0004-637X/706/2/1364; Steidel CC, 2003, ASTROPHYS J, V592, P728, DOI 10.1086/375772; Tacconi LJ, 2010, NATURE, V463, P781, DOI 10.1038/nature08773; TINSLEY BM, 1979, ASTROPHYS J, V229, P1046, DOI 10.1086/157039; van Zee L, 1998, ASTRON J, V116, P2805, DOI 10.1086/300647	30	176	176	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					811	813		10.1038/nature09451	http://dx.doi.org/10.1038/nature09451			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944741	Green Submitted			2022-12-28	WOS:000282898700059
J	Niebyl, JR				Niebyl, Jennifer R.			Nausea and Vomiting in Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPEREMESIS GRAVIDARUM; 1ST TRIMESTER; DOUBLE-BLIND; CHORIONIC-GONADOTROPIN; CONTROLLED-TRIAL; P6 ACUPRESSURE; BIRTH-DEFECTS; SAFETY; GINGER; CORTICOSTEROIDS	A 25-year-old woman presents with persistent nausea and vomiting 8 weeks after her last menstrual period in her first pregnancy. Her primary care provider is reluctant to give her medications. She has lost 5 lb (2.3 kg) in 6 weeks. How should she be treated?	Univ Iowa Hosp & Clin, Dept Obstet & Gynecol, Iowa City, IA 52242 USA	University of Iowa	Niebyl, JR (corresponding author), Univ Iowa Hosp & Clin, Dept Obstet & Gynecol, 200 Hawkins Dr, Iowa City, IA 52242 USA.	jennifer-niebyl@uiowa.edu	Beldar, Sagar V/C-8542-2011					ACOG, 2004, OBSTET GYNECOL, V103, P803; Arsenault Marc-Yvon, 2002, J Obstet Gynaecol Can, V24, P817; Attard CL, 2002, AM J OBSTET GYNECOL, V186, pS220, DOI 10.1067/mob.2002.122605; Bashiri A, 1995, EUR J OBSTET GYN R B, V63, P135, DOI 10.1016/0301-2115(95)02238-4; Borrelli F, 2005, OBSTET GYNECOL, V105, P849, DOI 10.1097/01.AOG.0000154890.47642.23; BRAUNSTEIN GD, 1976, J CLIN ENDOCR METAB, V42, P1123, DOI 10.1210/jcem-42-6-1123; Briggs GG, 2008, DRUGS PREGNANCY LACT; Broussard CN, 1998, GASTROENTEROL CLIN N, V27, P123, DOI 10.1016/S0889-8553(05)70350-2; Carlsson CPO, 2000, J PAIN SYMPTOM MANAG, V20, P273, DOI 10.1016/S0885-3924(00)00185-8; CZEIZEL AE, 1992, ARCH GYNECOL OBSTET, V251, P181, DOI 10.1007/BF02718384; DUNDEE JW, 1988, J ROY SOC MED, V81, P456, DOI 10.1177/014107688808100813; Einarson A, 2004, BJOG-INT J OBSTET GY, V111, P940, DOI 10.1111/j.1471-0528.2004.00236.x; Eliakim R, 2000, AM J PERINAT, V17, P207, DOI 10.1055/s-2000-9424; FISCHERRASMUSSEN W, 1991, EUR J OBSTET GYN R B, V38, P19, DOI 10.1016/0028-2243(91)90202-V; Folk JJ, 2004, J REPROD MED, V49, P497; GADSBY R, 1993, BRIT J GEN PRACT, V43, P245; Gardian G, 1999, ACTA NEUROL SCAND, V99, P196, DOI 10.1111/j.1600-0404.1999.tb07344.x; GOODWIN TM, 1992, J CLIN ENDOCR METAB, V75, P1333, DOI 10.1210/jc.75.5.1333; Goodwin TM, 1998, CLIN OBSTET GYNECOL, V41, P597, DOI 10.1097/00003081-199809000-00014; GROSS S, 1989, AM J OBSTET GYNECOL, V160, P906, DOI 10.1016/0002-9378(89)90307-4; HOLMES LB, 1983, TERATOLOGY, V27, P277, DOI 10.1002/tera.1420270216; Hsu JJ, 1996, OBSTET GYNECOL, V88, P343, DOI 10.1016/0029-7844(96)00174-3; Jednak MA, 1999, AM J PHYSIOL-GASTR L, V277, pG855, DOI 10.1152/ajpgi.1999.277.4.G855; Jewell D, 2003, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.cd000145, DOI 10.1002/14651858.CD000145]; KIRSHON B, 1988, OBSTET GYNECOL, V71, P1032; Knight B, 2001, OBSTET GYNECOL, V97, P184, DOI 10.1016/S0029-7844(00)01152-2; Koren G, 1998, NEW ENGL J MED, V338, P1128, DOI 10.1056/NEJM199804163381607; Kovac AL, 2000, DRUGS, V59, P213, DOI 10.2165/00003495-200059020-00005; Lacroix R, 2000, AM J OBSTET GYNECOL, V182, P931, DOI 10.1016/S0002-9378(00)70349-8; Levichek Z, 2002, CAN FAM PHYSICIAN, V48, P267; Matok I, 2009, NEW ENGL J MED, V360, P2528, DOI 10.1056/NEJMoa0807154; Mazzotta P, 2000, J PSYCHOSOM OBST GYN, V21, P129, DOI 10.3109/01674820009075620; MCKEIGUE PM, 1994, TERATOLOGY, V50, P27, DOI 10.1002/tera.1420500105; NEUTEL CI, 1995, CAN J PUBLIC HEALTH, V86, P66; Newman V, 1993, J Obstet Gynecol Neonatal Nurs, V22, P483, DOI 10.1111/j.1552-6909.1993.tb01833.x; OBrien B, 1996, AM J OBSTET GYNECOL, V174, P708, DOI 10.1016/S0002-9378(96)70454-4; Park-Wyllie L, 2000, TERATOLOGY, V62, P385, DOI 10.1002/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z; Portnoi G, 2004, AM J OBSTET GYNECOL, V190, P1140; Portnoi G, 2003, AM J OBSTET GYNECOL, V189, P1374, DOI 10.1067/S0002-9378(03)00649-5; Rosen T, 2003, OBSTET GYNECOL, V102, P129, DOI 10.1016/S0029-7844(03)00375-2; Safari HR, 1998, AM J OBSTET GYNECOL, V179, P921, DOI 10.1016/S0002-9378(98)70189-9; SAHAKIAN V, 1991, OBSTET GYNECOL, V78, P33; SCHUSTER K, 1985, HUM NUTR-CLIN NUTR, V39C, P75; Singh S, 1999, J Indian Med Assoc, V97, P346; Sullivan CA, 1996, AM J OBSTET GYNECOL, V174, P1565, DOI 10.1016/S0002-9378(96)70607-5; Tan PC, 2010, OBSTET GYNECOL, V115, P975, DOI 10.1097/AOG.0b013e3181d99290; Vutyavanich T, 2001, OBSTET GYNECOL, V97, P577, DOI 10.1016/S0029-7844(00)01228-X; VUTYAVANICH T, 1995, AM J OBSTET GYNECOL, V173, P881, DOI 10.1016/0002-9378(95)90359-3; WEIGEL MM, 1989, BRIT J OBSTET GYNAEC, V96, P1304, DOI 10.1111/j.1471-0528.1989.tb03228.x; Yost NP, 2003, OBSTET GYNECOL, V102, P1250, DOI 10.1016/j.obstetgynecol.2003.08.013	50	181	194	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2010	363	16					1544	1550		10.1056/NEJMcp1003896	http://dx.doi.org/10.1056/NEJMcp1003896			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663KP	20942670				2022-12-28	WOS:000282887100008
J	Simmons, JG				Simmons, John Galbraith			Lindau and the zeitgeist	NATURE			English	Editorial Material																			0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					S14	S15		10.1038/467S14a	http://dx.doi.org/10.1038/467S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944614	Bronze			2022-12-28	WOS:000282898700013
J	Zope, BN; Hibbitts, DD; Neurock, M; Davis, RJ				Zope, Bhushan N.; Hibbitts, David D.; Neurock, Matthew; Davis, Robert J.			Reactivity of the Gold/Water Interface During Selective Oxidation Catalysis	SCIENCE			English	Article							SUPPORTED GOLD NANOPARTICLES; LOW-TEMPERATURE OXIDATION; AQUEOUS-PHASE OXIDATION; CO OXIDATION; ALCOHOL OXIDATION; AEROBIC OXIDATION; CARBON-MONOXIDE; AU; OXYGEN; GLYCEROL	The selective oxidation of alcohols in aqueous phase over supported metal catalysts is facilitated by high-pH conditions. We have studied the mechanism of ethanol and glycerol oxidation to acids over various supported gold and platinum catalysts. Labeling experiments with O-18(2) and (H2O)-O-18 demonstrate that oxygen atoms originating from hydroxide ions instead of molecular oxygen are incorporated into the alcohol during the oxidation reaction. Density functional theory calculations suggest that the reaction path involves both solution-mediated and metal-catalyzed elementary steps. Molecular oxygen is proposed to participate in the catalytic cycle not by dissociation to atomic oxygen but by regenerating hydroxide ions formed via the catalytic decomposition of a peroxide intermediate.	[Zope, Bhushan N.; Hibbitts, David D.; Neurock, Matthew; Davis, Robert J.] Univ Virginia, Dept Chem Engn, Charlottesville, VA 22904 USA	University of Virginia	Davis, RJ (corresponding author), Univ Virginia, Dept Chem Engn, 102 Engineers Way,POB 400741, Charlottesville, VA 22904 USA.	rjd4f@virginia.edu	Hibbitts, David/J-5507-2014	Hibbitts, David/0000-0001-8606-7000	NSF [CTS-0624608, OISE 0730277, EEC-0813570]; U.S. Department of Energy (DOE) [DE-FG02-03ER15460]; DOE's Office of Biological and Environmental Research at Pacific Northwest National Laboratory; National Center for Computational Sciences at Oak Ridge National Laboratory	NSF(National Science Foundation (NSF)); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); DOE's Office of Biological and Environmental Research at Pacific Northwest National Laboratory; National Center for Computational Sciences at Oak Ridge National Laboratory	This work was supported by grants from NSF (CTS-0624608, OISE 0730277, and EEC-0813570) and the U.S. Department of Energy (DOE) (Basic Energy Sciences DE-FG02-03ER15460). We also kindly acknowledge the supercomputing time at the Environmental Molecular Science Laboratory, a national scientific user facility sponsored by the DOE's Office of Biological and Environmental Research located at Pacific Northwest National Laboratory, and the National Center for Computational Sciences at Oak Ridge National Laboratory.	Abad A, 2008, CHEM-EUR J, V14, P212, DOI 10.1002/chem.200701263; BALLINGER P, 1960, J AM CHEM SOC, V82, P795, DOI 10.1021/ja01489a008; Besson M, 2000, CATAL TODAY, V57, P127, DOI 10.1016/S0920-5861(99)00315-6; Bond G. C., 2006, CATALYTIC SCI SERIES, V6; Bond GC, 2000, GOLD BULL, V33, P41, DOI 10.1007/BF03216579; Carrettin S, 2002, CHEM COMMUN, P696, DOI 10.1039/b201112n; Clayden J., 2001, ORGANIC CHEM; Conte M, 2009, J AM CHEM SOC, V131, P7189, DOI 10.1021/ja809883c; Corma A, 2008, CHEM SOC REV, V37, P2096, DOI 10.1039/b707314n; Date M, 2004, ANGEW CHEM INT EDIT, V43, P2129, DOI 10.1002/anie.200453796; Deng XY, 2005, J AM CHEM SOC, V127, P9267, DOI 10.1021/ja050144j; Fristrup P, 2008, CATAL LETT, V120, P184, DOI 10.1007/s10562-007-9301-8; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; Gallezot P, 1997, CATAL TODAY, V37, P405, DOI 10.1016/S0920-5861(97)00024-2; Gangwal VR, 2005, J CATAL, V229, P389, DOI 10.1016/j.jcat.2004.11.021; Gewirth AA, 2010, INORG CHEM, V49, P3557, DOI 10.1021/ic9022486; Guzman J, 2004, J AM CHEM SOC, V126, P2672, DOI 10.1021/ja039426e; HAMMER B, 1995, NATURE, V376, P238, DOI 10.1038/376238a0; Haruta M, 2001, APPL CATAL A-GEN, V222, P427, DOI 10.1016/S0926-860X(01)00847-X; HARUTA M, 1993, J CATAL, V144, P175, DOI 10.1006/jcat.1993.1322; HARUTA M, 1989, J CATAL, V115, P301, DOI 10.1016/0021-9517(89)90034-1; Janssens TVW, 2007, TOP CATAL, V44, P15, DOI 10.1007/s11244-007-0335-3; Ketchie WC, 2007, J CATAL, V250, P264, DOI 10.1016/j.jcat.2007.06.011; Ketchie WC, 2007, J CATAL, V250, P94, DOI 10.1016/j.jcat.2007.06.001; Ketchie WC, 2007, TOP CATAL, V44, P307, DOI 10.1007/s11244-007-0304-x; Kung MC, 2007, J PHYS CHEM C, V111, P11767, DOI 10.1021/jp072102i; Lopez N, 2002, J AM CHEM SOC, V124, P11262, DOI 10.1021/ja026998a; Mallat T, 2004, CHEM REV, V104, P3037, DOI 10.1021/cr0200116; Nolan PD, 1999, J CHEM PHYS, V111, P3696, DOI 10.1063/1.479649; Ojifinni RA, 2008, J AM CHEM SOC, V130, P6801, DOI 10.1021/ja800351j; Prati L, 1998, J CATAL, V176, P552, DOI 10.1006/jcat.1998.2078; ROTTENBERG M, 1956, HELV CHIM ACTA, V227, P1073; Sanchez A, 1999, J PHYS CHEM A, V103, P9573, DOI 10.1021/jp9935992; Sanchez-Castillo MA, 2004, ANGEW CHEM INT EDIT, V43, P1140, DOI 10.1002/anie.200353238; SHELDON RA, 1994, CATAL TODAY, V19, P215, DOI 10.1016/0920-5861(94)80186-X; Valden M, 1998, SCIENCE, V281, P1647, DOI 10.1126/science.281.5383.1647; VANDENTILLAART JAA, 1994, APPL CATAL A-GEN, V120, P127, DOI 10.1016/0926-860X(94)80338-2	37	781	786	7	677	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2010	330	6000					74	78		10.1126/science.1195055	http://dx.doi.org/10.1126/science.1195055			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929807				2022-12-28	WOS:000282334500036
J	Rad, R; Rad, L; Wang, W; Cadinanos, J; Vassiliou, G; Rice, S; Campos, LS; Yusa, K; Banerjee, R; Li, MA; de la Rosa, J; Strong, A; Lu, D; Ellis, P; Conte, N; Yang, FT; Liu, PT; Bradley, A				Rad, Roland; Rad, Lena; Wang, Wei; Cadinanos, Juan; Vassiliou, George; Rice, Stephen; Campos, Lia S.; Yusa, Kosuke; Banerjee, Ruby; Li, Meng Amy; de la Rosa, Jorge; Strong, Alexander; Lu, Dong; Ellis, Peter; Conte, Nathalie; Yang, Fang Tang; Liu, Pentao; Bradley, Allan			PiggyBac Transposon Mutagenesis: A Tool for Cancer Gene Discovery in Mice	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; SLEEPING-BEAUTY; CHROMOSOMAL TRANSPOSITION; TRANSGENIC MICE; MOUSE; NETWORKS; SCREENS; SYSTEM	Transposons are mobile DNA segments that can disrupt gene function by inserting in or near genes. Here, we show that insertional mutagenesis by the PiggyBac transposon can be used for cancer gene discovery in mice. PiggyBac transposition in genetically engineered transposon-transposase mice induced cancers whose type (hematopoietic versus solid) and latency were dependent on the regulatory elements introduced into transposons. Analysis of 63 hematopoietic tumors revealed that PiggyBac is capable of genome-wide mutagenesis. The PiggyBac screen uncovered many cancer genes not identified in previous retroviral or Sleeping Beauty transposon screens, including Spic, which encodes a PU.1-related transcription factor, and Hdac7, a histone deacetylase gene. PiggyBac and Sleeping Beauty have different integration preferences. To maximize the utility of the tool, we engineered 21 mouse lines to be compatible with both transposon systems in constitutive, tissue-or temporal-specific mutagenesis. Mice with different transposon types, copy numbers, and chromosomal locations support wide applicability.	[Rad, Roland; Rad, Lena; Wang, Wei; Cadinanos, Juan; Vassiliou, George; Rice, Stephen; Campos, Lia S.; Yusa, Kosuke; Banerjee, Ruby; Li, Meng Amy; Strong, Alexander; Lu, Dong; Ellis, Peter; Conte, Nathalie; Yang, Fang Tang; Liu, Pentao; Bradley, Allan] Wellcome Trust Sanger Inst, Hinxton Cambridge CB10 1SA, England; [Cadinanos, Juan; de la Rosa, Jorge] IMOMA, Oviedo 33193, Spain	Wellcome Trust Sanger Institute	Bradley, A (corresponding author), Wellcome Trust Sanger Inst, Genome Campus, Hinxton Cambridge CB10 1SA, England.	abradley@sanger.ac.uk	Yang, Fan/GYU-4249-2022; Wilson, Matthew H/K-3193-2013	Yang, Fengtang/0000-0002-3573-2354; Vassiliou, George/0000-0003-4337-8022; Cadinanos, Juan/0000-0001-7561-7759; Conte, Nathalie/0000-0002-1010-3121; Bradley, Allan/0000-0002-2349-8839; de la Rosa, Jorge/0000-0002-0201-2078	Wellcome Trust; Deutsche Forschungsgemeinschaft; Fundacion Maria Cristina Masaveu Peterson	Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fundacion Maria Cristina Masaveu Peterson	We thank the research support facility team, B. L. Ng, B. Fu, and Y. Hooks for technical assistance; N. Carter and C. Lopez-Otin for experimental resources; L. Wessels, J. ten Hoeve, and J. de Ridder for software used in data analysis; D. Saur for technical advice; and H. Prosser for reagents. The work was supported by the Wellcome Trust. R. R. and J. R. are recipients of a fellowship from the Deutsche Forschungsgemeinschaft and the Fundacion Maria Cristina Masaveu Peterson, respectively.	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Collier LS, 2009, CANCER RES, V69, P8429, DOI 10.1158/0008-5472.CAN-09-1760; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Hoemann CD, 2000, MOL CELL BIOL, V20, P3831, DOI 10.1128/MCB.20.11.3831-3842.2000; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2009, NAT METHODS, V6, P415, DOI [10.1038/NMETH.1332, 10.1038/nmeth.1332]; Keng VW, 2005, NAT METHODS, V2, P763, DOI 10.1038/NMETH795; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kool J, 2009, NAT REV CANCER, V9, P389, DOI 10.1038/nrc2647; Liang Q, 2009, GENESIS, V47, P404, DOI 10.1002/dvg.20508; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Willis TG, 1998, BLOOD, V91, P1873, DOI 10.1182/blood.V91.6.1873.1873_1873_1881	23	163	183	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1104	1107		10.1126/science.1193004	http://dx.doi.org/10.1126/science.1193004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	20947725	Green Accepted			2022-12-28	WOS:000284374700044
J	Zhou, AW; Carrell, RW; Murphy, MP; Wei, ZQ; Yan, YH; Stanley, PLD; Stein, PE; Pipkin, FB; Read, RJ				Zhou, Aiwu; Carrell, Robin W.; Murphy, Michael P.; Wei, Zhenquan; Yan, Yahui; Stanley, Peter L. D.; Stein, Penelope E.; Pipkin, Fiona Broughton; Read, Randy J.			A redox switch in angiotensinogen modulates angiotensin release	NATURE			English	Article							OXIDATIVE STRESS; NITRIC-OXIDE; RENIN; HYPERTENSION; PREECLAMPSIA; SYSTEM; KIDNEY; MODEL	Blood pressure is critically controlled by angiotensins(1), which are vasopressor peptides specifically released by the enzyme renin from the tail of angiotensinogen-a non-inhibitory member of the serpin family of protease inhibitors(2,3). Although angiotensinogen has long been regarded as a passive substrate, the crystal structures solved here to 2.1 angstrom resolution show that the angiotensin cleavage site is inaccessibly buried in its amino-terminal tail. The conformational rearrangement that makes this site accessible for proteolysis is revealed in our 4.4 angstrom structure of the complex of human angiotensinogen with renin. The co-ordinated changes involved are seen to be critically linked by a conserved but labile disulphide bridge. Here we show that the reduced unbridged form of angiotensinogen is present in the circulation in a near 40:60 ratio with the oxidized sulphydryl-bridged form, which preferentially interacts with receptor-bound renin. We propose that this redox-responsive transition of angiotensinogen to a form that will more effectively release angiotensin at a cellular level contributes to the modulation of blood pressure. Specifically, we demonstrate the oxidative switch of angiotensinogen to its more active sulphydryl-bridged form in the maternal circulation in pre-eclampsia-the hypertensive crisis of pregnancy that threatens the health and survival of both mother and child.	[Carrell, Robin W.; Stein, Penelope E.] Univ Cambridge, Cambridge Inst Med Res, Dept Med, Cambridge CB2 0XY, England; [Zhou, Aiwu; Wei, Zhenquan; Yan, Yahui; Stanley, Peter L. D.; Read, Randy J.] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England; [Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Pipkin, Fiona Broughton] Univ Nottingham, City Hosp, Dept Obstet & Gynaecol, Nottingham NG5 1PB, England	University of Cambridge; University of Cambridge; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	Carrell, RW (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Med, Hills Rd, Cambridge CB2 0XY, England.	awz20@cam.ac.uk; rwc1000@cam.ac.uk	Murphy, Michael P/C-2120-2009; Read, Randy J/L-1418-2013	Murphy, Michael P/0000-0003-1115-9618; Read, Randy J/0000-0001-8273-0047; ZHOU, Aiwu/0000-0002-2555-5091	British Heart Foundation; Wellcome Trust; Isaac Newton Trust of the University of Cambridge; UK Medical Research Council with Daresbury SRS; UK Medical Research Council; Diamond Light Source; MRC [MC_U105663142] Funding Source: UKRI; British Heart Foundation [PG/09/072/27945] Funding Source: researchfish; Medical Research Council [MC_U105663142] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Isaac Newton Trust of the University of Cambridge; UK Medical Research Council with Daresbury SRS(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diamond Light Source; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the British Heart Foundation, the Wellcome Trust, the Isaac Newton Trust of the University of Cambridge and the UK Medical Research Council, with the support of the Daresbury SRS and Diamond Light Source. We acknowledge the assistance of G. Bunkoczi in data processing, H. Hong for the HPLC measurements of angiotensin, and T. Prime for analysing S-nitrosothiols.	Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Burton GJ, 2004, J SOC GYNECOL INVEST, V11, P342, DOI 10.1016/j.jsgi.2004.03.003; Dahm CC, 2006, J BIOL CHEM, V281, P10056, DOI 10.1074/jbc.M512203200; DEALWIS CG, 1994, J MOL BIOL, V236, P342, DOI 10.1006/jmbi.1994.1139; Dickson ME, 2006, HYPERTENSION, V48, P14, DOI 10.1161/01.HYP.0000227932.13687.60; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; Gimenez-Roqueplo AP, 1998, J BIOL CHEM, V273, P34480, DOI 10.1074/jbc.273.51.34480; Harrison DG, 2009, MED CLIN N AM, V93, P621, DOI 10.1016/j.mcna.2009.02.015; Hoffmann DS, 2008, HYPERTENSION, V51, P1058, DOI 10.1161/HYPERTENSIONAHA.107.107219; Hubel CA, 1999, P SOC EXP BIOL MED, V222, P222, DOI 10.1046/j.1525-1373.1999.d01-139.x; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; INOUE I, 1995, J BIOL CHEM, V270, P11430, DOI 10.1074/jbc.270.19.11430; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; Kilicdag EB, 2005, HYPERTENS PREGNANCY, V24, P147, DOI 10.1081/PRG-200059863; KIM HS, 1995, P NATL ACAD SCI USA, V92, P2735, DOI 10.1073/pnas.92.7.2735; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mistry HD, 2008, HYPERTENSION, V52, P881, DOI 10.1161/HYPERTENSIONAHA.108.116103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021; Nasir UM, 1998, BIOSCI BIOTECH BIOCH, V62, P338, DOI 10.1271/bbb.62.338; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Powell NA, 2005, BIOORG MED CHEM LETT, V15, P4713, DOI 10.1016/j.bmcl.2005.07.063; Sedeek M, 2008, AM J HYPERTENS, V21, P1152, DOI 10.1038/ajh.2008.239; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; STEIN PE, 1989, BIOCHEM J, V262, P103, DOI 10.1042/bj2620103; Streatfeild-James RMA, 1998, FEBS LETT, V436, P267, DOI 10.1016/S0014-5793(98)01145-4; Wilcox CS, 2005, AM J PHYSIOL-REG I, V289, pR913, DOI 10.1152/ajpregu.00250.2005	30	161	170	1	38	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					108	111		10.1038/nature09505	http://dx.doi.org/10.1038/nature09505			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20927107	Green Accepted, Green Submitted			2022-12-28	WOS:000283786900045
J	Demorest, PB; Pennucci, T; Ransom, SM; Roberts, MSE; Hessels, JWT				Demorest, P. B.; Pennucci, T.; Ransom, S. M.; Roberts, M. S. E.; Hessels, J. W. T.			A two-solar-mass neutron star measured using Shapiro delay	NATURE			English	Article							MILLISECOND PULSAR; MASS; BINARY; EQUATION; MATTER	Neutron stars are composed of the densest form of matter known to exist in our Universe, the composition and properties of which are still theoretically uncertain. Measurements of the masses or radii of these objects can strongly constrain the neutron star matter equation of state and rule out theoretical models of their composition(1,2). The observed range of neutron star masses, however, has hitherto been too narrow to rule out many predictions of 'exotic' non-nucleonic components(3-6). The Shapiro delay is a general-relativistic increase in light travel time through the curved space-time near a massive body(7). For highly inclined (nearly edge-on) binary millisecond radio pulsar systems, this effect allows us to infer the masses of both the neutron star and its binary companion to high precision(8,9). Here we present radio timing observations of the binary millisecond pulsar J1614-2230(10,11) that show a strong Shapiro delay signature. We calculate the pulsar mass to be (1.97 +/- 0.04) M(circle dot), which rules out almost all currently proposed(2-5) hyperon or boson condensate equations of state (M(circle dot), solar mass). Quark matter can support a star this massive only if the quarks are strongly interacting and are therefore not 'free' quarks(12).	[Demorest, P. B.; Ransom, S. M.] Natl Radio Astron Observ, Charlottesville, VA 22093 USA; [Pennucci, T.] Univ Virginia, Dept Astron, Charlottesville, VA 22094 USA; [Roberts, M. S. E.] Eureka Sci Inc, Oakland, CA 94602 USA; [Hessels, J. W. T.] Netherlands Inst Radio Astron ASTRON, NL-7990 AA Dwingeloo, Netherlands; [Hessels, J. W. T.] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands	National Radio Astronomy Observatory (NRAO); University of Virginia; Eureka Scientific; University of Amsterdam	Demorest, PB (corresponding author), Natl Radio Astron Observ, 520 Edgemont Rd, Charlottesville, VA 22093 USA.	pdemores@nrao.edu	Pennucci, Timothy/J-3688-2018; Hessels, Jason/GTO-3261-2022	Pennucci, Timothy/0000-0001-5465-2889; Hessels, Jason/0000-0003-2317-1446; Ransom, Scott/0000-0001-5799-9714; Roberts, Mallory/0000-0002-9396-9720				Alford M, 2007, NATURE, V445, pE7, DOI 10.1038/nature05582; Berti E, 2005, MON NOT R ASTRON SOC, V358, P923, DOI 10.1111/j.1365-2966.2005.08812.x; Champion DJ, 2008, SCIENCE, V320, P1309, DOI 10.1126/science.1157580; Cordes J. M., 2002, NE2001 1 NEW MODEL G; Crawford F, 2006, ASTROPHYS J, V652, P1499, DOI 10.1086/508403; DAMOUR T, 1986, ANN I H POINCARE-PHY, V44, P263; Freire PCC, 2008, ASTROPHYS J, V679, P1433, DOI 10.1086/587832; Freire PCC, 2008, ASTROPHYS J, V675, P670, DOI 10.1086/526338; FREIRE PCC, MON NOT R A IN PRESS; Glendenning NK, 1998, PHYS REV LETT, V81, P4564, DOI 10.1103/PhysRevLett.81.4564; Hobbs GB, 2006, MON NOT R ASTRON SOC, V369, P655, DOI 10.1111/j.1365-2966.2006.10302.x; Hotan AW, 2004, PUBL ASTRON SOC AUST, V21, P302, DOI 10.1071/AS04022; IBEN I, 1985, ASTROPHYS J SUPPL S, V58, P661, DOI 10.1086/191054; Jacoby BA, 2005, ASTROPHYS J, V629, pL113, DOI 10.1086/449311; Kurkela A, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.105021; Lackey BD, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.024021; Lattimer JM, 2007, PHYS REP, V442, P109, DOI 10.1016/j.physrep.2007.02.003; Lattimer JM, 2004, SCIENCE, V304, P536, DOI 10.1126/science.1090720; Lattimer JM, 2001, ASTROPHYS J, V550, P426, DOI 10.1086/319702; Lattimer JM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.111101; Ozel F, 2006, NATURE, V441, P1115, DOI 10.1038/nature04858; OZEL F, ASTROPHYS J IN PRESS; Podsiadlowski P, 2000, ASTROPHYS J, V529, P946, DOI 10.1086/308323; Podsiadlowski P, 2002, ASTROPHYS J, V565, P1107, DOI 10.1086/324686; Ransom SM, 2005, SCIENCE, V307, P892, DOI 10.1126/science.1108632; Schulze HJ, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.058801; SHAPIRO II, 1964, PHYS REV LETT, V13, P789, DOI 10.1103/PhysRevLett.13.789; Verbiest JPW, 2008, ASTROPHYS J, V679, P675, DOI 10.1086/529576; [No title captured]	29	2574	2608	1	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1081	1083		10.1038/nature09466	http://dx.doi.org/10.1038/nature09466			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20981094	Green Submitted			2022-12-28	WOS:000283548600041
J	Young, LH; Bazari, H; Durand, ML; Branda, JA				Young, Lucy H.; Bazari, Hasan; Durand, Marlene L.; Branda, John A.			Case 33-2010: A 22-Year-Old Woman with Blurred Vision and Renal Failure PATHOLOGICAL DIAGNOSES	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SULFADIAZINE-INDUCED CRYSTALLURIA; TUBULOINTERSTITIAL NEPHRITIS; WEGENERS GRANULOMATOSIS; ENDOPHTHALMITIS; UVEITIS; GLOMERULONEPHRITIS; SARCOIDOSIS		[Young, Lucy H.] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; [Bazari, Hasan; Durand, Marlene L.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Branda, John A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Young, Lucy H.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Bazari, Hasan; Durand, Marlene L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Branda, John A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Young, LH (corresponding author), Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA.		Branda, John/ABD-5620-2020	Young, Lucy/0000-0001-8634-7512	TBS Technologies; DiaSorin	TBS Technologies; DiaSorin	Dr. Durand reports owning stock in Amgen, Roche, Pfizer, and Novartis; and Dr. Branda reports receiving grant support from TBS Technologies and DiaSorin. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2006, NEW ENGL J MED, V354, P2803; Baker RJ, 2004, NEPHROL DIAL TRANSPL, V19, P8, DOI 10.1093/ndt/gfg464; Bodaghi B, 2001, MEDICINE, V80, P263, DOI 10.1097/00005792-200107000-00005; Chakrabarti A, 2008, RETINA-J RET VIT DIS, V28, P1400, DOI 10.1097/IAE.0b013e318185e943; COPPETO JR, 1985, J CLIN NEURO-OPHTHAL, V5, P17; DURAND ML, 2010, MANDELL DOUGLAS BENN, P1553; DURAND ML, 2010, MANDELL DOUGLAS BENN, P1561; Flynn HW, 2001, RETINA-J RET VIT DIS, V21, P572, DOI 10.1097/00006982-200112000-00002; Hara A, 2007, AM J MED SCI, V334, P308, DOI 10.1097/MAJ.0b013e3180a5e8c6; Kannan S, 2001, PEDIATR NEPHROL, V16, P423, DOI 10.1007/s004670000550; Laurel VL, 1999, J CLIN MICROBIOL, V37, P1612, DOI 10.1128/JCM.37.5.1612-1616.1999; MACHEMER R, 1995, GRAEF ARCH CLIN EXP, V233, P453, DOI 10.1007/BF00183425; Mahevas M, 2009, MEDICINE, V88, P98, DOI 10.1097/MD.0b013e31819de50f; Michel S, 2002, DIAGNOSIS TREATMENT, P17; MOLINA JM, 1991, AIDS, V5, P587, DOI 10.1097/00002030-199105000-00019; OKADA AA, 1994, OPHTHALMOLOGY, V101, P832; Pavesio CE, 2001, CURR OPIN OPHTHALMOL, V12, P471, DOI 10.1097/00055735-200112000-00013; Rastegar A, 1998, KIDNEY INT, V54, P313, DOI 10.1046/j.1523-1755.1998.00001.x; Rodriguez A, 1996, ARCH OPHTHALMOL-CHIC, V114, P593, DOI 10.1001/archopht.1996.01100130585016; Rothova A, 2000, BRIT J OPHTHALMOL, V84, P110, DOI 10.1136/bjo.84.1.110; SASSON JP, 1992, RADIOLOGY, V185, P739, DOI 10.1148/radiology.185.3.1438755; Seo P, 2004, AM J MED, V117, P39, DOI 10.1016/j.amjmed.2004.02.030; SPALTON DJ, 1981, BRIT J OPHTHALMOL, V65, P553, DOI 10.1136/bjo.65.8.553; TOURVILLE DR, 1976, AM J PATHOL, V82, P479; Weishaar PD, 1998, OPHTHALMOLOGY, V105, P57, DOI 10.1016/S0161-6420(98)71225-3; 2009, N ENGL J MED, V361, P179	26	3	4	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 28	2010	363	18					1749	1758		10.1056/NEJMcpc1005308	http://dx.doi.org/10.1056/NEJMcpc1005308			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671XF	20979476				2022-12-28	WOS:000283546400012
J	Nunes, VD; O'Flynn, N; Evans, J; Sawyer, L				Nunes, Vanessa Delgado; O'Flynn, Norma; Evans, Jonathan; Sawyer, Laura		Guideline Dev Grp	Guidelines Management of bedwetting in children and young people: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nunes, Vanessa Delgado; O'Flynn, Norma; Evans, Jonathan; Sawyer, Laura] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England	Royal College of Physicians	Nunes, VD (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	vanessa.nunes@rcplondon.ac.uk			National Institute for Health and Clinical Excellence	National Institute for Health and Clinical Excellence	The National Clinical Guideline Centre was commissioned and funded by the National Institute for Health and Clinical Excellence to write this summary.	Butler R, 2008, CHILD CARE HLTH DEV, V34, P65, DOI 10.1111/j.1365-2214.2007.00781.x; Butler RJ, 1998, J CHILD PSYCHOL PSYC, V39, P453, DOI 10.1111/1469-7610.00342; BUTLER RJ, 1994, NOCTURNAL ENURESIS C; Hagglof B, 1997, SCAND J UROL NEPHROL, V31, P79; Morison MJ, 2000, J ADV NURS, V31, P1216; *NAT I HLTH CLIN E, 2009, 89 NAT I HLTH CLIN E; *NAT I HLTH CLIN E, 2010, 111 NAT I HLTH CLIN; Neveus T, 2006, J UROLOGY, V176, P314, DOI 10.1016/S0022-5347(06)00305-3	8	11	11	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2010	341								c5399	10.1136/bmj.c5399	http://dx.doi.org/10.1136/bmj.c5399			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674YY	20980375				2022-12-28	WOS:000283790400009
J	Olsen, RQ; Regis, JT				Olsen, Robin Quesenberry; Regis, Joanna T.			Delirious deficiency	LANCET			English	Editorial Material							WERNICKES ENCEPHALOPATHY; ANOREXIA-NERVOSA		[Olsen, Robin Quesenberry; Regis, Joanna T.] Carilion Clin Family Med Residency, Roanoke, VA 24017 USA; [Olsen, Robin Quesenberry] Virginia Tech, Carilion Sch Med & Family Med, Dept Primary Care, Roanoke, VA USA	Virginia Polytechnic Institute & State University	Olsen, RQ (corresponding author), Carilion Clin Family Med Residency, 1314 Peters Creek Rd, Roanoke, VA 24017 USA.	rqolsen@carilionclinic.org						Patterson MC, 2009, NEUROLOGY, V73, P824, DOI 10.1212/WNL.0b013e3181b72652; Peters TE, 2007, J ADOLESCENT HEALTH, V40, P376, DOI 10.1016/j.jadohealth.2006.11.140; SHARP CW, 1994, INT J EAT DISORDER, V15, P125, DOI 10.1002/1098-108X(199403)15:2<125::AID-EAT2260150204>3.0.CO;2-O; Vasconcelos MM, 1999, PEDIATR NEUROL, V20, P289, DOI 10.1016/S0887-8994(98)00153-2	4	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 16	2010	376	9749					1362	1362		10.1016/S0140-6736(10)61010-0	http://dx.doi.org/10.1016/S0140-6736(10)61010-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671RX	20951893				2022-12-28	WOS:000283528600040
J	Kluwe, C; Ellington, AD				Kluwe, Christien; Ellington, Andrew D.			RNA GPS	SCIENCE			English	Editorial Material							SEQUENCE SPACE; RIBOZYMES; EVOLUTION		[Kluwe, Christien; Ellington, Andrew D.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Kluwe, C (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.	andy.ellington@mail.utexas.edu						Carothers JM, 2004, J AM CHEM SOC, V126, P5130, DOI 10.1021/ja031504a; Fontana W, 1998, SCIENCE, V280, P1451, DOI 10.1126/science.280.5368.1451; Held DM, 2003, J MOL EVOL, V57, P299, DOI 10.1007/s00239-003-2481-y; Katilius E, 2007, NUCLEIC ACIDS RES, V35, P7626, DOI 10.1093/nar/gkm922; Kennedy R, 2010, RNA, V16, P280, DOI 10.1261/rna.1923210; Lehman N, 2000, J MOL EVOL, V50, P481, DOI 10.1007/s002390010051; Levy M, 2005, RNA, V11, P1555, DOI 10.1261/rna.2121705; Pitt JN, 2010, SCIENCE, V330, P376, DOI 10.1126/science.1192001; Schultes EA, 2000, SCIENCE, V289, P448, DOI 10.1126/science.289.5478.448	9	1	1	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2010	330	6002					330	331		10.1126/science.1197667	http://dx.doi.org/10.1126/science.1197667			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947753				2022-12-28	WOS:000282986700027
J	Agre, P				Agre, Peter			The family naturalist	NATURE			English	Editorial Material																			0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					S11	S11		10.1038/467S11a	http://dx.doi.org/10.1038/467S11a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944611	Bronze			2022-12-28	WOS:000282898700010
J	Chi, P; Chen, Y; Zhang, L; Guo, XY; Wongvipat, J; Shamu, T; Fletcher, JA; Dewell, S; Maki, RG; Zheng, DY; Antonescu, CR; Allis, CD; Sawyers, CL				Chi, Ping; Chen, Yu; Zhang, Lei; Guo, Xingyi; Wongvipat, John; Shamu, Tambudzai; Fletcher, Jonathan A.; Dewell, Scott; Maki, Robert G.; Zheng, Deyou; Antonescu, Cristina R.; Allis, C. David; Sawyers, Charles L.			ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours	NATURE			English	Article							INTERSTITIAL-CELLS; GENE-EXPRESSION; MOUSE MODEL; MUTATIONS; CAJAL; INHIBITION; GIST	Gastrointestinal stromal tumour (GIST) is the most common human sarcoma and is primarily defined by activating mutations in the KIT or PDGFRA receptor tyrosine kinases(1,2). KIT is highly expressed in interstitial cells of Cajal (ICCs)-the presumed cell of origin for GIST-as well as in haematopoietic stem cells, melanocytes, mast cells and germ cells(2,3). Yet, families harbouring germline activating KIT mutations and mice with knock-in Kit mutations almost exclusively develop ICC hyperplasia and GIST(4-7), suggesting that the cellular context is important for KIT to mediate oncogenesis. Here we show that the ETS family member ETV1 is highly expressed in the subtypes of ICCs sensitive to oncogenic KIT mediated transformation(8), and is required for their development. In addition, ETV1 is universally highly expressed in GISTs and is required for growth of imatinib-sensitive and resistant GIST cell lines. Transcriptome profiling and global analyses of ETV1-binding sites suggest that ETV1 is a master regulator of an ICC-GIST-specific transcription network mainly through enhancer binding. The ETV1 transcriptional program is further regulated by activated KIT, which prolongs ETV1 protein stability and cooperates with ETV1 to promote tumorigenesis. We propose that GIST arises from ICCs with high levels of endogenous ETV1 expression that, when coupled with an activating KIT mutation, drives an oncogenic ETS transcriptional program. This differs from other ETS-dependent tumours such as prostate cancer, melanoma and Ewing sarcoma where genomic translocation or amplification drives aberrant ETS expression(9-11). It also represents a novel mechanism of oncogenic transcription factor activation.	[Chi, Ping; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Chi, Ping; Chen, Yu; Maki, Robert G.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Chen, Yu; Wongvipat, John; Shamu, Tambudzai; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Zhang, Lei; Antonescu, Cristina R.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Guo, Xingyi; Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Fletcher, Jonathan A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Brigham & Women's Hospital; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute	Sawyers, CL (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA.	alliscd@rockefeller.edu; sawyersc@mskcc.org	Pillay, Nischalan/F-9536-2012; Maki, Robert G./AAI-2793-2020; Maki, Robert G/J-9145-2019; Sawyers, Charles/G-5327-2016; ravegnini, gloria/K-1330-2016	Maki, Robert G/0000-0002-9853-2528; ravegnini, gloria/0000-0002-7774-402X; Shamu, Tambudzai/0000-0001-8944-8079; Zheng, Deyou/0000-0003-4354-5337	National Cancer Institute [K08CA140946, 5F32CA130372, CA47179, CA148260]; US National Institute of Mental Health [R21MH087840]; National Cancer Institute-American Society of Clinical Oncology Cancer Foundation Clinical Investigator Team; American Society of Clinical Oncology; Doris Duke; Charles H Revson; Charles A. Dana foundations; Rockefeller University; American Cancer Society [CCE-106841, P01CA47179]; Life Raft Group; GIST; Shuman Family Fund for GIST Research; Cycle for Survival; Albert Einstein College of Medicine; National Institutes of Health [GM40922]; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE [P30CA008748, K08CA140946, P50CA140146, P01CA047179, RC2CA148260, F32CA130372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087840] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute-American Society of Clinical Oncology Cancer Foundation Clinical Investigator Team; American Society of Clinical Oncology; Doris Duke(Doris Duke Charitable Foundation (DDCF)); Charles H Revson; Charles A. Dana foundations; Rockefeller University; American Cancer Society(American Cancer Society); Life Raft Group; GIST; Shuman Family Fund for GIST Research; Cycle for Survival; Albert Einstein College of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the National Cancer Institute (K08CA140946, to Y.C.), (5F32CA130372, to P. C.), (CA47179, to C. R. A. and R. G. M.), (CA148260, to R. G. M.), US National Institute of Mental Health (R21MH087840, to D.Z.), National Cancer Institute-American Society of Clinical Oncology Cancer Foundation Clinical Investigator Team Leadership Supplemental Award (to R. G. M.), American Society of Clinical Oncology Young Investigator Award (to P. C.), the Doris Duke (to C. L. S.), Charles H Revson (to Y.C.) and Charles A. Dana (to Y.C.) foundations, The Rockefeller University Fund (to C. D. A.), American Cancer Society Mentored Research Scholar Grant CCE-106841 (to C. R. A.), P01CA47179 (to C. R. A. and R. G. M.), the Life Raft Group (to C. R. A.), the GIST Cancer Research Fund (to C. R. A.), the Shuman Family Fund for GIST Research (to P. C., C. R. A. and R. G. M.), Cycle for Survival (to R. G. M.), Startup Funds from the Albert Einstein College of Medicine (to D.Z.), National Institutes of Health (GM40922, to C. D. A.) and the Starr Cancer Consortium (to P. C., Y.C., C. L. S. and C. D. A.). We thank the International Genomics Consortium for generating ExpO data. We thank G. Wang, P. Iaquinta, and H. Hieronymus for discussions, and especially T. M. Jessell and J. N. Betley for providing and breeding Etv1<SUP>-/-</SUP> mice.	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Antonescu CR, 2006, SEMIN DIAGN PATHOL, V23, P63, DOI 10.1053/j.semdp.2006.08.003; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bauer S, 2006, CANCER RES, V66, P9153, DOI 10.1158/0008-5472.CAN-06-0165; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Chen H, 2007, PHYSIOL GENOMICS, V31, P492, DOI 10.1152/physiolgenomics.00113.2007; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Jane-Valbuena J, 2010, CANCER RES, V70, P2075, DOI 10.1158/0008-5472.CAN-09-3092; Kindblom LG, 1998, AM J PATHOL, V152, P1259; Kwon JG, 2009, GASTROENTEROLOGY, V136, P630, DOI 10.1053/j.gastro.2008.10.031; Mertens F, 2009, SEMIN ONCOL, V36, P312, DOI 10.1053/j.seminoncol.2009.06.004; Miettinen M, 2006, ARCH PATHOL LAB MED, V130, P1466; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Nakai N, 2008, J PATHOL, V214, P302, DOI 10.1002/path.2296; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Ostrowski J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-413; Rubin BP, 2005, CANCER RES, V65, P6631, DOI 10.1158/0008-5472.CAN-05-0891; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Segal NH, 2003, AM J PATHOL, V163, P691, DOI 10.1016/S0002-9440(10)63696-6; Sommer G, 2003, P NATL ACAD SCI USA, V100, P6706, DOI 10.1073/pnas.1037763100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Ward SM, 2001, AM J PHYSIOL-GASTR L, V281, pG602, DOI 10.1152/ajpgi.2001.281.3.G602; Yamaguchi U, 2008, J CLIN ONCOL, V26, P4100, DOI 10.1200/JCO.2007.14.2331; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	33	213	226	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					849	U117		10.1038/nature09409	http://dx.doi.org/10.1038/nature09409			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20927104	Green Accepted			2022-12-28	WOS:000282898700068
J	Elwyn, G; Laitner, S; Coulter, A; Walker, E; Watson, P; Thomson, R				Elwyn, Glyn; Laitner, Steve; Coulter, Angela; Walker, Emma; Watson, Paul; Thomson, Richard			Implementing shared decision making in the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AIDS		[Elwyn, Glyn] Cardiff Univ, Dept Primary Care & Publ Hlth, Cardiff CF14 4Y, S Glam, Wales; [Laitner, Steve] NHS E England, Cambridge, England; [Coulter, Angela] Fdn Informed Med Decision Making, Boston, MA USA; [Walker, Emma] NHS Direct, London, England; [Watson, Paul] NHS NE Essex, Clacton On Sea, Essex, England; [Thomson, Richard] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Cardiff University; Newcastle University - UK	Elwyn, G (corresponding author), Cardiff Univ, Dept Primary Care & Publ Hlth, Cardiff CF14 4Y, S Glam, Wales.	elwyng@cardiff.ac.uk	Elwyn, G./L-4292-2015; Coulter, Angela/N-6998-2019; Elwyn, Glyn/B-4798-2009	Coulter, Angela/0000-0002-6308-8375; Elwyn, Glyn/0000-0002-0917-6286				Breslin M, 2008, PATIENT EDUC COUNS, V73, P465, DOI 10.1016/j.pec.2008.07.024; *CAR QUAL COMM, 2010, STAT HLTH CAR AD SOC; Coulter A, 2003, EUROPEAN PATIENT FUT; Department of Health, 2010, EQ EXC LIB NHS; Edwards A, 2009, SHARED DECISION MAKI; Elwyn G, 2005, HEALTH EXPECT, V8, P34, DOI 10.1111/j.1369-7625.2004.00311.x; ELWYN G, MED DECISIO IN PRESS; Elwyn G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004705; Gravel K, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-16; *HLTH FDN, SHAR DEC MAK MAGIC; Holmes-Rovner Margaret, 2000, Health Expect, V3, P182, DOI 10.1046/j.1369-6513.2000.00093.x; Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073; Joseph-Williams N, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1307; Kennedy ADM, 2002, JAMA-J AM MED ASSOC, V288, P2701, DOI 10.1001/jama.288.21.2701; Mulley AG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4073; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; O'Connor AM, 2007, HEALTH AFFAIR, V26, P716, DOI 10.1377/hlthaff.26.3.716; Stacey D, 2008, WORLDV EVID-BASED NU, V5, P25, DOI 10.1111/j.1741-6787.2007.00108.x; Washington State Legislature, 2007, 4105033 RCW WASH STA; Watson M, 2008, J CONSUM CULT, V8, P5, DOI 10.1177/1469540507085668; WIRRHAM E, 2006, IMPLEMENTING PATIENT	21	522	533	6	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 14	2010	341								c5146	10.1136/bmj.c5146	http://dx.doi.org/10.1136/bmj.c5146			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	668FF	20947577	Green Submitted			2022-12-28	WOS:000283253300006
J	Jeste, DV; Harris, JC				Jeste, Dilip V.; Harris, James C.			Wisdom-A Neuroscience Perspective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SELF		[Jeste, Dilip V.] Univ Calif San Diego, Sam & Rose Stein Inst Res Aging, La Jolla, CA 92093 USA; [Jeste, Dilip V.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Jeste, Dilip V.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Harris, James C.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Harris, James C.] Johns Hopkins Univ, Sch Med, Dept Behav Sci & Pediat, Baltimore, MD 21205 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins University	Jeste, DV (corresponding author), Univ Calif San Diego, Sam & Rose Stein Inst Res Aging, 9500 Gilman Dr,Mail Code 0664, La Jolla, CA 92093 USA.	djeste@ucsd.edu			NIMH NIH HHS [MH080002] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH080002] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARDELT M, 1997, J GERONTOL B-PSYCHOL, V52, P15, DOI DOI 10.1093/GERONB/52B.1.P15; Cato MA, 2004, J INT NEUROPSYCH SOC, V10, P453, DOI 10.1017/S1355617704103123; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Grossmann I, 2010, P NATL ACAD SCI USA, V107, P7246, DOI 10.1073/pnas.1001715107; Jeste DV, 2008, PSYCHIATRY, V71, P197, DOI 10.1521/psyc.2008.71.3.197; Lou HC, 2010, HUM BRAIN MAPP, V31, P185, DOI 10.1002/hbm.20855; Meeks TW, 2009, ARCH GEN PSYCHIAT, V66, P355, DOI 10.1001/archgenpsychiatry.2009.8; Miller BL, 2001, NEUROLOGY, V57, P817, DOI 10.1212/WNL.57.5.817; Parisi JM, 2009, EDUC GERONTOL, V35, P867, DOI 10.1080/03601270902782453; Sternberg R. J., 2005, HDB WISDOM PSYCHOL P	10	22	25	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1602	1603		10.1001/jama.2010.1458	http://dx.doi.org/10.1001/jama.2010.1458			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940386				2022-12-28	WOS:000282816500025
J	Mohammadi, D				Mohammadi, Dara			Public health insecticide development: a status of hiatus	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Mohammadi, D (corresponding author), The Lancet, London NW1 7BY, England.							Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004	1	0	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 9	2010	376	9748					1207	1207		10.1016/S0140-6736(10)61859-4	http://dx.doi.org/10.1016/S0140-6736(10)61859-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	664ZT	20934581				2022-12-28	WOS:000283003500010
J	Pyenson, ND; Irmis, RB; Lipps, JH				Pyenson, Nicholas D.; Irmis, Randall B.; Lipps, Jere H.			Comment on "Climate, Critters, and Cetaceans: Cenozoic Drivers of the Evolution of Modern Whales"	SCIENCE			English	Editorial Material							DIVERSITY; PRODUCTIVITY		[Pyenson, Nicholas D.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Pyenson, Nicholas D.] Burke Museum Nat Hist & Culture, Dept Mammal, Seattle, WA 98195 USA; [Pyenson, Nicholas D.] Burke Museum Nat Hist & Culture, Dept Paleontol, Seattle, WA 98195 USA; [Irmis, Randall B.] Utah Museum Nat Hist, Salt Lake City, UT 84112 USA; [Irmis, Randall B.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Lipps, Jere H.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Lipps, Jere H.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of British Columbia; Utah System of Higher Education; University of Utah; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Pyenson, ND (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA.	pyensonn@si.edu		Pyenson, Nicholas/0000-0003-4678-5782; Lipps, Jere/0000-0003-0592-7537				Barry JC, 2002, PALEOBIOLOGY, V28, P1, DOI 10.1666/0094-8373(2002)28[1:FAECIT]2.0.CO;2; Cardinale BJ, 2009, ECOLOGY, V90, P1227, DOI 10.1890/08-1038.1; Croll DA, 2005, MAR ECOL PROG SER, V289, P117, DOI 10.3354/meps289117; Demere TA, 2008, SYST BIOL, V57, P15, DOI 10.1080/10635150701884632; Lambert O, 2010, NATURE, V466, P105, DOI 10.1038/nature09067; Marx FG, 2010, SCIENCE, V327, P993, DOI 10.1126/science.1185581; Pyenson ND, 2009, GEOLOGY, V37, P519, DOI 10.1130/G25509A.1; Rabosky DL, 2009, NATURE, V457, P183, DOI 10.1038/nature07435; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Slater GJ, 2010, P ROY SOC B-BIOL SCI, V277, P3097, DOI 10.1098/rspb.2010.0408; Uhen MD, 2007, PALAEONTOL ELECTRON, V10; Worm B, 2003, TRENDS ECOL EVOL, V18, P628, DOI 10.1016/j.tree.2003.09.003	13	14	14	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001								10.1126/science.1189866	http://dx.doi.org/10.1126/science.1189866			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929760				2022-12-28	WOS:000282644600021
J	Brook, RH				Brook, Robert H.			What If Physicians Actually Had to Control Medical Costs?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									RAND Corp, Santa Monica, CA 90407 USA	RAND Corporation	Brook, RH (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90407 USA.	robert_brook@rand.org						*ACCR COUNC GRAD M, 2007, COMM PROGR REQ RES D; EIBNER C, 2009, TR733COMMASS RAND CO; HADORN DC, 1991, HASTINGS CENT REP, V21, pS11, DOI 10.2307/3563329; Harvey S., 2009, WINDMILL 2009 NHS RE; MECHANIC D, 1995, BRIT MED J, V310, P1655, DOI 10.1136/bmj.310.6995.1655; National Institute for Health and Clinical Excellence, 2009, GUID MAN; Strech D, 2008, J MED PHILOS, V33, P80, DOI 10.1093/jmp/jhm007	7	6	6	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2010	304	13					1489	1490		10.1001/jama.2010.1426	http://dx.doi.org/10.1001/jama.2010.1426			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	658SO	20924017				2022-12-28	WOS:000282509900027
J	Davis, BR; Candotti, F				Davis, Brian R.; Candotti, Fabio			Mosaicism-Switch or Spectrum?	SCIENCE			English	Editorial Material							WISKOTT-ALDRICH-SYNDROME; REVERTANT MOSAICISM; 2ND-SITE MUTATIONS; EPIDERMOLYSIS-BULLOSA; SOMATIC MOSAICISM; PATIENT; LYMPHOCYTES; SIBLINGS		[Davis, Brian R.] Univ Texas Hlth Sci Ctr, Brown Fdn Inst Mol Med, Ctr Stem Cell Res, Houston, TX 77030 USA; [Candotti, Fabio] NHGRI, Genet & Mol Biol Branch, Bethesda, MD 20892 USA	University of Texas System; University of Texas Health Science Center Houston; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Davis, BR (corresponding author), Univ Texas Hlth Sci Ctr, Brown Fdn Inst Mol Med, Ctr Stem Cell Res, Houston, TX 77030 USA.	brian.r.davis@uth.tmc.edu		Candotti, Fabio/0000-0001-6399-6042	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000121] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Boztug K, 2008, CLIN GENET, V74, P68, DOI 10.1111/j.1399-0004.2008.01019.x; Choate KA, 2010, SCIENCE, V330, P94, DOI 10.1126/science.1192280; Davis BR, 2008, BLOOD, V111, P5064, DOI 10.1182/blood-2007-06-095299; Davis BR, 2010, CLIN IMMUNOL, V135, P72, DOI 10.1016/j.clim.2009.12.011; Davis BR, 2009, IMMUNOL RES, V44, P127, DOI 10.1007/s12026-008-8091-4; Hirschhorn R, 2003, J MED GENET, V40, P721, DOI 10.1136/jmg.40.10.721; Jonkman MF, 2009, NEW ENGL J MED, V360, P1680, DOI 10.1056/NEJMc0809896; Lutskiy MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003444; Pasmooij AMG, 2005, AM J HUM GENET, V77, P727, DOI 10.1086/497344; Pasmooij AMG, 2007, J CLIN INVEST, V117, P1240, DOI 10.1172/JCI30465; Rieux-Laucat F, 2006, NEW ENGL J MED, V354, P1913, DOI 10.1056/NEJMoa053750; Wada T, 2005, BLOOD, V106, P2099, DOI 10.1182/blood-2005-03-0936	12	8	9	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					46	47		10.1126/science.1195991	http://dx.doi.org/10.1126/science.1195991			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929800				2022-12-28	WOS:000282334500026
J	Dawkins, R				Dawkins, Richard			George C. Williams (1926-2010)	SCIENCE			English	Biographical-Item									Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Dawkins, R (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.								0	1	1	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					49	49		10.1126/science.1197701	http://dx.doi.org/10.1126/science.1197701			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929802				2022-12-28	WOS:000282334500028
J	Easter, J; Waltzman, M; Ewald, MB				Easter, Joshua; Waltzman, Mark; Ewald, Michele Burns			Inside out	LANCET			English	Editorial Material									[Waltzman, Mark; Ewald, Michele Burns] Harvard Univ, Sch Med, Childrens Hosp Boston, Emergency Dept, Boston, MA 02115 USA; [Easter, Joshua] Denver Hlth, Dept Emergency Med, Denver, CO USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Denver Health Medical Center	Waltzman, M (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Emergency Dept, 300 Longwood Ave, Boston, MA 02115 USA.	mark.waltzman@childrens.harvard.edu							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2010	376	9751					1497	1497		10.1016/S0140-6736(10)60167-5	http://dx.doi.org/10.1016/S0140-6736(10)60167-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	680QC	20965559				2022-12-28	WOS:000284248500032
J	Doak, DF; Morris, WF				Doak, Daniel F.; Morris, William F.			Demographic compensation and tipping points in climate-induced range shifts	NATURE			English	Article							EXTINCTION; RESPONSES; IMPACTS; PLANTS	To persist, species are expected to shift their geographical ranges polewards or to higher elevations as the Earth's climate warms(1-4). However, although many species' ranges have shifted in historical times, many others have not, or have shifted only at the high-latitude or high-elevation limits, leading to range expansions rather than contractions(5-11). Given these idiosyncratic responses to climate warming, and their varied implications for species' vulnerability to climate change, a critical task is to understand why some species have not shifted their ranges, particularly at the equatorial or low-elevation limits, and whether such resilience will last as warming continues. Here we show that compensatory changes in demographic rates are buffering southern populations of two North American tundra plants against the negative effects of a warming climate, slowing their northward range shifts, but that this buffering is unlikely to continue indefinitely. Southern populations of both species showed lower survival and recruitment but higher growth of individual plants, possibly owing to longer, warmer growing seasons. Because of these and other compensatory changes, the population growth rates of southern populations are not at present lower than those of northern ones. However, continued warming may yet prove detrimental, as most demographic rates that improved in moderately warmer years declined in the warmest years, with the potential to drive future population declines. Our results emphasize the need for long-term, range-wide measurement of all population processes to detect demographic compensation and to identify nonlinear responses that may lead to sudden range shifts as climatic tipping points are exceeded.	[Doak, Daniel F.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Morris, William F.] Duke Univ, Dept Biol, Durham, NC 27708 USA	University of Wyoming; Duke University	Doak, DF (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	ddoak@uwyo.edu			NSF [DEB-9806818, DEB-0087096, DEB-0716433]	NSF(National Science Foundation (NSF))	This work was supported by NSF grants DEB-9806818, DEB-0087096 and DEB-0716433. We thank the many field and laboratory assistants who have helped over the years, and J. Estes, N. Haddad, A. Rose and W. Thuiller.	Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Chapin FS, 1996, ECOLOGY, V77, P822, DOI 10.2307/2265504; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; HARTE J, 1995, SCIENCE, V267, P876, DOI 10.1126/science.267.5199.876; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Mysterud A, 2001, NATURE, V410, P1096, DOI 10.1038/35074099; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Purves DW, 2009, P R SOC B, V276, P1477, DOI 10.1098/rspb.2008.1241; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; TULJAPURKAR S, 1990, POPULATION DYNAMICS, P91; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000	23	310	312	2	272	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2010	467	7318					959	962		10.1038/nature09439	http://dx.doi.org/10.1038/nature09439			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962844				2022-12-28	WOS:000283254700037
J	Chlebowski, RT; Anderson, GL; Gass, M; Lane, DS; Aragaki, AK; Kuller, LH; Manson, JE; Stefanick, ML; Ockene, J; Sarto, GE; Johnson, KC; Wactawski-Wende, J; Ravdin, PM; Schenken, R; Hendrix, SL; Rajkovic, A; Rohan, TE; Yasmeen, S; Prentice, RL				Chlebowski, Rowan T.; Anderson, Garnet L.; Gass, Margery; Lane, Dorothy S.; Aragaki, Aaron K.; Kuller, Lewis H.; Manson, JoAnn E.; Stefanick, Marcia L.; Ockene, Judith; Sarto, Gloria E.; Johnson, Karen C.; Wactawski-Wende, Jean; Ravdin, Peter M.; Schenken, Robert; Hendrix, Susan L.; Rajkovic, Aleksandar; Rohan, Thomas E.; Yasmeen, Shagufta; Prentice, Ross L.		WHI Investigators	Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HORMONE REPLACEMENT THERAPY; ANGIOGENESIS; MAMMOGRAPHY; RISK; SURVIVAL; BENEFITS; DISEASE; GROWTH; USERS	Context In the Women's Health Initiative randomized, placebo-controlled trial of estrogen plus progestin, after a mean intervention time of 5.6 (SD, 1.3) years (range, 3.7-8.6 years) and a mean follow-up of 7.9 (SD, 1.4) years, breast cancer incidence was increased among women who received combined hormone therapy. Breast cancer mortality among participants in the trial has not been previously reported. Objective To determine the effects of therapy with estrogen plus progestin on cumulative breast cancer incidence and mortality after a total mean follow-up of 11.0 (SD, 2.7) years, through August 14, 2009. Design, Setting, and Participants A total of 16 608 postmenopausal women aged 50 to 79 years with no prior hysterectomy from 40 US clinical centers were randomly assigned to receive combined conjugated equine estrogens, 0.625 mg/d, plus medroxyprogesterone acetate, 2.5 mg/d, or placebo pill. After the original trial completion date (March 31, 2005), reconsent was required for continued follow-up for breast cancer incidence and was obtained from 12 788 (83%) of the surviving participants. Main Outcome Measures Invasive breast cancer incidence and breast cancer mortality. Results In intention-to-treat analyses including all randomized participants and censoring those not consenting to additional follow-up on March 31, 2005, estrogen plus progestin was associated with more invasive breast cancers compared with placebo (385 cases [0.42% per year] vs 293 cases [0.34% per year]; hazard ratio [HR], 1.25; 95% confidence interval [CI], 1.07-1.46; P=.004). Breast cancers in the estrogen-plus-progestin group were similar in histology and grade to breast cancers in the placebo group but were more likely to be node-positive (81 [23.7%] vs43 [16.2%], respectively; HR, 1.78; 95% CI, 1.23-2.58; P=.03). There were more deaths directly attributed to breast cancer (25 deaths [0.03% per year] vs 12 deaths [0.01% per year]; HR, 1.96; 95% CI, 1.00-4.04; P=.049) as well as more deaths from all causes occurring after a breast cancer diagnosis (51 deaths [0.05% per year] vs 31 deaths [0.03% per year]; HR, 1.57; 95% CI, 1.01-2.48; P=.045) among women who received estrogen plus progestin compared with women in the placebo group. Conclusions Estrogen plus progestin was associated with greater breast cancer incidence, and the cancers are more commonly node-positive. Breast cancer mortality also appears to be increased with combined use of estrogen plus progestin.	[Chlebowski, Rowan T.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90502 USA; [Anderson, Garnet L.; Aragaki, Aaron K.; Prentice, Ross L.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Gass, Margery] Univ Cincinnati, Cincinnati, OH USA; [Lane, Dorothy S.] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Kuller, Lewis H.] Univ Pittsburgh, Pittsburgh, PA USA; [Manson, JoAnn E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Stefanick, Marcia L.] Stanford Prevent Res Ctr, Stanford, CA USA; [Ockene, Judith] Univ Massachusetts, Fallon Clin, Worcester, MA 01605 USA; [Sarto, Gloria E.] Univ Wisconsin, Madison, WI 53706 USA; [Johnson, Karen C.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA; [Wactawski-Wende, Jean] SUNY Buffalo, Buffalo, NY 14260 USA; [Ravdin, Peter M.] Canc Therapy & Res Ctr S Texas, San Antonio, TX 78229 USA; [Schenken, Robert] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Hendrix, Susan L.] Wayne State Sch Med, Detroit, MI USA; [Hendrix, Susan L.] Hurtzel Hosp, Detroit, MI USA; [Rajkovic, Aleksandar] Baylor Coll Med, Houston, TX 77030 USA; [Rohan, Thomas E.] Albert Einstein Coll Med, New York, NY USA; [Yasmeen, Shagufta] Univ Calif Davis, Sacramento, CA 95817 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Fred Hutchinson Cancer Center; University System of Ohio; University of Cincinnati; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Stanford University; University of Massachusetts System; University of Massachusetts Worcester; University of Wisconsin System; University of Wisconsin Madison; University of Tennessee System; University of Tennessee Health Science Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Wayne State University; Baylor College of Medicine; Yeshiva University; University of California System; University of California Davis	Chlebowski, RT (corresponding author), Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, 1124 W Carson St, Torrance, CA 90502 USA.	rchlebowski@gmail.com	Wactawski-Wende, Jean/AGH-5457-2022; Stafford, Randall/F-3974-2017	Wactawski-Wende, Jean/0000-0003-3096-9595; Caan, Bette/0000-0002-5803-310X; Stafford, Randall/0000-0003-1805-1271; Anderson, Garnet/0000-0001-5087-7837	AstraZeneca; Novartis; Pfizer; Amgen; Procter Gamble; Wyeth Laboratories; Upsher-Smith Laboratories; Wyeth Pharmaceuticals; Meditrina Pharmaceuticals Inc; Merck; Boehringer Ingelheim; Organon; National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH032106, N01WH042119, N01WH042116, N01WH042126, N01WH032101, N01WH042111, N01WH032118, N01WH032111, N01WH042120, N01WH042113, N01WH032115, N01WH042123, N01WH032102, N01WH032105, N01WH022110, N01WH032108, N01WH032112, N01WH042129, N01WH042107, N01WH042112, N01WH042124, N01WH032109, N01WH032119, N01WH042122, N01WH042117, N01WH042121, N01WH042131, N01WH032122, N01WH042110, N01WH042114, N01WH042118, N01WH042132, N01WH042109, N01WH032100, N01WH042108, N01WH032113, N01WH042125, N01WH042130, N01WH042115] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); Novartis(Novartis); Pfizer(Pfizer); Amgen(Amgen); Procter Gamble(Procter & Gamble); Wyeth Laboratories(Wyeth); Upsher-Smith Laboratories(Randox Laboratories); Wyeth Pharmaceuticals(Wyeth); Meditrina Pharmaceuticals Inc; Merck(Merck & Company); Boehringer Ingelheim(Boehringer Ingelheim); Organon; National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr Chlebowski reports that he has received consulting fees from AstraZeneca, Novartis, and Pfizer, lecture fees from AstraZeneca and Novartis, and grant funding from Amgen. Dr Gass reports that she has received funding for multisite clinical trials from Procter & Gamble and Wyeth Laboratories and consulting fees from Upsher-Smith Laboratories, Wyeth Pharmaceuticals, and Procter & Gamble. Dr Hendrix reports that she has received consulting fees from Meditrina Pharmaceuticals Inc, lecture fees from Merck, and grant funding from Boehringer Ingelheim and Organon. Dr Rohan reports that he has received consulting fees from legal firms regarding hormone therapy issues. No other financial disclosures were reported.; The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services, through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221.	Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson GL, 2006, MATURITAS, V55, P103, DOI 10.1016/j.maturitas.2006.05.004; Anderson GL, 2003, ANN EPIDEMIOL, V13, pS5, DOI 10.1016/S1047-2797(03)00043-7; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Calvo A, 2008, ONCOGENE, V27, P5373, DOI 10.1038/onc.2008.155; Chen WY, 2004, CANCER, V101, P1490, DOI 10.1002/cncr.20499; Chlebowski RT, 2008, ARCH INTERN MED, V168, P370, DOI 10.1001/archinternmed.2007.123; Chlebowski RT, 2009, LANCET, V374, P1243, DOI 10.1016/S0140-6736(09)61526-9; Chlebowski RT, 2009, NEW ENGL J MED, V360, P573, DOI 10.1056/NEJMoa0807684; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Christante D, 2008, AM J SURG, V196, P505, DOI 10.1016/j.amjsurg.2008.06.023; Curb JD, 2003, ANN EPIDEMIOL, V13, pS122, DOI 10.1016/S1047-2797(03)00048-6; Dobrzycka B, 2009, ENDOKRYNOL POL, V60, P210; Dong WL, 2008, CANCER EPIDEM BIOMAR, V17, P1096, DOI 10.1158/1055-9965.EPI-08-0201; Fournier A, 2009, J CLIN ONCOL, V27, P5138, DOI 10.1200/JCO.2008.21.6432; Haller DG, 2006, J CLIN ONCOL, V24, p149S; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; Heiss G, 2008, JAMA-J AM MED ASSOC, V299, P1036, DOI 10.1001/jama.299.9.1036; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; Holli K, 1998, J CLIN ONCOL, V16, P3115, DOI 10.1200/JCO.1998.16.9.3115; Hyder SM, 1998, CANCER RES, V58, P392; Joffe MM, 2001, EPIDEMIOLOGY, V12, P429, DOI 10.1097/00001648-200107000-00013; Kerlikowske K, 2003, J CLIN ONCOL, V21, P4314, DOI 10.1200/JCO.2003.05.151; Liang Y, 2007, CANCER RES, V67, P9929, DOI 10.1158/0008-5472.CAN-07-1103; Losordo DW, 2001, ARTERIOSCL THROM VAS, V21, P6, DOI 10.1161/01.ATV.21.1.6; National Cancer Institute, SURV EP END RES PROG; Newcomb PA, 2008, CANCER EPIDEM BIOMAR, V17, P864, DOI 10.1158/1055-9965.EPI-07-0610; Pinder MC, 2007, J CLIN ONCOL, V25, P3808, DOI 10.1200/JCO.2006.10.4976; Power ML, 2009, MENOPAUSE, V16, P500, DOI 10.1097/gme.0b013e31818fc36e; Prentice RL, 2008, AM J EPIDEMIOL, V167, P1207, DOI 10.1093/aje/kwn044; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Rosenberg LU, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2145; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sener SF, 2009, AM J SURG, V197, P403, DOI 10.1016/j.amjsurg.2008.11.014; Shen Y, 2005, JNCI-J NATL CANCER I, V97, P1195, DOI 10.1093/jnci/dji239; Sihto H, 2008, CLIN CANCER RES, V14, P4103, DOI 10.1158/1078-0432.CCR-07-5003; Stevenson JC, 2009, ATHEROSCLEROSIS, V207, P336, DOI 10.1016/j.atherosclerosis.2009.05.033; Toh S, 2010, ANN INTERN MED, V152, P211, DOI 10.7326/0003-4819-152-4-201002160-00005; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101	40	377	402	1	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2010	304	15					1684	1692		10.1001/jama.2010.1500	http://dx.doi.org/10.1001/jama.2010.1500			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666PZ	20959578	Green Accepted, Bronze			2022-12-28	WOS:000283129700022
J	Frankel, A; Vecchio, P				Frankel, Adam; Vecchio, Phillip			Personal View Commonly used, easily confused: let's eliminate hyper and hypo	BRITISH MEDICAL JOURNAL			English	Editorial Material							DOCTOR-PATIENT COMMUNICATION		[Frankel, Adam; Vecchio, Phillip] Princess Alexandra Hosp, Medicat Safety Team, Woolloongabba, Qld 4102, Australia		Frankel, A (corresponding author), Princess Alexandra Hosp, Medicat Safety Team, Woolloongabba, Qld 4102, Australia.	a.frankel@uq.edu.au; phillip_vecchio@health.qld.gov.au	Frankel, Adam J/A-5001-2013	Frankel, Adam J/0000-0002-5198-7664				Kountz DS, 2009, POSTGRAD MED, V121, P171, DOI 10.3810/pgm.2009.09.2065; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Roughead Elizabeth E, 2009, Aust New Zealand Health Policy, V6, P18, DOI 10.1186/1743-8462-6-18; Schroeder R E, 1999, J Health Adm Educ, V17, P175; SIMPSON M, 1991, BRIT MED J, V303, P1385, DOI 10.1136/bmj.303.6814.1385; Valentin A, 2006, INTENS CARE MED, V32, P1591, DOI 10.1007/s00134-006-0290-7	7	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2010	341								c5867	10.1136/bmj.c5867	http://dx.doi.org/10.1136/bmj.c5867			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	671ZL	20961983				2022-12-28	WOS:000283552700002
J	Golomb, BA; Erickson, LC; Koperski, S; Sack, D; Enkin, M; Howick, J				Golomb, Beatrice A.; Erickson, Laura C.; Koperski, Sabrina; Sack, Deanna; Enkin, Murray; Howick, Jeremy			What's in Placebos: Who Knows? Analysis of Randomized, Controlled Trials	ANNALS OF INTERNAL MEDICINE			English	Article							LACTOSE-INTOLERANCE; HEART-DISEASE; OLIVE OIL; COUGH	Background: No regulations govern placebo composition. The composition of placebos can influence trial outcomes and merits reporting. Purpose: To assess how often investigators specify the composition of placebos in randomized, placebo-controlled trials. Data Sources: 4 English-language general and internal medicine journals with high impact factors. Study Selection: 3 reviewers screened titles and abstracts of the journals to identify randomized, placebo-controlled trials published from January 2008 to December 2009. Data Extraction: Reviewers independently abstracted data from the introduction and methods sections of identified articles, recording treatment type (pill, injection, or other) and whether placebo composition was stated. Discrepancies were resolved by consensus. Data Synthesis: Most studies did not disclose the composition of the study placebo. Disclosure was less common for pills than for injections and other treatments (8.2% vs. 26.7%; P = 0.002). Limitation: Journals with high impact factors may not be representative. Conclusion: Placebos were seldom described in randomized, controlled trials of pills or capsules. Because the nature of the placebo can influence trial outcomes, placebo formulation should be disclosed in reports of placebo-controlled trials.	Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; McMaster Univ, Hamilton, ON, Canada; Univ Oxford, Ctr Evidence Based Med, Oxford, England	University of California System; University of California San Diego; McMaster University; University of Oxford	Golomb, BA (corresponding author), Univ Calif San Diego, Sch Med, 9500 Gilman Dr 0995, La Jolla, CA 92093 USA.	bgolomb@ucsd.edu	Koperski, Sabrina/E-8112-2011; Howick, Jeremy/ADP-7644-2022	Koperski, Sabrina/0000-0003-0001-6478; Howick, Jeremy/0000-0003-0280-7206	University of California Foundation [3929]; Medical Research Council/Economic and Social Research Council [G0800055]; Medical Research Council [G0800055] Funding Source: researchfish; MRC [G0800055] Funding Source: UKRI	University of California Foundation; Medical Research Council/Economic and Social Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	By University of California Foundation Fund 3929-Medical Reasoning. The manuscript was revised while Dr. Howick was a recipient of a Medical Research Council/Economic and Social Research Council Interdisciplinary Postdoctoral Fellowship (G0800055).	ACHESON J, 1972, ATHEROSCLEROSIS, V15, P177, DOI 10.1016/0021-9150(72)90067-6; Covas M. -I., 2008, Inflammopharmacology, V16, P216, DOI 10.1007/s10787-008-8019-6; Cullinen Kathleen, 2006, Med Health R I, V89, P113; DEAN AG, 2009, OPENEPI OPEN SOURCE, V2010; Eccles R, 2006, RESP PHYSIOL NEUROBI, V152, P340, DOI 10.1016/j.resp.2005.10.004; Fito M, 2005, ATHEROSCLEROSIS, V181, P149, DOI 10.1016/j.atherosclerosis.2004.12.036; Golomb B, 2002, JAMA-J AM MED ASSOC, V287, P2502; GOLOMB BA, 1995, NATURE, V375, P530, DOI 10.1038/375530a0; Golomb BA, 2009, AM J BIOETHICS, V9, P34, DOI 10.1080/15265160903244242; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; LOPRINZI CL, 1990, JNCI-J NATL CANCER I, V82, P1127, DOI 10.1093/jnci/82.13.1127; MCCANN IL, 1984, J PERS SOC PSYCHOL, V46, P1142, DOI 10.1037/0022-3514.46.5.1142; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Osterlund P, 2004, CLIN GASTROENTEROL H, V2, P696, DOI 10.1016/S1542-3565(04)00293-9; Paul IM, 2007, ARCH PEDIAT ADOL MED, V161, P1140, DOI 10.1001/archpedi.161.12.1140; Research Committee of the Scottish Society of Physicians, 1971, BMJ-BRIT MED J, V4, P775; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Wedlake L, 2008, EUR J CANCER, V44, P2212, DOI 10.1016/j.ejca.2008.07.018	21	43	44	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8					532	535		10.7326/0003-4819-153-8-201010190-00010	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956710				2022-12-28	WOS:000283054600006
J	Vila-Perello, M; Muir, TW				Vila-Perello, Miquel; Muir, Tom W.			Biological Applications of Protein Splicing	CELL			English	Article							SITE-SPECIFIC INCORPORATION; SIGNALING PROTEIN; CYCLIC-PEPTIDES; REAL-TIME; SEMISYNTHESIS; LIGATION; RECOGNITION; SELECTIVITY; CHEMISTRY; REVEALS	Protein splicing is a naturally occurring process in which a protein editor, called an intein, performs a molecular disappearing act by cutting itself out of a host protein in a traceless manner. In the two decades since its discovery, protein splicing has been harnessed for the development of several protein-engineering methods. Collectively, these technologies help bridge the fields of chemistry and biology, allowing hitherto impossible manipulations of protein covalent structure. These tools and their application are the subject of this Primer.	[Vila-Perello, Miquel; Muir, Tom W.] Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10021 USA	Rockefeller University	Muir, TW (corresponding author), Rockefeller Univ, Lab Synthet Prot Chem, 1230 York Ave, New York, NY 10021 USA.	muirt@rockefeller.edu	Muir, Tom/AHD-0860-2022	Muir, Tom/0000-0001-9635-0344	NCI NIH HHS [RC2 CA148354] Funding Source: Medline; NIGMS NIH HHS [R01 GM086868, R01 GM055843] Funding Source: Medline; NATIONAL CANCER INSTITUTE [RC2CA148354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055843, R01GM086868] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold U, 2002, J AM CHEM SOC, V124, P8522, DOI 10.1021/ja026114n; Bertozzi CR, 2001, SCIENCE, V291, P2357, DOI 10.1126/science.1059820; Brunsveld L, 2006, ANGEW CHEM INT EDIT, V45, P6622, DOI 10.1002/anie.200600855; Buskas T, 2006, GLYCOBIOLOGY, V16, p113R, DOI 10.1093/glycob/cwj125; Ceccarini G, 2009, CELL METAB, V10, P148, DOI 10.1016/j.cmet.2009.07.001; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chatterjee C, 2010, J BIOL CHEM, V285, P11045, DOI 10.1074/jbc.R109.080291; Chatterjee C, 2010, NAT CHEM BIOL, V6, P267, DOI [10.1038/NCHEMBIO.315, 10.1038/nchembio.315]; Chen JJ, 2010, NAT CHEM BIOL, V6, P270, DOI [10.1038/NCHEMBIO.316, 10.1038/nchembio.316]; Cheriyan M, 2009, ADV DRUG DELIVER REV, V61, P899, DOI 10.1016/j.addr.2009.04.021; Erlanson DA, 1996, CHEM BIOL, V3, P981, DOI 10.1016/S1074-5521(96)90165-9; Evans TC, 1998, PROTEIN SCI, V7, P2256, DOI 10.1002/pro.5560071103; Frutos S, 2010, NAT CHEM BIOL, V6, P527, DOI [10.1038/NCHEMBIO.371, 10.1038/nchembio.371]; Giriat I, 2003, J AM CHEM SOC, V125, P7180, DOI 10.1021/ja034736i; Hackenberger CPR, 2008, ANGEW CHEM INT EDIT, V47, P10030, DOI 10.1002/anie.200801313; Hahn ME, 2004, ANGEW CHEM INT EDIT, V43, P5800, DOI 10.1002/anie.200461141; Hahn ME, 2007, CHEMBIOCHEM, V8, P2100, DOI 10.1002/cbic.200700404; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Hofmann RM, 2001, BIOORG MED CHEM LETT, V11, P3091, DOI 10.1016/S0960-894X(01)00650-3; Kanno A, 2007, ANGEW CHEM INT EDIT, V46, P7595, DOI 10.1002/anie.200700538; Kent SBH, 2009, CHEM SOC REV, V38, P338, DOI 10.1039/b700141j; Kritzer JA, 2009, NAT CHEM BIOL, V5, P655, DOI 10.1038/nchembio.193; Kumar KSA, 2009, ANGEW CHEM INT EDIT, V48, P8090, DOI 10.1002/anie.200902936; Lepenies B, 2010, CURR OPIN CHEM BIOL, V14, P404, DOI 10.1016/j.cbpa.2010.02.016; Li J, 2008, HUM GENE THER, V19, P958, DOI 10.1089/hum.2008.009; Li X, 2009, ANGEW CHEM INT EDIT, V48, P9184, DOI 10.1002/anie.200904472; Lin MZ, 2008, PHYSIOLOGY, V23, P131, DOI 10.1152/physiol.00007.2008; Lockless SW, 2009, P NATL ACAD SCI USA, V106, P10999, DOI 10.1073/pnas.0902964106; Lu W, 2001, MOL CELL, V8, P759, DOI 10.1016/S1097-2765(01)00369-0; Lu XQ, 2010, J AM CHEM SOC, V132, P1748, DOI 10.1021/ja9088549; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Mootz HD, 2009, CHEMBIOCHEM, V10, P2579, DOI 10.1002/cbic.200900370; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Noren CJ, 2000, ANGEW CHEM INT EDIT, V39, P450; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Ozawa T, 2003, NAT BIOTECHNOL, V21, P287, DOI 10.1038/nbt791; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Pickin KA, 2008, J AM CHEM SOC, V130, P5667, DOI 10.1021/ja711244h; Piontek C, 2009, ANGEW CHEM INT EDIT, V48, P1941, DOI 10.1002/anie.200804735; Schwarzer D, 2005, CURR OPIN CHEM BIOL, V9, P561, DOI 10.1016/j.cbpa.2005.09.018; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Valiyaveetil FI, 2006, SCIENCE, V314, P1004, DOI 10.1126/science.1133415; Valiyaveetil FI, 2006, J AM CHEM SOC, V128, P11591, DOI 10.1021/ja0631955; Vila-Perello M, 2007, J AM CHEM SOC, V129, P8068, DOI 10.1021/ja072013j; Vitali F, 2006, EMBO J, V25, P150, DOI 10.1038/sj.emboj.7600911; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Wu YW, 2010, NAT CHEM BIOL, V6, P534, DOI [10.1038/NCHEMBIO.386, 10.1038/nchembio.386]; Xie N, 2009, BIOCONJUGATE CHEM, V20, P360, DOI 10.1021/bc800467a; Yuen CM, 2006, J AM CHEM SOC, V128, P8939, DOI 10.1021/ja062980e; Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979; Zuger S, 2005, NAT BIOTECHNOL, V23, P736, DOI 10.1038/nbt1097	56	126	141	0	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					191	200		10.1016/j.cell.2010.09.031	http://dx.doi.org/10.1016/j.cell.2010.09.031			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946979	Green Accepted, Bronze			2022-12-28	WOS:000283052200009
J	't Hooft, G				't Hooft, Gerardus			Nothing to fear from mistakes	NATURE			English	Editorial Material									Univ Utrecht, NL-3508 TC Utrecht, Netherlands; ['t Hooft, Gerardus] CERN, CH-1211 Geneva 23, Switzerland	Utrecht University; European Organization for Nuclear Research (CERN)	't Hooft, G (corresponding author), Univ Utrecht, NL-3508 TC Utrecht, Netherlands.								0	0	0	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					S7	S7		10.1038/467S7a	http://dx.doi.org/10.1038/467S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944622	Bronze			2022-12-28	WOS:000282898700006
J	Steinbrook, R; Kassirer, JP				Steinbrook, Robert; Kassirer, Jerome P.			Data availability for industry sponsored trials: what should medical journals require?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ROSIGLITAZONE; EXPRESSION		[Steinbrook, Robert] Dartmouth Med Sch, Hanover, NH 03756 USA; [Steinbrook, Robert] Yale Sch Med, New Haven, CT 06520 USA; [Kassirer, Jerome P.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Dartmouth College; Yale University; Tufts University	Steinbrook, R (corresponding author), Dartmouth Med Sch, Hanover, NH 03756 USA.	rsteinbrook@attglobal.net						Angell M, 2008, JAMA-J AM MED ASSOC, V300, P1069, DOI 10.1001/jama.300.9.1069; Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4848; Curfman GD, 2006, NEW ENGL J MED, V354, P1193, DOI 10.1056/NEJMe068054; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; DeAngelis CD, 2010, JAMA-J AM MED ASSOC, V303, P1196, DOI 10.1001/jama.2010.337; European Medicines Agency, 2010, EUR MED AG REC SUSP; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; International Committee of Medical Journal Editors, 2010, UN REQ MAN SUBM BIOM; Krumholz H, 2007, BMJ-BRIT MED J, V334, P120, DOI 10.1136/bmj.39024.487720.68; MARCINIAK TA, 2010, FDA BRIEFING DOCUMEN; *PHARM RES MAN AM, 2009, PRINC COND CLIN TRIA; Smith R, 2005, PLOS MED, V2, P364, DOI 10.1371/journal.pmed.0020138.g001; Steinbrook R, 2005, NEW ENGL J MED, V352, P2160, DOI 10.1056/NEJMp048353; Woodcock J, 2010, NEW ENGL J MED, V363, P1489, DOI 10.1056/NEJMp1010788; 2010, ANN INTERNAL MED	16	12	12	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 12	2010	341								c5391	10.1136/bmj.c5391	http://dx.doi.org/10.1136/bmj.c5391			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663KN	20940213				2022-12-28	WOS:000282886900010
J	Bulger, EM; May, S; Brasel, KJ; Schreiber, M; Kerby, JD; Tisherman, SA; Newgard, C; Slutsky, A; Coimbra, R; Emerson, S; Minei, JP; Bardarson, B; Kudenchuk, P; Baker, A; Christenson, J; Idris, A; Davis, D; Fabian, TC; Aufderheide, TP; Callaway, C; Williams, C; Banek, J; Vaillancourt, C; van Heest, R; Sopko, G; Hata, JS; Hoyt, DB				Bulger, Eileen M.; May, Susanne; Brasel, Karen J.; Schreiber, Martin; Kerby, Jeffrey D.; Tisherman, Samuel A.; Newgard, Craig; Slutsky, Arthur; Coimbra, Raul; Emerson, Scott; Minei, Joseph P.; Bardarson, Berit; Kudenchuk, Peter; Baker, Andrew; Christenson, Jim; Idris, Ahamed; Davis, Daniel; Fabian, Timothy C.; Aufderheide, Tom P.; Callaway, Clifton; Williams, Carolyn; Banek, Jane; Vaillancourt, Christian; van Heest, Rardi; Sopko, George; Hata, J. Steven; Hoyt, David B.		ROC Investigators	Out-of-Hospital Hypertonic Resuscitation Following Severe Traumatic Brain Injury A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLASGOW OUTCOME SCALE; RAPID-SEQUENCE INTUBATION; DISABILITY RATING-SCALE; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; SALINE RESUSCITATION; CONSENSUS CONFERENCE; PROSTAGLANDIN E(2); SEPSIS; SCORE	Context Hypertonic fluids restore cerebral perfusion with reduced cerebral edema and modulate inflammatory response to reduce subsequent neuronal injury and thus have potential benefit in resuscitation of patients with traumatic brain injury (TBI). Objective To determine whether out-of-hospital administration of hypertonic fluids improves neurologic outcome following severe TBI. Design, Setting, and Participants Multicenter, double-blind, randomized, placebo-controlled clinical trial involving 114 North American emergency medical services agencies within the Resuscitation Outcomes Consortium, conducted between May 2006 and May 2009 among patients 15 years or older with blunt trauma and a prehospital Glasgow Coma Scale score of 8 or less who did not meet criteria for hypovolemic shock. Planned enrollment was 2122 patients. Intervention A single 250-mL bolus of 7.5% saline/6% dextran 70 (hypertonic saline/dextran), 7.5% saline (hypertonic saline), or 0.9% saline (normal saline) initiated in the out-of-hospital setting. Main Outcome Measure Six-month neurologic outcome based on the Extended Glasgow Outcome Scale (GOSE) (dichotomized as >4 or <= 4). Results The study was terminated by the data and safety monitoring board after randomization of 1331 patients, having met prespecified futility criteria. Among the 1282 patients enrolled, 6-month outcomes data were available for 1087 (85%). Baseline characteristics of the groups were equivalent. There was no difference in 6-month neurologic outcome among groups with regard to proportions of patients with severe TBI (GOSE <= 4) (hypertonic saline/dextran vs normal saline: 53.7% vs 51.5%; difference, 2.2% [95% CI, -4.5% to 9.0%]; hypertonic saline vs normal saline: 54.3% vs 51.5%; difference, 2.9% [95% CI, -4.0% to 9.7%]; P=.67). There were no statistically significant differences in distribution of GOSE category or Disability Rating Score by treatment group. Survival at 28 days was 74.3% with hypertonic saline/dextran, 75.7% with hypertonic saline, and 75.1% with normal saline (P=.88). Conclusion Among patients with severe TBI not in hypovolemic shock, initial resuscitation with either hypertonic saline or hypertonic saline/dextran, compared with normal saline, did not result in superior 6-month neurologic outcome or survival.	[Bulger, Eileen M.] Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA; [May, Susanne; Emerson, Scott] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [Kudenchuk, Peter] Univ Washington, Dept Med, Seattle, WA 98104 USA; [Bardarson, Berit] Univ Washington, Clin Trials Ctr, Seattle, WA 98104 USA; [Brasel, Karen J.] Med Coll Wisconsin, Dept Surg, Milwaukee, WI 53226 USA; [Aufderheide, Tom P.] Med Coll Wisconsin, Dept Emergency Med, Milwaukee, WI 53226 USA; [Schreiber, Martin] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA; [Newgard, Craig] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA; [Newgard, Craig] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Kerby, Jeffrey D.; Williams, Carolyn] Univ Alabama, Dept Surg, Birmingham, AL 35294 USA; [Tisherman, Samuel A.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Callaway, Clifton] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA USA; [Slutsky, Arthur] Univ Toronto, Dept Med, Toronto, ON, Canada; [Baker, Andrew] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Baker, Andrew] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Coimbra, Raul] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Davis, Daniel] Univ Calif San Diego, Dept Emergency Med, San Diego, CA 92103 USA; [Minei, Joseph P.; Idris, Ahamed] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Christenson, Jim] Emergency & Hlth Serv Commiss, Vancouver, BC, Canada; [Fabian, Timothy C.] Univ Tennessee, Dept Surg, Memphis, TN USA; [Banek, Jane; Vaillancourt, Christian] Ottawa Res Inst, Dept Emergency Med, Ottawa, ON, Canada; [van Heest, Rardi] Royal Columbia Hosp, Trauma Serv, New Westminster, BC, Canada; [Sopko, George] NHLBI, NIH, Bethesda, MD 20892 USA; [Hata, J. Steven] Univ Iowa, Div Crit Care, Iowa City, IA USA; [Hoyt, David B.] Amer Coll Surg, Chicago, IL USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Medical College of Wisconsin; Medical College of Wisconsin; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; University of Toronto; University of Toronto; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Tennessee System; University of Tennessee Health Science Center; University of Ottawa; Ottawa Hospital Research Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Iowa; American College of Surgeons	Bulger, EM (corresponding author), Univ Washington, Harborview Med Ctr, Dept Surg, 325 9th Ave,POB 359796, Seattle, WA 98104 USA.	ebulger@u.washington.edu	Coimbra, Raul/AAP-3019-2020; Cheskes, Sheldon/I-4456-2015; Tisherman, Samuel A./AAK-9377-2020; Hata, J./ABI-1484-2020; Slutsky, Arthur/M-3325-2019; Welsford, Michelle/H-5535-2017	Coimbra, Raul/0000-0002-3759-6851; Cheskes, Sheldon/0000-0001-7835-3074; Tisherman, Samuel A./0000-0003-3810-3729; Idris, Ahamed/0000-0001-7113-6499; Welsford, Michelle/0000-0003-2682-641X; Gabriel, Erin/0000-0002-0504-8404; Callaway, Clifton/0000-0002-3309-1573; Hostler, David/0000-0002-7711-4001	National Heart, Lung, and Blood Institute [5U01 HL077863, HL077881, HL077871, HL077872, HL077866, HL077908, HL077867, HL077885, HL077887, HL077873, HL077865]; National Institute of Neurological Disorders and Stroke; US Army Medical Research and Materiel Command; Canadian Institutes of Health Research (CIHR) Institute of Circulatory and Respiratory Health; Defence Research and Development Canada; Heart and Stroke Foundation of Canada; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL077881, U01HL077885, U01HL077872, U01HL077908, U01HL077871, U01HL077863, U01HL077865, U01HL077873, U01HL077866, U01HL077867, U01HL077887] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Canadian Institutes of Health Research (CIHR) Institute of Circulatory and Respiratory Health(Canadian Institutes of Health Research (CIHR)); Defence Research and Development Canada; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Resuscitation Outcome Consortium is supported by a series of cooperative agreements with 10 regional clinical centers and 1 data coordinating center (5U01 HL077863, HL077881, HL077871, HL077872, HL077866, HL077908, HL077867, HL077885, HL077887, HL077873, HL077865) from the National Heart, Lung, and Blood Institute in partnership with the National Institute of Neurological Disorders and Stroke, US Army Medical Research and Materiel Command, the Canadian Institutes of Health Research (CIHR) Institute of Circulatory and Respiratory Health, Defence Research and Development Canada, and the Heart and Stroke Foundation of Canada.	BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brasel KJ, 2008, J AM COLL SURGEONS, V206, P220, DOI 10.1016/j.jamcollsurg.2007.07.020; Bulger EM, 2009, ANN EMERG MED, V53, P341, DOI 10.1016/j.annemergmed.2008.07.021; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Coimbra R, 1996, J SURG RES, V64, P203, DOI 10.1006/jsre.1996.0329; Coimbra R, 1997, J TRAUMA, V42, P602, DOI 10.1097/00005373-199704000-00004; COIMBRA R, 1995, SHOCK, V4, P45, DOI 10.1097/00024382-199507000-00007; COOKE RS, 1995, INJURY, V26, P399, DOI 10.1016/0020-1383(95)00064-G; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Davis DP, 2007, PREHOSP EMERG CARE, V11, P369, DOI 10.1080/10903120701537147; Davis DP, 2005, J EMERG MED, V29, P391, DOI 10.1016/j.jemermed.2005.04.012; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; *GLUE GRANT, 2009, INFL HOST RESP INJ C; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Inoue Y, 2008, CRIT CARE MED, V36, P2569, DOI 10.1097/CCM.0b013e3181841a91; JUNGER WG, 1994, CIRC SHOCK, V42, P190; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kittelson JM, 1999, BIOMETRICS, V55, P874, DOI 10.1111/j.0006-341X.1999.00874.x; Loomis WH, 2003, J BIOL CHEM, V278, P4590, DOI 10.1074/jbc.M207868200; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Sheffe H., 1959, ANAL VARIANCE; Tisherman SA, 2008, CIRCULATION, V118, P1585, DOI 10.1161/CIRCULATIONAHA.107.764084; Tyagi R, 2007, NEUROSURG REV, V30, P277, DOI 10.1007/s10143-007-0091-7; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Wakai A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub2; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; WANG SK, 1987, BIOMETRICS, V43, P193, DOI 10.2307/2531959; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	41	160	171	1	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2010	304	13					1455	1464		10.1001/jama.2010.1405	http://dx.doi.org/10.1001/jama.2010.1405			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658SO	20924011	Green Accepted, Bronze			2022-12-28	WOS:000282509900021
J	Yamada, K; Hirotsu, T; Matsuki, M; Butcher, RA; Tomioka, M; Ishihara, T; Clardy, J; Kunitomo, H; Iino, Y				Yamada, Koji; Hirotsu, Takaaki; Matsuki, Masahiro; Butcher, Rebecca A.; Tomioka, Masahiro; Ishihara, Takeshi; Clardy, Jon; Kunitomo, Hirofumi; Iino, Yuichi			Olfactory Plasticity Is Regulated by Pheromonal Signaling in Caenorhabditis elegans	SCIENCE			English	Article							DAUER PHEROMONE; C-ELEGANS; ADAPTATION; NEURONS; MEDIATE; EVOLUTION; ACTS	Population density-dependent dispersal is a well-characterized strategy of animal behavior in which dispersal rate increases when population density is higher. Caenorhabditis elegans shows positive chemotaxis to a set of odorants, but the chemotaxis switches from attraction to dispersal after prolonged exposure to the odorants. We show here that this plasticity of olfactory behavior is dependent on population density and that this regulation is mediated by pheromonal signaling. We show that a peptide, suppressor of NEP-2 (SNET-1), negatively regulates olfactory plasticity and that its expression is down-regulated by the pheromone. NEP-2, a homolog of the extracellular peptidase neprilysin, antagonizes SNET-1, and this function is essential for olfactory plasticity. These results suggest that population density information is transmitted through the external pheromone and endogenous peptide signaling to modulate chemotactic behavior.	[Yamada, Koji; Hirotsu, Takaaki; Matsuki, Masahiro; Tomioka, Masahiro; Kunitomo, Hirofumi; Iino, Yuichi] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; [Hirotsu, Takaaki; Ishihara, Takeshi] Kyushu Univ, Grad Sch Sci, Dept Biol, Fukuoka 8128581, Japan; [Butcher, Rebecca A.; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of Tokyo; Kyushu University; Harvard University; Harvard Medical School	Iino, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	iino@biochem.s.u-tokyo.ac.jp	Hirotsu, Takaaki/G-9358-2013; IINO, YUICHI/G-4962-2014; KUNITOMO, HIROFUMI/G-4963-2014; TOMIOKA, MASAHIRO/G-4890-2014	Hirotsu, Takaaki/0000-0003-3936-8382; KUNITOMO, HIROFUMI/0000-0001-7312-7051; TOMIOKA, MASAHIRO/0000-0002-7537-714X	NIH [CA24487, GM087533]; NATIONAL CANCER INSTITUTE [R01CA024487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM087533, R00GM087533] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge J. Ragains for synthesis of the dauer pheromone ascarosides. Y.I. and T. I. were supported by a Grant-in-aid for Scientific Research, J. C. by NIH grant CA24487, and R. A. B. by an NIH K99 Pathway to Independence Award (GM087533). We thank S. Mitani and P. Sengupta for srbc-64 and srbc-66 strains.	BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Butcher RA, 2008, P NATL ACAD SCI USA, V105, P14288, DOI 10.1073/pnas.0806676105; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; DEVAULT A, 1988, FEBS LETT, V231, P54, DOI 10.1016/0014-5793(88)80701-4; Hirotsu T, 2005, GENES CELLS, V10, P517, DOI 10.1111/j.1365-2443.2005.00856.x; Hu Patrick J, 2007, WormBook, P1; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699; Peckol EL, 2001, P NATL ACAD SCI USA, V98, P11032, DOI 10.1073/pnas.191352498; Poethke HJ, 2002, P ROY SOC B-BIOL SCI, V269, P637, DOI 10.1098/rspb.2001.1936; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; TAUSSIG R, 1984, P NATL ACAD SCI-BIOL, V81, P4988, DOI 10.1073/pnas.81.15.4988; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P1837, DOI 10.1098/rspb.1999.0854; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Yamada K, 2009, GENETICS, V181, P1347, DOI 10.1534/genetics.108.099002; Zahn TR, 2004, TRAFFIC, V5, P544, DOI 10.1111/j.1600-0854.2004.00195.x	23	64	69	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2010	329	5999					1647	1650		10.1126/science.1192020	http://dx.doi.org/10.1126/science.1192020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929849	Green Accepted			2022-12-28	WOS:000282098100042
J	MacLachlan, M; Mannan, H; McAuliffe, E				MacLachlan, Malcolm; Mannan, Hasheem; McAuliffe, Elfish			Staff skills not staff types for community-based rehabilitation	LANCET			English	Editorial Material									[MacLachlan, Malcolm; Mannan, Hasheem; McAuliffe, Elfish] Trinity Coll Dublin, Ctr Global Hlth, Dublin 2, Ireland; [MacLachlan, Malcolm; Mannan, Hasheem] Trinity Coll Dublin, Sch Psychol, Dublin 2, Ireland; [McAuliffe, Elfish] Trinity Coll Dublin, Sch Med, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	MacLachlan, M (corresponding author), Trinity Coll Dublin, Ctr Global Hlth, Dublin 2, Ireland.	malcolm.maclachlan@tcd.ie		McAuliffe, Eilish/0000-0002-9714-5040				*AFRICAN, 2010, 4 CAN INT C COMM BAS; Drum CE., 2009, DISABILITY PUBLIC HL; Dubois CA, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-87; Kruk ME, 2007, BJOG-INT J OBSTET GY, V114, P1253, DOI 10.1111/j.1471-0528.2007.01443.x; MacLachlan M, 2009, DISABILITY & INTERNATIONAL DEVELOPMENT: TOWARDS INCLUSIVE GLOBAL HEALTH, P1, DOI 10.1007/978-0-387-93840-0; MacLachlan M, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-6; McCord C, 2009, HEALTH AFFAIR, V28, pW876, DOI 10.1377/hlthaff.28.5.w876; Morgeson F, 2007, JOB WORK ANAL METHOD; United Nations, 2007, UN CONV RIGHTS PERS; *WHO, 2010, COMM BAS RE IN PRESS; World Health Organization, 2009, SPOTLIGHT HLTH WORKF, V7, P1	11	19	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2011	377	9782					1988	1989		10.1016/S0140-6736(10)61925-3	http://dx.doi.org/10.1016/S0140-6736(10)61925-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	782LR	20970181				2022-12-28	WOS:000292011700009
J	Hoffmann, M; Hilton-Taylor, C; Angulo, A; Bohm, M; Brooks, TM; Butchart, SHM; Carpenter, KE; Chanson, J; Collen, B; Cox, NA; Darwall, WRT; Dulvy, NK; Harrison, LR; Katariya, V; Pollock, CM; Quader, S; Richman, NI; Rodrigues, ASL; Tognelli, MF; Vie, JC; Aguiar, JM; Allen, DJ; Allen, GR; Amori, G; Ananjeva, NB; Andreone, F; Andrew, P; Ortiz, ALA; Baillie, JEM; Baldi, R; Bell, BD; Biju, SD; Bird, JP; Black-Decima, P; Blanc, JJ; Bolanos, F; Bolivar, W; Burfield, IJ; Burton, JA; Capper, DR; Castro, F; Catullo, G; Cavanagh, RD; Channing, A; Chao, NL; Chenery, AM; Chiozza, F; Clausnitzer, V; Collar, NJ; Collett, LC; Collette, BB; Fernandez, CFC; Craig, MT; Crosby, MJ; Cumberlidge, N; Cuttelod, A; Derocher, AE; Diesmos, AC; Donaldson, JS; Duckworth, JW; Dutson, G; Dutta, SK; Emslie, RH; Farjon, A; Fowler, S; Freyhof, J; Garshelis, DL; Gerlach, J; Gower, DJ; Grant, TD; Hammerson, GA; Harris, RB; Heaney, LR; Hedges, SB; Hero, JM; Hughes, B; Hussain, SA; Icochea, J; Inger, RF; Ishii, N; Iskandar, DT; Jenkins, RKB; Kaneko, Y; Kottelat, M; Kovacs, KM; Kuzmin, SL; La Marca, E; Lamoreux, JF; Lau, MWN; Lavilla, EO; Leus, K; Lewison, RL; Lichtenstein, G; Livingstone, SR; Lukoschek, V; Mallon, DP; McGowan, PJK; McIvor, A; Moehlman, PD; Molur, S; Alonso, AM; Musick, JA; Nowell, K; Nussbaum, RA; Olech, W; Orlov, NL; Papenfuss, TJ; Parra-Olea, G; Perrin, WF; Polidoro, BA; Pourkazemi, M; Racey, PA; Ragle, JS; Ram, M; Rathbun, G; Reynolds, RP; Rhodin, AGJ; Richards, SJ; Rodriguez, LO; Ron, SR; Rondinini, C; Rylands, AB; de Mitcheson, YS; Sanciangco, JC; Sanders, KL; Santos-Barrera, G; Schipper, J; Self-Sullivan, C; Shi, YC; Shoemaker, A; Short, FT; Sillero-Zubiri, C; Silvano, DL; Smith, KG; Smith, AT; Snoeks, J; Stattersfield, AJ; Symes, AJ; Taber, AB; Talukdar, BK; Temple, HJ; Timmins, R; Tobias, JA; Tsytsulina, K; Tweddle, D; Ubeda, C; Valenti, SV; van Dijk, PP; Veiga, LM; Veloso, A; Wege, DC; Wilkinson, M; Williamson, EA; Xie, F; Young, BE; Akcakaya, HR; Bennun, L; Blackburn, TM; Boitani, L; Dublin, HT; da Fonseca, GAB; Gascon, C; Lacher, TE; Mace, GM; Mainka, SA; McNeely, JA; Mittermeier, RA; Reid, GM; Rodriguez, JP; Rosenberg, AA; Samways, MJ; Smart, J; Stein, BA; Stuart, SN				Hoffmann, Michael; Hilton-Taylor, Craig; Angulo, Ariadne; Boehm, Monika; Brooks, Thomas M.; Butchart, Stuart H. M.; Carpenter, Kent E.; Chanson, Janice; Collen, Ben; Cox, Neil A.; Darwall, William R. T.; Dulvy, Nicholas K.; Harrison, Lucy R.; Katariya, Vineet; Pollock, Caroline M.; Quader, Suhel; Richman, Nadia I.; Rodrigues, Ana S. L.; Tognelli, Marcelo F.; Vie, Jean-Christophe; Aguiar, John M.; Allen, David J.; Allen, Gerald R.; Amori, Giovanni; Ananjeva, Natalia B.; Andreone, Franco; Andrew, Paul; Aquino Ortiz, Aida Luz; Baillie, Jonathan E. M.; Baldi, Ricardo; Bell, Ben D.; Biju, S. D.; Bird, Jeremy P.; Black-Decima, Patricia; Blanc, J. Julian; Bolanos, Federico; Bolivar-G, Wilmar; Burfield, Ian J.; Burton, James A.; Capper, David R.; Castro, Fernando; Catullo, Gianluca; Cavanagh, Rachel D.; Channing, Alan; Chao, Ning Labbish; Chenery, Anna M.; Chiozza, Federica; Clausnitzer, Viola; Collar, Nigel J.; Collett, Leah C.; Collette, Bruce B.; Fernandez, Claudia F. Cortez; Craig, Matthew T.; Crosby, Michael J.; Cumberlidge, Neil; Cuttelod, Annabelle; Derocher, Andrew E.; Diesmos, Arvin C.; Donaldson, John S.; Duckworth, J. W.; Dutson, Guy; Dutta, S. K.; Emslie, Richard H.; Farjon, Aljos; Fowler, Sarah; Freyhof, Joerg; Garshelis, David L.; Gerlach, Justin; Gower, David J.; Grant, Tandora D.; Hammerson, Geoffrey A.; Harris, Richard B.; Heaney, Lawrence R.; Hedges, S. Blair; Hero, Jean-Marc; Hughes, Baz; Hussain, Syed Ainul; Icochea M, Javier; Inger, Robert F.; Ishii, Nobuo; Iskandar, Djoko T.; Jenkins, Richard K. B.; Kaneko, Yoshio; Kottelat, Maurice; Kovacs, Kit M.; Kuzmin, Sergius L.; La Marca, Enrique; Lamoreux, John F.; Lau, Michael W. N.; Lavilla, Esteban O.; Leus, Kristin; Lewison, Rebecca L.; Lichtenstein, Gabriela; Livingstone, Suzanne R.; Lukoschek, Vimoksalehi; Mallon, David P.; McGowan, Philip J. K.; McIvor, Anna; Moehlman, Patricia D.; Molur, Sanjay; Munoz Alonso, Antonio; Musick, John A.; Nowell, Kristin; Nussbaum, Ronald A.; Olech, Wanda; Orlov, Nikolay L.; Papenfuss, Theodore J.; Parra-Olea, Gabriela; Perrin, William F.; Polidoro, Beth A.; Pourkazemi, Mohammad; Racey, Paul A.; Ragle, James S.; Ram, Mala; Rathbun, Galen; Reynolds, Robert P.; Rhodin, Anders G. J.; Richards, Stephen J.; Rodriguez, Lily O.; Ron, Santiago R.; Rondinini, Carlo; Rylands, Anthony B.; de Mitcheson, Yvonne Sadovy; Sanciangco, Jonnell C.; Sanders, Kate L.; Santos-Barrera, Georgina; Schipper, Jan; Self-Sullivan, Caryn; Shi, Yichuan; Shoemaker, Alan; Short, Frederick T.; Sillero-Zubiri, Claudio; Silvano, Debora L.; Smith, Kevin G.; Smith, Andrew T.; Snoeks, Jos; Stattersfield, Alison J.; Symes, Andrew J.; Taber, Andrew B.; Talukdar, Bibhab K.; Temple, Helen J.; Timmins, Rob; Tobias, Joseph A.; Tsytsulina, Katerina; Tweddle, Denis; Ubeda, Carmen; Valenti, Sarah V.; van Dijk, Peter Paul; Veiga, Liza M.; Veloso, Alberto; Wege, David C.; Wilkinson, Mark; Williamson, Elizabeth A.; Xie, Feng; Young, Bruce E.; Akcakaya, H. Resit; Bennun, Leon; Blackburn, Tim M.; Boitani, Luigi; Dublin, Holly T.; da Fonseca, Gustavo A. B.; Gascon, Claude; Lacher, Thomas E., Jr.; Mace, Georgina M.; Mainka, Susan A.; McNeely, Jeffery A.; Mittermeier, Russell A.; Reid, Gordon McGregor; Paul Rodriguez, Jon; Rosenberg, Andrew A.; Samways, Michael J.; Smart, Jane; Stein, Bruce A.; Stuart, Simon N.			The Impact of Conservation on the Status of the World's Vertebrates	SCIENCE			English	Article							GLOBAL BIODIVERSITY; CLIMATE-CHANGE; EXTINCTIONS; DECLINES; BENEFITS; FUTURE; INDEX	Using data for 25,780 species categorized on the International Union for Conservation of Nature Red List, we present an assessment of the status of the world's vertebrates. One-fifth of species are classified as Threatened, and we show that this figure is increasing: On average, 52 species of mammals, birds, and amphibians move one category closer to extinction each year. However, this overall pattern conceals the impact of conservation successes, and we show that the rate of deterioration would have been at least one-fifth again as much in the absence of these. Nonetheless, current conservation efforts remain insufficient to offset the main drivers of biodiversity loss in these groups: agricultural expansion, logging, overexploitation, and invasive alien species.	[Hoffmann, Michael; Stuart, Simon N.] United Nations Environm Programme World Conservat, IUCN SSC Species Survival Commiss, Cambridge CB3 0DL, England; [Cox, Neil A.; Tognelli, Marcelo F.] Conservat Int, IUCN CI Biodivers Assessment Unit, Arlington, VA 22202 USA; [Hilton-Taylor, Craig; Darwall, William R. T.; Katariya, Vineet; Pollock, Caroline M.; Allen, David J.; Collett, Leah C.; Cuttelod, Annabelle; Shi, Yichuan; Smith, Kevin G.] IUCN, Species Programme, Cambridge CB3 0DL, England; [Angulo, Ariadne] IUCN CI Biodivers Assessment Unit, Toronto, ON M5S 1X1, Canada; [Angulo, Ariadne; Carpenter, Kent E.; Chanson, Janice; Cox, Neil A.; Tognelli, Marcelo F.; Vie, Jean-Christophe; Lamoreux, John F.; Polidoro, Beth A.; Ragle, James S.; Sanciangco, Jonnell C.] IUCN, Species Programme, CH-1196 Gland, Switzerland; [Boehm, Monika; Collen, Ben; Richman, Nadia I.; Ram, Mala; Blackburn, Tim M.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Brooks, Thomas M.; Young, Bruce E.] NatureServe, Arlington, VA 22209 USA; [Brooks, Thomas M.] Univ Philippines Los Banos, World Agroforestry Ctr ICRAF, Laguna 4031, Philippines; [Brooks, Thomas M.] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas 7001, Australia; [Butchart, Stuart H. M.; Burfield, Ian J.; Collar, Nigel J.; Crosby, Michael J.; Stattersfield, Alison J.; Symes, Andrew J.; Wege, David C.; Bennun, Leon] BirdLife Int, Cambridge CB3 0NA, England; [Carpenter, Kent E.; Polidoro, Beth A.; Sanciangco, Jonnell C.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Chanson, Janice] IUCN CI Biodivers Assessment Unit, Cheltenham, Vic 3192, Australia; [Dulvy, Nicholas K.; Harrison, Lucy R.] Simon Fraser Univ, Dept Biol Sci, IUCN Shark Specialist Grp, Burnaby, BC V5A 1S6, Canada; [Quader, Suhel] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; [Rodrigues, Ana S. L.] CNRS, UMR5175, Ctr Ecol Fonct & Evolut, F-34293 Montpellier, France; [Tognelli, Marcelo F.] IADIZA CONICET, CCT Mendoza, RA-5500 Mendoza, Argentina; [Aguiar, John M.; Lacher, Thomas E., Jr.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Allen, Gerald R.] Western Australian Museum, Perth, WA 6986, Australia; [Amori, Giovanni] CNR, Inst Ecosyst Studies, I-00185 Rome, Italy; [Ananjeva, Natalia B.; Orlov, Nikolay L.] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; [Andreone, Franco] Museo Reg Sci Nat, I-10123 Turin, Italy; [Andrew, Paul] Taronga Conservat Soc Australia, Taronga Zoo, Sydney, NSW 2088, Australia; [Baillie, Jonathan E. M.] Zool Soc London, London NW1 4RY, England; [Baldi, Ricardo] Ctr Nacl Pagagon CONICET, Unidad Invest Ecol Terrestre, RA-9120 Puerto Madryn, Argentina; [Baldi, Ricardo] Wildlife Conservat Soc, Patagonian & Andean Steppe Program, RA-9120 Puerto Madryn, Argentina; [Bell, Ben D.] Victoria Univ Wellington, Sch Biol Sci, Ctr Biodivers & Restorat Ecol, Wellington 6140, New Zealand; [Biju, S. D.] Univ Delhi, Sch Environm Studies, Systemat Lab, Delhi 110007, India; [Bird, Jeremy P.] Pacific Inst Sustainable Dev, Ctr Biodivers & Biosecur Studies, Manado, North Sulawesi, Indonesia; [Black-Decima, Patricia] Univ Nacl Tucuman, Fac Ciencias Nat, RA-4000 San Miguel De Tucuman, Argentina; [Black-Decima, Patricia] Univ Nacl Tucuman, Inst Miguel Lillo, RA-4000 San Miguel De Tucuman, Argentina; [Bolanos, Federico] Univ Costa Rica, Escuela Biol, San Jose 115012060, Costa Rica; [Bolivar-G, Wilmar] Univ Valle, Fac Ciencias Nat & Exactas, Dept Biol, Secc Zool, Cali, Colombia; [Burton, James A.] Earthwatch Inst, Oxford OX2 7DE, England; [Burton, James A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Castro, Fernando] Univ Valle, Lab Herpetol, Cali, Colombia; [Catullo, Gianluca] WWF Italy Specis Off, I-00198 Rome, Italy; [Cavanagh, Rachel D.] British Antarctic Survey, Cambridge CB3 0ET, England; [Channing, Alan] Univ Western Cape, Biodivers & Conservat Biol Dept, ZA-7535 Bellville, South Africa; [Chao, Ning Labbish] Bioamazonia Conservat Int, Baltimore, MD 21230 USA; [Chao, Ning Labbish] Univ Fed Amazonas, Depto Ciencias Pesqueiras, BR-60700 Manaus, Amazonas, Brazil; [Chao, Ning Labbish] Natl Museum Marine Biol & Aquarium, Checheng 944, Pingtung, Taiwan; [Chiozza, Federica; Rondinini, Carlo; Boitani, Luigi] Univ Roma La Sapienza, Dept Anim & Human Biol, I-00185 Rome, Italy; [Clausnitzer, Viola] Senckenberg Museum Nat Hist Goerlitz, D-02806 Goerlitz, Germany; [Collette, Bruce B.] Smithsonian Inst, Natl Museum Nat Hist, Natl Marine Fisheries Serv Systemat Lab, Washington, DC 20013 USA; [Craig, Matthew T.] Univ Puerto Rico, Dept Marine Sci, Mayaguez, PR 00681 USA; [Cumberlidge, Neil] Univ Michigan, Dept Biol, Marquette, MI 49855 USA; [Derocher, Andrew E.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Diesmos, Arvin C.] Natl Museum Philippines, Div Zool, Herpetol Sect, Manila 1000, Philippines; [Donaldson, John S.] S African Natl Biodivers Inst, KRC, ZA-7735 Claremont, South Africa; [Dutson, Guy] Birds Australia, Carlton, Vic 3053, Australia; [Dutta, S. K.] N Orissa Univ, Mayurbhanj 757003, Orissa, India; [Emslie, Richard H.] IUCN SSC African Rhino Specialist Grp, ZA-3245 Hilton, South Africa; [Farjon, Aljos] Royal Bot Gardens, Herbarium Lib Art & Arch, Richmond TW9 3AB, Surrey, England; [Fowler, Sarah; Valenti, Sarah V.] NatureBur, Newbury RG14 5SJ, Berks, England; [Freyhof, Joerg] Leibniz Inst Freshwater Ecol & Inland Fisheries, D-12587 Berlin, Germany; [Garshelis, David L.] Minnesota Dept Nat Resources, Grand Rapids, MN 55744 USA; [Gerlach, Justin] Nat Protect Trust Seychelles, Cambridge CB1 7BX, England; [Gower, David J.; Wilkinson, Mark] Nat Hist Museum, Dept Zool, London SW7 5BD, England; [Grant, Tandora D.] San Diego Zoo Inst Conservat Res, Escondido, CA 92027 USA; [Hammerson, Geoffrey A.] NatureServe, Port Townsend, WA 98368 USA; [Harris, Richard B.] Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Heaney, Lawrence R.; Inger, Robert F.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Hedges, S. Blair] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Hero, Jean-Marc] Griffith Univ, Sch Environm, Environm Futures Ctr, Griffith, Qld 4222, Australia; [Hughes, Baz] Wildfowl & Wetlands Trust, Slimbridge GL2 7BT, Glos, England; [Hussain, Syed Ainul] Wildlife Inst India, Dehra Dun 248001, Uttar Pradesh, India; [Ishii, Nobuo] Tokyo Womans Christian Univ, Sch Arts & Sci, Suginami Ku, Tokyo 1678585, Japan; [Iskandar, Djoko T.] Inst Teknol Bandung, Sch Life Sci & Technol, Bandung 40132, Indonesia; [Jenkins, Richard K. B.] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury CT2 7NR, Kent, England; [Jenkins, Richard K. B.] Bangor Univ, Sch Environm & Nat Resources, Bangor LL57 2UW, Gwynedd, Wales; [Jenkins, Richard K. B.] Madagasikara Voakajy, Antananarivo 101, Madagascar; [Kaneko, Yoshio] Iwate Prefectural Univ, Takizawa, Iwate 0200193, Japan; [Kottelat, Maurice] Natl Univ Singapore, Dept Biol Sci, Raffles Museum Biodivers Res, Singapore 117546, Singapore; [Kovacs, Kit M.] Norwegian Polar Res Inst, N-9296 Tromso, Norway; [Kuzmin, Sergius L.] Russian Acad Sci, Inst Ecol & Evolut, Moscow 119071, Russia; [La Marca, Enrique] Univ Los Andes, Escuela Geog, Lab Biogeog, Merida 5101, Venezuela; [Lamoreux, John F.] IUCN Species Programme, Randolph, NH 03593 USA; [Lau, Michael W. N.] Kadoorie Farm & Bot Garden, Tai Po, Hong Kong, Peoples R China; [Lavilla, Esteban O.] Fdn Miguel Lillo CONICET, Inst Herpetol, RA-4000 San Miguel De Tucuman, Argentina; [Leus, Kristin] European Reg Off, Conservat Breeding Specialist Grp, B-2170 Merksem, Belgium; [Lewison, Rebecca L.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Lichtenstein, Gabriela] Inst Nacl Antropol & Pensamiento Latinoamer, RA-1426 Buenos Aires, DF, Argentina; [Livingstone, Suzanne R.] Univ Glasgow, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Lukoschek, Vimoksalehi] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Lukoschek, Vimoksalehi] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Mallon, David P.] Manchester Metropolitan Univ, Dept Biol Chem & Hlth Sci, Manchester M1 5GD, Lancs, England; [McGowan, Philip J. K.] Newcastle Univ, Biol Field Stn, World Pheasant Assoc, Newcastle Upon Tyne NE15 0HT, Tyne & Wear, England; [Moehlman, Patricia D.] Wildlife Trust Alliance, Arusha, Tanzania; [Molur, Sanjay] Zoo Outreach Org, Coimbatore 641004, Tamil Nadu, India; [Munoz Alonso, Antonio] Colegio Frontera Sur, San Cristobal Las Casas 29290, Chiapas, Mexico; [Musick, John A.] Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; [Nowell, Kristin] CAT, Cape Neddick, ME 03902 USA; [Nussbaum, Ronald A.] Univ Michigan, Museum Zool, Div Reptiles & Amphibians, Ann Arbor, MI 48109 USA; [Olech, Wanda] Warsaw Univ Life Sci, PL-02786 Warsaw, Poland; [Papenfuss, Theodore J.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Parra-Olea, Gabriela] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City 04510, DF, Mexico; [Perrin, William F.] NOAA, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92037 USA; [Pourkazemi, Mohammad] Int Sturgeon Res Inst, Rasht, Iran; [Racey, Paul A.] Univ Exeter Cornwall, Ctr Ecol & Conservat, Penryn TR10 9EZ, England; [Rathbun, Galen] Calif Acad Sci San Francisco, Dept Ornithol & Mammal, Cambria, CA 93428 USA; [Reynolds, Robert P.] Smithsonian Inst, Natl Museum Nat Hist, Patuxent Wildlife Res Ctr, USGS, Washington, DC 20013 USA; [Rhodin, Anders G. J.] Chelonian Res Fdn, Lunenburg, MA 01462 USA; [Richards, Stephen J.] S Australian Museum, Herpetol Dept, Adelaide, SA 5000, Australia; [Richards, Stephen J.] Conservat Int, Rapid Assessment Program, Atherton, Qld 4883, Australia; [Rodriguez, Lily O.] German Tech Cooperat GmbH, Lima 27, Peru; [Ron, Santiago R.] Pontificia Univ Catolica Ecuador, Escuela Biol, Museo Zool, Quito, Ecuador; [de Mitcheson, Yvonne Sadovy] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [de Mitcheson, Yvonne Sadovy] Soc Conservat Reef Fish Aggregat, San Diego, CA 92126 USA; [Sanders, Kate L.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Santos-Barrera, Georgina] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Evolut Biol, Mexico City 04510, DF, Mexico; [Schipper, Jan] Univ Hawaii, Pacific Cooperat Studies Unit, Big Isl Invas Species Comm, Hilo, HI 96720 USA; [Self-Sullivan, Caryn] Sirenian Int, Fredericksburg, VA 22401 USA; [Self-Sullivan, Caryn] Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA; [Shoemaker, Alan] IUCN SSC Tapir Specialist Grp, Columbia, SC 29210 USA; [Short, Frederick T.] Univ New Hampshire, Jackson Estuarine Lab, Dept Nat Resources & Environm, Durham, NH 03824 USA; [Sillero-Zubiri, Claudio] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Tubney OX13 5QL, England; [Silvano, Debora L.] Univ Catolica Brasilia, Zool Lab, BR-71966700 Taguatinga, DF, Brazil; [Smith, Andrew T.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Snoeks, Jos] Royal Museum Cent Africa, B-3080 Tervuren, Belgium; [Snoeks, Jos] Katholieke Univ Leuven, Lab Anim Div & Systemat, B-3000 Louvain, Belgium; [Taber, Andrew B.] Jalan CIFOR, Ctr Int Forestry Res, Situ Gede 16115, Bogor Barat, Indonesia; [Talukdar, Bibhab K.] Aaranyak & Int Rhino Fdn, Gauhati 781028, Assam, India; [Temple, Helen J.] Biodivers Consultancy Ltd, Cambridge CB2 9LJ, England; [Tobias, Joseph A.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Tsytsulina, Katerina] Natl Inst Biol Resources, Vertebrate Res Div, Inchon 404708, South Korea; [Tweddle, Denis] S African Inst Aquat Biodivers, ZA-6140 Grahamstown, South Africa; [Ubeda, Carmen] Univ Nacl Comahue, Ctr Reg Univ Bariloche, Dept Zool, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Veiga, Liza M.] Museu Paraense Emilio Goeldi, BR-66017970 Belem, Para, Brazil; [Veiga, Liza M.] Fed Univ Para, BR-66075110 Belem, Para, Brazil; [Veloso, Alberto] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile; [Williamson, Elizabeth A.] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Xie, Feng] Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610041, Peoples R China; [Akcakaya, H. Resit] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Dublin, Holly T.] IUCN ESARO, African Elephant Specialist Grp, IUCN SSC, Nairobi 00200, Kenya; [Dublin, Holly T.] Wildlife Conservat Soc, Bronx, NY 10460 USA; [da Fonseca, Gustavo A. B.] Global Environm Facil, Washington, DC 20433 USA; [da Fonseca, Gustavo A. B.] Univ Fed Minas Gerais, Dept Zool, BR-31270901 Belo Horizonte, MG, Brazil; [Mace, Georgina M.] Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; [Mainka, Susan A.; McNeely, Jeffery A.; Mittermeier, Russell A.; Smart, Jane] IUCN, CH-1196 Gland, Switzerland; [Reid, Gordon McGregor] N England Zool Soc, Chester Zoo, Chester CH2 1LH, Cheshire, England; [Paul Rodriguez, Jon] Inst Venezolano Invest Cient, Ctr Ecol, Caracas 1020A, Venezuela; [Samways, Michael J.] Univ Stellenbosch, Dept Conservat Ecol & Entomol, ZA-7602 Matieland, South Africa; [Stein, Bruce A.] Natl Wildlife Federat, Washington, DC 20004 USA; [Stuart, Simon N.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Stuart, Simon N.] Al Ain Wildlife Pk & Resort, Abu Dhabi, U Arab Emirates	Conservation International; Zoological Society of London; Nature Conservancy; CGIAR; World Agroforestry (ICRAF); University of the Philippines System; University of the Philippines Los Banos; University of Tasmania; BirdLife International; Old Dominion University; Simon Fraser University; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Texas A&M University System; Texas A&M University College Station; Western Australian Museum; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio degli Ecosistemi (ISE-CNR); Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Zoological Society of London; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Victoria University Wellington; University of Delhi; Universidad Nacional de Tucuman; Miguel Lillo Foundation; Universidad Nacional de Tucuman; Universidad Costa Rica; Universidad del Valle; University of Edinburgh; Universidad del Valle; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of the Western Cape; Universidade Federal de Amazonas; National Museum of Marine Biology & Aquarium; Sapienza University Rome; Senckenberg Gesellschaft fur Naturforschung (SGN); National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Puerto Rico; University of Puerto Rico Mayaguez; University of Michigan System; University of Michigan; University of Alberta; National Museum of the Philippines; South African National Biodiversity Institute; Royal Botanic Gardens, Kew; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Natural History Museum London; Zoological Society of San Diego; University of Montana System; University of Montana; Field Museum of Natural History (Chicago); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Griffith University; Wildlife Institute of India; Institute Technology of Bandung; University of Kent; Bangor University; Iwate Prefectural University; National University of Singapore; Norwegian Polar Institute; Russian Academy of Sciences; University of Los Andes Venezuela; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Miguel Lillo Foundation; California State University System; San Diego State University; University of Glasgow; University of California System; University of California Irvine; James Cook University; Manchester Metropolitan University; Newcastle University - UK; El Colegio de la Frontera Sur (ECOSUR); William & Mary; Virginia Institute of Marine Science; University of Michigan System; University of Michigan; Warsaw University of Life Sciences; University of California System; University of California Berkeley; Universidad Nacional Autonoma de Mexico; National Oceanic Atmospheric Admin (NOAA) - USA; University of Exeter; California Academy of Sciences; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of the Interior; United States Geological Survey; Pontificia Universidad Catolica del Ecuador; University of Hong Kong; University of Adelaide; Universidad Nacional Autonoma de Mexico; University of Hawaii System; University Hawaii Hilo; University System of Georgia; Georgia Southern University; University System Of New Hampshire; University of New Hampshire; University of Oxford; Universidade Catolica de Brasilia; Arizona State University; Arizona State University-Tempe; Royal Museum for Central Africa; KU Leuven; CGIAR; Center for International Forestry Research (CIFOR); University of Oxford; National Institute of Biological Resources; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; Universidad Nacional del Comahue; Museu Paraense Emilio Goeldi; Universidade Federal do Para; Universidad de Chile; University of Stirling; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Wildlife Conservation Society; Universidade Federal de Minas Gerais; Imperial College London; Venezuelan Institute Science Research; Stellenbosch University; University of Bath	Hoffmann, M (corresponding author), United Nations Environm Programme World Conservat, IUCN SSC Species Survival Commiss, 219 Huntingdon Rd, Cambridge CB3 0DL, England.	mike.hoffmann@iucn.org	Mace, Georgina M/I-3072-2016; Sanders, Kate L/D-1507-2019; Akcakaya, H. Resit/A-7830-2008; Williamson, Elizabeth/E-4727-2016; Rodrigues, Ana S.L./A-5914-2009; Cumberlidge, Neil/I-4044-2019; Olech, Wanda/AAB-5072-2022; Rodriguez, Jon P/G-7224-2012; Ron, Santiago/J-4203-2019; Ananjeva, Natalia/AAF-4308-2021; Lobo, Diele/I-9106-2012; Lukoschek, vimoksalehi/C-6126-2013; Hoffmann, Michael/E-6419-2010; Williamson, Elizabeth/B-9090-2011; Alonso, Luis Antonio Muñoz/V-7652-2019; Butchart, Stuart HM/Y-2711-2018; Derocher, Andrew/J-4469-2012; Rodriguez, Jon P/A-1491-2009; Rodrigues, Ana/GYQ-6273-2022; Blackburn, Tim/AAC-3144-2019; Böhm, Monika/E-1153-2018; Williamson, Elizabeth/N-8958-2019; Rondinini, Carlo/E-9027-2011; Veiga, Liza/C-6667-2009; Wilkinson, Mark/J-2026-2014; ANDREONE, FRANCO/H-4942-2012; Böhm, Michael/C-3638-2011; Pourkazemi, Mohammad/C-9510-2017; Harrison, Lucy/F-9494-2011; Dulvy, Nicholas/I-2895-2012; Tognelli, Marcelo/L-3958-2019; Iskasndar, Djoko/AAD-2204-2021; Blackburn, Tim M/A-7685-2011; Jenkins, Richard KB/A-4567-2012; Collen, Ben/F-2543-2016; Collen, Ben/D-5055-2011; Butchart, Stuart/AAJ-1852-2021; Donaldson, John/F-6833-2011; Orlov, Nikolai/AAF-4316-2021; Hu, Lile/E-7961-2015; Diesmos, Arvin C./AGG-8542-2022; Rinaldi2, Carlos/D-4479-2011; Stein, Bruce/S-5283-2019; Silvano, Débora/H-4235-2012; Self-Sullivan, Caryn/H-2605-2012; Collette, Bruce B./AAA-9532-2019; Schipper, Jan/N-5266-2015	Mace, Georgina M/0000-0001-8965-5211; Sanders, Kate L/0000-0002-9581-268X; Akcakaya, H. Resit/0000-0002-8679-5929; Williamson, Elizabeth/0000-0001-6848-9154; Rodrigues, Ana S.L./0000-0003-4775-0127; Olech, Wanda/0000-0002-6166-3954; Ron, Santiago/0000-0001-6300-9350; Lukoschek, vimoksalehi/0000-0002-0268-3808; Hoffmann, Michael/0000-0003-4785-2254; Alonso, Luis Antonio Muñoz/0000-0002-0225-0332; Derocher, Andrew/0000-0002-1104-7774; Rodriguez, Jon P/0000-0001-5019-2870; Blackburn, Tim/0000-0003-0152-2663; Böhm, Monika/0000-0003-0585-0832; Williamson, Elizabeth/0000-0001-6848-9154; Wilkinson, Mark/0000-0002-9459-8976; ANDREONE, FRANCO/0000-0001-9809-5818; Pourkazemi, Mohammad/0000-0002-0496-8049; Dulvy, Nicholas/0000-0002-4295-9725; Tognelli, Marcelo/0000-0002-9761-4505; Iskasndar, Djoko/0000-0002-8923-6081; Collen, Ben/0000-0003-2564-4243; Butchart, Stuart/0000-0002-1140-4049; Donaldson, John/0000-0002-7930-1695; Silvano, Débora/0000-0001-7349-5962; Self-Sullivan, Caryn/0000-0003-0785-3682; CASTRO HERRERA, FERNANDO/0000-0002-7626-0103; Gerlach, Justin/0000-0002-0157-0449; Lichtenstein, Gabriela/0000-0002-1717-0941; Tobias, Joseph/0000-0003-2429-6179; Samways, Michael J./0000-0003-4237-6025; Lavilla, Esteban Orlando/0000-0001-7024-3049; Rondinini, Carlo/0000-0002-6617-018X; Ubeda, Carmen/0000-0001-8962-4001; Blanc, Julian/0000-0003-4331-5339; Brooks, Thomas/0000-0001-8159-3116; Schipper, Jan/0000-0002-8338-7874; Sanciangco, Jonnell Cueto/0000-0001-8268-3180; Ragle, James/0000-0002-5829-3745; Molur, Sanjay/0000-0001-8230-518X; Richman, Nadia/0000-0003-4072-1622	NERC [cpb010001, bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025, cpb010001] Funding Source: researchfish; Division Of Environmental Biology [0818798] Funding Source: National Science Foundation	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Akcakaya HR, 2006, GLOBAL CHANGE BIOL, V12, P2037, DOI 10.1111/j.1365-2486.2006.01253.x; Baillie JEM, 2008, CONSERV LETT, V1, P18, DOI 10.1111/j.1755-263X.2008.00009.x; Boyd C, 2008, CONSERV LETT, V1, P37, DOI 10.1111/j.1755-263X.2008.00002.x; Brook BW, 2009, BIOL LETTERS, V5, P723, DOI 10.1098/rsbl.2009.0480; Brooke MD, 2008, CONSERV BIOL, V22, P417, DOI 10.1111/j.1523-1739.2008.00905.x; Brooks TM, 2009, CONSERV BIOL, V23, P1448, DOI 10.1111/j.1523-1739.2009.01334.x; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Butchart SHM, 2006, ORYX, V40, P266, DOI 10.1017/S0030605306000950; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Calix M., 2018, EUROPEAN RED LIST SA; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; CDB, 2002, CONTRIBUTION 6 NATL; Clucas B, 2008, BIODIVERS CONSERV, V17, P1517, DOI 10.1007/s10531-008-9361-0; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Cooper John, 2006, Marine Ornithology, V34, P1; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Donald PF, 2007, SCIENCE, V317, P810, DOI 10.1126/science.1146002; Dulvy NK, 2006, CAN J FISH AQUAT SCI, V63, P1267, DOI 10.1139/F06-035; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; GASCON C, 2007, AMPHIBIAN CONSERVATI; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Laurance WF, 2009, CONSERV BIOL, V23, P1427, DOI 10.1111/j.1523-1739.2009.01336.x; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Nogales M, 2004, CONSERV BIOL, V18, P310, DOI 10.1111/j.1523-1739.2004.00442.x; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Rodrigues ASL, 2006, SCIENCE, V313, P1051, DOI 10.1126/science.1131302; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Scott JM, 2010, CONSERV LETT, V3, P91, DOI 10.1111/j.1755-263X.2010.00096.x; Secretariat of the Convention on Biological Diversity, 2010, GLOB BIOD OUTL; Sitas N, 2009, ANIM CONSERV, V12, P231, DOI 10.1111/j.1469-1795.2009.00244.x; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; TEEB, 2008, EC ECOSYSTEMS BIODIV; TERBORGH J, 1988, CONSERV BIOL, V2, P402, DOI 10.1111/j.1523-1739.1988.tb00207.x; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	41	930	988	22	1015	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2010	330	6010					1503	1509		10.1126/science.1194442	http://dx.doi.org/10.1126/science.1194442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	20978281	Green Submitted			2022-12-28	WOS:000285153500055
J	Sutter, RW; John, TJ; Jain, H; Agarkhedkar, S; Ramanan, PV; Verma, H; Deshpande, J; Singh, AP; Sreevatsava, M; Malankar, P; Burton, A; Chatterjee, A; Jafari, H; Aylward, RB				Sutter, Roland W.; John, T. Jacob; Jain, Hemant; Agarkhedkar, Sharad; Ramanan, Padmasani Venkat; Verma, Harish; Deshpande, Jagadish; Singh, Ajit Pal; Sreevatsava, Meghana; Malankar, Pradeep; Burton, Anthony; Chatterjee, Arani; Jafari, Hamid; Aylward, R. Bruce			Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial	LANCET			English	Article							IMMUNIZATION; POLIOMYELITIS; TRIVALENT; EFFICACY	Background Poliovirus types 1 and 3 co circulate in poliomyelitis endemic countries We aimed to assess the immunogenic-ay of a novel bivalent types 1 and 3 oral poliovirus vaccine (bOPV) Methods We did a randomised double-blind controlled trial to assess the superiority of monovalent type 2 OPV (mOPV2) mOPV3, or bOPV over trivalent OPV (tOPV) and the non inferiority of bivalent vaccine compared with mOPV1 and mOPV3 The study was done at three centres in India between Aug 6 2008 and Dec 26, 2008 Random allocation was done by permuted blocks of ten The primary outcome was seroconversion after one monovalent or bivalent vaccine dose compared with a dose of trivalent vaccine at birth The secondary endpoints were seroconversion after two vaccine doses compared with after two trivalent vaccine doses and cumulative two-dose seroconversion Parents or guardians and study investigators were masked to treatment allocation Because of multiple comparisons, we defined p <= 0 01 as statistically significant This trial is registered with Current Controlled Trials ISRCTN 64725429 Results 900 newborn babies were randomly assigned to one of five vaccine groups (about 180 patients per group) of these 70 (8%) discontinued leaving 830 (92%) for analysis After the first dose seroconversion to poliovirus type 1 was 20% for both mOPV1 (33 of 168) and bOPV (32 of 159) compared with 15% for tOPV (25 of 168 p>0 01), to poliovirus type 2 was 21% (35 of 170) for mOPV2 compared with 25% (42 of 168) for tOPV (p>0 01) and to poliovirus type 3 was 12% (20 of 165) for mOPV3 and 7% (11 of 159) for bOPV compared with 4% (7 of 168) for tOPV (mOPV3 vs tOPV p=0 01, bOPV vs tOPV p>0 01) Cumulative two dose seroconversion to poliovirus type 1 was 90% (151 of 168) for mOPV1 and 86% (136 of 159) for bOPV compared with 63% (106 of 168) for tOPV (p<0 0001) to poliovirus type 2 was 90% (153 of 170) for mOPV2 compared with 91% (153 of 168) for tOPV (p>0 01) and to poliovirus type 3 was 84% (138 of 165) for mOPV3 and 74% (117 of 159) for bOPV compared with 52% (87 of 168) for tOPV (p<0 0001) The vaccines were well tolerated 19 serious adverse events occurred including one death however these events were not attributed to the trial interventions Interpretation The findings show the superiority of bOPV compared with tOPV, and the non inferiority of bOPV compared with mOPV1 and mOPV3	[Sutter, Roland W.] WHO, Polio Eradicat Dept, CH-1211 Geneva 27, Switzerland; [John, T. Jacob] India Expert Advisory Grp Polio Eradicat, Vellore, Tamil Nadu, India; [Jain, Hemant] Mahatma Gandhi Mem Med Coll, Indore, Madhya Pradesh, India; [Agarkhedkar, Sharad] Dr DY Patil Med Coll, Pune, Maharashtra, India; [Ramanan, Padmasani Venkat] Sri Ramachandra Med Coll & Res Inst, Chennai, Tamil Nadu, India; [Verma, Harish; Jafari, Hamid] WHO, Natl Polio Surveillance Project, New Delhi, India; [Deshpande, Jagadish] Enterovirus Res Ctr, Bombay, Maharashtra, India; [Singh, Ajit Pal; Chatterjee, Arani] Panacea Biotec, New Delhi, India	World Health Organization; MGM Medical College Indore; Dr DY Patil Vidyapeeth Pune; Dr D Y Patil Medical College, Hospital & Research Centre; Sri Ramachandra Institute of Higher Education & Research; World Health Organization; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); ICMR - Enterovirus Research Centre	Sutter, RW (corresponding author), WHO, Polio Eradicat Dept, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.			Deshpande, Jagadish/0000-0001-5194-0375	GAVI Alliance; WHO	GAVI Alliance; WHO(World Health Organization)	The trial was funded by GAVI Alliance and WHO The study sponsor (Panacea Biotec) formulated the study vaccines did the randomisation and monitored the trial We thank Sushma Nadkarni Sneha Rane Uma Nalavade and Sonali Sawant from the Enterovirus Research Centre Mumbai for doing the serology testing and stool processing We also thank the trial staff from the Chennai trial site especially A Prakash V Vilvanathan and B Rajesh from Indore trial site especially Ashish Dubey and Mukta Jam and from the Pune trial site especially Shalaka Agarkhedkar Geeta Karambelkar and Sampada Tambolkar for their assistance with trial implementation	ABBO AC, 1995, PEDIATR INFECT DIS J, V14, P100; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P178; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P281; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P77; Caceres VM, 2001, CLIN INFECT DIS, V33, P531, DOI 10.1086/321905; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P950; Conover William Jay, 1998, PRACTICAL NONPARAMET, V350; DOMOK I, 1969, 12 EUR S POL ALL DIS; DONG DX, 1986, B WORLD HEALTH ORGAN, V64, P853; DROSDOV SG, 1961, 4 SCI C I POL VIR EN, P52; Efron B., 1994, MONOGRAPHS STAT APPL; El-Sayed N, 2008, NEW ENGL J MED, V359, P1655, DOI 10.1056/NEJMoa0800390; *EXP PROGR IMM, 1991, WHOEPIRD91OREV1 EXP; Grassly NC, 2007, LANCET, V369, P1356, DOI 10.1016/S0140-6736(07)60531-5; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Greenwood BM, 1997, J INFECT DIS, V175, pS215; HALSEY N, 1985, B WORLD HEALTH ORGAN, V63, P1151; Jenkins HE, 2008, NEW ENGL J MED, V359, P1666, DOI 10.1056/NEJMoa0803259; JOHN TJ, 1976, B WORLD HEALTH ORGAN, V54, P115; PATRIARCA PA, 1988, LANCET, V1, P429; PODSEDLOVSKY TS, 1961, 4 SCI C I POL VIR EN, P59; *R DEV COR TEAM, 2006, R LANG ENV COMP; ROBERTSON H. E., 1962, CANADIAN JOUR PUBL HEALTH, V53, P179; *SAS I, 1989, SAS STAT US GUID VER, V1; Sutter R.W., 2008, VACCINES-BASEL, V5th ed., P631; *WHO, 2008, WKLY EPIDEMIOL REC, V83, P25; World Health Organization, 2010, Weekly Epidemiological Record, V85, P1; World Health Organization, 2004, WHOIVB0410	28	99	109	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 13	2010	376	9753					1682	1688		10.1016/S0140-6736(10)61230-5	http://dx.doi.org/10.1016/S0140-6736(10)61230-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	683DD	20980048				2022-12-28	WOS:000284451000033
J	Clarke, JA; Ksepka, DT; Salas-Gismondi, R; Altamirano, AJ; Shawkey, MD; D'Alba, L; Vinther, J; DeVries, TJ; Baby, P				Clarke, Julia A.; Ksepka, Daniel T.; Salas-Gismondi, Rodolfo; Altamirano, Ali J.; Shawkey, Matthew D.; D'Alba, Liliana; Vinther, Jakob; DeVries, Thomas J.; Baby, Patrice			Fossil Evidence for Evolution of the Shape and Color of Penguin Feathers	SCIENCE			English	Article							DIVING BIRDS	Penguin feathers are highly modified in form and function, but there have been no fossils to inform their evolution. A giant penguin with feathers was recovered from the late Eocene (similar to 36 million years ago) of Peru. The fossil reveals that key feathering features, including undifferentiated primary wing feathers and broad body contour feather shafts, evolved early in the penguin lineage. Analyses of fossilized color-imparting melanosomes reveal that their dimensions were similar to those of non-penguin avian taxa and that the feathering may have been predominantly gray and reddish-brown. In contrast, the dark black-brown color of extant penguin feathers is generated by large, ellipsoidal melanosomes previously unknown for birds. The nanostructure of penguin feathers was thus modified after earlier macrostructural modifications of feather shape linked to aquatic flight.	[Clarke, Julia A.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA; [Ksepka, Daniel T.] N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; [Ksepka, Daniel T.] N Carolina Museum Nat Sci, Dept Paleontol, Raleigh, NC 27601 USA; [Salas-Gismondi, Rodolfo; Altamirano, Ali J.] Univ Nacl Mayor San Marcos, Museo Hist Nat, Dept Paleontol Vertebrados, Lima 14, Peru; [Shawkey, Matthew D.; D'Alba, Liliana] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA; [Vinther, Jakob] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA; [DeVries, Thomas J.] Univ Washington, Burke Museum Nat Hist & Culture, Seattle, WA 98195 USA; [Baby, Patrice] Inst Rech Dev, Lab Mecanismes & Transferts Geol, F-31400 Toulouse, France; [Baby, Patrice] Univ Toulouse, F-31400 Toulouse, France	University of Texas System; University of Texas Austin; University of North Carolina; North Carolina State University; Universidad Nacional Mayor de San Marcos; University System of Ohio; University of Akron; Yale University; University of Washington; University of Washington Seattle; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse	Clarke, JA (corresponding author), Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA.	julia_clarke@jsg.utexas.edu	Baby, Patrice/D-2936-2009; D'Alba, Liliana/AAC-4969-2022; Ksepka, Daniel/A-2007-2009; /B-4978-2011; Vinther, Jakob/GZG-4679-2022; Baby, Patrice/AAL-6640-2021	Baby, Patrice/0000-0001-6142-5174; D'Alba, Liliana/0000-0002-2478-3455; /0000-0003-2218-2637; Baby, Patrice/0000-0001-6142-5174; Shawkey, Matthew/0000-0002-5131-8209; Vinther, Jakob/0000-0002-3584-9616; Salas-Gismondi, Rodolfo/0000-0001-9990-8841	National Science Foundation [DEB-0949897, DEB-0949899]; National Geographic Society Expeditions Council; Air Force Office of Scientific Research [FA9550-09-1-0159]	National Science Foundation(National Science Foundation (NSF)); National Geographic Society Expeditions Council(National Geographic Society); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	K. Browne helped produce the figures; W. Aguirre, P. Brinkman, and V. Schneider prepared the fossil. K. Middleton and M. Stucchi provided discussion. P. Unitt, K. Zyskowski, B. Wang, J. Tejada, J. Reyes, E. Diaz, and Z. Jiang provided professional assistance. The research was funded by the National Science Foundation (DEB-0949897 and DEB-0949899), the National Geographic Society Expeditions Council, the Air Force Office of Scientific Research (FA9550-09-1-0159), and University of Akron startup funds. MUSM 1444 is permanently deposited at the Museo de Historia Natural-UNMSM, Lima, Peru.	Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Berta A, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P861; BONSER RHC, 1995, J EXP BIOL, V198, P1029; Burtt E.H., 1986, ORNITHOL MONOGR, V38, P1; Clarke JA, 2007, P NATL ACAD SCI USA, V104, P11545, DOI 10.1073/pnas.0611099104; Dawson C, 1999, J THEOR BIOL, V199, P291, DOI 10.1006/jtbi.1999.0959; Denny M., 1993, AIR WATER; Fordyce R.E., 1990, P419; Jadwiszczak P, 2009, POL POLAR RES, V30, P3; Ksepka DT, 2010, B AM MUS NAT HIST, P1; Lovvorn JR, 2001, J EXP BIOL, V204, P1547; McGraw KJ, 2007, PIGM CELL RES, V20, P301, DOI 10.1111/j.1600-0749.2007.00386.x; McGraw KJ., 2006, BIRD COLORATION, P243; Rowland HM, 2009, PHILOS T R SOC B, V364, P519, DOI 10.1098/rstb.2008.0261; Slack KE, 2006, MOL BIOL EVOL, V23, P1144, DOI 10.1093/molbev/msj124; Stone-house Bernard, 1975, BIOL PENGUINS; STONEHOUSE B., 1967, ADVAN ECOL RESADVANCES IN ECOLOGICAL RESEARCH, V4, P131, DOI 10.1016/S0065-2504(08)60321-9; Tickell WLN, 2003, WATERBIRDS, V26, P1, DOI 10.1675/1524-4695(2003)026[0001:WP]2.0.CO;2; Vinther J, 2008, BIOL LETTERS, V4, P522, DOI 10.1098/rsbl.2008.0302; Voitkevich A.A.E., 1966, FEATHERS PLUMAGE BIR; WILSON RP, 1992, AM NAT, V140, P179, DOI 10.1086/285409	21	129	133	10	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2010	330	6006					954	957		10.1126/science.1193604	http://dx.doi.org/10.1126/science.1193604			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	20929737				2022-12-28	WOS:000284118000040
J	Karl, T; Harley, P; Emmons, L; Thornton, B; Guenther, A; Basu, C; Turnipseed, A; Jardine, K				Karl, T.; Harley, P.; Emmons, L.; Thornton, B.; Guenther, A.; Basu, C.; Turnipseed, A.; Jardine, K.			Efficient Atmospheric Cleansing of Oxidized Organic Trace Gases by Vegetation	SCIENCE			English	Article							DRY DEPOSITION; AEROSOLS; MODEL	The biosphere is the major source and sink of nonmethane volatile organic compounds (VOCs) in the atmosphere. Gas-phase chemical reactions initiate the removal of these compounds from the atmosphere, which ultimately proceeds via deposition at the surface or direct oxidation to carbon monoxide or carbon dioxide. We performed ecosystem-scale flux measurements that show that the removal of oxygenated VOC via dry deposition is substantially larger than is currently assumed for deciduous ecosystems. Laboratory experiments indicate efficient enzymatic conversion and potential up-regulation of various stress-related genes, leading to enhanced uptake rates as a response to ozone and methyl vinyl ketone exposure or mechanical wounding. A revised scheme for the uptake of oxygenated VOCs, incorporated into a global chemistry-transport model, predicts appreciable regional changes in annual dry deposition fluxes.	[Karl, T.; Harley, P.; Emmons, L.; Guenther, A.; Turnipseed, A.] Natl Ctr Atmospher Res, Boulder, CO 80301 USA; [Thornton, B.; Basu, C.] Univ No Colorado, Sch Biol Sci, Greeley, CO 80639 USA; [Jardine, K.] Univ Arizona, Tucson, AZ 85738 USA	National Center Atmospheric Research (NCAR) - USA; University of Northern Colorado; University of Arizona	Karl, T (corresponding author), Natl Ctr Atmospher Res, Boulder, CO 80301 USA.	tomkarl@ucar.edu	Jardine, Kolby J./N-2802-2013; Karl, Thomas/D-1891-2009; Emmons, Louisa K/R-8922-2016; Guenther, Alex B/B-1617-2008; Harley, Peter/E-1856-2014	Jardine, Kolby J./0000-0001-8491-9310; Karl, Thomas/0000-0003-2869-9426; Emmons, Louisa K/0000-0003-2325-6212; Guenther, Alex B/0000-0001-6283-8288; Harley, Peter/0000-0002-2647-1973; Basu, Chhandak/0000-0003-0520-0100	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	The National Center for Atmospheric Research is operated by the University Corporation for Atmospheric Research under sponsorship from the National Science Foundation.	Atkinson R, 2003, CHEM REV, V103, P4605, DOI 10.1021/cr0206420; COLLINS W, 2004, CLIMATIC CHANGE, V52, P453; Emmons LK, 2010, GEOSCI MODEL DEV, V3, P43, DOI 10.5194/gmd-3-43-2010; Fall R, 2003, CHEM REV, V103, P4941, DOI 10.1021/cr0206521; Goldstein AH, 2007, ENVIRON SCI TECHNOL, V41, P1514, DOI 10.1021/es072476p; Guenther A, 2006, ATMOS CHEM PHYS, V6, P3181, DOI 10.5194/acp-6-3181-2006; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; Jimenez JL, 2009, SCIENCE, V326, P1525, DOI 10.1126/science.1180353; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Lelieveld J, 2008, NATURE, V452, P737, DOI 10.1038/nature06870; Paulot F, 2009, SCIENCE, V325, P730, DOI 10.1126/science.1172910; Paulson C.A., 1970, J APPL METEOROL, V9, P857, DOI [10.1175/1520-0450(1970)0092.0.co;2, DOI 10.1175/1520-0450(1970)009<0857:TMROWS>2.0.CO;2, 10.1175/1520-0450(1970)009, DOI 10.1175/1520-0450(1970)009]; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; WESELY ML, 1989, ATMOS ENVIRON, V23, P1293, DOI 10.1016/0004-6981(89)90153-4; Zhang LM, 2002, ATMOS ENVIRON, V36, P537, DOI 10.1016/S1352-2310(01)00447-2	15	157	159	4	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2010	330	6005					816	819		10.1126/science.1192534	http://dx.doi.org/10.1126/science.1192534			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	20966216	Green Submitted			2022-12-28	WOS:000283855700041
J	Lopez-Garcia, C; Klein, AM; Simons, BD; Winton, DJ				Lopez-Garcia, Carlos; Klein, Allon M.; Simons, Benjamin D.; Winton, Douglas J.			Intestinal Stem Cell Replacement Follows a Pattern of Neutral Drift	SCIENCE			English	Article							MOUSE SMALL-INTESTINE; SOMATIC MUTATION; CRYPT; ORGANIZATION; COLON; CLONALITY; KINETICS; CYCLES	With the capacity for rapid self-renewal and regeneration, the intestinal epithelium is stereotypical of stem cell-supported tissues. Yet the pattern of stem cell turnover remains in question. Applying analytical methods from population dynamics and statistical physics to an inducible genetic labeling system, we showed that clone size distributions conform to a distinctive scaling behavior at short times. This result demonstrates that intestinal stem cells form an equipotent population in which the loss of a stem cell is compensated by the multiplication of a neighbor, leading to neutral drift dynamics in which clones expand and contract at random until they either take over the crypt or they are lost. Combined with long-term clonal fate data, we show that the rate of stem cell replacement is comparable to the cell division rate, implying that neutral drift and symmetrical cell divisions are central to stem cell homeostasis.	[Klein, Allon M.; Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Lopez-Garcia, Carlos; Winton, Douglas J.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Klein, Allon M.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Harvard University; Harvard Medical School	Simons, BD (corresponding author), Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	bds10@cam.ac.uk; doug.winton@cancer.org.uk	Simons, Benjamin/AAY-8920-2020	Simons, Benjamin/0000-0002-3875-7071; Lopez-Garcia, Carlos/0000-0001-9848-8216	Cancer Research UK; Cambridge Research Institute (CRI); CRI Biological Resource Unit and Histopathology Core; Seneca Foundation; Engineering and Physical Sciences Research Council [EP/F043325/1, EP/F032773/1]; EPSRC [EP/F043325/1, EP/F032773/1] Funding Source: UKRI; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cambridge Research Institute (CRI); CRI Biological Resource Unit and Histopathology Core; Seneca Foundation(Fundacion Seneca); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank H. Zecchini and R. Kemp at Cancer Research UK, Cambridge Research Institute (CRI), and the CRI Biological Resource Unit and Histopathology Core. This work was supported by Cancer Research UK (D.J.W.), Seneca Foundation (Region de Murcia, Spain) (C.L.-G.), the Engineering and Physical Sciences Research Council fellowship EP/F043325/1 (A. M. K.), and the Engineering and Physical Sciences Research Council Programme grant EP/F032773/1 (B. D. S.). A patent application on drug and toxicity testing has been submitted.	ALDEWACHI HS, 1979, VIRCHOWS ARCH B, V31, P37, DOI 10.1007/BF02889921; ALDEWACHI HS, 1975, VIRCHOWS ARCH B, V18, P225; Barker N, 2008, COLD SH Q B, V73, P351, DOI 10.1101/sqb.2008.72.003; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BJERKNES M, 1985, BIOPHYS J, V48, P85, DOI 10.1016/S0006-3495(85)83762-0; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; GRIFFITHS DFR, 1988, NATURE, V333, P461, DOI 10.1038/333461a0; Klein AM, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021910; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; LOEFFLER M, 1993, J THEOR BIOL, V160, P471, DOI 10.1006/jtbi.1993.1031; Loeffler M, 1997, J THEOR BIOL, V186, P41, DOI 10.1006/jtbi.1996.0340; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; PARK HS, 1995, AM J PATHOL, V147, P1416; Potten CS, 2002, J CELL SCI, V115, P2381; POTTEN CS, 1986, INT J RADIAT BIOL, V49, P257, DOI 10.1080/09553008514552541; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; WILLIAMS ED, 1992, AM J PATHOL, V141, P773; WINTON DJ, 1990, P ROY SOC B-BIOL SCI, V241, P13, DOI 10.1098/rspb.1990.0059; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; WRIGHT NA, 1982, CELL TISSUE KINET, V15, P595, DOI 10.1111/j.1365-2184.1982.tb01066.x	23	443	449	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2010	330	6005					822	825		10.1126/science.1196236	http://dx.doi.org/10.1126/science.1196236			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	20929733				2022-12-28	WOS:000283855700043
J	Rouget, C; Papin, C; Boureux, A; Meunier, AC; Franco, B; Robine, N; Lai, EC; Pelisson, A; Simonelig, M				Rouget, Christel; Papin, Catherine; Boureux, Anthony; Meunier, Anne-Cecile; Franco, Benedicte; Robine, Nicolas; Lai, Eric C.; Pelisson, Alain; Simonelig, Martine			Maternal mRNA deadenylation and decay by the piRNA pathway in the early Drosophila embryo	NATURE			English	Article							TRANSLATIONAL REGULATION; AXIS SPECIFICATION; BINDING-PROTEIN; GERMLINE; LOCALIZATION; NANOS; PIWI; MELANOGASTER; ACTIVATION; MUTATIONS	Piwi-associated RNAs (piRNAs), a specific class of 24- to 30-nucleotide-long RNAs produced by the Piwi-type of Argonaute proteins, have a specific germline function in repressing transposable elements. This repression is thought to involve heterochromatin formation and transcriptional and post-transcriptional silencing(1-6). The piRNA pathway has other essential functions in germline stem cell maintenance(7) and in maintaining germline DNA integrity(8-10). Here we uncover an unexpected function of the piRNA pathway in the decay of maternal messenger RNAs and in translational repression in the early embryo. A subset of maternal mRNAs is degraded in the embryo at the maternal-to-zygotic transition. In Drosophila, maternal mRNA degradation depends on the RNA-binding protein Smaug and the deadenylase CCR4(11-13), as well as the zygotic expression of a microRNA cluster(14). Using mRNA encoding the embryonic posterior morphogen Nanos (Nos) as a paradigm to study maternal mRNA decay, we found that CCR4-mediated deadenylation of nos depends on components of the piRNA pathway including piRNAs complementary to a specific region in the nos 3' untranslated region. Reduced deadenylation when piRNA-induced regulation is impaired correlates with nos mRNA stabilization and translational derepression in the embryo, resulting in head development defects. Aubergine, one of the Argonaute proteins in the piRNA pathway, is present in a complex with Smaug, CCR4, nos mRNA and piRNAs that target the nos 3' untranslated region, in the bulk of the embryo. We propose that piRNAs and their associated proteins act together with Smaug to recruit the CCR4 deadenylation complex to specific mRNAs, thus promoting their decay. Because the piRNAs involved in this regulation are produced from transposable elements, this identifies a direct developmental function for transposable elements in the regulation of gene expression.	[Rouget, Christel; Papin, Catherine; Meunier, Anne-Cecile; Franco, Benedicte; Simonelig, Martine] CNRS, UPR1142, Inst Human Genet, mRNA Regulat & Dev, F-34396 Montpellier 5, France; [Boureux, Anthony] Univ Montpellier 2, CNRS, UMR5237, CRBM, F-34293 Montpellier, France; [Robine, Nicolas; Lai, Eric C.] Sloan Kettering Inst, Dept Dev Biol, Rockefeller Res Labs 1017, New York, NY 10065 USA; [Pelisson, Alain] CNRS, UPR1142, Inst Human Genet, RNA Silencing & Control Transposit, F-34396 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Memorial Sloan Kettering Cancer Center; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Simonelig, M (corresponding author), CNRS, UPR1142, Inst Human Genet, mRNA Regulat & Dev, 141 Rue Cardonille, F-34396 Montpellier 5, France.	Martine.Simonelig@igh.cnrs.fr	Lai, Eric/AAO-1143-2021; Lai, Eric C/A-3412-2008	Lai, Eric/0000-0002-8432-5851; Robine, Nicolas/0000-0001-5698-8183; Simonelig, Martine/0000-0002-3731-6979	Centre National de la Recherche Scientifique [UPR1142]; Agence Nationale de la Recherche (ANR Blanche) [ANR-06-BLAN-0343]; Fondation pour la Recherche Medicale (FRM); Association pour la Recherche sur le Cancer (ARC); National Institutes of Health (NIH) [R01-GM083300]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083300] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR Blanche)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to A. Nakamura, M. Siomi, H. Siomi, C. Smibert, H. Lin, P. Macdonald, T. Schupbach, W. Theurkauf, R. Wharton and P. Zamore, for their gifts of antibodies or Drosophila stocks. We thank M. Benkirane for the gift of 29-O-methyl anti-miR129. This work was supported by the Centre National de la Recherche Scientifique UPR1142, the Agence Nationale de la Recherche (ANR Blanche ANR-06-BLAN-0343), the Fondation pour la Recherche Medicale (FRM, Equipe FRM 2007) and the Association pour la Recherche sur le Cancer (ARC Libre 2009) to M.S. and by the National Institutes of Health (NIH R01-GM083300) to E.C.L. C.R., A.C.M. and B.F. held salaries from ANR Blanche.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Benoit B, 1999, NUCLEIC ACIDS RES, V27, P3771, DOI 10.1093/nar/27.19.3771; Benoit B, 2005, DEV CELL, V9, P511, DOI 10.1016/j.devcel.2005.09.002; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Bushati N, 2008, CURR BIOL, V18, P501, DOI 10.1016/j.cub.2008.02.081; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Chou TB, 1996, GENETICS, V144, P1673; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Dahanukar A, 1996, GENE DEV, V10, P2610, DOI 10.1101/gad.10.20.2610; Dahanukar A, 1999, MOL CELL, V4, P209, DOI 10.1016/S1097-2765(00)80368-8; GAVIS ER, 1994, NATURE, V369, P315, DOI 10.1038/369315a0; GILLESPIE DE, 1995, GENE DEV, V9, P2495, DOI 10.1101/gad.9.20.2495; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; Juge F, 2002, EMBO J, V21, P6603, DOI 10.1093/emboj/cdf633; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; LEHMANN R, 1991, DEVELOPMENT, V112, P679; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Lim AK, 2009, J CELL BIOL, V186, P333, DOI 10.1083/jcb.200904063; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; SCHUPBACH T, 1991, GENETICS, V129, P1119; Semotok JL, 2005, CURR BIOL, V15, P284, DOI 10.1016/j.cub.2005.01.048; Tadros W, 2007, DEV CELL, V12, P143, DOI 10.1016/j.devcel.2006.10.005; Temme C, 2004, EMBO J, V23, P2862, DOI 10.1038/sj.emboj.7600273; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; WANG C, 1994, DEV DYNAM, V199, P103, DOI 10.1002/aja.1001990204; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Zaessinger S, 2006, DEVELOPMENT, V133, P4573, DOI 10.1242/dev.02649	40	314	329	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1128	U144		10.1038/nature09465	http://dx.doi.org/10.1038/nature09465			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20953170	Green Accepted			2022-12-28	WOS:000283548600052
J	West, XZ; Malinin, NL; Merkulova, AA; Tischenko, M; Kerr, BA; Borden, EC; Podrez, EA; Salomon, RG; Byzova, TV				West, Xiaoxia Z.; Malinin, Nikolay L.; Merkulova, Alona A.; Tischenko, Mira; Kerr, Bethany A.; Borden, Ernest C.; Podrez, Eugene A.; Salomon, Robert G.; Byzova, Tatiana V.			Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands	NATURE			English	Article							TOLL-LIKE RECEPTOR-2; MACULAR DEGENERATION; CHRONIC INFLAMMATION; PATTERN-RECOGNITION; INNATE IMMUNITY; SYSTEM; CANCER; CELLS; CD36	Reciprocity of inflammation, oxidative stress and neovascularization is emerging as an important mechanism underlying numerous processes from tissue healing and remodelling to cancer progression(1,2). Whereas the mechanism of hypoxia-driven angiogenesis is well understood(3,4), the link between inflammation-induced oxidation and de novo blood vessel growth remains obscure. Here we show that the end products of lipid oxidation, omega-(2-carboxyethyl) pyrrole (CEP) and other related pyrroles(5), are generated during inflammation and wound healing and accumulate at high levels in ageing tissues in mice and in highly vascularized tumours in both murine and human melanoma. The molecular patterns of carboxyalkylpyrroles are recognized by Toll-like receptor 2 (TLR2), but not TLR4 or scavenger receptors on endothelial cells, leading to an angiogenic response that is independent of vascular endothelial growth factor. CEP promoted angiogenesis in hindlimb ischaemia and wound healing models through MyD88-dependent TLR2 signalling. Neutralization of endogenous carboxyalkylpyrroles impaired wound healing and tissue revascularization and diminished tumour angiogenesis. Both TLR2 and MyD88 are required for CEP-induced stimulation of Rac1 and endothelial migration. Taken together, these findings establish a new function of TLR2 as a sensor of oxidation-associated molecular patterns, providing a key link connecting inflammation, oxidative stress, innate immunity and angiogenesis.	[West, Xiaoxia Z.; Malinin, Nikolay L.; Merkulova, Alona A.; Tischenko, Mira; Kerr, Bethany A.; Podrez, Eugene A.; Byzova, Tatiana V.] Cleveland Clin Fdn, Dept Mol Cardiol, JJ Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA; [West, Xiaoxia Z.; Salomon, Robert G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Borden, Ernest C.; Byzova, Tatiana V.] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Byzova, TV (corresponding author), Cleveland Clin Fdn, Dept Mol Cardiol, JJ Jacobs Ctr Thrombosis & Vasc Biol, NB50,9500 Euclid Ave, Cleveland, OH 44195 USA.	byzovat@ccf.org	Salomon, Robert G/C-3463-2008; Malinin, Nikolay/J-4271-2012; Malinin, Nikolay/Z-5308-2019; Kerr, Bethany/D-1644-2012	Malinin, Nikolay/0000-0002-2654-1783; Kerr, Bethany/0000-0002-2995-7549; Byzova, Tatiana/0000-0002-2615-875X; Salomon, Robert/0000-0001-9456-3557	NIH [HL073311, HL071625, CA126847, HL077213, GM021249]; American Heart Association [10SDG4300062]; NATIONAL CANCER INSTITUTE [R01CA126847] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311, R01HL071625, R01HL077213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021249] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Hong for the help with synthesis of CEP and CPP adducts, Y. Cui for expressing and purifying anti-CEP monoclonal antibodies, and J. Crabb for providing anti-CEP monoclonal antibody hybridoma cells. This work was supported by NIH grants HL073311, HL071625, CA126847 to T.V.B., HL077213 to E.A.P. and GM021249 to R.G.S. and an American Heart Association grant (10SDG4300062) to N.L.M.	Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Ebrahem Q, 2006, P NATL ACAD SCI USA, V103, P13480, DOI 10.1073/pnas.0601552103; Feng WY, 2008, J CELL BIOL, V183, P1145, DOI 10.1083/jcb.200802179; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Grote K, 2010, BLOOD, V115, P2543, DOI 10.1182/blood-2009-05-224402; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; Mahabeleshwar Ganapati H., 2006, V129, P197; Manley PW, 2002, J MED CHEM, V45, P5687, DOI 10.1021/jm020899q; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	32	330	339	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					972	U150		10.1038/nature09421	http://dx.doi.org/10.1038/nature09421			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20927103	Green Accepted			2022-12-28	WOS:000283254700040
J	Korula, J				Korula, Jacob			Early use of transjugular intrahepatic portosystemic shunts improved outcomes in patients with cirrhosis and variceal bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																		Afdhal NH, 2010, NEW ENGL J MED, V362, P2421, DOI 10.1056/NEJMe1003400; Garcia-Tsao G, 2010, NEW ENGL J MED, V362, P823, DOI 10.1056/NEJMra0901512; Gonzalez R, 2008, ANN INTERN MED, V149, P109, DOI 10.7326/0003-4819-149-2-200807150-00007	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8							JC4-6	10.7326/0003-4819-153-8-201010190-02006	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956702				2022-12-28	WOS:000283054600021
J	Minassian, C; D'Aiuto, F; Hingorani, AD; Smeeth, L				Minassian, Caroline; D'Aiuto, Francesco; Hingorani, Aroon D.; Smeeth, Liam			Invasive Dental Treatment and Risk for Vascular Events A Self-Controlled Case Series	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; PERIODONTAL THERAPY; ACUTE INFECTION; ATHEROSCLEROSIS; INFLAMMATION; ASSOCIATIONS; MARKERS; UPDATE	Background: Treatment of periodontal disease may reduce cardiovascular risk in the longer term, but studies have suggested a link among dental procedures, acute inflammation, and endothelial dysfunction. However, whether such acute inflammatory effects translate into a short-lived increased risk for vascular events is not known. Objective: To investigate whether invasive dental treatment transiently increases the risk for vascular events. Design: Self-controlled case series. Setting: Data came from the U.S. Medicaid claims database. Patients: All persons exposed to invasive dental treatment with a primary hospital discharge diagnosis of ischemic stroke (n = 650) or myocardial infarction (n = 525) from 2002 to 2006. Measurements: The incidence of ischemic stroke and myocardial infarction in periods immediately after invasive dental treatment was compared with the incidence in all other observed time periods. Incidence ratios and 95% CIs were calculated. Results: The rate of vascular events significantly increased in the first 4 weeks after invasive dental treatment (incidence ratio, 1.50 [95% CI, 1.09 to 2.06]) and gradually returned to the baseline rate within 6 months. The positive association remained after exclusion of persons with diabetes, hypertension, or coronary artery disease or persons with prescriptions for antiplatelet or salicylate drugs before treatment. Limitations: Power to examine the effects of invasive dental treatment on stroke and myocardial infarction separately was limited because of the low frequency of invasive dental procedures. Lack of information about use of over-the-counter drugs limited the ability to assess confounding by possible withholding of antiplatelet or salicylate drugs before invasive dental treatment or by the use of nonsteroidal anti-inflammatory drugs after treatment. Conclusion: Invasive dental treatment may be associated with a transient increase in the risk for vascular events. However, the absolute risks are minimal, and the long-term benefits on vascular health will probably outweigh the short-lived adverse effects.	[Smeeth, Liam] UCL, London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Eastman Dent Inst, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University College London	Smeeth, L (corresponding author), UCL, London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Eastman Dent Inst, Keppel St, London WC1E 7HT, England.	liam.smeeth@lshtm.ac.uk	; Smeeth, Liam/X-5862-2018	Hingorani, Aroon/0000-0001-8365-0081; Minassian, Caroline/0000-0001-9406-1928; Smeeth, Liam/0000-0002-9168-6022	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	Primary Funding Source: Wellcome Trust.	*AM DENT ASS, 2007, CURR DENT TERM 2007; D'Aiuto F, 2005, INFLAMM RES, V54, P412, DOI 10.1007/s00011-005-1375-4; D'Aiuto F, 2007, J CLIN PERIODONTOL, V34, P124, DOI 10.1111/j.1600-051X.2006.01037.x; D'Aiuto F, 2006, AM HEART J, V151, P977, DOI 10.1016/j.ahj.2005.06.018; Dietrich T, 2008, CIRCULATION, V117, P1668, DOI 10.1161/CIRCULATIONAHA.107.711507; Douglas IJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000154; El-Sharrawy Eman A, 2006, Anesth Prog, V53, P78, DOI 10.2344/0003-3006(2006)53[78:AOCPIA]2.0.CO;2; Farrington CP, 2010, J R STAT SOC C-APPL, V59, P457; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; FARRINGTON CP, 2006, J ROYAL STAT SOC C, V55, P1; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; Gibson JE, 2009, AM J EPIDEMIOL, V169, P761, DOI 10.1093/aje/kwn364; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Higashi Y, 2009, ATHEROSCLEROSIS, V206, P604, DOI 10.1016/j.atherosclerosis.2009.03.037; Hingorani AD, 2000, CIRCULATION, V102, P994, DOI 10.1161/01.CIR.102.9.994; Hocine M, 2005, STAT MED, V24, P4035, DOI 10.1002/sim.2413; Hubbard R, 2003, AM J EPIDEMIOL, V158, P77, DOI 10.1093/aje/kwg114; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; Loos BG, 2000, J PERIODONTOL, V71, P1528, DOI 10.1902/jop.2000.71.10.1528; MAMODE N, 1995, BMJ-BRIT MED J, V310, P1215, DOI 10.1136/bmj.310.6989.1215; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; Noack B, 2001, J PERIODONTOL, V72, P1221, DOI 10.1902/jop.2000.72.9.1221; Olsen I, 2008, TRANSFUS APHER SCI, V39, P173, DOI 10.1016/j.transci.2008.06.008; Persson GR, 2008, J CLIN PERIODONTOL, V35, P362, DOI 10.1111/j.1600-051X.2008.01281.x; Scannapieco Frank A, 2003, Ann Periodontol, V8, P38, DOI 10.1902/annals.2003.8.1.38; Slade GD, 2003, ARCH INTERN MED, V163, P1172, DOI 10.1001/archinte.163.10.1172; Slade GD, 2000, J DENT RES, V79, P49, DOI 10.1177/00220345000790010701; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Smeeth L, 2006, LANCET, V367, P1075, DOI 10.1016/S0140-6736(06)68474-2; Strom BL, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P1; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Whitaker HJ, 2009, STAT METHODS MED RES, V18, P7, DOI 10.1177/0962280208092342	36	63	67	1	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8					499	506		10.7326/0003-4819-153-8-201010190-00006	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956706				2022-12-28	WOS:000283054600002
J	Coe, FL; Asplin, JR				Coe, Fredric L.; Asplin, John R.			Stopping the Stones	SCIENCE			English	Editorial Material							CYSTINURIA; SLC7A9; MODEL		[Coe, Fredric L.] Univ Chicago, Chicago, IL 60637 USA; [Asplin, John R.] Litholink Corp, Chicago, IL 60612 USA	University of Chicago	Coe, FL (corresponding author), Univ Chicago, Chicago, IL 60637 USA.	f-coe@uchicago.edu; jasplin@litholink.com						Chillaron J, 2010, NAT REV NEPHROL, V6, P424, DOI 10.1038/nrneph.2010.69; Dolin DJ, 2005, J ENDOUROL, V19, P429, DOI 10.1089/end.2005.19.429; Evan AP, 2006, KIDNEY INT, V69, P2227, DOI 10.1038/sj.ki.5000268; Feliubadalo L, 1999, NAT GENET, V23, P52, DOI 10.1038/12652; Font-Llitjos M, 2007, AM J PHYSIOL-RENAL, V293, pF732, DOI 10.1152/ajprenal.00121.2007; LINDELL A, 1995, NEPHRON, V71, P407, DOI 10.1159/000188760; Nakagawa Y, 2000, J UROLOGY, V164, P1481, DOI 10.1016/S0022-5347(05)67011-5; PAK CYC, 1986, J UROLOGY, V136, P1003, DOI 10.1016/S0022-5347(17)45188-3; PRAS E, 1994, NAT GENET, V6, P415, DOI 10.1038/ng0494-415; Rimer JD, 2010, SCIENCE, V330, P337, DOI 10.1126/science.1191968; RODMAN JS, 1984, CLIN NEPHROL, V22, P273; Wilmer MJ, 2007, PEDIATR RES, V62, P151, DOI 10.1203/PDR.0b013e31809fd9a7	12	8	9	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2010	330	6002					325	326		10.1126/science.1197207	http://dx.doi.org/10.1126/science.1197207			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947749				2022-12-28	WOS:000282986700023
J	Lamont, T; Cousins, D; Hillson, R; Bischler, A; Terblanche, M				Lamont, Tara; Cousins, David; Hillson, Rowan; Bischler, Anna; Terblanche, Martinette			Safety Alerts Safer administration of insulin: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lamont, Tara; Cousins, David; Bischler, Anna; Terblanche, Martinette] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England; [Hillson, Rowan] Hillingdon Hosp, London UB8 3NN, England	Brunel University; Imperial College London	Lamont, T (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	tara.lamont@npsa.nhs.uk						Belknap S., 2001, INT J QUAL HEALTH C, V13, P339; Cox AR., 2009, BR J DIABETES VASC D, V9, P84, DOI 10.1177/1474651409103902; Derr RL, 2007, DIABETES SPECTR, V20, P177, DOI DOI 10.2337/diaspect.20.3.177; Fowler D., 2010, SAFE EFFECTIVE USE I; *NHS DIAB, 2010, FIND 2009 NAT DIAB I; PAGE MD, 1992, DIABETIC MED, V9, P938, DOI 10.1111/j.1464-5491.1992.tb01735.x; Rushmer R, 2008, DIABETIC MED, V25, P960, DOI 10.1111/j.1464-5491.2008.02470.x; United States Pharmacopeia, 2010, MEDMARX 5 ANN DAT RE	8	27	27	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 13	2010	341								c5269	10.1136/bmj.c5269	http://dx.doi.org/10.1136/bmj.c5269			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	668FB	20943723				2022-12-28	WOS:000283252900017
J	Bodenheimer, T; West, D				Bodenheimer, Thomas; West, David			Low-Cost Lessons from Grand Junction, Colorado	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bodenheimer, Thomas] Univ Calif San Francisco, Sch Med, Dept Family & Community Med, Ctr Excellence Primary Care, San Francisco, CA 94143 USA; [West, David] St Marys Hosp, Grand Junction, CO USA	University of California System; University of California San Francisco	Bodenheimer, T (corresponding author), Univ Calif San Francisco, Sch Med, Dept Family & Community Med, Ctr Excellence Primary Care, San Francisco, CA 94143 USA.							Berenson RA, 2010, NEW ENGL J MED, V363, P101, DOI 10.1056/NEJMp1005588; Gawande A., 2009, NEW YORKER; Medicare Payment Advisory Committee, 2009, REP C MEAS REG VAR S; Nichols L., 2009, GRAND JUNCTION COLOR; WEST D, 2009, MESA COUNTY COLORADO	5	8	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2010	363	15					1391	1393		10.1056/NEJMp1008450	http://dx.doi.org/10.1056/NEJMp1008450			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	659NV	20925540				2022-12-28	WOS:000282575100002
J	Kamerow, D				Kamerow, Douglas			Yankee Doodling Depressed about depression	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				BERWICK DM, 1985, JAMA-J AM MED ASSOC, V254, P1492, DOI 10.1001/jama.254.11.1492; Casacalenda N, 2002, AM J PSYCHIAT, V159, P1354, DOI 10.1176/appi.ajp.159.8.1354; Gonzalez O., 2010, Morbidity and Mortality Weekly Report, V59, P1229; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; O'Connor EA, 2009, ANN INTERN MED, V151, P793, DOI 10.7326/0003-4819-151-11-200912010-00007; Screening for Mental Health, NAT DEPR SCREEN DAY; *US PREV SERV TASK, 1989, GUID CLIN PREV SERV, P261; US Preventive Serv Task Force, 2009, ANN INTERN MED, V151, P784, DOI 10.7326/0003-4819-151-11-200912010-00006	8	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2010	341								c5516	10.1136/bmj.c5516	http://dx.doi.org/10.1136/bmj.c5516			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663JE	20926486				2022-12-28	WOS:000282879400002
J	Wang, YJ; Deng, XX; Mancarella, S; Hendron, E; Eguchi, S; Soboloff, J; Tang, XAD; Gill, DL				Wang, Youjun; Deng, Xiaoxiang; Mancarella, Salvatore; Hendron, Eunan; Eguchi, Satoru; Soboloff, Jonathan; Tang, Xiang D.; Gill, Donald L.			The Calcium Store Sensor, STIM1, Reciprocally Controls Orai and Ca(V)1.2 Channels	SCIENCE			English	Article							TRPC CHANNELS; CA2+ ENTRY; I-CRAC; ACTIVATION; DOMAINS; CELLS	Calcium signals, pivotal in controlling cell function, can be generated by calcium entry channels activated by plasma membrane depolarization or depletion of internal calcium stores. We reveal a regulatory link between these two channel subtypes mediated by the ubiquitous calcium-sensing STIM proteins. STIM1 activation by store depletion or mutational modification strongly suppresses voltage-operated calcium (Ca(V)1.2) channels while activating store-operated Orai channels. Both actions are mediated by the short STIM-Orai activating region (SOAR) of STIM1. STIM1 interacts with Ca(V)1.2 channels and localizes within discrete endoplasmic reticulum/plasma membrane junctions containing both Ca(V)1.2 and Orai1 channels. Hence, STIM1 interacts with and reciprocally controls two major calcium channels hitherto thought to operate independently. Such coordinated control of the widely expressed Ca(V)1.2 and Orai channels has major implications for Ca2+ signal generation in excitable and nonexcitable cells.	[Wang, Youjun; Deng, Xiaoxiang; Mancarella, Salvatore; Hendron, Eunan; Soboloff, Jonathan; Gill, Donald L.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Wang, Youjun; Deng, Xiaoxiang; Mancarella, Salvatore; Hendron, Eunan; Soboloff, Jonathan; Gill, Donald L.] Temple Univ, Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Eguchi, Satoru] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Tang, Xiang D.] Nankai Univ, Sch Med, Dept Pharmacol, Tianjin 300071, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Nankai University	Gill, DL (corresponding author), Temple Univ, Sch Med, Dept Biochem, 3400 N Broad St, Philadelphia, PA 19140 USA.	dgill@temple.edu	Soboloff, Jonathan/I-6995-2012; Wang, Youjun/H-4016-2013	Soboloff, Jonathan/0000-0001-5192-1297; Wang, Youjun/0000-0003-0961-1716; Deng, Xiaoxiang/0000-0002-7051-9057	NIH [HL55426, AI058173]; Novartis Institutes for Biomedical Research; American Heart Association; NSFC [30871011]; Tianjin S&T Support Project [08ZCKFSH04500]; "973" program [2010CB945001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058173] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Institutes for Biomedical Research; American Heart Association(American Heart Association); NSFC(National Natural Science Foundation of China (NSFC)); Tianjin S&T Support Project; "973" program(National Basic Research Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Rabbit smooth muscle alpha<INF>1C</INF>, beta<INF>2a</INF>, and alpha<INF>2</INF>-delta<INF>1</INF> DNA were gifts from M. Davis, University of Missouri School of Medicine. This work was supported by NIH grants HL55426 and AI058173 (D. L. G.), a Novartis Institutes for Biomedical Research fellowship (Y.W.), the American Heart Association (J.S.), NSFC 30871011, Tianjin S&T Support Project 08ZCKFSH04500, and "973" program 2010CB945001 (X.P.T.).	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Matza D, 2009, IMMUNOL REV, V231, P257, DOI 10.1111/j.1600-065X.2009.00805.x; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Shistik E, 1998, J BIOL CHEM, V273, P17901, DOI 10.1074/jbc.273.28.17901; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Suzuki Y, 2010, MOL IMMUNOL, V47, P640, DOI 10.1016/j.molimm.2009.10.013; Wang YJ, 2008, CLIN EXP PHARMACOL P, V35, P1127, DOI 10.1111/j.1440-1681.2008.05018.x; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900	27	264	265	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2010	330	6000					105	109		10.1126/science.1191086	http://dx.doi.org/10.1126/science.1191086			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929813	Green Accepted			2022-12-28	WOS:000282334500046
J	Destexhe, A				Destexhe, Alain			Dendrites Do It in Sequences	SCIENCE			English	Editorial Material							NEURONS; CORTEX		CNRS, Unite Neurosci Informat & Complex, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Destexhe, A (corresponding author), CNRS, Unite Neurosci Informat & Complex, F-91198 Gif Sur Yvette, France.	destexhe@unic.cnrs-gif.fr		Destexhe, Alain/0000-0001-7405-0455				Abeles M., 1991, CORTICONICS NEURONAL; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; JAHR CE, 1990, J NEUROSCI, V10, P3178; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Rall W, 1964, NEURAL THEORY MODELI, P73; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; STREHLER BL, 1986, P NATL ACAD SCI USA, V83, P9812, DOI 10.1073/pnas.83.24.9812	10	4	4	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1611	1612		10.1126/science.1196743	http://dx.doi.org/10.1126/science.1196743			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929837				2022-12-28	WOS:000282098100029
J	Musunuru, K; Pirruccello, JP; Do, R; Peloso, GM; Guiducci, C; Sougnez, C; Garimella, KV; Fisher, S; Abreu, J; Barry, AJ; Fennell, T; Banks, E; Ambrogio, L; Cibulskis, K; Kernytsky, A; Gonzalez, E; Rudzicz, N; Engert, JC; DePristo, MA; Daly, MJ; Cohen, JC; Hobbs, HH; Altshuler, D; Schonfeld, G; Gabriel, SB; Yue, P; Kathiresan, S				Musunuru, Kiran; Pirruccello, James P.; Do, Ron; Peloso, Gina M.; Guiducci, Candace; Sougnez, Carrie; Garimella, Kiran V.; Fisher, Sheila; Abreu, Justin; Barry, Andrew J.; Fennell, Tim; Banks, Eric; Ambrogio, Lauren; Cibulskis, Kristian; Kernytsky, Andrew; Gonzalez, Elena; Rudzicz, Nicholas; Engert, James C.; DePristo, Mark A.; Daly, Mark J.; Cohen, Jonathan C.; Hobbs, Helen H.; Altshuler, David; Schonfeld, Gustav; Gabriel, Stacey B.; Yue, Pin; Kathiresan, Sekar			Exome Sequencing, ANGPTL3 Mutations, and Familial Combined Hypolipidemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-DENSITY-LIPOPROTEIN; APO-B GENE; APOLIPOPROTEIN-B; FATTY LIVER; CAUCASIAN FAMILIES; HYPOBETALIPOPROTEINEMIA; METABOLISM; LIPASE; INHIBITION; CAPTURE	We sequenced all protein-coding regions of the genome (the "exome") in two family members with combined hypolipidemia, marked by extremely low plasma levels of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides. These two participants were compound heterozygotes for two distinct nonsense mutations in ANGPTL3 (encoding the angiopoietin-like 3 protein). ANGPTL3 has been reported to inhibit lipoprotein lipase and endothelial lipase, thereby increasing plasma triglyceride and HDL cholesterol levels in rodents. Our finding of ANGPTL3 mutations highlights a role for the gene in LDL cholesterol metabolism in humans and shows the usefulness of exome sequencing for identification of novel genetic causes of inherited disorders.	[Musunuru, Kiran; Pirruccello, James P.; Do, Ron; Daly, Mark J.; Altshuler, David; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Musunuru, Kiran; Pirruccello, James P.; Do, Ron; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Musunuru, Kiran; Daly, Mark J.; Altshuler, David; Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Peloso, Gina M.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Musunuru, Kiran; Pirruccello, James P.; Do, Ron; Guiducci, Candace; Sougnez, Carrie; Garimella, Kiran V.; Fisher, Sheila; Abreu, Justin; Barry, Andrew J.; Fennell, Tim; Banks, Eric; Ambrogio, Lauren; Cibulskis, Kristian; Kernytsky, Andrew; Gonzalez, Elena; DePristo, Mark A.; Daly, Mark J.; Altshuler, David; Gabriel, Stacey B.; Kathiresan, Sekar] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Musunuru, Kiran; Pirruccello, James P.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Do, Ron; Rudzicz, Nicholas; Engert, James C.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Peloso, Gina M.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Cohen, Jonathan C.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Cohen, Jonathan C.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Schonfeld, Gustav; Yue, Pin] Washington Univ, Sch Med, St Louis, MO USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johns Hopkins University; McGill University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL)	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, 185 Cambridge St,CPZN 5-252, Boston, MA 02114 USA.	skathiresan@partners.org	Cibulskis, Kristian/AAC-7380-2019; Daly, Mark J/B-2453-2017; Altshuler, David M/A-4476-2009	Daly, Mark J/0000-0002-0949-8752; Altshuler, David M/0000-0002-7250-4107; Cibulskis, Kristian/0000-0003-1343-1582; Gonzalez, Elena/0000-0003-4380-663X; Pirruccello, James/0000-0001-6088-4037; Garimella, Kiran/0000-0002-6212-5736; Engert, James/0000-0001-8411-4790	National Human Genome Research Institute of the National Institutes of Health (NIH) [U54 HG003067]; National Heart, Lung, and Blood Institute (NHLBI) of the NIH [RC1 HL099793, RC1 HL099634, RC2 HL101864, K99 HL098364, R01 HL082896]; Donovan Family Foundation; Sarnoff Cardiovascular Research Foundation; Canadian Institutes of Health Research; National Human Genome Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099793, RC1HL099634, K99HL098364, R01HL082896, RC2HL101864, RL1HL092550] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	National Human Genome Research Institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute (NHLBI) of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Donovan Family Foundation; Sarnoff Cardiovascular Research Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported by grants from the National Human Genome Research Institute of the National Institutes of Health (NIH) (Medical Sequencing Program grant U54 HG003067, to the Broad Institute for exome sequencing), the National Heart, Lung, and Blood Institute (NHLBI) of the NIH (RC1 HL099793, RC1 HL099634, and RC2 HL101864, to Dr. Kathiresan; K99 HL098364, to Dr. Musunuru; and R01 HL082896, to Drs. Cohen and Hobbs for analysis of ANGPTL3 in the Dallas Heart Study), the Donovan Family Foundation (to Dr. Kathiresan), the Sarnoff Cardiovascular Research Foundation (a research fellowship, to Mr. Pirruccello), and the Canadian Institutes of Health Research (a Canada Graduate Doctoral Scholarship, to Mr. Do).; Funded by the National Human Genome Research Institute and others	Ando Y, 2003, J LIPID RES, V44, P1216, DOI 10.1194/jlr.M300031-JLR200; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Elias N, 2000, ARTERIOSCL THROM VAS, V20, P1309, DOI 10.1161/01.ATV.20.5.1309; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hooper AJ, 2005, CRIT REV CL LAB SCI, V42, P515, DOI 10.1080/10408360500295113; Jin WJ, 2007, CELL METAB, V6, P129, DOI 10.1016/j.cmet.2007.07.009; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Lee EC, 2009, J BIOL CHEM, V284, P13735, DOI 10.1074/jbc.M807899200; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pulai JI, 1998, AM J MED GENET, V76, P79, DOI 10.1002/(SICI)1096-8628(19980226)76:1<79::AID-AJMG15>3.3.CO;2-E; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Schonfeld G, 2005, CELL MOL LIFE SCI, V62, P1372, DOI 10.1007/s00018-005-4473-0; Schonfeld G, 2003, J LIPID RES, V44, P470, DOI 10.1194/jlr.M200342-JLR200; Sherva R, 2007, J LIPID RES, V48, P2632, DOI 10.1194/jlr.M700078-JLR200; Shimamura M, 2007, ARTERIOSCL THROM VAS, V27, P366, DOI 10.1161/01.ATV.0000252827.51626.89; Shimizugawa T, 2002, J BIOL CHEM, V277, P33742, DOI 10.1074/jbc.M203215200; Tarugi P, 1996, GASTROENTEROLOGY, V111, P1125, DOI 10.1016/S0016-5085(96)70082-3; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Yuan B, 2000, AM J HUM GENET, V66, P1699, DOI 10.1086/302904; Yue P, 2005, METABOLISM, V54, P682, DOI 10.1016/j.metabol.2004.12.013	22	461	497	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2220	2227		10.1056/NEJMoa1002926	http://dx.doi.org/10.1056/NEJMoa1002926			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EP	20942659	Green Accepted			2022-12-28	WOS:000284832900009
J	Buckley, BB; Fuchs, GD; Bassett, LC; Awschalom, DD				Buckley, B. B.; Fuchs, G. D.; Bassett, L. C.; Awschalom, D. D.			Spin-Light Coherence for Single-Spin Measurement and Control in Diamond	SCIENCE			English	Article							COUPLED ELECTRON; NUCLEAR-SPIN; QUANTUM-DOT; DYNAMICS; CENTERS; CAVITY	The exceptional spin coherence of nitrogen-vacancy centers in diamond motivates their function in emerging quantum technologies. Traditionally, the spin state of individual centers is measured optically and destructively. We demonstrate dispersive, single-spin coupling to light for both nondestructive spin measurement, through the Faraday effect, and coherent spin manipulation, through the optical Stark effect. These interactions can enable the coherent exchange of quantum information between single nitrogen-vacancy spins and light, facilitating coherent measurement, control, and entanglement that is scalable over large distances.	[Buckley, B. B.; Fuchs, G. D.; Bassett, L. C.; Awschalom, D. D.] Univ Calif Santa Barbara, Ctr Spintron & Quantum Computat, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Awschalom, DD (corresponding author), Univ Calif Santa Barbara, Ctr Spintron & Quantum Computat, Santa Barbara, CA 93106 USA.	awsch@physics.ucsb.edu	Bassett, Lee/AAD-6466-2019	Bassett, Lee/0000-0001-8729-1530	Air Force Office of Scientific Research; Army Research Office; Defense Advanced Research Projects Agency	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Army Research Office; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	We sincerely thank D. M. Toyli, C. G. Yale, F. J. Heremans, and C. Santori for thoughtful comments. We gratefully acknowledge support from the Air Force Office of Scientific Research, the Army Research Office, and Defense Advanced Research Projects Agency.	Acosta V. M., PREPRINT; Aljunid SA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.153601; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Barclay PE, 2009, OPT EXPRESS, V17, P9588, DOI 10.1364/OE.17.009588; Batalov A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.195506; Berezovsky J, 2008, SCIENCE, V320, P349, DOI 10.1126/science.1154798; Chen JJ, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/9/095505; Childress L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.070504; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; COHENTANNOUDJI C, 1977, J PHYS B-AT MOL OPT, V10, P345, DOI 10.1088/0022-3700/10/3/005; Fu KMC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.256404; Grangier P, 1998, NATURE, V396, P537, DOI 10.1038/25059; Hanson R, 2008, SCIENCE, V320, P352, DOI 10.1126/science.1155400; Imamoglu A, 1999, PHYS REV LETT, V83, P4204, DOI 10.1103/PhysRevLett.83.4204; Jelezko F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076401; Kaiser F., PREPRINT; Kosaka H, 2009, NATURE, V457, P702, DOI 10.1038/nature07729; Lupascu A, 2007, NAT PHYS, V3, P119, DOI 10.1038/nphys509; Manson NB, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.104303; Manson NB, 2005, DIAM RELAT MATER, V14, P1705, DOI 10.1016/j.diamond.2005.06.027; Neumann P, 2010, NAT PHYS, V6, P249, DOI 10.1038/NPHYS1536; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Robledo L, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.177403; Santori C, 2006, OPT EXPRESS, V14, P7986, DOI 10.1364/OE.14.007986; Tamarat P, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/045004; Tamarat P, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.083002; Togan E, 2010, NATURE, V466, P730, DOI 10.1038/nature09256; Weber JR, 2010, P NATL ACAD SCI USA, V107, P8513, DOI 10.1073/pnas.1003052107; WEI CJ, 1995, PHYS REV LETT, V74, P1083, DOI 10.1103/PhysRevLett.74.1083	30	175	179	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1212	1215		10.1126/science.1196436	http://dx.doi.org/10.1126/science.1196436			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	20947728				2022-12-28	WOS:000284613700033
J	Armulik, A; Genove, G; Mae, M; Nisancioglu, MH; Wallgard, E; Niaudet, C; He, LQ; Norlin, J; Lindblom, P; Strittmatter, K; Johansson, BR; Betsholtz, C				Armulik, Annika; Genove, Guillem; Mae, Maarja; Nisancioglu, Maya H.; Wallgard, Elisabet; Niaudet, Colin; He, Liqun; Norlin, Jenny; Lindblom, Per; Strittmatter, Karin; Johansson, Bengt R.; Betsholtz, Christer			Pericytes regulate the blood-brain barrier	NATURE			English	Article							ENDOTHELIAL-CELLS; UP-REGULATION; MUTANT MICE; EXPRESSION; INDUCTION; LEADS; ABNORMALITIES; TRANSCRIPTS; ASTROCYTES; ACTIVATION	The blood-brain barrier (BBB) consists of specific physical barriers, enzymes and transporters, which together maintain the necessary extracellular environment of the central nervous system (CNS)(1). The main physical barrier is found in the CNS endothelial cell, and depends on continuous complexes of tight junctions combined with reduced vesicular transport(2). Other possible constituents of the BBB include extracellular matrix, astrocytes and pericytes(3), but the relative contribution of these different components to the BBB remains largely unknown(1,3). Here we demonstrate a direct role of pericytes at the BBB in vivo. Using a set of adult viable pericyte-deficient mouse mutants we show that pericyte deficiency increases the permeability of the BBB to water and a range of low-molecular-mass and high-molecular-mass tracers. The increased permeability occurs by endothelial transcytosis, a process that is rapidly arrested by the drug imatinib. Furthermore, we show that pericytes function at the BBB in at least two ways: by regulating BBB-specific gene expression patterns in endothelial cells, and by inducing polarization of astrocyte end-feet surrounding CNS blood vessels. Our results indicate a novel and critical role for pericytes in the integration of endothelial and astrocyte functions at the neurovascular unit, and in the regulation of the BBB.	[Armulik, Annika; Genove, Guillem; Mae, Maarja; Nisancioglu, Maya H.; Wallgard, Elisabet; Niaudet, Colin; He, Liqun; Norlin, Jenny; Strittmatter, Karin; Betsholtz, Christer] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, SE-17177 Stockholm, Sweden; [Lindblom, Per] AstraZeneca AB, Clin Dev, SE-43183 Molndal, Sweden; [Johansson, Bengt R.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Electron Microscopy Unit, SE-40530 Gothenburg, Sweden	Karolinska Institutet; AstraZeneca; University of Gothenburg	Betsholtz, C (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Scheelesvag 2, SE-17177 Stockholm, Sweden.	annika.armulik@ki.se; christer.betsholtz@ki.se	Andaloussi Mäe, Maarja/AAA-9215-2022; Genove, Guillem/F-1158-2011	Keller, Annika/0000-0003-1466-3633; He, Liqun/0000-0003-2127-7597; Genove, Guillem/0000-0002-8558-3107	Leducq Foundation; Swedish Governmental Agency for Innovation Systems (Vinnova); EU; Swedish Cancer Society and Research Council; Knut and Alice Wallenberg, Inga-Britt and Arne Lundberg, and Torsten and Ragnar Soderberg Foundations	Leducq Foundation(Leducq Foundation); Swedish Governmental Agency for Innovation Systems (Vinnova)(Vinnova); EU(European Commission); Swedish Cancer Society and Research Council; Knut and Alice Wallenberg, Inga-Britt and Arne Lundberg, and Torsten and Ragnar Soderberg Foundations(Knut & Alice Wallenberg Foundation)	We thank U. Eriksson and members of the Betsholtz laboratory for discussion, P. Soriano, L. Sorokin and R. Hallman for reagents, and S. Kamph and the Scheele animal house for technical assistance. This work was supported by the Leducq Foundation, the Swedish Governmental Agency for Innovation Systems (Vinnova), the EU Fp6 Program Lymphangiogenomics, the Swedish Cancer Society and Research Council, the Knut and Alice Wallenberg, Inga-Britt and Arne Lundberg, and Torsten and Ragnar Soderberg Foundations.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Bender A, 2008, NEUROBIOL AGING, V29, P1404, DOI 10.1016/j.neurobiolaging.2007.03.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernacki J, 2008, PHARMACOL REP, V60, P600; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.3.CO;2-E; He L, 2008, J AM SOC NEPHROL, V19, P260, DOI 10.1681/ASN.2007050588; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; KARNOVASKY MORRIS J., 1967, J CELL BIOL, V35, P213, DOI 10.1083/jcb.35.1.213; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; MOOS T, 1993, NEUROPATH APPL NEURO, V19, P120, DOI 10.1111/j.1365-2990.1993.tb00416.x; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; Sobue K, 1999, NEUROSCI RES, V35, P155, DOI 10.1016/S0168-0102(99)00079-6; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Tidhar A, 2001, DEV DYNAM, V220, P60, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1089>3.0.CO;2-X; Wallgard E, 2008, ARTERIOSCL THROM VAS, V28, P1469, DOI 10.1161/ATVBAHA.108.165738; Wolburg H, 2009, NEUROSCIENTIST, V15, P180, DOI 10.1177/1073858408329509; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	33	1630	1680	5	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					557	U231		10.1038/nature09522	http://dx.doi.org/10.1038/nature09522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	20944627				2022-12-28	WOS:000284584200041
J	Ellwood, MJ; Wille, M; Maher, W				Ellwood, Michael J.; Wille, Martin; Maher, William			Glacial Silicic Acid Concentrations in the Southern Ocean	SCIENCE			English	Article							CIRCUMPOLAR DEEP-WATER; DIATOMS; CIRCULATION; FRACTIONATION; NUTRIENTS	Reconstruction of nutrient concentrations in the deep Southern Ocean has produced conflicting results. The cadmium/calcium (Cd/Ca) data set suggests little change in nutrient concentrations during the last glacial period, whereas the carbon isotope data set suggests that nutrient concentrations were higher. We determined the silicon isotope composition of sponge spicules from the Atlantic and Pacific sectors of the Southern Ocean and found higher silicic acid concentrations in the Pacific sector during the last glacial period. We propose that this increase results from changes in the stoichiometric uptake of silicic acid relative to nitrate and phosphate by diatoms, thus facilitating a redistribution of nutrients across the Pacific and Southern Oceans. Our results are consistent with the global Cd/Ca data set and support the silicic acid leakage hypothesis.	[Ellwood, Michael J.; Wille, Martin] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Maher, William] Univ Canberra, Fac Sci Appl, Inst Appl Ecol, Canberra, ACT 2601, Australia	Australian National University; University of Canberra	Ellwood, MJ (corresponding author), Australian Natl Univ, Res Sch Earth Sci, GPO Box 4, Canberra, ACT 0200, Australia.	michael.ellwood@anu.edu.au	Wille, Martin/AAU-7512-2020; Wille, Martin/A-1973-2009; Ellwood, Michael/G-7390-2011	Maher, William A./0000-0001-7564-3383; Ellwood, Michael/0000-0003-4288-8530; Wille, Martin/0000-0003-1083-4730	Australian Research Council [DP0770820, DP0771519]	Australian Research Council(Australian Research Council)	We acknowledge the Antarctic Research Facility at Florida State University for E33-22 core samples and the Ocean Drilling Program for ODP177 site 1089 core samples. This research was supported with funds from the Australian Research Council (grants DP0770820 and DP0771519). This manuscript benefited from the thoughtful comments of two anonymous reviewers.	Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Barker S, 2009, NATURE, V457, P1097, DOI 10.1038/nature07770; BOYLE EA, 1992, ANNU REV EARTH PL SC, V20, P245, DOI 10.1146/annurev.ea.20.050192.001333; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; Chase Z, 2003, DEEP-SEA RES PT II, V50, P799, DOI 10.1016/S0967-0645(02)00595-7; De La Rocha CL, 1998, NATURE, V395, P680, DOI 10.1038/27174; De La Rocha CL, 1997, GEOCHIM COSMOCHIM AC, V61, P5051, DOI 10.1016/S0016-7037(97)00300-1; Ellwood MJ, 2006, EARTH PLANET SC LETT, V243, P749, DOI 10.1016/j.epsl.2006.01.016; Froelich PN, 1992, PALEOCEANOGRAPHY, V7, P739, DOI 10.1029/92PA02090; Georg RB, 2009, EARTH PLANET SC LETT, V283, P67, DOI 10.1016/j.epsl.2009.03.041; Hendry KR, 2010, EARTH PLANET SC LETT, V292, P290, DOI 10.1016/j.epsl.2010.02.005; Hodell DA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000367; HODELL DA, 2002, P OC DRILL PROGR SCI, V177; LEA DW, 1995, PALEOCEANOGRAPHY, V10, P733, DOI 10.1029/95PA01546; Matsumoto K, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001442; McCave IN, 2008, QUATERNARY SCI REV, V27, P1886, DOI 10.1016/j.quascirev.2008.07.010; MORTLOCK RA, 1991, NATURE, V351, P220, DOI 10.1038/351220a0; Moy AD, 2006, J QUATERNARY SCI, V21, P763, DOI 10.1002/jqs.1067; Ninnemann US, 2002, EARTH PLANET SC LETT, V201, P383, DOI 10.1016/S0012-821X(02)00708-2; Ninnemann US, 1997, PALEOCEANOGRAPHY, V12, P560, DOI 10.1029/97PA01032; Pichevin LE, 2009, NATURE, V459, P1114, DOI 10.1038/nature08101; Piotrowski AM, 2004, EARTH PLANET SC LETT, V225, P205, DOI 10.1016/j.epsl.2004.06.002; Rosenthal Y, 1997, PALEOCEANOGRAPHY, V12, P787, DOI 10.1029/97PA02508; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; SARMIENTO JL, 2007, GLOBAL BIOGEOCHEM CY, V21; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Skinner LC, 2010, SCIENCE, V328, P1147, DOI 10.1126/science.1183627; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; Wille M, 2010, EARTH PLANET SC LETT, V292, P281, DOI 10.1016/j.epsl.2010.01.036	29	32	33	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1088	1091		10.1126/science.1194614	http://dx.doi.org/10.1126/science.1194614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	20966217				2022-12-28	WOS:000284374700039
J	Aaron, HJ				Aaron, Henry J.			The Midterm Elections - High Stakes for Health Policy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brookings Inst, Washington, DC 20036 USA	Brookings Institution	Aaron, HJ (corresponding author), Brookings Inst, Washington, DC 20036 USA.							Aaron HJ, 2010, NEW ENGL J MED, V362, P1259, DOI 10.1056/NEJMp1003394; *GOP GOV, PLEDG AM; 2010, CNN OPINION RES 0928	3	11	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 28	2010	363	18					1685	1687		10.1056/NEJMp1011213	http://dx.doi.org/10.1056/NEJMp1011213			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	671XF	20925535				2022-12-28	WOS:000283546400001
J	Catena, F; Di Saverio, S				Catena, Fausto; Di Saverio, Salomone			Air in the Middle of the Abdomen	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Catena, Fausto; Di Saverio, Salomone] S Orsola Malpighi Univ Hosp, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna	Catena, F (corresponding author), S Orsola Malpighi Univ Hosp, Bologna, Italy.	salo75@inwind.it	Di Saverio, Salomone/G-1437-2012	Di Saverio, Salomone/0000-0001-5685-5022					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 28	2010	363	18					E28	E28		10.1056/NEJMicm0804366	http://dx.doi.org/10.1056/NEJMicm0804366			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671XF	20979466				2022-12-28	WOS:000283546400011
J	Choi, YL; Soda, M; Yamashita, Y; Ueno, T; Takashima, J; Nakajima, T; Yatabe, Y; Takeuchi, K; Hamada, T; Haruta, H; Ishikawa, Y; Kimura, H; Mitsudomi, T; Tanio, Y; Mano, H				Choi, Young Lim; Soda, Manabu; Yamashita, Yoshihiro; Ueno, Toshihide; Takashima, Junpei; Nakajima, Takahiro; Yatabe, Yasushi; Takeuchi, Kengo; Hamada, Toru; Haruta, Hidenori; Ishikawa, Yuichi; Kimura, Hideki; Mitsudomi, Tetsuya; Tanio, Yoshiro; Mano, Hiroyuki		ALK Lung Canc Study Grp	EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE; ACQUIRED-RESISTANCE; IMATINIB; IDENTIFICATION; GEFITINIB; FUSION; DOMAIN; ABL; EFFICACY	The EML4 (echinoderm microtubule-associated protein-like 4)-ALK (anaplastic lymphoma kinase) fusion-type tyrosine kinase is an oncoprotein found in 4 to 5% of non-small-cell lung cancers, and clinical trials of specific inhibitors of ALK for the treatment of such tumors are currently under way. Here, we report the discovery of two secondary mutations within the kinase domain of EML4-ALK in tumor cells isolated from a patient during the relapse phase of treatment with an ALK inhibitor. Each mutation developed independently in subclones of the tumor and conferred marked resistance to two different ALK inhibitors.	[Choi, Young Lim; Soda, Manabu; Yamashita, Yoshihiro; Ueno, Toshihide; Hamada, Toru; Haruta, Hidenori; Mano, Hiroyuki] Jichi Med Univ, Div Funct Genom, Shimotsuke, Tochigi 3290498, Japan; [Choi, Young Lim; Mano, Hiroyuki] Univ Tokyo, Grad Sch Med, Dept Med Genom, Tokyo, Japan; [Takashima, Junpei; Tanio, Yoshiro] Osaka Gen Med Ctr, Dept Internal Med, Osaka, Japan; [Nakajima, Takahiro; Kimura, Hideki] Chiba Canc Ctr, Div Thorac Dis, Chiba 2608717, Japan; [Yatabe, Yasushi] Aichi Canc Ctr Hosp, Dept Pathol, Aichi, Japan; [Mitsudomi, Tetsuya] Aichi Canc Ctr Hosp, Dept Thorac Surg, Aichi, Japan; [Takeuchi, Kengo] Japanese Fdn Canc Res, Inst Canc, Pathol Project Mol Targets, Tokyo 170, Japan; [Ishikawa, Yuichi] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Tokyo 170, Japan; [Mano, Hiroyuki] Japan Sci & Technol Agcy, Saitama, Japan	Jichi Medical University; University of Tokyo; Chiba Cancer Center; Aichi Cancer Center; Aichi Cancer Center; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japan Science & Technology Agency (JST)	Mano, H (corresponding author), Jichi Med Univ, Div Funct Genom, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	hmano@jichi.ac.jp	YATABE, Yasushi/J-6461-2014; Takeuchi, Kengo/C-3614-2008	YATABE, Yasushi/0000-0003-1788-559X; Nakajima, Takahiro/0000-0002-4937-5378; Mitsudomi, Tetsuya/0000-0001-9860-8505; Takeuchi, Kengo/0000-0002-1599-5800	Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Seoul National University Hospital; Grants-in-Aid for Scientific Research [22300326] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Seoul National University Hospital; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported in part by grants from the Ministry of Health, Labor, and Welfare of Japan; the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and the Japan Society for the Promotion of Science.; We thank Y.-J. Bang and the medical staff at Seoul National University Hospital for their support in the treatment of this patient, as well as Y. Togashi and S. Hatano for technical assistance.	Bossi RT, 2010, BIOCHEMISTRY-US, V49, P6813, DOI 10.1021/bi1005514; Branford S, 2009, BLOOD, V114, P5426, DOI 10.1182/blood-2009-08-215939; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Choi YL, 2007, LEUKEMIA RES, V31, P203, DOI 10.1016/j.leukres.2006.05.006; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Hindie V, 2009, NAT CHEM BIOL, V5, P758, DOI 10.1038/nchembio.208; Horn L, 2009, J CLIN ONCOL, V27, P4232, DOI 10.1200/JCO.2009.23.6661; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Linardou H, 2009, NAT REV CLIN ONCOL, V6, P352, DOI 10.1038/nrclinonc.2009.62; Lu LH, 2009, BIOCHEMISTRY-US, V48, P3600, DOI 10.1021/bi8020923; Mano H, 2008, CANCER SCI, V99, P2349, DOI 10.1111/j.1349-7006.2008.00972.x; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soda M, 2008, P NATL ACAD SCI USA, V105, P19893, DOI 10.1073/pnas.0805381105; Tamborini E, 2004, GASTROENTEROLOGY, V127, P294, DOI 10.1053/j.gastro.2004.02.021	20	873	947	2	99	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 28	2010	363	18					1734	1739		10.1056/NEJMoa1007478	http://dx.doi.org/10.1056/NEJMoa1007478			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671XF	20979473				2022-12-28	WOS:000283546400008
J	van Rijn, RM; van Ochten, J; Luijsterburg, PAJ; van Middelkoop, M; Koes, BW; Bierma-Zeinstra, SMA				van Rijn, Rogier M.; van Ochten, John; Luijsterburg, Pim A. J.; van Middelkoop, Marienke; Koes, Bart W.; Bierma-Zeinstra, Sita M. A.			Effectiveness of additional supervised exercises compared with conventional treatment alone in patients with acute lateral ankle sprains: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REHABILITATION; LIGAMENTS; INTERVENTION; INJURY; TEARS	Objective To summarise the effectiveness of adding supervised exercises to conventional treatment compared with conventional treatment alone in patients with acute lateral ankle sprains. Design Systematic review. Datasources Medline, Embase, Cochrane Central Register of Controlled Trials, Cinahl, and reference screening. Study selection Included studies were randomised controlled trials, quasi-randomised controlled trials, or clinical trials. Patients were adolescents or adults with an acute lateral ankle sprain. The treatment options were conventional treatment alone or conventional treatment combined with supervised exercises. Two reviewers independently assessed the risk of bias, and one reviewer extracted data. Because of clinical heterogeneity we analysed the data using a best evidence synthesis. Follow-up was classified as short term (up to two weeks), intermediate (two weeks to three months), and long term (more than three months). Results 11 studies were included. There was limited to moderate evidence to suggest that the addition of supervised exercises to conventional treatment leads to faster and better recovery and a faster return to sport at short term follow-up than conventional treatment alone. In specific populations (athletes, soldiers, and patients with severe injuries) this evidence was restricted to a faster return to work and sport only. There was no strong evidence of effectiveness for any of the outcome measures. Most of the included studies had a high risk of bias, with few having adequate statistical power to detect clinically relevant differences. Conclusion Additional supervised exercises compared with conventional treatment alone have some benefit for recovery and return to sport in patients with ankle sprain, though the evidence is limited or moderate and many studies are subject to bias.	[van Rijn, Rogier M.; van Ochten, John; Luijsterburg, Pim A. J.; van Middelkoop, Marienke; Koes, Bart W.; Bierma-Zeinstra, Sita M. A.] Erasmus MC, Univ Med Ctr, Dept Gen Practice, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	van Rijn, RM (corresponding author), Erasmus MC, Univ Med Ctr, Dept Gen Practice, POB 2040, NL-3000 CA Rotterdam, Netherlands.	r.vanrijn@erasmusmc.nl	Bierma-Zeinstra, Sita/AAF-2122-2019; Koes, Bart w/K-4614-2016	Koes, Bart w/0000-0002-0450-9969; van Middelkoop, Marienke/0000-0001-6926-0618	Department of General Practice, Erasmus MC University Medical Center	Department of General Practice, Erasmus MC University Medical Center	This study was funded by the Department of General Practice, Erasmus MC University Medical Center.	Bassett SF, 2007, PHYS THER, V87, P1132, DOI 10.2522/ptj.20060260; Bleakley CM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1964; BROOKS SC, 1981, BMJ-BRIT MED J, V282, P606, DOI 10.1136/bmj.282.6264.606; Fong DTP, 2007, SPORTS MED, V37, P73, DOI 10.2165/00007256-200737010-00006; Freeman M A, 1965, J Bone Joint Surg Br, V47, P661; Freeman M A, 1965, J Bone Joint Surg Br, V47, P678; GOUDSWAARD AN, 2000, DUTCH COLL GEN PRACT; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Holme E, 1999, SCAND J MED SCI SPOR, V9, P104; Hultman K, 2010, EUR J PHYSIOTHER, V12, P65, DOI 10.3109/14038190903174262; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P305, DOI 10.2106/00004623-199173020-00021; Karlsson J, 1996, SCAND J MED SCI SPOR, V6, P341; Kerkhoffs GM, 2002, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003762; Kerkhoffs GMMJ, 2002, COCHRANE DB SYST REV, V3; KERKHOFFSGM, 2002, COCHRANE DB SYST REV, V3; Mattacola CG, 2002, J ATHL TRAINING, V37, P413; McKeon PO, 2008, J ATHL TRAINING, V43, P305, DOI 10.4085/1062-6050-43.3.305; Nilsson S, 1983, J Oslo City Hosp, V33, P13; Oostendorp RAB, 1987, GENEESKD SPORT, V20, P45; Pijnenburg ACM, 2000, J BONE JOINT SURG AM, V82A, P761, DOI 10.2106/00004623-200006000-00002; Reinhardt C, 1999, DTSCH Z SPORTMED, V50, P89; Roycroft S, 1983, Physiotherapy, V69, P355; Rozzi SL, 1999, J ORTHOP SPORT PHYS, V29, P478, DOI 10.2519/jospt.1999.29.8.478; SCHMIKLI SL, 2004, NOC NSF ARNHEM; van der Linden M.W., 2004, 2 NATL STUDIE NAAR Z; van Os AG, 2005, J ORTHOP SPORT PHYS, V35, P95, DOI 10.2519/jospt.2005.35.2.95; van Rijn RM, 2008, AM J MED, V121, P324, DOI 10.1016/j.amjmed.2007.11.018; van Rijn RM, 2007, BRIT J GEN PRACT, V57, P793; van Rijn RM, 2009, AUST J PHYSIOTHER, V55, P107, DOI 10.1016/S0004-9514(09)70040-6; van Tulder MW, 2009, SPINE, V34, P1685, DOI 10.1097/BRS.0b013e3181ab6a78; Van Tulder MW, 2000, COCHRANE DB SYST REV, V2; VANDERWEES PJ, 2006, ROYAL DUTCH SOC PHYS; Wester JU, 1996, J ORTHOP SPORT PHYS, V23, P332, DOI 10.2519/jospt.1996.23.5.332	33	34	36	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	2010	341								c5688	10.1136/bmj.c5688	http://dx.doi.org/10.1136/bmj.c5688			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674YE	20978065	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000283786800006
J	Morris, K				Morris, Kelly			Profile Charles Rotimi: engaging Africa in human genomic research	LANCET			English	Biographical-Item												kellyvitalwriter@gmail.com							0	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 23	2010	376	9750					1383	1383		10.1016/S0140-6736(10)61943-5	http://dx.doi.org/10.1016/S0140-6736(10)61943-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672ZO	20971351	Bronze			2022-12-28	WOS:000283627500017
J	Wright, CF; Brice, P; Stewart, A; Burton, H				Wright, Caroline F.; Brice, Philippa; Stewart, Alison; Burton, Hilary			Realising the benefits of genetics for health	LANCET			English	Editorial Material							CONGENITAL-ANOMALIES; GENOME; CHALLENGES; BLOOD		[Wright, Caroline F.; Brice, Philippa; Stewart, Alison; Burton, Hilary] PHG Fdn, Strangeways Res Lab, Cambridge CB1 8RN, England		Wright, CF (corresponding author), PHG Fdn, Strangeways Res Lab, Cambridge CB1 8RN, England.	caroline.wright@phgfoundation.org	Wright, Caroline/N-5355-2015	Wright, Caroline/0000-0003-2958-5076				ALBERG C, 2010, BR J MIDWIFERY, V18, P220; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Burton H, 2010, HEART, V96, P474, DOI 10.1136/hrt.2009.189159; Burton H, 2010, J PUBLIC HEALTH-UK, V32, P259, DOI 10.1093/pubmed/fdp110; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Hadfield SG, 2007, BMJ-BRIT MED J, V335, P683, DOI 10.1136/bmj.39353.483160.BE; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Pollitt RJ, 2009, J INHERIT METAB DIS, V32, P395, DOI 10.1007/s10545-009-9962-0; Sagoo GS, 2009, GENET MED, V11, P139, DOI 10.1097/GIM.0b013e318194ee8f; Srinivasan BS, 2010, REPROD BIOMED ONLINE, V21, P537, DOI 10.1016/j.rbmo.2010.05.012; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; *UK DEP HLTH, 2010, STAT PUBL HLTH ANN R; Wright CF, 2009, HUM REPROD UPDATE, V15, P139, DOI 10.1093/humupd/dmn047	15	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 23	2010	376	9750					1370	1371		10.1016/S0140-6736(10)61310-4	http://dx.doi.org/10.1016/S0140-6736(10)61310-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672ZO	20971348				2022-12-28	WOS:000283627500008
J	Mitrofanov, IG; Sanin, AB; Boynton, WV; Chin, G; Garvin, JB; Golovin, D; Evans, LG; Harshman, K; Kozyrev, AS; Litvak, ML; Malakhov, A; Mazarico, E; McClanahan, T; Milikh, G; Mokrousov, M; Nandikotkur, G; Neumann, GA; Nuzhdin, I; Sagdeev, R; Shevchenko, V; Shvetsov, V; Smith, DE; Starr, R; Tretyakov, VI; Trombka, J; Usikov, D; Varenikov, A; Vostrukhin, A; Zuber, MT				Mitrofanov, I. G.; Sanin, A. B.; Boynton, W. V.; Chin, G.; Garvin, J. B.; Golovin, D.; Evans, L. G.; Harshman, K.; Kozyrev, A. S.; Litvak, M. L.; Malakhov, A.; Mazarico, E.; McClanahan, T.; Milikh, G.; Mokrousov, M.; Nandikotkur, G.; Neumann, G. A.; Nuzhdin, I.; Sagdeev, R.; Shevchenko, V.; Shvetsov, V.; Smith, D. E.; Starr, R.; Tretyakov, V. I.; Trombka, J.; Usikov, D.; Varenikov, A.; Vostrukhin, A.; Zuber, M. T.			Hydrogen Mapping of the Lunar South Pole Using the LRO Neutron Detector Experiment LEND	SCIENCE			English	Article							NEAR-SURFACE; ICE; PROSPECTOR; MERCURY; WATER; MOON; MARS	Hydrogen has been inferred to occur in enhanced concentrations within permanently shadowed regions and, hence, the coldest areas of the lunar poles. The Lunar Crater Observation and Sensing Satellite (LCROSS) mission was designed to detect hydrogen-bearing volatiles directly. Neutron flux measurements of the Moon's south polar region from the Lunar Exploration Neutron Detector (LEND) on the Lunar Reconnaissance Orbiter (LRO) spacecraft were used to select the optimal impact site for LCROSS. LEND data show several regions where the epithermal neutron flux from the surface is suppressed, which is indicative of enhanced hydrogen content. These regions are not spatially coincident with permanently shadowed regions of the Moon. The LCROSS impact site inside the Cabeus crater demonstrates the highest hydrogen concentration in the lunar south polar region, corresponding to an estimated content of 0.5 to 4.0% water ice by weight, depending on the thickness of any overlying dry regolith layer. The distribution of hydrogen across the region is consistent with buried water ice from cometary impacts, hydrogen implantation from the solar wind, and/or other as yet unknown sources.	[Mitrofanov, I. G.; Sanin, A. B.; Golovin, D.; Kozyrev, A. S.; Litvak, M. L.; Malakhov, A.; Mokrousov, M.; Nuzhdin, I.; Tretyakov, V. I.; Varenikov, A.; Vostrukhin, A.] Russian Acad Sci, Inst Space Res, Moscow 117997, Russia; [Boynton, W. V.; Harshman, K.] Univ Arizona, Tucson, AZ USA; [Chin, G.; Garvin, J. B.; Mazarico, E.; McClanahan, T.; Neumann, G. A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Evans, L. G.] Comp Sci Corp, Greenbelt, MD USA; [Milikh, G.; Nandikotkur, G.; Sagdeev, R.; Usikov, D.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Starr, R.] Catholic Univ, Washington, DC USA; [Shevchenko, V.] Moscow MV Lomonosov State Univ, Sternberg Astron Inst, Moscow, Russia; [Shvetsov, V.] Joint Inst Nucl Res, Dubna, Russia; [Smith, D. E.; Zuber, M. T.] MIT, Cambridge, MA 02139 USA; [Trombka, J.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA	Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; University of Arizona; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland College Park; Catholic University of America; Lomonosov Moscow State University; Joint Institute for Nuclear Research - Russia; Massachusetts Institute of Technology (MIT); University System of Maryland; University of Maryland College Park	Mitrofanov, IG (corresponding author), Russian Acad Sci, Inst Space Res, Moscow 117997, Russia.	imitrofa@space.ru	Evans, Larry/F-7462-2012; Chin, Gordon/E-1520-2012; Neumann, Gregory A/I-5591-2013; Golovin, Dmitry/F-8588-2017; Malakhov, Alexey Vladimirovich/F-7953-2017; Litvak, Maxim/C-6453-2017; Mazarico, Erwan/N-6034-2014; Sanin, Anton/T-9393-2017; McClanahan, Timothy/C-8164-2012	Neumann, Gregory A/0000-0003-0644-9944; Malakhov, Alexey Vladimirovich/0000-0003-4292-7077; Mazarico, Erwan/0000-0003-3456-427X; Garvin, James/0000-0003-1606-5645; Mitrofanov, Igor/0000-0001-7204-2101	NASA Exploration System Mission Directorate; Russian Federal Space Agency	NASA Exploration System Mission Directorate; Russian Federal Space Agency	The LRO Mission is supported by the NASA Exploration System Mission Directorate, and the LEND investigation is supported by the Russian Federal Space Agency. We acknowledge the LRO Project team at NASA's Goddard Space Flight Center for their outstanding support of the LEND investigation.	Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Chin G, 2007, SPACE SCI REV, V129, P391, DOI 10.1007/s11214-007-9153-y; Colaprete A, 2010, SCIENCE, V330, P463, DOI 10.1126/science.1186986; Crider DH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002030; Crider DH, 2003, ADV SPACE RES, V31, P2293, DOI 10.1016/S0273-1177(03)00530-1; Elphic RC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029954; Feldman WC, 1999, NUCL INSTRUM METH A, V422, P562, DOI 10.1016/S0168-9002(98)00934-6; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Lawrence DJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002637; Lawrence DJ, 2010, ASTROBIOLOGY, V10, P183, DOI 10.1089/ast.2009.0401; McKay D. S., 1991, LUNAR SOURCEBOOK, P285, DOI DOI 10.1006/ICAR.1999.6165; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; Mitrofanov IG, 2008, ASTROBIOLOGY, V8, P793, DOI 10.1089/ast.2007.0158; Mitrofanov IG, 2010, SPACE SCI REV, V150, P183, DOI 10.1007/s11214-009-9608-4; Paige DA, 2010, SCIENCE, V330, P479, DOI 10.1126/science.1187726; SALVAIL JR, 1994, ICARUS, V111, P441, DOI 10.1006/icar.1994.1155; Spudis P. D., 1998, Solar System Research, V32, P17; Vasavada AR, 1999, ICARUS, V141, P179, DOI 10.1006/icar.1999.6175; Vondrak R, 2010, SPACE SCI REV, V150, P7, DOI 10.1007/s11214-010-9631-5; Zuber MT, 2010, SPACE SCI REV, V150, P63, DOI 10.1007/s11214-009-9511-z	20	197	209	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					483	486		10.1126/science.1185696	http://dx.doi.org/10.1126/science.1185696			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966247				2022-12-28	WOS:000283329100033
J	Tingen, C; Rodriguez, S; Campo-Engelstein, L; Woodruff, TK				Tingen, C.; Rodriguez, S.; Campo-Engelstein, L.; Woodruff, T. K.			Politics and Parthenotes	SCIENCE			English	Editorial Material							PARTHENOGENETIC ACTIVATION; STEM-CELLS; FERTILITY; CHILDREN; OOCYTES; CANCER		[Tingen, C.; Rodriguez, S.; Campo-Engelstein, L.; Woodruff, T. K.] Northwestern Univ, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Rodriguez, S.; Campo-Engelstein, L.] Northwestern Univ, Ctr Bioeth Sci & Soc, Chicago, IL 60611 USA	Northwestern University; Northwestern University	Woodruff, TK (corresponding author), Northwestern Univ, Dept Obstet & Gynecol, Chicago, IL 60611 USA.	tkw@northwestern.edu		Tingen, Candace/0000-0003-3503-019X; Woodruff, Teresa/0000-0002-1197-3399				Aziz D, 2004, J PEDIATR SURG, V39, P750, DOI 10.1016/j.jpedsurg.2004.01.034; Barksdale EM, 2009, CURR OPIN PEDIATR, V21, P344, DOI 10.1097/MOP.0b013e32832b41ee; Chen VW, 2003, CANCER, V97, P2631, DOI 10.1002/cncr.11345; Cibelli JB, 2002, SCIENCE, V295, P819, DOI 10.1126/science.1065637; Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454; Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542; Lampert KP, 2008, SEX DEV, V2, P290, DOI 10.1159/000195678; Lehrman S, 2010, SCI AM, V303, P18, DOI 10.1038/scientificamerican0910-18; Marshall VS, 1998, BIOL REPROD, V59, P1491, DOI 10.1095/biolreprod59.6.1491; Mitalipov SM, 2001, BIOL REPROD, V65, P253, DOI 10.1095/biolreprod65.1.253; *NIH, 1994, REP; NOONAN J, 1996, INTERVENTION REFLECT; Revazova ES, 2007, CLONING STEM CELLS, V9, P432, DOI 10.1089/clo.2007.0033; Talmor-Cohen A, 2002, MOL CELL ENDOCRINOL, V187, P145, DOI 10.1016/S0303-7207(01)00691-8; Woodruff TK, 2010, NAT REV CLIN ONCOL, V7, P466, DOI 10.1038/nrclinonc.2010.81	15	11	13	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					453	453		10.1126/science.1196881	http://dx.doi.org/10.1126/science.1196881			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966235				2022-12-28	WOS:000283329100020
J	Hassan, F; Kamruzzaman, M; Mekalanos, JJ; Faruque, SM				Hassan, Faizule; Kamruzzaman, M.; Mekalanos, John J.; Faruque, Shah M.			Satellite phage TLC phi enables toxigenic conversion by CTX phage through dif site alteration	NATURE			English	Article							VIBRIO-CHOLERAE O139; FILAMENTOUS PHAGE; INTEGRATION; GENOME; TOXIN; FORM; RECOMBINASES; REPLICATION; GENES; XERD	Bacterial chromosomes often carry integrated genetic elements (for example plasmids, transposons, prophages and islands) whose precise function and contribution to the evolutionary fitness of the host bacterium are unknown. The CTX phi prophage, which encodes cholera toxin in Vibrio cholerae(1), is known to be adjacent to a chromosomally integrated element of unknown function termed the toxin-linked cryptic (TLC)(2). Here we report the characterization of a TLC-related element that corresponds to the genome of a satellite filamentous phage (TLC-Kn phi 1), which uses the morphogenesis genes of another filamentous phage (fs2 phi) to form infectious TLC-Kn phi 1 phage particles. The TLC-Kn phi 1 phage genome carries a sequence similar to the dif recombination sequence, which functions in chromosome dimer resolution using XerC and XerD recombinases(3). The dif sequence is also exploited by lysogenic filamentous phages (for example CTX phi) for chromosomal integration of their genomes. Bacterial cells defective in the dimer resolution often show an aberrant filamentous cell morphology(3,4). We found that acquisition and chromosomal integration of the TLC-Kn phi 1 genome restored a perfect dif site and normal morphology to V. cholerae wild-type and mutant strains with dif(-) filamentation phenotypes. Furthermore, lysogeny of a dif(-) non-toxigenic V. cholerae with TLC-Kn phi 1 promoted its subsequent toxigenic conversion through integration of CTX phi into the restored dif site. These results reveal a remarkable level of cooperative interactions between multiple filamentous phages in the emergence of the bacterial pathogen that causes cholera.	[Hassan, Faizule; Kamruzzaman, M.; Faruque, Shah M.] Int Ctr Diarrhoeal Dis Res, Mol Genet Lab, Dhaka 1212, Bangladesh; [Mekalanos, John J.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	International Centre for Diarrhoeal Disease Research (ICDDR); Harvard University; Harvard Medical School	Faruque, SM (corresponding author), Int Ctr Diarrhoeal Dis Res, Mol Genet Lab, Dhaka 1212, Bangladesh.	faruque@icddrb.org	Kamruzzaman, Muhammad/S-2756-2019	Faruque, Shah/0000-0002-7006-622X; Kamruzzaman, Muhammad/0000-0003-2005-9846	National Institutes of Health under Harvard Medical School and the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) [RO1-GM068851, RO1-AI070963]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068851] Funding Source: NIH RePORTER	National Institutes of Health under Harvard Medical School and the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. M. Zaved Waise and S. M. Nashir Udden for technical assistance. This research was funded in part by the National Institutes of Health (grants RO1-GM068851 and RO1-AI070963) under different sub-agreements between the Harvard Medical School and the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B). The ICDDR,B is supported by countries and agencies that share its concern for the health problems of developing countries.	BLAKELY G, 1993, CELL, V75, P351, DOI 10.1016/0092-8674(93)80076-Q; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Das B, 2010, P NATL ACAD SCI USA, V107, P4377, DOI 10.1073/pnas.0910212107; Davis BM, 2000, P NATL ACAD SCI USA, V97, P8572, DOI 10.1073/pnas.140109997; Davis BM, 2002, EMBO J, V21, P4240, DOI 10.1093/emboj/cdf427; Ehara M, 1997, FEMS MICROBIOL LETT, V154, P293, DOI 10.1016/S0378-1097(97)00345-5; Faruque SA, 2002, INFECT IMMUN, V70, P163, DOI 10.1128/IAI.70.1.163-170.2002; Faruque SM, 2003, P NATL ACAD SCI USA, V100, P1280, DOI 10.1073/pnas.0237385100; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Faruque SM, 2001, INFECT IMMUN, V69, P6084, DOI 10.1128/IAI.69.10.6084-6090.2001; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Huber KE, 2002, NATURE, V417, P656, DOI 10.1038/nature00782; Iida T, 2002, J BACTERIOL, V184, P4933, DOI 10.1128/JB.184.17.4933-4935.2002; Ikema M, 1998, MICROBIOL-SGM, V144, P1901, DOI 10.1099/00221287-144-7-1901; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kimsey HH, 2004, J BIOL CHEM, V279, P2640, DOI 10.1074/jbc.M311109200; McLeod SM, 2004, MOL MICROBIOL, V54, P935, DOI 10.1111/j.1365-2958.2004.04309.x; Rubin EJ, 1998, MOL MICROBIOL, V28, P1247, DOI 10.1046/j.1365-2958.1998.00889.x; Val ME, 2005, MOL CELL, V19, P559, DOI 10.1016/j.molcel.2005.07.002; Waldor MK, 1997, MOL MICROBIOL, V24, P917, DOI 10.1046/j.1365-2958.1997.3911758.x; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910	21	71	76	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					982	985		10.1038/nature09469	http://dx.doi.org/10.1038/nature09469			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20944629	Green Accepted, Bronze			2022-12-28	WOS:000283254700042
J	Ashton-Beaucage, D; Udell, CM; Lavoie, H; Baril, C; Lefrancois, M; Chagnon, P; Gendron, P; Caron-Lizotte, O; Bonneil, E; Thibault, P; Therrien, M				Ashton-Beaucage, Dariel; Udell, Christian M.; Lavoie, Hugo; Baril, Caroline; Lefrancois, Martin; Chagnon, Pierre; Gendron, Patrick; Caron-Lizotte, Olivier; Bonneil, Eric; Thibault, Pierre; Therrien, Marc			The Exon Junction Complex Controls the Splicing of mapk and Other Long Intron-Containing Transcripts in Drosophila	CELL			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; OSKAR MESSENGER-RNA; HUMAN RNPS1; MAMMALIAN-CELLS; MAGO NASHI; RAS; KINASE; GENE; COACTIVATOR; MUTATIONS	Signaling pathways are controlled by a vast array of posttranslational mechanisms. By contrast, little is known regarding the mechanisms that regulate the expression of their core components. We conducted an RNAi screen in Drosophila for factors modulating RAS/MAPK signaling and identified the Exon Junction Complex (EJC) as a key element of this pathway. The EJC binds the exon-exon junctions of mRNAs and thus far, has been linked exclusively to post-splicing events. Here, we report that the EJC is required for proper splicing of mapk transcripts by a mechanism that apparently controls exon definition. Moreover, whole transcriptome and RT-PCR analyses of EJC-depleted cells revealed that the splicing of long intron-containing genes, which includes mapk, is sensitive to EJC activity. These results identify a role for the EJC in the splicing of a subset of transcripts and suggest that RAS/MAPK signaling depends on the regulation of MAPK levels by the EJC.	[Ashton-Beaucage, Dariel; Udell, Christian M.; Lavoie, Hugo; Baril, Caroline; Lefrancois, Martin; Chagnon, Pierre; Gendron, Patrick; Caron-Lizotte, Olivier; Bonneil, Eric; Thibault, Pierre; Therrien, Marc] Univ Montreal, Inst Res Immunol & Canc, Lab Intracellular Signaling, Montreal, PQ H3C 3J7, Canada; [Therrien, Marc] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada; [Thibault, Pierre] Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Therrien, M (corresponding author), Univ Montreal, Inst Res Immunol & Canc, Lab Intracellular Signaling, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	marc.therrien@umontreal.ca		Thibault, Pierre/0000-0001-5993-0331; Gendron, Patrick/0000-0001-9829-2600; Ashton-Beaucage, Dariel/0000-0001-6987-5487; Lavoie, Hugo/0000-0003-0560-2409	Canadian Cancer Society; Canadian Institutes for Health Research	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	We are grateful to R. Boswell, E. Perkins, N. Perrimon, and D. St-Johnston, as well as the Bloomington and VDRC stock centers for fly stocks and cell lines. We thank Christian Charbonneau and Monica Nelea for assistance with microscopy; and Philippe Roux, Pierre Zindy, and Katherine Borden for their help with the polysome fractionation experiments. We also extend our gratitude to the IRIC HTS platform for use of the automated fluorescence microscope; to Michael Kubal (ABI) for help with analysis of the RNA-Seq data; and to Raphaelle Lambert for assistance with RT-qPCR and sequencing. D. A. B. is a recipient of Frederick Banting and Charles Best Canada Doctoral Scholarship. HL is a recipient of a Cancer Research Society postdoctoral fellowship. P. T. is recipient of a Tier I Canada Research Chair in Proteomics and Bioanalytical Spectrometry. M. T. is recipient of a Tier II Canada Research Chair in Intracellular Signaling. This work was supported by the Canadian Cancer Society and by the Canadian Institutes for Health Research.	BAKER NE, 1989, NATURE, V340, P150, DOI 10.1038/340150a0; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Berghella L, 1996, GENETICS, V144, P117; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; BOSWELL RE, 1991, DEVELOPMENT, V113, P373; Budagyan B, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P515; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Cheng CH, 2006, GENE DEV, V20, P1715, DOI 10.1101/gad.1430906; Degot S, 2004, J BIOL CHEM, V279, P33702, DOI 10.1074/jbc.M402754200; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Douziech M, 2003, EMBO J, V22, P5068, DOI 10.1093/emboj/cdg506; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Eldridge AG, 1999, P NATL ACAD SCI USA, V96, P6125, DOI 10.1073/pnas.96.11.6125; FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0; Fox-Walsh KL, 2005, P NATL ACAD SCI USA, V102, P16176, DOI 10.1073/pnas.0508489102; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; Gatfield D, 2002, J CELL BIOL, V159, P579, DOI 10.1083/jcb.200207128; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Gehring NH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000120; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Herold N, 2009, MOL CELL BIOL, V29, P281, DOI 10.1128/MCB.01415-08; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Karim FD, 1996, GENETICS, V143, P315; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO REP, V2, P1119, DOI 10.1093/embo-reports/kve245; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lee MH, 2007, PLOS GENET, V3, P2540, DOI 10.1371/journal.pgen.0030233; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Longman D, 2007, GENE DEV, V21, P1075, DOI 10.1101/gad.417707; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Macchi P, 2003, J NEUROSCI, V23, P5778; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Mayeda A, 1999, EMBO J, V18, P4560, DOI 10.1093/emboj/18.16.4560; McCracken S, 2003, J BIOL CHEM, V278, P44153, DOI 10.1074/jbc.M306856200; McCracken S, 2002, MOL CELL BIOL, V22, P148, DOI 10.1128/MCB.22.1.148-160.2002; McGuire AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r50; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; MELNICK MB, 1993, DEVELOPMENT, V118, P127; Merz C, 2007, RNA, V13, P116, DOI 10.1261/rna.336807; Mohr SE, 2001, GENE DEV, V15, P2886; MOUNT SM, 1992, NUCLEIC ACIDS RES, V20, P4255, DOI 10.1093/nar/20.16.4255; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Nykamp K, 2008, RNA, V14, P1378, DOI 10.1261/rna.1066008; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; PERKINS LA, 1992, CELL, V70, P225, DOI 10.1016/0092-8674(92)90098-W; Perkins LA, 1996, DEV BIOL, V180, P63, DOI 10.1006/dbio.1996.0285; ROY M, 2008, GENOMES RNA, V14, P1; Sakashita E, 2004, MOL CELL BIOL, V24, P1174, DOI 10.1128/MCB.24.3.1174-1187.2004; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Sterner DA, 1996, P NATL ACAD SCI USA, V93, P15081, DOI 10.1073/pnas.93.26.15081; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Therrien M, 2000, GENETICS, V156, P1231; Trembley JH, 2005, MOL CELL BIOL, V25, P1446, DOI 10.1128/MCB.25.4.1446-1457.2005; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; WASSARMAN DA, 1995, CURR OPIN GENET DEV, V5, P44, DOI 10.1016/S0959-437X(95)90052-7; WEN J, 2010, EMBO J; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; XU T, 1993, DEVELOPMENT, V117, P1223; Yu Y, 2008, CELL, V135, P1224, DOI 10.1016/j.cell.2008.10.046; Zebisch A, 2007, CURR MED CHEM, V14, P601, DOI 10.2174/092986707780059670	72	92	96	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					251	262		10.1016/j.cell.2010.09.014	http://dx.doi.org/10.1016/j.cell.2010.09.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946983	Bronze			2022-12-28	WOS:000283052200014
J	Bill, A; Schmitz, A; Albertoni, B; Song, JN; Heukamp, LC; Walrafen, D; Thorwirth, F; Verveer, PJ; Zimmer, S; Meffert, L; Schreiber, A; Chatterjee, S; Thomas, RK; Ullrich, RT; Lang, T; Famulok, M				Bill, Anke; Schmitz, Anton; Albertoni, Barbara; Song, Jin-Na; Heukamp, Lukas C.; Walrafen, David; Thorwirth, Franziska; Verveer, Peter J.; Zimmer, Sebastian; Meffert, Lisa; Schreiber, Arne; Chatterjee, Sampurna; Thomas, Roman K.; Ullrich, Roland T.; Lang, Thorsten; Famulok, Michael			RETRACTED: Cytohesins Are Cytoplasmic ErbB Receptor Activators (Retracted article. See vol. 165, pg. 1293, 2016)	CELL			English	Article; Retracted Publication							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; EGF RECEPTOR; KINASE DOMAIN; CLINICAL-RESPONSE; MUTATIONS; DIMERIZATION; INHIBITION; MECHANISM; FAMILY	Signaling by ErbB receptors requires the activation of their cytoplasmic kinase domains, which is initiated by ligand binding to the receptor ectodomains. Cytoplasmic factors contributing to the activation are unknown. Here we identify members of the cytohesin protein family as such factors. Cytohesin inhibition decreased ErbB receptor autophosphorylation and signaling, whereas cytohesin overexpression stimulated receptor activation. Monitoring epidermal growth factor receptor (EGFR) conformation by anisotropy microscopy together with cell-free reconstitution of cytohesin-dependent receptor autophosphorylation indicate that cytohesins facilitate conformational rearrangements in the intracellular domains of dimerized receptors. Consistent with cytohesins playing a prominent role in ErbB receptor signaling, we found that cytohesin overexpression correlated with EGF signaling pathway activation in human lung adenocarcinomas. Chemical inhibition of cytohesins resulted in reduced proliferation of EGFR-dependent lung cancer cells in vitro and in vivo. Our results establish cytohesins as cytoplasmic conformational activators of ErbB receptors that are of pathophysiological relevance.	[Bill, Anke; Schmitz, Anton; Albertoni, Barbara; Song, Jin-Na; Famulok, Michael] Univ Bonn, Program Unit Chem Biol & Med Chem, LIMES Inst, Biol Chem Lab, D-53121 Bonn, Germany; [Heukamp, Lukas C.; Zimmer, Sebastian; Meffert, Lisa] Univ Bonn, Inst Pathol, Univ Klinikum, D-53123 Bonn, Germany; [Walrafen, David; Schreiber, Arne; Lang, Thorsten] Univ Bonn, Program Unit Membrane Biol & Lipid Biochem, LIMES Inst, Lab Membrane Biochem, D-53121 Bonn, Germany; [Thorwirth, Franziska; Verveer, Peter J.] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44227 Dortmund, Germany; [Chatterjee, Sampurna; Thomas, Roman K.; Ullrich, Roland T.] Univ Cologne, Max Planck Inst Neurol Res, Klaus Joachim Zulich Labs, Max Planck Soc, D-50931 Cologne, Germany; [Chatterjee, Sampurna; Thomas, Roman K.; Ullrich, Roland T.] Univ Cologne, Fac Med, D-50931 Cologne, Germany; [Thomas, Roman K.] Max Planck Gesell, Chem Genom Ctr, D-44227 Dortmund, Germany; [Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol, D-50937 Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Dept Internal Med 1, D-50937 Cologne, Germany	University of Bonn; University of Bonn; University of Bonn; Max Planck Society; Max Planck Society; University of Cologne; University of Cologne; Max Planck Society; University of Cologne; University of Cologne	Famulok, M (corresponding author), Univ Bonn, Program Unit Chem Biol & Med Chem, LIMES Inst, Biol Chem Lab, Gerhard Domagk Str 1, D-53121 Bonn, Germany.	m.famulok@uni-bonn.de	Heukamp, Lukas C/A-8338-2013; Chatterjee, SAMPURNA/AAA-8398-2019; Heukamp, Lukas/G-9967-2012	Chatterjee, SAMPURNA/0000-0003-0850-0328; Heukamp, Lukas/0000-0002-3388-3482; Bill, Anke/0000-0003-1244-7574	Deutsche Krebshilfe; BMBF; DFG [SFB 645, SFB 704, SFB 832, GRK804]; Fritz-Thyssen-Stiftung; Fonds der Chemischen Industrie; Roche Research Foundation	Deutsche Krebshilfe(Deutsche Krebshilfe); BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Fritz-Thyssen-Stiftung; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Roche Research Foundation	We thank S. Rose-John for plasmid pMWOS-L-gp130, K. Nishio for PC9 cells, the Department of Nanobiophotonics, MPI Gottingen for Atto647N coupled secondary antibodies and access to STED microscopy, Silvio Rizzoli for providing MatLab routines for image analysis, Philippe I. H. Bastiaens for advice on the anisotropy measurements, V. Fieberg and Y. Aschenbach-Paul for technical assistance, J. Hannam, A. M. Hayallah, and X.-H. Bi for the synthesis of SecinH3 and XH1009, B. Neumaier for the synthesis of [<SUP>18</SUP>F]FLT, and the members of the Famulok laboratory for helpful discussions. This work was supported by grants from the DFG, the SFBs 645, 704, and 832, and the GRK804. The CIO Biobank is supported by the Deutsche Krebshilfe. A. B. and B. A. thank the Fonds der Chemischen Industrie and the Roche Research Foundation for scholarships. R. K. T. is supported by the Deutsche Krebshilfe, Fritz-Thyssen-Stiftung, and the BMBF NGFNplus-program. A. S. and M. F. are co-owners of a patent application for SecinH3.	Abulrob A, 2010, J BIOL CHEM, V285, P3145, DOI 10.1074/jbc.M109.073338; Anastasi S, 2007, ONCOGENE, V26, P7833, DOI 10.1038/sj.onc.1210590; Bergamin E, 2010, MOL CELL, V39, P100, DOI 10.1016/j.molcel.2010.06.007; Bi XH, 2008, ANGEW CHEM INT EDIT, V47, P9565, DOI 10.1002/anie.200803962; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bose R, 2009, EXP CELL RES, V315, P649, DOI 10.1016/j.yexcr.2008.07.031; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Brew C, 2009, ASSESS EVAL HIGH EDU, V34, P641, DOI 10.1080/02602930802468567; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Cui TX, 2002, MOL ENDOCRINOL, V16, P2113, DOI 10.1210/me.2001-0284; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Friedrichs N, 2007, HISTOPATHOLOGY, V51, P814, DOI 10.1111/j.1365-2559.2007.02887.x; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Heukamp LC, 2006, HISTOPATHOLOGY, V49, P242, DOI 10.1111/j.1365-2559.2006.02489.x; Inoue A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000113; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kolanus W, 2007, IMMUNOL REV, V218, P102, DOI 10.1111/j.1600-065X.2007.00542.x; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mayer G, 2001, P NATL ACAD SCI USA, V98, P4961, DOI 10.1073/pnas.091100698; Mi LZ, 2008, BIOCHEMISTRY-US, V47, P10314, DOI 10.1021/bi801006s; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Nagy P, 1999, J CELL SCI, V112, P1733; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Qiu C, 2009, BIOCHEMISTRY-US, V48, P6624, DOI 10.1021/bi900755n; Reschke M, 2010, HEPATOLOGY, V51, P1383, DOI 10.1002/hep.23428; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sharma SV, 2009, EXP CELL RES, V315, P557, DOI 10.1016/j.yexcr.2008.07.026; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Squire A, 2004, J STRUCT BIOL, V147, P62, DOI 10.1016/j.jsb.2003.10.013; Stuhlmann-Laeisz C, 2006, MOL BIOL CELL, V17, P2986, DOI 10.1091/mbc.E05-12-1129; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhu HJ, 2003, GROWTH FACTORS, V21, P15, DOI 10.1080/0897719031000096424; Zimmer S, 2009, J CANCER RES CLIN, V135, P723, DOI 10.1007/s00432-008-0509-9	53	57	58	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					201	211		10.1016/j.cell.2010.09.011	http://dx.doi.org/10.1016/j.cell.2010.09.011			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946980	Bronze			2022-12-28	WOS:000283052200010
J	Smithies, O				Smithies, Oliver			Science brick by brick	NATURE			English	Editorial Material									[Smithies, Oliver] Univ N Carolina, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Smithies, O (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.								0	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					S6	S6		10.1038/467S6a	http://dx.doi.org/10.1038/467S6a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944621	Bronze			2022-12-28	WOS:000282898700005
J	Freemantle, N				Freemantle, Nick			Commentary: journals must facilitate the dissemination and scrutiny of clinical research	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Freemantle, Nick] Univ Birmingham Edgbaston, Sch Hlth & Populat Sci, Birmingham B15 2SP, W Midlands, England	University of Birmingham	Freemantle, N (corresponding author), Univ Birmingham Edgbaston, Sch Hlth & Populat Sci, Birmingham B15 2SP, W Midlands, England.	N.Freemantle@bham.ac.uk		Freemantle, Nick/0000-0001-5807-5740				Freemantle N, 2004, FAM PRACT, V21, P335, DOI 10.1093/fampra/cmh425; Freemantle N, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4812; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; *JAMA, 2010, JAMA AUTH RESP FIN D; *NICE, 2010, NICE CLIN GUID, V108; TEMPLE R, 1980, NEW ENGL J MED, V303	6	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 12	2010	341								c5397	10.1136/bmj.c5397	http://dx.doi.org/10.1136/bmj.c5397			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663KN	20940214				2022-12-28	WOS:000282886900008
J	England, PC; Katz, RF				England, Philip C.; Katz, Richard F.			Melting above the anhydrous solidus controls the location of volcanic arcs	NATURE			English	Article							MANTLE; RATES; WATER; EXTRACTION; DEPTHS; BASALT; MODELS; CRUST; SLABS; HOT	Segregation of magma from the mantle in subduction zones is one of the principal mechanisms for chemical differentiation of the Earth. Fundamental aspects of this system, in particular the processes by which melt forms and travels to the Earth's surface, remain obscure. Systematics in the location of volcanic arcs, the surface expression of this melting, are widely considered to be a clue to processes taking place at depth, but many mutually incompatible interpretations of this clue exist (for example, see refs 1-6). We discriminate between those interpretations by the use of a simple scaling argument derived from a realistic mathematical model of heat transfer in subduction zones. The locations of the arcs cannot be explained by the release of fluids in reactions taking place near the top of the slab. Instead, the sharpness of the volcanic fronts, together with the systematics of their locations, requires that arcs must be located above the place where the boundary defined by the anhydrous solidus makes its closest approach to the trench. We show that heat carried by magma rising from this region is sufficient to modify the thermal structure of the wedge and determine the pathway through which both wet and dry melts reach the surface.	[England, Philip C.; Katz, Richard F.] Dept Earth Sci, Oxford OX1 3AN, England		England, PC (corresponding author), Dept Earth Sci, S Parks Rd, Oxford OX1 3AN, England.	philip@earth.ox.ac.uk	England, Philip C/A-1920-2010; Katz, Richard/D-3364-2009	England, Philip C/0000-0002-9024-8901; Katz, Richard/0000-0001-8746-5430	NERC [NE/H00081X/1] Funding Source: UKRI; Natural Environment Research Council [NER/A/S/2001/01067, NE/H00081X/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		BAKER MB, 1994, CONTRIB MINERAL PETR, V118, P111, DOI 10.1007/BF01052863; Balay S., 2001, PORTABLE EXTENSIBLE; Cagnioncle AM, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2007JB004934; Cameron BI, 2003, J VOLCANOL GEOTH RES, V119, P21, DOI 10.1016/S0377-0273(02)00304-9; Conder JA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015390; Conder JA, 2005, PHYS EARTH PLANET IN, V149, P155, DOI 10.1016/j.pepi.2004.08.018; CRISP JA, 1984, J VOLCANOL GEOTH RES, V20, P177, DOI 10.1016/0377-0273(84)90039-8; Dimalanta C, 2002, EARTH PLANET SC LETT, V202, P105, DOI 10.1016/S0012-821X(02)00761-6; Elkins-Tanton LT, 2001, GEOLOGY, V29, P631, DOI 10.1130/0091-7613(2001)029<0631:HSMMUT>2.0.CO;2; Engdahl ER, 1998, B SEISMOL SOC AM, V88, P722; England P, 2004, GEOPHYS J INT, V159, P1138, DOI 10.1111/j.1365-246X.2004.02419.x; England P, 2004, GEOPHYS J INT, V156, P377, DOI 10.1111/j.1365-246X.2003.02132.x; ENGLAND PC, NATURE IN PRESS, DOI DOI 10.1038/NATURE09154; Gill J., 1981, OROGENIC ANDESITES P; Grove TL, 2009, NATURE, V459, P694, DOI 10.1038/nature08044; Hirschmann MM, 1999, J PETROL, V40, P831, DOI 10.1093/petrology/40.5.831; Hirth G., 2003, INSIDE SUBDUCTION FA, V138, P83, DOI [10.1029/138GM06, DOI 10.1029/138GM06]; KARATO S, 1993, SCIENCE, V260, P771, DOI 10.1126/science.260.5109.771; Katz RF, 2007, PHYS EARTH PLANET IN, V163, P52, DOI 10.1016/j.pepi.2007.04.016; Katz RF, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000433; Katz RF, 2008, J PETROL, V49, P2099, DOI 10.1093/petrology/egn058; Kelley KA, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003732; KNEPLEY M, 2006, LECT NOTES COMPUTATI, V51, P413; Kushiro I., 1987, MAGMATIC PROCESSES P, P165; REYMER A, 1984, TECTONICS, V3, P63, DOI 10.1029/TC003i001p00063; Schmidt MW, 1998, EARTH PLANET SC LETT, V163, P361, DOI 10.1016/S0012-821X(98)00142-3; Sisson TW, 1998, NATURE, V391, P883, DOI 10.1038/36087; SPARKS DW, 1991, EARTH PLANET SC LETT, V105, P368, DOI 10.1016/0012-821X(91)90178-K; SPIEGELMAN M, 1993, PHILOS T ROY SOC A, V342, P23, DOI 10.1098/rsta.1993.0002; Syracuse EM, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001045; Tatsumi Y, 2009, J PETROL, V50, P1575, DOI 10.1093/petrology/egp044; Tatsumi Y., 2005, GSA TODAY, V15, P4, DOI [DOI 10.1130/1052-5173(2005)015[4:TSFHI0]2.0.C0;2, DOI 10.1130/1052-5173(2005)015[4:TSFHIO]2.0.CO;2]; Tatsumi Y., 1995, SUBDUCTION ZONE MAGM; Tichelaar BW, 1993, J GEOPHYS RES, V98, P2107, DOI [10.1029/92JB02045, DOI 10.1029/92JB02045]; TOVISH A, 1978, GEOPHYS RES LETT, V5, P329, DOI 10.1029/GL005i005p00329; ULMER P, 1995, SCIENCE, V268, P858, DOI 10.1126/science.268.5212.858; van Keken PE, 2008, PHYS EARTH PLANET IN, V171, P187, DOI 10.1016/j.pepi.2008.04.015; White SM, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001002	38	124	128	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2010	467	7316					700	U84		10.1038/nature09417	http://dx.doi.org/10.1038/nature09417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20930842	Green Submitted			2022-12-28	WOS:000282572500036
J	Massie, BM; O'Connor, CM; Metra, M; Ponikowski, P; Teerlink, JR; Cotter, G; Weatherley, BD; Cleland, JGF; Givertz, MM; Voors, AA; DeLucca, P; Mansoor, GA; Salerno, CM; Bloomfield, DM; Dittrich, HC				Massie, Barry M.; O'Connor, Christopher M.; Metra, Marco; Ponikowski, Piotr; Teerlink, John R.; Cotter, Gad; Weatherley, Beth Davison; Cleland, John G. F.; Givertz, Michael M.; Voors, Adriaan A.; DeLucca, Paul; Mansoor, George A.; Salerno, Christina M.; Bloomfield, Daniel M.; Dittrich, Howard C.		PROTECT Investigators Comm	Rolofylline, an Adenosine A(sub 1)-Receptor Antagonist, in Acute Heart Failure.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WORSENING RENAL-FUNCTION; A(1) RECEPTOR ANTAGONIST; RISK STRATIFICATION; OUTCOMES; IMPAIRMENT; KW-3902; IMPACT	Background: Worsening renal function, which is associated with adverse outcomes, often develops in patients with acute heart failure. Experimental and clinical studies suggest that counterregulatory responses mediated by adenosine may be involved. We tested the hypothesis that the use of rolofylline, an adenosine A(sub 1)-receptor antagonist, would improve dyspnea, reduce the risk of worsening renal function, and lead to a more favorable clinical course in patients with acute heart failure. Methods: We conducted a multicenter, double-blind, placebo-controlled trial involving patients hospitalized for acute heart failure with impaired renal function. Within 24 hours after presentation, 2033 patients were randomly assigned, in a 2:1 ratio, to receive daily intravenous rolofylline (30 mg) or placebo for up to 3 days. The primary end point was treatment success, treatment failure, or no change in the patient's clinical condition; this end point was defined according to survival, heart-failure status, and changes in renal function. Secondary end points were the post-treatment development of persistent renal impairment and the 60-day rate of death or readmission for cardiovascular or renal causes. Results: Rolofylline, as compared with placebo, did not provide a benefit with respect to the primary end point (odds ratio, 0.92; 95% confidence interval, 0.78 to 1.09; P=0.35). Persistent renal impairment developed in 15.0% of patients in the rolofylline group and in 13.7% of patients in the placebo group (P=0.44). By 60 days, death or readmission for cardiovascular or renal causes had occurred in similar proportions of patients assigned to rolofylline and placebo (30.7% and 31.9%, respectively; P=0.86). Adverse-event rates were similar overall; however, only patients in the rolofylline group had seizures, a known potential adverse effect of A(sub 1)-receptor antagonists. Conclusions: Rolofylline did not have a favorable effect with respect to the primary clinical composite end point, nor did it improve renal function or 60-day outcomes. It does not show promise in the treatment of acute heart failure with renal dysfunction. (Funded by NovaCardia, a subsidiary of Merck; ClinicalTrials.gov numbers, NCT00328692 and NCT00354458.) N Engl J Med 2010;363:1419-28.	[Massie, Barry M.; Teerlink, John R.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Massie, Barry M.; Teerlink, John R.] San Francisco VA Med Ctr, San Francisco, CA USA; [O'Connor, Christopher M.] Duke Univ, Med Ctr, Durham, NC USA; [Cotter, Gad; Weatherley, Beth Davison] Momentum Res, Durham, NC USA; [Metra, Marco] Univ Brescia, Brescia, Italy; [Ponikowski, Piotr] Med Univ, Clin Mil Hosp, Wroclaw, Poland; [Cleland, John G. F.] Univ Hull, Kingston Upon Hull, Yorks, England; [Givertz, Michael M.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Voors, Adriaan A.] Univ Groningen, Groningen, Netherlands; [DeLucca, Paul; Salerno, Christina M.] Merck Res Labs, N Wales, PA USA; [Mansoor, George A.; Bloomfield, Daniel M.] Merck Res Labs, Rahway, NJ USA; [Dittrich, Howard C.] NovaCardia, San Diego, CA USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Duke University; University of Brescia; Wroclaw Medical University; University of Hull; Harvard University; Brigham & Women's Hospital; University of Groningen; Merck & Company; Merck & Company	Massie, BM (corresponding author), San Francisco VA Med Ctr 111C, Div Cardiol, 4150 Clement St, San Francisco, CA 94121 USA.	barry.massie@va.gov	Cleland, John G./AAZ-4185-2020; Voors, Adriaan/ABE-6784-2020; Vasilieva, Elena/B-2137-2016; Böhm, Michael/C-3638-2011; Metra, marco/E-7101-2010; Zateyshchikov, Dmitry A/D-6575-2012; Georgescu, Catalina Arsenescu/R-5709-2017; Teerlink, John R/D-2986-2012; Ponikowski, Piotr/O-6454-2015; Boldueva, Svetlana/AAH-3862-2019; Zadionchenko, Vladimir/A-7445-2016; Mareev, Vyacheslav Yurievich/Q-1375-2017	Cleland, John G./0000-0002-1471-7016; Vasilieva, Elena/0000-0003-4111-0874; Zateyshchikov, Dmitry A/0000-0001-7065-2045; Georgescu, Catalina Arsenescu/0000-0001-5142-7598; Ponikowski, Piotr/0000-0002-3391-7064; Boldueva, Svetlana/0000-0002-1898-084X; Zadionchenko, Vladimir/0000-0003-2377-5266; Isnard, Richard/0000-0002-3439-8104; Cotter, Gad/0000-0002-9613-3339; Mareev, Vyacheslav Yurievich/0000-0002-7285-2048; Metra, Marco/0000-0001-6691-8568; Bozkurt, Biykem/0000-0002-6362-0253; Zile, Michael/0000-0001-7076-221X; GALINIER, Michel/0000-0003-1735-3390	NovaCardia, a subsidiary of Merck	NovaCardia, a subsidiary of Merck	Supported by NovaCardia, a subsidiary of Merck.	Cleland JGF, 2003, EUR HEART J, V24, P442, DOI 10.1016/S0195-668X(02)00823-0; Cotter G, 2008, J CARD FAIL, V14, P631, DOI 10.1016/j.cardfail.2008.08.010; Cowie MR, 2006, EUR HEART J, V27, P1216, DOI 10.1093/eurheartj/ehi859; Dittrich HC, 2007, J CARD FAIL, V13, P609, DOI 10.1016/j.cardfail.2007.08.006; DRAGUNOW M, 1990, PHARMACOL BIOCHEM BE, V36, P751, DOI 10.1016/0091-3057(90)90072-P; DUNWIDDIE TV, 1982, J PHARMACOL EXP THER, V220, P70; Felker GM, 2004, J CARD FAIL, V10, P460, DOI 10.1016/j.cardfail.2004.02.011; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Forman DE, 2004, J AM COLL CARDIOL, V43, P61, DOI 10.1016/j.jacc.2003.07.031; Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P557, DOI 10.1016/j.jacc.2008.10.041; Givertz MM, 2007, J AM COLL CARDIOL, V50, P1551, DOI 10.1016/j.jacc.2007.07.019; Gottlieb SS, 2002, J CARD FAIL, V8, P136, DOI 10.1054/jcaf.2002.125289; Gottlieb SS, 2002, CIRCULATION, V105, P1348, DOI 10.1161/hc1102.105264; Gottlieb SS, 2001, DRUGS, V61, P1387, DOI 10.2165/00003495-200161100-00002; Greenberg B, 2007, J AM COLL CARDIOL, V50, P600, DOI 10.1016/j.jacc.2007.03.059; Hillege HL, 2006, CIRCULATION, V113, P671, DOI 10.1161/CIRCULATIONAHA.105.580506; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Lloyd-Jones, 2009, CIRCULATION, V119, pE182, DOI 10.1161/CIRCULATIONAHA.108.191898; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; McMurray JJV, 2007, JAMA-J AM MED ASSOC, V298, P2009, DOI 10.1001/jama.298.17.2009; Mitrovic V, 2009, CIRC-HEART FAIL, V2, P523, DOI 10.1161/CIRCHEARTFAILURE.108.798389; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Smith GL, 2006, J AM COLL CARDIOL, V47, P1987, DOI 10.1016/j.jacc.2005.11.084; Teerlink JR, 2003, AM HEART J, V145, pS26, DOI 10.1067/mhj.2003.151; Vallon V, 2008, EUR J HEART FAIL, V10, P176, DOI 10.1016/j.ejheart.2008.01.010; Vallon V, 2006, PHYSIOL REV, V86, P901, DOI 10.1152/physrev.00031.2005; VANELTEREN P, 1960, B INT STATIST INST, V37, P351; Weatherley BD, 2010, J CARD FAIL, V16, P25, DOI 10.1016/j.cardfail.2009.10.025	28	374	391	2	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2010	363	15					1419	1428		10.1056/NEJMoa0912613	http://dx.doi.org/10.1056/NEJMoa0912613			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	659NV	20925544	Green Published, Green Accepted			2022-12-28	WOS:000282575100007
J	Hawkes, N				Hawkes, Nigel			Climate Change Giving it 10%	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						VIDEO BRIGHTON HOVE	1	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 6	2010	341								c5448	10.1136/bmj.c5448	http://dx.doi.org/10.1136/bmj.c5448			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663JE	20926481				2022-12-28	WOS:000282879400004
J	Thomas, DL				Thomas, David L.			Curing hepatitis C with pills: a step toward global control	LANCET			English	Editorial Material							PEGINTERFERON; INFECTION; RIBAVIRIN; ALPHA-2A		Johns Hopkins Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Thomas, DL (corresponding author), Johns Hopkins Sch Med, Dept Med, Baltimore, MD 21205 USA.	dthomas@jhmi.edu			NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013324] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA013324] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Falck-Ytter Y, 2002, ANN INTERN MED, V136, P288, DOI 10.7326/0003-4819-136-4-200202190-00008; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; GANE EJ, 2010, LANCET, DOI DOI 10.1016/S0140-6736(10)61497-3; Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8; Lettmeier B, 2008, J HEPATOL, V49, P528, DOI 10.1016/j.jhep.2008.04.021; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Volk ML, 2009, HEPATOLOGY, V50, P1750, DOI 10.1002/hep.23220; WHO, 2010, VIR HEP	9	25	25	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT-NOV	2010	376	9751					1441	1442		10.1016/S0140-6736(10)61497-3	http://dx.doi.org/10.1016/S0140-6736(10)61497-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	680QC	20951421	Green Accepted			2022-12-28	WOS:000284248500005
J	Rubinson, EH; Gowda, ASP; Spratt, TE; Gold, B; Eichman, BF				Rubinson, Emily H.; Gowda, A. S. Prakasha; Spratt, Thomas E.; Gold, Barry; Eichman, Brandt F.			An unprecedented nucleic acid capture mechanism for excision of DNA damage	NATURE			English	Article							HUMAN AP ENDONUCLEASE-1; CRYSTAL-STRUCTURE; BASE EXCISION; HEAT REPEATS; SUBSTRATE-SPECIFICITY; GLYCOSYLASE-I; ALKYLATED DNA; REPAIR; RECOGNITION; 3-METHYLADENINE	DNA glycosylases that remove alkylated and deaminated purine nucleobases are essential DNA repair enzymes that protect the genome, and at the same time confound cancer alkylation therapy, by excising cytotoxic N3-methyladenine bases formed by DNA-targeting anticancer compounds. The basis for glycosylase specificity towards N3- and N7-alkylpurines is believed to result from intrinsic instability of the modified bases and not from direct enzyme functional group chemistry. Here we present crystal structures of the recently discovered Bacillus cereus AlkD glycosylase in complex with DNAs containing alkylated, mismatched and abasic nucleotides. Unlike other glycosylases, AlkD captures the extrahelical lesion in a solvent-exposed orientation, providing an illustration for how hydrolysis of N3- and N7-alkylated bases may be facilitated by increased lifetime out of the DNA helix. The structures and supporting biochemical analysis of base flipping and catalysis reveal how the HEAT repeats of AlkD distort the DNA backbone to detect non-Watson-Crick base pairs without duplex intercalation.	[Rubinson, Emily H.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Rubinson, Emily H.; Eichman, Brandt F.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Gowda, A. S. Prakasha; Spratt, Thomas E.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Gold, Barry] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA	Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Eichman, BF (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37232 USA.	brandt.eichman@vanderbilt.edu		Eichman, Brandt/0000-0002-0965-2297; ALADAHALLI SANNE GOWDA, PRAKASHA GOWDA/0000-0002-0055-7103; Spratt, Thomas/0000-0002-6805-3729	US Department of Energy Office of Basic Energy Sciences; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; American Cancer Society; NIH [RO1 CA29088]; Vanderbilt Training Program in Molecular Toxicology; NATIONAL CANCER INSTITUTE [R01CA029088, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028, P30ES000267] Funding Source: NIH RePORTER	US Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Training Program in Molecular Toxicology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank J. Stivers for providing the pyrene phosphoramidite, Z. Warzak and LS-CAT beamline staff at the Advanced Photon Source (APS) for assistance with X-ray data collection, and T. Ellenberger, J. Stivers and P. O'Brien for comments on the manuscript. Use of the APS was supported by the US Department of Energy Office of Basic Energy Sciences. Use of LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor. This research was supported by a grant from the American Cancer Society (to B.F.E.) and the NIH (RO1 CA29088 to B.G.). E.H.R. was supported in part by the Vanderbilt Training Program in Molecular Toxicology. Additional support for local crystallography facilities was provided by the Vanderbilt Center in Molecular Toxicology and the Vanderbilt-Ingram Cancer Center.	ABOULELA F, 1985, NUCLEIC ACIDS RES, V13, P4811, DOI 10.1093/nar/13.13.4811; Adams PD, 2007, NATO SCI SER II-MATH, V245, P101, DOI 10.1007/978-1-4020-6316-9_9; Alseth I, 2006, MOL MICROBIOL, V59, P1602, DOI 10.1111/j.1365-2958.2006.05044.x; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Asaeda A, 2000, BIOCHEMISTRY-US, V39, P1959, DOI 10.1021/bi9917075; Baldwin MR, 2009, BIOCHEMISTRY-US, V48, P6022, DOI 10.1021/bi900517y; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Brown PJ, 2008, CANCER LETT, V260, P48, DOI 10.1016/j.canlet.2007.10.015; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Dalhus B, 2007, NUCLEIC ACIDS RES, V35, P2451, DOI 10.1093/nar/gkm039; Dinner AR, 2001, NATURE, V413, P752, DOI 10.1038/35099587; Drohat AC, 2002, NAT STRUCT BIOL, V9, P659, DOI 10.1038/nsb829; Eichman BF, 2003, EMBO J, V22, P4898, DOI 10.1093/emboj/cdg505; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ezaz-Nikpay K, 1994, Chem Biol, V1, P235, DOI 10.1016/1074-5521(94)90016-7; EZAZNIKPAY K, 1992, J AM CHEM SOC, V114, P6562, DOI 10.1021/ja00042a048; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Ganguly M, 2010, J PHYS CHEM B, V114, P7656, DOI 10.1021/jp101004k; Gates KS, 2004, CHEM RES TOXICOL, V17, P839, DOI 10.1021/tx049965c; Hecht SS, 1999, MUTAT RES-FUND MOL M, V424, P127, DOI 10.1016/S0027-5107(99)00014-7; Holt S, 1998, CARCINOGENESIS, V19, P1763, DOI 10.1093/carcin/19.10.1763; HUNTER WN, 1987, J BIOL CHEM, V262, P9962; Irani RJ, 2002, NUCLEOS NUCLEOT NUCL, V21, P737, DOI 10.1081/NCN-120016477; Jiang YL, 2003, BIOCHEMISTRY-US, V42, P1922, DOI 10.1021/bi027014x; Jiang YL, 2001, J BIOL CHEM, V276, P42347, DOI 10.1074/jbc.M106594200; Jones BN, 2008, METHOD ENZYMOL, V448, P23, DOI 10.1016/S0076-6879(08)02602-5; LARSON K, 1985, MUTAT RES, V150, P77, DOI 10.1016/0027-5107(85)90103-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Lee S, 2008, J AM CHEM SOC, V130, P11570, DOI 10.1021/ja8025328; Li L, 2009, CHEM RES TOXICOL, V22, P1464, DOI 10.1021/tx9001572; Lyons DM, 2009, J AM CHEM SOC, V131, P17742, DOI 10.1021/ja908378y; Maher RL, 2007, J BIOL CHEM, V282, P30577, DOI 10.1074/jbc.M704341200; Maher RL, 2007, DNA REPAIR, V6, P71, DOI 10.1016/j.dnarep.2006.09.001; Maiti A, 2009, J BIOL CHEM, V284, P36680, DOI 10.1074/jbc.M109.062356; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Metz AH, 2007, EMBO J, V26, P2411, DOI 10.1038/sj.emboj.7601649; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Mol CD, 2002, J MOL BIOL, V315, P373, DOI 10.1006/jmbi.2001.5264; Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400; O'Brien PJ, 2004, J BIOL CHEM, V279, P26876, DOI 10.1074/jbc.M403860200; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Plosky BS, 2008, NUCLEIC ACIDS RES, V36, P2152, DOI 10.1093/nar/gkn058; Rubinson EH, 2008, J MOL BIOL, V381, P13, DOI 10.1016/j.jmb.2008.05.078; SHUKER DEG, 1987, CARCINOGENESIS, V8, P959, DOI 10.1093/carcin/8.7.959; SHUKER DEG, 1992, CHEM RES TOXICOL, V5, P450, DOI 10.1021/tx00028a001; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Singer B., 1983, MOL BIOL MUTAGENS CA; Stivers JT, 2008, CHEM-EUR J, V14, P786, DOI 10.1002/chem.200701501; Stivers JT, 2004, PROG NUCLEIC ACID RE, V77, P37, DOI 10.1016/S0079-6603(04)77002-6; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; Tubbs JL, 2009, NATURE, V459, P808, DOI 10.1038/nature08076; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Williams DR, 2008, STRUCTURE, V16, P468, DOI 10.1016/j.str.2007.12.014; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yang CG, 2009, CHEMBIOCHEM, V10, P417, DOI 10.1002/cbic.200800580	65	62	64	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					406	U309		10.1038/nature09428	http://dx.doi.org/10.1038/nature09428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	20927102	Green Accepted			2022-12-28	WOS:000284313100036
J	Woolley, AW; Chabris, CF; Pentland, A; Hashmi, N; Malone, TW				Woolley, Anita Williams; Chabris, Christopher F.; Pentland, Alex; Hashmi, Nada; Malone, Thomas W.			Evidence for a Collective Intelligence Factor in the Performance of Human Groups	SCIENCE			English	Article							TEAMS	Psychologists have repeatedly shown that a single statistical factor-often called "general intelligence"-emerges from the correlations among people's performance on a wide variety of cognitive tasks. But no one has systematically examined whether a similar kind of "collective intelligence" exists for groups of people. In two studies with 699 people, working in groups of two to five, we find converging evidence of a general collective intelligence factor that explains a group's performance on a wide variety of tasks. This "c factor" is not strongly correlated with the average or maximum individual intelligence of group members but is correlated with the average social sensitivity of group members, the equality in distribution of conversational turn-taking, and the proportion of females in the group.	[Woolley, Anita Williams] Carnegie Mellon Univ, Tepper Sch Business, Pittsburgh, PA 15213 USA; [Chabris, Christopher F.] Union Coll, Schenectady, NY 12308 USA; [Chabris, Christopher F.; Pentland, Alex; Hashmi, Nada; Malone, Thomas W.] MIT, Ctr Collect Intelligence, Cambridge, MA 02142 USA; [Pentland, Alex] MIT, Media Lab, Cambridge, MA 02139 USA; [Hashmi, Nada; Malone, Thomas W.] MIT, Sloan Sch Management, Cambridge, MA 02142 USA	Carnegie Mellon University; Union College; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Woolley, AW (corresponding author), Carnegie Mellon Univ, Tepper Sch Business, Pittsburgh, PA 15213 USA.	awoolley@cmu.edu		Williams Woolley, Anita/0000-0003-0620-4744	National Science Foundation [IIS-0963451]; Army Research Office [56692-MA]; Carnegie Mellon University; Cisco Systems, Inc. through MIT Center for Collective Intelligence; Div Of Information & Intelligent Systems [0963285] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Army Research Office; Carnegie Mellon University; Cisco Systems, Inc. through MIT Center for Collective Intelligence; Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was made possible by financial support from the National Science Foundation (grant IIS-0963451), the Army Research Office (grant 56692-MA), the Berkman Faculty Development Fund at Carnegie Mellon University, and Cisco Systems, Inc., through their sponsorship of the MIT Center for Collective Intelligence. We would especially like to thank S. Kosslyn for his invaluable help in the initial conceptualization and early stages of this work and I. Aggarwal and W. Dong for substantial help with data collection and analysis. We are also grateful for comments and research assistance from L. Argote, E. Anderson, J. Chapman, M. Ding, S. Gaikwad, C. Huang, J. Introne, C. Lee, N. Nath, S. Pandey, N. Peterson, H. Ra, C. Ritter, F. Sun, E. Sievers, K. Tenabe, and R. Wong. The hardware and software used in collecting sociometric data are the subject of an MIT patent application and will be provided for academic research via a not-for-profit arrangement through A. P. In addition to the affiliations listed above, T. W. M. is also a member of the Strategic Advisory Board at InnoCentive, Inc.; a director of Seriosity, Inc.; and chairman of Phios Corporation.	[Anonymous], DELIBERATIVE DEMOCRA, DOI [10.7551/mitpress/11633.003.0005, DOI 10.7551/MITPRESS/2324.003.0014, DOI 10.7551/MITPRESS/8022.001.0001]; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1111/1469-7610.00715; Brand C., 1996, G FACTOR; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chabris CF, 2007, INTEGRATING THE MIND: DOMAIN GENERAL VERSUS DOMAIN SPECIFIC PROCESSES IN HIGHER COGNITION, P449; Deary I. J., 2000, LOOKING HUMAN INTELL; Devine DJ, 2001, SMALL GR RES, V32, P507, DOI 10.1177/104649640103200501; Gowers T, 2009, NATURE, V461, P879, DOI 10.1038/461879a; Hackman J. R., 1983, SMALL GROUPS SOCIAL, V1, P331; Hackman JR., 2002, LEADING TEAMS SETTIN; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; McGrath J. E., 1984, GROUPS INTERACTION P; MICHAELSEN LK, 1989, J APPL PSYCHOL, V74, P834, DOI 10.1037/0021-9010.74.5.834; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; TINDALE RS, 1992, J APPL PSYCHOL, V77, P102, DOI 10.1037/0021-9010.77.1.102; Woolley AW, 2009, ORGAN SCI, V20, P500, DOI 10.1287/orsc.1080.0382; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	17	1081	1108	19	376	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					686	688		10.1126/science.1193147	http://dx.doi.org/10.1126/science.1193147			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	672KB	20929725				2022-12-28	WOS:000283580600053
J	Iwashyna, TJ; Ely, EW; Smith, DM; Langa, KM				Iwashyna, Theodore J.; Ely, E. Wesley; Smith, Dylan M.; Langa, Kenneth M.			Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISABLED OLDER WOMEN; INTENSIVE-CARE-UNIT; QUALITY-OF-LIFE; MORTALITY; DELIRIUM; DECLINE; STATES; DEMENTIA; HEALTH; HOSPITALIZATION	Context Cognitive impairment and functional disability are major determinants of caregiving needs and societal health care costs. Although the incidence of severe sepsis is high and increasing, the magnitude of patients' long-term cognitive and functional limitations after sepsis is unknown. Objective To determine the change in cognitive impairment and physical functioning among patients who survive severe sepsis, controlling for their presepsis functioning. Design, Setting, and Patients A prospective cohort involving 1194 patients with 1520 hospitalizations for severe sepsis drawn from the Health and Retirement Study, a nationally representative survey of US residents (1998-2006). A total of 9223 respondents had a baseline cognitive and functional assessment and had linked Medicare claims; 516 survived severe sepsis and 4517 survived a nonsepsis hospitalization to at least 1 follow-up survey and are included in the analysis. Main Outcome Measures Personal interviews were conducted with respondents or proxies using validated surveys to assess the presence of cognitive impairment and to determine the number of activities of daily living (ADLs) and instrumental ADLs (IADLs) for which patients needed assistance. Results Survivors' mean age at hospitalization was 76.9 years. The prevalence of moderate to severe cognitive impairment increased 10.6 percentage points among patients who survived severe sepsis, an odds ratio (OR) of 3.34 (95% confidence interval [CI], 1.53-7.25) in multivariable regression. Likewise, a high rate of new functional limitations was seen following sepsis: in those with no limits before sepsis, a mean 1.57 new limitations (95% CI, 0.99-2.15); and for those with mild to moderate limitations before sepsis, a mean of 1.50 new limitations (95% CI, 0.87-2.12). In contrast, nonsepsis general hospitalizations were associated with no change in moderate to severe cognitive impairment (OR, 1.15; 95% CI, 0.80-1.67; P for difference vs sepsis=.01) and with the development of fewer new limitations (mean among those with no limits before hospitalization, 0.48; 95% CI, 0.39-0.57; P for difference vs sepsis <.001 and mean among those with mild to moderate limits, 0.43; 95% CI, 0.23-0.63; P for difference=.001). The declines in cognitive and physical function persisted for at least 8 years. Conclusions Severe sepsis in this older population was independently associated with substantial and persistent new cognitive impairment and functional disability among survivors. The magnitude of these new deficits was large, likely resulting in a pivotal downturn in patients' ability to live independently. JAMA. 2010; 304(16): 1787-1794	[Iwashyna, Theodore J.; Langa, Kenneth M.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Ely, E. Wesley] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Ely, E. Wesley] VA Tennessee Valley Geriatr Res & Educ Clin Ctr, Nashville, TN USA; [Smith, Dylan M.] SUNY Stony Brook, Med Ctr, Dept Prevent Med, Stony Brook, NY 11794 USA; [Langa, Kenneth M.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Langa, Kenneth M.] Ann Arbor Vet Affairs Hlth Serv, Res & Dev Serv Ctr Excellence, Ann Arbor, MI USA	University of Michigan System; University of Michigan; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Michigan System; University of Michigan	Iwashyna, TJ (corresponding author), 3A23 300 NIB,SPC 5419,300 N Ingalls, Ann Arbor, MI 48109 USA.	tiwashyn@umich.edu	Ely, E. Wesley/Z-2018-2019	Ely, E. Wesley/0000-0003-3957-2172; Iwashyna, Theodore/0000-0002-4226-9310; Langa, Kenneth/0000-0002-2798-1836	National Institutes of Health [K08 HL091249, R01 AG027010, R01 AG030155, AG027472]; Society of Critical Care Medicine; Michigan Institute for Clinical and Health Research [UL1RR024986]; National Institute on Aging [U01 AG09740]; Veterans Affairs Merit Award; Tennessee Valley Geriatric Research, Education and Clinical Center; National Institute of Diabetes and Digestive and Kidney Disease [P60 DK-20572]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL091249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027010, K23AG001023, U01AG009740, R01AG030155, R01AG027472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society of Critical Care Medicine; Michigan Institute for Clinical and Health Research; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs Merit Award(US Department of Veterans Affairs); Tennessee Valley Geriatric Research, Education and Clinical Center; National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants K08 HL091249, R01 AG027010, and R01 AG030155 from the National Institutes of Health; the Society of Critical Care Medicine's 2010 Vision Grant; and by pilot support from grant UL1RR024986 from the Michigan Institute for Clinical and Health Research. Grant U01 AG09740 from the National Institute on Aging provided funding for the Health and Retirement Study, which is performed at the Institute for Social Research, University of Michigan. Dr Ely was supported by grant AG027472 from the National Institutes of Health, by the Veterans Affairs Merit Award, and by the Tennessee Valley Geriatric Research, Education and Clinical Center. Consultative support was provided by the Measurement Core of the Michigan Diabetes Center through grant P60 DK-20572 from the National Institute of Diabetes and Digestive and Kidney Disease.	Alison P., 2009, FIXED EFFECTS REGRES; Alzheimer's Association, 2006, EARL ONS DEM NAT CHA; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Banaszak-Holl J, 2004, ALZ DIS ASSOC DIS, V18, P83, DOI 10.1097/01.wad.0000126619.80941.91; Boyd CM, 2005, J GERONTOL A-BIOL, V60, P888, DOI 10.1093/gerona/60.7.888; Boyd CM, 2009, J AM GERIATR SOC, V57, P1757, DOI 10.1111/j.1532-5415.2009.02455.x; Boyd CM, 2008, J AM GERIATR SOC, V56, P2171, DOI 10.1111/j.1532-5415.2008.02023.x; Callahan Leigh Ann, 2009, Crit Care Med, V37, pS354, DOI 10.1097/CCM.0b013e3181b6e439; CHELLURI L, 1993, JAMA-J AM MED ASSOC, V269, P3119, DOI 10.1001/jama.269.24.3119; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Fonda S, 2004, DOCUMENTATION PHYS F; Fong TG, 2009, NEUROLOGY, V72, P1570, DOI 10.1212/WNL.0b013e3181a4129a; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Fried TR, 2001, ARCH INTERN MED, V161, P2602, DOI 10.1001/archinte.161.21.2602; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Health and Retirement Study, 2008, SAMPL SIZ RESP RAT; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Herzog AR, 1997, J GERONTOL B-PSYCHOL, V52, P37, DOI 10.1093/geronb/52B.Special_Issue.37; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Iwashyna TJ, 2010, ANN INTERN MED, V153, P204, DOI 10.7326/0003-4819-153-3-201008030-00013; Jackson JC, 2004, NEUROPSYCHOL REV, V14, P87, DOI 10.1023/B:NERV.0000028080.39602.17; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; Kaarlola A, 2006, CRIT CARE MED, V34, P2120, DOI 10.1097/01.CCM.0000227656.31911.2E; Kuo HK, 2005, LANCET NEUROL, V4, P371, DOI 10.1016/S1474-4422(05)70099-5; Kuo HK, 2004, J GERONTOL A-BIOL, V59, P1191, DOI 10.1093/gerona/59.11.1191; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Langa KM, 2005, NEUROEPIDEMIOLOGY, V25, P181, DOI 10.1159/000087448; Langa KM, 2001, J GEN INTERN MED, V16, P770, DOI 10.1111/j.1525-1497.2001.10123.x; Langa KM, 2004, JAMA-J AM MED ASSOC, V292, P2901, DOI 10.1001/jama.292.23.2901; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McConnell S, 2008, EVALUATION REV, V32, P157, DOI 10.1177/0193841X07309115; Mehta KM, 2003, J GERONTOL A-BIOL, V58, P461; MIKKELSEN ME, 2008, AM THOR SOC MAY 21 T; Needham DM, 2008, JAMA-J AM MED ASSOC, V300, P1685, DOI 10.1001/jama.300.14.1685; Ofstedal MB., 2005, HRS DOCUMENTATION RE, DOI DOI 10.1371/journal.pone.0144722; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rozzini R, 2005, J GERONTOL A-BIOL, V60, P1180, DOI 10.1093/gerona/60.9.1180; Saint S, 2002, AM J RESP CRIT CARE, V165, P1475, DOI 10.1164/rccm.2110035; Schweickert WD, 2007, CHEST, V131, P1541, DOI 10.1378/chest.06-2065; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Sharshar T, 2009, CRIT CARE MED, V37, P3047, DOI 10.1097/CCM.0b013e3181b027e9; SPRUNG CL, 1990, CRIT CARE MED, V18, P801, DOI 10.1097/00003246-199008000-00001; WELSH KA, 1993, NEUROPSY NEUROPSY BE, V6, P103; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Yaffe K, 2002, JAMA-J AM MED ASSOC, V287, P2090, DOI 10.1001/jama.287.16.2090; Yende Sachin, 2007, Curr Infect Dis Rep, V9, P382, DOI 10.1007/s11908-007-0059-3; Ziegler-Graham K, 2008, ALZHEIMERS DEMENT, V4, P316, DOI 10.1016/j.jalz.2008.05.2479; Zivin K, 2010, AM J GERIAT PSYCHIAT, V18, P1036, DOI 10.1097/JGP.0b013e3181dba6d2	51	1404	1481	4	97	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2010	304	16					1787	1794		10.1001/jama.2010.1553	http://dx.doi.org/10.1001/jama.2010.1553			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671JZ	20978258	Green Accepted, Bronze			2022-12-28	WOS:000283501300019
J	Bettencourt, L; West, G				Bettencourt, Luis; West, Geoffrey			A unified theory of urban living	NATURE			English	Editorial Material							GENERAL-MODEL; CITIES; GROWTH		[Bettencourt, Luis; West, Geoffrey] Los Alamos Natl Lab, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Bettencourt, L (corresponding author), Los Alamos Natl Lab, Los Alamos, NM 87545 USA.		Bettencourt, Luis/R-9861-2019	Limb, Melanie Ruth/0000-0002-6258-3366				[Anonymous], 2010, GLOBAL SUSTAINABILIT; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; BETTENCOURT LMA, PLOS ONE IN PRESS; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Brown M.A., 2009, POLICY SOC, V27, P285, DOI [10.1016/j.polsoc.2009.01.001, DOI 10.1016/J.POLSOC.2009.01.001]; Jacobs Jane, 1961, DEATH LIFE GREAT AM; UN-Habitat, 2010, STAT WORLDS CIT 2010; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122	10	460	472	11	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					912	913		10.1038/467912a	http://dx.doi.org/10.1038/467912a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	668FT	20962823				2022-12-28	WOS:000283254700015
J	Jacobson, SG; Cideciyan, AV				Jacobson, Samuel G.; Cideciyan, Artur V.			Treatment Possibilities for Retinitis Pigmentosa.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jacobson, Samuel G.; Cideciyan, Artur V.] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Jacobson, SG (corresponding author), Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA.		Cideciyan, Artur V/A-1075-2007	Cideciyan, Artur V/0000-0002-2018-0905; Jacobson, Samuel/0000-0003-2122-169X				Bramall AN, 2010, ANNU REV NEUROSCI, V33, P441, DOI 10.1146/annurev-neuro-060909-153227; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Cideciyan AV, 2010, PROG RETIN EYE RES, V29, P398, DOI 10.1016/j.preteyeres.2010.04.002; Flannery JG, 2006, NEURON, V50, P1, DOI 10.1016/j.neuron.2006.03.027; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297	5	55	60	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2010	363	17					1669	1671		10.1056/NEJMcibr1007685	http://dx.doi.org/10.1056/NEJMcibr1007685			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668BD	20961252				2022-12-28	WOS:000283242700014
J	Lavrentovich, OD; Lazo, I; Pishnyak, OP				Lavrentovich, Oleg D.; Lazo, Israel; Pishnyak, Oleg P.			Nonlinear electrophoresis of dielectric and metal spheres in a nematic liquid crystal	NATURE			English	Article							ELECTRIC-FIELD	Electrophoresis is a motion of charged dispersed particles relative to a fluid in a uniform electric field(1). The effect is widely used to separate macromolecules, to assemble colloidal structures and to transport particles in nano- and microfluidic devices and displays(2-4). Typically, the fluid is isotropic (for example, water) and the electrophoretic velocity is linearly proportional to the electric field. In linear electrophoresis, only a direct-current (d.c.) field can drive the particles. An alternating-current (a.c.) field is more desirable because it makes it possible to overcome problems such as electrolysis and the absence of steady flows(5,6). Here we show that when the electrophoresis is performed in a liquid-crystalline nematic fluid, the effect becomes strongly nonlinear, with a velocity component that is quadratic in the applied voltage and has a direction that generally differs from the direction of linear velocity. The new phenomenon is caused by distortions of the liquid-crystal orientation around the particle that break the fore-aft (or left-right) symmetry. The effect makes it possible to transport both charged and neutral particles, even when the particles themselves are perfectly symmetric (spherical), thus allowing new approaches in display technologies, colloidal assembly and separation, microfluidic and micromotor applications.	[Lavrentovich, Oleg D.; Lazo, Israel; Pishnyak, Oleg P.] Kent State Univ, Inst Liquid Crystal, Kent, OH 44242 USA; [Lavrentovich, Oleg D.; Lazo, Israel; Pishnyak, Oleg P.] Kent State Univ, Chem Phys Interdisciplinary Program, Kent, OH 44242 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Lavrentovich, OD (corresponding author), Kent State Univ, Inst Liquid Crystal, Kent, OH 44242 USA.	olavrent@kent.edu	Lavrentovich, Oleg D/B-4996-2011; Lavrentovich, Oleg D./AAP-2151-2020	Lavrentovich, Oleg D./0000-0002-0128-0708	NSF [DMR 0906751]; Direct For Mathematical & Physical Scien [0906751] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We are grateful to L. Tortora for help with surface functionalization of the particles and discussions. The research was supported by NSF DMR 0906751.	Auroux PA, 2002, ANAL CHEM, V74, P2637, DOI 10.1021/ac020239t; Bazant MZ, 2009, ADV COLLOID INTERFAC, V152, P48, DOI 10.1016/j.cis.2009.10.001; Ciuchi F, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2819619; Comiskey B, 1998, NATURE, V394, P253, DOI 10.1038/28349; Dukhin AS, 2005, ELECTROPHORESIS, V26, P2149, DOI 10.1002/elps.200410408; GAMAYUNOV NI, 1987, COLLOID J USSR, V49, P615; Gangwal S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.058302; Gu YD, 2000, PHYS REV LETT, V85, P4719, DOI 10.1103/PhysRevLett.85.4719; Hayward RC, 2000, NATURE, V404, P56, DOI 10.1038/35003530; Kuksenok OV, 1996, PHYS REV E, V54, P5198, DOI 10.1103/PhysRevE.54.5198; Kumar S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066307; Murtsovkin VA, 1990, COLLOID J USSR, V52, P1081; Pishnyak OP, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.127802; Poulin P, 1997, SCIENCE, V275, P1770, DOI 10.1126/science.275.5307.1770; Ramos A, 1999, J COLLOID INTERF SCI, V217, P420, DOI 10.1006/jcis.1999.6346; Ryzhkova AV, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3386570; SIMONOV IN, 1977, COLLOID J USSR+, V39, P775; Squires TM, 2004, J FLUID MECH, V509, P217, DOI 10.1017/S0022112004009309; Tatarkova SA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.157801; van Dorp S, 2009, NAT PHYS, V5, P347, DOI 10.1038/NPHYS1230	20	112	115	5	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2010	467	7318					947	950		10.1038/nature09427	http://dx.doi.org/10.1038/nature09427			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962842	Green Submitted			2022-12-28	WOS:000283254700034
J	Jha, AK				Jha, Ashish K.			Meaningful Use of Electronic Health Records The Road Ahead	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; [Jha, Ashish K.] VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Jha, AK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	ajha@hsph.harvard.edu						Burt C. W., 2006, ELECT MED RECORD USE; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; FINNEGAN B, 2009, BOOSTING HLTH INFORM; Han YY, 2005, PEDIATRICS, V116, P1506, DOI 10.1542/peds.2005-1287; Hogan SO, 2010, HEALTH AFFAIR, V29, P601, DOI 10.1377/hlthaff.2009.1023; Jha AK, 2010, HEALTH AFFAIR, V29, P1951, DOI 10.1377/hlthaff.2010.0502; Jha AK, 2009, HEALTH AFFAIR, V28, pW1160, DOI 10.1377/hlthaff.28.6.w1160; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Sittig DF, 2010, JAMA-J AM MED ASSOC, V303, P450, DOI 10.1001/jama.2010.61; WALKER J, 2005, HLTH AFF MILLWOOD	10	126	126	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2010	304	15					1709	1710		10.1001/jama.2010.1497	http://dx.doi.org/10.1001/jama.2010.1497			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666PZ	20959581				2022-12-28	WOS:000283129700025
J	Curtis, JR; Vincent, JL				Curtis, J. Randall; Vincent, Jean-Louis			Critical Care 2 Ethics and end-of-life care for adults in the intensive care unit	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; SURROGATE DECISION-MAKING; ICU FAMILY CONFERENCES; MECHANICAL VENTILATION; ILL PATIENTS; SUSTAINING TREATMENTS; ADVANCE DIRECTIVES; PALLIATIVE CARE; NURSING STAFF; NORTH-AMERICA	The intensive care unit (ICU) is where patients are given some of the most technologically advanced life-sustaining treatments, and where difficult decisions are made about the usefulness of such treatments. The substantial regional variability in these ethical decisions is a result of many factors, including religious and cultural beliefs. Because most critically ill patients lack the capacity to make decisions, family and other individuals often act as the surrogate decision makers, and in many regions communication between the clinician and family is central to decision making in the ICU. Elsewhere, involvement of the family is reduced and that of the physicians is increased. End-of-life care is associated with increased burnout and distress among clinicians working in the ICU. Since many deaths in the ICU are preceded by a decision to withhold or withdraw life support, high-quality decision making and end-of-life care are essential in all regions, and can improve patient and family outcomes, and also retention of clinicians working in the ICU. To make such a decision requires adequate training, good communication between the clinician and family, and the collaboration of a well functioning interdisciplinary team.	[Curtis, J. Randall] Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care Med, Seattle, WA 98104 USA; [Vincent, Jean-Louis] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, Brussels, Belgium	Harborview Medical Center; University of Washington; University of Washington Seattle; Universite Libre de Bruxelles	Curtis, JR (corresponding author), Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care Med, Box 359762,325 9Th Ave, Seattle, WA 98104 USA.	jrc@u.washington.edu		Vincent, Jean-Louis/0000-0001-6011-6951	National Institute of Nursing Research [R01NR-05226]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR005226] Funding Source: NIH RePORTER	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Funding was provided by a grant from the National Institute of Nursing Research (R01NR-05226 to JRC). The sponsor was not involved in developing, drafting, or reviewing the report, or in the decision to publish.	American Thoracic Society, 1991, Ann Intern Med, V115, P478; Angus DC, 2004, CRIT CARE MED, V32, P638, DOI 10.1097/01.CCM.0000114816.62331.08; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Azoulay E, 2000, CRIT CARE MED, V28, P3044, DOI 10.1097/00003246-200008000-00061; Azoulay E, 2004, CRIT CARE MED, V32, P1832, DOI 10.1097/01.CCM.0000139693.88931.59; Azoulay E, 2009, AM J RESP CRIT CARE, V180, P853, DOI 10.1164/rccm.200810-1614OC; Azoulay E, 2009, INTENS CARE MED, V35, P623, DOI 10.1007/s00134-008-1310-6; Bakker J, 2008, AM J HOSP PALLIAT ME, V25, P152, DOI 10.1177/1049909108315511; Benbenishty J, 2006, INTENS CARE MED, V32, P129, DOI 10.1007/s00134-005-2864-1; Buckley TA, 2004, CRIT CARE MED, V32, P415, DOI 10.1097/01.CCM.0000110675.34569.A9; Bulow HH, 2008, INTENS CARE MED, V34, P423, DOI 10.1007/s00134-007-0973-8; Campbell ML, 1999, CRIT CARE MED, V27, P73, DOI 10.1097/00003246-199901000-00029; Carlet J, 2004, INTENS CARE MED, V30, P770, DOI 10.1007/s00134-004-2241-5; Carline JD, 2003, J PAIN SYMPTOM MANAG, V25, P19, DOI 10.1016/S0885-3924(02)00537-7; Chan JD, 2004, CHEST, V126, P286, DOI 10.1378/chest.126.1.286; Cohen S, 2005, INTENS CARE MED, V31, P1215, DOI 10.1007/s00134-005-2742-x; Cook D, 2003, NEW ENGL J MED, V349, P1123, DOI 10.1056/NEJMoa030083; COOK DJ, 1995, JAMA-J AM MED ASSOC, V273, P703, DOI 10.1001/jama.273.9.703; Curtis JR, 2008, CHEST, V134, P835, DOI 10.1378/chest.08-0235; Curtis JR, 2005, AM J RESP CRIT CARE, V171, P844, DOI 10.1164/rccm.200409-1267OC; *DEP HLTH NAT EX, 1996, GUID ADM DISCH INT C; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; Egol A, 1999, CRIT CARE MED, V27, P633; Ehlenbach WJ, 2009, NEW ENGL J MED, V361, P22, DOI 10.1056/NEJMoa0810245; Embriaco N, 2007, AM J RESP CRIT CARE, V175, P686, DOI 10.1164/rccm.200608-1184OC; Esteban A, 2001, INTENS CARE MED, V27, P1744, DOI 10.1007/s00134-001-1111-7; Evans LR, 2009, AM J RESP CRIT CARE, V179, P48, DOI 10.1164/rccm.200806-969OC; Ferrand E, 2003, AM J RESP CRIT CARE, V167, P1310, DOI 10.1164/rccm.200207-752OC; Ferrand E, 2001, LANCET, V357, P9, DOI 10.1016/S0140-6736(00)03564-9; Gajewska K, 2004, INTENS CARE MED, V30, P1224, DOI 10.1007/s00134-004-2308-3; Garland A, 2007, J PALLIAT MED, V10, P1298, DOI 10.1089/jpm.2007.0061; Gerstel E, 2008, AM J RESP CRIT CARE, V178, P798, DOI 10.1164/rccm.200711-1617OC; Giannini A, 2003, INTENS CARE MED, V29, P1902, DOI 10.1007/s00134-003-1919-4; Gries CJ, 2008, CHEST, V133, P704, DOI 10.1378/chest.07-1773; Heyland DK, 2003, CHEST, V124, P392, DOI 10.1378/chest.124.1.392; Heyland DK, 2003, J CRIT CARE, V18, P3, DOI 10.1053/jcrc.2003.YJCRC2; Kagawa-Singer M, 2001, JAMA-J AM MED ASSOC, V286, P2993, DOI 10.1001/jama.286.23.2993; Keenan SP, 1998, CRIT CARE MED, V26, P245, DOI 10.1097/00003246-199802000-00018; Kollef MH, 1999, CRIT CARE MED, V27, P2125, DOI 10.1097/00003246-199910000-00008; Kompanje EJO, 2008, INTENS CARE MED, V34, P1593, DOI 10.1007/s00134-008-1172-y; Lanken PN, 2008, AM J RESP CRIT CARE, V177, P912, DOI 10.1164/rccm.200605-587ST; Lanken PN, 1997, AM J RESP CRIT CARE, V156, P1282; Levin PD, 2005, CRIT CARE, V9, P230, DOI 10.1186/cc3487; Luce JM, 2000, AM J RESP CRIT CARE, V162, P2029, DOI 10.1164/ajrccm.162.6.1-00; Luce JM, 2007, AM J RESP CRIT CARE, V175, P1104, DOI 10.1164/rccm.200609-1397CP; Mani RK, 2009, INTENS CARE MED, V35, P1713, DOI 10.1007/s00134-009-1561-x; McDonagh JR, 2004, CRIT CARE MED, V32, P1484, DOI 10.1097/01.CCM.0000127262.16690.65; Mealer ML, 2007, AM J RESP CRIT CARE, V175, P693, DOI 10.1164/rccm.200606-735OC; Melltorp G, 1997, INTENS CARE MED, V23, P1264, DOI 10.1007/s001340050496; Moselli NM, 2006, ACTA ANAESTH SCAND, V50, P1177, DOI 10.1111/j.1399-6576.2006.01150.x; Nolin T, 2003, ACTA ANAESTH SCAND, V47, P501, DOI 10.1034/j.1399-6576.2003.00128.x; Norris K, 2007, J PALLIAT MED, V10, P1101, DOI 10.1089/jpm.2006.2546; Norris Wendi M, 2005, J Palliat Med, V8, P1016, DOI 10.1089/jpm.2005.8.1016; Pham K, 2008, CHEST, V134, P109, DOI 10.1378/chest.07-2852; Pochard F, 2001, CRIT CARE MED, V29, P1893, DOI 10.1097/00003246-200110000-00007; Poncet MC, 2007, AM J RESP CRIT CARE, V175, P698, DOI 10.1164/rccm.200606-806OC; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Prendergast TJ, 1997, AM J RESP CRIT CARE, V155, P15, DOI 10.1164/ajrccm.155.1.9001282; Ravitsky V, 2005, BRIT MED J, V330, P415, DOI 10.1136/bmj.330.7488.415; Schneiderman LJ, 2003, JAMA-J AM MED ASSOC, V290, P1166, DOI 10.1001/jama.290.9.1166; Selph RB, 2008, J GEN INTERN MED, V23, P1311, DOI 10.1007/s11606-008-0643-8; Silveira MJ, 2010, NEW ENGL J MED, V362, P1211, DOI 10.1056/NEJMsa0907901; Sprung CL, 2007, INTENS CARE MED, V33, P1732, DOI 10.1007/s00134-007-0693-0; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Stapleton RD, 2006, CRIT CARE MED, V34, P1679, DOI 10.1097/01.CCM.0000218409.58256.AA; Steinberg A, 2006, INTENS CARE MED, V32, P1234, DOI 10.1007/s00134-006-0186-6; Studdert DM, 2003, INTENS CARE MED, V29, P1489, DOI 10.1007/s00134-003-1853-5; Teno JM, 2007, J AM GERIATR SOC, V55, P189, DOI 10.1111/j.1532-5415.2007.01045.x; Thornton JD, 2009, CRIT CARE MED, V37, P89, DOI 10.1097/CCM.0b013e3181926430; Treece PD, 2004, CRIT CARE MED, V32, P1141, DOI 10.1097/01.CCM.0000125509.34805.0C; Truog RD, 2008, CRIT CARE MED, V36, P953, DOI 10.1097/CCM.0B013E3181659096; van der Heide A, 2003, LANCET, V362, P345, DOI 10.1016/S0140-6736(03)14019-6; Vincent JL, 1997, INTENS CARE MED, V23, P1181, DOI 10.1007/s001340050479; Vincent JL, 1999, CRIT CARE MED, V27, P1626, DOI 10.1097/00003246-199908000-00042; Wall RJ, 2007, CHEST, V132, P1425, DOI 10.1378/chest.07-0419; Wall RJ, 2007, CRIT CARE MED, V35, P1084, DOI 10.1097/01.CCM.0000259382.36414.06; West Heather F, 2005, J Palliat Med, V8, P797, DOI 10.1089/jpm.2005.8.797; White DB, 2010, CRIT CARE MED, V38, P743, DOI 10.1097/CCM.0b013e3181c58842; White DB, 2009, AM J RESP CRIT CARE, V180, P320, DOI 10.1164/rccm.200811-1776OC; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Wunsch H, 2005, INTENS CARE MED, V31, P823, DOI 10.1007/s00134-005-2644-y; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8; Yaguchi A, 2005, ARCH INTERN MED, V165, P1970, DOI 10.1001/archinte.165.17.1970; Yazigi A, 2005, INTENS CARE MED, V31, P562, DOI 10.1007/s00134-005-2578-4; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	85	204	211	4	44	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2010	376	9749					1347	1353		10.1016/S0140-6736(10)60143-2	http://dx.doi.org/10.1016/S0140-6736(10)60143-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671RX	20934213				2022-12-28	WOS:000283528600038
J	Hsu, JH; Wu, JR; Chen, HM; Huang, WT				Hsu, Jong-Hau; Wu, Jiunn-Ren; Chen, Huai-Min; Huang, Wan-Ting			Stroke, infective endocarditis and a blood filled cyst	LANCET			English	Editorial Material									[Hsu, Jong-Hau; Wu, Jiunn-Ren] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Paediat, Kaohsiung 807, Taiwan; [Chen, Huai-Min] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung 807, Taiwan; [Huang, Wan-Ting] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung 807, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Wu, JR (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Paediat, 100 Tzu Yu 1st Rd, Kaohsiung 807, Taiwan.	jirewu@cc.kmu.edu.tw							0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2010	376	9749					1338	1338		10.1016/S0140-6736(10)60275-9	http://dx.doi.org/10.1016/S0140-6736(10)60275-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671RX	20943263				2022-12-28	WOS:000283528600036
J	Kinra, S; Ben-Shlomo, Y				Kinra, Sanjay; Ben-Shlomo, Yoav			Rural MBBS degree in India	LANCET			English	Editorial Material							MEDICINE		[Kinra, Sanjay] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Sci, London WC1E 7HT, England; [Ben-Shlomo, Yoav] Univ Bristol, Dept Social Med, Bristol, Avon, England	University of London; London School of Hygiene & Tropical Medicine; University of Bristol	Kinra, S (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Sci, Keppel St, London WC1E 7HT, England.	sanjay.kinra@lshtm.ac.uk	Ben-Shlomo, Yoav/ABD-2004-2021	Ben-Shlomo, Yoav/0000-0001-6648-3007				Batalden P, 2007, JAMA-J AM MED ASSOC, V298, P1059, DOI 10.1001/jama.298.9.1059; Blumenthal D, 2001, JAMA-J AM MED ASSOC, V286, P1027, DOI 10.1001/jama.286.9.1027; Emanuel EJ, 2006, JAMA-J AM MED ASSOC, V296, P1128, DOI 10.1001/jama.296.9.1128; Mascarenhas A, 2010, INDIAN EXPRESS  0119; Remmen R, 1999, MED EDUC, V33, P600, DOI 10.1046/j.1365-2923.1999.00467.x; Rosenblatt RA, 2002, JAMA-J AM MED ASSOC, V288, P1063, DOI 10.1001/jama.288.9.1063; 1992, JAMA, V268, P2420; 2009, DECCAN CHRONICL 1012; 2010, RURAL MBBS DISCRIMIN	9	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 16	2010	376	9749					1284	1285		10.1016/S0140-6736(10)61006-9	http://dx.doi.org/10.1016/S0140-6736(10)61006-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	671RX	20951877				2022-12-28	WOS:000283528600009
J	Jewitt, D; Weaver, H; Agarwal, J; Mutchler, M; Drahus, M				Jewitt, David; Weaver, Harold; Agarwal, Jessica; Mutchler, Max; Drahus, Michal			A recent disruption of the main-belt asteroid P/2010 A2	NATURE			English	Article							DEBRIS DISKS; ORIGIN; DUST	Most inner main-belt asteroids are primitive rock and metal bodies in orbit about the Sun between Mars and Jupiter. Disruption, through high-velocity collisions or rotational spin-up, is believed to be the primary mechanism for the production and destruction of small asteroids(1,2) and a contributor to dust in the Sun's zodiacal cloud(3), while analogous collisions around other stars feed dust to their debris disks(4). Unfortunately, direct evidence about the mechanism or rate of disruption is lacking, owing to the rarity of the events. Here we report observations of P/2010 A2, a previously unknown inner-belt asteroid with a peculiar, comet-like morphology. The data reveal a nucleus of diameter approximately 120 metres with an associated tail of millimetre-sized dust particles. We conclude that it is most probably the remnant of a recent asteroidal disruption in February/March 2009, evolving slowly under the action of solar radiation pressure, in agreement with independent work(5).	[Jewitt, David; Drahus, Michal] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Jewitt, David] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; [Jewitt, David] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Weaver, Harold] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Agarwal, Jessica] European Space Agcy, European Space Res & Technol Ctr, NL-2200 AG Noordwijk, Netherlands; [Mutchler, Max] Space Telescope Sci Inst, Baltimore, MD 21218 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; European Space Agency; Space Telescope Science Institute	Jewitt, D (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, 3713 Geol Bldg,595 Charles Young Dr E, Los Angeles, CA 90095 USA.	jewitt@ucla.edu	Weaver, Harold A/D-9188-2016	Weaver, Harold A/0000-0003-0951-7762; Mutchler, Maximilian/0000-0002-0088-3021				Agarwal J, 2010, ICARUS, V207, P992, DOI 10.1016/j.icarus.2010.01.003; Benz W, 1999, ICARUS, V142, P5, DOI 10.1006/icar.1999.6204; BIRTWHISTLE P, 2010, CENT BUR ELECT TELEG, V2114; Bottke WF, 2005, ICARUS, V179, P63, DOI 10.1016/j.icarus.2005.05.017; BOTTKE WF, 1994, ICARUS, V107, P255, DOI 10.1006/icar.1994.1021; GRADIE J, 1982, SCIENCE, V216, P1405, DOI 10.1126/science.216.4553.1405; Holsapple KA, 2007, ICARUS, V187, P500, DOI 10.1016/j.icarus.2006.08.012; Hsieh HH, 2006, SCIENCE, V312, P561, DOI 10.1126/science.1125150; JEWITT D, 2010, 9109 IAU; Jutzi M, 2010, ICARUS, V207, P54, DOI 10.1016/j.icarus.2009.11.016; LEINERT C, 1983, ASTRON ASTROPHYS, V118, P345; LICANDRO J, 2010, CENT BUR ELECT TELEG, V2134; Michikami T, 2007, PLANET SPACE SCI, V55, P70, DOI 10.1016/j.pss.2006.05.002; Nesvorny D, 2008, ASTROPHYS J LETT, V679, pL143, DOI 10.1086/588841; Nesvorny D, 2010, ASTROPHYS J, V713, P816, DOI 10.1088/0004-637X/713/2/816; Rubincam DP, 2000, ICARUS, V148, P2, DOI 10.1006/icar.2000.6485; Taylor PA, 2007, SCIENCE, V316, P274, DOI 10.1126/science.1139038; Wyatt MC, 2008, ANNU REV ASTRON ASTR, V46, P339, DOI 10.1146/annurev.astro.45.051806.110525	18	101	101	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					817	819		10.1038/nature09456	http://dx.doi.org/10.1038/nature09456			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944743				2022-12-28	WOS:000282898700061
J	Stafford, N				Stafford, Ned			Science in the digital age	NATURE			English	Editorial Material																			0	15	15	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					S19	S21		10.1038/467S19a	http://dx.doi.org/10.1038/467S19a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944616	Bronze			2022-12-28	WOS:000282898700015
J	Chandra, A; Acosta, JD				Chandra, Anita; Acosta, Joie D.			Disaster Recovery Also Involves Human Recovery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Chandra, Anita; Acosta, Joie D.] RAND Corp, Arlington, VA 22202 USA	RAND Corporation	Chandra, A (corresponding author), RAND Corp, 1200 S Hayes St, Arlington, VA 22202 USA.	Anita_Chandra@rand.org						ACOSTA J, 2010, NAVIGATING LONG ROAD; Chandra A., 2009, ROLE NONGOVERNMENTAL; CHANDRA A, 2010, COMMUNITY RESILIENCE; *EM MED FDN, 2009, DEV NAT STAND ALL HA; Kates R.W., 1977, RECONSTRUCTION FOLLO, P1; NAVARRO M, 2010, NY TIMES        0617, pA19; PFEFFERBAUM BJ, 2009, HELPING FAMILIES COM, P265; U.S. Department of Health & Human Services, 2009, NAT HLTH SEC STRAT; *US DEP HOM SEC, 2010, NAT DIS REC IN PRESS; *US GOV ACC OFF, 2009, GAO09561	10	22	22	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1608	1609		10.1001/jama.2010.1456	http://dx.doi.org/10.1001/jama.2010.1456			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940389				2022-12-28	WOS:000282816500028
J	Okasha, S				Okasha, Samir			Altruism researchers must cooperate	NATURE			English	Editorial Material							GROUP SELECTION; KIN SELECTION; EVOLUTION		Univ Bristol, Dept Philosophy, Bristol BS8 1TB, Avon, England	University of Bristol	Okasha, S (corresponding author), Univ Bristol, Dept Philosophy, Bristol BS8 1TB, Avon, England.	Samir.Okasha@bristol.ac.uk			AHRC [AH/F017502/1] Funding Source: UKRI; Arts and Humanities Research Council [AH/F017502/1] Funding Source: researchfish	AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))		DUGATKIN LA, 1994, ADV STUD BEHAV, V23, P101, DOI 10.1016/S0065-3454(08)60352-6; Emlen Stephen T., 1997, P228; Foster KR, 2009, COLD SH Q B, V74, P403, DOI 10.1101/sqb.2009.74.041; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Lehmann L, 2007, P NATL ACAD SCI USA, V104, P6736, DOI 10.1073/pnas.0700662104; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; QUELLER DC, 1992, AM NAT, V139, P540, DOI 10.1086/285343; Silk J.B., 2005, MORAL SENTIMENTS MAT, P43; Williams G. C., 1966, P307; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; Wilson EO, 2005, SOC RES, V72, P159; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102	12	34	34	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2010	467	7316					653	655		10.1038/467653a	http://dx.doi.org/10.1038/467653a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	659NE	20930821	Bronze, Green Submitted			2022-12-28	WOS:000282572500015
J	Park, CY; Shcheglovitov, A; Dolmetsch, R				Park, Chan Young; Shcheglovitov, Aleksandr; Dolmetsch, Ricardo			The CRAC Channel Activator STIM1 Binds and Inhibits L-Type Voltage-Gated Calcium Channels	SCIENCE			English	Article							MEDIUM SPINY NEURONS; T-LYMPHOCYTES; SKELETAL-MUSCLE; PLASMA-MEMBRANE; CA2+ CHANNELS; STORE; ENTRY; ORAI1; INFLUX; SENSOR	Voltage-and store-operated calcium (Ca2+) channels are the major routes of Ca2+ entry in mammalian cells, but little is known about how cells coordinate the activity of these channels to generate coherent calcium signals. We found that STIM1 (stromal interaction molecule 1), the main activator of store-operated Ca2+ channels, directly suppresses depolarization-induced opening of the voltage-gated Ca2+ channel Ca(V)1.2. STIM1 binds to the C terminus of Ca(V)1.2 through its Ca2+ release-activated Ca2+ activation domain, acutely inhibits gating, and causes long-term internalization of the channel from the membrane. This establishes a previously unknown function for STIM1 and provides a molecular mechanism to explain the reciprocal regulation of these two channels in cells.	[Park, Chan Young; Shcheglovitov, Aleksandr; Dolmetsch, Ricardo] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Park, Chan Young] UNIST, Sch Nanobiotechnol & Chem Engn, Ulsan 689798, South Korea	Stanford University; Ulsan National Institute of Science & Technology (UNIST)	Dolmetsch, R (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu	Park, Chan Young/F-5696-2010; Tuluc, Petronel/C-2527-2011	Park, Chan Young/0000-0002-5183-3665; 	NIH [DP1OD003889, R21MH087898]; Simons Fund for Autism Research; California Institute for Regenerative Medicine [TG 01159]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048564] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003889] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Fund for Autism Research; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by NIH grants DP1OD003889 and R21MH087898, the Simons Fund for Autism Research, the California Institute for Regenerative Medicine grant TG 01159. We thank A. Budzillo for help with experiments, and R. Lewis and A. Nigh for feedback on the manuscript.	BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Calin-Jageman I, 2008, J NEUROCHEM, V105, P573, DOI 10.1111/j.1471-4159.2008.05286.x; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; FANGER CM, 1995, J CELL BIOL, V131, P655, DOI 10.1083/jcb.131.3.655; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Green EM, 2007, NEURON, V55, P615, DOI 10.1016/j.neuron.2007.07.024; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; HESS P, 1988, CAN J PHYSIOL PHARM, V66, P1218, DOI 10.1139/y88-201; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; Kotturi MF, 2005, MOL IMMUNOL, V42, P1461, DOI 10.1016/j.molimm.2005.01.014; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, BBA-MOL CELL RES, V1763, P1161, DOI 10.1016/j.bbamcr.2006.09.023; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tsien Richard W., 1995, Trends in Neurosciences, V18, P52, DOI 10.1016/0166-2236(95)93867-W; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	29	243	246	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2010	330	6000					101	105		10.1126/science.1191027	http://dx.doi.org/10.1126/science.1191027			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929812				2022-12-28	WOS:000282334500045
J	Miyagi, L; Kanitpanyacharoen, W; Kaercher, P; Lee, KKM; Wenk, HR				Miyagi, Lowell; Kanitpanyacharoen, Waruntorn; Kaercher, Pamela; Lee, Kanani K. M.; Wenk, Hans-Rudolf			Slip Systems in MgSiO3 Post-Perovskite: Implications for D '' Anisotropy	SCIENCE			English	Article							LATTICE PREFERRED ORIENTATION; SEISMIC ANISOTROPY; PHASE-TRANSITION; LOWER MANTLE; PLASTIC-DEFORMATION; BOUNDARY; CAIRO3; GPA; POSTPEROVSKITE; DISLOCATIONS	Understanding deformation of mineral phases in the lowermost mantle is important for interpreting seismic anisotropy in Earth's interior. Recently, there has been considerable controversy regarding deformation-induced slip in MgSiO3 post-perovskite. Here, we observe that (001) lattice planes are oriented at high angles to the compression direction immediately after transformation and before deformation. Upon compression from 148 gigapascals (GPa) to 185 GPa, this preferred orientation more than doubles in strength, implying slip on (001) lattice planes. This contrasts with a previous experiment that recorded preferred orientation likely generated during the phase transformation rather than deformation. If we use our results to model deformation and anisotropy development in the D '' region of the lower mantle, shear-wave splitting (characterized by fast horizontally polarized shear waves) is consistent with seismic observations.	[Miyagi, Lowell; Lee, Kanani K. M.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA; [Kanitpanyacharoen, Waruntorn; Kaercher, Pamela; Wenk, Hans-Rudolf] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	Yale University; University of California System; University of California Berkeley	Wenk, HR (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06511 USA.	wenk@berkeley.edu		Lee, Kanani/0000-0003-3003-4802	Office of Science, Office of Basic Energy Sciences, and Materials Sciences Division of the U.S. Department of Energy [DE-AC02-05CH11231]; Consortium for Materials Properties Research in Earth Sciences under NSF [EAR 06-49658]; Yale University; CDAC; NSF [EAR0836402, EAR0757608]	Office of Science, Office of Basic Energy Sciences, and Materials Sciences Division of the U.S. Department of Energy(United States Department of Energy (DOE)); Consortium for Materials Properties Research in Earth Sciences under NSF; Yale University; CDAC(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF))	The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, and Materials Sciences Division of the U.S. Department of Energy under contract DE-AC02-05CH11231. This research was partially supported by the Consortium for Materials Properties Research in Earth Sciences under NSF Cooperative Agreement EAR 06-49658. L. M. acknowledges support of the Bateman Fellowship at Yale University. H. R. W. acknowledges support from CDAC and NSF grants EAR0836402 and EAR0757608. We thank S. Gaudio, C. Lesher, S. Clark, J. Knight, and J. Yan for technical assistance. Comments from three anonymous reviewers improved the manuscript.	Andrault D, 2010, EARTH PLANET SC LETT, V293, P90, DOI 10.1016/j.epsl.2010.02.026; Carrez P, 2007, PHILOS MAG, V87, P3229, DOI 10.1080/14786430701268914; Catalli K, 2009, NATURE, V462, P782, DOI 10.1038/nature08598; Garnero EJ, 2008, SCIENCE, V320, P626, DOI 10.1126/science.1148028; Helmberger D, 2005, P NATL ACAD SCI USA, V102, P17257, DOI 10.1073/pnas.0502504102; Hernlund JW, 2005, NATURE, V434, P882, DOI 10.1038/nature03472; Hustoft J, 2008, AM MINERAL, V93, P1654, DOI 10.2138/am.2008.2938; Ishii M, 2004, PHYS EARTH PLANET IN, V146, P113, DOI 10.1016/j.pepi.2003.06.012; Lay T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032465; LEBENSOHN RA, 1994, MAT SCI ENG A-STRUCT, V175, P71, DOI 10.1016/0921-5093(94)91047-2; Long MD, 2006, PHYS EARTH PLANET IN, V156, P75, DOI 10.1016/j.pepi.2006.02.006; Loubet N, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002492; Lutterotti L, 1997, J APPL PHYS, V81, P594, DOI 10.1063/1.364220; Masters G., 2000, EARTHS DEEP INTERIOR, V117, P63, DOI DOI 10.1029/GM117P0063; McNamara AK, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001970; McNamara AK, 2005, NATURE, V437, P1136, DOI 10.1038/nature04066; Merkel S, 2006, SCIENCE, V311, P644, DOI 10.1126/science.1121808; Merkel S, 2007, SCIENCE, V316, P1729, DOI 10.1126/science.1140609; Metsue A, 2009, PHYS EARTH PLANET IN, V174, P165, DOI 10.1016/j.pepi.2008.04.003; Miyagi L, 2008, EARTH PLANET SC LETT, V268, P515, DOI 10.1016/j.epsl.2008.02.005; Miyajima N, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025001; Murakami M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021956; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Niwa K, 2007, PHYS CHEM MINER, V34, P679, DOI 10.1007/s00269-007-0182-6; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; Ohta K, 2006, GEOCHIM COSMOCHIM AC, V70, pA454, DOI 10.1016/j.gca.2006.06.915; Okada T, 2010, PHYS EARTH PLANET IN, V180, P195, DOI 10.1016/j.pepi.2009.08.002; Panning M, 2004, SCIENCE, V303, P351, DOI 10.1126/science.1091524; Santillan J, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026423; Shim SH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019639; Stackhouse S, 2005, EARTH PLANET SC LETT, V230, P1, DOI 10.1016/j.epsl.2004.11.021; Tackley PJ, 2000, SCIENCE, V288, P2002, DOI 10.1126/science.288.5473.2002; Tsuchiya T, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.144119; van der Hilst RD, 2007, SCIENCE, V315, P1813, DOI 10.1126/science.1137867; Walte NP, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036840; Wookey J, 2007, GEOPHYS MONOGR SER, V174, P171, DOI 10.1029/174GM13; Yamazaki D, 2006, EARTH PLANET SC LETT, V252, P372, DOI 10.1016/j.epsl.2006.10.004	37	73	75	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2010	329	5999					1639	1641		10.1126/science.1192465	http://dx.doi.org/10.1126/science.1192465			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929846				2022-12-28	WOS:000282098100039
J	Volpp, KG; Friedman, W; Romano, PS; Rosen, A; Silber, JH				Volpp, Kevin G.; Friedman, William; Romano, Patrick S.; Rosen, Amy; Silber, Jeffrey H.			Residency Training at a Crossroads: Duty-Hour Standards 2010	ANNALS OF INTERNAL MEDICINE			English	Article							MORTALITY; RISK; SLEEP; TIME	In 2003, the Accreditation Council for Graduate Medical Education (ACGME) implemented a single duty-hour standard nationwide. The evidence to date suggests that this neither improved nor worsened patient outcomes. In June 2010, the ACGME proposed a new set of duty-hour standards for implementation in July 2011. The main disadvantage of this approach is that there is no ability to determine whether different standards would have worked better to reduce resident fatigue while improving patient safety. Many unanswered questions remain about how to design duty-hour standards, but relatively little evidence exists. In addition, the same approach may not work in all specialties and all hospitals. A more flexible, dynamic policy that emphasizes ongoing testing and evaluation would be more likely to achieve improvements in clinical and educational outcomes.	[Silber, Jeffrey H.] Childrens Hosp Philadelphia, Ctr Outcomes Res, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; Univ Penn, Leonard Davis Inst Hlth Econ, Ctr Hlth Incent, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; Univ Florida, Gainesville, FL 32610 USA; Univ Calif Davis, Sch Med, Ctr Healthcare Policy & Res, Sacramento, CA 95817 USA; Vet Affairs Boston Healthcare Syst, Ctr Org Leadership & Management Res, Boston, MA USA; Boston Univ, Sch Publ Hlth, Boston, MA USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; State University System of Florida; University of Florida; University of California System; University of California Davis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University	Silber, JH (corresponding author), Childrens Hosp Philadelphia, Ctr Outcomes Res, 3535 Market St,Suite 1029, Philadelphia, PA 19104 USA.	silber@email.chop.edu	Romano, Patrick S/N-4225-2014; Friedman, William/GLR-1220-2022	Romano, Patrick S/0000-0001-6749-3979; Volpp, Kevin/0000-0003-1423-4599	National Heart, Lung, and Blood Institute [R01 HL082637]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082637] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By grant R01 HL082637 from the National Heart, Lung, and Blood Institute.	Antiel RM, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMp1008305; Arora VM, 2008, QUAL SAF HEALTH CARE, V17, P11, DOI 10.1136/qshc.2006.018952; Arora V, 2006, ANN INTERN MED, V144, P792, DOI 10.7326/0003-4819-144-11-200606060-00005; Arora VM, 2009, J HOSP MED, V4, P433, DOI 10.1002/jhm.573; Ayas NT, 2006, JAMA-J AM MED ASSOC, V296, P1055, DOI 10.1001/jama.296.9.1055; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Ericsson KA, 2008, ACAD EMERG MED, V15, P988, DOI 10.1111/j.1553-2712.2008.00227.x; Kirch DG, 2010, COMMUNICATION   0809; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Nasca P., 2010, BASICS ZYNADDSUBFX; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Pollack R, 2010, COMMUNICATION   0806; Richardson GS, 1996, SLEEP, V19, P718; Rosen AK, 2009, MED CARE, V47, P723, DOI 10.1097/MLR.0b013e31819a588f; Shetty KD, 2007, ANN INTERN MED, V147, P73, DOI 10.7326/0003-4819-147-2-200707170-00161; Silber JH, 2009, MED CARE, V47, P1191, DOI 10.1097/MLR.0b013e3181adcbff; Ulmer C, 2009, RESIDENT DUTY HOURS: ENHANCING SLEEP, SUPERVISION, AND SAFETY, P1; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P1197, DOI 10.1001/jama.300.10.1197; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Volpp KG, 2009, J GEN INTERN MED, V24, P1149, DOI 10.1007/s11606-009-1011-z	22	15	15	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12					826	+		10.7326/0003-4819-153-12-201012210-00287	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-00287			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	20956679	Green Accepted			2022-12-28	WOS:000285453700006
J	Waldo, GL; Ricks, TK; Hicks, SN; Cheever, ML; Kawano, T; Tsuboi, K; Wang, XY; Montell, C; Kozasa, T; Sondek, J; Harden, TK				Waldo, Gary L.; Ricks, Tiffany K.; Hicks, Stephanie N.; Cheever, Matthew L.; Kawano, Takeharu; Tsuboi, Kazuhito; Wang, Xiaoyue; Montell, Craig; Kozasa, Tohru; Sondek, John; Harden, T. Kendall			Kinetic Scaffolding Mediated by a Phospholipase C-beta and G(q) Signaling Complex	SCIENCE			English	Article							G-PROTEIN; RGS PROTEINS; ACTIVATION; RECEPTOR; DETERMINANTS; RECOGNITION; HYDROLYSIS; REGULATORS; SUBUNIT; BINDING	Transmembrane signals initiated by a broad range of extracellular stimuli converge on nodes that regulate phospholipase C (PLC)-dependent inositol lipid hydrolysis for signal propagation. We describe how heterotrimeric guanine nucleotide-binding proteins (G proteins) activate PLC-beta s and in turn are deactivated by these downstream effectors. The 2.7-angstrom structure of PLC-beta 3 bound to activated G alpha(q) reveals a conserved module found within PLC-beta s and other effectors optimized for rapid engagement of activated G proteins. The active site of PLC-beta 3 in the complex is occluded by an intramolecular plug that is likely removed upon G protein-dependent anchoring and orientation of the lipase at membrane surfaces. A second domain of PLC-beta 3 subsequently accelerates guanosine triphosphate hydrolysis by G alpha(q), causing the complex to dissociate and terminate signal propagation. Mutations within this domain dramatically delay signal termination in vitro and in vivo. Consequently, this work suggests a dynamic catch-and-release mechanism used to sharpen spatiotemporal signals mediated by diverse sensory inputs.	[Waldo, Gary L.; Ricks, Tiffany K.; Hicks, Stephanie N.; Cheever, Matthew L.; Sondek, John; Harden, T. Kendall] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Kawano, Takeharu; Tsuboi, Kazuhito; Kozasa, Tohru] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Wang, Xiaoyue; Montell, Craig] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Biol Chem, Baltimore, MD 21205 USA; [Wang, Xiaoyue; Montell, Craig] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Neurosci, Baltimore, MD 21205 USA; [Kozasa, Tohru] Univ Tokyo, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med, Tokyo 1538904, Japan; [Sondek, John] Univ N Carolina, Sch Med, Dept Biochem, Chapel Hill, NC 27599 USA; [Sondek, John; Harden, T. Kendall] Univ N Carolina, Sch Med, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; Johns Hopkins University; University of Tokyo; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Harden, TK (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA.	tkh@med.unc.edu	Wang, Xiaoyue/D-1046-2010; Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482; Sondek, John/0000-0002-1127-8310	NIH [GM38213, GM57391, GM61454, GM074001, EY010852]; Ruth L. Kirschstein National Service [F31]; United Negro College; Japan Society for the Promotion of Science; NATIONAL EYE INSTITUTE [R01EY010852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038213, R01GM061454, R01GM074001, R01GM057391, R01GM062299] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Negro College; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH grants GM38213 and GM57391 (J.S. and T.K.H.), GM61454 and GM074001 (T.K.), and EY010852 (C.M.). T.K.R. was supported by a Ruth L. Kirschstein National Service Award F31 Predoctoral Fellowship and a United Negro College Fund Merck Graduate Science Research Dissertation Fellowship. K.T. was supported by a Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science. We acknowledge the outstanding help with structural analyses by B. Temple, L. Betts, J. Vanhooke, T. Charpentier, V. Arshavsky, and M. Kosloff; with analysis of linker-deleted PLC-beta 3 by N. Vincent Jordan; with SPR analyses by A. Kimple; with [gamma<SUP>32</SUP>P]GTP purification by E. Lazarowski and the insightful comments on the manuscript by H. Dohlman, R. Nicholas, E. Ross, and K. Slep. Coordinates and structure factors for Ga<INF>q</INF>center dot PLC-b3 have been deposited under the PDB accession code 3OHM.	Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; MICHELL RH, 1975, BIOCHIM BIOPHYS ACTA, V415, P81, DOI 10.1016/0304-4157(75)90017-9; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Shankaranarayanan A, 2008, J BIOL CHEM, V283, P34923, DOI 10.1074/jbc.M805860200; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Skiba NP, 2000, J BIOL CHEM, V275, P32716, DOI 10.1074/jbc.C000413200; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Slep KC, 2008, P NATL ACAD SCI USA, V105, P6243, DOI 10.1073/pnas.0801569105; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Turcotte M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000148; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Venkatakrishnan G, 1996, J BIOL CHEM, V271, P5066; WALDO GL, 1991, J BIOL CHEM, V266, P14217; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Xiao WB, 2009, CANCER CELL, V16, P161, DOI 10.1016/j.ccr.2009.05.018; Zhong HL, 2003, J BIOL CHEM, V278, P7278, DOI 10.1074/jbc.M208819200	39	140	143	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2010	330	6006					974	980		10.1126/science.1193438	http://dx.doi.org/10.1126/science.1193438			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	20966218	Green Accepted			2022-12-28	WOS:000284118000046
J	Wen, LS				Wen, Leana S.			Red Sox Cap	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												lwen@partners.org		Wen, Leana/0000-0003-0259-0537					0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2010	304	16					1766	1767		10.1001/jama.2010.1532	http://dx.doi.org/10.1001/jama.2010.1532			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671JZ	20978249				2022-12-28	WOS:000283501300001
J	Hayne, PO; Greenhagen, BT; Foote, MC; Siegler, MA; Vasavada, AR; Paige, DA				Hayne, Paul O.; Greenhagen, Benjamin T.; Foote, Marc C.; Siegler, Matthew A.; Vasavada, Ashwin R.; Paige, David A.			Diviner Lunar Radiometer Observations of the LCROSS Impact	SCIENCE			English	Article							SURFACE	The Lunar Reconnaissance Orbiter (LRO) Diviner instrument detected a thermal emission signature 90 seconds after the Lunar Crater Observation and Sensing Satellite (LCROSS) Centaur impact and on two subsequent orbits. The impact heated a region of 30 to 200 square meters to at least 950 kelvin, providing a sustained heat source for the sublimation of up to similar to 300 kilograms of water ice during the 4 minutes of LCROSS post-impact observations. Diviner visible observations constrain the mass of the sunlit ejecta column to be similar to 10(-6) to 10(-5) kilograms per square meter, which is consistent with LCROSS estimates used to derive the relative abundance of the ice within the regolith.	[Hayne, Paul O.; Siegler, Matthew A.; Paige, David A.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Greenhagen, Benjamin T.; Foote, Marc C.; Vasavada, Ashwin R.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of California System; University of California Los Angeles; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Hayne, PO (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.	phayne@ucla.edu	Greenhagen, Benjamin T/C-3760-2016	Greenhagen, Benjamin T/0000-0002-8252-9922; Hayne, Paul/0000-0003-4399-0449				BELYAKOV GV, 1977, COMBUST EXPLO SHOCK+, V13, P524; BRASLAU D, 1970, J GEOPHYS RES, V75, P3987, DOI 10.1029/JB075i020p03987; Carrier W. D.  III, 1973, Moon, V6, P250, DOI 10.1007/BF00562206; Colaprete A, 2010, SCIENCE, V330, P463, DOI 10.1126/science.1186986; FANALE FP, 1984, ICARUS, V60, P476, DOI 10.1016/0019-1035(84)90157-X; FOOTE EJ, 2009, 40 LUN PLAN SCI C; Gladstone GR, 2010, SCIENCE, V330, P472, DOI 10.1126/science.1186474; Paige DA, 2010, SPACE SCI REV, V150, P125, DOI 10.1007/s11214-009-9529-2; Paige DA, 2010, SCIENCE, V330, P479, DOI 10.1126/science.1187726; Rehfuss D. E., 1974, Moon, V11, P19, DOI 10.1007/BF01877790; Schultz PH, 2010, SCIENCE, V330, P468, DOI 10.1126/science.1187454; Vasavada AR, 1999, ICARUS, V141, P179, DOI 10.1006/icar.1999.6175; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033; Zhang JA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038614	14	50	54	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					477	479		10.1126/science.1197135	http://dx.doi.org/10.1126/science.1197135			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966245				2022-12-28	WOS:000283329100031
J	Ghoreschi, K; Laurence, A; Yang, XP; Tato, CM; McGeachy, MJ; Konkel, JE; Ramos, HL; Wei, L; Davidson, TS; Bouladoux, N; Grainger, JR; Chen, QA; Kanno, Y; Watford, WT; Sun, HW; Eberl, G; Shevach, E; Belkaid, Y; Cua, DJ; Chen, WJ; O'Shea, JJ				Ghoreschi, Kamran; Laurence, Arian; Yang, Xiang-Ping; Tato, Cristina M.; McGeachy, Mandy J.; Konkel, Joanne E.; Ramos, Haydee L.; Wei, Lai; Davidson, Todd S.; Bouladoux, Nicolas; Grainger, John R.; Chen, Qian; Kanno, Yuka; Watford, Wendy T.; Sun, Hong-Wei; Eberl, GerRard; Shevach, EthanM.; Belkaid, Yasmine; Cua, Daniel J.; Chen, WanJun; O'Shea, John J.			Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling	NATURE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; HELPER-CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; PROINFLAMMATORY IL-17(+); TH17 CELLS; IN-VIVO; DIFFERENTIATION; LINEAGE; INFLAMMATION	CD4(+) T-helper cells that selectively produce interleukin (IL)-17 (T(H)17), are critical for host defence and autoimmunity(1-4). Although crucial for T(H)17 cells in vivo(5,6), IL-23 has been thought to be incapable of driving initial differentiation. Rather, IL-6 and transforming growth factor (TGF)-beta 1 have been proposed to be the factors responsible for initiating specification(7-10). Here we show that T(H)17 differentiation can occur in the absence of TGF-beta signalling. Neither IL-6 nor IL-23 alone efficiently generated T(H)17 cells; however, these cytokines in combination with IL-1 beta effectively induced IL-17 production in naive precursors, independently of TGF-beta. Epigenetic modification of the Il17a, Il17f and Rorc promoters proceeded without TGF-beta 1, allowing the generation of cells that co-expressed ROR gamma t (encoded by Rorc) and T-bet. T-bet(+)ROR gamma t(+) T(H)17 cells are generated in vivo during experimental allergic encephalomyelitis, and adoptively transferred T(H)17 cells generated with IL-23 without TGF-beta 1 were pathogenic in this disease model. These data indicate an alternative mode for T(H)17 differentiation. Consistent with genetic data linking IL23R with autoimmunity, our findings re-emphasize the importance of IL-23 and therefore may have therapeutic implications.	[Ghoreschi, Kamran; Laurence, Arian; Yang, Xiang-Ping; Ramos, Haydee L.; Wei, Lai; Kanno, Yuka; Watford, Wendy T.; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Tato, Cristina M.; McGeachy, Mandy J.; Cua, Daniel J.] Merck Res Labs, Palo Alto, CA 94304 USA; [Konkel, Joanne E.; Chen, WanJun] Natl Inst Dent & Craniofacial Res, Mucosal Immunol Unit, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA; [Davidson, Todd S.; Chen, Qian; Shevach, EthanM.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Bouladoux, Nicolas; Grainger, John R.; Belkaid, Yasmine] NIAID, Mucosal Immunol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Sun, Hong-Wei] NIAMSD, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Eberl, GerRard] Inst Pasteur, Lymphoid Tissue Dev Unit, F-75724 Paris, France	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Merck & Company; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ghoreschi, K (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	ghoreschik@mail.nih.gov; osheajo@mail.nih.gov	Wei, Lai/D-1088-2014; Laurence, Arian/A-8770-2009; Eberl, Gerard/A-1160-2013; Yang, Xiangping/B-4833-2011; Kanno, Yuka/B-5802-2013	Laurence, Arian/0000-0003-0942-8292; Kanno, Yuka/0000-0001-5668-9319; Bouladoux, Nicolas/0000-0003-1593-671X; Eberl, Gerard/0000-0002-1119-5638; Grainger, John/0000-0002-4052-5923; Watford, Wendy/0000-0003-4261-5399; Ghoreschi, Kamran/0000-0002-5526-7517; Tato, Cristina M./0000-0002-0614-756X; Belkaid, Yasmine/0000-0001-9962-3571; Yang, Xiang-Ping/0000-0001-9003-1772	NIAMS; NIDCR; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000224, ZIAAI001132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159, ZIHAR041173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000101] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank J. Simone, J. Lay (Flow Cytometry Section, NIAMS) and the NIAMS LACU staff for technical support. This work has been supported by the Intramural Research Programs of NIAMS, NIDCR and NIAID.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Das J, 2009, J EXP MED, V206, P2407, DOI 10.1084/jem.20082286; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	34	1013	1055	2	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					967	U144		10.1038/nature09447	http://dx.doi.org/10.1038/nature09447			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962846	Green Accepted			2022-12-28	WOS:000283254700039
J	Keshavjee, S; Girard, F; Harrington, M; Farmer, PE				Keshavjee, Salmaan; Girard, Francoise; Harrington, Mark; Farmer, Paul E.			Time for a bold new vision at the Stop TB Partnership	LANCET			English	Editorial Material							MULTIDRUG-RESISTANT TUBERCULOSIS		[Keshavjee, Salmaan; Farmer, Paul E.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Program Infect Dis & Social Change, Boston, MA 02115 USA; [Keshavjee, Salmaan; Farmer, Paul E.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Keshavjee, Salmaan; Farmer, Paul E.] Partners Hlth, Boston, MA USA; [Girard, Francoise] Open Soc Fdn, New York, NY USA; [Harrington, Mark] Treatment Act Grp, New York, NY USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Partners Healthcare System	Keshavjee, S (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Program Infect Dis & Social Change, Boston, MA 02115 USA.	salmaan_keshavjee@hms.harvard.edu		Keshavjee, Salmaan/0000-0002-6967-3305				[Anonymous], 2010, MULTIDRUG EXTENSIVEL; Broekmans J., 2005, INVESTING STRATEGIES, P4; Keshavjee S, 2008, ANN NY ACAD SCI, V1136, P1, DOI 10.1196/annals.1425.009; Keshavjee S, 2010, INT J TUBERC LUNG D, V14, P1222; Keshavjee S, 2008, STEMMING TIDE MULTID; Lindert K., 2007, NUTS BOLTS BRAZILS B; *STOP TB PARTN, 2010, BAS FRAM PARTN STOP; Szreter S, 2002, AM J PUBLIC HEALTH, V92, P722, DOI 10.2105/AJPH.92.5.722; United Nations, 2010, MILL DEV GOALS REP 2; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665	10	2	4	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 16	2010	376	9749					1283	1284		10.1016/S0140-6736(10)61887-9	http://dx.doi.org/10.1016/S0140-6736(10)61887-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	671RX	20951876				2022-12-28	WOS:000283528600008
J	Currie, TE; Greenhill, SJ; Gray, RD; Hasegawa, T; Mace, R				Currie, Thomas E.; Greenhill, Simon J.; Gray, Russell D.; Hasegawa, Toshikazu; Mace, Ruth			Rise and fall of political complexity in island South-East Asia and the Pacific	NATURE			English	Article							EVOLUTION	There is disagreement about whether human political evolution has proceeded through a sequence of incremental increases in complexity, or whether larger, non-sequential increases have occurred. The extent to which societies have decreased in complexity is also unclear. These debates have continued largely in the absence of rigorous, quantitative tests. We evaluated six competing models of political evolution in Austronesian-speaking societies using phylogenetic methods. Here we show that in the best-fitting model political complexity rises and falls in a sequence of small steps. This is closely followed by another model in which increases are sequential but decreases can be either sequential or in bigger drops. The results indicate that large, non-sequential jumps in political complexity have not occurred during the evolutionary history of these societies. This suggests that, despite the numerous contingent pathways of human history, there are regularities in cultural evolution that can be detected using computational phylogenetic methods.	[Currie, Thomas E.; Hasegawa, Toshikazu] Univ Tokyo, Grad Sch Arts & Sci, Evolutionary Cognit Sci Res Ctr, Tokyo 1538902, Japan; [Currie, Thomas E.; Mace, Ruth] UCL, Dept Anthropol, Human Evolutionary Ecol Grp, London WC1H 0BW, England; [Greenhill, Simon J.; Gray, Russell D.] Univ Auckland, Dept Psychol, Auckland 1142, New Zealand; [Greenhill, Simon J.] Univ Auckland, Computat Evolut Grp, Auckland 1142, New Zealand	University of Tokyo; University of London; University College London; University of Auckland; University of Auckland	Currie, TE (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Evolutionary Cognit Sci Res Ctr, Tokyo 1538902, Japan.	t.currie@ucl.ac.uk	Greenhill, Simon/I-3554-2019; Greenhill, Simon J/B-3114-2011; Gray, Russell/H-2078-2015	Greenhill, Simon/0000-0001-7832-6156; Greenhill, Simon J/0000-0001-7832-6156; Gray, Russell/0000-0002-9858-0191; Mace, Ruth/0000-0002-6137-7739	ESRC/NERC; Japan Society for the Promotion of Science; Royal Society of New Zealand; European Research Council	ESRC/NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)Economic & Social Research Council (ESRC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Royal Society of New Zealand(Royal Society of New Zealand); European Research Council(European Research Council (ERC)European Commission)	We thank R. Green, who passed away recently, for his advice and support of phylogenetic studies of cultural evolution. We thank R. Foley and M. Dunn for their comments during an earlier stage of this research, and R. Blust and A. Pawley for comments on the manuscript. T.C. was supported by an ESRC/NERC Interdisciplinary Studentship and a Japan Society for the Promotion of Science Postdoctoral Fellowship. S.G. and R.G. were supported by the Royal Society of New Zealand Marsden Fund. R.M. was supported by a European Research Council grant.	[Anonymous], 1999, CHIEFDOMS PATHWAYS C, DOI DOI 10.1017/CBO9780511558238.002; [Anonymous], 1997, GUNS GERMS STEEL; BELLWOOD P, 1996, ORIGINS ANCESTRY ALL, P19; Bondarenko D. M., 2002, SOCIAL EVOLUTION HIS, V1, P54; Campbell RB, 2009, CURR ANTHROPOL, V50, P821, DOI 10.1086/648398; Carneiro Robert L., 2003, EVOLUTIONISM CULTURA; Currie TE, 2009, P NATL ACAD SCI USA, V106, P7339, DOI 10.1073/pnas.0804698106; Dennett DC., 1996, DARWINS DANGEROUS ID; Flannery KV, 1972, ANNU REV ECOL SYST, V3, P399, DOI DOI 10.1146/ANNUREV.ES.03.110172.002151; Glover I., 2004, SE ASIA PREHISTORY H; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Hage P., 1999, ASIAN PERSPECT, V38, P200; Hazen RM, 2010, ELEMENTS, V6, P43, DOI 10.2113/gselements.6.1.43; Johnson Allen, 2000, EVOLUTION HUMAN SOC; Jordan FM, 2009, P ROY SOC B-BIOL SCI, V276, P1957, DOI 10.1098/rspb.2009.0088; KIRCH PV, 2001, RC HAWAIKI ANCESTRAL; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; Mace R, 2005, TRENDS ECOL EVOL, V20, P116, DOI 10.1016/j.tree.2004.12.002; Marcos S, 2008, EUR PHYS J A, V37, P251, DOI 10.1140/epja/i2008-10619-1; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Richerson PJ, 2009, HUM BIOL, V81, P211, DOI 10.3378/027.081.0306; Richerson PJ., 2001, P BR ACAD, V110, P197; Service E.R., 1962, PRIMITIVE SOCIAL ORG; SPENCER CS, 1990, J ANTHROPOL ARCHAEOL, V9, P1, DOI 10.1016/0278-4165(90)90004-W; Tainter JA, 2006, ANNU REV ANTHROPOL, V35, P59, DOI 10.1146/annurev.anthro.35.081705.123136; Turchin P, 2009, SOC EVOL HIST, V8, P167; Wright HT, 2006, J ANTHROPOL RES, V62, P305, DOI 10.3998/jar.0521004.0062.301; Yoffee N., 1993, ARCHAEOLOGICAL THEOR, P60; Yoffee Norman, 2005, MYTHS ARCHAIC STATE	30	129	132	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					801	804		10.1038/nature09461	http://dx.doi.org/10.1038/nature09461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944739				2022-12-28	WOS:000282898700057
J	Kappos, L; Mehling, M				Kappos, Ludwig; Mehling, Matthias			Dissociation of Voluntary and Emotional Innervation after Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kappos, Ludwig; Mehling, Matthias] Univ Basel Hosp, CH-4031 Basel, Switzerland	University of Basel	Kappos, L (corresponding author), Univ Basel Hosp, CH-4031 Basel, Switzerland.	lkappos@uhbs.ch		Mehling, Matthias/0000-0001-8599-1226					0	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2010	363	16					E25	E25		10.1056/NEJMicm0900573	http://dx.doi.org/10.1056/NEJMicm0900573			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663KP	20942661				2022-12-28	WOS:000282887100011
J	Coutts, G				Coutts, Gordon			Commentary: RECORD response	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Coutts, Gordon] Colchester Hosp Univ Fdn Trust, Colchester CO4 5JL, Essex, England		Coutts, G (corresponding author), Colchester Hosp Univ Fdn Trust, Colchester CO4 5JL, Essex, England.	Gordon.Coutts@colchesterhospital.nhs.uk						Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; MARCINIAK TA, 2010, FDA BRIEFING DOCUMEN	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 12	2010	341								c5409	10.1136/bmj.c5409	http://dx.doi.org/10.1136/bmj.c5409			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663KN	20940216				2022-12-28	WOS:000282886900009
J	Dillon, ME; Wang, G; Huey, RB				Dillon, Michael E.; Wang, George; Huey, Raymond B.			Global metabolic impacts of recent climate warming	NATURE			English	Article							TEMPERATURE; ECTOTHERMS; ANIMALS; ECOLOGY; PLANTS; SHIFT; SIZE; MASS	Documented shifts in geographical ranges(1,2), seasonal phenology(3,4), community interactions(5), genetics(3,6) and extinctions(7) have been attributed to recent global warming(8-10). Many such biotic shifts have been detected at mid-to high latitudes in the Northern Hemisphere(4,9,10)-a latitudinal pattern that is expected(4,8,10,11) because warming is fastest in these regions(8). In contrast, shifts in tropical regions are expected to be less marked(4,8,10,11) because warming is less pronounced there(8). However, biotic impacts of warming are mediated through physiology, and metabolic rate, which is a fundamental measure of physiological activity and ecological impact, increases exponentially rather than linearly with temperature in ectotherms(12). Therefore, tropical ectotherms (with warm baseline temperatures) should experience larger absolute shifts in metabolic rate than the magnitude of tropical temperature change itself would suggest, but the impact of climate warming on metabolic rate has never been quantified on a global scale. Here we show that estimated changes in terrestrial metabolic rates in the tropics are large, are equivalent in magnitude to those in the north temperate-zone regions, and are in fact far greater than those in the Arctic, even though tropical temperature change has been relatively small. Because of temperature's nonlinear effects on metabolism, tropical organisms, which constitute much of Earth's biodiversity, should be profoundly affected by recent and projected climate warming(2,13,14).	[Dillon, Michael E.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Wang, George; Huey, Raymond B.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Wyoming; University of Washington; University of Washington Seattle	Dillon, ME (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	Michael.Dillon@uwyo.edu	Huey, Raymond/F-1597-2010; Dillon, Michael/A-2564-2012	Dillon, Michael/0000-0002-7263-5537; Huey, Raymond/0000-0002-4962-8670	NSF [IOB-041684]	NSF(National Science Foundation (NSF))	We thank T. L. Daniel, C. Martinez del Rio, W. R. Rice and J. Tewksbury for discussion, and S. L. Chown for sharing his data on latitudinal variation in E. Research was funded in part by NSF IOB-041684 to R.B.H. and by an NSF Minority Postdoctoral Fellowship to M.E.D.	Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; Clarke A, 2006, FUNCT ECOL, V20, P405, DOI 10.1111/j.1365-2435.2006.01109.x; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; del Rio CM, 2008, TRENDS ECOL EVOL, V23, P256, DOI 10.1016/j.tree.2008.01.010; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Downs CJ, 2008, FUNCT ECOL, V22, P239, DOI 10.1111/j.1365-2435.2007.01371.x; DUNHAM AE, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P95; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hastings D. A., 1999, GLOBAL LAND ONE KILO; HERTZ PE, 1993, AM NAT, V142, P796, DOI 10.1086/285573; IPCC, 2007, CONTRIBUTION WORKING; Irlich UM, 2009, AM NAT, V174, P819, DOI 10.1086/647904; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Lott N., 2001, FCC INTEGRATED SURFA; O'Connor MP, 2007, OIKOS, V116, P1058, DOI 10.1111/j.2006.0030-1299.15534.x; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Portner HO, 2002, J EXP BIOL, V205, P2217; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Reich PB, 2006, NATURE, V439, P457, DOI 10.1038/nature04282; RICE WR, 1994, P NATL ACAD SCI USA, V91, P225, DOI 10.1073/pnas.91.1.225; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Savage VM, 2004, J THEOR BIOL, V227, P525, DOI 10.1016/j.jtbi.2003.11.030; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	32	584	600	12	568	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					704	U88		10.1038/nature09407	http://dx.doi.org/10.1038/nature09407			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20930843				2022-12-28	WOS:000282572500037
J	Laming, JM				Laming, J. Martin			More Supernova Surprises	SCIENCE			English	Editorial Material							SHOCK		USN, Res Lab, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Laming, JM (corresponding author), USN, Res Lab, Code 7674L, Washington, DC 20375 USA.	j.laming@nrl.navy.mil						CHEVALIER RA, 1982, ASTROPHYS J, V258, P790, DOI 10.1086/160126; France K, 2010, SCIENCE, V329, P1624, DOI 10.1126/science.1192134; Landau L.D., 1987, PHYS TODAY, V6; Liberman M.A., 1986, PHYS SHOCK WAVES GAS; Mancuso S, 2002, ASTRON ASTROPHYS, V383, P267, DOI 10.1051/0004-6361:20011721; MCKEE CF, 1974, ASTROPHYS J, V188, P335, DOI 10.1086/152721; Raymond JC, 2003, ASTROPHYS J, V597, P1106, DOI 10.1086/378663; Raymond JC, 2000, GEOPHYS RES LETT, V27, P1439, DOI 10.1029/1999GL003669	8	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1604	1605		10.1126/science.1196301	http://dx.doi.org/10.1126/science.1196301			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929831				2022-12-28	WOS:000282098100023
J	Scott, A; Khan, KM				Scott, Alexander; Khan, Karim M.			Corticosteroids: short-term gain for long-term pain?	LANCET			English	Editorial Material									[Khan, Karim M.] Univ British Columbia, Dept Family Practice, Ctr Hip Hlth & Mobil, Vancouver, BC V5Z 1M9, Canada; [Scott, Alexander] Univ British Columbia, Dept Phys Therapy, Ctr Hip Hlth & Mobil, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Khan, KM (corresponding author), Univ British Columbia, Dept Family Practice, Ctr Hip Hlth & Mobil, Vancouver, BC V5Z 1M9, Canada.	karim.khan@ubc.ca		Scott, Alex/0000-0003-0366-8404				Bisset L, 2006, BMJ-BRIT MED J, V333, P939, DOI 10.1136/bmj.38961.584653.AE; BUCHBINDER R, 2009, COCHRANE DB SYST REV, V1; Coombes BK, 2010, LANCET, V376, P1751, DOI 10.1016/S0140-6736(10)61160-9; Croisier JL, 2007, BRIT J SPORT MED, V41, P269, DOI 10.1136/bjsm.2006.033324; Dimmen S, 2009, KNEE SURG SPORT TR A, V17, P835, DOI 10.1007/s00167-009-0763-7; Green S, 2002, COCHRANE DB SYST REV, V2; Helliwell PS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3037; Khan KM, 2009, BRIT J SPORT MED, V43, P247, DOI 10.1136/bjsm.2008.054239; Nichols AW, 2005, CLIN J SPORT MED, V15, P370; Stovitz SD, 2003, PHYSICIAN SPORTSMED, V31, P35, DOI 10.3810/psm.2003.01.160; Svernlov B, 2001, SCAND J MED SCI SPOR, V11, P328, DOI 10.1034/j.1600-0838.2001.110603.x	11	20	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 20	2010	376	9754					1714	1715		10.1016/S0140-6736(10)61308-6	http://dx.doi.org/10.1016/S0140-6736(10)61308-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	690EI	20970846				2022-12-28	WOS:000284984900005
J	Pen, I; Uller, T; Feldmeyer, B; Harts, A; While, GM; Wapstra, E				Pen, Ido; Uller, Tobias; Feldmeyer, Barbara; Harts, Anna; While, Geoffrey M.; Wapstra, Erik			Climate-driven population divergence in sex-determining systems	NATURE			English	Article							ADAPTIVE SIGNIFICANCE; OFFSPRING SEX; EVOLUTION; RATIO; SIZE	Sex determination is a fundamental biological process, yet its mechanisms are remarkably diverse(1,2). In vertebrates, sex can be determined by inherited genetic factors or by the temperature experienced during embryonic development(2,3). However, the evolutionary causes of this diversity remain unknown. Here we show that live-bearing lizards at different climatic extremes of the species' distribution differ in their sex-determining mechanisms, with temperature-dependent sex determination in lowlands and genotypic sex determination in highlands. A theoretical model parameterized with field data accurately predicts this divergence in sex-determining systems and the consequence thereof for variation in cohort sex ratios among years. Furthermore, we show that divergent natural selection on sex determination across altitudes is caused by climatic effects on lizard life history and variation in the magnitude of between-year temperature fluctuations. Our results establish an adaptive explanation for intra-specific divergence in sex-determining systems driven by phenotypic plasticity and ecological selection, thereby providing a unifying framework for integrating the developmental, ecological and evolutionary basis for variation in vertebrate sex determination.	[Pen, Ido; Feldmeyer, Barbara; Harts, Anna] Univ Groningen, Theoret Biol Grp, NL-9750 AA Haren, Netherlands; [Uller, Tobias] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [While, Geoffrey M.; Wapstra, Erik] Univ Tasmania, Sch Zool, Hobart, Tas 7001, Australia	University of Groningen; University of Oxford; University of Tasmania	Pen, I (corresponding author), Univ Groningen, Theoret Biol Grp, POB 14, NL-9750 AA Haren, Netherlands.	i.r.pen@rug.nl	While, Geoffrey M/O-6306-2017; Wapstra, Erik/J-7482-2014; Feldmeyer, Barbara/F-9652-2013; Feldmeyer, Barbara/E-5067-2015	While, Geoffrey M/0000-0001-8122-9322; Wapstra, Erik/0000-0002-2050-8026; Feldmeyer, Barbara/0000-0002-0413-7245	Australian Research Council [DP0877948]; Hermon Slade Foundation; Wenner-Gren Foundations	Australian Research Council(Australian Research Council); Hermon Slade Foundation; Wenner-Gren Foundations	Funding was provided by the Australian Research Council to E.W., T.U. and I.P. (DP0877948), by the Hermon Slade Foundation to E.W., T.U. and I.P., and by the Wenner-Gren Foundations to T.U.	Adolph SC, 1996, OIKOS, V77, P267, DOI 10.2307/3546065; Atkins N., 2007, THESIS U TASMANIA; Bull J.J., 1983, EVOLUTION SEX DETERM; BULMER MG, 1982, EVOLUTION, V36, P13, DOI 10.1111/j.1558-5646.1982.tb05005.x; Cadby CD, 2010, INTEGR ZOOL, V5, P164, DOI 10.1111/j.1749-4877.2010.00201.x; CHARNOV EL, 1977, NATURE, V266, P828, DOI 10.1038/266828a0; CONOVER DO, 1987, NATURE, V326, P496, DOI 10.1038/326496a0; CONOVER DO, 1984, AM NAT, V123, P297, DOI 10.1086/284205; Crews D, 2009, SEMIN CELL DEV BIOL, V20, P251, DOI 10.1016/j.semcdb.2009.02.004; Janzen FJ, 2006, J EVOLUTION BIOL, V19, P1775, DOI 10.1111/j.1420-9101.2006.01138.x; Leimar O, 2006, AM NAT, V167, P367, DOI 10.1086/499566; Melville J, 2000, BIOL J LINN SOC, V70, P667; Neaves L, 2006, J EXP ZOOL PART A, V305A, P74, DOI 10.1002/jez.a.249; Olsson M, 2002, EVOLUTION, V56, P1538; Ospina-Alvarez N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002837; Quinn AE, 2007, SCIENCE, V316, P411, DOI 10.1126/science.1135925; Radder R., 2009, CURR BIOL, V19, P1; Uller T, 2007, TRENDS ECOL EVOL, V22, P292, DOI 10.1016/j.tree.2007.03.008; Uller T, 2009, SEMIN CELL DEV BIOL, V20, P304, DOI 10.1016/j.semcdb.2008.11.013; Valenzuela N., 2004, TEMPERATURE DEPENDEN; Van Dooren TJM, 2003, EVOLUTION, V57, P2667, DOI 10.1554/03-280; Wapstra E, 2004, P ROY SOC B-BIOL SCI, V271, pS230, DOI 10.1098/rsbl.2003.0152; Wapstra E, 2001, COPEIA, P646, DOI 10.1643/0045-8511(2001)001[0646:GVIAAS]2.0.CO;2; Wapstra E, 2001, J HERPETOL, V35, P194, DOI 10.2307/1566108; Wapstra E, 2009, J ANIM ECOL, V78, P84, DOI 10.1111/j.1365-2656.2008.01470.x; Warner DA, 2008, NATURE, V451, P566, DOI 10.1038/nature06519; Warner DA, 2009, EVOL ECOL, V23, P281, DOI 10.1007/s10682-007-9222-4; West-Eberhard Mary Jane, 2003, pi	28	120	122	3	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					436	U262		10.1038/nature09512	http://dx.doi.org/10.1038/nature09512			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	20981009				2022-12-28	WOS:000284313100042
J	Becks, L; Agrawal, AF				Becks, Lutz; Agrawal, Aneil F.			Higher rates of sex evolve in spatially heterogeneous environments	NATURE			English	Article							DELETERIOUS MUTATIONS; RECOMBINATION; SELECTION; EVOLUTION; ADVANTAGE; INCREASES	The evolution and maintenance of sexual reproduction has puzzled biologists for decades(1,2). Although this field is rich in hypotheses(3-5), experimental evidence is scarce. Some important experiments have demonstrated differences in evolutionary rates between sexual and asexual populations(6-8); other experiments have documented evolutionary changes in phenomena related to genetic mixing, such as recombination(9,10) and selfing(11). However, direct experiments of the evolution of sex within populations are extremely rare (but see ref. 12). Here we use the rotifer, Brachionus calyciflorus, which is capable of both sexual and asexual reproduction, to test recent theory(13-15) predicting that there is more opportunity for sex to evolve in spatially heterogeneous environments. Replicated experimental populations of rotifers were maintained in homogeneous environments, composed of either high-or low-quality food habitats, or in heterogeneous environments that consisted of a mix of the two habitats. For populations maintained in either type of homogeneous environment, the rate of sex evolves rapidly towards zero. In contrast, higher rates of sex evolve in populations experiencing spatially heterogeneous environments. The data indicate that the higher level of sex observed under heterogeneity is not due to sex being less costly or selection against sex being less efficient; rather sex is sufficiently advantageous in heterogeneous environments to overwhelm its inherent costs(2). Counter to some alternative theories(16,17) for the evolution of sex, there is no evidence that genetic drift plays any part in the evolution of sex in these populations.	[Becks, Lutz; Agrawal, Aneil F.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada; [Becks, Lutz] Univ Cologne, Ctr Biol Sci, Inst Zool, Dept Gen Ecol, D-50931 Cologne, Germany	University of Toronto; University of Cologne	Becks, L (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada.	lutz.becks@utoronto.ca	Becks, Lutz/I-8256-2012		Volkswagen Foundation [I/83 517]; Natural Sciences and Engineering Research Council (Canada)	Volkswagen Foundation(Volkswagen); Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank C. Kearns and N. G. Hairston Jr for providing the sediment with resting eggs from which the Brachionus cultures were established. This research was funded by the Volkswagen Foundation to L.B. (I/83 517) and the Natural Sciences and Engineering Research Council (Canada) to A.F.A.	Agrawal AF, 2006, CURR BIOL, V16, pR696, DOI 10.1016/j.cub.2006.07.063; Agrawal AF, 2009, AM NAT, V174, pS54, DOI 10.1086/599082; Agrawal AF, 2009, EVOLUTION, V63, P2131, DOI 10.1111/j.1558-5646.2009.00695.x; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; BELL G, 1982, MASTERPIECE NATURE E; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Feldman MW, 1996, ANNU REV GENET, V30, P261, DOI 10.1146/annurev.genet.30.1.261; FELSENSTEIN J, 1976, ANNU REV GENET, V10, P253, DOI 10.1146/annurev.ge.10.120176.001345; FELSENSTEIN J, 1976, GENETICS, V83, P845; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; Gilbert JJ, 2003, LIMNOL OCEANOGR, V48, P1297, DOI 10.4319/lo.2003.48.3.1297; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Hadany L, 2007, GENETICS, V176, P1713, DOI 10.1534/genetics.107.074203; HEDRICK PW, 1986, ANNU REV ECOL SYST, V17, P535; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Keightley PD, 2006, NATURE, V443, P89, DOI 10.1038/nature05049; KONDRASHOV AS, 1984, GENET RES, V44, P199, DOI 10.1017/S0016672300026392; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; KOROL AB, 1994, HEREDITY, V72, P64, DOI 10.1038/hdy.1994.7; Lenormand T, 2000, GENETICS, V156, P423; MAYNARD SMITH J., 1978, EVOLUTION SEX; Morran LT, 2009, NATURE, V462, P350, DOI 10.1038/nature08496; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Otto SP, 2004, SCIENCE, V304, P1018, DOI 10.1126/science.1094072; Otto SP, 2001, EVOLUTION, V55, P1921, DOI 10.1111/j.0014-3820.2001.tb01310.x; Peters AD, 2007, J EVOLUTION BIOL, V20, P1206, DOI 10.1111/j.1420-9101.2006.01283.x; Poon A, 2004, GENETICS, V166, P19, DOI 10.1534/genetics.166.1.19; Pylkov KV, 1998, GENET RES, V71, P247, DOI 10.1017/S0016672398003243; Roze D, 2010, GENETICS, V184, P1095, DOI 10.1534/genetics.109.108258; Team R. D. C., 2009, R LANGUAGE ENV STAT; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; WOLF HG, 1987, GENETICA, V72, P151, DOI 10.1007/BF00123174	32	100	101	3	308	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					89	+		10.1038/nature09449	http://dx.doi.org/10.1038/nature09449			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20944628				2022-12-28	WOS:000283786900041
J	Ou, GS; Stuurman, N; D'Ambrosio, M; Vale, RD				Ou, Guangshuo; Stuurman, Nico; D'Ambrosio, Michael; Vale, Ronald D.			Polarized Myosin Produces Unequal-Size Daughters During Asymmetric Cell Division	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; STEM-CELLS; CYTOKINESIS; NEUROBLAST; MECHANISMS; MIGRATION; DYNAMICS	Asymmetric positioning of the mitotic spindle before cytokinesis can produce different-sized daughter cells that have distinct fates. Here, we found an asymmetric division in the Caenorhabditis elegans Q neuroblast lineage that began with a centered spindle but generated different-sized daughters, the smaller (anterior) of which underwent apoptosis. During this division, more myosin II accumulated anteriorly, suggesting that asymmetric contractile forces might produce different-sized daughters. Indeed, partial inactivation of anterior myosin by chromophore-assisted laser inactivation created a more symmetric division and allowed the survival and differentiation of the anterior daughter. Thus, the balance of myosin activity on the two sides of a dividing cell can govern the size and fate of the daughters.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ou, GS (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	gou@ibp.ac.cn; vale@cmp.ucsf.edu	Stuurman, Nico/AAV-4894-2021	Stuurman, Nico/0000-0002-6179-8613	Damon Runyon Cancer Research Foundation; NIH; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038499] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Cai, D. Sherwood, J. Ziel, P. Zhang, I. Cheeseman, C. Kenyon, G. Garriga, and Caenorhabditis Genetics Center for reagents, equipments and strains, and thank C. Locke and W. Li for myosin quantifications. This work was supported by the Damon Runyon Cancer Research Foundation (G.O.) and the NIH and Howard Hughes Medical Institute (R.D.V.).	Cabernard C, 2010, NATURE, V467, P91, DOI 10.1038/nature09334; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; Cordes S, 2006, DEVELOPMENT, V133, P2747, DOI 10.1242/dev.02447; Diefenbach TJ, 2002, J CELL BIOL, V158, P1207, DOI 10.1083/jcb.200202028; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Hickson GRX, 2006, CURR BIOL, V16, P359, DOI 10.1016/j.cub.2005.12.043; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Jacobson K, 2008, TRENDS CELL BIOL, V18, P443, DOI 10.1016/j.tcb.2008.07.001; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Monier B, 2010, NAT CELL BIOL, V12, P60, DOI 10.1038/ncb2005; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Ou GS, 2009, J CELL BIOL, V185, P77, DOI 10.1083/jcb.200812077; Schneider SQ, 2003, ANNU REV GENET, V37, P221, DOI 10.1146/annurev.genet.37.110801.142443; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Vale RD, 2009, J CELL BIOL, V186, P727, DOI 10.1083/jcb.200902083; Wang FS, 1996, SCIENCE, V273, P660, DOI 10.1126/science.273.5275.660; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	20	119	122	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					677	680		10.1126/science.1196112	http://dx.doi.org/10.1126/science.1196112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	20929735	Green Accepted			2022-12-28	WOS:000283580600050
J	Butrynski, JE; D'Adamo, DR; Hornick, JL; Dal Cin, P; Antonescu, CR; Jhanwar, SC; Ladanyi, M; Capelletti, M; Rodig, SJ; Ramaiya, N; Kwak, EL; Clark, JW; Wilner, KD; Christensen, JG; Janne, PA; Maki, RG; Demetri, GD; Shapiro, GI				Butrynski, James E.; D'Adamo, David R.; Hornick, Jason L.; Dal Cin, Paola; Antonescu, Cristina R.; Jhanwar, Suresh C.; Ladanyi, Marc; Capelletti, Marzia; Rodig, Scott J.; Ramaiya, Nikhil; Kwak, Eunice L.; Clark, Jeffrey W.; Wilner, Keith D.; Christensen, James G.; Jaenne, Pasi A.; Maki, Robert G.; Demetri, George D.; Shapiro, Geoffrey I.			Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANAPLASTIC LYMPHOMA; KINASE; EXPRESSION; INHIBITOR; IMATINIB; FUSION; 2P23; GENE	Inflammatory myofibroblastic tumor (IMT) is a distinctive mesenchymal neoplasm characterized by a spindle-cell proliferation with an inflammatory infiltrate. Approximately half of IMTs carry rearrangements of the anaplastic lymphoma kinase (ALK) locus on chromosome 2p23, causing aberrant ALK expression. We report a sustained partial response to the ALK inhibitor crizotinib (PF-02341066, Pfizer) in a patient with ALK-translocated IMT, as compared with no observed activity in another patient without the ALK translocation. These results support the dependence of ALK-rearranged tumors on ALK-mediated signaling and suggest a therapeutic strategy for genomically identified patients with the aggressive form of this soft-tissue tumor.	[Butrynski, James E.; Demetri, George D.] Dana Farber Harvard Canc Ctr, Ludwig Ctr, Boston, MA 02115 USA; [Butrynski, James E.; Hornick, Jason L.; Capelletti, Marzia; Rodig, Scott J.; Kwak, Eunice L.; Clark, Jeffrey W.; Jaenne, Pasi A.; Demetri, George D.; Shapiro, Geoffrey I.] Harvard Univ, Sch Med, Boston, MA USA; [Hornick, Jason L.; Dal Cin, Paola; Rodig, Scott J.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Kwak, Eunice L.; Clark, Jeffrey W.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [D'Adamo, David R.; Antonescu, Cristina R.; Jhanwar, Suresh C.; Ladanyi, Marc; Maki, Robert G.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Wilner, Keith D.; Christensen, James G.] Pfizer Global Res & Dev, La Jolla, CA USA; [Shapiro, Geoffrey I.] Dana Farber Canc Inst, Early Drug Dev Ctr, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Memorial Sloan Kettering Cancer Center; Pfizer; Harvard University; Dana-Farber Cancer Institute	Demetri, GD (corresponding author), Dana Farber Harvard Canc Ctr, Ludwig Ctr, Dana 1212,44 Binney St, Boston, MA 02115 USA.	gdemetri@partners.org; geoffrey_shapiro@dfci.harvard.edu	Maki, Robert G./AAI-2793-2020; Rodig, Scott/Y-3889-2019; Maki, Robert G/J-9145-2019; Ladanyi, Marc/AAG-8585-2019; Capelletti, Marzia/L-6317-2016	Maki, Robert G/0000-0002-9853-2528; Capelletti, Marzia/0000-0001-5095-7060; Hornick, Jason/0000-0001-6475-8345	National Institutes of Health [R01-CA136851, P01-CA47179, RC2-CA148260]; National Cancer Institute-American Society of Clinical Oncology Cancer Foundation; Cycle for Survival; NATIONAL CANCER INSTITUTE [P01CA047179, R01CA136851, RC2CA148260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute-American Society of Clinical Oncology Cancer Foundation; Cycle for Survival; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Pfizer and by grants from the National Institutes of Health (R01-CA136851, to Dr. Janne; and P01-CA47179 and RC2-CA148260, to Dr. Maki), a Clinical Investigator Team Leadership Supplemental Award from the National Cancer Institute-American Society of Clinical Oncology Cancer Foundation (to Dr. Maki), and a grant from Cycle for Survival (to Dr. Maki).	Berger A, 2007, UROLOGY, V70, DOI 10.1016/j.urology.2007.04.047; Christensen JG, 2007, MOL CANCER THER, V6, P3314, DOI 10.1158/1535-7163.MCT-07-0365; Coffin CM, 2007, AM J SURG PATHOL, V31, P509, DOI 10.1097/01.pas.0000213393.57322.c7; Coffin CM, 2001, MODERN PATHOL, V14, P569, DOI 10.1038/modpathol.3880352; COFFIN CM, 1995, AM J SURG PATHOL, V19, P859, DOI 10.1097/00000478-199508000-00001; Cook JR, 2001, AM J SURG PATHOL, V25, P1364, DOI 10.1097/00000478-200111000-00003; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Giuriato S, 2007, CANCER BIOL THER, V6, P1318; Gleason BC, 2008, J CLIN PATHOL, V61, P428, DOI 10.1136/jcp.2007.049387; Griffin CA, 1999, CANCER RES, V59, P2776; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Hornick JL, 2010, MODERN PATHOL, V23, p21A; Kwak EL, 2009, J CLIN ONCOL, V27; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Ladanyi M, 2000, AM J PATHOL, V157, P341, DOI 10.1016/S0002-9440(10)64545-2; Lawrence B, 2000, AM J PATHOL, V157, P377, DOI 10.1016/S0002-9440(10)64550-6; Ma ZG, 2003, GENE CHROMOSOME CANC, V37, P98, DOI 10.1002/gcc.10177; MEIS JM, 1991, AM J SURG PATHOL, V15, P1146, DOI 10.1097/00000478-199112000-00005; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; PETTINATO G, 1990, AM J CLIN PATHOL, V94, P538, DOI 10.1093/ajcp/94.5.538; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Webb TR, 2009, EXPERT REV ANTICANC, V9, P331, DOI 10.1586/14737140.9.3.331	25	561	595	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 28	2010	363	18					1727	1733		10.1056/NEJMoa1007056	http://dx.doi.org/10.1056/NEJMoa1007056			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671XF	20979472	Green Accepted, Bronze			2022-12-28	WOS:000283546400007
J	Pare, G; Mehta, SR; Yusuf, S; Anand, SS; Connolly, SJ; Hirsh, J; Simonsen, K; Bhatt, DL; Fox, KAA; Eikelboom, JW				Pare, Guillaume; Mehta, Shamir R.; Yusuf, Salim; Anand, Sonia S.; Connolly, Stuart J.; Hirsh, Jack; Simonsen, Katy; Bhatt, Deepak L.; Fox, Keith A. A.; Eikelboom, John W.			Effects of CYP2C19 Genotype on Outcomes of Clopidogrel Treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE CORONARY SYNDROMES; ATRIAL-FIBRILLATION; EVENTS; ASPIRIN; POLYMORPHISMS; RATIONALE; THERAPY; VARIANT; DESIGN; TRIAL	BACKGROUND It has been suggested that clopidogrel may be less effective in reducing the rate of cardiovascular events among persons who are carriers of loss-of-function CYP2C19 alleles that are associated with reduced conversion of clopidogrel to its active metabolite. METHODS We genotyped patients from two large, randomized trials that showed that clopidogrel, as compared with placebo, reduced the rate of cardiovascular events (the primary efficacy outcome) among patients with acute coronary syndromes and among patients with atrial fibrillation. Patients were genotyped for three single-nucleotide polymorphisms ((star)2, (star)3, (star)17) that define the major CYP2C19 alleles. RESULTS Among 5059 genotyped patients with acute coronary syndromes, clopidogrel as compared with placebo significantly reduced the rate of the primary efficacy outcome, irrespective of the genetically determined metabolizer phenotype (P = 0.12 for heterogeneity). The effect of clopidogrel in reducing the rate of the primary efficacy outcome was similar in patients who were heterozygous or homozygous for loss-of-function alleles and in those who were not carriers of the alleles (rate among carriers, 8.0% with clopidogrel vs. 11.6% with placebo; hazard ratio with clopidogrel, 0.69; 95% confidence interval [CI], 0.49 to 0.98; rate among noncarriers, 9.5% vs. 13.0%; hazard ratio, 0.72; 95% CI, 0.59 to 0.87). In contrast, gain-of-function carriers derived more benefit from clopidogrel treatment as compared with placebo than did noncarriers (rate of primary outcome among carriers, 7.7% vs. 13.0%; hazard ratio, 0.55; 95% CI, 0.42 to 0.73; rate among noncarriers, 10.0% vs. 12.2%; hazard ratio, 0.85; 95% CI, 0.68 to 1.05; P = 0.02 for interaction). The effect of clopidogrel on bleeding did not vary according to genotypic subgroups. Among 1156 genotyped patients with atrial fibrillation, there was no evidence of an interaction with respect to either efficacy or bleeding between the study treatment and the metabolizer phenotype, loss-of-function carrier status, or gain-of-function carrier status. CONCLUSIONS Among patients with acute coronary syndromes or atrial fibrillation, the effect of clopidogrel as compared with placebo is consistent, irrespective of CYP2C19 loss-of- function carrier status.	[Pare, Guillaume; Mehta, Shamir R.; Yusuf, Salim; Anand, Sonia S.; Connolly, Stuart J.; Hirsh, Jack; Eikelboom, John W.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [Pare, Guillaume] McMaster Univ, David Braley Cardiac Vasc & Stroke Res Inst, Dept Med, Hamilton, ON L8L 2X2, Canada; [Pare, Guillaume; Yusuf, Salim; Anand, Sonia S.] McMaster Univ, Dept Epidemiol, Hamilton, ON L8L 2X2, Canada; [Pare, Guillaume] McMaster Univ, Dept Pathol, Hamilton, ON L8L 2X2, Canada; [Simonsen, Katy] Bristol Myers Squibb Co, New York, NY 10154 USA; [Bhatt, Deepak L.] Brigham & Womens Hosp, Vet Affairs Boston Healthcare Syst, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA USA; [Fox, Keith A. A.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Fox, Keith A. A.] Royal Infirm, Edinburgh, Midlothian, Scotland	McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; Bristol-Myers Squibb; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Harvard Medical School; University of Edinburgh; Royal Infirmary of Edinburgh	Pare, G (corresponding author), Hamilton Hlth Sci, Populat Hlth Res Inst, 237 Barton St E,Rm C3-103, Hamilton, ON L8L 2X2, Canada.	pareg@mcmaster.ca	Fox, keith A A/I-3742-2013; Eikelboom, John/AAG-6117-2019; Simonsen, Katy/A-4193-2012; Pare, Guillaume/T-9631-2018	Eikelboom, John/0000-0003-4126-1285; Pare, Guillaume/0000-0002-6795-4760; Fox, Keith/0000-0002-0140-2752; Yusuf, Salim/0000-0003-4776-5601	Sanofi-Aventis; Bristol-Myers Squibb; AstraZeneca; Eli Lilly; Novartis; Eisai; Medicines Company; Bayer; Johnson Johnson	Sanofi-Aventis(Sanofi-Aventis); Bristol-Myers Squibb(Bristol-Myers Squibb); AstraZeneca(AstraZeneca); Eli Lilly(Eli Lilly); Novartis(Novartis); Eisai(Eisai Co Ltd); Medicines Company; Bayer(Bayer AG); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA)	The CURE and ACTIVE A studies were funded by Sanofi-Aventis and Bristol-Myers Squibb.; Dr. Pare reports receiving consulting fees from Sanofi-Aventis and Bristol-Myers Squibb; Dr. Mehta, receiving consulting fees from AstraZeneca, Eli Lilly, and Novartis and grant support and consulting fees from Sanofi-Aventis and Bristol-Myers Squibb; Dr. Yusuf, receiving consulting fees and grant support from Sanofi-Aventis and Bristol-Myers Squibb; Dr. Anand, receiving lecture fees from Bristol-Myers Squibb; Dr. Connolly, receiving board membership fees, consulting fees, and grant support from Sanofi-Aventis and Bristol-Myers Squibb; Dr. Simonsen, being employed by and owning stock in Bristol-Myers Squibb; Dr. Bhatt, receiving grant support from Sanofi-Aventis, Bristol-Myers Squibb, Eisai, AstraZeneca, and The Medicines Company; Dr. Fox, receiving consulting fees, grant support, and lecture fees from Sanofi-Aventis, grant support and lectures fees from Bayer and Johnson & Johnson, grant support from Eli Lilly, and reimbursement for travel accommodations from Boehringer Ingelheim; and Dr. Eikelboom, receiving consulting fees, grant support, and lecture fees from Sanofi-Aventis, Bristol-Myers Squibb, and AstraZeneca, consulting fees and grant support from Novartis, and consulting fees and lecture fees from Eli Lilly. No other potential conflict of interest relevant to this article was reported.	[Anonymous], HUMAN CYTOCHROME P45; Berger JS, 2009, CIRCULATION, V120, P2337, DOI 10.1161/CIRCULATIONAHA.109.866533; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Connolly S, 2006, AM HEART J, V151, P1187, DOI 10.1016/j.ahj.2005.06.026; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Desai NR, 2009, J AM COLL CARDIOL, V53, P1273, DOI 10.1016/j.jacc.2008.12.044; Frere C, 2009, J THROMB HAEMOST, V7, P1409, DOI 10.1111/j.1538-7836.2009.03500.x; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2010, CIRCULATION, V121, P512, DOI 10.1161/CIRCULATIONAHA.109.885194; Sim SC, 2006, CLIN PHARMACOL THER, V79, P103, DOI 10.1016/j.clpt.2005.10.002; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Yusuf S, 2003, CIRCULATION, V107, P966, DOI 10.1161/01.CIR.0000051362.96946.15; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2001, NEW ENGL J MED, V345, P1716; Yusuf S, 2000, EUR HEART J, V21, P2033; [No title captured]	19	407	440	2	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 28	2010	363	18					1704	1714		10.1056/NEJMoa1008410	http://dx.doi.org/10.1056/NEJMoa1008410			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671XF	20979470	Green Submitted, Bronze			2022-12-28	WOS:000283546400005
J	De Roock, W; Jonker, DJ; Di Nicolantonio, F; Sartore-Bianchi, A; Tu, DS; Siena, S; Lamba, S; Arena, S; Frattini, M; Piessevaux, H; Van Cutsem, E; O'Callaghan, CJ; Khambata-Ford, S; Zalcberg, JR; Simes, J; Karapetis, CS; Bardelli, A; Tejpar, S				De Roock, Wendy; Jonker, Derek J.; Di Nicolantonio, Federica; Sartore-Bianchi, Andrea; Tu, Dongsheng; Siena, Salvatore; Lamba, Simona; Arena, Sabrina; Frattini, Milo; Piessevaux, Hubert; Van Cutsem, Eric; O'Callaghan, Chris J.; Khambata-Ford, Shirin; Zalcberg, John R.; Simes, John; Karapetis, Christos S.; Bardelli, Alberto; Tejpar, Sabine			Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GROWTH; OXALIPLATIN; IRINOTECAN; CARCINOMA; EFFICACY	Context Patients with metastatic colorectal cancer who have KRAS codon 12- or KRAS codon 13-mutated tumors are presently excluded from treatment with the anti-epidermal growth factor receptor monoclonal antibody cetuximab. Objective To test the hypothesis that KRAS codon 13 mutations are associated with a better outcome after treatment with cetuximab than observed with other KRAS mutations. Design, Setting, and Patients We studied the association between KRAS mutation status (p.G13D vs other KRAS mutations) and response and survival in a pooled data set of 579 patients with chemotherapy-refractory colorectal cancer treated with cetuximab between 2001 and 2008. Patients were included in the CO. 17, BOND, MABEL, EMR202600, EVEREST, BABEL, or SALVAGE clinical trials or received off-study treatment. Univariate and multivariate analyses, adjusting for possible prognostic factors and data set, were performed. The effect of the different mutations was studied in vitro by constructing isogenic cell lines with wild-type KRAS, p.G12V, or p.G13D mutant alleles and treating them with cetuximab. Main Outcome Measures The main efficacy end point was overall survival. Secondary efficacy end points were response rate and progression-free survival. Results In comparison with patients with other KRAS-mutated tumors, patients with p.G13D-mutated tumors (n=32) treated with cetuximab had longer overall survival (median, 7.6 [95% confidence interval {CI}, 5.7-20.5] months vs 5.7 [95% CI, 4.9-6.8] months; adjusted hazard ratio [HR], 0.50; 95% CI, 0.31-0.81; P=.005) and longer progression-free survival (median, 4.0 [95% CI, 1.9-6.2] months vs 1.9 [95% CI, 1.8-2.8] months; adjusted HR, 0.51; 95% CI, 0.32-0.81; P=.004). There was a significant interaction between KRAS mutation status (p.G13D vs other KRAS mutations) and overall survival benefit with cetuximab treatment (adjusted HR, 0.30; 95% CI, 0.14-0.67; P=.003). In vitro and mouse model analysis showed that although p.G12V-mutated colorectal cells were insensitive to cetuximab, p.G13D-mutated cells were sensitive, as were KRAS wild-type cells. Conclusions In this analysis, use of cetuximab was associated with longer overall and progression-free survival among patients with chemotherapy-refractory colorectal cancer with p.G13D-mutated tumors than with other KRAS-mutated tumors. Evaluation of cetuximab therapy in these tumors in prospective randomized trials may be warranted. JAMA. 2010; 304(16): 1812-1820	[Van Cutsem, Eric; Tejpar, Sabine] Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, Belgium; [Di Nicolantonio, Federica; Lamba, Simona; Arena, Sabrina; Bardelli, Alberto] Univ Turin, Sch Med, Inst Canc Res & Treatment, Mol Genet Lab, I-10060 Turin, Italy; [De Roock, Wendy; Tejpar, Sabine] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium; [Jonker, Derek J.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Di Nicolantonio, Federica; Bardelli, Alberto] Italian Fdn Canc Res, Inst Mol Oncol, Milan, Italy; [Sartore-Bianchi, Andrea; Siena, Salvatore] Osped Niguarda Ca Granda, Falck Div Med Oncol, Milan, Italy; [Tu, Dongsheng; O'Callaghan, Chris J.] Natl Canc Inst Canada, Clin Trials Grp, Kingston, ON, Canada; [Frattini, Milo] Inst Pathol, Lab Mol Diagnost, Locarno, Switzerland; [Piessevaux, Hubert] Clin Univ St Luc, B-1200 Brussels, Belgium; [Khambata-Ford, Shirin] Bristol Myers Squibb Res & Dev, Princeton, NJ USA; [Zalcberg, John R.] Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Zalcberg, John R.] Australasian Gastrointestinal Trials Grp, Melbourne, Vic, Australia; [Simes, John] Univ Sydney, Natl Hlth & Med Res Council, Clin Trials Ctr, Sydney, NSW 2006, Australia; [Karapetis, Christos S.] Flinders Med Ctr, Adelaide, SA, Australia; [Karapetis, Christos S.] Flinders Univ S Australia, Adelaide, SA, Australia	KU Leuven; University Hospital Leuven; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Turin; KU Leuven; University of Ottawa; Ottawa Hospital Research Institute; IFOM - FIRC Institute of Molecular Oncology; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Queens University - Canada; Canadian Cancer Trials Group; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Bristol-Myers Squibb; Peter Maccallum Cancer Center; University of Melbourne; University of Sydney; Flinders Medical Centre; Flinders University South Australia	Tejpar, S (corresponding author), Univ Hosp Gasthuisberg, Digest Oncol Unit, Herestr 49, B-3000 Louvain, Belgium.	a.bardelli@unito.it; sabine.tejpar@uzleuven.be	Di Nicolantonio, Federica/A-2503-2011; SIENA, SALVATORE/AAC-5806-2019; Vickers, Michael M/E-4095-2010; Arena, Sabrina/H-4985-2012; Piessevaux, Hubert/N-9558-2019; Sartore-Bianchi, Andrea/AAB-9848-2019; Van+Cutsem, Eric/ABE-1762-2021; Simes, Robert John/P-1497-2014; BARDELLI, Alberto/J-9721-2018	Di Nicolantonio, Federica/0000-0001-9618-2010; SIENA, SALVATORE/0000-0002-2681-2846; Arena, Sabrina/0000-0002-1318-2494; Piessevaux, Hubert/0000-0003-1193-0601; Sartore-Bianchi, Andrea/0000-0003-0780-0409; Zalcberg, John/0000-0002-6624-0782; Karapetis, Christos/0000-0003-1741-996X; BARDELLI, Alberto/0000-0003-1647-5070; Lamba, Simona Elena/0000-0003-3207-1594	Merck Serono; Amgen; Bristol-Myers Squibb; Horizon Discovery; Institute for the Promotion of Innovation Through Science and Technology in Flanders (IWT-Vlaanderen); Siena are supported by Associazione Italiana Ricerca Cancro and Oncologia Ca'Granda Onlus Fondazione; Belgian Federation Against Cancer; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Merck Serono(Merck & Company); Amgen(Amgen); Bristol-Myers Squibb(Bristol-Myers Squibb); Horizon Discovery; Institute for the Promotion of Innovation Through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Siena are supported by Associazione Italiana Ricerca Cancro and Oncologia Ca'Granda Onlus Fondazione(Fondazione AIRC per la ricerca sul cancro); Belgian Federation Against Cancer; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	Dr Siena reports serving as a member of advisory boards for Merck Serono, Amgen, AstraZeneca, and Celgene. Dr Van Cutsem reports receiving research funding from Merck Serono and Amgen. Dr Khambata-Ford reports owning equity in and is an employee of Bristol-Myers Squibb. Dr Zalcberg reports receiving travel and research support from Merck Serono and research support from Bristol-Myers Squibb. Dr Simes reports that his institution has received research grants from Bristol-Myers Squibb. Dr Karapetis reports serving as a member of an advisory board for Merck Serono. Dr Bardelli reports that he owns stock in and has received consultancy fees from Horizon Discovery. Dr Tejpar reports receiving research grants from Merck Serono. No other disclosures were reported.; Dr De Roock is supported by a PhD grant from the Institute for the Promotion of Innovation Through Science and Technology in Flanders (IWT-Vlaanderen). Drs Sartore-Bianchi and Siena are supported by Associazione Italiana Ricerca Cancro and Oncologia Ca'Granda Onlus Fondazione. Drs Van Cutsem and Tejpar are senior clinical investigators for the Fund for Scientific Research, Flanders and received research grants from the Belgian Federation Against Cancer.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; [Anonymous], 2008, CHMPEWP185042006 EMA; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; European Medicines Agency, 2007, QUEST ANSW MARK AUTH; Frattini M, 2007, BRIT J CANCER, V97, P1139, DOI 10.1038/sj.bjc.6604009; Guerrero S, 2000, CANCER RES, V60, P6750; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lee CN, 2010, J CLIN ONCOL, V28, pE111, DOI 10.1200/JCO.2009.24.0747; Lenz HJ, 2006, J CLIN ONCOL, V24, P4914, DOI 10.1200/JCO.2006.06.7595; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Pessino A, 2008, ANN ONCOL, V19, P711, DOI 10.1093/annonc/mdm516; Tejpar S, 2007, J CLIN ONCOL, V25; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; US Food and Drug Administration, CET ERB PAN VECT; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wellcome Trust Sanger Institute, CAT SOM MUT CANC; Wilke H, 2006, J CLIN ONCOL, V24, p158S	23	570	590	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2010	304	16					1812	1820		10.1001/jama.2010.1535	http://dx.doi.org/10.1001/jama.2010.1535			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671JZ	20978259	Bronze			2022-12-28	WOS:000283501300022
J	Steele, RJC; Kostourou, I; McClements, P; Watling, C; Libby, G; Weller, D; Brewster, DH; Black, R; Carey, FA; Fraser, C				Steele, R. J. C.; Kostourou, I.; McClements, P.; Watling, C.; Libby, G.; Weller, D.; Brewster, D. H.; Black, R.; Carey, F. A.; Fraser, C.			Effect of repeated invitations on uptake of colorectal cancer screening using faecal occult blood testing: analysis of prevalence and incidence screening	BRITISH MEDICAL JOURNAL			English	Article							DEMONSTRATION PILOT; UNITED-KINGDOM; PROGRAM; TRIAL; MORTALITY; ROUNDS	Objective To analyse the effects of prevalence and incidence screening on uptake and detection of cancer in an ongoing, dynamic programme for colorectal screening using faecal occult blood testing. Design Analysis of prevalence and incidence screening. Setting Three rounds of biennial colorectal screening using the guaiac faecal occult blood test in east and north east Scotland, March 2000 to May 2007. Participants Adults aged 50-69. Main outcome measures Uptake of screening, test positivity (percentage of those invited who returned a test that was positive and triggered an invitation for colonoscopy), positive predictive value, and stage of cancer. Results Of 510 990 screening episodes in all three rounds, 248 998 (48.7%) were for prevalence, 163 483 (32.0%) were for first incidence, and 98 509 (19.3%) were for second incidence. Uptake of a first invitation for prevalence screening was 53% and for a second and third invitation was 15% and 12%. In the cohort invited for the first round, uptake of prevalence screening rose from 55% in the first round to 63% in the third. The uptake of first incidence screening on a first invitation was 54% and on a second invitation was 86% and on a first invitation for second incidence screening was 46%. The positivity rate in prevalence screening was 1.9% and the uptake of colonoscopy was 87%. The corresponding values for a first incidence screen were 1.7% and 90% and for a second incidence screen were 1.1% and 94.5%. The positive predictive value of a positive faecal occult blood test result for cancer was 11.0% for prevalence screening, 6.5% for the first incidence screen, and 7.5% for the second incidence screen. The corresponding values for the positive predictive value for adenoma were 35.5%, 29.4%, and 26.7%. The proportion of cancers at stage I dropped from 46.5% for prevalence screening to 41% for first incidence screening and 35% for second incidence screening. Conclusions Repeat invitations to those who do not take up the offer of screening increases the number of those who accept, for both prevalence screening and incidence screening. Although the positive predictive value for both cancer and adenomas fell between the prevalence screen and the first incidence screen, they did not fall between the first and second incidence screens. The deterioration in cancer stage from prevalence to incidence screening suggests that some cancers picked up at incidence screening may have been missed on prevalence screening, but the stage distribution is still favourable. These data vindicate the policies of continuing to offer screening to those who fail to participate and continuing to offer biennial screening to those who have accepted previous offers.	[Steele, R. J. C.; Kostourou, I.] Univ Dundee, Dept Surg, Dundee DD1 4HN, Scotland; [Fraser, C.] Kings Cross Hosp, Scottish Bowel Screening Ctr, Screening Lab, Dundee, Scotland; [Weller, D.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9YL, Midlothian, Scotland; [Carey, F. A.] Univ Dundee, Dept Pathol, Dundee DD1 4HN, Scotland	University of Dundee; University of Edinburgh; University of Dundee	Steele, RJC (corresponding author), Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, Dundee DD1 9SY, Scotland.	r.j.c.steele@dundee.ac.uk		Steele, Robert JC/0000-0003-4248-6785; Libby, Gillian/0000-0003-2666-8669; Brewster, David/0000-0002-5346-5608	Scottish Government Health Department; Chief Scientist Office, Scottish Government Health Department [CZH/6/4]; Chief Scientist Office [CZH/6/4] Funding Source: researchfish	Scottish Government Health Department; Chief Scientist Office, Scottish Government Health Department; Chief Scientist Office	The pilot was funded by the Scottish Government Health Department and the analysis was supported by a grant from the Chief Scientist Office (grant No CZH/6/4), Scottish Government Health Department to establish a bowel screening research unit. The University of Dundee acts as the sponsor, and administers the grant that supports the bowel screening research unit. All authors are independent from the funders in terms of freedom to publish.	Anttila A, 2002, J MED SCREEN, V9, P153, DOI 10.1136/jms.9.4.153; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Benson VS, 2008, INT J CANCER, V122, P1357, DOI 10.1002/ijc.23273; Blanks RG, 2000, J MED SCREEN, V7, P195, DOI 10.1136/jms.7.4.195; Duffy SW, 2005, BRIT J CANCER, V92, P597, DOI 10.1038/sj.bjc.6602345; Faivre J, 2004, GASTROENTEROLOGY, V126, P1674, DOI 10.1053/j.gastro.2004.02.018; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Hol L, 2010, EUR J CANCER, V46, P2059, DOI 10.1016/j.ejca.2010.03.022; Hol L, 2010, GUT, V59, P62, DOI 10.1136/gut.2009.177089; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lindholm E, 2008, BRIT J SURG, V95, P1029, DOI 10.1002/bjs.6136; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Otten JDM, 1996, J EPIDEMIOL COMMUN H, V50, P353, DOI 10.1136/jech.50.3.353; Steele RJC, 2010, J MED SCREEN, V17, P68, DOI 10.1258/jms.2010.009120; Steele RJC, 2009, GUT, V58, P530, DOI 10.1136/gut.2008.162883; Steele RJC, 2004, BMJ-BRIT MED J, V329, P133, DOI 10.1136/bmj.38153.491887.7C; Steele RJC, 2001, J MED SCREEN, V8, P197, DOI 10.1136/jms.8.4.197; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040	19	53	53	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2010	341								c5531	10.1136/bmj.c5531	http://dx.doi.org/10.1136/bmj.c5531			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674YY	20980376	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000283790400004
J	Ockrim, Z; Yorston, D				Ockrim, Zoe; Yorston, David			Managing diabetic retinopathy	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LASER TREATMENT; PROGRESSION; VITRECTOMY; TYPE-2; COMPLICATIONS; ASSOCIATION		[Ockrim, Zoe] Moorfields Eye Hosp, London EC1V 2PD, England; [Yorston, David] Tennent Inst Ophthalmol, Glasgow, Scotland	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Ockrim, Z (corresponding author), Moorfields Eye Hosp, London EC1V 2PD, England.	zoe_ockrim@hotmail.com		Yorston, David/0000-0001-7259-5320				Abraham P, 2006, OPHTHALMOLOGY, V113, P2221, DOI 10.1016/j.ophtha.2006.07.032; ADDISON DJ, 1970, BRIT MED J, V1, P264, DOI 10.1136/bmj.1.5691.264; Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Ahmadieh H, 2009, OPHTHALMOLOGY, V116, P1943, DOI 10.1016/j.ophtha.2009.07.001; Aiello LP, 2007, ARCH OPHTHALMOL-CHIC, V125, P318; Browning DJ, 2008, OPHTHALMOLOGY, V115, P533, DOI 10.1016/j.ophtha.2007.06.042; Bunce C, 2008, EYE, V22, P905, DOI 10.1038/sj.eye.6702767; Chaturvedi N, 1998, LANCET, V351, P28, DOI 10.1016/S0140-6736(97)06209-0; Chew EY, 1996, ARCH OPHTHALMOL-CHIC, V114, P1079, DOI 10.1001/archopht.1996.01100140281004; DCCT Res Grp, 1991, AM J MED, V90, P450, DOI 10.1016/0002-9343(91)80085-Z; Diabet Control Complications Trial Res Grp, 1995, OPHTHALMOLOGY, V102, P647; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; FERRIS FL, 1987, OPHTHALMOLOGY, V94, P761; Fong DS, 2009, AM J OPHTHALMOL, V147, P583, DOI 10.1016/j.ajo.2008.10.016; Frank RN, 2002, AM J OPHTHALMOL, V133, P693, DOI 10.1016/S0002-9394(02)01321-1; Gerstein HC, 2000, LANCET, V355, P253; Hartnett ME, 2005, ARCH OPHTHALMOL-CHIC, V123, P387, DOI 10.1001/archopht.123.3.387; Home P, 2008, BMJ-BRIT MED J, V336, P458, DOI 10.1136/bmj.39499.514410.80; Hutchinson A, 2000, DIABETIC MED, V17, P495, DOI 10.1046/j.1464-5491.2000.00250.x; Ip MS, 2008, OPHTHALMOLOGY, V115, P1447, DOI 10.1016/j.ophtha.2008.06.015; Keech AC, 2007, LANCET, V370, P1687, DOI 10.1016/S0140-6736(07)61607-9; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; KOHNER EM, 1975, DIABETOLOGIA, V11, P27, DOI 10.1007/BF00422814; Laidlaw DAH, 2008, EYE, V22, P1337, DOI 10.1038/eye.2008.84; Lewis K, 2007, OPHTHAL EPIDEMIOL, V14, P375, DOI 10.1080/09286580701375195; *NAT I HLTH CLIN E, 2008, CG NAT I HLTH CLIN E, V66; Scanlon PH, 2008, J MED SCREEN, V15, P1, DOI 10.1258/jms.2008.008015; Scanlon PH, 2010, EYE, V24, P435, DOI 10.1038/eye.2009.320; Scotland GS, 2010, BRIT J OPHTHALMOL, V94, P712, DOI 10.1136/bjo.2008.151126; Sen K, 2002, DIABETES RES CLIN PR, V56, P1, DOI 10.1016/S0168-8227(01)00341-2; Stefansson E, 2001, ACTA OPHTHALMOL SCAN, V79, P435, DOI 10.1034/j.1600-0420.2001.790502.x; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Waugh N, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14360; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wong TY, 2009, DIABETES CARE, V32, P2307, DOI 10.2337/dc09-0615; Yorston D, 2008, BRIT J OPHTHALMOL, V92, P365, DOI 10.1136/bjo.2007.124495; Zander E, 2000, BRIT J OPHTHALMOL, V84, P871, DOI 10.1136/bjo.84.8.871; 1985, ARCH OPHTHALMOL-CHIC, V103, P1796	38	12	14	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2010	341								c5400	10.1136/bmj.c5400	http://dx.doi.org/10.1136/bmj.c5400			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674XN	20974661				2022-12-28	WOS:000283784400005
J	Karunatilaka, KS; Solem, A; Pyle, AM; Rueda, D				Karunatilaka, Krishanthi S.; Solem, Amanda; Pyle, Anna Marie; Rueda, David			Single-molecule analysis of Mss116-mediated group II intron folding	NATURE			English	Article							DEAD-BOX PROTEIN; CHAPERONE ACTIVITY; ATP HYDROLYSIS; SPECTROSCOPY; REQUIRES; RIBOZYME; FRET	DEAD-box helicases are conserved enzymes involved in nearly all aspects of RNA metabolism, but their mechanisms of action remain unclear. Here, we investigated the mechanism of the DEAD-box protein Mss116 on its natural substrate, the group II intron ai5 gamma. Group II introns are structurally complex catalytic RNAs considered evolutionarily related to the eukaryotic spliceosome, and an interesting paradigm for large RNA folding. We used single-molecule fluorescence to monitor the effect of Mss116 on folding dynamics of a minimal active construct, ai5 gamma-D135. The data show that Mss116 stimulates dynamic sampling between states along the folding pathway, an effect previously observed only with high Mg2+ concentrations. Furthermore, the data indicate that Mss116 promotes folding through discrete ATP-independent and ATP-dependent steps. We propose that Mss116 stimulates group II intron folding through a multi-step process that involves electrostatic stabilization of early intermediates and ATP hydrolysis during the final stages of native state assembly.	[Karunatilaka, Krishanthi S.; Solem, Amanda; Rueda, David] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [Pyle, Anna Marie] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Pyle, Anna Marie] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Pyle, Anna Marie] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Wayne State University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Rueda, D (corresponding author), Wayne State Univ, Dept Chem, 5101 Cass Ave, Detroit, MI 48202 USA.	anna.pyle@yale.edu; david.rueda@wayne.edu	Rueda, David S./F-9065-2014; Solem, Amanda/M-5959-2013; Solem, Amanda/A-3553-2010	Rueda, David S./0000-0003-4657-6323; Solem, Amanda/0000-0002-2056-9419; 	National Institutes of Health [R01GM085116, R01GM050313]; National Science Foundation [MCB-0747285]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085116, R01GM050313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. K. Sigel and O. Fedorova for many helpful and stimulating discussions and for commenting on the manuscript, and A. Feig, K. Musier-Forsyth and R. Lamichhane for protein gifts. This work was supported by the National Institutes of Health (R01GM085116 to D.R., R01GM050313 to A.M.P.) and the National Science Foundation (MCB-0747285 to D.R.). A.M.P. is an HHMI investigator.	Bifano AL, 2010, J MOL BIOL, V398, P429, DOI 10.1016/j.jmb.2010.03.025; Christian TD, 2009, P NATL ACAD SCI USA, V106, P21109, DOI 10.1073/pnas.0908640106; Clodi E, 1999, EMBO J, V18, P3776, DOI 10.1093/emboj/18.13.3776; Del Campo M, 2007, MOL CELL, V28, P159, DOI 10.1016/j.molcel.2007.07.028; Diges CM, 2001, EMBO J, V20, P5503, DOI 10.1093/emboj/20.19.5503; Fedorova O, 2007, J MOL BIOL, V366, P1099, DOI 10.1016/j.jmb.2006.12.003; Fedorova O, 2010, J MOL BIOL, V397, P799, DOI 10.1016/j.jmb.2010.02.001; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Halls C, 2007, J MOL BIOL, V365, P835, DOI 10.1016/j.jmb.2006.09.083; Hopkins JF, 2009, NUCLEIC ACIDS RES, V37, P6205, DOI 10.1093/nar/gkp646; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; KOCH JL, 1992, MOL CELL BIOL, V12, P1950, DOI 10.1128/MCB.12.5.1950; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Lamichhane R, 2010, P NATL ACAD SCI USA, V107, P4105, DOI 10.1073/pnas.0907072107; Lehmann K, 2003, CRIT REV BIOCHEM MOL, V38, P249, DOI 10.1080/713609236; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Linder P, 2000, CURR BIOL, V10, pR887, DOI 10.1016/S0960-9822(00)00857-5; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; MICHELS WJ, 1995, BIOCHEMISTRY-US, V34, P2965, DOI 10.1021/bi00009a028; Noah JW, 2003, BIOCHEMISTRY-US, V42, P12466, DOI 10.1021/bi035339n; Pyle AM, 2006, COLD SPRING HARB MON, V43, P469; Qin PZ, 1998, CURR OPIN STRUC BIOL, V8, P301, DOI 10.1016/S0959-440X(98)80062-6; Qin PZF, 1997, BIOCHEMISTRY-US, V36, P4718, DOI 10.1021/bi962665c; SHUMAN S, 1980, J BIOL CHEM, V255, P5396; Solem A, 2006, MOL CELL, V24, P611, DOI 10.1016/j.molcel.2006.10.032; Steiner M, 2008, P NATL ACAD SCI USA, V105, P13853, DOI 10.1073/pnas.0804034105; Steiner M, 2009, ANGEW CHEM INT EDIT, V48, P9739, DOI 10.1002/anie.200903809; Su LJ, 2005, NUCLEIC ACIDS RES, V33, P6674, DOI 10.1093/nar/gki973; Toor N, 2001, RNA, V7, P1142, DOI 10.1017/S1355838201010251; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Waldsich C, 2007, NAT STRUCT MOL BIOL, V14, P37, DOI 10.1038/nsmb1181; ZHANG A, 1995, RNA, V1, P783; Zhao R, 2009, METHODS, V49, P112, DOI 10.1016/j.ymeth.2009.04.017; ZINGLER N, 2010, NUCL ACIDS IN PRESS	35	62	63	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2010	467	7318					935	U75		10.1038/nature09422	http://dx.doi.org/10.1038/nature09422			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20944626	Green Accepted			2022-12-28	WOS:000283254700031
J	Kroto, HW				Kroto, Harold W.			Working at the coal face	NATURE			English	Editorial Material									[Kroto, Harold W.] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield									0	3	3	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					S13	S13		10.1038/467S13a	http://dx.doi.org/10.1038/467S13a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944613	Bronze			2022-12-28	WOS:000282898700012
J	Noppe, IC				Noppe, Illene C.			Sounds of My Father	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												noppei@uwgb.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1535	1536		10.1001/jama.2010.1404	http://dx.doi.org/10.1001/jama.2010.1404			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940374				2022-12-28	WOS:000282816500001
J	Arora, H; Du, P; Tan, KW; Hyun, JK; Grazul, J; Xin, HL; Muller, DA; Thompson, MO; Wiesner, U				Arora, Hitesh; Du, Phong; Tan, Kwan W.; Hyun, Jerome K.; Grazul, John; Xin, Huolin L.; Muller, David A.; Thompson, Michael O.; Wiesner, Ulrich			Block Copolymer Self-Assembly-Directed Single-Crystal Homo- and Heteroepitaxial Nanostructures	SCIENCE			English	Article							TIME-RESOLVED REFLECTIVITY; MESOPOROUS METAL-OXIDES; THIN-FILMS; SILICON; ARRAYS; LITHOGRAPHY; CRYSTALLIZATION	Epitaxy is a widely used method to grow high-quality crystals. One of the key challenges in the field of inorganic solids is the development of epitaxial single-crystal nanostructures. We describe their formation from block copolymer self-assembly-directed nanoporous templates on single-crystal Si backfilled with Si or NiSi through a laser-induced transient melt process. Depending on thickness, template removal leaves either an array of nanopillars or porous nanostructures behind. For stoichiometric NiSi deposition, the template pores provide confinement, enabling heteroepitaxial growth. Irradiation through a mask provides access to hierarchically structured materials. These results on etchable and non-etchable materials suggest a general strategy for growing epitaxial single-crystal nanostructured thin films for fundamental studies and a wide variety of applications, including energy conversion and storage.	[Arora, Hitesh; Du, Phong; Tan, Kwan W.; Thompson, Michael O.; Wiesner, Ulrich] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Arora, Hitesh] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [Hyun, Jerome K.; Xin, Huolin L.] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Grazul, John] Cornell Univ, Cornell Ctr Mat Res, Ithaca, NY 14853 USA; [Muller, David A.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Muller, David A.] Cornell Univ, Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University	Wiesner, U (corresponding author), Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.	ubw1@cornell.edu	Tan, Kwan W./D-6942-2011; Xin, Huolin L./E-2747-2010; Hyun, Jerome/AES-0697-2022; Hyun, Jerome/K-7884-2013; Tan, Kwan Wee/B-6201-2014; Muller, David/A-7745-2010	Tan, Kwan W./0000-0002-8289-6503; Xin, Huolin L./0000-0002-6521-868X; Hyun, Jerome/0000-0002-2630-5051; Hyun, Jerome/0000-0002-2630-5051; Muller, David/0000-0003-4129-0473; Thompson, Michael/0000-0002-4933-009X	NSF through Nanoscale Interdisciplinary Research Team [DMR-0404195, DMR-0605856]; U.S. Department of Homeland Security [06-G-031]; Energy Materials Center at Cornell [EMC2]; U.S. Department of Energy Office of Science, Office of Basic Energy Sciences [SC0001086]; Singapore Clean Energy Programme Office; NSF [DMR-0520404, ECS-0335765]	NSF through Nanoscale Interdisciplinary Research Team; U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); Energy Materials Center at Cornell; U.S. Department of Energy Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Singapore Clean Energy Programme Office; NSF(National Science Foundation (NSF))	The authors acknowledge financial support of this research by NSF through the Nanoscale Interdisciplinary Research Team program (grant DMR-0404195) and a creativity award to U. W. (grant DMR-0605856); the U.S. Department of Homeland Security (award no. 06-G-031); and the Energy Materials Center at Cornell (EMC2), an Energy Frontiers Research Center funded by the U.S. Department of Energy Office of Science, Office of Basic Energy Sciences, under award no. SC0001086. K. W. T. gratefully acknowledges the Singapore Clean Energy Programme Office for a National Research Foundation graduate fellowship. The use of facilities of the Cornell Center for Materials Research, with funding from the Materials Research Science and Engineering Center program of NSF (under cooperative agreement DMR-0520404), and of the Cornell Nanoscale Science and Technology Facility, supported by NSF under grant no. ECS-0335765, is gratefully acknowledged. The authors also thank J. Gregoire, P. Huang, M. Thomas, S. Warren, C. Garcia, and R. Dorin for assistance in these experiments and A. Burns for help with graphics. A provisional patent application titled "Method for Large Mismatch Heteroepitaxy on Silicon" has been filed with Cornell University.	Aizenberg J, 2003, SCIENCE, V299, P1205, DOI 10.1126/science.1079204; AUSTON DH, 1978, APPL PHYS LETT, V33, P437, DOI 10.1063/1.90369; Chou SY, 2002, NATURE, V417, P835, DOI 10.1038/nature00792; De Rosa C, 2000, NATURE, V405, P433, DOI 10.1038/35013018; Detavernier C, 2003, NATURE, V426, P641, DOI 10.1038/nature02198; Du P, 2004, ADV MATER, V16, P953, DOI 10.1002/adma.200306189; Finnemore AS, 2009, ADV MATER, V21, P3928, DOI 10.1002/adma.200900615; JELLISON GE, 1988, J MATER RES, V3, P498, DOI 10.1557/JMR.1988.0498; JELLISON GE, 1986, PHYS REV B, V34, P2407, DOI 10.1103/PhysRevB.34.2407; Joo SH, 2001, NATURE, V412, P169, DOI 10.1038/35084046; Kondo JN, 2008, CHEM MATER, V20, P835, DOI 10.1021/cm702176m; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Lee B, 2002, CHEM MATER, V14, P867, DOI 10.1021/cm010775m; LI JG, 1992, MATER LETT, V14, P329, DOI 10.1016/0167-577X(92)90047-N; Okabe A., 2000, SPATIAL TESSELLATION, P43, DOI 10.1002/9780470317013.ch2; Park M, 1997, SCIENCE, V276, P1401, DOI 10.1126/science.276.5317.1401; POATE JM, 1982, LASER ANNEALING SEMI; Ruiz R, 2008, SCIENCE, V321, P936, DOI 10.1126/science.1157626; Segalman RA, 2003, MACROMOLECULES, V36, P3272, DOI 10.1021/ma021367m; Stefik M, 2009, CHEM MATER, V21, P5466, DOI 10.1021/cm902626z; Tang CB, 2008, SCIENCE, V322, P429, DOI 10.1126/science.1162950; Templin M, 1997, SCIENCE, V278, P1795, DOI 10.1126/science.278.5344.1795; THOMPSON MO, 1984, PHYS REV LETT, V52, P2360, DOI 10.1103/PhysRevLett.52.2360; Thurn-Albrecht T, 2000, SCIENCE, V290, P2126, DOI 10.1126/science.290.5499.2126; Toberer ES, 2007, CHEM MATER, V19, P4833, DOI 10.1021/cm0714133; Vere A. W., 1987, CRYSTAL GROWTH PRINC; Warren SC, 2008, SCIENCE, V320, P1748, DOI 10.1126/science.1159950; YANAGISAWA T, 1990, B CHEM SOC JPN, V63, P988, DOI 10.1246/bcsj.63.988; Yang PD, 1998, NATURE, V396, P152; Yang PD, 1998, SCIENCE, V282, P2244, DOI 10.1126/science.282.5397.2244; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548	31	94	98	9	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					214	219		10.1126/science.1193369	http://dx.doi.org/10.1126/science.1193369			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929772				2022-12-28	WOS:000282644600040
J	Knox, SM; Lombaert, IMA; Reed, X; Vitale-Cross, L; Gutkind, JS; Hoffman, MP				Knox, S. M.; Lombaert, I. M. A.; Reed, X.; Vitale-Cross, L.; Gutkind, J. S.; Hoffman, M. P.			Parasympathetic Innervation Maintains Epithelial Progenitor Cells During Salivary Organogenesis	SCIENCE			English	Article							GLAND BRANCHING MORPHOGENESIS; SUBMANDIBULAR-GLAND; STEM-CELLS; CONDITIONAL EXPRESSION; K-RAS; DIFFERENTIATION; MECHANISMS; NERVES; LIVER; SKIN	The maintenance of a progenitor cell population as a reservoir of undifferentiated cells is required for organ development and regeneration. However, the mechanisms by which epithelial progenitor cells are maintained during organogenesis are poorly understood. We report that removal of the parasympathetic ganglion in mouse explant organ culture decreased the number and morphogenesis of keratin 5-positive epithelial progenitor cells. These effects were rescued with an acetylcholine analog. We demonstrate that acetylcholine signaling, via the muscarinic M1 receptor and epidermal growth factor receptor, increased epithelial morphogenesis and proliferation of the keratin 5-positive progenitor cells. Parasympathetic innervation maintained the epithelial progenitor cell population in an undifferentiated state, which was required for organogenesis. This mechanism for epithelial progenitor cell maintenance may be targeted for organ repair or regeneration.	[Knox, S. M.; Lombaert, I. M. A.; Reed, X.; Hoffman, M. P.] Natl Inst Dent & Craniofacial Res, Matrix & Morphogenesis Unit, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA; [Vitale-Cross, L.; Gutkind, J. S.] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Hoffman, MP (corresponding author), Natl Inst Dent & Craniofacial Res, Matrix & Morphogenesis Unit, Lab Cell & Dev Biol, NIH, 30 Convent Dr, Bethesda, MD 20892 USA.	mhoffman@mail.nih.gov	Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016; Kim, Ji-Youn/A-5779-2017; Knox, Sarah Monica/GNW-5445-2022	Gutkind, J. Silvio/0000-0002-5150-4482; VItale-Cross, Lynn/0000-0001-7850-547X	National Institute of Dental and Craniofacial Research, NIH; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551, ZIADE000722] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors would like to thank V. N. Patel, I. T. Rebustini, L. M. Angerer, K. G. Ten-Hagen, K. M. Yamada, and S. Powers for discussions and critical reading of this manuscript. The study was supported by the Intramural Research Program of the National Institute of Dental and Craniofacial Research, NIH.	Avril-Delplanque A, 2005, STEM CELLS, V23, P992, DOI 10.1634/stemcells.2004-0197; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; COUGHLIN MD, 1975, DEV BIOL, V43, P123, DOI 10.1016/0012-1606(75)90136-0; Hai B, 2010, STEM CELLS DEV, V19, P1793, DOI 10.1089/scd.2009.0499; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Hudson DL, 2001, J HISTOCHEM CYTOCHEM, V49, P271, DOI 10.1177/002215540104900214; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783; Macias E, 2008, CANCER RES, V68, P162, DOI 10.1158/0008-5472.CAN-07-2461; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Pavlov I. P., 1906, SCIENCE, V24, P613, DOI DOI 10.1126/SCIENCE.24.620.613; Peters B, 2001, MOL BIOL CELL, V12, P1775, DOI 10.1091/mbc.12.6.1775; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Proctor GB, 2007, AUTON NEUROSCI-BASIC, V133, P3, DOI 10.1016/j.autneu.2006.10.006; Raimondi AR, 2006, AM J PATHOL, V168, P1654, DOI 10.2353/ajpath.2006.050847; Rebustini IT, 2009, DEV CELL, V17, P482, DOI 10.1016/j.devcel.2009.07.016; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Schafer MKH, 1998, NEUROSCIENCE, V84, P361, DOI 10.1016/S0306-4522(97)80196-0; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Steinberg Z, 2005, DEVELOPMENT, V132, P1223, DOI 10.1242/dev.01690; Vitale-Cross L, 2004, CANCER RES, V64, P8804, DOI 10.1158/0008-5472.CAN-04-2623	24	226	229	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1645	1647		10.1126/science.1192046	http://dx.doi.org/10.1126/science.1192046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929848	Green Accepted			2022-12-28	WOS:000282098100041
J	Rubtsov, YP; Niec, RE; Josefowicz, S; Li, L; Darce, J; Mathis, D; Benoist, C; Rudensky, AY				Rubtsov, Yuri P.; Niec, Rachel E.; Josefowicz, Steven; Li, Li; Darce, Jaime; Mathis, Diane; Benoist, Christophe; Rudensky, Alexander Y.			Stability of the Regulatory T Cell Lineage in Vivo	SCIENCE			English	Article							TRANSCRIPTION FACTOR FOXP3; DIFFERENTIATION; SELF; AUTOIMMUNITY; HOMEOSTASIS; GENERATION; INDUCTION; ORIGIN	Tissue maintenance and homeostasis can be achieved through the replacement of dying cells by differentiating precursors or self-renewal of terminally differentiated cells or relies heavily on cellular longevity in poorly regenerating tissues. Regulatory T cells (T(reg) cells) represent an actively dividing cell population with critical function in suppression of lethal immune-mediated inflammation. The plasticity of T(reg) cells has been actively debated because it could factor importantly in protective immunity or autoimmunity. By using inducible labeling and tracking of T(reg) cell fate in vivo, or transfers of highly purified T(reg) cells, we have demonstrated notable stability of this cell population under physiologic and inflammatory conditions. Our results suggest that self-renewal of mature T(reg) cells serves as a major mechanism of maintenance of the T(reg) cell lineage in adult mice.	[Rubtsov, Yuri P.; Niec, Rachel E.; Josefowicz, Steven; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Rubtsov, Yuri P.; Niec, Rachel E.; Josefowicz, Steven; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Li, Li; Darce, Jaime; Mathis, Diane; Benoist, Christophe] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.	rudenska@mskcc.org	Rubtsov, Yury P/A-8227-2014; Li, Li/C-8478-2011; Josefowicz, Steven Z/B-8716-2011	Rubtsov, Yury P/0000-0001-9175-3013; Niec, Rachel/0000-0002-8525-3693; josefowicz, steven/0000-0001-7453-779X	NIH [GM07739, AI51530]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051530, R37AI034206, R37AI051530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Forbush, T. Chu, L. Karpik, A. Bravo, J. Herlihy, P. Zarin, G. Gerard, A. Ortiz-Lopes, and K. Hattori for assistance with mouse colony management; F. Costantini for R26Y mice; V. Kuchroo for Foxp3-IRES-GFP mice; P. Chambon for Cre-ERT2 plasmid; E. Pamer, C. Shi, and E. Leiner for L. monocytogenes and assistance with experiments; and P. Fink and K. Simmons for cells from Rag2pGFP mice and helpful discussion. R.E.N. was supported by NIH Medical Scientist Training Program grant GM07739. A.Y.R. is an investigator with the Howard Hughes Medical Institute, and this work was also supported by grant AI51530 from the NIH to C. B. and D.M.	Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bayer AL, 2007, J IMMUNOL, V178, P4062, DOI 10.4049/jimmunol.178.7.4062; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Hori S, 2003, ADV IMMUNOL, V81, P331, DOI 10.1016/S0065-2776(03)81008-8; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Malek TR, 2008, J CLIN IMMUNOL, V28, P635, DOI 10.1007/s10875-008-9235-y; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007	27	496	509	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1667	1671		10.1126/science.1191996	http://dx.doi.org/10.1126/science.1191996			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929851	Green Accepted			2022-12-28	WOS:000282098100048
J	Zhai, YP; Pierre, D; Si, R; Deng, WL; Ferrin, P; Nilekar, AU; Peng, GW; Herron, JA; Bell, DC; Saltsburg, H; Mavrikakis, M; Flytzani-Stephanopoulos, M				Zhai, Yanping; Pierre, Danny; Si, Rui; Deng, Weiling; Ferrin, Peter; Nilekar, Anand U.; Peng, Guowen; Herron, Jeffrey A.; Bell, David C.; Saltsburg, Howard; Mavrikakis, Manos; Flytzani-Stephanopoulos, Maria			Alkali-Stabilized Pt-OHx Species Catalyze Low-Temperature Water-Gas Shift Reactions	SCIENCE			English	Article							AUGMENTED-WAVE METHOD; CO OXIDATION; MECHANISM; CERIA; NA; ALUMINA; ENERGY; STEP; AU	We report that alkali ions (sodium or potassium) added in small amounts activate platinum adsorbed on alumina or silica for the low-temperature water-gas shift (WGS) reaction (H2O + CO -> H-2 + CO2) used for producing H2. The alkali ion-associated surface OH groups are activated by CO at low temperatures (similar to 100 degrees C) in the presence of atomically dispersed platinum. Both experimental evidence and density functional theory calculations suggest that a partially oxidized Pt-alkali-O-x(OH)(y) species is the active site for the low-temperature Pt-catalyzed WGS reaction. These findings are useful for the design of highly active and stable WGS catalysts that contain only trace amounts of a precious metal without the need for a reducible oxide support such as ceria.	[Zhai, Yanping; Pierre, Danny; Si, Rui; Deng, Weiling; Saltsburg, Howard; Flytzani-Stephanopoulos, Maria] Tufts Univ, Dept Biol & Chem Engn, Medford, MA 02155 USA; [Ferrin, Peter; Nilekar, Anand U.; Peng, Guowen; Herron, Jeffrey A.; Mavrikakis, Manos] Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA; [Bell, David C.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Tufts University; University of Wisconsin System; University of Wisconsin Madison; Harvard University	Flytzani-Stephanopoulos, M (corresponding author), Tufts Univ, Dept Biol & Chem Engn, Medford, MA 02155 USA.	manos@engr.wisc.edu; maria.flytzani-stephanopoulos@tufts.edu	Mavrikakis, Manos/D-5702-2012	Mavrikakis, Manos/0000-0002-5293-5356; Bell, David/0000-0002-8215-127X	U.S. Department of Energy (DOE)/Basic Energy Sciences (BES) Hydrogen Fuel Initiative [DE-FG02-05ER15730]; NSF [0304515, 0828666]; Synchrotron Catalysis Consortium at Brookhaven National Laboratory; Micromeritics Corporation; U.S. DOE/BES [DE-FG02-05ER15731, DE-FG02-03ER15468]; DOE	U.S. Department of Energy (DOE)/Basic Energy Sciences (BES) Hydrogen Fuel Initiative(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Synchrotron Catalysis Consortium at Brookhaven National Laboratory; Micromeritics Corporation; U.S. DOE/BES(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE))	Work at Tufts was supported by the U.S. Department of Energy (DOE)/Basic Energy Sciences (BES) Hydrogen Fuel Initiative Program (grant no. DE-FG02-05ER15730) and by the NSF (NIRT grant no. 0304515 and CBET grant no 0828666). We also gratefully acknowledge the support by the Synchrotron Catalysis Consortium at Brookhaven National Laboratory, and the Micromeritics Corporation for generously supplying the Autochem II 2920 as part of their Instrument Grant Program. Work at UW was supported by U.S. DOE/BES (grant nos. DE-FG02-05ER15731 and DE-FG02-03ER15468). Computational work was performed at supercomputing centers located at National Energy Research Scientific Computing Center, Pacific Northwest National Laboratory, Argonne National Laboratory, and Oak Ridge National Laboratory, all supported by DOE. We also thank Division of Information Technology, Center for High Throughput Computing, and R. Nabar at UW. The authors declare that they have no competing financial interests.	Allard LF, 2009, J ELECTRON MICROSC, V58, P199, DOI 10.1093/jmicro/dfp016; AMENOMIYA Y, 1982, J CATAL, V76, P345, DOI 10.1016/0021-9517(82)90265-2; Azzam KG, 2007, J CATAL, V251, P163, DOI 10.1016/j.jcat.2007.07.011; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Boaro M, 2009, APPL CATAL B-ENVIRON, V88, P272, DOI 10.1016/j.apcatb.2008.11.010; Campbell CT, 2001, J CATAL, V204, P520, DOI 10.1006/jcat.2001.3396; Deng WL, 2007, TOP CATAL, V44, P199, DOI 10.1007/S11244-007-0293-9; Derrouiche S, 2007, APPL SURF SCI, V253, P5894, DOI 10.1016/j.apsusc.2006.12.063; Evin HN, 2008, CATAL LETT, V122, P9, DOI 10.1007/s10562-007-9352-x; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; Goguet A, 2004, J PHYS CHEM B, V108, P20240, DOI 10.1021/jp047242w; Gokhale AA, 2008, J AM CHEM SOC, V130, P1402, DOI 10.1021/ja0768237; Gorte RJ, 2005, CATAL TODAY, V104, P18, DOI 10.1016/j.cattod.2005.03.034; Grabow LC, 2008, J PHYS CHEM C, V112, P4608, DOI 10.1021/jp7099702; Herzing AA, 2008, SCIENCE, V321, P1331, DOI 10.1126/science.1159639; Jacobs G, 2004, APPL CATAL A-GEN, V268, P255, DOI 10.1016/j.apcata.2004.03.048; Konsolakis M, 2000, J CATAL, V193, P330, DOI 10.1006/jcat.2000.2888; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kwak JH, 2009, SCIENCE, V325, P1670, DOI 10.1126/science.1176745; Meunier FC, 2007, J CATAL, V252, P18, DOI 10.1016/j.jcat.2007.09.003; OVESEN CV, 1992, J CATAL, V134, P445, DOI 10.1016/0021-9517(92)90334-E; Panagiotopoulou P, 2007, CHEM ENG J, V134, P16, DOI 10.1016/j.cej.2007.03.054; Panagiotopoulou P, 2009, J CATAL, V267, P57, DOI 10.1016/j.jcat.2009.07.014; PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244; Phatak AA, 2007, CATAL TODAY, V123, P224, DOI 10.1016/j.cattod.2007.02.031; Pierre D, 2007, TOP CATAL, V46, P363, DOI 10.1007/s11244-007-9013-8; Pigos JM, 2007, APPL CATAL A-GEN, V319, P47, DOI 10.1016/j.apcata.2006.11.014; Reveles JU, 2009, NAT CHEM, V1, P310, DOI [10.1038/nchem.249, 10.1038/NCHEM.249]; Zhu XL, 2009, CATAL LETT, V129, P135, DOI 10.1007/s10562-008-9799-4	30	542	543	16	689	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1633	1636		10.1126/science.1192449	http://dx.doi.org/10.1126/science.1192449			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929844				2022-12-28	WOS:000282098100037
J	Pennington, H				Pennington, Hugh			Escherichia coli O157	LANCET			English	Review							HEMOLYTIC-UREMIC SYNDROME; SHIGA-TOXIN; HOUSEHOLD TRANSMISSION; HUMAN INFECTION; DOSE-RESPONSE; CATTLE; EMERGENCE; VIRULENCE; OUTBREAK; EPIDEMIOLOGY	Escherichia coli 0157 is an uncommon but serious cause of gastroenteritis. This bacterium is noteworthy because a few, but significant, number of infected people develop the haemolytic uraemic syndrome, which is the most frequent cause of acute renal failure in children in the Americas and Europe. Many infections of E coli 0157 could be prevented by the more effective application of evidence-based methods, which is especially important because once an infection has been established, no therapeutic interventions are available to lessen the risk of the development of the haemolytic uraemic syndrome. This Review takes into account the evolution and geographical distibution of E coli 0157 (and its close pathogenic relatives); the many and varied routes of transmission from its major natural hosts, ruminant farm animals; and other aspects of its epidemiology, its virulence factors, the diagnosis and management of infection and their complications, the repercussions of infection including costs, and prevention.	[Pennington, Hugh] Univ Aberdeen, Aberdeen, Scotland	University of Aberdeen	Pennington, H (corresponding author), Carlton Pl, Aberdeen AB15 4BR, Scotland.	mmb036@abdn.ac.uk						Abu-Ali GS, 2010, MICROBIOL-SGM, V156, P408, DOI 10.1099/mic.0.033126-0; Ake JA, 2005, PEDIATRICS, V115, pE673, DOI 10.1542/peds.2004-2236; Baker M, 1999, NZ PUBLIC HLTH REPOR, V6, P9; Brown MH., 2000, HACCP MEAT IND; *CDC, 1982, MMWR-MORBID MORTAL W, V31, P580; *CDCP, MULT OUTBR E COL 015; CDCP, 2009, MMWR RECOMM REP, V58, P1; Centers for Disease Control and Prevention, 2006, MMWR-MORBID MORTAL W, V55, P1045; Chart H, 2008, J MED MICROBIOL, V57, P1389, DOI 10.1099/jmm.0.2008/003632-0; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Chase-Topping ME, 2007, J CLIN MICROBIOL, V45, P1594, DOI 10.1128/JCM.01690-06; Chattopadhyay S, 2007, J MOL EVOL, V64, P204, DOI 10.1007/s00239-006-0063-5; Cobbold RN, 2007, APPL ENVIRON MICROB, V73, P1563, DOI 10.1128/AEM.01742-06; Cowden JM, 2001, EPIDEMIOL INFECT, V126, P335, DOI 10.1017/S0950268801005520; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; DJURETIC T, 1997, EURO SURVEILL, V1; *ECDC, 2007, 2007Q3 STECVTEC ECDC; *ECDC, 2008, Q1 STECVTEC; Effler P, 2001, EMERG INFECT DIS, V7, P812; Eriksson KJ, 2001, ARCH DIS CHILD, V84, P434, DOI 10.1136/adc.84.5.434; Ethelberg S, 2004, EMERG INFECT DIS, V10, P842, DOI 10.3201/eid1005.030576; *EUR FOOD SAF AUTH, 2010, EFSA J, V1496; Feng P, 1998, J INFECT DIS, V177, P1750, DOI 10.1086/517438; Friesema I, 2008, EURO SURVEILL, V13; Goh S, 2002, EPIDEMIOL INFECT, V129, P451, DOI 10.1017/S0950268802007835; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; Hall G, 2008, EMERG INFECT DIS, V14, P1601, DOI 10.3201/eid1410.071042; HATAYA H, 1997, REPORT OUTBREAK E CO; *HLTH PROT AG, HLTH PROT AG NAT STA; Howie H, 2003, EPIDEMIOL INFECT, V131, P1063, DOI 10.1017/S0950268803001250; Hussein HS, 2005, MEAT SCI, V71, P676, DOI 10.1016/j.meatsci.2005.05.012; Hussein HS, 2005, J FOOD PROTECT, V68, P2224, DOI 10.4315/0362-028X-68.10.2224; Hussein HS, 2005, J DAIRY SCI, V88, P450, DOI 10.3168/jds.S0022-0302(05)72706-5; Innocent GT, 2005, EPIDEMIOL INFECT, V133, P1033, DOI 10.1017/S0950268805003687; Jenke C, 2010, EMERG INFECT DIS, V16, P610, DOI 10.3201/eid1604.091361; KARCH H, 1995, J CLIN MICROBIOL, V33, P1602, DOI 10.1128/JCM.33.6.1602-1605.1995; Khandaker S. A., 2004, American Journal of Applied Sciences, V1, P302; Kistemann T, 2004, EPIDEMIOL INFECT, V132, P495, DOI 10.1017/S0950268803001729; Leopold SR, 2009, P NATL ACAD SCI USA, V106, P8713, DOI 10.1073/pnas.0812949106; Leotta GA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-46; LIVERNOIS J, 2001, EC COSTS WALKERTON W; Low JC, 2005, APPL ENVIRON MICROB, V71, P93, DOI 10.1128/AEM.71.1.93-97.2005; Lynn RM, 2005, EMERG INFECT DIS, V11, P590, DOI 10.3201/eid1104.040833; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; MANNIX M, 2007, EURO SURVEILL, V12; Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Michael M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003595.pub2; Milnes AS, 2008, EPIDEMIOL INFECT, V136, P739, DOI 10.1017/S0950268807009223; NAUTA MJ, 257851003 RIVM; Newton HJ, 2009, EMERG INFECT DIS, V15, P372, DOI [10.3201/eid1502.080631, 10.3201/eid1503.080631]; Noris M, 2005, J AM SOC NEPHROL, V16, P1035, DOI 10.1681/ASN.2004100861; O'Connor Dennis R., 2002, REPORT WALKERTON I 1; O'Sullivan M B, 2008, Euro Surveill, V13; OBRIEN SJ, 2008, P PATH E COL NETW C, P92; Parry SM, 1998, EMERG INFECT DIS, V4, P657, DOI 10.3201/eid0404.980419; Pennington H., 1997, PENNINGTON GROUP REP; PENNINGTON TH, 2010, RISK COMMUNICATION P, P81; Pennington TH, 2009, PUBLIC INQUIRY SEPTE; PENNINGTON TH, 2001, MOL MED MICROBIOLOGY; Persson S, 2007, J CLIN MICROBIOL, V45, P2020, DOI 10.1128/JCM.02591-06; Pollock KGJ, 2009, J MED MICROBIOL, V58, P397, DOI 10.1099/jmm.0.007179-0; POLLOCK KGJ, 2010, HLTH PROT SCOTL WKLY, V44; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Rice Catherine, 2009, Morbidity and Mortality Weekly Report, V58, P1; ROBAEYS G, 1987, LANCET, V1, P1495; Roberts JA, 2000, J PUBLIC HEALTH MED, V22, P99, DOI 10.1093/pubmed/22.1.99; Rosser T, 2008, INFECT IMMUN, V76, P5598, DOI 10.1128/IAI.01180-08; RYDEVIK G, 2008, P PATH E COL NETW C; Sakuma M, 2006, EMERG INFECT DIS, V12, P323, DOI 10.3201/eid1202.050268; Scheiring J, 2008, PEDIATR NEPHROL, V23, P1749, DOI 10.1007/s00467-008-0935-6; SHINAGAWA K, 1997, KOSHU EISEI KENKYU, V46, P104; Siegler RL, 2003, PEDIATR NEPHROL, V18, P92, DOI 10.1007/s00467-002-1035-7; Smith DR, 2009, FOODBORNE PATHOG DIS, V6, P155, DOI 10.1089/fpd.2008.0136; Snedeker KG, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-144; Spina N, 2005, J CLIN MICROBIOL, V43, P2938, DOI 10.1128/JCM.43.6.2938-2939.2005; Stahl AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006990; Strachan NJC, 2005, INT J FOOD MICROBIOL, V103, P35, DOI 10.1016/j.ijfoodmicro.2004.11.023; Strachan NJC, 2005, VET REC, V156, P282, DOI 10.1136/vr.156.9.282; Strachan NJC, 2002, INT J FOOD MICROBIOL, V75, P39, DOI 10.1016/S0168-1605(01)00727-9; Strachan NJC, 2006, INT J FOOD MICROBIOL, V112, P129, DOI 10.1016/j.ijfoodmicro.2006.06.021; Synge B, 2000, VET REC, V147, P27; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; TARR PI, 2008, P PATH E COL NETW C, P8; TAYLOR CM, 1986, BRIT MED J, V292, P1513, DOI 10.1136/bmj.292.6534.1513; Teunis PFM, 2008, EPIDEMIOL INFECT, V136, P761, DOI 10.1017/S0950268807008771; Valcour JE, 2002, EMERG INFECT DIS, V8, P252, DOI 10.3201/eid0803.010159; *VTEC, 2007, 20072 VTEC; Werber D, 2008, CLIN INFECT DIS, V46, P1189, DOI 10.1086/587670; Wick LM, 2005, J BACTERIOL, V187, P1783, DOI 10.1128/JB.187.5.1783-1791.2005; 2009, REV MAJOR OUTBREAK E; 2009, CAN COMMUN DIS REP W, V35, P1; 2010, HLTH PROTECTION SCOT	93	272	279	1	79	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 23	2010	376	9750					1428	1435		10.1016/S0140-6736(10)60963-4	http://dx.doi.org/10.1016/S0140-6736(10)60963-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672ZO	20971366				2022-12-28	WOS:000283627500037
J	Kristensen, FB; Gerhardus, A				Kristensen, Finn Borlum; Gerhardus, Ansgar			Health technology assessments: what do differing conclusions tell us?	BRITISH MEDICAL JOURNAL			English	Editorial Material							HPV VACCINATION; DECISION		[Kristensen, Finn Borlum] Natl Board Hlth, Secretariat European Network Hlth Technol Assessm, Copenhagen, Denmark; [Kristensen, Finn Borlum] Univ So Denmark, Fac Hlth Sci, DK-5000 Odense C, Denmark; [Gerhardus, Ansgar] Univ Bielefeld, Dept Epidemiol & Int Publ Hlth, Bielefeld, Germany	University of Southern Denmark; University of Bielefeld	Kristensen, FB (corresponding author), Natl Board Hlth, Secretariat European Network Hlth Technol Assessm, Copenhagen, Denmark.	fbk@sst.dk	Gerhardus, Ansgar/L-9746-2018	Gerhardus, Ansgar/0000-0003-3637-7419; Kristensen, Finn Boerlum/0000-0003-0263-0754				de Kok IMCM, 2009, JNCI-J NATL CANCER I, V101, P1083, DOI 10.1093/jnci/djp183; Eisenberg JM, 2002, HEALTH AFFAIR, V21, P166, DOI 10.1377/hlthaff.21.3.166; Gerhardus A, 2010, J EPIDEMIOL COMMUN H, V64, P377, DOI 10.1136/jech.2009.090183; Godlee F, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5405; Haug C, 2009, JAMA-J AM MED ASSOC, V302, P795, DOI 10.1001/jama.2009.1215; Health Information and Quality Authority (IE), 2008, ROL HUM PAP VACC RED; Hutton J, 2008, INT J TECHNOL ASSESS, V24, P511, DOI 10.1017/S0266462308080677; *INT NETW AG HLTH, MEMB; International Network of Agencies for Health Technology Assessment, HTA CHECKL; Kristensen FB, 2009, INT J TECHNOL ASSESS, V25, P1, DOI 10.1017/S0266462309990626; Lampe K, 2009, INT J TECHNOL ASSESS, V25, P9, DOI 10.1017/S0266462309990638; Lippman A, 2008, J EPIDEMIOL COMMUN H, V62, P570, DOI 10.1136/jech.2008.074740; *NAT BOARD HLTH DE, 2007, RED RISK CERV CANC V; NILSEN E, 2007, VAKSINER MOT HUMANT; Rothman SM, 2009, JAMA-J AM MED ASSOC, V302, P781, DOI 10.1001/jama.2009.1179; *SWED COUNC TECHN, 2008, ALLM BARNV MOT HPV 1; THIRY N, 2008, HPV VACCINATION PREV; Zechmeister I, 2007, OKONOMISCHE EVALUATI	18	11	11	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 22	2010	341								c5236	10.1136/bmj.c5236	http://dx.doi.org/10.1136/bmj.c5236			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	671ZS	20971784				2022-12-28	WOS:000283553400002
J	Dyer, C				Dyer, Clare			Professional Regulation Have we heeded the lessons from Shipman?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Dyer, Clare] BMJ, London WC1H 9JR, England		Dyer, C (corresponding author), BMJ, London WC1H 9JR, England.	ClareDyer@aol.com						*SHIPM INQ, SHIPM INQ REP; Smith J., SHIPMAN INQUIRY WAS	2	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 18	2010	341								c5711	10.1136/bmj.c5711	http://dx.doi.org/10.1136/bmj.c5711			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	671ZF	20956445				2022-12-28	WOS:000283552100007
J	Vincent, JL; Singer, M				Vincent, Jean-Louis; Singer, Mervyn			Critical Care 3 Critical care: advances and future perspectives	LANCET			English	Article							ACTIVATED PROTEIN-C; INTENSIVE INSULIN THERAPY; SURVIVING SEPSIS CAMPAIGN; QUALITY-OF-LIFE; ILL PATIENTS; INTRAVENOUS IMMUNOGLOBULIN; HEMODYNAMIC OPTIMIZATION; ECONOMIC OUTCOMES; DIGESTIVE-TRACT; SEPTIC SHOCK	Intensive care offers a standard of monitoring, intervention, and organ support that cannot be readily delivered in a general ward. Its expansion in the past few decades, including the creation of emergency and outreach teams, emphasises that intensive care has an increasingly prominent role within the hospital. Although outcomes are clearly improving, intensive care remains a nascent specialty in which we are still learning how to harness a powerful ability to manipulate physiology, biochemistry, and immunology to achieve best outcomes for the patient. The results of many multicentre studies have not lent support to, or have even confounded, expectations, drawing attention to several issues related to patient heterogeneity, trial design, and elucidation of underlying pathophysiological processes. However, these results have generated constructive introspection and reappraisal of treatments and management strategies that have benefited the patient. In addition to the medical, financial, and logistical challenges in the future, exciting opportunities will arise as new developments in diagnostic tests, therapeutic interventions, and technology are used to exploit an increasing awareness of how critical illness should be managed.	[Vincent, Jean-Louis] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, Brussels, Belgium; [Singer, Mervyn] UCL, Dept Med, Bloomsbury Inst Intens Care Med, London, England	Universite Libre de Bruxelles; University of London; University College London	Vincent, JL (corresponding author), Erasme Univ Hosp, Dept Intens Care, Route Lennik 808, B-1070 Brussels, Belgium.	jlvincen@ulb.ac.be	Singer, Mervyn/Q-6142-2019; Singer, Mervyn/J-4425-2012	Singer, Mervyn/0000-0002-1042-6350; Singer, Mervyn/0000-0002-1042-6350; Vincent, Jean-Louis/0000-0001-6011-6951	Eisai; Eli Lilly; Artisan; Astellas; UK Department of Health's National Institute for Health Research Comprehensive Biomedical Research Centre	Eisai(Eisai Co Ltd); Eli Lilly(Eli Lilly); Artisan; Astellas(Astellas Pharmaceuticals); UK Department of Health's National Institute for Health Research Comprehensive Biomedical Research Centre	J-LV has served as a paid consultant for Eli Lilly, Eisai, and GlaxoSmithKline; participated in clinical trials sponsored by Eisai, Eli Lilly, Artisan, and Astellas; and been an invited speaker at conferences supported by Eli Lilly, Esai, and GlaxoSmithKline. MS has served as a consultant to, and has been an invited speaker at conferences supported by, Eli Lilly and Deltas Medical. Additionally, Deltex Medical provides a yearly unrestricted donation to MS's research fund at University College London.; University College London Hospital/University College London receives support from the UK Department of Health's National Institute for Health Research Comprehensive Biomedical Research Centre funding scheme.	Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; *AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Angus DC, 2004, CRIT CARE MED, V32, P2199, DOI 10.1097/01.CCM.0000145228.62451.F6; Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; Armstrong L, 1999, AM J RESP CRIT CARE, V160, P1910, DOI 10.1164/ajrccm.160.6.9811084; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Breslow MJ, 2004, CRIT CARE MED, V32, P31, DOI 10.1097/01.CCM.0000104204.61296.41; Brienza N, 2009, CRIT CARE MED, V37, P2079, DOI 10.1097/CCM.0b013e3181a00a43; Cheung AM, 2006, AM J RESP CRIT CARE, V174, P538, DOI 10.1164/rccm.200505-693OC; Cuthbertson BH, 2010, CRIT CARE, V14, DOI 10.1186/cc8848; de Backer D, 2006, CRIT CARE MED, V34, P1918, DOI 10.1097/01.CCM.0000220498.48773.3C; de Jonge E, 2003, LANCET, V362, P1011, DOI 10.1016/S0140-6736(03)14409-1; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dhainaut JF, 2004, J THROMB HAEMOST, V2, P1924, DOI 10.1111/j.1538-7836.2004.00955.x; Eichacker PQ, 2007, INTENS CARE MED, V33, P396, DOI 10.1007/s00134-007-0556-8; Eichacker PQ, 2006, NEW ENGL J MED, V355, P1640, DOI 10.1056/NEJMp068197; ESCARCE JJ, 1990, JAMA-J AM MED ASSOC, V264, P2389, DOI 10.1001/jama.264.18.2389; Esteban A, 2004, NEW ENGL J MED, V350, P2452, DOI 10.1056/NEJMoa032736; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Flabouris Arthas, 2008, Crit Care Resusc, V10, P97; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Gomersall CD, 2000, CRIT CARE MED, V28, P607, DOI 10.1097/00003246-200003000-00001; Griffiths RD, 2007, CURR OPIN CRIT CARE, V13, P508, DOI 10.1097/MCC.0b013e3282efae05; Gupta A, 2009, J AM SOC NEPHROL, V20, P267, DOI 10.1681/ASN.2008030294; GUTIERREZ G, 1992, LANCET, V339, P195, DOI 10.1016/0140-6736(92)90002-K; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Herzig SJ, 2009, JAMA-J AM MED ASSOC, V301, P2120, DOI 10.1001/jama.2009.722; Hillman Ken, 2002, Curr Opin Crit Care, V8, P594, DOI 10.1097/00075198-200212000-00019; Jackson JC, 2009, CRIT CARE CLIN, V25, P615, DOI 10.1016/j.ccc.2009.04.005; Joyce DE, 2004, CRIT CARE MED, V32, pS280, DOI 10.1097/01.CCM.0000128037.72072.22; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Kreyrnann KG, 2007, CRIT CARE MED, V35, P2677, DOI 10.1097/01.CCM.0000295263.12774.97; Laupland KB, 2007, CRIT CARE MED, V35, P2686, DOI 10.1097/01.CCM.0000295312.13466.1C; Lopez A, 2004, CRIT CARE MED, V32, P21, DOI 10.1097/01.CCM.0000105581.01815.C6; Mackenzie AF, 2005, INTENS CARE MED, V31, P1624, DOI 10.1007/s00134-005-2829-4; MacLaren R, 2008, CRIT CARE MED, V36, P3184, DOI 10.1097/CCM.0b013e31818f2269; Marshall JC, 2008, J LEUKOCYTE BIOL, V83, P471, DOI 10.1189/jlb.0607380; Marshall JC, 2009, CRIT CARE MED, V37, P2290, DOI 10.1097/CCM.0b013e3181a02afc; Martin G, 2009, CRIT CARE, V13, DOI 10.1186/cc7936; Matzo M, 2009, BIOSECUR BIOTERROR, V7, P199, DOI 10.1089/bsp.2009.0017; Moran JL, 2008, CRIT CARE MED, V36, P46, DOI 10.1097/01.CCM.0000295313.08084.58; Nadel S, 2007, LANCET, V369, P836, DOI 10.1016/S0140-6736(07)60411-5; Nobre V, 2008, AM J RESP CRIT CARE, V177, P498, DOI 10.1164/rccm.200708-1238OC; Ospina-Tascon GA, 2008, CRIT CARE MED, V36, P1311, DOI 10.1097/CCM.0b013e318168ea3e; Papadimos Thomas J, 2008, Patient Saf Surg, V2, P3, DOI 10.1186/1754-9493-2-3; Poeze M, 2005, CRIT CARE, V9, pR771, DOI 10.1186/cc3902; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Pontes-Arruda A, 2008, JPEN-PARENTER ENTER, V32, P596, DOI 10.1177/0148607108324203; Pronovost P, 2006, CRIT CARE MED, V34, P1988, DOI 10.1097/01.CCM.0000226412.12612.B6; Pronovost PJ, 1999, JAMA-J AM MED ASSOC, V281, P1310, DOI 10.1001/jama.281.14.1310; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Protti A, 2006, CRIT CARE, V10, DOI 10.1186/cc5014; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rubinson L, 2008, CHEST, V133, p18S, DOI 10.1378/chest.07-2690; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Shulman R, 2005, CRIT CARE, V9, pR516, DOI 10.1186/cc3793; Singer M, 2004, LANCET, V364, P545, DOI 10.1016/S0140-6736(04)16815-3; Singer M, 2007, LANCET, V370, P636, DOI 10.1016/S0140-6736(07)61317-8; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Tan T, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b822; Turgeon AF, 2007, ANN INTERN MED, V146, P193, DOI 10.7326/0003-4819-146-3-200702060-00009; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; *VET AFF TOT PAR N, 1991, NEW ENGL J MED, V325, P525, DOI DOI 10.1056/NEJM199108223250801; Vincent JL, 2006, PLOS MED, V3, P1488, DOI 10.1371/journal.pmed.0030346; Vincent JL, 2010, CRIT CARE MED, V38, P283, DOI 10.1097/CCM.0b013e3181b785a2; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 2005, CRIT CARE MED, V33, P2266, DOI 10.1097/01.CCM.0000181729.46010.83; Vincent JL, 2005, CRIT CARE MED, V33, P1225, DOI 10.1097/01.CCM.0000165962.16682.46; Wagner F, 2009, CRIT CARE, V13, DOI 10.1186/cc7700; Zambon M, 2008, CHEST, V133, P1120, DOI 10.1378/chest.07-2134	79	50	54	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2010	376	9749					1354	1361		10.1016/S0140-6736(10)60575-2	http://dx.doi.org/10.1016/S0140-6736(10)60575-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671RX	20934211				2022-12-28	WOS:000283528600039
J	Buhr, ED; Yoo, SH; Takahashi, JS				Buhr, Ethan D.; Yoo, Seung-Hee; Takahashi, Joseph S.			Temperature as a Universal Resetting Cue for Mammalian Circadian Oscillators	SCIENCE			English	Article							HEAT-SHOCK FACTOR-1; SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; INDIVIDUAL FIBROBLASTS; REVEALS PERSISTENT; PERIPHERAL-TISSUES; BODY-TEMPERATURE; DNA-BINDING; CLOCK GENE; ENTRAINMENT	Environmental temperature cycles are a universal entraining cue for all circadian systems at the organismal level with the exception of homeothermic vertebrates. We report here that resistance to temperature entrainment is a property of the suprachiasmatic nucleus (SCN) network and is not a cell-autonomous property of mammalian clocks. This differential sensitivity to temperature allows the SCN to drive circadian rhythms in body temperature, which can then act as a universal cue for the entrainment of cell-autonomous oscillators throughout the body. Pharmacological experiments show that network interactions in the SCN are required for temperature resistance and that the heat shock pathway is integral to temperature resetting and temperature compensation in mammalian cells. These results suggest that the evolutionarily ancient temperature resetting response can be used in homeothermic animals to enhance internal circadian synchronization.	[Buhr, Ethan D.; Yoo, Seung-Hee; Takahashi, Joseph S.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Buhr, Ethan D.; Yoo, Seung-Hee; Takahashi, Joseph S.] Northwestern Univ, Ctr Funct Genom, Evanston, IL 60208 USA; [Yoo, Seung-Hee; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Northwestern University; Northwestern University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Takahashi, JS (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	joseph.takahashi@utsouthwestern.edu	Takahashi, Joseph S/E-8482-2012	Takahashi, Joseph S/0000-0003-0384-8878; Buhr, Ethan/0000-0002-9250-6644	NIH [P50 MH074924, T32 AG 20418]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020418] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Takahashi laboratory for helpful discussions; S. Panda and J. B. Hogenesch for providing the U-2 OS cells; S. A. Kay for providing PG 99-465; and R. I. Morimoto for providing HSP70 antibody. We especially thank V. Kumar and K. Shimomura for suggestions and discussion on the manuscript. This work was supported by NIH P50 MH074924 to J. S. T. and T32 AG 20418 to E. D. B. J. S. T. is an Investigator and S.H.Y. was an Associate in the Howard Hughes Medical Institute. J. S. T. has a paid consulting relationship with, and owns stock in, ReSet Therapeutics, Inc., a biotechnology company that works on circadian rhythms and metabolism.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; CHOI HS, 1991, J BIOL CHEM, V266, P11858; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; de la Iglesia HO, 2004, CURR BIOL, V14, P796, DOI 10.1016/j.cub.2004.04.034; Diernfellner ACR, 2005, GENE DEV, V19, P1968, DOI 10.1101/gad.345905; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Herzog ED, 2003, J NEUROPHYSIOL, V90, P763, DOI 10.1152/jn.00129.2003; HOFFMANN K, 1969, OECOLOGIA, V3, P184, DOI 10.1007/BF00416981; HONMA S, 1988, PHYSIOL BEHAV, V44, P247, DOI 10.1016/0031-9384(88)90146-1; Honma S, 2008, J BIOL RHYTHM, V23, P91, DOI 10.1177/0748730407311124; Kabrita CS, 2008, BRAIN RES, V1195, P20, DOI 10.1016/j.brainres.2007.12.020; Kaushik R, 2007, PLOS BIOL, V5, P1257, DOI 10.1371/journal.pbio.0050146; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lahiri K, 2005, PLOS BIOL, V3, P2005, DOI 10.1371/journal.pbio.0030351; Liu Y, 1998, SCIENCE, V281, P825, DOI 10.1126/science.281.5378.825; Liu Y, 1997, CELL, V89, P477, DOI 10.1016/S0092-8674(00)80228-7; Low KH, 2008, NEURON, V60, P1054, DOI 10.1016/j.neuron.2008.10.048; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; MOSSER DD, 1990, P NATL ACAD SCI USA, V87, P3748, DOI 10.1073/pnas.87.10.3748; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; Prolo LM, 2005, J NEUROSCI, V25, P404, DOI 10.1523/JNEUROSCI.4133-04.2005; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Rensing L, 2002, CHRONOBIOL INT, V19, P807, DOI 10.1081/CBI-120014569; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Sehadova H, 2009, NEURON, V64, P251, DOI 10.1016/j.neuron.2009.08.026; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Tataroglu O, 2006, J BIOL RHYTHM, V21, P185, DOI 10.1177/0748730406287529; Wadekar SA, 2004, MOL ENDOCRINOL, V18, P500, DOI 10.1210/me.2003-0215; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yokota S, 2000, CANCER RES, V60, P2942; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshida T, 2009, P NATL ACAD SCI USA, V106, P1648, DOI 10.1073/pnas.0806741106	48	544	555	14	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					379	385		10.1126/science.1195262	http://dx.doi.org/10.1126/science.1195262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947768	Green Accepted			2022-12-28	WOS:000282986700044
J	Luo, SJ; Kleemann, GA; Ashraf, JM; Shaw, WM; Murphy, CT				Luo, Shijing; Kleemann, Gunnar A.; Ashraf, Jasmine M.; Shaw, Wendy M.; Murphy, Coleen T.			TGF-beta and Insulin Signaling Regulate Reproductive Aging via Oocyte and Germline Quality Maintenance	CELL			English	Article							AGE-RELATED-CHANGES; CAENORHABDITIS-ELEGANS; LIFE-SPAN; GENE-EXPRESSION; STEM-CELLS; SPERM; NONDISJUNCTION; ABNORMALITIES; TEMPERATURE; DROSOPHILA	Reproductive cessation is perhaps the earliest aging phenotype that humans experience. Similarly, reproduction of Caenorhabditis elegans ceases in midadulthood. Although somatic aging has been studied in both worms and humans, mechanisms regulating reproductive aging are not yet understood. Here, we show that TGF-beta Sma/Mab and Insulin/IGF-1 signaling regulate C. elegans reproductive aging by modulating multiple aspects of the reproductive process, including embryo integrity, oocyte fertilizability, chromosome segregation fidelity, DNA damage resistance, and oocyte and germline morphology. TGF-beta activity regulates reproductive span and germline/oocyte quality noncell-autonomously and is temporally and transcriptionally separable from its regulation of growth. Chromosome segregation, cell cycle, and DNA damage response genes are upregulated in TGF-beta mutant oocytes, decline in aged mammalian oocytes, and are critical for oocyte quality maintenance. Our data suggest that C. elegans and humans share many aspects of reproductive aging, including the correlation between reproductive aging and declining oocyte quality and mechanisms determining oocyte quality.	[Luo, Shijing; Kleemann, Gunnar A.; Ashraf, Jasmine M.; Shaw, Wendy M.; Murphy, Coleen T.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Luo, Shijing; Kleemann, Gunnar A.; Ashraf, Jasmine M.; Shaw, Wendy M.; Murphy, Coleen T.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Murphy, CT (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	ctmurphy@princeton.edu		Murphy, Coleen/0000-0002-8257-984X	NIH [1DP2OD004402-01, P50 GM071508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004402] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Cathy Savage-Dunn (CUNY) for CS122 and pCS227; David Sherwood (Duke University) for NK640; Barth Grant (Rutgers) for RT130 and alpha-RME-2 antibody; members of the Murphy Laboratory and Z. Gitai for comments on the manuscript; and March of Dimes Basil O'Connor Starting Scholar, NIH New Innovator (1DP2OD004402-01), and NIH (P50 GM071508) awards for funding.	Andux S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000295; Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Blondin P, 1997, J ANDROL, V18, P454; Cant MA, 2008, P NATL ACAD SCI USA, V105, P5332, DOI 10.1073/pnas.0711911105; Carlson ME, 2009, AGING CELL, V8, P676, DOI 10.1111/j.1474-9726.2009.00517.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Garigan D, 2002, GENETICS, V161, P1101; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Ghazi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000639; Goud P, 1999, FERTIL STERIL, V72, P245, DOI 10.1016/S0015-0282(99)00231-9; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Greenstein David, 2005, WormBook, P1, DOI 10.1895/wormbook.1.53.1; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hagedorn EJ, 2009, DEV CELL, V17, P187, DOI 10.1016/j.devcel.2009.06.006; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; HARTGE P, 1979, GENETICS, V91, P67; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes SE, 2007, PLOS GENET, V3, P254, DOI 10.1371/journal.pgen.0030025; Jud M, 2007, DEV GENES EVOL, V217, P221, DOI 10.1007/s00427-006-0130-3; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Liang J, 2003, DEVELOPMENT, V130, P6453, DOI 10.1242/dev.00863; Liang J, 2007, DEV BIOL, V305, P714, DOI 10.1016/j.ydbio.2007.02.038; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Luo SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000789; Magli MC, 2007, FERTIL STERIL, V87, P534, DOI 10.1016/j.fertnstert.2006.07.1512; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; Miller Michael A., 2006, V351, P193; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; ROSE AM, 1979, GENETICS, V92, P409; Rubio C, 2003, HUM REPROD, V18, P182, DOI 10.1093/humrep/deg015; Saito TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000735; Savage-Dunn C, 2000, DEV BIOL, V223, P70, DOI 10.1006/dbio.2000.9713; Savage-Dunn Cathy, 2005, WormBook, P1; Shaw WM, 2007, CURR BIOL, V17, P1635, DOI 10.1016/j.cub.2007.08.058; Steuerwald NM, 2007, REPROD BIOMED ONLINE, V14, P700, DOI 10.1016/S1472-6483(10)60671-2; Stolk L, 2009, NAT GENET, V41, P645, DOI 10.1038/ng.387; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Tang L, 2010, MOL BIOL CELL, V21, P885, DOI 10.1091/mbc.E09-09-0811; TOKUNAGA C, 1970, GENETICS, V65, P75; Trombly DJ, 2009, SEMIN REPROD MED, V27, P14, DOI 10.1055/s-0028-1108006; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141; Wang JJ, 2002, DEVELOPMENT, V129, P4989; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680; Zhao R, 2008, AGING CELL, V7, P344, DOI 10.1111/j.1474-9726.2008.00379.x	57	155	161	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					299	312		10.1016/j.cell.2010.09.013	http://dx.doi.org/10.1016/j.cell.2010.09.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946987	Bronze, Green Accepted			2022-12-28	WOS:000283052200018
J	Murakami, K; Yasunaga, T; Noguchi, TQP; Gomibuchi, Y; Ngo, KX; Uyeda, TQP; Wakabayashi, T				Murakami, Kenji; Yasunaga, Takuo; Noguchi, Taro Q. P.; Gomibuchi, Yuki; Ngo, Kien X.; Uyeda, Taro Q. P.; Wakabayashi, Takeyuki			Structural Basis for Actin Assembly, Activation of ATP Hydrolysis, and Delayed Phosphate Release	CELL			English	Article							ATOMIC MODEL; F-ACTIN; ELECTRON-MICROGRAPHS; INORGANIC-PHOSPHATE; CRYSTAL-STRUCTURE; POLYMERIZATION; FILAMENT; ADP; VISUALIZATION; TROPOMYOSIN	Assembled actin filaments support cellular signaling, intracellular trafficking, and cytokinesis. ATP hydrolysis triggered by actin assembly provides the structural cues for filament turnover in vivo. Here, we present the cryo-electron microscopic (cryo-EM) structure of filamentous actin (F-actin) in the presence of phosphate, with the visualization of some alpha-helical backbones and large side chains. A complete atomic model based on the EM map identified intermolecular interactions mediated by bound magnesium and phosphate ions. Comparison of the F-actin model with G-actin monomer crystal structures reveals a critical role for bending of the conserved proline-rich loop in triggering phosphate release following ATP hydrolysis. Crystal structures of G-actin show that mutations in this loop trap the catalytic site in two intermediate states of the ATPase cycle. The combined structural information allows us to propose a detailed molecular mechanism for the biochemical events, including actin polymerization and ATPase activation, critical for actin filament dynamics.	[Murakami, Kenji; Gomibuchi, Yuki; Wakabayashi, Takeyuki] Teikyo Univ, Sch Sci & Engn, Dept Biosci, Utsunomiya, Tochigi 3208551, Japan; [Wakabayashi, Takeyuki] Teikyo Univ, Fac Med Technol, Dept Judo Therapy, Utsunomiya, Tochigi 3208551, Japan; [Yasunaga, Takuo] Kyushu Inst Technol, Fac Comp Sci & Syst Engn, Dept Biosci & Bioinformat, Fukuoka 820850, Japan; [Noguchi, Taro Q. P.; Ngo, Kien X.; Uyeda, Taro Q. P.] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058562, Japan; [Wakabayashi, Takeyuki] Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Teikyo University; Teikyo University; Kyushu Institute of Technology; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Wakabayashi, T (corresponding author), Teikyo Univ, Sch Sci & Engn, Dept Biosci, Toyosatodai 1-1, Utsunomiya, Tochigi 3208551, Japan.	wakabayashi@nasu.bio.teikyo-u.ac.jp	NGO, Kien Xuan/GLU-7155-2022; Yasunaga, Takuo/C-8316-2009	Yasunaga, Takuo/0000-0002-2494-9603; NGO, Kien Xuan/0000-0002-9710-5452	Ministry of Education, Science, Technology, and Sports of Japan; SENTAN,	Ministry of Education, Science, Technology, and Sports of Japan; SENTAN,(Japan Science & Technology Agency (JST))	We thank Dr. Murray Stewart (MRC Lab. Mol. Biol., Cambridge) for discussions and advice on crystallography; Dr. Ralph Davis and Dr. Karl-Magnus Larsson (Stanford University) for critical reading of the manuscript; Dr. Akihiro Narita for his contribution to this work at the early stages; Dr. Soichi Wakatsuki and colleagues at Photon Factory, KEK for data collection at the synchrotron site; Dr. Koji Yonekura for the program to calculate a figure of merit; Dr. Hideo Higuchi for fluorometry; and Yuji Tuji, Akito Tominaga, Ryuta Mikawa, and Harumi Kiuchi for assistance with crystallography and/or biochemical experiments. This work was supported by grants from Human Frontier Science Program and Grant-in-Aid for Scientific Research on Priority Areas (Bio-supramolecule) from the Ministry of Education, Science, Technology, and Sports of Japan to T.W. and a grant from SENTAN, JST to T.Q.P.U.	Baek K, 2008, P NATL ACAD SCI USA, V105, P11748, DOI 10.1073/pnas.0805852105; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Blanchoin L, 2002, BIOCHEMISTRY-US, V41, P597, DOI 10.1021/bi011214b; CARLIER MF, 1986, J BIOL CHEM, V261, P778; CARLIER MF, 1986, BIOCHEMISTRY-US, V25, P7789, DOI 10.1021/bi00372a001; DANCKER P, 1990, BIOCHIM BIOPHYS ACTA, V1035, P197, DOI 10.1016/0304-4165(90)90116-E; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fujiwara I, 2007, P NATL ACAD SCI USA, V104, P8827, DOI 10.1073/pnas.0702510104; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Heintz D, 1996, BIOCHEMISTRY-US, V35, P12686, DOI 10.1021/bi961159k; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KHAITLINA SY, 1993, EUR J BIOCHEM, V218, P911, DOI 10.1111/j.1432-1033.1993.tb18447.x; Klenchin VA, 2003, NAT STRUCT BIOL, V10, P1058, DOI 10.1038/nsb1006; Klenchin VA, 2006, J MOL BIOL, V362, P140, DOI 10.1016/j.jmb.2006.07.001; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LAKI K, 1962, ARCH BIOCHEM BIOPHYS, V98, P323, DOI 10.1016/0003-9861(62)90190-X; Liu X, 2006, P NATL ACAD SCI USA, V103, P13694, DOI 10.1073/pnas.0606321103; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Matsuura Y, 2000, J MOL BIOL, V296, P579, DOI 10.1006/jmbi.1999.3467; Narita A, 2007, J MOL BIOL, V365, P480, DOI 10.1016/j.jmb.2006.06.056; Noda K, 2006, J PLASMA PHYS, V72, P1037, DOI 10.1017/S0022377806005174; Noguchi TQP, 2007, J BIOL CHEM, V282, P27721, DOI 10.1074/jbc.M703165200; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; NONOMURA Y, 1975, J BIOCHEM, V78, P1101, DOI 10.1093/oxfordjournals.jbchem.a130988; Nyman T, 2002, J MOL BIOL, V317, P577, DOI 10.1006/jmbi.2002.5436; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RICKARD JE, 1986, J MOL BIOL, V191, P273, DOI 10.1016/0022-2836(86)90264-0; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; Saeki K, 1996, BIOCHEMISTRY-US, V35, P14465, DOI 10.1021/bi961292c; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Wriggers W, 1999, PROTEINS, V35, P262, DOI 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N; Yasunaga T, 1996, J STRUCT BIOL, V116, P155, DOI 10.1006/jsbi.1996.0025; Yasunaga T, 2008, J ELECTRON MICROSC, V57, P101, DOI 10.1093/jmicro/dfn006; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830	43	108	109	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					275	287		10.1016/j.cell.2010.09.034	http://dx.doi.org/10.1016/j.cell.2010.09.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946985	Bronze			2022-12-28	WOS:000283052200016
J	Meyer, A				Meyer, Axel			George C. Williams (1926-2010) OBITUARY	NATURE			English	Biographical-Item									Univ Konstanz, Dept Biol, D-78457 Constance, Germany	University of Konstanz	Meyer, A (corresponding author), Univ Konstanz, Dept Biol, D-78457 Constance, Germany.	axel.meyer@uni-konstanz.de	Meyer, Axel/C-9826-2009	Meyer, Axel/0000-0002-0888-8193				WILLIAMS GP, PUBLICATION LIST	1	1	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					790	790		10.1038/467790a	http://dx.doi.org/10.1038/467790a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944730	Bronze			2022-12-28	WOS:000282898700049
J	Snodgrass, C; Tubiana, C; Vincent, JB; Sierks, H; Hviid, S; Moissl, R; Boehnhardt, H; Barbieri, C; Koschny, D; Lamy, P; Rickman, H; Rodrigo, R; Carry, B; Lowry, SC; Laird, RJM; Weissman, PR; Fitzsimmons, A; Marchi, S; A'Hearn, M; Angrilli, F; Barucci, A; Bertaux, JL; Cremonese, G; Da Deppo, V; Davidsson, B; Debei, S; De Cecco, M; Fornasier, S; Gutierrez, P; Ip, WH; Keller, HU; Knollenberg, J; Kramm, JR; Kuehrt, E; Kueppers, M; Lara, LM; Lazzarin, M; Lopez-Moreno, JJ; Marzari, F; Michalik, H; Naletto, G; Sabau, L; Thomas, N; Wenzel, KP				Snodgrass, Colin; Tubiana, Cecilia; Vincent, Jean-Baptiste; Sierks, Holger; Hviid, Stubbe; Moissl, Richard; Boehnhardt, Hermann; Barbieri, Cesare; Koschny, Detlef; Lamy, Philippe; Rickman, Hans; Rodrigo, Rafael; Carry, Benoit; Lowry, Stephen C.; Laird, Ryan J. M.; Weissman, Paul R.; Fitzsimmons, Alan; Marchi, Simone; A'Hearn, M.; Angrilli, F.; Barucci, A.; Bertaux, J. -L.; Cremonese, G.; Da Deppo, V.; Davidsson, B.; Debei, S.; De Cecco, M.; Fornasier, S.; Gutierrez, P.; Ip, W. -H.; Keller, H. U.; Knollenberg, J.; Kramm, J. R.; Kuehrt, E.; Kueppers, M.; Lara, L. M.; Lazzarin, M.; Lopez-Moreno, J. J.; Marzari, F.; Michalik, H.; Naletto, G.; Sabau, L.; Thomas, N.; Wenzel, K. -P.		OSIRIS Team	A collision in 2009 as the origin of the debris trail of asteroid P/2010 A2	NATURE			English	Article							BELT; HISTORY; COMETS; EJECTA; MODEL	The peculiar object P/2010 A2 was discovered(1) in January 2010 and given a cometary designation because of the presence of a trail of material, although there was no central condensation or coma. The appearance of this object, in an asteroidal orbit (small eccentricity and inclination) in the inner main asteroid belt attracted attention as a potential new member of the recently recognized(2) class of main-belt comets. If confirmed, this new object would expand the range in heliocentric distance over which main-belt comets are found. Here we report observations of P/2010 A2 by the Rosetta spacecraft. We conclude that the trail arose from a single event, rather than a period of cometary activity, in agreement with independent results(3). The trail is made up of relatively large particles of millimetre to centimetre size that remain close to the parent asteroid. The shape of the trail can be explained by an initial impact ejecting large clumps of debris that disintegrated and dispersed almost immediately. We determine that this was an asteroid collision that occurred around 10 February 2009.	[Snodgrass, Colin; Tubiana, Cecilia; Vincent, Jean-Baptiste; Sierks, Holger; Hviid, Stubbe; Moissl, Richard; Boehnhardt, Hermann; Kramm, J. R.] Max Planck Inst Sonnensyst Forsch, Max Planck Str 2, D-37191 Katlenburg Lindau, Germany; [Snodgrass, Colin] European So Observ, Santiago 19, Chile; [Barbieri, Cesare; Marchi, Simone; Lazzarin, M.] Univ Padua, Dept Astron, I-35122 Padua, Italy; [Koschny, Detlef; Wenzel, K. -P.] European Space Agcy, Res & Sci Support Dept, NL-2201 AZ Noordwijk, Netherlands; [Lamy, Philippe] Univ Aix Marseille, CNRS, Lab Astrophys Marseille, UMR6110, F-13388 Marseille 13, France; [Rickman, Hans; Davidsson, B.] Uppsala Univ, Dept Astron & Space Sci, S-75120 Uppsala, Sweden; [Rickman, Hans] PAS Space Res Ctr, PL-00716 Warsaw, Poland; [Rodrigo, Rafael; Gutierrez, P.; Lara, L. M.; Lopez-Moreno, J. J.] CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; [Carry, Benoit; Barucci, A.; Fornasier, S.] Observ Paris, LESIA, F-92195 Meudon, France; [Lowry, Stephen C.; Laird, Ryan J. M.] Univ Kent, Ctr Astrophys & Planetary Sci, Canterbury CT2 7NH, Kent, England; [Weissman, Paul R.] Jet Prop Lab, Pasadena, CA 91101 USA; [Fitzsimmons, Alan] Queens Univ Belfast, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland; [A'Hearn, M.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Angrilli, F.] Univ Padua, Dept Mech Engn, Via Venezia 1, I-35131 Padua, Italy; [Bertaux, J. -L.] LATMOS, CNRS, UVSQ, IPSL, 11 Blvd Alembert, F-78280 Guyancourt, France; [Cremonese, G.] Osserv Astron Padova, INAF, Vicolo Osservatorio 5, I-35122 Padua, Italy; [Da Deppo, V.] CNR IFN UOS, Padova LUXOR, Via Trasea 7, I-35131 Padua, Italy; [De Cecco, M.] Univ Trent, UNITN, Via Mesiano 77, I-38100 Trento, Italy; [Ip, W. -H.] Natl Cent Univ, Inst Astron, Chungli 32054, Taiwan; [Keller, H. U.; Michalik, H.] TU Braunschweig, Inst Datentech & Kommunikat, Hans Sommer Str 66, D-38106 Braunschweig, Germany; [Knollenberg, J.; Kuehrt, E.] DLR Inst Planetary Res, Rutherfordstr 2, D-12489 Berlin, Germany; [Kueppers, M.] ESA ESAC, Camino Bajo del Castillo S-N, Madrid 28691, Spain; [Marzari, F.] Univ Padua, Dept Phys, Via Marzolo 8, I-35131 Padua, Italy; [Naletto, G.] Univ Padua, Dept Informat Engn, Via Gradenigo 6-B, I-35131 Padua, Italy; [Sabau, L.] Inst Nacl Tecn Aeroespacial, Carretera Ajalvir PK 4, Madrid 28850, Spain; [Thomas, N.] Univ Bern, Abt Weltraumforsch & Planetol, Phys Inst, Sidlerstr 5, CH-3012 Bern, Switzerland	Max Planck Society; European Southern Observatory; University of Padua; European Space Agency; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Uppsala University; Polish Academy of Sciences; Space Research Centre of the Polish Academy of Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; University of Kent; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Queens University Belfast; University System of Maryland; University of Maryland College Park; University of Padua; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris Saclay; Istituto Nazionale Astrofisica (INAF); University of Padua; University of Trento; National Central University; Braunschweig University of Technology; Helmholtz Association; German Aerospace Centre (DLR); European Space Agency; University of Padua; University of Padua; University of Bern	Snodgrass, C (corresponding author), Max Planck Inst Sonnensyst Forsch, Max Planck Str 2, D-37191 Katlenburg Lindau, Germany.	snodgrass@mps.mpg.de	Da Deppo, Vania/D-2897-2012; Marzari, Francesco/X-2440-2019; Gutiérrez, Pedro J/AAJ-6177-2020; Rickman, Hans/X-7631-2018; Moreno, Jose Juan Lopez/M-5537-2019; Tubiana, Cecilia/AAG-8209-2019	Da Deppo, Vania/0000-0001-6273-8738; Gutiérrez, Pedro J/0000-0002-7332-6269; Rickman, Hans/0000-0002-9603-6619; Moreno, Jose Juan Lopez/0000-0002-7946-2624; Tubiana, Cecilia/0000-0001-8475-9898; Snodgrass, Colin/0000-0001-9328-2905; Lara, Luisa M./0000-0002-7184-920X; Debei, Stefano/0000-0002-6757-6616; Cremonese, Gabriele/0000-0001-9021-1140; De Cecco, Mariolino/0000-0003-1562-0328; Lowry, Stephen/0000-0002-5605-4329; Vincent, Jean-Baptiste/0000-0001-6575-3079; Carry, Benoit/0000-0001-5242-3089	ASI; CNES; DLR; Ministerio de Educacion y Ciencia; SNSB; ESA; STFC [ST/H002553/1, PP/E001823/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/H002553/1, PP/E001823/1] Funding Source: researchfish	ASI(Agenzia Spaziale Italiana (ASI)); CNES(Centre National D'etudes Spatiales); DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); Ministerio de Educacion y Ciencia(Spanish Government); SNSB; ESA(European Space Agency); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank R. Schulz and the Rosetta operations team for enabling these 'target of opportunity' observations to be performed. OSIRIS is funded by the national space agencies ASI, CNES, DLR, the Spanish Space Program (Ministerio de Educacion y Ciencia), SNSB and the ESA. The ground-based observations were collected (in part) at the European Southern Observatory, Chile, under programmes 084.C-0594(A) and 185.C-1033(A).	Bagnulo S, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913339; BEISSER K, 1987, ASTROPHYS SPACE SCI, V139, P5, DOI 10.1007/BF00643808; BIRTWHISTLE P, 2010, 9105 IAU; Bottke WF, 2005, ICARUS, V179, P63, DOI 10.1016/j.icarus.2005.05.017; BURNS JA, 1979, ICARUS, V40, P1, DOI 10.1016/0019-1035(79)90050-2; DOHNANYI JS, 1969, J GEOPHYS RES, V74, P2531, DOI 10.1029/JB074i010p02531; FINSON ML, 1968, ASTROPHYS J, V154, P327, DOI 10.1086/149761; Holsapple KA, 2007, ICARUS, V187, P345, DOI 10.1016/j.icarus.2006.08.029; Hsieh HH, 2010, MON NOT R ASTRON SOC, V403, P363, DOI 10.1111/j.1365-2966.2009.16120.x; Hsieh HH, 2006, SCIENCE, V312, P561, DOI 10.1126/science.1125150; JEWITT D, 2010, 9109 IAU; Jutzi M, 2010, ICARUS, V207, P54, DOI 10.1016/j.icarus.2009.11.016; Keller HU, 2007, SPACE SCI REV, V128, P433, DOI 10.1007/s11214-006-9128-4; LICANDRO J, 2010, 9109 IAU; LIEN DJ, 1998, BAAS, V30, P1035; Marchi S, 2010, PLANET SPACE SCI, V58, P1116, DOI 10.1016/j.pss.2010.03.017; Michikami T, 2007, PLANET SPACE SCI, V55, P70, DOI 10.1016/j.pss.2006.05.002; Moreno F, 2010, ASTROPHYS J LETT, V718, pL132, DOI 10.1088/2041-8205/718/2/L132; Nesvorny D, 2002, NATURE, V417, P720, DOI 10.1038/nature00789; Nesvorny D, 2006, ASTRON J, V132, P582, DOI 10.1086/505392; Nesvorny D, 2010, ASTROPHYS J, V713, P816, DOI 10.1088/0004-637X/713/2/816; SEKANINA Z, 2010, 9110 IAU; Sykes MV, 2004, SPACE SCI S, P677	23	75	75	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					814	816		10.1038/nature09453	http://dx.doi.org/10.1038/nature09453			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944742	Green Submitted			2022-12-28	WOS:000282898700060
J	Green, AW; Glazebrook, K; McGregor, PJ; Abraham, RG; Poole, GB; Damjanov, I; McCarthy, PJ; Colless, M; Sharp, RG				Green, Andrew W.; Glazebrook, Karl; McGregor, Peter J.; Abraham, Roberto G.; Poole, Gregory B.; Damjanov, Ivana; McCarthy, Patrick J.; Colless, Matthew; Sharp, Robert G.			High star formation rates as the origin of turbulence in early and modern disk galaxies	NATURE			English	Article							TO 2-3 GALAXIES; FORMING GALAXIES; H-ALPHA; PHYSICAL-PROPERTIES; HIGH-REDSHIFT; KINEMATICS; SPECTROSCOPY; DYNAMICS; UNIVERSE; GHASP	Observations of star formation and kinematics in early galaxies at high spatial and spectral resolution have shown that two-thirds are massive rotating disk galaxies(1-5), with the remainder being less massive non-rotating objects(2,4,6-8). The line-of-sight-averaged velocity dispersions are typically five times higher than in today's disk galaxies. This suggests that gravitationally unstable, gas-rich disks in the early Universe are fuelled by cold, dense accreting gas flowing along cosmic filaments and penetrating hot galactic gas halos(9,10). These accreting flows, however, have not been observed(11), and cosmic accretion cannot power the observed level of turbulence(12). Here we report observations of a sample of rare, high-velocity-dispersion disk galaxies in the nearby Universe where cold accretion is unlikely to drive their high star formation rates. We find that their velocity dispersions are correlated with their star formation rates, but not their masses or gas fractions, which suggests that star formation is the energetic driver of galaxy disk turbulence at all cosmic epochs.	[Green, Andrew W.; Glazebrook, Karl; Poole, Gregory B.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; [McGregor, Peter J.] Australian Natl Univ, Res Sch Astron & Astrophys, Weston, ACT 2611, Australia; [Abraham, Roberto G.; Damjanov, Ivana] Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [McCarthy, Patrick J.] Observ Carnegie Inst Washington, Pasadena, CA 91101 USA; [Colless, Matthew; Sharp, Robert G.] Australian Astron Observ, Epping, NSW 1710, Australia	Swinburne University of Technology; Australian National University; University of Toronto; Carnegie Institution for Science	Green, AW (corresponding author), Swinburne Univ Technol, Ctr Astrophys & Supercomp, POB 218, Hawthorn, Vic 3122, Australia.	agreen@astro.swin.edu.au	Glazebrook, Karl/N-3488-2015; Colless, Matthew/G-3495-2011	Glazebrook, Karl/0000-0002-3254-9044; Colless, Matthew/0000-0001-9552-8075; Poole, Gregory/0000-0003-1777-7388; Sharp, Rob/0000-0003-4877-7866; Green, Andrew/0000-0003-3052-0819; Damjanov, Ivana/0000-0003-4797-5246	Australian Research Council; Swinburne University of Technology; Anglo-Australian Observatory; ANU2.3-m telescope	Australian Research Council(Australian Research Council); Swinburne University of Technology; Anglo-Australian Observatory; ANU2.3-m telescope	A.W.G. and K.G. acknowledge financial support from the Australian Research Council. A.W.G. acknowledges a special scholarship from the Chancellery of the Swinburne University of Technology. We wish to thank the staff of the Anglo-Australian Observatory and the staff of the ANU2.3-m telescope for their support of these observations.	Brinchmann J, 2004, MON NOT R ASTRON SOC, V351, P1151, DOI 10.1111/j.1365-2966.2004.07881.x; Dekel A, 2006, MON NOT R ASTRON SOC, V368, P2, DOI 10.1111/j.1365-2966.2006.10145.x; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Dib S, 2006, ASTROPHYS J, V638, P797, DOI 10.1086/498857; Dopita M, 2007, ASTROPHYS SPACE SCI, V310, P255, DOI 10.1007/s10509-007-9510-z; Elmegreen BG, 2008, ASTROPHYS J, V688, P67, DOI 10.1086/592190; Elmegreen BG, 2010, ASTROPHYS J, V712, P294, DOI 10.1088/0004-637X/712/1/294; Epinat B, 2008, MON NOT R ASTRON SOC, V390, P466, DOI 10.1111/j.1365-2966.2008.13796.x; Epinat B, 2010, MON NOT R ASTRON SOC, V401, P2113, DOI 10.1111/j.1365-2966.2009.15688.x; Epinat B, 2009, ASTRON ASTROPHYS, V504, P789, DOI 10.1051/0004-6361/200911995; Flores H, 2006, ASTRON ASTROPHYS, V455, P107, DOI 10.1051/0004-6361:20054217; Genzel R, 2006, NATURE, V442, P786, DOI 10.1038/nature05052; Gilbank DG, 2010, MON NOT R ASTRON SOC, V405, P2594, DOI 10.1111/j.1365-2966.2010.16640.x; Glazebrook K, 2009, NATURE, V460, P694, DOI 10.1038/460694a; James PA, 2008, ASTRON ASTROPHYS, V482, P507, DOI 10.1051/0004-6361:20078560; Jones TA, 2010, MON NOT R ASTRON SOC, V404, P1247, DOI 10.1111/j.1365-2966.2010.16378.x; Kauffmann G, 2003, MON NOT R ASTRON SOC, V341, P33, DOI 10.1046/j.1365-8711.2003.06291.x; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Kennicutt RC, 1998, ASTROPHYS J, V498, P541, DOI 10.1086/305588; Law DR, 2009, ASTROPHYS J, V697, P2057, DOI 10.1088/0004-637X/697/2/2057; Lemoine-Busserolle M, 2010, MON NOT R ASTRON SOC, V401, P1657, DOI 10.1111/j.1365-2966.2009.15807.x; Menci N, 2005, ASTROPHYS J, V632, P49, DOI 10.1086/432788; PEI YCC, 1992, ASTROPHYS J, V395, P130, DOI 10.1086/171637; Schreiber NMF, 2009, ASTROPHYS J, V706, P1364, DOI 10.1088/0004-637X/706/2/1364; Sharp R, 2006, PROC SPIE, V6269, DOI 10.1117/12.671022; Stark DP, 2008, NATURE, V455, P775, DOI 10.1038/nature07294; TULLY RB, 1974, ASTROPHYS J SUPPL S, V27, P415, DOI 10.1086/190304	29	92	92	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					684	686		10.1038/nature09452	http://dx.doi.org/10.1038/nature09452			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20930839	Green Submitted			2022-12-28	WOS:000282572500032
J	Litton, P; Miller, FG				Litton, Paul; Miller, Franklin G.			What Physician-Investigators Owe Patients Who Participate in Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLINICAL-RESEARCH; ETHICS; TRIALS		[Litton, Paul] Univ Missouri, Sch Law, Columbia, MO 65211 USA; [Miller, Franklin G.] NIH, Bethesda, MD 20892 USA	University of Missouri System; University of Missouri Columbia; National Institutes of Health (NIH) - USA	Litton, P (corresponding author), Univ Missouri, Sch Law, 203 Hulston Hall, Columbia, MO 65211 USA.	littonp@missouri.edu		Litton, Paul/0000-0001-9418-0978				Appelbaum Paul S, 2004, IRB, V26, P1, DOI 10.2307/3564231; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Emanuel EJ, 2001, NEW ENGL J MED, V345, P915, DOI 10.1056/NEJM200109203451211; Horng S, 2002, NEW ENGL J MED, V347, P137, DOI 10.1056/NEJMsb021025; Litton P, 2005, J LAW MED ETHICS, V33, P566, DOI 10.1111/j.1748-720X.2005.tb00519.x; Miller FG, 2003, NEW ENGL J MED, V348, P1383, DOI 10.1056/NEJMsb030228; Miller PB, 2006, J MED ETHICS, V32, P542, DOI 10.1136/jme.2005.014670; Morreim EH, 2005, J LAW MED ETHICS, V33, P586, DOI 10.1111/j.1748-720X.2005.tb00521.x	8	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2010	304	13					1491	1492		10.1001/jama.2010.1409	http://dx.doi.org/10.1001/jama.2010.1409			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	658SO	20924018				2022-12-28	WOS:000282509900028
J	Amzica, F				Amzica, Florin			Comment on "The Human K-Complex Represents an Isolated Cortical Down-State"	SCIENCE			English	Editorial Material							SLEEP ARCHITECTURE; SLOW; CHILDREN		Univ Montreal, Sch Dent Med, Dept Stomatol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Amzica, F (corresponding author), Univ Montreal, Sch Dent Med, Dept Stomatol, Montreal, PQ H3C 3J7, Canada.	florin.amzica@umontreal.ca						Amzica F, 1998, NEUROSCIENCE, V82, P671; Amzica F, 1997, NEUROLOGY, V49, P952, DOI 10.1212/WNL.49.4.952; AMZICA F, 1995, J NEUROSCI, V15, P4658; Bastlund JF, 2005, EPILEPSIA, V46, P934, DOI 10.1111/j.1528-1167.2005.63204.x; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; CONTRERAS D, 1995, J NEUROSCI, V15, P604; HALASZ P, 1993, PHYSIOL BEHAV, V54, P795, DOI 10.1016/0031-9384(93)90094-V; Halasz P, 1998, NEUROPHYSIOL CLIN, V28, P461, DOI 10.1016/S0987-7053(99)80016-1; Maganti R, 2005, EPILEPSIA, V46, P104, DOI 10.1111/j.0013-9580.2005.06804.x; Myatchin I, 2007, PEDIATR NEUROL, V36, P106, DOI 10.1016/j.pediatrneurol.2006.09.014; ROTH M, 1956, ELECTROEN CLIN NEURO, V8, P385, DOI 10.1016/0013-4694(56)90004-9; Walder B, 2007, ANAESTHESIST, V56, P7, DOI 10.1007/s00101-006-1086-4	12	8	8	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000								10.1126/science.1182138	http://dx.doi.org/10.1126/science.1182138			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929794				2022-12-28	WOS:000282334500017
J	Miller, JR; Outlaw, RA; Holloway, BC				Miller, John R.; Outlaw, R. A.; Holloway, B. C.			Graphene Double-Layer Capacitor with ac Line-Filtering Performance	SCIENCE			English	Article							ELECTROPHORETIC DEPOSITION; ELECTROCHEMICAL CAPACITORS; ELECTRODES; SUPERCAPACITORS; FILMS	Electric double-layer capacitors (DLCs) can have high storage capacity, but their porous electrodes cause them to perform like resistors in filter circuits that remove ripple from rectified direct current. We have demonstrated efficient filtering of 120-hertz current with DLCs with electrodes made from vertically oriented graphene nanosheets grown directly on metal current collectors. This design minimized electronic and ionic resistances and produced capacitors with RC time constants of less than 200 microseconds, in contrast with similar to 1 second for typical DLCs. Graphene nanosheets have a preponderance of exposed edge planes that greatly increases charge storage as compared with that of designs that rely on basal plane surfaces. Capacitors constructed with these electrodes could be smaller than the low-voltage aluminum electrolyte capacitors that are typically used in electronic devices.	[Miller, John R.] JME Inc, Shaker Hts, OH 44120 USA; [Miller, John R.] Case Western Reserve Univ, Great Lakes Energy Inst, Cleveland, OH 44106 USA; [Outlaw, R. A.] Coll William & Mary, Dept Appl Sci, Williamsburg, VA 23185 USA; [Holloway, B. C.] Def Adv Res Projects Agcy, Arlington, VA 22203 USA	Case Western Reserve University; William & Mary; United States Department of Defense; Defense Advanced Research Projects Agency (DARPA)	Miller, JR (corresponding author), JME Inc, 17210 Parkland Dr, Shaker Hts, OH 44120 USA.	jmecapacitor@att.net	Miller, John J/GZG-5663-2022		DARPA Defense Sciences Office	DARPA Defense Sciences Office	This work was supported in part by DARPA Defense Sciences Office, 3701 N. Fairfax Dr., Arlington, VA 22203.	Boos D.L., 1991, 1 INT SEM DOUBL LAYE; BURKE AF, 1990, 34 POW SOURC C CHERR; Conway BE, 2013, ELECTROCHEMICAL SUPE; De Levie R., 1967, ADV ELECTROCHEMISTRY; Du C., 2007, NLB, V4, P569; Du CS, 2006, NANOTECHNOLOGY, V17, P5314, DOI 10.1088/0957-4484/17/21/005; Du CS, 2006, J POWER SOURCES, V160, P1487, DOI 10.1016/j.jpowsour.2006.02.092; Honda Y, 2007, ELECTROCHEM SOLID ST, V10, pA106, DOI 10.1149/1.2437665; Miller J.R., 2007, BATTERY ENERGY STORA, V18, P61; Miller JR, 2008, ELECTROCHEM SOC INTE, V17, P53; Miller JR, 2008, SCIENCE, V321, P651, DOI 10.1126/science.1158736; Niu CM, 1997, APPL PHYS LETT, V70, P1480, DOI 10.1063/1.118568; Raistrick I.D., 1992, ELECTROCHEMISTRY SEM, P297; RANDIN JP, 1971, J ELECTROCHEM SOC, V118, P711, DOI 10.1149/1.2408151; SCHINDALL J, 2007, 2007 ADV CAP WORLD S; Soneda Y, 2004, J PHYS CHEM SOLIDS, V65, P219, DOI 10.1016/j.jpcs.2003.10.017; Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y; Wang JJ, 2004, APPL PHYS LETT, V85, P1265, DOI 10.1063/1.1782253; Zhao X, 2009, J POWER SOURCES, V194, P1208, DOI 10.1016/j.jpowsour.2009.06.004; Zhu MY, 2007, CARBON, V45, P2229, DOI 10.1016/j.carbon.2007.06.017	20	1093	1128	11	787	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1637	1639		10.1126/science.1194372	http://dx.doi.org/10.1126/science.1194372			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929845				2022-12-28	WOS:000282098100038
J	Goodpaster, BH; DeLany, JP; Otto, AD; Kuller, L; Vockley, J; South-Paul, JE; Thomas, SB; Brown, J; McTigue, K; Hames, KC; Lang, W; Jakicic, JM				Goodpaster, Bret H.; DeLany, James P.; Otto, Amy D.; Kuller, Lewis; Vockley, Jerry; South-Paul, Jeannette E.; Thomas, Stephen B.; Brown, Jolene; McTigue, Kathleen; Hames, Kazanna C.; Lang, Wei; Jakicic, John M.			Effects of Diet and Physical Activity Interventions on Weight Loss and Cardiometabolic Risk Factors in Severely Obese Adults A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TYPE-2 DIABETES-MELLITUS; LOW-CALORIE DIET; INSULIN-RESISTANCE; OVERWEIGHT WOMEN; FAT DISTRIBUTION; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; LOW-CARBOHYDRATE; GASTRIC BYPASS; MORBID-OBESITY	Context The prevalence of severe obesity is increasing markedly, as is prevalence of comorbid conditions such as hypertension and type 2 diabetes mellitus; however, apart from bariatric surgery and pharmacotherapy, few clinical trials have evaluated the treatment of severe obesity. Objective To determine the efficacy of a weight loss and physical activity intervention on the adverse health risks of severe obesity. Design, Setting, and Participants Single-blind randomized trial conducted from February 2007 through April 2010 at the University of Pittsburgh. Participants were 130 (37% African American) severely obese (class II or III) adult participants without diabetes recruited from the community. Interventions One-year intensive lifestyle intervention consisting of diet and physical activity. One group (initial physical activity) was randomized to diet and physical activity for the entire 12 months; the other group (delayed physical activity) had the identical dietary intervention but with physical activity delayed for 6 months. Main Outcome Measures Changes in weight. Secondary outcomes were additional components comprising cardiometabolic risk, including waist circumference, abdominal adipose tissue, and hepatic fat content. Results Of 130 participants randomized, 101 (78%) completed the 12-month follow-up assessments. Although both intervention groups lost a significant amount of weight at 6 months, the initial-activity group lost significantly more weight in the first 6 months compared with the delayed-activity group (10.9 kg [95% confidence interval {CI}, 9.1-12.7] vs 8.2 kg [95% CI, 6.4-9.9], P=.02 for group x time interaction). Weight loss at 12 months, however, was similar in the 2 groups (12.1 kg [95% CI, 10.0-14.2] vs 9.9 kg [95% CI, 8.0-11.7], P=.25 for group x time interaction). Waist circumference, visceral abdominal fat, hepatic fat content, blood pressure, and insulin resistance were all reduced in both groups. The addition of physical activity promoted greater reductions in waist circumference and hepatic fat content. Conclusion Among patients with severe obesity, a lifestyle intervention involving diet combined with initial or delayed initiation of physical activity resulted in clinically significant weight loss and favorable changes in cardiometabolic risk factors.	[Goodpaster, Bret H.; DeLany, James P.; Brown, Jolene; Hames, Kazanna C.] Univ Pittsburgh, Sch Med, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA 15213 USA; [McTigue, Kathleen] Univ Pittsburgh, Sch Med, Dept Med, Div Gen Internal Med, Pittsburgh, PA 15213 USA; [Vockley, Jerry] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15213 USA; [Otto, Amy D.; Hames, Kazanna C.; Jakicic, John M.] Univ Pittsburgh, Dept Hlth & Phys Act, Phys Act & Weight Management Res Ctr, Pittsburgh, PA 15213 USA; [Kuller, Lewis] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15213 USA; [Vockley, Jerry] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15213 USA; [Thomas, Stephen B.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Behav & Community Hlth Sci, Pittsburgh, PA 15213 USA; [South-Paul, Jeannette E.] Univ Pittsburgh, Sch Med, Dept Family Med, Pittsburgh, PA 15213 USA; [Lang, Wei] Wake Forest Univ, Sch Med, Dept Biostat Sci, Wake Forest, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University	Goodpaster, BH (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Endocrinol & Metab, MUH N810,3459 5th Ave, Pittsburgh, PA 15213 USA.	bgood@pitt.edu	Vockley, Jerry/AAF-8523-2020; Vockley, Jerry/B-5210-2016	Vockley, Jerry/0000-0002-8180-6457; Vockley, Jerry/0000-0002-8180-6457; DeLany, James/0000-0003-0366-3849	Bodymedia Inc; Beverage Institute for Health Wellness; Commonwealth of Pennsylvania Department of Health; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [T32 DK07052]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007052, R01DK078775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	Bodymedia Inc; Beverage Institute for Health Wellness(General Electric); Commonwealth of Pennsylvania Department of Health; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Jakicic reported serving on the scientific advisory board for Free and Clear, serving as a consultant to Proctor & Gamble Inc, BodyMedia Inc, and the University of Pittsburgh Medical Center Health Plan; and receiving research funding from Bodymedia Inc and the Beverage Institute for Health & Wellness. No other authors reported disclosures.; This study was funded by the Commonwealth of Pennsylvania Department of Health. Dr Brown was supported by National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases grant T32 DK07052.	ANDERSON J W, 1992, American Journal of Clinical Nutrition, V56, p244S, DOI 10.1093/ajcn/56.1.244S; Anderson JW, 2007, AM J CLIN NUTR, V86, P301, DOI 10.1093/ajcn/86.2.301; Brown CD, 2000, OBES RES, V8, P605, DOI 10.1038/oby.2000.79; Cossrow N, 2004, J CLIN ENDOCR METAB, V89, P2590, DOI 10.1210/jc.2004-0339; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Espeland M, 2007, DIABETES CARE, V30, P1374; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; FLICKINGER EG, 1984, ANN SURG, V199, P555, DOI 10.1097/00000658-198405000-00010; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Goodpaster BH, 1999, DIABETES, V48, P839, DOI 10.2337/diabetes.48.4.839; Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777; Hwang JH, 2007, AM J PHYSIOL-ENDOC M, V293, pE1663, DOI 10.1152/ajpendo.00590.2006; Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201; Jakicic JM, 2003, JAMA-J AM MED ASSOC, V290, P1323, DOI 10.1001/jama.290.10.1323; Jakicic JM, 1999, JAMA-J AM MED ASSOC, V282, P1554, DOI 10.1001/jama.282.16.1554; JAKICIC JM, 1995, INT J OBESITY, V19, P893; Jakicic JM, 2008, ARCH INTERN MED, V168, P1550, DOI 10.1001/archinte.168.14.1550; Jakicic JM, 2009, OBESITY, V17, pS34, DOI 10.1038/oby.2009.386; Katsuki A, 2003, DIABETES CARE, V26, P2341, DOI 10.2337/diacare.26.8.2341; Kelley DE, 2001, J CLIN ENDOCR METAB, V86, P5412, DOI 10.1210/jc.86.11.5412; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McKimmie RL, 2008, AM J GASTROENTEROL, V103, P3029, DOI 10.1111/j.1572-0241.2008.02188.x; Miyazaki Y, 2002, AM J PHYSIOL-ENDOC M, V283, pE1135, DOI 10.1152/ajpendo.0327.2001; Monkhouse SJW, 2009, POSTGRAD MED J, V85, P678, DOI 10.1136/pgmj.2009.082271; O'Brien PE, 2006, ANN INTERN MED, V144, P625, DOI 10.7326/0003-4819-144-9-200605020-00005; Paeratakul S, 2002, INT J OBESITY, V26, P1205, DOI 10.1038/sj.ijo.0802026; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Ryan DH, 2010, ARCH INTERN MED, V170, P146, DOI 10.1001/archinternmed.2009.508; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Sturm R, 2003, ARCH INTERN MED, V163, P2146, DOI 10.1001/archinte.163.18.2146; WADDEN TA, 1989, INT J OBESITY, V13, P39; Wing RR, 2007, MED SCI SPORT EXER, V39, P2107, DOI 10.1249/mss.0b013e31815614cb; Yanovski SZ, 2002, NEW ENGL J MED, V346, P591, DOI 10.1056/NEJMra012586	38	367	378	0	83	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2010	304	16					1795	1802		10.1001/jama.2010.1505	http://dx.doi.org/10.1001/jama.2010.1505			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671JZ	20935337	Green Accepted, Bronze			2022-12-28	WOS:000283501300020
J	Chessman, AW				Chessman, Alexander W.			Review: Evidence for the effectiveness of prophylactic drugs for tension-type headache in adults is limited	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Med Univ S Carolina, Charleston, SC 29425 USA	Medical University of South Carolina	Chessman, AW (corresponding author), Med Univ S Carolina, Charleston, SC 29425 USA.							Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; Winkler AS, 2009, CEPHALALGIA, V29, P1317, DOI 10.1111/j.1468-2982.2009.01885.x	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8							JC4-8	10.7326/0003-4819-153-8-201010190-02008	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956704				2022-12-28	WOS:000283054600023
J	Kim, J; Woo, AJ; Chu, JL; Snow, JW; Fujiwara, Y; Kim, CG; Cantor, AB; Orkin, SH				Kim, Jonghwan; Woo, Andrew J.; Chu, Jianlin; Snow, Jonathan W.; Fujiwara, Yuko; Kim, Chul Geun; Cantor, Alan B.; Orkin, Stuart H.			A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs	CELL			English	Article							RNAI SCREEN; C-MYC; DEVELOPMENTAL REGULATORS; ESSENTIAL COFACTOR; SELF-RENEWAL; PLURIPOTENCY; COMPLEX; PROTEIN; GENES; TRRAP	c-Myc (Myc) is an important transcriptional regulator in embryonic stem (ES) cells, somatic cell reprogramming, and cancer. Here, we identify a Myc-centered regulatory network in ES cells by combining protein-protein and protein-DNA interaction studies and show that Myc interacts with the NuA4 complex, a regulator of ES cell identity. In combination with regulatory network information, we define three ES cell modules (Core, Polycomb, and Myc) and show that the modules are functionally separable, illustrating that the overall ES cell transcription program is composed of distinct units. With these modules as an analytical tool, we have reassessed the hypothesis linking an ES cell signature with cancer or cancer stem cells. We find that the Myc module, independent of the Core module, is active in various cancers and predicts cancer outcome. The apparent similarity of cancer and ES cell signatures reflects, in large part, the pervasive nature of Myc regulatory networks.	[Kim, Jonghwan; Woo, Andrew J.; Chu, Jianlin; Snow, Jonathan W.; Fujiwara, Yuko; Cantor, Alan B.; Orkin, Stuart H.] Childrens Hosp, Dept Pediat Oncol, Boston, MA 02115 USA; [Kim, Jonghwan; Woo, Andrew J.; Chu, Jianlin; Snow, Jonathan W.; Fujiwara, Yuko; Cantor, Alan B.; Orkin, Stuart H.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Kim, Jonghwan; Chu, Jianlin; Snow, Jonathan W.; Fujiwara, Yuko; Orkin, Stuart H.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Kim, Jonghwan; Woo, Andrew J.; Chu, Jianlin; Snow, Jonathan W.; Fujiwara, Yuko; Cantor, Alan B.; Orkin, Stuart H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Fujiwara, Yuko; Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Kim, Chul Geun] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Hanyang University	Orkin, SH (corresponding author), Childrens Hosp, Dept Pediat Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	Kim, Jonghwan/AAR-2815-2021	Woo, Andrew/0000-0003-1198-6373; Kim, Jonghwan/0000-0002-9919-9843; Kim, Chul Geun/0000-0002-5848-3338; Cantor, Alan/0000-0002-5136-028X	NIH/NIGMS [K99GM088384]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM088384] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jennifer Trowbridge for critical reading of the manuscript, the Taplin Biological Mass Spectrometry Facility at Harvard Medical School for mass-spectrometry and peptide identification, and the Microarray Core Facility at the Dana Farber Cancer Institute for ChIP sample processing. The project described is partially supported by Award Number K99GM088384 to J.K. from the NIH/NIGMS. S.H.O. is an investigator of the Howard Hughes Medical Institute.	Ard PG, 2002, MOL CELL BIOL, V22, P5650, DOI 10.1128/MCB.22.16.5650-5661.2002; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Cole MD, 2006, SEMIN CANCER BIOL, V16, P241, DOI 10.1016/j.semcancer.2006.08.003; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kang JS, 2009, TRENDS BIOCHEM SCI, V34, P491, DOI 10.1016/j.tibs.2009.06.003; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schoenhals M, 2009, BIOCHEM BIOPH RES CO, V383, P157, DOI 10.1016/j.bbrc.2009.02.156; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wolfer A, 2010, P NATL ACAD SCI USA, V107, P3698, DOI 10.1073/pnas.0914203107; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wong DJ, 2008, CELL CYCLE, V7, P3622, DOI 10.4161/cc.7.23.7104; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	52	495	508	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					313	324		10.1016/j.cell.2010.09.010	http://dx.doi.org/10.1016/j.cell.2010.09.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946988	Green Accepted, Bronze			2022-12-28	WOS:000283052200019
J	Krishnan, M; Mojarad, N; Kukura, P; Sandoghdar, V				Krishnan, Madhavi; Mojarad, Nassiredin; Kukura, Philipp; Sandoghdar, Vahid			Geometry-induced electrostatic trapping of nanometric objects in a fluid	NATURE			English	Article							OPTICAL MANIPULATION; BROWNIAN-MOTION; NANOPARTICLES; NANOSLIT; DNA; BIOMOLECULES; PRESSURE; DYNAMICS; FORCE	The ability to trap an object-whether a single atom or a macroscopic entity-affects fields as diverse as quantum optics(1), soft condensed-matter physics, biophysics and clinical medicine(2). Many sophisticated methodologies have been developed to counter the randomizing effect of Brownian motion in solution(3-10), but stable trapping of nanometre-sized objects remains challenging(8-10). Optical tweezers are widely used traps, but require sufficiently polarizable objects and thus are unable to manipulate small macromolecules. Confinement of single molecules has been achieved using electrokinetic feedback guided by tracking of a fluorescent label, but photophysical constraints limit the trap stiffness and lifetime(8). Here we show that a fluidic slit with appropriately tailored topography has a spatially modulated electrostatic potential that can trap and levitate charged objects in solution for up to several hours. We illustrate this principle with gold particles, polymer beads and lipid vesicles with diameters of tens of nanometres, which are all trapped without external intervention and independently of their mass and dielectric function. The stiffness and stability of our electrostatic trap is easily tuned by adjusting the system geometry and the ionic strength of the solution, and it lends itself to integration with other manipulation mechanisms. We anticipate that these features will allow its use for contact-free confinement of single proteins and macromolecules, and the sorting and fractionation of nanometre-sized objects or their assembly into high-density arrays.	[Krishnan, Madhavi; Mojarad, Nassiredin; Kukura, Philipp; Sandoghdar, Vahid] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Krishnan, M (corresponding author), ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland.	mkrishnan@ethz.ch	Sandoghdar, Vahid/AAT-8856-2020; Krishnan, Madhavi/J-4217-2015	Sandoghdar, Vahid/0000-0003-2594-4801; Krishnan, Madhavi/0000-0003-1274-7155; Kukura, Philipp/0000-0003-0136-7704	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank A. Alt for expert assistance in electron-beam lithography and the staff of the Center for Micro-and Nanoscience (FIRST), ETH Zurich, for clean-room support; H. Ewers for assistance in producing lipid vesicles; M. Celebrano and A. Renn for experimental input; M. Agio for discussions; and E. Petrov and R. Klemm for reading the manuscript. M.K. acknowledges a Marie Curie Intra-European Fellowship for Career Development of the European Commission, and greatly appreciates the support of B. Eichler, I. Monch and P. Schwille in the early stages of the project.	Adamczyk Z, 1996, ADV COLLOID INTERFAC, V63, P41, DOI 10.1016/0001-8686(95)00281-2; [Anonymous], 1992, INTERMOLECULAR SURFA; ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156; Behrens SH, 2001, J CHEM PHYS, V115, P6716, DOI 10.1063/1.1404988; Chiou PY, 2005, NATURE, V436, P370, DOI [10.1038/nature03831, 10.1038/nature0383l]; Cohen AE, 2006, P NATL ACAD SCI USA, V103, P4362, DOI 10.1073/pnas.0509976103; Cordovez B, 2009, OPT EXPRESS, V17, P21134, DOI 10.1364/OE.17.021134; DUBOIS M, 1992, J CHEM PHYS, V96, P2278, DOI 10.1063/1.462078; Eichmann SL, 2008, LANGMUIR, V24, P714, DOI 10.1021/la702571z; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; Hansen PM, 2005, NANO LETT, V5, P1937, DOI 10.1021/nl051289r; Jacobsen V., 2007, NANOBIOPHOTONICS, V3, P143, DOI DOI 10.1016/S1574-0641(07)80014-3; Jamshidi A, 2008, NAT PHOTONICS, V2, P85, DOI 10.1038/nphoton.2007.277; Jo K, 2007, P NATL ACAD SCI USA, V104, P2673, DOI 10.1073/pnas.0611151104; Juan ML, 2009, NAT PHYS, V5, P915, DOI 10.1038/NPHYS1422; KAPLAN PD, 1994, PHYS REV LETT, V73, P2793, DOI 10.1103/PhysRevLett.73.2793; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Krishnan M, 2007, NANO LETT, V7, P1270, DOI 10.1021/nl0701861; Krishnan M, 2008, SMALL, V4, P1900, DOI 10.1002/smll.200800227; Kukura P, 2009, NAT METHODS, V6, P923, DOI 10.1038/nmeth.1395; Loeb A. L., 1961, ELECT DOUBLE LAYER S; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; MacDonald MP, 2003, NATURE, V426, P421, DOI 10.1038/nature02144; MAXWELL JC, 1954, TREATISE ELECT MAGNE, V1, P116; Polin M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041406; Reisner W, 2009, P NATL ACAD SCI USA, V106, P79, DOI 10.1073/pnas.0811468106; Soyka F, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.208301; Stebe KJ, 2009, SCIENCE, V325, P159, DOI 10.1126/science.1174401; Tessier F, 2006, ELECTROPHORESIS, V27, P686, DOI 10.1002/elps.200500457; Yang AHJ, 2009, NATURE, V457, P71, DOI 10.1038/nature07593	32	179	184	1	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					692	U75		10.1038/nature09404	http://dx.doi.org/10.1038/nature09404			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20930840				2022-12-28	WOS:000282572500034
J	Gane, EJ; Roberts, SK; Stedman, CAM; Angus, PW; Ritchie, B; Elston, R; Ipe, D; Morcos, PN; Baher, L; Najera, I; Chu, T; Lopatin, U; Berrey, MM; Bradford, W; Laughlin, M; Shulman, NS; Smith, PF				Gane, Edward J.; Roberts, Stuart K.; Stedman, Catherine A. M.; Angus, Peter W.; Ritchie, Brett; Elston, Rob; Ipe, David; Morcos, Peter N.; Baher, Linda; Najera, Isabel; Chu, Tom; Lopatin, Uri; Berrey, M. Michelle; Bradford, William; Laughlin, Mark; Shulman, Nancy S.; Smith, Patrick F.			Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial	LANCET			English	Article							INDUCIBLE PROTEIN-10; LIVER FIBROSIS; IN-VIVO; VIRUS; TELAPREVIR; ITMN-191; PEGINTERFERON; RESISTANCE; RIBAVIRIN; DYNAMICS	Background Present interferon-based standard of care treatment for chronic hepatitis C virus (HCV) infection is limited by both efficacy and tolerability. We assessed the safety, tolerability, and antiviral activity of an all-oral combination treatment with two experimental anti-HCV drugs-RG7128, a nucleoside polymerase inhibitor; and danoprevir, an NS3/4A protease inhibitor in patients with chronic HCV infection. Methods Patients from six centres in New Zealand and Australia who were chronically infected with HCV genotype 1 received up to 13 days oral combination treatment with RG7128 (500 mg or 1000 mg twice daily) and danoprevir (100 mg or 200 mg every 8 h or 600 mg or 900 mg twice daily) or placebo. Eligible patients were sequentially enrolled into one of seven treatment cohorts and were randomly assigned by interactive voice or web response system to either active treatment or placebo. Patients were separately randomly assigned within each cohort with a block size that reflected the number of patients in the cohort and the ratio of treatment to placebo. The random allocation schedule was computer generated. Dose escalation was started in HCV treatment-naive patients; standard of care treatment-experienced patients, including previous null responders, were enrolled in higher-dose danoprevir cohorts. Investigators, personnel at the study centre, and patients were masked to treatment allocation. However, the pharmacist who prepared the doses, personnel involved in pharmacokinetic sample analyses, statisticians who prepared data summaries, and the clinical pharmacologists who reviewed the data before deciding to initiate dosing in the next cohort were not masked to treatment allocation. The primary outcome was change in HCV RNA concentration from baseline to day 14 in patients who received 13 days of combination treatment. All patients who completed treatment with the study drugs were included in the analyses. This study is registered with ClinicalTrials.gov, NCT00801255. Findings 88 patients were randomly assigned to a study drug treatment regimen (n=74 over seven treatment groups; 73 received at least one dose of study drug) or to placebo (n=14, all of whom received at least one dose). The median change in HCV RNA concentration from baseline to day 14 ranged from -3.7 to -5.2 log(10) IU/mL in the cohorts that received 13 days of combination treatment. At the highest combination doses tested (1000 mg RG7128 and 900 mg danoprevir twice daily), the median change in HCV RNA concentration from baseline to day 14 was -5.1 log(10) IU/mL (IQR -5.6 to -4.7) in treatment-naive patients and -4.9 log(10) IU/mL in previous standard of care null responders (-5.2 to -4.5) compared with an increase of 0.1 log(10) IU/mL in the placebo group. The combination of RG7128 and danoprevir was well tolerated with no treatment-related serious or severe adverse events, no grade 3 or 4 changes in laboratory parameters, and no safety-related treatment discontinuations. Interpretation This oral combination of a nucleoside analogue polymerase inhibitor and protease inhibitor holds promise as an interferon-free treatment for chronic HCV.	[Roberts, Stuart K.] Alfred Hosp, Melbourne, Vic, Australia; [Stedman, Catherine A. M.] Christchurch Clin Studies, Christchurch, New Zealand; [Angus, Peter W.] Austin Hosp, Heidelberg, Vic 3084, Australia; [Ritchie, Brett] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Elston, Rob; Ipe, David; Morcos, Peter N.; Baher, Linda; Najera, Isabel; Chu, Tom; Lopatin, Uri; Laughlin, Mark; Shulman, Nancy S.; Smith, Patrick F.] Roche Palo Alto, Palo Alto, CA USA; [Berrey, M. Michelle] Pharmasset, Princeton, NJ USA; [Bradford, William] Intermune, Brisbane, CA USA; [Gane, Edward J.] Auckland Clin Studies, Auckland, New Zealand	Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Royal Adelaide Hospital; Roche Holding	Gane, EJ (corresponding author), Auckland City Hosp, New Zealand Liver Unit, Auckland 1142, New Zealand.	edgane@adhb.govt.nz	Lopatin, Uri/O-2952-2017	Lopatin, Uri/0000-0002-9544-0492; Smith, Patrick/0000-0002-6003-0805	Roche Palo Alto; Roche	Roche Palo Alto(Roche Holding); Roche(Roche Holding)	This study was sponsored by Roche Palo Alto. We thank Scott Seiwert and Bill Symonds for their contribution to the study and for reviewing the draft, and the INFORM-1 study team and the patients who participated in the clinical trial.; EJG was the recipient of the Roche grant for this clinical trial, and has received consultancy fees and support for travel to meetings from Roche, consultancy fees for acting as an advisory board member for Novartis and Merck, and payment for lectures including service on speaker bureaus for Novartis and GlaxoSmithKline. SKR is a member of a Roche advisory board (not related to this study) and receives consultancy fees from Roche. PWA received travel expenses to attend an Australian Roche advisory board meeting from Roche. BR received a fee for monitoring patients as required during a clinical trial and received financial support for travel to meetings for this study from Roche. RE, DI, PNM, LB, IN, TC, UL, MMB, ML, NSS, and PFS are Roche employees. UL, ML, NSS, and PFS receive stock options from Roche. WB is an InterMune employee and receives stock options from InterMune. CAMS declares that she has no conflicts of interest.	[Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; Butera D, 2005, BLOOD, V106, P1175, DOI 10.1182/blood-2005-01-0126; Davila JA, 2004, GASTROENTEROLOGY, V127, P1372, DOI 10.1053/j.gastro.2004.07.020; Davis GL, 2003, LIVER TRANSPLANT, V9, P331, DOI 10.1053/jlts.2003.50073; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Forestier N, 2009, J HEPATOL, V50, pS35, DOI 10.1016/S0168-8278(09)60087-8; Forestier N, 2008, HEPATOLOGY, V48, p1132A; Gane EJ, 2010, J HEPATOL, V52, pS16; Gane EJ, 2008, HEPATOLOGY, V48, p729A; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; McCown M, 2009, J HEPATOL, V50, pS348, DOI 10.1016/S0168-8278(09)60961-2; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Meynard JL, 2009, J ANTIMICROB CHEMOTH, V63, P579, DOI 10.1093/jac/dkn531; Molto J, 2007, CLIN PHARMACOKINET, V46, P85, DOI 10.2165/00003088-200746010-00005; Nakai K, 2008, DRUG METAB DISPOS, V36, P1786, DOI 10.1124/dmd.107.020073; National Institute of Allergy and Infectious Diseases NIoH  US, DIV AIDS TABL GRAD S; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Neville Lewis F., 1997, Cytokine and Growth Factor Reviews, V8, P207, DOI 10.1016/S1359-6101(97)00015-4; Ohnishi A, 2005, J CLIN PHARMACOL, V45, P1221, DOI 10.1177/0091270005280787; Pawlotsky JM, 2009, NAT REV GASTRO HEPAT, V6, P383, DOI 10.1038/nrgastro.2009.102; POGAM SL, 2009, J HEPATOL S1, V50, pS348; Reesink H, 2008, J HEPATOL, V48, pS28, DOI 10.1016/S0168-8278(08)60066-5; Sarrazin C, 2009, HEPATOLOGY, V50, p953A; Seiwert SD, 2008, ANTIMICROB AGENTS CH, V52, P4432, DOI 10.1128/AAC.00699-08; Shudo E, 2009, EXPERT OPIN DRUG MET, V5, P321, DOI [10.1517/17425250902787616 , 10.1517/17425250902787616]; Stuyver Lieven J., 2006, Antiviral Chemistry & Chemotherapy, V17, P79; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Ungo JR, 1998, AM J RESP CRIT CARE, V157, P1871, DOI 10.1164/ajrccm.157.6.9711039; Wise M, 2008, HEPATOLOGY, V47, P1128, DOI 10.1002/hep.22165	33	273	289	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2010	376	9751					1467	1475		10.1016/S0140-6736(10)61384-0	http://dx.doi.org/10.1016/S0140-6736(10)61384-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	680QC	20951424				2022-12-28	WOS:000284248500029
J	Nishimura, Y; Bortnik, J; Li, W; Thorne, RM; Lyons, LR; Angelopoulos, V; Mende, SB; Bonnell, JW; Le Contel, O; Cully, C; Ergun, R; Auster, U				Nishimura, Y.; Bortnik, J.; Li, W.; Thorne, R. M.; Lyons, L. R.; Angelopoulos, V.; Mende, S. B.; Bonnell, J. W.; Le Contel, O.; Cully, C.; Ergun, R.; Auster, U.			Identifying the Driver of Pulsating Aurora	SCIENCE			English	Article							SOURCE REGION; THEMIS; CHORUS; ELECTRONS	Pulsating aurora, a spectacular emission that appears as blinking of the upper atmosphere in the polar regions, is known to be excited by modulated, downward-streaming electrons. Despite its distinctive feature, identifying the driver of the electron precipitation has been a long-standing problem. Using coordinated satellite and ground-based all-sky imager observations from the THEMIS mission, we provide direct evidence that a naturally occurring electromagnetic wave, lower-band chorus, can drive pulsating aurora. Because the waves at a given equatorial location in space correlate with a single pulsating auroral patch in the upper atmosphere, our findings can also be used to constrain magnetic field models with much higher accuracy than has previously been possible.	[Nishimura, Y.; Bortnik, J.; Li, W.; Thorne, R. M.; Lyons, L. R.] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Nishimura, Y.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan; [Angelopoulos, V.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; [Angelopoulos, V.; Mende, S. B.; Bonnell, J. W.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Angelopoulos, V.] NASA, Jet Prop Lab, Pasadena, CA 91109 USA; [Le Contel, O.] UPMC Paris Sud 11, Ecole Polytech, CNRS, Lab Phys Plasmas, F-94107 St Maur Des Fosses, France; [Cully, C.] Swedish Inst Space Phys, SE-98128 Uppsala, Sweden; [Ergun, R.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Auster, U.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Geophys & Extraterr Phys, D-38106 Braunschweig, Germany	University of California System; University of California Los Angeles; Nagoya University; University of California System; University of California Los Angeles; University of California System; University of California Berkeley; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Colorado System; University of Colorado Boulder; Braunschweig University of Technology	Nishimura, Y (corresponding author), Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA.	toshi@atmos.ucla.edu	Cully, Christopher/P-2539-2016; Li, Wen/F-3722-2011	LE CONTEL, Olivier/0000-0003-2713-7966; Angelopoulos, Vassilis/0000-0001-7024-1561; Cully, Christopher/0000-0001-7242-8872	NASA [NAS5-02099, 9F007-046101]; NSF [ATM-0802843, AGS-0840178]; Japan Society for the Promotion of Science; CNES; CNRS	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CNES(Centre National D'etudes Spatiales); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by NASA contract NAS5-02099, 9F007-046101; NSF grants ATM-0802843 and AGS-0840178; and a Research Fellowship from the Japan Society for the Promotion of Science. The French involvement (Search-coil magnetometer) on THEMIS is supported by CNES and CNRS.	Agapitov O, 2010, ANN GEOPHYS-GERMANY, V28, P1377, DOI 10.5194/angeo-28-1377-2010; Angelopoulos V, 2008, SPACE SCI REV, V141, P5, DOI 10.1007/s11214-008-9336-1; Auster HU, 2008, SPACE SCI REV, V141, P235, DOI 10.1007/s11214-008-9365-9; Bonnell JW, 2008, SPACE SCI REV, V141, P303, DOI 10.1007/s11214-008-9469-2; Bortnik J, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035500; BREKKE A, 1972, PLANET SPACE SCI, V20, P53, DOI 10.1016/0032-0633(72)90140-7; BRYANT DA, 1971, J ATMOS TERR PHYS, V33, P859, DOI 10.1016/0021-9169(71)90086-9; CORONITI FV, 1970, J GEOPHYS RES, V75, P1863, DOI 10.1029/JA075i010p01863; Cully CM, 2008, SPACE SCI REV, V141, P343, DOI 10.1007/s11214-008-9417-1; DAVIDSON GT, 1990, SPACE SCI REV, V53, P45, DOI 10.1007/BF00217428; GOUGH MP, 1981, ADV SPACE RES, V1, P345; Horne RB, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009736; JOHNSTONE AD, 1978, NATURE, V274, P119, DOI 10.1038/274119a0; JOHNSTONE AD, 1983, ANN GEOPHYS, V1, P397; Le Contel O, 2008, SPACE SCI REV, V141, P509, DOI 10.1007/s11214-008-9371-y; Li W, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013554; Li W, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2007JA012368; Liang J, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA015148; MCEWEN DJ, 1981, CAN J PHYS, V59, P1106, DOI 10.1139/p81-146; Mende SB, 2008, SPACE SCI REV, V141, P357, DOI 10.1007/s11214-008-9380-x; Meredith NP, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017698; Ni B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034032; OMHOLT A, 1960, PLANET SPACE SCI, V2, P246, DOI 10.1016/0032-0633(60)90022-2; SANDAHL I, 1980, GEOPHYS RES LETT, V7, P309, DOI 10.1029/GL007i005p00309; Santolik O, 2004, ANN GEOPHYS-GERMANY, V22, P2555, DOI 10.5194/angeo-22-2555-2004; SCOURFIELD MW, 1972, PLANET SPACE SCI, V20, P1843, DOI 10.1016/0032-0633(72)90117-1; TSYGANENKO N, 1996, J GEOPHYS RES, V12, P27187; WARD IA, 1982, J ATMOS TERR PHYS, V44, P931, DOI 10.1016/0021-9169(82)90056-3; YAMAMOTO T, 1988, J GEOPHYS RES, V93, P897, DOI 10.1029/JA093iA02p00897	29	221	222	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					81	84		10.1126/science.1193186	http://dx.doi.org/10.1126/science.1193186			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929809				2022-12-28	WOS:000282334500038
J	Chou, CW; Hume, DB; Rosenband, T; Wineland, DJ				Chou, C. W.; Hume, D. B.; Rosenband, T.; Wineland, D. J.			Optical Clocks and Relativity	SCIENCE			English	Article							ATOMIC CLOCKS; FREQUENCY STANDARDS; SPECTROSCOPY; SPACE; LINK	Observers in relative motion or at different gravitational potentials measure disparate clock rates. These predictions of relativity have previously been observed with atomic clocks at high velocities and with large changes in elevation. We observed time dilation from relative speeds of less than 10 meters per second by comparing two optical atomic clocks connected by a 75-meter length of optical fiber. We can now also detect time dilation due to a change in height near Earth's surface of less than 1 meter. This technique may be extended to the field of geodesy, with applications in geophysics and hydrology as well as in space-based tests of fundamental physics.	[Chou, C. W.; Hume, D. B.; Rosenband, T.; Wineland, D. J.] NIST, Div Time & Frequency, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA	Chou, CW (corresponding author), NIST, Div Time & Frequency, Boulder, CO 80305 USA.	chinwen@nist.gov			Office of Naval Research; NIST	Office of Naval Research(Office of Naval Research); NIST(National Institute of Standards & Technology (NIST) - USA)	This work was supported by the Office of Naval Research and NIST. We thank N. Pavlis and M. Weiss for helpful discussions and J. C. Bergquist and N. Ashby for suggestions on the manuscript. Not subject to U. S. copyright.	Ashby N., 1999, 1385 NIST; Berkeland DJ, 1998, J APPL PHYS, V83, P5025, DOI 10.1063/1.367318; Bjerhammar A., 1985, Bulletin Geodesique, V59, P207, DOI 10.1007/BF02520327; Chou CW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070802; Colombo O. L., 1980, 296 OH STAT U DEP GE; DEHMELT HG, 1982, IEEE T INSTRUM MEAS, V31, P83, DOI 10.1109/TIM.1982.6312526; Djerroud K, 2010, OPT LETT, V35, P1479, DOI 10.1364/OL.35.001479; Einstein A, 1905, ANN PHYS-BERLIN, V17, P891; Gill P, 2005, METROLOGIA, V42, pS125, DOI 10.1088/0026-1394/42/3/S13; Grosche G, 2009, OPT LETT, V34, P2270, DOI 10.1364/OL.34.002270; HAFELE JC, 1972, SCIENCE, V177, P166, DOI 10.1126/science.177.4044.166; HASSELKAMP D, 1979, Z PHYS A-HADRON NUCL, V289, P151, DOI 10.1007/BF01435932; ITANO WM, 1993, PHYS REV A, V47, P3554, DOI 10.1103/PhysRevA.47.3554; Kefelian F, 2009, OPT LETT, V34, P1573, DOI 10.1364/OL.34.001573; Kleppner D, 2006, PHYS TODAY, V59, P10, DOI 10.1063/1.2195297; Muller H, 2010, NATURE, V463, P926, DOI 10.1038/nature08776; Muller J, 2008, J GEODESY, V82, P133, DOI 10.1007/s00190-007-0168-7; Newbury NR, 2007, OPT LETT, V32, P3056, DOI 10.1364/OL.32.003056; Parker TE, 2010, METROLOGIA, V47, P1, DOI 10.1088/0026-1394/47/1/001; POTZEL W, 1992, HYPERFINE INTERACT, V72, P195; POUND RV, 1960, PHYS REV LETT, V4, P337, DOI 10.1103/PhysRevLett.4.337; Reinhardt S, 2007, NAT PHYS, V3, P861, DOI 10.1038/nphys778; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; Rossi B, 1941, PHYS REV, V59, P223, DOI 10.1103/PhysRev.59.223; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Schmidt R, 2008, SURV GEOPHYS, V29, P319, DOI 10.1007/s10712-008-9033-3; Sprenger B, 2009, OPT LETT, V34, P965, DOI 10.1364/OL.34.000965; Takamoto M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.063002; Tapley BD, 2004, SCIENCE, V305, P503, DOI 10.1126/science.1099192; Tino GM, 2007, NUCL PHYS B-PROC SUP, V166, P159, DOI 10.1016/j.nuclphysbps.2006.12.061; VESSOT RFC, 1980, PHYS REV LETT, V45, P2081, DOI 10.1103/PhysRevLett.45.2081; WINELAND DJ, 1987, PHYS REV A, V36, P2220, DOI 10.1103/PhysRevA.36.2220; Young BC, 1999, PHYS REV LETT, V82, P3799, DOI 10.1103/PhysRevLett.82.3799	33	503	573	8	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1630	1633		10.1126/science.1192720	http://dx.doi.org/10.1126/science.1192720			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929843	Green Published			2022-12-28	WOS:000282098100036
J	Morgenstern, M				Morgenstern, Markus			STM Ready for the Time Domain	SCIENCE			English	Editorial Material									[Morgenstern, Markus] Rhein Westfal TH Aachen, Inst Phys B 2, D-52074 Aachen, Germany; [Morgenstern, Markus] Rhein Westfal TH Aachen, ARA FIT, D-52074 Aachen, Germany	RWTH Aachen University; RWTH Aachen University	Morgenstern, M (corresponding author), Rhein Westfal TH Aachen, Inst Phys B 2, D-52074 Aachen, Germany.	mmorgens@physik.rwth-aachen.de	Morgenstern, Markus/K-7785-2013	Morgenstern, Markus/0000-0002-3993-6880				Balashov T, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187201; Bode M, 2003, REP PROG PHYS, V66, P523, DOI 10.1088/0034-4885/66/4/203; CROMMIE MF, 1993, NATURE, V363, P524, DOI 10.1038/363524a0; Gawronski H, 2008, SCIENCE, V319, P930, DOI 10.1126/science.1152473; Heinrich AJ, 2004, SCIENCE, V306, P466, DOI 10.1126/science.1101077; Loth S, 2010, SCIENCE, V329, P1628, DOI [10.1126/science.1191688, 10.1126/science.191688]; NUNES G, 1993, SCIENCE, V262, P1029, DOI 10.1126/science.262.5136.1029; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Sirker J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.216602; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Takeuchi O, 2004, APPL PHYS LETT, V85, P3268, DOI 10.1063/1.1804238; Van Waeyenberge B, 2006, NATURE, V444, P461, DOI 10.1038/nature05240	12	6	6	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2010	329	5999					1609	1610		10.1126/science.1194918	http://dx.doi.org/10.1126/science.1194918			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929835				2022-12-28	WOS:000282098100027
J	Rothwell, PM; Wilson, M; Elwin, CE; Norrving, B; Algra, A; Warlow, CP; Meade, TW				Rothwell, Peter M.; Wilson, Michelle; Elwin, Carl-Eric; Norrving, Bo; Algra, Ale; Warlow, Charles P.; Meade, Tom W.			Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials	LANCET			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TRANSIENT ISCHEMIC ATTACK; ADENOMA RECURRENCE; PRIMARY PREVENTION; GENE-EXPRESSION; RISK; CYCLOOXYGENASE-2; SURVIVAL; COLON; CHEMOPREVENTION	Background High-dose aspirin (>= 500 mg daily) reduces long-term incidence of colorectal cancer, but adverse effects might limit its potential for long-term prevention. The long-term effectiveness of lower doses (75-300 mg daily) is unknown. We assessed the effects of aspirin on incidence and mortality due to colorectal cancer in relation to dose, duration of treatment, and site of tumour. Methods We followed up four randomised trials of aspirin versus control in primary (Thrombosis Prevention Trial, British Doctors Aspirin Trial) and secondary (Swedish Aspirin Low Dose Trial, UK-TA Aspirin Trial) prevention of vascular events and one trial of different doses of aspirin (Dutch TIA Aspirin Trial) and established the effect of aspirin on risk of colorectal cancer over 20 years during and after the trials by analysis of pooled individual patient data. Results In the four trials of aspirin versus control (mean duration of scheduled treatment 6.0 years), 391 (2.8%) of 14 033 patients had colorectal cancer during a median follow-up of 18.3 years. Allocation to aspirin reduced the 20-year risk of colon cancer (incidence hazard ratio [HR] 0.76, 0.60-0.96, p=0.02; mortality HR 0.65, 0.48-0.88, p=0.005), but not rectal cancer (0.90, 0.63-1.30, p=0.58; 0.80, 0.50-1.28, p=0.35). Where subsite data were available, aspirin reduced risk of cancer of the proximal colon (0.45, 0.28-0.74, p=0.001; 0.34, 0.18-0.66, p=0.001), but not the distal colon (1.10, 0.73-1.64, p=0.66; 1.21, 0.66-2.24, p=0.54; for incidence difference p=0.04, for mortality difference p=0.01). However, benefit increased with scheduled duration of treatment, such that allocation to aspirin of 5 years or longer reduced risk of proximal colon cancer by about 70% (0.35, 0.20-0.63; 0.24, 0.11-0.52; both p<0.0001) and also reduced risk of rectal cancer (0.58, 0.36-0.92, p=0.02; 0.47, 0.26-0.87, p=0.01). There was no increase in benefit at doses of aspirin greater than 75 mg daily, with an absolute reduction of 1.76% (0.61-2.91; p=0.001) in 20-year risk of any fatal colorectal cancer after 5-years scheduled treatment with 75-300 mg daily. However, risk of fatal colorectal cancer was higher on 30 mg versus 283 mg daily on long-term follow-up of the Dutch TIA trial (odds ratio 2.02, 0.70-6.05, p=0.15). Interpretation Aspirin taken for several years at doses of at least 75 mg daily reduced long-term incidence and mortality due to colorectal cancer. Benefit was greatest for cancers of the proximal colon, which are not otherwise prevented effectively by screening with sigmoidoscopy or colonoscopy.	[Rothwell, Peter M.; Wilson, Michelle] Univ Oxford, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford, England; [Elwin, Carl-Eric] Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden; [Norrving, Bo] Lund Univ, Neurol Sect, Dept Clin Sci, S-22100 Lund, Sweden; [Algra, Ale] Rudolf Magnus Inst Neurosci, Dept Neurol, NL-3508 TA Utrecht, Netherlands; [Algra, Ale] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Warlow, Charles P.] Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland; [Meade, Tom W.] Univ London, London Sch Hyg & Trop Med, London, England	University of Oxford; Karolinska Institutet; Lund University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine	Rothwell, PM (corresponding author), John Radcliffe Hosp, Univ Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX3 9DU, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020; Hug, Balthasar L./G-1568-2010	Rothwell, Peter/0000-0001-9739-9211; Norrving, Bo/0000-0002-8024-5096	Boehringer Ingelheim; Stroke Prevention Research Unit, Oxford, UK; NIHR; MRC [G0701113] Funding Source: UKRI; Medical Research Council [G0701113] Funding Source: researchfish	Boehringer Ingelheim(Boehringer Ingelheim); Stroke Prevention Research Unit, Oxford, UK; NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	PMR and BN have received honoraria for talks, advisory boards and clinical trial committees from several pharmaceutical companies with an interest in antiplatelet agents, including AstraZeneca, Bayer, Boehringer Ingelheim, Sanofi-BMS, and Servier. AA has received honoraria for advisory boards and research funding from Boehringer Ingelheim. The other authors declare no conflicts of interest.; We thank Richard Peto and Jill Boreham for access to data from the British Doctors Aspirin Trial; Christine Knottenbelt and Marilyn Goulding for their help in accessing long-term follow-up data from the TPT cohort; Birgit Peterson for help in collating data on causes of deaths in the SALT trial cohort; and Ziyah Mehta for help with analysis and production of graphs. The cost of cancer registry and death certificate follow-up of the UK-TIA Aspirin Trial was met by unrestricted research funds from the Stroke Prevention Research Unit, Oxford, UK. PMR is in receipt of an NIHR Senior Investigator Award.	Abela JE, 2009, BIOSCI TRENDS, V3, P158; [Anonymous], 1991, Lancet, V338, P1345; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Baron JA, 2006, GASTROENTEROLOGY, V131, P1674, DOI 10.1053/j.gastro.2006.08.079; Barry EL, 2009, CANCER EPIDEM BIOMAR, V18, P2726, DOI 10.1158/1055-9965.EPI-09-0363; BEDENNE L, 1992, CANCER, V69, P883, DOI 10.1002/1097-0142(19920215)69:4<883::AID-CNCR2820690408>3.0.CO;2-B; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848; BREWSTER D, 1995, PUBLIC HEALTH, V109, P285, DOI 10.1016/S0033-3506(95)80206-1; Brewster DH, 2002, EUR J CANCER, V38, P414, DOI 10.1016/S0959-8049(01)00385-9; BUFILL JA, 1990, ANN INTERN MED, V113, P779, DOI 10.7326/0003-4819-113-10-779; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; Chapple KS, 2000, AM J PATHOL, V156, P545, DOI 10.1016/S0002-9440(10)64759-1; Cole BF, 2009, J NATL CANCER I, V101, P256, DOI 10.1093/jnci/djn485; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Ederer F, 1999, J CLIN EPIDEMIOL, V52, P447, DOI 10.1016/S0895-4356(99)00016-5; Elsaleh H, 2000, LANCET, V355, P1745, DOI 10.1016/S0140-6736(00)02261-3; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Fasey N, 2002, BRIT J GEN PRACT, V52, P208; Flossmann E, 2007, INT J EPIDEMIOL, V36, P962, DOI 10.1093/ije/dym200; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Friedman GD, 1998, PHARMACOEPIDEM DR S, V7, P99, DOI 10.1002/(SICI)1099-1557(199803/04)7:2<99::AID-PDS320>3.0.CO;2-0; Greving JP, 2008, CIRCULATION, V117, P2875, DOI 10.1161/CIRCULATIONAHA.107.735340; HAWKINS MM, 1992, BRIT J CANCER, V66, P408, DOI 10.1038/bjc.1992.279; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; JUULMOLLER S, 1992, LANCET, V340, P1421, DOI 10.1016/0140-6736(92)92619-Q; Kelloff GJ, 2004, CLIN CANCER RES, V10, P3908, DOI 10.1158/1078-0432.CCR-03-0789; KOZUKA S, 1975, DIS COLON RECTUM, V18, P494, DOI 10.1007/BF02587218; Leopoldo S, 2008, ANN SURG ONCOL, V15, P1429, DOI 10.1245/s10434-007-9757-1; Levine JS, 2006, NEW ENGL J MED, V355, P2551, DOI 10.1056/NEJMcp063038; Logan RFA, 2008, GASTROENTEROLOGY, V134, P29, DOI 10.1053/j.gastro.2007.10.014; Mahipal A, 2006, CANCER EPIDEM BIOMAR, V15, P1785, DOI 10.1158/1055-9965.EPI-05-0674; Meade TW, 1998, LANCET, V351, P233; Nasir Aejaz, 2004, Clin Colorectal Cancer, V3, P243, DOI 10.3816/CCC.2004.n.005; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Pollock A M, 1995, Qual Health Care, V4, P184, DOI 10.1136/qshc.4.3.184; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Smalley W, 1999, ARCH INTERN MED, V159, P161, DOI 10.1001/archinte.159.2.161; Sturmer T, 1998, ANN INTERN MED, V128, P713, DOI 10.7326/0003-4819-128-9-199805010-00003; van Wijk I, 2005, LANCET, V365, P2098, DOI 10.1016/S0140-6736(05)66734-7; VANGIJN J, 1991, NEW ENGL J MED, V325, P1261, DOI 10.1056/NEJM199110313251801; Wallace K, 2009, CANCER EPIDEM BIOMAR, V18, P2310, DOI 10.1158/1055-9965.EPI-09-0211; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X	52	932	967	3	109	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 20	2010	376	9754					1741	1750		10.1016/S0140-6736(10)61543-7	http://dx.doi.org/10.1016/S0140-6736(10)61543-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	690EI	20970847				2022-12-28	WOS:000284984900030
J	Long, MA; Jin, DZZ; Fee, MS				Long, Michael A.; Jin, Dezhe Z.; Fee, Michale S.			Support for a synaptic chain model of neuronal sequence generation	NATURE			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; IDENTIFIED HVC NEURONS; WHOLE-CELL RECORDINGS; ZEBRA FINCH; TERMINAL DENDRITES; NEURAL ACTIVITY; VOCAL CONTROL; NUCLEUS HVC; IN-VITRO; SONGBIRD	In songbirds, the remarkable temporal precision of song is generated by a sparse sequence of bursts in the premotor nucleus HVC. To distinguish between two possible classes of models of neural sequence generation, we carried out intracellular recordings of HVC neurons in singing zebra finches (Taeniopygia guttata). We found that the subthreshold membrane potential is characterized by a large, rapid depolarization 5-10 ms before burst onset, consistent with a synaptically connected chain of neurons in HVC. We found no evidence for the slow membrane potential modulation predicted by models in which burst timing is controlled by subthreshold dynamics. Furthermore, bursts ride on an underlying depolarization of similar to 10-ms duration, probably the result of a regenerative calcium spike within HVC neurons that could facilitate the propagation of activity through a chain network with high temporal precision. Our results provide insight into the fundamental mechanisms by which neural circuits can generate complex sequential behaviours.	[Long, Michael A.; Fee, Michale S.] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Jin, Dezhe Z.] Penn State Univ, Dept Phys, University Pk, PA 16802 USA	Massachusetts Institute of Technology (MIT); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Fee, MS (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	fee@mit.edu	Jin, Dezhe/AAE-6788-2020	Fee, Michale/0000-0001-7539-1745	National Institutes of Health [MH067105, DC009280]; Alfred P. Sloan Research Fellowship; National Science Foundation [IOS-0827731]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC009280, R00DC009280] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Wilson, S. Seung, A. Andalman, J. Goldberg and A. Gray for comments on earlier versions of this manuscript. We would also like to thank A. Andalman, D. Aronov and T. Ramee for help with acquisition and analysis software. This work is supported by funding from the National Institutes of Health to M.S.F. (MH067105) and M.A.L. (DC009280), and from the Alfred P. Sloan Research Fellowship and the National Science Foundation to D.Z.J. (IOS-0827731).	Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; AMARI SI, 1972, IEEE T COMPUT, VC 21, P1197, DOI 10.1109/T-C.1972.223477; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; CONNORS BW, 1982, J PHARMACOL EXP THER, V220, P476; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Dutar P, 1998, J NEUROPHYSIOL, V80, P1828, DOI 10.1152/jn.1998.80.4.1828; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Foster DJ, 2007, HIPPOCAMPUS, V17, P1093, DOI 10.1002/hipo.20345; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; Glaze CM, 2007, J NEUROSCI, V27, P7631, DOI 10.1523/JNEUROSCI.1065-07.2007; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hahnloser RHR, 2006, J NEUROPHYSIOL, V96, P794, DOI 10.1152/jn.01064.2005; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Jin DZ, 2007, J COMPUT NEUROSCI, V23, P283, DOI 10.1007/s10827-007-0032-z; Jun JK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000723; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Kubota M, 1998, J NEUROPHYSIOL, V80, P914, DOI 10.1152/jn.1998.80.2.914; Larkum ME, 2002, J NEUROSCI, V22, P6991; Lashley K.S., 1951, PROBLEM SERIAL ORDER, V21; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Lewicki MS, 1996, J NEUROSCI, V16, P5854; Li MR, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011918; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mooney R, 2005, J NEUROSCI, V25, P1952, DOI 10.1523/JNEUROSCI.3726-04.2005; MOONEY R, 1992, J NEUROSCI, V12, P2464; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Rosen MJ, 2003, NEURON, V39, P177, DOI 10.1016/S0896-6273(03)00357-X; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; Shima K, 2007, NATURE, V445, P315, DOI 10.1038/nature05470; Solis MM, 2005, J NEUROSCI, V25, P2811, DOI 10.1523/JNEUROSCI.5285-04.2005; STENT GS, 1978, SCIENCE, V200, P1348, DOI 10.1126/science.663615; VU ET, 1994, J NEUROSCI, V14, P6924; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	46	238	242	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					394	399		10.1038/nature09514	http://dx.doi.org/10.1038/nature09514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	20972420	Green Submitted, Green Accepted			2022-12-28	WOS:000284313100034
J	Nolan, JP; Soar, J				Nolan, Jerry P.; Soar, Jasmeet			Dispatcher-assisted bystander CPR: a KISS for a kiss	LANCET			English	Editorial Material							HOSPITAL CARDIAC ARRESTS; COMPRESSION-ONLY CPR; CARDIOPULMONARY-RESUSCITATION; CHEST-COMPRESSION; SURVIVAL		[Nolan, Jerry P.] Royal United Hosp NHS Trust, Dept Anaesthesia, Bath BA1 3NG, Avon, England; [Soar, Jasmeet] N Bristol NHS Trust, Southmead Hosp, Dept Anaesthesia, Bristol, Avon, England	North Bristol NHS Trust; Southmead Hospital	Nolan, JP (corresponding author), Royal United Hosp NHS Trust, Dept Anaesthesia, Bath BA1 3NG, Avon, England.	jerry.nolan@nhs.net	Soar, Jasmeet/HGA-2279-2022; Nolan, Jerry P./ABF-2561-2020	Soar, Jasmeet/0000-0001-5970-6073; Nolan, Jerry/0000-0003-3141-3812				Bobrow BJ, 2010, JAMA-J AM MED ASSOC, V304, P1447, DOI 10.1001/jama.2010.1392; Bobrow BJ, 2008, CIRCULATION, V118, P2550, DOI 10.1161/CIRCULATIONAHA.108.799940; Hallstrom A, 2000, NEW ENGL J MED, V342, P1546, DOI 10.1056/NEJM200005253422101; Handley AJ, 2005, RESUSCITATION, V67, pS7, DOI 10.1016/j.resuscitation.2005.10.007; Hupfl M, 2010, LANCET, V376, P1552, DOI 10.1016/S0140-6736(10)61454-7; Kitamura T, 2010, CIRCULATION, V122, P293, DOI 10.1161/CIRCULATIONAHA.109.926816; Kitamura T, 2010, LANCET, V375, P1347, DOI 10.1016/S0140-6736(10)60064-5; O'Neill JF, 2007, RESUSCITATION, V74, P63, DOI 10.1016/j.resuscitation.2006.11.007; Rea TD, 2001, CIRCULATION, V104, P2513, DOI 10.1161/hc4601.099468; Rea TD, 2010, NEW ENGL J MED, V363, P423, DOI 10.1056/NEJMoa0908993; Roppolo LP, 2005, RESUSCITATION, V65, P203, DOI 10.1016/j.resuscitation.2004.11.025; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Svensson L, 2010, NEW ENGL J MED, V363, P434, DOI 10.1056/NEJMoa0908991	13	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 6	2010	376	9752					1522	1524		10.1016/S0140-6736(10)61857-0	http://dx.doi.org/10.1016/S0140-6736(10)61857-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	680QE	20951423				2022-12-28	WOS:000284248700007
J	Han, L; Monne, M; Okumura, H; Schwend, T; Cherry, AL; Flot, D; Matsuda, T; Jovine, L				Han, Ling; Monne, Magnus; Okumura, Hiroki; Schwend, Thomas; Cherry, Amy L.; Flot, David; Matsuda, Tsukasa; Jovine, Luca			Insights into Egg Coat Assembly and Egg-Sperm Interaction from the X-Ray Structure of Full-Length ZP3	CELL			English	Article							ZONA-PELLUCIDA DOMAIN; SITE-DIRECTED MUTAGENESIS; MASS-SPECTROMETRY; VITELLINE ENVELOPE; RECEPTOR ACTIVITY; COMBINING SITE; FEMALE MICE; PROTEINS; MOUSE; GLYCOPROTEIN	ZP3, a major component of the zona pellucida (ZP) matrix coating mammalian eggs, is essential for fertilization by acting as sperm receptor. By retaining a propeptide that contains a polymerization-blocking external hydrophobic patch (EHP), we determined the crystal structure of an avian homolog of ZP3 at 2.0 angstrom resolution. The structure unveils the fold of a complete ZP domain module in a homodimeric arrangement required for secretion and reveals how EHP prevents premature incorporation of ZP3 into the ZP. This suggests mechanisms underlying polymerization and how local structural differences, reflected by alternative disulfide patterns, control the specificity of ZP subunit interaction. Close relative positioning of a conserved O-glycan important for sperm binding and the hypervariable, positively selected C-terminal region of ZP3 suggests a concerted role in the regulation of species-restricted gamete recognition. Alternative conformations of the area around the O-glycan indicate how sperm binding could trigger downstream events via intramolecular signaling.	[Han, Ling; Monne, Magnus; Okumura, Hiroki; Schwend, Thomas; Cherry, Amy L.; Jovine, Luca] Karolinska Inst, Dept Biosci & Nutr, SE-14183 Huddinge, Sweden; [Han, Ling; Monne, Magnus; Okumura, Hiroki; Schwend, Thomas; Cherry, Amy L.; Jovine, Luca] Karolinska Inst, Ctr Biosci, SE-14183 Huddinge, Sweden; [Okumura, Hiroki] Meijo Univ, Fac Agr, Dept Appl Biol Chem, Tempaku Ku, Nagoya, Aichi 4688502, Japan; [Flot, David] EMBL Grenoble, F-38042 Grenoble 9, France; [Matsuda, Tsukasa] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Karolinska Institutet; Karolinska Institutet; Meijo University; European Molecular Biology Laboratory (EMBL); Nagoya University	Jovine, L (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Halsovagen 7, SE-14183 Huddinge, Sweden.	luca.jovine@ki.se	Monné, Magnus/D-5642-2012; Jovine, Luca/E-8170-2010; Jovine, Luca/J-3563-2019	Monné, Magnus/0000-0003-2344-3878; Jovine, Luca/0000-0002-2679-6946; Jovine, Luca/0000-0002-2679-6946; Cherry, Amy/0000-0002-8222-1071	Center for Biosciences; Swedish Research Council [2005-5102, 2007-6068]; European Community [ERG 31055]; Scandinavia-Japan Sasakawa Foundation; Japan Society for the Promotion of Science; MEXT; EMBO	Center for Biosciences; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Community(European Commission); Scandinavia-Japan Sasakawa Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); EMBO(European Molecular Biology Organization (EMBO))	We thank CMC Biologics for expression plasmids pDEF38 and pNEF38; the ESRF for provision of synchrotron radiation facilities and Joanne McCarthy for assistance; Pavel Afonine, Ralf Grosse-Kunstleve, and Tom Terwilliger for help with PHENIX; Elmar Krieger and Alessandra Villa for help with molecular dynamics simulations; Hans Hebert for electron microscopy; Hisako Watanabe for help with sperm preparation; Franco Cotelli, Eveline Litscher, Rune Toftgard, and Paul Wassarman for discussions and comments. This work was supported by the Center for Biosciences; the Swedish Research Council (grants 2005-5102 and 2007-6068); the European Community (Marie Curie ERG 31055); the Scandinavia-Japan Sasakawa Foundation; Grant-in-aids from the Japan Society for the Promotion of Science and MEXT; and an EMBO Young Investigator award to L.J. Author Contributions: L.H. expressed proteins and analyzed mutants; M.M. generated constructs, purified and crystallized proteins, carried out model building, and refined the structures; H.O. generated and characterized constructs, expressed proteins, and performed and analyzed sperm binding assays; T.S. performed mass spectrometric analysis; A.L.C. analyzed crystallographic data; D.F. assisted data collection at ESRF; T.M. performed and analyzed sperm binding assays; L.J. directed the research, solved the structure, took part in structure refinement, ran molecular dynamics simulations, and wrote the manuscript with contributions from all other authors. L.J. dedicates this work to Marta, Smilla, and Sofia.	BARRATT CLR, 1993, HUM REPROD S; Bausek N, 2004, BIOL REPROD, V71, P684, DOI 10.1095/biolreprod.104.028605; BLEIL JD, 1980, CELL, V20, P873, DOI 10.1016/0092-8674(80)90334-7; Boja ES, 2005, BIOCHEMISTRY-US, V44, P16445, DOI 10.1021/bi051883f; Boja ES, 2003, J BIOL CHEM, V278, P34189, DOI 10.1074/jbc.M304026200; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; Callebaut I, 2007, BIOINFORMATICS, V23, P1871, DOI 10.1093/bioinformatics/btm265; Chalabi S, 2006, BIOCHEMISTRY-US, V45, P637, DOI 10.1021/bi0512804; Chen J, 1998, P NATL ACAD SCI USA, V95, P6193, DOI 10.1073/pnas.95.11.6193; Darie CC, 2004, BIOCHEMISTRY-US, V43, P7459, DOI 10.1021/bi0495937; Fernandes I, 2010, DEV CELL, V18, P64, DOI 10.1016/j.devcel.2009.11.009; FLORMAN HM, 1985, CELL, V41, P313, DOI 10.1016/0092-8674(85)90084-4; Gahlay G, 2010, SCIENCE, V329, P216, DOI 10.1126/science.1188178; Hasegawa A, 2006, REPRODUCTION, V132, P455, DOI 10.1530/rep.1.01016; Jansa SA, 2003, J MOL EVOL, V56, P294, DOI 10.1007/s00239-002-2401-6; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Jovine L, 2004, P NATL ACAD SCI USA, V101, P5922, DOI 10.1073/pnas.0401600101; Kanai S, 2008, MOL REPROD DEV, V75, P847, DOI 10.1002/mrd.20836; Kaul Renuka, 2001, Reprod Biomed Online, V2, P33; KINLOCH RA, 1995, P NATL ACAD SCI USA, V92, P263, DOI 10.1073/pnas.92.1.263; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; Liu CY, 1996, P NATL ACAD SCI USA, V93, P5431, DOI 10.1073/pnas.93.11.5431; Llorca O, 2007, J MOL BIOL, V365, P694, DOI 10.1016/j.jmb.2006.10.015; McLaughlin EA, 2010, MOL CELL ENDOCRINOL, DOI DOI 10.10.1016/J.MCE.2010.04.004; MILLAR SE, 1989, SCIENCE, V246, P935, DOI 10.1126/science.2479101; Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599; Monne M, 2006, SEMIN REPROD MED, V24, P204, DOI 10.1055/s-2006-948550; Okumura H, 2007, BIOL REPROD, V76, P9, DOI 10.1095/biolreprod.106.056267; Pan JZ, 2000, MOL REPROD DEV, V55, P175, DOI 10.1002/(SICI)1098-2795(200002)55:2&lt;175::AID-MRD6&gt;3.0.CO;2-6; Quesada C, 2004, J BIOL CHEM, V279, P26627, DOI 10.1074/jbc.M401588200; Rankin T, 1996, DEVELOPMENT, V122, P2903; Sanejouand YH, 2004, PROTEINS, V57, P205, DOI 10.1002/prot.20197; Sasanami T, 2003, BIOL REPROD, V68, P1613, DOI 10.1095/biolreprod.102.011841; Sasanami T, 2006, CELLS TISSUES ORGANS, V183, P41, DOI 10.1159/000094905; Schaeffer C, 2009, MOL BIOL CELL, V20, P589, DOI 10.1091/mbc.E08-08-0876; Shur BD, 2008, INT J DEV BIOL, V52, P703, DOI 10.1387/ijdb.082571bs; Sugiyama H, 1999, J BIOCHEM-TOKYO, V125, P469, DOI 10.1093/oxfordjournals.jbchem.a022310; Swann CA, 2007, REPRODUCTION, V133, P697, DOI 10.1530/REP-06-0043; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Takeuchi Y, 1999, EUR J BIOCHEM, V260, P736, DOI 10.1046/j.1432-1327.1999.00203.x; Turner LM, 2006, MOL BIOL EVOL, V23, P1656, DOI 10.1093/molbev/msl035; Vo LH, 2000, BIOL REPROD, V62, P766, DOI 10.1095/biolreprod62.3.766; Waclawek M, 1998, BIOL REPROD, V59, P1230, DOI 10.1095/biolreprod59.5.1230; Wassarman PM, 2008, INT J DEV BIOL, V52, P665, DOI 10.1387/ijdb.072524pw; Yasumasu S, 2010, J BIOCHEM, V148, P439, DOI 10.1093/jb/mvq086; Zhao M, 2004, BIOCHEMISTRY-US, V43, P12090, DOI 10.1021/bi048958k	47	108	115	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2010	143	3					404	415		10.1016/j.cell.2010.09.041	http://dx.doi.org/10.1016/j.cell.2010.09.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	20970175	Green Submitted, Bronze			2022-12-28	WOS:000283603900014
J	Bambra, C				Bambra, Clare			Personal View Doctors are key to welfare reform	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Durham, Wolfson Res Inst, Durham DH1 3HP, England	Durham University	Bambra, C (corresponding author), Univ Durham, Wolfson Res Inst, Durham DH1 3HP, England.	clare.bambra@durham.ac.uk	Bambra, Clare l/C-1392-2010	Bambra, Clare l/0000-0002-1294-6851					0	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2010	341								c6029	10.1136/bmj.c6029	http://dx.doi.org/10.1136/bmj.c6029			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674YY	20980370	Green Accepted, Green Submitted			2022-12-28	WOS:000283790400006
J	Pitt, JN; Ferre-D'Amare, AR				Pitt, Jason N.; Ferre-D'Amare, Adrian R.			Rapid Construction of Empirical RNA Fitness Landscapes	SCIENCE			English	Article							IN-VITRO; SELECTION; EVOLUTION; SEQUENCES; RIBOZYMES; MOLECULES; BINDING; LIGANDS	Evolution is an adaptive walk through a hypothetical fitness landscape, which depicts the relationship between genotypes and the fitness of each corresponding phenotype. We constructed an empirical fitness landscape for a catalytic RNA by combining next-generation sequencing, computational analysis, and "serial depletion," an in vitro selection protocol. By determining the reaction rate constant for every point mutant of a catalytic RNA, we demonstrated that abundance in serially depleted pools correlates with biochemical activity (correlation coefficient r = 0.67, standard score Z = 7.4). Therefore, enumeration of each genotype by deep sequencing yielded a fitness landscape containing similar to 10(7) unique sequences, without requiring measurement of the phenotypic fitness for each sequence. High-throughput mapping between genotype and phenotype may apply to artificial selections, host-pathogen interactions, and other biomedically relevant evolutionary phenomena.	[Ferre-D'Amare, Adrian R.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Fred Hutchinson Cancer Center	Ferre-D'Amare, AR (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, 1100 Fairview Ave N, Seattle, WA 98109 USA.	aferre@fhcrc.org			W.M. Keck Foundation; Howard Hughes Medical Institute (HHMI)	W.M. Keck Foundation(W.M. Keck Foundation); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute)	We thank R. Basom, A. Marty, and the staff of the Fred Hutchison Cancer Research Center Genomics Shared Resource for performing the Illumina sequencing and D. Bartel, B. Fritz, R. Knight, H. Malik, W. Noble, H. Robins, A. Roll-Mecak, and M. Tewari for discussions. This work was supported by the W.M. Keck Foundation and the Howard Hughes Medical Institute (HHMI). A.R.F.-D. is an investigator of the HHMI. Illumina sequence data have been deposited with the National Center for Biotechnology Information Sequence Read Archive with accession code SRA020870.	Carothers JM, 2004, J AM CHEM SOC, V126, P5130, DOI 10.1021/ja031504a; de la Pena M, 2009, RNA, V15, P1949, DOI 10.1261/rna.1889509; Domingo E, 2009, EMBO REP, V10, P444, DOI 10.1038/embor.2009.61; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fernandez G, 2007, J VIROL, V81, P2485, DOI 10.1128/JVI.01594-06; Hurst LD, 1996, Q REV BIOL, V71, P317, DOI 10.1086/419442; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; JOYCE GF, 1989, GENE, V82, P83, DOI 10.1016/0378-1119(89)90033-4; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; LEHMAN N, 1993, CURR BIOL, V3, P723, DOI 10.1016/0960-9822(93)90019-K; Pitt JN, 2010, NUCLEIC ACIDS RES, V38, P7908, DOI 10.1093/nar/gkq661; Pitt JN, 2009, J AM CHEM SOC, V131, P3532, DOI 10.1021/ja8067325; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Schuster P, 2001, BIOL CHEM, V382, P1301, DOI 10.1515/BC.2001.162; Schuster P, 2009, EUR REV, V17, P281, DOI 10.1017/S1062798709000787; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Stich M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-46; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Turk RM, 2010, P NATL ACAD SCI USA, V107, P4585, DOI 10.1073/pnas.0912895107; Vlassov A, 2001, P NATL ACAD SCI USA, V98, P7706, DOI 10.1073/pnas.141041098; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	26	114	119	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					376	379		10.1126/science.1192001	http://dx.doi.org/10.1126/science.1192001			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947767	Green Accepted			2022-12-28	WOS:000282986700043
J	Shoval, O; Alon, U				Shoval, Oren; Alon, Uri			SnapShot: Network Motifs	CELL			English	Editorial Material							FEEDFORWARD LOOP; GENE-REGULATION; CELL		[Shoval, Oren; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shoval, O (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.							Alon U., 2006, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6	10	85	86	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 15	2010	143	2					326	U158		10.1016/j.cell.2010.09.050	http://dx.doi.org/10.1016/j.cell.2010.09.050			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946989	Bronze			2022-12-28	WOS:000283052200020
J	Guly, CM; Forrester, JV				Guly, Catherine M.; Forrester, John V.			Investigation and management of uveitis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							REFRACTORY UVEITIS; THERAPY; CYCLOSPORINE; POSTERIOR; INFLIXIMAB; BLINDNESS; ALPHA		[Guly, Catherine M.] Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland; [Forrester, John V.] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen	Guly, CM (corresponding author), Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland.	catherine.guly@doctors.org.uk						[Anonymous], 1999, Am J Ophthalmol, V127, P537; Daniel E, 2010, AM J OPHTHALMOL, V149, P423, DOI 10.1016/j.ajo.2009.09.026; Deuter CME, 2006, RETINA-J RET VIT DIS, V26, P786, DOI 10.1097/01.iae.0000244265.75771.71; Diaz-Llopis M, 2008, J OCUL PHARMACOL TH, V24, P351, DOI 10.1089/jop.2007.0104; Dick A. D., 2008, PRACTICAL MANUAL INT; Durrani OM, 2004, BRIT J OPHTHALMOL, V88, P1159, DOI 10.1136/bjo.2003.037226; Gangaputra S, 2009, OPHTHALMOLOGY, V116, P2188, DOI 10.1016/j.ophtha.2009.04.020; Gilbert RE, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002218, DOI 10.1002/14651858.CD002218]; ISLAM N, 2007, BMJ CLIN EVID, V12, P705; Jabs DA, 2000, AM J OPHTHALMOL, V130, P492, DOI 10.1016/S0002-9394(00)00659-0; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Kempen John H, 2009, BMJ, V339, pb2480, DOI 10.1136/bmj.b2480; Kotter I, 2003, BRIT J OPHTHALMOL, V87, P423, DOI 10.1136/bjo.87.4.423; Lee RWJ, 2010, BRIT J OPHTHALMOL, V94, P269, DOI 10.1136/bjo.2009.176750; Maini R, 2004, BRIT J OPHTHALMOL, V88, P512, DOI 10.1136/bjo.2002.013334; Mansour AM, 2009, AM J OPHTHALMOL, V148, P310, DOI 10.1016/j.ajo.2009.03.023; Murphy CC, 2005, ARCH OPHTHALMOL-CHIC, V123, P634, DOI 10.1001/archopht.123.5.634; NUSSENBLATT RB, 1991, AM J OPHTHALMOL, V112, P138, DOI 10.1016/S0002-9394(14)76692-9; Pavesio C, 2010, OPHTHALMOLOGY, V117, P567, DOI 10.1016/j.ophtha.2009.11.027; Plskova J, 2007, AM J OPHTHALMOL, V144, P55, DOI 10.1016/j.ajo.2007.03.050; Rothova A, 1996, BRIT J OPHTHALMOL, V80, P332, DOI 10.1136/bjo.80.4.332; ROTHOVA A, 1992, BRIT J OPHTHALMOL, V76, P137, DOI 10.1136/bjo.76.3.137; Royal College of Ophthalmologists, 2006, GUID SCREEN UV JUV I; Suhler EB, 2009, ARCH OPHTHALMOL-CHIC, V127, P819, DOI 10.1001/archophthalmol.2009.141; SuttorpSchulten MSA, 1996, BRIT J OPHTHALMOL, V80, P844, DOI 10.1136/bjo.80.9.844; van Kooij B, 2006, OCUL IMMUNOL INFLAMM, V14, P73, DOI 10.1080/09273940500545684; Yamada Y, 2010, BRIT J OPHTHALMOL, V94, P284, DOI 10.1136/bjo.2009.158840; YAZICI H, 1990, NEW ENGL J MED, V322, P281, DOI 10.1056/NEJM199002013220501	28	36	39	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2010	341								c4976	10.1136/bmj.c4976	http://dx.doi.org/10.1136/bmj.c4976			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668FB	20943722				2022-12-28	WOS:000283252900012
J	Riess, H				Riess, Helen			Empathy in Medicine-A Neurobiological Perspective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PSYCHOTHERAPY		Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wang Ambulatory Care Ctr,Dept Psychiat, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Riess, H (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wang Ambulatory Care Ctr,Dept Psychiat, 15 Parkman St,Ste 812, Boston, MA 02114 USA.	hriess@partners.org						Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Decety J, 2010, NEUROIMAGE, V50, P1676, DOI 10.1016/j.neuroimage.2010.01.025; GLUCKSMAN ML, 1981, PSYCHOTHER PSYCHOSOM, V36, P185, DOI 10.1159/000287543; Hickson GB, 2002, JAMA-J AM MED ASSOC, V287, P2951, DOI 10.1001/jama.287.22.2951; Hojat M, 2009, ACAD MED, V84, P1182, DOI 10.1097/ACM.0b013e3181b17e55; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Marci Carl, 2005, Am J Psychother, V59, P213; Marci CD, 2007, J NERV MENT DIS, V195, P103, DOI 10.1097/01.nmd.0000253731.71025.fc; Shanafelt TD, 2009, JAMA-J AM MED ASSOC, V302, P1338, DOI 10.1001/jama.2009.1385; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x	10	69	69	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1604	1605		10.1001/jama.2010.1455	http://dx.doi.org/10.1001/jama.2010.1455			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940387				2022-12-28	WOS:000282816500026
J	Telfer, S; Lambin, X; Birtles, R; Beldomenico, P; Burthe, S; Paterson, S; Begon, M				Telfer, Sandra; Lambin, Xavier; Birtles, Richard; Beldomenico, Pablo; Burthe, Sarah; Paterson, Steve; Begon, Mike			Species Interactions in a Parasite Community Drive Infection Risk in a Wildlife Population	SCIENCE			English	Article							COWPOX; HOST; ASSOCIATIONS; COINFECTION; HELMINTH; RODENTS; IMPACT	Most hosts, including humans, are simultaneously or sequentially infected with several parasites. A key question is whether patterns of coinfection arise because infection by one parasite species affects susceptibility to others or because of inherent differences between hosts. We used time-series data from individual hosts in natural populations to analyze patterns of infection risk for a microparasite community, detecting large positive and negative effects of other infections. Patterns remain once variations in host susceptibility and exposure are accounted for. Indeed, effects are typically of greater magnitude, and explain more variation in infection risk, than the effects associated with host and environmental factors more commonly considered in disease studies. We highlight the danger of mistaken inference when considering parasite species in isolation rather than parasite communities.	[Telfer, Sandra; Paterson, Steve; Begon, Mike] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Telfer, Sandra; Lambin, Xavier] Univ Aberdeen, Sch Biol Sci, Aberdeen AB24 2TZ, Scotland; [Birtles, Richard] Univ Liverpool, Sch Vet Sci, Liverpool CH64 7TE, Merseyside, England; [Beldomenico, Pablo] Univ Nacl Litoral, Fac Ciencias Vet, RA-3080 Esperanza, Santa Fe, Argentina; [Burthe, Sarah] Ctr Ecol & Hydrol Edinburgh, Penicuik EH26 0QB, Midlothian, Scotland	University of Liverpool; University of Aberdeen; University of Liverpool; National University of the Littoral; UK Centre for Ecology & Hydrology (UKCEH)	Telfer, S (corresponding author), Univ Liverpool, Sch Biol Sci, Crown St, Liverpool L69 7ZB, Merseyside, England.	s.telfer@abdn.ac.uk	Paterson, Steve/D-2154-2009; Burthe, Sarah J/Q-9505-2016; Lambin, Xavier/E-8284-2011	Paterson, Steve/0000-0002-1307-2981; Burthe, Sarah J/0000-0001-8871-3432; Lambin, Xavier/0000-0003-4643-2653; BELDOMENICO, Pablo/0000-0001-5039-8975; Begon, Mike/0000-0003-1715-5327; Telfer, Sandra/0000-0002-9596-0711; Birtles, Richard/0000-0002-4216-5044	Natural Environment Research Council [GR3/13051]; Wellcome Trust [075202/Z/04/Z, 070675/Z/03/Z]; Dorothy Hodgkin Studentship; Natural Environment Research Council [CEH010021] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Dorothy Hodgkin Studentship; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the following for data collection in the field and laboratory and for discussion and comments: R. Anderson, M. Bennett, K. Bown, S. Gebert, C. Glover, A. Goodsall, G. Hutcheson, D. Jones, L. Lukomski, J. Rogers, A. Smith, G. Telford, and D. Tidhar. The work was supported by funding from the Natural Environment Research Council (GR3/13051) and The Wellcome Trust (075202/Z/04/Z; 070675/Z/03/Z). P. B. was supported by a Dorothy Hodgkin Studentship and is currently a career investigator of the Argentine Council for Science and Technology (CONICET). Metadata are available at the Knowledge Network for Biocomplexity (KNB) data repository (http://knb.ecoinformatics.org). After discussion of specific requirements, more detailed data will be made available on request from mbegon@liv.ac.uk or s.telfer@abdn.ac.uk.	Akaike H, 1973, P 2 INT S INF THEOR, P267, DOI DOI 10.2307/2334537; Behnke JM, 2008, PARASITOLOGY, V135, P751, DOI 10.1017/S0031182008000334; Belongia EA, 2002, VECTOR-BORNE ZOONOT, V2, P265, DOI 10.1089/153036602321653851; Birtles RJ, 2005, ANN NY ACAD SCI, V1063, P270, DOI 10.1196/annals.1355.044; Booth M, 2006, TRENDS PARASITOL, V22, P359, DOI 10.1016/j.pt.2006.06.007; Burthe S, 2008, J ANIM ECOL, V77, P110, DOI 10.1111/j.1365-2656.2007.01302.x; Chantrey J, 1999, EPIDEMIOL INFECT, V122, P455, DOI 10.1017/S0950268899002423; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; Graham AL, 2005, J INFECT DIS, V191, P410, DOI 10.1086/426871; Graham AL, 2008, P NATL ACAD SCI USA, V105, P566, DOI 10.1073/pnas.0707221105; Irwin P, 2005, ARTHROPOD BORNE INFE, P63; Jackson JA, 2006, INT J PARASITOL, V36, P1341, DOI 10.1016/j.ijpara.2006.07.003; Johns JL, 2009, INFECT IMMUN, V77, P4070, DOI 10.1128/IAI.00570-09; Jolles AE, 2008, ECOLOGY, V89, P2239, DOI 10.1890/07-0995.1; Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018; Lello J, 2004, NATURE, V428, P840, DOI 10.1038/nature02490; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; PURNELL RE, 1977, VET REC, V100, P4, DOI 10.1136/vr.100.1.4; Rodriguez M, 1999, PARASITE IMMUNOL, V21, P177, DOI 10.1046/j.1365-3024.1999.00218.x; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; Telfer S, 2008, PARASITOLOGY, V135, P767, DOI 10.1017/S0031182008000395; Telfer S, 2007, PARASITOLOGY, V134, P413, DOI 10.1017/S0031182006001624; Telfer S, 2005, OIKOS, V109, P317, DOI 10.1111/j.0030-1299.2005.13734.x	24	388	398	4	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					243	246		10.1126/science.1190333	http://dx.doi.org/10.1126/science.1190333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929776	Green Accepted			2022-12-28	WOS:000282644600048
J	Yamagishi, Y; Honda, T; Tanno, Y; Watanabe, Y				Yamagishi, Yuya; Honda, Takashi; Tanno, Yuji; Watanabe, Yoshinori			Two Histone Marks Establish the Inner Centromere and Chromosome Bi-Orientation	SCIENCE			English	Article							SISTER-CHROMATID COHESION; AURORA-B; MITOTIC CHROMOSOME; SHUGOSHIN; KINETOCHORE; SPINDLE; LOCALIZATION; ATTACHMENT; MEIOSIS; CHECKPOINT	For proper partitioning of chromosomes in mitosis, the chromosomal passenger complex (CPC) including Aurora B and survivin must be localized at the center of paired kinetochores, at the site called the inner centromere. It is largely unknown what defines the inner centromere and how the CPC is targeted to this site. Here, we show that the phosphorylation of histone H3-threonine 3 (H3-pT3) mediated by Haspin cooperates with Bub1-mediated histone 2A-serine 121 (H2A-S121) phosphorylation in targeting the CPC to the inner centromere in fission yeast and human cells. H3-pT3 promotes nucleosome binding of survivin, whereas phosphorylated H2A-S121 facilitates the binding of shugoshin, the centromeric CPC adaptor. Haspin colocalizes with cohesin by associating with Pds5, whereas Bub1 localizes at kinetochores. Thus, the inner centromere is defined by intersection of two histone kinases.	[Yamagishi, Yuya; Honda, Takashi; Tanno, Yuji; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan; [Yamagishi, Yuya; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Tokyo 1130033, Japan; [Honda, Takashi; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp		Watanabe, Yoshinori/0000-0002-5488-4812	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [21000010] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Hauf for critical reading of the manuscript, the Yeast Genetic Resource Centre for yeast strains, and all the members of our laboratory for their valuable support and discussion. This work was supported in part by Japan Society for the Promotion of Science research fellowships (to Y.Y., T.H., and Y.T.); the Global Center of Excellence Program; and a Grant-in-Aid for Specially Promoted Research (to Y.W.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Hamant O, 2005, CURR BIOL, V15, P948, DOI 10.1016/j.cub.2005.04.049; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; KERREBROCK AW, 1995, CELL, V83, P247, DOI 10.1016/0092-8674(95)90166-3; Kiburz BM, 2005, GENE DEV, V19, P3017, DOI 10.1101/gad.1373005; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Morishita J, 2001, GENES CELLS, V6, P743, DOI 10.1046/j.1365-2443.2001.00459.x; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Resnick TD, 2006, DEV CELL, V11, P57, DOI 10.1016/j.devcel.2006.04.021; Rivera T, 2009, CHROMOSOMA, V118, P223, DOI 10.1007/s00412-008-0190-4; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Tanaka TU, 2008, CHROMOSOMA, V117, P521, DOI 10.1007/s00412-008-0173-5; Tsukahara T, 2010, NATURE, V467, P719, DOI 10.1038/nature09390; Vanoosthuyse V, 2007, MOL BIOL CELL, V18, P1657, DOI 10.1091/mbc.E06-10-0890; Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217	27	330	341	3	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					239	243		10.1126/science.1194498	http://dx.doi.org/10.1126/science.1194498			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929775				2022-12-28	WOS:000282644600047
J	Kral, A; O'Donoghue, GM				Kral, Andrej; O'Donoghue, Gerard M.			Medical Progress: Profound Deafness in Childhood.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SHORT-TERM-MEMORY; COCHLEAR IMPLANTS; CORTICAL REORGANIZATION; ELECTRICAL-STIMULATION; LANGUAGE-DEVELOPMENT; SPEECH-PERCEPTION; CHILDREN; HEARING; AGE; DEPRIVATION		[Kral, Andrej] Hannover Med Sch, Inst Audioneurotechnol, D-30625 Hannover, Germany; [Kral, Andrej] Hannover Med Sch, Dept Expt Otol Ear Nose & Throat Clin, D-30625 Hannover, Germany; [Kral, Andrej] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX 75230 USA; [O'Donoghue, Gerard M.] Natl Inst Hlth Res Nottingham, Natl Biomed Res Unit Hearing, Nottingham, England; [O'Donoghue, Gerard M.] Nottingham Univ Hosp Natl Hlth Serv Trust, Queens Med Ctr, Dept Otolaryngol, Nottingham, England	Hannover Medical School; Hannover Medical School; University of Texas System; University of Texas Dallas; University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham	Kral, A (corresponding author), Hannover Med Sch, Inst Audioneurotechnol, Feodor Lynen Str 35, D-30625 Hannover, Germany.	kral.andrej@mh-hannover.de		Kral, Andrej/0000-0002-7762-4642	Med-El	Med-El	Dr. Kral reports receiving grant support from Med-El, given to University Medical Center Hamburg-Eppendorf on his behalf, and reimbursement for travel expenses from Amplifon, Med-El, and the Geers Foundation; and Dr. O'Donoghue, receiving honoraria from the Cochlear Corporation and Advanced Bionics and reimbursement for travel expenses from Advanced Bionics and Med-El. No other potential conflict of interest relevant to this article was reported.	ALEXIADES D, 2008, PEDIAT AUDIOLOGY DIA, P183; Aramakis VB, 2000, J NEUROSCI, V20, P6106, DOI 10.1523/JNEUROSCI.20-16-06106.2000; Archbold S, 2008, INT J PEDIATR OTORHI, V72, P1471, DOI 10.1016/j.ijporl.2008.06.016; Backhouse S, 2008, EXP NEUROL, V214, P193, DOI 10.1016/j.expneurol.2008.08.002; Barker DH, 2009, DEV PSYCHOPATHOL, V21, P373, DOI 10.1017/S0954579409000212; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Beadle EAR, 2005, OTOL NEUROTOL, V26, P1152, DOI 10.1097/01.mao.0000180483.16619.8f; Berlin CI, 2010, INT J AUDIOL, V49, P30, DOI 10.3109/14992020903160892; Boutla M, 2004, NAT NEUROSCI, V7, P997, DOI 10.1038/nn1298; Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333; Calonge N, 2008, PEDIATRICS, V122, P143, DOI 10.1542/peds.2007-2210; Champoux F, 2009, NEUROPSYCHOLOGIA, V47, P17, DOI 10.1016/j.neuropsychologia.2008.08.028; Colletti V, 2009, PROG BRAIN RES, V175, P333, DOI 10.1016/S0079-6123(09)17523-4; CONEL JL, 1939, POSTNATAL DEV HUMAN, V1; Damen GWJA, 2007, OTOL NEUROTOL, V28, P463, DOI 10.1097/MAO.0b013e318033efee; Dammeyer J, 2010, J DEAF STUD DEAF EDU, V15, P50, DOI 10.1093/deafed/enp024; DAVIS AC, COMPREHENSI IN PRESS; Delaroche M, 2006, INT J PEDIATR OTORHI, V70, P993, DOI 10.1016/j.ijporl.2005.10.010; *DEP HLTH, 2008, TRANSF SERV CHIDR HE; Dorman ME, 2004, AM SCI, V92, P436, DOI 10.1511/2004.5.436; Doucet ME, 2006, BRAIN, V129, P3376, DOI 10.1093/brain/awl264; Drennan VR, 2007, JARO-J ASSOC RES OTO, V8, P373, DOI 10.1007/s10162-007-0074-y; Fallon JB, 2008, HEARING RES, V238, P110, DOI 10.1016/j.heares.2007.08.004; Geers AE, 2009, J DEAF STUD DEAF EDU, V14, P371, DOI 10.1093/deafed/enn046; Gilley PM, 2008, BRAIN RES, V1239, P56, DOI 10.1016/j.brainres.2008.08.026; Giraud AL, 2001, NEURON, V30, P657, DOI 10.1016/S0896-6273(01)00318-X; Gordon KA, 2008, CLIN NEUROPHYSIOL, V119, P2347, DOI 10.1016/j.clinph.2008.06.013; Gordon KA, 2009, OTOL NEUROTOL, V30, P319, DOI 10.1097/MAO.0b013e31819a8f4c; Gravel Judith S, 2005, Am J Audiol, V14, pS217, DOI 10.1044/1059-0889(2005/023); HALL JW, 2009, PEDIAT AUDIOLOGICAL, P72; Hartley R, 2010, J COMPUT ASSIST LEAR, V26, P4, DOI 10.1111/j.1365-2729.2009.00340.x; Hayes H, 2009, EAR HEARING, V30, P128, DOI 10.1097/AUD.0b013e3181926524; Hussong A, 2010, INT J COMPUT ASS RAD, V5, P163, DOI 10.1007/s11548-009-0368-0; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; Johnson C, 2010, J SPEECH LANG HEAR R, V53, P237, DOI 10.1044/1092-4388(2009/08-0139); Kentish R, 2009, PAEDIAT AUDIOLOGICAL, P488; Kirk K. I., 2009, COCHLEAR IMPLANTS PR, V2nd, P191; Koo D, 2008, ANN NY ACAD SCI, V1145, P83, DOI 10.1196/annals.1416.025; Kral A, 2005, CEREB CORTEX, V15, P552, DOI 10.1093/cercor/bhh156; Kral A, 2007, BRAIN RES REV, V56, P259, DOI 10.1016/j.brainresrev.2007.07.021; Kral A, 2006, PROG BRAIN RES, V157, P283, DOI 10.1016/S0079-6123(06)57018-9; Kuhl P, 2008, ANNU REV NEUROSCI, V31, P511, DOI 10.1146/annurev.neuro.30.051606.094321; Leake PA, 2008, JARO-J ASSOC RES OTO, V9, P349, DOI 10.1007/s10162-008-0127-x; Leigh G., 2008, DEAF COGNITION FDN O, DOI DOI 10.1093/ACPROF:OSO/9780195368673.003.0002; Lin FR, 2006, INT J PEDIATR OTORHI, V70, P1695, DOI 10.1016/j.ijporl.2006.05.009; Litovsky RY, 2010, J ACOUST SOC AM, V127, P400, DOI 10.1121/1.3257546; Loundon N, 2010, ARCH OTOLARYNGOL, V136, P12, DOI 10.1001/archoto.2009.187; Lovett RES, 2010, ARCH DIS CHILD, V95, P107, DOI 10.1136/adc.2009.160325; Luterman D, 2001, EARLY CHILDHOOD DEAFNESS, P149; Marschark M., 2008, DEAF COGNITION FDN O, P309; McCann DC, 2009, ARCH DIS CHILD, V94, P293, DOI 10.1136/adc.2008.151217; Meinzen-Derr J, 2010, LARYNGOSCOPE, V120, P405, DOI 10.1002/lary.20728; Middlebrooks JC, 2005, CURR OPIN NEUROBIOL, V15, P488, DOI 10.1016/j.conb.2005.06.004; Middlebrooks JC, 2010, J NEUROSCI, V30, P1937, DOI 10.1523/JNEUROSCI.4949-09.2010; Miyamoto RT, 2008, ACTA OTO-LARYNGOL, V128, P373, DOI 10.1080/00016480701785012; Moeller MP, 2007, EAR HEARING, V28, P740, DOI 10.1097/AUD.0b013e318157f07f; Mohr PE, 2000, INT J TECHNOL ASSESS, V16, P1120, DOI 10.1017/S0266462300103162; Moore BCJ, 2000, BRIT J AUDIOL, V34, P205, DOI 10.3109/03005364000000131; Moore DR, 2009, PHILOS T R SOC B, V364, P409, DOI 10.1098/rstb.2008.0187; Nelken I, 2008, FRONT NEUROSCI-SWITZ, V2, P107, DOI 10.3389/neuro.01.009.2008; *NHS NAT I HLTH CL, 2009, COCHL IMPL CHILDR AD; Nickel R, 2008, CURR OPIN OTOLARYNGO, V16, P452, DOI 10.1097/MOO.0b013e32830e20b0; Niparko JK, 2010, JAMA-J AM MED ASSOC, V303, P1498, DOI 10.1001/jama.2010.451; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; Pisoni DB, 2008, DEAF COGNITION FDN O, P52, DOI [10.1093/acprof, DOI 10.1093/ACPROF:OSO/9780195368673.003.0003]; Ponton CW, 2001, AUDIOL NEURO-OTOL, V6, P363, DOI 10.1159/000046846; Putzar L, 2007, NAT NEUROSCI, V10, P1243, DOI 10.1038/nn1978; Ramos A, 2009, ACTA OTO-LARYNGOL, V129, P533, DOI 10.1080/00016480802294369; Roland JT, 2009, LARYNGOSCOPE, V119, P2205, DOI 10.1002/lary.20489; Rouger J, 2007, P NATL ACAD SCI USA, V104, P7295, DOI 10.1073/pnas.0609419104; Ruben RJ, 1997, ACTA OTO-LARYNGOL, V117, P202, DOI 10.3109/00016489709117769; Rudner M, 2009, SCAND J PSYCHOL, V50, P495, DOI 10.1111/j.1467-9450.2009.00744.x; Ryugo DK, 2005, SCIENCE, V310, P1490, DOI 10.1126/science.1119419; Schroeder L, 2006, PEDIATRICS, V117, P1101, DOI 10.1542/peds.2005-1335; Sharma A, 2007, INT J AUDIOL, V46, P494, DOI 10.1080/14992020701524836; Sharma Anu, 2005, J Am Acad Audiol, V16, P564, DOI 10.3766/jaaa.16.8.5; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Summerfield AQ, 2005, J PUBLIC HEALTH, V27, P55, DOI 10.1093/pubmed/fdh188; Svirsky MA, 2004, AUDIOL NEURO-OTOL, V9, P224, DOI 10.1159/000078392; Talbot KN, 2008, CLIN OTOLARYNGOL, V33, P536, DOI 10.1111/j.1749-4486.2008.01822.x; Tillein J, 2010, CEREB CORTEX, V20, P492, DOI 10.1093/cercor/bhp222; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Traxler C.B., 2000, J DEAF STUD DEAF EDU, V5, P337, DOI DOI 10.1093/DEAFED/5.4.337; Uziel AS, 2007, OTOL NEUROTOL, V28, P615, DOI 10.1097/01.mao.0000281802.59444.02; Van Naarden K, 1999, PEDIATRICS, V103, P570, DOI 10.1542/peds.103.3.570; Wallace MT, 2006, J NEUROSCI, V26, P11844, DOI 10.1523/JNEUROSCI.3295-06.2006; Woodson EA, 2010, ADV OTO-RHINO-LARYNG, V67, P125, DOI 10.1159/000262604; Yoshinaga-Itano C, 1998, PEDIATRICS, V102, P1161, DOI 10.1542/peds.102.5.1161; Yoshinaga-Itano C., 2006, ADV SPOKEN LANGUAGE, P298, DOI DOI 10.1093/ACPROF:OSO/9780195179873.001.0001; Yucel E, 2008, INT J PEDIATR OTORHI, V72, P869, DOI 10.1016/j.ijporl.2008.02.017; Zhou XM, 2009, NAT NEUROSCI, V12, P26, DOI 10.1038/nn.2239; 2002, MMWR MORB MORTAL WKL, V51, P931	94	258	272	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2010	363	15					1438	1450		10.1056/NEJMra0911225	http://dx.doi.org/10.1056/NEJMra0911225			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	659NV	20925546				2022-12-28	WOS:000282575100009
J	Bashutski, JD; Eber, RM; Kinney, JS; Benavides, E; Maitra, S; Braun, TM; Giannobile, WV; McCauley, LK				Bashutski, Jill D.; Eber, Robert M.; Kinney, Janet S.; Benavides, Erika; Maitra, Samopriyo; Braun, Thomas M.; Giannobile, William V.; McCauley, Laurie K.			Teriparatide and Osseous Regeneration in the Oral Cavity.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERIODONTAL WOUND REPAIR; PARATHYROID-HORMONE; POSTMENOPAUSAL WOMEN; INTRABONY DEFECTS; BONE; MATRIX; OSTEONECROSIS; THERAPY; DISEASE; DEBRIDEMENT	Background: Intermittent administration of teriparatide, a drug composed of the first 34 amino acids of parathyroid hormone, has anabolic effects on bone. Although teriparatide has been evaluated for the treatment of osteoporosis and for the healing of fractures, clinical trials evaluating it for the treatment of osseous conditions of the oral cavity in humans are lacking. Methods: A total of 40 patients with severe, chronic periodontitis underwent periodontal surgery and received daily injections of teriparatide (20 microg) or placebo, along with oral calcium (1000 mg) and vitamin D (800 IU) supplementation, for 6 weeks. The patients were followed for 1 year. The primary outcome was a radiographic linear measurement of alveolar bone level. Secondary outcomes included clinical variables, bone turnover markers in serum and oral fluid, systemic bone mineral density, and quality of life. Results: Radiographic linear resolution of osseous defects was significantly greater after teriparatide therapy than after placebo beginning at 6 months, with a mean linear gain in bone at 1 year of 29% as compared with 3% (P<0.001). Clinical improvement was greater in patients taking teriparatide than in those taking placebo, with a reduction in periodontal probing depth of 33% versus 20% (2.42 mm vs. 1.32 mm) and a gain in clinical attachment level of 22% versus 7% (1.58 mm vs. 0.42 mm) in target lesions at 1 year (P=0.02 for both comparisons). No serious adverse events were reported; however, the number of patients in the study was small. No significant differences were noted with respect to the other variables that were assessed. Conclusions: Teriparatide, as compared with placebo, was associated with improved clinical outcomes, greater resolution of alveolar bone defects, and accelerated osseous wound healing in the oral cavity. Teriparatide may offer therapeutic potential for localized bone defects in the jaw. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT00277706.) N Engl J Med 2010;363:2396-405.	[McCauley, Laurie K.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Bashutski, Jill D.; Eber, Robert M.; Kinney, Janet S.; Benavides, Erika; Giannobile, William V.; McCauley, Laurie K.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Bashutski, Jill D.; Eber, Robert M.; Kinney, Janet S.; Braun, Thomas M.; Giannobile, William V.; McCauley, Laurie K.] Univ Michigan, Sch Dent, Michigan Ctr Oral Hlth Res, Ann Arbor, MI 48109 USA; [Maitra, Samopriyo; Braun, Thomas M.] Univ Michigan, Dept Biostat, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Giannobile, William V.] Univ Michigan, Coll Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	McCauley, LK (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 1011 N Univ Ave, Ann Arbor, MI 48109 USA.	mccauley@umich.edu	McCauley, Laurie/G-4041-2012	Giannobile, William/0000-0002-7102-9746	Eli Lilly; American Academy of Periodontology Foundation; National Center for Research Resources, National Institutes of Health [UL1RR024986]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024987, UL1RR024986] Funding Source: NIH RePORTER	Eli Lilly(Eli Lilly); American Academy of Periodontology Foundation; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported in part by Eli Lilly, the American Academy of Periodontology Foundation Tarrson Regeneration Scholarship, and a grant (UL1RR024986) from the National Center for Research Resources, National Institutes of Health, to the University of Michigan Clinical Research Unit.	Aspenberg P, 2010, J BONE MINER RES, V25, P404, DOI 10.1359/jbmr.090731; Barros SP, 2003, J DENT RES, V82, P791, DOI 10.1177/154405910308201006; Bhongade Manohar L, 2007, J Contemp Dent Pract, V8, P25; Curtis JW, 2000, NEW ENGL J MED, V342, P895; Dempster DW, 2001, J BONE MINER RES, V16, pS179; DUCKWORTH JE, 1983, J PERIODONTOL, V54, P435, DOI 10.1902/jop.1983.54.7.435; Dybvik T, 2007, J PERIODONTOL, V78, P403, DOI 10.1902/jop.2007.060263; El-Shinnawi Una M, 2003, J Int Acad Periodontol, V5, P5; Gapski R, 2004, J PERIODONTOL, V75, P441, DOI 10.1902/jop.2004.75.3.441; Gapski R, 2009, J CLIN PERIODONTOL, V36, P149, DOI 10.1111/j.1600-051X.2008.01351.x; GIANNOBILE WV, 1995, J CLIN PERIODONTOL, V22, P903, DOI 10.1111/j.1600-051X.1995.tb01793.x; Graziani F, 2009, J CLIN PERIODONTOL, V36, P419, DOI 10.1111/j.1600-051X.2009.01388.x; Harper RP, 2007, J ORAL MAXIL SURG, V65, P573, DOI 10.1016/j.joms.2006.10.076; Heijl L, 1997, J CLIN PERIODONTOL, V24, P705, DOI 10.1111/j.1600-051X.1997.tb00253.x; Heitz-Mayfield LJA, 2002, J CLIN PERIODONTOL, V29, P92, DOI 10.1034/j.1600-051X.29.s3.5.x; ISIDOR F, 1986, J PERIODONTAL RES, V21, P462, DOI 10.1111/j.1600-0765.1986.tb01482.x; Jeffcoat Marjorie K, 2007, J Int Acad Periodontol, V9, P70; Jung RE, 2007, CLIN ORAL IMPLAN RES, V18, P319, DOI 10.1111/j.1600-0501.2007.01342.x; Jung RE, 2007, INT J ORAL MAX IMPL, V22, P258; Kitamura M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002611; Lane N, 2005, J PERIODONTOL, V76, P1113, DOI 10.1902/jop.2005.76.7.1113; Lau AN, 2009, J RHEUMATOL, V36, P1835, DOI 10.3899/jrheum.081176; Laurell L, 1998, J PERIODONTOL, V69, P303, DOI 10.1902/jop.1998.69.3.303; Michalowicz BS, 2006, NEW ENGL J MED, V355, P1885, DOI 10.1056/NEJMoa062249; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205; Offenbacher S, 2009, J PERIODONTOL, V80, P190, DOI [10.1902/jop.2009.080007, 10.1902/jop.2009.080007 ]; Pettway GJ, 2008, BONE, V42, P806, DOI 10.1016/j.bone.2007.11.017; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; PIHLSTROM BL, 1984, J PERIODONTOL, V55, P499, DOI 10.1902/jop.1984.55.9.499; Reddy M S, 1993, Dent Clin North Am, V37, P553; Rocha ML, 2004, J PERIODONTOL, V75, P1579, DOI 10.1902/jop.2004.75.12.1579; Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004; Schneider A, 2003, J ORTHOP RES, V21, P859, DOI 10.1016/S0736-0266(03)00042-1; Sculean Anton, 2003, Clin Oral Investig, V7, P108, DOI 10.1007/s00784-003-0200-0; Shirakata Y, 2008, J PERIODONTOL, V79, P25, DOI [10.1902/jop.2008.070141, 10.1902/jop.2008.070141 ]; SLADE GD, 1994, COMMUNITY DENT HLTH, V11, P3; Takaishi Y, 2003, J INT MED RES, V31, P575, DOI 10.1177/147323000303100614; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Trombelli L, 2002, J CLIN PERIODONTOL, V29, P117, DOI 10.1034/j.1600-051X.29.s3.7.x; Tsiridis E, 2007, J ORTHOP RES, V25, P1193, DOI 10.1002/jor.20420	41	153	165	3	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2010	363	25					2396	2405		10.1056/NEJMoa1005361	http://dx.doi.org/10.1056/NEJMoa1005361			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZK	20950166	Green Accepted			2022-12-28	WOS:000285340200005
J	Eisele, YS; Obermuller, U; Heilbronner, G; Baumann, F; Kaeser, SA; Wolburg, H; Walker, LC; Staufenbiel, M; Heikenwalder, M; Jucker, M				Eisele, Yvonne S.; Obermueller, Ulrike; Heilbronner, Goetz; Baumann, Frank; Kaeser, Stephan A.; Wolburg, Hartwig; Walker, Lary C.; Staufenbiel, Matthias; Heikenwalder, Mathias; Jucker, Mathias			Peripherally Applied A beta-Containing Inoculates Induce Cerebral beta-Amyloidosis	SCIENCE			English	Article							ALZHEIMER-DISEASE; PATHOGENESIS; DEPOSITION; PRIONS	The intracerebral injection of beta-amyloid-containing brain extracts can induce cerebral beta-amyloidosis and associated pathologies in susceptible hosts. We found that intraperitoneal inoculation with beta-amyloid-rich extracts induced beta-amyloidosis in the brains of beta-amyloid precursor protein transgenic mice after prolonged incubation times.	[Eisele, Yvonne S.; Obermueller, Ulrike; Heilbronner, Goetz; Baumann, Frank; Kaeser, Stephan A.; Jucker, Mathias] Univ Tubingen, Dept Cellular Neurol, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Eisele, Yvonne S.; Obermueller, Ulrike; Heilbronner, Goetz; Baumann, Frank; Kaeser, Stephan A.; Jucker, Mathias] DZNE German Ctr Neurodegenerat Dis, D-72076 Tubingen, Germany; [Heilbronner, Goetz] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, D-72074 Tubingen, Germany; [Wolburg, Hartwig] Univ Tubingen, Dept Pathol, D-72076 Tubingen, Germany; [Walker, Lary C.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Walker, Lary C.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Staufenbiel, Matthias] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland; [Heikenwalder, Mathias] Univ Zurich Hosp, Dept Pathol, Inst Neuropathol, CH-8091 Zurich, Switzerland	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Emory University; Emory University; Novartis; University of Zurich; University Zurich Hospital	Jucker, M (corresponding author), Univ Tubingen, Dept Cellular Neurol, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany.	mathias.jucker@uni-tuebingen.de	Baumann, Frank/F-7737-2016; Heikenwalder, Mathias/AAA-2269-2020; Eisele, Yvonne/E-7897-2015; Walker, L C/J-6541-2015	Eisele, Yvonne/0000-0002-3868-4327; Walker, L C/0000-0001-9166-3261; Jucker, Mathias/0000-0001-9045-1072	Competence Network on Degenerative Dementias [BMBF-01GI0705]; Bundesministerium fur Bildung und Forschung as part of ERA-Net NEURON (MIPROTRAN); Center for Integrative Neuroscience (Deutsche Forschungsgemeinschaft); NIH [RR-00165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER	Competence Network on Degenerative Dementias; Bundesministerium fur Bildung und Forschung as part of ERA-Net NEURON (MIPROTRAN); Center for Integrative Neuroscience (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank M.-J. Runser, L. Jacobson (Basel), F. Langer, J. Coomaraswamy, S. Grathwohl, N. Varvel, T. Hamaguchi, C. Schafer, A. Bosch, G. Frommer-Kastle, U. Scheurlen (Tubingen) for experimental help and A. Aguzzi (Zurich) for insightful comments. This work was supported by the Competence Network on Degenerative Dementias (BMBF-01GI0705), the Bundesministerium fur Bildung und Forschung as part of ERA-Net NEURON (MIPROTRAN), the Center for Integrative Neuroscience (Deutsche Forschungsgemeinschaft), and NIH RR-00165.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Bremer J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007160; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; KIMBERLIN RH, 1978, J COMP PATHOL, V88, P39, DOI 10.1016/0021-9975(78)90059-2; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morris JC, 2009, ARCH NEUROL-CHICAGO, V66, P1469, DOI 10.1001/archneurol.2009.269; Prusiner SB, 2004, PRION BIOL DIS; Storandt M, 2009, ARCH NEUROL-CHICAGO, V66, P1476, DOI 10.1001/archneurol.2009.272; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Walker LC, 2006, TRENDS NEUROSCI, V29, P438, DOI 10.1016/j.tins.2006.06.010; Zhang-Nunes SX, 2006, BRAIN PATHOL, V16, P30, DOI 10.1111/j.1750-3639.2006.tb00559.x	15	436	444	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					980	982		10.1126/science.1194516	http://dx.doi.org/10.1126/science.1194516			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	20966215	Green Accepted			2022-12-28	WOS:000284118000047
J	Sawa, S; Cherrier, M; Lochner, M; Satoh-Takayama, N; Fehling, HJ; Langa, F; Di Santo, JP; Eberl, G				Sawa, Shinichiro; Cherrier, Marie; Lochner, Matthias; Satoh-Takayama, Naoko; Fehling, Hans Joerg; Langa, Francina; Di Santo, James P.; Eberl, Gerard			Lineage Relationship Analysis of ROR gamma t(+) Innate Lymphoid Cells	SCIENCE			English	Article							ROR-GAMMA-T; TISSUE-INDUCER CELLS; NATURAL-KILLER-CELLS; PROINFLAMMATORY IL-17(+); NKP46(+) CELLS; HELPER-CELLS; IN-VIVO; DIFFERENTIATION; IMMUNITY; ORGANOGENESIS	Lymphoid tissue-inducer (LTi) cells initiate the development of lymphoid tissues through the activation of local stromal cells in a process similar to inflammation. LTi cells express the nuclear hormone receptor ROR gamma t, which also directs the expression of the proinflammatory cytokine interleukin-17 in T cells. We show here that LTi cells are part of a larger family of proinflammatory ROR gamma t(+) innate lymphoid cells (ILCs) that differentiate from distinct fetal liver ROR gamma t(+) precursors. The fate of ROR gamma t(+) ILCs is determined by mouse age, and after birth, favors the generation of cells involved in intestinal homeostasis and defense. Contrary to ROR gamma t(+) T cells, however, ROR gamma t(+) ILCs develop in the absence of microbiota. Our study indicates that ROR gamma t(+) ILCs evolve to preempt intestinal colonization by microbial symbionts.	[Sawa, Shinichiro; Cherrier, Marie; Lochner, Matthias; Eberl, Gerard] Inst Pasteur, Lymphoid Tissue Dev Unit, F-75724 Paris, France; [Sawa, Shinichiro; Cherrier, Marie; Lochner, Matthias; Eberl, Gerard] CNRS, URA1961, F-75724 Paris, France; [Lochner, Matthias] Hannover Med Sch, Ctr Expt & Clin Infect Res, TWINCORE, Inst Infect Immunol, D-3000 Hannover, Germany; [Lochner, Matthias] Helmholtz Ctr Infect Res, Hannover, Germany; [Satoh-Takayama, Naoko; Di Santo, James P.] Inst Pasteur, Innate Immun Unit, F-75724 Paris, France; [Satoh-Takayama, Naoko; Di Santo, James P.] INSERM, U668, F-75724 Paris, France; [Fehling, Hans Joerg] Univ Clin Ulm, Inst Immunol, Ulm, Germany; Inst Pasteur, Ctr Ingenieurie Genet Murine, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Ulm University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Eberl, G (corresponding author), Inst Pasteur, Lymphoid Tissue Dev Unit, F-75724 Paris, France.	gerard.eberl@pasteur.fr	Eberl, Gerard/A-1160-2013; Di Santo, James P/M-4298-2014; Lochner, Matthias/L-6963-2015	Di Santo, James P/0000-0002-7146-1862; Lochner, Matthias/0000-0002-7979-5613; Cherrier, Marie/0000-0001-5323-4239; Eberl, Gerard/0000-0002-1119-5638	Institut Pasteur; Mairie de Paris; Agence Nationale de la Recherche; European Commission; Deutsche Forschungsgemeinschaft [FE-578/3-1]; Schlumberger Foundation	Institut Pasteur(European Commission); Mairie de Paris(Region Ile-de-France); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Schlumberger Foundation(Schlumberger)	We thank the members of the Lymphoid Tissue Development lab for discussions and critical reading of the manuscript and L. Polomack, S. Dulauroy, G. Chauveau-Le Friec, and the team of the Centre d'Ingenierie Genetique Murine for technical assistance. We also thank R. Varona for CCR6-deficient mice, I. Gomperts-Boneca for Nod1- and Nod2-deficient mice, and H. Bujard for LC-1-Cre mice. This work was supported by the Institut Pasteur, grants from the Mairie de Paris, the Agence Nationale de la Recherche, and an Excellence Grant from the European Commission. M. L. was supported by the Deutsche Forschungsgemeinschaft and the Schlumberger Foundation. H.J.F. is funded by the Deutsche Forschungsgemeinschaft (FE-578/3-1). The authors have no competing financial interests.	Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Lugering A, 2010, CLIN EXP IMMUNOL, V160, P440, DOI 10.1111/j.1365-2249.2010.04103.x; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nishikawa S, 2000, CURR OPIN IMMUNOL, V12, P342, DOI 10.1016/S0952-7915(00)00097-2; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	30	379	390	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					665	669		10.1126/science.1194597	http://dx.doi.org/10.1126/science.1194597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	20929731				2022-12-28	WOS:000283580600047
J	Neafsey, DE; Lawniczak, MKN; Park, DJ; Redmond, SN; Coulibaly, MB; Traore, SF; Sagnon, N; Costantini, C; Johnson, C; Wiegand, RC; Collins, FH; Lander, ES; Wirth, DF; Kafatos, FC; Besansky, NJ; Christophides, GK; Muskavitch, MAT				Neafsey, D. E.; Lawniczak, M. K. N.; Park, D. J.; Redmond, S. N.; Coulibaly, M. B.; Traore, S. F.; Sagnon, N.; Costantini, C.; Johnson, C.; Wiegand, R. C.; Collins, F. H.; Lander, E. S.; Wirth, D. F.; Kafatos, F. C.; Besansky, N. J.; Christophides, G. K.; Muskavitch, M. A. T.			SNP Genotyping Defines Complex Gene-Flow Boundaries Among African Malaria Vector Mosquitoes	SCIENCE			English	Article							ANOPHELES-GAMBIAE S.S.; INCIPIENT SPECIATION; MOLECULAR-FORMS; DIFFERENTIATION; DIVERGENCE; ISLANDS	Mosquitoes in the Anopheles gambiae complex show rapid ecological and behavioral diversification, traits that promote malaria transmission and complicate vector control efforts. A high-density, genome-wide mosquito SNP-genotyping array allowed mapping of genomic differentiation between populations and species that exhibit varying levels of reproductive isolation. Regions near centromeres or within polymorphic inversions exhibited the greatest genetic divergence, but divergence was also observed elsewhere in the genomes. Signals of natural selection within populations were overrepresented among genomic regions that are differentiated between populations, implying that differentiation is often driven by population-specific selective events. Complex genomic differentiation among speciating vector mosquito populations implies that tools for genome-wide monitoring of population structure will prove useful for the advancement of malaria eradication.	[Neafsey, D. E.; Park, D. J.; Johnson, C.; Wiegand, R. C.; Lander, E. S.; Wirth, D. F.; Muskavitch, M. A. T.] Broad Inst, Cambridge, MA 02142 USA; [Lawniczak, M. K. N.; Redmond, S. N.; Kafatos, F. C.; Christophides, G. K.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Coulibaly, M. B.; Traore, S. F.] Malaria Res & Training Ctr, Bamako, Mali; [Sagnon, N.] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Costantini, C.] Inst Rech Dev, Unite Rech R016, Montpellier, France; [Costantini, C.] Org Coordinat Lutte Endemies Afrique Cent, Yaounde, Cameroon; [Collins, F. H.; Besansky, N. J.] Univ Notre Dame, Notre Dame, IN 46556 USA; [Wirth, D. F.; Muskavitch, M. A. T.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Muskavitch, M. A. T.] Boston Coll, Chestnut Hill, MA 02467 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Imperial College London; Institut de Recherche pour le Developpement (IRD); University of Notre Dame; Harvard University; Harvard T.H. Chan School of Public Health; Boston College	Muskavitch, MAT (corresponding author), Broad Inst, Cambridge, MA 02142 USA.	marc.muskavitch@bc.edu	Costantini, Carlo/F-3470-2012; Coulibaly, Mamadou/AAE-7006-2019	Costantini, Carlo/0000-0003-1016-129X; redmond, seth/0000-0003-2653-760X; Lawniczak, Mara/0000-0002-3006-2080; Christophides, George/0000-0002-3323-1687	Burroughs Wellcome Fund [1008238]; Broad Institute; Wellcome Trust [077229/Z/05/Z]; National Human Genome Research Institute; Harvard School of Public Health Department of Immunology and Infectious Diseases; Biotechnology and Biological Sciences Research Council [BB/E002641/1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; BBSRC [BB/E002641/1] Funding Source: UKRI	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Broad Institute; Wellcome Trust(Wellcome TrustEuropean Commission); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Harvard School of Public Health Department of Immunology and Infectious Diseases; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Burroughs Wellcome Fund Request 1008238, the Broad Institute Director's Fund, the Wellcome Trust Programme grant 077229/Z/05/Z to F.C.K. and G.K.C., National Human Genome Research Institute support to E.S.L., the Harvard School of Public Health Department of Immunology and Infectious Diseases, and the DeLuca Professorship from Boston College to M.A.T.M. In addition, M.K.N.L. was supported by a Biotechnology and Biological Sciences Research Council research grant BB/E002641/1 to G.K.C. Sequencing data for array validation have been deposited in the National Center for Biotechnology Information Short Read Archive with accession numbers SRX005397 to SRX005403. SNPs have been submitted to dbSNP Build B133 (ss/rs numbers in progress) and, meanwhile, are listed in the supporting online material. ArrayExpress accession number: A-AFFY-167.	Besansky NJ, 2003, P NATL ACAD SCI USA, V100, P10818, DOI 10.1073/pnas.1434337100; Butlin RK, 2005, MOL ECOL, V14, P2621, DOI 10.1111/j.1365-294X.2005.02617.x; Cassone BJ, 2008, MOL ECOL, V17, P2491, DOI 10.1111/j.1365-294X.2008.03774.x; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; Coluzzi M., 1982, Progress in Clinical and Biological Research, V96, P143; Curtis C.F., 1982, P290; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; Fanello C, 2003, INSECT MOL BIOL, V12, P241, DOI 10.1046/j.1365-2583.2003.00407.x; Koufopanou V, 2002, MOL BIOL EVOL, V19, P239, DOI 10.1093/oxfordjournals.molbev.a004077; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; Manoukis NC, 2008, P NATL ACAD SCI USA, V105, P2940, DOI 10.1073/pnas.0709806105; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Navarro A, 2003, EVOLUTION, V57, P447, DOI 10.1554/0014-3820(2003)057[0447:APIGIP]2.0.CO;2; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rogers DW, 2008, P NATL ACAD SCI USA, V105, P19390, DOI 10.1073/pnas.0809723105; Slotman M, 2004, GENETICS, V167, P275, DOI 10.1534/genetics.167.1.275; Slotman MA, 2007, MOL ECOL, V16, P639, DOI 10.1111/j.1365-294X.2006.03172.x; Slotman MA, 2006, AM J TROP MED HYG, V74, P641, DOI 10.4269/ajtmh.2006.74.641; Stump AD, 2005, P NATL ACAD SCI USA, V102, P15930, DOI 10.1073/pnas.0508161102; Takken W, 2002, TROP MED INT HEALTH, V7, P1022, DOI 10.1046/j.1365-3156.2002.00983.x; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; White BJ, 2007, PLOS GENET, V3, P2404, DOI 10.1371/journal.pgen.0030217; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269	33	134	134	4	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					514	517		10.1126/science.1193036	http://dx.doi.org/10.1126/science.1193036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966254	Green Published, Green Accepted			2022-12-28	WOS:000283329100043
J	Leon, MB; Smith, CR; Mack, M; Miller, DC; Moses, JW; Svensson, LG; Tuzcu, EM; Webb, JG; Fontana, GP; Makkar, RR; Brown, DL; Block, PC; Guyton, RA; Pichard, AD; Bavaria, JE; Herrmann, HC; Douglas, PS; Petersen, JL; Akin, JJ; Anderson, WN; Wang, DL; Pocock, S				Leon, Martin B.; Smith, Craig R.; Mack, Michael; Miller, D. Craig; Moses, Jeffrey W.; Svensson, Lars G.; Tuzcu, E. Murat; Webb, John G.; Fontana, Gregory P.; Makkar, Raj R.; Brown, David L.; Block, Peter C.; Guyton, Robert A.; Pichard, Augusto D.; Bavaria, Joseph E.; Herrmann, Howard C.; Douglas, Pamela S.; Petersen, John L.; Akin, Jodi J.; Anderson, William N.; Wang, Duolao; Pocock, Stuart		PARTNER Trial Investigators	Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-RISK PATIENTS; THORACIC SURGEONS; ELDERLY-PATIENTS; HEART-VALVE; REPLACEMENT; PROGRESSION; PROSTHESIS; MORTALITY; AGE; FEASIBILITY	Background: Many patients with severe aortic stenosis and coexisting conditions are not candidates for surgical replacement of the aortic valve. Recently, transcatheter aortic-valve implantation (TAVI) has been suggested as a less invasive treatment for high-risk patients with aortic stenosis. Methods: We randomly assigned patients with severe aortic stenosis, whom surgeons considered not to be suitable candidates for surgery, to standard therapy (including balloon aortic valvuloplasty) or transfemoral transcatheter implantation of a balloon-expandable bovine pericardial valve. The primary end point was the rate of death from any cause. Results: A total of 358 patients with aortic stenosis who were not considered to be suitable candidates for surgery underwent randomization at 21 centers (17 in the United States). At 1 year, the rate of death from any cause (Kaplan-Meier analysis) was 30.7% with TAVI, as compared with 50.7% with standard therapy (hazard ratio with TAVI, 0.55; 95% confidence interval [CI], 0.40 to 0.74; P<0.001). The rate of the composite end point of death from any cause or repeat hospitalization was 42.5% with TAVI as compared with 71.6% with standard therapy (hazard ratio, 0.46; 95% CI, 0.35 to 0.59; P<0.001). Among survivors at 1 year, the rate of cardiac symptoms (New York Heart Association class III or IV) was lower among patients who had undergone TAVI than among those who had received standard therapy (25.2% vs. 58.0%, P<0.001). At 30 days, TAVI, as compared with standard therapy, was associated with a higher incidence of major strokes (5.0% vs. 1.1%, P=0.06) and major vascular complications (16.2% vs. 1.1%, P<0.001). In the year after TAVI, there was no deterioration in the functioning of the bioprosthetic valve, as assessed by evidence of stenosis or regurgitation on an echocardiogram. Conclusions: In patients with severe aortic stenosis who were not suitable candidates for surgery, TAVI, as compared with standard therapy, significantly reduced the rates of death from any cause, the composite end point of death from any cause or repeat hospitalization, and cardiac symptoms, despite the higher incidence of major strokes and major vascular events. (Funded by Edwards Lifesciences; ClinicalTrials.gov number, NCT00530894.) N Engl J Med 2010;363:1597-1607.	[Leon, Martin B.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, Ctr Heart, 173 Ft Washington Ave,2nd Fl, New York, NY 10032 USA; [Leon, Martin B.; Smith, Craig R.; Moses, Jeffrey W.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY 10032 USA; [Mack, Michael; Brown, David L.] Med City Dallas, Dallas, TX USA; [Miller, D. Craig] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Akin, Jodi J.; Anderson, William N.] Edwards Lifesci, Irvine, CA USA; [Svensson, Lars G.; Tuzcu, E. Murat] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Webb, John G.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Webb, John G.] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Fontana, Gregory P.; Makkar, Raj R.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Block, Peter C.; Guyton, Robert A.] Emory Univ, Sch Med, Atlanta, GA USA; [Pichard, Augusto D.] Washington Hosp Ctr, Washington, DC 20010 USA; [Bavaria, Joseph E.; Herrmann, Howard C.] Hosp Univ Penn, Philadelphia, PA 19104 USA; [Douglas, Pamela S.; Petersen, John L.] Duke Univ, Med Ctr, Durham, NC USA; [Wang, Duolao; Pocock, Stuart] London Sch Hyg & Trop Med, London, England	Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Medical City Dallas Hospital; Stanford University; Edwards Lifesciences; Cleveland Clinic Foundation; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; Cedars Sinai Medical Center; Emory University; MedStar Washington Hospital Center; University of Pennsylvania; Pennsylvania Medicine; Duke University; University of London; London School of Hygiene & Tropical Medicine	Leon, MB (corresponding author), Columbia Univ, Med Ctr, New York Presbyterian Hosp, Ctr Heart, 173 Ft Washington Ave,2nd Fl, New York, NY 10032 USA.	ml2398@columbia.edu	Asch, Federico/AAS-7653-2021; Doğan, Ali/AAN-5331-2020	Asch, Federico/0000-0002-1744-5271; Douglas, Pamela/0000-0001-9876-4049; Miller, D. Craig/0000-0001-7619-0080	Edwards Lifesciences; Medtronic; St. Jude Medical; Abbott; Lilly; Johnson Johnson; Daiichi Sankyo; Sorin Medical; Direct Flow Medical	Edwards Lifesciences; Medtronic(Medtronic); St. Jude Medical(St. Jude Medical); Abbott(Abbott Laboratories); Lilly(Eli Lilly); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Daiichi Sankyo(Daiichi Sankyo Company Limited); Sorin Medical; Direct Flow Medical	Sponsored by Edwards Lifesciences.r Dr. Leon reports receiving consulting fees from Medtronic and owning stock options in Sadra Medical; Dr. Moses, receiving buyout of options in Heart Leaflet Technologies from Bracco; Dr. Wang, receiving grant support from Edwards Lifesciences; Dr. Mack, receiving lecture fees from Edwards Lifesciences and consulting fees from Medtronic; Dr. Miller, receiving consulting fees from Medtronic and St. Jude Medical; Dr. Webb, receiving grant support, consulting fees, and travel reimbursement from Edwards Lifesciences; Dr. Pocock, receiving grant support and consulting fees from Edwards Lifesciences; Dr. Makkar, receiving consulting fees, grant support, and lecture fees from Abbott, Medtronic, and Lilly, consulting fees and grant support from Johnson & Johnson and Daiichi Sankyo, and grant support from St. Jude Medical; Dr. Fontana, receiving consulting fees and lecture fees from Sorin Medical, consulting fees from and stock options in Entourage Medical Technologies, and consulting fees from St. Jude Medical; Dr. Block, receiving board membership fees from Medtronic and CoreValve, consulting fees from and stock options in Medtronic and Direct Flow Medical, and lecture fees from Edwards Lifesciences; Dr. Pichard, being employed as director of the Catheterization Laboratory at Washington Hospital Center and receiving lecture fees from St. Jude Medical; Dr. Bavaria, receiving grant support from Edwards Lifesciences; Ms. Akin, being employed by, owning stock options in, and receiving travel reimbursement from Edwards Lifesciences; Dr. Anderson, receiving consulting fees from and stock options in Edwards Lifesciences; and Dr. Douglas, receiving grant support from Edwards Lifesciences. No other potential conflict of interest relevant to this article was reported.	Akins CW, 2008, J THORAC CARDIOV SUR, V135, P732, DOI 10.1016/j.jtcvs.2007.12.002; Bach DS, 2009, CIRC-CARDIOVASC QUAL, V2, P533, DOI 10.1161/CIRCOUTCOMES.109.848259; Bonow RO, 2006, CIRCULATION, V118, pe523, DOI DOI 10.1161/CIRCULATI0NAHA.108.190748; Bouma BJ, 1999, HEART, V82, P143, DOI 10.1136/hrt.82.2.143; CHEITLIN MD, 1979, AM HEART J, V98, P689, DOI 10.1016/0002-8703(79)90465-4; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Cribier A, 2004, J AM COLL CARDIOL, V43, P698, DOI 10.1016/j.jacc.2003.11.026; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; Cribier A, 2006, J AM COLL CARDIOL, V47, P1214, DOI 10.1016/j.jacc.2006.01.049; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; DAVIES SW, 1991, EUR HEART J, V12, P10, DOI 10.1093/oxfordjournals.eurheartj.a059815; Dewey TM, 2008, J THORAC CARDIOV SUR, V135, P180, DOI 10.1016/j.jtcvs.2007.09.011; DIEUSANIO M, 2010, J THORAC CARDIO 0702; Finkelstein DM, 1999, STAT MED, V18, P1341, DOI 10.1002/(SICI)1097-0258(19990615)18:11&lt;1341::AID-SIM129&gt;3.0.CO;2-7; Ghanem A, 2010, J AM COLL CARDIOL, V55, P1427, DOI 10.1016/j.jacc.2009.12.026; Grube E, 2006, CIRCULATION, V114, P1616, DOI 10.1161/CIRCULATIONAHA.106.639450; Grube E, 2008, CIRC-CARDIOVASC INTE, V1, P167, DOI 10.1161/CIRCINTERVENTIONS.108.819839; Himbert D, 2009, J AM COLL CARDIOL, V54, P303, DOI 10.1016/j.jacc.2009.04.032; Iung B, 2005, EUR HEART J, V26, P2714, DOI 10.1093/eurheartj/ehi471; Kahlert P, 2010, CIRCULATION, V121, P870, DOI 10.1161/CIRCULATIONAHA.109.855866; KELLY TA, 1988, AM J CARDIOL, V61, P123, DOI 10.1016/0002-9149(88)91317-3; LUND O, 1990, CIRCULATION, V82, P124, DOI 10.1161/01.CIR.82.1.124; MURPHY ES, 1981, CIRCULATION, V64, P184; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; OTTO CM, 1989, J AM COLL CARDIOL, V13, P545, DOI 10.1016/0735-1097(89)90590-1; PETER M, 1993, CHEST, V103, P1715, DOI 10.1378/chest.103.6.1715; Piazza Nicolo, 2008, EuroIntervention, V4, P242, DOI 10.4244/EIJV4I2A43; Rodes-Cabau J, 2010, J AM COLL CARDIOL, V55, P1080, DOI 10.1016/j.jacc.2009.12.014; Ross J Jr, 1968, Circulation, V38, P61; SCHWARZ F, 1982, CIRCULATION, V66, P1105, DOI 10.1161/01.CIR.66.5.1105; Shahian DM, 2009, ANN THORAC SURG, V88, pS43, DOI 10.1016/j.athoracsur.2009.05.055; Shroyer ALW, 2003, ANN THORAC SURG, V75, P1856, DOI 10.1016/S0003-4975(03)00179-6; Svensson LG, 2008, ANN THORAC SURG, V86, P46, DOI 10.1016/j.athoracsur.2008.04.049; Thomas M, 2010, CIRCULATION, V122, P62, DOI 10.1161/CIRCULATIONAHA.109.907402; TURINA J, 1987, EUR HEART J, V8, P471, DOI 10.1093/oxfordjournals.eurheartj.a062307; Varadarajan P, 2006, ANN THORAC SURG, V82, P2111, DOI 10.1016/j.athoracsur.2006.07.048; Walther T, 2007, CIRCULATION, V116, pI240, DOI 10.1161/CIRCULATIONAHA.106.677237; Webb JG, 2006, CIRCULATION, V113, P842, DOI 10.1161/CIRCULATIONAHA.105.582882; Webb JG, 2009, CIRCULATION, V119, P3009, DOI 10.1161/CIRCULATIONAHA.108.837807	39	4980	5157	6	296	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2010	363	17					1597	1607		10.1056/NEJMoa1008232	http://dx.doi.org/10.1056/NEJMoa1008232			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668BD	20961243	Green Accepted			2022-12-28	WOS:000283242700004
J	Rosenzweig, C; Solecki, W; Hammer, SA; Mehrotra, S				Rosenzweig, Cynthia; Solecki, William; Hammer, Stephen A.; Mehrotra, Shagun			Cities lead the way in climate-change action	NATURE			English	Editorial Material									[Rosenzweig, Cynthia] Goddard Inst Space Studies, Climate Impacts Grp, New York, NY 10025 USA; [Solecki, William] CUNY, Inst Sustainable Cities, New York, NY 10065 USA; [Hammer, Stephen A.] Joint US China Collaborat Clean Energy, Energy Smart Cities Initiat, Shanghai 200041, Peoples R China; [Mehrotra, Shagun] Columbia Univ, Earth Inst, Climate & Cities Facil, New York, NY 10027 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; City University of New York (CUNY) System; Columbia University	Rosenzweig, C (corresponding author), Goddard Inst Space Studies, Climate Impacts Grp, New York, NY 10025 USA.	crosenzweig@giss.nasa.gov						Bloomberg MR, 2010, ANN NY ACAD SCI, V1196, P1, DOI [10.1111/j.1749-6632.2009.05415.x, 10.1111/j.1749-6632.2009.05415_1.x]; de Sherbinin A., 2011, CHOICE REV ONLINE; Mehrotra S, 2009, FRAMEWORK CITY CLIMA; Parry M. L., 2007, CLIMATE CHANGE 2007; United Nations, 2009, WORLD POP PROSP 2009; World Bank, 2010, WORLD DEV REP 2010 P	6	439	444	11	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2010	467	7318					909	911		10.1038/467909a	http://dx.doi.org/10.1038/467909a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	668FT	20962822				2022-12-28	WOS:000283254700014
J	Charlesworth, B				Charlesworth, Brian			Variation Catches a Ride	SCIENCE			English	Editorial Material							BACKGROUND SELECTION; HITCHHIKING		Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Charlesworth, B (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland.	brian.charlesworth@ed.ac.uk						CHARLESWORTH B, 1993, GENETICS, V134, P1289; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; HUDSON RR, 1995, GENETICS, V141, P1605; Kimura M., 1983, NEUTRAL THEORY MOL E; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Rockman MV, 2010, SCIENCE, V330, P372, DOI 10.1126/science.1194208; Stephan W, 2010, PHILOS T R SOC B, V365, P1245, DOI 10.1098/rstb.2009.0278	7	3	3	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					326	327		10.1126/science.1197700	http://dx.doi.org/10.1126/science.1197700			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947750				2022-12-28	WOS:000282986700024
J	Arii, J; Goto, H; Suenaga, T; Oyama, M; Kozuka-Hata, H; Imai, T; Minowa, A; Akashi, H; Arase, H; Kawaoka, Y; Kawaguchi, Y				Arii, Jun; Goto, Hideo; Suenaga, Tadahiro; Oyama, Masaaki; Kozuka-Hata, Hiroko; Imai, Takahiko; Minowa, Atsuko; Akashi, Hiroomi; Arase, Hisashi; Kawaoka, Yoshihiro; Kawaguchi, Yasushi			Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1	NATURE			English	Article							LIGHT-CHAIN KINASE; CATALYTIC-ACTIVITY; CELL-FUSION; GLYCOPROTEINS GB; MEMBRANE-FUSION; IN-VITRO; PROTEIN; ACTIVATION; ALPHA; US3	Herpes simplex virus-1 (HSV-1), the prototype of the a-herpesvirus family, causes life-long infections in humans. Although generally associated with various mucocutaneous diseases, HSV-1 is also involved in lethal encephalitis(1). HSV-1 entry into host cells requires cellular receptors for both envelope glycoproteins B (gB) and D (gD)(2-4). However, the gB receptors responsible for its broad host range in vitro and infection of critical targets in vivo1 remain unknown. Here we show that non-muscle myosin heavy chain IIA (NMHC-IIA), a subunit of non-muscle myosin IIA (NM-IIA), functions as an HSV-1 entry receptor by interacting with gB. A cell line that is relatively resistant to HSV-1 infection(5) became highly susceptible to infection by this virus when NMHC-IIA was overexpressed. Antibody to NMHC-IIA blocked HSV-1 infection in naturally permissive target cells. Furthermore, knockdown of NMHC-IIA in the permissive cells inhibited HSV-1 infection as well as cell-cell fusion when gB, gD, gH and gL were coexpressed. Cell-surface expression of NMHC-IIA was markedly and rapidly induced during the initiation of HSV-1 entry. A specific inhibitor of myosin light chain kinase, which regulates NM-IIA by phosphorylation(6), reduced the redistribution of NMHC-IIA as well as HSV-1 infection in cell culture and in a murine model for herpes stromal keratitis. NMHC-IIA is ubiquitously expressed in various human tissues and cell types(7) and, therefore, is implicated as a functional gB receptor that mediates broad HSV-1 infectivity both in vitro and in vivo. The identification of NMHC-IIA as an HSV-1 entry receptor and the involvement of NM-IIA regulation in HSV-1 infection provide an insight into HSV-1 entry and identify new targets for antiviral drug development.	[Arii, Jun; Imai, Takahiko; Minowa, Atsuko; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis,Div Viral Infect, Dept Infect Dis Control,Minato Ku, Tokyo 1088639, Japan; [Arii, Jun; Akashi, Hiroomi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, Tokyo 1138657, Japan; [Goto, Hideo; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol,Minato Ku, Tokyo 1088639, Japan; [Suenaga, Tadahiro; Arase, Hisashi] Osaka Univ, Microbial Dis Res Inst, Dept Immunochem, Suita, Osaka 5650871, Japan; [Oyama, Masaaki; Kozuka-Hata, Hiroko] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo 1088639, Japan; [Arase, Hisashi] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Arase, Hisashi] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens,Minato Ku, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53711 USA; [Kawaoka, Yoshihiro] ERATO Infect Induced Host Responses Project, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Osaka University; University of Tokyo; Osaka University; Japan Science & Technology Agency (JST); University of Tokyo; University of Wisconsin System; University of Wisconsin Madison; Japan Science & Technology Agency (JST)	Kawaguchi, Y (corresponding author), Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis,Div Viral Infect, Dept Infect Dis Control,Minato Ku, Tokyo 1088639, Japan.	ykawagu@ims.u-tokyo.ac.jp	Arase, Hisashi/C-8442-2009	Arase, Hisashi/0000-0002-1153-3166; Kawaguchi, Yasushi/0000-0001-8232-6925; Kozuka-Hata, Hiroko/0000-0002-9286-6594; Oyama, Masaaki/0000-0001-6478-3735	Japan Initiative for Global Research Network on Infectious Diseases; Founding Research Center for Emerging; Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health of Japan; Takeda Science Foundation; ERATO (Japan Science and Technology Agency); Japan Society for the Promotion of Science	Japan Initiative for Global Research Network on Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Founding Research Center for Emerging; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health of Japan; Takeda Science Foundation(Takeda Science Foundation (TSF)); ERATO (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank P. G. Spear, L. W. Enquist, Y. Matsuura, N. Mizushima, S. Sugano, R. Adelstein, T. Ichimura, K. Araki-Sasaki, Y. Mori and M. Takahashi for providing reagents, S. Koyama for technical assistance and K. Wells and S. Watson for critical reading of this manuscript. This study was supported by Grants-in-aid for Scientific Research, Grants-in-aid for Scientific Research in Priority Areas, Grants-in-aid for Specially Promoted Research, and contract research funds for the Program of Japan Initiative for Global Research Network on Infectious Diseases and the Program of Founding Research Center for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Science, Sports and Culture of Japan, by Grants-in-aid from the Ministry of Health of Japan, by grants from the Takeda Science Foundation, and by ERATO (Japan Science and Technology Agency). J. A. was supported by research fellowships from the Japan Society for the Promotion of Science by Young Scientists.	[Anonymous], 2007, FIELDS VIROLOGY; Arii J, 2009, J VIROL, V83, P4520, DOI 10.1128/JVI.02601-08; Balliet JW, 2006, J VIROL, V80, P440, DOI 10.1128/JVI.80.1.440-450.2006; Bender FC, 2003, J VIROL, V77, P9542, DOI 10.1128/JVI.77.17.9542-9552.2003; CHAMSAI PT, 1989, VIROLOGY, V170, P468, DOI 10.1016/0042-6822(89)90438-8; Cheshenko N, 2003, J CELL BIOL, V163, P283, DOI 10.1083/jcb.200301084; Demmin GL, 2001, J VIROL, V75, P10856, DOI 10.1128/JVI.75.22.10856-10869.2001; Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Haraguchi T, 2007, FEBS LETT, V581, P4949, DOI 10.1016/j.febslet.2007.09.028; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kato A, 2008, J VIROL, V82, P6172, DOI 10.1128/JVI.00044-08; Kawaguchi Y, 1997, J VIROL, V71, P1019, DOI 10.1128/JVI.71.2.1019-1024.1997; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; LI DQ, 1994, P NATL ACAD SCI USA, V91, P853, DOI 10.1073/pnas.91.3.853; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Okuma K, 1999, VIROLOGY, V254, P235, DOI 10.1006/viro.1998.9530; OLDEN K, 1976, CELL, V8, P383, DOI 10.1016/0092-8674(76)90150-1; Oyama M, 2009, MOL CELL PROTEOMICS, V8, P226, DOI 10.1074/mcp.M800186-MCP200; Pertel PE, 2001, VIROLOGY, V279, P313, DOI 10.1006/viro.2000.0713; Polcicova K, 2005, P NATL ACAD SCI USA, V102, P11462, DOI 10.1073/pnas.0503230102; Sagou K, 2009, J VIROL, V83, P5773, DOI 10.1128/JVI.00103-09; SAITOH M, 1987, J BIOL CHEM, V262, P7796; SARMIENTO M, 1979, J VIROL, V29, P1149, DOI 10.1128/JVI.29.3.1149-1158.1979; Sato MK, 2007, MOL BIOL CELL, V18, P1009, DOI 10.1091/mbc.E06-08-0706; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Shimizu S, 2006, J PHYSIOL-LONDON, V570, P219, DOI 10.1113/jphysiol.2005.097998; Spear PG, 2006, VIROLOGY, V344, P17, DOI 10.1016/j.virol.2005.09.016; Suenaga T, 2010, P NATL ACAD SCI USA, V107, P866, DOI 10.1073/pnas.0913351107; TOOTHAKER LE, 1991, BLOOD, V78, P1826; Turner A, 1998, J VIROL, V72, P873, DOI 10.1128/JVI.72.1.873-875.1998; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590	34	158	173	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					859	U129		10.1038/nature09420	http://dx.doi.org/10.1038/nature09420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944748				2022-12-28	WOS:000282898700070
J	Lane, NE; Schnitzer, TJ; Birbara, CA; Mokhtarani, M; Shelton, DL; Smith, MD; Brown, MT				Lane, Nancy E.; Schnitzer, Thomas J.; Birbara, Charles A.; Mokhtarani, Masoud; Shelton, David L.; Smith, Mike D.; Brown, Mark T.			Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NERVE GROWTH-FACTOR; CLINICAL-TRIALS; NGF; METAANALYSIS; ARTHRITIS; AFFINITY; CRITERIA; RECEPTOR; SULFATE; DRUGS	BACKGROUND Increased expression of nerve growth factor in injured or inflamed tissue is associated with increased pain. This proof-of-concept study was designed to investigate the safety and analgesic efficacy of tanezumab, a humanized monoclonal antibody that binds and inhibits nerve growth factor. METHODS We randomly assigned 450 patients with osteoarthritis of the knee to receive tanezumab (administered at a dose of 10, 25, 50, 100, or 200 mu g per kilogram of body weight) or placebo on days 1 and 56. The primary efficacy measures were knee pain while walking and the patient's global assessment of response to therapy. We also assessed pain, stiffness, and physical function using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC); the rate of response using the criteria of the Outcome Measures for Rheumatology Committee and Osteoarthritis Research Society International Standing Committee for Clinical Trials Response Criteria Initiative (OMERACT-OARSI); and safety. RESULTS When averaged over weeks 1 through 16, the mean reductions from baseline in knee pain while walking ranged from 45 to 62% with various doses of tanezumab, as compared with 22% with placebo (P<0.001). Tanezumab, as compared with placebo, was also associated with significantly greater improvements in the response to therapy as assessed with the use of the patients' global assessment measure (mean increases in score of 29 to 47% with various doses of tanezumab, as compared with 19% with placebo; P <= 0.001). The rate of response according to the OMERACT-OARSI criteria ranged from 74 to 93% with tanezumab treatment, as compared with 44% with placebo (P<0.001). The rates of adverse events were 68% and 55% in the tanezumab and placebo groups, respectively. The most common adverse events among tanezumab-treated patients were headache (9% of the patients), upper respiratory tract infection (7%), and paresthesia (7%). CONCLUSIONS In this proof-of-concept study, treatment with tanezumab was associated with a reduction in joint pain and improvement in function, with mild and moderate adverse events, among patients with moderate-to-severe osteoarthritis of the knee.	[Lane, Nancy E.] Univ Calif Davis, Sch Med, Dept Med, Sacramento, CA 95817 USA; [Schnitzer, Thomas J.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Birbara, Charles A.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Mokhtarani, Masoud; Shelton, David L.] Rinat Neurosci, San Francisco, CA USA; [Smith, Mike D.; Brown, Mark T.] Pfizer, New London, CT USA	University of California System; University of California Davis; Northwestern University; Feinberg School of Medicine; University of Massachusetts System; University of Massachusetts Worcester; Pfizer	Lane, NE (corresponding author), Univ Calif Davis, Sch Med, Dept Med, 4800 2nd Ave,Suite 2600, Sacramento, CA 95817 USA.	nelane@ucdavis.edu			Rinat Neuroscience, Pfizer; Pfizer; National Institutes of Health [K24-AR04884]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR048841] Funding Source: NIH RePORTER	Rinat Neuroscience, Pfizer(Pfizer); Pfizer(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by Rinat Neuroscience, now a subsidiary of Pfizer. Editorial support was provided by Papia Das and Elizabeth Young of UBC Scientific Solutions and was funded by Pfizer. Dr. Lane was also supported by a grant (K24-AR04884) from the National Institutes of Health.	Abdiche YN, 2008, PROTEIN SCI, V17, P1326, DOI 10.1110/ps.035402.108; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; BARKER PA, 1992, MOL CELL BIOCHEM, V110, P1, DOI 10.1007/BF02385000; Bjordal JM, 2007, EUR J PAIN, V11, P125, DOI 10.1016/j.ejpain.2006.02.013; Bjordal JM, 2004, BMJ-BRIT MED J, V329, P1317, DOI 10.1136/bmj.38273.626655.63; Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Dray A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2178; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Frade JM, 1998, BIOESSAYS, V20, P137, DOI 10.1002/(SICI)1521-1878(199802)20:2<137::AID-BIES6>3.0.CO;2-Q; Friess H, 1999, ANN SURG, V230, P615, DOI 10.1097/00000658-199911000-00002; Halliday DA, 1998, NEUROCHEM RES, V23, P919, DOI 10.1023/A:1022475432077; Hao JX, 2000, NEUROSCI LETT, V286, P208, DOI 10.1016/S0304-3940(00)01107-1; Hawker GA, 2006, CURR OPIN RHEUMATOL, V18, P526; HEFTI F, 2006, J PAIN, V7, pS45; Hefti FF, 2006, TRENDS PHARMACOL SCI, V27, P85, DOI 10.1016/j.tips.2005.12.001; Johnsen SP, 2005, ARCH INTERN MED, V165, P978, DOI 10.1001/archinte.165.9.978; Kahan A, 2009, ARTHRITIS RHEUM-US, V60, P524, DOI 10.1002/art.24255; Lane N, 2005, ARTHRITIS RHEUM-US, V52, pS461; McMahon SB, 1996, PHILOS T R SOC B, V351, P431, DOI 10.1098/rstb.1996.0039; MCMAHON SB, 1995, NAT MED, V1, P774, DOI 10.1038/nm0895-774; Miller LJ, 2002, UROLOGY, V59, P603, DOI 10.1016/S0090-4295(01)01597-7; Nicol GD, 2007, MOL INTERV, V7, P26, DOI 10.1124/mi.7.1.6; Petruska JC, 2004, NEUROSCI LETT, V361, P168, DOI 10.1016/j.neulet.2003.12.012; Pham T, 2004, OSTEOARTHR CARTILAGE, V12, P389, DOI 10.1016/j.joca.2004.02.001; Ramer MS, 1999, EUR J NEUROSCI, V11, P837, DOI 10.1046/j.1460-9568.1999.00491.x; Rowbotham MC, 2001, PAIN, V94, P131, DOI 10.1016/S0304-3959(01)00371-2; Ruiz G, 2004, BRAIN RES, V1011, P1, DOI 10.1016/j.brainres.2004.02.001; Salaffi F, 2004, EUR J PAIN, V8, P283, DOI 10.1016/j.ejpain.2003.09.004; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; SHELTON DL, 2008, ANESTHESIOLOGY, V109, pA597; Skaper SD, 2008, CNS NEUROL DISORD-DR, V7, P46, DOI 10.2174/187152708783885174; Whelton A, 2000, Am J Ther, V7, P63, DOI 10.1097/00045391-200007020-00004; WOOLF CJ, 1994, NEUROSCIENCE, V62, P327, DOI 10.1016/0306-4522(94)90366-2; Zahn PK, 2004, J PAIN, V5, P157, DOI 10.1016/j.jpain.2004.02.538; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013	38	465	491	2	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2010	363	16					1521	1531		10.1056/NEJMoa0901510	http://dx.doi.org/10.1056/NEJMoa0901510			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663KP	20942668	Green Accepted, Bronze			2022-12-28	WOS:000282887100006
J	Ling, W; Casadonte, P; Bigelow, G; Kampman, KM; Patkar, A; Bailey, GL; Rosenthal, RN; Beebe, KL				Ling, Walter; Casadonte, Paul; Bigelow, George; Kampman, Kyle M.; Patkar, Ashwin; Bailey, Genie L.; Rosenthal, Richard N.; Beebe, Katherine L.			Buprenorphine Implants for Treatment of Opioid Dependence A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METHADONE-MAINTENANCE; OPIATE ADDICTION; INJECTION; MORTALITY; IV	Context Limitations of existing pharmacological treatments for opioid dependence include low adherence, medication diversion, and emergence of withdrawal symptoms. Objective To determine the efficacy of buprenorphine implants that provide a low, steady level of buprenorphine over 6 months for the treatment of opioid dependence. Design, Setting, and Participants A randomized, placebo-controlled, 6-month trial conducted at 18 sites in the United States between April 2007 and June 2008. One hundred sixty-three adults, aged 18 to 65 years, diagnosed with opioid dependence. One hundred eight were randomized to receive buprenorphine implants and 55 to receive placebo implants. Intervention After induction with sublingual buprenorphine-naloxone tablets, patients received either 4 buprenorphine implants (80 mg per implant) or 4 placebo implants. A fifth implant was available if a threshold for rescue use of sublingual buprenorphine-naloxone treatment was exceeded. Standardized individual drug counseling was provided to all patients. Main Outcome Measure The percentage of urine samples negative for illicit opioids for weeks 1 through 16 and for weeks 17 through 24. Results The buprenorphine implant group had significantly more urine samples negative for illicit opioids during weeks 1 through 16 (P=.04). Patients with buprenorphine implants had a mean percentage of urine samples that tested negative for illicit opioids across weeks 1 through 16 of 40.4% (95% confidence interval [CI], 34.2%-46.7%) and a median of 40.7%; whereas those in the placebo group had a mean of 28.3% (95% CI, 20.3%-36.3%) and a median of 20.8%. A total of 71 of 108 patients (65.7%) who received buprenorphine implants completed the study vs 17 of 55 (30.9%) who received placebo implants (P<.001). Those who received buprenorphine implants also had fewer clinician-rated (P<.001) and patient-rated (P=.004) withdrawal symptoms, had lower patient ratings of craving (P<.001), and experienced a greater change on clinician global ratings of severity of opioid dependence (P<.001) and on the clinician global ratings of improvement (P<.001) than those who received placebo implants. Minor implant site reactions were the most common adverse events: 61 patients (56.5%) in the buprenorphine group and 29 (52.7%) in the placebo group. Conclusion Among persons with opioid dependence, the use of buprenorphine implants compared with placebo resulted in less opioid use over 16 weeks as assessed by urine samples. Trial Registration clinicaltrials.gov Identifier: NCT00447564 JAMA. 2010;304(14):1576-1583 www.jama.com	[Ling, Walter] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, UCLA Integrated Subst Abuse Programs, Los Angeles, CA 90025 USA; [Casadonte, Paul] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Bigelow, George] Johns Hopkins Univ, Sch Med, Behav Pharmacol Res Unit, Baltimore, MD USA; [Kampman, Kyle M.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Patkar, Ashwin] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [Bailey, Genie L.] Brown Univ, Dept Psychiat & Human Behav, Warren Alpert Med Sch, Providence, RI 02912 USA; [Rosenthal, Richard N.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Beebe, Katherine L.] Titan Pharmaceut, San Francisco, CA USA	University of California System; University of California Los Angeles; New York University; Johns Hopkins University; University of Pennsylvania; Duke University; Brown University; Columbia University	Ling, W (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, UCLA Integrated Subst Abuse Programs, 11075 Santa Monica Blvd,200, Los Angeles, CA 90025 USA.	lwalter@ucla.edu	Rosenthal, Richard Nelson/AAD-3629-2022; Rosenthal, Richard/GSN-2347-2022	Rosenthal, Richard Nelson/0000-0002-6011-809X; , Walter/0000-0003-0664-5099	Reckitt Benckiser; Titan; Hythiam; Abbott Laboratories; Acura Pharmaceuticals; Takeda Pharmaceuticals; Teva Pharmaceuticals; Pain Therapeutics Inc.; National Institutes of Health; Substance Abuse and Mental Health Services Administration; AstraZeneca; Bristol-Myers Squibb; Cephalon; Forest; GlaxoSmithKline; J J; Jazz Pharmaceuticals; Lundbeck; McNeil Inc; Organon; Pfizer; Shire; Titan Pharmaceuticals	Reckitt Benckiser; Titan; Hythiam; Abbott Laboratories(Abbott Laboratories); Acura Pharmaceuticals; Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Teva Pharmaceuticals(Teva Pharmaceutical Industries); Pain Therapeutics Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Substance Abuse and Mental Health Services Administration(United States Department of Health & Human Services); AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Cephalon; Forest; GlaxoSmithKline(GlaxoSmithKline); J J; Jazz Pharmaceuticals(Jazz Pharmaceuticals); Lundbeck(Lundbeck Corporation); McNeil Inc; Organon; Pfizer(Pfizer); Shire; Titan Pharmaceuticals	Dr Ling reports receiving research support from Reckitt Benckiser, Titan, and Hythiam; speaker fees from Reckitt Benckiser; and is a member of the Advisory Board of US World Med. Dr Casadonte reports being a paid mentor in the Physician Clinical Support System for training physicians in buprenorphine and his university has received research support from Titan. Dr Bigelow reports no conflicts relevant to this study. In recent years he has received consulting payments from Abbott Laboratories, Acura Pharmaceuticals, Takeda Pharmaceuticals, and Teva Pharmaceuticals, and through his university has received research support from Titan and Pain Therapeutics Inc. Dr Kampman reports receiving honoraria from Reckitt Benckiser and through his University has received research support from Titan. Dr Patkar reports receiving research grant support from the National Institutes of Health, Substance Abuse and Mental Health Services Administration, AstraZeneca, Bristol-Myers Squibb, Cephalon, Forest, GlaxoSmithKline, J & J, Jazz Pharmaceuticals, Lundbeck, McNeil Inc, Organon, Pfizer, Shire, and Titan Pharmaceuticals; having been a consultant to Bristol-Myers Squibb, GlaxoSmithKline, Cephalon/Alkermes, and Reckitt Benckiser; and having been on the speaker's bureau for Bristol-Myers Squibb, Cephalon, Alkermes, Merck, Pfizer, and Reckitt Benckiser. Dr Bailey reports having been on the speaker's bureaus of Forest and Pfizer and having received research support from Titan and Alkermes. Dr Rosenthal reports receiving research support from National Institute on Drug Abuse and Titan. Dr Beebe is an employee of Titan Pharmaceuticals.; This study was funded by Titan Pharmaceuticals.	Aceijas C, 2004, AIDS, V18, P2295, DOI 10.1097/00002030-200411190-00010; Alho H, 2007, DRUG ALCOHOL DEPEN, V88, P75, DOI 10.1016/j.drugalcdep.2006.09.012; Bell J, 2009, ADDICTION, V104, P1193, DOI 10.1111/j.1360-0443.2009.02627.x; Bell JR, 2009, DRUG ALCOHOL DEPEN, V104, P73, DOI 10.1016/j.drugalcdep.2009.03.020; Bruce RD, 2009, AM J DRUG ALCOHOL AB, V35, P68, DOI 10.1080/00952990802585406; Elkader A, 2005, CLIN PHARMACOKINET, V44, P661, DOI 10.2165/00003088-200544070-00001; English D.R., 1995, QUANTIFICATION DRUG; Fischer G, 1999, ADDICTION, V94, P1337, DOI 10.1046/j.1360-0443.1999.94913376.x; Fudala PJ, 2003, NEW ENGL J MED, V349, P949, DOI 10.1056/NEJMoa022164; Gowing L, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002025.PUB4; Guy W., 1976, DHEW PUBL; HANDELSMAN L, 1987, AM J DRUG ALCOHOL AB, V13, P293, DOI 10.3109/00952998709001515; Kakko J, 2007, AM J PSYCHIAT, V164, P797, DOI 10.1176/appi.ajp.164.5.797; Luty J, 2005, BMJ-BRIT MED J, V331, P1352, DOI 10.1136/bmj.331.7529.1352; Marsch LA, 1998, ADDICTION, V93, P515, DOI 10.1046/j.1360-0443.1998.9345157.x; Mercer D.E., 1999, NIH PUBLICATION; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Strain EC, 1996, J CLIN PSYCHOPHARM, V16, P58, DOI 10.1097/00004714-199602000-00010; Substance Abuse and Mental Health Services Administration, 2009, RES 2008 NAT SURV DR; VANELTEREN P, 1960, B INT STATIST INST, V37, P351; Wesson DR, 2003, J PSYCHOACTIVE DRUGS, V35, P253, DOI 10.1080/02791072.2003.10400007; White J, 2009, DRUG ALCOHOL DEPEN, V103, P37, DOI 10.1016/j.drugalcdep.2009.03.008; Winstock AR, 2008, INT J DRUG POLICY, V19, P450, DOI 10.1016/j.drugpo.2007.03.002	23	101	105	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1576	1583		10.1001/jama.2010.1427	http://dx.doi.org/10.1001/jama.2010.1427			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940383	Bronze			2022-12-28	WOS:000282816500022
J	Navrotsky, A; Ma, CC; Lilova, K; Birkner, N				Navrotsky, Alexandra; Ma, Chengcheng; Lilova, Kristina; Birkner, Nancy			Nanophase Transition Metal Oxides Show Large Thermodynamically Driven Shifts in Oxidation-Reduction Equilibria	SCIENCE			English	Article							TEMPERATURE; ENERGETICS; STABILITY; ENERGIES	Knowing the thermodynamic stability of transition metal oxide nanoparticles is important for understanding and controlling their role in a variety of industrial and environmental systems. Using calorimetric data on surface energies for cobalt, iron, manganese, and nickel oxide systems, we show that surface energy strongly influences their redox equilibria and phase stability. Spinels (M3O4) commonly have lower surface energies than metals (M), rocksalt oxides (MO), and trivalent oxides (M2O3) of the same metal; thus, the contraction of the stability field of the divalent oxide and expansion of the spinel field appear to be general phenomena. Using tabulated thermodynamic data for bulk phases to calculate redox phase equilibria at the nanoscale can lead to errors of several orders of magnitude in oxygen fugacity and of 100 to 200 kelvin in temperature.	[Navrotsky, Alexandra; Ma, Chengcheng; Lilova, Kristina; Birkner, Nancy] Univ Calif Davis, Agr & Technol Organized Res Unit, Peter A Rock Thermochem Lab & Nanomat Environm, Davis, CA 95616 USA	University of California System; University of California Davis	Navrotsky, A (corresponding author), Univ Calif Davis, Agr & Technol Organized Res Unit, Peter A Rock Thermochem Lab & Nanomat Environm, Davis, CA 95616 USA.	anavrotsky@ucdavis.edu	Birkner, Nancy/AAF-2615-2020; Birkner, Nancy/N-2900-2015	Lilova, Kristina/0000-0002-9433-3310; Birkner, Nancy/0000-0001-8347-4380	U.S. Department of Energy [DE-FGO2-05ER1S667, DE-FGO2-07ER14749]	U.S. Department of Energy(United States Department of Energy (DOE))	The work received support from the U.S. Department of Energy, grants DE-FGO2-05ER1S667 (Co-O and Ni-O) and DE-FGO2-07ER14749 (Fe-O and Mn-O). We thank H. Ma, B. Olsen, B. Woodfield, W. Casey, and Y. Du for technical assistance and valuable discussion.	Bomati-Miguel O, 2008, CHEM MATER, V20, P591, DOI 10.1021/cm071178o; Castro RHR, 2006, CHEM MATER, V18, P1867, DOI 10.1021/cm052599d; Chen CJ, 2010, J PHYS CHEM C, V114, P4258, DOI 10.1021/jp908153y; DAVIES PK, 1986, J AM CERAM SOC, V69, pC124, DOI 10.1111/j.1151-2916.1986.tb07457.x; Dietl T, 2000, SCIENCE, V287, P1019, DOI 10.1126/science.287.5455.1019; Feng J., 2009, ANGEW CHEM, V121, P1873; HARMER MP, 1983, J AM CERAM SOC, V66, pC44, DOI 10.1111/j.1151-2916.1983.tb10031.x; Kanan MW, 2008, SCIENCE, V321, P1072, DOI 10.1126/science.1162018; Kashefi K, 2003, SCIENCE, V301, P934, DOI 10.1126/science.1086823; Majzlan J, 2003, AM MINERAL, V88, P846; MAJZLAN J, 2003, THESIS U CALIFORNIA; McHale JM, 1997, SCIENCE, V277, P788, DOI 10.1126/science.277.5327.788; McHale JM, 1998, CHEM MATER, V10, P1083, DOI 10.1021/cm9706659; MEHANDJIEV D, 1980, THERMOCHIM ACTA, V37, P145, DOI 10.1016/0040-6031(80)80035-9; Mozaffari M, 2009, J MAGN MAGN MATER, V321, P2981, DOI 10.1016/j.jmmm.2009.04.034; Navrotsky A, 2008, SCIENCE, V319, P1635, DOI 10.1126/science.1148614; Navrotsky A, 2007, J CHEM THERMODYN, V39, P1, DOI 10.1016/j.jct.2006.09.011; Papaefthymiou GC, 2009, NANO TODAY, V4, P438, DOI 10.1016/j.nantod.2009.08.006; Ranade MR, 2002, P NATL ACAD SCI USA, V99, P6476, DOI 10.1073/pnas.251534898; Robie R. A., 1979, USGS BULL, V1452, DOI DOI 10.3133/B2131; Stern K. H., 2000, HIGH TEMPERATURE PRO, P17; TYSON WR, 1977, SURF SCI, V62, P267, DOI 10.1016/0039-6028(77)90442-3; Ueda K, 2001, APPL PHYS LETT, V79, P988, DOI 10.1063/1.1384478; Wang L, 2004, CHEM MATER, V16, P5394, DOI 10.1021/cm049040i; Welch SA, 2002, GEOCHIM COSMOCHIM AC, V66, P213, DOI 10.1016/S0016-7037(01)00771-2; Xie XW, 2009, NATURE, V458, P746, DOI 10.1038/nature07877	26	255	255	9	209	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2010	330	6001					199	201		10.1126/science.1195875	http://dx.doi.org/10.1126/science.1195875			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929770				2022-12-28	WOS:000282644600035
J	Vaaje-Kolstad, G; Westereng, B; Horn, SJ; Liu, ZL; Zhai, H; Sorlie, M; Eijsink, VGH				Vaaje-Kolstad, Gustav; Westereng, Bjorge; Horn, Svein J.; Liu, Zhanliang; Zhai, Hong; Sorlie, Morten; Eijsink, Vincent G. H.			An Oxidative Enzyme Boosting the Enzymatic Conversion of Recalcitrant Polysaccharides	SCIENCE			English	Article							BINDING PROTEIN CBP21; GLYCOSIDE HYDROLASE FAMILY; SERRATIA-MARCESCENS; BIOFUELS	Efficient enzymatic conversion of crystalline polysaccharides is crucial for an economically and environmentally sustainable bioeconomy but remains unfavorably inefficient. We describe an enzyme that acts on the surface of crystalline chitin, where it introduces chain breaks and generates oxidized chain ends, thus promoting further degradation by chitinases. This enzymatic activity was discovered and further characterized by using mass spectrometry and chromatographic separation methods to detect oxidized products generated in the absence or presence of H(2)(18)O or (18)O(2). There are strong indications that similar enzymes exist that work on cellulose. Our findings not only demonstrate the existence of a hitherto unknown enzyme activity but also provide new avenues toward more efficient enzymatic conversion of biomass.	[Vaaje-Kolstad, Gustav; Westereng, Bjorge; Horn, Svein J.; Liu, Zhanliang; Zhai, Hong; Sorlie, Morten; Eijsink, Vincent G. H.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway	Norwegian University of Life Sciences	Eijsink, VGH (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, POB 5003, N-1432 As, Norway.	vincent.eijsink@umb.no	Horn, Svein/F-9723-2010; Westereng, Bjørge/A-1688-2013; Horn, Svein Jarle/C-6258-2008	Westereng, Bjørge/0000-0002-5141-7231; Horn, Svein Jarle/0000-0002-1590-9001; Vaaje-Kolstad, Gustav/0000-0002-3077-8003	Norwegian Research Council [171991/V40, 164653, 186946/I30, 190877/S60]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	We thank A. C. Bunaes for technical assistance and G. Vriend for helpful discussions. This work was supported by Norwegian Research Council grants 171991/V40, 164653, 186946/I30, and 190877/S60.	Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Davies GJ, 2003, BIOCHEM SOC T, V31, P523, DOI 10.1042/BST0310523; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; Fetzner S, 2010, APPL MICROBIOL BIOT, V86, P791, DOI 10.1007/s00253-010-2455-0; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Karkehabadi S, 2008, J MOL BIOL, V383, P144, DOI 10.1016/j.jmb.2008.08.016; Moser F, 2008, BIOTECHNOL BIOENG, V100, P1066, DOI 10.1002/bit.21856; REESE ET, 1950, J BACTERIOL, V59, P485, DOI 10.1128/JB.59.4.485-497.1950; Suzuki K, 1998, BIOSCI BIOTECH BIOCH, V62, P128, DOI 10.1271/bbb.62.128; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010	14	820	856	21	418	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					219	222		10.1126/science.1192231	http://dx.doi.org/10.1126/science.1192231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929773				2022-12-28	WOS:000282644600041
J	Mahadevan, MS				Mahadevan, Mani S.			Exposing a DUX Tale	SCIENCE			English	Editorial Material							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; ENCODES; GENE		Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia	Mahadevan, MS (corresponding author), Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA.	mahadevan@virginia.edu						Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Bosnakovski D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007003; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; de Greef JC, 2009, HUM MUTAT, V30, P1449, DOI 10.1002/humu.21091; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; LEMMERS RJL, SCIENCE, V329, P1650, DOI DOI 10.11256/SCIENCE.1189044; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522	9	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1607	1608		10.1126/science.1195984	http://dx.doi.org/10.1126/science.1195984			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929834				2022-12-28	WOS:000282098100026
J	Hupfl, M; Selig, HF; Nagele, P				Huepfl, Michael; Selig, Harald F.; Nagele, Peter			Chest-compression-only versus standard cardiopulmonary resuscitation: a meta-analysis	LANCET			English	Article							BASIC LIFE-SUPPORT; HOSPITAL CARDIAC ARRESTS; SURVIVAL; CPR	Background In out-of-hospital cardiac arrest, dispatcher-assisted chest-compression-only bystander CPR might be superior to standard bystander CPR (chest compression plus rescue ventilation), but trial findings have not shown significantly improved outcomes. We aimed to establish the association of chest-compression-only CPR with survival in patients with out-of-hospital cardiac arrest. Methods Medline and Embase were systematically reviewed for studies published between January, 1985, and August, 2010, in which chest-compression-only bystander CPR was compared with standard bystander CPR for adult patients with out-of-hospital cardiac arrest. In the primary meta-analysis, we included trials in which patients were randomly allocated to receive one of the two CPR techniques, according to dispatcher instructions; and in the secondary meta-analysis, we included observational cohort studies of chest-compression-only CPR. All studies had to supply survival data. The primary outcome was survival to hospital discharge. A fixed-effects model was used for both meta-analyses because of an absence of heterogeneity among the studies (I-2=0%). Findings In the primary meta-analysis, pooled data from three randomised trials showed that chest-compression-only CPR was associated with improved chance of survival compared with standard CPR (14% [211/1500] vs 12% [178/1531]; risk ratio 1.22, 95% CI 1.01-1.46). The absolute increase in survival was 2.4% (95% CI 0.1-4.9), and the number needed to treat was 41 (95% CI 20-1250). In the secondary meta-analysis of seven observational cohort studies, no difference was recorded between the two CPR techniques (8% [223/2731] vs 8% [863/11 152]; risk ratio 0.96, 95% CI 0.83-1.11). Interpretation For adults with out-of-hospital cardiac arrest, instructions to bystanders from emergency medical services dispatch should focus on chest-compression-only CPR.	[Nagele, Peter] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Huepfl, Michael; Selig, Harald F.] Med Univ Vienna, Dept Anesthesiol Crit Care & Pain Therapy, Vienna, Austria	Washington University (WUSTL); Medical University of Vienna	Nagele, P (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, 660 S Euclid Ave,Box 8054, St Louis, MO 63110 USA.	nagelep@wustl.edu	Nagele, Peter/AAW-1651-2020; Nagele, Peter/A-2922-2008; Nagele, Peter/ABA-5189-2020	Nagele, Peter/0000-0001-8369-3858; Nagele, Peter/0000-0001-8369-3858; 	Roche Diagnostics; Gerson Lehrman Group; US National Institutes of Health; American Heart Association; St John's Ambulance Service, Vienna, Austria; Novo Nordisk; National Institute of General Medical Sciences, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM087534] Funding Source: NIH RePORTER	Roche Diagnostics; Gerson Lehrman Group; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); St John's Ambulance Service, Vienna, Austria; Novo Nordisk(Novo Nordisk); National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	PN's institution has received research support from Roche Diagnostics, unrelated to this study; PN has received consultancy fees from Gerson Lehrman Group; and PN and his institution have received grants from the US National Institutes of Health and American Heart Association. MH is receiving a salary and has received payment for development of educational presentations from St John's Ambulance Service, Vienna, Austria; and has received research support, lecture fees, and travel support from Novo Nordisk. HFS declares that he has no conflicts of interest.; We thank J Philipp Miller, director division of Biostatistics, Washington University School of Medicine, St Louis, MO, USA, for his statistical contributions during report preparation and revision. PN is supported by grants from the National Institute of General Medical Sciences, National Institutes of Health, and from the American Heart Association.	[Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; BERG RA, 1993, CIRCULATION, V88, P1907, DOI 10.1161/01.CIR.88.4.1907; Bohm K, 2007, CIRCULATION, V116, P2908, DOI 10.1161/CIRCULATIONAHA.107.710194; Ewy GA, 2007, CIRCULATION, V116, P2894, DOI 10.1161/CIRCULATIONAHA.107.751065; Ewy GA, 2007, CIRCULATION, V116, P2525, DOI 10.1161/CIRCULATIONAHA.107.711820; Gold LS, 2008, PREHOSP EMERG CARE, V12, P406, DOI 10.1080/10903120802096696; Hallstrom A, 2000, NEW ENGL J MED, V342, P1546, DOI 10.1056/NEJM200005253422101; Handley AJ, 2005, RESUSCITATION, V67, pS7, DOI 10.1016/j.resuscitation.2005.10.007; Heidenreich JW, 2004, RESUSCITATION, V62, P283, DOI 10.1016/j.resuscitation.2004.05.013; Iwami T, 2007, CIRCULATION, V116, P2900, DOI 10.1161/CIRCULATIONAHA.107.723411; Kern KB, 2002, CIRCULATION, V105, P645, DOI 10.1161/hc0502.102963; Kitamura T, 2010, CIRCULATION, V122, P293, DOI 10.1161/CIRCULATIONAHA.109.926816; Kitamura T, 2010, LANCET, V375, P1347, DOI 10.1016/S0140-6736(10)60064-5; Koster RW, 2008, RESUSCITATION, V77, P283, DOI 10.1016/j.resuscitation.2008.04.008; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nagao K, 2007, LANCET, V369, P920; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nolan J, 2010, ANAESTHESIA, V65, P771, DOI 10.1111/j.1365-2044.2010.06448.x; Olasveengen TM, 2008, ACTA ANAESTH SCAND, V52, P914, DOI 10.1111/j.1399-6576.2008.01723.x; Ong MEH, 2008, RESUSCITATION, V78, P119, DOI 10.1016/j.resuscitation.2008.03.012; Rea TD, 2010, NEW ENGL J MED, V363, P423, DOI 10.1056/NEJMoa0908993; Sanders AB, 2002, ANN EMERG MED, V40, P553, DOI 10.1067/mem.2002.129507; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Svensson L, 2010, NEW ENGL J MED, V363, P434, DOI 10.1056/NEJMoa0908991; VANHOEYWEGHEN RJ, 1993, RESUSCITATION, V26, P47, DOI 10.1016/0300-9572(93)90162-J; Waalewijn RA, 2001, RESUSCITATION, V50, P273, DOI 10.1016/S0300-9572(01)00354-9	26	184	194	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 6	2010	376	9752					1552	1557		10.1016/S0140-6736(10)61454-7	http://dx.doi.org/10.1016/S0140-6736(10)61454-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	680QE	20951422	Green Accepted			2022-12-28	WOS:000284248700032
J	Ginhoux, F; Greter, M; Leboeuf, M; Nandi, S; See, P; Gokhan, S; Mehler, MF; Conway, SJ; Ng, LG; Stanley, ER; Samokhvalov, IM; Merad, M				Ginhoux, Florent; Greter, Melanie; Leboeuf, Marylene; Nandi, Sayan; See, Peter; Gokhan, Solen; Mehler, Mark F.; Conway, Simon J.; Ng, Lai Guan; Stanley, E. Richard; Samokhvalov, Igor M.; Merad, Miriam			Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages	SCIENCE			English	Article							MOUSE BRAIN; YOLK-SAC; CELLS; RECEPTOR; ORIGIN; MICE; HEMATOPOIESIS; FRACTALKINE; PHAGOCYTES; MONOCYTES	Microglia are the resident macrophages of the central nervous system and are associated with the pathogenesis of many neurodegenerative and brain inflammatory diseases; however, the origin of adult microglia remains controversial. We show that postnatal hematopoietic progenitors do not significantly contribute to microglia homeostasis in the adult brain. In contrast to many macrophage populations, we show that microglia develop in mice that lack colony stimulating factor-1 (CSF-1) but are absent in CSF-1 receptor-deficient mice. In vivo lineage tracing studies established that adult microglia derive from primitive myeloid progenitors that arise before embryonic day 8. These results identify microglia as an ontogenically distinct population in the mononuclear phagocyte system and have implications for the use of embryonically derived microglial progenitors for the treatment of various brain disorders.	[Ginhoux, Florent; Greter, Melanie; Leboeuf, Marylene; Merad, Miriam] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Ginhoux, Florent; Greter, Melanie; Leboeuf, Marylene; Merad, Miriam] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Ginhoux, Florent; See, Peter; Ng, Lai Guan] BIOPOLIS, Singapore Immunol Network SIgN, Singapore 138648, Singapore; [Nandi, Sayan; Stanley, E. Richard] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Gokhan, Solen; Mehler, Mark F.] Albert Einstein Coll Med, Inst Brain Disorders & Neural Regenerat, Rose F Kennedy Ctr Res Intellectual & Dev Disabil, Bronx, NY 10461 USA; [Gokhan, Solen; Mehler, Mark F.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Dept Psychiat, Bronx, NY 10461 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Dept Behav Sci, Bronx, NY 10461 USA; [Conway, Simon J.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Samokhvalov, Igor M.] RIKEN Kobe, CDB, Lab Stem Cell Biol, Kobe, Hyogo 6500047, Japan	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Indiana University System; Indiana University Bloomington; RIKEN	Ginhoux, F (corresponding author), Mt Sinai Sch Med, Dept Gene & Cell Med, 1425 Madison Ave, New York, NY 10029 USA.	Florent_ginhoux@immunol.a-star.edu.sg; Miriam.Merad@mssm.edu	Stanley, Evan R/J-9154-2013; Ng, Lai Guan/N-6980-2019; Ng, Lai Guan/E-5673-2011	Stanley, Evan R/0000-0002-2910-2065; Ng, Lai Guan/0000-0003-1905-3586; Ng, Lai Guan/0000-0003-1905-3586; Greter, Melanie/0000-0002-7220-5369; See, Peter/0000-0003-4428-7763	NIH [CA112100, HL086899, AI080884, CA32551, CA26504, MH66290, NS38902]; RIKEN; National Science Foundation of Switzerland; NATIONAL CANCER INSTITUTE [R37CA026504, R01CA032551, R01CA112100, R01CA026504] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060714, R01HL086899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038902] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RIKEN; National Science Foundation of Switzerland(Swiss National Science Foundation (SNSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Nishikawa, H. Snoeck, and P. S. Frenette for intellectual input in the study; the RIKEN CDB Laboratory for Animal Resources and Genetic Engineering for providing the Runx1-MER-Cre-MER mice; G. Hoeffel, X. H. Zong, R. Basu and H. Ketchum for technical assistance; and L. Robinson for critical review and editing of the manuscript. This work was supported by NIH grants CA112100, HL086899, and AI080884 to M. M.; CA32551 and CA26504 to E. R. S.; and MH66290 and NS38902 to M. M. I. M. S. is supported by a grant from RIKEN Strategic Programs for Research and Development (President's Fund). M. G. is supported by the National Science Foundation of Switzerland. Runx1-MER-Cre-MER mice have CDB accession. no. CDB0524K (www.cdb.riken.jp/arg/mutant%20mice%20list.html).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; BLEVINS G, 1995, J NEUROSCI RES, V40, P535, DOI 10.1002/jnr.490400412; Bogunovic M, 2006, J EXP MED, V203, P2627, DOI 10.1084/jem.20060667; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Koushik SV, 2001, FASEB J, V15, P1209, DOI 10.1096/fj.00-0696fje; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; LEONG SK, 1992, GLIA, V6, P39, DOI 10.1002/glia.440060106; Lichanska AM, 2000, EXP HEMATOL, V28, P601, DOI 10.1016/S0301-472X(00)00157-0; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; LING EA, 1979, J ANAT, V128, P847; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Ovchinnikov DA, 2008, J LEUKOCYTE BIOL, V83, P430, DOI 10.1189/jlb.0807585; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; SOROKIN SP, 1992, ANAT REC, V232, P527, DOI 10.1002/ar.1092320410; Vallieres L, 2003, J NEUROSCI, V23, P5197; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822	31	2953	3025	15	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2010	330	6005					841	845		10.1126/science.1194637	http://dx.doi.org/10.1126/science.1194637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	20966214	Green Accepted			2022-12-28	WOS:000283855700049
J	Thyagarajan, A; Ting, AY				Thyagarajan, Amar; Ting, Alice Y.			Imaging Activity-Dependent Regulation of Neurexin-Neuroligin Interactions Using trans-Synaptic Enzymatic Biotinylation	CELL			English	Article							AMPA RECEPTORS; SYNAPSE DEVELOPMENT; POSTSYNAPTIC PROTEINS; RECYCLING ENDOSOMES; LIVING CELLS; RECRUITMENT; SITE; ACTIVATION; MATURATION; MONOVALENT	The functions of trans-synaptic adhesion molecules, such as neurexin and neuroligin, have been difficult to study due to the lack of methods to directly detect their binding in living neurons. Here, we use biotin labeling of intercellular contacts (BLINC), a method for imaging protein interactions based on interaction-dependent biotinylation of a peptide by E. coli biotin ligase, to visualize neurexin-neuroligin trans-interactions at synapses and study their role in synapse development. We found that both developmental maturation and acute synaptic activity stimulate the growth of neurexin-neuroligin adhesion complexes via a combination of neurexin and neuroligin surface insertion and internalization arrest. Both mechanisms require NMDA receptor activity. We also discovered that disruption of activity-induced neurexin-neuroligin complex growth prevents recruitment of the AMPA receptor, a hallmark of mature synapses. Our results provide support for neurexin-neuroligin function in synapse maturation and introduce a general method to study intercellular protein-protein interactions.	[Thyagarajan, Amar; Ting, Alice Y.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Ting, AY (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ating@mit.edu			NIH [DP1 OD003961-01]; McKnight Foundation; Sloan Foundation; MIT; Autism Speaks postdoctoral fellowship; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003961] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; Sloan Foundation(Alfred P. Sloan Foundation); MIT; Autism Speaks postdoctoral fellowship; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the late Alaa El-Husseini (University of British Columbia), Michael Ehlers (Duke), Craig Garner (Stanford), and Joshua Sanes (Harvard) for their advice, plasmids, and critical comments on the manuscript. Masahito Yamagata (Harvard), Brian Chen (McGill), Yasunori Hayashi (RIKEN), Miguel Bosch (MIT), and Ann-Marie Craig (University of British Columbia) provided plasmids and antibodies. Mark Howarth made key intellectual contributions, performed preliminary experiments, and provided biotin-AMP. Daniel Dai and Yi Zheng assisted with neuron cultures and provided mSA protein. Funding was provided by the NIH (DP1 OD003961-01), McKnight Foundation, Sloan Foundation, and MIT. A. Thyagarajan was supported by an Autism Speaks postdoctoral fellowship.	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Blanpied TA, 2003, NEUROBIOL AGING, V24, P1095, DOI 10.1016/j.neurobiolaging.2003.04.004; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fairless R, 2008, J NEUROSCI, V28, P12969, DOI 10.1523/JNEUROSCI.5294-07.2008; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fernandez-Suarez M, 2008, J AM CHEM SOC, V130, P9251, DOI 10.1021/ja801445p; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Garner CC, 2006, CELL TISSUE RES, V326, P249, DOI 10.1007/s00441-006-0278-1; Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; Groc L, 2006, TRENDS NEUROSCI, V29, P132, DOI 10.1016/j.tins.2006.01.005; Gutierrez RC, 2009, EUR J NEUROSCI, V30, P2042, DOI 10.1111/j.1460-9568.2009.07007.x; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Heine M, 2008, P NATL ACAD SCI USA, V105, P20947, DOI 10.1073/pnas.0804007106; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Howarth M, 2008, NAT METHODS, V5, P397, DOI 10.1038/NMETH.1206; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Mazzoni A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000439; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sudhof TC, 2008, NEURON, V60, P469, DOI 10.1016/j.neuron.2008.10.011; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Uttamapinant C, 2010, P NATL ACAD SCI USA, V107, P10914, DOI 10.1073/pnas.0914067107; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Weaver LH, 2001, P NATL ACAD SCI USA, V98, P6045, DOI 10.1073/pnas.111128198; Wittenmayer N, 2009, P NATL ACAD SCI USA, V106, P13564, DOI 10.1073/pnas.0905819106; Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459	39	30	30	8	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2010	143	3					456	469		10.1016/j.cell.2010.09.025	http://dx.doi.org/10.1016/j.cell.2010.09.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	20933261	Green Accepted, Bronze			2022-12-28	WOS:000283603900018
J	Planavsky, NJ; Rouxel, OJ; Bekker, A; Lalonde, SV; Konhauser, KO; Reinhard, CT; Lyons, TW				Planavsky, Noah J.; Rouxel, Olivier J.; Bekker, Andrey; Lalonde, Stefan V.; Konhauser, Kurt O.; Reinhard, Christopher T.; Lyons, Timothy W.			The evolution of the marine phosphate reservoir	NATURE			English	Article							SILICA CYCLE; PHOSPHORUS; IRON; DEPLETION; SEDIMENTS	Phosphorus is a biolimiting nutrient that has an important role in regulating the burial of organic matter and the redox state of the ocean-atmosphere system(1). The ratio of phosphorus to iron in iron-oxide-rich sedimentary rocks can be used to track dissolved phosphate concentrations if the dissolved silica concentration of sea water is estimated(2-5). Here we present iron and phosphorus concentration ratios from distal hydrothermal sediments and iron formations through time to study the evolution of the marine phosphate reservoir. The data suggest that phosphate concentrations have been relatively constant over the Phanerozoic eon, the past 542 million years (Myr) of Earth's history. In contrast, phosphate concentrations seem to have been elevated in Precambrian oceans. Specifically, there is a peak in phosphorus-to-iron ratios in Neoproterozoic iron formations dating from 750 to 635 Myr ago, indicating unusually high dissolved phosphate concentrations in the aftermath of widespread, low-latitude 'snowball Earth' glaciations. An enhanced postglacial phosphate flux would have caused high rates of primary productivity and organic carbon burial and a transition to more oxidizing conditions in the ocean and atmosphere. The snowball Earth glaciations and Neoproterozoic oxidation are both suggested as triggers for the evolution and radiation of metazoans(6,7). We propose that these two factors are intimately linked; a glacially induced nutrient surplus could have led to an increase in atmospheric oxygen, paving the way for the rise of metazoan life.	[Planavsky, Noah J.; Reinhard, Christopher T.; Lyons, Timothy W.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Planavsky, Noah J.; Rouxel, Olivier J.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Rouxel, Olivier J.] Univ Europeene Bretagne, European Inst Marine Studies, F-29280 Plouzane, France; [Bekker, Andrey] Univ Manitoba, Dept Geol Sci, Winnipeg, MB R3T 2N2, Canada; [Lalonde, Stefan V.; Konhauser, Kurt O.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada	University of California System; University of California Riverside; Woods Hole Oceanographic Institution; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); University of Manitoba; University of Alberta	Lyons, TW (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.	timothy.lyons@ucr.edu	Lalonde, Stefan V/I-8879-2014; Rouxel, Olivier J/F-3954-2014; Reinhard, Christopher/A-1736-2011	Lalonde, Stefan V/0000-0003-1318-2280; Rouxel, Olivier J/0000-0002-1431-222X; Konhauser, Kurt/0000-0001-7722-7068; Bekker, Andrey/0000-0002-1154-0585	NSF; NASA Astrobiology Institute; NASA; NSF-EAR; NSERC; NSF-OCE; NSF-GSF	NSF(National Science Foundation (NSF)); NASA Astrobiology Institute; NASA(National Aeronautics & Space Administration (NASA)); NSF-EAR(National Science Foundation (NSF)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF-OCE(National Science Foundation (NSF)); NSF-GSF	This work was supported by funding from the NSF-GSF program and the NASA Astrobiology Institute, to N.J.P.; from the NASA Exobiology Program and the NSF-EAR, to T. W. L.; from NSERC, to A. B., K.O.K. and S. V. L.; from NSF-OCE grants to O.J.R.; and from the NSF and the NASA Astrobiology Institute, to A. B.	Arvidson RS, 2006, AM J SCI, V306, P135, DOI 10.2475/ajs.306.3.135; Bjerrum CJ, 2002, NATURE, V417, P159, DOI 10.1038/417159a; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 2008, SCIENCE, V321, P949, DOI 10.1126/science.1154499; Cohen PA, 2009, P NATL ACAD SCI USA, V106, P6519, DOI 10.1073/pnas.0902322106; Edmonds HN, 2004, GEOCHIM COSMOCHIM AC, V68, P759, DOI 10.1016/S0016-7037(03)00498-8; Feely RA, 1998, GEOPHYS RES LETT, V25, P2253, DOI 10.1029/98GL01546; Follmi KB, 2009, GEOCHIM COSMOCHIM AC, V73, P2252, DOI 10.1016/j.gca.2009.01.017; Halverson GP, 2005, GEOL SOC AM BULL, V117, P1181, DOI 10.1130/B25630.1; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Holland HD., 1984, CHEM EVOLUTION ATMOS, DOI [10.1515/9780691220239, DOI 10.1515/9780691220239]; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; HOWARTH RW, 1988, ANNU REV ECOL SYST, V19, P89, DOI 10.1146/annurev.es.19.110188.000513; JAHNKE RA, 1984, AM J SCI, V284, P58, DOI 10.2475/ajs.284.1.58; Jiang GQ, 2003, NATURE, V426, P822, DOI 10.1038/nature02201; KNOLL AH, 1999, SCIENCE, V284, P2129, DOI DOI 10.1126/SCIENCE.284.5423.2129; Konhauser KO, 2007, SCIENCE, V315, P1234, DOI 10.1126/science.1136328; Konhauser KO, 2009, NATURE, V458, P750, DOI 10.1038/nature07858; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Maliva RG, 2005, GEOL SOC AM BULL, V117, P835, DOI 10.1130/B25555.1; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Poulton SW, 2006, GEOCHIM COSMOCHIM AC, V70, P5883, DOI 10.1016/j.gca.2006.01.030; Racki G, 2000, EARTH-SCI REV, V52, P83, DOI 10.1016/S0012-8252(00)00024-6; Ridgwell A, 2005, EARTH PLANET SC LETT, V234, P299, DOI 10.1016/j.epsl.2005.03.006; RUTTENBERG KC, 1993, GEOCHIM COSMOCHIM AC, V57, P991, DOI 10.1016/0016-7037(93)90035-U; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; SIEVER R, 1992, GEOCHIM COSMOCHIM AC, V56, P3265, DOI 10.1016/0016-7037(92)90303-Z; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Wheat CG, 1996, GEOCHIM COSMOCHIM AC, V60, P3593, DOI 10.1016/0016-7037(96)00189-5; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	30	276	303	9	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2010	467	7319					1088	1090		10.1038/nature09485	http://dx.doi.org/10.1038/nature09485			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20981096				2022-12-28	WOS:000283548600043
J	Mega, JL; Simon, T; Collet, JP; Anderson, JL; Antman, EM; Bliden, K; Cannon, CP; Danchin, N; Giusti, B; Gurbel, P; Horne, BD; Hulot, JS; Kastrati, A; Montalescot, G; Neumann, FJ; Shen, L; Sibbing, D; Steg, PG; Trenk, D; Wiviott, SD; Sabatine, MS				Mega, Jessica L.; Simon, Tabassome; Collet, Jean-Philippe; Anderson, Jeffrey L.; Antman, Elliott M.; Bliden, Kevin; Cannon, Christopher P.; Danchin, Nicolas; Giusti, Betti; Gurbel, Paul; Horne, Benjamin D.; Hulot, Jean-Sebastian; Kastrati, Adnan; Montalescot, Gilles; Neumann, Franz-Josef; Shen, Lei; Sibbing, Dirk; Steg, P. Gabriel; Trenk, Dietmar; Wiviott, Stephen D.; Sabatine, Marc S.			Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							OF-FUNCTION POLYMORPHISM; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; MYOCARDIAL-INFARCTION; STENT THROMBOSIS; TASK-FORCE; PHARMACODYNAMICS; RESPONSIVENESS; ASSOCIATION; PRASUGREL	Content Clopidogrel, one of the most commonly prescribed medications, is a prodrug requiring CYP450 biotransformation. Data suggest its pharmacologic effect varies based on CYP2C19 genotype, but there is uncertainty regarding the clinical risk imparted by specific genotypes. Objective To define the risk of major adverse cardiovascular outcomes among carriers of 1 (approximate to 26% prevalence in whites) and carriers of 2 (approximate to 2% prevalence in whites) reduced-function CYP2C19 genetic variants in patients treated with clopidogrel. Data Sources and Study Selection A literature search was conducted (January 2000-August 2010) in MEDLINE, Cochrane Database of Systematic Reviews, and EMBASE. Genetic studies were included in which clopidogrel was initiated in predominantly invasively managed patients in a manner consistent with the current guideline recommendations and in which clinical outcomes were ascertained. Data Extraction Investigators from 9 studies evaluating CYP2C19 genotype and clinical outcomes in patients treated with clopidogrel contributed the relevant hazard ratios (HRs) and 95% confidence intervals (CIs) for specific cardiovascular outcomes by genotype. Results Among 9685 patients (91.3% who underwent percutaneous coronary intervention and 54.5% who had an acute coronary syndrome), 863 experienced the composite end point of cardiovascular death, myocardial infarction, or stroke; and 84 patients had stent thrombosis among the 5894 evaluated for such. Overall, 71.5% were noncarriers, 26.3% had 1 reduced-function CYP2C19 allele, and 2.2% had 2 reduced-function CYP2C19 alleles. A significantly increased risk of the composite end point was evident in both carriers of 1 (HR, 1.55; 95% CI, 1.11-2.17; P=.01) and 2 (HR, 1.76; 95% CI, 1.24-2.50; P=.002) reduced-function CYP2C19 alleles, as compared with noncarriers. Similarly, there was a significantly increased risk of stent thrombosis in both carriers of 1 (HR, 2.67; 95% CI, 1.69-4.22; P<.0001) and 2 (HR, 3.97; 95% CI, 1.75-9.02; P=.001) CYP2C19 reduced-function alleles, as compared with noncarriers. Conclusion Among patients treated with clopidogrel for percutaneous coronary intervention, carriage of even 1 reduced-function CYP2C19 allele appears to be associated with a significantly increased risk of major adverse cardiovascular events, particularly stent thrombosis. JAMA. 2010; 304(16): 1821-1830	[Mega, Jessica L.; Antman, Elliott M.; Cannon, Christopher P.; Wiviott, Stephen D.; Sabatine, Marc S.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, TIMI Study Grp, Boston, MA 02115 USA; [Mega, Jessica L.; Antman, Elliott M.; Cannon, Christopher P.; Wiviott, Stephen D.; Sabatine, Marc S.] Harvard Univ, Sch Med, Boston, MA USA; [Simon, Tabassome] AP HP, Dept Pharmacol, Paris, France; [Simon, Tabassome; Collet, Jean-Philippe] Univ Paris 06, Paris, France; [Collet, Jean-Philippe] Grp Hosp Pitie Salpetriere, Inst Cardiol, INSERM, U937, F-75634 Paris, France; [Anderson, Jeffrey L.; Horne, Benjamin D.] Intermt Med Ctr, Cardiovasc Dept, Murray, UT USA; [Bliden, Kevin; Gurbel, Paul] Sinai Hosp, Sinai Ctr Thrombosis Res, Baltimore, MD 21215 USA; [Danchin, Nicolas] Hop Europeen Georges Pompidou, Div Coronary Artery Dis, Paris, France; [Danchin, Nicolas] Univ Paris 05, Paris, France; [Giusti, Betti] Univ Florence, Dept Med & Surg Crit Care, Florence, Italy; [Hulot, Jean-Sebastian] Pitie Salpetriere Univ Hosp, Inst Cardiol, Paris, France; [Hulot, Jean-Sebastian] Pitie Salpetriere Univ Hosp, Dept Pharmacol, Paris, France; [Kastrati, Adnan; Sibbing, Dirk] Deutsch Herzzentrum Munich, Dept Cardiol, Munich, Germany; [Montalescot, Gilles] CHU Pitie Salpetriere, Inst Cardiol, Paris, France; [Shen, Lei] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Steg, P. Gabriel] Univ Paris 07, INSERM, U698, Paris, France; [Steg, P. Gabriel] Hop Bichat Assistance Publ, Paris, France; [Trenk, Dietmar] Herz Zentrum Bad Krozingen, Dept Clin Pharmacol, Bad Krozingen, Germany	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Intermountain Healthcare; Intermountain Medical Center; Sinai Center Thrombosis Research; Sinai Hospital of Baltimore; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Florence; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; German Heart Centre Munich; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Eli Lilly; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Mega, JL (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, TIMI Study Grp, 350 Longwood Ave,1st Floor, Boston, MA 02115 USA.	jmega@partners.org; msabatine@partners.org	Giusti, Betti/K-6978-2016; Hulot, Jean-Sébastien/A-2278-2016; Sabatine, Marc/AAJ-6751-2020; Horne, Benjamin/GQP-7851-2022; STEG, Philippe Gabriel/Z-1567-2019; , Kastrati/Y-2389-2019; Wiviott, Stephen/HIK-2534-2022; Danchin, Nicolas/AAN-8291-2020; Cannon, Christopher P/AAY-7644-2020	Giusti, Betti/0000-0002-8708-9444; Hulot, Jean-Sébastien/0000-0001-5463-6117; Sabatine, Marc/0000-0002-0691-3359; Cannon, Christopher P/0000-0003-4596-2791; SIMON, Tabassome/0000-0002-4550-0450; STEG, Philippe Gabriel/0000-0001-6896-2941	Bayer Healthcare; Bristol-Myers Squibb; Daiichi Sankyo; Eli Lilly; Johnson Johnson; Sanofi-Aventis; AstraZeneca; Novartis; Servier; Pfizer; Caisse d'Assurance Maladie; Guerbet Medical; Medtronic; Boston Scientific; Cordis; Stago; Centocor; Fondation de France; INSERM; Federation Francaise de Cardiologie; Societe Francaise de Cardiologie; Accumetrics; GlaxoSmithKline; Intekrin Therapeutics; Merck; Takeda; Medicines Company; Schering Plough; Millennium; Bayer; Haemonetics; Biotronik; Medco Research Institute; Medco Health Solutions; Abbott Vascular; ITC Edison; Eisai; Menarini; Portola; Sharpe Dohme; Dynabyte; Astellas; Daiichi Sankyo/Lilly; Otsuka; Roche; Merck-Schering Plough; Arena; National Institutes of Health [K99/R00HL098461-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL098461] Funding Source: NIH RePORTER	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Bristol-Myers Squibb(Bristol-Myers Squibb); Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Sanofi-Aventis(Sanofi-Aventis); AstraZeneca(AstraZeneca); Novartis(Novartis); Servier(Servier); Pfizer(Pfizer); Caisse d'Assurance Maladie; Guerbet Medical; Medtronic(Medtronic); Boston Scientific(Boston Scientific); Cordis; Stago; Centocor; Fondation de France(Fondation de France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Federation Francaise de Cardiologie; Societe Francaise de Cardiologie; Accumetrics; GlaxoSmithKline(GlaxoSmithKline); Intekrin Therapeutics; Merck(Merck & Company); Takeda(Takeda Pharmaceutical Company Ltd); Medicines Company; Schering Plough(Merck & CompanySchering Plough Corporation); Millennium(Takeda Pharmaceutical Company Ltd); Bayer(Bayer AG); Haemonetics; Biotronik; Medco Research Institute; Medco Health Solutions; Abbott Vascular(Abbott Laboratories); ITC Edison; Eisai(Eisai Co Ltd); Menarini(Menarini Group); Portola; Sharpe Dohme; Dynabyte; Astellas(Astellas Pharmaceuticals); Daiichi Sankyo/Lilly(Daiichi Sankyo Company LimitedEli Lilly); Otsuka(Otsuka Pharmaceutical); Roche(Roche Holding); Merck-Schering Plough(Merck & CompanySchering Plough Corporation); Arena(Australian Renewable Energy Agency (ARENA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Mega reports receiving research grant funding from Bayer Healthcare, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, Johnson & Johnson, and Sanofi-Aventis; research supplies from Accumetrics and Nanosphere; consulting fees from AstraZeneca, Bristol-Myers Squibb, and Sanofi-Aventis; and lecture fees from Novartis. Dr Simon reports receiving research grant funding from Servier, Pfizer, Daiichi Sankyo, Eli Lilly, Sanofi-Aventis, AstraZeneca, and Caisse d'Assurance Maladie; and consulting fees from Eli Lilly, Daiichi Sankyo, Sanofi-Aventis, Bristol-Myers Squibb, and AstraZeneca. Dr Collet reports receiving research grant funding from Bristol-Myers Squibb, Sanofi-Aventis, Eli Lilly, Guerbet Medical, Medtronic, Boston Scientific, Cordis, Stago, Centocor, Fondation de France, INSERM, Federation Francaise de Cardiologie, and Societe Francaise de Cardiologie; lecture fees from Bristol-Myers Squibb, Sanofi-Aventis, and Eli Lilly; and consulting fees from Sanofi-Aventis, Eli Lilly, and Bristol-Myers Squibb. Dr Anderson reports receiving consulting fees from Bristol-Myers Squibb and Sanofi-Aventis. Dr Antman reports receiving research grant funding from Daiichi Sankyo and Eli Lilly; consulting fees from Sanofi-Aventis; and lecture fees from Eli Lilly and Sanofi-Aventis. Dr Cannon reports receiving research grant funding from Accumetrics, AstraZeneca, GlaxoSmithKline, Intekrin Therapeutics, Merck, and Takeda; serving on the advisory board for Bristol-Myers Squibb/Sanofi, Novartis, and Alnylam and donating the funds to charity; and serving as a clinical advisor with equity in Automedics Medical Systems. Dr Danchin reports receiving research grant funding from AstraZeneca, Eli Lilly, Merck, Novartis, Pfizer, Sanofi-Aventis, Servier, and The Medicines Company; lecture fees from AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Menarini, Merck-Serono, MSD-Schering Plough, Servier, and Sanofi-Aventis; and consulting fees from AstraZeneca, Eli Lilly, Novo, Sanofi-Aventis, and Servier. Dr Gurbel reports receiving research grant funding from Schering Plough, Millennium, AstraZeneca, Bayer, Haemonetics, Medtronic, and Boston Scientific; and honoraria from Schering Plough, AstraZeneca, Bayer, Portola, and Medtronic. Dr Hulot reports receiving research grant support from Fondation de France, INSERM, Federation Francaise de Cardiologie, Biotronik, and Medco Research Institute; consulting fees from Biotronik and Medco Health Solutions; and lecture fees from Sanofi-Aventis, Daiichi Sankyo, Eli Lilly, and Bristol-Myers Squibb. Dr Montalescot reports receiving research grant funding from Abbott Vascular, Bristol-Myers Squibb, Boston Scientific, Centocor, Cordis, Eli Lilly, Federation Francaise de Cardiologie, Fondation de France, Guerbet Medical, INSERM, ITC Edison, Medtronic, Pfizer, Sanofi-Aventis, Societe Francaise de Cardiologie, and Stago; consulting fees from AstraZeneca, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, Daiichi-Sankyo, Eisai, Eli Lilly, Menarini, Novartis, Pfizer, Portola, Sanofi-Aventis Group, Schering-Plough, and The Medicines Company; and lecture fees from Abbott Vascular, Accumetrics, AstraZeneca, Bristol-Myers Squibb, Cordis, Daiichi-Sankyo, Eli Lilly, GlaxoSmithKline, Menarini, Merck Sharpe & Dohme, Pfizer, Sanofi-Aventis, and Schering-Plough. Dr Shen reports being employed and having ownership interest in Eli Lilly. Dr Sibbing reports receiving consulting fees from Eli Lilly and lecture fees from Dynabyte and The Medicines Company.; Dr Steg reports receiving research grant funding from Servier; consultingfees from Astellas, AstraZeneca, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo/Lilly, GlaxoSmithKline, Medtronic, Merck, Otsuka, Pfizer, Roche, Sanofi-Aventis, Servier, and The Medicines Company; and is a stockholder in Aterovax. Dr Trenk reports receiving research grant support from Eli Lilly; consulting fees from Eli Lilly, Daiichi Sankyo, and AstraZeneca; and lecture fees from Eli Lilly and Daiichi Sankyo. Dr Wiviott reports receiving research grant funding from Eli Lilly, Daiichi Sankyo, and Merck-Schering Plough; honoraria from AstraZeneca, Novartis; Eli Lilly, and Daiichi Sankyo; and consulting fees from AstraZeneca, Sanofi-Aventis, Portola, and Arena. Dr Sabatine reports receiving research grant funding from AstraZeneca, Bristol-Myers Squibb, Daiichi Sankyo, Schering Plough (now Merck), and Sanofi-Aventis; honoraria from Bristol-Myers Squibb, Sanofi-Aventis, and Eli Lilly; and consulting fees from AstraZeneca, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, and Sanofi-Aventis. The other authors reported no disclosures.; Dr Mega is supported in part by grant K99/R00HL098461-01 from the National Institutes of Health.	Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Anderson JL, 2009, J AM COLL CARDIOL, V53, pA27; Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; Bhatt D., 2009, CHARISMA GENOMICS SU; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bonello L, 2008, J AM COLL CARDIOL, V51, P1404, DOI 10.1016/j.jacc.2007.12.044; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; *BRIST MYERS SQUIB, PLAV PRESCR INF; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Damani SB, 2010, J AM COLL CARDIOL, V56, P109, DOI 10.1016/j.jacc.2010.03.029; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Desta Z, 2002, CLIN PHARMACOKINET, V41, P913, DOI 10.2165/00003088-200241120-00002; Fontana P, 2007, J THROMB HAEMOST, V5, P2153, DOI 10.1111/j.1538-7836.2007.02722.x; Frere C, 2008, AM J CARDIOL, V101, P1088, DOI 10.1016/j.amjcard.2007.11.065; Giusti B, 2007, PHARMACOGENET GENOM, V17, P1057, DOI 10.1097/FPC.0b013e3282f1b2be; Giusti B, 2010, PHARMACOGN PERS MED, V3, P33, DOI 10.2147/PGPM.S5056; Giusti B, 2009, AM J CARDIOL, V103, P806, DOI 10.1016/j.amjcard.2008.11.048; Gladding P, 2009, JACC-CARDIOVASC INTE, V2, P1095, DOI 10.1016/j.jcin.2009.08.018; Gladding P, 2008, JACC-CARDIOVASC INTE, V1, P620, DOI 10.1016/j.jcin.2008.09.008; Gurbel PA, 2007, J AM COLL CARDIOL, V50, P1822, DOI 10.1016/j.jacc.2007.07.051; Gurbel PA, 2010, J AM COLL CARDIOL, V56, P112, DOI 10.1016/j.jacc.2010.04.008; Holmes DR, 2010, CIRCULATION, V122, P537, DOI 10.1161/CIR.0b013e3181ee08ed; Hulot JS, 2010, J THROMB HAEMOST, V8, P610, DOI 10.1111/j.1538-7836.2009.03729.x; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; Kim KA, 2008, CLIN PHARMACOL THER, V84, P236, DOI 10.1038/clpt.2008.20; Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; MAURICE CB, 2008, J MOL DIAGN, V10, P557, DOI DOI 10.2353/JMOLDX.2008.080036; Mega JL, 2009, CIRCULATION, V119, P2553, DOI 10.1161/CIRCULATIONAHA.109.851949; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mega JL, 2008, J AM COLL CARDIOL  S, V51, P178, DOI DOI 10.1016/J.JACC.2008.02.007; *NIH, NCT00827411 NIH; *NIH, NCT00910299 NIH; Pare G, 2010, NEW ENGL J MED, V363, P1704, DOI 10.1056/NEJMoa1008410; Pena A, 2009, CIRCULATION, V119, P2854, DOI 10.1161/CIRCULATIONAHA.108.857722; Price MJ, 2009, AM HEART J, V157, P818, DOI 10.1016/j.ahj.2009.02.012; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2009, EUR HEART J, V30, P916, DOI 10.1093/eurheartj/ehp041; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Steinberg KK, 1997, AM J EPIDEMIOL, V145, P917; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Umemura K, 2008, J THROMB HAEMOST, V6, P1439, DOI 10.1111/j.1538-7836.2008.03050.x; US Food and Drug Administration, FDA DRUG SAF COMM RE; Varenhorst C, 2009, EUR HEART J, V30, P1744, DOI 10.1093/eurheartj/ehp157; VONEL, 2007, BRIT MED J, V335, P806; WALLENTIN L, LANCET; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2001, NEW ENGL J MED, V345, P494	53	797	848	2	72	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2010	304	16					1821	1830		10.1001/jama.2010.1543	http://dx.doi.org/10.1001/jama.2010.1543			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671JZ	20978260	Green Accepted			2022-12-28	WOS:000283501300023
J	Blau, N; van Spronsen, FJ; Levy, HL				Blau, Nenad; van Spronsen, Francjan J.; Levy, Harvey L.			Phenylketonuria	LANCET			English	Article							PHENYLALANINE-HYDROXYLASE DEFICIENCY; QUALITY-OF-LIFE; EARLY-TREATED PHENYLKETONURIA; NEWBORN SCREENING-PROGRAM; GTP CYCLOHYDROLASE-I; NEUTRAL AMINO-ACIDS; ADULT PATIENTS; SAPROPTERIN DIHYDROCHLORIDE; NUTRITIONAL MANAGEMENT; BLOOD PHENYLALANINE	Phenylketonuria is the most prevalent disorder caused by an inborn error in aminoacid metabolism. It results from mutations in the phenylalanine hydroxylase gene. Phenotypes can vary from a very mild increase in blood phenylalanine concentrations to a severe classic phenotype with pronounced hyperphenylalaninaemia, which, if untreated, results in profound and irreversible mental disability. Neonatal screening programmes identify individuals with phenylketonuria. The initiation of a phenylalanine-restricted diet very soon after birth prevents most of the neuropsychological complications. However, the diet is difficult to maintain and compliance is often poor, especially in adolescents, young adults, and pregnant women. Tetrahydrobiopterin stimulates phenylalanine hydroxylase activity in about 20% of patients, and in those patients serves as a useful adjunct to the phenylalanine-restricted diet because it increases phenylalanine tolerance and allows some dietary freedom. Possible future treatments include enzyme substitution with phenylalanine ammonia lyase, which degrades phenylalanine, and gene therapy to restore phenylalanine hydroxylase activity.	[Blau, Nenad] Univ Childrens Hosp, Div Clin Chem & Biochem, CH-8032 Zurich, Switzerland; [Blau, Nenad] Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [van Spronsen, Francjan J.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Groningen, Netherlands; [van Spronsen, Francjan J.] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Groningen, Netherlands; [Levy, Harvey L.] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA	University Children's Hospital Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Groningen; University of Groningen; Harvard University; Boston Children's Hospital; Harvard Medical School	Blau, N (corresponding author), Univ Childrens Hosp, Div Clin Chem & Biochem, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	nenad.blau@kispi.uzh.ch		Blau, Nenad/0000-0003-4347-3230	Swiss National Science Foundation [3100A0-119982/1]; BioMarin Pharmaceuticals, USA; Scientific Hospital Supplies, Milupa; Merck Serono	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); BioMarin Pharmaceuticals, USA; Scientific Hospital Supplies, Milupa; Merck Serono(Merck & Company)	We thank many colleagues for providing national recommendations for treatment of phenylketonuria patients. Supported in part by the Swiss National Science Foundation grant no. 3100A0-119982/1. NB is a member of scientific advisory board of Merck Serono SA, Switzerland, has received grants for lecturing and research from BioMarin Pharmaceuticals, USA and for lecturing from Merck Serono SA, Switzerland and Scientific Hospital Supplies, Germany. FS has been a member of scientific advisory committees of Scientific Hospital Supplies and Merck Serono SA, and has received grants for lecturing and research from Scientific Hospital Supplies, Milupa, and Merck Serono. HL. has received honoraria for limited consultancy, grants for small studies, and travel expenses reimbursement from BioMarin Pharmaceuticals, USA.	Albrecht J, 2009, NEUROSCI BIOBEHAV R, V33, P414, DOI 10.1016/j.neubiorev.2008.11.001; Anastasoaie V, 2008, MOL GENET METAB, V95, P17, DOI 10.1016/j.ymgme.2008.06.014; Anderson PJ, 2007, DEV NEUROPSYCHOL, V32, P645, DOI 10.1080/87565640701375963; [Anonymous], 2000, Pediatr Nurs, V26, P539; [Anonymous], 2001, METABOLIC MOL BASES, DOI DOI 10.1036/OMMBID.97; Antshel KM, 2003, J ABNORM CHILD PSYCH, V31, P565, DOI 10.1023/A:1026239921561; Aoki K, 2007, J INHERIT METAB DIS, V30, P608, DOI 10.1007/s10545-007-0602-2; Arnold GL, 1998, ACTA PAEDIATR, V87, P565, DOI 10.1080/08035259850158308; Baieli S, 2003, J AUTISM DEV DISORD, V33, P201, DOI 10.1023/A:1022999712639; Bekhof J, 2003, EUR J PEDIATR, V162, P440, DOI 10.1007/s00431-003-1197-8; Bernegger C, 2002, MOL GENET METAB, V77, P304, DOI 10.1016/S1096-7192(02)00171-3; BICKEL H, 1953, LANCET, V265, P812; Blau N, 2004, MOL GENET METAB, V82, P101, DOI 10.1016/j.ymgme.2004.03.006; BLAU N, 2005, PHYS GUIDE LAB DIAGN, P89; Blau N., 2001, METABOLIC MOL BASIS, P1725; Blau N, 2008, J INHERIT METAB DIS, V31, P2, DOI 10.1007/s10545-007-9979-1; Blau N, 2010, MOL GENET METAB, V99, P109, DOI 10.1016/j.ymgme.2009.09.005; Blau N, 2009, MOL GENET METAB, V96, P158, DOI 10.1016/j.ymgme.2009.01.002; Bonafe L, 2001, AM J HUM GENET, V69, P269, DOI 10.1086/321970; Borrajo GJC, 2007, J INHERIT METAB DIS, V30, P466, DOI 10.1007/s10545-007-0669-9; Bosch AM, 2007, J INHERIT METAB DIS, V30, P29, DOI 10.1007/s10545-006-0433-6; Bowersox J, 2001, PEDIATRICS, V108, P972; Burton BK, 2007, J INHERIT METAB DIS, V30, P700, DOI 10.1007/s10545-007-0605-z; Channon S, 2007, ARCH DIS CHILD, V92, P213, DOI 10.1136/adc.2006.104786; Crone MR, 2005, J INHERIT METAB DIS, V28, P627, DOI 10.1007/s10545-005-0014-0; Desviat LR, 1999, EUR J HUM GENET, V7, P386, DOI 10.1038/sj.ejhg.5200312; Diamond A, 1997, MONOGR SOC RES CHILD, V62, P1; Ding Z, 2008, MOL THER, V16, P673, DOI 10.1038/mt.2008.17; Fiege B, 2007, J PEDIATR-US, V150, P627, DOI 10.1016/j.jpeds.2007.02.017; Folling A, 1934, H-S Z PHYSIOL CHEM, V227, P169, DOI 10.1515/bchm2.1934.227.1-4.169; Gassio R, 2005, DEV MED CHILD NEUROL, V47, P443, DOI 10.1017/S0012162205000861; Gassio R, 2003, ACTA PAEDIATR, V92, P1474, DOI 10.1080/08035250310006683; Gassio R, 2010, MOL GENET METAB, V99, pS75, DOI 10.1016/j.ymgme.2009.10.187; Gersting SW, 2008, AM J HUM GENET, V83, P5, DOI 10.1016/j.ajhg.2008.05.013; Ghozlan A, 2004, MOL GENET METAB, V83, P337, DOI 10.1016/j.ymgme.2004.07.004; GULDBERG P, 1995, J MED GENET, V32, P976, DOI 10.1136/jmg.32.12.976; GUTHRIE R, 1963, PEDIATRICS, V32, P338; GUTTLER F, 1980, ACTA PAEDIATR SCAND, P1; Harding CO, 2008, CLIN GENET, V74, P97, DOI 10.1111/j.1399-0004.2008.01027.x; Hoeksma M, 2009, MOL GENET METAB, V96, P177, DOI 10.1016/j.ymgme.2008.12.019; Horster F, 2006, PEDIATR RES, V59, P544, DOI 10.1203/01.pdr.0000203091.45988.8d; Huijbregts SCJ, 2002, NEUROPSYCHOLOGIA, V40, P7, DOI 10.1016/S0028-3932(01)00078-1; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; Jiang Jianhui, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P185; Jung SC, 2008, J KOREAN MED SCI, V23, P877, DOI 10.3346/jkms.2008.23.5.877; KANT TS, 2010, MOL GENET METAB, V99, P4; Karacic I, 2009, MOL GENET METAB, V97, P165, DOI 10.1016/j.ymgme.2009.03.009; Kayaalp E, 1997, AM J HUM GENET, V61, P1309, DOI 10.1086/301638; Koch R, 2000, PEDIATRICS, V106, P1093, DOI 10.1542/peds.106.5.1093; Koch R, 2003, PEDIATRICS, V112, P1523; Kure S, 1999, J PEDIATR-US, V135, P375, DOI 10.1016/S0022-3476(99)70138-1; LaClair CE, 2009, J FOOD SCI, V74, pE199, DOI 10.1111/j.1750-3841.2009.01134.x; Lambruschini N, 2005, MOL GENET METAB, V86, pS54, DOI 10.1016/j.ymgme.2005.05.014; Lee PJ, 2009, J NEUROL NEUROSUR PS, V80, P631, DOI 10.1136/jnnp.2008.151175; Lee P, 2008, AM J MED GENET A, V146A, P2851, DOI 10.1002/ajmg.a.32562; LENKE RR, 1980, NEW ENGL J MED, V303, P1202, DOI 10.1056/NEJM198011203032104; Leuzzi V, 2004, J INHERIT METAB DIS, V27, P115, DOI 10.1023/B:BOLI.0000028781.94251.1f; Levy H, 2007, MOL GENET METAB, V92, P287, DOI 10.1016/j.ymgme.2007.09.017; Levy HL, 2007, LANCET, V370, P504, DOI 10.1016/S0140-6736(07)61234-3; Lim K, 2007, MOL GENET METAB, V92, P176, DOI 10.1016/j.ymgme.2007.06.004; Lindner M., 2006, PKU BH4 ADV PHENYLKE, P180; Loeber JG, 2007, J INHERIT METAB DIS, V30, P430, DOI 10.1007/s10545-007-0644-5; MacDonald MJ, 2007, BIOCHEM CELL BIOL, V85, P273, DOI 10.1139/O07-018; Maillot F, 2008, AM J CLIN NUTR, V88, P700, DOI 10.1093/ajcn/88.3.700; Martynyuk AE, 2005, MOL GENET METAB, V86, pS34, DOI 10.1016/j.ymgme.2005.06.014; Matalon R, 2007, J INHERIT METAB DIS, V30, P153, DOI 10.1007/s10545-007-0556-4; Mazur A, 2010, MED PRIN PRACT, V19, P46, DOI 10.1159/000252834; Moyle JJ, 2007, NEUROPSYCHOL REV, V17, P91, DOI 10.1007/s11065-007-9021-2; Ney DM, 2009, J INHERIT METAB DIS, V32, P32, DOI 10.1007/s10545-008-0952-4; Olsson GM, 2007, J INHERIT METAB DIS, V30, P708, DOI 10.1007/s10545-007-0493-2; Ozalp I, 2001, TURKISH J PEDIATR, V43, P97; Pangkanon S, 2009, SE ASIAN J TROP MED, V40, P525; PEARSEN KD, 1990, RADIOLOGY, V177, P437, DOI 10.1148/radiology.177.2.2217781; Pey AL, 2005, MOL GENET METAB, V86, pS43, DOI 10.1016/j.ymgme.2005.04.008; Pietz J, 1997, PEDIATRICS, V99, P345, DOI 10.1542/peds.99.3.345; Pietz J, 1999, J CLIN INVEST, V103, P1169, DOI 10.1172/JCI5017; Rebuffat A, 2010, HUM GENE THER, V21, P463, DOI 10.1089/hum.2009.127; Sarkissian CN, 2008, P NATL ACAD SCI USA, V105, P20894, DOI 10.1073/pnas.0808421105; Schindeler S, 2007, MOL GENET METAB, V91, P48, DOI 10.1016/j.ymgme.2007.02.002; Scriver CR, 2007, HUM MUTAT, V28, P831, DOI 10.1002/humu.20526; Shefer S, 2000, J NEUROSCI RES, V61, P549, DOI 10.1002/1097-4547(20000901)61:5<549::AID-JNR10>3.0.CO;2-0; Simon E, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-25; SMITH I, 1990, ARCH DIS CHILD, V65, P472, DOI 10.1136/adc.65.5.472; Surtees R, 2000, EUR J PEDIATR, V159, pS109, DOI 10.1007/PL00014370; Thony B, 2006, HUM MUTAT, V27, P870, DOI 10.1002/humu.20366; Trefz FK, 2009, J PEDIATR-US, V154, P700, DOI 10.1016/j.jpeds.2008.11.040; van Calcar SC, 2009, AM J CLIN NUTR, V89, P1068, DOI 10.3945/ajcn.2008.27280; van Spronsen FJ, 2009, J INHERIT METAB DIS, V32, P58, DOI 10.1007/s10545-008-0966-y; VanZutphen KH, 2007, CLIN GENET, V72, P13, DOI 10.1111/j.1399-0004.2007.00816.x; WAISBREN SE, 1991, J INHERIT METAB DIS, V14, P755, DOI 10.1007/BF01799946; WAISBREN SE, 1994, J INHERIT METAB DIS, V17, P584, DOI 10.1007/BF00711596; Waisbren SE, 2007, MOL GENET METAB, V92, P63, DOI 10.1016/j.ymgme.2007.05.006; Walter JH, 2002, LANCET, V360, P55, DOI 10.1016/S0140-6736(02)09334-0; Walter John H, 2004, Int J Adolesc Med Health, V16, P41; WEGLAGE J, 1992, EUR J PEDIATR, V151, P522, DOI 10.1007/BF01957759; White DA, 2002, J INT NEUROPSYCH SOC, V8, P1, DOI 10.1017/S135561770102001X; Widaman KF, 2003, PEDIATRICS, V112, P1537; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0; Zhan JY, 2009, WORLD J PEDIATR, V5, P136, DOI 10.1007/s12519-009-0027-0; Zschocke J, 1997, HUM GENET, V100, P189, DOI 10.1007/s004390050488; Zschocke J, 2003, HUM MUTAT, V21, P345, DOI 10.1002/humu.10192; Zurfluh MR, 2008, HUM MUTAT, V29, P167, DOI 10.1002/humu.20637	102	674	714	7	312	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 23	2010	376	9750					1417	1427		10.1016/S0140-6736(10)60961-0	http://dx.doi.org/10.1016/S0140-6736(10)60961-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672ZO	20971365				2022-12-28	WOS:000283627500036
J	Korver, AMH; Konings, S; Dekker, FW; Beers, M; Wever, CC; Frijns, JHM; Oudesluys-Murphy, AM				Korver, Anna M. H.; Konings, Saskia; Dekker, Friedo W.; Beers, Mieke; Wever, Capi C.; Frijns, Johan H. M.; Oudesluys-Murphy, Anne M.		DECIBEL Collaborative Study Grp	Newborn Hearing Screening vs Later Hearing Screening and Developmental Outcomes in Children With Permanent Childhood Hearing Impairment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; CONTROLLED-TRIAL; CURRENT STATE; LANGUAGE; HEALTH; GUIDELINES; KNOWLEDGE	Context Newborn hearing screening programs have been implemented in many countries because it was thought that the earlier permanent childhood hearing impairment is detected, the less developmentally disadvantaged children would become. To date, however, no strong evidence exists for universal introduction of newborn hearing screening. Objective To study the effect of newborn hearing screening vs distraction hearing screening, conducted at 9 months of age, on development, spoken communication, and quality of life. Design, Setting, and Participants Between 2002 and 2006, all 65 regions in the Netherlands replaced distraction hearing screening with newborn hearing screening. Consequently, the type of hearing screening offered was based on availability at the place and date of birth and was independent of developmental prognoses of individual children. All children born in the Netherlands between 2003 and 2005 were included. At the age of 3 to 5 years, all children with permanent childhood hearing impairment were identified. Evaluation ended December 2009. Main Outcome Measures Performance (education and spoken and signed communication), development (general and language), and quality of life. Results During the study period, 335 560 children were born in a newborn hearing screening region and 234 826 children in a distraction hearing screening region. At follow-up, 263 children in newborn hearing screening regions (0.78 per 1000 children) and 171 children in distraction hearing screening regions (0.73 per 1000 children) had been diagnosed with permanent childhood hearing impairment. Three hundred one children (69.4%) participated in analysis of general performance measures. There was no difference between groups in the primary mode of communication or type of education. Analysis of extensive developmental outcomes included 80 children born in newborn hearing screening regions and 70 in distraction hearing screening regions. Multivariate analysis of variance showed that overall, children in newborn hearing screening regions had higher developmental outcome scores compared with children in distraction hearing screening regions (Wilks lambda = 0.79; F-12=2.705; P=.003). For social development, the mean between-group difference in quotient points was 8.8(95% CI, 0.8 to 16.7) and for gross motor development, 9.1(95% CI, 1.1 to 17.1). For quality of life, the mean between-group difference was 5.3 (95% CI, 1.7 to 8.9), also in favor of children in newborn hearing screening regions. Conclusion Compared with distraction hearing screening, a newborn hearing screening program was associated with better developmental outcomes at age 3 to 5 years among children with permanent childhood hearing impairment. JAMA. 2010; 304(15): 1701-1708	[Korver, Anna M. H.; Oudesluys-Murphy, Anne M.] Leiden Univ, Med Ctr, Dept Social Pediat, Willem Alexander Children & Youth Ctr, NL-2333 ZA Leiden, Netherlands; [Konings, Saskia; Beers, Mieke; Wever, Capi C.; Frijns, Johan H. M.] Leiden Univ, Med Ctr, Dept Otorhinolaryngol, NL-2333 ZA Leiden, Netherlands; [Dekker, Friedo W.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2333 ZA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Korver, AMH (corresponding author), Leiden Univ, Med Ctr, Dept Social Pediat, Willem Alexander Children & Youth Ctr, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	a.m.h.korver@lumc.nl	Kant, Sarina/F-8596-2010; Kunst, Henricus P.M./J-6456-2012; Dekker, Friedo W/B-6452-2011; Cremers, C.W.R.J./L-4254-2015; Frijns, Johan H.M./H-6249-2011	Kunst, Henricus P.M./0000-0003-1162-6394; Dekker, Friedo W/0000-0002-2433-2494; Frijns, Johan H.M./0000-0002-1180-3314; Oudesluys-Murphy, Anne Marie/0000-0003-2282-0571; van den Akker-van Marle, M. Elske/0000-0002-5269-509X; le Cessie, Saskia/0000-0003-2154-4923; Rieffe, Carolien/0000-0002-7584-6698	Willem-Alexander Children's Fund; Wieger Wakinoerfund; Heinsius Houbolt Fund	Willem-Alexander Children's Fund; Wieger Wakinoerfund; Heinsius Houbolt Fund	This study received funding from the Willem-Alexander Children's Fund, the Wieger Wakinoerfund, and the Heinsius Houbolt Fund.	[Anonymous], 2006, MACARTHUR BATES COMM; Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333; Calderon R, 1998, VOLTA REV, V100, P53; Engelen V, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-68; Fellinger J, 2008, EUR CHILD ADOLES PSY, V17, P414, DOI 10.1007/s00787-008-0683-y; Fortnum HM, 2001, BRIT MED J, V323, P536, DOI 10.1136/bmj.323.7312.536; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hertogh EM, 2010, J CLIN EPIDEMIOL, V63, P900, DOI 10.1016/j.jclinepi.2009.10.007; IRETON H, 1995, CLIN PEDIATR, V34, P248, DOI 10.1177/000992289503400504; Kennedy C, 2005, LANCET, V366, P660, DOI 10.1016/S0140-6736(05)67138-3; Kennedy CR, 1999, ACTA PAEDIATR, V88, P73, DOI 10.1080/080352599750029448; Kennedy CR, 2006, NEW ENGL J MED, V354, P2131, DOI 10.1056/NEJMoa054915; Korver AMH, 2009, J CLIN VIROL, V46, pS27, DOI 10.1016/j.jcv.2009.09.007; Martens EP, 2006, EPIDEMIOLOGY, V17, P260, DOI 10.1097/01.ede.0000215160.88317.cb; Moeller MP, 2007, EAR HEARING, V28, P740, DOI 10.1097/AUD.0b013e318157f07f; Nelson HD, 2008, PEDIATRICS, V122, pE266, DOI 10.1542/peds.2007-1422; OudesluysMurphy AM, 1996, EUR J PEDIATR, V155, P429, DOI 10.1007/BF01955176; Rassen JA, 2009, J CLIN EPIDEMIOL, V62, P1226, DOI 10.1016/j.jclinepi.2008.12.005; Sininger YS, 2010, EAR HEARING, V31, P166, DOI 10.1097/AUD.0b013e3181c8e7b6; Thompson DC, 2001, JAMA-J AM MED ASSOC, V286, P2000, DOI 10.1001/jama.286.16.2000; Vandenbroucke JP, 2004, LANCET, V363, P1728, DOI 10.1016/S0140-6736(04)16261-2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Wake M, 2005, ARCH DIS CHILD, V90, P238, DOI 10.1136/adc.2003.039354; Watkin PM, 1999, ARCH DIS CHILD, V81, P380, DOI 10.1136/adc.81.5.380; Wolff R, 2010, ARCH DIS CHILD, V95, P130, DOI 10.1136/adc.2008.151092; Yoshinaga-Itano C, 2001, Semin Neonatol, V6, P521, DOI 10.1053/siny.2001.0075; Yoshinaga-Itano C, 1998, PEDIATRICS, V102, P1161, DOI 10.1542/peds.102.5.1161	27	132	139	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2010	304	15					1701	1708		10.1001/jama.2010.1501	http://dx.doi.org/10.1001/jama.2010.1501			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666PZ	20959580				2022-12-28	WOS:000283129700024
J	Fekete, T				Fekete, Thomas			Concurrent PPIs and antibiotics for incident C. difficile infection were associated with increased risk for recurrent infection	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CLOSTRIDIUM-DIFFICILE		Temple Univ, Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Fekete, T (corresponding author), Temple Univ, Sch Med, Philadelphia, PA 19122 USA.		Fekete, Thomas/AFI-5367-2022					Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Garey KW, 2008, J HOSP INFECT, V70, P298, DOI 10.1016/j.jhin.2008.08.012; Turgeon DK, 2003, J CLIN MICROBIOL, V41, P667, DOI 10.1128/JCM.41.2.667-670.2003	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8							JC4-12	10.7326/0003-4819-153-8-201010190-02012	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956696				2022-12-28	WOS:000283054600027
J	Gutknecht, DR				Gutknecht, David R.			Review: Vibration testing and monofilament testing are most accurate for diagnosing large-fiber peripheral neuropathy in diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							FOOT ULCERS		Geisinger Med Ctr, Danville, PA 17822 USA	Geisinger Medical Center	Gutknecht, DR (corresponding author), Geisinger Med Ctr, Danville, PA 17822 USA.							Crawford F, 2007, QJM-INT J MED, V100, P65; Leese GP, 2006, DIABETES CARE, V29, P2562, DOI 10.2337/dc06-1471; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8							JC4-10	10.7326/0003-4819-153-8-201010190-02010	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956694				2022-12-28	WOS:000283054600025
J	Iorio, A				Iorio, Alfonso			A 9-factor score predicted 2-year risk for bleeding in outpatients with, or at high risk for, atherothrombosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CLOPIDOGREL; ASPIRIN; EVENTS; TRIAL		McMaster Univ, Hamilton, ON, Canada	McMaster University	Iorio, A (corresponding author), McMaster Univ, Hamilton, ON, Canada.		Iorio, Alfonso/B-9478-2013	Iorio, Alfonso/0000-0002-3331-8766				Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411	3	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8							JC4-13	10.7326/0003-4819-153-8-201010190-02013	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956697				2022-12-28	WOS:000283054600028
J	Lobo, MK; Covington, HE; Chaudhury, D; Friedman, AK; Sun, HS; Damez-Werno, D; Dietz, DM; Zaman, S; Koo, JW; Kennedy, PJ; Mouzon, E; Mogri, M; Neve, RL; Deisseroth, K; Han, MH; Nestler, EJ				Lobo, Mary Kay; Covington, Herbert E., III; Chaudhury, Dipesh; Friedman, Allyson K.; Sun, HaoSheng; Damez-Werno, Diane; Dietz, David M.; Zaman, Samir; Koo, Ja Wook; Kennedy, Pamela J.; Mouzon, Ezekiell; Mogri, Murtaza; Neve, Rachael L.; Deisseroth, Karl; Han, Ming-Hu; Nestler, Eric J.			Cell Type-Specific Loss of BDNF Signaling Mimics Optogenetic Control of Cocaine Reward	SCIENCE			English	Article							CONDITIONED-PLACE PREFERENCE; MESOLIMBIC DOPAMINE SYSTEM; NUCLEUS-ACCUMBENS; IN-VIVO; BASAL GANGLIA; NEUROTROPHIC FACTOR; DELTA-FOSB; KINASE-B; RECEPTOR; NEURONS	The nucleus accumbens is a key mediator of cocaine reward, but the distinct roles of the two subpopulations of nucleus accumbens projection neurons, those expressing dopamine D1 versus D2 receptors, are poorly understood. We show that deletion of TrkB, the brain-derived neurotrophic factor (BDNF) receptor, selectively from D1+ or D2+ neurons oppositely affects cocaine reward. Because loss of TrkB in D2+ neurons increases their neuronal excitability, we next used optogenetic tools to control selectively the firing rate of D1+ and D2+ nucleus accumbens neurons and studied consequent effects on cocaine reward. Activation of D2+ neurons, mimicking the loss of TrkB, suppresses cocaine reward, with opposite effects induced by activation of D1+ neurons. These results provide insight into the molecular control of D1+ and D2+ neuronal activity as well as the circuit-level contribution of these cell types to cocaine reward.	[Lobo, Mary Kay; Covington, Herbert E., III; Sun, HaoSheng; Damez-Werno, Diane; Dietz, David M.; Zaman, Samir; Koo, Ja Wook; Kennedy, Pamela J.; Mouzon, Ezekiell; Han, Ming-Hu; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA; [Mogri, Murtaza; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; Stanford University; Massachusetts Institute of Technology (MIT)	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA.	eric.nestler@mssm.edu	Han, Ming-Hu/G-8836-2012; Lobo, Mary Kay/K-7734-2015; Dietz, David/AAW-4574-2021; Dietz, David/J-9458-2015	Lobo, Mary Kay/0000-0002-9419-2079; Dietz, David/0000-0002-6927-9236; Dietz, David/0000-0002-6927-9236; Sun, Haosheng/0000-0003-3919-559X	National Institute on Drug Abuse; MSSM [NIDA T32 DA007135-26A2]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007359, P01DA008227, T32DA007135, R01DA014133] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); MSSM; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank N. Heintz and P. Greengard (Rockefeller University) and C. R. Gerfen (NIH/NIMH) for providing us with D1-Cre, D2-Cre, D1-GFP, and D2-GFP mice. We thank M. S. Levine and X. W. Yang (UCLA) for providing us with D1-GFP and D2-GFP mice. We thank L. Parada (UTSouthwestern) for providing us with the flTrkB mice. We thank V. Lessman (Otto-von-Guericke-Universitat) for providing us with the TrkB (full length)-GFP construct. This work was supported by grants from the National Institute on Drug Abuse, and M. K. L. is supported by the Drug Abuse Research Training Program at MSSM (NIDA T32 DA007135-26A2).	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ambroggi F, 2009, NAT NEUROSCI, V12, P247, DOI 10.1038/nn.2282; Bahi A, 2008, PSYCHOPHARMACOLOGY, V199, P169, DOI 10.1007/s00213-008-1164-1; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; CAO JL, 2010, P NATL ACAD IN PRESS; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Crooks KR, 2010, NEUROPHARMACOLOGY, V58, P1067, DOI 10.1016/j.neuropharm.2010.01.014; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Freeman AY, 2003, NEUROSCIENCE, V117, P147, DOI 10.1016/S0306-4522(02)00802-3; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Graham DL, 2009, BIOL PSYCHIAT, V65, P696, DOI 10.1016/j.biopsych.2008.09.032; Grimm JW, 2003, J NEUROSCI, V23, P742; Heusner CL, 2005, J NEUROSCI, V25, P6651, DOI 10.1523/JNEUROSCI.1474-05.2005; Horger BA, 1999, J NEUROSCI, V19, P4110; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Koya E, 2009, NAT NEUROSCI, V12, P1069, DOI 10.1038/nn.2364; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Lu L, 2006, TRENDS NEUROSCI, V29, P695, DOI 10.1016/j.tins.2006.10.005; Luikart BW, 2003, NEUROSCIENCE, V117, P847, DOI 10.1016/S0306-4522(02)00719-4; Mikkelsen JD, 2005, EUR J PHARMACOL, V519, P223, DOI 10.1016/j.ejphar.2005.06.049; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Peoples L L, 2007, ScientificWorldJournal, V7, P22; Renthal W, 2008, J NEUROSCI, V28, P7344, DOI 10.1523/JNEUROSCI.1043-08.2008; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Self DW, 2010, RECEPT SER, P479, DOI 10.1007/978-1-60327-333-6_17; Valjent E, 2000, J NEUROSCI, V20, P8701; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005; Vassoler FM, 2008, J NEUROSCI, V28, P8735, DOI 10.1523/JNEUROSCI.5277-07.2008; Zhang JH, 2006, J NEUROSCI, V26, P13287, DOI 10.1523/JNEUROSCI.3795-06.2006	40	572	584	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					385	390		10.1126/science.1188472	http://dx.doi.org/10.1126/science.1188472			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947769	Green Accepted			2022-12-28	WOS:000282986700045
J	McDonald, B; Pittman, K; Menezes, GB; Hirota, SA; Slaba, I; Waterhouse, CCM; Beck, PL; Muruve, DA; Kubes, P				McDonald, Braedon; Pittman, Keir; Menezes, Gustavo B.; Hirota, Simon A.; Slaba, Ingrid; Waterhouse, Christopher C. M.; Beck, Paul L.; Muruve, Daniel A.; Kubes, Paul			Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation	SCIENCE			English	Article							TOLL-LIKE RECEPTORS; DYING CELLS; NLRP3 INFLAMMASOME; NALP3 INFLAMMASOME; IMMUNE-SYSTEM; INJURY; IDENTIFICATION; HEPATOTOXICITY; RELEASE; HMGB1	Neutrophils are recruited from the blood to sites of sterile inflammation, where they contribute to wound healing but may also cause tissue damage. By using spinning disk confocal intravital microscopy, we examined the kinetics and molecular mechanisms of neutrophil recruitment to sites of focal hepatic necrosis in vivo. Adenosine triphosphate released from necrotic cells activated the Nlrp3 inflammasome to generate an inflammatory microenvironment that alerted circulating neutrophils to adhere within liver sinusoids. Subsequently, generation of an intravascular chemokine gradient directed neutrophil migration through healthy tissue toward foci of damage. Lastly, formyl-peptide signals released from necrotic cells guided neutrophils through nonperfused sinusoids into the injury. Thus, dynamic in vivo imaging revealed a multistep hierarchy of directional cues that guide neutrophil localization to sites of sterile inflammation.	[McDonald, Braedon; Pittman, Keir; Menezes, Gustavo B.; Slaba, Ingrid; Waterhouse, Christopher C. M.; Muruve, Daniel A.; Kubes, Paul] Univ Calgary, Immunol Res Grp, Calgary, AB T2N 4N1, Canada; [Hirota, Simon A.; Beck, Paul L.] Univ Calgary, Snyder Inst Infect Immun & Inflammat, Gastrointestinal Res Grp, Calgary, AB T2N 4N1, Canada; [Waterhouse, Christopher C. M.] Univ Calgary, Dept Pediat, Div Pediat Gastroenterol, Calgary, AB T2N 4N1, Canada; [Beck, Paul L.; Muruve, Daniel A.] Univ Calgary, Dept Med, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Kubes, P (corresponding author), Univ Calgary, Immunol Res Grp, Calgary, AB T2N 4N1, Canada.	pkubes@ucalgary.ca	Menezes, Gustavo B/B-3350-2013		Canadian Institutes of Health Research; Alberta Innovates (Health Solutions)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates (Health Solutions)	We thank C. Badick for excellent technical support. This study was supported by grants from the Canadian Institutes of Health Research and Alberta Innovates (Health Solutions).	Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Hyman MC, 2009, J CLIN INVEST, V119, P1136, DOI 10.1172/JCI36433; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kono H, 2010, J IMMUNOL, V184, P4470, DOI 10.4049/jimmunol.0902485; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Liu ZX, 2006, HEPATOLOGY, V43, P1220, DOI 10.1002/hep.21175; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	23	835	855	4	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					362	366		10.1126/science.1195491	http://dx.doi.org/10.1126/science.1195491			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947763				2022-12-28	WOS:000282986700039
J	Stefl, R; Oberstrass, FC; Hood, JL; Jourdan, M; Zimmermann, M; Skrisovska, L; Maris, C; Peng, L; Hofr, C; Emeson, RB; Allain, FHT				Stefl, Richard; Oberstrass, Florian C.; Hood, Jennifer L.; Jourdan, Muriel; Zimmermann, Michal; Skrisovska, Lenka; Maris, Christophe; Peng, Li; Hofr, Ctirad; Emeson, Ronald B.; Allain, Frederic H-T			The Solution Structure of the ADAR2 dsRBM-RNA Complex Reveals a Sequence-Specific Readout of the Minor Groove	CELL			English	Article							DOUBLE-STRANDED-RNA; TORSION ANGLE DYNAMICS; DSRNA-BINDING DOMAIN; ADENOSINE DEAMINASES; RIBONUCLEASE-III; EDITING ENZYME; PROTEIN-KINASE; GLUR-B; NMR; RECOGNITION	Sequence-dependent recognition of dsDNA-binding proteins is well understood, yet sequence-specific recognition of dsRNA by proteins remains largely unknown, despite their importance in RNA maturation pathways. Adenosine deaminases that act on RNA (ADARs) recode genomic information by the site-selective deamination of adenosine. Here, we report the solution structure of the ADAR2 double-stranded RNA-binding motifs (dsRBMs) bound to a stem-loop pre-mRNA encoding the R/G editing site of GluR-2. The structure provides a molecular basis for how dsRBMs recognize the shape, and also more surprisingly, the sequence of the dsRNA. The unexpected direct readout of the RNA primary sequence by dsRBMs is achieved via the minor groove of the dsRNA and this recognition is critical for both editing and binding affinity at the R/G site of GluR-2. More generally, our findings suggest a solution to the sequence-specific paradox faced by many dsRBM-containing proteins that are involved in post-transcriptional regulation of gene expression.	[Stefl, Richard; Oberstrass, Florian C.; Jourdan, Muriel; Skrisovska, Lenka; Maris, Christophe; Allain, Frederic H-T] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Peng, Li; Emeson, Ronald B.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Hood, Jennifer L.] Vanderbilt Univ, Grad Program Neurosci, Nashville, TN 37232 USA; [Stefl, Richard] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, CZ-62500 Brno, Czech Republic; [Zimmermann, Michal; Hofr, Ctirad] Masaryk Univ, Fac Sci, Inst Expt Biol, Dept Funct Genom & Prote, CZ-62500 Brno, Czech Republic	Swiss Federal Institutes of Technology Domain; ETH Zurich; Vanderbilt University; Vanderbilt University; Masaryk University Brno; Masaryk University Brno	Allain, FHT (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	allain@mol.biol.ethz.ch	Hofr, Ctirad/E-3322-2012; Stefl, Richard/D-7010-2012	Stefl, Richard/0000-0003-0558-5952; Emeson, Ronald/0000-0002-4585-1648	Swiss National Science Foundation [3100A0-118118]; SNF-NCCR; National Institutes of Health [R01 NS33323]; Ministry of Education of the Czech Republic [MSM0021622413, Ingo LA08008]; GACR [204/08/1212, 305/10/1490]; GAAV [IAA401630903]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033323] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SNF-NCCR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); GACR(Grant Agency of the Czech Republic); GAAV(Grant Agency of the Czech Republic); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Swiss National Science Foundation (Nr. 3100A0-118118) and the SNF-NCCR structural biology to F. H. T. A and the National Institutes of Health (R01 NS33323) to R. B. E. R. S. is supported by the Ministry of Education of the Czech Republic (MSM0021622413, Ingo LA08008), GACR (204/08/1212, 305/10/1490), GAAV (IAA401630903), HHMI/EMBO start-up grant, and HFSP Career Development Award. M.Z. and C. H. are supported by GACR (204/08/H054) and by the Ministry of Education of the Czech Republic (MSM0021622415). M.Z. is in receipt of a Brno City Scholarship for Talented Ph.D.Students. The coordinates of the structures of GluR-2 LSL RNA, ADAR2 dsRBM1 bound to GluR-2 USL RNA, ADAR2 dsRBM2 bound to GluR-2 LSL RNA and ADAR2 dsRBM12 bound to GluR-2 have been deposited in the Protein Data Bank with accession codes 2l2j, 2I3c, 2l2k, and 2I3j, respectively.	Aruscavage PJ, 2000, RNA, V6, P257, DOI 10.1017/S1355838200991921; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Blaszczyk J, 2004, STRUCTURE, V12, P457, DOI 10.1016/j.str.2004.02.004; Case D. A., 2002, AMBER 7; Chilibeck KA, 2006, J BIOL CHEM, V281, P16530, DOI 10.1074/jbc.M511831200; Cho DSC, 2003, J BIOL CHEM, V278, P17093, DOI 10.1074/jbc.M213127200; DeLano W.L, PYMOL MOL GRAPHICS S; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Gallo A, 2003, EMBO J, V22, P3421, DOI 10.1093/emboj/cdg327; Gan JH, 2006, CELL, V124, P355, DOI 10.1016/j.cell.2005.11.034; Gan J, 2008, MOL MICROBIOL, V67, P143, DOI 10.1111/j.1365-2958.2007.06032.x; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HEALE BS, 2009, EMBO J; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Katoh T, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1120; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuzmic P, 2006, MOL CELL ENDOCRINOL, V248, P172, DOI 10.1016/j.mce.2005.10.012; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEGAULT P, 1994, J AM CHEM SOC, V116, P8390, DOI 10.1021/ja00097a066; Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Liu Y, 2000, P NATL ACAD SCI USA, V97, P12541, DOI 10.1073/pnas.97.23.12541; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Macbeth MR, 2004, RNA, V10, P1563, DOI 10.1261/rna.7920904; MCMILLAN NAJ, 1995, J BIOL CHEM, V270, P2601, DOI 10.1074/jbc.270.6.2601; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Oberstrass FC, 2006, NAT STRUCT MOL BIOL, V13, P160, DOI 10.1038/nsmb1038; Ohman M, 2000, RNA, V6, P687, DOI 10.1017/S1355838200000200; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Parks Malcolm R, 2004, J Transl Med, V2, P28, DOI 10.1186/1479-5876-2-28; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Sansam CL, 2003, P NATL ACAD SCI USA, V100, P14018, DOI 10.1073/pnas.2336131100; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Steffensen M, 2002, INSUR MATH ECON, V31, P71, DOI 10.1016/S0167-6687(02)00127-0; Stefl R, 2006, STRUCTURE, V14, P345, DOI 10.1016/j.str.2005.11.013; Stefl R, 2005, RNA, V11, P592, DOI 10.1261/rna.7276805; Stefl R, 2005, EMBO REP, V6, P33, DOI 10.1038/sj.embor.7400325; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Tonkin LA, 2003, SCIENCE, V302, P1725, DOI 10.1126/science.1091340; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Tsui V, 2000, J BIOMOL NMR, V16, P9, DOI 10.1023/A:1008302430561; Valente L, 2005, PROG NUCLEIC ACID RE, V79, P299, DOI 10.1016/S0079-6603(04)79006-6; Valente L, 2007, J BIOL CHEM, V282, P16054, DOI 10.1074/jbc.M611392200; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Wu HH, 2004, P NATL ACAD SCI USA, V101, P8307, DOI 10.1073/pnas.0402627101; Xu M, 2006, MOL BIOL CELL, V17, P3211, DOI 10.1091/mbc.E06-02-0162; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	63	168	174	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					225	237		10.1016/j.cell.2010.09.026	http://dx.doi.org/10.1016/j.cell.2010.09.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946981	Bronze, Green Accepted			2022-12-28	WOS:000283052200012
J	Tateno, S; Hirose, K; Ohishi, Y; Tatsumi, Y				Tateno, Shigehiko; Hirose, Kei; Ohishi, Yasuo; Tatsumi, Yoshiyuki			The Structure of Iron in Earth's Inner Core	SCIENCE			English	Article							CENTERED-CUBIC IRON; SITU X-RAY; THERMAL-EXPANSION; 300 GPA; PHASE; TEMPERATURE; ELASTICITY; ANISOTROPY; STABILITY; ALLOY	Earth's solid inner core is mainly composed of iron (Fe). Because the relevant ultrahigh pressure and temperature conditions are difficult to produce experimentally, the preferred crystal structure of Fe at the inner core remains uncertain. Static compression experiments showed that the hexagonal close-packed (hcp) structure of Fe is stable up to 377 gigapascals and 5700 kelvin, corresponding to inner core conditions. The observed weak temperature dependence of the c/a axial ratio suggests that hcp Fe is elastically anisotropic at core temperatures. Preferred orientation of the hcp phase may explain previously observed inner core seismic anisotropy.	[Tateno, Shigehiko; Hirose, Kei] Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; [Tateno, Shigehiko; Hirose, Kei; Tatsumi, Yoshiyuki] Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan; [Ohishi, Yasuo] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Tokyo Institute of Technology; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Synchrotron Radiation Research Institute	Tateno, S (corresponding author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan.	tateno.s.aa@m.titech.ac.jp; kei@geo.titech.ac.jp	Hirose, Kei/C-2165-2009; Tateno, Shigehiko/D-4640-2011	Hirose, Kei/0000-0003-4366-7721; 	JSPS	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank N. Sata, T. Komabayashi, and Y. Tanaka for technical support. The synchrotron XRD measurements were conducted at beamline BL10XU of the SPring-8 synchrotron radiation facility (proposal nos. 2009B0087 and 2010A0087). S. T. was supported by the JSPS Research Fellowships for Young Scientists.	Alfe D, 2007, CONTEMP PHYS, V48, P63, DOI 10.1080/00107510701529653; Belonoshko AB, 2003, NATURE, V424, P1032, DOI 10.1038/nature01954; BOEHLER R, 1993, NATURE, V363, P534, DOI 10.1038/363534a0; Boehler R, 2008, J PHYS CONF SER, V121, DOI 10.1088/1742-6596/121/2/022018; BOEHLER R, 1990, J GEOPHYS RES-SOLID, V95, P21731, DOI 10.1029/JB095iB13p21731; Cote AS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032788; Dubrovinsky L, 2007, SCIENCE, V316, P1880, DOI 10.1126/science.1142105; Dubrovinsky LS, 2000, PHYS REV LETT, V84, P1720, DOI 10.1103/PhysRevLett.84.1720; Frost DJ, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006302; Gannarelli CMS, 2005, PHYS EARTH PLANET IN, V152, P67, DOI 10.1016/j.pepi.2005.06.003; Kuwayama Y, 2005, SCIENCE, V309, P923, DOI 10.1126/science.1114879; Kuwayama Y, 2008, EARTH PLANET SC LETT, V273, P379, DOI 10.1016/j.epsl.2008.07.001; Lord OT, 2009, EARTH PLANET SC LETT, V284, P157, DOI 10.1016/j.epsl.2009.04.017; Luo W, 2010, P NATL ACAD SCI USA, V107, P9962, DOI 10.1073/pnas.1004076107; Ma YZ, 2004, PHYS EARTH PLANET IN, V143, P455, DOI 10.1016/j.pepi.2003.06.005; MAO HK, 1990, J GEOPHYS RES-SOLID, V95, P21737, DOI 10.1029/JB095iB13p21737; Mattesini M, 2010, P NATL ACAD SCI USA, V107, P9507, DOI 10.1073/pnas.1004856107; Mikhaylushkin AS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.165505; Monnereau M, 2010, SCIENCE, V328, P1014, DOI 10.1126/science.1186212; MORELLI A, 1986, GEOPHYS RES LETT, V13, P1545, DOI 10.1029/GL013i013p01545; Prakapenka VB, 2003, HIGH TEMP-HIGH PRESS, V35-6, P237, DOI 10.1068/htjr098; Rouquette J, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2892400; Sata N, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006975; Stacey F. D., 2008, PHYS EARTH; Steinle-Neumann G, 2001, NATURE, V413, P57, DOI 10.1038/35092536; STIXRUDE L, 1995, SCIENCE, V267, P1972, DOI 10.1126/science.267.5206.1972; Vocadlo L, 2003, NATURE, V424, P536, DOI 10.1038/nature01829	27	280	291	3	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					359	361		10.1126/science.1194662	http://dx.doi.org/10.1126/science.1194662			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947762				2022-12-28	WOS:000282986700038
J	Zhang, MJ; Su, YQ; Sugiura, K; Xia, GL; Eppig, JJ				Zhang, Meijia; Su, You-Qiang; Sugiura, Koji; Xia, Guoliang; Eppig, John J.			Granulosa Cell Ligand NPPC and Its Receptor NPR2 Maintain Meiotic Arrest in Mouse Oocytes	SCIENCE			English	Article							NATRIURETIC-PEPTIDE; CUMULUS CELLS; CYCLIC-GMP; MATURATION; GPR3; FOLLICLES; VITRO; OVARY; BMP15	Granulosa cells of mammalian Graafian follicles maintain oocytes in meiotic arrest, which prevents their precocious maturation. We show that mouse mural granulosa cells, which line the follicle wall, express natriuretic peptide precursor type C (Nppc) messenger RNA (mRNA), whereas cumulus cells surrounding oocytes express mRNA of the NPPC receptor NPR2, a guanylyl cyclase. NPPC increased cGMP levels in cumulus cells and oocytes and inhibited meiotic resumption in vitro. Meiotic arrest was not sustained in most Graafian follicles of Nppc or Npr2 mutant mice, and meiosis resumed precociously. Oocyte-derived paracrine factors promoted cumulus cell expression of Npr2 mRNA. Therefore, the granulosa cell ligand NPPC and its receptor NPR2 in cumulus cells prevent precocious meiotic maturation, which is critical for maturation and ovulation synchrony and for normal female fertility.	[Zhang, Meijia; Xia, Guoliang] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Zhang, Meijia; Su, You-Qiang; Sugiura, Koji; Eppig, John J.] Jackson Lab, 600 Main St, Bar Harbor 04609, ME USA	China Agricultural University; Jackson Laboratory	Eppig, JJ (corresponding author), Jackson Lab, 600 Main St, Bar Harbor 04609, ME USA.	glxia@cau.edu.cn; john.eppig@jax.org	Sugiura, Koji/AAE-2966-2019; Su, You-Qiang/C-6160-2019	Sugiura, Koji/0000-0001-8945-3353; Su, You-Qiang/0000-0003-3537-6246; Xia, Guoliang/0000-0003-3674-0142; Zhang, Meijia/0000-0001-7803-3054	Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD23839, HD21970]; National Basic Research Program of China [2007CB947401, 2006CB504003]; State Key Laboratory for Agrobiotechnology of China [2009SKLAB07-5]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD023839] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD021970, R37HD021970] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Basic Research Program of China(National Basic Research Program of China); State Key Laboratory for Agrobiotechnology of China; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank G. Cox, T. Gridley, and M. A. Handel for comments in preparation of the manuscript and L. Jaffe for helpful discussions. J.J.E., K. S., and Y.-Q.S. were supported by grants HD23839 and HD21970 from Eunice Kennedy Shriver National Institute of Child Health and Human Development. M.Z. and G. X. received support from National Basic Research Program of China (grants 2007CB947401 and 2006CB504003) and grant 2009SKLAB07-5 from State Key Laboratory for Agrobiotechnology of China. We also thank M. Mazuk, Baylor College of Medicine, for providing GDF9 and BMP15 and M. O'Brien and K. Wigglesworth for technical assistance.	Diaz FJ, 2007, J CELL SCI, V120, P1330, DOI 10.1242/jcs.000968; EDWARDS RG, 1965, NATURE, V208, P349, DOI 10.1038/208349a0; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; Jankowski M, 1997, BIOL REPROD, V56, P59, DOI 10.1095/biolreprod56.1.59; Ledent C, 2005, P NATL ACAD SCI USA, V102, P8922, DOI 10.1073/pnas.0503840102; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Norris RP, 2009, DEVELOPMENT, V136, P1869, DOI 10.1242/dev.035238; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Pincus G, 1935, J EXP MED, V62, P665, DOI 10.1084/jem.62.5.665; Richard FJ, 2001, BIOL REPROD, V65, P1444, DOI 10.1095/biolreprod65.5.1444; Su YQ, 2008, DEVELOPMENT, V135, P111, DOI 10.1242/dev.009068; Sugiura K, 2007, DEVELOPMENT, V134, P2593, DOI 10.1242/dev.006882; TORNELL J, 1990, ENDOCRINOLOGY, V126, P1504, DOI 10.1210/endo-126-3-1504; Tsuji T, 2008, BIOCHEM BIOPH RES CO, V376, P186, DOI 10.1016/j.bbrc.2008.08.139; Vaccari S, 2009, BIOL REPROD, V81, P595, DOI 10.1095/biolreprod.109.077768	15	354	396	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					366	369		10.1126/science.1193573	http://dx.doi.org/10.1126/science.1193573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947764	Green Accepted			2022-12-28	WOS:000282986700040
J	Penzias, AA				Penzias, Arno Allan			A runaway success	NATURE			English	Editorial Material									[Penzias, Arno Allan] USA, Washington, DC USA; [Penzias, Arno Allan] Columbia Univ, New York, NY 10027 USA; [Penzias, Arno Allan] Bell Labs, Murray Hill, NJ 07974 USA	Columbia University; AT&T									0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					S4	S4		10.1038/467S4a	http://dx.doi.org/10.1038/467S4a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944619	Bronze			2022-12-28	WOS:000282898700003
J	Wagner, CR; Kuervers, L; Baillie, DL; Yanowitz, JL				Wagner, Cynthia R.; Kuervers, Lynnette; Baillie, David L.; Yanowitz, Judith L.			xnd-1 regulates the global recombination landscape in Caenorhabditis elegans	NATURE			English	Article							DOUBLE-STRAND BREAKS; MEIOTIC RECOMBINATION; C-ELEGANS; DNA; COMPLEX; PRDM9; CROSSOVERS; GERMLINE; HOTSPOTS; REVEALS	Meiotic crossover (CO) recombination establishes physical linkages between homologous chromosomes that are required for their proper segregation into developing gametes, and promotes genetic diversity by shuffling genetic material between parental chromosomes. COs require the formation of double strand breaks (DSBs) to create the substrate for strand exchange. DSBs occur in small intervals called hotspots(1-3) and significant variation in hotspot usage exists between and among individuals(4). This variation is thought to reflect differences in sequence identity and chromatin structure, DNA topology and/or chromosome domain organization(1,5-9). Chromosomes show different frequencies of nondisjunction (NDJ)(10), reflecting inherent differences in meiotic crossover control, yet the underlying basis of these differences remains elusive. Here we show that a novel chromatin factor, X non-disjunction factor 1 (xnd-1), is responsible for the global distribution of COs in C. elegans. xnd-1 is also required for formation of double-strand breaks (DSBs) on the X, but surprisingly XND-1 protein is autosomally enriched. We show that xnd-1 functions independently of genes required for X chromosome-specific gene silencing, revealing a novel pathway that distinguishes the X from autosomes in the germ line, and further show that xnd-1 exerts its effects on COs, at least in part, by modulating levels of H2A lysine 5 acetylation.	[Wagner, Cynthia R.; Yanowitz, Judith L.] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Kuervers, Lynnette; Baillie, David L.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Yanowitz, Judith L.] Magee Womens Res Inst, Pittsburgh, PA 15213 USA; [Yanowitz, Judith L.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA	Carnegie Institution for Science; Simon Fraser University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yanowitz, JL (corresponding author), Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA.	yanowitzjl@mwri.magee.edu	Yanowitz, Judith L/AGJ-8504-2022	Yanowitz, Judith L/0000-0001-6886-8787	Carnegie Institution of Washington, NIH [K01AG031296]; MWRI; NSERC; NATIONAL INSTITUTE ON AGING [K01AG031296] Funding Source: NIH RePORTER	Carnegie Institution of Washington, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MWRI; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Bembenek, A. Bortvin, G. Deshpande, M. Halpern, V. Jantsch, A. MacQueen and D. Mets for comments on the manuscript; the Koshland lab and Baltimore Area Worm Club for discussions; M. Siddiqi for microscopy support. We are indebted to the Caenorhabditis Genetics Center and the C. elegans Knockout Consortium for worm stocks and Y. Kohara for cDNAs. This work was supported by the Carnegie Institution of Washington, NIH K01AG031296, and MWRI start-up funds to J.L.Y.D.L.B. was supported by a Canada Research Chair and a grant from NSERC.	BARNES TM, 1995, GENETICS, V141, P159; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; BRENNER S, 1974, GENETICS, V77, P71; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Ceol CJ, 2004, DEV CELL, V6, P563, DOI 10.1016/S1534-5807(04)00065-6; CHAN A, 2006, PROTOCOL 21 ANTIBODY; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Fong YY, 2002, SCIENCE, V296, P2235, DOI 10.1126/science.1070790; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; HODGKIN J, 1979, GENETICS, V91, P67; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kelly WG, 1997, GENETICS, V146, P227; Kelly WG, 2002, DEVELOPMENT, V129, P479; Lim JGY, 2008, GENETICS, V180, P715, DOI 10.1534/genetics.108.090142; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Mieczkowski PA, 2007, P NATL ACAD SCI USA, V104, P3955, DOI 10.1073/pnas.0700412104; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Petty EL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000699; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Robine N, 2007, MOL CELL BIOL, V27, P1868, DOI 10.1128/MCB.02063-06; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Smolikov S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000088; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tsai CJ, 2008, GENE DEV, V22, P194, DOI 10.1101/gad.1618508; ZETKA MC, 1995, GENETICS, V141, P1339	36	56	57	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					839	U103		10.1038/nature09429	http://dx.doi.org/10.1038/nature09429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944745	Green Accepted, Green Submitted			2022-12-28	WOS:000282898700066
J	Wu, FZ; Huang, YL				Wu, Fu-Zong; Huang, Yi-Luan			Funnel Chest	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wu, Fu-Zong; Huang, Yi-Luan] Kaohsiung Vet Gen Hosp, Kaohsiung, Taiwan	Kaohsiung Veterans General Hospital	Wu, FZ (corresponding author), Kaohsiung Vet Gen Hosp, Kaohsiung, Taiwan.	cmvwu@hotmail.com	Wu, Fu-Zong/J-8941-2019	Wu, Fu-Zong/0000-0003-2556-6118					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2010	363	16					1559	1559		10.1056/NEJMicm1001328	http://dx.doi.org/10.1056/NEJMicm1001328			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663KP	20942672				2022-12-28	WOS:000282887100010
J	Gibiansky, ML; Conrad, JC; Jin, F; Gordon, VD; Motto, DA; Mathewson, MA; Stopka, WG; Zelasko, DC; Shrout, JD; Wong, GCL				Gibiansky, Maxsim L.; Conrad, Jacinta C.; Jin, Fan; Gordon, Vernita D.; Motto, Dominick A.; Mathewson, Margie A.; Stopka, Wiktor G.; Zelasko, Daria C.; Shrout, Joshua D.; Wong, Gerard C. L.			Bacteria Use Type IV Pili to Walk Upright and Detach from Surfaces	SCIENCE			English	Article							BIOFILM FORMATION; MOTILITY	Bacterial biofilms are structured multicellular communities involved in a broad range of infections. Knowing how free-swimming bacteria adapt their motility mechanisms near surfaces is crucial for understanding the transition between planktonic and biofilm phenotypes. By translating microscopy movies into searchable databases of bacterial behavior, we identified fundamental type IV pili-driven mechanisms for Pseudomonas aeruginosa surface motility involved in distinct foraging strategies. Bacteria stood upright and "walked" with trajectories optimized for two-dimensional surface exploration. Vertical orientation facilitated surface detachment and could influence biofilm morphology.	[Gibiansky, Maxsim L.; Jin, Fan; Gordon, Vernita D.; Wong, Gerard C. L.] Univ Calif Los Angeles, Dept Bioengn, Calif Nano Syst Inst, Los Angeles, CA 90024 USA; [Conrad, Jacinta C.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA; [Mathewson, Margie A.; Stopka, Wiktor G.; Zelasko, Daria C.; Wong, Gerard C. L.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Motto, Dominick A.; Shrout, Joshua D.] Univ Notre Dame, Dept Civil Engn & Geol Sci, Notre Dame, IN 46556 USA	University of California System; University of California Los Angeles; University of Houston System; University of Houston; University of Illinois System; University of Illinois Urbana-Champaign; University of Notre Dame	Wong, GCL (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Calif Nano Syst Inst, Los Angeles, CA 90024 USA.	gclwong@seas.ucla.edu	Shrout, Joshua D/C-4743-2012; Conrad, Jacinta/D-6432-2013	Shrout, Joshua D/0000-0001-9509-2187; Conrad, Jacinta/0000-0001-6084-4772; Gordon, Vernita/0000-0002-5989-9378; fan, jin/0000-0003-2313-0388				Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; Tolker-Nielsen T, 2000, J BACTERIOL, V182, P6482, DOI 10.1128/JB.182.22.6482-6489.2000	7	139	144	9	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					197	U50		10.1126/science.1194238	http://dx.doi.org/10.1126/science.1194238			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929769	Green Published			2022-12-28	WOS:000282644600033
J	Kotov, NA				Kotov, Nicholas A.			Inorganic Nanoparticles as Protein Mimics	SCIENCE			English	Editorial Material							SEMICONDUCTOR NANOPARTICLES; QUANTUM DOTS; SIZE; DNA		Univ Michigan, Dept Biomed Engn, Dept Chem Engn, Dept Mat Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kotov, NA (corresponding author), Univ Michigan, Dept Biomed Engn, Dept Chem Engn, Dept Mat Sci, Ann Arbor, MI 48109 USA.	kotov@umich.edu	Kotov, Nicholas/AAZ-4204-2021; Nanozymes, Nanozymes/D-8197-2019	Kotov, Nicholas/0000-0002-6864-5804; 				AGRANOVSKY AA, 1995, P NATL ACAD SCI USA, V92, P2470, DOI 10.1073/pnas.92.7.2470; Aubin-Tam ME, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034001; Bayraktar H, 2006, CHEM COMMUN, P1390, DOI 10.1039/b516096k; Bharali DJ, 2005, P NATL ACAD SCI USA, V102, P11539, DOI 10.1073/pnas.0504926102; Cai YR, 2007, J MATER CHEM, V17, P3780, DOI 10.1039/b705129h; CHEMSEDDINE A, 1993, BER BUNSEN PHYS CHEM, V97, P636, DOI 10.1002/bbpc.19930970417; Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675; Errington J, 2001, NAT REV MOL CELL BIO, V2, P538, DOI 10.1038/35080005; Ishii D, 2003, NATURE, V423, P628, DOI 10.1038/nature01663; Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m; Klein J, 2007, P NATL ACAD SCI USA, V104, P2029, DOI 10.1073/pnas.0611610104; Li XQ, 2008, CATAL LETT, V124, P413, DOI 10.1007/s10562-008-9494-5; Mahtab R, 2000, J AM CHEM SOC, V122, P14, DOI 10.1021/ja9907156; Manea F, 2004, ANGEW CHEM INT EDIT, V43, P6165, DOI 10.1002/anie.200460649; Mohanan JL, 2005, SCIENCE, V307, P397, DOI 10.1126/science.1106525; Seleverstov O, 2006, NANO LETT, V6, P2826, DOI 10.1021/nl0619711; Sinyagin AY, 2006, J PHYS CHEM B, V110, P7500, DOI 10.1021/jp057105e; Sleytr UB, 1999, ANGEW CHEM INT EDIT, V38, P1035, DOI 10.1002/(SICI)1521-3773(19990419)38:8<1034::AID-ANIE1034>3.0.CO;2-#; Srivastava S, 2010, SCIENCE, V327, P1355, DOI 10.1126/science.1177218; Tang ZY, 2006, SCIENCE, V314, P274, DOI 10.1126/science.1128045; Tang ZY, 2002, SCIENCE, V297, P237, DOI 10.1126/science.1072086	21	265	269	5	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2010	330	6001					188	189		10.1126/science.1190094	http://dx.doi.org/10.1126/science.1190094			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929766				2022-12-28	WOS:000282644600030
J	Liu, TG; Khosla, C				Liu, Tiangang; Khosla, Chaitan			A Balancing Act for Taxol Precursor Pathways in E. coli	SCIENCE			English	Editorial Material							STEREOCONTROLLED SYNTHESIS; ESCHERICHIA-COLI; PINENE PATH; BIOSYNTHESIS; TAXANES		[Liu, Tiangang] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Liu, TG (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	liutg@stanford.edu; khosla@stanford.edu		Khosla, Chaitan/0000-0001-6529-495X	NCI NIH HHS [R01 CA 077248] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077248] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Holton RA., 1995, TAXOL SCI APPL, P97, DOI DOI 10.1002/CHIN.199552275; Huang QL, 2001, BIOORGAN MED CHEM, V9, P2237, DOI 10.1016/S0968-0896(01)00072-4; Kirby J, 2009, ANNU REV PLANT BIOL, V60, P335, DOI 10.1146/annurev.arplant.043008.091955; Leonard E, 2007, APPL ENVIRON MICROB, V73, P7246, DOI 10.1128/AEM.01411-07; Roberts SC, 2007, NAT CHEM BIOL, V3, P387, DOI 10.1038/nchembio.2007.8; Suffness M, 1995, TAXOL SCI APPL, P3; Wender PA, 1997, J AM CHEM SOC, V119, P2755, DOI 10.1021/ja9635387; Wender PA, 1997, J AM CHEM SOC, V119, P2757, DOI 10.1021/ja963539z	9	18	25	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					44	45		10.1126/science.1195014	http://dx.doi.org/10.1126/science.1195014			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929799				2022-12-28	WOS:000282334500025
J	Loth, S; Etzkorn, M; Lutz, CP; Eigler, DM; Heinrich, AJ				Loth, Sebastian; Etzkorn, Markus; Lutz, Christopher P.; Eigler, D. M.; Heinrich, Andreas J.			Measurement of Fast Electron Spin Relaxation Times with Atomic Resolution	SCIENCE			English	Article							SCANNING-TUNNELING-MICROSCOPY; NANOSCALE; RESONANCE; SURFACES; DIAMOND	Single spins in solid-state systems are often considered prime candidates for the storage of quantum information, and their interaction with the environment the main limiting factor for the realization of such schemes. The lifetime of an excited spin state is a sensitive measure of this interaction, but extending the spatial resolution of spin relaxation measurements to the atomic scale has been a challenge. We show how a scanning tunneling microscope can measure electron spin relaxation times of individual atoms adsorbed on a surface using an all-electronic pump-probe measurement scheme. The spin relaxation times of individual Fe-Cu dimers were found to vary between 50 and 250 nanoseconds. Our method can in principle be generalized to monitor the temporal evolution of other dynamical systems.	[Loth, Sebastian; Lutz, Christopher P.; Eigler, D. M.; Heinrich, Andreas J.] IBM Res Div, Almaden Res Ctr, San Jose, CA 95120 USA; [Etzkorn, Markus] Ecole Polytech Fed Lausanne, Inst Phys Matiere Condensee, CH-1015 Lausanne, Switzerland	International Business Machines (IBM); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Loth, S (corresponding author), IBM Res Div, Almaden Res Ctr, 650 Harry Rd, San Jose, CA 95120 USA.	lothseb@us.ibm.com; heinrich@almaden.ibm.com	Loth, Sebastian/ABG-5237-2020	Loth, Sebastian/0000-0002-1587-3678	Office of Naval Research; Alexander von Humboldt Foundation; European Science Foundation	Office of Naval Research(Office of Naval Research); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); European Science Foundation(European Science Foundation (ESF)European Commission)	We thank B. Melior for technical assistance. S. L., C. P. L., and A.J.H. acknowledge financial support from the Office of Naval Research, S. L. from the Alexander von Humboldt Foundation, and M. E. from European Science Foundation project FunSMARTs II.	Ardavan A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.057201; Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Barwick B, 2008, SCIENCE, V322, P1227, DOI 10.1126/science.1164000; Bode M, 2007, NATURE, V447, P190, DOI 10.1038/nature05802; Browne WR, 2006, NAT NANOTECHNOL, V1, P25, DOI 10.1038/nnano.2006.45; Chen X, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.197208; Choi T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035430; Durkan C, 2002, APPL PHYS LETT, V80, P458, DOI 10.1063/1.1434301; Freedman DE, 2010, J AM CHEM SOC, V132, P1224, DOI 10.1021/ja909560d; Gatteschi D, 2006, MESOSCOPIC PHYS NANO, P1; Gupta JA, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.115416; Heinrich AJ, 2004, SCIENCE, V306, P466, DOI 10.1126/science.1101077; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hirjibehedin CF, 2006, SCIENCE, V312, P1021, DOI 10.1126/science.1125398; Hirjibehedin CF, 2007, SCIENCE, V317, P1199, DOI 10.1126/science.1146110; Komori F, 2004, PROG SURF SCI, V77, P1, DOI 10.1016/j.progsurf.2004.06.002; Leuenberger MN, 2001, NATURE, V410, P789, DOI 10.1038/35071024; Loth S, 2010, NAT PHYS, V6, P340, DOI 10.1038/NPHYS1616; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; NUNES G, 1993, SCIENCE, V262, P1029, DOI 10.1126/science.262.5136.1029; Rost MJ, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1915288; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; Sangregorio C, 1997, PHYS REV LETT, V78, P4645, DOI 10.1103/PhysRevLett.78.4645; Slichter C. P., 1996, PRINCIPLES MAGNETIC; Takeuchi O, 2004, APPL PHYS LETT, V85, P3268, DOI 10.1063/1.1804238; Tsukahara N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.167203; Wernsdorfer W, 1999, SCIENCE, V284, P133, DOI 10.1126/science.284.5411.133; Wiesendanger R, 2009, REV MOD PHYS, V81, P1495, DOI 10.1103/RevModPhys.81.1495	28	243	244	10	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1628	1630		10.1126/science.1191688	http://dx.doi.org/10.1126/science.1191688			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929842	Green Submitted, Green Published			2022-12-28	WOS:000282098100035
J	Benamouzig, R; Uzzan, B				Benamouzig, Robert; Uzzan, Bernard			Aspirin to prevent colorectal cancer: time to act?	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; TRANSIENT ISCHEMIC ATTACK; LOW-DOSE ASPIRIN; RISK; MG		[Benamouzig, Robert] Avicenne Hosp, Dept Gastroenterol, F-93009 Bobigny, France; [Uzzan, Bernard] Avicenne Hosp, Dept Pharmacol, F-93009 Bobigny, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP	Benamouzig, R (corresponding author), Avicenne Hosp, Dept Gastroenterol, F-93009 Bobigny, France.	robert.benamouzig@avc.aphp.fr	BENAMOUZIG, Robert/W-8067-2019	BENAMOUZIG, ROBERT/0000-0003-1952-6830				BOTHWELL PM, 2010, LANCET, V61, DOI DOI 10.1016/S0140-6736(10)61543-7; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; Cole BF, 2009, J NATL CANCER I, V101, P256, DOI 10.1093/jnci/djn485; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; GANN PH, 1993, JNCI-J NATL CANCER I, V85, P1220, DOI 10.1093/jnci/85.15.1220; MEADE TW, 1988, EUR HEART J, V9, P836, DOI 10.1093/oxfordjournals.eurheartj.a062576; NORRVING B, 1991, LANCET, V338, P1345; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; VANGIJN J, 1991, NEW ENGL J MED, V325, P1261, DOI 10.1056/NEJM199110313251801; Wallace K, 2009, CANCER EPIDEM BIOMAR, V18, P2310, DOI 10.1158/1055-9965.EPI-09-0211	13	6	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 20	2010	376	9754					1713	1714		10.1016/S0140-6736(10)61509-7	http://dx.doi.org/10.1016/S0140-6736(10)61509-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	690EI	20970845				2022-12-28	WOS:000284984900004
J	Feng, LA; Campbell, EB; Hsiung, YC; MacKinnon, R				Feng, Liang; Campbell, Ernest B.; Hsiung, Yichun; MacKinnon, Roderick			Structure of a Eukaryotic CLC Transporter Defines an Intermediate State in the Transport Cycle	SCIENCE			English	Article							MUSCLE CHLORIDE CHANNEL; DEPENDENT K+ CHANNEL; X-RAY-STRUCTURE; CYTOPLASMIC DOMAIN; MOLECULAR-BASIS; /H+ ANTIPORTER; OSTEOPETROSIS; SELECTIVITY; MUTATIONS; TRANSMEMBRANE	CLC proteins transport chloride (Cl-) ions across cell membranes to control the electrical potential of muscle cells, transfer electrolytes across epithelia, and control the pH and electrolyte composition of intracellular organelles. Some members of this protein family are Cl- ion channels, whereas others are secondary active transporters that exchange Cl- ions and protons (H+) with a 2: 1 stoichiometry. We have determined the structure of a eukaryotic CLC transporter at 3.5 angstrom resolution. Cytoplasmic cystathionine beta-synthase (CBS) domains are strategically positioned to regulate the ion-transport pathway, and many disease-causing mutations in human CLCs reside on the CBS-transmembrane interface. Comparison with prokaryotic CLC shows that a gating glutamate residue changes conformation and suggests a basis for 2: 1 Cl-/H+ exchange and a simple mechanistic connection between CLC channels and transporters.	[Feng, Liang; Campbell, Ernest B.; Hsiung, Yichun; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu			NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIBIB NIH HHS [P30 EB009998] Funding Source: Medline; NIGMS NIH HHS [R01 GM043949-21, R01 GM043949-20, R01 GM043949] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Accardi A, 2006, J MOL BIOL, V362, P691, DOI 10.1016/j.jmb.2006.07.081; Accardi A, 2010, BBA-BIOMEMBRANES, V1798, P1457, DOI 10.1016/j.bbamem.2010.02.022; Bennetts B, 2005, J BIOL CHEM, V280, P32452, DOI 10.1074/jbc.M502890200; Bergsdorf EY, 2009, J BIOL CHEM, V284, P11184, DOI 10.1074/jbc.M901170200; Chen TY, 2008, PHYSIOL REV, V88, P351, DOI 10.1152/physrev.00058.2006; DAVE S, CHANNELS AUSTIN, DOI DOI 10.4161/CHAN.4.4.12445; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Duffield M, 2003, J GEN PHYSIOL, V121, P149, DOI 10.1085/jgp.20028741; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Engh AM, 2005, J GEN PHYSIOL, V125, P601, DOI 10.1085/jgp.200509258; Frattini A, 2003, J BONE MINER RES, V18, P1740, DOI 10.1359/jbmr.2003.18.10.1740; Garcia-Olivares J, 2008, J PHYSIOL-LONDON, V586, P5325, DOI 10.1113/jphysiol.2008.158097; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Hebeisen S, 2005, BIOPHYS J, V89, P1710, DOI 10.1529/biophysj.104.056093; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Hryciw DH, 1998, J BIOL CHEM, V273, P4304, DOI 10.1074/jbc.273.8.4304; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jayaram H, 2008, P NATL ACAD SCI USA, V105, P11194, DOI 10.1073/pnas.0804503105; Jencks W. P., 1987, CATALYSIS CHEM ENZYM; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lossin C, 2008, ADV GENET, V63, P25, DOI 10.1016/S0065-2660(08)01002-X; Maduke M, 1998, BIOCHEMISTRY-US, V37, P1315, DOI 10.1021/bi972418o; Maduke M, 2000, ANNU REV BIOPH BIOM, V29, P411, DOI 10.1146/annurev.biophys.29.1.411; Markovic S, 2007, STRUCTURE, V15, P715, DOI 10.1016/j.str.2007.04.013; Matsuda JJ, 2010, J BIOL CHEM, V285, P2569, DOI 10.1074/jbc.M109.018002; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; Miller C, 2009, PHILOS T R SOC B, V364, P175, DOI 10.1098/rstb.2008.0138; Pangrazio A, 2010, HUM MUTAT, V31, pE1071, DOI 10.1002/humu.21167; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Picollo A, 2009, NAT STRUCT MOL BIOL, V16, P1294, DOI 10.1038/nsmb.1704; Pusch M, 2002, HUM MUTAT, V19, P423, DOI 10.1002/humu.10063; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; SchmidtRose T, 1997, J BIOL CHEM, V272, P20515, DOI 10.1074/jbc.272.33.20515; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Waguespack SG, 2003, J BONE MINER RES, V18, P1513, DOI 10.1359/jbmr.2003.18.8.1513; Walden M, 2007, J GEN PHYSIOL, V129, P317, DOI 10.1085/jgp.200709756; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; ZHANG JM, 1994, J BIOL CHEM, V269, P23518; Zifarelli G, 2007, REV PHYSIOL BIOCH P, V158, P23, DOI 10.1007/112_2006_0605; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284	49	195	198	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2010	330	6004					635	641		10.1126/science.1195230	http://dx.doi.org/10.1126/science.1195230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	20929736	Green Accepted			2022-12-28	WOS:000283580600038
J	Flores-Suarez, R; Reyes-del Valle, J				Flores-Suarez, Roberto; Reyes-del Valle, Jorge			A Foreign Body	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Flores-Suarez, Roberto; Reyes-del Valle, Jorge] Inst Salud Estado Mexico, Nezahualcoyotl, Mexico		Flores-Suarez, R (corresponding author), Inst Salud Estado Mexico, Nezahualcoyotl, Mexico.			FLORES SUAREZ, ROBERTO/0000-0002-0914-0486					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 28	2010	363	18					1748	1748		10.1056/NEJMicm0707656	http://dx.doi.org/10.1056/NEJMicm0707656			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671XF	20979475				2022-12-28	WOS:000283546400010
J	Rock, CL; Flatt, SW; Sherwood, NE; Karanja, N; Pakiz, B; Thomson, CA				Rock, Cheryl L.; Flatt, Shirley W.; Sherwood, Nancy E.; Karanja, Njeri; Pakiz, Bilge; Thomson, Cynthia A.			Effect of a Free Prepared Meal and Incentivized Weight Loss Program on Weight Loss and Weight Loss Maintenance in Obese and Overweight Women A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LIFE-STYLE INTERVENTION; C-REACTIVE PROTEIN; RISK-FACTORS; CARDIOVASCULAR-DISEASE; US ADULTS; HEALTH; DIET; REDUCTION; PLASMA; CANCER	Context The prevalence of overweight and obesity in the United States remains high. Commercial weight loss programs may contribute to efforts to reduce the prevalence of overweight and obesity, although few studies have examined their efficacy in controlled trials. Objective To test whether a free prepared meal and incentivized structured weight loss program promotes greater weight loss and weight loss maintenance at 2 years compared with usual care. Design, Setting, and Participants A randomized controlled trial of weight loss and weight loss maintenance in 442 overweight or obese women (body mass index, 25-40) aged 18 to 69 years (mean age, 44 years) conducted at US institutions over 2 years with follow-up between November 2007 and April 2010. Intervention The program, which involves in-person center-based or telephone-based one-to-one weight loss counseling, was available over a 2-year period. Behavioral goals were an energy-reduced, nutritionally adequate diet, facilitated by the inclusion of prepackaged food items in a planned menu during the initial weight loss phase, and increased physical activity. Participants assigned to usual care received 2 individualized weight loss counseling sessions with a dietetics professional and monthly contacts. Main Outcome Measures Weight loss and weight loss maintenance. Results Weight data were available at 24 months for 407 women (92.1% of the study sample). In an intent-to-treat analysis with baseline value substitution, mean weight loss was 7.4 kg (95% confidence interval [CI], 6.1-8.7 kg) or 7.9% (95% CI, 6.5%-9.3%) of initial weight at 24 months for the center-based group, 6.2 kg (95% CI, 4.9-7.6 kg) or 6.8% (95% CI, 5.2%-8.4%) for the telephone-based group, and 2.0 kg (95% CI, 0.6-3.3 kg) or 2.1% (95% CI, 0.7%-3.5%) for the usual care control group after 24 months (P<.001 for intervention effect). Conclusion Compared with usual care, this structured weight loss program resulted in greater weight loss over 2 years.	[Rock, Cheryl L.; Flatt, Shirley W.; Pakiz, Bilge] Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Rock, Cheryl L.; Flatt, Shirley W.; Pakiz, Bilge] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Sherwood, Nancy E.] HealthPartners Res Fdn, Minneapolis, MN USA; [Sherwood, Nancy E.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Karanja, Njeri] Kaiser Permanente Ctr Hlth Res, Portland, OR USA; [Thomson, Cynthia A.] Univ Arizona, Arizona Canc Ctr, Dept Nutr Sci, Tucson, AZ USA	University of California System; University of California San Diego; HealthPartners Institute for Education & Research; University of Minnesota System; University of Minnesota Twin Cities; Kaiser Permanente; Arizona Center Cancer Care; University of Arizona	Rock, CL (corresponding author), Moores UCSD Canc Ctr, 3855 Hlth Sci Dr,Off 3077, La Jolla, CA 92093 USA.	clrock@ucsd.edu		Sherwood, Nancy/0000-0002-3365-9018	Jenny Craig Inc (Carlsbad, California); NATIONAL CANCER INSTITUTE [R01CA148791] Funding Source: NIH RePORTER	Jenny Craig Inc (Carlsbad, California); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Jenny Craig Inc (Carlsbad, California), which provided program activities, materials, and prepackaged foods to individuals assigned to the commercial weight loss program. Funding was provided through a clinical trial contract to the coordinating center (School of Medicine, University of California, San Diego), which subsequently disbursed funds to the collaborating clinical sites and the laboratories. Data from the clinical sites and the laboratories were forwarded to the coordinating center where they were pooled for analysis.	BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Broekmans WMR, 2000, J NUTR, V130, P1578, DOI 10.1093/jn/130.6.1578; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Djousse L, 2009, JAMA-J AM MED ASSOC, V302, P394, DOI 10.1001/jama.2009.1062; Espeland M, 2007, DIABETES CARE, V30, P1374; Finley CE, 2007, INT J OBESITY, V31, P292, DOI 10.1038/sj.ijo.0803395; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Furlow EA, 2009, J AM DIET ASSOC, V109, P1417, DOI 10.1016/j.jada.2009.05.003; Gamboa-Pinto AJ, 1998, J NUTR, V128, P1933, DOI 10.1093/jn/128.11.1933; He FJ, 2006, LANCET, V367, P320, DOI 10.1016/S0140-6736(06)68069-0; Heshka S, 2003, JAMA-J AM MED ASSOC, V289, P1792, DOI 10.1001/jama.289.14.1792; Jakicic JM, 2003, JAMA-J AM MED ASSOC, V290, P1323, DOI 10.1001/jama.290.10.1323; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kris-Etherton PM, 2002, AM J MED, V113, P71, DOI 10.1016/S0002-9343(01)00995-0; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Lowe MR, 2008, BRIT J NUTR, V99, P925, DOI 10.1017/S0007114507862416; MCARDLE WD, 1972, MED SCI SPORT EXER, V4, P182; McTigue KM, 2003, ANN INTERN MED, V139, P933, DOI 10.7326/0003-4819-139-11-200312020-00013; Metz JA, 2000, ARCH INTERN MED, V160, P2150, DOI 10.1001/archinte.160.14.2150; Mills PJ, 2009, SLEEP BREATH, V13, P415, DOI 10.1007/s11325-009-0268-0; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Mond JM, 2004, BEHAV RES THER, V42, P551, DOI 10.1016/S0005-7967(03)00161-X; Morgan LM, 2009, PUBLIC HEALTH NUTR, V12, P799, DOI 10.1017/S1368980008003236; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Nejat EJ, 2010, MATURITAS, V65, P106, DOI 10.1016/j.maturitas.2009.09.006; Nguyen NT, 2008, J AM COLL SURGEONS, V207, P928, DOI 10.1016/j.jamcollsurg.2008.08.022; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; Pierce JP, 2007, JAMA-J AM MED ASSOC, V298, P289, DOI 10.1001/jama.298.3.289; Puglisi MJ, 2008, J NUTR, V138, P2293, DOI 10.3945/jn.108.097188; Roberts WL, 2001, CLIN CHEM, V47, P418; Rock CL, 2007, OBESITY, V15, P939, DOI 10.1038/oby.2007.614; Rock CL, 2001, J AM DIET ASSOC, V101, P1167, DOI 10.1016/S0002-8223(01)00286-3; Rolls BJ, 2000, MED CLIN N AM, V84, P401, DOI 10.1016/S0025-7125(05)70228-5; Tsai AG, 2005, ANN INTERN MED, V142, P56, DOI 10.7326/0003-4819-142-1-200501040-00012; *US BUR LAB STAT, 2009, EC NEWS REL CONS EXP; Wadden TA, 2004, OBES RES, V12, p151S, DOI 10.1038/oby.2004.282; Wadden TA, 2006, OBESITY, V14, P737; Wadden TA, 2009, OBESITY, V17, pS76; Ware JH, 2003, NEW ENGL J MED, V348, P2136, DOI 10.1056/NEJMe030054; Wing RR, 2001, OBES RES, V9, p271S, DOI 10.1038/oby.2001.130; [No title captured]	44	116	116	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2010	304	16					1803	1811		10.1001/jama.2010.1503	http://dx.doi.org/10.1001/jama.2010.1503			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671JZ	20935338				2022-12-28	WOS:000283501300021
J	McCartney, M				McCartney, Margaret			Obesity Slimmed down surgery	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Colquitt JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub3; NICE, 2006, OB GUID PREV ID ASS; Picot J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13410; 2009, DRUGS THER B, V47, P125	4	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 26	2010	341								c5499	10.1136/bmj.c5499	http://dx.doi.org/10.1136/bmj.c5499			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674YE	20978064				2022-12-28	WOS:000283786800024
J	Jubany, LI; Selva-O'Callaghan, A; Perez-Vega, C; Grau-Junyent, JM; Hernandez-Losa, J; Vilardell-Tarres, M				Jubany, L. I.; Selva-O'Callaghan, A.; Perez-Vega, C.; Grau-Junyent, J. M.; Hernandez-Losa, J.; Vilardell-Tarres, M.			The patient has the diagnosis	LANCET			English	Editorial Material							WHIPPLES-DISEASE		[Jubany, L. I.; Selva-O'Callaghan, A.; Vilardell-Tarres, M.] Vall Hebron Gen Hosp, Dept Internal Med, Barcelona, Spain; [Hernandez-Losa, J.] Vall Hebron Gen Hosp, Dept Pathol, Mol Biol Lab, Barcelona, Spain; [Perez-Vega, C.] Mateu Orfila Hosp, Dept Internal Med, Mahon, Baleares, Spain; [Grau-Junyent, J. M.] IDIBAPS, Hosp Clin Prov, Muscle Res Grp, Barcelona, Spain	Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Hospital Mateu Orfila; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Selva-O'Callaghan, A (corresponding author), C Siracusa 12 BIS A, Barcelona 08012, Spain.	aselva@vhebron.net	Javier, Hernandez Losa/C-1173-2008	Javier, Hernandez Losa/0000-0003-1526-3201; Selva-O'Callaghan, Albert/0000-0003-2823-9761				Chatelain D, 2008, ARTHRITIS RHEUM, V58, P2565, DOI 10.1002/art.23700; Puget M, 2006, MUSCLE NERVE, V34, P794, DOI 10.1002/mus.20650; Schneider T, 2008, LANCET INFECT DIS, V8, P179, DOI 10.1016/S1473-3099(08)70042-2; SWASH M, 1977, GUT, V18, P800, DOI 10.1136/gut.18.10.800; Venmans BJ, 1997, LANCET, V349, P433, DOI 10.1016/S0140-6736(97)80059-1	5	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 23	2010	376	9750					1436	1436		10.1016/S0140-6736(10)61049-5	http://dx.doi.org/10.1016/S0140-6736(10)61049-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672ZO	20971367				2022-12-28	WOS:000283627500038
J	Folk, JC; Stone, EM				Folk, James C.; Stone, Edwin M.			Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; COMPLEMENT FACTOR-H; PHOTODYNAMIC THERAPY; MACULOPATHY; MEMBRANES; RISK; VERTEPORFIN; BEVACIZUMAB; LESIONS; PHOTOCOAGULATION	This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major clinical studies, the clinical use of this therapy, and potential adverse effects are reviewed. Relevant formal guidelines, if they exist, are presented. The article ends with the authors' clinical recommendations.	[Folk, James C.; Stone, Edwin M.] Univ Iowa, Carver Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Stone, Edwin M.] Univ Iowa, Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA	University of Iowa; Howard Hughes Medical Institute; University of Iowa	Stone, EM (corresponding author), Univ Iowa, Carver Coll Med, Dept Ophthalmol & Visual Sci, 375 Newton Rd,4111 MERF, Iowa City, IA 52242 USA.	edwin-stone@uiowa.edu	Mohammed, Imran/J-8271-2012	Mohammed, Imran/0000-0002-8412-0768; Folk, James/0000-0002-6271-2906; Stone, Edwin M./0000-0003-3343-4414	Robert C. Watzke Research Fund; Research to Prevent Blindness; Foundation Fighting Blindness [EY016822]; National Eye Institute; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY016822] Funding Source: NIH RePORTER	Robert C. Watzke Research Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness(European Commission); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by the Robert C. Watzke Research Fund, Research to Prevent Blindness, the Foundation Fighting Blindness, a grant (EY016822) from the National Eye Institute, and the Howard Hughes Medical Institute.	American Academy of Ophthalmology Retina Panel, 2008, PREF PRACT PATT GUID; [Anonymous], 1991, ARCH OPHTHALMOL, V109, P1242; [Anonymous], 1991, ARCH OPHTHALMOL, V109, P1220; [Anonymous], 1999, ARCH OPHTHALMOL, V117, P1329; [Anonymous], 2000, ARCH OPHTHALMOL, V118, P488; Bashshur ZF, 2009, AM J OPHTHALMOL, V148, P59, DOI 10.1016/j.ajo.2009.02.006; BOK D, 1993, J CELL SCI, P189; Boyer DS, 2007, OPHTHALMOLOGY, V114, P246, DOI 10.1016/j.ophtha.2006.10.045; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Brown Gary C, 2005, Trans Am Ophthalmol Soc, V103, P173; Brown MM, 2008, OPHTHALMOLOGY, V115, P1039, DOI 10.1016/j.ophtha.2007.08.033; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ehlers JP, 2010, OPHTHAL SURG LAS IM, V41, P182, DOI 10.3928/15428877-20100303-05; Ferrara N, 2006, RETINA-J RET VIT DIS, V26, P859, DOI 10.1097/01.iae.0000242842.14624.e7; Fong DS, 2010, OPHTHALMOLOGY, V117, P298, DOI 10.1016/j.ophtha.2009.07.023; Frank RN, 1996, AM J OPHTHALMOL, V122, P393, DOI 10.1016/S0002-9394(14)72066-5; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Green W R, 1999, Mol Vis, V5, P27; GREEN WR, 1993, OPHTHALMOLOGY, V100, P1519; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hammond CJ, 2002, OPHTHALMOLOGY, V109, P730, DOI 10.1016/S0161-6420(01)01049-1; HAYREH SS, 1972, BRIT J OPHTHALMOL, V56, P736, DOI 10.1136/bjo.56.10.736; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P571; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; KLEIN R, 1995, INVEST OPHTH VIS SCI, V36, P182; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Krohne TU, 2008, AM J OPHTHALMOL, V146, P508, DOI 10.1016/j.ajo.2008.05.036; Kvanta A, 1996, INVEST OPHTH VIS SCI, V37, P1929; Lalwani GA, 2009, AM J OPHTHALMOL, V148, P43, DOI 10.1016/j.ajo.2009.01.024; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Martin DF, 2010, NEW ENGL J MED, V363, P105, DOI 10.1056/NEJMp1001201; MILLER JW, 1994, AM J PATHOL, V145, P574; Otani A, 2002, MICROVASC RES, V64, P162, DOI 10.1006/mvre.2002.2407; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Ranpura V, 2010, ACTA ONCOL, V49, P287, DOI 10.3109/02841860903524396; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schmidt-Erfurth UM, 2007, ACTA OPHTHALMOL SCAN, V85, P486, DOI 10.1111/j.1600-0420.2007.00979.x; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Spaide R, 2007, AM J OPHTHALMOL, V143, P679, DOI 10.1016/j.ajo.2007.02.024; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Tufail A, 2010, BMJ-BRIT MED J, V340, pc2459; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zareparsi S, 2005, HUM MOL GENET, V14, P1449, DOI 10.1093/hmg/ddi154	49	69	72	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2010	363	17					1648	1655		10.1056/NEJMct1000495	http://dx.doi.org/10.1056/NEJMct1000495			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668BD	20961248				2022-12-28	WOS:000283242700009
J	Heath, I				Heath, Iona			Life and Death The costs of the reverberating bedpan	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath22@yahoo.co.uk						2010, BMJ, V341, pC5541	1	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 21	2010	341								c5541	10.1136/bmj.c5541	http://dx.doi.org/10.1136/bmj.c5541			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	671ZQ	20966013				2022-12-28	WOS:000283553200012
J	Lee, S; Bluemle, MJ; Bates, FS				Lee, Sangwoo; Bluemle, Michael J.; Bates, Frank S.			Discovery of a Frank-Kasper sigma Phase in Sphere-Forming Block Copolymer Melts	SCIENCE			English	Article							QUASI-CRYSTALLINE; CUBIC PHASES; LIQUID; TRANSITIONS; BEHAVIOR	Sphere-forming block copolymers are known to self-assemble into body-centered cubic crystals near the order-disorder transition temperature. Small-angle x-ray scattering and transmission electron microscopy experiments on diblock and tetrablock copolymer melts have revealed an equilibrium phase characterized by a large tetragonal unit cell containing 30 microphase-separated spheres. This structure, referred to as the sigma (sigma) phase by Frank and Kasper more than 50 years ago, nucleates and grows from the body-centered cubic phase similar to its occurrence in metal alloys and is a crystal approximant to dodecagonal quasicrystals. Formation of the s phase in undiluted linear block copolymers (and certain branched dendrimers) appears to be mediated by macromolecular packing frustration, an entropic contribution to the interparticle interactions that control the sphere-packing geometry.	[Lee, Sangwoo; Bluemle, Michael J.; Bates, Frank S.] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Bates, FS (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	bates@cems.umn.edu		Bates, Frank/0000-0003-3977-1278; Lee, Sangwoo/0000-0003-4215-0317	Department of Energy [4000041622]; National Science Foundation [DMR-0704192]; University of Minnesota Materials Research Science and Engineering Center (MRSEC); E. I. Dupont de Nemours Company; Dow Chemical Company; State of Illinois; U.S. Department of Energy, Office of Science, Basic Energy Sciences [DE-AC02-06CH11357]; NSF through National Nanotechnology Infrastructure Network	Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); University of Minnesota Materials Research Science and Engineering Center (MRSEC)(National Science Foundation (NSF)); E. I. Dupont de Nemours Company; Dow Chemical Company; State of Illinois; U.S. Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); NSF through National Nanotechnology Infrastructure Network	This work was supported by the Department of Energy through a subcontract to UT-Battelle (4000041622), the National Science Foundation through grant DMR-0704192, and the University of Minnesota Materials Research Science and Engineering Center (MRSEC). Portions of this work were performed at the DuPont-Northwestern-Dow Collaborative Access Team (DND-CAT) located at Sector 5 of the Advanced Photon Source (APS). DND-CAT is supported by E. I. Dupont de Nemours & Company, the Dow Chemical Company, and the State of Illinois. Use of the APS was supported by the U.S. Department of Energy, Office of Science, Basic Energy Sciences, under contract DE-AC02-06CH11357. Parts of this work were carried out in the University of Minnesota I. T. Characterization Facility, which receives partial support from NSF through the National Nanotechnology Infrastructure Network program. The authors gratefully acknowledge helpful discussions with N. Balsara and T. P. Lodge.	ALEXANDER S, 1978, PHYS REV LETT, V41, P702, DOI 10.1103/PhysRevLett.41.702; ANDERSON DM, 1988, P NATL ACAD SCI USA, V85, P5364, DOI 10.1073/pnas.85.15.5364; Arakcheeva A, 2003, ACTA CRYSTALLOGR B, V59, P324, DOI 10.1107/S0108768103009005; Ashcroft N.W., 1976, SOLID STATE PHYS; BATES FS, 1982, MACROMOLECULES, V15, P589, DOI 10.1021/ma00230a073; Bates FS, 1999, PHYS TODAY, V52, P32, DOI 10.1063/1.882522; Bluemle MJ, 2010, MACROMOLECULES, V43, P4449, DOI 10.1021/ma100510p; CLARK NA, 1979, NATURE, V281, P57, DOI 10.1038/281057a0; DICKINS GJ, 1956, ACTA CRYSTALLOGR, V9, P297, DOI 10.1107/S0365110X56000826; Dotera T, 2007, PHILOS MAG, V87, P3011, DOI 10.1080/14786430601083348; DZUGUTOV M, 1992, PHYS REV A, V46, pR2984, DOI 10.1103/PhysRevA.46.R2984; Elmer JW, 2007, METALL MATER TRANS A, V38A, P464, DOI 10.1007/s11661-006-9076-3; FRANK FC, 1959, ACTA CRYSTALLOGR, V12, P483, DOI 10.1107/S0365110X59001499; Hayashida K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.195502; Janot C., 1994, QUASICRYSTALS PRIMER; Joannopoulos JD, 2008, PHOTONIC CRYSTALS: MOLDING THE FLOW OF LIGHT, 2ND EDITION, P1; Keys AS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.235503; Kossuth MB, 1999, J RHEOL, V43, P167, DOI 10.1122/1.550981; LAWSON AC, 1988, ACTA CRYSTALLOGR B, V44, P89, DOI 10.1107/S0108768187009406; LEIBLER L, 1980, MACROMOLECULES, V13, P1602, DOI 10.1021/ma60078a047; LEVINE D, 1984, PHYS REV LETT, V53, P2477, DOI 10.1103/PhysRevLett.53.2477; Lifshitz R, 2007, PHILOS MAG, V87, P3021, DOI 10.1080/14786430701358673; Matsen MW, 1996, MACROMOLECULES, V29, P7641, DOI 10.1021/ma960744q; Meng LL, 2006, NANO LETT, V6, P2249, DOI 10.1021/nl061626b; PUSEY PN, 1986, NATURE, V320, P340, DOI 10.1038/320340a0; Rosen BM, 2009, J AM CHEM SOC, V131, P17500, DOI 10.1021/ja907882n; Roth J, 2000, PHYS REV E, V61, P6845, DOI 10.1103/PhysRevE.61.6845; Schmidt SC, 1999, MACROMOLECULES, V32, P4794, DOI 10.1021/ma9900277; SEDDON JM, 1990, BIOCHIM BIOPHYS ACTA, V1031, P1, DOI 10.1016/0304-4157(90)90002-T; SHECHTMAN D, 1984, PHYS REV LETT, V53, P1951, DOI 10.1103/PhysRevLett.53.1951; Ungar G, 2005, SOFT MATTER, V1, P95, DOI 10.1039/b502443a; Ungar G, 2003, SCIENCE, V299, P1208, DOI 10.1126/science.1078849; Wittlinger J, 1997, ACTA CRYSTALLOGR B, V53, P745, DOI 10.1107/S0108768197005739; Zeng XB, 2004, NATURE, V428, P157, DOI 10.1038/nature02368	34	311	312	6	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					349	353		10.1126/science.1195552	http://dx.doi.org/10.1126/science.1195552			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947759				2022-12-28	WOS:000282986700035
J	Pyc, MA; Rawson, KA				Pyc, Mary A.; Rawson, Katherine A.			Why Testing Improves Memory: Mediator Effectiveness Hypothesis	SCIENCE			English	Article							RETRIEVAL		[Pyc, Mary A.; Rawson, Katherine A.] Kent State Univ, Dept Psychol, Kent, OH 44242 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Pyc, MA (corresponding author), Kent State Univ, Dept Psychol, Kent, OH 44242 USA.	mpyc@kent.edu			James S. McDonnell Foundation	James S. McDonnell Foundation	Research supported by a Collaborative Award from the James S. McDonnell Foundation 21st Century Science Initiative in Bridging Brain, Mind and Behavior.	Bahrick HP, 2005, J MEM LANG, V52, P566, DOI 10.1016/j.jml.2005.01.012; Dunlosky J, 2005, DEV PSYCHOL, V41, P389, DOI 10.1037/0012-1649.41.2.389; Karpicke JD, 2008, SCIENCE, V319, P966, DOI 10.1126/science.1152408	4	244	251	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2010	330	6002					335	335		10.1126/science.1191465	http://dx.doi.org/10.1126/science.1191465			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	664TY	20947756				2022-12-28	WOS:000282986700030
J	Shilo, BZ				Shilo, Ben-Zion			Insider Influence on ErbB Activity	CELL			English	Editorial Material							GROWTH-FACTOR RECEPTOR; EGF RECEPTOR; KINASE MUSK; ACTIVATION; MECHANISM; DOMAIN	The receptor tyrosine kinase ErbB is activated by ligand-induced dimerization, leading to transphosphorylation of the cytoplasmic kinase domains. Bill et al. (2010) now demonstrate that transphosphorylation can be modulated from within the cell by the cytoplasmic protein cytohesin, providing new insights into ErbB-dependent processes during normal development and cancer.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shilo, BZ (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	benny.shilo@weizmann.ac.il		Shilo, Ben Zion/0000-0003-4903-8889				Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; Bergamin E, 2010, MOL CELL, V39, P100, DOI 10.1016/j.molcel.2010.06.007; Bill A, 2010, CELL, V143, P201, DOI 10.1016/j.cell.2010.09.011; Brew C, 2009, ASSESS EVAL HIGH EDU, V34, P641, DOI 10.1080/02602930802468567; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Inoue A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000113; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	10	0	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					181	182		10.1016/j.cell.2010.09.042	http://dx.doi.org/10.1016/j.cell.2010.09.042			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946975	Bronze			2022-12-28	WOS:000283052200005
J	Eyding, D; Lelgemann, M; Grouven, U; Harter, M; Kromp, M; Kaiser, T; Kerekes, MF; Gerken, M; Wieseler, B				Eyding, Dirk; Lelgemann, Monika; Grouven, Ulrich; Haerter, Martin; Kromp, Mandy; Kaiser, Thomas; Kerekes, Michaela F.; Gerken, Martin; Wieseler, Beate			Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DOUBLE-BLIND; SEXUAL DYSFUNCTION; PUBLICATION BIAS; CLINICAL-TRIALS; ANTIDEPRESSANT; NORADRENALINE; EFFICACY; CITALOPRAM; INDUSTRY; SPONSORSHIP	Objectives To assess the benefits and harms of reboxetine versus placebo or selective serotonin reuptake inhibitors (SSRIs) in the acute treatment of depression, and to measure the impact of potential publication bias in trials of reboxetine. Design Systematic review and meta-analysis including unpublished data. Data sources Bibliographic databases (Medline, Embase, PsycINFO, BIOSIS, and Cochrane Library), clinical trial registries, trial results databases, and regulatory authority websites up until February 2009, as well as unpublished data from the manufacturer of reboxetine (Pfizer, Berlin). Eligibility criteria Double blind, randomised, controlled trials of acute treatment (six weeks or more) with reboxetine versus placebo or SSRIs in adults with major depression. Outcome measures Remission and response rates (benefit outcomes), as well as rates of patients with at least one adverse event and withdrawals owing to adverse events (harm outcomes). Data extraction and data synthesis The procedures for data extraction and assessment of risk of bias were always conducted by one person and checked by another. If feasible, data were pooled by meta-analyses (random effects model). Publication bias was measured by comparing results of published and unpublished trials. Results We analysed 13 acute treatment trials that were placebo controlled, SSRI controlled, or both, which included 4098 patients. Data on 74% (3033/4098) of these patients were unpublished. In the reboxetine versus placebo comparison, no significant differences in remission rates were shown (odds ratio 1.17, 95% confidence interval 0.91 to 1.51; P=0.216). Substantial heterogeneity (I-2=67.3%) was shown in the meta-analysis of the eight trials that investigated response rates for reboxetine versus placebo. A sensitivity analysis that excluded a small inpatient trial showed no significant difference in response rates between patients receiving reboxetine and those receiving placebo (OR 1.24, 95% CI 0.98 to 1.56; P=0.071; I-2=42.1%). Reboxetine was inferior to SSRIs (fluoxetine, paroxetine, and citalopram) for remission rates (OR 0.80, 95% CI 0.67 to 0.96; P=0.015) and response rates (OR 0.80, 95% CI 0.67 to 0.95; P=0.01). Reboxetine was inferior to placebo for both harm outcomes (P<0.001 for both), and to fluoxetine for withdrawals owing to adverse events (OR 1.79, 95% CI 1.06 to 3.05; P=0.031). Published data overestimated the benefit of reboxetine versus placebo by up to 115% and reboxetine versus SSRIs by up to 23%, and also underestimated harm. Conclusions Reboxetine is, overall, an ineffective and potentially harmful antidepressant. Published evidence is affected by publication bias, underlining the urgent need for mandatory publication of trial data.	[Kaiser, Thomas; Wieseler, Beate] Inst Qual & Efficiency Hlth Care, Dept Drug Assessment, D-51105 Cologne, Germany; [Eyding, Dirk] German Canc Soc, Berlin, Germany; [Lelgemann, Monika] Med Advisory Serv Social Hlth Insurance, Essen, Germany; [Grouven, Ulrich] Hannover Med Sch, Hannover, Germany; [Haerter, Martin] Univ Clin Eppendorf, Dept Med Psychol, Hamburg, Germany; [Gerken, Martin] Univ Bremen, Hlth Technol Assessment Ctr, Bremen, Germany	Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bremen	Wieseler, B (corresponding author), Inst Qual & Efficiency Hlth Care, Dept Drug Assessment, Dillenburger Str 27, D-51105 Cologne, Germany.	beate.wieseler@iqwig.de	Gerken, Martin/O-8130-2019	Gerken, Martin/0000-0002-2803-9383; Harter, Martin/0000-0001-7443-9890; Wieseler, Beate/0000-0002-3519-754X; Kaiser, Thomas/0000-0003-0795-538X	IQWiG	IQWiG	This work was supported by IQWiG. The original health technology assessment report was commissioned by the German Federal Joint Committee. MG, MH, and ML acted as consultants for the preparation of the original health technology assessment report. For this they were reimbursed by IQWiG.	Andreoli V, 2002, J CLIN PSYCHOPHARM, V22, P393, DOI 10.1097/00004714-200208000-00010; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Baldwin D, 2006, J PSYCHOPHARMACOL, V20, P91, DOI 10.1177/0269881105056666; Ban TA, 1998, HUM PSYCHOPHARM CLIN, V13, pS29, DOI 10.1002/(SICI)1099-1077(199802)13:1+<S29::AID-HUP980>3.0.CO;2-D; Barbui C, 2004, J CLIN PSYCHOPHARM, V24, P126, DOI 10.1097/01.jcp.0000115665.45074.0d; Bech P, 2002, PSYCHOPHARMACOLOGY, V163, P20, DOI 10.1007/s00213-002-1147-6; Berlanga C, 2006, J AFFECT DISORDERS, V95, P119, DOI 10.1016/j.jad.2006.04.029; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chuluunkhuu Gandulam, 2008, Kobe J Med Sci, V54, pE147; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Clayton AH, 2003, INT CLIN PSYCHOPHARM, V18, P151, DOI 10.1097/01.yic.0000066456.73432.09; Dubini A, 1997, J PSYCHOPHARMACOL, V11, pS17; Dubini A, 1997, EUR NEUROPSYCHOPHARM, V7, pS49, DOI 10.1016/S0924-977X(97)00419-7; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Ferguson JM, 2002, INT CLIN PSYCHOPHARM, V17, P45, DOI 10.1097/00004850-200203000-00001; Ferguson JM, 2003, INT CLIN PSYCHOPHARM, V18, P9, DOI 10.1097/00004850-200301000-00002; Hajos M, 2004, CNS DRUG REV, V10, P23; *I QUAL EFF HLTH C, 2009, BUPR MIRT REB TREATM; *I QUAL EFF HLTH C, 2008, BUPR MIRT REB TREATM; *I QUAL EFF HLTH C, 2008, GEN METH VERS 3 0; *INT C HARM TECHN, 1995, E3 INT C HARM TECHN; Jureidini JN, 2008, INT J RISK SAF MED, V29, P73, DOI DOI 10.3233/JRS-2008-0426; Kelly RE, 2006, PSYCHOL MED, V36, P1647, DOI 10.1017/S0033291706008567; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Langworth S, 2006, J CLIN PSYCHOPHARM, V26, P121, DOI 10.1097/01.jcp.0000204138.20417.c3; LANGWORTH S, 2003, Z20200043 PHARM LTD; Massana J, 1999, INT CLIN PSYCHOPHARM, V14, P73, DOI 10.1097/00004850-199903000-00003; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Montgomery S, 2003, J CLIN PSYCHOPHARM, V23, P45, DOI 10.1097/00004714-200302000-00008; National Collaborating Centre for Mental, 2010, DEPR TREATM MAN DEPR; Page ME, 2003, CNS DRUG REV, V9, P327; Papakostas GI, 2008, EUR NEUROPSYCHOPHARM, V18, P122, DOI 10.1016/j.euroneuro.2007.07.005; Perlis RH, 2005, AM J PSYCHIAT, V162, P1957, DOI 10.1176/appi.ajp.162.10.1957; *PHARM LTD, 2001, M20200032 PHARM LTD; *PHARM LTD, 1993, CTN20124ADE091 PHARM; *PHARM LTD, 1995, CTN016FCE20124 PHARM; *PHARM LTD, 2009, SUMM PROD CHAR EDR 4; *PHARM LTD, 1995, CTN015FCE20124 PHARM; *PHARM LTD, 1995, 9550080 PHARM LTD; *PHARM UPJ, 2001, COMP PLAC 3 FIX DOS; *PHARM UPJ, 2004, REB PNU155950E VS PA; *PHARM UPJ, 2001, REB PNU155950E VERS; *PHARM UPJ, 2001, REB PLAC PAR COMP PA; Preskorn Sheldon H, 2004, J Psychiatr Pract, V10, P57, DOI 10.1097/00131746-200401000-00006; SCHWABE U, 2009, DRUG PRESCRIPTION RE; Schwartz G, 2002, EUR NEUROPSYCHOPHARM, V12, pS204; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Song, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4100; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; STERLING TD, 1959, J AM STAT ASSOC, V54, P30, DOI 10.2307/2282137; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Tungaraza T, 2007, BRIT J PSYCHIAT, V191, P82, DOI 10.1192/bjp.bp.106.024547; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Versiani M, 2000, J CLIN PSYCHOPHARM, V20, P28, DOI 10.1097/00004714-200002000-00006; Versiani M, 2000, INT J PSYCHIAT CLIN, V4, P293, DOI 10.1080/13651500050517858; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1	59	216	222	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 12	2010	341								c4737	10.1136/bmj.c4737	http://dx.doi.org/10.1136/bmj.c4737			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663KN	20940209	Green Published, hybrid			2022-12-28	WOS:000282886900004
J	Richards, M; Brayne, C				Richards, Marcus; Brayne, Carol			Alzheimer's disease What do we mean by Alzheimer's disease?	BRITISH MEDICAL JOURNAL			English	Editorial Material							DEMENTIA; DIAGNOSIS; LIFE; SERVICES; HEALTH		[Richards, Marcus] MRC Unit Lifelong Hlth & Ageing, London WC1B 5JU, England; [Brayne, Carol] Univ Cambridge, Inst Publ Hlth, Cambridge CB2 0SR, England	University of Cambridge	Richards, M (corresponding author), MRC Unit Lifelong Hlth & Ageing, London WC1B 5JU, England.	m.richards@nshd.mrc.ac.uk	Brayne, Carol/AAA-4285-2020	Brayne, Carol/0000-0001-5307-663X; Richards, Marcus/0000-0001-9191-2192	MRC [MC_U123092722, G9901400] Funding Source: UKRI; Medical Research Council [G9901400, MC_U123092722] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Banerjee S, 2009, INT J GERIATR PSYCH, V24, P748, DOI 10.1002/gps.2191; BERRIOS GE, 1990, INT J GERIATR PSYCH, V5, P355, DOI 10.1002/gps.930050603; BRAYNE C, 1988, LANCET, V1, P1265; Brayne C, 2006, PLOS MED, V3, P1922, DOI 10.1371/journal.pmed.0030397; Brayne C, 2007, NAT REV NEUROSCI, V8, P233, DOI 10.1038/nrn2091; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Esiri MM, 2001, LANCET, V357, P169; HACHINSKI V, 2008, JAMA-J AM MED ASSOC, V300, P2171; Hatch SL, 2007, J GERONTOL B-PSYCHOL, V62, pS404, DOI 10.1093/geronb/62.6.S404; Iacono D, 2009, NEUROLOGY, V73, P665, DOI 10.1212/WNL.0b013e3181b01077; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; Luengo-Fernandez R., 2010, DEMENTIA 2010; Martyn C, 2010, BMJ-BRIT MED J, V340, P1219; Matthews FE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000180; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; National Audit Office, 2007, IMPR SERV SUPP PEOPL; Rothschild D, 1937, AM J PSYCHIAT, V93, P757, DOI 10.1176/ajp.93.4.757; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Smith EE, 2009, STROKE, V40, P2601, DOI 10.1161/STROKEAHA.108.536839; *UK GOV DEP HLTH, 2009, LIV WELL DEM NAT DEM; Whalley LJ, 2006, LANCET NEUROL, V5, P87, DOI 10.1016/S1474-4422(05)70286-6; DSM 5 FUTURE PSYCHIA	22	33	34	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 12	2010	341								c4670	10.1136/bmj.c4670	http://dx.doi.org/10.1136/bmj.c4670			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663KN	20940218				2022-12-28	WOS:000282886900022
J	Markel, H				Markel, Howard			Calling Dr Kildare The Literary Lives of Frederick Schiller Faust, aka Max Brand	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Michigan, Ctr Hist Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Markel, H (corresponding author), Univ Michigan, Ctr Hist Med, 100 Simpson Inst,Box 0724,100 Observ, Ann Arbor, MI 48109 USA.	howard@umich.edu						DANS PE, 2000, DOCTORS MOVIES BOIL, P64; EASTON R, 1970, MAX BRAND BIG WESTER; GALE RL, 1999, AM NATL BIOGRAPHY, P767; Kalisch P A, 1985, Med Herit, V1, P348; NOLAN WF, 1985, MAX BRAND W GIANT LI; 2010, UNIVERSAL BACKLOT SE	6	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2010	304	13					1501	1502		10.1001/jama.2010.1272	http://dx.doi.org/10.1001/jama.2010.1272			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	658SO	20924021				2022-12-28	WOS:000282509900031
J	Yoon, HJ; Kuwabara, J; Kim, JH; Mirkin, CA				Yoon, Hyo Jae; Kuwabara, Junpei; Kim, Jun-Hyun; Mirkin, Chad A.			Allosteric Supramolecular Triple-Layer Catalysts	SCIENCE			English	Article							ASSEMBLED COORDINATION CAGE; LIGAND REARRANGEMENT; DIELS-ALDER; CHEMISTRY; TRANSITION; SEPARATION; TRIMERS; COMPLEX; DESIGN	Allosteric regulation of organometallic catalysts could allow for greater control over reactions. We report an allosteric supramolecular structure in which a monometallic catalytic site has been buried in the middle layer of a triple-layer complex. Small molecules and elemental anions can open and close this complex and reversibly expose and conceal the catalytic center. The ring-opening polymerization of e-caprolactone can be turned on by the in situ opening of the triple-layer complex and then completely turned off by reforming it through the abstraction of Cl(-), the allosteric effector agent, without appreciable loss of catalytic activity. This process can regulate the molecular weights of the resulting polymers.	[Mirkin, Chad A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	chadnano@northwestern.edu	Yoon, Hyo Jae/E-3145-2012; Kuwabara, Junpei/G-6915-2016; Mirkin, Chad A/E-3911-2010	Yoon, Hyo Jae/0000-0002-2501-0251; Kuwabara, Junpei/0000-0002-9032-5655; Mirkin, Chad/0000-0002-6634-7627; Kim, Jun-Hyun/0000-0001-8145-6269	U.S. Air Force Office of Scientific Research (AFOSR); Multidisciplinary University Research Initiative (MURI); Army Research Office (ARO); NSF; U.S. Department of Defense	U.S. Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Multidisciplinary University Research Initiative (MURI)(MURI); Army Research Office (ARO); NSF(National Science Foundation (NSF)); U.S. Department of Defense(United States Department of Defense)	C.A.M. acknowledges the U.S. Air Force Office of Scientific Research (AFOSR), the Director of Defense Research and Engineering (DDRE) for Multidisciplinary University Research Initiative (MURI) funding, the Army Research Office (ARO), and NSF for support of this research. C. A. M. is grateful for a National Security Science and Engineering Faculty Fellowship from the U.S. Department of Defense. We thank C. L. Stern for x-ray crystallographic analysis. Crystallographic data have been submitted to the Cambridge Crystallographic Database with reference numbers CCDC-778135 (7a) and CCDC-778134 (8a) and are available free of charge at www.ccdc.cam.ac.uk/data_request/cif.	Albrecht M, 1998, CHEM SOC REV, V27, P281, DOI 10.1039/a827281z; Artsimovitch I, 2005, CELL, V122, P351, DOI 10.1016/j.cell.2005.07.014; Britt D, 2009, P NATL ACAD SCI USA, V106, P20637, DOI 10.1073/pnas.0909718106; Brown AM, 2004, J AM CHEM SOC, V126, P14316, DOI 10.1021/ja045316b; Caulder DL, 1999, ACCOUNTS CHEM RES, V32, P975, DOI 10.1021/ar970224v; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Chi YG, 2008, J AM CHEM SOC, V130, P17287, DOI 10.1021/ja806584q; CRAM DJ, 1991, ANGEW CHEM INT EDIT, V30, P1024, DOI 10.1002/anie.199110241; Fujita M, 2005, ACCOUNTS CHEM RES, V38, P369, DOI 10.1021/ar040153h; Gianneschi NC, 2005, ACCOUNTS CHEM RES, V38, P825, DOI 10.1021/ar980101q; Gianneschi NC, 2005, J AM CHEM SOC, V127, P1644, DOI 10.1021/ja0437306; Holliday BJ, 2001, ANGEW CHEM INT EDIT, V40, P2022, DOI 10.1002/1521-3773(20010601)40:11<2022::AID-ANIE2022>3.3.CO;2-4; Jeon YM, 2006, ORGANOMETALLICS, V25, P2729, DOI 10.1021/om0602310; Kesanli B, 2003, COORDIN CHEM REV, V246, P305, DOI 10.1016/j.cct.2003.08.004; Krossing I, 2004, ANGEW CHEM INT EDIT, V43, P2066, DOI 10.1002/anie.200300620; Lehn J. M., 1995, SUPRAMOLECULAR CHEMI; Leininger S, 2000, CHEM REV, V100, P853, DOI 10.1021/cr9601324; Leung KCF, 2006, CHEM MATER, V18, P5919, DOI 10.1021/cm061682d; Marty M, 1998, CHEM COMMUN, P2265, DOI 10.1039/a806070c; Mattevi A, 1996, FEBS LETT, V389, P15, DOI 10.1016/0014-5793(96)00462-0; Norskov JK, 2009, NATURE, V461, P1223, DOI 10.1038/4611223a; Oliveri CG, 2008, ACCOUNTS CHEM RES, V41, P1618, DOI 10.1021/ar800025w; Pluth MD, 2007, SCIENCE, V316, P85, DOI 10.1126/science.1138748; Rebek J, 2009, ACCOUNTS CHEM RES, V42, P1660, DOI 10.1021/ar9001203; Sanders JKM, 1998, CHEM-EUR J, V4, P1378, DOI 10.1002/(SICI)1521-3765(19980807)4:8<1378::AID-CHEM1378>3.3.CO;2-V; Seo JS, 2000, NATURE, V404, P982, DOI 10.1038/35010088; Shin HJ, 2010, NAT MATER, V9, P442, DOI [10.1038/NMAT2740, 10.1038/nmat2740]; Ten Breteler MR, 2007, J POLYM SCI POL CHEM, V45, P429, DOI 10.1002/pola.21841; Wang J, 2002, POLYMER, V43, P1357, DOI 10.1016/S0032-3861(01)00673-5; Yoon HJ, 2008, J AM CHEM SOC, V130, P11590, DOI 10.1021/ja804076q; Yoshizawa M, 2000, J AM CHEM SOC, V122, P6311, DOI 10.1021/ja000779c; Yoshizawa M, 2006, SCIENCE, V312, P251, DOI 10.1126/science.1124985; Yoshizawa M, 2003, J AM CHEM SOC, V125, P3243, DOI 10.1021/ja020718+; ZAERA F, 1986, ACCOUNTS CHEM RES, V19, P24, DOI 10.1021/ar00121a004	34	239	240	1	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					66	69		10.1126/science.1193928	http://dx.doi.org/10.1126/science.1193928			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	656KW	20929805				2022-12-28	WOS:000282334500034
J	Sheard, LB; Tan, X; Mao, HB; Withers, J; Ben-Nissan, G; Hinds, TR; Kobayashi, Y; Hsu, FF; Sharon, M; Browse, J; He, SY; Rizo, J; Howe, GA; Zheng, N				Sheard, Laura B.; Tan, Xu; Mao, Haibin; Withers, John; Ben-Nissan, Gili; Hinds, Thomas R.; Kobayashi, Yuichi; Hsu, Fong-Fu; Sharon, Michal; Browse, John; He, Sheng Yang; Rizo, Josep; Howe, Gregg A.; Zheng, Ning			Jasmonate perception by inositol-phosphate-potentiated COI1-JAZ co-receptor	NATURE			English	Article							BOX PROTEIN TIR1; REGULATED DEFENSE; ISOLEUCINE; RECEPTOR; CORONATINE; MECHANISM; ACID; RECOGNITION; REPRESSION; SOFTWARE	Jasmonates are a family of plant hormones that regulate plant growth, development and responses to stress. The F-box protein CORONATINE INSENSITIVE 1 (COI1) mediates jasmonate signalling by promoting hormone-dependent ubiquitylation and degradation of transcriptional repressor JAZ proteins. Despite its importance, the mechanism of jasmonate perception remains unclear. Here we present structural and pharmacological data to show that the true Arabidopsis jasmonate receptor is a complex of both COI1 and JAZ. COI1 contains an open pocket that recognizes the bioactive hormone (3R, 7S)-jasmonoyl-L-isoleucine (JA-Ile) with high specificity. High-affinity hormone binding requires a bipartite JAZ degron sequence consisting of a conserved a-helix for COI1 docking and a loop region to trap the hormone in its binding pocket. In addition, we identify a third critical component of the jasmonate co-receptor complex, inositol pentakisphosphate, which interacts with both COI1 and JAZ adjacent to the ligand. Our results unravel the mechanism of jasmonate perception and highlight the ability of F-box proteins to evolve as multi-component signalling hubs.	[Sheard, Laura B.; Tan, Xu; Mao, Haibin; Hinds, Thomas R.; Zheng, Ning] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Withers, John; He, Sheng Yang; Howe, Gregg A.] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; [Withers, John; He, Sheng Yang] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Ben-Nissan, Gili; Sharon, Michal] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Kobayashi, Yuichi] Tokyo Inst Technol, Dept Biol Engn, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Hsu, Fong-Fu] Washington Univ, Sch Med, Dept Internal Med, Div Endocrinol Diabet Metab & Lipid Res, St Louis, MO 63110 USA; [Browse, John] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Howe, Gregg A.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Michigan State University; Michigan State University; Weizmann Institute of Science; Tokyo Institute of Technology; Washington University (WUSTL); Washington State University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Michigan State University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zheng, N (corresponding author), Univ Washington, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	nzheng@u.washington.edu	Mao, Haibin/B-7609-2011; Howe, Gregg A/N-1887-2014; Tan, Xu/E-7170-2011	Howe, Gregg A/0000-0002-9218-979X; Tan, Xu/0000-0003-4861-4573; Hsu, Fong-Fu/0000-0001-5368-0183; Browse, John/0000-0002-2554-2821; He, Sheng Yang/0000-0003-1308-498X; Sharon, Michal/0000-0003-3933-0595	Howard Hughes Medical Institute; National Institutes of Health [R01 CA107134, T32 GM07270, R01GM57795, R01AI068718]; National Science Foundation [0929100]; US Department of Energy [DE-FG02-99ER20323, DE-FG02-91ER20021]; Michigan State University; Welch Foundation [I-1304]; European Research Council (ERC) under the European Community [239679]; NATIONAL CANCER INSTITUTE [R01CA107134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057795, T32GM007270] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); Michigan State University; Welch Foundation(The Welch Foundation); European Research Council (ERC) under the European Community(European Research Council (ERC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the beamline staff of the Advanced Light Source at the University of California at Berkeley and the Advanced Photon Source at Argonne National Laboratory for help with data collection. We also thank P. Rajagopal and R. Klevit for <SUP>31</SUP>P NMR analysis, M. Sadilek for mass spectrometry analysis, L. Katsir, C. Hague and J. Lyssand for radioligand binding assay assistance, and C. Mecey and M. Melotto for initial cloning of coi1(sdm) mutants. We also thank members of the Zheng laboratory and W. Xu laboratory and R. Gardner for discussion and help. This work is supported by the Howard Hughes Medical Institute and grants from the National Institutes of Health (R01 CA107134 to N.Z., T32 GM07270 to L.B.S., R01GM57795 to G.A.H., R01AI068718 to S.Y.H.), National Science Foundation (0929100 to N.Z.), US Department of Energy (DE-FG02-99ER20323 to J.B. and DE-FG02-91ER20021 to G.A.H. and S.Y.H.), Michigan State University Plant Science Fellowship (J.W.), the Welch Foundation (I-1304 to J.R.) and the European Research Council (ERC) under the European Community's Seventh Framework Program (FP7/2007-2013)/ERC Grant agreement no. 239679 (G.B.-N. and M.S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2010, PLANT J, V63, P613, DOI 10.1111/j.1365-313X.2010.04265.x; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Grunewald W, 2009, EMBO REP, V10, P923, DOI 10.1038/embor.2009.103; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Koo AJK, 2009, PLANT J, V59, P974, DOI 10.1111/j.1365-313X.2009.03924.x; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Melotto M, 2008, PLANT J, V55, P979, DOI 10.1111/j.1365-313X.2008.03566.x; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Nettleton EJ, 1998, J MOL BIOL, V281, P553, DOI 10.1006/jmbi.1998.1937; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Ogawa N, 2008, TETRAHEDRON LETT, V49, P7124, DOI 10.1016/j.tetlet.2008.09.144; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SADRZADEH SMH, 1993, J PHARMACOL TOXICOL, V30, P103, DOI 10.1016/1056-8719(93)90013-5; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Shimada A, 2008, NATURE, V456, P520, DOI 10.1038/nature07546; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; STEPHENS LR, 1991, BIOCHEM J, V275, P485, DOI 10.1042/bj2750485; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730	38	894	964	14	286	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					400	U301		10.1038/nature09430	http://dx.doi.org/10.1038/nature09430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	20927106	Green Accepted, Green Submitted			2022-12-28	WOS:000284313100035
J	Branch, DW; Gibson, M; Silver, RM				Branch, D. Ware; Gibson, Mark; Silver, Robert M.			Recurrent Miscarriage	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOLECULAR-WEIGHT HEPARIN; LOW-DOSE ASPIRIN; RANDOMIZED CONTROLLED-TRIAL; UTERINE ANOMALIES; HYSTEROSCOPIC METROPLASTY; REPRODUCTIVE OUTCOMES; PREGNANCY OUTCOMES; MATERNAL AGE; PLUS HEPARIN; FETAL LOSS	A 32-year-old woman presents for evaluation after three consecutive miscarriages. Before these miscarriages, she had one successful pregnancy. The patient reports no medical problems or previous surgeries. In her first miscarriage, uterine bleeding and cramping started in the 7th week of gestation, and an ultrasonographic evaluation showed an empty gestational sac of 6 weeks' size. In her next pregnancy, she presented with a miscarriage in the 8th week. The third miscarriage was identified by ultrasonographic testing as a dead embryo measuring 7.5 weeks' size. How should her case be evaluated and managed?	[Branch, D. Ware; Gibson, Mark; Silver, Robert M.] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT 84132 USA; [Branch, D. Ware] Intermt Healthcare, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center	Branch, DW (corresponding author), Univ Utah, Hlth Sci Ctr, 30 N 1900 East,2B200 SOM, Salt Lake City, UT 84132 USA.	ware.branch@hsc.utah.edu						Abalovich M, 2002, THYROID, V12, P63, DOI 10.1089/105072502753451986; *AM COLL OBST GYN, 2001, ACOG PRACT B MAN REC, V24; American Society for Reproductive Medicine, 2008, PAT FACT SHEET REC P; Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; ASHTON D, 1988, OBSTET GYNECOL, V72, P28; Baird DT, 2006, HUM REPROD UPDATE, V12, P193, DOI 10.1093/humupd/dmk003; Bates SM, 2008, CHEST, V133, p844S, DOI 10.1378/chest.08-0761; Branch DW, 2010, REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY: INTEGRATING MODERN CLINICAL AND LABORATORY PRACTICE, P281, DOI 10.1007/978-1-4419-1436-1_17; BRANCH DW, 2007, HIGH RISK PREGNANCY, P60; Brigham SA, 1999, HUM REPROD, V14, P2868, DOI 10.1093/humrep/14.11.2868; Carp H, 2001, FERTIL STERIL, V75, P678, DOI 10.1016/S0015-0282(00)01801-X; Clark P, 2010, BLOOD, V115, P4162, DOI 10.1182/blood-2010-01-267252; Clifford K, 1996, BRIT MED J, V312, P1508, DOI 10.1136/bmj.312.7045.1508; Craig LB, 2002, FERTIL STERIL, V78, P487, DOI 10.1016/S0015-0282(02)03247-8; Dizon-Townson D, 2005, OBSTET GYNECOL, V106, P517, DOI 10.1097/01.AOG.0000173986.32528.ca; Duggan M, 2001, PATHOLOGY, V33, P292; Engels H, 2008, AM J MED GENET A, V146A, P2611, DOI 10.1002/ajmg.a.32500; Farquharson RG, 2002, OBSTET GYNECOL, V100, P1361; Farquharson RG, 2002, OBSTET GYNECOL, V100, P408, DOI 10.1016/S0029-7844(02)02165-8; Gris JC, 2004, BLOOD, V103, P3695, DOI 10.1182/blood-2003-12-4250; Heinonen PK, 2006, FERTIL STERIL, V85, P700, DOI 10.1016/j.fertnstert.2005.08.039; Heinonen PK, 1997, J AM ASSOC GYN LAP, V4, P311, DOI 10.1016/S1074-3804(05)80221-X; Henriksen TB, 2004, AM J EPIDEMIOL, V160, P661, DOI 10.1093/aje/kwh259; JORDAN J, 1994, FERTIL STERIL, V62, P54; Kaandorp SP, 2010, NEW ENGL J MED, V362, P1586, DOI 10.1056/NEJMoa1000641; Keymolen K, 2009, HUM REPROD, V24, P2365, DOI 10.1093/humrep/dep201; Klatsky PC, 2008, AM J OBSTET GYNECOL, V198, P357, DOI 10.1016/j.ajog.2007.12.039; Kutteh WH, 1996, AM J OBSTET GYNECOL, V174, P1584, DOI 10.1016/S0002-9378(96)70610-5; Laskin CA, 2009, J RHEUMATOL, V36, P279, DOI [10.3899/jrheum.080763), 10.3899/jrheum.080763]; Legro RS, 2007, NEW ENGL J MED, V356, P551, DOI 10.1056/NEJMoa063971; Meza-Espinoza JP, 2008, GYNECOL OBSTET INVES, V66, P237, DOI 10.1159/000147170; MILLS JL, 1988, NEW ENGL J MED, V319, P1617, DOI 10.1056/NEJM198812223192501; Mishra GD, 2000, AUST NZ J PUBL HEAL, V24, P413, DOI 10.1111/j.1467-842X.2000.tb01604.x; Ober C, 1999, LANCET, V354, P365, DOI 10.1016/S0140-6736(98)12055-X; Palomba S, 2009, FERTIL STERIL, V92, P1646, DOI 10.1016/j.fertnstert.2008.08.087; PORTER TF, 2006, COCHRANE DB SYST REV, V2; Pritts EA, 2009, FERTIL STERIL, V91, P1215, DOI 10.1016/j.fertnstert.2008.01.051; Rai R, 2000, HUM REPROD, V15, P612, DOI 10.1093/humrep/15.3.612; Rai R, 1997, BRIT MED J, V314, P253, DOI 10.1136/bmj.314.7076.253; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Robertson L, 2006, BRIT J HAEMATOL, V132, P171, DOI 10.1111/j.1365-2141.2005.05847.x; *ROYAL COLL OBST G, 2003, 17 RCOG; Said JM, 2010, OBSTET GYNECOL, V115, P5, DOI 10.1097/AOG.0b013e3181c68907; Salim R, 2003, HUM REPROD, V18, P162, DOI 10.1093/humrep/deg030; Sierra S, 2006, SEMIN REPROD MED, V24, P17, DOI 10.1055/s-2006-931797; Silver RM, 2010, OBSTET GYNECOL, V115, P14, DOI 10.1097/AOG.0b013e3181c88918; Soc Assisted Reprod Technology, 2008, FERTIL STERIL, V90, pS136, DOI 10.1016/j.fertnstert.2008.08.062; Staessen C, 2004, HUM REPROD, V19, P2849, DOI 10.1093/humrep/deh536; Sullivan AE, 2004, OBSTET GYNECOL, V104, P784, DOI 10.1097/01.AOG.0000137832.86727.e2; Valli E, 2004, J AM ASSOC GYN LAP, V11, P240, DOI 10.1016/S1074-3804(05)60206-X; Warren JE, 2008, CLIN OBSTET GYNECOL, V51, P84, DOI 10.1097/GRF.0b013e318161719c; Warren JE, 2009, OBSTET GYNECOL, V114, P1093, DOI 10.1097/AOG.0b013e3181bc6ab0; Warren JE, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.021; Weng XP, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.803; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; LUPUS IN PRESS	56	234	261	1	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 28	2010	363	18					1740	1747		10.1056/NEJMcp1005330	http://dx.doi.org/10.1056/NEJMcp1005330			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671XF	20979474				2022-12-28	WOS:000283546400009
J	Khajetoorians, AA; Chilian, B; Wiebe, J; Schuwalow, S; Lechermann, F; Wiesendanger, R				Khajetoorians, Alexander A.; Chilian, Bruno; Wiebe, Jens; Schuwalow, Sergej; Lechermann, Frank; Wiesendanger, Roland			Detecting excitation and magnetization of individual dopants in a semiconductor	NATURE			English	Article							QUANTUM DOTS; SPECTROSCOPY; SURFACE; SPINS; SPINTRONICS; MICROSCOPY; GAAS; MN	An individual magnetic atom doped into a semiconductor is a promising building block for bottom-up spintronic devices and quantum-logic gates(1-3). Moreover, it provides a perfect model system for the atomic-scale investigation of fundamental effects such as magnetism in dilute magnetic semiconductors(4). However, dopants in semiconductors so far have not been studied by magnetically sensitive techniques with atomic resolution that correlate the atomic structure with the dopant's magnetism. Here we show electrical excitation and read-out of a spin associated with a single magnetic dopant in a semiconductor host. We use spin-resolved scanning tunnelling spectroscopy to measure the spin excitations and the magnetization curve of individual iron surface-dopants embedded within a two-dimensional electron gas confined to an indium antimonide (110) surface. The dopants act like isolated quantum spins the states of which are governed by a substantial magnetic anisotropy that forces the spin to lie in the surface plane. This result is corroborated by our first principles calculations. The demonstrated methodology opens new routes for the investigation of sample systems that are more widely studied in the field of spintronics-that is, Mn in GaAs (ref. 5), magnetic ions in semiconductor quantum dots(3), nitrogen-vacancy centres in diamond(6) and phosphorus spins in silicon(7).	[Khajetoorians, Alexander A.; Chilian, Bruno; Wiebe, Jens; Wiesendanger, Roland] Univ Hamburg, Inst Appl Phys, D-20355 Hamburg, Germany; [Schuwalow, Sergej; Lechermann, Frank] Univ Hamburg, Inst Theoret Phys 1, D-20355 Hamburg, Germany	University of Hamburg; University of Hamburg	Wiebe, J (corresponding author), Univ Hamburg, Inst Appl Phys, Jungiusstr 11, D-20355 Hamburg, Germany.	jwiebe@physnet.uni-hamburg.de	Wiesendanger, Roland/P-9726-2016; Wiebe, Jens/C-7580-2018; Lechermann, Frank/K-4745-2013; Khajetoorians, Alexander A/F-9698-2015	Wiesendanger, Roland/0000-0002-0472-4183; Wiebe, Jens/0000-0003-1668-6142; Schuwalow, Sergej/0000-0002-5446-018X	ERC; Deutsche Forschungsgemeinschaft [SFB668]; Graduiertenkolleg [1286]; City of Hamburg via the cluster of excellence	ERC(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduiertenkolleg(German Research Foundation (DFG)); City of Hamburg via the cluster of excellence	J.W. would like to thank M. Morgenstern, and S. S. would like to thank M. Karolak for discussions. A. A. K. acknowledges M. Grobis for technical discussions. We gratefully acknowledge financial support from the ERC Advanced Grant "FURORE'', by the Deutsche Forschungsgemeinschaft via the SFB668, the Graduiertenkolleg 1286 "Functional Metal-Semiconductor Hybrid Systems'', as well as by the city of Hamburg via the cluster of excellence "Nanospintronics''. All DFT calculations were done at the North-German Supercomputing Alliance (HLRN).	Awschalom DD, 2007, NAT PHYS, V3, P153, DOI 10.1038/nphys551; Balashov T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.257203; Chen X, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.197208; Fernandez-Rossier J, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.256802; Fransson J, 2009, NANO LETT, V9, P2414, DOI 10.1021/nl901066a; Fuechsle M, 2010, NAT NANOTECHNOL, V5, P502, DOI [10.1038/NNANO.2010.95, 10.1038/nnano.2010.95]; Hanson R, 2008, NATURE, V453, P1043, DOI 10.1038/nature07129; Harris JGE, 2001, PHYS REV LETT, V86, P4644, DOI 10.1103/PhysRevLett.86.4644; Hashimoto K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.256802; Heinrich AJ, 2004, SCIENCE, V306, P466, DOI 10.1126/science.1101077; Hirjibehedin CF, 2007, SCIENCE, V317, P1199, DOI 10.1126/science.1146110; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Kitchen D, 2006, NATURE, V442, P436, DOI 10.1038/nature04971; Le Gall C, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.127402; Lorente N, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.176601; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Loth S, 2010, NAT PHYS, V6, P340, DOI 10.1038/NPHYS1616; Meier F, 2008, SCIENCE, V320, P82, DOI 10.1126/science.1154415; Mochizuki T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.267204; Neumann P, 2010, NAT PHYS, V6, P249, DOI 10.1038/NPHYS1536; Persson M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.050801; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Tang JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.106803; Tsukahara N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.167203; WHITMAN LJ, 1990, PHYS REV B, V42, P7288, DOI 10.1103/PhysRevB.42.7288; Wiebe J, 2004, REV SCI INSTRUM, V75, P4871, DOI 10.1063/1.1794431; Yakunin AM, 2007, NAT MATER, V6, P512, DOI 10.1038/nmat1936; Zhou LH, 2010, NAT PHYS, V6, P187, DOI 10.1038/NPHYS1514; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323	29	81	81	1	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1084	1087		10.1038/nature09519	http://dx.doi.org/10.1038/nature09519			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20981095				2022-12-28	WOS:000283548600042
J	Sandhu, M; Wood, A; Young, E				Sandhu, Manjinder; Wood, Angela; Young, Elizabeth			Genomic risk prediction	LANCET			English	Editorial Material							UTILITY; CANCER		[Sandhu, Manjinder; Wood, Angela; Young, Elizabeth] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England; [Sandhu, Manjinder; Young, Elizabeth] Wellcome Trust Sanger Inst, Cambridge, England	University of Cambridge; Wellcome Trust Sanger Institute	Sandhu, M (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England.	manj.sandhu@srl.cam.ac.uk	Wood, Angela/GZA-5762-2022	Wood, Angela/0000-0002-7937-304X	MRC [G0701619, G0801566] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; British Heart Foundation [PG/08/094/26019] Funding Source: Medline; Medical Research Council [G0701619, G0801566] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Grosse SD, 2006, GENET MED, V8, P448, DOI 10.1097/01.gim.0000227935.26763.c6; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Romanens M, 2010, EUR J CARDIOV PREV R, V17, P18, DOI 10.1097/HJR.0b013e3283347059; Talmud PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4838; Wray NR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000864; Xu JF, 2009, PROSTATE, V69, P1565, DOI 10.1002/pros.21002	11	6	6	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 23	2010	376	9750					1366	1367		10.1016/S0140-6736(10)61921-6	http://dx.doi.org/10.1016/S0140-6736(10)61921-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672ZO	20971347				2022-12-28	WOS:000283627500005
J	Oh, SH; Chisholm, MF; Kauffmann, Y; Kaplan, WD; Luo, WD; Ruhle, M; Scheu, C				Oh, Sang Ho; Chisholm, Matthew F.; Kauffmann, Yaron; Kaplan, Wayne D.; Luo, Weidong; Ruehle, Manfred; Scheu, Christina			Oscillatory Mass Transport in Vapor-Liquid-Solid Growth of Sapphire Nanowires	SCIENCE			English	Article							SURFACE-DIFFUSION; ALUMINUM; INTERFACES; TEMPERATURE; DYNAMICS	In vapor-liquid-solid (VLS) growth, the liquid phase plays a pivotal role in mediating mass transport from the vapor source to the growth front of a nanowire. Such transport often takes place through the liquid phase. However, we observed by in situ transmission electron microscopy a different behavior for self-catalytic VLS growth of sapphire nanowires. The growth occurs in a layer-by-layer fashion and is accomplished by interfacial diffusion of oxygen through the ordered liquid aluminum atoms. Oscillatory growth and dissolution reactions at the top rim of the nanowires occur and supply the oxygen required to grow a new (0006) sapphire layer. A periodic modulation of the VLS triple-junction configuration accompanies these oscillatory reactions.	[Oh, Sang Ho] Pohang Univ Sci & Technol, Dept Mat Sci & Engn, Pohang 790784, South Korea; [Oh, Sang Ho] Pohang Univ Sci & Technol, Natl Ctr Nanomat Technol, Pohang 790784, South Korea; [Chisholm, Matthew F.; Luo, Weidong] Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA; [Kauffmann, Yaron; Kaplan, Wayne D.] Technion Israel Inst Technol, Dept Mat Engn, IL-32000 Haifa, Israel; [Luo, Weidong] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; [Ruehle, Manfred] Max Planck Inst Met Res, D-70569 Stuttgart, Germany; [Scheu, Christina] Univ Munich, Dept Chem, D-81377 Munich, Germany; [Scheu, Christina] Univ Munich, Ctr NanoSci, D-81377 Munich, Germany	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); United States Department of Energy (DOE); Oak Ridge National Laboratory; Technion Israel Institute of Technology; Vanderbilt University; Max Planck Society; University of Munich; University of Munich	Oh, SH (corresponding author), Pohang Univ Sci & Technol, Dept Mat Sci & Engn, Pohang 790784, South Korea.	shoh@postech.ac.kr	Kaplan, Wayne D./C-9100-2011; Kauffmann, Yaron/B-7301-2013; Luo, Weidong/A-8418-2009; Oh, Sang Ho/AAG-1891-2020	Kaplan, Wayne D./0000-0001-9202-391X; Luo, Weidong/0000-0003-3829-1547; Oh, Sang Ho/0000-0001-5808-7821; Kauffmann, Yaron/0000-0002-0117-6222	German Science Foundation via the Graduiertenkolleg Innere Grenzflachen [GRK 285/3]; German-Israel Fund [I-779-42.10/2003]; POSCO; Basic Science Research Institute [2.0006028]; Ministry of Education, Science and Technology [2010-0005834]; Excellence cluster Nanosystems Initiative Munich; Materials Sciences and Engineering Division of the U.S. Department of Energy	German Science Foundation via the Graduiertenkolleg Innere Grenzflachen; German-Israel Fund; POSCO; Basic Science Research Institute; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Excellence cluster Nanosystems Initiative Munich; Materials Sciences and Engineering Division of the U.S. Department of Energy(United States Department of Energy (DOE))	The in situ TEM experiments were carried out using the Stuttgart high-voltage microscope (JEM-ARM 1250) at the Max-Planck-Institut fur Metallforschung. We thank F. Phillipp, R. Hoschen, and U. Salzberger for technical support, and D. Chatain and the participants of the 3 Phase, Interface, Component Systems (PICS3) meeting for stimulating discussions. Supported by the German Science Foundation via the Graduiertenkolleg Innere Grenzflachen (GRK 285/3), the German-Israel Fund (grant I-779-42.10/2003), the Nano and Steel Fusion Research Program funded by the POSCO (S.H.O.) Basic Science Research Institute grant 2.0006028 (S.H.O.), the Basic Science Research Program through the National Research Foundation funded by the Ministry of Education, Science and Technology (grant 2010-0005834) (S.H.O.), the excellence cluster Nanosystems Initiative Munich (C.S. and S.H.O.), and the Materials Sciences and Engineering Division of the U.S. Department of Energy (M.F.C. and W.L.).	Chatain D, 2004, NAT MATER, V3, P843, DOI 10.1038/nmat1275; GIVARGIZOV EI, 1975, J CRYST GROWTH, V31, P20, DOI 10.1016/0022-0248(75)90105-0; Hao YF, 2006, NANO LETT, V6, P1650, DOI 10.1021/nl060695n; Hashibon A, 2001, INTERFACE SCI, V9, P175, DOI 10.1023/A:1015190207719; Hofmann S, 2008, NAT MATER, V7, P372, DOI 10.1038/nmat2140; Jensen LE, 2004, NANO LETT, V4, P1961, DOI 10.1021/nl048825k; Kaplan WD, 2006, ANNU REV MATER RES, V36, P1, DOI 10.1146/annurev.matsci.36.020105.104035; Kodambaka S, 2007, SCIENCE, V316, P729, DOI 10.1126/science.1139105; Kuykendall T, 2004, NAT MATER, V3, P524, DOI 10.1038/nmat1177; LAURENT V, 1988, ACTA METALL MATER, V36, P1797, DOI 10.1016/0001-6160(88)90248-9; Lee G, 2009, ANGEW CHEM INT EDIT, V48, P7366, DOI 10.1002/anie.200902451; Levi G, 2002, ACTA MATER, V50, P75, DOI 10.1016/S1359-6454(01)00333-0; Levi G, 2002, J AM CERAM SOC, V85, P1601, DOI 10.1111/j.1151-2916.2002.tb00318.x; Li WF, 2006, PHYS STATUS SOLIDI A, V203, P294, DOI 10.1002/pssa.200521409; Oh SH, 2005, SCIENCE, V310, P661, DOI 10.1126/science.1118611; ROPER SM, 2007, PHYS REV LETT, V102; Ross FM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146104; Saka H, 2005, J MATER RES, V20, P1629, DOI 10.1557/JMR.2005.0212; Schwarz KW, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.206101; Siegel DJ, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.085415; Siem EJ, 2004, PHILOS MAG, V84, P991, DOI 10.1080/14786430310001639897; Stach EA, 2003, NANO LETT, V3, P867, DOI 10.1021/nl034222h; Tian BZ, 2009, NAT NANOTECHNOL, V4, P824, DOI [10.1038/nnano.2009.304, 10.1038/NNANO.2009.304]; WANG HY, 1994, J APPL PHYS, V76, P1557, DOI 10.1063/1.358515; Wu YY, 2001, J AM CHEM SOC, V123, P3165, DOI 10.1021/ja0059084	25	138	139	5	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					489	493		10.1126/science.1190596	http://dx.doi.org/10.1126/science.1190596			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966248				2022-12-28	WOS:000283329100035
J	Bloom, SL; Uppot, R; Roberts, DJ				Bloom, Steven L.; Uppot, Raul; Roberts, Drucilla J.			Case 32-2010: A Pregnant Woman with Abdominal Pain and Fluid in the Peritoneal Cavity.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEGMENTAL MEDIOLYTIC ARTERIOPATHY; SPLENIC ARTERY ANEURYSM; ECTOPIC DECIDUA; UTERINE ARTERY; SPONTANEOUS RUPTURE; DISEASE		[Bloom, Steven L.] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA; [Uppot, Raul] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Roberts, Drucilla J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Uppot, Raul] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Roberts, Drucilla J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Bloom, SL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA.		Roberts, Drucilla/AAB-6379-2022; Uppot, Raul/AAF-1859-2019					Angelakis E J, 1993, Obstet Gynecol Surv, V48, P145, DOI 10.1097/00006254-199303000-00001; Bekeredjian R, 2005, CIRCULATION, V112, P125, DOI 10.1161/CIRCULATIONAHA.104.488825; BUTTNER A, 1993, PATHOL RES PRACT, V189, P352; Chan RJ, 1998, ARTHRITIS RHEUM, V41, P935, DOI 10.1002/1529-0131(199805)41:5<935::AID-ART22>3.0.CO;2-N; DAVIDSEN MB, 1995, EUR J SURG, V161, P775; ELLMAN JS, 1963, OBSTET GYNECOL, V21, P75; Fiori O, 2007, J REPROD MED, V52, P657; Flieder DB, 1998, HUM PATHOL, V29, P1495, DOI 10.1016/S0046-8177(98)90021-1; GINSBURG KA, 1987, OBSTET GYNECOL, V69, P474; HOLDSWORTH RJ, 1992, BRIT J OBSTET GYNAEC, V99, P595, DOI 10.1111/j.1471-0528.1992.tb13828.x; Lie JT, 1996, CARDIOVASC PATHOL, V5, P305, DOI 10.1016/S1054-8807(96)00071-3; Miller DA, 1997, OBSTET GYNECOL, V89, P671, DOI 10.1016/S0029-7844(97)00073-2; O'Connell M P, 2005, J Obstet Gynaecol, V25, P511; O'Leary SM, 2006, OBSTET GYNECOL, V108, P776, DOI 10.1097/01.AOG.0000200596.98039.c5; Parangi S, 2007, AM J SURG, V193, P223, DOI 10.1016/j.amjsurg.2006.04.021; RICHTER MA, 1983, J REPROD MED, V28, P430; Sherer DM, 2000, GYNECOL OBSTET INVES, V50, P92, DOI 10.1159/000010289; Swaegers MCR, 1997, EUR J OBSTET GYN R B, V75, P145, DOI 10.1016/S0301-2115(97)00121-8; Taussig FJ, 1906, SURG GYNECOL OBSTET, V2, P292; WEISS G, 1984, ANNU REV PHYSIOL, V46, P43; WILLIAMS JJ, 1988, J FAM PRACTICE, V26, P73; WILLMAN A, 1988, ECON LETT, V26, P77, DOI 10.1016/0165-1765(88)90056-0; ZAYTSEV P, 1987, AM J SURG PATHOL, V11, P526, DOI 10.1097/00000478-198707000-00004	23	5	7	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2010	363	17					1657	1665		10.1056/NEJMcpc1003884	http://dx.doi.org/10.1056/NEJMcpc1003884			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668BD	20961250				2022-12-28	WOS:000283242700012
J	Heidenreich, P				Heidenreich, Paul			CT coronary angiography was more accurate than stress testing for diagnosing CAD, especially in patients at intermediate risk	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COST-EFFECTIVENESS; STRATEGIES		VA Palo Alto Hlth Care Syst, Palo Alto, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Heidenreich, P (corresponding author), VA Palo Alto Hlth Care Syst, Palo Alto, CA USA.		Heidenreich, Paul/AAU-6864-2021	Heidenreich, Paul/0000-0001-7730-8490				Garber AM, 1999, ANN INTERN MED, V130, P719, DOI 10.7326/0003-4819-130-9-199905040-00003; Kuntz KM, 1999, ANN INTERN MED, V130, P709, DOI 10.7326/0003-4819-130-9-199905040-00002	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8							JC4-9	10.7326/0003-4819-153-8-201010190-02009	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956705				2022-12-28	WOS:000283054600024
J	Murff, HJ				Murff, Harvey J.			Colorectal cancer screening with fecal immunochemical testing had higher adherence than screening with guaiac-based FOBT	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Vanderbilt Univ, Nashville, TN 37203 USA	Vanderbilt University	Murff, HJ (corresponding author), Vanderbilt Univ, Nashville, TN 37203 USA.				NATIONAL CANCER INSTITUTE [R01CA143288] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA143288-01A1, R01 CA143288] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Centers for Disease Control and Prevention, COL CANC SCREEN RAT; Hol L, 2010, GUT, V59, P62, DOI 10.1136/gut.2009.177089; Jemal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009584; Richardson L. C., 2010, Morbidity and Mortality Weekly Report, V59, P808; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; VANROSSUM LG, 2010, INT J CANC      0629	6	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8							JC4-5	10.7326/0003-4819-153-8-201010190-02005	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956701				2022-12-28	WOS:000283054600020
J	Robinson, CJ				Robinson, Christopher J.			Aspirin alone or combined with nadroparin did not increase live birth rates in women with unexplained recurrent miscarriage	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Med Univ S Carolina, Charleston, SC 29425 USA	Medical University of South Carolina	Robinson, CJ (corresponding author), Med Univ S Carolina, Charleston, SC 29425 USA.		Robinson, Christopher/H-7992-2019						0	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8							JC4-7	10.7326/0003-4819-153-8-201010190-02007	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956703				2022-12-28	WOS:000283054600022
J	Perrings, C; Naeem, S; Ahrestani, F; Bunker, DE; Burkill, P; Canziani, G; Elmqvist, T; Ferrati, R; Fuhrman, JA; Jaksic, F; Kawabata, Z; Kinzig, A; Mace, GM; Milano, F; Mooney, H; Prieur-Richard, AH; Tschirhart, J; Weisser, W				Perrings, C.; Naeem, S.; Ahrestani, F.; Bunker, D. E.; Burkill, P.; Canziani, G.; Elmqvist, T.; Ferrati, R.; Fuhrman, J. A.; Jaksic, F.; Kawabata, Z.; Kinzig, A.; Mace, G. M.; Milano, F.; Mooney, H.; Prieur-Richard, A. -H.; Tschirhart, J.; Weisser, W.			Ecosystem Services for 2020	SCIENCE			English	Editorial Material							AGRICULTURAL SUSTAINABILITY; BIODIVERSITY INDICATORS; CHALLENGES; POLICY; SCIENCE		[Perrings, C.; Kinzig, A.] Arizona State Univ, Tempe, AZ 85287 USA; [Naeem, S.; Ahrestani, F.] Columbia Univ, New York, NY 10027 USA; [Bunker, D. E.] New Jersey Inst Technol, Newark, NJ 07102 USA; [Burkill, P.] Sir Alister Hardy Fdn Ocean Sci, Plymouth PL1 2PB, Devon, England; [Canziani, G.; Ferrati, R.; Milano, F.] Univ Nacl Ctr, Buenos Aires, DF, Argentina; [Elmqvist, T.] Stockholm Univ, SE-10691 Stockholm, Sweden; [Fuhrman, J. A.] Univ So Calif, Los Angeles, CA 90089 USA; [Jaksic, F.] Pontificia Univ Catolica Chile, Santiago, Chile; [Kawabata, Z.] Res Inst Humanity & Nat, Kyoto 6038047, Japan; [Mace, G. M.] Univ London Imperial Coll Sci Technol & Med, Ascot SL5 7PY, Berks, England; [Mooney, H.] Stanford Univ, Stanford, CA 94305 USA; [Prieur-Richard, A. -H.] Museum Natl Hist Nat, F-75231 Paris 05, France; [Tschirhart, J.] Univ Wyoming, Laramie, WY 82071 USA; [Weisser, W.] Univ Jena, D-07743 Jena, Germany	Arizona State University; Arizona State University-Tempe; Columbia University; New Jersey Institute of Technology; Comision Nacional de Energia Atomica (CNEA); Stockholm University; University of Southern California; Pontificia Universidad Catolica de Chile; Research Institute for Humanity & Nature (RIHN); Imperial College London; Stanford University; Museum National d'Histoire Naturelle (MNHN); University of Wyoming; Friedrich Schiller University of Jena	Perrings, C (corresponding author), Arizona State Univ, Tempe, AZ 85287 USA.	Charles.Perrings@asu.edu	Weisser, Wolfgang W/B-9718-2014; Elmqvist, Thomas/AAY-6344-2021; Jaksic, Fabian M/G-1705-2014; Ahrestani, Farshid/B-4844-2012; Mace, Georgina M/I-3072-2016; Fuhrman, Jed A/C-6461-2013	Weisser, Wolfgang W/0000-0002-2757-8959; Elmqvist, Thomas/0000-0002-4617-6197; Jaksic, Fabian M/0000-0003-0098-0291; Ahrestani, Farshid/0000-0002-0979-4359; Mace, Georgina M/0000-0001-8965-5211; Fuhrman, Jed A/0000-0002-2361-1985	Natural Environment Research Council [SAH01001] Funding Source: researchfish; NERC [SAH01001] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bracken MES, 2008, P NATL ACAD SCI USA, V105, P924, DOI 10.1073/pnas.0704103105; Bulling MT, 2010, PHILOS T R SOC B, V365, P2107, DOI 10.1098/rstb.2010.0022; Bunker DE, 2005, SCIENCE, V310, P1029, DOI 10.1126/science.1117682; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; CBD (Convention on Biological Diversity), 2010, REV UPD STRAT PLAN T; Godbold JA, 2009, MAR ECOL PROG SER, V396, P273, DOI 10.3354/meps08401; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Larigauderie A, 2010, CURR OPIN ENV SUST, V2, P9, DOI 10.1016/j.cosust.2010.02.006; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; Mace GM, 2010, CURR OPIN ENV SUST, V2, P3, DOI 10.1016/j.cosust.2010.03.003; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; McIntyre PB, 2007, P NATL ACAD SCI USA, V104, P4461, DOI 10.1073/pnas.0608148104; *MILL EC ASS, 2005, EC HUM WELL BEING GE; Mooney H, 2009, SCIENCE, V325, P1474, DOI 10.1126/science.1180935; Pretty J, 2008, PHILOS T R SOC B, V363, P447, DOI 10.1098/rstb.2007.2163; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Secretariat of the convention on biological diversity, 2020, GLOBAL BIODIVERSITY; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	21	129	149	6	251	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2010	330	6002					323	324		10.1126/science.1196431	http://dx.doi.org/10.1126/science.1196431			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947748				2022-12-28	WOS:000282986700022
J	Barnes, N				Barnes, Nick			Publish your computer code: it is good enough	NATURE			English	Editorial Material									Climate Code Fdn, Sheffield S17 4DL, S Yorkshire, England		Barnes, N (corresponding author), Climate Code Fdn, Sheffield S17 4DL, S Yorkshire, England.	nb@climatecode.org							0	157	157	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					753	753		10.1038/467753a	http://dx.doi.org/10.1038/467753a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944687	Bronze			2022-12-28	WOS:000282898700020
J	Coulter, A				Coulter, Angela			Do patients want a choice and does it work?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIAC-SURGERY		[Coulter, Angela] Fdn Informed Med Decision Making, Boston, MA 02108 USA		Coulter, A (corresponding author), Fdn Informed Med Decision Making, Boston, MA 02108 USA.	acoulter@fimdm.org	Coulter, Angela/N-6998-2019	Coulter, Angela/0000-0002-6308-8375				Boyd J., 2007, 2006 INPATIENTS IMPO; Brereton L, 2010, IMPACT NHS MARKET; Bridgewater B, 2007, HEART, V93, P744, DOI 10.1136/hrt.2006.106393; Cooper Z., 2010, DOES HOSP COMPETITIO; Coulter, 2006, ENGAGING PATIENTS TH; Coulter A., 2005, PATIENTS EXPERIENCE; Delbanco T, 2001, Health Expect, V4, P144, DOI 10.1046/j.1369-6513.2001.00145.x; *DEP HLTH, 2009, NHS CONS; Department of Health, 2010, YOUR CHOIC GP PRACT; Dixon A., 2010, PATIENT CHOICE PATIE; Dixon S, 2009, REPORT NATL PATIENT; ELLINS J, 2008, CHOICE COMPETITION P; Fotaki M, 2008, J HEALTH SERV RES PO, V13, P178, DOI 10.1258/jhsrp.2008.007163; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Gaynor M, 2010, 10242 U BRIST CTR MA; Legare F, 2008, PATIENT EDUC COUNS, V73, P526, DOI 10.1016/j.pec.2008.07.018; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; O'Connor AM, 2007, HEALTH AFFAIR, V26, P716, DOI 10.1377/hlthaff.26.3.716; Reeves R, 2004, PATIENTS EXPERIENCE; Secretary of State for Health, 2010, CM7881; Stevenson FA, 2004, HEALTH EXPECT, V7, P235, DOI 10.1111/j.1369-7625.2004.00281.x; Treasure T, 2009, DEUT MED WOCHENSCHR, V134, pS237, DOI 10.1055/s-0029-1241922	22	62	62	2	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 14	2010	341								c4989	10.1136/bmj.c4989	http://dx.doi.org/10.1136/bmj.c4989			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	668FF	20947576				2022-12-28	WOS:000283253300002
J	Lockman, S; Hughes, MD; McIntyre, J; Zheng, Y; Chipato, T; Conradie, F; Sawe, F; Asmelash, A; Hosseinipour, MC; Mohapi, L; Stringer, E; Mngqibisa, R; Siika, A; Atwine, D; Hakim, J; Shaffer, D; Kanyama, C; Wools-Kaloustian, K; Salata, RA; Hogg, E; Alston-Smith, B; Walawander, A; Purcelle-Smith, E; Eshleman, S; Rooney, J; Rahim, S; Mellors, JW; Schooley, RT; Currier, JS				Lockman, S.; Hughes, M. D.; McIntyre, J.; Zheng, Y.; Chipato, T.; Conradie, F.; Sawe, F.; Asmelash, A.; Hosseinipour, M. C.; Mohapi, L.; Stringer, E.; Mngqibisa, R.; Siika, A.; Atwine, D.; Hakim, J.; Shaffer, D.; Kanyama, C.; Wools-Kaloustian, K.; Salata, R. A.; Hogg, E.; Alston-Smith, B.; Walawander, A.; Purcelle-Smith, E.; Eshleman, S.; Rooney, J.; Rahim, S.; Mellors, J. W.; Schooley, R. T.; Currier, J. S.		OCTANE A5208 Study Team	Antiretroviral Therapies in Women after Single-Dose Nevirapine Exposure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NAIVE HIV-1-INFECTED PATIENTS; TO-CHILD TRANSMISSION; SUBTYPE-A; RESISTANCE MUTATIONS; DRUG-RESISTANCE; HIV-1 VARIANTS; INITIAL TREATMENT; PREVENTION; K103N; PERSISTENCE	BACKGROUND Peripartum administration of single-dose nevirapine reduces mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) but selects for nevirapine-resistant virus. METHODS In seven African countries, women infected with HIV-1 whose CD4+ T-cell counts were below 200 per cubic millimeter and who either had or had not taken single-dose nevirapine at least 6 months before enrollment were randomly assigned to receive antiretroviral therapy with tenofovir-emtricitabine plus nevirapine or tenofovir-emtricitabine plus lopinavir boosted by a low dose of ritonavir. The primary end point was the time to confirmed virologic failure or death. RESULTS A total of 241 women who had been exposed to single-dose nevirapine began the study treatments (121 received nevirapine and 120 received ritonavir-boosted lopin-avir). Significantly more women in the nevirapine group reached the primary end point than in the ritonavir-boosted lopinavir group (26% vs. 8%) (adjusted P = 0.001). Virologic failure occurred in 37 (28 in the nevirapine group and 9 in the ritonavir-boosted lopinavir group), and 5 died without prior virologic failure (4 in the nevirapine group and 1 in the ritonavir-boosted lopinavir group). The group differences appeared to decrease as the interval between single-dose nevirapine exposure and the start of antiretroviral therapy increased. Retrospective bulk sequencing of baseline plasma samples showed nevirapine resistance in 33 of 239 women tested (14%). Among 500 women without prior exposure to single-dose nevirapine, 34 of 249 in the nevirapine group (14%) and 36 of 251 in the ritonavir-boosted lopinavir group (14%) had virologic failure or died. CONCLUSIONS In women with prior exposure to peripartum single-dose nevirapine (but not in those without prior exposure), ritonavir-boosted lopinavir plus tenofovir-emtricitabine was superior to nevirapine plus tenofovir-emtricitabine for initial antiretroviral therapy.	[Lockman, S.] Harvard Univ, Sch Publ Hlth, IID, FXB 406, Boston, MA 02115 USA; [Lockman, S.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Lockman, S.; Asmelash, A.] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [McIntyre, J.] Anova Hlth Inst, Johannesburg, South Africa; [Conradie, F.] Univ Witwatersrand, Johannesburg, South Africa; [Mohapi, L.] Chris Hani Baragwaneth Hosp, Johannesburg, South Africa; [Chipato, T.; Hakim, J.] Univ Zimbabwe, Harare, Zimbabwe; [Sawe, F.; Shaffer, D.] Kenya Govt Med Res Ctr, Walter Reed Project, Kericho, Kenya; [Sawe, F.; Shaffer, D.] US Mil HIV Res Program, Kericho, Kenya; [Hosseinipour, M. C.; Kanyama, C.] Univ N Carolina Project, Kamuzu Cent Hosp, Lilongwe, Malawi; [Stringer, E.] Univ Alabama Birmingham, Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Mngqibisa, R.] Univ KwaZulu Natal, Durban, South Africa; [Siika, A.] Moi Univ, Fac Hlth Sci, Eldoret, Kenya; [Atwine, D.] Joint Clin Res Ctr, Kampala, Uganda; [Wools-Kaloustian, K.] Indiana Univ Sch Med, Indianapolis, IN USA; [Salata, R. A.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Hogg, E.] Social & Sci Syst, Clin Trials Grp Operat Ctr, Silver Spring, MD USA; [Alston-Smith, B.; Purcelle-Smith, E.] NIH, Bethesda, MD 20892 USA; [Walawander, A.] Frontier Sci & Technol Res Fdn Inc, Chestnut Hill, MA USA; [Eshleman, S.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Rooney, J.] Gilead Sci Inc, Foster City, CA 94404 USA; [Rahim, S.] Abbott Labs, Abbott Pk, IL 60064 USA; [Mellors, J. W.] Univ Pittsburgh, Med Ctr, UPMC Presbyterian Hosp, Pittsburgh, PA USA; [Schooley, R. T.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Currier, J. S.] Univ Calif Los Angeles, Los Angeles, CA 90024 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Botswana-Harvard AIDS Institute Partnership; University of Witwatersrand; University of Zimbabwe; Kenya Medical Research Institute; University of Kwazulu Natal; Moi University; Joint Clinic Research Center - United Arab Emirates; Indiana University System; Indiana University Bloomington; Case Western Reserve University; Social & Scientific Systems; National Institutes of Health (NIH) - USA; Frontier Science Foundation; Johns Hopkins University; Johns Hopkins Medicine; Gilead Sciences; Abbott Laboratories; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UPMC Presbyterian; University of California System; University of California San Diego; University of California System; University of California Los Angeles	Lockman, S (corresponding author), Harvard Univ, Sch Publ Hlth, IID, FXB 406, 651 Huntington Ave, Boston, MA 02115 USA.	slockman@hsph.harvard.edu	McIntyre, James/V-7115-2019		National Institute of Allergy and Infectious Diseases [U01AI068636, AI38838, SDMC AI68634]; National Center for Research; National Institutes of Health [K24 AI56933, 5401A1068636-04]; Boehringer Ingelheim; Medicines Development; Pfizer; Tibotec; Virionyx; Schering-Plough; Merck; Abbott Speakers Bureau; Abbott Virology; Gilead Sciences; Idenix Pharmaceuticals; Chimerix; RFS Pharmaceuticals,; Panacos Pharmaceuticals; Abbott Laboratories; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068636, K24AI056933, U01AI068634, UM1AI068634] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim(Boehringer Ingelheim); Medicines Development; Pfizer(Pfizer); Tibotec; Virionyx; Schering-Plough(Merck & CompanySchering Plough Corporation); Merck(Merck & Company); Abbott Speakers Bureau; Abbott Virology; Gilead Sciences(Gilead Sciences); Idenix Pharmaceuticals; Chimerix; RFS Pharmaceuticals,; Panacos Pharmaceuticals; Abbott Laboratories(Abbott Laboratories); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by grants (U01AI068636, AI38838, and SDMC AI68634) from the National Institute of Allergy and Infectious Diseases to the AIDS Clinical Trials Group, by grants from the National Center for Research to the General Clinical Research Center Units, and by grants (K24 AI56933, to Dr. Currier, and 5401A1068636-04, to the Virology Support Laboratory for Adult AIDS Clinical Trials Group) from the National Institutes of Health. Study drugs were provided by Abbott Laboratories, Boehringer Ingelheim Pharmaceuticals, Gilead Sciences, Bristol-Myers Squibb, and GlaxoSmithKline.; Dr. Hughes reports receiving fees as a member of the data and safety monitoring boards for Boehringer Ingelheim, Medicines Development, Pfizer, Tibotec, and Virionyx and the receipt by his department of financial support from Schering-Plough and Merck for an annual educational workshop; Dr. McIntyre, receiving financial support from the Abbott Speakers Bureau; Dr. Hosseinipour, receiving financial support from Abbott Virology for educational presentations; Dr. Mohapi, receiving reimbursement for travel expenses from Pfizer Laboratories; Dr. Wools-Kaloustian, receiving grant support from Gilead Sciences; Dr. Rooney, being a full-time employee of (and having stock options in) Gilead Sciences; Dr. Rahim, being a full-time employee of (and having stock options in) Abbott Laboratories at the time the study was conducted; Dr. Mellors, serving on the scientific advisory board for Gilead Sciences, receiving consulting fees from Merck, Idenix Pharmaceuticals, Chimerix, RFS Pharmaceuticals, Panacos Pharmaceuticals, and Abbott Laboratories, receiving grant support from Merck, having stock options in RFS Pharmaceuticals, and receiving reimbursement for travel expenses from Gilead Sciences, Merck, Chimerix, Idenix Pharmaceuticals, RFS Pharmaceuticals, and Panacos Pharmaceuticals; Dr. Schooley, receiving consulting fees from GlaxoSmithKline and Abbott Laboratories and reimbursement for travel expenses from Abbott Laboratories; and Dr. Currier, receiving consulting fees from GlaxoSmithKline and grant support from Merck and Tibotec. No other potential conflict of interest relevant to this article was reported.	Chaix ML, 2006, J INFECT DIS, V193, P482, DOI 10.1086/499966; Chi BH, 2008, LANCET, V371, P650; Chi BH, 2007, LANCET, V370, P1698, DOI 10.1016/S0140-6736(07)61605-5; Chi BH, 2007, AIDS, V21, P957, DOI 10.1097/QAD.0b013e32810996b2; Coovadia A, 2009, CLIN INFECT DIS, V48, P462, DOI 10.1086/596486; *CYT, 2007, E 5 US MAN; *DIV AIDS, 2004, DIV AIDS TABL GRAD S; Eron J, 2006, LANCET, V368, P1238, DOI 10.1016/S0140-6736(06)69155-1; Joseph E, 2006, LANCET, V368, P476, DOI 10.1016/S0140-6736(06)69155-1; Eshleman SH, 2005, JAIDS-J ACQ IMM DEF, V40, P24, DOI 10.1097/01.qai.0000174656.71276.d6; Eshleman SH, 2005, J INFECT DIS, V192, P30, DOI 10.1086/430764; Eshleman SH, 2004, JAIDS-J ACQ IMM DEF, V35, P126, DOI 10.1097/00126334-200402010-00004; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; Flys T, 2005, J INFECT DIS, V192, P24, DOI 10.1086/430742; Flys TS, 2007, J INFECT DIS, V195, P711, DOI 10.1086/511433; Flys TS, 2006, JAIDS-J ACQ IMM DEF, V42, P610, DOI 10.1097/01.qai.0000221686.67810.20; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; JOURDAIN G, 2004, 11 C RETR OPP INF SA; Kassaye S, 2007, AIDS RES HUM RETROV, V23, P1055, DOI 10.1089/aid.2007.0045; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Loubser S, 2006, AIDS, V20, P995, DOI 10.1097/01.aids.0000222071.60620.1d; McIntyre JA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000172; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; MORRIS L, 2004, 15 INT AIDS C BANGK; Ortiz R, 2008, AIDS, V22, P1389, DOI 10.1097/QAD.0b013e32830285fb; Palmer S, 2006, P NATL ACAD SCI USA, V103, P7094, DOI 10.1073/pnas.0602033103; Rey D, 2009, J ANTIMICROB CHEMOTH, V63, P380, DOI 10.1093/jac/dkn471; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Stringer JSA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000233; *UNAIDS, AIDS EP UPD NOV 2009; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; van Zyl GU, 2008, J MED VIROL, V80, P942, DOI 10.1002/jmv.21157; Walmsley S, 2002, NEW ENGL J MED, V346, P2039, DOI 10.1056/NEJMoa012354; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2008, UN ACC SCAL PRIOR HI; World Health Organization, 2021, ANT DRUGS TREAT PREG	38	88	90	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2010	363	16					1499	1509		10.1056/NEJMoa0906626	http://dx.doi.org/10.1056/NEJMoa0906626			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663KP	20942666	Green Accepted			2022-12-28	WOS:000282887100004
J	Biller-Andorno, N; Capron, AM				Biller-Andorno, Nikola; Capron, Alexander Morgan			"Gratuities" for donated organs: ethically indefensible	LANCET			English	Editorial Material							REGULATED SYSTEM; KIDNEY; STATE		[Capron, Alexander Morgan] Univ So Calif, Pacific Ctr Hlth Policy & Eth, Los Angeles, CA 90089 USA; [Biller-Andorno, Nikola] Univ Zurich, Inst Biomed Eth, Zurich, Switzerland	University of Southern California; University of Zurich	Capron, AM (corresponding author), Univ So Calif, Pacific Ctr Hlth Policy & Eth, Los Angeles, CA 90089 USA.	acapron@law.usc.edu		Biller-Andorno, Nikola/0000-0001-7661-1324				Caplan A, 2009, JOINT COUNCIL EUROPE; Danovitch GM, 2006, CLIN J AM SOC NEPHRO, V1, P1133, DOI 10.2215/CJN.03030906; Delmonico FL, 2002, NEW ENGL J MED, V346, P2002, DOI 10.1056/NEJMsb013216; Delmonico FL, 2009, CURR OPIN ORGAN TRAN, V14, P116, DOI 10.1097/MOT.0b013e32832917c9; Goyal M, 2002, JAMA-J AM MED ASSOC, V288, P1589, DOI 10.1001/jama.288.13.1589; Jha V, 2006, NAT CLIN PRACT NEPHR, V2, P466, DOI 10.1038/ncpneph0268; Kerstein SJ, 2009, KENNEDY INST ETHIC J, V19, P147, DOI 10.1353/ken.0.0280; Matas AJ, 2008, CURR OPIN ORGAN TRAN, V13, P379, DOI 10.1097/MOT.0b013e328308b2d9; MCINDOE A, 2010, STRAITS TIMES   0713; Moazam F, 2009, HASTINGS CENT REP, V39, P29; Rid A, 2009, J MED ETHICS, V35, P558, DOI 10.1136/jme.2008.026856; Rothman SM, 2006, AM J TRANSPLANT, V6, P1524, DOI 10.1111/j.1600-6143.2006.01325.x; Shimazono Y, 2007, B WORLD HEALTH ORGAN, V85, P955, DOI 10.2471/BLT.06.039370; World Health Assembly, 2010, HUM ORG TISS TRANSPL; Zargooshi J, 2001, J UROLOGY, V166, P1790, DOI 10.1016/S0022-5347(05)65677-7	15	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 23	2011	377	9775					1390	1391		10.1016/S0140-6736(10)61419-5	http://dx.doi.org/10.1016/S0140-6736(10)61419-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UF	20971502				2022-12-28	WOS:000289963000009
J	Daneman, R; Zhou, L; Kebede, AA; Barres, BA				Daneman, Richard; Zhou, Lu; Kebede, Amanuel A.; Barres, Ben A.			Pericytes are required for blood-brain barrier integrity during embryogenesis	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; ENDOTHELIAL-CELLS; IN-VITRO; UP-REGULATION; ASTROCYTES; OCCLUDIN; RATS; CNS; OLIGODENDROCYTES; MORPHOGENESIS	Vascular endothelial cells in the central nervous system (CNS) forma barrier that restricts the movement of molecules and ions between the blood and the brain. This blood-brain barrier (BBB) is crucial to ensure proper neuronal function and protect the CNS from injury and disease(1). Transplantation studies have demonstrated that the BBB is not intrinsic to the endothelial cells, but is induced by interactions with the neural cells(2). Owing to the close spatial relationship between astrocytes and endothelial cells, it has been hypothesized that astrocytes induce this critical barrier postnatally(3), but the timing of BBB formation has been controversial(4-9). Here we demonstrate that the barrier is formed during embryogenesis as endothelial cells invade the CNS and pericytes are recruited to the nascent vessels, over a week before astrocyte generation. Analysing mice with null and hypomorphic alleles of Pdgfrb, which have defects in pericyte generation, we demonstrate that pericytes are necessary for the formation of the BBB, and that absolute pericyte coverage determines relative vascular permeability. We demonstrate that pericytes regulate functional aspects of the BBB, including the formation of tight junctions and vesicle trafficking in CNS endothelial cells. Pericytes do not induce BBB-specific gene expression in CNS endothelial cells, but inhibit the expression of molecules that increase vascular permeability and CNS immune cell infiltration. These data indicate that pericyte-endothelial cell interactions are critical to regulate the BBB during development, and disruption of these interactions may lead to BBB dysfunction and neuroinflammation during CNS injury and disease.	[Daneman, Richard; Kebede, Amanuel A.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Zhou, Lu; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University	Daneman, R (corresponding author), Univ Calif San Francisco, Dept Anat, 513 Parnassus Ave,HSW1301, San Francisco, CA 94143 USA.	Richard.daneman@ucsf.edu			NINDS [R01-NS045621]; Myelin Repair Foundation; NMSS [RG3936A7]; UCSF; AHA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045621] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Myelin Repair Foundation; NMSS(National Multiple Sclerosis Society); UCSF; AHA(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Perrino for electron microscopy preparations. Work was supported by grants from the NINDS (R01-NS045621; B.A.B), Myelin Repair Foundation (B.A.B., R.D.), NMSS (Grant-RG3936A7; B.A.B.), UCSF Fellow's Program (R.D.) and AHA (R.D.).	BAUER HC, 1993, DEV BRAIN RES, V75, P269, DOI 10.1016/0165-3806(93)90031-5; Bolz S, 1996, CELL TISSUE RES, V284, P355, DOI 10.1007/s004410050596; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; BUTT AM, 1990, J PHYSIOL-LONDON, V429, P47, DOI 10.1113/jphysiol.1990.sp018243; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Ek CJ, 2006, J COMP NEUROL, V496, P13, DOI 10.1002/cne.20885; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; He ZJ, 2009, CHINESE MED J-PEKING, V122, P2346, DOI 10.3760/cma.j.issn.0366-6999.2009.19.029; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hirase T, 1997, J CELL SCI, V110, P1603; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Ioannidou S, 2006, P NATL ACAD SCI USA, V103, P16770, DOI 10.1073/pnas.0603501103; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Kniesel U, 1996, DEV BRAIN RES, V96, P229, DOI 10.1016/S0165-3806(96)00117-4; Korn J, 2002, J COMP NEUROL, V442, P78, DOI 10.1002/cne.1423; Lai CH, 2005, BRAIN RES REV, V50, P258, DOI 10.1016/j.brainresrev.2005.07.004; Lee SW, 2009, INT J MOL MED, V23, P279, DOI 10.3892/ijmm_00000128; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Motiejunaite R, 2008, EXP EYE RES, V86, P171, DOI 10.1016/j.exer.2007.10.013; Nag S, 2005, LAB INVEST, V85, P1189, DOI 10.1038/labinvest.3700325; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; Shue EH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-29; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Weidenfeller C, 2007, J NEUROCHEM, V101, P555, DOI 10.1111/j.1471-4159.2006.04394.x; Wosik K, 2007, J NEUROSCI, V27, P9032, DOI 10.1523/JNEUROSCI.2088-07.2007; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	33	1234	1272	7	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 25	2010	468	7323					562	U238		10.1038/nature09513	http://dx.doi.org/10.1038/nature09513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	20944625	Green Accepted			2022-12-28	WOS:000284584200042
J	Scherber, C; Eisenhauer, N; Weisser, WW; Schmid, B; Voigt, W; Fischer, M; Schulze, ED; Roscher, C; Weigelt, A; Allan, E; Bessler, H; Bonkowski, M; Buchmann, N; Buscot, F; Clement, LW; Ebeling, A; Engels, C; Halle, S; Kertscher, I; Klein, AM; Koller, R; Konig, S; Kowalski, E; Kummer, V; Kuu, A; Lange, M; Lauterbach, D; Middelhoff, C; Migunova, VD; Milcu, A; Muller, R; Partsch, S; Petermann, JS; Renker, C; Rottstock, T; Sabais, A; Scheu, S; Schumacher, J; Temperton, VM; Tscharntke, T				Scherber, Christoph; Eisenhauer, Nico; Weisser, Wolfgang W.; Schmid, Bernhard; Voigt, Winfried; Fischer, Markus; Schulze, Ernst-Detlef; Roscher, Christiane; Weigelt, Alexandra; Allan, Eric; Bessler, Holger; Bonkowski, Michael; Buchmann, Nina; Buscot, Francois; Clement, Lars W.; Ebeling, Anne; Engels, Christof; Halle, Stefan; Kertscher, Ilona; Klein, Alexandra-Maria; Koller, Robert; Koenig, Stephan; Kowalski, Esther; Kummer, Volker; Kuu, Annely; Lange, Markus; Lauterbach, Dirk; Middelhoff, Cornelius; Migunova, Varvara D.; Milcu, Alexandru; Mueller, Ramona; Partsch, Stephan; Petermann, Jana S.; Renker, Carsten; Rottstock, Tanja; Sabais, Alexander; Scheu, Stefan; Schumacher, Jens; Temperton, Vicky M.; Tscharntke, Teja			Bottom-up effects of plant diversity on multitrophic interactions in a biodiversity experiment	NATURE			English	Article							TROPHIC GROUPS; TOP-DOWN; COMMUNITIES; ECOSYSTEMS; GRASSLANDS; SERVICES; WEB	Biodiversity is rapidly declining(1), and this may negatively affect ecosystem processes(2), including economically important ecosystem services(3). Previous studies have shown that biodiversity has positive effects on organisms and processes(4) across trophic levels(5). However, only a few studies have so far incorporated an explicit food-web perspective(6). In an eight-year biodiversity experiment, we studied an unprecedented range of above-and below-ground organisms and multitrophic interactions. A multitrophic data set originating from a single long-term experiment allows mechanistic insights that would not be gained from meta-analysis of different experiments. Here we show that plant diversity effects dampen with increasing trophic level and degree of omnivory. This was true both for abundance and species richness of organisms. Furthermore, we present comprehensive above-ground/below-ground biodiversity food webs. Both above ground and below ground, herbivores responded more strongly to changes in plant diversity than did carnivores or omnivores. Density and richness of carnivorous taxa was independent of vegetation structure. Below-ground responses to plant diversity were consistently weaker than above-ground responses. Responses to increasing plant diversity were generally positive, but were negative for biological invasion, pathogen infestation and hyperparasitism. Our results suggest that plant diversity has strong bottom-up effects on multitrophic interaction networks, with particularly strong effects on lower trophic levels. Effects on higher trophic levels are indirectly mediated through bottom-up trophic cascades.	[Scherber, Christoph; Ebeling, Anne; Tscharntke, Teja] Univ Gottingen, Dept Crop Sci, D-37077 Gottingen, Germany; [Scherber, Christoph; Weisser, Wolfgang W.; Voigt, Winfried; Roscher, Christiane; Weigelt, Alexandra; Allan, Eric; Clement, Lars W.; Ebeling, Anne; Halle, Stefan; Kertscher, Ilona; Klein, Alexandra-Maria; Kowalski, Esther; Lange, Markus; Lauterbach, Dirk; Mueller, Ramona] Univ Jena, Inst Ecol, D-07743 Jena, Germany; [Eisenhauer, Nico; Partsch, Stephan; Sabais, Alexander; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Eisenhauer, Nico] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Schmid, Bernhard; Petermann, Jana S.] Univ Zurich, Inst Environm Sci, CH-8057 Zurich, Switzerland; [Fischer, Markus] Univ Bern, CH-3013 Bern, Switzerland; [Fischer, Markus; Kummer, Volker; Rottstock, Tanja] Univ Potsdam, Inst Biochem & Biol, D-14469 Potsdam, Germany; [Schulze, Ernst-Detlef; Middelhoff, Cornelius; Schumacher, Jens; Temperton, Vicky M.] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Roscher, Christiane] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, D-06120 Halle, Germany; [Weigelt, Alexandra] Univ Leipzig, Inst Biol 1, D-04103 Leipzig, Germany; [Bessler, Holger; Engels, Christof] Humboldt Univ, Dept Plant Nutr, D-14195 Berlin, Germany; [Bonkowski, Michael; Koller, Robert] Univ Cologne, Cologne Bioctr, Dept Terr Ecol, D-50674 Cologne, Germany; [Buchmann, Nina] Swiss Fed Inst Technol, Inst Plant Anim & Agroecosyst Sci, LFW C56, CH-8092 Zurich, Switzerland; [Buscot, Francois; Koenig, Stephan] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, D-06102 Halle, Germany; [Klein, Alexandra-Maria] Leuphana Univ Lueneburg, Inst Ecol & Environm Chem, D-21335 Luneburg, Germany; [Kuu, Annely] Tallinn Univ Technol, Tartu Coll, EE-51008 Tartu, Estonia; [Migunova, Varvara D.] KI Skryabin All Russian Inst Helminthol, Moscow 117218, Russia; [Milcu, Alexandru] Imperial Coll London, Div Biol, NERC Ctr Populat Biol, Ascot SL5 7PY, Berks, England; [Petermann, Jana S.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Renker, Carsten] Mainz Museum Nat Hist, D-55116 Mainz, Germany; [Schumacher, Jens] Univ Jena, Inst Stochast, D-07743 Jena, Germany; [Temperton, Vicky M.] Forschungszentrum Julich GmbH, Phytosphere Inst ICG 3, D-52425 Julich, Germany	University of Gottingen; Friedrich Schiller University of Jena; University of Gottingen; University of Minnesota System; University of Minnesota Twin Cities; University of Zurich; University of Bern; University of Potsdam; Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Humboldt University of Berlin; University of Cologne; Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leuphana University Luneburg; Tallinn University of Technology; Federal Scientific Centre VIEV; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of British Columbia; Friedrich Schiller University of Jena; Helmholtz Association; Research Center Julich	Scherber, C (corresponding author), Univ Gottingen, Dept Crop Sci, Grisebachstr 6, D-37077 Gottingen, Germany.	christoph.scherber@agr.uni-goettingen.de	Buscot, Francois/A-4125-2016; Allan, Eric/AAR-9566-2020; Weisser, Wolfgang W/B-9718-2014; Tscharntke, Teja/N-5123-2014; Klein, Alexandra-Maria/J-5871-2016; Schmid, Bernhard/C-8625-2009; Migunova, Varvara/Q-3899-2018; Koenig, Stephan/GRX-2480-2022; Scherber, Christoph/B-6611-2009; Petermann, Jana/E-2130-2013; Petermann, Jana/AAK-9787-2020; Eisenhauer, Nico/I-5932-2012; Fischer, Markus/C-6411-2008; Buchmann, Nina/E-6095-2011; Scheu, Stefan/H-7049-2015; Kuu, Annely/AAL-4740-2020; Eisenhauer, Nico/I-3191-2019; Bonkowski, Michael/C-3700-2013; Schulze, Ernst-Detlef/K-9627-2014; Milcu, Alexandru/X-6267-2018	Buscot, Francois/0000-0002-2364-0006; Allan, Eric/0000-0001-9641-9436; Weisser, Wolfgang W/0000-0002-2757-8959; Klein, Alexandra-Maria/0000-0003-2139-8575; Schmid, Bernhard/0000-0002-8430-3214; Scherber, Christoph/0000-0001-7924-8911; Petermann, Jana/0000-0002-3898-5656; Petermann, Jana/0000-0002-3898-5656; Eisenhauer, Nico/0000-0002-0371-6720; Fischer, Markus/0000-0002-5589-5900; Buchmann, Nina/0000-0003-0826-2980; Eisenhauer, Nico/0000-0002-0371-6720; Bonkowski, Michael/0000-0003-2656-1183; Koller, Robert/0000-0001-7251-7242; Kuu, Annely/0000-0002-0335-6243; Milcu, Alexandru/0000-0002-2889-1234; Temperton, Vicky/0000-0003-0543-4521	Deutsche Forschungsgemeinschaft [FOR 456]; NERC [cpb010001] Funding Source: UKRI; Natural Environment Research Council [cpb010001] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank J. M. Tylianakis, P. Batary, Y. Clough, M. J. Crawley, J. Fox, J. Frund, D. Gladbach and A. Hector for comments that improved this manuscript. The gardeners, technicians, student helpers and managers of the Jena Experiment are acknowledged for their assistance. This work was supported by the Deutsche Forschungsgemeinschaft (FOR 456).	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Cardinale Bradley, 2009, P105; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; De Deyn GB, 2004, OIKOS, V106, P576, DOI 10.1111/j.0030-1299.2004.13265.x; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Eisenhauer N, 2010, ECOLOGY, V91, P485, DOI 10.1890/08-2338.1; Ghazoul J, 2006, J ECOL, V94, P295, DOI 10.1111/j.1365-2745.2006.01098.x; Goudard A, 2008, AM NAT, V171, P91, DOI 10.1086/523945; Grace JB., 2015, STRUCTURAL EQUATION; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; HUNTER MD, 1992, ECOLOGY, V73, P724; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Legendre P., 2012, NUMERICAL ECOLOGY; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Myers N, 1996, P NATL ACAD SCI USA, V93, P2764, DOI 10.1073/pnas.93.7.2764; OGUSHI T, 2007, ECOLOGICAL COMMUNITI; Petchey OL, 2004, OIKOS, V104, P467, DOI 10.1111/j.0030-1299.2004.13257.x; PRICE PW, 1992, BIOTROPICA, V24, P273, DOI 10.2307/2388522; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SCHMID B, 2010, BIODIVERSITY ECOSYST, P14; Srivastava DS, 2009, ECOLOGY, V90, P1073, DOI 10.1890/08-0439.1; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Wardle DA, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P155	29	601	626	29	797	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 25	2010	468	7323					553	556		10.1038/nature09492	http://dx.doi.org/10.1038/nature09492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	20981010				2022-12-28	WOS:000284584200040
J	Hay, SI; Gething, PW; Snow, RW				Hay, Simon I.; Gething, Peter W.; Snow, Robert W.			India's invisible malaria burden	LANCET			English	Editorial Material									[Snow, Robert W.] Univ Oxford, KEMRI, Wellcome Trust Res Programme, Nairobi, Kenya; [Hay, Simon I.; Gething, Peter W.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX3 7LJ, England; [Snow, Robert W.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 7LJ, England	University of Oxford; University of Oxford	Snow, RW (corresponding author), Univ Oxford, KEMRI, Wellcome Trust Res Programme, Nairobi, Kenya.	rsnow@nairobi.kemri-wellcome.org	Snow, Robert William/AFR-1436-2022; Hay, Simon Iain/F-8967-2015; Gething, Peter/ABD-2110-2020; Gething, Peter/GQR-1884-2022	Snow, Robert William/0000-0003-3725-6088; Hay, Simon Iain/0000-0002-0611-7272; Gething, Peter/0000-0001-6759-5449	Wellcome Trust [079080, 079091] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; DASH AP, 2009, ESTIMATION TRUE MALA, P91; DHINGRA N, 1940, LANCET          1021, DOI DOI 10.1016/S0140-6736(10)60831-8; Diamond-Smith Nadia, 2009, Malar J, V8, P24, DOI 10.1186/1475-2875-8-24; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; SNOW RW, 1992, LANCET, V340, P351, DOI 10.1016/0140-6736(92)91414-4; WHO, 2010, WORLD MALARIA REPORT 2010, P1	8	41	44	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 20	2010	376	9754					1716	1717		10.1016/S0140-6736(10)61084-7	http://dx.doi.org/10.1016/S0140-6736(10)61084-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	690EI	20970180	Green Accepted			2022-12-28	WOS:000284984900006
J	Mannini, M; Pineider, F; Danieli, C; Totti, F; Sorace, L; Sainctavit, P; Arrio, MA; Otero, E; Joly, L; Cezar, JC; Cornia, A; Sessoli, R				Mannini, M.; Pineider, F.; Danieli, C.; Totti, F.; Sorace, L.; Sainctavit, Ph.; Arrio, M. -A.; Otero, E.; Joly, L.; Cezar, J. C.; Cornia, A.; Sessoli, R.			Quantum tunnelling of the magnetization in a monolayer of oriented single-molecule magnets	NATURE			English	Article							ANISOTROPY; DICHROISM; FE; SPINTRONICS; SPECTRA; EDGE; GOLD	A fundamental step towards atomic- or molecular-scale spintronic devices has recently been made by demonstrating that the spin of an individual atom deposited on a surface(1), or of a small paramagnetic molecule embedded in a nanojunction(2), can be externally controlled. An appealing next step is the extension of such a capability to the field of information storage, by taking advantage of the magnetic bistability and rich quantum behaviour of single-molecule magnets(3-6) (SMMs). Recently, a proof of concept that the magnetic memory effect is retained when SMMs are chemically anchored to a metallic surface(7) was provided. However, control of the nanoscale organization of these complex systems is required for SMMs to be integrated into molecular spintronic devices(8,9). Here we show that a preferential orientation of Fe(4) complexes on a gold surface can be achieved by chemical tailoring. As a result, the most striking quantum feature of SMMs-their stepped hysteresis loop, which results from resonant quantum tunnelling of the magnetization(5,6)-can be clearly detected using synchrotron-based spectroscopic techniques. With the aid of multiple theoretical approaches, we relate the angular dependence of the quantum tunnelling resonances to the adsorption geometry, and demonstrate that molecules predominantly lie with their easy axes close to the surface normal. Our findings prove that the quantum spin dynamics can be observed in SMMs chemically grafted to surfaces, and offer a tool to reveal the organization of matter at the nanoscale.	[Mannini, M.; Pineider, F.; Totti, F.; Sorace, L.; Sessoli, R.] Univ Florence, Dept Chem Ugo Schiff, I-50019 Sesto Fiorentino, Italy; [Mannini, M.; Pineider, F.; Totti, F.; Sorace, L.; Sessoli, R.] Univ Florence, INSTM Res Unit, I-50019 Sesto Fiorentino, Italy; [Mannini, M.] Univ Florence, ISTM CNR, URT Firenze, I-50019 Sesto Fiorentino, Italy; [Danieli, C.; Cornia, A.] Univ Modena & Reggio Emilia, Dept Chem, I-41100 Modena, Italy; [Danieli, C.; Cornia, A.] Univ Modena & Reggio Emilia, INSTM Res Unit, I-41100 Modena, Italy; [Sainctavit, Ph.; Arrio, M. -A.] Univ Paris 06, CNRS, UMR7590, Inst Mineral & Phys Milieux Condenses, F-75252 Paris, France; [Otero, E.] Synchrotron Soleil, F-91192 Gif Sur Yvette, France; [Joly, L.] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Cezar, J. C.] European Synchrotron Radiat Facil, F-38043 Grenoble, France	University of Florence; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie Molecolari (ISTM-CNR); University of Florence; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); SOLEIL Synchrotron; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; European Synchrotron Radiation Facility (ESRF)	Sessoli, R (corresponding author), Univ Florence, Dept Chem Ugo Schiff, I-50019 Sesto Fiorentino, Italy.	roberta.sessoli@unifi.it	Cezar, Julio Criginski/B-2731-2008; , Chicco/D-5043-2011; Joly, Loïc/I-2391-2016; Cezar, Julio Criginski/D-5039-2012; Cornia, Andrea/N-8587-2015; Sessoli, Roberta/K-5863-2015; Sorace, Lorenzo/F-7872-2019; Mannini, Matteo/B-5966-2013; Pineider, Francesco/K-9174-2013	Cezar, Julio Criginski/0000-0002-7904-6874; , Chicco/0000-0003-4752-0495; Joly, Loïc/0000-0002-0137-2821; Cezar, Julio Criginski/0000-0002-7904-6874; Cornia, Andrea/0000-0001-9765-3128; Sessoli, Roberta/0000-0003-3783-2700; Sorace, Lorenzo/0000-0003-4785-1331; Mannini, Matteo/0000-0001-7549-2124; Pineider, Francesco/0000-0003-4066-4031	European Community [226716]; Italian CNR [PM.P05.012]; Italian MIUR; Ente CRF	European Community(European Commission); Italian CNR(Consiglio Nazionale delle Ricerche (CNR)); Italian MIUR(Ministry of Education, Universities and Research (MIUR)); Ente CRF	We acknowledge D. Gatteschi and J. Villain for discussions. F. Scheurer, J. P. Kappler, B. Muller, F. Nolting and N. Brookes are acknowledged for their contribution to the development of the synchrotron experimental set-ups used in this work. This work is based on experiments performed at the Swiss Light Source, Paul Scherrer Institute, Villigen, Switzerland, and the European Synchrotron Radiation Facility, Grenoble, France. The research leading to these results received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 226716, through the projects MolSpinQIP (FP7-ICT-2007-C-211284) and ERANET 'NanoSci-ERA: Nanoscience in European Research Area', from the Italian CNR, through the Commessa PM.P05.012, from the Italian MIUR, through the project PRIN 2008, and from Ente CRF. DFT calculations were carried out within the DEISA Extreme Computing Initiative projects AMNOS and QUNA.	Barra AL, 2007, J AM CHEM SOC, V129, P10754, DOI 10.1021/ja0717921; Bencini A, 2009, SUPERLATTICE MICROST, V46, P4, DOI 10.1016/j.spmi.2008.12.006; Bogani L, 2008, NAT MATER, V7, P179, DOI 10.1038/nmat2133; BROUDER C, 1990, J PHYS-CONDENS MAT, V2, P701, DOI 10.1088/0953-8984/2/3/018; Friedman JR, 1996, PHYS REV LETT, V76, P3830, DOI 10.1103/PhysRevLett.76.3830; Gambardella P, 2009, NAT MATER, V8, P189, DOI [10.1038/nmat2376, 10.1038/NMAT2376]; Gatteschi D, 2006, MESOSCOPIC PHYS NANO, P1; Gregoli L, 2009, CHEM-EUR J, V15, P6456, DOI 10.1002/chem.200900483; Heersche HB, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.206801; Jo MH, 2006, NANO LETT, V6, P2014, DOI 10.1021/nl061212i; Juhin A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195103; Letard I, 2007, J APPL PHYS, V101, DOI 10.1063/1.2745318; Loth S, 2010, NAT PHYS, V6, P340, DOI 10.1038/NPHYS1616; Mannini M, 2008, CHEM-EUR J, V14, P7530, DOI 10.1002/chem.200800693; Mannini M, 2009, ADV MATER, V21, P167, DOI 10.1002/adma.200801883; Mannini M, 2009, NAT MATER, V8, P194, DOI [10.1038/NMAT2374, 10.1038/nmat2374]; Margheriti L, 2009, SMALL, V5, P1460, DOI 10.1002/smll.200801594; Misiorny M, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/18003; Nakajima R, 1999, PHYS REV B, V59, P6421, DOI 10.1103/PhysRevB.59.6421; Parks JJ, 2010, SCIENCE, V328, P1370, DOI 10.1126/science.1186874; Pineider F, 2010, J MATER CHEM, V20, P187, DOI 10.1039/b916895h; Rocha AR, 2005, NAT MATER, V4, P335, DOI 10.1038/nmat1349; SESSOLI R, 1993, NATURE, V365, P141, DOI 10.1038/365141a0; Tancini E, 2010, CHEM-EUR J, V16, P10482, DOI 10.1002/chem.201001040; Thomas L, 1996, NATURE, V383, P145, DOI 10.1038/383145a0; vanderLaan G, 1996, CHEM PHYS LETT, V252, P272, DOI 10.1016/0009-2614(96)00118-2; VandeVondele J, 2005, COMPUT PHYS COMMUN, V167, P103, DOI 10.1016/j.cpc.2004.12.014; ZIEMELIS K, 2008, MILESTONE 22 NATURE; Zyazin AS, 2010, NANO LETT, V10, P3307, DOI 10.1021/nl1009603	29	505	507	7	288	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 18	2010	468	7322					417	421		10.1038/nature09478	http://dx.doi.org/10.1038/nature09478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	20981008				2022-12-28	WOS:000284313100038
J	Bhatt, DL; Cryer, BL; Contant, CF; Cohen, M; Lanas, A; Schnitzer, TJ; Shook, TL; Lapuerta, P; Goldsmith, MA; Laine, L; Scirica, BM; Murphy, SA; Cannon, CP				Bhatt, Deepak L.; Cryer, Byron L.; Contant, Charles F.; Cohen, Marc; Lanas, Angel; Schnitzer, Thomas J.; Shook, Thomas L.; Lapuerta, Pablo; Goldsmith, Mark A.; Laine, Loren; Scirica, Benjamin M.; Murphy, Sabina A.; Cannon, Christopher P.		COGENT Investigators	Clopidogrel with or without Omeprazole in Coronary Artery Disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-DOSE ASPIRIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROTON PUMP INHIBITORS; ST-SEGMENT ELEVATION; ANTIPLATELET-THERAPY; MYOCARDIAL-INFARCTION; STATIN-INTERACTION; CONTROLLED TRIAL; RISK; INTERVENTION	Background: Gastrointestinal complications are an important problem of antithrombotic therapy. Proton-pump inhibitors (PPIs) are believed to decrease the risk of such complications, though no randomized trial has proved this in patients receiving dual antiplatelet therapy. Recently, concerns have been raised about the potential for PPIs to blunt the efficacy of clopidogrel. Methods: We randomly assigned patients with an indication for dual antiplatelet therapy to receive clopidogrel in combination with either omeprazole or placebo, in addition to aspirin. The primary gastrointestinal end point was a composite of overt or occult bleeding, symptomatic gastroduodenal ulcers or erosions, obstruction, or perforation. The primary cardiovascular end point was a composite of death from cardiovascular causes, nonfatal myocardial infarction, revascularization, or stroke. The trial was terminated prematurely when the sponsor lost financing. Results: We planned to enroll about 5000 patients; a total of 3873 were randomly assigned and 3761 were included in analyses. In all, 51 patients had a gastrointestinal event; the event rate was 1.1% with omeprazole and 2.9% with placebo at 180 days (hazard ratio with omeprazole, 0.34, 95% confidence interval [CI], 0.18 to 0.63; P<0.001). The rate of overt upper gastrointestinal bleeding was also reduced with omeprazole as compared with placebo (hazard ratio, 0.13; 95% CI, 0.03 to 0.56; P=0.001). A total of 109 patients had a cardiovascular event, with event rates of 4.9% with omeprazole and 5.7% with placebo (hazard ratio with omeprazole, 0.99; 95% CI, 0.68 to 1.44; P=0.96); high-risk subgroups did not show significant heterogeneity. The two groups did not differ significantly in the rate of serious adverse events, though the risk of diarrhea was increased with omeprazole. Conclusions: Among patients receiving aspirin and clopidogrel, prophylactic use of a PPI reduced the rate of upper gastrointestinal bleeding. There was no apparent cardiovascular interaction between clopidogrel and omeprazole, but our results do not rule out a clinically meaningful difference in cardiovascular events due to use of a PPI. (Funded by Cogentus Pharmaceuticals; ClinicalTrials.gov number, NCT00557921.) N Engl J Med 2010;363:1909-17.	[Bhatt, Deepak L.] VA Boston Healthcare Syst, Boston, MA 02132 USA; [Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA USA; [Bhatt, Deepak L.; Contant, Charles F.; Scirica, Benjamin M.; Murphy, Sabina A.; Cannon, Christopher P.] Brigham & Womens Hosp, Thrombolysis Myocardial Infarct TIMI Study Grp, Boston, MA 02115 USA; [Cryer, Byron L.] Univ Texas SW, Dallas, TX USA; [Cryer, Byron L.] VA N Texas Hlth Care Syst, Dallas, TX USA; [Cohen, Marc] Newark Beth Israel Med Ctr, Newark, NJ USA; [Lanas, Angel] Univ Zaragoza, Inst Aragones Ciencias Salud, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Zaragoza, Spain; [Schnitzer, Thomas J.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Schnitzer, Thomas J.] Northwestern Univ, Feinberg Sch Med, Dept Internal Med Rheumatol, Chicago, IL 60611 USA; [Shook, Thomas L.] Parexel Int, Waltham, MA USA; [Lapuerta, Pablo] Cogentus Pharmaceut, Menlo Pk, CA USA; [Laine, Loren] Univ So Calif, Los Angeles, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; Newark Beth Israel Medical Center; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Zaragoza; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Parexel International; University of Southern California	Bhatt, DL (corresponding author), VA Boston Healthcare Syst, 1400 VFW Pkwy, Boston, MA 02132 USA.	dlbhattmd@post.harvard.edu	Ramshev, Konstantin/GYU-1641-2022; Cannon, Christopher P/AAY-7644-2020; Stegeman, Dick/E-4952-2012; Kubica, Jacek/D-6906-2014	Ramshev, Konstantin/0000-0002-6978-6641; Cannon, Christopher P/0000-0003-4596-2791; Kubica, Jacek/0000-0001-8250-754X; GALINIER, Michel/0000-0003-1735-3390; Kiat, Hosen/0000-0002-2899-118X; Lanas, Fernando/0000-0003-3595-9759	Cogentus Pharmaceuticals	Cogentus Pharmaceuticals	Supported by Cogentus Pharmaceuticals.	Bhatt DL, 2008, AM J GASTROENTEROL, V103, P2890, DOI 10.1111/j.1572-0241.2008.02216.x; Bhatt DL, 2007, NEW ENGL J MED, V357, P2078, DOI 10.1056/NEJMe0706859; Bhatt DL, 2009, NEW ENGL J MED, V361, P940, DOI 10.1056/NEJMp0806848; Bhatt DL, 2009, JAMA-J AM MED ASSOC, V302, P896, DOI 10.1001/jama.2009.1249; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; *CLOP UNST ANG PRE, 2001, NEW ENGL J MED, V345, P1716; *CLOP UNST ANG PRE, 2001, NEW ENGL J MED, V345, P1506; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Cryer B, 2005, NEW ENGL J MED, V352, P287, DOI 10.1056/NEJMe048330; Cryer B, 2009, GASTROENTEROL CLIN N, V38, P289, DOI 10.1016/j.gtc.2009.03.005; Depta JP, 2010, CLEV CLIN J MED, V77, P113, DOI 10.3949/ccjm.77a.09173; *EUR MED AG, PUBL STAT POSS INT C; Food and Drug Administration, INF HEALTHC PROF UPD; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; *IMS, TOP 15 GLOB PROD; Juurlink DN, 2009, CAN MED ASSOC J, V180, P713, DOI 10.1503/cmaj.082001; Lai KC, 2002, NEW ENGL J MED, V346, P2033, DOI 10.1056/NEJMoa012877; Lanas A, 2000, NEW ENGL J MED, V343, P834, DOI 10.1056/NEJM200009213431202; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; Meadows TA, 2007, CIRC RES, V100, P1261, DOI 10.1161/01.RES.0000264509.36234.51; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Moukarbel GV, 2009, EUR HEART J, V30, P2226, DOI 10.1093/eurheartj/ehp256; Ng FH, 2010, GASTROENTEROLOGY, V138, P82, DOI 10.1053/j.gastro.2009.09.063; O'Donoghue ML, 2009, LANCET, V374, P989, DOI 10.1016/S0140-6736(09)61525-7; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Sanofi-Aventis, PLAV PRESCR INF; Saw J, 2007, J AM COLL CARDIOL, V50, P291, DOI 10.1016/j.jacc.2007.01.097; Schomig A, 2009, NEW ENGL J MED, V361, P1108, DOI 10.1056/NEJMe0906549; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2009, THROMB HAEMOSTASIS, V101, P714, DOI 10.1160/TH08-12-0808; Siller-Matula JM, 2009, AM HEART J, V157, P148, DOI 10.1016/j.ahj.2008.09.017; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Small DS, 2008, J CLIN PHARMACOL, V48, P475, DOI 10.1177/0091270008315310; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Steinhubl SR, 2003, JAMA-J AM MED ASSOC, V289, P987; Steinhubl SR, 2006, AM HEART J, V152, P200, DOI 10.1016/j.ahj.2006.01.001; Taha AS, 2009, LANCET, V374, P119, DOI 10.1016/S0140-6736(09)61246-0; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yeomans N, 2008, AM J GASTROENTEROL, V103, P2465, DOI 10.1111/j.1572-0241.2008.01995.x; Yusuf S, 2001, NEW ENGL J MED, V345, P494	46	809	866	1	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 11	2010	363	20					1909	1917		10.1056/NEJMoa1007964	http://dx.doi.org/10.1056/NEJMoa1007964			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	678CR	20925534				2022-12-28	WOS:000284047600006
J	Sanchez, SE; Petrillo, E; Beckwith, EJ; Zhang, X; Rugnone, ML; Hernando, CE; Cuevas, JC; Herz, MAG; Depetris-Chauvin, A; Simpson, CG; Brown, JWS; Cerdan, PD; Borevitz, JO; Mas, P; Ceriani, MF; Kornblihtt, AR; Yanovsky, MJ				Sanchez, Sabrina E.; Petrillo, Ezequiel; Beckwith, Esteban J.; Zhang, Xu; Rugnone, Matias L.; Hernando, C. Esteban; Cuevas, Juan C.; Herz, Micaela A. Godoy; Depetris-Chauvin, Ana; Simpson, Craig G.; Brown, John W. S.; Cerdan, Pablo D.; Borevitz, Justin O.; Mas, Paloma; Fernanda Ceriani, M.; Kornblihtt, Alberto R.; Yanovsky, Marcelo J.			A methyl transferase links the circadian clock to the regulation of alternative splicing	NATURE			English	Article							ARABIDOPSIS-THALIANA; DROSOPHILA-MELANOGASTER; RECIPROCAL REGULATION; ARGININE METHYLATION; PHOSPHOLIPASE-C; GENE; METHYLTRANSFERASE; EXPRESSION; REQUIRES; BEHAVIOR	Circadian rhythms allow organisms to time biological processes to the most appropriate phases of the day-night cycle(1). Posttranscriptional regulation is emerging as an important component of circadian networks(2-6), but the molecular mechanisms linking the circadian clock to the control of RNA processing are largely unknown. Here we show that PROTEIN ARGININE METHYL TRANSFERASE 5 (PRMT5), which transfers methyl groups to arginine residues present in histones(7) and Sm spliceosomal proteins(8,9), links the circadian clock to the control of alternative splicing in plants. Mutations in PRMT5 impair several circadian rhythms in Arabidopsis thaliana and this phenotype is caused, at least in part, by a strong alteration in alternative splicing of the core-clock gene PSEUDO RESPONSE REGULATOR 9 (PRR9). Furthermore, genome-wide studies show that PRMT5 contributes to the regulation of many pre-messenger-RNA splicing events, probably by modulating 5'-splice-site recognition. PRMT5 expression shows daily and circadian oscillations, and this contributes to the mediation of the circadian regulation of expression and alternative splicing of a subset of genes. Circadian rhythms in locomotor activity are also disrupted in dart5-1, a mutant affected in the Drosophila melanogaster PRMT5 homologue, and this is associated with alterations in splicing of the core-clock gene period and several clock-associated genes. Our results demonstrate a key role for PRMT5 in the regulation of alternative splicing and indicate that the interplay between the circadian clock and the regulation of alternative splicing by PRMT5 constitutes a common mechanism that helps organisms to synchronize physiological processes with daily changes in environmental conditions.	[Sanchez, Sabrina E.; Rugnone, Matias L.; Hernando, C. Esteban; Yanovsky, Marcelo J.] UBA CONICET, Fac Agron, IFEVA, Buenos Aires, DF, Argentina; [Petrillo, Ezequiel; Herz, Micaela A. Godoy; Kornblihtt, Alberto R.] UBA CONICET, FCEyN, IFIBYNE, Buenos Aires, DF, Argentina; [Beckwith, Esteban J.; Depetris-Chauvin, Ana; Cerdan, Pablo D.; Fernanda Ceriani, M.; Yanovsky, Marcelo J.] IIBBA CONICET, Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Zhang, Xu; Borevitz, Justin O.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Cuevas, Juan C.; Mas, Paloma] Consortium CSIC IRTA UAB, CRAG, Barcelona 08034, Spain; [Simpson, Craig G.; Brown, John W. S.] SCRI, Genet Programme, Dundee DD2 5DA, Scotland; [Brown, John W. S.] Univ Dundee, SCRI, Div Plant Sci, Dundee DD2 5DA, Scotland	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Chicago; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; James Hutton Institute; James Hutton Institute; University of Dundee	Yanovsky, MJ (corresponding author), UBA CONICET, Fac Agron, IFEVA, C1417DSE, Buenos Aires, DF, Argentina.	yanovsky@agro.uba.ar	Borevitz, Justin/B-5423-2012; Mas, Paloma/B-8215-2016	Borevitz, Justin/0000-0001-8408-3699; Mas, Paloma/0000-0002-3780-8041; Kornblihtt, Alberto/0000-0003-4322-0831; Ceriani, Maria/0000-0001-8945-3070; Hernando, Carlos Esteban/0000-0002-7459-2083; Cuevas, Juan C/0000-0003-0909-1247; Simpson, Craig/0000-0002-1723-1492; Petrillo, Ezequiel/0000-0002-0025-3708	Fundacion Antorchas; Agencia Nacional de Promocion de Ciencia y Tecnologia of Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina; University of Buenos Aires; European Union Network of Excellence on Alternative Splicing (EURASNET); Ministerio de Educacion y Ciencia; European Young Investigator Awards; EMBO; Proyecto de Investigacion Cientifica y Tecnologica [2006-1249]	Fundacion Antorchas; Agencia Nacional de Promocion de Ciencia y Tecnologia of Argentina(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires(University of Buenos Aires); European Union Network of Excellence on Alternative Splicing (EURASNET); Ministerio de Educacion y Ciencia(Spanish Government); European Young Investigator Awards; EMBO(European Molecular Biology Organization (EMBO)); Proyecto de Investigacion Cientifica y Tecnologica	We thank E. M. Farre and S. L. Harmer for seeds; J. J. Casal and S. Mora-Garcia for critical reading of the manuscript; the laboratories of A. R. K. and M.J.Y. for discussions; J. Fuller and P. Tondi for technical assistance. This work was supported by grants from the Fundacion Antorchas, the Agencia Nacional de Promocion de Ciencia y Tecnologia of Argentina, the Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina and the University of Buenos Aires to M.J.Y. and A.R.K., and from the European Union Network of Excellence on Alternative Splicing (EURASNET) to A.R.K. and J.W.S.B. M.J.Y. and A.R.K. are Howard Hughes Medical Institute international research scholars. P.M.'s laboratory is supported by a Ministerio de Educacion y Ciencia grant, the European Young Investigator Awards and the EMBO Young Investigator Awards; M.F.C.'s laboratory is supported by Proyecto de Investigacion Cientifica y Tecnologica 2006-1249.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Anne J, 2007, DEVELOPMENT, V134, P137, DOI 10.1242/dev.02687; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; Collins BH, 2004, P NATL ACAD SCI USA, V101, P1945, DOI 10.1073/pnas.0308240100; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Gonsalvez GB, 2008, RNA, V14, P878, DOI 10.1261/rna.940708; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Guo JH, 2009, CELL, V138, P1236, DOI 10.1016/j.cell.2009.06.043; Hazen SP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r17; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Majercak J, 2004, MOL CELL BIOL, V24, P3359, DOI 10.1128/MCB.24.8.3359-3372.2004; Matsushika A, 2002, PLANT CELL PHYSIOL, V43, P833, DOI 10.1093/pcp/pcf118; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Michael TP, 2008, PLOS BIOL, V6, P1887, DOI 10.1371/journal.pbio.0060225; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Pei YX, 2007, PLANT PHYSIOL, V144, P1913, DOI 10.1104/pp.107.099531; Perales M, 2007, PLANT CELL, V19, P2111, DOI 10.1105/tpc.107.050807; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Raczynska KD, 2010, NUCLEIC ACIDS RES, V38, P265, DOI 10.1093/nar/gkp869; Rezaval C, 2007, EUR J NEUROSCI, V25, P683, DOI 10.1111/j.1460-9568.2007.05317.x; Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Schmitz RJ, 2008, P NATL ACAD SCI USA, V105, P411, DOI 10.1073/pnas.0710423104; Schoning JC, 2008, NUCLEIC ACIDS RES, V36, P6977, DOI 10.1093/nar/gkn847; Schor IE, 2009, P NATL ACAD SCI USA, V106, P4325, DOI 10.1073/pnas.0810666106; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Simpson CG, 2008, PLANT J, V53, P1035, DOI 10.1111/j.1365-313X.2007.03392.x; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang X, 2007, EMBO J, V26, P1934, DOI 10.1038/sj.emboj.7601647; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhang D, 2001, MOL CELL, V7, P319, DOI 10.1016/S1097-2765(01)00180-0; Zhang N, 2002, P NATL ACAD SCI USA, V99, P3330, DOI 10.1073/pnas.042529999; Zhang X, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r165; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	45	215	222	1	71	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					112	+		10.1038/nature09470	http://dx.doi.org/10.1038/nature09470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20962777	Green Published, Green Submitted			2022-12-28	WOS:000283786900046
J	Kirkegaard, H; Johnsen, NF; Christensen, J; Frederiksen, K; Overvad, K; Tjonneland, A				Kirkegaard, Helene; Johnsen, Nina Fons; Christensen, Jane; Frederiksen, Kirsten; Overvad, Kim; Tjonneland, Anne			Association of adherence to lifestyle recommendations and risk of colorectal cancer: a prospective Danish cohort study	BRITISH MEDICAL JOURNAL			English	Article							FOOD FREQUENCY QUESTIONNAIRE; COLON-CANCER; PHYSICAL-ACTIVITY; POOLED ANALYSIS; MEAT CONSUMPTION; CHRONIC DISEASES; COMBINED IMPACT; ALCOHOL INTAKE; METAANALYSIS; MEN	Objectives To evaluate the association between a simple lifestyle index based on the recommendations for five lifestyle factors and the incidence of colorectal cancer, and to estimate the proportion of colorectal cancer cases attributable to lack of adherence to the recommendations. Design Prospective cohort study. Setting General population of Copenhagen and Aarhus, Denmark. Participants 55 487 men and women aged 50-64 years at baseline (1993-7), not previously diagnosed with cancer. Main outcome measure Risk of colorectal cancer in relation to points achieved in the lifestyle index (based on physical activity, waist circumference, smoking, alcohol intake, and diet (dietary fibre, energy percentage from fat, red and processed meat, and fruits and vegetables)) modelled through Cox regression. Results During a median follow-up of 9.9 years, 678 men and women had colorectal cancer diagnosed. After adjustment for potential confounders, each additional point achieved on the lifestyle index, corresponding to one additional recommendation that was met, was associated with a lower risk of colorectal cancer (incidence rate ratio 0.89 (95% confidence interval 0.82 to 0.96). In this population an estimated total of 13% (95% CI 4% to 22%) of the colorectal cancer cases were attributable to lack of adherence to merely one additional recommendation among all participants except the healthiest. If all participants had followed the five recommendations 23% (9% to 37%) of the colorectal cancer cases might have been prevented. Results were similar for colon and rectal cancer, but only statistically significant for colon cancer. Conclusions Adherence to the recommendations for physical activity, waist circumference, smoking, alcohol intake, and diet may reduce colorectal cancer risk considerably, and in this population 23% of the cases might be attributable to lack of adherence to the five lifestyle recommendations. The simple structure of the lifestyle index facilitates its use in public health practice.	[Kirkegaard, Helene; Johnsen, Nina Fons; Christensen, Jane; Frederiksen, Kirsten; Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, DK-2100 Copenhagen O, Denmark; [Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, DK-8000 Aarhus, Denmark	Danish Cancer Society; Aarhus University	Kirkegaard, H (corresponding author), Danish Canc Soc, Inst Canc Epidemiol, Strandboulevarden 49, DK-2100 Copenhagen O, Denmark.	helene.kirkegaard@webspeed.dk		Kirkegaard, Helene/0000-0001-6877-916X; Johnsen, Nina Fons/0000-0001-6272-0730; Tjonneland, Anne/0000-0003-4385-2097; Overvad, Kim/0000-0001-6429-7921	Danish Cancer Society	Danish Cancer Society(Danish Cancer Society)	This study was supported by the Danish Cancer Society.	Ahmed FE, 2004, J ENVIRON SCI HEAL C, V22, P91, DOI 10.1081/LESC-200038263; ALEXANDER J, 2004, NORDIC NUTR RECOMMEN; ANDERSEN PK, 1993, STAT MODELS BASED ON, P476; Botteri E, 2008, JAMA-J AM MED ASSOC, V300, P2765, DOI 10.1001/jama.2008.839; Boyle P, 2008, WORLD CANC REPORT 20; Cho EY, 2004, ANN INTERN MED, V140, P603, DOI 10.7326/0003-4819-140-8-200404200-00007; Cust AE, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-33; Dai Z, 2007, WORLD J GASTROENTERO, V13, P4199, DOI 10.3748/wjg.v13.i31.4199; Driver JA, 2007, AM J MED, V120, P257, DOI 10.1016/j.amjmed.2006.05.055; Emberson JR, 2005, EUR HEART J, V26, P1774, DOI 10.1093/eurheartj/ehi224; Estaquio C, 2008, J NUTR, V138, P946, DOI 10.1093/jn/138.5.946; Ford ES, 2009, ARCH INTERN MED, V169, P1355, DOI 10.1001/archinternmed.2009.237; HALLUND J, 2007, FRUITS VEGETABLES HL; Haveman-Nies A, 2002, AM J EPIDEMIOL, V156, P962, DOI 10.1093/aje/kwf144; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Janssen I, 2005, AM J PREV MED, V29, P194, DOI 10.1016/j.amepre.2005.05.003; Jiao L, 2009, ARCH INTERN MED, V169, P764, DOI 10.1001/archinternmed.2009.46; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Kirkwood BR, 2003, ESSENTIAL MED STAT; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Koushik A, 2007, JNCI-J NATL CANCER I, V99, P1471, DOI 10.1093/jnci/djm155; Lahelma E, 2010, HEALTH PLACE, V16, P61, DOI 10.1016/j.healthplace.2009.08.004; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; Larsson SC, 2006, INT J CANCER, V119, P2657, DOI 10.1002/ijc.22170; Liang PS, 2009, INT J CANCER, V124, P2406, DOI 10.1002/ijc.24191; Meng LX, 1999, PREV MED, V29, P296, DOI 10.1006/pmed.1999.0538; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Moskal A, 2007, INT J CANCER, V120, P664, DOI 10.1002/ijc.22299; OVERVAD K, 1991, INT J EPIDEMIOL, V20, P900, DOI 10.1093/ije/20.4.900; Park Y, 2005, JAMA-J AM MED ASSOC, V294, P2849, DOI 10.1001/jama.294.22.2849; PERDERSEN BK, 2004, PHYS ACTIVITY HDB PR; Platz EA, 2000, CANCER CAUSE CONTROL, V11, P579, DOI 10.1023/A:1008999232442; Pols M, 1997, INT J EPIDEMIOL S1, V26, P181; Reedy J, 2008, AM J EPIDEMIOL, V168, P38, DOI 10.1093/aje/kwn097; Samad AKA, 2005, COLORECTAL DIS, V7, P204, DOI 10.1111/j.1463-1318.2005.00747.x; Sandhu MS, 2001, CANCER EPIDEM BIOMAR, V10, P439; Seidell Jaap C., 2001, American Journal of Clinical Nutrition, V73, P123; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Storm HH, 1997, DAN MED BULL, V44, P535; *SUNDH DENM, 2008, CANC REG 2005 2006 N; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; TJONNELAND A, 1992, INT J EPIDEMIOL, V21, P770, DOI 10.1093/ije/21.4.770; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; Wei EK, 2009, AM J EPIDEMIOL, V170, P863, DOI 10.1093/aje/kwp210; WHO, 2000, OB PREV MAN GLOB EP; WHO, 1987, 5 YEAR ACT PLAN SMOK; Wolin KY, 2009, BRIT J CANCER, V100, P611, DOI 10.1038/sj.bjc.6604917; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Cancer Research Fund/American Institute for Cancer Research, 2009, POL ACT CANC PREV FO	50	116	118	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 26	2010	341								c5504	10.1136/bmj.c5504	http://dx.doi.org/10.1136/bmj.c5504			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674YE	20978063	Green Published, hybrid			2022-12-28	WOS:000283786800005
J	Colaprete, A; Schultz, P; Heldmann, J; Wooden, D; Shirley, M; Ennico, K; Hermalyn, B; Marshall, W; Ricco, A; Elphic, RC; Goldstein, D; Summy, D; Bart, GD; Asphaug, E; Korycansky, D; Landis, D; Sollitt, L				Colaprete, Anthony; Schultz, Peter; Heldmann, Jennifer; Wooden, Diane; Shirley, Mark; Ennico, Kimberly; Hermalyn, Brendan; Marshall, William; Ricco, Antonio; Elphic, Richard C.; Goldstein, David; Summy, Dustin; Bart, Gwendolyn D.; Asphaug, Erik; Korycansky, Don; Landis, David; Sollitt, Luke			Detection of Water in the LCROSS Ejecta Plume	SCIENCE			English	Article							LUNAR RADIOMETER OBSERVATIONS; ICE	Several remote observations have indicated that water ice may be presented in permanently shadowed craters of the Moon. The Lunar Crater Observation and Sensing Satellite (LCROSS) mission was designed to provide direct evidence (1). On 9 October 2009, a spent Centaur rocket struck the persistently shadowed region within the lunar south pole crater Cabeus, ejecting debris, dust, and vapor. This material was observed by a second "shepherding" spacecraft, which carried nine instruments, including cameras, spectrometers, and a radiometer. Near-infrared absorbance attributed to water vapor and ice and ultraviolet emissions attributable to hydroxyl radicals support the presence of water in the debris. The maximum total water vapor and water ice within the instrument field of view was 155 +/- 12 kilograms. Given the estimated total excavated mass of regolith that reached sunlight, and hence was observable, the concentration of water ice in the regolith at the LCROSS impact site is estimated to be 5.6 +/- 2.9% by mass. In addition to water, spectral bands of a number of other volatile compounds were observed, including light hydrocarbons, sulfur-bearing species, and carbon dioxide.	[Colaprete, Anthony; Heldmann, Jennifer; Wooden, Diane; Shirley, Mark; Ennico, Kimberly; Marshall, William; Ricco, Antonio; Elphic, Richard C.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Schultz, Peter; Hermalyn, Brendan] Brown Univ, Providence, RI 02912 USA; [Goldstein, David; Summy, Dustin] Univ Texas Austin, Austin, TX 78712 USA; [Bart, Gwendolyn D.] Univ Idaho, Moscow, ID 83844 USA; [Asphaug, Erik; Korycansky, Don] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Landis, David] Aurora Design & Technol, Palm Harbor, FL 34685 USA; [Sollitt, Luke] The Citadel, Charleston, SC 29409 USA; [Marshall, William] Univ Space Res Assoc, Mountain View, CA 94043 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Brown University; University of Texas System; University of Texas Austin; Idaho; University of Idaho; University of California System; University of California Santa Cruz; Universities Space Research Association (USRA)	Colaprete, A (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	Anthony.Colaprete-1@nasa.gov	Ricco, Antonio J/A-5273-2010; Goldstein, David/AAY-8125-2020; Asphaug, Erik/AAC-9455-2020; Ennico, Kimberly/L-9606-2014; Bart, Gwendolyn/B-1365-2009	Bart, Gwendolyn/0000-0002-4768-2972; Ricco, Antonio/0000-0002-2355-4984	LCROSS Project; NASA's Exploration Systems Mission Directorate (ESMD); NASA Science Mission Directorate (SMD); LRO	LCROSS Project; NASA's Exploration Systems Mission Directorate (ESMD); NASA Science Mission Directorate (SMD)(National Aeronautics & Space Administration (NASA)); LRO	We thank the LCROSS Project and NASA's Exploration Systems Mission Directorate (ESMD) and NASA Science Mission Directorate (SMD) for support, and are very grateful to the LRO project and the LRO instrument leads for supporting the LCROSS targeting and impact observations, and for the three referees who provided reviews that greatly improved this paper. R.C.E. was supported by an LRO Participating Scientist grant.	ARNOLD JR, 1979, J GEOPHYS RES, V84, P5659, DOI 10.1029/JB084iB10p05659; Bockelee-Morvan D, 2004, SPACE SCI S, P391; CLARK RN, 1990, J GEOPHYS RES-SOLID, V95, P12653, DOI 10.1029/JB095iB08p12653; Clark RN, 2009, SCIENCE, V326, P562, DOI 10.1126/science.1178105; COLAPRETE A, 2009, 40 LUN PLAN SCI SC L; Crider DH, 2000, J GEOPHYS RES-PLANET, V105, P26773, DOI 10.1029/2000JE001277; ELPHIC RC, 2007, GEOPHYS RES LET, V13; ENNICO K, 2009, 40 LUN PLAN SCI C LU; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Gladstone GR, 2010, SCIENCE, V330, P472, DOI 10.1126/science.1186474; HANSEN JE, 1970, J ATMOS SCI, V27, P265, DOI 10.1175/1520-0469(1970)027<0265:NILSBT>2.0.CO;2; Hayne PO, 2010, SCIENCE, V330, P477, DOI 10.1126/science.1197135; Hodges R.R., 1981, LUNAR PLANETARY I SC, P451; MCCLANAHAN TP, 2009, 40 LUN PLAN SCI LUN; Mitrofanov IG, 2010, SCIENCE, V330, P483, DOI 10.1126/science.1185696; Noda H, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035692; Paige DA, 2010, SCIENCE, V330, P479, DOI 10.1126/science.1187726; Pieters CM, 2009, SCIENCE, V326, P568, DOI 10.1126/science.1178658; Press W. H., 2007, NUMERICAL RECIPES; ROUSSELOT P, 1991, ASTEORIDS COMETS MET; Schultz PH, 2007, ICARUS, V190, P295, DOI 10.1016/j.icarus.2007.06.006; Schultz PH, 2010, SCIENCE, V330, P468, DOI 10.1126/science.1187454; Spudis P. D., 1998, Solar System Research, V32, P17; SUMMY D, 2009, 40 LUN PLAN SCI C LU; Sunshine JM, 2009, SCIENCE, V326, P565, DOI 10.1126/science.1179788; TEODORO LFA, 2009, ANN M LUN EXPL AN GR; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033; Wooden DH, 2004, SPACE SCI S, P33	28	448	469	3	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					463	468		10.1126/science.1186986	http://dx.doi.org/10.1126/science.1186986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966242				2022-12-28	WOS:000283329100028
J	Liu, B; Tahk, S; Yee, KM; Fan, GP; Shuai, K				Liu, Bin; Tahk, Samuel; Yee, Kathleen M.; Fan, Guoping; Shuai, Ke			The Ligase PIAS1 Restricts Natural Regulatory T Cell Differentiation by Epigenetic Repression	SCIENCE			English	Article							TRANSCRIPTION FACTOR FOXP3; DNA METHYLATION; STAT5 ACTIVATION; EXPRESSION; GENE; MAINTENANCE; LINEAGE; SUMO-1; DNMT3A	CD4(+)Foxp3(+) regulatory T (T(reg)) cells are important for maintaining immune tolerance. Understanding the molecular mechanism that regulates T(reg) differentiation will facilitate the development of effective therapeutic strategies against autoimmune diseases. We report here that the SUMO E3 ligase PIAS1 restricts the differentiation of natural T(reg) cells by maintaining a repressive chromatin state of the Foxp3 promoter. PIAS1 acts by binding to the Foxp3 promoter to recruit DNA methyltransferases and heterochromatin protein 1 for epigenetic modifications. Pias1 deletion caused promoter demethylation, reduced histone H3 methylation at Lys(9), and enhanced promoter accessibility. Consistently, Pias1(-/-) mice displayed an increased natural T(reg) cell population and were resistant to the development of experimental autoimmune encephalomyelitis. Our studies have identified an epigenetic mechanism that negatively regulates the differentiation of natural T(reg) cells.	[Liu, Bin; Tahk, Samuel; Shuai, Ke] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Yee, Kathleen M.; Shuai, Ke] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Fan, Guoping] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Liu, B (corresponding author), Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, 11-934 Factor Bldg,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	bliu@ucla.edu; kshuai@mednet.ucla.edu		Fan, Guoping/0000-0001-5235-6410	NIH [R01AI063286, R01GM085797]; UCLA Jonsson Comprehensive Cancer Center; National Institutes of Health [K01 AR52717-01]; UCLA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR052717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085797] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Jonsson Comprehensive Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Chernishof and I. Garcia for technical assistance, C. Dong for helpful discussions, and the UCLA flow cytometry core facility. Supported by grants from the NIH (R01AI063286 and R01GM085797) and the UCLA Jonsson Comprehensive Cancer Center (K. S.). B. L. is supported by a Research Scientist Development Award from the National Institutes of Health (K01 AR52717-01). S.T. is supported by a UCLA Tumor Immunology Training Fellowship. K.S. and B.L. are inventors of a U.S. patent entitled "PIAS molecules that recognize and bind STAT proteins and uses thereof" (Patent No.: US 7,265,202 B1).	Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fragale A, 2008, J IMMUNOL, V181, P1673, DOI 10.4049/jimmunol.181.3.1673; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; Ling Y, 2004, NUCLEIC ACIDS RES, V32, P598, DOI 10.1093/nar/gkh195; Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056; Liu QY, 2008, CHEM J CHINESE U, V29, P505; Lu LF, 2009, GENE DEV, V23, P1270, DOI 10.1101/gad.1791009; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Nagar M, 2008, INT IMMUNOL, V20, P1041, DOI 10.1093/intimm/dxn062; Park J, 2008, J MOL MED, V86, P1269, DOI 10.1007/s00109-008-0392-5; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	30	77	79	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					521	525		10.1126/science.1193787	http://dx.doi.org/10.1126/science.1193787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966256	Green Accepted			2022-12-28	WOS:000283329100045
J	Su, XH; Chakravarti, D; Cho, MS; Liu, LZ; Gi, YJ; Lin, YL; Leung, ML; El-Naggar, A; Creighton, CJ; Suraokar, MB; Wistuba, I; Flores, ER				Su, Xiaohua; Chakravarti, Deepavali; Cho, Min Soon; Liu, Lingzhi; Gi, Young Jin; Lin, Yu-Li; Leung, Marco L.; El-Naggar, Adel; Creighton, Chad J.; Suraokar, Milind B.; Wistuba, Ignacio; Flores, Elsa R.			TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs	NATURE			English	Article							LI-FRAUMENI-SYNDROME; P63 EXPRESSION; P53; CANCER; P73; MUTANT; MICE; PROGRESSION; CARCINOMA; FAMILY	Aberrant expression of microRNAs (miRNAs) and the enzymes that control their processing have been reported in multiple biological processes including primary and metastatic tumours(1-6), but the mechanisms governing this are not clearly understood. Here we show that TAp63, a p53 family member, suppresses tumorigenesis and metastasis, and coordinately regulates Dicer and miR-130b to suppress metastasis. Metastatic mouse and human tumours deficient in TAp63 express Dicer at very low levels, and we found that modulation of expression of Dicer and miR-130b markedly affected the metastatic potential of cells lacking TAp63. TAp63 binds to and transactivates the Dicer promoter, demonstrating direct transcriptional regulation of Dicer by TAp63. These data provide a novel understanding of the roles of TAp63 in tumour and metastasis suppression through the coordinate transcriptional regulation of Dicer and miR-130b and may have implications for the many processes regulated by miRNAs.	[Su, Xiaohua; Chakravarti, Deepavali; Cho, Min Soon; Liu, Lingzhi; Gi, Young Jin; Lin, Yu-Li; Leung, Marco L.; Flores, Elsa R.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Chakravarti, Deepavali; Cho, Min Soon; Flores, Elsa R.] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [El-Naggar, Adel; Suraokar, Milind B.; Wistuba, Ignacio] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Flores, ER (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	elsaflores@mdanderson.org	Leung, Marco/AAH-3178-2021	Hartl, Carla/0000-0001-9769-7462; Liu, Ling-Zhi/0000-0001-9234-457X	NCI [CA16672]; American Cancer Society [RSG-07-082-01-MGO]; Susan G. Komen Foundation [BCTR600208]; Hildegardo E. and Olga M. Flores Foundation; NCI-Cancer Center [CA-16672]; Genitourinary Cancer SPORE [P50CA091846]; Lung Cancer SPORE [P50CA070907, U01DE019765]; Rita Allen Foundation; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [P50CA070907, P30CA016672, P50CA091846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE019765] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Hildegardo E. and Olga M. Flores Foundation; NCI-Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genitourinary Cancer SPORE; Lung Cancer SPORE; Rita Allen Foundation; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank C.-g. Liu for technical assistance with miRNA analyses and A. Multani for metaphase analyses (funded by NCI CA16672); K. Y. Tsai for scientific discussions and comments on the manuscript; and D. Yu, J. Jackson and S. Rehman for reagents and advice. This work was supported by grants to E.R.F. from the American Cancer Society (RSG-07-082-01-MGO), the Susan G. Komen Foundation (BCTR600208) and the Hildegardo E. and Olga M. Flores Foundation. This work was supported in part by an NCI-Cancer Center Core Grant (CA-16672) (University of Texas M. D. Anderson Cancer Center), a Career Development Award from the Genitourinary Cancer SPORE (P50CA091846) to E.R.F., Lung Cancer SPORE (P50CA070907) to I. W. and U01DE019765 to A.E.-N. E.R.F. is a scholar of the Rita Allen Foundation and the V Foundation for Cancer Research.	Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Keyes WM, 2006, P NATL ACAD SCI USA, V103, P8435, DOI 10.1073/pnas.0602477103; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maruya SI, 2004, CLIN CANCER RES, V10, P3825, DOI 10.1158/1078-0432.CCR-03-0370; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Park BJ, 2000, CANCER RES, V60, P3370; Park HR, 2004, TUMORI, V90, P239, DOI 10.1177/030089160409000214; Pruneri G, 2005, J PATHOL, V206, P337, DOI 10.1002/path.1787; Su XH, 2009, EMBO J, V28, P1904, DOI 10.1038/emboj.2009.151; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	29	339	351	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					986	U168		10.1038/nature09459	http://dx.doi.org/10.1038/nature09459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962848	Green Accepted			2022-12-28	WOS:000283254700043
J	Merugu, S				Merugu, Srinivas			Benazepril plus amlodipine reduced CV events more than benazepril plus hydrochlorothiazide in hypertension with or without diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									St Vincent Char Med Ctr, Cleveland, OH USA		Merugu, S (corresponding author), St Vincent Char Med Ctr, Cleveland, OH USA.							SCHWARTZ PJ, 1994, CIRCULATION, V89, P2892	1	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8							JC4-2	10.7326/0003-4819-153-8-201010190-02002	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956698				2022-12-28	WOS:000283054600017
J	Rockman, MV; Skrovanek, SS; Kruglyak, L				Rockman, Matthew V.; Skrovanek, Sonja S.; Kruglyak, Leonid			Selection at Linked Sites Shapes Heritable Phenotypic Variation in C. elegans	SCIENCE			English	Article							GENE-EXPRESSION; NATURAL-SELECTION; DNA POLYMORPHISM; EVOLUTION; GENOME; RECOMBINATION; CONSEQUENCES; MUTATION; TRAITS	Mutation generates the heritable variation that genetic drift and natural selection shape. In classical quantitative genetic models, drift is a function of the effective population size and acts uniformly across traits, whereas mutation and selection act trait-specifically. We identified thousands of quantitative trait loci (QTLs) influencing transcript abundance traits in a cross of two Caenorhabditis elegans strains; although trait-specific mutation and selection explained some of the observed pattern of QTL distribution, the pattern was better explained by trait-independent variation in the intensity of selection on linked sites. Our results suggest that traits in C. elegans exhibit different levels of variation less because of their own attributes than because of differences in the effective population sizes of the genomic regions harboring their underlying loci.	[Rockman, Matthew V.] NYU, Dept Biol, New York, NY 10003 USA; [Rockman, Matthew V.] NYU, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Rockman, Matthew V.; Skrovanek, Sonja S.; Kruglyak, Leonid] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Rockman, Matthew V.; Skrovanek, Sonja S.; Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolutionary Biol, Carl Icahn Lab, Princeton, NJ 08544 USA; [Skrovanek, Sonja S.; Kruglyak, Leonid] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA	New York University; New York University; Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University	Rockman, MV (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.	mrockman@nyu.edu; leonid@genomics.princeton.edu			NIH National Center for Research Resources; NIH [R01 HG004321, R01 GM089972, P50 GM071508]; Jane Coffin Childs Fellowship; Ellison Foundation; James S. McDonnell Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089972, P50GM071508] Funding Source: NIH RePORTER	NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Fellowship; Ellison Foundation(Lawrence Ellison Foundation); James S. McDonnell Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Andersen, A. Chang, J. Gerke, R. Ghosh, D. Gresham, M. Hahn, A. Paaby, D. Pollard, H. Seidel, and J. Shapiro for comments on the manuscript. We thank the Caenorhabditis Genetics Center, funded by the NIH National Center for Research Resources, for strains. Our work was supported by the NIH (grants R01 HG004321 to L. K., R01 GM089972 to M. V. R., and P50 GM071508 to the Lewis-Sigler Institute), a Jane Coffin Childs Fellowship (M. V. R.), an Ellison Foundation New Scholar Award (M. V. R.), and a James S. McDonnell Foundation Centennial Fellowship (L. K.). L. K. is an investigator of the Howard Hughes Medical Institute. Microarray data have been deposited at the Gene Expression Omnibus with accession number GSE23857.	Arnold SJ, 2008, EVOLUTION, V62, P2451, DOI 10.1111/j.1558-5646.2008.00472.x; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; BARNES TM, 1995, GENETICS, V141, P159; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Cutter AD, 2003, MOL BIOL EVOL, V20, P665, DOI 10.1093/molbev/msg072; Cutter AD, 2010, GENOME RES, V20, P1103, DOI 10.1101/gr.104331.109; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Denver DR, 2009, P NATL ACAD SCI USA, V106, P16310, DOI 10.1073/pnas.0904895106; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Fay JC, 2008, HEREDITY, V100, P191, DOI 10.1038/sj.hdy.6801000; Genissel A, 2008, MOL BIOL EVOL, V25, P101, DOI 10.1093/molbev/msm247; Graustein A, 2002, GENETICS, V161, P99; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Houle D, 1998, GENETICA, V102-3, P241, DOI 10.1023/A:1017034925212; HUDSON RR, 1995, GENETICS, V141, P1605; Jovelin R, 2009, MOL BIOL EVOL, V26, P2373, DOI 10.1093/molbev/msp142; Kaiser VB, 2009, TRENDS GENET, V25, P9, DOI 10.1016/j.tig.2008.10.009; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Lawniczak MKN, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r125; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Noor MAF, 2001, GENETICS, V159, P581; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Ronald J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000678; Tung J, 2009, MOL BIOL EVOL, V26, P2047, DOI 10.1093/molbev/msp113; Visscher PM, 2007, AM J HUM GENET, V81, P1104, DOI 10.1086/522934; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878	31	154	155	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					372	376		10.1126/science.1194208	http://dx.doi.org/10.1126/science.1194208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947766	Green Accepted			2022-12-28	WOS:000282986700042
J	van Weeren, RJ; Rottgering, HJA; Bruggen, M; Hoeft, M				van Weeren, Reinout J.; Rottgering, Huub J. A.; Brueggen, Marcus; Hoeft, Matthias			Particle Acceleration on Megaparsec Scales in a Merging Galaxy Cluster	SCIENCE			English	Article							HEAD-TAIL GALAXIES; RADIO-EMISSION; SHOCK-WAVES; RELICS; HALO	Galaxy clusters form through a sequence of mergers of smaller galaxy clusters and groups. Models of diffusive shock acceleration suggest that in shocks that occur during cluster mergers, particles are accelerated to relativistic energies, similar to conditions within supernova remnants. In the presence of magnetic fields, these particles emit synchrotron radiation and may form so-called radio relics. We detected a radio relic that displays highly aligned magnetic fields, a strong spectral index gradient, and a narrow relic width, giving a measure of the magnetic field in an unexplored site of the universe. Our observations show that diffusive shock acceleration also operates on scales much larger than in supernova remnants and that shocks in galaxy clusters are capable of producing extremely energetic cosmic rays.	[van Weeren, Reinout J.; Rottgering, Huub J. A.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Brueggen, Marcus] Jacobs Univ Bremen, D-28725 Bremen, Germany; [Hoeft, Matthias] Thuringer Landessternwarte, D-07778 Tautenburg, Germany	Leiden University; Leiden University - Excl LUMC; Jacobs University	van Weeren, RJ (corresponding author), Leiden Univ, Leiden Observ, POB 9513, NL-2300 RA Leiden, Netherlands.	rvweeren@strw.leidenuniv.nl		van Weeren, Reinout/0000-0002-0587-1660	Netherlands Foundation for Scientific Research (NWO); Royal Academy of Arts and Sciences (KNAW)	Netherlands Foundation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Royal Academy of Arts and Sciences (KNAW)	The WSRT is operated by ASTRON (Netherlands Institute for Radio Astronomy) with support from the Netherlands Foundation for Scientific Research (NWO). We thank the staff of the GMRT who have made these observations possible. The GMRT is run by the National Centre for Radio Astrophysics of the Tata Institute of Fundamental Research. The National Radio Astronomy Observatory is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities Inc. Supported by the Royal Academy of Arts and Sciences (KNAW) (R.J.v.W.). We thank G. Brunetti for discussions.	Bagchi J, 2006, SCIENCE, V314, P791, DOI 10.1126/science.1131189; BLANDFORD R, 1987, PHYS REP, V154, P1, DOI 10.1016/0370-1573(87)90134-7; Bonafede A, 2009, ASTRON ASTROPHYS, V503, P707, DOI 10.1051/0004-6361/200912520; Bonafede A, 2009, ASTRON ASTROPHYS, V494, P429, DOI 10.1051/0004-6361:200810588; Clarke TE, 2006, ASTRON J, V131, P2900, DOI 10.1086/504076; Clarke TE, 2001, ASTROPHYS J, V547, pL111, DOI 10.1086/318896; DRURY LOC, 1983, REP PROG PHYS, V46, P973, DOI 10.1088/0034-4885/46/8/002; Ensslin TA, 1998, ASTRON ASTROPHYS, V332, P395; Ensslin TA, 2002, MON NOT R ASTRON SOC, V331, P1011, DOI 10.1046/j.1365-8711.2002.05261.x; Ensslin TA, 2001, ASTRON ASTROPHYS, V366, P26, DOI 10.1051/0004-6361:20000198; Feretti L, 2005, ADV SPACE RES-SERIES, V36, P729, DOI 10.1016/j.asr.2004.12.004; Finoguenov A, 2010, ASTROPHYS J, V715, P1143, DOI 10.1088/0004-637X/715/2/1143; Hoeft M, 2008, MON NOT R ASTRON SOC, V391, P1511, DOI 10.1111/j.1365-2966.2008.13955.x; Kocevski DD, 2007, ASTROPHYS J, V662, P224, DOI 10.1086/513303; Ma CJ, 2009, ASTROPHYS J LETT, V693, pL56, DOI 10.1088/0004-637X/693/2/L56; Markevitch M, 1998, ASTROPHYS J, V504, P27, DOI 10.1086/306080; Markevitch M, 2005, ASTROPHYS J, V627, P733, DOI 10.1086/430695; MILEY GK, 1973, ASTRON ASTROPHYS, V26, P413; Miniati F, 2001, ASTROPHYS J, V562, P233, DOI 10.1086/323434; Nakazawa K, 2009, PUBL ASTRON SOC JPN, V61, P339, DOI 10.1093/pasj/61.2.339; Pfrommer C, 2008, MON NOT R ASTRON SOC, V385, P1211, DOI 10.1111/j.1365-2966.2008.12956.x; Roettiger K, 1999, ASTROPHYS J, V518, P603, DOI 10.1086/307327; Ryu D, 2003, ASTROPHYS J, V593, P599, DOI 10.1086/376723; Sijbring D, 1998, ASTRON ASTROPHYS, V331, P901; van Weeren RJ, 2009, ASTRON ASTROPHYS, V506, P1083, DOI 10.1051/0004-6361/200912287; van Weeren RJ, 2009, ASTRON ASTROPHYS, V505, P991, DOI 10.1051/0004-6361/200912528; Vink J, 2003, ASTROPHYS J, V584, P758, DOI 10.1086/345832; Voges W, 1999, ASTRON ASTROPHYS, V349, P389	29	282	282	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					347	349		10.1126/science.1194293	http://dx.doi.org/10.1126/science.1194293			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20929732	Green Submitted			2022-12-28	WOS:000282986700034
J	Schindel, D				Schindel, David			Biology without borders	NATURE			English	Editorial Material												schindeld@si.edu						*AUSTR NAT RES MAN, 2002, NAT CONS APPR ACC UT; Grajal A, 1999, CONSERV BIOL, V13, P6, DOI 10.1046/j.1523-1739.1999.013001006.x; *SECR CONV BIOL DI, 2008, TECHN SER SECR CONV, V38; *SECR CONV BIOL DI, 2002, APP 2 BONN GUID ACC	4	16	17	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					779	781		10.1038/467779a	http://dx.doi.org/10.1038/467779a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944713	Bronze			2022-12-28	WOS:000282898700033
J	Del Mar, C				Del Mar, Chris			Commentary: but what should journals actually do to keep industry sponsored research unbiased?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Del Mar, Chris] Bond Univ, Gold Coast, Qld 4229, Australia	Bond University	Del Mar, C (corresponding author), Bond Univ, Gold Coast, Qld 4229, Australia.	cdelmar@bond.edu.au	Del Mar, Chris/B-1136-2008	Del Mar, Chris/0000-0003-3821-8163				Cohen D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2912; SINGH RB, 1992, BRIT MED J, V304, P1015, DOI 10.1136/bmj.304.6833.1015	2	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 12	2010	341								c5406	10.1136/bmj.c5406	http://dx.doi.org/10.1136/bmj.c5406			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663KN	20940215				2022-12-28	WOS:000282886900007
J	Smith, PC				Smith, Peter C.			Measuring and improving health-system productivity	LANCET			English	Editorial Material									[Smith, Peter C.] Univ London Imperial Coll Sci Technol & Med, Sch Business, London SW7 2AZ, England; [Smith, Peter C.] Inst Global Hlth Innovat, London SW7 2AZ, England	Imperial College London; Imperial College London	Smith, PC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Business, London SW7 2AZ, England.	peter.smith@imperial.ac.uk		Smith, Peter/0000-0003-0058-7588				Busse R, 2008, HEALTH ECON, V17, pS1, DOI 10.1002/hec.1330; Hussey PS, 2009, HEALTH SERV RES, V44, P784, DOI 10.1111/j.1475-6773.2008.00942.x; Jacobs R, 2006, MEASURING EFFICIENCY; Joumard I., 2008, HLTH STATUS DETERMIN; Office for National Statistics, 2009, HLTH CAR OUTP 1995 2; Smith P. C., 2009, MEASURING VALUE MONE; World Health Organization, 2000, WORLD HLTH REP 2000	7	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 9	2010	376	9748					1198	1200		10.1016/S0140-6736(10)61547-4	http://dx.doi.org/10.1016/S0140-6736(10)61547-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	664ZT	20934579				2022-12-28	WOS:000283003500005
J	Miller, AL; Falk, RH; Levy, BD; Loscalzo, J				Miller, Amy Leigh; Falk, Rodney H.; Levy, Bruce D.; Loscalzo, Joseph			A Heavy Heart.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPLICATING IDIOPATHIC MYELOFIBROSIS; STEM-CELL TRANSPLANTATION; AMYLOIDOSIS; MELPHALAN; DIAGNOSIS; LIGHT		[Levy, Bruce D.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.		Loscalzo, Joseph/ABD-8980-2021		FoldRx	FoldRx	Dr. Falk reports receiving honoraria for consulting and grant support from FoldRx. No other potential conflict of interest relevant to this article was reported.	AKIKUSA B, 1987, ARCH PATHOL LAB MED, V111, P525; Arbustini E, 1997, AMYLOID, V4, P157, DOI 10.3109/13506129709014380; Buesche G, 2006, HISTOPATHOLOGY, V48, P133, DOI 10.1111/j.1365-2559.2005.02302.x; Chan KW, 1999, AM J KIDNEY DIS, V34, DOI 10.1016/S0272-6386(99)70032-6; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; Falk RH, 2005, CIRCULATION, V112, P2047, DOI 10.1161/CIRCULATIONAHA.104.489187; Ng B, 2005, ARCH INTERN MED, V165, P1425, DOI 10.1001/archinte.165.12.1425; Palladini G, 2004, BLOOD, V103, P2936, DOI 10.1182/blood-2003-08-2788; Skinner M, 2004, ANN INTERN MED, V140, P85, DOI 10.7326/0003-4819-140-2-200401200-00008	9	3	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2010	363	15					1464	1469		10.1056/NEJMcps0804916	http://dx.doi.org/10.1056/NEJMcps0804916			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	659NV	20925549				2022-12-28	WOS:000282575100013
J	Gostin, LO				Gostin, Lawrence O.			The Right to Bear Arms A Uniquely American Entitlement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Law Ctr NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				*CDCP, 1997, MMWR-MORBID MORTAL W, V46, P101; Gostin L, 2008, JAMA-J AM MED ASSOC, V300, P1575, DOI 10.1001/jama.300.13.1575; KELLERMANN AL, 1986, NEW ENGL J MED, V314, P1557, DOI 10.1056/NEJM198606123142406	3	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2010	304	13					1485	1486		10.1001/jama.2010.1419	http://dx.doi.org/10.1001/jama.2010.1419			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658SO	20924015				2022-12-28	WOS:000282509900025
J	Rock, JR; Hogan, BLM				Rock, Jason R.; Hogan, Brigid L. M.			Branching Takes Nerve	SCIENCE			English	Editorial Material							REGENERATION; RECEPTORS		[Rock, Jason R.; Hogan, Brigid L. M.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University	Hogan, BLM (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	b.hogan@cellbio.duke.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL071303] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bhide SA, 2009, CLIN ONCOL-UK, V21, P737, DOI 10.1016/j.clon.2009.09.002; Dou YC, 2006, ARCH DERMATOL RES, V298, P31, DOI 10.1007/s00403-006-0657-1; DRACHMAN DB, 1971, EXP NEUROL, V32, P1, DOI 10.1016/0014-4886(71)90159-2; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Proctor GB, 2007, AUTON NEUROSCI-BASIC, V133, P3, DOI 10.1016/j.autneu.2006.10.006; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; SINGER M, 1948, J EXP ZOOL, V108, P279, DOI 10.1002/jez.1401080207; Wongtrakool C, 2007, AM J PHYSIOL-LUNG C, V293, pL611, DOI 10.1152/ajplung.00038.2007	10	8	8	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1610	1611		10.1126/science.1196016	http://dx.doi.org/10.1126/science.1196016			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929836				2022-12-28	WOS:000282098100028
J	Chen, YH; Hu, L; Punta, M; Bruni, R; Hillerich, B; Kloss, B; Rost, B; Love, J; Siegelbaum, SA; Hendrickson, WA				Chen, Yu-hang; Hu, Lei; Punta, Marco; Bruni, Renato; Hillerich, Brandan; Kloss, Brian; Rost, Burkhard; Love, James; Siegelbaum, Steven A.; Hendrickson, Wayne A.			Homologue structure of the SLAC1 anion channel for closing stomata in leaves	NATURE			English	Article							ABSCISIC-ACID; CHLORIDE CHANNEL; GUARD-CELL; PLASMA-MEMBRANE; SULFITE EFFLUX; PROTEIN; SELECTIVITY; MODEL; GENE; CONSERVATION	The plant SLAC1 anion channel controls turgor pressure in the aperture-defining guard cells of plant stomata, thereby regulating the exchange of water vapour and photosynthetic gases in response to environmental signals such as drought or high levels of carbon dioxide. Here we determine the crystal structure of a bacterial homologue (Haemophilus influenzae) of SLAC1 at 1.20 angstrom resolution, and use structure-inspired mutagenesis to analyse the conductance properties of SLAC1 channels. SLAC1 is a symmetrical trimer composed from quasi-symmetrical subunits, each having ten transmembrane helices arranged from helical hairpin pairs to form a central five-helix transmembrane pore that is gated by an extremely conserved phenylalanine residue. Conformational features indicate a mechanism for control of gating by kinase activation, and electrostatic features of the pore coupled with electrophysiological characteristics indicate that selectivity among different anions is largely a function of the energetic cost of ion dehydration.	[Chen, Yu-hang; Rost, Burkhard; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Chen, Yu-hang; Punta, Marco; Bruni, Renato; Hillerich, Brandan; Kloss, Brian; Rost, Burkhard; Love, James; Hendrickson, Wayne A.] New York Struct Biol Ctr, NYCOMPS, New York, NY 10027 USA; [Hu, Lei; Siegelbaum, Steven A.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Dept Comp Sci, D-85748 Munich, Germany; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Inst Adv Study, D-85748 Munich, Germany; [Siegelbaum, Steven A.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Siegelbaum, Steven A.; Hendrickson, Wayne A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Hendrickson, Wayne A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University; Columbia University; Technical University of Munich; Technical University of Munich; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University	Hendrickson, WA (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	wayne@convex.hhmi.columbia.edu	Hu, Lei/B-1455-2009; Rost, Burkhard/A-1908-2016; Punta, Marco/ABH-4698-2020	Rost, Burkhard/0000-0003-0179-8424; Punta, Marco/0000-0002-0050-0676; Bruni, Renato/0000-0002-2312-0254; Kloss, Brian/0000-0003-0130-8739	New York Consortium on Membrane Protein Structure (NYCOMPS) from the NIGMS Protein Structure Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM095315, U54GM075026, R01GM034102] Funding Source: NIH RePORTER	New York Consortium on Membrane Protein Structure (NYCOMPS) from the NIGMS Protein Structure Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Mancia, L. Shapiro and M. Zhou for discussions; P. Rodriguez and A. Morrison for help with cloning and expression; J. Cheung, M. Collins, C. Min, S. Ye and Z. Zhang for advice in protein chemistry and crystallography; J. Schwanof and R. Abramowitz for help with synchrotron experiments; J. Riley for help with Xenopus oocyte injections; and M. Su for advice on the PSI-BLAST analysis of SLAC relatives. This project was supported in part by an award to the New York Consortium on Membrane Protein Structure (NYCOMPS) from the NIGMS Protein Structure Initiative. Beamline X4A at the National Synchrotron Light Source (NSLS), a DOE facility at Brookhaven National Laboratory, is supported by the New York Structural Biology Center.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; DeLano W.L, PYMOL MOL GRAPHICS S; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FATT P, 1958, J PHYSIOL-LONDON, V142, P516, DOI 10.1113/jphysiol.1958.sp006034; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Grobler J, 1995, YEAST, V11, P1485, DOI 10.1002/yea.320111503; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Kendrick BS, 2001, ANAL BIOCHEM, V299, P136, DOI 10.1006/abio.2001.5411; Kouyama T, 2010, J MOL BIOL, V396, P564, DOI 10.1016/j.jmb.2009.11.061; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lechenne B, 2007, MICROBIOL-SGM, V153, P905, DOI 10.1099/mic.0.2006/003335-0; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Meyer S, 2010, PLANT J, V63, P1054, DOI 10.1111/j.1365-313X.2010.04302.x; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Park H, 2000, YEAST, V16, P881, DOI 10.1002/1097-0061(200007)16:10<881::AID-YEA576>3.0.CO;2-3; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Picollo A, 2009, NAT STRUCT MOL BIOL, V16, P1294, DOI 10.1038/nsmb.1704; Punta Marco, 2009, Journal of Structural and Functional Genomics, V10, P255, DOI 10.1007/s10969-009-9071-1; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Saji S, 2008, PLANT CELL PHYSIOL, V49, P2, DOI 10.1093/pcp/pcm174; Sasaki T, 2010, PLANT CELL PHYSIOL, V51, P354, DOI 10.1093/pcp/pcq016; SCHMIDT C, 1994, PLANT PHYSIOL, V106, P383, DOI 10.1104/pp.106.1.383; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; SCHROEDER JI, 1992, P NATL ACAD SCI USA, V89, P5025, DOI 10.1073/pnas.89.11.5025; SCHROEDER JI, 1989, NATURE, V338, P427, DOI 10.1038/338427a0; Sirichandra C, 2009, J EXP BOT, V60, P1439, DOI 10.1093/jxb/ern340; TAYLOR DE, 1994, J BACTERIOL, V176, P2740, DOI 10.1128/JB.176.9.2740-2742.1994; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; Vahisalu T, 2010, PLANT J, V62, P442, DOI 10.1111/j.1365-313X.2010.04159.x; WALTER EG, 1991, GENE, V101, P1, DOI 10.1016/0378-1119(91)90217-Y; WRIGHT EM, 1977, PHYSIOL REV, V57, P109, DOI 10.1152/physrev.1977.57.1.109; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730	57	94	100	7	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2010	467	7319					1074	U157		10.1038/nature09487	http://dx.doi.org/10.1038/nature09487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20981093	Green Accepted			2022-12-28	WOS:000283548600040
J	Sikora, K				Sikora, Karol			Are the spending cuts fair? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sikora, Karol] Univ Buckingham Med Sch, Buckingham MK18 1EG, England		Sikora, K (corresponding author), Univ Buckingham Med Sch, Buckingham MK18 1EG, England.	Karol.Sikora@cancerpartnersuk.org						Konow J, 2003, J ECON LIT, V41, P1188, DOI 10.1257/002205103771800013; LLEWELYN T, 2004, SHORT HIST DISTRIBUT; Ritchie H, 2005, UNDERSTANDING WORKLE; Treasury HM, SPEND REV 2010	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 27	2010	341								c6049	10.1136/bmj.c6049	http://dx.doi.org/10.1136/bmj.c6049			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674YY	20980379				2022-12-28	WOS:000283790400002
J	Zecevic, M; Horton, R				Zecevic, Maja; Horton, Richard			September 11, a decade on: a call for papers	LANCET			English	Editorial Material									[Zecevic, Maja] The Lancet, New York, NY 10016 USA; [Horton, Richard] The Lancet, London NW1 7BY, England		Zecevic, M (corresponding author), The Lancet, New York, NY 10016 USA.								0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 23	2010	376	9750					1365	1365		10.1016/S0140-6736(10)61933-2	http://dx.doi.org/10.1016/S0140-6736(10)61933-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	672ZO	20971346				2022-12-28	WOS:000283627500004
J	Crabtree, RH				Crabtree, Robert H.			Creating Ligands with Multiple Personalities	SCIENCE			English	Editorial Material							CH ACTIVATION		Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University	Crabtree, RH (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.	robert.crabtree@yale.edu						Bart SC, 2006, J AM CHEM SOC, V128, P13901, DOI 10.1021/ja064557b; Crabtree RH, 2004, J ORGANOMET CHEM, V689, P4083, DOI 10.1016/j.jorganchem.2004.07.034; Das S, 2006, SCIENCE, V312, P1941, DOI 10.1126/science.1127899; Hashiguchi BG, 2010, J AM CHEM SOC, V132, P12542, DOI 10.1021/ja102518m; Periana RA, 2003, SCIENCE, V301, P814, DOI 10.1126/science.1086466; Periana RA, 1998, SCIENCE, V280, P560, DOI 10.1126/science.280.5363.560	6	28	28	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					455	456		10.1126/science.1197652	http://dx.doi.org/10.1126/science.1197652			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966237				2022-12-28	WOS:000283329100022
J	Thiffeault, JL				Thiffeault, Jean-Luc			Chaos in the Gulf	SCIENCE			English	Editorial Material							COHERENT STRUCTURES; FLOWS		Univ Wisconsin, Dept Math, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Thiffeault, JL (corresponding author), Univ Wisconsin, Dept Math, Madison, WI 53706 USA.	jeanluc@math.wisc.edu	Thiffeault, Jean-Luc/AGQ-6191-2022	Thiffeault, Jean-Luc/0000-0001-7724-7966				AREF H, 1984, J FLUID MECH, V143, P1, DOI 10.1017/S0022112084001233; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; Haller G, 2001, PHYSICA D, V149, P248, DOI 10.1016/S0167-2789(00)00199-8; Haller G, 2002, PHYS FLUIDS, V14, P1851, DOI 10.1063/1.1477449; Haller G, 1998, PHYSICA D, V119, P352, DOI 10.1016/S0167-2789(98)00091-8; HENON M, 1966, CR ACAD SCI A MATH, V262, P312; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Mezic I, 2010, SCIENCE, V330, P486, DOI 10.1126/science.1194607	9	5	6	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					458	459		10.1126/science.1197554	http://dx.doi.org/10.1126/science.1197554			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966239				2022-12-28	WOS:000283329100024
J	McCartney, M				McCartney, Margaret			Medicine and the Media What's keeping the Chilean miners down?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaretmccartney@doctors.org.uk	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				2010, BMJ, V341, pC5860	1	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 21	2010	341								c5860	10.1136/bmj.c5860	http://dx.doi.org/10.1136/bmj.c5860			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	671ZQ	20966014				2022-12-28	WOS:000283553200013
J	Shin, J; Bossenz, M; Chung, Y; Ma, H; Byron, M; Taniguchi-Ishigaki, N; Zhu, XC; Jiao, BW; Hall, LL; Green, MR; Jones, SN; Hermans-Borgmeyer, I; Lawrence, JB; Bach, I				Shin, JongDae; Bossenz, Michael; Chung, Young; Ma, Hong; Byron, Meg; Taniguchi-Ishigaki, Naoko; Zhu, Xiaochun; Jiao, Baowei; Hall, Lisa L.; Green, Michael R.; Jones, Stephen N.; Hermans-Borgmeyer, Irm; Lawrence, Jeanne B.; Bach, Ingolf			Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice	NATURE			English	Article							HOMEODOMAIN TRANSCRIPTION FACTORS; EMBRYONIC STEM-CELLS; DOSAGE COMPENSATION; LIM COFACTORS; EXPRESSION; GENE; LINES; RLIM; DIFFERENTIATION; DISRUPTION	Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X chromosome (Xm)(1,2). Both forms of XCI require the non-coding Xist RNA that coats the inactive X chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X chromosome (Delta m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in Delta m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.	[Shin, JongDae; Ma, Hong; Taniguchi-Ishigaki, Naoko; Zhu, Xiaochun; Jiao, Baowei; Green, Michael R.; Bach, Ingolf] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Green, Michael R.; Bach, Ingolf] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Zhu, Xiaochun; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Byron, Meg; Hall, Lisa L.; Jones, Stephen N.; Lawrence, Jeanne B.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA; [Bossenz, Michael; Hermans-Borgmeyer, Irm] Univ Hamburg, Ctr Mol Neurobiol, D-20246 Hamburg, Germany; [Chung, Young] Stem Cell & Regenerat Med Int Inc, Marlborough, MA 01752 USA; [Chung, Young] CHA Univ, Sch Med, Seoul 135081, South Korea	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Hamburg; Pochon Cha University	Bach, I (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	ingolf.bach@umassmed.edu	Chung, Young Gie/AAC-8149-2020	Lawrence, Jeanne/0000-0001-6572-3128; JIAO, BAOWEI/0000-0001-8559-9160	National Institutes of Health (National Cancer Institute) [R01CA131158]; National Institute of Diabetes and Digestive and Kidney Diseases [5 P30 DK32520, GM053234]; NATIONAL CANCER INSTITUTE [R01CA131158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053234, R01GM033977] Funding Source: NIH RePORTER	National Institutes of Health (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Boyartchuk, T. Fazzio, E. Heard, P. Kaufman, O. Rando, D. Riethmacher and J. Sharp for advice and/or reagents, D. Kim for help in ES cell analysis, and J. Zhu for statistics. I.B. is a member of the University of Massachusetts DERC (DK32520). This work was supported by National Institutes of Health grants R01CA131158 (National Cancer Institute) and 5 P30 DK32520 (National Institute of Diabetes and Digestive and Kidney Diseases) to I.B., and GM053234 to J.B.L.	Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; BARLOW PW, 1972, J EMBRYOL EXP MORPH, V27, P447; BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Chung Y, 2006, NATURE, V439, P216, DOI 10.1038/nature04277; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; Chung Y, 2006, METHOD ENZYMOL, V418, P135, DOI 10.1016/S0076-6879(06)18009-X; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; FEINBERG RF, 1989, LAB INVEST, V61, P20; Gungor C, 2007, P NATL ACAD SCI USA, V104, P15000, DOI 10.1073/pnas.0703738104; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Johnsen SA, 2009, CANCER RES, V69, P128, DOI 10.1158/0008-5472.CAN-08-1630; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Kalantry S, 2009, NATURE, V460, P647, DOI 10.1038/nature08161; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Nagy A., 2003, MANIPULATING MOUSE E; Novik EI, 2006, TISSUE ENG, V12, P1515, DOI 10.1089/ten.2006.12.1515; NUSSLEINVOLHARD C, 1987, SCIENCE, V238, P1675, DOI 10.1126/science.3686007; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; OSHIMA RG, 1983, DEV BIOL, V99, P447, DOI 10.1016/0012-1606(83)90294-4; Ostendorff HP, 2000, GENOMICS, V69, P120, DOI 10.1006/geno.2000.6311; Ostendorff HP, 2006, DEV DYNAM, V235, P786, DOI 10.1002/dvdy.20669; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Panning B, 2004, METHOD ENZYMOL, V376, P419; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007	37	120	122	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					977	U157		10.1038/nature09457	http://dx.doi.org/10.1038/nature09457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962847	Green Accepted			2022-12-28	WOS:000283254700041
J	Lagu, T; Lindenauer, PK				Lagu, Tara; Lindenauer, Peter K.			Putting the Public Back in Public Reporting of Health Care Quality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lagu, Tara; Lindenauer, Peter K.] Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA 01199 USA; [Lagu, Tara] Baystate Med Ctr, Div Gen Internal Med & Geriatr, Springfield, MA 01199 USA; [Lagu, Tara; Lindenauer, Peter K.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Baystate Medical Center; Baystate Medical Center; Tufts University	Lagu, T (corresponding author), Baystate Med Ctr, Ctr Qual Care Res, 280 Chestnut St,3rd Floor, Springfield, MA 01199 USA.	lagutc@gmail.com	Lagu, Tara/GPT-5173-2022	Lagu, Tara/0000-0001-6155-5796				Berwick DM, 2003, MED CARE, V41, pI30; Chang JT, 2006, ANN INTERN MED, V144, P665, DOI 10.7326/0003-4819-144-9-200605020-00010; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Giordano LA, 2010, MED CARE RES REV, V67, P27, DOI 10.1177/1077558709341065; Lagu T, 2010, J GEN INTERN MED, V25, P942, DOI 10.1007/s11606-010-1383-0; LOPEZ A, 2010, SOC GEN INT MED ANN; *NAT HLTH SERV, NHS CHOIC TERMS COND; National Health Service, NHS CHOIC; Rothberg MB, 2008, HEALTH AFFAIR, V27, P1680, DOI 10.1377/hlthaff.27.6.1680; The Kaiser Family Foundation, 2008 UPD CONS VIEWS	10	49	49	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2010	304	15					1711	1712		10.1001/jama.2010.1499	http://dx.doi.org/10.1001/jama.2010.1499			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666PZ	20959582				2022-12-28	WOS:000283129700026
J	Roy-Bornstein, C				Roy-Bornstein, Carolyn			A Room With a View	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												carolynroybornstein@gmail.com							0	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2010	304	15					1646	1646		10.1001/jama.2010.1498	http://dx.doi.org/10.1001/jama.2010.1498			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666PZ	20959567				2022-12-28	WOS:000283129700001
J	Connolly, B; Oczkowski, W				Connolly, Barbara; Oczkowski, Wieslaw			Individual and combined confrontation visual field tests performed poorly as a screen for visual field abnormalities	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LESIONS		[Connolly, Barbara; Oczkowski, Wieslaw] McMaster Univ, Hamilton, ON, Canada	McMaster University	Connolly, B (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Anderson NE, 2005, J NEUROL NEUROSUR PS, V76, P545, DOI 10.1136/jnnp.2004.043679; JOHNSON LN, 1991, J NATL MED ASSOC, V83, P895; Pandit RJ, 2001, LANCET, V358, P1339, DOI 10.1016/S0140-6736(01)06448-0; TROBE JD, 1981, ANN NEUROL, V10, P28, DOI 10.1002/ana.410100105	4	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8							JC4-11	10.7326/0003-4819-153-8-201010190-02011	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956695				2022-12-28	WOS:000283054600026
J	Fabre, J; Murphy, P; Matesanz, R				Fabre, John; Murphy, Paul; Matesanz, Rafael			Presumed consent: a distraction in the quest for increasing rates of organ donation	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Fabre, John] Kings Coll London, Sch Med, James Black Ctr, Dept Hepatol & Transplantat, London SE5 9NU, England; [Murphy, Paul] Leeds Gen Infirm, Neuroanaesthesia & Critical Care, Leeds LS1 3EX, W Yorkshire, England; [Matesanz, Rafael] Minist Hlth & Social Policy, Org Nacl Trasplantes, Madrid 28029, Spain	University of London; King's College London; Leeds General Infirmary; University of Leeds	Fabre, J (corresponding author), Kings Coll London, Sch Med, James Black Ctr, Dept Hepatol & Transplantat, London SE5 9NU, England.	john.fabre@kcl.ac.uk						Bird SM, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2188; Briggs JD, 1997, NEPHROL DIAL TRANSPL, V12, P2251, DOI 10.1093/ndt/12.11.2251; Csillag C, 1998, LANCET, V352, P1367, DOI 10.1016/S0140-6736(05)60767-2; English V, 2007, BRIT MED J, V334, P1088, DOI 10.1136/bmj.39199.475301.AD; Matesanz R., 2007, TRANSPLANT REV-ORLAN, V21, P177, DOI [10.1016/J.TRRE.2007.07.005, DOI 10.1016/J.TRRE.2007.07.005, 10.1016/j.trre.2007.07.005]; Murphy P, 2008, ANAESTHESIA, V63, P526, DOI 10.1111/j.1365-2044.2007.05397.x; *NHS BLOOD TRANSPL, 2009, UK POT DON AUD; *NHS BLOOD TRANSPL, TRANSPL ACT UK 2008; *ORG NAC TRANSPL, 2009, MEM ACT DON REP; Organ Donation Taskforce, 2008, POT IMP OPT OUT SYST; Snoeijs MG, 2007, TRANSPLANT REV, V21, P219; Zink S, 2006, CRIT CARE NURSE, V26, P129	12	53	53	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 18	2010	341								c4973	10.1136/bmj.c4973	http://dx.doi.org/10.1136/bmj.c4973			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	671ZF	20959281				2022-12-28	WOS:000283552100009
J	Rothenberg, ME; Clarke, MF; Diehn, M				Rothenberg, Michael E.; Clarke, Michael F.; Diehn, Maximilian			The Myc Connection: ES Cells and Cancer	CELL			English	Editorial Material							STEM-CELLS; EXPRESSION	Gene profiling experiments have revealed similarities between cancer and embryonic stem (ES) cells. Kim et al. (2010) dissect the gene expression signature of ES cells into three functional modules and find that the Myc module, including genes targeted by Myc-interacting proteins, accounts for most of the similarity between ES and cancer cells.	[Diehn, Maximilian] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA; [Rothenberg, Michael E.] Stanford Univ, Div Gastroenterol & Hepatol, Sch Med, Dept Med, Stanford, CA 94305 USA; [Clarke, Michael F.] Stanford Univ, Div Oncol, Sch Med, Dept Med, Stanford, CA 94305 USA; [Rothenberg, Michael E.; Clarke, Michael F.; Diehn, Maximilian] Stanford Univ, Ctr Canc, Sch Med, Stanford, CA 94305 USA; [Rothenberg, Michael E.; Clarke, Michael F.; Diehn, Maximilian] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Diehn, M (corresponding author), Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA.	diehn@stanford.edu		Diehn, Maximilian/0000-0003-2032-0581				Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Fortunel NO, 2003, SCIENCE, V302, P393; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; PROCHOWNIK EV, 1986, NATURE, V322, P848, DOI 10.1038/322848a0; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009	10	18	19	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					184	186		10.1016/j.cell.2010.09.046	http://dx.doi.org/10.1016/j.cell.2010.09.046			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946977	Bronze			2022-12-28	WOS:000283052200007
J	Green, HW; Chen, WP; Brudzinski, MR				Green, Harry W., II; Chen, Wang-Ping; Brudzinski, Michael R.			Seismic evidence of negligible water carried below 400-km depth in subducting lithosphere	NATURE			English	Article							METASTABLE OLIVINE WEDGE; MANTLE; ZONE; SERPENTINIZATION; DEHYDRATION; REMNANT; PHASE; JAPAN; SLAB; H2O	Strong evidence exists that water is carried from the surface into the upper mantle by hydrous minerals in the uppermost 10-12 km of subducting lithosphere, and more water may be added as the lithosphere bends and goes downwards. Significant amounts of that water are released as the lithosphere heats up, triggering earthquakes and fluxing arc volcanism(1). In addition, there is experimental evidence for high solubility of water in olivine, the most abundant mineral in the upper mantle, for even higher solubility in olivine's high-pressure polymorphs, wadsleyite and ringwoodite(2), and for the existence of dense hydrous magnesium silicates that potentially could carry water well into the lower mantle(3) (deeper than 1,000 km). Here we compare experimental and seismic evidence to test whether patterns of seismicity and the stabilities of these potentially relevant hydrous phases are consistent with a wet lithosphere. We show that there is nearly a one-to-one correlation between dehydration of minerals and seismicity at depths less than about 250 km, and conclude that the dehydration of minerals is the trigger of instability that leads to seismicity. At greater depths, however, we find no correlation between occurrences of earthquakes and depths where breakdown of hydrous phases is expected. Lastly, we note that there is compelling evidence for the existence of metastable olivine (which, if present, can explain the distribution of deep-focus earthquakes(4-7)) west of and within the subducting Tonga slab(8) and also in three other subduction zones, despite metastable olivine being incompatible with even extremely small amounts of water (of the order of 100 p.p.m. by weight(7)). We conclude that subducting slabs are essentially dry at depths below 400 km and thus do not provide a pathway for significant amounts of water to enter the mantle transition zone or the lower mantle.	[Green, Harry W., II] Univ Calif Riverside, Inst Geophys & Planetary Phys, Riverside, CA 92521 USA; [Green, Harry W., II] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Chen, Wang-Ping] Univ Illinois, Dept Geol, Urbana, IL 61801 USA; [Brudzinski, Michael R.] Miami Univ, Dept Geol, Oxford, OH 45056 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of Illinois System; University of Illinois Urbana-Champaign; University System of Ohio; Miami University	Green, HW (corresponding author), Univ Calif Riverside, Inst Geophys & Planetary Phys, Riverside, CA 92521 USA.	harry.green@ucr.edu	Brudzinski, Michael/A-8301-2011		NSF [EAR0552011, EAR-0652626, EAR-0125938, EAR9909362, EAR0551995, EAR552002]; National Science Council of Taiwan at the Academia Sinica	NSF(National Science Foundation (NSF)); National Science Council of Taiwan at the Academia Sinica	We thank L. Dobrzhinetskaya, P. Silver, J. Smyth, T.-L. Tseng, H. Zhang and J. Zhang for discussions. H. W. G. thanks D. LeFay for technical support. This work was supported by NSF grants EAR0552011, EAR-0652626, EAR-0125938 (H.W.G.), EAR9909362, EAR0551995 (W.-P.C.) and EAR552002 (M.R.B.). W.-P.C. acknowledges a distinguished visiting professorship, funded by the National Science Council of Taiwan, at the Academia Sinica.	Angel RJ, 2001, PHYS EARTH PLANET IN, V127, P181, DOI 10.1016/S0031-9201(01)00227-8; Bolfan-Casanova N, 2006, GEOPHYS MONOGR SER, V168, P57, DOI 10.1029/168GM06; Bostock MG, 2002, NATURE, V417, P536, DOI 10.1038/417536a; Brudzinski MR, 2007, SCIENCE, V316, P1472, DOI 10.1126/science.1139204; Brudzinski MR, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003470; Chen WP, 2001, SCIENCE, V292, P2475, DOI 10.1126/science.292.5526.2475; Diedrich T, 2009, CHEM GEOL, V262, P87, DOI 10.1016/j.chemgeo.2009.01.011; DIXON TH, 2007, SEISMOGENIC ZONE SUB, P147; GREEN HW, 1989, NATURE, V341, P733, DOI 10.1038/341733a0; GREEN HW, 1990, NATURE, V348, P720, DOI 10.1038/348720a0; Green HW, 2002, REV MINERAL GEOCHEM, V51, P181, DOI 10.2138/gsrmg.51.1.181; GREEN HW, 1995, ANNU REV EARTH PL SC, V23, P169, DOI 10.1146/annurev.ea.23.050195.001125; Hacker BR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001127; IIDAKA T, 1992, NATURE, V356, P593, DOI 10.1038/356593a0; IIDAKA T, 1994, SCIENCE, V263, P1116, DOI 10.1126/science.263.5150.1116; IIZUKA Y, 1995, P JPN ACAD B-PHYS, V71, P159, DOI 10.2183/pjab.71.159; Jiang GM, 2008, EARTH PLANET SC LETT, V270, P300, DOI 10.1016/j.epsl.2008.03.037; Jung H, 2004, NATURE, V428, P545, DOI 10.1038/nature02412; Kaneshima S, 2007, EARTH PLANET SC LETT, V258, P219, DOI 10.1016/j.epsl.2007.03.035; Kohlstedt DL, 1996, CONTRIB MINERAL PETR, V123, P345, DOI 10.1007/s004100050161; Mosenfelder JL, 2001, PHYS EARTH PLANET IN, V127, P165, DOI 10.1016/S0031-9201(01)00226-6; Peacock SM, 2001, GEOLOGY, V29, P299, DOI 10.1130/0091-7613(2001)029<0299:ATLPOD>2.0.CO;2; RALEIGH CB, 1965, J GEOPHYS RES, V70, P3965, DOI 10.1029/JZ070i016p03965; Ranero CR, 2003, NATURE, V425, P367, DOI 10.1038/nature01961; Smyth JR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026194; Stalder R, 2001, CONTRIB MINERAL PETR, V140, P670, DOI 10.1007/s004100000208; Toffelmier DA, 2007, NATURE, V447, P991, DOI 10.1038/nature05922; Tseng TL, 2008, EARTH PLANET SC LETT, V268, P450, DOI 10.1016/j.epsl.2008.01.038; ULMER P, 1995, SCIENCE, V268, P858, DOI 10.1126/science.268.5212.858; WIENS DA, 1993, NATURE, V364, P790, DOI 10.1038/364790a0; Zhang HJ, 2004, GEOLOGY, V32, P361, DOI 10.1130/G20261.2; Zhang JF, 2004, NATURE, V428, P633, DOI 10.1038/nature02475	33	71	76	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					828	831		10.1038/nature09401	http://dx.doi.org/10.1038/nature09401			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20927105				2022-12-28	WOS:000282898700064
J	Hajjar, LA; Vincent, JL; Galas, FRBG; Nakamura, RE; Silva, CMP; Santos, MH; Fukushima, J; Kalil, R; Sierra, DB; Lopes, NH; Mauad, T; Roquim, AC; Sundin, MR; Leao, WC; Almeida, JP; Pomerantzeff, PM; Dallan, LO; Jatene, FB; Stolf, NAG; Auler, JOC				Hajjar, Ludhmila A.; Vincent, Jean-Louis; Galas, Filomena R. B. G.; Nakamura, Rosana E.; Silva, Carolina M. P.; Santos, Marilia H.; Fukushima, Julia; Kalil Filho, Roberto; Sierra, Denise B.; Lopes, Neuza H.; Mauad, Thais; Roquim, Aretusa C.; Sundin, Marcia R.; Leao, Wanderson C.; Almeida, Juliano P.; Pomerantzeff, Pablo M.; Dallan, Luis O.; Jatene, Fabio B.; Stolf, Noedir A. G.; Auler, Jose O. C., Jr.			Transfusion Requirements After Cardiac Surgery The TRACS Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RED-BLOOD-CELL; LONG-TERM SURVIVAL; ARTERY-BYPASS SURGERY; NORMOTHERMIC CARDIOPULMONARY BYPASS; INTENSIVE-CARE-UNIT; INCREASED MORTALITY; CLINICAL-TRIAL; GRAFT-SURGERY; MORBIDITY; HEMATOCRIT	Context Perioperative red blood cell transfusion is commonly used to address anemia, an independent risk factor for morbidity and mortality after cardiac operations; however, evidence regarding optimal blood transfusion practice in patients undergoing cardiac surgery is lacking. Objective To define whether a restrictive perioperative red blood cell transfusion strategy is as safe as a liberal strategy in patients undergoing elective cardiac surgery. Design, Setting, and Patients The Transfusion Requirements After Cardiac Surgery (TRACS) study, a prospective, randomized, controlled clinical noninferiority trial conducted between February 2009 and February 2010 in an intensive care unit at a university hospital cardiac surgery referral center in Brazil. Consecutive adult patients (n=502) who underwent cardiac surgery with cardiopulmonary bypass were eligible; analysis was by intention-to-treat. Intervention Patients were randomly assigned to a liberal strategy of blood transfusion (to maintain a hematocrit >= 30%) or to a restrictive strategy (hematocrit >= 24%). Main Outcome Measure Composite end point of 30-day all-cause mortality and severe morbidity (cardiogenic shock, acute respiratory distress syndrome, or acute renal injury requiring dialysis or hemofiltration) occurring during the hospital stay. The noninferiority margin was predefined at -8% (ie, 8% minimal clinically important increase in occurrence of the composite end point). Results Hemoglobin concentrations were maintained at a mean of 10.5 g/dL(95% confidence interval [CI], 10.4-10.6) in the liberal-strategy group and 9.1 g/dL (95% CI, 9.09.2) in the restrictive-strategy group (P<.001). A total of 198 of 253 patients (78%) in the liberal-strategy group and 118 of 249 (47%) in the restrictive-strategy group received a blood transfusion (P<.001). Occurrence of the primary end point was similar between groups (10% liberal vs 11% restrictive; between-group difference, 1% [95% CI, -6% to 4%]; P=.85). Independent of transfusion strategy, the number of transfused red blood cell units was an independent risk factor for clinical complications or death at 30 days (hazard ratio for each additional unit transfused, 1.2 [95% CI, 1.1-1.4]; P=.002). Conclusion Among patients undergoing cardiac surgery, the use of a restrictive perioperative transfusion strategy compared with a more liberal strategy resulted in noninferior rates of the combined outcome of 30-day all-cause mortality and severe morbidity. Trial Registration clinicaltrials.gov Identifier: NCT01021631 JAMA. 2010; 304(14):1559-1567 www.jama.com	[Hajjar, Ludhmila A.; Galas, Filomena R. B. G.; Nakamura, Rosana E.; Silva, Carolina M. P.; Santos, Marilia H.; Fukushima, Julia; Kalil Filho, Roberto; Sierra, Denise B.; Lopes, Neuza H.; Mauad, Thais; Roquim, Aretusa C.; Sundin, Marcia R.; Leao, Wanderson C.; Almeida, Juliano P.; Pomerantzeff, Pablo M.; Dallan, Luis O.; Jatene, Fabio B.; Stolf, Noedir A. G.; Auler, Jose O. C., Jr.] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor,Surg Intens Care Unit, Sao Paulo, Brazil; [Hajjar, Ludhmila A.; Galas, Filomena R. B. G.; Nakamura, Rosana E.; Silva, Carolina M. P.; Santos, Marilia H.; Fukushima, Julia; Kalil Filho, Roberto; Sierra, Denise B.; Lopes, Neuza H.; Mauad, Thais; Roquim, Aretusa C.; Sundin, Marcia R.; Leao, Wanderson C.; Almeida, Juliano P.; Pomerantzeff, Pablo M.; Dallan, Luis O.; Jatene, Fabio B.; Auler, Jose O. C., Jr.] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor,Dept Anesthesiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Vincent, JL (corresponding author), Erasme Univ Hosp, Dept Intens Care, Route Lennik 808, B-1070 Brussels, Belgium.	jlvincen@ulb.ac.be	Filho, Roberto Kalil/D-4994-2014; Dallan, Luis A.O/I-2728-2013; Stolf, Noedir Antonio Groppo/ABG-2530-2020; Pomerantzeff, Pablo M A/L-5525-2016; Jatene, Fabio B/D-1679-2012; Auler, José Otavio Costa/C-4492-2017; Hajjar, Ludhmila A/K-3512-2017; Mauad, Thais/G-1254-2012	Stolf, Noedir Antonio Groppo/0000-0002-5893-8216; Pomerantzeff, Pablo M A/0000-0003-0566-1038; Auler, José Otavio Costa/0000-0002-3919-1743; Mauad, Thais/0000-0002-3354-1466; SANTOS, MARILIA/0000-0003-4107-0470; Abrahao Hajjar, Ludhmila/0000-0001-5645-2055; dallan, luis alberto/0000-0002-8655-8966; Vincent, Jean-Louis/0000-0001-6011-6951				Berger K, 2009, BRIT J ANAESTH, V103, P511, DOI 10.1093/bja/aep201; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bilgin YM, 2004, CIRCULATION, V109, P2755, DOI 10.1161/01.CIR.0000130162.11925.21; Bracey AW, 1999, TRANSFUSION, V39, P1070, DOI 10.1046/j.1537-2995.1999.39101070.x; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; Croce MA, 2000, AM SURGEON, V66, P133; DeFoe GR, 2001, ANN THORAC SURG, V71, P769, DOI 10.1016/S0003-4975(00)02393-6; Despotis G J, 1999, Semin Thorac Cardiovasc Surg, V11, P84; Despotis GJ, 2007, HEMATOL ONCOL CLIN N, V21, P147, DOI 10.1016/j.hoc.2006.11.002; Efstathiou A, 2003, J CARDIOVASC SURG, V44, P197; Engoren MC, 2002, ANN THORAC SURG, V74, P1180, DOI 10.1016/S0003-4975(02)03766-9; Ferraris VA, 2007, ANN THORAC SURG, V83, P27, DOI 10.1016/j.athoracsur.2007.02.099; Gauvin F, 2008, TRANSFUSION, V48, P801, DOI 10.1111/j.1537-2995.2007.01614.x; Haase M, 2009, J THORAC CARDIOV SUR, V138, P1370, DOI 10.1016/j.jtcvs.2009.07.007; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; JOHNSON RG, 1992, J THORAC CARDIOV SUR, V104, P307; Karkouti K, 2001, TRANSFUSION, V41, P1193, DOI 10.1046/j.1537-2995.2001.41101193.x; Klugkist M, 2008, ANAESTHESIST, V57, P464, DOI 10.1007/s00101-008-1356-4; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koch CG, 2006, CRIT CARE MED, V34, P1608, DOI 10.1097/01.CCM.0000217920.48559.D8; Koch CG, 2006, ANN THORAC SURG, V81, P1650, DOI 10.1016/j.athoracsur.2005.12.037; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Kuduvalli M, 2005, EUR J CARDIO-THORAC, V27, P592, DOI 10.1016/j.ejcts.2005.01.030; Leal-Noval SM, 2001, CHEST, V119, P1461, DOI 10.1378/chest.119.5.1461; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Madjdpour C, 2006, CRIT CARE MED, V34, pS102, DOI 10.1097/01.CCM.0000214317.26717.73; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; Masse Linda, 2005, Crit Care Nurs Clin North Am, V17, P375, DOI 10.1016/j.ccell.2005.07.005; Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Reeves BC, 2008, CURR OPIN CARDIOL, V23, P607, DOI 10.1097/HCO.0b013e328310fc95; Rogers MAM, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-37; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Scott BH, 2003, ANESTH ANALG, V97, P958, DOI [10.1213/01.ANE.0000081790.75298.D8, 10.1213/01.ANE.0000081790.85298.D8]; Scott BH, 2008, ANN CARD ANAESTH, V11, P15, DOI 10.4103/0971-9784.38444; Snyder-Ramos SA, 2008, TRANSFUSION, V48, P1284, DOI 10.1111/j.1537-2995.2008.01666.x; Spiess BD, 2001, ANN THORAC SURG, V72, pS1832, DOI 10.1016/S0003-4975(01)03259-3; Stover EP, 1998, ANESTHESIOLOGY, V88, P327, DOI 10.1097/00000542-199802000-00009; Surgenor SD, 2009, ANESTH ANALG, V108, P1741, DOI 10.1213/ane.0b013e3181a2a696; Tang ATM, 2002, ANN THORAC SURG, V74, P372, DOI 10.1016/S0003-4975(02)03715-3; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; van Straten AHM, 2010, J CARDIOTHOR VASC AN, V24, P413, DOI 10.1053/j.jvca.2010.01.001; Vincent JL, 2006, CRIT CARE MED, V34, pS96, DOI 10.1097/01.CCM.0000214314.57109.CD; von Heymann C, 2006, CRIT CARE, V10, DOI 10.1186/cc4891; WEISEL RD, 1984, J THORAC CARDIOV SUR, V88, P26; Whitson BA, 2010, J SURG RES, V158, P20, DOI 10.1016/j.jss.2008.10.015; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615; Zacharias A, 1996, CHEST, V110, P1173, DOI 10.1378/chest.110.5.1173	49	728	750	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1559	1567		10.1001/jama.2010.1446	http://dx.doi.org/10.1001/jama.2010.1446			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940381	Bronze			2022-12-28	WOS:000282816500020
J	Lafferty, KD				Lafferty, Kevin D.			Interacting Parasites	SCIENCE			English	Editorial Material							HETEROLOGOUS IMMUNITY; COMMUNITY STRUCTURE; TRENDS		Univ Calif Santa Barbara, Inst Marine Sci, US Geol Survey, Western Ecol Res Ctr, Santa Barbara, CA 93106 USA	United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Barbara	Lafferty, KD (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, US Geol Survey, Western Ecol Res Ctr, Santa Barbara, CA 93106 USA.	kevin.lafferty@lifesci.ucsb.edu	Lafferty, Kevin D./B-3888-2009					Bassetti S, 2005, EMERG INFECT DIS, V11, P637, DOI 10.3201/eid1104.040639; CASWELL H, 1978, AM NAT, V112, P127, DOI 10.1086/283257; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Fenton A, 2010, PARASITOLOGY, V137, P1027, DOI 10.1017/S0031182009991788; Graham AL, 2008, P NATL ACAD SCI USA, V105, P566, DOI 10.1073/pnas.0707221105; KURIS AM, 1994, ANNU REV ECOL SYST, V25, P189, DOI 10.1146/annurev.es.25.110194.001201; Lafferty KD, 2009, TRENDS PARASITOL, V25, P564, DOI 10.1016/j.pt.2009.09.003; LEWIS JW, 1968, J ZOOL, V154, P313, DOI 10.1111/j.1469-7998.1968.tb01666.x; Page KR, 2006, CELL MICROBIOL, V8, P185, DOI 10.1111/j.1462-5822.2005.00653.x; RIGAUD T, P R SOC B; Rohde K, 1998, INT J PARASITOL, V28, P461, DOI 10.1016/S0020-7519(97)00209-9; SELIK RM, 1984, AM J MED, V76, P493, DOI 10.1016/0002-9343(84)90669-7; TAYLOR MG, 1973, B WORLD HEALTH ORGAN, V49, P57; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333	15	24	25	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					187	188		10.1126/science.1196915	http://dx.doi.org/10.1126/science.1196915			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929765				2022-12-28	WOS:000282644600029
J	Eibner, C; Hussey, PS; Girosi, F				Eibner, Christine; Hussey, Peter S.; Girosi, Federico			The Effects of the Affordable Care Act on Workers' Health Insurance Coverage.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Eibner, Christine; Hussey, Peter S.; Girosi, Federico] RAND Corp, Arlington, VA USA	RAND Corporation	Eibner, C (corresponding author), RAND Corp, Arlington, VA USA.			Girosi, Federico/0000-0003-3937-2285				Blumenthal D, 2006, NEW ENGL J MED, V355, P82, DOI 10.1056/NEJMhpr060703; Eibner C., 2010, ESTABLISHING STATE H; Gabel JR, 2008, HEALTH AFFAIR, V27, pW566, DOI 10.1377/hlthaff.27.6.w566	3	11	11	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2010	363	15					1393	1395		10.1056/NEJMp1008047	http://dx.doi.org/10.1056/NEJMp1008047			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	659NV	20925541				2022-12-28	WOS:000282575100004
J	Arie, S				Arie, Sophie			International Health Hungry for profit	BRITISH MEDICAL JOURNAL			English	Editorial Material												ariesophie@yahoo.co.uk						Defourny I., 2007, MANAGEMENT MODERATE; Diop EHI, 2003, AM J CLIN NUTR, V78, P302, DOI 10.1093/ajcn/78.2.302; PRUDHON C, 21 SCN; World Health Organization, 2007, JOINT STAT COMM BAS	4	4	4	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 6	2010	341								c5221	10.1136/bmj.c5221	http://dx.doi.org/10.1136/bmj.c5221			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663JE	20926480				2022-12-28	WOS:000282879400005
J	Stuessy, T				Stuessy, Tod			The Rise of Sunflowers	SCIENCE			English	Editorial Material									Univ Vienna, Dept Systemat & Evolutionary Bot, Biodivers Ctr, A-1030 Vienna, Austria	University of Vienna	Stuessy, T (corresponding author), Univ Vienna, Dept Systemat & Evolutionary Bot, Biodivers Ctr, Rennweg 14, A-1030 Vienna, Austria.	tod.stuessy@univie.ac.at						Barreda VD, 2010, SCIENCE, V329, P1621, DOI 10.1126/science.1193108; Barreda V, 2010, REV PALAEOBOT PALYNO, V160, P102, DOI 10.1016/j.revpalbo.2010.02.004; Becker HF., 1969, PALAEONTOGRAPHICA B, V127, P1; Bremer K, 2001, PLANT SYST EVOL, V229, P137, DOI 10.1007/s006060170009; CREPET WL, 1978, BRITTONIA, V30, P483, DOI 10.2307/2806356; DRINNAN AN, 1990, ANTARCTIC PALEOBIOLOGY, P192; Funk VA., 2005, BIOL SKRIFTER, V55, P343; Graham A., 1996, COMPOSITAE SYSTEMATI, V1, P123; Hellwig F. H., 2007, FAMILIES GENERA VASC, V8, P19, DOI DOI 10.1007/978-3-540-31051-8_4; JANSEN RK, 1987, P NATL ACAD SCI USA, V84, P5818, DOI 10.1073/pnas.84.16.5818; Kilian N., 2009, SYSTEMATICS EVOLUTIO; Olmstead RG, 2000, MOL PHYLOGENET EVOL, V16, P96, DOI 10.1006/mpev.1999.0769; Pearson PN, 2009, NATURE, V461, P1110, DOI 10.1038/nature08447; Stuessy T, 2009, SYSTEMATICS EVOLUTIO, P215, DOI DOI 10.1038/ncomms5956; TORRES GT, 1985, B ANTART CHIL, V5, P17	15	8	8	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1605	1606		10.1126/science.1195336	http://dx.doi.org/10.1126/science.1195336			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929832				2022-12-28	WOS:000282098100024
J	Chia, NY; Chan, YS; Feng, B; Lu, XY; Orlov, YL; Moreau, D; Kumar, P; Yang, L; Jiang, JM; Lau, MS; Huss, M; Soh, BS; Kraus, P; Li, P; Lufkin, T; Lim, B; Clarke, ND; Bard, F; Ng, HH				Chia, Na-Yu; Chan, Yun-Shen; Feng, Bo; Lu, Xinyi; Orlov, Yuriy L.; Moreau, Dimitri; Kumar, Pankaj; Yang, Lin; Jiang, Jianming; Lau, Mei-Sheng; Huss, Mikael; Soh, Boon-Seng; Kraus, Petra; Li, Pin; Lufkin, Thomas; Lim, Bing; Clarke, Neil D.; Bard, Frederic; Ng, Huck-Hui			A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity	NATURE			English	Article							DEFINED FACTORS; MOUSE EMBRYOS; SELF-RENEWAL; LINES; ESTABLISHMENT; TRANSCRIPTION; EXPRESSION; REGULATOR; PROTEINS; COMPLEX	The derivation of human ES cells (hESCs) from human blastocysts represents one of the milestones in stem cell biology(1). The full potential of hESCs in research and clinical applications requires a detailed understanding of the genetic network that governs the unique properties of hESCs. Here, we report a genome-wide RNA interference screen to identify genes which regulate self-renewal and pluripotency properties in hESCs. Interestingly, functionally distinct complexes involved in transcriptional regulation and chromatin remodelling are among the factors identified in the screen. To understand the roles of these potential regulators of hESCs, we studied transcription factor PRDM14 to gain new insights into its functional roles in the regulation of pluripotency. We showed that PRDM14 regulates directly the expression of key pluripotency gene POU5F1 through its proximal enhancer. Genome-wide location profiling experiments revealed that PRDM14 colocalized extensively with other key transcription factors such as OCT4, NANOG and SOX2, indicating that PRDM14 is integrated into the core transcriptional regulatory network. More importantly, in a gain-of-function assay, we showed that PRDM14 is able to enhance the efficiency of reprogramming of human fibroblasts in conjunction with OCT4, SOX2 and KLF4. Altogether, our study uncovers a wealth of novel hESC regulators wherein PRDM14 exemplifies a key transcription factor required for the maintenance of hESC identity and the reacquisition of pluripotency in human somatic cells.	[Chia, Na-Yu; Chan, Yun-Shen; Feng, Bo; Lu, Xinyi; Yang, Lin; Jiang, Jianming; Lau, Mei-Sheng; Ng, Huck-Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; [Chia, Na-Yu; Ng, Huck-Hui] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Chan, Yun-Shen; Ng, Huck-Hui] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Lu, Xinyi; Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Orlov, Yuriy L.; Huss, Mikael; Clarke, Neil D.] Genome Inst Singapore, Computat & Syst Biol Grp, Singapore 138672, Singapore; [Moreau, Dimitri; Kumar, Pankaj; Bard, Frederic] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Lim, Bing] Harvard Univ, Sch Med, Ctr Life Sci, Boston, MA 02115 USA; [Clarke, Neil D.; Bard, Frederic; Ng, Huck-Hui] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Harvard University; Harvard Medical School; National University of Singapore	Ng, HH (corresponding author), Genome Inst Singapore, Gene Regulat Lab, 60 Biopolis St, Singapore 138672, Singapore.	fbard@imcb.a-star.edu.sg; nghh@gis.a-star.edu.sg	Chan, Yun-Shen/GWC-4616-2022; jiang, jianming/B-3421-2012; Clarke, Neil/D-9613-2014; Lufkin, Thomas/B-5352-2011; Kraus, Petra/I-5849-2014; Lufkin, Thomas/AAG-7476-2019; Orlov, Yuriy L/F-1520-2013; BARD, Frederic/G-9914-2011; Feng, Bo/D-7831-2014; Ng, Huck Hui/A-1135-2009; Moreau, Dimitri/E-5092-2012	jiang, jianming/0000-0003-3251-2716; Lufkin, Thomas/0000-0002-7902-4771; Kraus, Petra/0000-0002-6716-5550; Lufkin, Thomas/0000-0002-7902-4771; Orlov, Yuriy L/0000-0003-0587-1609; BARD, Frederic/0000-0002-3783-4805; Feng, Bo/0000-0002-4018-3257; Moreau, Dimitri/0000-0002-9282-3324; Huss, Mikael/0000-0003-0839-2451; CHIA, NA YU/0000-0003-1092-4699; LU, Xinyi/0000-0002-3885-3960	Biomedical Research Council (BMRC); Agency for Science, Technology and Research (A*STAR); Singapore Stem Cell Consortium	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Singapore Stem Cell Consortium	We are grateful to the Biomedical Research Council (BMRC), Agency for Science, Technology and Research (A*STAR) and Singapore Stem Cell Consortium for funding. We are grateful to K. Kuay, L.-P. Yaw, C.-K. Tong and C.-W. Chang for technical assistance. We acknowledge V. Cacheux-Rataboul for karyotype analysis and the GTB group for sequencing. We are grateful to A. Surani, P. Tesar and R. Mckay for gift of EpiSCs and Q. Yu for plasmids. We thank A. Colman, A. Hutchins and T. Huber for comments on the manuscript.	Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Casamassimi A, 2007, BIOCHIMIE, V89, P1439, DOI 10.1016/j.biochi.2007.08.002; Chamovitz DA, 2009, EMBO REP, V10, P352, DOI 10.1038/embor.2009.33; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pera MF, 2004, DEVELOPMENT, V131, P5515, DOI 10.1242/dev.01451; Rino J, 2009, TRENDS CELL BIOL, V19, P375, DOI 10.1016/j.tcb.2009.05.004; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sharov AA, 2009, DNA RES, V16, P261, DOI 10.1093/dnares/dsp014; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; Van Hoof D, 2006, MOL CELL PROTEOMICS, V5, P1261, DOI 10.1074/mcp.M500405-MCP200; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808	30	346	374	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					316	U207		10.1038/nature09531	http://dx.doi.org/10.1038/nature09531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	20953172				2022-12-28	WOS:000284051000053
J	Jackson, JL; Shimeall, W; Sessums, L; DeZee, KJ; Becher, D; Diemer, M; Berbano, E; O'Malley, PG				Jackson, Jeffrey L.; Shimeall, William; Sessums, Laura; DeZee, Kent J.; Becher, Dorothy; Diemer, Margretta; Berbano, Elizabeth; O'Malley, Patrick G.			Tricyclic antidepressants and headaches: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							TENSION-TYPE HEADACHE; DOUBLE-BLIND; PROPHYLACTIC TREATMENT; MIGRAINE PROPHYLAXIS; SPINAL MANIPULATION; PUBLICATION BIAS; MIXED HEADACHE; AMITRIPTYLINE; TRIAL; CLOMIPRAMINE	Objective To evaluate the efficacy and relative adverse effects of tricyclic antidepressants in the treatment of migraine, tension-type, and mixed headaches. Design Meta-analysis. Data sources Medline, Embase, the Cochrane Trials Registry, and PsycLIT. Studies reviewed Randomised trials of adults receiving tricyclics as only treatment for a minimum of four weeks. Data extraction Frequency of headaches (number of headache attacks for migraine and number of days with headache for tension-type headaches), intensity of headache, and headache index. Results 37 studies met the inclusion criteria. Tricyclics significantly reduced the number of days with tension-type headache and number of headache attacks from migraine than placebo (average standardised mean difference -1.29, 95% confidence interval -2.18 to -0.39 and -0.70, -0.93 to -0.48) but not compared with selective serotonin reuptake inhibitors (-0.80, -2.63 to 0.02 and -0.20, -0.60 to 0.19). The effect of tricyclics increased with longer duration of treatment (beta=-0.11, 95% confidence interval -0.63 to -0.15; P<0.0005). Tricyclics were also more likely to reduce the intensity of headaches by at least 50% than either placebo (tension-type: relative risk 1.41, 95% confidence interval 1.02 to 1.89; migraine: 1.80, 1.24 to 2.62) or selective serotonin reuptake inhibitors (1.73, 1.34 to 2.22 and 1.72, 1.15 to 2.55). Tricyclics were more likely to cause adverse effects than placebo (1.53, 95% confidence interval 1.11 to 2.12) and selective serotonin reuptake inhibitors (2.22, 1.52 to 3.32), including dry mouth (P<0.0005 for both), drowsiness (P<0.0005 for both), and weight gain (P<0.001 for both), but did not increase dropout rates (placebo: 1.22, 0.83 to 1.80, selective serotonin reuptake inhibitors: 1.16, 0.81 to 2.97). Conclusions Tricyclic antidepressants are effective in preventing migraine and tension-type headaches and are more effective than selective serotonin reuptake inhibitors, although with greater adverse effects. The effectiveness of tricyclics seems to increase over time.	[Jackson, Jeffrey L.] Zablocki VA, Div Gen Med, Milwaukee, WI 53295 USA; [Sessums, Laura; Becher, Dorothy; Diemer, Margretta; Berbano, Elizabeth] Walter Reed Army Med Ctr, Washington, DC 20307 USA; [Shimeall, William] Natl Naval Med Ctr, Bethesda, MD USA; [DeZee, Kent J.; O'Malley, Patrick G.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA	Jackson, JL (corresponding author), Zablocki VA, Div Gen Med, 5000 Natl Ave, Milwaukee, WI 53295 USA.	Jeffrey.jackson6@va.gov	Jackson, Jeffrey/AAA-3519-2019	Jackson, Jeffrey/0000-0002-9820-5834				Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Amelin AV, 2000, ZH NEVROPATOL PSIKH, V100, P20; ANDERSEN E, 1983, BRAIN RES, V269, P57, DOI 10.1016/0006-8993(83)90962-9; [Anonymous], 1962, JAMA-J AM MED ASSOC, V179, P717; BANK J, 1994, HEADACHE, V34, P476, DOI 10.1111/j.1526-4610.1994.hed3408476.x; Bendtsen L, 1996, J NEUROL NEUROSUR PS, V61, P285, DOI 10.1136/jnnp.61.3.285; BOLINE PD, 1995, J MANIP PHYSIOL THER, V18, P148; BONUSO S, 1983, CEPHALALGIA, V3, P175, DOI 10.1177/03331024830030S130; BOTNEY M, 1983, ANN NEUROL, V13, P160, DOI 10.1002/ana.410130209; Boz C, 2003, J HEADACHE PAIN, V4, P72; Bulut S, 2004, CLIN NEUROL NEUROSUR, V107, P44, DOI 10.1016/j.clineuro.2004.03.004; CANEPARI C, 1985, Clinica Terapeutica, V115, P463; Couch J R, 1974, Trans Am Neurol Assoc, V99, P94; Couch J R, 1976, Trans Am Neurol Assoc, V101, P234; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DIAMOND S, 1971, HEADACHE, V11, P110, DOI 10.1111/j.1526-4610.1971.hed1103110.x; Dodick DW, 2009, CLIN THER, V31, P542, DOI 10.1016/j.clinthera.2009.03.020; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; EBERHARD G, 1989, NORDIC J PSYCHIA S20, V43, P114; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; GARVEY MJ, 1983, BRIT J PSYCHIAT, V143, P544, DOI 10.1192/bjp.143.6.544; Gleser LJ, 1996, STAT MED, V15, P2493, DOI 10.1002/(SICI)1097-0258(19961215)15:23<2493::AID-SIM381>3.0.CO;2-C; GOBEL H, 1994, PAIN, V59, P241, DOI 10.1016/0304-3959(94)90077-9; GOMERSALL JD, 1973, J NEUROL NEUROSUR PS, V36, P684, DOI 10.1136/jnnp.36.4.684; HENDLER N, 1984, J CLIN PSYCHIAT, V45, P30; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOLROYD KA, 1991, J CONSULT CLIN PSYCH, V59, P387, DOI 10.1037/0022-006X.59.3.387; Holroyd KA, 2001, JAMA-J AM MED ASSOC, V285, P2208, DOI 10.1001/jama.285.17.2208; Hu XH, 1999, ARCH INTERN MED, V159, P813, DOI 10.1001/archinte.159.8.813; INDACO A, 1988, NEUROLOGY, V38, P1720, DOI 10.1212/WNL.38.11.1720; Jackson JL, 1998, PSYCHOSOMATICS, V39, P431, DOI 10.1016/S0033-3182(98)71302-7; JACOBS H, 1972, J NEUROL NEUROSUR PS, V35, P500, DOI 10.1136/jnnp.35.4.500; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Keskinbora K, 2008, CLIN NEUROL NEUROSUR, V110, P979, DOI 10.1016/j.clineuro.2008.05.025; Kroenke K, 1997, AM J MED, V103, P339, DOI 10.1016/S0002-9343(97)00241-6; Kroenke K, 1994, Arch Fam Med, V3, P774; LANCE JW, 1964, LANCET, V1, P1236; LANGEMARK M, 1990, HEADACHE, V30, P118, DOI 10.1111/j.1526-4610.1990.hed3003118.x; LANGOHR HD, 1985, HEADACHE, V25, P107, DOI 10.1111/j.1526-4610.1985.hed2502107.x; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; LOLDRUP D, 1989, PSYCHOPHARMACOLOGY, V99, P1, DOI 10.1007/BF00634443; Martin-Araguz A, 2003, REV NEUROLOGIA, V37, P101, DOI 10.33588/rn.3702.2002498; MATHEW NT, 1981, HEADACHE, V21, P105, DOI 10.1111/j.1526-4610.1981.hed2103105.x; Mitsikostas DD, 1997, ACTA NEUROL SCAND, V96, P247; Moja PL, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002919.pub2; MORLAND TJ, 1979, HEADACHE, V19, P382, DOI 10.1111/j.1526-4610.1979.hed1907382.x; NAPPI G, 1990, HEADACHE, V30, P439, DOI 10.1111/j.1526-4610.1990.hed3007439.x; Nelson CF, 1998, J MANIP PHYSIOL THER, V21, P511; NOONE JF, 1980, J INT MED RES, V8, P49; OKASHA A, 1973, BRIT J PSYCHIAT, V122, P181, DOI 10.1192/bjp.122.2.181; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; PFAFFENRATH V, 1994, CEPHALALGIA, V14, P149, DOI 10.1046/j.1468-2982.1994.1402149.x; Rampello L, 2004, NEUROPSYCHOBIOLOGY, V50, P322, DOI 10.1159/000080960; RAPOPORT AM, 1994, NEUROLOGY, V44, P25; Rasmussen BK, 2001, CEPHALALGIA, V21, P774, DOI 10.1046/j.1468-2982.2001.00248.x; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Sharp S, 1998, STATA TECH B, V7, DOI DOI 10.1002/SIM.1187/FULL); Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Tarasova SV, 2009, ZH NEVROPATOLIOGII P, V108, P43; Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461; Tomkins GE, 2001, AM J MED, V111, P54, DOI 10.1016/S0002-9343(01)00762-8; Vernon H, 2009, J MANIP PHYSIOL THER, V32, P344, DOI 10.1016/j.jmpt.2009.04.004; Walker Z, 1998, HEADACHE, V38, P523, DOI 10.1046/j.1526-4610.1998.3807523.x; Wang Shuu-Jiun, 2003, Curr Neurol Neurosci Rep, V3, P104, DOI 10.1007/s11910-003-0060-7; ZIEGLER DK, 1987, ARCH NEUROL-CHICAGO, V44, P486, DOI 10.1001/archneur.1987.00520170016015	68	101	101	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2010	341								c5222	10.1136/bmj.c5222	http://dx.doi.org/10.1136/bmj.c5222			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671ZL	20961988	Green Published, hybrid			2022-12-28	WOS:000283552700001
J	Menikoff, J				Menikoff, Jerry			Making Research Consent Transparent	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Off Human Res Protect, Rockville, MD 20852 USA		Menikoff, J (corresponding author), Off Human Res Protect, 1101 Wootton Pkwy,Ste 200, Rockville, MD 20852 USA.	jerry.menikoff@hhs.gov						Asamoah AK, 2010, NEW ENGL J MED, V362, P2341, DOI 10.1056/NEJMp1005202; Harmon A., 2010, NY TIMES        0421; Miller JD, 2010, JAMA-J AM MED ASSOC, V303, P773, DOI 10.1001/jama.2010.207; *US FDA, 2010, FDA STAT AV TIDE TRI; WILSON JM, 2000, COMMUNICATION   0303; 2007, NATURE, V13, P999; CONSENT FORM TIDE TR	7	4	4	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2010	304	15					1713	1714		10.1001/jama.2010.1492	http://dx.doi.org/10.1001/jama.2010.1492			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666PZ	20959583				2022-12-28	WOS:000283129700027
J	Koretz, RL				Koretz, Ronald L.			Once-only flexible sigmoidoscopy screening reduced colorectal cancer incidence and mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Olive View UCLA Med Ctr, Sylmar, CA 91342 USA	University of California System; University of California Los Angeles	Koretz, RL (corresponding author), Olive View UCLA Med Ctr, 14445 Olive View Dr, Sylmar, CA 91342 USA.							Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Hoff G, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1846	3	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8							JC4-4	10.7326/0003-4819-153-8-201010190-02004	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956700				2022-12-28	WOS:000283054600019
J	Diamond, J				Diamond, Jared			The Benefits of Multilingualism	SCIENCE			English	Editorial Material							BILINGUAL-CHILDREN; EXECUTIVE CONTROL		Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Diamond, J (corresponding author), Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA.	jdiamond@geog.ucla.edu						Bialystok E., 2001, BILINGUALISM DEV; Bialystok E, 2007, NEUROPSYCHOLOGIA, V45, P459, DOI 10.1016/j.neuropsychologia.2006.10.009; Bialystok E, 2010, DEV PSYCHOL, V46, P93, DOI 10.1037/a0015466; Bialystok E, 2009, COGNITION, V112, P494, DOI 10.1016/j.cognition.2009.06.014; Bialystok E, 2009, BRAIN LANG, V109, P93, DOI 10.1016/j.bandl.2008.09.001; Carlson SM, 2008, DEVELOPMENTAL SCI, V11, P282, DOI 10.1111/j.1467-7687.2008.00675.x; Costa A, 2008, COGNITION, V106, P59, DOI 10.1016/j.cognition.2006.12.013; Kovacs AM, 2009, P NATL ACAD SCI USA, V106, P6556, DOI 10.1073/pnas.0811323106; Kovacs AM, 2009, SCIENCE, V325, P611, DOI 10.1126/science.1173947; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45	10	45	47	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2010	330	6002					332	333		10.1126/science.1195067	http://dx.doi.org/10.1126/science.1195067			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	664TY	20947754				2022-12-28	WOS:000282986700028
J	Rotimi, CN; Jorde, LB				Rotimi, Charles N.; Jorde, Lynn B.			GENOMIC MEDICINE Ancestry and Disease in the Age of Genomic Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CANCER RISK VARIANTS; STAGE RENAL-DISEASE; GENETIC-VARIATION; PROSTATE-CANCER; ADMIXTURE PROPORTIONS; AFRICAN-AMERICAN; COPY-NUMBER; LINKAGE DISEQUILIBRIUM; NUCLEOTIDE DIVERSITY; NATURAL-HISTORY		[Rotimi, Charles N.] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20851 USA; [Jorde, Lynn B.] Univ Utah, Hlth Sci Ctr, Dept Human Genet, Salt Lake City, UT 84132 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Utah System of Higher Education; University of Utah	Rotimi, CN (corresponding author), NHGRI, Ctr Res Genom & Global Hlth, NIH, 12 South Dr,MSC 5635, Bethesda, MD 20851 USA.	rotimic@mail.nih.gov			Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health; National Science Foundation; National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362] Funding Source: NIH RePORTER	Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported by the Intramural Research Program of the Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health (Dr. Rotimi), and by grants from the National Science Foundation and the National Institutes of Health (to Dr. Jorde).	Abel S, 2008, NEW ENGL J MED, V358, P2515; Adeyemo A, 2010, PUBLIC HEALTH GENOMI, V13, P72, DOI 10.1159/000218711; Amos W, 2010, P R SOC B, V277, P131, DOI 10.1098/rspb.2009.1473; Ayodo G, 2007, AM J HUM GENET, V81, P234, DOI 10.1086/519221; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Bolnick DA, 2007, SCIENCE, V318, P399, DOI 10.1126/science.1150098; Braun L, 2002, PERSPECT BIOL MED, V45, P159, DOI 10.1353/pbm.2002.0023; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; *CEN BUR, 2008, RAC ETHN CLASS US CE; Cheng I, 2008, EUR J HUM GENET, V16, P496, DOI 10.1038/sj.ejhg.5201959; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; *FOOD DRUG ADM, 2008, INF HEALTHC PROF AB; Freedman BI, 2003, J AM SOC NEPHROL, V14, pS192, DOI 10.1097/01.ASN.0000070075.89996.4A; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Halder I, 2009, HUM MUTAT, V30, P1299, DOI 10.1002/humu.21045; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Hughes DA, 2004, PHARMACOGENETICS, V14, P335, DOI 10.1097/00008571-200406000-00002; Ingelman-Sundberg M, 2008, NEW ENGL J MED, V358, P637, DOI 10.1056/NEJMe0708842; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; JALLOW M, 2009, NAT GENET       0524; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Jorde LB, 2004, NAT GENET, V36, pS28, DOI 10.1038/ng1435; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Klag MJ, 1997, JAMA-J AM MED ASSOC, V277, P1293, DOI 10.1001/jama.277.16.1293; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V300, P2715, DOI 10.1001/jama.2008.823; Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632; Lee SSJ, 2009, SCIENCE, V325, P946; Lee SSJ, 2009, SCIENCE, V325, P38, DOI 10.1126/science.1173038; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; LI WH, 1991, GENETICS, V129, P513; Luzzatto L, 2006, HAEMATOLOGICA, V91, P1303; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MENOTTIRAYMOND M, 1993, P NATL ACAD SCI USA, V90, P3172, DOI 10.1073/pnas.90.8.3172; MerryweatherClarke AT, 1997, J MED GENET, V34, P275, DOI 10.1136/jmg.34.4.275; Need AC, 2009, TRENDS GENET, V25, P489, DOI 10.1016/j.tig.2009.09.012; Nolan David, 2003, J HIV Ther, V8, P36; Novembre J, 2008, NATURE, V456, P274, DOI 10.1038/nature07566; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Park WB, 2009, CLIN INFECT DIS, V48, P365, DOI 10.1086/595890; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Phillips E, 2009, MOL DIAGN THER, V13, P1, DOI 10.2165/01250444-200913010-00001; Rao M, 2009, AM J KIDNEY DIS, V53, P579, DOI 10.1053/j.ajkd.2009.02.005; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; *REN DAT SYST, 2007, USRDS 2007 ANN DAT R; Robbins C, 2007, GENOME RES, V17, P1717, DOI 10.1101/gr.6782707; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Royal CD, 2010, AM J HUM GENET, V86, P661, DOI 10.1016/j.ajhg.2010.03.011; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sankar P, 2004, JAMA-J AM MED ASSOC, V291, P2985, DOI 10.1001/jama.291.24.2985; Sankar P, 2002, SCIENCE, V298, P1337, DOI 10.1126/science.1074447; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Scriver CR, 2001, ANNU REV GENOM HUM G, V2, P69, DOI 10.1146/annurev.genom.2.1.69; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Shavers VL, 2002, JNCI-J NATL CANCER I, V94, P334; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; SMEDLEY BD, 2003, UNEQUAL TREATMENTS C; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Watkins WS, 2003, GENOME RES, V13, P1607, DOI 10.1101/gr.894603; Witte JS, 2007, NAT GENET, V39, P579, DOI 10.1038/ng0507-579; Xing JC, 2009, GENOME RES, V19, P815, DOI 10.1101/gr.085589.108; Yngvadottir B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-237; Yu N, 2004, GENETICS, V166, P1375, DOI 10.1534/genetics.166.3.1375; [No title captured]	86	126	131	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2010	363	16					1551	1558		10.1056/NEJMra0911564	http://dx.doi.org/10.1056/NEJMra0911564			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663KP	20942671	Bronze			2022-12-28	WOS:000282887100009
J	Woodcock, J; Sharfstein, JM; Hamburg, M				Woodcock, Janet; Sharfstein, Joshua M.; Hamburg, Margaret			Regulatory Action on Rosiglitazone by the US Food and Drug Administration	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Woodcock, Janet] Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Sharfstein, Joshua M.; Hamburg, Margaret] US FDA, Dept Hlth & Human Serv, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Woodcock, J (corresponding author), Ctr Drug Evaluat & Res, Silver Spring, MD USA.							[Anonymous], GUID IND DIAB MELL E; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; United States Food and Drug Administration (FDA), FDA DRUG SAF COMM ON	6	114	116	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2010	363	16					1489	1491		10.1056/NEJMp1010788	http://dx.doi.org/10.1056/NEJMp1010788			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663KP	20942663				2022-12-28	WOS:000282887100001
J	Bennett-Guerrero, E; Zhao, Y; O'Brien, SM; Ferguson, TB; Peterson, ED; Gammie, JS; Song, HK				Bennett-Guerrero, Elliott; Zhao, Yue; O'Brien, Sean M.; Ferguson, T. B., Jr.; Peterson, Eric D.; Gammie, James S.; Song, Howard K.			Variation in Use of Blood Transfusion in Coronary Artery Bypass Graft Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-THORACIC-SURGEONS; LONG-TERM SURVIVAL; CARDIAC-SURGERY; CELL TRANSFUSION; CABG SURGERY; CONSERVATION; VARIABILITY; MORTALITY; SOCIETY; OPERATIONS	Context Perioperative blood transfusions are costly and have safety concerns. As a result, there have been multiple initiatives to reduce transfusion use. However, the degree to which perioperative transfusion rates vary among hospitals is unknown. Objective To assess hospital-level variation in use of allogeneic red blood cell (RBC), fresh-frozen plasma, and platelet transfusions in patients undergoing coronary artery bypass graft (CABG) surgery. Design, Setting, and Patients An observational cohort of 102 470 patients undergoing primary isolated CABG surgery with cardiopulmonary bypass during calendar year 2008 at 798 sites in the United States, contributing data to the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Main Outcome Measures Perioperative (intraoperative and postoperative) transfusion of RBCs, fresh-frozen plasma, and platelets. Results At hospitals performing at least 100 on-pump CABG operations (82 446 cases at 408 sites), the rates of blood transfusion ranged from 7.8% to 92.8% for RBCs, 0% to 97.5% for fresh-frozen plasma, and 0.4% to 90.4% for platelets. Multivariable analysis including data from all 798 sites (102 470 cases) revealed that after adjustment for patient-level risk factors, hospital transfusion rates varied by geographic location (P=.007), academic status (P=.03), and hospital volume (P<.001). However, these 3 hospital characteristics combined only explained 11.1% of the variation in hospital risk-adjusted RBC usage. Case mix explained 20.1% of the variation between hospitals in RBC usage. Conclusion Wide variability occurred in the rates of transfusion of RBCs and other blood products, independent of case mix, among patients undergoing CABG surgery with cardiopulmonary bypass in US hospitals in an adult cardiac surgical database. JAMA. 2010;304(14):1568-1575 www.jama.com	[Bennett-Guerrero, Elliott] Duke Univ, Med Ctr, Duke Clin Res Inst, Div Perioperat Clin Res, Durham, NC 27710 USA; [Zhao, Yue; O'Brien, Sean M.] Duke Univ, Med Ctr, Duke Clin Res Inst, Div Biostat, Durham, NC 27710 USA; [Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Div Cardiol, Durham, NC 27710 USA; [Ferguson, T. B., Jr.] E Carolina Heart Inst, Dept Cardiovasc Sci, Greenville, NC USA; [Gammie, James S.] Univ Maryland, Med Ctr, Div Cardiac Surg, Baltimore, MD 21201 USA; [Song, Howard K.] Oregon Hlth & Sci Univ, Div Cardiothorac Surg, Portland, OR 97201 USA	Duke University; Duke University; Duke University; University of North Carolina; East Carolina University; University System of Maryland; University of Maryland Baltimore; Oregon Health & Science University	Bennett-Guerrero, E (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, Div Perioperat Clin Res, POB 3094, Durham, NC 27710 USA.	elliott.bennettguerrero@duke.edu	O'Brien, Sean/H-6268-2013; Peterson, Eric David/ABF-5033-2021		National Institutes of Health [R01 HL101382-01]; Society of Thoracic Surgeons (STS) through the National Adult Cardiac Surgery Database and the Duke Clinical Research Institute (DCRI)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society of Thoracic Surgeons (STS) through the National Adult Cardiac Surgery Database and the Duke Clinical Research Institute (DCRI)	Dr Bennett-Guerrero is principal investigator (grant R01 HL101382-01 from the National Institutes of Health) for a multicenter study assessing the impact of blood transfusion on peripheral and cerebral oxygenation and the microcirculation. He is also a named inventor on a patent application related to methods of washing red blood cells. No other authors have any disclosures.; This study was supported by the Society of Thoracic Surgeons (STS) through the National Adult Cardiac Surgery Database and the Duke Clinical Research Institute (DCRI).; This study was sponsored by the STS. Specifically, the DCRI has a contract with the STS to be their National Cardiac Data Warehouse and Analysis Center. In this role, the DCRI independently harvests data from each participating STS center, creates a national analysis database, and performs statistical analyses. The proposal for this study was submitted to and approved of by the STS National Database Publications Committee. After approval, the manuscript was reviewed by the coauthors and a final version was approved by the publications committee. The STS was involved in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; and in the review and approval of the manuscript.	Covin R, 2003, ARCH PATHOL LAB MED, V127, P415; DeAnda A, 2006, AM J MED QUAL, V21, P230, DOI 10.1177/1062860606289784; Edwards FH, 1998, J INVASIVE CARDIOL, V10, P485; Engoren MC, 2002, ANN THORAC SURG, V74, P1180, DOI 10.1016/S0003-4975(02)03766-9; Ferguson TB, 2002, JAMA-J AM MED ASSOC, V287, P2221, DOI 10.1001/jama.287.17.2221; Ferguson TB, 2003, JAMA-J AM MED ASSOC, V290, P49, DOI 10.1001/jama.290.1.49; Ferguson TB, 2000, ANN THORAC SURG, V69, P680, DOI 10.1016/S0003-4975(99)01538-6; Ferraris VA, 2007, ANN THORAC SURG, V83, P27, DOI 10.1016/j.athoracsur.2007.02.099; GOODNOUGH LT, 1991, JAMA-J AM MED ASSOC, V265, P86, DOI 10.1001/jama.265.1.86; Helm RE, 1998, ANN THORAC SURG, V65, P125, DOI 10.1016/S0003-4975(97)01004-7; JACOBS JP, 2008, 46 ANN M SOC THOR SU; Koch CG, 2006, CRIT CARE MED, V34, P1608, DOI 10.1097/01.CCM.0000217920.48559.D8; Koch CG, 2006, ANN THORAC SURG, V81, P1650, DOI 10.1016/j.athoracsur.2005.12.037; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Kuduvalli M, 2005, EUR J CARDIO-THORAC, V27, P592, DOI 10.1016/j.ejcts.2005.01.030; Maddux FW, 2009, AM J MED QUAL, V24, P403, DOI 10.1177/1062860609339384; Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977; Peterson ED, 2004, JAMA-J AM MED ASSOC, V291, P195, DOI 10.1001/jama.291.2.195; Rosengart TK, 1997, J AM COLL SURGEONS, V184, P618; Scott BH, 2008, ANN CARD ANAESTH, V11, P15, DOI 10.4103/0971-9784.38444; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Shander A, 2007, BEST PRAC RES-CL ANA, V21, P271, DOI 10.1016/j.bpa.2007.01.002; Shander A, 2010, TRANSFUSION, V50, P753, DOI 10.1111/j.1537-2995.2009.02518.x; Shibata K, 2002, ANN THORAC SURG, V73, P739, DOI 10.1016/S0003-4975(01)03392-6; Snyder-Ramos SA, 2008, TRANSFUSION, V48, P1284, DOI 10.1111/j.1537-2995.2008.01666.x; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; Stover EP, 1998, ANESTHESIOLOGY, V88, P327, DOI 10.1097/00000542-199802000-00009; Surgenor SD, 2006, CIRCULATION, V114, pI43, DOI 10.1161/CIRCULATIONAHA.105.001271; US Department of Health and Human Services, 2007, 2007 NATIONWIDE BLOO; Van der Linden P, 2001, CAN J ANAESTH, V48, P894, DOI 10.1007/BF03017357; Welke KF, 2004, ANN THORAC SURG, V77, P1137, DOI 10.1016/j.athoracsur.2003.07.030	31	338	348	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1568	1575		10.1001/jama.2010.1406	http://dx.doi.org/10.1001/jama.2010.1406			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940382	Bronze			2022-12-28	WOS:000282816500021
J	Wakefield, MA; Loken, B; Hornik, RC				Wakefield, Melanie A.; Loken, Barbara; Hornik, Robert C.			Use of mass media campaigns to change health behaviour	LANCET			English	Review							PHYSICAL-ACTIVITY INTERVENTION; SEAT-BELT USE; COMMUNICATION CAMPAIGNS; SMOKING-CESSATION; CHILD MALTREATMENT; COMMUNITY; PREVENTION; INCREASE; CANCER; POLICY	Mass media campaigns are widely used to expose high proportions of large populations to messages through routine uses of existing media, such as television, radio, and newspapers. Exposure to such messages is, therefore, generally passive. Such campaigns are frequently competing with factors, such as pervasive product marketing, powerful social norms, and behaviours driven by addiction or habit. In this Review we discuss the outcomes of mass media campaigns in the context of various health-risk behaviours (eg, use of tobacco, alcohol, and other drugs, heart disease risk factors, sex-related behaviours, road safety, cancer screening and prevention, child survival, and organ or blood donation). We conclude that mass media campaigns can produce positive changes or prevent negative changes in health-related behaviours across large populations. We assess what contributes to these outcomes, such as concurrent availability of required services and products, availability of community-based programmes, and policies that support behaviour change. Finally, we propose areas for improvement, such as investment in longer better-funded campaigns to achieve adequate population exposure to media messages.	[Wakefield, Melanie A.] Canc Council Victoria, Ctr Behav Res Canc, Carlton, Vic 3053, Australia; [Loken, Barbara] Univ Minnesota, Carlson Sch Management, Minneappolis, MN USA; [Hornik, Robert C.] Univ Penn, Annenberg Sch Commun, Philadelphia, PA 19104 USA	Cancer Council Victoria; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania	Wakefield, MA (corresponding author), Canc Council Victoria, Ctr Behav Res Canc, 1 Rathdowne St, Carlton, Vic 3053, Australia.	melanie.wakefield@cancervic.org.au	Wakefield, Melanie/E-5019-2012	Hornik, Robert/0000-0002-2148-8805; Wakefield, Melanie/0000-0002-6183-5699	Australian National Health and Medical Research Council; US National Cancer Institute [P20-CA095856-06]; NATIONAL CANCER INSTITUTE [P20CA095856] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MAW is supported by an Australian National Health and Medical Research Council Principal Research Fellowship. RCH is supported by a grant from the US National Cancer Institute P20-CA095856-06. We thank Susan Mello and Judith Stanke for assistance in literature searches.	Abroms LC, 2008, ANNU REV PUBL HEALTH, V29, P219, DOI 10.1146/annurev.publhealth.29.020907.090824; Adams V, 2009, SOC SCI MED, V68, P410, DOI 10.1016/j.socscimed.2008.11.006; Allain JP, 2008, TRANSFUSION, V48, P735, DOI 10.1111/j.1537-2995.2007.01599.x; Anderson JO, 2009, HEALTH EDUC RES, V24, P867, DOI 10.1093/her/cyp023; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Atienza AA, 2002, EPIDEMIOL REV, V24, P72, DOI 10.1093/epirev/24.1.72; Babor TF, 2003, ALCOHOL NO ORDINARY; Bala M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004704.pub2; Baron RC, 2008, AM J PREV MED, V35, pS34, DOI 10.1016/j.amepre.2008.04.002; Bertrand JT, 2006, HEALTH EDUC RES, V21, P567, DOI 10.1093/her/cyl036; Black ME, 2002, CAN J PUBLIC HEALTH, V93, P386, DOI 10.1007/BF03404575; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Block LG, 2002, AM J PUBLIC HEALTH, V92, P1346, DOI 10.2105/AJPH.92.8.1346; Bricker JB, 2003, ADDICTION, V98, P585, DOI 10.1046/j.1360-0443.2003.00343.x; Brownson RC, 2006, ANNU REV PUBL HEALTH, V27, P341, DOI 10.1146/annurev.publhealth.27.021405.102137; Cavill N, 2004, J SPORT SCI, V22, P771, DOI 10.1080/02640410410001712467; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Cleland J, 2006, LANCET, V368, P1788, DOI 10.1016/S0140-6736(06)69738-9; DEJONG W, 1992, MILBANK Q, V70, P661, DOI 10.2307/3350215; Dinh-Zarr TB, 2001, AM J PREV MED, V21, P48, DOI 10.1016/S0749-3797(01)00378-6; Ditter SM, 2005, AM J PREV MED, V28, P280, DOI 10.1016/j.amepre.2005.02.013; Dobbinson SJ, 2008, AM J PREV MED, V34, P94, DOI 10.1016/j.amepre.2007.09.024; Dodge KA, 2008, AM PSYCHOL, V63, P573, DOI 10.1037/0003-066X.63.7.573; Durkin SJ, 2009, AM J PUBLIC HEALTH, V99, P2217, DOI 10.2105/AJPH.2009.161638; Economos CD, 2007, OBESITY, V15, P1325, DOI 10.1038/oby.2007.155; Elder RW, 2004, AM J PREV MED, V27, P57, DOI 10.1016/j.amepre.2004.03.002; Elwood J.M., 2009, CUTANEOUS MELANOMA, P107; Emery SL, 2007, AM J PREV MED, V33, pS257, DOI 10.1016/j.amepre.2007.07.003; Erceg-Hurn D, 2008, PREV SCI, V9, P256, DOI 10.1007/s11121-008-0098-5; FARQUHAR JW, 1978, AM J EPIDEMIOL, V108, P103, DOI 10.1093/oxfordjournals.aje.a112593; Farrelly MC, 2009, AM J PREV MED, V36, P379, DOI 10.1016/j.amepre.2009.01.019; Farrelly MC, 2002, AM J PUBLIC HEALTH, V92, P901, DOI 10.2105/AJPH.92.6.901; Finlay SJ, 2005, PREV MED, V40, P121, DOI 10.1016/j.ypmed.2004.04.018; Finn JC, 2007, MED J AUSTRALIA, V187, P293, DOI 10.5694/j.1326-5377.2007.tb01247.x; Fishbein M., 2010, PREDICTING CHANGING, DOI 10.4324/9780203838020; FORTMANN SP, 1986, AM J EPIDEMIOL, V123, P656, DOI 10.1093/oxfordjournals.aje.a114285; French SA, 2001, ANNU REV PUBL HEALTH, V22, P309, DOI 10.1146/annurev.publhealth.22.1.309; Frieden TR, 2007, LANCET, V369, P1758, DOI 10.1016/S0140-6736(07)60782-X; Hauck FR, 2008, PEDIATRICS, V122, P660, DOI 10.1542/peds.2007-0135; Hill D, 2008, ARCH DERMATOL, V144, P538, DOI 10.1001/archderm.144.4.538; Hornik R, 2003, COMMUN THEOR, V13, P204, DOI 10.1111/j.1468-2885.2003.tb00289.x; Hornik R, 2001, DIFFUSION PROCESSES AND FERTILITY TRANSITION: SELECTED PERSPECTIVES, P208; Hornik R.C., 2002, PUBLIC HLTH COMMUNIC; Hornik RC, 2002, LEA COMMUN SER, P219; Hornik R, 2008, AM J PUBLIC HEALTH, V98, P2229, DOI 10.2105/AJPH.2007.125849; Huhman ME, 2007, AM J PREV MED, V32, P38, DOI 10.1016/j.amepre.2006.08.030; Hutchinson P, 2006, J HEALTH COMMUN, V11, P91, DOI 10.1080/10810730600974647; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; Kotler P, 2008, SOCIAL MARKETING INF; Kotler P., 2009, PRINCIPLES MARKETING, V5th; Longshore D, 2006, ADDICT BEHAV, V31, P496, DOI 10.1016/j.addbeh.2005.05.032; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Marcus AC, 1998, PREV MED, V27, P13, DOI 10.1006/pmed.1997.0251; Marcus BH, 2006, CIRCULATION, V114, P2739, DOI 10.1161/CIRCULATIONAHA.106.179683; Matson-Koffman DM, 2005, AM J HEALTH PROMOT, V19, P167, DOI 10.4278/0890-1171-19.3.167; MCDIVITT JA, 1993, STUD FAMILY PLANN, V24, P295, DOI 10.2307/2939223; Mikton C, 2009, B WORLD HEALTH ORGAN, V87, P353, DOI 10.2471/BLT.08.057075; Moreira T., 2009, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858.CD006748.pub2, DOI 10.1002/14651858, 10.1002/14651858]; Morgan SE, 2009, COMMUN THEOR, V19, P29, DOI 10.1111/j.1468-2885.2008.01331.x; Morrison DS, 2003, J EPIDEMIOL COMMUN H, V57, P327, DOI 10.1136/jech.57.5.327; Mullins R, 2008, HEALTH EDUC RES, V23, P477, DOI 10.1093/her/cym021; Myhre SL, 2000, J HEALTH COMMUN, V5, P29, DOI 10.1080/10810730050019546; National Cancer Institute, 2008, TOB CONTR MON, V19; Niederdeppe J, 2008, TOB CONTROL, V17, P205, DOI 10.1136/tc.2007.024331; Niederdeppe J, 2008, SOC SCI MED, V67, P1343, DOI 10.1016/j.socscimed.2008.06.037; Noar SM, 2009, J HEALTH COMMUN, V14, P15, DOI 10.1080/10810730802592239; Noar SM, 2006, J HEALTH COMMUN, V11, P21, DOI 10.1080/10810730500461059; Norman GJ, 2007, AM J PREV MED, V33, P336, DOI 10.1016/j.amepre.2007.05.007; Orwin R., 2006, EVALUATION NATL YOUT; Palmgreen P, 2007, AM J PUBLIC HEALTH, V97, P1644, DOI 10.2105/AJPH.2005.072843; Pasick RJ, 2004, CANCER-AM CANCER SOC, V101, P1146, DOI 10.1002/cncr.20508; Pechmann C, 2006, AM J PUBLIC HEALTH, V96, P906, DOI 10.2105/AJPH.2004.057273; Pegurri E, 2005, VACCINE, V23, P1624, DOI 10.1016/j.vaccine.2004.02.029; Piotrow P. T., 1997, HLTH COMMUNICATION L; Pomerleau J, 2005, J NUTR, V135, P2486, DOI 10.1093/jn/135.10.2486; Potter SJ, 2009, VIOLENCE AGAINST WOM, V15, P106, DOI 10.1177/1077801208327482; Prinz RJ, 2009, PREV SCI, V10, P1, DOI 10.1007/s11121-009-0123-3; Randolph W, 2004, ANNU REV PUBL HEALTH, V25, P419, DOI 10.1146/annurev.publhealth.25.101802.123046; Reger B, 2000, AM J PREV MED, V18, P271, DOI 10.1016/S0749-3797(00)00118-5; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Roccella EJ, 2002, LEA COMMUN SER, P73; Salzberg PM, 2004, J SAFETY RES, V35, P215, DOI 10.1016/j.jsr.2004.03.008; Sanigorski AM, 2008, INT J OBESITY, V32, P1060, DOI 10.1038/ijo.2008.79; Saraiya M, 2004, AM J PREV MED, V27, P422, DOI 10.1016/j.amepre.2004.08.009; Slapak Maurice, 2004, Ann Transplant, V9, P46; Sly DF, 2005, PREV MED, V41, P503, DOI 10.1016/j.ypmed.2004.11.027; Smith CA, 2006, COGNITION EMOTION, V20, P1, DOI 10.1080/02699930500465950; Snyder LB, 2004, J HEALTH COMMUN, V9, P71, DOI 10.1080/10810730490271548; SOUMERAI SB, 1992, MILBANK Q, V70, P155, DOI 10.2307/3350088; Spoth R, 2008, PEDIATRICS, V121, pS311, DOI 10.1542/peds.2007-2243E; Swaim RC, 2008, PREV SCI, V9, P202, DOI 10.1007/s11121-008-0096-7; Thompson ME, 2009, HEALTH POLICY PLANN, V24, P101, DOI 10.1093/heapol/czn048; Waisbord S.L., 2005, WHY INVEST COMMUNICA; Wakefield M, 2006, AM J PUBLIC HEALTH, V96, P2154, DOI 10.2105/AJPH.2005.083352; Wakefield MA, 2008, AM J PUBLIC HEALTH, V98, P1443, DOI 10.2105/AJPH.2007.128991; Wallack L, 1996, HEALTH EDUC QUART, V23, P293, DOI 10.1177/109019819602300303; Wellings K, 2002, LEA COMMUN SER, P131; Williams AF, 1996, J SAFETY RES, V27, P33, DOI 10.1016/0022-4375(95)00027-5; Williams DM, 2008, MED SCI SPORT EXER, V40, pS567, DOI 10.1249/MSS.0b013e31817c7006; WILMOTH TA, 1995, SOC SCI MED, V41, P579, DOI 10.1016/0277-9536(94)00363-X; ZIMICKI S, 1994, B WORLD HEALTH ORGAN, V72, P409	104	1252	1262	26	613	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 9	2010	376	9748					1261	1271		10.1016/S0140-6736(10)60809-4	http://dx.doi.org/10.1016/S0140-6736(10)60809-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	664ZT	20933263	Green Published, Green Accepted			2022-12-28	WOS:000283003500036
J	Musacchio, A				Musacchio, Andrea			Surfing Chromosomes (and Survivin)	SCIENCE			English	Editorial Material							INNER CENTROMERE; BI-ORIENTATION; AURORA; KINETOCHORES; SHUGOSHIN; BUB1		European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy	IRCCS European Institute of Oncology (IEO)	Musacchio, A (corresponding author), European Inst Oncol, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy.	andrea.musacchio@ifom-ieo-campus.it		Musacchio, Andrea/0000-0003-2362-8784				Boyarchuk Y, 2007, J CELL BIOL, V176, P919, DOI 10.1083/jcb.200609044; Carmena M, 2009, CURR OPIN CELL BIOL, V21, P796, DOI 10.1016/j.ceb.2009.09.008; Huang HM, 2007, J CELL BIOL, V177, P413, DOI 10.1083/jcb.200701122; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Maresca TJ, 2010, J CELL SCI, V123, P825, DOI 10.1242/jcs.064790; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tsukahara T, 2010, NATURE, V467, P719, DOI 10.1038/nature09390; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498	15	8	8	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					183	184		10.1126/science.1197261	http://dx.doi.org/10.1126/science.1197261			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929762				2022-12-28	WOS:000282644600026
J	Gray, CM; Loubser, S; Kriel, C; Mercer, M; Brookes, H				Gray, Clive M.; Loubser, Shayne; Kriel, Carina; Mercer, Monica; Brookes, Heather			Immunology for Clinicians: A "Trojan Horse" Approach	SCIENCE			English	Editorial Material									[Gray, Clive M.; Loubser, Shayne; Kriel, Carina; Mercer, Monica] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Brookes, Heather] Univ Johannesburg, Johannesburg, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Johannesburg	Gray, CM (corresponding author), Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa.	cgray@nicd.ac.za		Gray, Clive/0000-0002-9293-901X				Abdool Karim S. S., 2010, HIV AIDS S AFRICA; Davis C., TEACHING MAT USING C; Debard N, 2005, NAT REV IMMUNOL, V5, P736, DOI 10.1038/nri1687; Kreber C., 2001, TEACH HIGH EDUC, V6, P217, DOI DOI 10.1080/13562510120045203; Maguire L., 2009, J SCHOLARSHIP LEARN, V9, P93; UNAIDS, 2009, 2009 AIDS EP UPD	6	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1613	1614		10.1126/science.1186963	http://dx.doi.org/10.1126/science.1186963			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	653NK	20929838				2022-12-28	WOS:000282098100030
J	Peters, SP; Kunselman, SJ; Icitovic, N; Moore, WC; Pascual, R; Ameredes, BT; Boushey, HA; Calhoun, WJ; Castro, M; Cherniack, RM; Craig, T; Denlinger, L; Engle, LL; DiMango, EA; Fahy, JV; Israel, E; Jarjour, N; Kazani, SD; Kraft, M; Lazarus, SC; Lemanske, RF; Lugogo, N; Martin, RJ; Meyers, DA; Ramsdell, J; Sorkness, CA; Sutherland, ER; Szefler, SJ; Wasserman, SI; Walter, MJ; Wechsler, ME; Chinchilli, VM; Bleecker, ER				Peters, Stephen P.; Kunselman, Susan J.; Icitovic, Nikolina; Moore, Wendy C.; Pascual, Rodolfo; Ameredes, Bill T.; Boushey, Homer A.; Calhoun, William J.; Castro, Mario; Cherniack, Reuben M.; Craig, Timothy; Denlinger, Loren; Engle, Linda L.; DiMango, Emily A.; Fahy, John V.; Israel, Elliot; Jarjour, Nizar; Kazani, Shamsah D.; Kraft, Monica; Lazarus, Stephen C.; Lemanske, Robert F., Jr.; Lugogo, Njira; Martin, Richard J.; Meyers, Deborah A.; Ramsdell, Joe; Sorkness, Christine A.; Sutherland, E. Rand; Szefler, Stanley J.; Wasserman, Stephen I.; Walter, Michael J.; Wechsler, Michael E.; Chinchilli, Vernon M.; Bleecker, Eugene R.		Natl Heart Lung Blood Inst	Tiotropium Bromide Step-Up Therapy for Adults with Uncontrolled Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED TRIAL; INHALED CORTICOSTEROIDS; PERSISTENT ASTHMA; CHILDHOOD ASTHMA; QUESTIONNAIRE; EXACERBATIONS; FLUTICASONE; MONTELUKAST; VALIDATION; SALMETEROL	BACKGROUND Long-acting beta-agonist (LABA) therapy improves symptoms in patients whose asthma is poorly controlled by an inhaled glucocorticoid alone. Alternative treatments for adults with uncontrolled asthma are needed. METHODS In a three-way, double-blind, triple-dummy crossover trial involving 210 patients with asthma, we evaluated the addition of tiotropium bromide (a long-acting anticholinergic agent approved for the treatment of chronic obstructive pulmonary disease but not asthma) to an inhaled glucocorticoid, as compared with a doubling of the dose of the inhaled glucocorticoid (primary superiority comparison) or the addition of the LABA salmeterol (secondary noninferiority comparison). RESULTS The use of tiotropium resulted in a superior primary outcome, as compared with a doubling of the dose of an inhaled glucocorticoid, as assessed by measuring the morning peak expiratory flow (PEF), with a mean difference of 25.8 liters per minute (P<0.001) and superiority in most secondary outcomes, including evening PEF, with a difference of 35.3 liters per minute (P<0.001); the proportion of asthma-control days, with a difference of 0.079 (P = 0.01); the forced expiratory volume in 1 second (FEV(1)) before bronchodilation, with a difference of 0.10 liters (P = 0.004); and daily symptom scores, with a difference of -0.11 points (P<0.001). The addition of tiotropium was also noninferior to the addition of salmeterol for all assessed outcomes and increased the prebronchodilator FEV(1) more than did salmeterol, with a difference of 0.11 liters (P = 0.003). CONCLUSIONS When added to an inhaled glucocorticoid, tiotropium improved symptoms and lung function in patients with inadequately controlled asthma. Its effects appeared to be equivalent to those with the addition of salmeterol.	[Peters, Stephen P.] Wake Forest Univ Hlth Sci, Ctr Genom & Personalized Med Res, Winston Salem, NC 27157 USA; [Kraft, Monica; Lugogo, Njira] Duke Univ, Durham, NC USA; [Kunselman, Susan J.; Icitovic, Nikolina; Craig, Timothy; Engle, Linda L.; Chinchilli, Vernon M.] Penn State Univ, Hershey, PA USA; [Ameredes, Bill T.; Calhoun, William J.] Univ Texas Med Branch Galveston, Galveston, TX USA; [Boushey, Homer A.; Fahy, John V.; Lazarus, Stephen C.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Castro, Mario; Walter, Michael J.] Washington Univ, St Louis, MO USA; [Cherniack, Reuben M.; Martin, Richard J.; Sutherland, E. Rand; Szefler, Stanley J.] Natl Jewish Hlth, Denver, CO USA; [Denlinger, Loren; Jarjour, Nizar; Lemanske, Robert F., Jr.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Sorkness, Christine A.] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; [DiMango, Emily A.] Columbia Univ, Med Ctr, New York, NY USA; [Israel, Elliot; Kazani, Shamsah D.; Wechsler, Michael E.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Israel, Elliot; Kazani, Shamsah D.; Wechsler, Michael E.] Harvard Univ, Sch Med, Boston, MA USA; [Ramsdell, Joe; Wasserman, Stephen I.] Univ Calif San Diego, San Diego, CA 92103 USA	Wake Forest University; Wake Forest University School of Medicine; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California San Francisco; Washington University (WUSTL); National Jewish Health; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Columbia University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Diego	Peters, SP (corresponding author), Wake Forest Univ Hlth Sci, Ctr Genom & Personalized Med Res, Med Ctr Blvd, Winston Salem, NC 27157 USA.	sppeters@wfubmc.edu	Wechsler, Michael/B-3979-2013; Wechsler, Michael/AAC-5506-2019	Wechsler, Michael/0000-0003-3505-2946; Szefler, Stanley/0000-0002-6911-3199; Calhoun, William/0000-0001-7075-712X	National Heart, Lung, and Blood Institute [U10 HL074225, U10 HL074227, U10 HL074231, U10 HL074204, U10 HL074212, U10 HL074073, U10 HL074206, U10 HL074208, U10 HL074218]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL074206, U10HL074218, U10HL074212, U10HL074204, U10HL074227, U10HL074208, U10HL074073, U10HL074231, U10HL074225] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Heart, Lung, and Blood Institute (U10 HL074225, U10 HL074227, U10 HL074231, U10 HL074204, U10 HL074212, U10 HL074073, U10 HL074206, U10 HL074208, and U10 HL074218).	Barnes PJ, 2000, CHEST, V117, P63; Barnes PJ, 2001, EXPERT OPIN INV DRUG, V10, P733, DOI 10.1517/13543784.10.4.733; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Drazen JM, 2009, NEW ENGL J MED, V360, P1671, DOI 10.1056/NEJMe0902057; Food and Drug Administration, 2010, GUID IND NON CLIN TR; *FOOD DRUG ADM, LONG ACT BET AG LABA; Gibson PG, 2007, J ALLERGY CLIN IMMUN, V119, P344, DOI 10.1016/j.jaci.2006.10.043; GREENSTONE IR, 2005, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858; JENNRICH RI, 1986, BIOMETRICS, V42, P805, DOI 10.2307/2530695; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; Lemanske RF, 2001, JAMA-J AM MED ASSOC, V285, P2594, DOI 10.1001/jama.285.20.2594; Lemanske RF, 2010, NEW ENGL J MED, V362, P975, DOI 10.1056/NEJMoa1001278; National Asthma Education and Prevention Program National Heart Lung and Blood Institute, 2007, NIH PUBL; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Pauwels RA, 1998, NEW ENGL J MED, V338, P139; Powell H., 2004, COCHRANE DB SYST REV, V2; Revicki DA, 1998, CHEST, V114, P998, DOI 10.1378/chest.114.4.998; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; Vonesh E.F., 1997, LINEAR NONLINEAR MOD; VONMUTIU, 2010, NEW ENGL J MED, V362, P1042; Wechsler ME, 2009, LANCET, V374, P1754, DOI 10.1016/S0140-6736(09)61492-6; Westby M., 2004, COCHRANE DB SYST REV, V3; Woolcock A, 1996, AM J RESP CRIT CARE, V153, P1481, DOI 10.1164/ajrccm.153.5.8630590; Zeiger RS, 2006, J ALLERGY CLIN IMMUN, V117, P45, DOI 10.1016/j.jaci.2005.10.012	28	386	416	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 28	2010	363	18					1715	1726		10.1056/NEJMoa1008770	http://dx.doi.org/10.1056/NEJMoa1008770			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671XF	20979471	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000283546400006
J	Guo, Z; Kozlov, S; Lavin, MF; Person, MD; Paull, TT				Guo, Zhi; Kozlov, Sergei; Lavin, Martin F.; Person, Maria D.; Paull, Tanya T.			ATM Activation by Oxidative Stress	SCIENCE			English	Article							TELANGIECTASIA GENE-PRODUCT; ATAXIA-TELANGIECTASIA; DNA-DAMAGE; DEFICIENT MICE; PROTEIN; PHOSPHORYLATION; PURIFICATION; CELLS; ANTIOXIDANTS; MANGANESE	The ataxia-telangiectasia mutated (ATM) protein kinase is activated by DNA double-strand breaks (DSBs) through the Mre11-Rad50-Nbs1 (MRN) DNA repair complex and orchestrates signaling cascades that initiate the DNA damage response. Cells lacking ATM are also hypersensitive to insults other than DSBs, particularly oxidative stress. We show that oxidation of ATM directly induces ATM activation in the absence of DNA DSBs and the MRN complex. The oxidized form of ATM is a disulfide-cross-linked dimer, and mutation of a critical cysteine residue involved in disulfide bond formation specifically blocked activation through the oxidation pathway. Identification of this pathway explains observations of ATM activation under conditions of oxidative stress and shows that ATM is an important sensor of reactive oxygen species in human cells.	[Guo, Zhi; Paull, Tanya T.] Univ Texas Austin, Dept Mol Genet & Microbiol, Howard Hughes Med Inst, Austin, TX 78712 USA; [Guo, Zhi; Paull, Tanya T.] Univ Texas Austin, ICMB, Austin, TX 78712 USA; [Kozlov, Sergei; Lavin, Martin F.] Univ Queensland, Queensland Inst Med Res, Radiat Biol & Oncol Lab, Brisbane, Qld 4006, Australia; [Kozlov, Sergei; Lavin, Martin F.] Univ Queensland, Sch Med, Brisbane, Qld 4006, Australia; [Person, Maria D.] Univ Texas Austin, Coll Pharm, ICMB Analyt Instrumentat Facil Core, Austin, TX 78712 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; University of Texas System; University of Texas Austin	Paull, TT (corresponding author), Univ Texas Austin, Dept Mol Genet & Microbiol, Howard Hughes Med Inst, Austin, TX 78712 USA.	tpaull@mail.utexas.edu	Guo, Zhi/A-4589-2013; Kozlov, Sergei/T-9779-2019; Kozlov, Sergei/M-2067-2014; Lavin, Martin F/F-5961-2014	Kozlov, Sergei/0000-0001-6183-7339; Lavin, Martin F/0000-0002-5940-4769; Paull, Tanya/0000-0002-2991-651X	NIH [CA132813]; NHMRC [569591]; NIEHS [007784]; NATIONAL CANCER INSTITUTE [R01CA132813] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to members of the Paull laboratory as well as to M. Weitzman for cell lines; to D. Johnson, G. Georgiou, J. Huibregtse, and K. Dalby for discussion; and to C. Walker for communication of data in press. This work was supported by NIH grant CA132813 (Paull laboratory), NHMRC 569591 (Lavin laboratory), and NIEHS 007784 (ICMB mass spectrometry core facility).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Bencokova Z, 2009, MOL CELL BIOL, V29, P526, DOI 10.1128/MCB.01301-08; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chan DW, 2000, J BIOL CHEM, V275, P7803, DOI 10.1074/jbc.275.11.7803; CHESSA L, 1992, AM J MED GENET, V42, P741, DOI 10.1002/ajmg.1320420524; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Gilad S, 1998, AM J HUM GENET, V62, P551, DOI 10.1086/301755; HaMai D, 2004, NEUROCHEM INT, V44, P223, DOI 10.1016/S0197-0186(03)00152-9; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kim DY, 2007, J NEUROCHEM, V101, P1316, DOI 10.1111/j.1471-4159.2007.04483.x; Kobayashi M, 2006, GENES CELLS, V11, P779, DOI 10.1111/j.1365-2443.2006.00976.x; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Lee JH, 2006, METHOD ENZYMOL, V408, P529, DOI 10.1016/S0076-6879(06)08033-5; Lee SM, 2005, J SHELLFISH RES, V24, P99; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Reliene R, 2008, FOOD CHEM TOXICOL, V46, P1371, DOI 10.1016/j.fct.2007.08.028; Reliene R, 2007, J NUTR, V137, p229S, DOI 10.1093/jn/137.1.229S; Sasaki M, 2008, FREE RADICAL RES, V42, P625, DOI 10.1080/10715760802244768; Shackelford RE, 2001, J BIOL CHEM, V276, P21951, DOI 10.1074/jbc.M011303200; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Smith GCM, 1999, P NATL ACAD SCI USA, V96, P11134, DOI 10.1073/pnas.96.20.11134; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Toyoshima M, 1998, AM J MED GENET, V75, P141, DOI 10.1002/(SICI)1096-8628(19980113)75:2<141::AID-AJMG4>3.0.CO;2-W; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; VOS O, 1976, INT J RADIAT BIOL, V29, P513, DOI 10.1080/09553007614550611; Watters D, 1999, J BIOL CHEM, V274, P34277, DOI 10.1074/jbc.274.48.34277	31	770	788	1	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					517	521		10.1126/science.1192912	http://dx.doi.org/10.1126/science.1192912			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966255	Green Submitted			2022-12-28	WOS:000283329100044
J	O'Donnell, MR; Jarand, J; Loveday, M; Padayatchi, N; Zelnick, J; Werner, L; Naidoo, K; Master, I; Osburn, G; Kvasnovsky, C; Shean, K; Pai, M; Van der Walt, M; Horsburgh, CR; Dheda, K				O'Donnell, Max R.; Jarand, Julie; Loveday, Marian; Padayatchi, Nesri; Zelnick, Jennifer; Werner, Lise; Naidoo, Kasavan; Master, Iqbal; Osburn, Garth; Kvasnovsky, Charlotte; Shean, Karen; Pai, Madhukar; Van der Walt, Martie; Horsburgh, Charles R.; Dheda, Keertan			High Incidence of Hospital Admissions With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Among South African Health Care Workers	ANNALS OF INTERNAL MEDICINE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; NOSOCOMIAL TRANSMISSION; RISK; HIV; INFECTION; TB	Background: Nosocomial transmission has been described in extensively drug-resistant tuberculosis (XDR-TB) and HIV co-infected patients in South Africa. However, little is known about the rates of drug-resistant tuberculosis among health care workers in countries with high tuberculosis and HIV burden. Objective: To estimate rates of multidrug-resistant tuberculosis (MDR-TB) and XDR-TB hospitalizations among health care workers in KwaZulu-Natal, South Africa. Design: Retrospective study of patients with drug-resistant tuberculosis who were admitted from 2003 to 2008 for the initiation of drug-resistant tuberculosis therapy. Setting: A public tuberculosis referral hospital in KwaZulu-Natal, South Africa. Participants: 231 health care workers and 4151 non-health care workers admitted for initiation of MDR-TB or XDR-TB treatment. Measurements: Hospital admission rates and hospital admission incidence rate ratios. Results: Estimated incidence of MDR-TB hospitalization was 64.8 per 100 000 health care workers versus 11.9 per 100 000 non-health care workers (incidence rate ratio, 5.46 [95% CI, 4.75 to 6.28]). Estimated incidence of XDR-TB hospitalizations was 7.2 per 100 000 health care workers versus 1.1 per 100 000 non-health care workers (incidence rate ratio, 6.69 [CI, 4.38 to 10.20]). A higher percentage of health care workers than non-health care workers with MDR-TB or XDR-TB were women (78% vs. 47%; P < 0.001), and health care workers were less likely to report previous tuberculosis treatment (41% vs. 92%; P < 0.001). HIV infection did not differ between health care workers and nonhealth care workers (55% vs. 57%); however, among HIV-infected patients, a higher percentage of health care workers were receiving antiretroviral medications (63% vs. 47%; P < 0.001). Limitation: The study had an observational retrospective design, is subject to referral bias, and had no information on type of health care work or duration of occupational exposure to tuberculosis. Conclusion: Health care workers in this HIV-endemic area were substantially more likely to be hospitalized with either MDR-TB or XDR-TB than were non-health care workers. The increased risk may be explained by occupational exposure, underlining the urgent need for tuberculosis infection-control programs.	Boston Univ, Sch Med, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Boston, MA USA; Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, Durban, South Africa; Univ Calgary, Calgary, AB, Canada; MRC, Cape Town, South Africa; Salem State Coll, Sch Social Work, Salem, MA 01970 USA; King George V Mem Hosp, Sydenham, South Africa; Emory Univ, Sch Med, Atlanta, GA USA; Rollins Sch Publ Hlth, Atlanta, GA USA; UCL, London, England; McGill Univ, Montreal, PQ, Canada	Boston University; Boston University; University of Kwazulu Natal; University of Calgary; Massachusetts System of Public Higher Education; Salem State University; Emory University; Emory University; Rollins School Public Health; University of London; University College London; McGill University	O'Donnell, MR (corresponding author), Albert Einstein Coll Med, Div Pulm Med, 1301 Morris Pk Ave, Bronx, NY 10461 USA.	max.odonnell@einstein.yu.edu	padayatchi, nesri/Q-2780-2019; van der Walt, Martie/CAH-0101-2022; PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021; Mitchell, Ellen/H-5475-2013; Loveday, Marian/M-8016-2013	padayatchi, nesri/0000-0003-2543-9071; van der Walt, Martie/0000-0001-9987-3167; PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Loveday, Marian/0000-0001-9205-9314; Horsburgh, C./0000-0001-6838-7895; Naidoo, Kogieleum/0000-0002-8874-6661	National Institutes of Health, National Institutes of Allergy and Infectious Diseases [T32 AI52074]; American Thoracic Society; Centre for AIDS Programme of Research; National Institutes of Health; U.S. Department of Health and Human Services the Centre for AIDS Programme of Research [A1069469]; Fogarty International Center, National Institutes of Health [D43TW00231]; Canadian Institutes of Health Research; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052074, U01AI069469] Funding Source: NIH RePORTER	National Institutes of Health, National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Thoracic Society; Centre for AIDS Programme of Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Health and Human Services the Centre for AIDS Programme of Research; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. O'Donnell was supported by the National Institutes of Health (T32 AI52074; National Institutes of Allergy and Infectious Diseases) and an American Thoracic Society Career Development Award. In addition, Drs. O'Donnell and Padayatchi were supported by the Centre for AIDS Programme of Research. The National Institutes of Health and the U.S. Department of Health and Human Services funds the Centre for AIDS Programme of Research (A1069469). Dr. Padayatchi was also supported by Columbia University-Southern African Fogarty AIDS International Training and Research Programme funded by the Fogarty International Center, National Institutes of Health (D43TW00231). Dr. Pai is supported by a New Investigator Award from the Canadian Institutes of Health Research. These funding sources played no role in the study design or data analysis.	Askew GL, 1997, PEDIATRICS, V100, P19, DOI 10.1542/peds.100.1.19; Basu S, 2008, EPIDEMIOL INFECT, V136, P1585, DOI 10.1017/S0950268808000964; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; BUTHELEZI S, 2008, 2 GLOB XDR TB TASK F; *CDCP, 2006, MMWR-MORBID MORTAL W, V55, P1176; CLEVELAND JL, 1995, INFECT CONT HOSP EP, V16, P7; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Dimitrova B, 2005, INT J TUBERC LUNG D, V9, P43; DOOLEY SW, 1992, JAMA-J AM MED ASSOC, V267, P2632, DOI 10.1001/jama.267.19.2632; Galgalo T, 2008, INT J TUBERC LUNG D, V12, P949; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; GANDHI NR, 2006, JAMA-J AM MED ASSOC, V296, P2927; GANDHI NR, 2008, J CLIN EPIDEMIOL, V61, P344; *HLTH SYST TRUST, 2007, S AFR HLTH REV; James P, 2009, INT J TUBERC LUNG D, V13, P795; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Karim QA, 2002, INT J EPIDEMIOL, V31, P37, DOI 10.1093/ije/31.1.37; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Naidoo S, 2006, INT J TUBERC LUNG D, V10, P676; O'Donnell MR, 2009, INT J TUBERC LUNG D, V13, P855; PEARSON ML, 1992, ANN INTERN MED, V117, P191, DOI 10.7326/0003-4819-117-3-191; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; REISNER BS, 1995, DIAGN MICR INFEC DIS, V22, P325, DOI 10.1016/0732-8893(95)00147-7; Rusch-Gerdes S, 2006, J CLIN MICROBIOL, V44, P688, DOI 10.1128/JCM.44.3.688-692.2006; Sotgiu G, 2008, INT J TUBERC LUNG D, V12, P606; *STAT S AFR, 2007, S AFR COMM SURV; *STAT S AFR, 2001, S AFR NAT POP CENS; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2008, GLOB TUB CONTR SURV; Zelnick J, 2005, J PUBLIC HEALTH POL, V26, P163, DOI 10.1057/palgrave.jphp.3200021	33	146	151	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8					516	522		10.7326/0003-4819-153-8-201010190-00008	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956708	Green Accepted			2022-12-28	WOS:000283054600004
J	Edery, I				Edery, Isaac			Temperatures to Communicate By	SCIENCE			English	Editorial Material							TRANSCRIPTION FACTOR; PERIPHERAL CLOCKS; CIRCADIAN CLOCKS; ENTRAINMENT; RHYTHMS		Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Edery, I (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.	edery@cabm.rutgers.edu						Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Busza A, 2007, J NEUROSCI, V27, P10722, DOI 10.1523/JNEUROSCI.2479-07.2007; Dardente H, 2007, CHRONOBIOL INT, V24, P195, DOI 10.1080/07420520701283693; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Rensing L, 2002, CHRONOBIOL INT, V19, P807, DOI 10.1081/CBI-120014569; RENSING L, 1987, CHRONOBIOL INT, V4, P543, DOI 10.3109/07420528709078546; Sandstrom ME, 2009, AMINO ACIDS, V37, P279, DOI 10.1007/s00726-008-0144-4; Sehadova H, 2009, NEURON, V64, P251, DOI 10.1016/j.neuron.2009.08.026; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919	13	7	7	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2010	330	6002					329	330		10.1126/science.1197747	http://dx.doi.org/10.1126/science.1197747			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947752				2022-12-28	WOS:000282986700026
J	Neumann, PJ; Weinstein, MC				Neumann, Peter J.; Weinstein, Milton C.			Legislating against Use of Cost-Effectiveness Information	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH		[Neumann, Peter J.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Evaluat Value & Risk Hlth, Boston, MA USA; [Weinstein, Milton C.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Tufts Medical Center; Harvard University; Harvard T.H. Chan School of Public Health	Neumann, PJ (corresponding author), Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Evaluat Value & Risk Hlth, Boston, MA USA.							Neumann PJ, 2009, HEALTH AFFAIR, V28, P1366, DOI 10.1377/hlthaff.28.5.1366; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Weinstein MC, 2010, NEW ENGL J MED, V362, P460, DOI 10.1056/NEJMsb0911104	3	176	176	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2010	363	16					1495	1497		10.1056/NEJMp1007168	http://dx.doi.org/10.1056/NEJMp1007168			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663KP	20942664				2022-12-28	WOS:000282887100003
J	Browse, J				Browse, John			Saving the Bilayer	SCIENCE			English	Editorial Material							MEMBRANE LIPID-COMPOSITION; PLANT COLD-ACCLIMATION; FREEZING TOLERANCE; ARABIDOPSIS-THALIANA; SPINACH-CHLOROPLASTS; MECHANISMS; RESPONSES; MUTANTS; OUTER; GENE		Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Washington State University	Browse, J (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	jab@wsu.edu		Browse, John/0000-0002-2554-2821				BLOCK MA, 1983, J BIOL CHEM, V258, P3281; BURKE MJ, 1976, ANNU REV PLANT PHYS, V27, P507, DOI 10.1146/annurev.pp.27.060176.002451; DORNE AJ, 1985, J CELL BIOL, V100, P1690, DOI 10.1083/jcb.100.5.1690; Fourrier N, 2008, PLANT J, V55, P734, DOI 10.1111/j.1365-313X.2008.03549.x; McKown R, 1996, J EXP BOT, V47, P1919, DOI 10.1093/jxb/47.12.1919; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; *NSF, DBI0701919 NSF; STEPONKUS PL, 1988, P NATL ACAD SCI USA, V85, P9026, DOI 10.1073/pnas.85.23.9026; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thorlby G, 2004, PLANT CELL, V16, P2192, DOI 10.1105/tpc.104.024018; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; VANBESOUW A, 1978, BIOCHIM BIOPHYS ACTA, V529, P44, DOI 10.1016/0005-2760(78)90102-9; Warren G, 1996, PLANT PHYSIOL, V111, P1011, DOI 10.1104/pp.111.4.1011; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010	16	10	10	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					185	186		10.1126/science.1196737	http://dx.doi.org/10.1126/science.1196737			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929764				2022-12-28	WOS:000282644600028
J	Mendell, JR; Campbell, K; Rodino-Klapac, L; Sahenk, Z; Shilling, C; Lewis, S; Bowles, D; Gray, S; Li, CW; Galloway, G; Malik, V; Coley, B; Clark, KR; Li, JA; Xiao, XA; Samulski, J; McPhee, SW; Samulski, RJ; Walker, CM				Mendell, Jerry R.; Campbell, Katherine; Rodino-Klapac, Louise; Sahenk, Zarife; Shilling, Chris; Lewis, Sarah; Bowles, Dawn; Gray, Steven; Li, Chengwen; Galloway, Gloria; Malik, Vinod; Coley, Brian; Clark, K. Reed; Li, Juan; Xiao, Xiao; Samulski, Jade; McPhee, Scott W.; Samulski, R. Jude; Walker, Christopher M.			Brief Report: Dystrophin Immunity in Duchenne's Muscular Dystrophy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE-TRANSFER; CONGENITAL AMAUROSIS; MUSCLE; REARRANGEMENTS; DEGENERATION; RESPONSES; THERAPY; HUMANS; TRIAL; MICE	We report on delivery of a functional dystrophin transgene to skeletal muscle in six patients with Duchenne's muscular dystrophy. Dystrophin-specific T cells were detected after treatment, providing evidence of transgene expression even when the functional protein was not visualized in skeletal muscle. Circulating dystrophin-specific T cells were unexpectedly detected in two patients before vector treatment. Revertant dystrophin fibers, which expressed functional, truncated dystrophin from the deleted endogenous gene after spontaneous in-frame splicing, contained epitopes targeted by the autoreactive T cells. The potential for T-cell immunity to self and nonself dystrophin epitopes should be considered in designing and monitoring experimental therapies for this disease. (Funded by the Muscular Dystrophy Association and others; ClinicalTrials.gov number, NCT00428935.).	[Campbell, Katherine; Walker, Christopher M.] Nationwide Childrens Hosp, Ctr Vaccines & Immun, Res Inst, Columbus, OH 43205 USA; [Mendell, Jerry R.; Rodino-Klapac, Louise; Sahenk, Zarife; Shilling, Chris; Lewis, Sarah; Galloway, Gloria; Malik, Vinod; Coley, Brian; Clark, K. Reed] Nationwide Childrens Hosp, Ctr Gene Therapy, Res Inst, Columbus, OH 43205 USA; [Mendell, Jerry R.; Campbell, Katherine; Rodino-Klapac, Louise; Sahenk, Zarife; Walker, Christopher M.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Bowles, Dawn; Gray, Steven; Li, Chengwen; Samulski, R. Jude] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC USA; [Li, Juan; Xiao, Xiao] Univ N Carolina, Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC USA; [Samulski, Jade; McPhee, Scott W.] Asklepios BioPharmaceut, Chapel Hill, NC USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Walker, CM (corresponding author), Nationwide Childrens Hosp, Ctr Vaccines & Immun, Res Inst, Rm WA4011,700 Childrens Dr, Columbus, OH 43205 USA.	christopher.walker@nationwidechildrens.org	Rodino-Klapac, Louise/E-3968-2011; Clark, Kelly/E-2900-2011; xiao, xiang/GWU-6035-2022; Bowles, Dawn/R-6153-2019; Galloway, Gloria/E-3095-2011	Coley, Brian/0000-0003-0354-4727; Rodino-Klapac, Louise/0000-0002-8966-5177	Muscular Dystrophy Association; Jesse's Journey Foundation; Asklepios BioPharmaceutical; Public Health Services [1R01 AI060388]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060388] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); Jesse's Journey Foundation; Asklepios BioPharmaceutical; Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Muscular Dystrophy Association, the Jesse's Journey Foundation, Asklepios BioPharmaceutical, and a Public Health Services grant (1R01 AI060388 to Dr. Walker).	Angelini C, 2007, MUSCLE NERVE, V36, P424, DOI 10.1002/mus.20812; BRANTLY ML, 2008, NEW ENGL J MED, V358, P2231; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Fabb SA, 2002, HUM MOL GENET, V11, P733, DOI 10.1093/hmg/11.7.733; Ferrer A, 2000, GENE THER, V7, P1439, DOI 10.1038/sj.gt.3301259; Gregorevic P, 2006, NAT MED, V12, P787, DOI 10.1038/nm1439; GUSSONI E, 1994, J IMMUNOL, V153, P4798; Harkiolaki M, 2009, IMMUNITY, V30, P610, DOI 10.1016/j.immuni.2009.03.009; Harkiolaki M, 2009, IMMUNITY, V30, P348, DOI 10.1016/j.immuni.2009.01.009; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; KLEIN CJ, 1992, AM J HUM GENET, V50, P950; Maguire AM, 2010, LANCET, V375, P30; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; MANTEGAZZA R, 1993, J CLIN INVEST, V91, P2880, DOI 10.1172/JCI116533; Mendell JR, 2009, ANN NEUROL, V66, P290, DOI 10.1002/ana.21732; MENDELL JR, 1989, NEW ENGL J MED, V320, P1592, DOI 10.1056/NEJM198906153202405; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Mingozzi F, 2009, BLOOD, V114, P2077, DOI 10.1182/blood-2008-07-167510; Muntoni F, 2007, CURR OPIN NEUROL, V20, P590, DOI 10.1097/WCO.0b013e3282efc157; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wang B, 2000, P NATL ACAD SCI USA, V97, P13714, DOI 10.1073/pnas.240335297; Wells Dominic J, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S146239940200515X	25	404	428	1	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2010	363	15					1429	1437		10.1056/NEJMoa1000228	http://dx.doi.org/10.1056/NEJMoa1000228			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	659NV	20925545	Green Accepted			2022-12-28	WOS:000282575100008
J	Garattini, S; Bertele, V				Garattini, Silvio; Bertele, Vittorio			Personal View Rosiglitazone and the need for a new drug safety agency	BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK		[Garattini, Silvio] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy; [Bertele, Vittorio] Mario Negri Inst Pharmacol Res, Drug Regulatory Policies Lab, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Garattini, S (corresponding author), Mario Negri Inst Pharmacol Res, Via Eritrea 62, I-20157 Milan, Italy.	silvio.garattini@marionegri.it	Garattini, Silvio/AAA-6390-2020; Bertele, Vittorio/AAA-6461-2020	Garattini, Silvio/0000-0003-0647-9297; Bertele, Vittorio/0000-0002-0032-7033				Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5291; Green J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4444; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761	6	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 6	2010	341								c5506	10.1136/bmj.c5506	http://dx.doi.org/10.1136/bmj.c5506			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663JE	20926483				2022-12-28	WOS:000282879400010
J	Korley, FK; Pham, JC; Kirsch, TD				Korley, Frederick Kofi; Pham, Julius Cuong; Kirsch, Thomas Dean			Use of Advanced Radiology During Visits to US Emergency Departments for Injury-Related Conditions, 1998-2007	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CERVICAL-SPINE INJURY; COMPUTED-TOMOGRAPHY; TRAUMA PATIENTS; RADIATION-EXPOSURE; BLUNT TRAUMA; HEAD TRAUMA; CT; RADIOGRAPHY; CRITERIA; RULE	Context Excessive use of medical imaging increases health care costs and exposure to ionizing radiation (a potential carcinogen) without yielding significant benefits to all patients. Objective To determine whether there has been a change in the prevalence of emergency department visits for injury-related conditions for which computed tomography (CT) or magnetic resonance imaging (MRI) was obtained and whether there has been a change in the diagnosis of life-threatening conditions and patient disposition. Design, Setting, and Participants Retrospective cross-sectional analysis of emergency department visits using data from the National Hospital Ambulatory Medical Care Survey (1998-2007). Sampled visits were weighted to produce estimates for the United States. Main Outcomes Measures Proportion of visits for injury-related conditions during which a CT or MRI was obtained, a life-threatening condition was diagnosed (eg, cervical spine fracture, skull fracture, intracranial bleeding, liver and spleen laceration), and which resulted in hospital and intensive care unit admission. Results The prevalence of CT or MRI use during emergency department visits for injury-related conditions increased from 6% (95% confidence interval [CI], 5%-7%) (257 of 5237 visits) in 1998 to 15% (95% CI, 14%-17%) (981 of 6567 visits) in 2007 (P<.001 for trend). There was a small increase in the prevalence of life-threatening conditions (1.7% [95% CI, 1.2%-2.2%; 59 of 5237 visits] in 1998 and 2.0% [95% CI, 1.6%-2.5%; 142 of 6567 visits] in 2007; P=.04 for trend). There was no change in prevalence of visits during which patients were either admitted to the hospital (5.9% [95% CI, 4.9%-6.9%] in 1998 and 5.5% [95% CI, 4.7%-6.5%] in 2007; P=.50 for trend) or to an intensive care unit (0.62% [95% CI, 0.40%-1.00%] in 1998 and 0.80% [95% CI, 0.53%-1.21%] in 2007; P=.14 for trend). Visits during which CT or MRI was obtained lasted 126 minutes (95% CI, 123-131 minutes) longer than those for which CT or MRI was not obtained. Conclusion From 1998 to 2007, the prevalence of CT or MRI use during emergency department visits for injury-related conditions increased significantly, without an equal increase in the prevalence of life-threatening conditions. JAMA. 2010; 304(13): 1465-1471	[Korley, Frederick Kofi; Pham, Julius Cuong; Kirsch, Thomas Dean] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; [Pham, Julius Cuong] Johns Hopkins Univ, Sch Med, Dept Anesthesia & Crit Care Med, Baltimore, MD USA; [Kirsch, Thomas Dean] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Korley, FK (corresponding author), 5801 Smith Ave,Davis Bldg,Ste 3220, Baltimore, MD 21209 USA.	fkorley1@jhmi.edu			National Center Research Resources, National Institutes of Health (NIH) [5KL2RR025006]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025006] Funding Source: NIH RePORTER	National Center Research Resources, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Dr Korley is supported by the Robert E. Meyerhoff Professorship at the Johns Hopkins University School of Medicine, and by grant 5KL2RR025006 from the National Center Research Resources, a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research.	[Anonymous], 2014, INT CLASS DIS 9 REV; Atzema C, 2004, ANN EMERG MED, V44, P47, DOI 10.1016/j.annemergmed.2004.02.032; Baker LC, 2008, HEALTH AFFAIR, V27, P1467, DOI 10.1377/hlthaff.27.6.1467; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Board of Radiation Effects Research Division on Earth and Life Sciences National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Boland GWL, 2009, EUR RADIOL, V19, P9, DOI 10.1007/s00330-008-1159-7; Boone John M, 2008, J Am Coll Radiol, V5, P132, DOI 10.1016/j.jacr.2007.07.008; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Broder J, 2007, EMERG RADIOL, V14, P227, DOI 10.1007/s10140-007-0618-9; Broder J, 2006, EMERG RADIOL, V13, P25, DOI 10.1007/s10140-006-0493-9; Charlson ME, 2005, J GEN INTERN MED, V20, P497, DOI 10.1111/j.1525-1497.2005.0085.x; Deunk J, 2009, J TRAUMA, V66, P1108, DOI 10.1097/TA.0b013e31817e55c3; Doria AS, 2006, RADIOLOGY, V241, P83, DOI 10.1148/radiol.2411050913; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Griffen MM, 2003, J TRAUMA, V55, P222, DOI 10.1097/01.TA.0000083332.93868.E2; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Holmes JF, 2005, J TRAUMA, V58, P902, DOI 10.1097/01.TA.0000162138.36519.2A; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; MADDEN C, 1995, ACAD EMERG MED, V2, P248, DOI 10.1111/j.1553-2712.1995.tb03217.x; Markel TA, 2009, J TRAUMA, V67, P23, DOI 10.1097/TA.0b013e318184ba9a; McCaig L F, 1994, Vital Health Stat 1, P1; Mitchell AM, 2007, J THROMB HAEMOST, V5, P50, DOI 10.1111/j.1538-7836.2006.02251.x; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Pham JC, 2009, ACAD EMERG MED, V16, P949, DOI 10.1111/j.1553-2712.2009.00515.x; Pines JM, 2009, MED CARE, V47, P782, DOI 10.1097/MLR.0b013e31819748e9; PITTS SR, 2008, NATL HLTH STAT REPOR, V7, P1; Prologo JD, 2004, AM J ROENTGENOL, V183, P1093, DOI 10.2214/ajr.183.4.1831093; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Schneider D, 1979, VITAL HLTH STAT, V2, pi; Self ML, 2003, AM J SURG, V186, P609, DOI 10.1016/j.amjsurg.2003.08.003; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Tien HC, 2007, J TRAUMA, V62, P151, DOI 10.1097/TA.0b013e31802d9700; U.S. Government Accountability Office, MEDICARE B	36	254	258	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2010	304	13					1465	1471		10.1001/jama.2010.1408	http://dx.doi.org/10.1001/jama.2010.1408			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658SO	20924012	Bronze			2022-12-28	WOS:000282509900022
J	Rid, A; Emanuel, EJ; Wendler, D				Rid, Annette; Emanuel, Ezekiel J.; Wendler, David			Evaluating the Risks of Clinical Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS LIVER-BIOPSY; HEALTH UTILITIES INDEX; QUALITY-OF-LIFE; PEDIATRIC RESEARCH; OPTIMAL NUMBER; MINIMAL RISK; IMMUNOTHERAPY; COMPLICATIONS; BENEFIT; ETHICS	The ethical appropriateness of clinical research depends on protecting participants from excessive risks. Yet no systematic framework has been developed to assess research risks, and as a result, investigators, funders, and review boards rely only on their intuitive judgments. Because intuitive judgments of risk are subject to well-documented cognitive biases, this approach raises concern that research participants are not being adequately protected. To address this situation, we delineate a method called the systematic evaluation of research risks (SERR), which evaluates the risks of research interventions by comparing these interventions with the risks of comparator activities that have been deemed acceptable. This method involves a 4-step process: (1) identify the potential harms posed by the proposed research intervention; (2) categorize the magnitude of the potential harms into 1 of 7 harm levels on a harm scale; (3) quantify or estimate the likelihood of each potential harm; and (4) compare the likelihood of each potential harm from the research intervention with the likelihood of harms of the same magnitude occurring as a result of an appropriate comparator activity. By explicitly delineating, quantifying, and comparing the risks of research interventions with the risks posed by appropriate comparator activities, SERR offers a way to minimize the influence of cognitive biases on the evaluation of research risks and thereby better protect research participants from excessive risks. JAMA. 2010; 304(13): 1472-1479	[Rid, Annette; Emanuel, Ezekiel J.; Wendler, David] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA; [Rid, Annette] Univ Zurich, Inst Biomed Eth, Zurich, Switzerland	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of Zurich	Wendler, D (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	dwendler@nih.gov			Department of Bioethics at the National Institutes of Health (NIH) Clinical Center; Swiss National Science Foundation	Department of Bioethics at the National Institutes of Health (NIH) Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the Department of Bioethics at the National Institutes of Health (NIH) Clinical Center. Dr Rid reports receipt of support by a grant from the Swiss National Science Foundation.	Andrews CI, 2004, RISK ANAL, V24, P1323, DOI 10.1111/j.0272-4332.2004.00529.x; [Anonymous], 2006, ETH GUID BIOM RES HU; Arruda E, 1997, J CLIN MICROBIOL, V35, P2864, DOI 10.1128/JCM.35.11.2864-2868.1997; Bernstein DI, 2004, J ALLERGY CLIN IMMUN, V113, P1129, DOI 10.1016/j.jaci.2004.02.006; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Brown PO, 2003, PLOS BIOL, V1, P1, DOI 10.1371/journal.pbio.0000036; Cadranel JF, 2000, HEPATOLOGY, V32, P477, DOI 10.1053/jhep.2000.16602; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada and Social Sciences and Humanities Research Council of Canada, 2005, TRIC POL STAT ETH CO; Codreanu F, 2006, Eur Ann Allergy Clin Immunol, V38, P52; Council for International Organizations of Medical Sciences (CIOMS), INT ETH GUID BIOM RE; COX EP, 1980, J MARKETING RES, V17, P407, DOI 10.1177/002224378001700401; *DEP HLTH HUM SERV, 1998, PUBL DEP HLTH HUM SE; Devenney I, 2000, ANN ALLERG ASTHMA IM, V85, P455, DOI 10.1016/S1081-1206(10)62571-9; Erickson P, 1998, QUAL LIFE RES, V7, P101, DOI 10.1023/A:1008897107977; FEENY D, 1995, PHARMACOECONOMICS, V7, P490, DOI 10.2165/00019053-199507060-00004; Feinberg J., 1984, MORAL LIMITS CRIMINA, V1; Field Marilyn J., 2004, ETHICAL CONDUCT CLIN; FINKEL AM, 1995, ENVIRON HEALTH PERSP, V103, P376, DOI 10.2307/3432292; Fischoff B, 1981, ACCEPTABLE RISK; Floyd T, 2001, ARCH ORTHOP TRAUM SU, V121, P433, DOI 10.1007/s004020100267; Furlong WJ, 2001, ANN MED, V33, P375, DOI 10.3109/07853890109002092; GARIBALDI RA, 1985, AM J MED, V78, P32, DOI 10.1016/0002-9343(85)90361-4; GILMORE IT, 1995, GUT, V36, P437, DOI 10.1136/gut.36.3.437; Grange-Messent V, 1999, CELL MOL BIOL, V45, P1; GREENWALD R, 1977, AM J DIG DIS, V22, P1109, DOI 10.1007/BF01072867; Hansson SO, 2003, ERKENNTNIS, V59, P291, DOI 10.1023/A:1026005915919; Ingram JG, 2008, AM J SPORT MED, V36, P1116, DOI 10.1177/0363546508314400; KAPLAN RM, 1979, MED CARE, V17, P501, DOI 10.1097/00005650-197905000-00005; Lenk C, 2004, J MED ETHICS, V30, P85, DOI 10.1136/jme.2003.005900; Levine R. J., 1981, ETHICS REGULATION CL; LIN MS, 1993, ANN ALLERGY, V71, P557; LOCKEY RF, 1987, J ALLERGY CLIN IMMUN, V79, P660, DOI 10.1016/S0091-6749(87)80164-1; London AJ, 2007, J MED PHILOS, V32, P99, DOI 10.1080/03605310701255727; Malnick S, 2005, J CLIN GASTROENTEROL, V39, P900, DOI 10.1097/01.mcg.0000180803.49328.a7; MCGILL DB, 1990, GASTROENTEROLOGY, V99, P1396, DOI 10.1016/0016-5085(90)91167-5; Miller FG, 2009, J MED ETHICS, V35, P445, DOI 10.1136/jme.2008.026062; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; MINUK GY, 1987, GASTROENTEROLOGY, V92, P290, DOI 10.1016/0016-5085(87)90119-3; Murray C.J.L., 1996, HARVARD SCH PUBLIC H; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Nathanson A, 2007, AM J SPORT MED, V35, P113, DOI 10.1177/0363546506293702; *NCI, 2006, NCI COMM TERM CRIT A; *OFF HUM RES PROT, OFF HUM RES PROT DAT; OKUDA K, 1978, GASTROENTEROLOGY, V74, P1204; PERRAULT J, 1978, GASTROENTEROLOGY, V74, P103; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; Preston CC, 2000, ACTA PSYCHOL, V104, P1, DOI 10.1016/S0001-6918(99)00050-5; REID MJ, 1993, J ALLERGY CLIN IMMUN, V92, P6, DOI 10.1016/0091-6749(93)90030-J; ROSSER R, 1978, INT J EPIDEMIOL, V7, P347, DOI 10.1093/ije/7.4.347; *S AFR MRC, 2002, GUID ETH MED RES GEN; Shah S, 2004, JAMA-J AM MED ASSOC, V291, P476, DOI 10.1001/jama.291.4.476; Shrader-Frechette K. S., 1991, RISK RATIONALITY PHI; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Slovic P, 2000, PERCEPTION RISK; STARR C, 1969, SCIENCE, V165, P1232, DOI 10.1126/science.165.3899.1232; Sunstein Cass, 2002, RISK REASON; TURKELTAUB PC, 1989, J ALLERGY CLIN IMMUN, V84, P886, DOI 10.1016/0091-6749(89)90384-9; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Uganda National Council for Science and Technology, 2007, NAT GUID RES INV HUM; Valyasevi MA, 1999, ANN ALLERG ASTHMA IM, V83, P132, DOI 10.1016/S1081-1206(10)62624-5; VANTHIEL DH, 1993, TRANSPLANTATION, V55, P1087, DOI 10.1097/00007890-199305000-00029; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WEINSTEIN ND, 1989, SCIENCE, V246, P1232, DOI 10.1126/science.2686031; Wendler D, 2005, HASTINGS CENT REP, V35, P37, DOI 10.1353/hcr.2005.0087; Wendler D, 2005, JAMA-J AM MED ASSOC, V294, P826, DOI 10.1001/jama.294.7.826; Wendler D., 2010, ETHICS PEDIAT RES; Wendler D, 2006, J PEDIATR-US, V149, P855, DOI 10.1016/j.jpeds.2006.08.064; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wood A, 2004, NAT MED, V10, P1283, DOI 10.1038/nm1204-1283	70	67	73	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2010	304	13					1472	1479		10.1001/jama.2010.1414	http://dx.doi.org/10.1001/jama.2010.1414			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	658SO	20924013				2022-12-28	WOS:000282509900023
J	Summerhayes, GR; Leavesley, M; Fairbairn, A; Mandui, H; Field, J; Ford, A; Fullagar, R				Summerhayes, Glenn R.; Leavesley, Matthew; Fairbairn, Andrew; Mandui, Herman; Field, Judith; Ford, Anne; Fullagar, Richard			Human Adaptation and Plant Use in Highland New Guinea 49,000 to 44,000 Years Ago	SCIENCE			English	Article							OCCUPATION	After their emergence by 200,000 years before the present in Africa, modern humans colonized the globe, reaching Australia and New Guinea by 40,000 to 50,000 years ago. Understanding how humans lived and adapted to the range of environments in these areas has been difficult because well-preserved settlements are scarce. Data from the New Guinea Highlands (at an elevation of similar to 2000 meters) demonstrate the exploitation of the endemic nut Pandanus and yams in archaeological sites dated to 49,000 to 36,000 years ago, which are among the oldest human sites in this region. The sites also contain stone tools thought to be used to remove trees, which suggests that the early inhabitants cleared forest patches to promote the growth of useful plants.	[Summerhayes, Glenn R.; Ford, Anne] Univ Otago, Dept Anthropol Gender & Sociol, Dunedin, New Zealand; [Leavesley, Matthew] Univ Papua New Guinea, Dept Anthropol, Natl Capital Dist, Papua N Guinea; [Fairbairn, Andrew] Univ Queensland, Sch Social Sci, Dept Archaeol, Brisbane, Qld 4072, Australia; [Mandui, Herman] Natl Museum & Art Gallery Papua New Guinea, Boroko Natl Capital Dist, Papua N Guinea; [Field, Judith] Univ Sydney, Australian Ctr Microscopy & Microanal F09, Sydney, NSW 2006, Australia; [Fullagar, Richard] Scarp Archaeol, S Sydney Hub, NSW 2015, Australia	University of Otago; University of Papua New Guinea; University of Queensland; University of Sydney	Summerhayes, GR (corresponding author), Univ Otago, Dept Anthropol Gender & Sociol, POB 56, Dunedin, New Zealand.	Glenn.summerhayes@otago.ac.nz	Field, Judith H/C-7677-2011; Fullagar, Richard/AAT-1155-2020	Fullagar, Richard/0000-0003-1047-1466; summerhayes, glenn/0000-0002-0654-1305; Field, Judith/0000-0001-6807-1858; Fairbairn, Andrew/0000-0002-4004-6957	Marsden Fund Council; Ivane Valley; National Research Institute of PNG; National Museum and Art Gallery of PNG	Marsden Fund Council(Royal Society of New ZealandMarsden Fund (NZ)); Ivane Valley; National Research Institute of PNG; National Museum and Art Gallery of PNG	This research was supported by the Marsden Fund Council from government funding administered by the Royal Society of New Zealand. We thank G. Hope for introducing us to the Ivane Valley and companionship in the field; the communities of the Ivane Valley for their support; and the National Research Institute of PNG and the National Museum and Art Gallery of PNG for their support and affiliation. The authors acknowledge the facilities as well as scientific and technical assistance from the staff at the Australian Microscopy and Microanalysis Research Facility and the Australian Centre for Microscopy and Microanalysis at the University of Sydney. We thank L. O'Neill and M. Hennessey for the illustrations and J. Allen and M. Weisler for providing comments on a draft of the paper. J. F. thanks R. Torrence for access to the Australian Museum PNG starch reference collection. R. F. is indebted to the Australian Museum and the University of Sydney for facilitating the import of quarantined material and access to laboratory space.	Daniau AL, 2010, QUATERNARY SCI REV, V29, P2918, DOI 10.1016/j.quascirev.2009.11.008; Fairbairn AS, 2006, WORLD ARCHAEOL, V38, P371, DOI 10.1080/00438240600813293; Farrera I, 1999, CLIM DYNAM, V15, P823, DOI 10.1007/s003820050317; GROUBE L, 1986, NATURE, V324, P453, DOI 10.1038/324453a0; Groube L., 1989, Foraging and farming: the evolution of plant exploitation., P292; Hope G, 2009, QUATERNARY SCI REV, V28, P2261, DOI 10.1016/j.quascirev.2009.04.012; Mountain M.-J., 1991, MAN HALF ESSAYS PACI, P510; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; STONE BC, 1984, ECON BOT, V38, P304, DOI 10.1007/BF02859008; White JP, 1970, P PREHIST SOC, V36, P152	11	248	254	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2010	330	6000					78	81		10.1126/science.1193130	http://dx.doi.org/10.1126/science.1193130			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	656KW	20929808				2022-12-28	WOS:000282334500037
J	Pagani, L; Steinacker, J; Bacmann, A; Stutz, A; Henning, T				Pagani, Laurent; Steinacker, Juergen; Bacmann, Aurore; Stutz, Amelia; Henning, Thomas			The Ubiquity of Micrometer-Sized Dust Grains in the Dense Interstellar Medium	SCIENCE			English	Article							MOLECULAR CLOUDS; STAR-FORMATION; EXTINCTION LAW; DARK CLOUDS; SPITZER; CORES; COAGULATION; TELESCOPE; OPHIUCHUS; GROWTH	Cold molecular clouds are the birthplaces of stars and planets, where dense cores of gas collapse to form protostars. The dust mixed in these clouds is thought to be made of grains of an average size of 0.1 micrometer. We report the widespread detection of the coreshine effect as a direct sign of the existence of grown, micrometer-sized dust grains. This effect is seen in half of the cores we have analyzed in our survey, spanning all Galactic longitudes, and is dominated by changes in the internal properties and local environment of the cores, implying that the coreshine effect can be used to constrain fundamental core properties such as the three-dimensional density structure and ages and also the grain characteristics themselves.	[Pagani, Laurent; Steinacker, Juergen] Observ Paris, LERMA, F-75014 Paris, France; [Pagani, Laurent; Steinacker, Juergen] Observ Paris, CNRS, UMR 8112, F-75014 Paris, France; [Steinacker, Juergen; Stutz, Amelia; Henning, Thomas] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Bacmann, Aurore] Univ Grenoble 1, CNRS, Lab Astrophys Grenoble, UMR 5571, F-38041 Grenoble 09, France; [Stutz, Amelia] Univ Arizona, Dept Astron, Tucson, AZ 85721 USA; [Stutz, Amelia] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA	UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Arizona; University of Arizona	Pagani, L (corresponding author), Observ Paris, LERMA, 61 Ave Observ, F-75014 Paris, France.	laurent.pagani@obspm.fr	Henning, Thomas K/O-4372-2018	Henning, Thomas K/0000-0002-1493-300X; Bacmann, Aurore/0000-0003-1263-4986; Stutz, Amelia/0000-0003-2300-8200	NASA; Observatoire de Paris	NASA(National Aeronautics & Space Administration (NASA)); Observatoire de Paris	This work is based in part on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. J.S. is grateful for the hospitality and financial support of the Observatoire de Paris and LERMA, where some of this work was performed. We also thank two anonymous reviewers.	Andre P, 2009, STRUCTURE FORMATION IN ASTROPHYSICS, P254, DOI 10.1017/CBO9780511575198.012; Bacmann A, 2000, ASTRON ASTROPHYS, V361, P555; Bergin EA, 2007, ANNU REV ASTRON ASTR, V45, P339, DOI 10.1146/annurev.astro.45.071206.100404; Bouwman J, 2008, ASTROPHYS J, V683, P479, DOI 10.1086/587793; Chapman NL, 2009, ASTROPHYS J, V690, P496, DOI 10.1088/0004-637X/690/1/496; Foster JB, 2006, ASTROPHYS J, V636, pL105, DOI 10.1086/500131; Hartmann L, 2009, ACCRETION PROCESSES, V2nd; Kiss C, 2006, MON NOT R ASTRON SOC, V373, P1213, DOI 10.1111/j.1365-2966.2006.11100.x; MATHIS JS, 1977, ASTROPHYS J, V217, P425, DOI 10.1086/155591; McClure M, 2009, ASTROPHYS J LETT, V693, pL81, DOI 10.1088/0004-637X/693/2/L81; Mckee CF, 2007, ANNU REV ASTRON ASTR, V45, P565, DOI 10.1146/annurev.astro.45.051806.110602; Ormel CW, 2009, ASTRON ASTROPHYS, V502, P845, DOI 10.1051/0004-6361/200811158; OSSENKOPF V, 1993, ASTRON ASTROPHYS, V280, P617; REYNOLDS RJ, 1976, ASTROPHYS J, V206, P679, DOI 10.1086/154427; Ridderstad M, 2006, ASTRON ASTROPHYS, V451, P961, DOI 10.1051/0004-6361:20053467; Steinacker J, 2005, ASTRON ASTROPHYS, V434, P167, DOI 10.1051/0004-6361:20041978; Steinacker J, 2010, ASTRON ASTROPHYS, V511, DOI 10.1051/0004-6361/200912835; Stutz AM, 2009, ASTROPHYS J, V707, P137, DOI 10.1088/0004-637X/707/1/137; Tachihara K, 2000, ASTROPHYS J, V528, P817, DOI 10.1086/308189; Tielens AGGM, 2008, ANNU REV ASTRON ASTR, V46, P289, DOI 10.1146/annurev.astro.46.060407.145211; van der Tak FFS, 2005, ASTRON ASTROPHYS, V439, P195, DOI 10.1051/0004-6361:20052792; Zasowski G, 2009, ASTROPHYS J, V707, P510, DOI 10.1088/0004-637X/707/1/510	23	125	125	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1622	1624		10.1126/science.1193211	http://dx.doi.org/10.1126/science.1193211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929841	Green Submitted			2022-12-28	WOS:000282098100033
J	Kromhout, D; Giltay, EJ; Geleijnse, JM				Kromhout, Daan; Giltay, Erik J.; Geleijnse, Johanna M.		Alpha Omega Trial Grp	n-3 Fatty Acids and Cardiovascular Events after Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; SUDDEN CARDIAC DEATH; ALPHA-LINOLENIC ACID; FISH CONSUMPTION; BLOOD-INSTITUTE; NATIONAL-HEART; DIETARY-SUPPLEMENTS; RISK; LUNG; ASSOCIATION	BACKGROUND Results from prospective cohort studies and randomized, controlled trials have provided evidence of a protective effect of n-3 fatty acids against cardiovascular diseases. We examined the effect of the marine n-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and of the plant-derived alpha-linolenic acid (ALA) on the rate of cardiovascular events among patients who have had a myocardial infarction. METHODS In a multicenter, double-blind, placebo-controlled trial, we randomly assigned 4837 patients, 60 through 80 years of age (78% men), who had had a myocardial infarction and were receiving state-of-the-art antihypertensive, antithrombotic, and lipid-modifying therapy to receive for 40 months one of four trial margarines: a margarine supplemented with a combination of EPA and DHA (with a targeted additional daily intake of 400 mg of EPA-DHA), a margarine supplemented with ALA (with a targeted additional daily intake of 2 g of ALA), a margarine supplemented with EPA-DHA and ALA, or a placebo margarine. The primary end point was the rate of major cardiovascular events, which comprised fatal and nonfatal cardiovascular events and cardiac interventions. Data were analyzed according to the intention-to-treat principle, with the use of Cox proportional-hazards models. RESULTS The patients consumed, on average, 18.8 g of margarine per day, which resulted in additional intakes of 226 mg of EPA combined with 150 mg of DHA, 1.9 g of ALA, or both, in the active-treatment groups. During the follow-up period, a major cardiovascular event occurred in 671 patients (13.9%). Neither EPA-DHA nor ALA reduced this primary end point (hazard ratio with EPA-DHA, 1.01; 95% confidence interval [CI], 0.87 to 1.17; P = 0.93; hazard ratio with ALA, 0.91; 95% CI, 0.78 to 1.05; P = 0.20). In the prespecified subgroup of women, ALA, as compared with placebo and EPA-DHA alone, was associated with a reduction in the rate of major cardiovascular events that approached significance (hazard ratio, 0.73; 95% CI, 0.51 to 1.03; P = 0.07). The rate of adverse events did not differ significantly among the study groups. CONCLUSIONS Low-dose supplementation with EPA-DHA or ALA did not significantly reduce the rate of major cardiovascular events among patients who had had a myocardial infarction and who were receiving state-of-the-art antihypertensive, antithrombotic, and lipid-modifying therapy.	[Kromhout, Daan; Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, NL-6700 EV Wageningen, Netherlands; [Giltay, Erik J.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands	Wageningen University & Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kromhout, D (corresponding author), Wageningen Univ, Div Human Nutr, POB 8129, NL-6700 EV Wageningen, Netherlands.	daan.kromhout@wur.nl	Giltay, Erik J./AAL-9948-2021; Geleijnse, Johanna Marianna M/B-5749-2012; Kromhout, Daan/A-8566-2014; Oude Griep, Linda/M-5112-2013	Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Oude Griep, Linda/0000-0001-7697-7473; Giltay, Erik/0000-0001-8874-2292	Netherlands Heart Foundation; National Institutes of Health; Unilever R&D, the Netherlands; Unilever	Netherlands Heart Foundation(Netherlands Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Unilever R&D, the Netherlands(Netherlands Government); Unilever(Unilever)	Supported by the Netherlands Heart Foundation, the National Institutes of Health, and Unilever R&D, the Netherlands. Unilever provided an unrestricted grant for the distribution of trial margarines to the patients.	Albert CM, 2005, CIRCULATION, V112, P3232, DOI 10.1161/CIRCULATIONAHA.105.572008; Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; [Anonymous], 1992, INT STAT CLASS DIS R, V1-3; Brouwer IA, 2004, J NUTR, V134, P919, DOI 10.1093/jn/134.4.919; Djousse L, 2005, CIRCULATION, V111, pE190; Djousse L, 2003, AM J CLIN NUTR, V77, P819, DOI 10.1093/ajcn/77.4.819; Elmadfa I, 2009, ANN NUTR METAB, V55, P56, DOI 10.1159/000228996; Geleijnse JM, 2010, AM HEART J, V159, P539, DOI 10.1016/j.ahj.2009.12.033; *GISSI PREV INV, 2001, LANCET, V357, P642; Grundy SM, 2003, CIRCULATION, V107, P1834, DOI 10.1161/01.CIR.0000059746.10326.09; Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico, 2007, LANCET, V369, P106; He K, 2004, CIRCULATION, V109, pE107; He K, 2004, STROKE, V35, P1538, DOI 10.1161/01.STR.0000130856.31468.47; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; Leon H, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2931; London B, 2007, CIRCULATION, V116, pE320, DOI 10.1161/CIRCULATIONAHA.107.712984; Marik PE, 2009, CLIN CARDIOL, V32, P365, DOI 10.1002/clc.20604; McLennan PL, 2007, J CARDIOVASC MED, V8, pS15, DOI 10.2459/01.JCM.0000289272.87803.ce; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Roger VL, 2010, CIRCULATION, V121, P863, DOI 10.1161/CIRCULATIONAHA.109.897249; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; Smith PJ, 2009, AM J CLIN NUTR, V89, P1315, DOI 10.3945/ajcn.2008.26829; Streppel MT, 2008, EUR HEART J, V29, P2024, DOI 10.1093/eurheartj/ehn294; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; Thies F, 2003, LANCET, V361, P477, DOI 10.1016/S0140-6736(03)12468-3; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	30	694	712	0	80	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 18	2010	363	21					2015	2026		10.1056/NEJMoa1003603	http://dx.doi.org/10.1056/NEJMoa1003603			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	681KC	20929341				2022-12-28	WOS:000284310000006
J	Crawford, NW; Buttery, JP				Crawford, Nigel W.; Buttery, Jim P.			Poliomyelitis eradication: another step forward	LANCET			English	Editorial Material							POLIO		[Crawford, Nigel W.; Buttery, Jim P.] Royal Childrens Hosp, SAEFVIC Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Crawford, Nigel W.; Buttery, Jim P.] Royal Childrens Hosp, Dept Gen Med, Melbourne, Vic 3052, Australia; [Crawford, Nigel W.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Buttery, Jim P.] Monash Univ, Dept Paediat, Monash Childrens Hosp, Paediat Infect Dis Unit, Melbourne, Vic 3004, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Monash University	Crawford, NW (corresponding author), Royal Childrens Hosp, SAEFVIC Murdoch Childrens Res Inst, Flemington Rd, Melbourne, Vic 3052, Australia.							Aylward B, 2000, AM J PUBLIC HEALTH, V90, P1515, DOI 10.2105/AJPH.90.10.1515; *GLOB POL ER IN, 2010, GLOB POL CAS COUNT; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Heinsbroek E, 2010, VACCINE, V28, P3778, DOI 10.1016/j.vaccine.2010.02.095; Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073; Jenkins HE, 2008, NEW ENGL J MED, V359, P1666, DOI 10.1056/NEJMoa0803259; Sutter R.W., 2008, VACCINES-BASEL, V5th ed., P631; SUTTER RW, 2010, LANCET, DOI DOI 10.1016/S0140.6736(10)61230.5; Usher AD, 2010, LANCET, V375, P791, DOI 10.1016/S0140-6736(10)60328-5; *WHO, 2010, GLOB POL ER IN FIN R; 1988, 41 WORLD HLTH ASSEMB	11	7	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 13	2010	376	9753					1624	1625		10.1016/S0140-6736(10)61427-4	http://dx.doi.org/10.1016/S0140-6736(10)61427-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	683DD	20980047				2022-12-28	WOS:000284451000007
J	Kodera, N; Yamamoto, D; Ishikawa, R; Ando, T				Kodera, Noriyuki; Yamamoto, Daisuke; Ishikawa, Ryoki; Ando, Toshio			Video imaging of walking myosin V by high-speed atomic force microscopy	NATURE			English	Article							HAND-OVER-HAND; PROCESSIVE MYOSIN; MECHANISM; ADP; COORDINATION; MOVEMENT; DYNAMICS; KINETICS; BINDING; STROKE	The dynamic behaviour of myosin V molecules translocating along actin filaments has been mainly studied by optical microscopy. The processive hand-over-hand movement coupled with hydrolysis of adenosine triphosphate was thereby demonstrated. However, the protein molecules themselves are invisible in the observations and have therefore been visualized by electron microscopy in the stationary states. The concomitant assessment of structure and dynamics has been unfeasible, a situation prevailing throughout biological research. Here we directly visualize myosin V molecules walking along actin tracks, using high-speed atomic force microscopy. The high-resolution movies not only provide corroborative 'visual evidence' for previously speculated or demonstrated molecular behaviours, including lever-arm swing, but also reveal more detailed behaviours of the molecules, leading to a comprehensive understanding of the motor mechanism. Our direct and dynamic high-resolution visualization is a powerful new approach to studying the structure and dynamics of biomolecules in action.	[Kodera, Noriyuki; Yamamoto, Daisuke; Ando, Toshio] Kanazawa Univ, Dept Phys, Kanazawa, Ishikawa 9201192, Japan; [Kodera, Noriyuki; Yamamoto, Daisuke; Ando, Toshio] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Ishikawa, Ryoki] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol, Maebashi, Gunma 3718511, Japan	Kanazawa University; Japan Science & Technology Agency (JST); Gunma University	Ando, T (corresponding author), Kanazawa Univ, Dept Phys, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	tando@kenroku.kanazawa-u.ac.jp	Kodera, Noriyuki/AAJ-1797-2020; ANDO, Toshio/E-7054-2015; Kodera, Noriyuki/E-6569-2015	ANDO, Toshio/0000-0001-8819-154X; Kodera, Noriyuki/0000-0003-4880-8423	JST; JSPS; MEXT-Japan	JST(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Uchihashi and H. Yamashita for technical assistance and discussion, and J. Sellers for critical reading of the draft and for comments. This work was supported by CREST/JST, Special Coordination Funds for Promoting Science and Technology (Effective Promotion of Joint Research with Industry, Academia, and Government) from JST, a Grant-in-Aid for Basic Research (S) from JSPS, and Knowledge Cluster/MEXT-Japan.	Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ando T, 2008, PROG SURF SCI, V83, P337, DOI 10.1016/j.progsurf.2008.09.001; Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Forgacs E, 2008, J BIOL CHEM, V283, P766, DOI 10.1074/jbc.M704313200; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Hansma PK, 2006, SCIENCE, V314, P601, DOI 10.1126/science.1133497; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Kitazawa M, 2003, JPN J APPL PHYS 1, V42, P4844, DOI 10.1143/JJAP.42.4844; Kodera N, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2336113; Koide H, 2006, BIOCHEMISTRY-US, V45, P11598, DOI 10.1021/bi0613877; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Oguchi Y, 2008, P NATL ACAD SCI USA, V105, P7714, DOI 10.1073/pnas.0800564105; Okada T, 2007, BIOCHEM BIOPH RES CO, V354, P379, DOI 10.1016/j.bbrc.2006.12.200; Oke OA, 2010, P NATL ACAD SCI USA, V107, P2509, DOI 10.1073/pnas.0906907107; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sakamoto T, 2008, NATURE, V455, P128, DOI 10.1038/nature07188; Sellers J. R., 2008, MYOS SUP MOL MOT, P289; Sellers JR, 2010, NAT STRUCT MOL BIOL, V17, P590, DOI 10.1038/nsmb.1820; Shibata M, 2010, NAT NANOTECHNOL, V5, P208, DOI [10.1038/NNANO.2010.7, 10.1038/nnano.2010.7]; Syed S, 2006, EMBO J, V25, P1795, DOI 10.1038/sj.emboj.7601060; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Viani MB, 2000, NAT STRUCT BIOL, V7, P644, DOI 10.1038/77936; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Yamamoto D, 2010, METHOD ENZYMOL, V475, P541, DOI 10.1016/S0076-6879(10)75020-5; Yamamoto D, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384009; Yamashita H, 2009, J STRUCT BIOL, V167, P153, DOI 10.1016/j.jsb.2009.04.011; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	35	560	571	10	252	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					72	+		10.1038/nature09450	http://dx.doi.org/10.1038/nature09450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20935627	Green Submitted			2022-12-28	WOS:000283786900037
J	King, D				King, David			Spending review leaves research in the lurch	NATURE			English	Editorial Material											King, D (corresponding author), Univ Oxford, Smith Sch Enterprise & Environm, Oxford OX1 2JD, England.	director@smithschool.ox.ac.uk							0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1007	1007		10.1038/4671007a	http://dx.doi.org/10.1038/4671007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	671XW	20981049	Bronze			2022-12-28	WOS:000283548600004
J	Fiorin, G; Carnevale, V; DeGrado, WF				Fiorin, Giacomo; Carnevale, Vincenzo; DeGrado, William F.			The Flu's Proton Escort	SCIENCE			English	Editorial Material							INFLUENZA-A VIRUS; ION-CHANNEL; M2; MECHANISM; PROTEIN; CONDUCTION; NMR		[Fiorin, Giacomo; Carnevale, Vincenzo] Temple Univ, Inst Computat Mol Sci, Philadelphia, PA 19122 USA; [Fiorin, Giacomo; Carnevale, Vincenzo] Temple Univ, Dept Chem, Philadelphia, PA 19122 USA; [DeGrado, William F.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania	Fiorin, G (corresponding author), Temple Univ, Inst Computat Mol Sci, Philadelphia, PA 19122 USA.	wdegrado@mail.med.upenn.edu	Carnevale, Vincenzo/D-8015-2014	Carnevale, Vincenzo/0000-0002-1918-8280	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054616] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acharya R, 2010, P NATL ACAD SCI USA, V107, P15075, DOI 10.1073/pnas.1007071107; Balannik V, 2010, BIOCHEMISTRY-US, V49, P696, DOI 10.1021/bi901799k; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Cady SD, 2009, BIOCHEMISTRY-US, V48, P7356, DOI 10.1021/bi9008837; Cady SD, 2009, J MOL BIOL, V385, P1127, DOI 10.1016/j.jmb.2008.11.022; Chen HN, 2007, BIOPHYS J, V93, P3470, DOI 10.1529/biophysj.107.105742; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; Hu FH, 2010, SCIENCE, V330, P505, DOI 10.1126/science.1191714; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Khurana E, 2009, P NATL ACAD SCI USA, V106, P1069, DOI 10.1073/pnas.0811720106; Kochendoerfer GG, 1999, BIOCHEMISTRY-US, V38, P11905, DOI 10.1021/bi990720m; Leiding T, 2010, P NATL ACAD SCI USA, V107, P15409, DOI 10.1073/pnas.1009997107; Ma CL, 2009, P NATL ACAD SCI USA, V106, P12283, DOI 10.1073/pnas.0905726106; Nguyen PA, 2008, BIOCHEMISTRY-US, V47, P9934, DOI 10.1021/bi801315m; Ohigashi Y, 2009, P NATL ACAD SCI USA, V106, P18775, DOI 10.1073/pnas.0910584106; Pielak RM, 2010, BIOCHEM BIOPH RES CO, V401, P58, DOI 10.1016/j.bbrc.2010.09.008; Pinto LH, 2006, PHOTOCH PHOTOBIO SCI, V5, P629, DOI 10.1039/b517734k; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Rossman JS, 2010, J VIROL, V84, P5078, DOI 10.1128/JVI.00119-10; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Sharma M, 2010, SCIENCE, V330, P509, DOI 10.1126/science.1191750; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528	24	10	10	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					456	458		10.1126/science.1197748	http://dx.doi.org/10.1126/science.1197748			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966238	Green Accepted			2022-12-28	WOS:000283329100023
J	Lane, N; Martin, W				Lane, Nick; Martin, William			The energetics of genome complexity	NATURE			English	Article							MITOCHONDRIAL GENE-EXPRESSION; EUKARYOTIC GENOMES; EVOLUTION; BACTERIA; ORIGIN; CELL; OXYGEN; DNA; COMPARTMENTALIZATION; CHROMOSOMES	All complex life is composed of eukaryotic (nucleated) cells. The eukaryotic cell arose from prokaryotes just once in four billion years, and otherwise prokaryotes show no tendency to evolve greater complexity. Why not? Prokaryotic genome size is constrained by bioenergetics. The endosymbiosis that gave rise to mitochondria restructured the distribution of DNA in relation to bioenergetic membranes, permitting a remarkable 200,000-fold expansion in the number of genes expressed. This vast leap in genomic capacity was strictly dependent on mitochondrial power, and prerequisite to eukaryote complexity: the key innovation en route to multicellular life.	[Lane, Nick] UCL, Dept Genet Evolut & Environm, London W1E 6BT, England; [Martin, William] Univ Dusseldorf, Inst Bot 3, D-40225 Dusseldorf, Germany	University of London; University College London; Heinrich Heine University Dusseldorf	Lane, N (corresponding author), UCL, Dept Genet Evolut & Environm, Gower St, London W1E 6BT, England.	nick.lane@ucl.ac.uk	Martin, William F./O-5446-2015; Martin, William/C-5680-2008	Martin, William F./0000-0003-1478-6449; Lane, Nick/0000-0002-5433-3973	UCL; German Research Foundation; European Research Council (Networkorigins)	UCL; German Research Foundation(German Research Foundation (DFG)); European Research Council (Networkorigins)(European Research Council (ERC))	We are indebted to A. Hidalgo, D. Braben, F. Harold, J. Ellis, H. Schulz-Vogt, J. Allen, G. Shields and L. Sweetlove for many discussions and comments on the manuscript, M. Farmer, H. Schulz-Vogt and R. Allen for microscopic images. N.L. is very grateful to the UCL Provost's Venture Research Fellowship, W. M. to the German Research Foundation and the European Research Council (Networkorigins) for funding.	ALLEN JF, 1993, J THEOR BIOL, V165, P609, DOI 10.1006/jtbi.1993.1210; Allen JF, 2003, PHILOS T R SOC B, V358, P19, DOI 10.1098/rstb.2002.1191; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; Brighouse A, 2010, CELL MOL LIFE SCI, V67, P3449, DOI 10.1007/s00018-010-0436-1; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Cavalier-Smith T, 2009, INT J BIOCHEM CELL B, V41, P307, DOI 10.1016/j.biocel.2008.10.002; Chomyn A, 2001, J BIOENERG BIOMEMBR, V33, P251, DOI 10.1023/A:1010791204961; Cox CJ, 2008, P NATL ACAD SCI USA, V105, P20356, DOI 10.1073/pnas.0810647105; DANIELS EW, 1968, Z ZELLFORSCH MIK ANA, V91, P159, DOI 10.1007/BF00364307; Davidov Y, 2009, BIOESSAYS, V31, P748, DOI 10.1002/bies.200900018; de Duve C, 2007, NAT REV GENET, V8, P395, DOI 10.1038/nrg2071; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; FENCHEL T, 1983, MICROBIAL ECOL, V9, P99, DOI 10.1007/BF02015125; Forterre P, 2010, P NATL ACAD SCI USA, V107, P12739, DOI 10.1073/pnas.1007720107; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; Harold F. M., 1986, VITAL FORCE STUDY BI; Johnston DT, 2009, P NATL ACAD SCI USA, V106, P16925, DOI 10.1073/pnas.0909248106; Koonin EV, 2009, NUCLEIC ACIDS RES, V37, P1011, DOI 10.1093/nar/gkp089; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kunin V, 2003, GENOME RES, V13, P1589, DOI 10.1101/gr.1092603; Kuo CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001050; Kurland CG, 2006, SCIENCE, V312, P1011, DOI 10.1126/science.1121674; Lane CE, 2008, TRENDS ECOL EVOL, V23, P268, DOI 10.1016/j.tree.2008.02.004; Lane N., 2005, POWER SEX SUICIDE MI; Lane N., 2009, LIFE ASCENDING 10 GR; Lindsay MR, 2001, ARCH MICROBIOL, V175, P413, DOI 10.1007/s002030100280; Lonhienne TGA, 2010, P NATL ACAD SCI USA, V107, P12883, DOI 10.1073/pnas.1001085107; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Makarieva AM, 2005, P ROY SOC B-BIOL SCI, V272, P2219, DOI 10.1098/rspb.2005.3225; MARGULIS L, 1976, NATURE, V264, P620, DOI 10.1038/264620a0; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Mendell JE, 2008, P NATL ACAD SCI USA, V105, P6730, DOI 10.1073/pnas.0707522105; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Nilsson M, 1997, BIOTECHNOL BIOENG, V54, P461, DOI 10.1002/(SICI)1097-0290(19970605)54:5<461::AID-BIT6>3.0.CO;2-C; Parfrey LW, 2008, MOL BIOL EVOL, V25, P787, DOI 10.1093/molbev/msn032; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Pinevich AV, 1997, ENDOCYTOBIOSIS CELL, V12, P9; Piruat JI, 2005, J BIOL CHEM, V280, P42676, DOI 10.1074/jbc.M507044200; Pisani D, 2007, MOL BIOL EVOL, V24, P1752, DOI 10.1093/molbev/msm095; Rivera MC, 2004, NATURE, V431, P152, DOI 10.1038/nature02848; Robinson NP, 2007, P NATL ACAD SCI USA, V104, P5806, DOI 10.1073/pnas.0700206104; Rocher C, 2008, J BIOENERG BIOMEMBR, V40, P59, DOI 10.1007/s10863-008-9130-5; Rokas A, 2008, ANNU REV GENET, V42, P235, DOI 10.1146/annurev.genet.42.110807.091513; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Schulz HN, 2002, APPL ENVIRON MICROB, V68, P5746, DOI 10.1128/AEM.68.11.5746-5749.2002; Schulz HN, 2001, ANNU REV MICROBIOL, V55, P105, DOI 10.1146/annurev.micro.55.1.105; SHAY JW, 1990, J BIOL CHEM, V265, P14802; Shimizu M, 2010, P NATL ACAD SCI USA, V107, P10760, DOI 10.1073/pnas.0911692107; Simon DM, 2008, NUCLEIC ACIDS RES, V36, P7219, DOI 10.1093/nar/gkn867; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Szathmary E, 1995, MAJOR TRANSITIONS EV; Tielens AGM, 2002, TRENDS BIOCHEM SCI, V27, P564, DOI 10.1016/S0968-0004(02)02193-X; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Van Der Giezen M, 2009, J EUKARYOT MICROBIOL, V56, P221, DOI 10.1111/j.1550-7408.2009.00407.x; Vats P, 2009, CELL MOL LIFE SCI, V66, P3353, DOI 10.1007/s00018-009-0092-5; Vellai T, 1998, J MOL EVOL, V46, P499, DOI 10.1007/PL00006331; Vellai T, 1999, P ROY SOC B-BIOL SCI, V266, P1571, DOI 10.1098/rspb.1999.0817; von Dohlen CD, 2001, NATURE, V412, P433, DOI 10.1038/35086563; Wagner A, 2005, MOL BIOL EVOL, V22, P1365, DOI 10.1093/molbev/msi126; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; WILLIAMS RS, 1986, J BIOL CHEM, V261, P376; WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390; WUJEK DE, 1979, T AM MICROSC SOC, V98, P143, DOI 10.2307/3225953; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102; Yutin N, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-9; [No title captured]	74	694	711	16	287	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					929	934		10.1038/nature09486	http://dx.doi.org/10.1038/nature09486			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962839				2022-12-28	WOS:000283254700030
J	Fisher, ES; Shortell, SM				Fisher, Elliott S.; Shortell, Stephen M.			Accountable Care Organizations Accountable for What, to Whom, and How	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Shortell, Stephen M.] Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, Berkeley, CA 94720 USA; [Fisher, Elliott S.] Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA	University of California System; University of California Berkeley; Dartmouth College	Shortell, SM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, 417E Univ Hall, Berkeley, CA 94720 USA.	shortell@berkeley.edu						Berwick DM, 2003, MED CARE, V41, pI30; Devers K, 2009, CAN ACCOUNTABLE CARE; Institute of Medicine, 2006, PERF MEAS ACC IMPR; McClellan M, 2010, HEALTH AFFAIR, V29, P982, DOI 10.1377/hlthaff.2010.0194; National Priorities Partnership, 2008, NAT PRIOR GOALS AL O; National Quality Forum, 2010, MEAS FRAM EV EFF PAT; *QUAL AFF, ALT QUAL CONTR BER; Shortell SM, 2010, HEALTH AFFAIR, V29, P1293, DOI 10.1377/hlthaff.2010.0453; Shortell SM, 2010, JAMA-J AM MED ASSOC, V303, P1747, DOI 10.1001/jama.2010.575	9	167	169	1	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2010	304	15					1715	1716		10.1001/jama.2010.1513	http://dx.doi.org/10.1001/jama.2010.1513			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666PZ	20959584				2022-12-28	WOS:000283129700028
J	Neily, J; Mills, PD; Young-Xu, YN; Carney, BT; West, P; Berger, DH; Mazzia, LM; Paull, DE; Bagian, JP				Neily, Julia; Mills, Peter D.; Young-Xu, Yinong; Carney, Brian T.; West, Priscilla; Berger, David H.; Mazzia, Lisa M.; Paull, Douglas E.; Bagian, James P.			Association Between Implementation of a Medical Team Training Program and Surgical Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK ADJUSTMENT; OPERATING-ROOM; MORBIDITY; QUALITY; SAFETY; COMMUNICATION; BRIEFINGS; CHECKLIST; IMPACT; NSQIP	Context There is insufficient information about the effectiveness of medical team training on surgical outcomes. The Veterans Health Administration (VHA) implemented a formalized medical team training program for operating room personnel on a national level. Objective To determine whether an association existed between the VHA Medical Team Training program and surgical outcomes. Design, Setting, and Participants A retrospective health services study with a contemporaneous control group was conducted. Outcome data were obtained from the VHA Surgical Quality Improvement Program (VASQIP) and from structured interviews in fiscal years 2006 to 2008. The analysis included 182 409 sampled procedures from 108 VHA facilities that provided care to veterans. The VHA's nationwide training program required briefings and debriefings in the operating room and included checklists as an integral part of this process. The training included 2 months of preparation, a 1-day conference, and 1 year of quarterly coaching interviews Main Outcome Measure The rate of change in the mortality rate 1 year after facilities enrolled in the training program compared with the year before and with non-training sites. Results The 74 facilities in the training program experienced an 18% reduction in annual mortality (rate ratio [RR], 0.82; 95% confidence interval [CI], 0.76-0.91; P=.01) compared with a 7% decrease among the 34 facilities that had not yet undergone training (RR, 0.93; 95% CI, 0.80-1.06; P=.59). The risk-adjusted mortality rates at baseline were 17 per 1000 procedures per year for the trained facilities and 15 per 1000 procedures per year for the nontrained facilities. At the end of the study, the rates were 14 per 1000 procedures per year for both groups. Propensity matching of the trained and nontrained groups demonstrated that the decline in the risk-adjusted surgical mortality rate was about 50% greater in the training group (RR, 1.49; 95% CI, 1.10-2.07; P=.01) than in the nontraining group. A dose-response relationship for additional quarters of the training program was also demonstrated: for every quarter of the training program, a reduction of 0.5 deaths per 1000 procedures occurred (95% CI, 0.2-1.0; P=.001). Conclusion Participation in the VHA Medical Team Training program was associated with lower surgical mortality. JAMA. 2010; 304(15): 1693-1700	[Neily, Julia; Mills, Peter D.; Young-Xu, Yinong; Carney, Brian T.; West, Priscilla; Mazzia, Lisa M.; Paull, Douglas E.; Bagian, James P.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Vet Affairs,Natl Ctr Patient Safety, Hanover, NH 03756 USA; [Mills, Peter D.; Young-Xu, Yinong] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Psychiat, Hanover, NH 03756 USA; [Berger, David H.] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Berger, David H.] Baylor Coll Med, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX 77030 USA; [Bagian, James P.] Univ Texas Med Branch, Galveston, TX USA; [Bagian, James P.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA	Dartmouth College; Dartmouth College; Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; University of Texas System; University of Texas Medical Branch Galveston; Uniformed Services University of the Health Sciences - USA	Neily, J (corresponding author), 215 N Main St, White River Jct, VT 05009 USA.	Julia.Neily@va.gov	Hefner, Jennifer/P-5962-2014	Hefner, Jennifer/0000-0001-8083-8038; Paull, Douglas/0000-0001-8876-2824; Bagian, James/0000-0003-1792-6099				*AM COLL SURG, ACS NSQIP HIST ACS N; Awad SS, 2005, AM J SURG, V190, P770, DOI 10.1016/j.amjsurg.2005.07.018; Daley J, 1997, J AM COLL SURGEONS, V185, P328, DOI 10.1016/S1072-7515(01)00939-5; Davenport DL, 2007, J AM COLL SURGEONS, V205, P778, DOI 10.1016/j.jamcollsurg.2007.07.039; Defontes James, 2004, Perm J, V8, P21; Diggle P. J., 1996, ANAL LONGITUDINAL DA; Dunn EJ, 2007, JT COMM J QUAL PATIE, V33, P317, DOI 10.1016/S1553-7250(07)33036-5; Grogan EL, 2004, J AM COLL SURGEONS, V199, P843, DOI 10.1016/j.jamcollsurg.2004.08.021; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; *JOINT COMM, JOINT COMM SENT EV; Khuri SF, 2005, SURGERY, V138, P837, DOI 10.1016/j.surg.2005.08.016; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; KHURI SF, 1995, J AM COLL SURGEONS, V180, P519; Khuri SF, 2007, J AM COLL SURGEONS, V204, P1089, DOI 10.1016/j.jamcollsurg.2007.03.028; Leonard M, 2004, QUAL SAF HEALTH CARE, V13, pI85, DOI 10.1136/qshc.2004.010033; Lingard L, 2008, ARCH SURG-CHICAGO, V143, P12, DOI 10.1001/archsurg.2007.21; Makary MA, 2007, J AM COLL SURGEONS, V204, P236, DOI 10.1016/j.jamcollsurg.2006.10.018; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; Morey JC, 2002, HEALTH SERV RES, V37, P1553, DOI 10.1111/1475-6773.01104; Musson DM., 2004, HARVARD HLTH POLICY, V5, P25; Neily J, 2010, QUAL SAF HEALTH CARE, V19, P360, DOI 10.1136/qshc.2008.031005; Neily J, 2009, ARCH SURG-CHICAGO, V144, P1028, DOI 10.1001/archsurg.2009.126; Paull DE, 2009, AM J SURG, V198, P675, DOI 10.1016/j.amjsurg.2009.07.008; Pratt SD, 2007, JT COMM J QUAL PATIE, V33, P720; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Sorbero ME, 2008, OUTCOME MEASURES EFF; SZABO CR, 2005, VETERANS HEALTHCARE; WEST A, J RURAL HLTH; Williams K A, 1999, Air Med J, V18, P149, DOI 10.1016/S1067-991X(99)90028-7	32	624	632	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2010	304	15					1693	1700		10.1001/jama.2010.1506	http://dx.doi.org/10.1001/jama.2010.1506			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666PZ	20959579	Bronze			2022-12-28	WOS:000283129700023
J	Douketis, J; Tosetto, A; Marcucci, M; Baglin, T; Cushman, M; Eichinger, S; Palareti, G; Poli, D; Tait, RC; Iorio, A				Douketis, James; Tosetto, Alberto; Marcucci, Maura; Baglin, Trevor; Cushman, Mary; Eichinger, Sabine; Palareti, Gualtiero; Poli, Daniela; Tait, R. Campbell; Iorio, Alfonso			Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability of D-Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism	ANNALS OF INTERNAL MEDICINE			English	Review							ORAL ANTICOAGULANT-THERAPY; LOW-INTENSITY WARFARIN; THROMBIN GENERATION; DURATION; EPISODE; DISEASE; EVENT; LONG; MEN	Background: In patients with a first unprovoked venous thromboembolism (VTE), an elevated D-dimer level after anticoagulation is stopped is a risk factor for recurrent VTE. However, questions remain about the utility of measuring D-dimer in clinical practice. Purpose: To determine whether the timing of testing, patient age, and the cut point used to define a positive or negative result affect the ability of D-dimer testing to distinguish risk for recurrent disease. Data Sources: Comprehensive search of electronic databases (MEDLINE, EMBASE, CINAHL, and the Cochrane Central Register of Controlled Trials) until July 2010, supplemented by reviewing conference abstracts and contacting content experts. Study Selection: 7 prospective studies that investigated an association between D-dimer, measured after stopping anticoagulation, and disease recurrence in patients with a first unprovoked VTE (proximal deep venous thrombosis, pulmonary embolism, or both). Data Extraction: Patient-level databases were obtained, transferred to a central database, checked, completed with further information provided by study investigators, and pooled into a single database. Data Synthesis: 1818 patients with a first unprovoked VTE were followed for a mean of 26.9 months (SD, 19.1). A study-stratified multivariate Cox regression model, which included patient age, sex, hormone therapy use at the time of the index event, body mass index, timing of postanticoagulation D-dimer testing, and inherited thrombophilia as possible confounders, indicated that the hazard ratio for D-dimer status (positive vs. negative) was 2.59 (95% CI, 1.90 to 3.52). Only male sex had a significant effect on risk for recurrent VTE independent of D-dimer status. The Cox regression model and the log-rank test confirmed that the risk for recurrent VTE was higher in patients with a positive D-dimer result than in those with a negative result, regardless of the timing of postanticoagulation D-dimer testing or patient age. No study- or assay-specific D-dimer effect was found, and reassessing the analysis after recoding data according to specific quantitative D-dimer cut points (500 mu g/L and 250 mu g/L) did not change the results. Limitations: Unmeasured variables could have affected the risk for recurrent VTE. The study population was predominantly white. Conclusion: In patients with a first unprovoked VTE who have their D-dimer level measured after stopping anticoagulation, the timing of D-dimer testing, patient age, and the assay cut point used do not affect the ability of D-dimer to distinguish patients with a higher or lower risk for recurrent VTE.	McMaster Univ, Hamilton, ON, Canada; S Bortolo Hosp, Vicenza, Italy; Univ Perugia, I-06100 Perugia, Italy; Addenbrookes Hosp, Cambridge, England; Univ Vermont, Burlington, VT USA; Med Univ Vienna, Vienna, Austria; Univ Hosp S Orsola Malpighi, Bologna, Italy; Azienda Osped Univ Careggi, Florence, Italy; Royal Infirm, Glasgow G31 2ER, Lanark, Scotland	McMaster University; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; University of Perugia; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Vermont; Medical University of Vienna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Florence; Azienda Ospedaliero Universitaria Careggi; Royal Infirmary of Edinburgh	Douketis, J (corresponding author), St Josephs Healthcare Hamilton, Room F-544,50 Charlton Ave E, Hamilton, ON L8N 4A6, Canada.	jdouket@mcmaster.ca	Iorio, Alfonso/B-9478-2013; Tait, Robert/AAC-6541-2022; Tosetto, Alberto/AAB-9320-2022; Tait, Campbell/AFQ-8204-2022; Douketis, James/AAO-5659-2021; Tosetto, Alberto/AAM-3200-2020	Iorio, Alfonso/0000-0002-3331-8766; Tait, Robert/0000-0003-4842-6783; Tait, Campbell/0000-0003-4842-6783; Tosetto, Alberto/0000-0002-0119-5204; Marcucci, Maura/0000-0002-8468-7991; Cushman, Mary/0000-0002-7871-6143	FCSA (Italian Federation of Anticoagulation Clinics); Oesterreichische National-bank (Jubilaeumsfonds); Medizinisch-Wissenschaftlicher Fonds des Buergermeisters der Bundeshauptstadt Wien; Wiener Staedtische Versicherung; Scottish Government Health Department [CZB/4/24]; National Heart, Lung, and Blood Institute [HL-57951, HL-58036]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058036, R01HL057951] Funding Source: NIH RePORTER	FCSA (Italian Federation of Anticoagulation Clinics); Oesterreichische National-bank (Jubilaeumsfonds); Medizinisch-Wissenschaftlicher Fonds des Buergermeisters der Bundeshauptstadt Wien; Wiener Staedtische Versicherung; Scottish Government Health Department; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The source studies were funded by the FCSA (Italian Federation of Anticoagulation Clinics); Oesterreichische National-bank (Jubilaeumsfonds); Medizinisch-Wissenschaftlicher Fonds des Buergermeisters der Bundeshauptstadt Wien; Wiener Staedtische Versicherung; Scottish Government Health Department (Chief Scientist grant CZB/4/24); and the National Heart, Lung, and Blood Institute (grants HL-57951 and HL-58036).	Adam SS, 2009, BLOOD, V113, P2878, DOI 10.1182/blood-2008-06-165845; Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Agnelli G, 2008, J THROMB THROMBOLYS, V25, P37, DOI 10.1007/s11239-007-0103-z; ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; Baglin T, 2008, J THROMB HAEMOST, V6, P577, DOI 10.1111/j.1538-7836.2008.02889.x; Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; Cundiff David Keith, 2008, Medscape J Med, V10, P258; Cushman M, 2003, BLOOD, V101, P1243, DOI 10.1182/blood-2002-05-1416; Eichinger S, 2003, JAMA-J AM MED ASSOC, V290, P1071, DOI 10.1001/jama.290.8.1071; Eichinger S, 2009, J THROMB HAEMOST, V7, P291, DOI 10.1111/j.1538-7836.2009.03383.x; ELIAS A, 1993, THROMB HAEMOSTASIS, V69, P302; Fekrazad MH, 2009, J THROMB THROMBOLYS, V28, P270, DOI 10.1007/s11239-009-0374-7; Goldhaber SZ, 2009, ANN INTERN MED, V150, P644, DOI 10.7326/0003-4819-150-9-200905050-00012; Heit JA, 2005, J THROMB HAEMOST, V3, P1611, DOI 10.1111/j.1538-7836.2005.01415.x; Ho WK, 2006, ARCH INTERN MED, V166, P729, DOI 10.1001/archinte.166.7.729; Janssen KJM, 2010, J CLIN EPIDEMIOL, V63, P721, DOI 10.1016/j.jclinepi.2009.12.008; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Keeling D, 2006, BLOOD REV, V20, P173, DOI 10.1016/j.blre.2005.09.001; Koopman L, 2007, J CLIN EPIDEMIOL, V60, P1002, DOI 10.1016/j.jclinepi.2007.01.018; Le Gal G, 2004, J THROMB HAEMOST, V2, P1244, DOI 10.1111/j.1538-7836.2004.00795.x; LEGAL G, 2010, THROMB HAEMOST, V104; Linkins LA, 2004, J THROMB HAEMOST, V2, P1256, DOI 10.1111/j.1538-7836.2004.00824.x; Lutsey PL, 2006, J THROMB HAEMOST, V4, P2629, DOI 10.1111/j.1538-7836.2006.02237.x; Lutsey PL, 2009, J THROMB HAEMOST, V7, P1639, DOI 10.1111/j.1538-7836.2009.03561.x; MacCallum PK, 2004, BRIT J HAEMATOL, V127, P448, DOI 10.1111/j.1365-2141.2004.05222.x; Merlin T, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-34; Millett GA, 2008, JAMA-J AM MED ASSOC, V300, P1674, DOI 10.1001/jama.300.14.1674; Palareti G, 2003, CIRCULATION, V108, P313, DOI 10.1161/01.CIR.0000079162.69615.0F; Palareti G, 2007, CURR OPIN PULM MED, V13, P393, DOI 10.1097/MCP.0b013e3282058b94; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Poli D, 2008, J THROMB HAEMOST, V6, P708, DOI 10.1111/j.1538-7836.2008.02900.x; Prandoni P, 2007, HAEMATOLOGICA, V92, P199, DOI 10.3324/haematol.10516; Prandoni P, 2009, ANN INTERN MED, V150, P577, DOI 10.7326/0003-4819-150-9-200905050-00003; Righini M, 2000, AM J MED, V109, P357, DOI 10.1016/S0002-9343(00)00493-9; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493; Shrivastava S, 2006, J THROMB HAEMOST, V4, P1208, DOI 10.1111/j.1538-7836.2006.01935.x; Smith CT, 2005, STAT MED, V24, P1307, DOI 10.1002/sim.2050; Snow V, 2007, ANN INTERN MED, V146, P204, DOI 10.7326/0003-4819-146-3-200702060-00149; Spencer FA, 2008, THROMB HAEMOSTASIS, V100, P780, DOI 10.1160/TH08-04-0255; Spencer FA, 2009, J THROMB THROMBOLYS, V28, P401, DOI 10.1007/s11239-009-0378-3; Spencer FA, 2009, THROMB HAEMOSTASIS, V101, P878, DOI 10.1160/TH08-06-0352; Sud S, 2009, ANN INTERN MED, V151, DOI 10.7326/0003-4819-151-2-200907210-02002; TAIT R, 2007, J THROMB HAEMOST, V5; Verhovsek M, 2008, ANN INTERN MED, V149, P481, DOI 10.7326/0003-4819-149-7-200810070-00008; Wells G.A., 2000, VIS COMMUN Q; Wells PS, 2007, J THROMB HAEMOST, V5, P41, DOI 10.1111/j.1538-7836.2007.02493.x	49	127	136	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8					523	531		10.7326/0003-4819-153-8-201010190-00009	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956709				2022-12-28	WOS:000283054600005
J	Shaw, DE; Maragakis, P; Lindorff-Larsen, K; Piana, S; Dror, RO; Eastwood, MP; Bank, JA; Jumper, JM; Salmon, JK; Shan, YB; Wriggers, W				Shaw, David E.; Maragakis, Paul; Lindorff-Larsen, Kresten; Piana, Stefano; Dror, Ron O.; Eastwood, Michael P.; Bank, Joseph A.; Jumper, John M.; Salmon, John K.; Shan, Yibing; Wriggers, Willy			Atomic-Level Characterization of the Structural Dynamics of Proteins	SCIENCE			English	Article							PANCREATIC TRYPSIN-INHIBITOR; DISULFIDE BOND ISOMERIZATION; FOLDING TRANSITION-STATES; BETA-HAIRPIN FORMATION; PHI-VALUE ANALYSIS; WW DOMAIN; RELAXATION DISPERSION; FORCE-FIELD; SPEED LIMIT; SIMULATIONS	Molecular dynamics (MD) simulations are widely used to study protein motions at an atomic level of detail, but they have been limited to time scales shorter than those of many biologically critical conformational changes. We examined two fundamental processes in protein dynamics-protein folding and conformational change within the folded state-by means of extremely long all-atom MD simulations conducted on a special-purpose machine. Equilibrium simulations of a WW protein domain captured multiple folding and unfolding events that consistently follow a well-defined folding pathway; separate simulations of the protein's constituent substructures shed light on possible determinants of this pathway. A 1-millisecond simulation of the folded protein BPTI reveals a small number of structurally distinct conformational states whose reversible interconversion is slower than local relaxations within those states by a factor of more than 1000.	[Shaw, David E.; Maragakis, Paul; Lindorff-Larsen, Kresten; Piana, Stefano; Dror, Ron O.; Eastwood, Michael P.; Bank, Joseph A.; Jumper, John M.; Salmon, John K.; Shan, Yibing; Wriggers, Willy] DE Shaw Res, New York, NY 10036 USA; [Shaw, David E.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	D. E. Shaw Research; Columbia University	Shaw, DE (corresponding author), DE Shaw Res, 120 W 45th St, New York, NY 10036 USA.	David.Shaw@DEShawResearch.com	Lindorff-Larsen, Kresten/K-6469-2014	Lindorff-Larsen, Kresten/0000-0002-4750-6039; Wriggers, Willy/0000-0001-5326-3152; Dror, Ron/0000-0002-6418-2793				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Best RB, 2005, P NATL ACAD SCI USA, V102, P6732, DOI 10.1073/pnas.0408098102; Chakrapani S, 2005, P NATL ACAD SCI USA, V102, P87, DOI 10.1073/pnas.0406777102; Chung HS, 2009, P NATL ACAD SCI USA, V106, P11837, DOI 10.1073/pnas.0901178106; Cota E, 2000, J MOL BIOL, V302, P713, DOI 10.1006/jmbi.2000.4053; Deechongkit S, 2004, NATURE, V430, P101, DOI 10.1038/nature02611; Ensign DL, 2009, BIOPHYS J, V96, pL53, DOI 10.1016/j.bpj.2009.01.024; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Freddolino PL, 2008, BIOPHYS J, V94, pL75, DOI 10.1529/biophysj.108.131565; Freddolino PL, 2009, BIOPHYS J, V96, P3772, DOI 10.1016/j.bpj.2009.02.033; Gardino AK, 2009, CELL, V139, P1109, DOI 10.1016/j.cell.2009.11.022; Geierhaas CD, 2008, PROTEIN ENG DES SEL, V21, P215, DOI 10.1093/protein/gzm092; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Grey MJ, 2003, J AM CHEM SOC, V125, P14324, DOI 10.1021/ja0367389; Jager M, 2006, P NATL ACAD SCI USA, V103, P10648, DOI 10.1073/pnas.0600511103; Jager M, 2009, PROTEIN SCI, V18, P1806, DOI 10.1002/pro.172; Jager M, 2001, J MOL BIOL, V311, P373, DOI 10.1006/jmbi.2001.4873; Juraszek J, 2010, BIOPHYS J, V98, P646, DOI 10.1016/j.bpj.2009.10.039; KARPLUS M, 1994, PROTEIN SCI, V3, P650; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kubelka J, 2006, J MOL BIOL, V359, P546, DOI 10.1016/j.jmb.2006.03.034; Lei HX, 2007, CURR OPIN STRUC BIOL, V17, P187, DOI 10.1016/j.sbi.2007.03.003; LEVITT M, 1975, NATURE, V253, P694, DOI 10.1038/253694a0; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu F, 2008, P NATL ACAD SCI USA, V105, P2369, DOI 10.1073/pnas.0711908105; Liu F, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3262489; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; McCallister EL, 2000, NAT STRUCT BIOL, V7, P669, DOI 10.1038/77971; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Noe F, 2009, P NATL ACAD SCI USA, V106, P19011, DOI 10.1073/pnas.0905466106; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Nymeyer H, 2000, P NATL ACAD SCI USA, V97, P634, DOI 10.1073/pnas.97.2.634; OTTING G, 1993, BIOCHEMISTRY-US, V32, P3571, DOI 10.1021/bi00065a008; OTTING G, 1991, SCIENCE, V254, P974, DOI 10.1126/science.1948083; Persson E, 2008, J AM CHEM SOC, V130, P1774, DOI 10.1021/ja0775873; Petrovich M, 2006, J MOL BIOL, V360, P865, DOI 10.1016/j.jmb.2006.05.050; Settanni G, 2005, P NATL ACAD SCI USA, V102, P628, DOI 10.1073/pnas.0406754102; Shaw D. E, 2009, P ACM IEEE C SUP SC0; Snow CD, 2002, NATURE, V420, P102, DOI 10.1038/nature01160; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; WAGNER G, 1987, J MOL BIOL, V196, P227, DOI 10.1016/0022-2836(87)90524-9; WLODAWER A, 1984, J MOL BIOL, V180, P301, DOI 10.1016/S0022-2836(84)80006-6; WUTHRICH K, 1975, FEBS LETT, V50, P265, DOI 10.1016/0014-5793(75)80504-7; Zhou YQ, 1999, J MOL BIOL, V285, P1371, DOI 10.1006/jmbi.1998.2374	48	1277	1286	11	506	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2010	330	6002					341	346		10.1126/science.1187409	http://dx.doi.org/10.1126/science.1187409			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947758				2022-12-28	WOS:000282986700033
J	Okie, S				Okie, Susan			Reviving the FDA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Georgetown Univ, Sch Med, Washington, DC 20057 USA	Georgetown University	Okie, S (corresponding author), Georgetown Univ, Sch Med, Washington, DC 20057 USA.							*FOOD DRUG ADM, CDRH PREL INT EV; *FOOD DRUG ADM, 2009, REV REGEN MEN DEP PR; *FOOD DRUG ADM, 2009, FIN REP POSTM REQ PO; NEUMAN W, 2009, NY TIMES        0917, pB1	4	8	9	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2010	363	16					1492	1494		10.1056/NEJMp1009686	http://dx.doi.org/10.1056/NEJMp1009686			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663KP	20925536				2022-12-28	WOS:000282887100002
J	Hecht, R; Stover, J; Bollinger, L; Muhib, F; Case, K; de Ferranti, D				Hecht, Robert; Stover, John; Bollinger, Lori; Muhib, Farzana; Case, Kelsey; de Ferranti, David			Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009-31	LANCET			English	Review							HIV	As the global HIV/AIDS pandemic nears the end of its third decade, the challenges of efficient mobilisation of funds and management of resources are increasingly prominent. The aids2031 project modelled long-term funding needs for HIV/AIDS in developing countries with a range of scenarios and substantial variation in costs: ranging from US$397 to $722 billion globally between 2009 and 2031, depending on policy choices adopted by governments and donors. We examine what these figures mean for individual developing countries, and estimate the proportion of HIV/AIDS funding that they and donors will provide. Scenarios for expanded HIV/AIDS prevention, treatment, and mitigation were analysed for 15 representative countries. We suggest that countries will move in increasingly divergent directions over the next 20 years; middle-income countries with a low burden of HIV/AIDS will gradually be able to take on the modest costs of their HIV/AIDS response, whereas low-income countries with a high burden of disease will remain reliant upon external support for their rapidly expanding costs. A small but important group of middle-income countries with a high prevalence of HIV/AIDS (eg, South Africa) form a third category, in which rapid scale-up in the short term, matched by outside funds, could be phased down within 10 years assuming strategic investments are made for prevention and efficiency gains are made in treatment.	[Hecht, Robert; Muhib, Farzana; de Ferranti, David] Results Dev Inst, Washington, DC 20009 USA; [Stover, John; Bollinger, Lori] Futures Inst, Glastonbury, CT USA; [Case, Kelsey] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth, London, England	Imperial College London	Hecht, R (corresponding author), Results Dev Inst, 1875 Connecticut Ave NW,Suite 1210, Washington, DC 20009 USA.	rhecht@resultsfordevelopment.org						*AIDS2031 WORK GRO, AS EC RAP TRANS HIV; BHAKEECHEEP S, 2009, M FOR WORK GROUP WHO; BOLLINGER L, 2010, 18 INT AIDS C VIENN; BOLLINGER L, ESTIMATING LONG TERM; *GLOB FUND FIGHT A, 2009, PROGR REP IMPL GLOB; *GLOB FUND FIGHT A, GRANT PORTF; *GLOB FUND FIGHT A, MIDT REV 2 VOL REPL; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Hallett TB, 2010, AIDS, V24, P147, DOI 10.1097/QAD.0b013e32833062dc; Hecht R, 2009, HEALTH AFFAIR, V28, P1591, DOI 10.1377/hlthaff.28.6.1591; Izazola-Licea JA, 2009, JAIDS-J ACQ IMM DEF, V52, pS119, DOI 10.1097/QAI.0b013e3181baeeda; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; LUI B, 2007, AIDS, V21, P123; *NAT AIDS CONTR CO, 2010, MOZ 2008 PROGR REP U; *NAT AIDS CONTR CO, 2010, UG PROGR REP UN GEN; *NAT AIDS CONTR CO, 2010, PROGR REP UN GEN ASS; Over M., 2008, 144 CTR GLOB DEV; PEPFAR, 2009, US PRES EM PLAN AIDS; *RES DEV I, 2010, AIDS2031 CAMB CAS ST; *RES DEV I, 2009, AIDS2031 COSTS FIN W; STOVER J, 2009, COSTS ANTIRETROVIRAL; The Kaiser Family Foundation, GLOB HLTH FACTS; *UNAIDS, 2008, 2008 REP GLOB AIDS E; UNAIDS, 2008, RED AIDS AS CRAFT EF; UNAIDS, 2009, WHAT COUNTR NEED INV; *UNAIDS, 2009, HIV PREV RESP MOD TR; UNAIDS/WHO, AIDS EP UPD NOV 2009; *USAID UNAIDS WHO, 2004, COV SEL SERV HIV AID; *WHO UNICEF UNAIDS, UN ACC SCAL PRIOR HI; World Bank, WORLD DEV IND ONL; World Health Organization, 2009, RAP ADV ANT THER HIV; ZUMA J, 2009, COMMUNICATION   1029; Zuma Jacob, 2009, COMMUNICATION   1201	33	70	73	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 9	2010	376	9748					1254	1260		10.1016/S0140-6736(10)61255-X	http://dx.doi.org/10.1016/S0140-6736(10)61255-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	664ZT	20934597				2022-12-28	WOS:000283003500035
J	Kondo, S; Miura, T				Kondo, Shigeru; Miura, Takashi			Reaction-Diffusion Model as a Framework for Understanding Biological Pattern Formation	SCIENCE			English	Review							LATERAL-INHIBITION; ZEBRAFISH; ACTIVATION; GENERATION; WAVES; WNT	The Turing, or reaction-diffusion (RD), model is one of the best-known theoretical models used to explain self-regulated pattern formation in the developing animal embryo. Although its real-world relevance was long debated, a number of compelling examples have gradually alleviated much of the skepticism surrounding the model. The RD model can generate a wide variety of spatial patterns, and mathematical studies have revealed the kinds of interactions required for each, giving this model the potential for application as an experimental working hypothesis in a wide variety of morphological phenomena. In this review, we describe the essence of this theory for experimental biologists unfamiliar with the model, using examples from experimental studies in which the RD model is effectively incorporated.	[Kondo, Shigeru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Miura, Takashi] Kyoto Univ, Grad Sch Med, Dept Anat & Dev Biol, Kyoto 6068501, Japan	Osaka University; Kyoto University	Kondo, S (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	skondo@fbs.osaka-u.ac.jp	Miura, Takashi/AAF-3003-2021	Miura, Takashi/0000-0002-9465-275X; Kondo, Shigeru/0000-0003-0192-5526				ALON U, 2006, INTRO SYSTEMS BIOL; Asai R, 1999, MECH DEVELOP, V89, P87, DOI 10.1016/S0925-4773(99)00211-7; Augustin R, 2006, DEV BIOL, V296, P62, DOI 10.1016/j.ydbio.2006.04.003; CABRERA CV, 1990, DEVELOPMENT, V110, P733; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; Dormann D, 2001, DEVELOPMENT, V128, P4535; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Harris MP, 2005, P NATL ACAD SCI USA, V102, P11734, DOI 10.1073/pnas.0500781102; Iovine MK, 2005, DEV BIOL, V278, P208, DOI 10.1016/j.ydbio.2004.11.005; Jung HS, 1998, DEV BIOL, V196, P11, DOI 10.1006/dbio.1998.8850; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; MAINI PK, 1991, B MATH BIOL, V53, P701, DOI 10.1007/BF02461550; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; MEINHARDT H, 1974, J CELL SCI, V15, P321; Meinhardt H., 1995, ALGORITHMIC BEAUTY S; Meinhardt H., 1982, MODELS BIOL PATTERN; Miura T, 2000, DEV DYNAM, V217, P241, DOI 10.1002/(SICI)1097-0177(200003)217:3<241::AID-DVDY2>3.0.CO;2-K; Murray J. D., 2001, MATH BIOL, V18; MURRAY JD, 1983, J MATH BIOL, V17, P125; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Nakamura T, 2006, DEV CELL, V11, P495, DOI 10.1016/j.devcel.2006.08.002; NEWMAN SA, 1979, SCIENCE, V205, P662, DOI 10.1126/science.462174; Newman Stuart A, 2009, Int J Dev Biol, V53, P663, DOI 10.1387/ijdb.072553cc; Parichy DM, 2009, SEMIN CELL DEV BIOL, V20, P63, DOI 10.1016/j.semcdb.2008.12.010; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Rauch EM, 2004, J THEOR BIOL, V226, P401, DOI 10.1016/j.jtbi.2003.09.018; Sanderson A. R., 2006, Journal of Graphics Tools, V11, P47; Sardet C, 1998, BIOPHYS CHEM, V72, P131, DOI 10.1016/S0301-4622(98)00129-X; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Song LS, 2005, ANN NY ACAD SCI, V1047, P99, DOI 10.1196/annals.1341.009; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; SWINDALE NV, 1980, PROC R SOC SER B-BIO, V208, P243, DOI 10.1098/rspb.1980.0051; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1007/BF02459572; Ueda HR, 2007, COLD SPRING HARB SYM, V72, P365, DOI 10.1101/sqb.2007.72.047; Watanabe M, 2006, EMBO REP, V7, P893, DOI 10.1038/sj.embor.7400757; Wolpert L., 2011, PRINCIPLES DEV; Yamaguchi M, 2007, P NATL ACAD SCI USA, V104, P4790, DOI 10.1073/pnas.0607790104	39	933	948	7	373	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2010	329	5999					1616	1620		10.1126/science.1179047	http://dx.doi.org/10.1126/science.1179047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929839				2022-12-28	WOS:000282098100031
J	Gladstone, GR; Hurley, DM; Retherford, KD; Feldman, PD; Pryor, WR; Chaufray, JY; Versteeg, M; Greathouse, TK; Steffl, AJ; Throop, H; Parker, JW; Kaufmann, DE; Egan, AF; Davis, MW; Slater, DC; Mukherjee, J; Miles, PF; Hendrix, AR; Colaprete, A; Stern, SA				Gladstone, G. Randall; Hurley, Dana M.; Retherford, Kurt D.; Feldman, Paul D.; Pryor, Wayne R.; Chaufray, Jean-Yves; Versteeg, Maarten; Greathouse, Thomas K.; Steffl, Andrew J.; Throop, Henry; Parker, Joel Wm.; Kaufmann, David E.; Egan, Anthony F.; Davis, Michael W.; Slater, David C.; Mukherjee, Joey; Miles, Paul F.; Hendrix, Amanda R.; Colaprete, Anthony; Stern, S. Alan			LRO-LAMP Observations of the LCROSS Impact Plume	SCIENCE			English	Article							MOLECULAR-HYDROGEN; BAND SYSTEM; LUNAR; MISSION; TABLE	On 9 October 2009, the Lunar Crater Observation and Sensing Satellite (LCROSS) sent a kinetic impactor to strike Cabeus crater, on a mission to search for water ice and other volatiles expected to be trapped in lunar polar soils. The Lyman Alpha Mapping Project (LAMP) ultraviolet spectrograph onboard the Lunar Reconnaissance Orbiter (LRO) observed the plume generated by the LCROSS impact as far-ultraviolet emissions from the fluorescence of sunlight by molecular hydrogen and carbon monoxide, plus resonantly scattered sunlight from atomic mercury, with contributions from calcium and magnesium. The observed light curve is well simulated by the expansion of a vapor cloud at a temperature of similar to 1000 kelvin, containing similar to 570 kilograms (kg) of carbon monoxide, similar to 140 kg of molecular hydrogen, similar to 160 kg of calcium, similar to 120 kg of mercury, and similar to 40 kg of magnesium.	[Gladstone, G. Randall; Retherford, Kurt D.; Chaufray, Jean-Yves; Versteeg, Maarten; Greathouse, Thomas K.; Davis, Michael W.; Slater, David C.; Mukherjee, Joey; Miles, Paul F.] SW Res Inst, San Antonio, TX 78238 USA; [Hurley, Dana M.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Feldman, Paul D.] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Pryor, Wayne R.] Cent Arizona Coll, Coolidge, AZ 85228 USA; [Steffl, Andrew J.; Throop, Henry; Parker, Joel Wm.; Kaufmann, David E.; Egan, Anthony F.; Stern, S. Alan] SW Res Inst, Boulder, CO 80302 USA; [Hendrix, Amanda R.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Colaprete, Anthony] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Southwest Research Institute; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Johns Hopkins University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Gladstone, GR (corresponding author), SW Res Inst, San Antonio, TX 78238 USA.	rgladstone@swri.edu	Hurley, Dana/F-4488-2015; Davis, Michael/AAK-3433-2021	Hurley, Dana/0000-0003-1052-1494; Davis, Michael/0000-0003-4338-1635; Parker, Joel/0000-0002-3672-0603	NASA; NASA Lunar Science Institute [NNA09DB31A]	NASA(National Aeronautics & Space Administration (NASA)); NASA Lunar Science Institute	We thank the LRO project and other LRO instrument leads for supporting the LCROSS support observations. In particular we thank C. Tooley, D. Everett, M. Houghton, A. Bartels, R. Saylor, R. Vondrak, G. Chin, J. Keller, T. Johnson, and C. Baker for making it happen. We also thank D. Goldstein and D. Summy for useful simulations and predictions, R. Killen and D. Boice for helpful discussions, and the referees for excellent comments. The LAMP is funded by NASA, whose financial support we gratefully acknowledge. One of us (D.M.H.) also acknowledges support from NASA Lunar Science Institute grant NNA09DB31A.	ABGRALL H, 1993, ASTRON ASTROPHYS SUP, V101, P323; ABGRALL H, 1993, ASTRON ASTROPHYS SUP, V101, P273; Abgrall H, 1997, ASTROPHYS J, V481, P557, DOI 10.1086/304017; ANDERS E, 1977, PHILOS T R SOC A, V285, P23, DOI 10.1098/rsta.1977.0040; ARNOLD JR, 1979, J GEOPHYS RES, V84, P5659, DOI 10.1029/JB084iB10p05659; Blanford G., 1985, LUNAR BASES SPACE AC, P603; Chin G, 2007, SPACE SCI REV, V129, P391, DOI 10.1007/s11214-007-9153-y; Colaprete A, 2010, SCIENCE, V330, P463, DOI 10.1126/science.1186986; Crider DH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002030; CRIDER DH, 2000, J GEOPHYS RES, V26, P773; Curdt W, 2001, ASTRON ASTROPHYS, V375, P591, DOI 10.1051/0004-6361:20010364; Gladstone GR, 2010, SPACE SCI REV, V150, P161, DOI 10.1007/s11214-009-9578-6; Goldstein DB, 2009, AIP CONF PROC, V1084, P1061; Hodges R.R., 1981, LUNAR PLANETARY I SC, P451; HUEBNER WF, 1992, ASTROPHYS SPACE SCI, V195, P1, DOI 10.1007/BF00644558; Korycansky DG, 2009, METEORIT PLANET SCI, V44, P603, DOI 10.1111/j.1945-5100.2009.tb00755.x; McClintock WE, 2009, SCIENCE, V324, P610, DOI 10.1126/science.1172525; Paige DA, 2010, SCIENCE, V330, P479, DOI 10.1126/science.1187726; PILLINGER CT, 1979, REP PROG PHYS, V42, P897, DOI 10.1088/0034-4885/42/5/003; Reed GW, 1999, METEORIT PLANET SCI, V34, P809, DOI 10.1111/j.1945-5100.1999.tb01394.x; Tozzi GP, 1998, ASTRON ASTROPHYS, V330, P753; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033	22	103	105	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					472	476		10.1126/science.1186474	http://dx.doi.org/10.1126/science.1186474			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966244				2022-12-28	WOS:000283329100030
J	Gong, ZF; Liu, JQ; Guo, C; Zhou, YQ; Teng, Y; Liu, L				Gong, Zhefeng; Liu, Jiangqu; Guo, Chao; Zhou, Yanqiong; Teng, Yan; Liu, Li			Two Pairs of Neurons in the Central Brain Control Drosophila Innate Light Preference	SCIENCE			English	Article							SENSORY NEURONS; MELANOGASTER; BEHAVIOR; ULTRASTRUCTURE; EXPRESSION; DISTINCT; CIRCUIT; MEDIATE; SWITCH; CLOCK	Appropriate preferences for light or dark conditions can be crucial for an animal's survival. Innate light preferences are not static in some animals, including the fruit fly Drosophila melanogaster, which prefers darkness in the feeding larval stage but prefers light in adulthood. To elucidate the neural circuit underlying light preference, we examined the neurons involved in larval phototactic behavior by regulating neuronal functions. Modulating activity of two pairs of isomorphic neurons in the central brain switched the larval light preference between photophobic and photophilic. These neurons were found to be immediately downstream of pdf-expressing lateral neurons, which are innervated by larval photoreceptors. Our results revealed a neural mechanism that could enable the adjustment of animals' response strategies to environmental stimuli according to biological needs.	[Gong, Zhefeng; Liu, Jiangqu; Guo, Chao; Zhou, Yanqiong; Liu, Li] Chinese Acad Sci, State Key Lab Brain & Cognit Sci, Inst Biophys, Beijing 100101, Peoples R China; [Liu, Jiangqu; Guo, Chao; Zhou, Yanqiong] Chinese Acad Sci, Grad Univ, Beijing 100039, Peoples R China; [Teng, Yan] Chinese Acad Sci, Inst Biophys, Prot Sci Core Facil Ctr, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Gong, ZF (corresponding author), Chinese Acad Sci, State Key Lab Brain & Cognit Sci, Inst Biophys, Beijing 100101, Peoples R China.	zfgong@moon.ibp.ac.cn; liuli@sun5.ibp.ac.cn			National Natural Sciences Foundation of China [30770682, 30621004, 30625022]; '973 Program' [2005CB522804, 2009CB918702]; Chinese Academy of Sciences [KSCX2-YW-R-247]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); '973 Program'(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank K. Rao for antibody to Pdf; J. Blau, K. Scott, M. Rosbach, T. Lee, C. Feng, Y. Zhong, W. Yi, Y. Jan, and R. Jiao for fly stocks and constructs; and C. Wang and X. Hao for facility setup. We thank the DGRC (Kyoto) and the Bloomington fly stock center for the fly stocks, and Developmental Studies Hybridoma Bank for antibodies. We also thank H. Gong for technical assistance, and J. Fleming and R. Wolf for valuable comments. This work was supported by the National Natural Sciences Foundation of China [grant 30770682 (Z.G.) and grants 30621004 and 30625022 (L.L.)], the '973 Program' [grants 2005CB522804 and 2009CB918702 (L.L.)], and the Knowledge Innovation Program of the Chinese Academy of Sciences [grant KSCX2-YW-R-247 (L.L.)].	Ben-Shahar Y, 2003, J EXP BIOL, V206, P2507, DOI 10.1242/jeb.00442; Busto M, 1999, J NEUROSCI, V19, P3337; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; DIRCKSEN H, 1987, CELL TISSUE RES, V250, P377; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; GROSSFIELD J, 1971, P NATL ACAD SCI USA, V68, P2669, DOI 10.1073/pnas.68.11.2669; Hassan J, 2005, J COMP NEUROL, V481, P266, DOI 10.1002/cne.20383; Helfrich-Forster C, 2002, J NEUROSCI, V22, P9255; Li WZ, 2009, CELL TISSUE RES, V336, P509, DOI 10.1007/s00441-009-0781-2; Malpel S, 2002, DEVELOPMENT, V129, P1443; MANNING M, 1981, BEHAV GENET, V11, P557, DOI 10.1007/BF01065790; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; SAWIN FP, 1994, J INSECT BEHAV, V7, P553, DOI 10.1007/BF02025449; SawinMcCormack EP, 1995, J NEUROGENET, V10, P119, DOI 10.3109/01677069509083459; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Sprecher SG, 2008, NATURE, V454, P533, DOI 10.1038/nature07062; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021	25	62	67	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					499	502		10.1126/science.1195993	http://dx.doi.org/10.1126/science.1195993			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966250				2022-12-28	WOS:000283329100038
J	Lawniczak, MKN; Emrich, SJ; Holloway, AK; Regier, AP; Olson, M; White, B; Redmond, S; Fulton, L; Appelbaum, E; Godfrey, J; Farmer, C; Chinwalla, A; Yang, SP; Minx, P; Nelson, J; Kyung, K; Walenz, BP; Garcia-Hernandez, E; Aguiar, M; Viswanathan, LD; Rogers, YH; Strausberg, RL; Saski, CA; Lawson, D; Collins, FH; Kafatos, FC; Christophides, GK; Clifton, SW; Kirkness, EF; Besansky, NJ				Lawniczak, M. K. N.; Emrich, S. J.; Holloway, A. K.; Regier, A. P.; Olson, M.; White, B.; Redmond, S.; Fulton, L.; Appelbaum, E.; Godfrey, J.; Farmer, C.; Chinwalla, A.; Yang, S. -P.; Minx, P.; Nelson, J.; Kyung, K.; Walenz, B. P.; Garcia-Hernandez, E.; Aguiar, M.; Viswanathan, L. D.; Rogers, Y. -H.; Strausberg, R. L.; Saski, C. A.; Lawson, D.; Collins, F. H.; Kafatos, F. C.; Christophides, G. K.; Clifton, S. W.; Kirkness, E. F.; Besansky, N. J.			Widespread Divergence Between Incipient Anopheles gambiae Species Revealed by Whole Genome Sequences	SCIENCE			English	Article							MOLECULAR-FORMS; ECOLOGICAL SPECIATION; GENE FLOW; ISLANDS; SEGREGATION; CULICIDAE; SELECTION; DIPTERA; S.S.	The Afrotropical mosquito Anopheles gambiae sensu stricto, a major vector of malaria, is currently undergoing speciation into the M and S molecular forms. These forms have diverged in larval ecology and reproductive behavior through unknown genetic mechanisms, despite considerable levels of hybridization. Previous genome-wide scans using gene-based microarrays uncovered divergence between M and S that was largely confined to gene-poor pericentromeric regions, prompting a speciation-with-ongoing-gene-flow model that implicated only about 3% of the genome near centromeres in the speciation process. Here, based on the complete M and S genome sequences, we report widespread and heterogeneous genomic divergence inconsistent with appreciable levels of interform gene flow, suggesting a more advanced speciation process and greater challenges to identify genes critical to initiating that process.	[White, B.; Collins, F. H.; Besansky, N. J.] Univ Notre Dame, Eck Inst Global Hlth, Dept Biol Sci, Notre Dame, IN 46556 USA; [Lawniczak, M. K. N.; Redmond, S.; Kafatos, F. C.; Christophides, G. K.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England; [Emrich, S. J.; Regier, A. P.; Olson, M.] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Holloway, A. K.] J David Gladstone Inst, San Francisco, CA 94158 USA; [Fulton, L.; Appelbaum, E.; Godfrey, J.; Farmer, C.; Chinwalla, A.; Yang, S. -P.; Minx, P.; Nelson, J.; Kyung, K.; Clifton, S. W.] Washington Univ, Genome Ctr, St Louis, MO 63108 USA; [Walenz, B. P.; Garcia-Hernandez, E.; Aguiar, M.; Viswanathan, L. D.; Rogers, Y. -H.; Strausberg, R. L.; Kirkness, E. F.] J Craig Venter Inst, Rockville, MD 20850 USA; [Saski, C. A.] Clemson Univ, Clemson Univ Genom Inst, Clemson, SC 29634 USA; [Lawson, D.] European Bioinformat Inst EMBL EBI, Cambridge CB10 1SD, England	University of Notre Dame; Imperial College London; University of Notre Dame; University of California System; University of California San Francisco; The J David Gladstone Institutes; Washington University (WUSTL); J. Craig Venter Institute; Clemson University; European Molecular Biology Laboratory (EMBL)	Besansky, NJ (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Dept Biol Sci, Notre Dame, IN 46556 USA.	nbesansk@nd.edu	Holloway, Alisha/H-9574-2013	Holloway, Alisha/0000-0001-9810-389X; Lawniczak, Mara/0000-0002-3006-2080; redmond, seth/0000-0003-2653-760X; Lawson, Daniel/0000-0001-7765-983X; Chinwalla, Asif/0000-0001-7831-3996; Christophides, George/0000-0002-3323-1687	National Human Genome Research Institute [U54-HG00379, U54-HG03068]; NIH [RO1 AI63508, AI076584]; Biotechnology and Biological Sciences Research Council [BB/E002641/1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003068, R01HG000379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076584, R01AI063508] Funding Source: NIH RePORTER; BBSRC [BB/E002641/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C519670/1] Funding Source: researchfish	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank W. M. Gelbart, an early advocate of this project, and J. L. Feder, P. Nosil, and M. W. Hahn for critical review. P. Howell of MR4 provided mosquitoes. Funding for genome sequencing of M (U54-HG00379) and S (U54-HG03068) was provided by the National Human Genome Research Institute. N.J.B. was supported by NIH (RO1 AI63508 and AI076584). M.K.N.L. was supported by Biotechnology and Biological Sciences Research Council research grant BB/E002641/1 to G.K.C. Sequence data are deposited with GenBank (accessions ABKP00000000 and ABKQ00000000).	Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Carneiro M, 2009, GENETICS, V181, P593, DOI 10.1534/genetics.108.096826; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Diabate A, 2006, J MED ENTOMOL, V43, P480, DOI 10.1603/0022-2585(2006)43[480:MSOTMM]2.0.CO;2; Diabate A, 2007, J MED ENTOMOL, V44, P60, DOI 10.1603/0022-2585(2007)44[60:ETEOPI]2.0.CO;2; Diabate A, 2009, P ROY SOC B-BIOL SCI, V276, P4215, DOI 10.1098/rspb.2009.1167; Du W, 2005, INSECT MOL BIOL, V14, P179, DOI 10.1111/j.1365-2583.2005.00544.x; Feder JL, 2010, EVOLUTION, V64, P1729, DOI [10.1111/j.1558-5646.2009.00943.x, 10.1111/j.1558-5646.2010.00943.x]; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; Li YF, 2008, EVOLUTION, V62, P2984, DOI 10.1111/j.1558-5646.2008.00486.x; Mehren JE, 2007, CURR BIOL, V17, pR240, DOI 10.1016/j.cub.2007.02.014; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x	24	206	208	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					512	514		10.1126/science.1195755	http://dx.doi.org/10.1126/science.1195755			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966253	Green Accepted			2022-12-28	WOS:000283329100042
J	Jung, M; Reichstein, M; Ciais, P; Seneviratne, SI; Sheffield, J; Goulden, ML; Bonan, G; Cescatti, A; Chen, JQ; de Jeu, R; Dolman, AJ; Eugster, W; Gerten, D; Gianelle, D; Gobron, N; Heinke, J; Kimball, J; Law, BE; Montagnani, L; Mu, QZ; Mueller, B; Oleson, K; Papale, D; Richardson, AD; Roupsard, O; Running, S; Tomelleri, E; Viovy, N; Weber, U; Williams, C; Wood, E; Zaehle, S; Zhang, K				Jung, Martin; Reichstein, Markus; Ciais, Philippe; Seneviratne, Sonia I.; Sheffield, Justin; Goulden, Michael L.; Bonan, Gordon; Cescatti, Alessandro; Chen, Jiquan; de Jeu, Richard; Dolman, A. Johannes; Eugster, Werner; Gerten, Dieter; Gianelle, Damiano; Gobron, Nadine; Heinke, Jens; Kimball, John; Law, Beverly E.; Montagnani, Leonardo; Mu, Qiaozhen; Mueller, Brigitte; Oleson, Keith; Papale, Dario; Richardson, Andrew D.; Roupsard, Olivier; Running, Steve; Tomelleri, Enrico; Viovy, Nicolas; Weber, Ulrich; Williams, Christopher; Wood, Eric; Zaehle, Soenke; Zhang, Ke			Recent decline in the global land evapotranspiration trend due to limited moisture supply	NATURE			English	Article							VALIDATION; BIOSPHERE; PRODUCTS; CLIMATE; IMPACT; CYCLE	More than half of the solar energy absorbed by land surfaces is currently used to evaporate water(1). Climate change is expected to intensify the hydrological cycle(2) and to alter evapotranspiration, with implications for ecosystem services and feedback to regional and global climate. Evapotranspiration changes may already be under way, but direct observational constraints are lacking at the global scale. Until such evidence is available, changes in the water cycle on land-a key diagnostic criterion of the effects of climate change and variability-remain uncertain. Here we provide a data-driven estimate of global land evapotranspiration from 1982 to 2008, compiled using a global monitoring network(3), meteorological and remote-sensing observations, and a machine-learning algorithm(4). In addition, we have assessed evapotranspiration variations over the same time period using an ensemble of process-based land-surface-models. Our results suggest that global annual evapotranspiration increased on average by 7.1 +/- 1.0 millimetres per year per decade from 1982 to 1997. After that, coincident with the last major El Nino event in 1998, the global evapotranspiration increase seems to have ceased until 2008. This change was driven primarily by moisture limitation in the Southern Hemisphere, particularly Africa and Australia. In these regions, microwave satellite observations indicate that soil moisture decreased from 1998 to 2008. Hence, increasing soil-moisture limitations on evapotranspiration largely explain the recent decline of the global land-evapotranspiration trend. Whether the changing behaviour of evapotranspiration is representative of natural climate variability or reflects a more permanent reorganization of the land water cycle is a key question for earth system science.	[Jung, Martin; Reichstein, Markus; Tomelleri, Enrico; Weber, Ulrich; Zaehle, Soenke] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Ciais, Philippe; Viovy, Nicolas] CNRS, CEA, LSCE, F-91191 Gif Sur Yvette, France; [Ciais, Philippe; Viovy, Nicolas] UVSQ, F-91191 Gif Sur Yvette, France; [Seneviratne, Sonia I.; Mueller, Brigitte] ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Sheffield, Justin; Wood, Eric] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; [Goulden, Michael L.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Bonan, Gordon; Oleson, Keith] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Cescatti, Alessandro] Commiss European Communities, Directorate Gen Joint Res Ctr, Inst Environm & Sustainabil, Climate Change Unit, I-21027 Ispra, VA, Italy; [Chen, Jiquan] Univ Toledo, Dept Environm Sci, Toledo, OH 43606 USA; [de Jeu, Richard; Dolman, A. Johannes] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hydrol & Geoenvironm Sci, NL-1081 HV Amsterdam, Netherlands; [Eugster, Werner] ETH, Inst Plant Sci, CH-8092 Zurich, Switzerland; [Gerten, Dieter; Heinke, Jens] Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany; [Gianelle, Damiano] Fdn Edmund Mach, Environm & Nat Resources Area, Ist Agr San Michele Adige, Res & Innovat Ctr, Trento, Italy; [Gobron, Nadine] Commiss European Communities, DG Joint Res Ctr, Inst Environm & Sustainabil, Global Environm Monitoring Unit, I-21027 Ispra, VA, Italy; [Kimball, John; Zhang, Ke] Univ Montana, Flathead Lake Biol Stn, Div Biol Sci, Polson, MT 59860 USA; [Law, Beverly E.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Montagnani, Leonardo] Forest Serv & Agcy Environm, I-39100 Bolzano, Italy; [Mu, Qiaozhen; Running, Steve] Univ Montana, Numer Terradynam Simulat Grp, Coll Forestry & Conservat, Missoula, MT 59812 USA; [Papale, Dario] Univ Tuscia, Dept Forest Environm & Resources, I-01100 Viterbo, Italy; [Richardson, Andrew D.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Roupsard, Olivier] Cirad Persyst, UPR Fonctionnement & Pilotage Ecosyst Plantat 80, F-34060 Montpellier, France; [Williams, Christopher] Clark Univ, Grad Sch Geog, Worcester, MA 01610 USA	Max Planck Society; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Swiss Federal Institutes of Technology Domain; ETH Zurich; Princeton University; University of California System; University of California Irvine; National Center Atmospheric Research (NCAR) - USA; European Commission Joint Research Centre; EC JRC ISPRA Site; University System of Ohio; University of Toledo; Vrije Universiteit Amsterdam; Swiss Federal Institutes of Technology Domain; ETH Zurich; Potsdam Institut fur Klimafolgenforschung; Fondazione Edmund Mach; European Commission Joint Research Centre; EC JRC ISPRA Site; University of Montana System; University of Montana; Oregon State University; University of Montana System; University of Montana; Tuscia University; Harvard University; CIRAD; Clark University	Jung, M (corresponding author), Max Planck Inst Biogeochem, D-07745 Jena, Germany.	mjung@bgc-jena.mpg.de; mreichstein@bgc-jena.mpg.de	Roupsard, Olivier/C-1219-2008; de Jeu, Richard/AAE-6922-2019; Viovy, Nicolas/S-2631-2018; Mueller, Brigitte/E-2594-2011; Eugster, Werner/E-5116-2010; Zhang, Ke/B-3227-2012; Papale, Dario/W-7302-2019; Gianelle, Damiano Dr./G-9437-2011; Kimball, John S/B-9234-2011; Cescatti, Alessandro/ABE-6319-2020; Law, Beverly Elizabeth/G-3882-2010; Oleson, Keith/A-9328-2008; Seneviratne, Sonia I./G-8761-2011; Richardson, Andrew/F-5691-2011; Chen, Jiquan/D-1955-2009; Goulden, Michael L/B-9934-2008; Ciais, Philippe/A-6840-2011; Tomelleri, Enrico/N-6147-2014; Montagnani, Leonardo/F-1837-2016; Tomelleri, Enrico/AAJ-3219-2020; Zaehle, Sönke/C-9528-2017; Gerten, Dieter/B-2975-2013; Mu, Qiaozhen/G-5695-2010; Reichstein, Markus/A-7494-2011	Roupsard, Olivier/0000-0002-1319-142X; Viovy, Nicolas/0000-0002-9197-6417; Mueller, Brigitte/0000-0003-1876-4722; Eugster, Werner/0000-0001-6067-0741; Zhang, Ke/0000-0001-5288-9372; Papale, Dario/0000-0001-5170-8648; Gianelle, Damiano Dr./0000-0001-7697-5793; Law, Beverly Elizabeth/0000-0002-1605-1203; Oleson, Keith/0000-0002-0057-9900; Seneviratne, Sonia I./0000-0001-9528-2917; Richardson, Andrew/0000-0002-0148-6714; Ciais, Philippe/0000-0001-8560-4943; Tomelleri, Enrico/0000-0001-6546-6459; Montagnani, Leonardo/0000-0003-2957-9071; Tomelleri, Enrico/0000-0001-6546-6459; Zaehle, Sönke/0000-0001-5602-7956; Gerten, Dieter/0000-0002-6214-6991; Reichstein, Markus/0000-0001-5736-1112; Dolman, A.J./0000-0003-0099-0457; Williams, Christopher A./0000-0002-5047-0639; Chen, Jiquan/0000-0003-0761-9458; Wood, Eric/0000-0001-7037-9675; Sheffield, Justin/0000-0003-2400-0630; Goulden, Michael/0000-0002-9379-3948	Canadian Foundation for Climate and Atmospheric Sciences; Natural Sciences and Engineering Research Council of Canada; BIOCAP; Environment Canada and Natural Resources Canada; European Union [036946, 226520]; Max-Planck Society; US National Science Foundation [ATM-0910766]; Euro-Mediterranean Centre for Climate Change; Directorate For Geosciences [0910766] Funding Source: National Science Foundation	Canadian Foundation for Climate and Atmospheric Sciences; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); BIOCAP; Environment Canada and Natural Resources Canada; European Union(European Commission); Max-Planck Society(Max Planck SocietyFoundation CELLEX); US National Science Foundation(National Science Foundation (NSF)); Euro-Mediterranean Centre for Climate Change; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work used eddy covariance data acquired by the FLUXNET community and in particular by the following networks: AmeriFlux (US Department of Energy, Biological and Environmental Research, Terrestrial Carbon Program; DE-FG02-04ER63917 and DE-FG02-04ER63911), AfriFlux, AsiaFlux, CarboAfrica, CarboEuropeIP, CarboItaly, CarboMont, ChinaFlux, Fluxnet-Canada (supported by the Canadian Foundation for Climate and Atmospheric Sciences, the Natural Sciences and Engineering Research Council of Canada, BIOCAP, Environment Canada and Natural Resources Canada), GreenGrass, KoFlux, the Largescale Biosphere-Atmosphere Experiment in Amazonia, the Nordic Centre for Studies of Ecosystem Carbon Exchange, OzFlux, the Terrestrial Carbon Observatory System Siberia and US-China Carbon Consortium. We acknowledge the support to the eddy covariance data harmonization provided by CarboEuropeIP; the Food and Agriculture Organization of the United Nations' Global Terrestrial Observing System Terrestrial Carbon Observations; the Integrated Land Ecosystem-Atmosphere Processes Study, a core project of the International Geosphere-Biosphere Programme; the Max Planck Institute for Biogeochemistry; the National Science Foundation; the University of Tuscia; Universite Laval; Environment Canada; and the US Department of Energy. We acknowledge database development and technical support from Berkeley Water Center, Lawrence Berkeley National Laboratory, Microsoft Research eScience, Oak Ridge National Laboratory, University of California, Berkeley and University of Virginia. We thank the members of FLUXNET (http://www.fluxdata.org/DataInfo) for their help with the data on this work. TRMM soil moisture retrievals and analysis were supported by the European Union (FP6) funded integrated project called WATCH (contract number 036946) that supported A.J.D. and R.d.J. M.J. and M.R. were supported by the European Union (FP7) integrated project COMBINE (number 226520) and a grant from the Max-Planck Society establishing the MPRG Biogeochemical Model-Data Integration. C. W. was supported by the US National Science Foundation under grant ATM-0910766. D. P. acknowledges the support of the Euro-Mediterranean Centre for Climate Change. We acknowledge institutions and projects for free access to relevant data: the Global Runoff Data Centre, the Global Soil Wetness Project 2, the Global Precipitation Climatology Centre, the Global Precipitation Climatology Project, the Global Historical Climatology Network, the Potsdam Institute for Climate Impact Research, the University of East Anglia, the National Oceanic and Atmospheric Administration Earth System Research Laboratory and the European Centre for Medium-Range Weather Forecasts.	Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Budyko MI., 1974, CLIMATE LIFE; Dirmeyer PA, 2006, B AM METEOROL SOC, V87, P1381, DOI 10.1175/BAMS-87-10-1381; Gedney N, 2006, NATURE, V439, P835, DOI 10.1038/nature04504; Gerten D, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035258; Gobron N, 2008, REMOTE SENS ENVIRON, V112, P1871, DOI 10.1016/j.rse.2007.09.011; Gobron N, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006511; Huntington TG, 2006, J HYDROL, V319, P83, DOI 10.1016/j.jhydrol.2005.07.003; Jung M, 2006, REMOTE SENS ENVIRON, V101, P534, DOI 10.1016/j.rse.2006.01.020; Jung M, 2009, BIOGEOSCIENCES, V6, P2001, DOI 10.5194/bg-6-2001-2009; Koster RD, 2004, SCIENCE, V305, P1138, DOI 10.1126/science.1100217; Milliman JD, 2008, GLOBAL PLANET CHANGE, V62, P187, DOI 10.1016/j.gloplacha.2008.03.001; Moffat AM, 2007, AGR FOREST METEOROL, V147, P209, DOI 10.1016/j.agrformet.2007.08.011; Oki T, 2006, SCIENCE, V313, P1068, DOI 10.1126/science.1128845; OSTERLE H, 2003, TERRA NOSTRA, V6, P326; Owe M, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000769; Papale D, 2006, BIOGEOSCIENCES, V3, P571, DOI 10.5194/bg-3-571-2006; Piao SL, 2007, P NATL ACAD SCI USA, V104, P15242, DOI 10.1073/pnas.0707213104; Roderick ML, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031166; Schneider U., 2008, GLOBAL PRECIPITATION; Scipal K, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035599; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Seneviratne SI, 2006, NATURE, V443, P205, DOI 10.1038/nature05095; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Simmons AJ, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012442; Trenberth KE, 2009, B AM METEOROL SOC, V90, P311, DOI 10.1175/2008BAMS2634.1; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Twine TE, 2000, AGR FOREST METEOROL, V103, P279, DOI 10.1016/S0168-1923(00)00123-4; VAUTARD R, 2007, GEOPHYS RES LETT; Wild M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034842	30	1369	1481	60	1197	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2010	467	7318					951	954		10.1038/nature09396	http://dx.doi.org/10.1038/nature09396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20935626	Green Published			2022-12-28	WOS:000283254700035
J	Macilwain, C				Macilwain, Colin			Scientists vs engineers: this time it's financial	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	1	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					885	885		10.1038/467885a	http://dx.doi.org/10.1038/467885a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	668FT	20962798	Bronze			2022-12-28	WOS:000283254700004
J	Zheng, XT; Xu, X; Zhou, ZH; Miao, DS; Zhang, FC				Zheng, Xiaoting; Xu, Xing; Zhou, Zhonghe; Miao, Desui; Zhang, Fucheng			Comment on "Narrow Primary Feather Rachises in Confuciusornis and Archaeopteryx Suggest Poor Flight Ability"	SCIENCE			English	Editorial Material								Nudds and Dyke (Reports, 14 May 2010, p. 887) compared the rachis diameters of the primary feathers of Archaeopteryx and Confuciusornis to those of modern birds and found that the primary feathers of these two basal birds were too weak to support sustained flight. Our measurements of Confuciusornis specimens suggest that their conclusions need to be further evaluated.	[Xu, Xing; Zhou, Zhonghe; Zhang, Fucheng] Chinese Acad Sci, Key Lab Evolutionary Systemat Vertebrates, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [Zheng, Xiaoting] Shandong Tianyu Museum Nat, Pingyi 273300, Shandong, Peoples R China; [Zheng, Xiaoting] Linyi Normal Coll, Linyi 276000, Shandong, Peoples R China; [Miao, Desui] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Linyi University; University of Kansas	Xu, X (corresponding author), Chinese Acad Sci, Key Lab Evolutionary Systemat Vertebrates, Inst Vertebrate Paleontol & Paleoanthropol, 142 Xiwai St, Beijing 100044, Peoples R China.	xingxu@vip.sina.com						Chiappe Luis M., 1999, Bulletin of the American Museum of Natural History, V242, P1; Nudds RL, 2010, SCIENCE, V328, P887, DOI 10.1126/science.1188895; Zhou ZH, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P237	3	8	9	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002								10.1126/science.1193223	http://dx.doi.org/10.1126/science.1193223			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947746				2022-12-28	WOS:000282986700019
J	Guichard, A; McGillivray, SM; Cruz-Moreno, B; van Sorge, NM; Nizet, V; Bier, E				Guichard, Annabel; McGillivray, Shauna M.; Cruz-Moreno, Beatriz; van Sorge, Nina M.; Nizet, Victor; Bier, Ethan			Anthrax toxins cooperatively inhibit endocytic recycling by the Rab11/Sec15 exocyst	NATURE			English	Article							LETHAL FACTOR; EDEMA FACTOR; WING VEIN; SEC15; RAB11; MORPHOGENESIS; PATHOGENESIS; COMPONENTS; ENDOSOMES; EFFECTOR	Bacillus anthracis is the causative agent of anthrax in humans and other mammals(1,2). In lethal systemic anthrax, proliferating bacilli secrete large quantities of the toxins lethal factor (LF) and oedema factor (EF), leading to widespread vascular leakage and shock. Whereas host targets of LF (mitogen-activated protein-kinase kinases) and EF (cAMP-dependent processes)(3) have been implicated in the initial phase of anthrax(1,2), less is understood about toxin action during the final stage of infection. Here we use Drosophila melanogaster to identify the Rab11/Sec15 exocyst, which acts at the last step of endocytic recycling, as a novel target of both EF and LF. EF reduces levels of apically localized Rab11 and indirectly blocks vesicle formation by its binding partner and effector Sec15 (Sec15-GFP), whereas LF acts more directly to reduce Sec15-GFP vesicles. Convergent effects of EF and LF on Rab11/Sec15 inhibit expression of and signalling by the Notch ligand Delta and reduce DE-cadherin levels at adherens junctions. In human endothelial cells, the two toxins act in a conserved fashion to block formation of Sec15 vesicles, inhibit Notch signalling, and reduce cadherin expression at adherens junctions. This coordinated disruption of the Rab11/Sec15 exocyst by anthrax toxins may contribute to toxin-dependent barrier disruption and vascular dysfunction during B. anthracis infection.	[Guichard, Annabel; Cruz-Moreno, Beatriz; Bier, Ethan] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [McGillivray, Shauna M.; van Sorge, Nina M.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [McGillivray, Shauna M.] Texas Christian Univ, Dept Biol, Ft Worth, TX 76129 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Texas Christian University; University of California System; University of California San Diego	Bier, E (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ebier@ucsd.edu	McGillivray, Shauna/AAN-3074-2021; van Sorge, Nina/E-3290-2017; Nizet, Victor/AAF-3190-2019	McGillivray, Shauna/0000-0002-8863-1522; van Sorge, Nina/0000-0002-2695-5863; Nizet, Victor/0000-0003-3847-0422	National Institutes of Health (NIH) [AI070654, NS29870, AI077780]; IRACDA NIH [GM068524]; Hartwell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780, R56AI070654, R01AI070654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS029870, R01NS029870] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IRACDA NIH; Hartwell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Kurciyan for help in analysing the effects of expressing wild-type and dominant-negative forms of Rab in Drosophila, A. Cooper and members of the E.B. and V.N. laboratories and H. Bellen for comments on the manuscript and suggestions. We thank S. Leppla for providing purified preparations of LF, EF and PA, S. Stibitz for B. anthracis mutants, and the following investigators for providing antibodies: R. Cohen (anti-Rab11), A. Parks (anti-Dl), K. Irvine (anti-Serrate) and J. Collier (anti-LF). Support for these studies was provided by National Institutes of Health (NIH) R01 grants AI070654 and NS29870 (E. B.), AI077780 (V. N.), an IRACDA NIH postdoctoral fellowship GM068524 (S.M.M.) and a Biomedical Research Fellowship from The Hartwell Foundation (S.M.M.).	Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; Cook O, 2004, DEVELOPMENT, V131, P2113, DOI 10.1242/dev.01100; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Firoved AM, 2005, AM J PATHOL, V167, P1309, DOI 10.1016/S0002-9440(10)61218-7; Fortini ME, 2009, CURR OPIN GENET DEV, V19, P323, DOI 10.1016/j.gde.2009.04.005; Gozes Y, 2006, INFECT IMMUN, V74, P1266, DOI 10.1128/IAI.74.2.1266-1272.2006; Guichard A, 2006, P NATL ACAD SCI USA, V103, P3244, DOI 10.1073/pnas.0510748103; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Kuo SR, 2008, MICROB PATHOGENESIS, V44, P467, DOI 10.1016/j.micpath.2007.12.001; Lacy DB, 2002, CURR TOP MICROBIOL, V271, P61; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Lunde K, 2003, DEVELOPMENT, V130, P235, DOI 10.1242/dev.00207; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Mourez M, 2005, REV PHYSIOL BIOCH P, V152, P135, DOI 10.1007/s10254-004-0028-2; ONEILL JW, 1994, BIOTECHNIQUES, V17, P870; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; SALMINEN A, 1989, J CELL BIOL, V109, P1023, DOI 10.1083/jcb.109.3.1023; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Tessier J, 2007, INFECT IMMUN, V75, P1895, DOI 10.1128/IAI.01632-06; Tournier JN, 2007, CELL MICROBIOL, V9, P555, DOI 10.1111/j.1462-5822.2006.00866.x; van Sorge NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002964; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Wu H, 2008, TRENDS CELL BIOL, V18, P397, DOI 10.1016/j.tcb.2008.06.007; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200	33	77	78	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					854	U123		10.1038/nature09446	http://dx.doi.org/10.1038/nature09446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944747	Green Accepted			2022-12-28	WOS:000282898700069
J	Rathi, A				Rathi, Akshat			Turning the tables	NATURE			English	Editorial Material									Univ Oxford, Oxford OX1 2JD, England	University of Oxford	Rathi, A (corresponding author), Univ Oxford, Oxford OX1 2JD, England.								0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					S22	S23		10.1038/467S22a	http://dx.doi.org/10.1038/467S22a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944618	Bronze			2022-12-28	WOS:000282898700016
J	Virtanen, A; Joutsensaari, J; Koop, T; Kannosto, J; Yli-Pirila, P; Leskinen, J; Makela, JM; Holopainen, JK; Poschl, U; Kulmala, M; Worsnop, DR; Laaksonen, A				Virtanen, Annele; Joutsensaari, Jorma; Koop, Thomas; Kannosto, Jonna; Yli-Pirila, Pasi; Leskinen, Jani; Makela, Jyrki M.; Holopainen, Jarmo K.; Poeschl, Ulrich; Kulmala, Markku; Worsnop, Douglas R.; Laaksonen, Ari			An amorphous solid state of biogenic secondary organic aerosol particles	NATURE			English	Article							ATMOSPHERIC PARTICLES; OLEIC-ACID; MODEL; OXIDATION; CLIMATE; CHEMISTRY; DIFFUSION; EMISSIONS; PRODUCTS; FORESTS	Secondary organic aerosol (SOA) particles are formed in the atmosphere from condensable oxidation products of anthropogenic and biogenic volatile organic compounds (VOCs)(1-7). On a global scale, biogenic VOCs account for about 90% of VOC emissions(1,8) and of SOA formation (90 billion kilograms of carbon per year)(1-4). SOA particles can scatter radiation and act as cloud condensation or ice nuclei, and thereby influence the Earth's radiation balance and climate(1,2,5,9,10). They consist of a myriad of different compounds with varying physicochemical properties, and little information is available on the phase state of SOA particles. Gas-particle partitioning models usually assume that SOA particles are liquid(1,5,11), but here we present experimental evidence that they can be solid under ambient conditions. We investigated biogenic SOA particles formed from oxidation products of VOCs in plant chamber experiments and in boreal forests within a few hours after atmospheric nucleation events. On the basis of observed particle bouncing in an aerosol impactor and of electron microscopy we conclude that biogenic SOA particles can adopt an amorphous solid-most probably glassy-state. This amorphous solid state should provoke a rethinking of SOA processes because it may influence the partitioning of semi-volatile compounds, reduce the rate of heterogeneous chemical reactions, affect the particles' ability to accommodate water and act as cloud condensation or ice nuclei, and change the atmospheric lifetime of the particles(12-15). Thus, the results of this study challenge traditional views of the kinetics and thermodynamics of SOA formation and transformation in the atmosphere and their implications for air quality and climate.	[Virtanen, Annele; Kannosto, Jonna; Makela, Jyrki M.] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland; [Joutsensaari, Jorma; Worsnop, Douglas R.; Laaksonen, Ari] Univ Eastern Finland, Dept Math & Phys, Kuopio 70211, Finland; [Koop, Thomas] Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany; [Yli-Pirila, Pasi; Leskinen, Jani; Holopainen, Jarmo K.] Univ Eastern Finland, Dept Environm Sci, Kuopio 70211, Finland; [Poeschl, Ulrich] Max Planck Inst Chem, Biogeochem Dept, D-55128 Mainz, Germany; [Kulmala, Markku; Worsnop, Douglas R.] Univ Helsinki, Dept Phys, Helsinki 00014, Finland; [Kulmala, Markku] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden; [Worsnop, Douglas R.] Aerodyne Res Inc, Billerica, MA 01821 USA; [Worsnop, Douglas R.; Laaksonen, Ari] Finnish Meteorol Inst, FIN-00101 Helsinki, Finland	Tampere University; University of Eastern Finland; University of Bielefeld; University of Eastern Finland; Max Planck Society; University of Helsinki; Stockholm University; Aerodyne Research; Finnish Meteorological Institute	Virtanen, A (corresponding author), Tampere Univ Technol, Dept Phys, POB 692, FIN-33101 Tampere, Finland.	annele.virtanen@tut.fi; thomas.koop@uni-bielefeld.de	Pöschl, Ulrich/A-6263-2010; Koop, Thomas/B-7861-2008; Mäkelä, Jyrki/G-4223-2014; Kulmala, Markku T/I-7671-2016; Worsnop, Douglas R/D-2817-2009; Holopainen, Jarmo K./B-1656-2008; Laaksonen, Ari/B-5094-2011; Virtanen, Annele/E-7699-2010	Pöschl, Ulrich/0000-0003-1412-3557; Koop, Thomas/0000-0002-7571-3684; Kulmala, Markku T/0000-0003-3464-7825; Worsnop, Douglas R/0000-0002-8928-8017; Holopainen, Jarmo K./0000-0001-5026-3245; Laaksonen, Ari/0000-0002-1657-2383; Virtanen, Annele/0000-0002-2917-5344; Makela, Jyrki Mikael/0000-0002-6757-3589	Academy of Finland [110763, 111543, 131019, 218115]; Maj and Tor Nessling foundation	Academy of Finland(Academy of Finland); Maj and Tor Nessling foundation	We acknowledge support by the Academy of Finland (decision numbers 110763, 111543, 131019, 218115 and Centre of Excellence Programme) and the Maj and Tor Nessling foundation. We also acknowledge J. Keskinen and A. Arffman for fruitful discussions concerning impactor performance, H. Kuuluvainen for his help in bounce factor measurements, K. Rissa for SEM imaging, L. Hao, P. Tiitta, A. Kortelainen and P. Miettinen for aerosol mass spectrometer analyses and their help during experiments, J. Jokiniemi, U. Tapper and J. Lyyranen (VTT Technical Research Centre of Finland) for the development of SEM sample collection and image analysis methods, A. Diekmann for the differential scanning calorimeter measurements and T. Wagner for providing polystyrene samples.	Bahreini R, 2005, ENVIRON SCI TECHNOL, V39, P5674, DOI 10.1021/es048061a; Claeys M, 2004, SCIENCE, V303, P1173, DOI 10.1126/science.1092805; DAHNEKE B, 1971, J COLLOID INTERF SCI, V37, P342, DOI 10.1016/0021-9797(71)90302-X; Ehn M, 2007, ATMOS CHEM PHYS, V7, P211, DOI 10.5194/acp-7-211-2007; Fuzzi S, 2006, ATMOS CHEM PHYS, V6, P2017, DOI 10.5194/acp-6-2017-2006; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; HAMERI K, 2000, REP SER AEROSOL SCI, V47, P47; Hari P, 2005, BOREAL ENVIRON RES, V10, P315; *IPCC, 2007, CLIM CHANG 2007 PHYS, P161; Jimenez JL, 2009, SCIENCE, V326, P1525, DOI 10.1126/science.1180353; Joutsensaari J, 2005, ATMOS CHEM PHYS, V5, P1489, DOI 10.5194/acp-5-1489-2005; Kalberer M, 2004, SCIENCE, V303, P1659, DOI 10.1126/science.1092185; Kanakidou M, 2005, ATMOS CHEM PHYS, V5, P1053, DOI 10.5194/acp-5-1053-2005; Kavouras IG, 1998, NATURE, V395, P683, DOI 10.1038/27179; Laaksonen A, 2008, ATMOS CHEM PHYS, V8, P2657, DOI 10.5194/acp-8-2657-2008; Marcolli C, 2004, J PHYS CHEM A, V108, P2216, DOI [10.1021/jp036080l, 10.1021/jp0360801]; Maria SF, 2004, SCIENCE, V306, P1921, DOI 10.1126/science.1103491; Mentel TF, 2009, ATMOS CHEM PHYS, V9, P4387, DOI 10.5194/acp-9-4387-2009; Mikhailov E, 2009, ATMOS CHEM PHYS, V9, P9491, DOI 10.5194/acp-9-9491-2009; Murray BJ, 2008, ATMOS CHEM PHYS, V8, P5423, DOI 10.5194/acp-8-5423-2008; PANKOW JF, 1994, ATMOS ENVIRON, V28, P189, DOI 10.1016/1352-2310(94)90094-9; PANKOW JF, 1987, ATMOS ENVIRON, V21, P2275, DOI 10.1016/0004-6981(87)90363-5; PARKER R, 1995, CARBOHYD RES, V273, P147, DOI 10.1016/0008-6215(95)00120-I; Shiraiwa M, 2010, ATMOS CHEM PHYS, V10, P3673, DOI 10.5194/acp-10-3673-2010; STEIN SW, 1994, ATMOS ENVIRON, V28, P1739, DOI 10.1016/1352-2310(94)90136-8; Tunved P, 2006, SCIENCE, V312, P261, DOI 10.1126/science.1123052; Zahardis J, 2007, ATMOS CHEM PHYS, V7, P1237, DOI 10.5194/acp-7-1237-2007; Zobrist B, 2008, ATMOS CHEM PHYS, V8, P5221, DOI 10.5194/acp-8-5221-2008	29	553	557	13	559	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					824	827		10.1038/nature09455	http://dx.doi.org/10.1038/nature09455			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944744				2022-12-28	WOS:000282898700063
J	Zoungas, S; Patel, A; Chalmers, J; de Galan, BE; Li, QA; Billot, L; Woodward, M; Ninomiya, T; Neal, B; MacMahon, S; Grobbee, DE; Kengne, AP; Marre, M; Heller, S				Zoungas, Sophia; Patel, Anushka; Chalmers, John; de Galan, Bastiaan E.; Li, Qiang; Billot, Laurent; Woodward, Mark; Ninomiya, Toshiharu; Neal, Bruce; MacMahon, Stephen; Grobbee, Diederick E.; Kengne, Andre Pascal; Marre, Michel; Heller, Simon		ADVANCE Collaborative Grp	Severe Hypoglycemia and Risks of Vascular Events and Death.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BAROREFLEX SENSITIVITY; MORTALITY; ASSOCIATION; VARIABILITY; OUTCOMES; ADVANCE; GLUCOSE; ABILITY	Background: Severe hypoglycemia may increase the risk of a poor outcome in patients with type 2 diabetes assigned to an intensive glucose-lowering intervention. We analyzed data from a large study of intensive glucose lowering to explore the relationship between severe hypoglycemia and adverse clinical outcomes. Methods: We examined the associations between severe hypoglycemia and the risks of macrovascular or microvascular events and death among 11,140 patients with type 2 diabetes, using Cox proportional-hazards models with adjustment for covariates measured at baseline and after randomization. Results: During a median follow-up period of 5 years, 231 patients (2.1%) had at least one severe hypoglycemic episode; 150 had been assigned to intensive glucose control (2.7% of the 5571 patients in that group), and 81 had been assigned to standard glucose control (1.5% of the 5569 patients in that group). The median times from the onset of severe hypoglycemia to the first major macrovascular event, the first major microvascular event, and death were 1.56 years (interquartile range, 0.84 to 2.41), 0.99 years (interquartile range, 0.40 to 2.17), and 1.05 years (interquartile range, 0.34 to 2.41), respectively. During follow-up, severe hypoglycemia was associated with a significant increase in the adjusted risks of major macrovascular events (hazard ratio, 2.88; 95% confidence interval [CI], 2.01 to 4.12), major microvascular events (hazard ratio, 1.81; 95% CI, 1.19 to 2.74), death from a cardiovascular cause (hazard ratio, 2.68; 95% CI, 1.72 to 4.19), and death from any cause (hazard ratio, 2.69; 95% CI, 1.97 to 3.67) (P<0.001 for all comparisons). Similar associations were apparent for a range of nonvascular outcomes, including respiratory, digestive, and skin conditions (P<0.01 for all comparisons). No relationship was found between repeated episodes of severe hypoglycemia and vascular outcomes or death. Conclusions: Severe hypoglycemia was strongly associated with increased risks of a range of adverse clinical outcomes. It is possible that severe hypoglycemia contributes to adverse outcomes, but these analyses indicate that hypoglycemia is just as likely to be a marker of vulnerability to such events. (Funded by Servier and the National Health and Medical Research Council of Australia; ClinicalTrials.gov number, NCT00145925.) N Engl J Med 2010;363:1410-8.	[Zoungas, Sophia; Patel, Anushka; Chalmers, John; de Galan, Bastiaan E.; Li, Qiang; Billot, Laurent; Woodward, Mark; Ninomiya, Toshiharu; Neal, Bruce; MacMahon, Stephen; Kengne, Andre Pascal] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2050, Australia; [Zoungas, Sophia] Monash Univ, Sch Publ Hlth, Melbourne, Vic 3004, Australia; [de Galan, Bastiaan E.] Radboud Univ Nijmegen, Med Ctr, Dept Gen Internal Med, NL-6525 ED Nijmegen, Netherlands; [Grobbee, Diederick E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Woodward, Mark] Mt Sinai Sch Med, New York, NY USA; [Marre, Michel] Hop Bichat Claude Bernard, F-75877 Paris 18, France; [Marre, Michel] Univ Paris, F-75252 Paris, France; [Heller, Simon] Univ Sheffield, Sheffield, S Yorkshire, England; [Heller, Simon] Sheffield Teaching Hosp Natl Hlth Serv Fdn Trust, Sheffield, S Yorkshire, England	University of Sydney; Monash University; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Icahn School of Medicine at Mount Sinai; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Sheffield	Zoungas, S (corresponding author), Univ Sydney, George Inst Int Hlth, POB M201,Missenden Rd, Sydney, NSW 2050, Australia.	szoungas@george.org.au	Kengne, Andre Pascal/ABB-3696-2020; de Galan, Bastiaan E/H-3161-2015; Grobbee, Diederick/C-7651-2014; Woodward, Mark/L-6817-2017; Billot, Laurent/Y-1241-2019; Woodward, Mark/D-8492-2015	de Galan, Bastiaan E/0000-0002-1255-7741; Grobbee, Diederick/0000-0003-4472-4468; Billot, Laurent/0000-0002-4975-9793; Marre, Michel/0000-0002-3071-1837; Woodward, Mark/0000-0001-9800-5296; Zoungas, Sophia/0000-0003-2672-0949; MacMahon, Stephen/0000-0003-2064-7699; Chalmers, John/0000-0002-9931-0580; Neal, Bruce/0000-0002-0490-7465; Heller, Simon/0000-0002-2425-9565; Patel, Anushka/0000-0003-3825-4092	Servier; National Health and Medical Research Council of Australia	Servier(Servier); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Supported by grants from Servier and the National Health and Medical Research Council of Australia.	Adler GK, 2009, DIABETES, V58, P360, DOI 10.2337/db08-1153; BIGGER JT, 1993, CIRCULATION, V88, P927, DOI 10.1161/01.CIR.88.3.927; Bonds Denise E, 2010, BMJ, V340, pb4909, DOI 10.1136/bmj.b4909; Cryer PE, 2005, DIABETES, V54, P3592, DOI 10.2337/diabetes.54.12.3592; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; De Ferrari GM, 2007, J AM COLL CARDIOL, V50, P2285, DOI 10.1016/j.jacc.2007.08.043; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Desouza C, 2003, DIABETES CARE, V26, P1485, DOI 10.2337/diacare.26.5.1485; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; DUH E, 1994, ANN INTERN MED, V121, P945, DOI 10.7326/0003-4819-121-12-199412150-00007; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Hoekstra JBL, 2009, DIABETOLOGIA, V52, pS237; Hosmer DW, 1997, STAT MED, V16, P965; Kosiborod M, 2008, CIRCULATION, V117, P1018, DOI 10.1161/CIRCULATIONAHA.107.740498; Kosiborod M, 2009, JAMA-J AM MED ASSOC, V301, P1556, DOI 10.1001/jama.2009.496; La Rovere MT, 1998, LANCET, V351, P478; MacMahon S, 2001, LANCET, V357, P455, DOI 10.1016/S0140-6736(00)04017-4; Maser RE, 2003, DIABETES CARE, V26, P1895, DOI 10.2337/diacare.26.6.1895; MILLER ME, 2008, DIABETES-METAB RES, V24, P353; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pinto DS, 2005, J AM COLL CARDIOL, V46, P178, DOI 10.1016/j.jacc.2005.03.052; Skyler JS, 2009, J AM COLL CARDIOL, V53, P298, DOI [10.1016/j.jacc.2008.10.008, 10.2337/dc08-9026]; Svensson AM, 2005, EUR HEART J, V26, P1255, DOI 10.1093/eurheartj/ehi230; Therneau T. M., 2013, MODELING SURVIVAL DA, DOI 10.1007/978-1-4757-3294-8; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Wright A, 1998, ANN INTERN MED, V128, P165, DOI 10.7326/0003-4819-128-3-199802010-00001	28	1030	1060	0	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2010	363	15					1410	1418		10.1056/NEJMoa1003795	http://dx.doi.org/10.1056/NEJMoa1003795			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	659NV	20925543	Green Published, Bronze			2022-12-28	WOS:000282575100006
J	Heazell, AE				Heazell, Alexander E.			Personal View Towards an end to stillbirths	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Manchester, Manchester M13 9PL, Lancs, England	University of Manchester	Heazell, AE (corresponding author), Univ Manchester, Manchester M13 9PL, Lancs, England.	alexander.heazell@manchester.ac.uk		Heazell, Alexander/0000-0002-4303-7845	National Institute for Health Research [CL-2009-06-002] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Ahman E, 2007, NEONATAL PERINATAL M; [Anonymous], 2009, STUD STILLB CLAIMS; *CONF ENQ STILLB D, 1998, 5 ANN REP CONF ENQ S; *CONF ENQ STILLB D, 2001, 8 ANN REP CONF ENQ S; Confidential Enquiry into Maternal and Child Health, 2009, PER MORT 2007 ENGL W; Guildea ZES, 2001, ARCH DIS CHILD, V84, P307, DOI 10.1136/adc.84.4.307; Haws RA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S5; Henley A, 2008, SEMIN FETAL NEONAT M, V13, P325, DOI 10.1016/j.siny.2008.03.003; *NAT I HLTH RES, 2008, TRANSF HLTH RES 1 2; Scott J, 2009, SAVING BABIES LIVES	10	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 6	2010	341								c5070	10.1136/bmj.c5070	http://dx.doi.org/10.1136/bmj.c5070			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663JE	20926491				2022-12-28	WOS:000282879400015
J	Gosden, C				Gosden, Chris			When Humans Arrived in the New Guinea Highlands	SCIENCE			English	Editorial Material									Univ Oxford, Inst Archaeol, Oxford OX1 2PG, England	University of Oxford	Gosden, C (corresponding author), Univ Oxford, Inst Archaeol, 36 Beaumont St, Oxford OX1 2PG, England.	chris.gosden@arch.ox.ac.uk						O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Renfrew C., 2009, SAPIENT MIND ARCHAEO; Summerhayes GR, 2010, SCIENCE, V330, P78, DOI 10.1126/science.1193130	3	11	12	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					41	42		10.1126/science.1195448	http://dx.doi.org/10.1126/science.1195448			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	656KW	20929797				2022-12-28	WOS:000282334500023
J	Johnson, WE; Onorato, DP; Roelke, ME; Land, ED; Cunningham, M; Belden, RC; McBride, R; Jansen, D; Lotz, M; Shindle, D; Howard, J; Wildt, DE; Penfold, LM; Hostetler, JA; Oli, MK; O'Brien, SJ				Johnson, Warren E.; Onorato, David P.; Roelke, Melody E.; Land, E. Darrell; Cunningham, Mark; Belden, Robert C.; McBride, Roy; Jansen, Deborah; Lotz, Mark; Shindle, David; Howard, JoGayle; Wildt, David E.; Penfold, Linda M.; Hostetler, Jeffrey A.; Oli, Madan K.; O'Brien, Stephen J.			Genetic Restoration of the Florida Panther	SCIENCE			English	Article							CONSERVATION; PUMAS	The rediscovery of remnant Florida panthers (Puma concolor coryi) in southern Florida swamplands prompted a program to protect and stabilize the population. In 1995, conservation managers translocated eight female pumas (P. c. stanleyana) from Texas to increase depleted genetic diversity, improve population numbers, and reverse indications of inbreeding depression. We have assessed the demographic, population-genetic, and biomedical consequences of this restoration experiment and show that panther numbers increased threefold, genetic heterozygosity doubled, survival and fitness measures improved, and inbreeding correlates declined significantly. Although these results are encouraging, continued habitat loss, persistent inbreeding, infectious agents, and possible habitat saturation pose new dilemmas. This intensive management program illustrates the challenges of maintaining populations of large predators worldwide.	[Johnson, Warren E.; O'Brien, Stephen J.] NCI, Lab Genom Divers, Frederick, MD 21702 USA; [Onorato, David P.; Land, E. Darrell; Cunningham, Mark; Lotz, Mark; Shindle, David] Florida Fish & Wildlife Conservat Commiss, Naples, FL 34114 USA; [Roelke, Melody E.] NCI, SAIC Frederick, Lab Genom Divers, Frederick, MD 21702 USA; [Belden, Robert C.] US Fish & Wildlife Serv, Vero Beach, FL 32960 USA; [McBride, Roy] Livestock Protect Co, Alpine, TX 79832 USA; [Jansen, Deborah] Big Cypress Natl Preserve, Ochopee, FL 34141 USA; [Howard, JoGayle; Wildt, David E.] Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA; [Penfold, Linda M.] White Oak Conservat Ctr, Yulee, FL 32046 USA; [Hostetler, Jeffrey A.; Oli, Madan K.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Florida Fish & Wildlife Conservation Commission; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; United States Department of the Interior; US Fish & Wildlife Service; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; State University System of Florida; University of Florida	Johnson, WE (corresponding author), NCI, Lab Genom Divers, Frederick, MD 21702 USA.	warjohns@mail.nih.gov; Dave.Onorato@MyFWC.com; stephenobrien@nih.gov	Johnson, Warren/D-4149-2016; Hostetler, Jeffrey A./A-3345-2011; Onorato, Dave/AAD-2563-2021; OBRIEN, STEPHEN/ABD-1346-2020	Johnson, Warren/0000-0002-5954-186X; Hostetler, Jeffrey A./0000-0003-3669-1758; Onorato, Dave/0000-0002-4716-6847; OBRIEN, STEPHEN/0000-0001-7857-0757	Florida Fish and Wildlife Conservation Commission (FWC); Everglades National Park (EVER); BCNP; U.S. Fish and Wildlife Service; National Cancer Institute, National Institutes of Health (NIH) [N01-CO-12400]; NIH, National Cancer Institute, Center for Cancer Research; Florida Panther Research and Management Trust; NATIONAL CANCER INSTITUTE [ZIABC005367] Funding Source: NIH RePORTER	Florida Fish and Wildlife Conservation Commission (FWC); Everglades National Park (EVER); BCNP; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Panther Research and Management Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We dedicate this study to the memory of Ulysses Seal and Ernst Mayr, important heroes in the conservation struggle of the Florida panther. Funded by the Florida Fish and Wildlife Conservation Commission (FWC) via purchases of Florida panther license plates. Other major funding for the field work was provided by Everglades National Park (EVER), the BCNP, and federal funds from the U.S. Fish and Wildlife Service (especially in the early years) as well as from the National Cancer Institute, National Institutes of Health (NIH), under contract number N01-CO-12400. This research was supported in part by the Intramural Research Program of NIH, National Cancer Institute, Center for Cancer Research, and the Florida Panther Research and Management Trust Fund. All panther captures, sampling, and radio collaring were authorized by U. S. Fish and Wildlife Service Endangered Species Permits TE01553-3 (FWC) and TE146761-1 (BCNP). We thank many individuals for their help in this project, who are named in SOM reference S25.	BARONE MA, 1994, J MAMMAL, V75, P150, DOI 10.2307/1382247; Culver M, 2008, ANIM CONSERV, V11, P104, DOI 10.1111/j.1469-1795.2007.00154.x; Culver M, 2000, J HERED, V91, P186, DOI 10.1093/jhered/91.3.186; Cunningham MW, 2008, J WILDLIFE DIS, V44, P537, DOI 10.7589/0090-3558-44.3.537; Cunningham MW, 1999, J WILDLIFE DIS, V35, P519, DOI 10.7589/0090-3558-35.3.519; Currier M.J.P, 1983, MAMMALIAN SPECIES, V200, P1, DOI [10.2307/3503951, DOI 10.2307/3503951]; FOSTER ML, 1995, WILDLIFE SOC B, V23, P95; Frankham R, 1998, NATURE, V392, P441, DOI 10.1038/33022; Hedrick PW, 2010, CONSERV GENET, V11, P615, DOI 10.1007/s10592-009-9999-5; Hedrick PW, 2000, ANNU REV ECOL SYST, V31, P139, DOI 10.1146/annurev.ecolsys.31.1.139; Janis MW, 2002, J WILDLIFE MANAGE, V66, P839, DOI 10.2307/3803148; Kautz R, 2006, BIOL CONSERV, V130, P118, DOI 10.1016/j.biocon.2005.12.007; Lacy RC, 1997, J MAMMAL, V78, P320, DOI 10.2307/1382885; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; McBride RT, 2008, SOUTHEAST NAT, V7, P381, DOI 10.1656/1528-7092-7.3.381; O'Brien SJ., 2003, TEARS CHEETAH OTHER; OBRIEN SJ, 1990, NATL GEOGR RES, V6, P485; OBRIEN SJ, 1991, SCIENCE, V251, P1187, DOI 10.1126/science.251.4998.1187; Roelke ME, 2006, J WILDLIFE DIS, V42, P234, DOI 10.7589/0090-3558-42.2.234; ROELKE ME, 1993, J WILDLIFE DIS, V29, P36, DOI 10.7589/0090-3558-29.1.36; ROELKE ME, 1993, CURR BIOL, V3, P340, DOI 10.1016/0960-9822(93)90197-V; Seal US., 1994, PLAN GENETIC RESTORA	22	337	343	4	477	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2010	329	5999					1641	1645		10.1126/science.1192891	http://dx.doi.org/10.1126/science.1192891			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929847	Green Accepted			2022-12-28	WOS:000282098100040
J	Frieden, TR; Collins, FS				Frieden, Thomas R.; Collins, Francis S.			Intentional Infection of Vulnerable Populations in 1946-1948 Another Tragic History Lesson	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Frieden, Thomas R.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Collins, Francis S.] NIH, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS D-14, Atlanta, GA 30333 USA.	txf2@cdc.gov		Frieden, Thomas/0000-0002-4759-2256				[Anonymous], 1979, BELMONT REPORT ETHIC; Lederer Susan, 1995, SUBJECTED SCI HUMAN; MAGNUSON HJ, 1956, MEDICINE, V35, P33, DOI 10.1097/00005792-195602000-00002; MAHONEY J F, 1946, Am J Syph Gonorrhea Vener Dis, V30, P1; Office of Human Subjects Research National Institutes of Health, REG ETH GUID; Reverby Susan M., 2009, EXAMINING TUSKEGEE I; SUSAN M, REVERBY FACULTY PAGE; *US DEP HHS, INF 1946 1948 US PUB	8	24	24	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2010	304	18					2063	2064		10.1001/jama.2010.1554	http://dx.doi.org/10.1001/jama.2010.1554			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677OB	20937719	Green Published			2022-12-28	WOS:000284000600028
J	Bodin, K; Ellmerich, S; Kahan, MC; Tennent, GA; Loesch, A; Gilbertson, JA; Hutchinson, WL; Mangione, PP; Gallimore, JR; Millar, DJ; Minogue, S; Dhillon, AP; Taylor, GW; Bradwell, AR; Petrie, A; Gillmore, JD; Bellotti, V; Botto, M; Hawkins, PN; Pepys, MB				Bodin, Karl; Ellmerich, Stephan; Kahan, Melvyn C.; Tennent, Glenys A.; Loesch, Andrzej; Gilbertson, Janet A.; Hutchinson, Winston L.; Mangione, Palma P.; Gallimore, J. Ruth; Millar, David J.; Minogue, Shane; Dhillon, Amar P.; Taylor, Graham W.; Bradwell, Arthur R.; Petrie, Aviva; Gillmore, Julian D.; Bellotti, Vittorio; Botto, Marina; Hawkins, Philip N.; Pepys, Mark B.			Antibodies to human serum amyloid P component eliminate visceral amyloid deposits	NATURE			English	Article							PHARMACOLOGICAL DEPLETION; AL AMYLOIDOSIS; COMPLEMENT; FIBRILS; MICE	Accumulation of amyloid fibrils in the viscera and connective tissues causes systemic amyloidosis, which is responsible for about one in a thousand deaths in developed countries(1). Localized amyloid can also have serious consequences; for example, cerebral amyloid angiopathy is an important cause of haemorrhagic stroke. The clinical presentations of amyloidosis are extremely diverse and the diagnosis is rarely made before significant organ damage is present(1). There is therefore a major unmet need for therapy that safely promotes the clearance of established amyloid deposits. Over 20 different amyloid fibril proteins are responsible for different forms of clinically significant amyloidosis and treatments that substantially reduce the abundance of the respective amyloid fibril precursor proteins can arrest amyloid accumulation(1). Unfortunately, control of fibril-protein production is not possible in some forms of amyloidosis and in others it is often slow and hazardous(1). There is no therapy that directly targets amyloid deposits for enhanced clearance. However, all amyloid deposits contain the normal, non-fibrillar plasma glycoprotein, serum amyloid P component (SAP)(2,3). Here we show that administration of anti-human-SAP antibodies to mice with amyloid deposits containing human SAP triggers a potent, complement-dependent, macrophage-derived giant cell reaction that swiftly removes massive visceral amyloid deposits without adverse effects. Anti-SAP-antibody treatment is clinically feasible because circulating human SAP can be depleted in patients by the bis-D-proline compound CPHPC4, thereby enabling injected anti-SAP antibodies to reach residual SAP in the amyloid deposits. The unprecedented capacity of this novel combined therapy to eliminate amyloid deposits should be applicable to all forms of systemic and local amyloidosis.	[Bodin, Karl; Ellmerich, Stephan; Kahan, Melvyn C.; Tennent, Glenys A.; Loesch, Andrzej; Gilbertson, Janet A.; Hutchinson, Winston L.; Mangione, Palma P.; Gallimore, J. Ruth; Millar, David J.; Taylor, Graham W.; Gillmore, Julian D.; Bellotti, Vittorio; Hawkins, Philip N.; Pepys, Mark B.] UCL, Ctr Amyloidosis & Acute Phase Prot, Div Med, London NW3 2PF, England; [Mangione, Palma P.; Bellotti, Vittorio] Univ Pavia, Dipartimento Biochim, I-27100 Pavia, Italy; [Minogue, Shane] UCL, Ctr Mol Cell Biol, Div Med, London NW3 2PF, England; [Dhillon, Amar P.] UCL, Dept Histopathol, London NW3 2PF, England; [Bradwell, Arthur R.] Univ Birmingham, Sch Med, Dept Immun & Infect, Birmingham B15 2TT, W Midlands, England; [Bradwell, Arthur R.] Binding Site Ltd, Birmingham B14 4ZB, W Midlands, England; [Petrie, Aviva] UCL Eastman Dent Inst, Biostat Unit, London WC1X 8LD, England; [Botto, Marina] Univ London Imperial Coll Sci Technol & Med, Fac Med, Rheumatol Sect, London W12 0NN, England	University of London; University College London; University of Pavia; University of London; University College London; University of London; University College London; University of Birmingham; University of London; University College London; Imperial College London	Pepys, MB (corresponding author), UCL, Ctr Amyloidosis & Acute Phase Prot, Div Med, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	m.pepys@ucl.ac.uk	Bellotti, Vittorio/A-6201-2014	Bellotti, Vittorio/0000-0001-8678-662X; Mangione, Palma/0000-0003-0260-1400; Taylor, Graham/0000-0002-9672-8463; Bradwell, Arthur/0000-0002-1562-1606	Medical Research Council [G97900510]; University College London; Erik and Edith Fernstroms Foundation for Medical Research; Swedish Research Council; Medical Research Council [G7900510, G0901596] Funding Source: researchfish; National Centre for the Replacement [G0800737/1] Funding Source: researchfish; MRC [G0901596, G7900510] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University College London(General Electric); Erik and Edith Fernstroms Foundation for Medical Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by Medical Research Council Programme Grant G97900510 to M.B.P. and P.N.H. and by the University College London Amyloidosis Research Fund. K.B. was supported by the Erik and Edith Fernstroms Foundation for Medical Research and a Postdoctoral Fellowship from the Swedish Research Council. K.B. dedicates his work to his late father, Gunnar Bodin. We thank S. Gordon, S. Wood, S. Kolstoe, J. Raynes, P. Simons and R. Al-Shawi for information, advice, reagents and support, and B. Jones for processing the manuscript.	Argiles A, 2002, NEPHROL DIAL TRANSPL, V17, P1136, DOI 10.1093/ndt/17.6.1136; Botto M, 1997, NAT MED, V3, P855, DOI 10.1038/nm0897-855; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; BREATHNACH SM, 1981, NATURE, V293, P652, DOI 10.1038/293652a0; DEBEER FC, 1982, J IMMUNOL METHODS, V50, P17, DOI 10.1016/0022-1759(82)90300-3; DYCK RF, 1980, J EXP MED, V152, P1162, DOI 10.1084/jem.152.5.1162; Gillmore JD, 2010, BRIT J HAEMATOL, V148, P760, DOI 10.1111/j.1365-2141.2009.08036.x; HAWKINS PN, 1990, CLIN EXP IMMUNOL, V81, P325; HAWKINS PN, 1988, J EXP MED, V167, P903, DOI 10.1084/jem.167.3.903; KLAUS GGB, 1979, IMMUNOLOGY, V38, P687; Lachmann HJ, 2007, NEW ENGL J MED, V356, P2361, DOI 10.1056/NEJMoa070265; Lachmann HJ, 2003, BRIT J HAEMATOL, V122, P78, DOI 10.1046/j.1365-2141.2003.04433.x; Nakamura Y, 1999, PATHOL INT, V49, P898, DOI 10.1046/j.1440-1827.1999.00962.x; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; PEPYS MB, 1979, CLIN EXP IMMUNOL, V38, P284; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; Pepys MB, 1997, AMYLOID, V4, P274, DOI 10.3109/13506129709003838; Solomon A, 2003, CANCER BIOTHER RADIO, V18, P853, DOI 10.1089/108497803322702824; Solomon A, 2003, CLIN CANCER RES, V9, p3831S; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; van Rooijen N, 2010, METHODS MOL BIOL, V605, P189, DOI 10.1007/978-1-60327-360-2_13; Verine J, 2007, HUM PATHOL, V38, P1798, DOI 10.1016/j.humpath.2007.04.013; WALL JS, 2010, BLOOD           0603, DOI DOI 10.1182/BLOOD-2010-03-273797; WEISS SW, 1973, AM J PATHOL, V72, P447; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; ZUCKERFRANKLIN D, 1970, J ULTRA MOL STRUCT R, V32, P247, DOI 10.1016/S0022-5320(70)80005-3	26	239	247	0	32	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					93	97		10.1038/nature09494	http://dx.doi.org/10.1038/nature09494			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20962779	Green Accepted			2022-12-28	WOS:000283786900042
J	Valsecchi, F; Glebbeek, E; Farr, WM; Fragos, T; Willems, B; Orosz, JA; Liu, JF; Kalogera, V				Valsecchi, Francesca; Glebbeek, Evert; Farr, Will M.; Fragos, Tassos; Willems, Bart; Orosz, Jerome A.; Liu, Jifeng; Kalogera, Vassiliki			Formation of the black-hole binary M33 X-7 through mass exchange in a tight massive system	NATURE			English	Article							X-RAY BINARY; ECLIPSING BINARY; EVOLUTION; STARS; M-33; ACCRETION; SPIN	The X-ray source M33 X-7 in the nearby galaxy Messier 33 is among the most massive X-ray binary stellar systems known, hosting a rapidly spinning, 15.65M(circle dot) black hole orbiting an underluminous, 70M(circle dot) main-sequence companion in a slightly eccentric 3.45-day orbit(1,2) (M-circle dot, solar mass). Although post-main-sequence mass transfer explains the masses and tight orbit(3), it leaves unexplained the observed X-ray luminosity, the star's underluminosity, the black hole's spin and the orbital eccentricity. A common envelope phase(1), or rotational mixing(4), could explain the orbit, but the former would lead to a merger and the latter to an overluminous companion. A merger would also ensue if mass transfer to the black hole were invoked for its spin-up(5). Here we report simulations of evolutionary tracks which reveal that if M33 X-7 started as a primary body of 85M(circle dot)-99M(circle dot) and a secondary body of 28M(circle dot)-32M(circle dot), in a 2.8-3.1-d orbit, its observed properties can be consistently explained. In this model, the main-sequence primary transfers part of its envelope to the secondary and loses the rest in a wind; it ends its life as a 16M(circle dot) helium star with an iron-nickel core that collapses to a black hole (with or without an accompanying supernova). The release of binding energy, and possibly collapse asymmetries, 'kick' the nascent black hole into an eccentric orbit. Wind accretion explains the X-ray luminosity, and the black-hole spin can be natal.	[Valsecchi, Francesca; Farr, Will M.; Fragos, Tassos; Willems, Bart; Kalogera, Vassiliki] Northwestern Univ, CIERA, Evanston, IL 60208 USA; [Valsecchi, Francesca; Farr, Will M.; Fragos, Tassos; Willems, Bart; Kalogera, Vassiliki] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA; [Glebbeek, Evert] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Orosz, Jerome A.] San Diego State Univ, Dept Astron, San Diego, CA 92182 USA; [Liu, Jifeng] Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China; [Fragos, Tassos; Liu, Jifeng] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Northwestern University; Northwestern University; McMaster University; California State University System; San Diego State University; Chinese Academy of Sciences; National Astronomical Observatory, CAS; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Valsecchi, F (corresponding author), Northwestern Univ, CIERA, 2145 Sheridan Rd, Evanston, IL 60208 USA.	francesca@u.northwestern.edu	Fragos, Tassos/A-3581-2016	Fragos, Tassos/0000-0003-1474-1523	Division Of Astronomical Sciences [0908930] Funding Source: National Science Foundation	Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Abubekerov MK, 2009, ASTRON REP+, V53, P232, DOI 10.1134/S1063772909030056; Bonanos AZ, 2004, ASTROPHYS J, V611, DOI 10.1086/423671; Bonanos AZ, 2009, ASTROPHYS J, V691, P407, DOI 10.1088/0004-637X/691/1/407; Bondi H, 1944, MON NOT R ASTRON SOC, V104, P0273, DOI 10.1093/mnras/104.5.273; Hirschi R, 2005, ASTRON ASTROPHYS, V443, P581, DOI 10.1051/0004-6361:20053329; Li LX, 2005, ASTROPHYS J SUPPL S, V157, P335, DOI 10.1086/428089; Liu JF, 2010, ASTROPHYS J LETT, V719, pL109, DOI 10.1088/2041-8205/719/1/L109; Massey P, 2002, ASTROPHYS J, V565, P982, DOI 10.1086/324783; McClintock JE, 2006, ASTROPHYS J, V652, P518, DOI 10.1086/508457; Mendez EM, 2008, ASTROPHYS J LETT, V689, pL9; Orosz JA, 2000, ASTRON ASTROPHYS, V364, P265; Orosz JA, 2007, NATURE, V449, P872, DOI 10.1038/nature06218; Parmar AN, 2001, ASTRON ASTROPHYS, V368, P420, DOI 10.1051/0004-6361:20010027; Pietsch W, 2006, ASTROPHYS J, V646, P420, DOI 10.1086/504704; Pietsch W, 2004, ASTRON ASTROPHYS, V413, P879, DOI 10.1051/0004-6361:20034081; Podsiadlowski P, 2003, MON NOT R ASTRON SOC, V341, P385, DOI 10.1046/j.1365-8711.2003.06464.x; Rauw G, 2004, ASTRON ASTROPHYS, V420, pL9, DOI 10.1051/0004-6361:20040150; Shporer A, 2007, ASTRON ASTROPHYS, V462, P1091, DOI 10.1051/0004-6361:20066354; Taam RE, 2000, ANNU REV ASTRON ASTR, V38, P113, DOI 10.1146/annurev.astro.38.1.113; Tauris T.M., 2006, COMPACT STELLAR XRAY, P623; U V, 2009, ASTROPHYS J, V704, P1120, DOI 10.1088/0004-637X/704/2/1120; van der Hucht KA, 2001, NEW ASTRON REV, V45, P135, DOI 10.1016/S1387-6473(00)00112-3; VERBUNT F, 1993, ANNU REV ASTRON ASTR, V31, P93; Zhang SN, 1997, ASTROPHYS J, V482, pL155, DOI 10.1086/310705	25	46	46	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					77	79		10.1038/nature09463	http://dx.doi.org/10.1038/nature09463			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20962778	Green Submitted			2022-12-28	WOS:000283786900038
J	Goldberg, EE; Kohn, JR; Lande, R; Robertson, KA; Smith, SA; Igic, B				Goldberg, Emma E.; Kohn, Joshua R.; Lande, Russell; Robertson, Kelly A.; Smith, Stephen A.; Igic, Boris			Species Selection Maintains Self-Incompatibility	SCIENCE			English	Article							MATING SYSTEMS; POLYMORPHISM; EVOLUTION; DIVERSIFICATION; FERTILIZATION; SPECIATION; DIVERSITY; PLANTS; RATES	Identifying traits that affect rates of speciation and extinction and, hence, explain differences in species diversity among clades is a major goal of evolutionary biology. Detecting such traits is especially difficult when they undergo frequent transitions between states. Self-incompatibility, the ability of hermaphrodites to enforce outcrossing, is frequently lost in flowering plants, enabling self-fertilization. We show, however, that in the nightshade plant family (Solanaceae), species with functional self-incompatibility diversify at a significantly higher rate than those without it. The apparent short-term advantages of potentially self-fertilizing individuals are therefore offset by strong species selection, which favors obligate outcrossing.	[Goldberg, Emma E.; Robertson, Kelly A.; Igic, Boris] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; [Kohn, Joshua R.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Lande, Russell] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; [Smith, Stephen A.] Natl Evolutionary Synth Ctr, Durham, NC 27705 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California San Diego; Imperial College London; The National Evolutionary Synthesis Center	Igic, B (corresponding author), Univ Illinois, Dept Biol Sci, 840 W Taylor St,M-C 067, Chicago, IL 60607 USA.	boris@uic.edu	Smith, Stephen/AAE-8623-2019	Smith, Stephen/0000-0003-2035-9531; Goldberg, Emma/0000-0002-7311-9606	NSF [DEB-0919089]; Division Of Environmental Biology [0919089] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. FitzJohn, A. Mooers, R. Olmstead, T. Paape, L. Popovic, D. L. Shade, and R. Ree for help and discussions. Data are deposited in the Dryad database with accession no. 1888. Funded by NSF grant DEB-0919089 to B.I.	Barrett SCH, 2003, PHILOS T R SOC B, V358, P991, DOI 10.1098/rstb.2003.1301; Busch JW, 2008, TRENDS PLANT SCI, V13, P128, DOI 10.1016/j.tplants.2008.01.002; Darwin C, 1903, MORE LETT C DARWIN R; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; FitzJohn RG, 2009, SYST BIOL, V58, P595, DOI 10.1093/sysbio/syp067; Franklin-Tong V. E., 2008, P237, DOI 10.1007/978-3-540-68486-2_11; Glemin S, 2006, P ROY SOC B-BIOL SCI, V273, P3011, DOI 10.1098/rspb.2006.3657; Goldberg EE, 2008, EVOLUTION, V62, P2727, DOI 10.1111/j.1558-5646.2008.00505.x; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; GOULD SJ, 1982, SCIENCE, V216, P380, DOI 10.1126/science.7041256; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Igic B, 2006, P NATL ACAD SCI USA, V103, P1359, DOI 10.1073/pnas.0506283103; Igic B, 2004, NEW PHYTOL, V161, P97, DOI 10.1046/j.1469-8137.2003.00952.x; Igic B, 2008, INT J PLANT SCI, V169, P93, DOI 10.1086/523362; Igic B, 2006, EVOLUTION, V60, P1098, DOI 10.1111/j.0014-3820.2006.tb01186.x; IOERGER TR, 1990, P NATL ACAD SCI USA, V87, P9732, DOI 10.1073/pnas.87.24.9732; Jablonski D, 2008, ANNU REV ECOL EVOL S, V39, P501, DOI 10.1146/annurev.ecolsys.39.110707.173510; KAROLY K, 1994, AM NAT, V144, P677, DOI 10.1086/285700; Lewontin R. C., 1970, ANNU REV ECOL SYST, V1, P1, DOI [DOI 10.1146/ANNUREV.ES.01.110170.000245, 10.1146/annurev.es.01.110170.000245]; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; Maddison WP, 2006, EVOLUTION, V60, P1743, DOI 10.1554/05-666.1; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Olmstead RG, 2007, ACTA HORTIC, P255, DOI 10.17660/ActaHortic.2007.745.11; Porcher E, 2005, EVOLUTION, V59, P46, DOI 10.1111/j.0014-3820.2005.tb00893.x; Rabosky DL, 2010, TRENDS ECOL EVOL, V25, P68, DOI 10.1016/j.tree.2009.07.002; Schoen DJ, 2008, INT J PLANT SCI, V169, P119, DOI 10.1086/523356; SCHOEN DJ, 1991, P NATL ACAD SCI USA, V88, P4494, DOI 10.1073/pnas.88.10.4494; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; STEBBINS GL, 1974, FLOWERING PLANTS; Steinbachs JE, 2002, MOL BIOL EVOL, V19, P825, DOI 10.1093/oxfordjournals.molbev.a004139; Williams G. C, 1992, NATURAL SELECTION DO; ZAVADA MS, 1986, AM NAT, V128, P538, DOI 10.1086/284586	32	324	329	2	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					493	495		10.1126/science.1194513	http://dx.doi.org/10.1126/science.1194513			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966249				2022-12-28	WOS:000283329100036
J	Ferris, TG; Torchiana, DF				Ferris, Timothy G.; Torchiana, David F.			Public Release of Clinical Outcomes Data -- Online CABG Report Cards.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							QUALITY MEASUREMENT; SURGERY		[Ferris, Timothy G.; Torchiana, David F.] Massachusetts Gen Hosp, Massachusetts Gen Phys Org, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Ferris, TG (corresponding author), Massachusetts Gen Hosp, Massachusetts Gen Phys Org, Boston, MA 02114 USA.							Dranove D, 2003, J POLIT ECON, V111, P555, DOI 10.1086/374180; O'Brien SM, 2007, ANN THORAC SURG, V83, pS13, DOI 10.1016/j.athoracsur.2007.01.055; OConnor GT, 1996, JAMA-J AM MED ASSOC, V275, P841, DOI 10.1001/jama.275.11.841; Shahian DM, 2007, ANN THORAC SURG, V83, pS3, DOI 10.1016/j.athoracsur.2007.01.053	4	62	63	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2010	363	17					1593	1595		10.1056/NEJMp1009423	http://dx.doi.org/10.1056/NEJMp1009423			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668BD	20961241				2022-12-28	WOS:000283242700003
J	Radu, A; Pichon, C; Camparo, P; Antoine, M; Allory, Y; Couvelard, A; Fromont, G; Hai, MTV; Ghinea, N				Radu, Aurelian; Pichon, Christophe; Camparo, Philippe; Antoine, Martine; Allory, Yves; Couvelard, Anne; Fromont, Gaelle; Hai, Mai Thu Vu; Ghinea, Nicolae			Expression of Follicle-Stimulating Hormone Receptor in Tumor Blood Vessels.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELL-PROLIFERATION; PROSTATE-CANCER; BREAST-CANCER; FSH; LOCALIZATION; CARCINOMAS; PROTEINS	Background: In adult humans, the follicle-stimulating hormone (FSH) receptor is expressed only in the granulosa cells of the ovary and the Sertoli cells of the testis. It is minimally expressed by the endothelial cells of gonadal blood vessels. Methods: We used immunohistochemical and immunoblotting techniques involving four separate FSH-receptor-specific monoclonal antibodies that recognize different FSH receptor epitopes and in situ hybridization to detect FSH receptor in tissue samples from patients with a wide range of tumors. Immunoelectron microscopy was used to detect FSH receptor in mouse tumors. Results: In all 1336 patients examined, FSH receptor was expressed by endothelial cells in tumors of all grades, including early T1 tumors. The tumors were located in the prostate, breast, colon, pancreas, urinary bladder, kidney, lung, liver, stomach, testis, and ovary. In specimens obtained during surgery performed to remove tumors, the FSH receptor was not expressed in the normal tissues located more than 10 mm from the tumors. The tumor lymphatic vessels did not express FSH receptor. The endothelial cells that expressed FSH receptor were located at the periphery of the tumors in a layer that was approximately 10 mm thick; this layer extended both into and outside of the tumor. Immunoelectron microscopy in mice with xenograft tumors, after perfusion with anti-FSH-receptor antibodies coupled to colloidal gold, showed that the FSH receptor is exposed on the luminal endothelial surface and can bind and internalize circulating ligands. Conclusions: FSH receptor is selectively expressed on the surface of the blood vessels of a wide range of tumors. (Funded by INSERM.) N Engl J Med 2010;363:1621-30.	[Allory, Yves; Hai, Mai Thu Vu; Ghinea, Nicolae] Univ Paris Est, INSERM, U955, Eq 07, Creteil, France; [Radu, Aurelian] Mt Sinai Sch Med, New York, NY USA; [Pichon, Christophe] INSERM, U753, Villejuif, France; [Camparo, Philippe] Val de Grace Hosp, Paris, France; [Antoine, Martine] Tenon Hosp, Paris, France; [Couvelard, Anne] Beaujon Hosp, Clichy, France; [Fromont, Gaelle] Ctr Hosp Univ Poitiers, Poitiers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); Val-de-Grace Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Poitiers; Universite de Poitiers	Ghinea, N (corresponding author), Univ Paris Est, INSERM, U955, Eq 07, 8 Rue Gen Sarrail, Creteil, France.	nicolae.ghinea@inserm.fr	fromont, gaelle/N-8708-2016; Ghinea, Nicolae/G-3188-2013	Anne, Couvelard/0000-0002-6316-1210	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	Supported by INSERM.	Alam H, 2009, ENDOCRINOLOGY, V150, P915, DOI 10.1210/en.2008-0850; Begum R, 2003, HISTOPATHOLOGY, V43, P244, DOI 10.1046/j.1365-2559.2003.01714.x; Belien JAM, 1999, J PATHOL, V189, P309; Ben-Josef E, 1999, J UROLOGY, V161, P970, DOI 10.1016/S0022-5347(01)61831-7; BOCKERS TM, 1994, CELL TISSUE RES, V278, P595; Castro-Fernandez C, 2004, ENDOCRINE, V25, P49, DOI 10.1385/ENDO:25:1:49; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Eble J, 2004, WHO CLASSIFICATION T; Fernebro J, 2007, APMIS, V115, P707, DOI 10.1111/j.1600-0463.2007.apm_650.x; FOX SB, 1993, CANCER RES, V53, P4161; Green FL, 2006, AM JOINT COMMITTEE C; Hai MTV, 2004, BIOL CELL, V96, P133, DOI 10.1016/j.biolcel.2003.11.008; Macklon NS, 1998, MATURITAS, V30, P181, DOI 10.1016/S0378-5122(98)00072-3; Mariani S, 2006, J UROLOGY, V175, P2072, DOI 10.1016/S0022-5347(06)00273-4; Ohashi K, 1997, VIRCHOWS ARCH, V430, P107, DOI 10.1007/BF01008031; Plant TM, 2001, ENDOCR REV, V22, P764, DOI 10.1210/er.22.6.764; Rodins K, 2002, CLIN CANCER RES, V8, P1075; Shoji M, 1999, AM J PATHOL, V154, P909, DOI 10.1016/S0002-9440(10)65338-2; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; SPRENGEL R, 1990, MOL ENDOCRINOL, V4, P525, DOI 10.1210/mend-4-4-525; Vannier B, 1996, BIOCHEMISTRY-US, V35, P1358, DOI 10.1021/bi952290f; Zeng HY, 2003, J BIOL CHEM, V278, P20738, DOI 10.1074/jbc.M209712200	22	219	239	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2010	363	17					1621	1630		10.1056/NEJMoa1001283	http://dx.doi.org/10.1056/NEJMoa1001283			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668BD	20961245				2022-12-28	WOS:000283242700006
J	Heisler, M; Vijan, S; Makki, F; Piette, JD				Heisler, Michele; Vijan, Sandeep; Makki, Fatima; Piette, John D.			Diabetes Control With Reciprocal Peer Support Versus Nurse Care Management A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							SELF-MANAGEMENT; INSULIN THERAPY; SOCIAL SUPPORT; GLYCEMIC CONTROL; CHRONIC ILLNESS; INTERVENTIONS; HEALTH; EDUCATION; DISEASE; METAANALYSIS	Background: Resource barriers complicate diabetes care management. Support from peers may help patients manage their diabetes. Objective: To compare a reciprocal peer-support (RPS) program with nurse care management (NCM). Design: Randomized, controlled trial. (ClinicalTrials.gov registration number: NCT00320112) Setting: 2 U.S. Department of Veterans Affairs health care facilities. Patients: 244 men with hemoglobin A(1c) (HbA(1c)) levels greater than 7.5% during the previous 6 months. Measurements: The primary outcome was 6-month change in HbA(1c) level. Secondary outcomes were changes in insulin therapy; blood pressure; and patient reports of medication adherence, diabetes-related support, and emotional distress. Intervention: Patients in the RPS group attended an initial group session to set diabetes-related behavioral goals, receive peer communication skills training, and be paired with another age-matched peer patient. Peers were encouraged to talk weekly using a telephone platform that recorded call occurrence and provided reminders to promote peer contact. These patients could also participate in optional group sessions at 1, 3, and 6 months. Patients in the NCM group attended a 1.5-hour educational session and were assigned to a nurse care manager. Results: Of the 244 patients enrolled, 216 (89%) completed the HbA(1c) assessments and 231 (95%) completed the survey assessments at 6 months. Mean HbA(1c) level decreased from 8.02% to 7.73% (change, -0.29%) in the RPS group and increased from 7.93% to 8.22% (change, 0.29%) in the NCM group. The difference in HbA(1c) change between groups was 0.58% (P = 0.004). Among patients with a baseline HbA(1c) level greater than 8.0%, those in the RPS group had a mean decrease of 0.88%, compared with a 0.07% decrease among those in the NCM group (between-group difference, 0.81%; P < 0.001). Eight patients in the RPS group started insulin therapy, compared with 1 patient in the NCM group (P = 0.020). Groups did not differ in blood pressure, self-reported medication adherence, or diabetes-specific distress, but the RPS group reported improvement in diabetes social support. Limitation: The study included only male veterans and lasted only 6 months. Conclusion: Reciprocal peer support holds promise as a method for diabetes care management.	[Heisler, Michele] Univ Michigan, Sch Med, Vet Affairs Ann Arbor Hlth Syst, Ann Arbor, MI 48113 USA; Ann Arbor Vet Affairs Hlth Care Syst, Ann Arbor, MI USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Heisler, M (corresponding author), Univ Michigan, Sch Med, Vet Affairs Ann Arbor Hlth Syst, Box 130170,MS 152, Ann Arbor, MI 48113 USA.	mheisler@umich.edu	Heisler, Michele/B-5774-2015	Heisler, Michele/0000-0002-6889-2063	U.S. Department of Veterans Affairs Health Services Research and Development Service [IIR 04-239]; Michigan Diabetes Research and Training Center (National Institutes of Health [NIH]) [5P60-DK20572]; Robert Wood Johnson Foundation; Michigan Institute for Clinical and Health Research (NIH) [UL1RR024986]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs); Michigan Diabetes Research and Training Center (National Institutes of Health [NIH])(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Michigan Institute for Clinical and Health Research (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By the U.S. Department of Veterans Affairs Health Services Research and Development Service (grant IIR 04-239), the Michigan Diabetes Research and Training Center (National Institutes of Health [NIH] grant 5P60-DK20572), the Robert Wood Johnson Foundation Clinical Scholars Program, and the Michigan Institute for Clinical and Health Research (NIH grant UL1RR024986).	*AM COLL PHYS, 2010, PAT CTR MED HOM; Arsie MP, 2000, ACTA DIABETOL, V37, P1, DOI 10.1007/s005920070028; Bandura A., 1986, SOCIAL FDN THOUGHT A; Barrera M, 2002, AM J COMMUN PSYCHOL, V30, P637, DOI 10.1023/A:1016369114780; Bodenheimer T, 2009, PATIENT EDUC COUNS, V76, P174, DOI 10.1016/j.pec.2009.06.001; Brown SL, 2003, PSYCHOL SCI, V14, P320, DOI 10.1111/1467-9280.14461; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clancy DE, 2007, J GEN INTERN MED, V22, P620, DOI 10.1007/s11606-007-0150-3; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Dale J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006903.pub2; Dennis CL, 2003, INT J NURS STUD, V40, P321, DOI 10.1016/S0020-7489(02)00092-5; Donaldson L, 2003, BRIT MED J, V326, P1279, DOI 10.1136/bmj.326.7402.1279; DOULL M, 2007, COCHRANE DB SYST REV; Funnell MM, 2004, DIABETES EDUCATOR, V30, P274, DOI 10.1177/014572170403000220; Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030; Glasgow RE, 2006, AM J PREV MED, V30, P67, DOI 10.1016/j.amepre.2005.08.037; Griffiths C, 2007, BMJ-BRIT MED J, V334, P1254, DOI 10.1136/bmj.39227.698785.47; Harada ND, 2002, MED CARE, V40, P117; Hayward RA, 1997, JAMA-J AM MED ASSOC, V278, P1663, DOI 10.1001/jama.278.20.1663; Heisler M, 2005, DIABETES EDUCATOR, V31, P869, DOI 10.1177/0145721705283247; Heisler M, 2002, J GEN INTERN MED, V17, P243, DOI 10.1046/j.1525-1497.2002.10905.x; Heisler M, 2007, ARCH INTERN MED, V167, P1853, DOI 10.1001/archinte.167.17.1853; Helgeson VS, 2000, HEALTH PSYCHOL, V19, P107, DOI 10.1037/0278-6133.19.2.107; Hunt LM, 1997, DIABETES CARE, V20, P292, DOI 10.2337/diacare.20.3.292; Imai K, 2009, STAT SCI, V24, P29, DOI 10.1214/08-STS274; Joseph DH, 2001, DIABETES EDUCATOR, V27, P703, DOI 10.1177/014572170102700511; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Knight K, 2005, AM J MANAG CARE, V11, P242; Korytkowski M, 2002, INT J OBESITY, V26, pS18, DOI 10.1038/sj.ijo.0802173; LAVORI PW, 1995, STAT MED, V14, P1913, DOI 10.1002/sim.4780141707; Lorig K R, 2001, Eff Clin Pract, V4, P256; Lorig K, 2009, DIABETES EDUCATOR, V35, P641, DOI 10.1177/0145721709335006; Murray DM, 1998, DESIGN ANAL GROUP RA; Norris SL, 2002, AM J PREV MED, V22, P15, DOI 10.1016/S0749-3797(02)00423-3; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Piette JD, 2001, DIABETES CARE, V24, P202, DOI 10.2337/diacare.24.2.202; Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626; ROLLNICK S, 2008, HLTH BEHAV CHANGE GU; Rubin DB, 1987, MULTIPLE IMPUTATION; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Schwartz CE, 1999, SOC SCI MED, V48, P1563, DOI 10.1016/S0277-9536(99)00049-0; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; SHOJANIA KG, 2010, AHRQ PUBLICATION, V2; Tang TS, 2005, DIABETES EDUCATOR, V31, P91, DOI 10.1177/0145721704273231; Trento M, 2008, J ENDOCRINOL INVEST, V31, P1038, DOI 10.1007/BF03345645; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vijan S, 2005, J GEN INTERN MED, V20, P479, DOI 10.1111/j.1525-1497.2005.0117.x; Wagner EH, 2001, DIABETES CARE, V24, P695, DOI 10.2337/diacare.24.4.695; Weingarten SR, 2002, BRIT MED J, V325, P925, DOI 10.1136/bmj.325.7370.925	52	252	259	2	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8					507	515		10.7326/0003-4819-153-8-201010190-00007	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	665SA	20956707	Green Accepted			2022-12-28	WOS:000283054600003
J	Levy, DL; Heald, R				Levy, Daniel L.; Heald, Rebecca			Nuclear Size Is Regulated by Importin alpha and Ntf2 in Xenopus	CELL			English	Article							SYSTEMS-ANALYSIS; PROTEIN IMPORT; EGG EXTRACTS; PORE COMPLEX; TRANSPORT; ENVELOPE; RAN; LAMINA; CELLS; ORGANIZATION	The size of the nucleus varies among different cell types, species, and disease states, but mechanisms of nuclear size regulation are poorly understood. We investigated nuclear scaling in the pseudotetraploid frog Xenopus laevis and its smaller diploid relative Xenopus tropicalis, which contains smaller cells and nuclei. Nuclear scaling was recapitulated in vitro using egg extracts, demonstrating that titratable cytoplasmic factors determine nuclear size to a greater extent than DNA content. Nuclear import rates correlated with nuclear size, and varying the concentrations of two transport factors, importin alpha and Ntf2, was sufficient to account for nuclear scaling between the two species. Both factors modulated lamin B3 import, with importin alpha increasing overall import rates and Ntf2 reducing import based on cargo size. Importin alpha also contributes to nuclear size changes during early X. laevis development. Thus, nuclear transport mechanisms are physiological regulators of both interspecies and developmental nuclear scaling.	[Levy, Daniel L.; Heald, Rebecca] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Heald, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	bheald@berkeley.edu	Levy, Daniel/AAA-7205-2019	Levy, Daniel/0000-0002-7853-3275; Heald, Rebecca/0000-0001-6671-6528	NIH [DP1 OD000818]; American Cancer Society [PF-09-041-01-DDC]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000818] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Steve Bird, Mary Dasso, Dirk Gorlich, David Halpin, Richard Harland, Petr Kalab, Jan Liphardt, Alan Lowe, Andreas Merdes, Jon Soderholm, and Karsten Weis for reagents. We acknowledge Steve Bird and Saori Haigo for conducting the initial nuclear scaling experiments in egg extracts; Saori Haigo, Esther Kieserman, and Richard Harland's laboratory for help with Xenopus embryos; and Abby Dernburg for use of the Marianas SDC microscope. We thank members of the Heald lab for helpful advice; Rose Loughlin, Jeff Tang, Karsten Weis, and David Weisblat for constructive comments on the manuscript; and Favian Hernandez for artwork. R.H. is supported by the NIH Director's Pioneer Award (DP1 OD000818) and The Miller Institute for Basic Research in Science. D. L. L. acknowledges support from an American Cancer Society postdoctoral fellowship (PF-09-041-01-DDC).	AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; Brown KS, 2007, J CELL BIOL, V176, P765, DOI 10.1083/jcb.200610043; Cavalier-Smith T, 2005, ANN BOT-LONDON, V95, P147, DOI 10.1093/aob/mci010; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; D'Angelo MA, 2006, SCIENCE, V312, P440, DOI 10.1126/science.1124196; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Fankhauser G, 1939, J HERED, V30, P379, DOI 10.1093/oxfordjournals.jhered.a104767; Feldherr C, 1998, J CELL SCI, V111, P1889; Goldberg MW, 2008, J CELL SCI, V121, P215, DOI 10.1242/jcs.022020; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; Grammer TC, 2005, MECH DEVELOP, V122, P263, DOI 10.1016/j.mod.2004.11.003; Hachet V, 2004, EMBO J, V23, P1526, DOI 10.1038/sj.emboj.7600154; Hall MN, 2004, CELL GROWTH CONTROL; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; HEITLINGER E, 1991, J CELL BIOL, V113, P485, DOI 10.1083/jcb.113.3.485; HORNER HA, 1983, J CELL SCI, V63, P135; JENKINS H, 1993, J CELL SCI, V106, P275; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; Lemaitre JM, 1998, J CELL BIOL, V142, P1159, DOI 10.1083/jcb.142.5.1159; LOEWINGER L, 1988, EMBO J, V7, P2301, DOI 10.1002/j.1460-2075.1988.tb03073.x; LOWE AR, 2010, NATURE IN PRESS, DOI DOI 10.10.1038/NATURE09285; Madrid AS, 2006, CHROMOSOMA, V115, P98, DOI 10.1007/s00412-005-0043-3; Manor U, 2008, SEMIN CELL DEV BIOL, V19, P502, DOI 10.1016/j.semcdb.2008.07.006; Maresca Thomas J., 2006, V322, P459; Marshall WF, 2008, SEMIN CELL DEV BIOL, V19, P520, DOI 10.1016/j.semcdb.2008.07.007; Marshall WF, 2002, TRENDS CELL BIOL, V12, P414, DOI 10.1016/S0962-8924(02)02341-3; MAUL GG, 1977, J CELL BIOL, V73, P748, DOI 10.1083/jcb.73.3.748; Montorzi M, 2000, MOL REPROD DEV, V55, P75, DOI 10.1002/(SICI)1098-2795(200001)55:1<75::AID-MRD10>3.0.CO;2-Z; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Neumann FR, 2007, J CELL BIOL, V179, P593, DOI 10.1083/jcb.200708054; NEWPORT JW, 1990, J CELL BIOL, V111, P2247, DOI 10.1083/jcb.111.6.2247; NIEUWKOOP PD, 1967, NORMAL TABLE XENOPOU; Prufert K, 2004, J CELL SCI, V117, P6105, DOI 10.1242/jcs.01532; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; Riddick G, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100160; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Smith A, 1998, CURR BIOL, V8, P1403, DOI 10.1016/S0960-9822(98)00023-2; Smith AE, 2002, SCIENCE, V295, P488, DOI 10.1126/science.1064732; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Theerthagiri G, 2010, J CELL BIOL, V189, P1129, DOI 10.1083/jcb.200912045; Tuxhorn J, 1998, CELL MOTIL CYTOSKEL, V40, P133, DOI 10.1016/j.semcdb.2008.07.005; Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	43	158	161	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					288	298		10.1016/j.cell.2010.09.012	http://dx.doi.org/10.1016/j.cell.2010.09.012			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946986	Bronze, Green Accepted			2022-12-28	WOS:000283052200017
J	Shoemaker, CJ; Eyler, DE; Green, R				Shoemaker, Christopher J.; Eyler, Daniel E.; Green, Rachel			Dom34:Hbs1 Promotes Subunit Dissociation and Peptidyl-tRNA Drop-Off to Initiate No-Go Decay	SCIENCE			English	Article							YEAST TRANSLATION INITIATION; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNAS; TERMINATION; RIBOSOME; RELEASE; ELONGATION; ERF1; RECONSTITUTION; DEGRADATION	No-go decay (NGD) is one of several messenger RNA (mRNA) surveillance systems dedicated to the removal of defective mRNAs from the available pool. Two interacting factors, Dom34 and Hbs1, are genetically implicated in NGD in yeast. Using a reconstituted yeast translation system, we show that Dom34: Hbs1 interacts with the ribosome to promote subunit dissociation and peptidyl-tRNA drop-off. Our data further indicate that these recycling activities are shared by the homologous translation termination factor complex eRF1:eRF3, suggesting a common ancestral function. Because Dom34: Hbs1 activity exhibits no dependence on either peptide length or A-site codon identity, we propose that this quality-control system functions broadly to recycle ribosomes throughout the translation cycle whenever stalls occur.	[Green, Rachel] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	ragreen@jhmi.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059425] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM059425] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Algire MA, 2002, RNA, V8, P382, DOI 10.1017/S1355838202029527; Alkalaeva EZ, 2006, CELL, V125, P1125, DOI 10.1016/j.cell.2006.04.035; Atkinson GC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-290; Carr-Schmid A, 2002, MOL CELL BIOL, V22, P2564, DOI 10.1128/MCB.22.8.2564-2574.2002; Cole SE, 2009, MOL CELL, V34, P440, DOI 10.1016/j.molcel.2009.04.017; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Frolova L, 1996, RNA, V2, P334; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Gandhi R, 2008, J BIOL CHEM, V283, P32218, DOI 10.1074/jbc.M803785200; Gartmann M, 2010, J BIOL CHEM, V285, P14848, DOI 10.1074/jbc.C109.096057; Graille M, 2008, J BIOL CHEM, V283, P7145, DOI 10.1074/jbc.M708224200; Khoshnevis S, 2010, EMBO REP, V11, P214, DOI 10.1038/embor.2009.272; Kolitz SE, 2009, RNA, V15, P138, DOI 10.1261/rna.1318509; Kurata S, 2010, P NATL ACAD SCI USA, V107, P10854, DOI 10.1073/pnas.1006247107; Lee HH, 2007, MOL CELL, V27, P938, DOI 10.1016/j.molcel.2007.07.019; Passos DO, 2009, MOL BIOL CELL, V20, P3025, DOI 10.1091/mbc.E09-01-0028; PELTZ SW, 1993, GENE DEV, V7, P1737, DOI 10.1101/gad.7.9.1737; Pisarev AV, 2007, CELL, V131, P286, DOI 10.1016/j.cell.2007.08.041; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Si K, 1999, MOL CELL BIOL, V19, P1416; Soudet J, 2010, EMBO J, V29, P80, DOI 10.1038/emboj.2009.307; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; VOGEL Z, 1971, EUR J BIOCHEM, V21, P582, DOI 10.1111/j.1432-1033.1971.tb01504.x; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zavialov AV, 2005, MOL CELL, V18, P675, DOI 10.1016/j.molcel.2005.05.016	28	221	229	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2010	330	6002					369	372		10.1126/science.1192430	http://dx.doi.org/10.1126/science.1192430			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947765	Green Accepted			2022-12-28	WOS:000282986700041
J	Mims, C				Mims, Christopher			Generation X-change	NATURE			English	Editorial Material																			0	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					S16	S18		10.1038/467S16a	http://dx.doi.org/10.1038/467S16a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944615	Bronze			2022-12-28	WOS:000282898700014
J	McGuire, AL; Evans, BJ; Caulfield, T; Burke, W				McGuire, Amy L.; Evans, Barbara J.; Caulfield, Timothy; Burke, Wylie			Regulating Direct-to-Consumer Personal Genome Testing	SCIENCE			English	Editorial Material							DISEASE; RISK		[McGuire, Amy L.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Evans, Barbara J.] Univ Houston, Ctr Law, Hlth Law & Policy Inst, Houston, TX 77204 USA; [Caulfield, Timothy] Univ Alberta, Hlth Law Inst, Edmonton, AB T6G 2H5, Canada; [Burke, Wylie] Univ Washington, Sch Med, Dept Bioeth & Humanities, Seattle, WA 98195 USA	Baylor College of Medicine; University of Houston System; University of Houston; University of Alberta; University of Washington; University of Washington Seattle	McGuire, AL (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA.	amcguire@bcm.edu			NHGRI NIH HHS [R01HG004333, P50HG3374-06] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004333, P50HG003374] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		American College of Medical Genetics, STAT DIR TO CONS GEN; American Medical Association, DIR TO CONS GEN TEST; Chao S, 2008, ALZ DIS ASSOC DIS, V22, P94, DOI 10.1097/WAD.0b013e31815a9dcc; Collins FS, 2001, JAMA-J AM MED ASSOC, V286, P2322, DOI 10.1001/jama.286.18.2322; *DEP HLTH HUM GEN, 2009, COMM FRAM PRINC DIR; European Commission, 2010, EUR EC, V39, P1, DOI DOI 10.2791/49877; Evans BJ, 2010, NOTRE DAME LAW REV, V85, P419; *FDA, FDA CDRH PUBL M OV L; *FDA, 2010, OV DEV REG; Fed. Trade Comm, 2006, AT HOM GEN TESTS HLT; *FTC, COMM ACT; *GAO, 2006, NUTR TEST TESTS PURC; *GAPP, GAPP KNOWL BAS; Green RC, 2009, NEW ENGL J MED, V361, P245, DOI 10.1056/NEJMoa0809578; Heshka JT, 2008, GENET MED, V10, P19, DOI 10.1097/GIM.0b013e31815f524f; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Javitt GH, 2007, FOOD DRUG LAW J, V62, P617; McGuire AL, 2008, JAMA-J AM MED ASSOC, V300, P2669, DOI 10.1001/jama.2008.803; National Center for Biotechnology Information, GENETESTS; National Institutes of Health, GEN TEST REG; Secretary's Advisory Committee On Genetics Health And Society (SACGHS), 2008, US SYST OV GEN TEST; United States Government Accountability Office (GAO), 2010, DIR TO CONS GEN TEST; Wright C., 2009, BAN DIRECT TO CONSUM	23	34	35	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					181	182		10.1126/science.1194006	http://dx.doi.org/10.1126/science.1194006			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	660LP	20929761				2022-12-28	WOS:000282644600025
J	Hoerauf, A				Hoerauf, Achim			Microflora, Helminths, and the Immune System -- Who Controls Whom?.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Clin, Bonn, Germany	University of Bonn	Hoerauf, A (corresponding author), Univ Clin, Bonn, Germany.							Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Kefalakes H, 2009, EUR J CLIN PHARMACOL, V65, P963, DOI 10.1007/s00228-009-0719-3; Zapater P, 2009, GASTROENTEROLOGY, V137, P1669, DOI 10.1053/j.gastro.2009.07.058	4	4	4	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2010	363	15					1476	1478		10.1056/NEJMcibr1007689	http://dx.doi.org/10.1056/NEJMcibr1007689			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	659NV	20925552				2022-12-28	WOS:000282575100016
J	Luft, HS				Luft, Harold S.			Becoming Accountable - Opportunities and Obstacles for ACOs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Palo Alto Med Fdn, Res Inst, Palo Alto, CA 94301 USA	Palo Alto Medical Foundation Research Institute	Luft, HS (corresponding author), Palo Alto Med Fdn, Res Inst, Palo Alto, CA 94301 USA.							Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; LEIBENLUFT RH, 2010, HLTH REFORM MARKET C; Minott J., 2010, GROUP EMPLOYED MODEL	3	31	31	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2010	363	15					1389	1391		10.1056/NEJMp1009380	http://dx.doi.org/10.1056/NEJMp1009380			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	659NV	20925539				2022-12-28	WOS:000282575100001
J	Barreda, VD; Palazzesi, L; Telleria, MC; Katinas, L; Crisci, JV; Bremer, K; Passalia, MG; Corsolini, R; Brizuela, RR; Bechis, F				Barreda, V. D.; Palazzesi, L.; Telleria, M. C.; Katinas, L.; Crisci, J. V.; Bremer, K.; Passalia, M. G.; Corsolini, R.; Rodriguez Brizuela, R.; Bechis, F.			Eocene Patagonia Fossils of the Daisy Family	SCIENCE			English	Article							ASTERACEAE; DIVERSITY; POLLEN		[Barreda, V. D.; Palazzesi, L.; Rodriguez Brizuela, R.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Paleobot, Secc Paleopalinol, Buenos Aires, DF, Argentina; [Barreda, V. D.; Palazzesi, L.; Telleria, M. C.; Katinas, L.; Crisci, J. V.; Passalia, M. G.; Bechis, F.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Telleria, M. C.; Crisci, J. V.] Museo La Plata, Lab Sistemat & Biol Evolut, La Plata, Argentina; [Telleria, M. C.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Lab Actuopalinol, Buenos Aires, DF, Argentina; [Katinas, L.; Crisci, J. V.] Museo La Plata, Div Plantas Vasc, La Plata, Argentina; [Bremer, K.] Stockholm Univ, SE-10691 Stockholm, Sweden; [Passalia, M. G.] Inst Invest Biodiversidad & Medioambiente, Lab Palinol & Paleobot, San Carlos De Bariloche, Rio Negro, Argentina; [Corsolini, R.] Museo Lago Gutierrez Dr Rosendo Pascual Geol & Pa, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Bechis, F.] Univ Nacl Rio Negro, Inst Invest Diversidad Cultural & Proc Cambio, San Carlos De Bariloche, Rio Negro, Argentina	Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); National University of La Plata; Museo La Plata; Stockholm University	Barreda, VD (corresponding author), Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Paleobot, Secc Paleopalinol, Ave Angel Gallardo 470,C1405DJR, Buenos Aires, DF, Argentina.	vbarreda@macn.gov.ar		Palazzesi, Luis/0000-0001-8026-4679; Barreda, Viviana Dora/0000-0002-1560-1277	CONICET; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); NSF; Direct For Biological Sciences [0919071] Funding Source: National Science Foundation	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank P. C. Hoch for the critical reading of the manuscript. Financial support was provided by grants of CONICET, Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), and NSF.	Barreda V, 2007, BOT REV, V73, P31, DOI 10.1663/0006-8101(2007)73[31:PVTDTP]2.0.CO;2; Barreda V, 2010, REV PALAEOBOT PALYNO, V160, P102, DOI 10.1016/j.revpalbo.2010.02.004; Barreda V, 2009, REV PALAEOBOT PALYNO, V154, P22, DOI 10.1016/j.revpalbo.2008.11.005; Blackmore S, 2010, PLANT SYST EVOL, V284, P17, DOI 10.1007/s00606-009-0232-2; Telleria MC, 2010, PLANT SYST EVOL, V285, P75, DOI 10.1007/s00606-009-0257-6; Funk VA., 2005, BIOL SKRIFTER, V55, P343; Graham A., 1996, COMPOSITAE SYSTEMATI, V1, P123; Kim KJ, 2005, MOL BIOL EVOL, V22, P1783, DOI 10.1093/molbev/msi174; Macphail M. K., 1994, Papers and Proceedings of the Royal Society of Tasmania, V128, P1; Martinez-Millan M, 2010, BOT REV, V76, P83, DOI 10.1007/s12229-010-9040-1; Scott L, 2006, REV PALAEOBOT PALYNO, V142, P47, DOI 10.1016/j.revpalbo.2006.07.010; Wilf P, 2005, AM NAT, V165, P634, DOI 10.1086/430055; Zavada MS, 2000, GRANA, V39, P39, DOI 10.1080/00173130150503795; Zhao Zaiming, 2006, Lundellia, V9, P51	14	67	72	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2010	329	5999					1621	1621		10.1126/science.1193108	http://dx.doi.org/10.1126/science.1193108			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929840				2022-12-28	WOS:000282098100032
J	Zhang, P; Wang, JW; Shi, YG				Zhang, Peng; Wang, Jiawei; Shi, Yigong			Structure and mechanism of the S component of a bacterial ECF transporter	NATURE			English	Article							ABC TRANSPORTERS; BINDING	The energy-coupling factor (ECF) transporters, responsible for vitamin uptake in prokaryotes, are a unique family of membrane transporters(1,2). Each ECF transporter contains a membrane-embedded, substrate-binding protein (known as the S component), an energy-coupling module that comprises two ATP-binding proteins (known as the A and A' components) and a transmembrane protein (known as the T component). The structure and transport mechanism of the ECF family remain unknown. Here we report the crystal structure of RibU, the S component of the ECF-type riboflavin transporter from Staphylococcus aureus at 3.6-angstrom resolution. RibU contains six transmembrane segments, adopts a previously unreported transporter fold and contains a riboflavin molecule bound to the L1 loop and the periplasmic portion of transmembrane segments 4-6. Structural analysis reveals the essential ligand-binding residues, identifies the putative transport path and, with sequence alignment, uncovers conserved structural features and suggests potential mechanisms of action among the ECF transporters. [GRAPHICS] .	[Shi, Yigong] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Prot Sci Lab, Beijing 100084, Peoples R China; [Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Zhang, Peng] Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA; [Wang, Jiawei] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Wang, Jiawei] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Princeton University; Tsinghua University; Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Prot Sci Lab, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010	Wang, Jiawei/0000-0001-9893-8539; Shi, Yigong/0000-0003-2030-168X; zhang, peng/0000-0003-0408-2923	National Institutes of Health [R01 GM084964]; Ministry of Science and Technology of China [2009CB918801]; National Natural Science Foundation of China [30888001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Yan for technical advice, A. Schmedel for administrative assistance and E. coli Genetic Resources at Yale Coli Genetic Stock Center for providing mutant E. coli strains. This work was supported by the National Institutes of Health (R01 GM084964), funds from the Ministry of Science and Technology of China (grant number 2009CB918801) and Project 30888001 supported by National Natural Science Foundation of China.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANDRIN SV, 1983, GENETIKA+, V19, P1419; Burgess CM, 2006, J BACTERIOL, V188, P2752, DOI 10.1128/JB.188.8.2752-2760.2006; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Davidson AL, 2007, TRENDS MICROBIOL, V15, P448, DOI 10.1016/j.tim.2007.09.005; Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x; DeLano W.L, PYMOL MOL GRAPHICS S; Duurkens RH, 2007, J BIOL CHEM, V282, P10380, DOI 10.1074/jbc.M608583200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hakemian AS, 2008, BIOCHEMISTRY-US, V47, P6793, DOI 10.1021/bi800598h; Hebbeln P, 2007, P NATL ACAD SCI USA, V104, P2909, DOI 10.1073/pnas.0609905104; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Lieberman RL, 2005, NATURE, V434, P177, DOI 10.1038/nature03311; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Neubauer O, 2009, J BACTERIOL, V191, P6482, DOI 10.1128/JB.00965-09; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rodionov DA, 2006, J BACTERIOL, V188, P317, DOI 10.1128/JB.188.1.317-327.2006; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Vogl C, 2007, J BACTERIOL, V189, P7367, DOI 10.1128/JB.00590-07	25	72	76	4	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					717	U148		10.1038/nature09488	http://dx.doi.org/10.1038/nature09488			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	20972419				2022-12-28	WOS:000284836700046
J	Coombes, BK; Bisset, L; Vicenzino, B				Coombes, Brooke K.; Bisset, Leanne; Vicenzino, Bill			Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials	LANCET			English	Article							COMPARING SUBACROMIAL INJECTION; CHRONIC ACHILLES TENDINOPATHY; UPDATED METHOD GUIDELINES; PLATELET-RICH PLASMA; DOUBLE-BLIND; LATERAL EPICONDYLITIS; TENNIS ELBOW; LOCAL INJECTION; GLYCOSAMINOGLYCAN POLYSULFATE; SCLEROSING INJECTIONS	Background Few evidence-based treatment guidelines for tendinopathy exist. We undertook a systematic review of randomised trials to establish clinical efficacy and risk of adverse events for treatment by injection. Methods We searched eight databases without language, publication, or date restrictions. We included randomised trials assessing efficacy of one or more peritendinous injections with placebo or non-surgical interventions for tendinopathy, scoring more than 50% on the modified physiotherapy evidence database scale. We undertook meta-analyses with a random-effects model, and estimated relative risk and standardised mean differences (SMDs). The primary outcome of clinical efficacy was protocol-defined pain score in the short term (4 weeks, range 0-12), intermediate term (26 weeks, 13-26), or long term (52 weeks, >= 52). Adverse events were also reported. Findings 3824 trials were identified and 41 met inclusion criteria, providing data for 2672 participants. We showed consistent findings between many high-quality randomised controlled trials that corticosteroid injections reduced pain in the short term compared with other interventions, but this effect was reversed at intermediate and long terms. For example, in pooled analysis of treatment for lateral epicondylalgia, corticosteroid injection had a large effect (defined as SMD>0.8) on reduction of pain compared with no intervention in the short term (SMD 1.44, 95% CI 1.17-1.71, p<0.0001), but no intervention was favoured at intermediate term (-0.40, -0.67 to -0.14, p<0.003) and long term (-0.31, -0.61 to -0.01, p=0.05). Short-term efficacy of corticosteroid injections for rotator-cuff tendinopathy is not clear. Of 991 participants who received corticosteroid injections in studies that reported adverse events, only one (0.1%) had a serious adverse event (tendon rupture). By comparison with placebo, reductions in pain were reported after injections of sodium hyaluronate (short [3.91, 3.54-4.28, p<0.0001], intermediate [2.89, 2.58-3.20, p<0.0001], and long [3.91, 3.55-4.28, p<0.0001] terms), botulinum toxin (short term [1.23, 0.67-1.78, p<0.0001]), and prolotherapy (intermediate term [2.62, 1.36-3.88, p<0.0001]) for treatment of lateral epicondylalgia. Lauromacrogol (polidocanol), aprotinin, and platelet-rich plasma were not more efficacious than was placebo for Achilles tendinopathy, while prolotherapy was not more effective than was eccentric exercise. Interpretation Despite the effectiveness of corticosteroid injections in the short term, non-corticosteroid injections might be of benefit for long-term treatment of lateral epicondylalgia. However, response to injection should not be generalised because of variation in effect between sites of tendinopathy.	[Coombes, Brooke K.; Vicenzino, Bill] Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, St Lucia, Qld 4072, Australia; [Bisset, Leanne] Griffith Univ, Sch Physiotherapy & Exercise Sci, Nathan, Qld 4111, Australia; [Bisset, Leanne] Royal Brisbane & Womens Hosp, Physiotherapy Dept, Herston, Qld, Australia	University of Queensland; Griffith University; Royal Brisbane & Women's Hospital	Vicenzino, B (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, Bldg 84A, St Lucia, Qld 4072, Australia.	b.vicenzino@uq.edu.au	Vicenzino, Bill/A-8492-2011; Bisset, Leanne/AAS-8947-2021; Coombes, Brooke/D-3456-2015	Vicenzino, Bill/0000-0003-0253-5933; Bisset, Leanne/0000-0001-8807-7093; Coombes, Brooke/0000-0002-6163-1047	National Health and Medical Research Council of Australia [511238]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Payment of translation services was funded from National Health and Medical Research Council of Australia, Project Grant 511238 (chief investigators BV and LB), as was part of the PhD scholarship for BKC. The National Health and Medical Research Council of Australia had no access to data used for this study.	ADEBAJO AO, 1990, J RHEUMATOL, V17, P1207; AKERMARK C, 1995, INT J SPORTS MED, V16, P196, DOI 10.1055/s-2007-972991; Akgun K, 2004, CLIN RHEUMATOL, V23, P496, DOI 10.1007/s10067-004-0930-7; Alfredson H, 2005, KNEE SURG SPORT TR A, V13, P338, DOI 10.1007/s00167-004-0585-6; Alvarez CM, 2005, AM J SPORT MED, V33, P255, DOI 10.1177/0363546504267345; Alvarez-Nemegyei J, 2008, REUMATOL CLIN, V4, P49, DOI 10.1016/S1699-258X(08)71799-6; *AUSTR GOV DEP HLT, 2007, SAF INF TRAS APR INJ; Bisset L, 2006, BMJ-BRIT MED J, V333, P939, DOI 10.1136/bmj.38961.584653.AE; Blair B, 1996, J BONE JOINT SURG AM, V78A, P1685, DOI 10.2106/00004623-199611000-00007; Brown R, 2006, BRIT J SPORT MED, V40, P275, DOI 10.1136/bjsm.2005.021931; Buchbinder R., 2003, COCHRANE DB SYST REV, V2003, pCD004016, DOI [DOI 10.1002/14651858.CD004016, 10.1002/14651858.CD004016]; Capasso G, 1997, SPORTS EXERC INJURY, V3, P111; Cloke DJ, 2008, J SHOULDER ELB SURG, V17, p17S, DOI 10.1016/j.jse.2007.07.005; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cook JL, 2001, SCAND J MED SCI SPOR, V11, P321, DOI 10.1034/j.1600-0838.2001.110602.x; Coombes BK, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-76; de Vos RJ, 2010, JAMA-J AM MED ASSOC, V303, P144, DOI 10.1001/jama.2009.1986; Ekeberg OM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3112; Fredberg U, 2004, SCAND J RHEUMATOL, V33, P94, DOI 10.1080/03009740310004126; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Gaujoux-Viala C, 2009, ANN RHEUM DIS, V68, P1843, DOI 10.1136/ard.2008.099572; Gill SS, 2004, J BONE JOINT SURG AM, V86A, P802, DOI 10.2106/00004623-200404000-00020; Green S, 1998, BRIT MED J, V316, P354, DOI 10.1136/bmj.316.7128.354; Haker E., 1993, Pain Clinic, V6, P103; Hay EM, 1999, BRIT MED J, V319, P964, DOI 10.1136/bmj.319.7215.964; Hay EM, 2003, ANN RHEUM DIS, V62, P394, DOI 10.1136/ard.62.5.394; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hoksrud A, 2006, AM J SPORT MED, V34, P1738, DOI 10.1177/0363546506289168; Karthikeyan S, 2010, J BONE JOINT SURG BR, V92B, P77, DOI 10.1302/0301-620X.92B1.22137; Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004; Khan KM, 2002, BRIT MED J, V324, P626, DOI 10.1136/bmj.324.7338.626; Kraushaar BS, 1999, J BONE JOINT SURG AM, V81A, P259, DOI 10.2106/00004623-199902000-00014; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lindenhovius A, 2008, J HAND SURG-AM, V33A, P909, DOI 10.1016/j.jhsa.2008.02.004; Maffulli N, 2004, MED SCI SPORT EXER, V36, P1470, DOI 10.1249/01.MSS.0000139895.94846.8D; Maher CG, 2008, PHYS THER, V88, P1068, DOI 10.2522/ptj.20080002; Mahler F, 1992, Br J Sports Med, V26, P7; McInerney JJ, 2003, EMERG MED J, V20, P218, DOI 10.1136/emj.20.3.218; Newcomer KL, 2001, CLIN J SPORT MED, V11, P214, DOI 10.1097/00042752-200110000-00002; Nichols AW, 2005, CLIN J SPORT MED, V15, P370; Okcu G, 2002, CLIN RES, V13, P158; Olaussen M, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-152; Osborne H, 2010, J SCI MED SPORT, V13, P380, DOI 10.1016/j.jsams.2009.09.009; Paavola Mika, 2002, Foot Ankle Clin, V7, P501, DOI 10.1016/S1083-7515(02)00056-6; Peerbooms JC, 2010, AM J SPORT MED, V38, P255, DOI 10.1177/0363546509355445; Petrella RJ, 2010, BMC SPORTS SCI MED R, V2, DOI 10.1186/1758-2555-2-4; PETRI M, 1987, ARTHRITIS RHEUM-US, V30, P1040, DOI 10.1002/art.1780300911; PRICE R, 1991, BRIT J RHEUMATOL, V30, P39; Rees JD, 2009, AM J SPORT MED, V37, P1855, DOI 10.1177/0363546508324283; Rutten MJCM, 2007, ACTA ORTHOP, V78, P254, DOI 10.1080/17453670710013762; SAARTOK T, 1986, ORTHOPEDICS, V9, P191; Scarpone M, 2008, CLIN J SPORT MED, V18, P248, DOI 10.1097/JSM.0b013e318170fc87; SENGUL I, 2008, TURK J PHYS MED REHA, V54, P138; Shrier I, 1996, CLIN J SPORT MED, V6, P245, DOI 10.1097/00042752-199610000-00007; Smidt N, 2002, LANCET, V359, P657, DOI 10.1016/S0140-6736(02)07811-X; Smidt N, 2002, PAIN, V96, P23, DOI 10.1016/S0304-3959(01)00388-8; Stahl S, 1997, J BONE JOINT SURG AM, V79A, P1648, DOI 10.2106/00004623-199711000-00006; SUNDQVIST H, 1987, INT J SPORTS MED, V8, P298, DOI 10.1055/s-2008-1025673; Tonks JH, 2007, INT J CLIN PRACT, V61, P240, DOI 10.1111/j.1742-1241.2006.01140.x; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; VECCHIO PC, 1993, BRIT J RHEUMATOL, V32, P743; VERHAAR JA, J BONE JOINT SURG BR, V199, P128; WHITE RH, 1986, J RHEUMATOL, V13, P608; Willberg L, 2008, KNEE SURG SPORT TR A, V16, P859, DOI 10.1007/s00167-008-0579-x; Wong SM, 2005, ANN INTERN MED, V143, P793, DOI 10.7326/0003-4819-143-11-200512060-00007; Yelland MJ, 2011, BRIT J SPORT MED, V45, P421, DOI 10.1136/bjsm.2009.057968; Zeisig E, 2008, BRIT J SPORT MED, V42, P267, DOI 10.1136/bjsm.2007.042762	68	490	512	5	150	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 20	2010	376	9754					1751	1767		10.1016/S0140-6736(10)61160-9	http://dx.doi.org/10.1016/S0140-6736(10)61160-9			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	690EI	20970844	Green Published			2022-12-28	WOS:000284984900031
J	Wu, BL; Chien, EYT; Mol, CD; Fenalti, G; Liu, W; Katritch, V; Abagyan, R; Brooun, A; Wells, P; Bi, FC; Hamel, DJ; Kuhn, P; Handel, TM; Cherezov, V; Stevens, RC				Wu, Beili; Chien, Ellen Y. T.; Mol, Clifford D.; Fenalti, Gustavo; Liu, Wei; Katritch, Vsevolod; Abagyan, Ruben; Brooun, Alexei; Wells, Peter; Bi, F. Christopher; Hamel, Damon J.; Kuhn, Peter; Handel, Tracy M.; Cherezov, Vadim; Stevens, Raymond C.			Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists	SCIENCE			English	Article							ANTI-HIV ACTIVITY; CRYSTAL-STRUCTURE; RECEPTOR DIMERIZATION; LIGAND; GP120; REVEALS; IDENTIFICATION; MIGRATION; RESIDUES; CELLS	Chemokine receptors are critical regulators of cell migration in the context of immune surveillance, inflammation, and development. The G protein-coupled chemokine receptor CXCR4 is specifically implicated in cancer metastasis and HIV-1 infection. Here we report five independent crystal structures of CXCR4 bound to an antagonist small molecule IT1t and a cyclic peptide CVX15 at 2.5 to 3.2 angstrom resolution. All structures reveal a consistent homodimer with an interface including helices V and VI that may be involved in regulating signaling. The location and shape of the ligand-binding sites differ from other G protein-coupled receptors and are closer to the extracellular surface. These structures provide new clues about the interactions between CXCR4 and its natural ligand CXCL12, and with the HIV-1 glycoprotein gp120.	[Wu, Beili; Chien, Ellen Y. T.; Mol, Clifford D.; Fenalti, Gustavo; Liu, Wei; Kuhn, Peter; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Katritch, Vsevolod; Abagyan, Ruben; Hamel, Damon J.; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Katritch, Vsevolod; Abagyan, Ruben; Hamel, Damon J.; Handel, Tracy M.] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Brooun, Alexei; Wells, Peter; Bi, F. Christopher] Pfizer Worldwide Res & Dev, San Diego, CA 92121 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Pfizer	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu	Cherezov, Vadim/L-9812-2013; Katritch, Vsevolod/Q-8357-2016; Liu, Wei/F-1820-2011; Katritch, Vsevolod/Y-2721-2019; Stevens, Raymond/K-7272-2015	Cherezov, Vadim/0000-0002-5265-3914; Katritch, Vsevolod/0000-0003-3883-4505; Stevens, Raymond/0000-0002-4522-8725	Protein Structure Initiative [U54 GM074961]; NIH Roadmap Initiative [P50 GM073197]; NIH [R21 RR025336, R21 AI087189, R01 AI037113, R01 GM081763, GM075915]; Pfizer; NSF [IIS0308078]; Science Foundation Ireland [02-IN1-B266]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104];  [F32 GM083463];  [R01 GM071872]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087189, R01AI037113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074961, R01GM071872, R01GM089857, R01GM075915, U54GM094618, R01GM081763, P50GM073197, F32GM083463] Funding Source: NIH RePORTER	Protein Structure Initiative; NIH Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); NSF(National Science Foundation (NSF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Protein Structure Initiative grant U54 GM074961 for structure production, NIH Roadmap Initiative grant P50 GM073197 for technology development, NIH grants R21 RR025336 and R21 AI087189 to V. C., and Pfizer. T. M. H. acknowledges support from NIH R01 AI037113 and R01 GM081763, D.J.H. from F32 GM083463, and R. A. from R01 GM071872. The authors thank J. Velasquez for help on molecular biology, T. Trinh and K. Allin for help on baculovirus expression, I. Wilson and D. Burton for careful review and scientific feedback on the manuscript, W. Schief for electron microscopy models of gp120-gp41-CD4 complex, G. W. Han for evaluating the structure quality and preparation for PDB submission, and A. Walker for assistance with manuscript preparation. The authors acknowledge E. La Chapelle on chemistry tool compound synthesis; A. Rane on radiolabeling of [<SUP>3</SUP>H]BIMA; M. Cui for help developing [<SUP>3</SUP>H]BIMA binding assay; Y. Zheng, The Ohio State University, and M. Caffrey, Trinity College (Dublin, Ireland), for the generous loan of the in meso robot [built with support from the National Institutes of Health (GM075915), the NSF (IIS0308078), and Science Foundation Ireland (02-IN1-B266)]; and J. Smith, R. Fischetti, and N. Sanishvili at the General Medicine and Cancer Institutes Collaborative Access Team (GM/CA-CAT) beamline at the Advanced Photon Source for assistance in development and use of the minibeam and beamtime. The GM/CA-CAT beamline (23-ID) is supported by the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Sciences (Y1-GM-1104). R. C. S. is the founder and is a board member of Receptos, a biotech company focused on GPCR structure-based drug discovery. Transfer of IT1t, CVX15, and [3H] BIMA will require a Material Transfer Agreement (MTA) with Pfizer, and transfer of all other constructs and biological materials requires an MTA with the Scripps Research Institute. Atomic coordinates and structure factors have been deposited in the Protein Data Bank with identification codes 3ODU (CXCR4-2-IT1t, P21), 3OE0 (CXCR4-3-CVX15, C2), 3OE8 (CXCR4-2-IT1t, P1), 3OE9 (CXCR4-3-IT1t, P1), and 3OE6 (CXCR4-1-IT1t, I222).	Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Appay V, 1999, J BIOL CHEM, V274, P27505, DOI 10.1074/jbc.274.39.27505; Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CLARKLEWIS I, 1995, J LEUKOCYTE BIOL, V57, P703, DOI 10.1002/jlb.57.5.703; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077; Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941; DeMarco SJ, 2006, BIOORGAN MED CHEM, V14, P8396, DOI 10.1016/j.bmc.2006.09.003; Diskin R, 2010, NAT STRUCT MOL BIOL, V17, P608, DOI 10.1038/nsmb.1796; Doranz BJ, 1999, J VIROL, V73, P2752, DOI 10.1128/JVI.73.4.2752-2761.1999; Fanelli F, 2006, J COMPUT AID MOL DES, V20, P449, DOI 10.1007/s10822-006-9064-0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Filizola M, 2010, LIFE SCI, V86, P590, DOI 10.1016/j.lfs.2009.05.004; Fulton AM, 2009, CURR ONCOL REP, V11, P125, DOI 10.1007/s11912-009-0019-1; Gupta SK, 2001, IMMUNOL LETT, V78, P29, DOI 10.1016/S0165-2478(01)00228-0; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Isik N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003424; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Moncunill G, 2008, MOL PHARMACOL, V73, P1264, DOI 10.1124/mol.107.042911; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nemoto W, 2006, CURR PROTEIN PEPT SC, V7, P561, DOI 10.2174/138920306779025657; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pello OM, 2008, EUR J IMMUNOL, V38, P537, DOI 10.1002/eji.200737630; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Reggio PH, 2006, AAPS J, V8, pE322; Roth CB, 2008, J MOL BIOL, V376, P1305, DOI 10.1016/j.jmb.2007.12.028; Salanga CL, 2009, CELL MOL LIFE SCI, V66, P1370, DOI 10.1007/s00018-008-8666-1; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Tamamura H, 2003, FEBS LETT, V550, P79, DOI 10.1016/S0014-5793(03)00824-X; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Thoma G, 2008, J MED CHEM, V51, P7915, DOI 10.1021/jm801065q; Tian SM, 2005, J VIROL, V79, P12667, DOI 10.1128/JVI.79.20.12667-12673.2005; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Vohra S, 2007, BIOCHEM SOC T, V35, P749, DOI 10.1042/BST0350749; Wang JH, 2008, DRUG DISCOV TODAY, V13, P625, DOI 10.1016/j.drudis.2008.04.004; Wang JH, 2006, MOL CANCER THER, V5, P2474, DOI 10.1158/1535-7163.MCT-05-0261; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wells TNC, 1996, J LEUKOCYTE BIOL, V59, P53, DOI 10.1002/jlb.59.1.53; Zhou HP, 2000, ARCH BIOCHEM BIOPHYS, V373, P211, DOI 10.1006/abbi.1999.1555; Zlotnik A, 2008, J PATHOL, V215, P211, DOI 10.1002/path.2350; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	65	1389	1441	7	385	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1066	1071		10.1126/science.1194396	http://dx.doi.org/10.1126/science.1194396			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	20929726	Green Accepted			2022-12-28	WOS:000284374700033
J	Lee, S; Yoon, BE; Berglund, K; Oh, SJ; Park, H; Shin, HS; Augustine, GJ; Lee, CJ				Lee, Soojung; Yoon, Bo-Eun; Berglund, Ken; Oh, Soo-Jin; Park, Hyungju; Shin, Hee-Sup; Augustine, George J.; Lee, C. Justin			Channel-Mediated Tonic GABA Release from Glia	SCIENCE			English	Article							CEREBELLAR GRANULE CELLS; SYNAPTIC INHIBITION; RAT CEREBELLUM; ACTIVATION; ASTROCYTES; NEURONS; RECEPTORS; CHLORIDE; BRAIN; DEGENERATION	Synaptic inhibition is based on both tonic and phasic release of the inhibitory transmitter gamma-aminobutyric acid (GABA). Although phasic GABA release arises from Ca2+-dependent exocytosis from neurons, the mechanism of tonic GABA release is unclear. Here we report that tonic inhibition in the cerebellum is due to GABA being released from glial cells by permeation through the Bestrophin 1 (Best1) anion channel. We demonstrate that GABA directly permeates through Best1 to yield GABA release and that tonic inhibition is eliminated by silencing of Best1. Glial cells express both GABA and Best1, and selective expression of Best1 in glial cells, after preventing general expression of Best1, fully rescues tonic inhibition. Our results identify a molecular mechanism for tonic inhibition and establish a role for interactions between glia and neurons in mediating tonic inhibition.	[Lee, Soojung; Yoon, Bo-Eun; Oh, Soo-Jin; Park, Hyungju; Shin, Hee-Sup; Lee, C. Justin] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea; [Yoon, Bo-Eun; Oh, Soo-Jin; Shin, Hee-Sup; Augustine, George J.; Lee, C. Justin] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea; [Berglund, Ken; Augustine, George J.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Augustine, George J.] Duke NUS Grad Med Sch, Program Neurosci & Behav Disorders, Singapore, Singapore; [Yoon, Bo-Eun; Lee, C. Justin] Univ Sci & Technol, Neurosci Program, Taejon, South Korea	Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); Duke University; National University of Singapore	Lee, CJ (corresponding author), Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea.	cjl@kist.re.kr	Lee, C. Justin/AAC-1663-2019; Augustine, George James/J-9228-2013; Park, Hyungju/C-4608-2016	Park, Hyungju/0000-0002-9010-9434; Lee, C Justin/0000-0002-3555-0980	KIST; International Cooperation Program; Korean national honor scientist grant; NIMH; World Class Institute	KIST(Korea Institute of Science & Technology Information (KISTI)); International Cooperation Program; Korean national honor scientist grant; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); World Class Institute	We thank J. Park for the ANO1 clone, J. Adelman for the human SK1 clone, K. Kunzelmann for mouse Best1 antibody, and J. Lee for image analysis. We specially thank K. McCarthy for his generous gift of hGFAP-CreERT2 transgenic mice. This study was supported by the KIST Core Competency Program and International Cooperation Program, by a Korean national honor scientist grant, an NIMH grant, and a World Class Institute grant to the Center for Functional Connectomics.	AMIN J, 1994, RECEPTOR CHANNEL, V2, P227; BARDAKDJIAN J, 1979, NEUROCHEM RES, V4, P517, DOI 10.1007/BF00964645; Bellamy TC, 2006, CEREBELLUM, V5, P116, DOI 10.1080/14734220600724569; Berglund K, 2008, BRAIN CELL BIOL, V36, P101, DOI 10.1007/s11068-008-9031-x; BLOMQVIST A, 1988, J NEUROCYTOL, V17, P629, DOI 10.1007/BF01260990; Bond CT, 2005, CURR OPIN NEUROBIOL, V15, P305, DOI 10.1016/j.conb.2005.05.001; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Carland JE, 2004, NEUROPHARMACOLOGY, V46, P770, DOI 10.1016/j.neuropharm.2003.11.027; Cavelier P, 2005, PROG BIOPHYS MOL BIO, V87, P3, DOI 10.1016/j.pbiomolbio.2004.06.001; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; CHANPALAY V, 1972, Z ANAT ENTWICKLUNGS, V138, P1, DOI 10.1007/BF00519921; Chebib M, 2004, CLIN EXP PHARMACOL P, V31, P800, DOI 10.1111/j.1440-1681.2004.04083.x; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Gadea A, 2001, J NEUROSCI RES, V63, P461, DOI 10.1002/jnr.1040; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Jia F, 2005, J NEUROPHYSIOL, V94, P4491, DOI 10.1152/jn.00421.2005; Jones SM, 2009, J NEUROPHYSIOL, V102, P691, DOI 10.1152/jn.00285.2009; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; Kirischuk S, 1995, J NEUROSCI, V15, P7861; Kozlov AS, 2006, P NATL ACAD SCI USA, V103, P10058, DOI 10.1073/pnas.0603741103; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Kunzelmann K, 2009, CELL CALCIUM, V46, P233, DOI 10.1016/j.ceca.2009.09.003; LANDIS DMD, 1983, DEV BRAIN RES, V8, P231, DOI 10.1016/0165-3806(83)90008-1; MARTINEZRODRIGUEZ R, 1993, CELL MOL BIOL, V39, P115; Muller T, 1995, INT REV NEUROBIOL, V38, P341, DOI 10.1016/S0074-7742(08)60530-9; O'Driscoll KE, 2009, BIOCHEM BIOPH RES CO, V384, P476, DOI 10.1016/j.bbrc.2009.05.008; OCHI S, 1993, GLIA, V9, P188, DOI 10.1002/glia.440090304; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; OTIS TS, 1991, BRAIN RES, V545, P142, DOI 10.1016/0006-8993(91)91280-E; Park H, 2009, J NEUROSCI, V29, P13063, DOI 10.1523/JNEUROSCI.3193-09.2009; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Qu ZQ, 2008, AM J PHYSIOL-CELL PH, V294, pC1371, DOI 10.1152/ajpcell.00398.2007; Qu ZQ, 2006, J NEUROSCI, V26, P5411, DOI 10.1523/JNEUROSCI.5500-05.2006; Ribak CE, 1996, ANAT EMBRYOL, V194, P379; Rossi DJ, 2003, J PHYSIOL-LONDON, V548, P97, DOI 10.1113/jphysiol.2002.036459; Santhakumar V, 2006, J NEUROSCI, V26, P3357, DOI 10.1523/JNEUROSCI.4799-05.2006; Takayama K, 2008, NEUROSCI LETT, V443, P7, DOI 10.1016/j.neulet.2008.07.058; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Yu K, 2007, INVEST OPHTH VIS SCI, V48, P4694, DOI 10.1167/iovs.07-0301	46	363	371	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2010	330	6005					790	796		10.1126/science.1184334	http://dx.doi.org/10.1126/science.1184334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	20929730				2022-12-28	WOS:000283855700035
J	Weitz, RT; Allen, MT; Feldman, BE; Martin, J; Yacoby, A				Weitz, R. T.; Allen, M. T.; Feldman, B. E.; Martin, J.; Yacoby, A.			Broken-Symmetry States in Doubly Gated Suspended Bilayer Graphene	SCIENCE			English	Article							BERRYS PHASE; QUANTUM	The single-particle energy spectra of graphene and its bilayer counterpart exhibit multiple degeneracies that arise through inherent symmetries. Interactions among charge carriers should spontaneously break these symmetries and lead to ordered states that exhibit energy gaps. In the quantum Hall regime, these states are predicted to be ferromagnetic in nature, whereby the system becomes spin polarized, layer polarized, or both. The parabolic dispersion of bilayer graphene makes it susceptible to interaction-induced symmetry breaking even at zero magnetic field. We investigated the underlying order of the various broken-symmetry states in bilayer graphene suspended between top and bottom gate electrodes. We deduced the order parameter of the various quantum Hall ferromagnetic states by controllably breaking the spin and sublattice symmetries. At small carrier density, we identified three distinct broken-symmetry states, one of which is consistent with either spontaneously broken time-reversal symmetry or spontaneously broken rotational symmetry.	[Weitz, R. T.; Allen, M. T.; Feldman, B. E.; Martin, J.; Yacoby, A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University	Yacoby, A (corresponding author), Harvard Univ, Dept Phys, 11 Oxford St, Cambridge, MA 02138 USA.	yacoby@physics.harvard.edu	Weitz, Thomas/AAG-8819-2019; Martin, Jens/H-9029-2013; Weitz, R. Thomas/E-8294-2010	Weitz, R. Thomas/0000-0001-5404-7355; Feldman, Benjamin/0000-0002-4962-0548	U. S. Department of Energy Office of Science (DOE SCGF); U.S. DOE, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-SC0001819]; 2009 U.S. Office of Naval Research Multi University Research Initiative (MURI) on Graphene Advanced Terahertz Engineering (Gate) at Massachusetts Institute of Technology, Harvard; Boston University; Harvard's Nanoscale Science and Engineering Center under NSF [PHY-0646094]	U. S. Department of Energy Office of Science (DOE SCGF)(United States Department of Energy (DOE)); U.S. DOE, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); 2009 U.S. Office of Naval Research Multi University Research Initiative (MURI) on Graphene Advanced Terahertz Engineering (Gate) at Massachusetts Institute of Technology, Harvard(MURI); Boston University; Harvard's Nanoscale Science and Engineering Center under NSF	We acknowledge discussions with R. Nandikshore, L. Levitov, M. Rudner, S. Sachdev, B. I. Halperin, A. H. MacDonald, and G. Barak and experimental help by S. Foletti. R. T. W. acknowledges financial support of the Alexander von Humboldt Foundation. M. T. A. acknowledges financial support from the U. S. Department of Energy Office of Science Graduate Fellowship (DOE SCGF) administered by the Oak Ridge Institute for Science and Education (ORISE). This work was supported by the U.S. DOE, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under award # DE-SC0001819 (R. T. W., M. T. A., and B. E. F.); by the 2009 U.S. Office of Naval Research Multi University Research Initiative (MURI) on Graphene Advanced Terahertz Engineering (Gate) at Massachusetts Institute of Technology, Harvard, and Boston University (J. M.); and by Harvard's Nanoscale Science and Engineering Center under NSF award PHY-0646094. The authors declare that they have no competing financial interests.	Abanin DA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.196806; Bolotin KI, 2008, SOLID STATE COMMUN, V146, P351, DOI 10.1016/j.ssc.2008.02.024; Castro EV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.216802; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Ezawa M, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.094701; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Gorbar EV, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.155451; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Kuzmenko AB, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115441; Mak KF, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.256405; McCann E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.086805; McCann E, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.161403; Min H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.041407; Min HK, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.155115; Moser J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2789673; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Novoselov KS, 2006, NAT PHYS, V2, P177, DOI 10.1038/nphys245; Oostinga JB, 2008, NAT MATER, V7, P151, DOI 10.1038/nmat2082; Raghu S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.156401; Shimshoni E, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.206408; Shkolnikov YP, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.226805; Vafek O, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.041401; YANG K, 1994, PHYS REV LETT, V72, P732, DOI 10.1103/PhysRevLett.72.732; Zhang F, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.041402; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhang YB, 2009, NATURE, V459, P820, DOI 10.1038/nature08105	30	331	334	1	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2010	330	6005					812	816		10.1126/science.1194988	http://dx.doi.org/10.1126/science.1194988			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	20947726	Green Submitted			2022-12-28	WOS:000283855700040
J	Crone, TJ; Tolstoy, M				Crone, Timothy J.; Tolstoy, Maya			Magnitude of the 2010 Gulf of Mexico Oil Leak	SCIENCE			English	Article									[Crone, Timothy J.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Tolstoy, Maya] Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA	Columbia University; Columbia University	Crone, TJ (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	crone@ldeo.columbia.edu	Crone, Timothy/A-9360-2009	Crone, Timothy/0000-0002-8100-5633	Lamont-Doherty Earth Observatory; NSF [0623285, 0917955]	Lamont-Doherty Earth Observatory; NSF(National Science Foundation (NSF))	This research was supported by the Lamont-Doherty Earth Observatory and by NSF under grants 0623285 and 0917955.	Crone TJ, 2008, EXP FLUIDS, V45, P899, DOI 10.1007/s00348-008-0508-2; Crone TJ, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002926	2	364	375	0	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					634	634		10.1126/science.1195840	http://dx.doi.org/10.1126/science.1195840			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	20929734				2022-12-28	WOS:000283580600037
J	Annas, GJ				Annas, George J.			Resurrection of a Stem-Cell Funding Barrier - Dickey-Wicker in Court	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							POLITICS		Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Annas GJ, 1996, NEW ENGL J MED, V334, P1329, DOI 10.1056/NEJM199605163342012; Annas GJ, 2004, NATURE, V431, P19, DOI 10.1038/431019a; FLANNERY EJ, 2000, COMMISSIONED PAPERS, V2, pD1; *NAT BIOETH ADV CO, 1999, ETH ISS HUM STEM CEL, V1	4	10	10	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 28	2010	363	18					1687	1689		10.1056/NEJMp1010466	http://dx.doi.org/10.1056/NEJMp1010466			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671XF	20979467				2022-12-28	WOS:000283546400002
J	Kwak, EL; Bang, YJ; Camidge, DR; Shaw, AT; Solomon, B; Maki, RG; Ou, SHI; Dezube, BJ; Janne, PA; Costa, DB; Varella-Garcia, M; Kim, WH; Lynch, TJ; Fidias, P; Stubbs, H; Engelman, JA; Sequist, LV; Tan, WW; Gandhi, L; Mino-Kenudson, M; Wei, GC; Shreeve, SM; Ratain, MJ; Settleman, J; Christensen, JG; Haber, DA; Wilner, K; Salgia, R; Shapiro, GI; Clark, JW; Iafrate, AJ				Kwak, Eunice L.; Bang, Yung-Jue; Camidge, D. Ross; Shaw, Alice T.; Solomon, Benjamin; Maki, Robert G.; Ou, Sai-Hong I.; Dezube, Bruce J.; Jaenne, Pasi A.; Costa, Daniel B.; Varella-Garcia, Marileila; Kim, Woo-Ho; Lynch, Thomas J.; Fidias, Panos; Stubbs, Hannah; Engelman, Jeffrey A.; Sequist, Lecia V.; Tan, WeiWei; Gandhi, Leena; Mino-Kenudson, Mari; Wei, Greg C.; Shreeve, S. Martin; Ratain, Mark J.; Settleman, Jeffrey; Christensen, James G.; Haber, Daniel A.; Wilner, Keith; Salgia, Ravi; Shapiro, Geoffrey I.; Clark, Jeffrey W.; Iafrate, A. John			Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EML4-ALK FUSION GENE; ACTIVATING MUTATIONS; 2ND-LINE TREATMENT; PHASE-II; GEFITINIB; ALK; IDENTIFICATION; TUMORS; EGFR; CHEMOTHERAPY	BACKGROUND Oncogenic fusion genes consisting of EML4 and anaplastic lymphoma kinase (ALK) are present in a subgroup of non-small-cell lung cancers, representing 2 to 7% of such tumors. We explored the therapeutic efficacy of inhibiting ALK in such tumors in an early-phase clinical trial of crizotinib (PF-02341066), an orally available small-molecule inhibitor of the ALK tyrosine kinase. METHODS After screening tumor samples from approximately 1500 patients with non-small-cell lung cancer for the presence of ALK rearrangements, we identified 82 patients with advanced ALK-positive disease who were eligible for the clinical trial. Most of the patients had received previous treatment. These patients were enrolled in an expanded cohort study instituted after phase 1 dose escalation had established a recommended crizotinib dose of 250 mg twice daily in 28-day cycles. Patients were assessed for adverse events and response to therapy. RESULTS Patients with ALK rearrangements tended to be younger than those without the rearrangements, and most of the patients had little or no exposure to tobacco and had adenocarcinomas. At a mean treatment duration of 6.4 months, the overall response rate was 57% (47 of 82 patients, with 46 confirmed partial responses and 1 confirmed complete response); 27 patients (33%) had stable disease. A total of 63 of 82 patients (77%) were continuing to receive crizotinib at the time of data cutoff, and the estimated probability of 6-month progression-free survival was 72%, with no median for the study reached. The drug resulted in grade 1 or 2 (mild) gastrointestinal side effects. CONCLUSIONS The inhibition of ALK in lung tumors with the ALK rearrangement resulted in tumor shrinkage or stable disease in most patients.	[Kwak, Eunice L.; Shaw, Alice T.; Lynch, Thomas J.; Fidias, Panos; Stubbs, Hannah; Engelman, Jeffrey A.; Sequist, Lecia V.; Mino-Kenudson, Mari; Settleman, Jeffrey; Haber, Daniel A.; Clark, Jeffrey W.; Iafrate, A. John] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Dezube, Bruce J.; Costa, Daniel B.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Jaenne, Pasi A.; Gandhi, Leena; Shapiro, Geoffrey I.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Bang, Yung-Jue; Kim, Woo-Ho] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Camidge, D. Ross; Varella-Garcia, Marileila] Univ Colorado, Ctr Canc, Aurora, CO USA; [Solomon, Benjamin] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Maki, Robert G.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Ou, Sai-Hong I.] Univ Calif Irvine, Irvine, CA USA; [Tan, WeiWei; Wei, Greg C.; Shreeve, S. Martin; Christensen, James G.; Wilner, Keith] Pfizer Pharmaceut Inc, La Jolla, CA USA; [Ratain, Mark J.; Salgia, Ravi] Univ Chicago, Chicago, IL 60637 USA	Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Seoul National University (SNU); University of Colorado System; University of Colorado Anschutz Medical Campus; Peter Maccallum Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California Irvine; Pfizer; University of Chicago	Kwak, EL (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 55 Fruit St,Profess Off Bldg,Rm 238, Boston, MA 02114 USA.	ekwak@partners.org	Camidge, David Ross/AAG-9144-2019; Ou, Sai-Hong/AAA-3389-2020; Bang, Yung Jue/J-2759-2012; Maki, Robert G./AAI-2793-2020; Maki, Robert G/J-9145-2019	Bang, Yung Jue/0000-0001-6000-4597; Maki, Robert G/0000-0002-9853-2528; Costa, Daniel/0000-0002-0689-395X; Solomon, Benjamin/0000-0003-3059-5730; Gandhi, Leena/0000-0002-2398-9179	Pfizer; Massachusetts General Hospital (MGH) Cancer Center; Aid for Cancer Research Foundation; National Cancer Institute [CA090578, CA58187, CA46934]; National Institutes of Health [R01CA136851]; American Society of Clinical Oncology (ASCO) Cancer Foundation; NCI-ASCO Cancer Foundation [CA47179, CA06516]; John and Carol Barry Award; NATIONAL CANCER INSTITUTE [P20CA090578, P30CA062203, P01CA047179, P30CA006516, P50CA090578, R01CA136851, P50CA058187, P30CA046934] Funding Source: NIH RePORTER	Pfizer(Pfizer); Massachusetts General Hospital (MGH) Cancer Center; Aid for Cancer Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Clinical Oncology (ASCO) Cancer Foundation; NCI-ASCO Cancer Foundation; John and Carol Barry Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Pfizer; by grants from the Massachusetts General Hospital (MGH) Cancer Center, the Aid for Cancer Research Foundation, and from an anonymous donor (to MGH); grants from the National Cancer Institute (CA090578, to MGH, Dana-Farber Cancer Institute [DFCI], and Beth Israel Deaconess Medical Center [BIDMC]) and the National Institutes of Health (R01CA136851, to DFCI); a Career Development Award from the American Society of Clinical Oncology (ASCO) Cancer Foundation (to BIDMC); Clinical Investigator Team Leadership Awards from the NCI-ASCO Cancer Foundation (CA47179, to Memorial Sloan-Kettering Cancer Center; and CA06516, to DFCI); a John and Carol Barry Award (to Dr. Kwak); and grants from the National Cancer Institute (CA58187 and CA46934, to the University of Colorado Cancer Center).	Asahina H, 2006, BRIT J CANCER, V95, P998, DOI 10.1038/sj.bjc.6603393; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Christensen JG, 2007, MOL CANCER THER, V6, P3314, DOI 10.1158/1535-7163.MCT-07-0365; Di Maio M, 2009, J CLIN ONCOL, V27, P1836, DOI 10.1200/JCO.2008.17.5844; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Gridelli C, 2008, J THORAC ONCOL, V3, P430, DOI 10.1097/JTO.0b013e318168c815; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kutok JL, 2002, J CLIN ONCOL, V20, P3691, DOI 10.1200/JCO.2002.12.033; Kwak EL, 2009, J CLIN ONCOL, V27; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mano H, 2008, CANCER SCI, V99, P2349, DOI 10.1111/j.1349-7006.2008.00972.x; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; Mino-Kenudson M, 2010, CLIN CANCER RES, V16, P1561, DOI 10.1158/1078-0432.CCR-09-2845; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Perner S, 2008, NEOPLASIA, V10, P298, DOI 10.1593/NEO.07878; Pulford K, 2004, CELL MOL LIFE SCI, V61, P2939, DOI 10.1007/s00018-004-4275-9; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Takeuchi K, 2008, CLIN CANCER RES, V14, P6618, DOI 10.1158/1078-0432.CCR-08-1018; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181	28	3438	3602	8	351	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 28	2010	363	18					1693	1703		10.1056/NEJMoa1006448	http://dx.doi.org/10.1056/NEJMoa1006448			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671XF	20979469	Bronze, Green Accepted			2022-12-28	WOS:000283546400004
J	Brook, RH				Brook, Robert H.			The End of the Quality Improvement Movement Long Live Improving Value	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; IMPACT		[Brook, Robert H.] RAND Corp, Santa Monica, CA USA; [Brook, Robert H.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Brook, Robert H.] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA	RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Brook, RH (corresponding author), RAND Hlth, 1776 Main St,POB 2138, Santa Monica, CA 90407 USA.	robert_brook@rand.org						BROOK RH, 1970, NEW ENGL J MED, V283, P904, DOI 10.1056/NEJM197010222831705; Galvin RS, 2005, HEALTH AFFAIR, V24, P228, DOI 10.1377/hlthaff.24.1.228; Kenney C.C., 2008, PUBLIC AFFAIRS; Kohn KT, 2000, ERR IS HUMAN BUILDIN; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Ovretveit J, 2009, REV EVIDENCE WHICH I, P95; Pawlson LG, 2002, HEALTH AFFAIR, V21, P200, DOI 10.1377/hlthaff.21.3.200; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; ROBERTS JS, 1987, JAMA-J AM MED ASSOC, V258, P936, DOI 10.1001/jama.258.7.936; SANAZARO PJ, 1972, NEW ENGL J MED, V287, P1125, DOI 10.1056/NEJM197211302872206	10	40	44	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2010	304	16					1831	1832		10.1001/jama.2010.1555	http://dx.doi.org/10.1001/jama.2010.1555			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671JZ	20978261				2022-12-28	WOS:000283501300024
J	Toynbee, P				Toynbee, Polly			Are the spending cuts fair? No	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Toynbee, Polly] Guardian, London N1 9GU, England		Toynbee, P (corresponding author), Guardian, London N1 9GU, England.	polly.toynbee@guardian.co.uk							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 27	2010	341								c6053	10.1136/bmj.c6053	http://dx.doi.org/10.1136/bmj.c6053			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674YY	20980381				2022-12-28	WOS:000283790400003
J	Paige, DA; Siegler, MA; Zhang, JA; Hayne, PO; Foote, EJ; Bennett, KA; Vasavada, AR; Greenhagen, BT; Schofield, JT; McCleese, DJ; Foote, MC; DeJong, E; Bills, BG; Hartford, W; Murray, BC; Allen, CC; Snook, K; Soderblom, LA; Calcutt, S; Taylor, FW; Bowles, NE; Bandfield, JL; Elphic, R; Ghent, R; Glotch, TD; Wyatt, MB; Lucey, PG				Paige, David A.; Siegler, Matthew A.; Zhang, Jo Ann; Hayne, Paul O.; Foote, Emily J.; Bennett, Kristen A.; Vasavada, Ashwin R.; Greenhagen, Benjamin T.; Schofield, John T.; McCleese, Daniel J.; Foote, Marc C.; DeJong, Eric; Bills, Bruce G.; Hartford, Wayne; Murray, Bruce C.; Allen, Carlton C.; Snook, Kelly; Soderblom, Laurence A.; Calcutt, Simon; Taylor, Fredric W.; Bowles, Neil E.; Bandfield, Joshua L.; Elphic, Richard; Ghent, Rebecca; Glotch, Timothy D.; Wyatt, Michael B.; Lucey, Paul G.			Diviner Lunar Radiometer Observations of Cold Traps in the Moon's South Polar Region	SCIENCE			English	Article							WATER ICE; MERCURY; STABILITY; SURFACE; POLES	Diviner Lunar Radiometer Experiment surface-temperature maps reveal the existence of widespread surface and near-surface cryogenic regions that extend beyond the boundaries of persistent shadow. The Lunar Crater Observation and Sensing Satellite (LCROSS) struck one of the coldest of these regions, where subsurface temperatures are estimated to be 38 kelvin. Large areas of the lunar polar regions are currently cold enough to cold-trap water ice as well as a range of both more volatile and less volatile species. The diverse mixture of water and high-volatility compounds detected in the LCROSS ejecta plume is strong evidence for the impact delivery and cold-trapping of volatiles derived from primitive outer solar system bodies.	[Paige, David A.; Siegler, Matthew A.; Zhang, Jo Ann; Hayne, Paul O.; Foote, Emily J.; Bennett, Kristen A.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Vasavada, Ashwin R.; Greenhagen, Benjamin T.; Schofield, John T.; McCleese, Daniel J.; Foote, Marc C.; DeJong, Eric; Bills, Bruce G.; Hartford, Wayne] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Murray, Bruce C.] CALTECH, Pasadena, CA 90025 USA; [Allen, Carlton C.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Snook, Kelly] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Soderblom, Laurence A.] US Geol Survey, Flagstaff, AZ 86001 USA; [Calcutt, Simon; Taylor, Fredric W.; Bowles, Neil E.] Univ Oxford, Oxford OX1 3PU, England; [Bandfield, Joshua L.] Univ Washington, Seattle, WA 98195 USA; [Elphic, Richard] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Ghent, Rebecca] Univ Toronto, Toronto, ON M5S 3B1, Canada; [Glotch, Timothy D.] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Wyatt, Michael B.] Brown Univ, Providence, RI 02912 USA; [Lucey, Paul G.] Univ Hawaii, Honolulu, HI 96822 USA	University of California System; University of California Los Angeles; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; United States Department of the Interior; United States Geological Survey; University of Oxford; University of Washington; University of Washington Seattle; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Toronto; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Brown University; University of Hawaii System	Paige, DA (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, 595 Charles E Young Dr E, Los Angeles, CA 90095 USA.	dap@moon.ucla.edu	Greenhagen, Benjamin T/C-3760-2016	Greenhagen, Benjamin T/0000-0002-8252-9922; Bandfield, Joshua/0000-0003-3571-3716; Calcutt, Simon/0000-0002-0102-3170; Taylor, Fred/0000-0002-0675-9769; Hayne, Paul/0000-0003-4399-0449	National Aeronautics and Space Administration; Science and Technology Facilities Council [ST/H00243X/1] Funding Source: researchfish	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the many people at the Jet Propulsion Laboratory and the Goddard Space Flight Center who contributed to the success of the Diviner instrument and the LRO project. We also thank the National Aeronautics and Space Administration for funding this investigation.	Araki H, 2009, SCIENCE, V323, P897, DOI 10.1126/science.1164146; Bills BG, 1999, GEOPHYS RES LETT, V26, P3045, DOI 10.1029/1999GL008348; Chin G, 2007, SPACE SCI REV, V129, P391, DOI 10.1007/s11214-007-9153-y; Colaprete A, 2010, SCIENCE, V330, P463, DOI 10.1126/science.1186986; Crider DH, 2003, ADV SPACE RES, V31, P2293, DOI 10.1016/S0273-1177(03)00530-1; Elphic RC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029954; Feldman WC, 2001, J GEOPHYS RES-PLANET, V106, P23231, DOI 10.1029/2000JE001444; Gladstone GR, 2010, SCIENCE, V330, P472, DOI 10.1126/science.1186474; Hansen CJ, 1996, ICARUS, V120, P247, DOI 10.1006/icar.1996.0049; Harmon JK, 2007, SPACE SCI REV, V132, P307, DOI 10.1007/s11214-007-9234-y; Hayne PO, 2010, SCIENCE, V330, P477, DOI 10.1126/science.1197135; HODGES RR, 1980, LUN PLAN SCI C, V11, P2463; INGERSOLL AP, 1992, ICARUS, V100, P40, DOI 10.1016/0019-1035(92)90016-Z; LANGSETH MG, 1976, P LUNAR PLANET SCI C, V7, P3143; Lawrence DJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002637; MITROFANOV I, 2010, LUN PLAN SCI C, V41, P2250; MORGAN TH, 1991, J GEOPHYS RES-SPACE, V96, P1351, DOI 10.1029/90JA02127; Paige DA, 2010, SPACE SCI REV, V150, P125, DOI 10.1007/s11214-009-9529-2; PAIGE DA, 1992, SCIENCE, V258, P643, DOI 10.1126/science.258.5082.643; Schorghofer N, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002779; Schultz PH, 2010, SCIENCE, V330, P468, DOI 10.1126/science.1187454; TAYLOR GJ, 2004, P SPAC RES ROUNDT 6; Vasavada AR, 1999, ICARUS, V141, P179, DOI 10.1006/icar.1999.6175; WARD WR, 1975, SCIENCE, V189, P377, DOI 10.1126/science.189.4200.377; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033; Zhang JA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041806; Zhang JA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038614	27	268	272	1	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					479	482		10.1126/science.1187726	http://dx.doi.org/10.1126/science.1187726			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966246				2022-12-28	WOS:000283329100032
J	Vogt, N; Desplan, C				Vogt, Nina; Desplan, Claude			Flipping the Light Switch	SCIENCE			English	Editorial Material							DROSOPHILA-MELANOGASTER; NEURONS; GLOMERULI; BRAIN		[Vogt, Nina; Desplan, Claude] NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA	New York University	Vogt, N (corresponding author), NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA.	cd38@nyu.edu		Vogt, Nina/0000-0002-2658-9138; Desplan, Claude/0000-0002-6914-1413	NEI NIH HHS [R01 EY017916-04S1, EY017916, R01 EY017916] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY017916] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BERREUR P, 1984, GEN COMP ENDOCR, V54, P76, DOI 10.1016/0016-6480(84)90201-6; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gong ZF, 2010, SCIENCE, V330, P499, DOI 10.1126/science.1195993; King-Jones K, 2005, CELL, V121, P773, DOI 10.1016/j.cell.2005.03.030; Malpel S, 2002, DEVELOPMENT, V129, P1443; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; SawinMcCormack EP, 1995, J NEUROGENET, V10, P119, DOI 10.3109/01677069509083459; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Sprecher SG, 2008, NATURE, V454, P533, DOI 10.1038/nature07062; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0	10	1	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					454	455		10.1126/science.1197702	http://dx.doi.org/10.1126/science.1197702			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966236	Green Accepted			2022-12-28	WOS:000283329100021
J	Iglehart, JK				Iglehart, John K.			The ACGME's Final Duty-Hour Standards -- Special PGY-1 Limits and Strategic Napping.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		BLUM AB, US PUBLIC OPINION RE; *COMM OPT GRAD MED, 2008, RES DUT HOURS ENH SL; DINGELL JD, 2007, COMMUNICATION   0329; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; *PUBL CIT, 2010, PET RED MED RES WORK	5	20	20	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2010	363	17					1589	1591		10.1056/NEJMp1010613	http://dx.doi.org/10.1056/NEJMp1010613			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668BD	20973151				2022-12-28	WOS:000283242700001
J	Matchar, DB; Jacobson, A; Dolor, R; Edson, R; Uyeda, L; Phibbs, CS; Vertrees, JE; Shih, MC; Holodniy, M; Lavori, P				Matchar, David B.; Jacobson, Alan; Dolor, Rowena; Edson, Robert; Uyeda, Lauren; Phibbs, Ciaran S.; Vertrees, Julia E.; Shih, Mei-Chiung; Holodniy, Mark; Lavori, Philip		THINRS Executive Comm Site	Effect of Home Testing of International Normalized Ratio on Clinical Events.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MANAGING ANTICOAGULATION; ORAL ANTICOAGULATION; ATRIAL-FIBRILLATION; PATIENT; DESIGN; MANAGEMENT; SERVICES; QUALITY; TRIALS; IMPACT	Background: Warfarin anticoagulation reduces thromboembolic complications in patients with atrial fibrillation or mechanical heart valves, but effective management is complex, and the international normalized ratio (INR) is often outside the target range. As compared with venous plasma testing, point-of-care INR measuring devices allow greater testing frequency and patient involvement and may improve clinical outcomes. Methods: We randomly assigned 2922 patients who were taking warfarin because of mechanical heart valves or atrial fibrillation and who were competent in the use of point-of-care INR devices to either weekly self-testing at home or monthly high-quality testing in a clinic. The primary end point was the time to a first major event (stroke, major bleeding episode, or death). Results: The patients were followed for 2.0 to 4.75 years, for a total of 8730 patient-years of follow-up. The time to the first primary event was not significantly longer in the self-testing group than in the clinic-testing group (hazard ratio, 0.88; 95% confidence interval, 0.75 to 1.04; P=0.14). The two groups had similar rates of clinical outcomes except that the self-testing group reported more minor bleeding episodes. Over the entire follow-up period, the self-testing group had a small but significant improvement in the percentage of time during which the INR was within the target range (absolute difference between groups, 3.8 percentage points; P<0.001). At 2 years of follow-up, the self-testing group also had a small but significant improvement in patient satisfaction with anticoagulation therapy (P=0.002) and quality of life (P<0.001). Conclusions: As compared with monthly high-quality clinic testing, weekly self-testing did not delay the time to a first stroke, major bleeding episode, or death to the extent suggested by prior studies. These results do not support the superiority of self-testing over clinic testing in reducing the risk of stroke, major bleeding episode, and death among patients taking warfarin therapy. (Funded by the Department of Veterans Affairs Cooperative Studies Program; ClinicalTrials.gov number, NCT00032591.) N Engl J Med 2010;363:1608-20.	[Matchar, David B.; Dolor, Rowena] Vet Affairs Med Ctr, Hlth Serv Res Field Program, Durham, NC USA; [Matchar, David B.; Dolor, Rowena] Duke Univ, Med Ctr, Dept Med, Div Gen Med, Durham, NC 27710 USA; [Matchar, David B.; Dolor, Rowena] Duke Univ, Med Ctr, Ctr Clin Hlth Policy Res, Durham, NC USA; [Matchar, David B.] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Jacobson, Alan] Jerry L Pettis Mem Vet Adm Med Ctr, Res & Dev Serv 151, Loma Linda, CA 92354 USA; [Jacobson, Alan] Loma Linda Univ, Dept Internal Med, Loma Linda, CA 92350 USA; [Edson, Robert; Uyeda, Lauren; Shih, Mei-Chiung; Holodniy, Mark] VA Palo Alto Hlth Care Syst, Cooperat Studies Program Coordinating Ctr 151K, Palo Alto, CA USA; [Phibbs, Ciaran S.] VA Palo Alto Hlth Care Syst, Hlth Econ Resource Ctr, Palo Alto, CA USA; [Holodniy, Mark] VA Palo Alto Hlth Care Syst, Med Serv, Palo Alto, CA USA; [Phibbs, Ciaran S.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Phibbs, Ciaran S.] Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Shih, Mei-Chiung; Lavori, Philip] Stanford Univ, Dept Hlth Res Policy, Div Biostat, Stanford, CA 94305 USA; [Holodniy, Mark] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA; [Vertrees, Julia E.] Clin Res Pharm Coordinating Ctr, VA Cooperat Studies Program, Albuquerque, NM USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University; Duke University; National University of Singapore; Loma Linda University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Stanford University; Stanford University	Matchar, DB (corresponding author), 2400 Pratt St, Durham, NC 27705 USA.	david.matchar@duke-nus.edu.sg	Schnoor, Jerald L/B-1951-2008; Matchar, David/M-3951-2019	Dolor, Rowena/0000-0001-7317-9468; Phibbs, Ciaran/0000-0002-4353-3507; Holodniy, Mark/0000-0002-6655-7982; Matchar, David/0000-0003-3020-2108	Department of Veterans Affairs; Boehringer Ingelheim; Biosite; Farallon Medical; HemoSense; Inverness Medical; Pfizer Medical; Quality Assured Services; Roche Diagnostics; Sanofi-Aventis; Tapestry Medical	Department of Veterans Affairs(US Department of Veterans Affairs); Boehringer Ingelheim(Boehringer Ingelheim); Biosite; Farallon Medical; HemoSense; Inverness Medical; Pfizer Medical(Pfizer); Quality Assured Services; Roche Diagnostics; Sanofi-Aventis(Sanofi-Aventis); Tapestry Medical	Supported by the Department of Veterans Affairs Cooperative Studies Program.; Dr. Matchar reports receiving consulting fees from Boehringer Ingelheim and receiving honoraria from Roche. Dr. Jacobson reports being an advisory board member for the Anticoagulation Forum and the Loma Linda Veterans Association for Research, receiving consulting fees from Biosite, Boehringer Ingelheim, Daiichi Sankyo, Farallon Medical, HemoSense, Inverness Medical, Pfizer Medical, Quality Assured Services, Roche Diagnostics, Sanofi-Aventis, and Tapestry Medical, receiving grants or grants pending from Biosite, Boehringer Ingelheim, Farallon Medical, HemoSense, Inverness Medical, and Sanofi-Aventis, receiving honoraria from GlaxoSmithKline and Tapestry Medical, and receiving fees for the development of educational presentations and for serving on speakers' bureaus from Boehringer Ingelheim and GlaxoSmithKline, and receiving travel support from Biosite, Boehringer Ingelheim, Daiichi Sankyo, GlaxoSmithKline, and Sanofi-Aventis. No other potential conflict of interest relevant to this article was reported.	Ansell J, 2005, INT J CARDIOL, V99, P37, DOI 10.1016/j.ijcard.2003.11.008; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Ansell J, 2007, AM J MED QUAL, V22, P327, DOI 10.1177/1062860607303003; COX DR, 1972, J R STAT SOC B, V34, P187; DOLOR RJ, 2010, J THROMB THROMB 0714; Fairclough DL, 2002, DESIGN ANAL QUALITY; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Heneghan C, 2006, LANCET, V367, P404, DOI 10.1016/S0140-6736(06)68139-7; Horsman John, 2003, Health Qual Life Outcomes, V1, P54, DOI 10.1186/1477-7525-1-54; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Matchar DB, 2005, J THROMB THROMBOLYS, V19, P163, DOI 10.1007/s11239-005-1452-0; Matchar DB, 2002, AM J MED, V113, P42, DOI 10.1016/S0002-9343(02)01131-2; Matchar DB, 2000, J THROMB THROMBOLYS, V9, pS7; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Samsa Greg, 2004, Health Qual Life Outcomes, V2, P22, DOI 10.1186/1477-7525-2-22; Schulman S, 2003, NEW ENGL J MED, V349, P675, DOI 10.1056/NEJMcp025373	21	183	189	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2010	363	17					1608	1620		10.1056/NEJMoa1002617	http://dx.doi.org/10.1056/NEJMoa1002617			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668BD	20961244				2022-12-28	WOS:000283242700005
J	Di Napoli, M				Di Napoli, Mario			Prior intensive insulin treatment reduced long-term risk for peripheral neuropathy in type 1 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COMPLICATIONS		San Camillo Lellis Gen Hosp, Rieti, Italy		Di Napoli, M (corresponding author), San Camillo Lellis Gen Hosp, Rieti, Italy.		Di Napoli, Mario/H-3475-2019; Di Napoli, Mario/J-6418-2014	Di Napoli, Mario/0000-0001-9609-4926; Di Napoli, Mario/0000-0001-9609-4926				Huysman F, 2009, ACTA CHIR BELG, V109, P587; LeRoith D, 2005, DIABETES-METAB RES, V21, P85, DOI 10.1002/dmrr.530; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tesfaye S, 2005, NEW ENGL J MED, V352, P341, DOI 10.1056/NEJMoa032782; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8	5	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8							JC4-3	10.7326/0003-4819-153-8-201010190-02003	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956699				2022-12-28	WOS:000283054600018
J	Austin, MA; Wills, KE; Blizzard, L; Walters, EH; Wood-Baker, R				Austin, Michael A.; Wills, Karen E.; Blizzard, Leigh; Walters, Eugene H.; Wood-Baker, Richard			Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE EXACERBATIONS; NONINVASIVE VENTILATION; RESPIRATORY-FAILURE; AUDIT; COPD; AMBULANCES; SURVIVAL; ACIDOSIS; RISK; CARE	Objectives To compare standard high flow oxygen treatment with titrated oxygen treatment for patients with an acute exacerbation of chronic obstructive pulmonary disease in the prehospital setting. Design Cluster randomised controlled parallel group trial. Setting Ambulance service in Hobart, Tasmania, Australia. Participants 405 patients with a presumed acute exacerbation of chronic obstructive pulmonary disease who were treated by paramedics, transported, and admitted to the Royal Hobart Hospital during the trial period; 214 had a diagnosis of chronic obstructive pulmonary disease confirmed by lung function tests in the previous five years. Interventions High flow oxygen treatment compared with titrated oxygen treatment in the prehospital (ambulance/paramedic) setting. Main outcome measure Prehospital or in-hospital mortality. Results In an intention to treat analysis, the risk of death was significantly lower in the titrated oxygen arm compared with the high flow oxygen arm for all patients (high flow oxygen n=226; titrated oxygen n=179) and for the subgroup of patients with confirmed chronic obstructive pulmonary disease (high flow n=117; titrated n=97). Overall mortality was 9% (21 deaths) in the high flow oxygen arm compared with 4% (7 deaths) in the titrated oxygen arm; mortality in the subgroup with confirmed chronic obstructive pulmonary disease was 9% (11 deaths) in the high flow arm compared with 2% (2 deaths) in the titrated oxygen arm. Titrated oxygen treatment reduced mortality compared with high flow oxygen by 58% for all patients (relative risk 0.42, 95% confidence interval 0.20 to 0.89; P=0.02) and by 78% for the patients with confirmed chronic obstructive pulmonary disease (0.22, 0.05 to 0.91; P=0.04). Patients with chronic obstructive pulmonary disease who received titrated oxygen according to the protocol were significantly less likely to have respiratory acidosis (mean difference in pH 0.12 (SE 0.05); P=0.01; n=28) or hypercapnia (mean difference in arterial carbon dioxide pressure ?33.6 (16.3) mm Hg; P=0.02; n=29) than were patients who received high flow oxygen. Conclusions Titrated oxygen treatment significantly reduced mortality, hypercapnia, and respiratory acidosis compared with high flow oxygen in acute exacerbations of chronic obstructive pulmonary disease. These results provide strong evidence to recommend the routine use of titrated oxygen treatment in patients with breathlessness and a history or clinical likelihood of chronic obstructive pulmonary disease in the prehospital setting. Trial registration Australian New Zealand Clinical Trials Register ACTRN12609000236291.	[Austin, Michael A.; Wills, Karen E.; Blizzard, Leigh; Walters, Eugene H.; Wood-Baker, Richard] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7001, Australia; [Austin, Michael A.; Wood-Baker, Richard] Royal Hobart Hosp, Dept Resp, Hobart, Tas, Australia; [Austin, Michael A.] Tasmanian Ambulance Service, Hobart, Tas, Australia	University of Tasmania; Menzies Institute for Medical Research; Royal Hobart Hospital	Austin, MA (corresponding author), Univ Tasmania, Menzies Res Inst, Hobart, Tas 7001, Australia.	maaustin@utas.edu.au	Wills, Karen/M-2652-2019; WALTERS, Eugene/AAL-2264-2021; Wills, Karen E/H-4390-2012	Wills, Karen/0000-0003-3897-2908; Wills, Karen E/0000-0003-3897-2908; Walters, Eugene/0000-0002-0993-4374	Australian College of Ambulance Professionals (ACAP)	Australian College of Ambulance Professionals (ACAP)	The Australian College of Ambulance Professionals (ACAP) provided funding. FlaemNova, Milan, Italy, donated Walkie nebulisation air compressors. Neither of the study sponsors had a role in study design; data collection, analysis, or interpretation; or the writing of the report.	Ak A, 2006, TOHOKU J EXP MED, V210, P285, DOI 10.1620/tjem.210.285; *AM LUNG ASS, 2010, CHRON OBSTR PULM DIS; [Anonymous], 2005, NUNNS APPL RESP PHYS; AUSTIN M, 2006, COCHRANE DB SYST REV, V3; Becker HF, 1996, J APPL PHYSIOL, V81, P1683, DOI 10.1152/jappl.1996.81.4.1683; British Lung Foundation, 2007, INV LIV CHRON OBSTR; CAMPBELL EJ, 1967, AM REV RESPIR DIS, V96, P626; Denniston AKO, 2002, CLIN MED, V2, P449, DOI 10.7861/clinmedicine.2-5-449; DONALD K, 1949, LANCET, V257, P1056; Eiser DN, 2004, COMPARISON CONTROLLE; ELLIOTT DMW, 2004, PROSPECTIVE RANDOMIS; Gooptu B, 2006, EMERG MED J, V23, P636, DOI 10.1136/emj.2005.029991; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Gunen H, 2005, EUR RESPIR J, V26, P234, DOI 10.1183/09031936.05.00024804; Hale KE, 2008, EMERG MED J, V25, P773, DOI 10.1136/emj.2008.059287; Halpern MT, 2003, RESP MED, V97, pS81, DOI 10.1016/S0954-6111(03)80028-8; Hurd SS, 2002, PULM PHARMACOL THER, V15, P353, DOI 10.1006/pupt.2002.0381; JEFFREY AA, 1992, THORAX, V47, P34, DOI 10.1136/thx.47.1.34; Joosten SA, 2007, MED J AUSTRALIA, V186, P235, DOI 10.5694/j.1326-5377.2007.tb00879.x; LAMBERTSEN CJ, 1953, J APPL PHYSIOL, V5, P471, DOI 10.1152/jappl.1953.5.9.471; McKenzie DK, 2003, MED J AUSTRALIA, V178, pS7; Mittmann N, 2008, RESP MED, V102, P413, DOI 10.1016/j.rmed.2007.10.010; New A, 2006, EMERG MED J, V23, P144, DOI 10.1136/emj.2005.027458; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; Plant PK, 2000, THORAX, V55, P550, DOI 10.1136/thorax.55.7.550; Plant PK, 2001, THORAX, V56, P708, DOI 10.1136/thorax.56.9.708; Price LC, 2006, THORAX, V61, P837, DOI 10.1136/thx.2005.049940; Robinson T, 2001, AM J RESP CRIT CARE, V163, P1755; SASSOON CSH, 1987, AM REV RESPIR DIS, V135, P907, DOI 10.1164/arrd.1987.135.4.907; Scales DC, 2008, CRIT CARE MED, V36, P1654, DOI 10.1097/CCM.0b013e3181701525; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; WESTLAKE EK, 1955, Q J MED, V24, P155; WIJESINGHE M, 2009, INTERN MED J, V39, P1; World Health Organisation, 2010, CHRON OBSTR PULM DIS	34	266	282	0	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2010	341								c5462	10.1136/bmj.c5462	http://dx.doi.org/10.1136/bmj.c5462			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671ZF	20959284	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000283552100011
J	Adhikari, NKJ; Fowler, RA; Bhagwanjee, S; Rubenfeld, GD				Adhikari, Neill K. J.; Fowler, Robert A.; Bhagwanjee, Satish; Rubenfeld, Gordon D.			Critical Care 1 Critical care and the global burden of critical illness in adults	LANCET			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; INTENSIVE-CARE; UNITED-STATES; MECHANICAL VENTILATION; SEVERE SEPSIS; NATIONAL-AUDIT; ILL PATIENTS; SOUTH-AFRICA; OF-LIFE	Critical care has evolved from treatment of poliomyelitis victims with respiratory failure in an intensive care unit to treatment of severely ill patients irrespective of location or specific technology. Population-based studies in the developed world suggest that the burden of critical illness is higher than generally appreciated and will increase as the population ages. Critical care capacity has long been needed in the developing world, and efforts to improve the care of the critically ill in these settings are starting to occur. Expansion of critical care to handle the consequences of an ageing population, natural disasters, conflict, inadequate primary care, and higher-risk medical therapies will be challenged by high costs at a time of economic constraint. To meet this challenge, investigators in this discipline will need to measure the global burden of critical illness and available critical-care resources, and develop both preventive and therapeutic interventions that are generalisable across countries.	[Adhikari, Neill K. J.; Fowler, Robert A.; Rubenfeld, Gordon D.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Adhikari, Neill K. J.; Fowler, Robert A.; Rubenfeld, Gordon D.] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Bhagwanjee, Satish] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Washington; University of Washington Seattle	Rubenfeld, GD (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	gordon.rubenfeld@sunnybrook.ca						*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; Angus DC, 2004, CRIT CARE MED, V32, P638, DOI 10.1097/01.CCM.0000114816.62331.08; Angus Derek C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P207; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; [Anonymous], COCHRANE DATABASE SY; Barrett H, 2006, INTENS CARE MED, V32, P1371, DOI 10.1007/s00134-006-0215-5; Barrett H, 2005, INTENS CARE MED, V31, P553, DOI 10.1007/s00134-005-2583-7; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bersten AD, 2002, AM J RESP CRIT CARE, V165, P443, DOI 10.1164/ajrccm.165.4.2101124; Bhagwanjee S, 2007, SAMJ S AFR MED J, V97, P1311; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Breslow MJ, 2007, J CRIT CARE, V22, P66, DOI 10.1016/j.jcrc.2007.01.006; Burnham G, 2006, LANCET, V368, P1421, DOI 10.1016/S0140-6736(06)69491-9; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; CARSON SS, 2006, J INTENSIVE CARE MED, V2, P173; Celis E, 2002, CRIT CARE, V6, P405; Cheng AC, 2008, PLOS MED, V5, P1173, DOI 10.1371/journal.pmed.0050175; *COBATRICE COLL, 2009, INTENS CARE MED, DOI DOI 10.1007/S00134-009-1514-4; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; Cook D, 2003, NEW ENGL J MED, V349, P1123, DOI 10.1056/NEJMoa030083; Cuthbertson BH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3723; Davydow DS, 2008, PSYCHOSOM MED, V70, P512, DOI 10.1097/PSY.0b013e31816aa0dd; Degoricija V, 2002, CROAT MED J, V43, P713; Devereaux A, 2008, CHEST, V133, p1S, DOI 10.1378/chest.08-0649; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Dowdy DW, 2005, INTENS CARE MED, V31, P611, DOI 10.1007/s00134-005-2592-6; DRENNAN K, 2008, INTENSIVE CARE RESOU; Du B, 2010, CRIT CARE, V14, DOI 10.1186/cc8222; Dunser MW, 2006, CRIT CARE MED, V34, P1234, DOI 10.1097/01.CCM.0000208360.70835.87; Ely EW, 1996, NEW ENGL J MED, V335, P1864, DOI 10.1056/NEJM199612193352502; Engelhardt HT, 1998, J MED PHILOS, V23, P643; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Fowler RA, 2003, JAMA-J AM MED ASSOC, V290, P367, DOI 10.1001/jama.290.3.367; Gao HY, 2007, INTENS CARE MED, V33, P667, DOI 10.1007/s00134-007-0532-3; Garrard C, 1998, BMJ-BRIT MED J, V316, P1841; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Grenvik A, 2009, CRIT CARE CLIN, V25, P239, DOI 10.1016/j.ccc.2008.11.001; Halpern NA, 2004, CRIT CARE MED, V32, P1254, DOI 10.1097/01.CCM.0000128577.31689.4C; Hariharan S, 2007, W INDIAN MED J, V56, P144; Harrison DA, 2006, CRIT CARE, V10, DOI 10.1186/cc4854; Harrison DA, 2007, CRIT CARE MED, V35, P1091, DOI 10.1097/01.CCM.0000259468.24532.44; Haynes Alex B, 2009, N Engl J Med, V360, P491, DOI 10.1056/NEJMsa0810119; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Horton R, 2009, LANCET, V373, P355, DOI 10.1016/S0140-6736(09)60116-1; IBSEN B, 1954, P ROY SOC MED, V47, P72, DOI 10.1177/003591575404700120; Jackson Richard, 2008, GRAYING GREAT POWERS; Jochberger S, 2008, ANESTH ANALG, V106, P942, DOI 10.1213/ane.0b013e318166ecb8; Jonsen A R, 1986, Law Med Health Care, V14, P172; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Kahn JM, 2009, CRIT CARE MED, V37, P2149, DOI 10.1097/CCM.0b013e3181a009d0; Kelley MA, 2004, CHEST, V125, P1514, DOI 10.1378/chest.125.4.1514; KELLEY MA, 1988, NEW ENGL J MED, V318, P1613, DOI 10.1056/NEJM198806163182410; Kirigia Joses M, 2006, Afr J Health Sci, V13, P86; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lazongas C, 2008, AM J RESP CRIT CARE, V177, pA41; Levy MM, 2008, ANN INTERN MED, V148, P801, DOI 10.7326/0003-4819-148-11-200806030-00002; Linde-Zwirble WT, 2004, CRIT CARE, V8, P222, DOI 10.1186/cc2917; Lott JP, 2009, AM J RESP CRIT CARE, V179, P676, DOI 10.1164/rccm.200808-1281OC; Luhr OR, 1999, AM J RESP CRIT CARE, V159, P1849, DOI 10.1164/ajrccm.159.6.9808136; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Metnitz PGH, 2005, INTENS CARE MED, V31, P1336, DOI 10.1007/s00134-005-2762-6; Moran JL, 2008, CRIT CARE MED, V36, P46, DOI 10.1097/01.CCM.0000295313.08084.58; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; Needham DM, 2005, CRIT CARE MED, V33, P574, DOI [10.1097/01.CCM.0000155992.21174.31, 10.1097/01.ccm.0000155992.21174.31]; Needham DM, 2004, CRIT CARE MED, V32, P1504, DOI 10.1097/01.CCM.0000129972.31533.37; Phua J, 2009, AM J RESP CRIT CARE, V179, P220, DOI 10.1164/rccm.200805-722OC; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Razzak JA, 2002, B WORLD HEALTH ORGAN, V80, P900; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Robnett MK, 2006, CRIT CARE MED, V34, pS25, DOI 10.1097/01.CCM.0000203087.42439.53; Rosenthal VD, 2008, AM J INFECT CONTROL, V36, P627, DOI [10.1016/j.ajic.2008.10.009, 10.1016/j.ajic.2008.06.003]; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubenfeld GD, 1999, CHEST, V116, P1347, DOI 10.1378/chest.116.5.1347; Rubenfeld GD, 2004, CRIT CARE MED, V32, P1289, DOI 10.1097/01.CCM.0000127266.39560.96; Rubenfeld GD, 2003, CRIT CARE MED, V31, pS276, DOI 10.1097/01.CCM.0000057904.62683.2B; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Scribante J, 2007, SAMJ S AFR MED J, V97, P1315; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; Tu JV, 2009, CAN MED ASSOC J, V180, pE118, DOI 10.1503/cmaj.081197; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; Villar J, 2007, AM J RESP CRIT CARE, V176, P795, DOI 10.1164/rccm.200610-1534OC; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; WALTHER SM, 2004, LAKARTIDNINGEN, V101, P3771; Walther Sten M, 2004, Lakartidningen, V101, P3771; Ward NS, 2008, CRIT CARE MED, V36, P471, DOI 10.1097/CCM.0B013E3181629511; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Weinert CR, 2003, AM J RESP CRIT CARE, V167, P1304, DOI 10.1164/rccm.200205-478OC; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Winters BD, 2007, CRIT CARE MED, V35, P1238, DOI 10.1097/01.CCM.0000262388.85669.68; Wunsch H, 2005, J CRIT CARE, V20, P264, DOI 10.1016/j.jcrc.2005.08.002; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8; Wunsch H, 2009, AM J RESP CRIT CARE, V180, P875, DOI 10.1164/rccm.200902-0201OC; Yatawatte A B, 2004, Ceylon Med J, V49, P51	100	683	715	5	69	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2010	376	9749					1339	1346		10.1016/S0140-6736(10)60446-1	http://dx.doi.org/10.1016/S0140-6736(10)60446-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671RX	20934212	Green Published, Bronze			2022-12-28	WOS:000283528600037
J	Goodwin, SS; Vale, RD				Goodwin, Sarah S.; Vale, Ronald D.			Patronin Regulates the Microtubule Network by Protecting Microtubule Minus Ends	CELL			English	Article							GAMMA-TUBULIN; DYNAMICS; CENTROSOME; LENGTH; NUCLEATION; DEPOLYMERIZATION; COOPERATE; KINESINS; COMPLEX; FAMILY	Tubulin assembles into microtubule polymers that have distinct plus and minus ends. Most microtubule plus ends in living cells are dynamic; the transitions between growth and shrinkage are regulated by assembly-promoting and destabilizing proteins. In contrast, minus ends are generally not dynamic, suggesting their stabilization by some unknown protein. Here, we have identified Patronin (also known as ssp4) as a protein that stabilizes microtubule minus ends in Drosophila S2 cells. In the absence of Patronin, minus ends lose subunits through the actions of the Kinesin-13 microtubule depolymerase, leading to a sparse interphase microtubule array and short, disorganized mitotic spindles. In vitro, the selective binding of purified Patronin to microtubule minus ends is sufficient to protect them against Kinesin-13-induced depolymerization. We propose that Patronin caps and stabilizes microtubule minus ends, an activity that serves a critical role in the organization of the microtubule cytoskeleton.	[Goodwin, Sarah S.; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Goodwin, Sarah S.; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu		Goodwin, Sarah/0000-0003-4686-0914	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM038499-22, R37 GM038499] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038499] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Baines AJ, 2009, MOL BIOL EVOL, V26, P2005, DOI 10.1093/molbev/msp115; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Bouissou A, 2009, J CELL BIOL, V187, P327, DOI 10.1083/jcb.200905060; Cooper JR, 2010, NAT STRUCT MOL BIOL, V17, P77, DOI 10.1038/nsmb.1728; Dammermann A, 2003, CURR BIOL, V13, pR614, DOI 10.1016/S0960-9822(03)00530-X; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Ehrhardt DW, 2008, CURR OPIN CELL BIOL, V20, P107, DOI 10.1016/j.ceb.2007.12.004; Fan J, 1996, J MOL BIOL, V259, P325, DOI 10.1006/jmbi.1996.0322; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Keating TJ, 1997, P NATL ACAD SCI USA, V94, P5078, DOI 10.1073/pnas.94.10.5078; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Kwok BH, 2007, CURR OPIN CELL BIOL, V19, P36, DOI 10.1016/j.ceb.2006.12.003; Laycock JE, 2006, J CELL SCI, V119, P2354, DOI 10.1242/jcs.02957; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Mennella V, 2005, NAT CELL BIOL, V7, P235, DOI 10.1038/ncb1222; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; MITCHISON TJ, 1993, SCIENCE, V261, P1044, DOI 10.1126/science.8102497; Moores CA, 2002, MOL CELL, V9, P903, DOI 10.1016/S1097-2765(02)00503-8; Moores CA, 2006, J CELL SCI, V119, P3905, DOI 10.1242/jcs.03224; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; Rath U, 2009, MOL BIOL CELL, V20, P4696, DOI 10.1091/mbc.E09-07-0557; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Rodionov V, 1999, P NATL ACAD SCI USA, V96, P115, DOI 10.1073/pnas.96.1.115; Rodionov VI, 1997, SCIENCE, V275, P215, DOI 10.1126/science.275.5297.215; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Rogers GC, 2008, MOL BIOL CELL, V19, P3163, DOI 10.1091/mbc.E07-10-1069; Rusan NM, 2009, TRAFFIC, V10, P472, DOI 10.1111/j.1600-0854.2009.00880.x; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Verollet C, 2006, J CELL BIOL, V172, P517, DOI 10.1083/jcb.200511071; Vorobjev IA, 1997, J CELL SCI, V110, P2635; Vorobjev IA, 1999, J CELL SCI, V112, P2277; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Wiese C, 2000, NAT CELL BIOL, V2, P358, DOI 10.1038/35014051; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yvon AMC, 1997, J CELL SCI, V110, P2391; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	47	165	169	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					263	274		10.1016/j.cell.2010.09.022	http://dx.doi.org/10.1016/j.cell.2010.09.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946984	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000283052200015
J	Peterca, M; Percec, V				Peterca, Mihai; Percec, Virgil			Recasting Metal Alloy Phases with Block Copolymers	SCIENCE			English	Editorial Material							SUPRAMOLECULAR DENDRIMERS; CRYSTALS; COLUMNS; SPHERES		[Peterca, Mihai; Percec, Virgil] Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA	University of Pennsylvania	Percec, V (corresponding author), Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA.	percec@sas.upenn.edu	Peterca, Mihai/C-9504-2009; Percec, Virgil/H-6316-2014	Peterca, Mihai/0000-0002-7247-4008; Percec, Virgil/0000-0001-5926-0489				Bates FS, 1999, PHYS TODAY, V52, P32, DOI 10.1063/1.882522; Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868; FRANK FC, 1959, ACTA CRYSTALLOGR, V12, P483, DOI 10.1107/S0365110X59001499; Joannopoulos JD, 1997, NATURE, V386, P143, DOI 10.1038/386143a0; Lee S, 2010, SCIENCE, V330, P349, DOI 10.1126/science.1195552; Lehn JM, 2002, SCIENCE, V295, P2400, DOI 10.1126/science.1071063; Percec V, 2006, J AM CHEM SOC, V128, P3324, DOI 10.1021/ja060062a; Percec V, 2008, J AM CHEM SOC, V130, P13079, DOI 10.1021/ja8034703; Percec V, 2010, SCIENCE, V328, P1009, DOI 10.1126/science.1185547; Percec V, 2009, J AM CHEM SOC, V131, P7662, DOI 10.1021/ja8094944; Percec V, 2009, J AM CHEM SOC, V131, P1294, DOI 10.1021/ja8087778; Peterca M, 2010, J AM CHEM SOC, V132, P11288, DOI 10.1021/ja104432d; Rosen BM, 2009, J AM CHEM SOC, V131, P17500, DOI 10.1021/ja907882n; Rosen BM, 2009, CHEM REV, V109, P6275, DOI 10.1021/cr900157q; SHOEMAKER DP, 1986, ACTA CRYSTALLOGR B, V42, P3, DOI 10.1107/S0108768186098671; Ungar G, 2003, SCIENCE, V299, P1208, DOI 10.1126/science.1078849; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Zeng XB, 2004, NATURE, V428, P157, DOI 10.1038/nature02368; Ziherl P, 2000, PHYS REV LETT, V85, P3528, DOI 10.1103/PhysRevLett.85.3528	19	37	37	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					333	334		10.1126/science.1196698	http://dx.doi.org/10.1126/science.1196698			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947755				2022-12-28	WOS:000282986700029
J	Shokrollahi, K; Whitaker, IS; Manning, SR; Mannasiev, D; Hiew, LY; Cooper, MACS				Shokrollahi, K.; Whitaker, I. S.; Manning, S. R.; Mannasiev, D.; Hiew, L. Y.; Cooper, M. A. C. S.			10-Minute Consultation Macromastia (large breasts): request for breast reduction	BRITISH MEDICAL JOURNAL			English	Editorial Material							MAMMAPLASTY; SURGERY		[Manning, S. R.] Sandwell Dist Gen Hosp, Lyndon B71 4NU, West Bromwich, England; [Shokrollahi, K.; Whitaker, I. S.; Hiew, L. Y.; Cooper, M. A. C. S.] Morriston Hosp, Welsh Ctr Burns & Plast Surg, Swansea SA6 6NL, W Glam, Wales; [Mannasiev, D.] Yardley Wood, Goodrest Croft Surg, Birmingham B14 4DU, England	Morriston Hospital	Manning, SR (corresponding author), Sandwell Dist Gen Hosp, Lyndon B71 4NU, West Bromwich, England.	stephen.manning@doctors.org.uk	Shokrollahi, Kayvan/V-4993-2019; Whitaker, Iain/O-5896-2019	Shokrollahi, Kayvan/0000-0003-1044-7781; Whitaker, Iain/0000-0002-3922-2079				Dafydd H, 2009, ANN PLAS SURG, V62, P244, DOI 10.1097/SAP.0b013e31817fe502; Greenbaum AR, 2003, BRIT J PLAST SURG, V56, P230, DOI 10.1016/S0007-1226(03)00122-X; Klassen A, 2000, ANN PLAS SURG, V45, P676; Klassen A, 1996, BMJ-BRIT MED J, V313, P454; Klassen A, 1996, BRIT J PLAST SURG, V49, P433, DOI 10.1016/S0007-1226(96)90025-9	5	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 13	2010	341								c5408	10.1136/bmj.c5408	http://dx.doi.org/10.1136/bmj.c5408			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668FB	20943725	Green Accepted			2022-12-28	WOS:000283252900014
J	Lie, KK; Groholt, EK; Eskild, A				Lie, Kari Kveim; Groholt, Else-Karin; Eskild, Anne			Association of cerebral palsy with Apgar score in low and normal birthweight infants: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERINATAL FACTORS; GESTATIONAL-AGE; RISK; SURVEILLANCE; PREVALENCE; EVENTS; NORWAY	Objectives To assess the association of Apgar score 5 minutes after birth with cerebral palsy in both normal weight and low birthweight children, and also the association with the cerebral palsy subdiagnoses of quadriplegia, diplegia, and hemiplegia. Design Population based cohort study. Setting The Medical Birth Registry of Norway was used to identify all babies born between 1986 and 1995. These data were linked to the Norwegian Registry of Cerebral Palsy in Children born 1986-95, which was established on the basis of discharge diagnoses at all paediatric departments in Norway. Population All singletons without malformations born in Norway during 1986-95 and who survived the first year of life (n=543 064). Main outcome measure Cerebral palsy diagnosed before the age of 5 years. Results 988 children (1.8 in 1000) were diagnosed with cerebral palsy before the age of 5 years. In total, 11% (39/369) of the children with Apgar score of less than 3 at birth were diagnosed with cerebral palsy, compared with only 0.1% (162/179 515) of the children with Apgar score of 10 (odds ratio (OR) 53, 95% CI 35 to 80 after adjustment for birth weight). In children with a birth weight of 2500 g or more, those with an Apgar score of less than 4 were much more likely to have cerebral palsy than those who had an Apgar score of more than 8 (OR 125, 95% confidence interval 91 to 170). The corresponding OR in children weighing less than 1500 g was 5 (95% CI 2 to 9). Among children with Apgar score of less than 4, 10-17% in all birthweight groups developed cerebral palsy. Low Apgar score was strongly associated with each of the three subgroups of spastic cerebral palsy, although the association was strongest for quadriplegia (adjusted OR 137 for Apgar score <4 v Apgar score >8,95% CI 77 to 244). Conclusions Low Apgar score was strongly associated with cerebral palsy. This association was high in children with normal birth weight and modest in children with low birth weight. The strength of the association differed between subgroups of spastic cerebral palsy. Given that Apgar score is a measure of vitality shortly after birth, our findings suggest that the causes of cerebral palsy are closely linked to factors that reduce infant vitality.	[Lie, Kari Kveim; Groholt, Else-Karin] Norwegian Inst Publ Hlth, Div Epidemiol, N-0403 Oslo, Norway; [Eskild, Anne] Akershus Univ Hosp, Dept Obstet & Gynaecol, Nordbyhagen, Norway; [Eskild, Anne] Akershus Univ Hosp, Med Fac Div, Nordbyhagen, Norway; [Eskild, Anne] Norwegian Inst Publ Hlth, Div Mental Hlth, N-0403 Oslo, Norway	Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH)	Lie, KK (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, POB 4404, N-0403 Oslo, Norway.	kari.kveim.lie@fhi.no			Norwegian Foundation for Health and Rehabilitation	Norwegian Foundation for Health and Rehabilitation	The study was funded by the Norwegian Foundation for Health and Rehabilitation, which had no role in the study planning, data collection, or analysis, or in the writing the article or in the decision to submit the article for publication.	Andersen GL, 2008, EUR J PAEDIATR NEURO, V12, P4, DOI 10.1016/j.ejpn.2007.05.001; APGAR V, 1953, Curr Res Anesth Analg, V32, P260; BEHNKE M, 1987, AM J PERINAT, V4, P121, DOI 10.1055/s-2007-999752; BLAIR E, 1988, J PEDIATR-US, V112, P515, DOI 10.1016/S0022-3476(88)80161-6; Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701; CATLIN EA, 1986, J PEDIATR-US, V109, P865, DOI 10.1016/S0022-3476(86)80715-6; Gainsborough M, 2008, DEV MED CHILD NEUROL, V50, P828, DOI 10.1111/j.1469-8749.2008.03141.x; Grether JK, 1996, J PEDIATR-US, V128, P407, DOI 10.1016/S0022-3476(96)70292-5; Hegyi T, 1998, PEDIATRICS, V101, P77, DOI 10.1542/peds.101.1.77; Himpens E, 2008, DEV MED CHILD NEUROL, V50, P334, DOI 10.1111/j.1469-8749.2008.02047.x; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Jacobsson B, 2002, ACTA PAEDIATR, V91, P946, DOI 10.1080/080352502760148685; Krageloh-Mann I, 2009, BRAIN DEV-JPN, V31, P537, DOI 10.1016/j.braindev.2009.03.009; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; Meberg A, 2004, J PERINAT MED, V32, P434, DOI 10.1515/JPM.2004.143; Moster D, 2001, J PEDIATR-US, V138, P798, DOI 10.1067/mpd.2001.114694; MURPHY DJ, 1995, LANCET, V346, P1449, DOI 10.1016/S0140-6736(95)92471-X; NELSON KB, 1981, PEDIATRICS, V68, P36; O'Shea TM, 1998, AM J EPIDEMIOL, V147, P362; Oh W, 1996, PEDIATRICS, V98, P141; Pinheiro JMB, 2009, ARCH DIS CHILD-FETAL, V94, pF70, DOI 10.1136/adc.2008.145037; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Stanley F, 2000, CLIN DEV MED; Stark AR, 2006, PEDIATRICS, V117, P1444, DOI 10.1542/peds.2006-0325; Thorngren-Jerneck K, 2006, OBSTET GYNECOL, V108, P1499, DOI 10.1097/01.AOG.0000247174.27979.6b; Topp M, 1997, ACTA OBSTET GYN SCAN, V76, P843, DOI 10.3109/00016349709024363; Tran U, 2005, EARLY HUM DEV, V81, P555, DOI 10.1016/j.earlhumdev.2004.12.009; Walstab JE, 2004, AUST NZ J OBSTET GYN, V44, P342, DOI 10.1111/j.1479-828X.2004.00249.x	28	75	83	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2010	341								c4990	10.1136/bmj.c4990	http://dx.doi.org/10.1136/bmj.c4990			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663JJ	20929920	Green Published, hybrid			2022-12-28	WOS:000282880500002
J	Arensburger, P; Megy, K; Waterhouse, RM; Abrudan, J; Amedeo, P; Antelo, B; Bartholomay, L; Bidwell, S; Caler, E; Camara, F; Campbell, CL; Campbell, KS; Casola, C; Castro, MT; Chandramouliswaran, I; Chapman, SB; Christley, S; Costas, J; Eisenstadt, E; Feschotte, C; Fraser-Liggett, C; Guigo, R; Haas, B; Hammond, M; Hansson, BS; Hemingway, J; Hill, SR; Howarth, C; Ignell, R; Kennedy, RC; Kodira, CD; Lobo, NF; Mao, CH; Mayhew, G; Michel, K; Mori, A; Liu, NN; Naveira, H; Nene, V; Nguyen, N; Pearson, MD; Pritham, EJ; Puiu, D; Qi, YM; Ranson, H; Ribeiro, JMC; Roberston, HM; Severson, DW; Shumway, M; Stanke, M; Strausberg, RL; Sun, C; Sutton, G; Tu, ZJ; Tubio, JMC; Unger, MF; Vanlandingham, DL; Vilella, AJ; White, O; White, JR; Wondji, CS; Wortman, J; Zdobnov, EM; Birren, B; Christensen, BM; Collins, FH; Cornel, A; Dimopoulos, G; Hannick, LI; Higgs, S; Lanzaro, GC; Lawson, D; Lee, NH; Muskavitch, MAT; Raikhel, AS; Atkinson, PW				Arensburger, Peter; Megy, Karine; Waterhouse, Robert M.; Abrudan, Jenica; Amedeo, Paolo; Antelo, Beatriz; Bartholomay, Lyric; Bidwell, Shelby; Caler, Elisabet; Camara, Francisco; Campbell, Corey L.; Campbell, Kathryn S.; Casola, Claudio; Castro, Marta T.; Chandramouliswaran, Ishwar; Chapman, Sinead B.; Christley, Scott; Costas, Javier; Eisenstadt, Eric; Feschotte, Cedric; Fraser-Liggett, Claire; Guigo, Roderic; Haas, Brian; Hammond, Martin; Hansson, Bill S.; Hemingway, Janet; Hill, Sharon R.; Howarth, Clint; Ignell, Rickard; Kennedy, Ryan C.; Kodira, Chinnappa D.; Lobo, Neil F.; Mao, Chunhong; Mayhew, George; Michel, Kristin; Mori, Akio; Liu, Nannan; Naveira, Horacio; Nene, Vishvanath; Nguyen, Nam; Pearson, Matthew D.; Pritham, Ellen J.; Puiu, Daniela; Qi, Yumin; Ranson, Hilary; Ribeiro, Jose M. C.; Roberston, Hugh M.; Severson, David W.; Shumway, Martin; Stanke, Mario; Strausberg, Robert L.; Sun, Cheng; Sutton, Granger; Tu, Zhijian (Jake); Tubio, Jose Manuel C.; Unger, Maria F.; Vanlandingham, Dana L.; Vilella, Albert J.; White, Owen; White, Jared R.; Wondji, Charles S.; Wortman, Jennifer; Zdobnov, Evgeny M.; Birren, Bruce; Christensen, Bruce M.; Collins, Frank H.; Cornel, Anthony; Dimopoulos, George; Hannick, Linda I.; Higgs, Stephen; Lanzaro, Gregory C.; Lawson, Daniel; Lee, Norman H.; Muskavitch, Marc A. T.; Raikhel, Alexander S.; Atkinson, Peter W.			Sequencing of Culex quinquefasciatus Establishes a Platform for Mosquito Comparative Genomics	SCIENCE			English	Article							AEDES-AEGYPTI; PIPIENS; VECTOR	Culex quinquefasciatus (the southern house mosquito) is an important mosquito vector of viruses such as West Nile virus and St. Louis encephalitis virus, as well as of nematodes that cause lymphatic filariasis. C. quinquefasciatus is one species within the Culex pipiens species complex and can be found throughout tropical and temperate climates of the world. The ability of C. quinquefasciatus to take blood meals from birds, livestock, and humans contributes to its ability to vector pathogens between species. Here, we describe the genomic sequence of C. quinquefasciatus: Its repertoire of 18,883 protein-coding genes is 22% larger than that of Aedes aegypti and 52% larger than that of Anopheles gambiae with multiple gene-family expansions, including olfactory and gustatory receptors, salivary gland genes, and genes associated with xenobiotic detoxification.	[Arensburger, Peter; Raikhel, Alexander S.; Atkinson, Peter W.] Univ Calif Riverside, Ctr Dis Vector Res, Riverside, CA 92521 USA; [Megy, Karine; Hammond, Martin; Vilella, Albert J.; Lawson, Daniel] European Bioinformat Inst EMBL EBI, Cambridge CB10 1SD, England; [Waterhouse, Robert M.; Zdobnov, Evgeny M.] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; [Waterhouse, Robert M.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Abrudan, Jenica; Christley, Scott; Kennedy, Ryan C.; Lobo, Neil F.; Mori, Akio; Severson, David W.; Unger, Maria F.; Collins, Frank H.] Univ Notre Dame, Notre Dame, IN 46556 USA; [Amedeo, Paolo; Caler, Elisabet; Chandramouliswaran, Ishwar; Eisenstadt, Eric; Hannick, Linda I.] J Craig Venter Inst, Rockville, MD 20850 USA; [Tubio, Jose Manuel C.] Univ Santiago, Complexo Hosp, Santiago De Compostela 15706, Spain; [Bartholomay, Lyric] Iowa State Univ, Ames, IA 50011 USA; [Bidwell, Shelby; Camara, Francisco; Guigo, Roderic] Univ Pompeu Fabra, Ctr Gene Regulat, E-08003 Barcelona, Catalonia, Spain; [Campbell, Corey L.] Colorado State Univ, Ft Collins, CO 80523 USA; [Campbell, Kathryn S.] Harvard Univ, Cambridge, MA 02138 USA; [Casola, Claudio] Indiana Univ, Bloomington, IN 47405 USA; [Castro, Marta T.] Hosp Llobregat, Programa Epigenet & Biol Canc, Hosp Duran & Reynals, Barcelona 08907, Spain; [Chapman, Sinead B.; Haas, Brian; Howarth, Clint; Pearson, Matthew D.; White, Jared R.; Birren, Bruce; Muskavitch, Marc A. T.] Broad Inst, Cambridge, MA 02142 USA; [Costas, Javier] Fdn Publ Galega Med Xenomica Servizo Galego Saude, Santiago De Compostela 15706, Spain; [Feschotte, Cedric; Nguyen, Nam; Pritham, Ellen J.; Sun, Cheng] Univ Texas Arlington, Arlington, TX 76019 USA; [Fraser-Liggett, Claire; White, Owen; Wortman, Jennifer] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Hansson, Bill S.] Max Planck Inst Chem Ecol, D-07749 Jena, Germany; [Hemingway, Janet; Ranson, Hilary; Wondji, Charles S.] Univ Liverpool Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Hill, Sharon R.; Ignell, Rickard] Swedish Univ Agr Sci, S-23053 Alnarp, Sweden; [Kodira, Chinnappa D.] Roche Grp, Branford, CT 06405 USA; [Mao, Chunhong; Qi, Yumin; Tu, Zhijian (Jake)] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA; [Mayhew, George; Christensen, Bruce M.] Univ Wisconsin, Madison, WI 53706 USA; [Michel, Kristin] Kansas State Univ, Manhattan, KS 66506 USA; [Liu, Nannan] Auburn Univ, Auburn, AL 36849 USA; [Naveira, Horacio] Univ A Coruna, Dept Bioloxia Celular & Mol, Coruna 15071 A, Spain; [Nene, Vishvanath] Int Livestock Res Inst, Nairobi, Kenya; [Puiu, Daniela] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Ribeiro, Jose M. C.; Shumway, Martin] Natl Inst Hlth, Bethesda, MD 20892 USA; [Roberston, Hugh M.] Univ Illinois, Urbana, IL 61801 USA; [Stanke, Mario] Univ Gottingen, D-37077 Gottingen, Germany; [Cornel, Anthony] Univ Texas Galveston, Med Branch, Galveston, TX 77555 USA; [Vanlandingham, Dana L.; Zdobnov, Evgeny M.; Higgs, Stephen] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Zdobnov, Evgeny M.; Lanzaro, Gregory C.] Univ Calif Davis, Parlier, CA 93648 USA; [Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Lee, Norman H.] George Washington Univ, Med Ctr, Washington, DC 20037 USA; [Muskavitch, Marc A. T.] Boston Coll, Chestnut Hill, MA 02467 USA; [Muskavitch, Marc A. T.] Harvard Sch Publ Hlth, Boston, MA 02115 USA	University of California System; University of California Riverside; European Molecular Biology Laboratory (EMBL); University of Geneva; Swiss Institute of Bioinformatics; University of Notre Dame; J. Craig Venter Institute; Universidade de Santiago de Compostela; Iowa State University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Colorado State University; Harvard University; Indiana University System; Indiana University Bloomington; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; University of Barcelona; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Texas System; University of Texas Arlington; University System of Maryland; University of Maryland Baltimore; Max Planck Society; Liverpool School of Tropical Medicine; Swedish University of Agricultural Sciences; Roche Holding; Virginia Polytechnic Institute & State University; University of Wisconsin System; University of Wisconsin Madison; Kansas State University; Auburn University System; Auburn University; Universidade da Coruna; CGIAR; International Livestock Research Institute (ILRI); University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; University of Illinois System; University of Illinois Urbana-Champaign; University of Gottingen; University of Texas System; University of Texas Medical Branch Galveston; Imperial College London; University of California System; University of California Davis; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; George Washington University; Boston College; Harvard University; Harvard T.H. Chan School of Public Health	Arensburger, P (corresponding author), Univ Calif Riverside, Ctr Dis Vector Res, Riverside, CA 92521 USA.	arensburger@gmail.com	Tubio, Jose/AAG-7345-2019; Mayhew, George F/B-4042-2016; Guigo, Roderic/D-1303-2010; Michel, Kristin/F-3400-2011; Wondji, Charles/AAG-1510-2020; Naveira, Horacio/I-7802-2019; Feschotte, Cedric/C-4048-2011; Naveira, Horacio/H-7249-2014; Hansson, Bill/G-2774-2013; Ferreira, Francisco Câmara/G-9841-2015; Costas, Javier/B-5016-2008; Zdobnov, Evgeny/AAB-2745-2022; Waterhouse, Robert M/A-1858-2010; Hill, Sharon R/A-5121-2008; Tubio, Jose M.C./H-5076-2015; Sun, Cheng/AAW-7354-2021; Zdobnov, Evgeny M/K-1133-2012; Stanke, Mario/P-7876-2019	Tubio, Jose/0000-0003-3540-2459; Mayhew, George F/0000-0003-0609-6018; Guigo, Roderic/0000-0002-5738-4477; Naveira, Horacio/0000-0002-3840-1569; Naveira, Horacio/0000-0002-3840-1569; Hansson, Bill/0000-0002-4811-1223; Ferreira, Francisco Câmara/0000-0002-1971-5466; Costas, Javier/0000-0003-0306-3990; Zdobnov, Evgeny/0000-0002-5178-1498; Waterhouse, Robert M/0000-0003-4199-9052; Hill, Sharon R/0000-0002-6474-0214; Tubio, Jose M.C./0000-0003-3540-2459; Sun, Cheng/0000-0001-7476-9224; Stanke, Mario/0000-0001-8696-0384; Ribeiro, Jose/0000-0002-9107-0818; Campbell, Corey L./0000-0002-6384-1259; Wortman, Jennifer/0000-0002-8713-1227; Vilella, Albert/0000-0002-2005-2516; Lawson, Daniel/0000-0001-7765-983X; Wondji, Charles S./0000-0003-0791-3673; Hannick, Linda/0000-0002-8018-8466; Dimopoulos, George/0000-0001-6755-8111; Nene, Vishvanath/0000-0001-7066-4169; Fraser, Claire/0000-0003-1462-2428; Hemingway, Janet/0000-0002-3200-7173; Ranson, Hilary/0000-0003-2332-8247; Megy, Karyn/0000-0002-2826-3879; Casola, Claudio/0000-0003-4853-1866	NIH [HHSN266200400039C]; National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services [N01-AI-30071, HHSN266200400001C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant HHSN266200400039C and by the National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services under contract numbers N01-AI-30071 and HHSN266200400001C. The assembled genome was deposited in the GenBank database with accession number AAWU00000000.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P437; Benedict M, 2008, VECTOR-BORNE ZOONOT, V8, P127, DOI 10.1089/vbz.2007.0273; Cornel AJ, 2003, J MED ENTOMOL, V40, P36, DOI 10.1603/0022-2585-40.1.36; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Kasai S, 2000, INSECT BIOCHEM MOLEC, V30, P163, DOI 10.1016/S0965-1748(99)00114-9; Komagata O, 2010, INSECT BIOCHEM MOLEC, V40, P146, DOI 10.1016/j.ibmb.2010.01.006; Mori A, 1999, J HERED, V90, P160, DOI 10.1093/jhered/90.1.160; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Ribeiro JMC, 2009, ADV INSECT PHYSIOL, V37, P59, DOI 10.1016/S0065-2806(09)37002-2; Vinogradova E.B., 2000, CULEX PIPIENS PIPIEN	12	337	354	1	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2010	330	6000					86	88		10.1126/science.1191864	http://dx.doi.org/10.1126/science.1191864			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929810	Green Accepted			2022-12-28	WOS:000282334500040
J	Cahalan, MD				Cahalan, Michael D.			How to STIMulate Calcium Channels	SCIENCE			English	Editorial Material							OPERATED CA2+ ENTRY; CRAC CHANNEL; INFLUX; ORAI1; PORE		Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University of California System; University of California Irvine	Cahalan, MD (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	mcahalan@uci.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS014609] Funding Source: NIH RePORTER; NINDS NIH HHS [R37 NS014609-33, R37 NS014609] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	12	13	14	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					43	44		10.1126/science.1196348	http://dx.doi.org/10.1126/science.1196348			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929798	Green Submitted, Green Accepted			2022-12-28	WOS:000282334500024
J	Packer, C				Packer, Craig			A Bit of Texas in Florida	SCIENCE			English	Editorial Material									Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Packer, C (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	packer@umn.edu						Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Packer C, 2005, NATURE, V436, P927, DOI 10.1038/436927a; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Trinkel M, 2008, ANIM CONSERV, V11, P138, DOI 10.1111/j.1469-1795.2008.00163.x	4	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1606	1607		10.1126/science.1196738	http://dx.doi.org/10.1126/science.1196738			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	653NK	20929833				2022-12-28	WOS:000282098100025
J	Bajaj, VS; Paulsen, J; Harel, E; Pines, A				Bajaj, Vikram S.; Paulsen, Jeffrey; Harel, Elad; Pines, Alexander			Zooming In on Microscopic Flow by Remotely Detected MRI	SCIENCE			English	Article							MAGNETIC-RESONANCE; MICROFLUIDIC CHIP; NMR; RESOLUTION; MAGNETOMETER; BIOSENSOR	Magnetic resonance imaging (MRI) can elucidate the interior structure of an optically opaque object in unparalleled detail but is ultimately limited by the need to enclose the object within a detection coil; acquiring the image with increasingly smaller pixels reduces the sensitivity, because each pixel occupies a proportionately smaller fraction of the detector's volume. We developed a technique that overcomes this limitation by means of remotely detected MRI. Images of fluids flowing in channel assemblies are encoded into the phase and intensity of the constituent molecules' nuclear magnetic resonance signals and then decoded by a volume-matched detector after the fluids flow out of the sample. In combination with compressive sampling, we thus obtain microscopic images of flow and velocity distributions similar to 10(6) times faster than is possible with conventional MRI on this hardware. Our results illustrate the facile integration of MRI with microfluidic assays and suggest generalizations to other systems involving microscopic flow.	[Bajaj, Vikram S.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bajaj, VS (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.	vsbajaj@lbl.gov; pines@berkeley.edu			U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-AC02-05CH11231]	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE))	We thank D. Wemmer for his careful reading of the manuscript and L.-S. Bouchard for helpful discussions. Supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under contract DE-AC02-05CH11231 (V. S. B., J.P., E. H., A. P.). We thank the Agilent Foundation for its generous and unrestricted gift. The Lawrence Berkeley National Laboratory has applied for a patent on aspects of this method. The authors declare no competing interests. Author contributions: V. S. B., J.P., E. H., and A. P. designed the experiments. V. S. B., J.P., and E. H. performed the experiments. V. S. B. and J.P. analyzed the data and wrote the paper.	Callaghan P., 1991, PRINCIPLES NUCL MAGN; CORY DG, 1990, MAGNET RESON MED, V14, P435, DOI 10.1002/mrm.1910140303; deMello AJ, 2006, NATURE, V442, P394, DOI 10.1038/nature05062; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Fukushima E, 1999, ANNU REV FLUID MECH, V31, P95, DOI 10.1146/annurev.fluid.31.1.95; Granwehr J, 2007, MAGN RESON IMAGING, V25, P449, DOI 10.1016/j.mri.2006.11.011; Harel E, 2008, J MAGN RESON, V193, P199, DOI 10.1016/j.jmr.2008.04.037; Hilty C, 2005, P NATL ACAD SCI USA, V102, P14960, DOI 10.1073/pnas.0507566102; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Koster S, 2007, LAB CHIP, V7, P1394, DOI 10.1039/b709706a; Ledbetter MP, 2008, P NATL ACAD SCI USA, V105, P2286, DOI 10.1073/pnas.0711505105; Lee H, 2008, NAT MED, V14, P869, DOI 10.1038/nm.1711; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Maguire Y, 2007, P NATL ACAD SCI USA, V104, P9198, DOI 10.1073/pnas.0703001104; Massin C, 2003, J MAGN RESON, V164, P242, DOI 10.1016/S1090-7807(03)00151-4; Monat C, 2007, NAT PHOTONICS, V1, P106, DOI 10.1038/nphoton.2006.96; Moule AJ, 2003, P NATL ACAD SCI USA, V100, P9122, DOI 10.1073/pnas.1133497100; OLSON DL, 1995, SCIENCE, V270, P1967, DOI 10.1126/science.270.5244.1967; POPE JM, 1993, CONCEPT MAGNETIC RES, V5, P281; Schroder L, 2006, SCIENCE, V314, P446, DOI 10.1126/science.1131847; Song YQ, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2833581; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075; Wensink H, 2005, LAB CHIP, V5, P280, DOI 10.1039/b414832k; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wolters AM, 2002, CURR OPIN CHEM BIOL, V6, P711, DOI 10.1016/S1367-5931(02)00382-4; Wu HK, 2004, P NATL ACAD SCI USA, V101, P12809, DOI 10.1073/pnas.0405299101; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064	27	46	46	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 19	2010	330	6007					1078	1081		10.1126/science.1192313	http://dx.doi.org/10.1126/science.1192313			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	20929729				2022-12-28	WOS:000284374700036
J	Adeyi, O; Atun, R				Adeyi, Olusoji; Atun, Rifat			Universal access to malaria medicines: innovation in financing and delivery	LANCET			English	Editorial Material									[Adeyi, Olusoji; Atun, Rifat] Global Fund Fight AIDS TB & Malaria, CH-1214 Geneva, Switzerland; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, London, England	Imperial College London	Adeyi, O (corresponding author), Global Fund Fight AIDS TB & Malaria, Chemin Blandonnet 8, CH-1214 Geneva, Switzerland.	Olusoji.Adeyi@Theglobalfund.org	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983				ACTwatch Group, 2009, 5 PAN AFR MAL C NAIR; AMFm Task Force of the Roll Back Malaria Partnership, 2007, AFF MED FAC MAL AMFM; [Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 2010, ECONOMIST       0107; Arrow Kenneth J., 2004, SAV LIV BUYING TIM E; Frost L, 2009, PROCESS EVALUATION P; *GLOB FUND, 2009, 5 YEAR EV GLOB FUND; Gwatkin D. R., 2005, REACHING POOR HLTH N; Laxminarayan R, 2006, HEALTH AFFAIR, V25, P325, DOI 10.1377/hlthaff.25.2.325; Laxminarayan R, 2009, HEALTH AFFAIR, V28, P949, DOI 10.1377/hlthaff.28.4.949; Lim SS, 2008, LANCET, V372, P2031, DOI 10.1016/S0140-6736(08)61869-3; President's Malaria Initiative, PRES MAL IN; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN MA; Sabot OJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006857; Talisuna A, 2009, LANCET, V374, P1224, DOI 10.1016/S0140-6736(09)61767-0; The Global Fund, 2009, GLOB FUND 5 YEAR EV; The Global Fund, 2010, AFF MED FAC MAL FREQ; The World Bank, 2010, COUNT MAL OUT JUN 4; WHO, 2006, GUID TREATM MAL; WHO, 2010, GUID TREATM MAL, V2nd	20	33	33	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2010	376	9755					1869	1871		10.1016/S0140-6736(10)61189-0	http://dx.doi.org/10.1016/S0140-6736(10)61189-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	696KG	20940074				2022-12-28	WOS:000285439700036
J	Hu, FH; Luo, WB; Hong, M				Hu, Fanghao; Luo, Wenbin; Hong, Mei			Mechanisms of Proton Conduction and Gating in Influenza M2 Proton Channels from Solid-State NMR	SCIENCE			English	Article							A VIRUS; ION-CHANNEL; TAUTOMERIC EQUILIBRIA; TRANSMEMBRANE PEPTIDE; BINDING-SITE; ACID-BASE; H-BOND; HISTIDINE; MODEL; SPECTROSCOPY	The M2 protein of influenza viruses forms an acid-activated tetrameric proton channel. We used solid-state nuclear magnetic resonance spectroscopy to determine the structure and functional dynamics of the pH-sensing and proton-selective histidine-37 in M2 bound to a cholesterol-containing virus-envelope-mimetic membrane so as to better understand the proton conduction mechanism. In the high-pH closed state, the four histidines form an edge-face p-stacked structure, preventing the formation of a hydrogen-bonded water chain to conduct protons. In the low-pH conducting state, the imidazoliums hydrogen-bond extensively with water and undergo microsecond ring reorientations with an energy barrier greater than 59 kilojoules per mole. This barrier is consistent with the temperature dependence of proton conductivity, suggesting that histidine-37 dynamically shuttles protons into the virion. We propose a proton conduction mechanism in which ring-flip-assisted imidazole deprotonation is the rate-limiting step.	[Hu, Fanghao; Luo, Wenbin; Hong, Mei] Iowa State Univ, Dept Chem, Ames, IA 50011 USA	Iowa State University	Hong, M (corresponding author), Iowa State Univ, Dept Chem, Ames, IA 50011 USA.	mhong@iastate.edu		Hong, Mei/0000-0001-5255-5858	NSF [MCB-543473]; NIH [GM088204]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088204] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Li for discussions. This work was supported by NSF grant MCB-543473 and NIH grant GM088204.	Ash EL, 2000, P NATL ACAD SCI USA, V97, P10371, DOI 10.1073/pnas.97.19.10371; BACHOVCHIN WW, 1978, J AM CHEM SOC, V100, P8041, DOI 10.1021/ja00494a001; Brinen LS, 1996, BIOCHEMISTRY-US, V35, P5999, DOI 10.1021/bi9530200; Bureekaew S, 2009, NAT MATER, V8, P831, DOI [10.1038/NMAT2526, 10.1038/nmat2526]; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Cady SD, 2009, BIOCHEMISTRY-US, V48, P7356, DOI 10.1021/bi9008837; Chen HN, 2007, BIOPHYS J, V93, P3470, DOI 10.1529/biophysj.107.105742; DEREWENDA ZS, 1994, J MOL BIOL, V241, P83, DOI 10.1006/jmbi.1994.1475; Fischbach I, 2004, J PHYS CHEM B, V108, P18500, DOI 10.1021/jp046848h; Gandhi CS, 1999, J BIOL CHEM, V274, P5474, DOI 10.1074/jbc.274.9.5474; Henry B, 2002, J AM CHEM SOC, V124, P2025, DOI 10.1021/ja011638t; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Khurana E, 2009, P NATL ACAD SCI USA, V106, P1069, DOI 10.1073/pnas.0811720106; Lin TI, 2001, J VIROL, V75, P3647, DOI 10.1128/JVI.75.8.3647-3656.2001; Luo WB, 2007, J PHYS CHEM B, V111, P10825, DOI 10.1021/jp073823k; Luo WB, 2010, J AM CHEM SOC, V132, P2378, DOI 10.1021/ja9096219; Luo WB, 2009, BIOCHEMISTRY-US, V48, P6361, DOI 10.1021/bi900716s; Ma CL, 2009, P NATL ACAD SCI USA, V106, P12283, DOI 10.1073/pnas.0905726106; Mauritz KA, 2004, CHEM REV, V104, P4535, DOI 10.1021/cr0207123; Mould JA, 2000, J BIOL CHEM, V275, P8592, DOI 10.1074/jbc.275.12.8592; MUNOWITZ M, 1982, J AM CHEM SOC, V104, P1192, DOI 10.1021/ja00369a007; NAGLE JF, 1978, P NATL ACAD SCI USA, V75, P298, DOI 10.1073/pnas.75.1.298; Nishimura K, 2002, BIOCHEMISTRY-US, V41, P13170, DOI 10.1021/bi0262799; Okada A, 2001, BIOCHEMISTRY-US, V40, P6053, DOI 10.1021/bi0028441; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; Scheiner S, 2002, J AM CHEM SOC, V124, P13257, DOI 10.1021/ja027200q; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Song XJ, 2001, MAGN RESON CHEM, V39, pS30, DOI 10.1002/mrc.956; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; WANG C, 1995, BIOPHYS J, V69, P1363, DOI 10.1016/S0006-3495(95)80003-2; Waters ML, 2002, CURR OPIN CHEM BIOL, V6, P736, DOI 10.1016/S1367-5931(02)00359-9; Yi M, 2008, J PHYS CHEM B, V112, P7977, DOI 10.1021/jp800171m; Yi MG, 2009, P NATL ACAD SCI USA, V106, P13311, DOI 10.1073/pnas.0906553106	34	254	258	8	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					505	508		10.1126/science.1191714	http://dx.doi.org/10.1126/science.1191714			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966251	Green Accepted			2022-12-28	WOS:000283329100040
J	Babiarz, KS; Miller, G; Yi, HM; Zhang, LX; Rozelle, S				Babiarz, Kimberly Singer; Miller, Grant; Yi, Hongmei; Zhang, Linxiu; Rozelle, Scott			New evidence on the impact of China's New Rural Cooperative Medical Scheme and its implications for rural primary healthcare: multivariate difference-in-difference analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SYSTEM; LESSONS; CHOICE; REFORM	Objectives To determine whether China's New Rural Cooperative Medical Scheme (NCMS), which aims to provide health insurance to 800 million rural citizens and to correct distortions in rural primary care, and the individual policy attributes have affected the operation and use of village health clinics. Design We performed a difference-in-difference analysis using multivariate linear regressions, controlling for clinic and individual attributes as well as village and year effects. Setting 100 villages within 25 rural counties across five Chinese provinces in 2004 and 2007. Participants 160 village primary care clinics and 8339 individuals. Main outcome measures Clinic outcomes were log average weekly patient flow, log average monthly gross income, log total annual net income, and the proportion of monthly gross income from medicine sales. Individual outcomes were probability of seeking medical care, log annual "out of pocket" health expenditure, and two measures of exposure to financial risk (probability of incurring out of pocket health expenditure above the 90th percentile of spending among the uninsured and probability of financing medical care by borrowing or selling assets). Results For village clinics, we found that NCMS was associated with a 26% increase in weekly patient flow and a 29% increase in monthly gross income, but no change in annual net revenue or the proportion of monthly income from drug revenue. For individuals, participation in NCMS was associated with a 5% increase in village clinic use, but no change in overall medical care use. Also, out of pocket medical spending fell by 19% and the two measures of exposure to financial risk declined by 24-63%. These changes occurred across heterogeneous county programmes, even in those with minimal benefit packages. Conclusions NCMS provides some financial risk protection for individuals in rural China and has partly corrected distortions in Chinese rural healthcare (reducing the oversupply of specialty services and prescription drugs). However, the scheme may have also shifted uncompensated new responsibilities to village clinics. Given renewed interest among Chinese policy makers in strengthening primary care, the effect of NCMS deserves greater attention.	[Miller, Grant] Stanford Med Sch, Stanford, CA USA; [Miller, Grant] Natl Bur Econ Res, Stanford, CA USA; [Babiarz, Kimberly Singer] Univ Calif Davis, Dept Agr & Resource Econ, Davis, CA 95616 USA; [Yi, Hongmei; Zhang, Linxiu] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Ctr Chinese Agr Policy, Beijing, Peoples R China; [Rozelle, Scott] Stanford Univ, Freeman Spogli Inst Int Studies, Stanford, CA 94305 USA	Stanford University; National Bureau of Economic Research; University of California System; University of California Davis; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Stanford University	Miller, G (corresponding author), Stanford Med Sch, Stanford, CA USA.	ngmiller@stanford.edu	ZHANG, LIN/GYD-9123-2022	Yi, Hongmei/0000-0002-6934-0498; Miller, Grant/0000-0003-3191-2558	Stanford University; Massachusetts Institute of Technology; Chinese Academy of Sciences [Science 100, KSCX2-YW-N-039]; Ford Foundation; International Development Research Centre; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K01HD053504] Funding Source: NIH RePORTER	Stanford University(Stanford University); Massachusetts Institute of Technology; Chinese Academy of Sciences(Chinese Academy of Sciences); Ford Foundation; International Development Research Centre; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We acknowledge funding from the following groups: Stanford University's Presidential Fund for Interdisciplinary International Studies; Massachusetts Institute of Technology; the Chinese Academy of Sciences (Science 100 and KSCX2-YW-N-039); and Social Protection in Asia's (SPA) policy research and network building programme, which is funded by the Ford Foundation and the International Development Research Centre and is managed by the Institute for Human Development, New Delhi, India, and the Institute of Development Studies, Brighton, UK. The funding sources did not have a role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.	Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Brown PH, 2009, CHINA QUART, P304, DOI 10.1017/S0305741009000320; Brown PH, 2009, HEALTH ECON, V18, pS47, DOI 10.1002/hec.1508; *DEP RUR HLTH MAN, 2009, NEW RUR COOP MED SCH; HSIAO WC, 1984, NEW ENGL J MED, V310, P932, DOI 10.1056/NEJM198404053101428; Hsiao WC, 2001, J HEALTH POLIT POLIC, V26, P733, DOI 10.1215/03616878-26-4-733; HSIAO WCL, 1995, SOC SCI MED, V41, P1047, DOI 10.1016/0277-9536(94)00421-O; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; LINDELOWM M, 2005, CHINAS HLTH SECTOR W; Liu X., 2004, HLTH SECTOR CHINA PO; Liu YL, 2004, HEALTH POLICY PLANN, V19, P159, DOI 10.1093/heapol/czh019; Liu YL, 2003, J HEALTH POPUL NUTR, V21, P216; Rozelle S, 1996, CHINA J, V35, P63, DOI 10.2307/2950276; Wagstaff A, 2009, DIR DEV, P1, DOI 10.1596/978-0-8213-7982-0; Wagstaff A, 2005, CAN INSURANCE INCREA; Wagstaff A, 2009, J HEALTH ECON, V28, P1, DOI 10.1016/j.jhealeco.2008.10.007; WHO (World Health Organization), 2004, IMPL NEW COOP MED SC; *WORLD BANK, 2005, PUBL EXP ROL GOV FIN; *WORLD BANK, 1997, FINANCING HLTH CARE; *WORLD BANK, 2005, INS RUR CHIN RIS CHA; Yip W, 2004, SOC SCI MED, V58, P267, DOI 10.1016/S0277-9536(03)00010-8; Yip W, 2008, IMPACT RURAL MUTUAL; Yip WC, 1998, HEALTH POLICY PLANN, V13, P311, DOI 10.1093/heapol/13.3.311; Yip WC, 1997, HEALTH AFFAIR, V16, P244, DOI 10.1377/hlthaff.16.6.244; Yip W, 2008, HEALTH AFFAIR, V27, P460, DOI 10.1377/hlthaff.27.2.460; Zhou ZL, 2009, HEALTH ECON, V18, pS129, DOI 10.1002/hec.1519	26	92	92	1	73	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2010	341								c5617	10.1136/bmj.c5617	http://dx.doi.org/10.1136/bmj.c5617			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	671ZQ	20966008	Green Published, hybrid			2022-12-28	WOS:000283553200002
J	Patel, K				Patel, Kinesh			Starting Out Why patients should complain	BRITISH MEDICAL JOURNAL			English	Editorial Material												kinesh_patel@yahoo.co.uk							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2010	341								c5836	10.1136/bmj.c5836	http://dx.doi.org/10.1136/bmj.c5836			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	671ZL	20961980				2022-12-28	WOS:000283552700012
J	Gaiduk, A; Yorulmaz, M; Ruijgrok, PV; Orrit, M				Gaiduk, A.; Yorulmaz, M.; Ruijgrok, P. V.; Orrit, M.			Room-Temperature Detection of a Single Molecule's Absorption by Photothermal Contrast	SCIENCE			English	Article							FLUORESCENCE; SPECTROSCOPY; LIMITS	So far, single-molecule imaging has predominantly relied on fluorescence detection. We imaged single nonfluorescent azo dye molecules in room-temperature glycerol by the refractive effect of the heat that they release in their environment upon intense illumination. This photothermal technique provides contrast for the absorbing objects only, irrespective of scattering by defects or roughness, with a signal-to-noise ratio of similar to 10 for a single molecule in an integration time of 300 milliseconds. In the absence of oxygen, virtually no bleaching event was observed, even after more than 10 minutes of illumination. In a solution saturated with oxygen, the average bleaching time was of the order of 1 minute. No blinking was observed in the absorption signal. On the basis of bleaching steps, we obtained an average absorption cross section of 4 angstroms(2) for a single chromophore.	[Gaiduk, A.; Yorulmaz, M.; Ruijgrok, P. V.; Orrit, M.] Leiden Univ, Inst Phys, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Orrit, M (corresponding author), Leiden Univ, Inst Phys, POB 9504, NL-2300 RA Leiden, Netherlands.	orrit@molphys.leidenuniv.nl	ORRIT, Michel/ABC-1795-2020; ORRIT, Michel/I-2426-2013; Ruijgrok, Paul/H-2358-2011; Gaiduk, Alexander/C-2556-2011	ORRIT, Michel/0000-0002-3607-3426; Ruijgrok, Paul/0000-0002-9599-9392; Yorulmaz, Mustafa/0000-0002-2015-9890	European Research Council; Netherlands Organization for Scientific Research	European Research Council(European Research Council (ERC)European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We acknowledge financial support by European Research Council (Advanced Grant SiMoSoMa). This work is a part of the research program of the Stichting voor Fundamenteel Onderzoek der Materie, which is financially supported by the Netherlands Organization for Scientific Research. We thank H. van der Meer for precious help with the experimental setup.	Arbouet A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.127401; Berciaud S, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.045424; Berciaud S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.257402; Bohren C. F., 1998, ABSORPTION SCATTERIN; Boyer D, 2002, SCIENCE, V297, P1160, DOI 10.1126/science.1073765; Butter JYP, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2360268; DIDENKO VV, 2006, METHODS MOL BIOL FLU; Gaiduk A, 2010, CHEM SCI, V1, P343, DOI 10.1039/c0sc00210k; Gerhardt I, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.033601; Hwang J, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.021802; Ignatovich FV, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.013901; Kador L, 1999, J CHEM PHYS, V111, P8755, DOI 10.1063/1.480222; Keller RA, 1996, APPL SPECTROSC, V50, pA12, DOI 10.1366/0003702963905600; Kukura P, 2009, NANO LETT, V9, P926, DOI 10.1021/nl801735y; Lu SJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3308485; Marras SAE, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf121; Min W, 2009, NATURE, V461, P1105, DOI 10.1038/nature08438; MOERNER WE, 1989, PHYS REV LETT, V62, P2535, DOI 10.1103/PhysRevLett.62.2535; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; ORRIT M, 1990, PHYS REV LETT, V65, P2716, DOI 10.1103/PhysRevLett.65.2716; Stahl SW, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3157466; Tokeshi M, 2001, ANAL CHEM, V73, P2112, DOI 10.1021/ac001479g; van Dijk MA, 2006, PHYS CHEM CHEM PHYS, V8, P3486, DOI 10.1039/b606090k; Wrigge G, 2008, OPT EXPRESS, V16, P17358, DOI 10.1364/OE.16.017358	24	310	319	10	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					353	356		10.1126/science.1195475	http://dx.doi.org/10.1126/science.1195475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947760				2022-12-28	WOS:000282986700036
J	Rimer, JD; An, ZH; Zhu, ZN; Lee, MH; Goldfarb, DS; Wesson, JA; Ward, MD				Rimer, Jeffrey D.; An, Zhihua; Zhu, Zina; Lee, Michael H.; Goldfarb, David S.; Wesson, Jeffrey A.; Ward, Michael D.			Crystal Growth Inhibitors for the Prevention of L-Cystine Kidney Stones Through Molecular Design	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPY; CALCIUM-OXALATE MONOHYDRATE; HEXAGONAL L-CYSTINE; MALARIA PIGMENT; CRYSTALLIZATION; NUCLEATION; ADDITIVES; BINDING; MODEL; DIMETHYLESTER	Crystallization of L-cystine is a critical step in the pathogenesis of cystine kidney stones. Treatments for this disease are somewhat effective but often lead to adverse side effects. Real-time in situ atomic force microscopy (AFM) reveals that L-cystine dimethylester (L-CDME) and L-cystine methylester (L-CME) dramatically reduce the growth velocity of the six symmetry-equivalent {100} steps because of specific binding at the crystal surface, which frustrates the attachment of L-cystine molecules. L-CDME and L-CME produce L-cystine crystals with different habits that reveal distinct binding modes at the crystal surfaces. The AFM observations are mirrored by reduced crystal yield and crystal size in the presence of L-CDME and L-CME, collectively suggesting a new pathway to the prevention of L-cystine stones by rational design of crystal growth inhibitors.	[Rimer, Jeffrey D.; An, Zhihua; Zhu, Zina; Lee, Michael H.; Ward, Michael D.] NYU, Dept Chem, New York, NY 10003 USA; [Rimer, Jeffrey D.; An, Zhihua; Zhu, Zina; Lee, Michael H.; Ward, Michael D.] NYU, Inst Mol Design, New York, NY 10003 USA; [Goldfarb, David S.] New York Harbor Vet Affairs Med Ctr, Nephrol Sect, New York, NY 10010 USA; [Goldfarb, David S.] NYU, Sch Med, New York, NY 10010 USA; [Wesson, Jeffrey A.] Dept Vet Affairs Med Ctr, Div Nephrol, Milwaukee, WI 53295 USA; [Wesson, Jeffrey A.] Med Coll Wisconsin, Milwaukee, WI 53295 USA	New York University; New York University; New York University; Medical College of Wisconsin	Ward, MD (corresponding author), NYU, Dept Chem, 100 Washington Sq E, New York, NY 10003 USA.	mdw3@nyu.edu	Wesson, Jeffrey/ABA-8942-2021; An, Zhihua/A-6662-2009	Lee, Michael/0000-0002-5739-8369; Goldfarb, David/0000-0002-9215-1273	NIH [NIDDK R01-DK068551]; NYU Molecular Design Institute; Office of Rare Disease Research [1U54DK083908-01]; NSF/U.S. Department of Energy (DOE) (NSF/DOE) [CHE-0535644]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK083908, R01DK068551] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [0822838] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYU Molecular Design Institute; Office of Rare Disease Research; NSF/U.S. Department of Energy (DOE) (NSF/DOE)(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported primarily by NIH (NIDDK R01-DK068551) and the NYU Molecular Design Institute. The authors also acknowledge support from the Office of Rare Disease Research (1U54DK083908-01) and the Advanced Photon Source, ChemMatCARS Sector 15, which is principally supported by NSF/U.S. Department of Energy (DOE) (NSF/DOE; CHE-0535644). The authors thank C. Hu, M. Li, Y.-S. Chen, and G. Kowach for technical assistance and B. Kahr for helpful discussions.	Ahmed K, 2006, POSTGRAD MED J, V82, P799, DOI 10.1136/pgmj.2005.044156; Becker G, 2007, NEPHROLOGY, V12, pS4, DOI 10.1111/j.1440-1797.2006.00722.x; Buller R, 2002, CRYST GROWTH DES, V2, P553, DOI 10.1021/cg025550i; Carta R, 1996, J CHEM ENG DATA, V41, P414, DOI 10.1021/je9501853; CHANEY MO, 1974, ACTA CRYSTALLOGR B, V30, P711, DOI 10.1107/S0567740874003566; Clydesdale G, 2003, J PHYS CHEM B, V107, P4826, DOI 10.1021/jp022423o; Dahaoui S, 1999, J PHYS CHEM A, V103, P6240, DOI 10.1021/jp990641k; DAVEY RJ, 1992, J CHEM SOC FARADAY T, V88, P3461, DOI 10.1039/ft9928803461; Dolin DJ, 2005, J ENDOUROL, V19, P429, DOI 10.1089/end.2005.19.429; FOREMAN JW, 1987, METABOLISM, V36, P1185, DOI 10.1016/0026-0495(87)90246-0; Fujiki Y, 2006, ANGEW CHEM INT EDIT, V45, P4764, DOI 10.1002/anie.200601470; GIRIJA EK, 1995, J MATER SCI-MATER M, V6, P617, DOI 10.1007/BF00123439; Grohe B, 2007, J AM CHEM SOC, V129, P14946, DOI 10.1021/ja0745613; Guo SW, 2002, LANGMUIR, V18, P4284, DOI 10.1021/la011754+; HILLIER AC, 1994, SCIENCE, V263, P1261, DOI 10.1126/science.263.5151.1261; Jung T, 2004, LANGMUIR, V20, P8587, DOI 10.1021/la0488755; Kessler A, 2008, NEUROCHEM RES, V33, P737, DOI 10.1007/s11064-007-9486-7; LEVITT LS, 1975, INDIAN J PHYS, V49, P696; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Mattoo A, 2008, SEMIN NEPHROL, V28, P181, DOI 10.1016/j.semnephrol.2008.01.011; MICHAELS AS, 1961, J PHYS CHEM-US, V65, P1730, DOI 10.1021/j100827a014; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; Nakagawa Y, 2000, J UROLOGY, V164, P1481, DOI 10.1016/S0022-5347(05)67011-5; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; OUGHTON BM, 1959, ACTA CRYSTALLOGR, V12, P396, DOI 10.1107/S0365110X59001177; Sheng XX, 2005, P NATL ACAD SCI USA, V102, P267, DOI 10.1073/pnas.0406835101; Sizemore JP, 2009, CRYST GROWTH DES, V9, P2637, DOI 10.1021/cg8011124; Solomonov I, 2007, J AM CHEM SOC, V129, P2615, DOI 10.1021/ja0674183; Stephenson AE, 2008, SCIENCE, V322, P724, DOI 10.1126/science.1159417; Tiller W. A., 1991, SCI CRYSTALLIZATION; Ward MD, 2001, CHEM REV, V101, P1697, DOI 10.1021/cr000020j; WEISSBUCH I, 1991, SCIENCE, V253, P637, DOI 10.1126/science.253.5020.637; Weissbuch I, 2003, CRYST GROWTH DES, V3, P125, DOI 10.1021/cg0200560; Wilmer MJ, 2007, PEDIATR RES, V62, P151, DOI 10.1203/PDR.0b013e31809fd9a7	34	155	159	4	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					337	341		10.1126/science.1191968	http://dx.doi.org/10.1126/science.1191968			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947757	Green Accepted			2022-12-28	WOS:000282986700032
J	Alushin, GM; Ramey, VH; Pasqualato, S; Ball, DA; Grigorieff, N; Musacchio, A; Nogales, E				Alushin, Gregory M.; Ramey, Vincent H.; Pasqualato, Sebastiano; Ball, David A.; Grigorieff, Nikolaus; Musacchio, Andrea; Nogales, Eva			The Ndc80 kinetochore complex forms oligomeric arrays along microtubules	NATURE			English	Article							CHROMOSOME BI-ORIENTATION; ELECTRON-MICROSCOPY; ATTACHMENT SITE; MOLECULAR ARCHITECTURE; OUTER KINETOCHORE; STRUCTURAL BASIS; SPINDLE POLE; RESOLUTION; HEC1; VISUALIZATION	The Ndc80 complex is a key site of regulated kinetochore-microtubule attachment (a process required for cell division), but the molecular mechanism underlying its function remains unknown. Here we present a subnanometre-resolution cryo-electron microscopy reconstruction of the human Ndc80 complex bound to microtubules, sufficient for precise docking of crystal structures of the component proteins. We find that the Ndc80 complex binds the microtubule with a tubulin monomer repeat, recognizing alpha- and beta-tubulin at both intra-and inter-tubulin dimer interfaces in a manner that is sensitive to tubulin conformation. Furthermore, Ndc80 complexes self-associate along protofilaments through interactions mediated by the amino-terminal tail of the NDC80 protein, which is the site of phospho-regulation by Aurora B kinase. The complex's mode of interaction with the microtubule and its oligomerization suggest a mechanism by which Aurora B could regulate the stability of load-bearing kinetochore-microtubule attachments.	[Ball, David A.; Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Alushin, Gregory M.; Ramey, Vincent H.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Pasqualato, Sebastiano; Musacchio, Andrea] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Grigorieff, Nikolaus] Brandeis Univ, Rosenstiel Basic Med Res Ctr, Howard Hughes Med Inst, Waltham, MA 02453 USA; [Musacchio, Andrea] Italian Inst Technol, Res Unit, I-20139 Milan, Italy; [Nogales, Eva] Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; IRCCS European Institute of Oncology (IEO); Brandeis University; Howard Hughes Medical Institute; Istituto Italiano di Tecnologia - IIT; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Nogales, E (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	enogales@lbl.gov	Pasqualato, Sebastiano/G-1032-2011	Alushin, Gregory/0000-0001-7250-4484; Grigorieff, Nikolaus/0000-0002-1506-909X; Musacchio, Andrea/0000-0003-2362-8784; Pasqualato, Sebastiano/0000-0002-9038-7768	National Institute of General Medical Sciences	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to K. H. Downing for supporting the work carried out by D.A.B., to C. Ciferri for his knowledge and advice about the Ndc80 complex and critical reading of the manuscript, and to P. Grob and S. Lipscomb for electron-microscopy and computer support, respectively. We also acknowledge D. Typke and B. Glaeser for advice on data collection, and C. Sindelar for discussion of data processing strategies. This work was funded by a grant from the National Institute of General Medical Sciences (E.N.). E.N. and N.G. are Howard Hughes Medical Institute Investigators.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Amat F, 2008, J STRUCT BIOL, V161, P260, DOI 10.1016/j.jsb.2007.07.007; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; ARNAL I, 1995, CURR BIOL, V5, P900, DOI 10.1016/S0960-9822(95)00180-1; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Chen JZ, 2009, P NATL ACAD SCI USA, V106, P10644, DOI 10.1073/pnas.0904024106; Chen YM, 1997, MOL CELL BIOL, V17, P6049, DOI 10.1128/MCB.17.10.6049; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2003, CURR BIOL, V13, P2103, DOI 10.1016/j.cub.2003.10.056; des Georges A, 2008, NAT STRUCT MOL BIOL, V15, P1102, DOI 10.1038/nsmb.1482; Dong YM, 2007, NAT CELL BIOL, V9, P516, DOI 10.1038/ncb1576; Egelman EH, 2007, J STRUCT BIOL, V157, P83, DOI 10.1016/j.jsb.2006.05.015; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Goddard TD, 2005, STRUCTURE, V13, P473, DOI 10.1016/j.str.2005.01.006; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Hoenger A, 2008, METHOD CELL BIOL, V84, P425, DOI 10.1016/S0091-679X(07)84014-3; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Kemmler S, 2009, EMBO J, V28, P1099, DOI 10.1038/emboj.2009.62; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; LOMBILLO VA, 1995, NATURE, V373, P161, DOI 10.1038/373161a0; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maresca TJ, 2009, J CELL BIOL, V184, P373, DOI 10.1083/jcb.200808130; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mizuno N, 2007, P NATL ACAD SCI USA, V104, P20832, DOI 10.1073/pnas.0710406105; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Ramey VH, 2009, J STRUCT BIOL, V167, P97, DOI 10.1016/j.jsb.2009.05.002; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Stewart A, 2004, ULTRAMICROSCOPY, V102, P67, DOI 10.1016/j.ultramic.2004.08.008; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; WADE RH, 1990, J MOL BIOL, V212, P775, DOI 10.1016/0022-2836(90)90236-F; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Wang HW, 2008, J MOL BIOL, V383, P894, DOI 10.1016/j.jmb.2008.08.077; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2006, STRUCTURE, V14, P1003, DOI 10.1016/j.str.2006.04.007; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; WILSON L, 1982, J MOL BIOL, V159, P125, DOI 10.1016/0022-2836(82)90035-3; Wilson-Kubalek EM, 2008, J CELL BIOL, V182, P1055, DOI 10.1083/jcb.200804170	57	214	215	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					805	U68		10.1038/nature09423	http://dx.doi.org/10.1038/nature09423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944740	Green Accepted, Green Submitted			2022-12-28	WOS:000282898700058
J	Chekeni, FB; Elliott, MR; Sandilos, JK; Walk, SF; Kinchen, JM; Lazarowski, ER; Armstrong, AJ; Penuela, S; Laird, DW; Salvesen, GS; Isakson, BE; Bayliss, DA; Ravichandran, KS				Chekeni, Faraaz B.; Elliott, Michael R.; Sandilos, Joanna K.; Walk, Scott F.; Kinchen, Jason M.; Lazarowski, Eduardo R.; Armstrong, Allison J.; Penuela, Silvia; Laird, Dale W.; Salvesen, Guy S.; Isakson, Brant E.; Bayliss, Douglas A.; Ravichandran, Kodi S.			Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis	NATURE			English	Article							ACTIVATION; CLEAVAGE; ACCUMULATION; FAMILY; CELLS	Apoptotic cells release 'find-me' signals at the earliest stages of death to recruit phagocytes(1). The nucleotides ATP and UTP represent one class of find-me signals(2), but their mechanism of release is not known. Here, we identify the plasma membrane channel pannexin 1 (PANX1) as a mediator of find-me signal/nucleotide release from apoptotic cells. Pharmacological inhibition and siRNA-mediated knockdown of PANX1 led to decreased nucleotide release and monocyte recruitment by apoptotic cells. Conversely, PANX1 overexpression enhanced nucleotide release from apoptotic cells and phagocyte recruitment. Patch-clamp recordings showed that PANX1 was basally inactive, and that induction of PANX1 currents occurred only during apoptosis. Mechanistically, PANX1 itself was a target of effector caspases (caspases 3 and 7), and a specific caspase-cleavage site within PANX1 was essential for PANX1 function during apoptosis. Expression of truncated PANX1 (at the putative caspase cleavage site) resulted in a constitutively open channel. PANX1 was also important for the 'selective' plasma membrane permeability of early apoptotic cells to specific dyes(3). Collectively, these data identify PANX1 as a plasma membrane channel mediating the regulated release of find-me signals and selective plasma membrane permeability during apoptosis, and a new mechanism of PANX1 activation by caspases.	[Chekeni, Faraaz B.; Elliott, Michael R.; Walk, Scott F.; Kinchen, Jason M.; Armstrong, Allison J.; Ravichandran, Kodi S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Chekeni, Faraaz B.; Sandilos, Joanna K.; Bayliss, Douglas A.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Elliott, Michael R.; Walk, Scott F.; Kinchen, Jason M.; Armstrong, Allison J.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Kinchen, Jason M.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Isakson, Brant E.] Univ Virginia, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Isakson, Brant E.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Lazarowski, Eduardo R.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Penuela, Silvia; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada; [Salvesen, Guy S.] Burnham Inst Med Res, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill; Western University (University of Western Ontario); Sanford Burnham Prebys Medical Discovery Institute	Ravichandran, KS (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.	Ravi@virgina.edu	Penuela, Silvia/A-6961-2010; Laird, Dale w/E-4176-2015; Kinchen, Jason/ABC-5663-2021; Laird, Dale W/AAL-2407-2020	Penuela, Silvia/0000-0003-4829-5517; Laird, Dale W/0000-0002-4568-3285; Kinchen, Jason/0000-0001-8430-2265; Ravichandran, Kodi/0000-0001-9049-1410; Elliott, Michael/0000-0002-0642-482X	NIGMS; NHLBI; AHA; National Institutes of Health; American Heart Association; American Cancer Society; American Asthma Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL096400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055432, T32AI007496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033583] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHA(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); American Asthma Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Ravichandran laboratory for their comments and suggestions. We also thank R. E. Campbell for providing the construct for mBlueberry2. This work was supported by the Pharmacological Sciences Training Grant (F. B. C. andJ. K. S.) (NIGMS), a F30 pre-doctoral fellowship from the NHLBI (F. B. C.), a pre-doctoral fellowship from the AHA (J. K. S.), and grants from the National Institutes of Health (K. S. R.). J. M. K. is supported by grants from the American Heart Association (Scientist Development Grant) and the American Cancer Society. K. S. R. is a William Benter Senior Fellow of the American Asthma Foundation.	Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Chen XD, 2009, J NEUROPHYSIOL, V101, P129, DOI 10.1152/jn.01352.2007; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Denault Jean-Bernard, 2008, V414, P191; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; Johnson CE, 2008, CELL, V134, P720, DOI 10.1016/j.cell.2008.08.019; Kadl A, 2009, ARTHRITIS RHEUM-US, V60, P1362, DOI 10.1002/art.24448; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lazarowski ER, 1999, BRIT J PHARMACOL, V127, P1272, DOI 10.1038/sj.bjp.0702654; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Scemes E, 2009, PFLUG ARCH EUR J PHY, V457, P1207, DOI 10.1007/s00424-008-0591-5; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Wee LJK, 2007, BIOINFORMATICS, V23, P3241, DOI 10.1093/bioinformatics/btm334	33	749	769	4	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					863	U136		10.1038/nature09413	http://dx.doi.org/10.1038/nature09413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944749	Green Accepted, Green Submitted			2022-12-28	WOS:000282898700071
J	Gross, DJ				Gross, David J.			The frontier physicist	NATURE			English	Editorial Material									Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Gross, DJ (corresponding author), Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA.								0	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					S8	S8		10.1038/467S8a	http://dx.doi.org/10.1038/467S8a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944623	Bronze			2022-12-28	WOS:000282898700007
J	Ruschak, AM; Religa, TL; Breuer, S; Witt, S; Kay, LE				Ruschak, Amy M.; Religa, Tomasz L.; Breuer, Sarah; Witt, Susanne; Kay, Lewis E.			The proteasome antechamber maintains substrates in an unfolded state	NATURE			English	Article							SIDE-CHAIN DYNAMICS; 20S PROTEASOME; NMR-SPECTROSCOPY; FOLDING PATHWAY; METHYL-GROUPS; BETA-SHEET; WW DOMAIN; RELAXATION; PROTEIN; MECHANISM	Eukaryotes and archaea use a protease called the proteasome that has an integral role in maintaining cellular function through the selective degradation of proteins(1-4). Proteolysis occurs in a barrelshaped 20S core particle, which in Thermoplasma acidophilum is built from four stacked homoheptameric rings of subunits, alpha and beta, arranged alpha(7)beta(7)beta(7)alpha(7) (ref. 5). These rings form three interconnected cavities, including a pair of antechambers (formed by alpha(7)beta(7)) through which substrates are passed before degradation and a catalytic chamber (beta(7)beta(7)) where the peptide-bond hydrolysis reaction occurs(4,5). Although it is clear that substrates must be unfolded to enter through narrow, gated passageways (13 angstrom in diameter) located on the alpha-rings(1,6,7), the structural and dynamical properties of substrates inside the proteasome antechamber remain unclear. Confinement in the antechamber might be expected to promote folding and thus impede proteolysis. Here we investigate the folding, stability and dynamics of three small protein substrates in the antechamber by methyl transverse-relaxation-optimized NMR spectroscopy(8). We show that these substrates interact actively with the antechamber walls and have drastically altered kinetic and equilibrium properties that maintain them in unstructured states so as to be accessible for hydrolysis.	[Ruschak, Amy M.; Religa, Tomasz L.; Kay, Lewis E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Ruschak, Amy M.; Religa, Tomasz L.; Kay, Lewis E.] Univ Toronto, Dept Biochem & Chem, Toronto, ON M5S 1A8, Canada; [Breuer, Sarah; Witt, Susanne] Max Planck Inst Biochem, Dept Biol Struct, D-82152 Martinsried, Germany	University of Toronto; University of Toronto; Max Planck Society	Kay, LE (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	kay@pound.med.utoronto.ca			European Molecular Biology Organization [ALTF 827-2006]; Canadian Institutes of Health Research (CIHR); Canada Research Chair in Biochemistry; Natural Sciences and Engineering Research Council of Canada	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Biochemistry(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors would like to thank J. Forman-Kay for providing laboratory space and for discussions, R. Muhandiram for NMR support, H. Lin for help designing protein purification protocols, X. Li and A. Shimmer for assistance with the plate reader, and W. Baumeister for discussions. T. L. R. acknowledges The European Molecular Biology Organization (ALTF 827-2006) and The Canadian Institutes of Health Research (CIHR) for postdoctoral fellowships. L. E. K. holds a Canada Research Chair in Biochemistry. This work was supported by grants from the CIHR and the Natural Sciences and Engineering Research Council of Canada.	Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Cheng AG, 2009, OLIGONUCLEOTIDES, V19, P203, DOI 10.1089/oli.2008.0176; Choy WY, 2003, J AM CHEM SOC, V125, P1748, DOI 10.1021/ja021179b; Clore GM, 2007, CURR OPIN STRUC BIOL, V17, P603, DOI 10.1016/j.sbi.2007.08.013; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ellis RJ, 2003, CURR BIOL, V13, pR881, DOI 10.1016/j.cub.2003.10.051; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Fitzkee NC, 2004, P NATL ACAD SCI USA, V101, P12497, DOI 10.1073/pnas.0404236101; Forster A, 2003, TRENDS CELL BIOL, V13, P550, DOI 10.1016/j.tcb.2003.09.001; Hutschenreiter S, 2004, EMBO J, V23, P2488, DOI 10.1038/sj.emboj.7600262; Jager M, 2006, P NATL ACAD SCI USA, V103, P10648, DOI 10.1073/pnas.0600511103; Jager M, 2001, J MOL BIOL, V311, P373, DOI 10.1006/jmbi.2001.4873; Jager M, 2008, BIOPOLYMERS, V90, P751, DOI 10.1002/bip.21101; Kisselev AF, 2000, J BIOL CHEM, V275, P14831, DOI 10.1074/jbc.275.20.14831; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Marques AJ, 2009, CHEM REV, V109, P1509, DOI 10.1021/cr8004857; MATSUNAGA N, 1977, J PHYS CHEM-US, V6, P1133; Mayor U, 2003, NATURE, V421, P863, DOI 10.1038/nature01428; Neudecker P, 2006, J MOL BIOL, V363, P958, DOI 10.1016/j.jmb.2006.08.047; Ruschak AM, 2010, J BIOMOL NMR, V46, P75, DOI 10.1007/s10858-009-9376-1; Sharon M, 2006, J BIOL CHEM, V281, P9569, DOI 10.1074/jbc.M511951200; Sprangers R, 2007, NAT METHODS, V4, P697, DOI 10.1038/NMETH1080; Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512; Stollar EJ, 2003, J BIOL CHEM, V278, P43699, DOI 10.1074/jbc.M308029200; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Tugarinov V, 2007, J AM CHEM SOC, V129, P1743, DOI 10.1021/ja067827z; Tugarinov V, 2006, J AM CHEM SOC, V128, P7299, DOI 10.1021/ja060817d; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Zhou HX, 2008, ARCH BIOCHEM BIOPHYS, V469, P76, DOI 10.1016/j.abb.2007.07.013; ZWICKL P, 1994, NAT STRUCT BIOL, V1, P765, DOI 10.1038/nsb1194-765	34	93	93	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					868	U142		10.1038/nature09444	http://dx.doi.org/10.1038/nature09444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944750				2022-12-28	WOS:000282898700072
J	Weinberg, AN; Branda, JA				Weinberg, Arnold N.; Branda, John A.			A Woman with Fever after a Cat Bite Infection with Francisella tularensis (tularemia)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Conference on Medical Case	MAY 01, 2009	MA				DIAGNOSIS; THERAPY		[Weinberg, Arnold N.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Branda, John A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Weinberg, Arnold N.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Branda, John A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Weinberg, AN (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA.		Branda, John/ABD-5620-2020					BEVANGER L, 1994, CLIN DIAGN LAB IMMUN, V1, P238, DOI 10.1128/CDLI.1.2.238-240.1994; CAPELLAN J, 1993, CLIN INFECT DIS, V16, P472, DOI 10.1093/clind/16.4.472; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; ERICSSON M, 1994, J INFECT DIS, V170, P110, DOI 10.1093/infdis/170.1.110; Feldman KA, 2003, J AM VET MED ASSOC, V222, P725, DOI 10.2460/javma.2003.222.725; Goldstein EJC, 1999, CURR CLIN TOPICS INF, V19, P99; Kotten CN, 2010, MANDELL DOUGLAS BENN, V2, P3999; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; LINDQUIST D, 2007, MANUAL CLIN MICROBIO, V1, P815; Nigrovic LE, 2008, INFECT DIS CLIN N AM, V22, P489, DOI 10.1016/j.idc.2008.03.004; Perez-Castrillon JL, 2001, CLIN INFECT DIS, V33, P573, DOI 10.1086/322601; Splettstoesser WD, 2005, J VET MED B, V52, P249, DOI 10.1111/j.1439-0450.2005.00863.x; SYRJALA H, 1986, J INFECT DIS, V153, P142, DOI 10.1093/infdis/153.1.142; Talan DA, 1999, NEW ENGL J MED, V340, P85, DOI 10.1056/NEJM199901143400202; Tarnvik A, 2007, ANN NY ACAD SCI, V1105, P378, DOI 10.1196/annals.1409.017; Westling K, 2006, J INFECTION, V53, P403, DOI 10.1016/j.jinf.2006.01.001; ZURLO JJ, 2010, MANDELL DOUGLAS BENN, V2, P2939	17	7	7	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2010	363	16					1560	1568		10.1056/NEJMcpc1007103	http://dx.doi.org/10.1056/NEJMcpc1007103			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	663KP	20942673				2022-12-28	WOS:000282887100012
J	Bobrow, BJ; Spaite, DW; Berg, RA; Stolz, U; Sanders, AB; Kern, KB; Vadeboncoeur, TF; Clark, LL; Gallagher, JV; Stapczynski, JS; LoVecchio, F; Mullins, TJ; Humble, WO; Ewy, GA				Bobrow, Bentley J.; Spaite, Daniel W.; Berg, Robert A.; Stolz, Uwe; Sanders, Arthur B.; Kern, Karl B.; Vadeboncoeur, Tyler F.; Clark, Lani L.; Gallagher, John V.; Stapczynski, J. Stephan; LoVecchio, Frank; Mullins, Terry J.; Humble, Will O.; Ewy, Gordon A.			Chest Compression-Only CPR by Lay Rescuers and Survival From Out-of-Hospital Cardiac Arrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BYSTANDER CARDIOPULMONARY-RESUSCITATION; AMERICAN-HEART-ASSOCIATION; HEALTH-CARE PROFESSIONALS; BASIC LIFE-SUPPORT; VENTRICULAR-FIBRILLATION; STROKE-FOUNDATION; TASK-FORCE; STATEMENT; VENTILATION; COMMITTEE	Context Chest compression-only bystander cardiopulmonary resuscitation (CPR) may be as effective as conventional CPR with rescue breathing for out-of-hospital cardiac arrest. Objective To investigate the survival of patients with out-of-hospital cardiac arrest using compression-only CPR (COCPR) compared with conventional CPR. Design, Setting, and Patients A 5-year prospective observational cohort study of survival in patients at least 18 years old with out-of-hospital cardiac arrest between January 1, 2005, and December 31, 2009, in Arizona. The relationship between layperson bystander CPR and survival to hospital discharge was evaluated using multivariable logistic regression. Main Outcome Measure Survival to hospital discharge. Results Among 5272 adults with out-of-hospital cardiac arrest of cardiac etiology not observed by responding emergency medical personnel, 779 were excluded because bystander CPR was provided by a health care professional or the arrest occurred in a medical facility. A total of 4415 met all inclusion criteria for analysis, including 2900 who received no bystander CPR, 666 who received conventional CPR, and 849 who received COCPR. Rates of survival to hospital discharge were 5.2% (95% confidence interval [CI], 4.4%-6.0%) for the no bystander CPR group, 7.8% (95% CI, 5.8%-9.8%) for conventional CPR, and 13.3% (95% CI, 11.0%-15.6%) for COCPR. The adjusted odds ratio (AOR) for survival for conventional CPR vs no CPR was 0.99 (95% CI, 0.69-1.43), for COCPR vs no CPR, 1.59 (95% CI, 1.18-2.13), and for COCPR vs conventional CPR, 1.60 (95% CI, 1.08-2.35). From 2005 to 2009, lay rescuer CPR increased from 28.2% (95% CI, 24.6%-31.8%) to 39.9% (95% CI, 36.8%-42.9%; P<.001); the proportion of CPR that was COCPR increased from 19.6% (95% CI, 13.6%-25.7%) to 75.9% (95% CI, 71.7%-80.1%; P<.001). Overall survival increased from 3.7% (95% CI, 2.2%-5.2%) to 9.8% (95% CI, 8.0%-11.6%; P<.001). Conclusion Among patients with out-of-hospital cardiac arrest, layperson compression-only CPR was associated with increased survival compared with conventional CPR and no bystander CPR in this setting with public endorsement of chest compression-only CPR. JAMA. 2010; 304(13): 1447-1454	[Bobrow, Bentley J.; Mullins, Terry J.; Humble, Will O.] Arizona Dept Hlth Serv, 150 N 18th Ave,Ste 540, Phoenix, AZ 85007 USA; [Bobrow, Bentley J.; Spaite, Daniel W.; Stolz, Uwe] Univ Arizona, Dept Emergency Med, Arizona Emergency Med Res Ctr, Tucson, AZ USA; [Bobrow, Bentley J.; Sanders, Arthur B.; Kern, Karl B.; Clark, Lani L.; Ewy, Gordon A.] Univ Arizona, Sarver Heart Ctr, Tucson, AZ USA; [Berg, Robert A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Vadeboncoeur, Tyler F.] Mayo Clin, Jacksonville, FL 32224 USA; [Gallagher, John V.] Phoenix Fire Dept, Phoenix, AZ USA; [Bobrow, Bentley J.; Stapczynski, J. Stephan; LoVecchio, Frank] Maricopa Cty Gen Hosp, Dept Emergency Med, Phoenix, AZ USA	Arizona Department of Health Services; University of Arizona; University of Arizona; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Mayo Clinic; Maricopa County General Hospital	Bobrow, BJ (corresponding author), Arizona Dept Hlth Serv, 150 N 18th Ave,Ste 540, Phoenix, AZ 85007 USA.	bobrowb@azdhs.gov		Spaite, Daniel/0000-0003-2601-6476	Medtronic Foundation; American Heart Association	Medtronic Foundation; American Heart Association(American Heart Association)	Drs Bobrow, Ewy, and Spaite reported that the University of Arizona has received support from the Medtronic Foundation involving community-based translation of resuscitation science. Dr Bobrow reported being a member of the American Heart Association Basic Life Support Committee and in the past having received a grant from the American Heart Association to study ultrabrief CPR video training. No other disclosures were reported.	[Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Assar D, 2000, RESUSCITATION, V45, P7, DOI 10.1016/S0300-9572(00)00152-0; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Becker LB, 1997, CIRCULATION, V96, P2102, DOI 10.1161/01.CIR.96.6.2102; BERG RA, 1993, CIRCULATION, V88, P1907, DOI 10.1161/01.CIR.88.4.1907; Berg RA, 1997, CIRCULATION, V96, P4364; Berg RA, 2001, CIRCULATION, V104, P2465, DOI 10.1161/hc4501.098926; Bobrow BJ, 2008, PREHOSP EMERG CARE, V12, P381, DOI 10.1080/10903120802100670; Bobrow BJ, 2008, JAMA-J AM MED ASSOC, V299, P1158, DOI 10.1001/jama.299.10.1158; Bobrow BJ, 2009, ANN EMERG MED, V54, P656, DOI 10.1016/j.annemergmed.2009.06.011; Bobrow BJ, 2009, ANN EMERG MED, V54, pe1; Coons SJ, 2009, RESUSCITATION, V80, P334, DOI 10.1016/j.resuscitation.2008.11.024; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; GALLAGHER EJ, 1995, JAMA-J AM MED ASSOC, V274, P1922, DOI 10.1001/jama.274.24.1922; Hallstrom A, 2000, NEW ENGL J MED, V342, P1546, DOI 10.1056/NEJM200005253422101; Heidenreich JW, 2004, RESUSCITATION, V62, P283, DOI 10.1016/j.resuscitation.2004.05.013; Iwami T, 2007, CIRCULATION, V116, P2900, DOI 10.1161/CIRCULATIONAHA.107.723411; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Kellum MJ, 2008, ANN EMERG MED, V52, P244, DOI 10.1016/j.annemergmed.2008.02.006; Kern KB, 1998, RESUSCITATION, V39, P179, DOI 10.1016/S0300-9572(98)00141-5; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; LOCKE CJ, 1995, ARCH INTERN MED, V155, P938, DOI 10.1001/archinte.155.9.938; Nagao K, 2007, LANCET, V369, P920; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Rea TD, 2010, NEW ENGL J MED, V363, P423, DOI 10.1056/NEJMoa0908993; SANDERS AB, 1985, J AM COLL CARDIOL, V6, P113, DOI 10.1016/S0735-1097(85)80261-8; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Sayre MR, 2008, CIRCULATION, V117, P2162, DOI 10.1161/CIRCULATIONAHA.107.189380; Stiell IG, 1999, ANN EMERG MED, V33, P44, DOI 10.1016/S0196-0644(99)70415-4; Svensson L, 2010, NEW ENGL J MED, V363, P434, DOI 10.1056/NEJMoa0908991; *US BUR CENS, AR QUICKFACTS; Vadeboncoeur T, 2007, RESUSCITATION, V75, P68, DOI 10.1016/j.resuscitation.2007.02.015; Vaillancourt C, 2008, CAN J EMERG MED, V10, P51, DOI 10.1017/S1481803500010010; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; Wik L, 2003, JAMA-J AM MED ASSOC, V289, P1389, DOI 10.1001/jama.289.11.1389; Willerson JT, 2000, CIRCULATION, V102, P1	37	327	349	1	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2010	304	13					1447	1454		10.1001/jama.2010.1392	http://dx.doi.org/10.1001/jama.2010.1392			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658SO	20924010				2022-12-28	WOS:000282509900020
J	Thuerey, J; Urquhart, DS; Wilkinson, G				Thuerey, J.; Urquhart, D. S.; Wilkinson, G.			Picture Quiz A baby with noisy breathing	BRITISH MEDICAL JOURNAL			English	Editorial Material							TRACHEOESOPHAGEAL FISTULA; ESOPHAGEAL ATRESIA; EPIDEMIOLOGY; MANAGEMENT; DIAGNOSIS; REPAIR		[Thuerey, J.; Urquhart, D. S.; Wilkinson, G.] Royal Hosp Sick Children, Edinburgh EH 9 1LF, Midlothian, Scotland		Thuerey, J (corresponding author), Royal Hosp Sick Children, Edinburgh EH 9 1LF, Midlothian, Scotland.	jana.thuerey@gmail.com						Bruch SW, 2010, J PEDIATR SURG, V45, P337, DOI 10.1016/j.jpedsurg.2009.10.070; CHETCUTI P, 1993, ARCH DIS CHILD, V68, P167, DOI 10.1136/adc.68.2.167; DEPAEPE A, 1993, ARCH DIS CHILD, V68, P743, DOI 10.1136/adc.68.6.743; Gross R.E, 1953, SURG INFANCY CHILDHO; Konkin DE, 2003, J PEDIATR SURG, V38, P1726, DOI 10.1016/j.jpedsurg.2003.08.039; Little DC, 2003, J PEDIATR SURG, V38, P852, DOI 10.1016/S0022-3468(03)00110-6; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Ng J, 2006, ACTA RADIOL, V47, P801, DOI 10.1080/02841850600854902; Patkowski D, 2009, J LAPAROENDOSC ADV S, V19, pS19, DOI 10.1089/lap.2008.0139; Shaw-Smith C, 2006, J MED GENET, V43, P545, DOI 10.1136/jmg.2005.038158; Spitz Lewis, 1993, Current Opinion in Pediatrics, V5, P347; STRINGER MD, 1995, J PEDIATR SURG, V30, P1258, DOI 10.1016/0022-3468(95)90480-8	12	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 6	2010	341								c4402	10.1136/bmj.c4402	http://dx.doi.org/10.1136/bmj.c4402			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663JE	20926489				2022-12-28	WOS:000282879400018
J	Bartholomay, LC; Waterhouse, RM; Mayhew, GF; Campbell, CL; Michel, K; Zou, Z; Ramirez, JL; Das, S; Alvarez, K; Arensburger, P; Bryant, B; Chapman, SB; Dong, YM; Erickson, SM; Karunaratne, SHPP; Kokoza, V; Kodira, CD; Pignatelli, P; Shin, SW; Vanlandingham, DL; Atkinson, PW; Birren, B; Christophides, GK; Clem, RJ; Hemingway, J; Higgs, S; Megy, K; Ranson, H; Zdobnov, EM; Raikhel, AS; Christensen, BM; Dimopoulos, G; Muskavitch, MAT				Bartholomay, Lyric C.; Waterhouse, Robert M.; Mayhew, George F.; Campbell, Corey L.; Michel, Kristin; Zou, Zhen; Ramirez, Jose L.; Das, Suchismita; Alvarez, Kanwal; Arensburger, Peter; Bryant, Bart; Chapman, Sinead B.; Dong, Yuemei; Erickson, Sara M.; Karunaratne, S. H. P. Parakrama; Kokoza, Vladimir; Kodira, Chinnappa D.; Pignatelli, Patricia; Shin, Sang Woon; Vanlandingham, Dana L.; Atkinson, Peter W.; Birren, Bruce; Christophides, George K.; Clem, Rollie J.; Hemingway, Janet; Higgs, Stephen; Megy, Karine; Ranson, Hilary; Zdobnov, Evgeny M.; Raikhel, Alexander S.; Christensen, Bruce M.; Dimopoulos, George; Muskavitch, Marc A. T.			Pathogenomics of Culex quinquefasciatus and Meta-Analysis of Infection Responses to Diverse Pathogens	SCIENCE			English	Article							MOSQUITO AEDES-AEGYPTI; INNATE IMMUNE-RESPONSE; ANOPHELES-GAMBIAE; DIPTERA-CULICIDAE; RNA INTERFERENCE; VECTOR MOSQUITOS; VIRUS-INFECTION; HEMOCYTES; DEFENSE; PATHWAY	The mosquito Culex quinquefasciatus poses a substantial threat to human and veterinary health as a primary vector of West Nile virus (WNV), the filarial worm Wuchereria bancrofti, and an avian malaria parasite. Comparative phylogenomics revealed an expanded canonical C. quinquefasciatus immune gene repertoire compared with those of Aedes aegypti and Anopheles gambiae. Transcriptomic analysis of C. quinquefasciatus genes responsive to WNV, W. bancrofti, and non-native bacteria facilitated an unprecedented meta-analysis of 25 vector-pathogen interactions involving arboviruses, filarial worms, bacteria, and malaria parasites, revealing common and distinct responses to these pathogen types in three mosquito genera. Our findings provide support for the hypothesis that mosquito-borne pathogens have evolved to evade innate immune responses in three vector mosquito species of major medical importance.	[Chapman, Sinead B.; Birren, Bruce; Muskavitch, Marc A. T.] Broad Inst, Cambridge, MA 02142 USA; [Bartholomay, Lyric C.] Iowa State Univ, Dept Entomol, Ames, IA 50011 USA; [Waterhouse, Robert M.; Zdobnov, Evgeny M.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Waterhouse, Robert M.; Zdobnov, Evgeny M.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Mayhew, George F.; Erickson, Sara M.; Christensen, Bruce M.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Campbell, Corey L.] Colorado State Univ, Microbiol Immunol & Pathol Dept, Ft Collins, CO 80523 USA; [Michel, Kristin; Bryant, Bart; Clem, Rollie J.] Kansas State Univ, Arthropod Genom Ctr, Div Biol, Mol & Cellular Dev Biol Program, Manhattan, KS 66506 USA; [Zou, Zhen; Alvarez, Kanwal; Bryant, Bart; Kokoza, Vladimir; Shin, Sang Woon; Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Ramirez, Jose L.; Das, Suchismita; Dong, Yuemei; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Malaria Res Inst, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Arensburger, Peter; Atkinson, Peter W.] Univ Calif Riverside, Ctr Dis Vector Res, Dept Entomol, Riverside, CA 92521 USA; [Chapman, Sinead B.] Broad Inst, Cambridge, MA 02142 USA; [Karunaratne, S. H. P. Parakrama; Pignatelli, Patricia; Hemingway, Janet; Ranson, Hilary] Univ Liverpool Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Karunaratne, S. H. P. Parakrama] Univ Peradeniya, Fac Sci, Peradeniya 20400, LK, Sri Lanka; [Karunaratne, S. H. P. Parakrama] Univ Peradeniya, Dept Zool, Peradeniya 20400, LK, Sri Lanka; [Kodira, Chinnappa D.] 454 Life Sci, Branford, CT 06405 USA; [Vanlandingham, Dana L.; Higgs, Stephen] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Waterhouse, Robert M.; Christophides, George K.; Zdobnov, Evgeny M.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Div Cell & Mol Biol, London SW7 2AZ, England; [Megy, Karine] European Bioinformat Inst EMBL, Cambridge CB10 1SD, England; [Muskavitch, Marc A. T.] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA; [Muskavitch, Marc A. T.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Iowa State University; University of Geneva; Swiss Institute of Bioinformatics; University of Wisconsin System; University of Wisconsin Madison; Colorado State University; Kansas State University; University of California System; University of California Riverside; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Riverside; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Liverpool School of Tropical Medicine; University of Peradeniya; University of Peradeniya; University of Texas System; University of Texas Medical Branch Galveston; Imperial College London; European Molecular Biology Laboratory (EMBL); Boston College; Harvard University; Harvard T.H. Chan School of Public Health	Muskavitch, MAT (corresponding author), Broad Inst, Cambridge, MA 02142 USA.	marc.muskavitch@bc.edu	Waterhouse, Robert M/A-1858-2010; Zdobnov, Evgeny/AAB-2745-2022; Mayhew, George F/B-4042-2016; Zdobnov, Evgeny M/K-1133-2012; zou, zhen/C-6134-2016; Alvarez, Kanwal/AAQ-6451-2020; Michel, Kristin/F-3400-2011	Waterhouse, Robert M/0000-0003-4199-9052; Zdobnov, Evgeny/0000-0002-5178-1498; Mayhew, George F/0000-0003-0609-6018; zou, zhen/0000-0003-3550-7656; Ranson, Hilary/0000-0003-2332-8247; Megy, Karyn/0000-0002-2826-3879; Christophides, George/0000-0002-3323-1687; Ramirez, Jose Luis/0000-0001-9607-1097; Dimopoulos, George/0000-0001-6755-8111; Shin, Sang Woon/0000-0001-9467-0803; Dong, Yuemei/0000-0002-7902-2899; Hemingway, Janet/0000-0002-3200-7173; Clem, Rollie/0000-0002-2368-720X	Iowa Agriculture and Home Economics Experiment Station, Ames, IA, USA; Foundation for the National Institutes of Health, Grand Challenges in Global Health Initiative; NIH [P20 RR017686, R21 AI067642, R01 AI59492, R01 AI19769, R01 AI67698, R01 AI061576, R01 AI059492, R01 AI078997, F31 AI080161-01A1, T32 A107536]; CDC [T01CCT622892]; NIAID/NIH/DHHS [HHSN266200400039C, HHSN266200400001C]; Swiss National Science Foundation [3100A0]; Johns Hopkins Malaria Research Institute Core Facilities at the Johns Hopkins Malaria Research Institute; Giorgi-Cavlieri Foundation; Wellcome Trust; American Society for Microbiology; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095842, R01AI059492, R01AI067698, F31AI080161, T32AI007414, R01AI019769, R01AI061576, T32AI007417, R21AI067642, R01AI078997] Funding Source: NIH RePORTER	Iowa Agriculture and Home Economics Experiment Station, Ames, IA, USA; Foundation for the National Institutes of Health, Grand Challenges in Global Health Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIAID/NIH/DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Johns Hopkins Malaria Research Institute Core Facilities at the Johns Hopkins Malaria Research Institute; Giorgi-Cavlieri Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); American Society for Microbiology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Iowa Agriculture and Home Economics Experiment Station, Ames, IA, USA, to L. C. B.; funding from the Foundation for the National Institutes of Health, Grand Challenges in Global Health Initiative to C. L. C.; NIH grant P20 RR017686 to K. M.; NIH grant R21 AI067642 to R.J.C.; CDC grant T01CCT622892 to S. H.; NIAID/NIH/DHHS contract number HHSN266200400039C to University of Notre Dame (VectorBase); NIAID/NIH/DHHS contract number HHSN266200400001C to the Broad Institute; Swiss National Science Foundation grant 3100A0 to E.M.Z.; NIH grant R01 AI59492 to A. S. R.; NIH grants R01 AI19769 and R01 AI67698 to B. M. C; NIH grants R01 AI061576, R01 AI059492, and R01 AI078997 and Johns Hopkins Malaria Research Institute Core Facilities at the Johns Hopkins Malaria Research Institute to G. D.; and the DeLuca Professorship from Boston College to M. A. T. M. R. M. W. was supported by the Giorgi-Cavlieri Foundation, Swiss National Science Foundation grant 3100A0 to E.M.Z. and a Wellcome Trust Ph.D. fellowship. J.L.R. was supported by NIH individual NRSA training grant F31 AI080161-01A1 and by the American Society for Microbiology Robert D. Watkins Graduate Research Fellowship. S. H. P. P. K. was supported by a Wellcome Trust Fellowship. D. L. V. was supported by NIH grant T32 A107536. The microarray data reported in this paper have been deposited in the Gene Expression Omnibus (GEO) database (accession #: GSE23045).	Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Bartholomay LC, 2004, INSECT MOL BIOL, V13, P125, DOI 10.1111/j.0962-1075.2004.00467.x; Bartholomay LC, 2003, MOL BIOCHEM PARASIT, V130, P43, DOI 10.1016/S0166-6851(03)00143-9; Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47; Campbell CL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-425; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; Erickson SM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000529; Girard YA, 2005, J MED ENTOMOL, V42, P429, DOI 10.1603/0022-2585(2005)042[0429:USOWNV]2.0.CO;2; Girard YA, 2010, J MED ENTOMOL, V47, P421, DOI 10.1603/ME09249; Hillyer JF, 2004, MICROBES INFECT, V6, P448, DOI 10.1016/j.micinf.2004.01.005; Hillyer JF, 2003, J PARASITOL, V89, P62, DOI 10.1645/0022-3395(2003)089[0062:RPAMOB]2.0.CO;2; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Kriventseva EV, 2008, NUCLEIC ACIDS RES, V36, pD271, DOI 10.1093/nar/gkm845; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; SILVERLY R, 1972, MOSQUITOES INDIANA, P92; Wang H, 2008, J GEN VIROL, V89, P2651, DOI 10.1099/vir.0.2008/005314-0	24	116	121	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					88	90		10.1126/science.1193162	http://dx.doi.org/10.1126/science.1193162			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929811	Green Accepted			2022-12-28	WOS:000282334500041
J	Laughlin, G				Laughlin, Gregory			A Dance of Extrasolar Planets	SCIENCE			English	Editorial Material							TRANSIT; SYSTEM		Univ Calif Santa Cruz, Dept Astron & Astrophys, UCO Lick Observ, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Laughlin, G (corresponding author), Univ Calif Santa Cruz, Dept Astron & Astrophys, UCO Lick Observ, Santa Cruz, CA 95064 USA.	laugh@ucolick.org						Agol E, 2005, MON NOT R ASTRON SOC, V359, P567, DOI 10.1111/j.1365-2966.2005.08922.x; Barbieri M, 2007, ASTRON ASTROPHYS, V476, pL13, DOI 10.1051/0004-6361:20078787; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Charbonneau D., 2006, PROTOSTARS PLANETS 5, P701; Garcia-Melendo E, 2009, ASTROPHYS J, V698, P558, DOI 10.1088/0004-637X/698/1/558; Grant R, 1852, HIST PHYS ASTRONOMY; Holman MJ, 2010, SCIENCE, V330, P51, DOI 10.1126/science.1195778; Holman MJ, 2005, SCIENCE, V307, P1288, DOI 10.1126/science.1107822; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; Mayor M, 2009, ASTRON ASTROPHYS, V493, P639, DOI 10.1051/0004-6361:200810451; Rivera EJ, 2010, ASTROPHYS J, V719, P890, DOI 10.1088/0004-637X/719/1/890	11	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2010	330	6000					47	48		10.1126/science.1196505	http://dx.doi.org/10.1126/science.1196505			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	656KW	20929801				2022-12-28	WOS:000282334500027
